PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Edama, M; Onishi, H; Kumaki, K; Kageyama, I; Watanabe, H; Nashimoto, S				Edama, M.; Onishi, H.; Kumaki, K.; Kageyama, I.; Watanabe, H.; Nashimoto, S.			Effective and selective stretching of the medial head of the gastrocnemius	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Achilles tendon; triceps surae muscle; ultrasonography	MUSCLE-TENDON UNIT; IN-VIVO; HAMSTRING INJURIES; PASSIVE STIFFNESS; ACHILLES-TENDON; SOLEUS MUSCLE; TIME-COURSE; ARCHITECTURE; PERFORMANCE; PREVENTION	Muscle injury frequently occurs in the medial head of the gastrocnemius (MG), and stretching is used for treatment. However, there are no studies based on anatomical considerations and biomechanics. This study therefore examined the macroscopic anatomical structure of the triceps surae muscle to design an effective and selective MG stretching method, before quantitatively verifying that method by ultrasonography. The macroscopic anatomy was analyzed in 16 Japanese cadavers (25 legs). Based on the anatomical findings and the arrangement of fascicles in the MG, we concluded that ankle inversion might be advantageous for selective stretching of the tendon fiber bundles into which the MG inserts. We devised a method in which the limb was initially positioned with the knee joint in extension and the ankle joint in plantar flexion. Then, the ankle was dorsiflexed and inverted. The proposed method was compared with standard stretching and verified by ultrasonography in eight healthy adult males. This method effectively and selectively stretched the MG, producing a significantly decreased pennation angle and increased muscle fiber length. This method may be beneficial for preventing future injuries and may enhance the effect of therapy on the MG.	[Edama, M.; Onishi, H.] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata 9503198, Japan; [Edama, M.; Kageyama, I.] Nippon Dent Univ, Sch Life Dent Niigata, Dept Anat, Niigata, Japan; [Kumaki, K.] Niigata Univ Rehabil, Dept Phys Therapy, Niigata, Japan; [Watanabe, H.; Nashimoto, S.] Niigata Med Ctr, Dept Rehabil, Niigata, Japan	Edama, M (reprint author), Niigata Univ Hlth & Welf, Kita Ku, Shimami Cho 1398, Niigata 9503198, Japan.	edama@nuhw.ac.jp			Japan Society for the Promotion of Science [24800070]	This study was supported by a Research Activity Start-up grant (24800070) from the Japan Society for the Promotion of Science.	Agur AM, 2003, CLIN ANAT, V16, P285, DOI 10.1002/ca.10112; Abellaneda S, 2009, J APPL PHYSIOL, V106, P169, DOI 10.1152/japplphysiol.90577.2008; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Ryan ED, 2010, EUR J APPL PHYSIOL, V108, P207, DOI 10.1007/s00421-009-1284-2; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Kumagai K, 2000, J APPL PHYSIOL, V88, P811; Agata N, 2009, MUSCLE NERVE, V39, P456, DOI 10.1002/mus.21103; Spernoga SG, 2001, J ATHL TRAINING, V36, P44; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Szaro P, 2009, ANN ANAT, V191, P586, DOI 10.1016/j.aanat.2009.07.006; McHugh MP, 2010, SCAND J MED SCI SPOR, V20, P169, DOI 10.1111/j.1600-0838.2009.01058.x; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; Hwang JH, 2006, ARCH PHYS MED REHAB, V87, P20, DOI 10.1016/j.apmr.2005.08.002; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; Ryan ED, 2008, J ORTHOP SPORT PHYS, V38, P632, DOI 10.2519/jospt.2008.2843; Lersch C, 2012, CLIN BIOMECH, V27, P955, DOI 10.1016/j.clinbiomech.2012.07.001; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1013/jphysiol.2001.012756; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398; CUMMINS EJ, 1946, SURG GYNECOL OBSTET, V83, P107; Chow RS, 2000, EUR J APPL PHYSIOL, V82, P236, DOI 10.1007/s004210050677; FUKUNAGA T, 1992, J ORTHOPAED RES, V10, P926, DOI 10.1002/jor.1100100623; Jan E, 1996, AM J SPORTS MED, V24, P2; Kwak HS, 2006, CLIN IMAG, V30, P48, DOI 10.1016/j.clinimag.2005.07.004; Malliaropoulos N, 2004, MED SCI SPORT EXER, V36, P756, DOI 10.1249/01.MSS.0000126393.20025.5E; Mizuno T, 2011, SCAND J MED SCI SPOR, V23, P1; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129; Noonan T J, 1999, J Am Acad Orthop Surg, V7, P262; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Reurink G, 2012, BRIT J SPORT MED, V46, P103, DOI 10.1136/bjsports-2011-090447; van Gils C C, 1996, J Foot Ankle Surg, V35, P41	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	APR	2015	25	2					242	250		10.1111/sms.12203		9	Sport Sciences	Sport Sciences	CE5LB	WOS:000351875200024		
J	Orai, N; Ichii, K; Ishii, S				Orai, Naoki; Ichii, Koji; Ishii, Shiho			A trial of simple and easy health monitoring for power poles by using 'ipod'	SCIENCE CHINA-TECHNOLOGICAL SCIENCES			English	Article						iPod; health monitoring; power pole; natural frequency		At present, the regular inspection of power poles is just a visual inspection based on the inspector's experience. Thus, overlook of the deteriorated poles can come off. In order to avoid an accident due to the overlook of the deteriorated poles, the authors propose a simple and easy health monitoring method for power poles using 'iPod'. Since the applicability of 'iPod' as a vibration sensor in this purpose was not clear, it was examined in the following procedure. First, the authors proposed a tool to fix the 'iPod' to a power pole, and the performance of 'iPod' as a vibration measurement device was compared with a conventional acceleration sensor. As a result, it was confirmed that 'iPod' could give almost the same response with the conventional sensor in terms of the observed predominant frequency. Next, vibration measurements were conducted at power poles in a field. As a result, the observed predominant frequency corresponded to the calculated 2nd natural frequency of power poles. Although some power poles were supported by some additional wires from the ground, the measurements were successful at almost all the sites. Hence, the authors confirmed that the 'iPod' based health monitoring is possible.	[Orai, Naoki; Ichii, Koji; Ishii, Shiho] Hiroshima Univ, Grad Sch Engn, Hiroshima 7398527, Japan	Ichii, K (reprint author), Hiroshima Univ, Grad Sch Engn, Hiroshima 7398527, Japan.	ichiikoji@hiroshima-u.ac.jp	Ichii, Koji/D-6376-2011		Electric Technology Research Foundation of Chugoku	This work was supported by the Electric Technology Research Foundation of Chugoku. Professor Huei-Tsyr Chen from the National Central University, Taiwan, gave us precious advice.	Elmasry MIS, 2004, P AMER CONTR CONF, P3526; Kondo K, 1993, BASICS ENG VIBRATION, P278; Lin TK, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/11/115012; Mori S, 2010, P ANN IEEE PHOT SOC, P1; Mori S, 2008, P INT C DIS DEV KATH, P240; Nishimura A, 1989, RTRI REPORT, V3, P41; Ruiz E, 2011, ADV GEOTEC ENG, DOI [10.1061/41165(397)188, DOI 10.1061/41165(397)188]; Scott C, 2006, 2006 S APPL GEOPH EN	8	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7321	1869-1900		SCI CHINA TECHNOL SC	Sci. China-Technol. Sci.	APR	2015	58	4					712	719		10.1007/s11431-015-5782-7		8	Engineering, Multidisciplinary; Materials Science, Multidisciplinary	Engineering; Materials Science	CE5HM	WOS:000351861900014		
J	Monkawa, A; Gessei, T; Takimoto, Y; Jo, N; Wada, T; Sanari, N				Monkawa, Akira; Gessei, Tomoko; Takimoto, Yuki; Jo, Nobuaki; Wada, Toshiaki; Sanari, Nobuyuki			Highly sensitive and rapid gas biosensor for formaldehyde based on an enzymatic cycling system	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Enzymatic cycling system; WST-8 formazan; Formaldehyde dehydrogenase; Formaldehyde	BIO-SNIFFER; GASEOUS FORMALDEHYDE; TETRAZOLIUM SALT; DEHYDROGENASE; WATER; PURIFICATION; SENSOR; CELLS; ASSAY; NADH	An enzymatic cycling system for detecting formaldehyde in water and indoor environments has been developed. The system is based on both the dehydrogenation of formaldehyde and the reduction of nicotinamide adenine dinucleotide (NAD+) in the presence of formaldehyde dehydrogenase. NADH generated in the reaction then reduces 4-[3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt (WST-8) to yellow WST-8 formazan in the presence of enzyme diaphorase. The quantity of formaldehyde can be detected by the color change resulting from the formation of WST-8 formazan. The assay solution was optimized with respect to the pH, type of buffer, and enzyme and WST-8 concentrations. The limit of detection for formaldehyde in water was found to be 10 ppb after 3 min. The assay solution also displayed a highly selective response to formaldehyde over other pollutant gases present in indoor air. In addition, formaldehyde gas was detected after bubbling prepared formaldehyde/air mixtures with known formaldehyde concentrations in assay solutions. The limit of detection for formaldehyde gas was 1.5 ppb after 5 min. This system can quickly and accurately detect low concentration of formaldehyde in water and gas. (C) 2014 Elsevier B.V. All rights reserved.	[Monkawa, Akira; Gessei, Tomoko; Takimoto, Yuki; Jo, Nobuaki] Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, Tokyo 1350064, Japan; [Wada, Toshiaki; Sanari, Nobuyuki] Sibata Sci Technol Ltd, Soka City, Saitama, Japan	Monkawa, A (reprint author), Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, 2-4-10 Aomi, Tokyo 1350064, Japan.	monkawa.akira@iri-tokyo.jp			Japan Science and Technology Agency (JST); Bureau of Industrial and Labor Affairs, Tokyo Metropolitan Government	This research was supported partly by two grant programs, i.e., "The Local Collective Research Development Program" of the Japan Science and Technology Agency (JST) and the "Technological Strategies for Solving Urban Issues Program" of the Bureau of Industrial and Labor Affairs, Tokyo Metropolitan Government.	Akshath US, 2012, BIOSENS BIOELECTRON, V38, P411, DOI 10.1016/j.bios.2012.05.003; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; ANDO M, 1979, J BIOCHEM-TOKYO, V85, P1165; LI JK, 1991, BIOTECHNOL BIOENG, V37, P1043, DOI 10.1002/bit.260371109; Allouch A, 2013, SENSOR ACTUAT B-CHEM, V181, P551, DOI 10.1016/j.snb.2013.02.043; Suzuki Y, 2003, ENVIRON SCI TECHNOL, V37, P5695, DOI 10.1021/es0305050; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kudo H, 2010, BIOSENS BIOELECTRON, V26, P854, DOI 10.1016/j.bios.2010.07.099; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Lobo MJ, 1997, ELECTROANAL, V9, P191, DOI 10.1002/elan.1140090302; LEVIN JO, 1985, ANAL CHEM, V57, P1032, DOI 10.1021/ac00283a016; KORPAN YI, 1993, ANAL BIOCHEM, V215, P216, DOI 10.1006/abio.1993.1578; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36; Azuma M, 2003, IND HEALTH, V41, P306, DOI 10.2486/indhealth.41.306; Beane Freeman LE, 2009, JNCI-J NATL CANCER I, V101, P751, DOI DOI 10.1093/JNCI/DJP416; Ben M.A., 2007, BIOSENS BIO ELECT, V22, P2790; Branco RD, 2010, APPL BIOCHEM BIOTECH, V162, P1558, DOI 10.1007/s12010-010-8937-9; Hammerle M, 2010, BIOSENS BIOELECTRON, V25, P1521, DOI 10.1016/j.bios.2009.10.022; Gooding J.J., 1996, SENSOR ACTUAT B-CHEM, P516; Ha Z.H., 2011, SENSOR ACTUAT B-CHEM, V192, P680; International Agency for Research on Cancer, 2012, REV HUM CARC CHEM F, V100 F, P401; LUONG JHT, 1986, APPL MICROBIOL BIOT, V24, P65; KAPLAN F, 1969, ARCH BIOCHEM BIOPHYS, V132, P91, DOI 10.1016/0003-9861(69)90340-3; Khampha W, 2004, ANAL CHIM ACTA, V520, P133, DOI 10.1016/j.aca.2004.05.044; KIRKMAN HN, 1986, J BIOL CHEM, V261, P4033; Kudo H, 2010, SENSOR ACTUAT B-CHEM, V147, P676, DOI 10.1016/j.snb.2010.03.066; Lam LH, 2008, ANAL SCI, V24, P1057, DOI 10.2116/analsci.24.1057; Mitsubayashi K, 2008, SENSOR ACTUAT B-CHEM, V130, P32, DOI 10.1016/j.snb.2007.07.086; Mong Q., SENSOR ACTUAT B-CHEM, V192, P218; Nengsih S, 2012, SENSORS-BASEL, V12, P10309, DOI 10.3390/s120810309; RITCHIE IM, 1987, AM J PUBLIC HEALTH, V77, P323, DOI 10.2105/AJPH.77.3.323; Valero E, 1996, ANAL BIOCHEM, V239, P47, DOI 10.1006/abio.1996.0289; World Health Organization, 2010, WHO GUID IND AIR QUA, P140; Zhu AP, 2011, ANAL BIOCHEM, V419, P266, DOI 10.1016/j.ab.2011.08.037	34	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						241	247		10.1016/j.snb.2014.11.148		7	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000032		
J	Tanaka, Y; Fujita, H				Tanaka, Yo; Fujita, Hideaki			Fluid driving system for a micropump by differentiating iPS cells into cardiomyocytes on a tent-like structure	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						iPS cell; Embryoid body; Differentiation; Cardiomyocytes; Micropump	CULTURED CARDIOMYOCYTES; POLYMER MICROPILLARS; CARDIAC TISSUE; THIN-FILMS; FABRICATION; MUSCLE; HYBRID; MICRODEVICES; PROPULSION; ACTUATORS	A number of recent studies have exploited the sizes and functional properties of microdevices and cellular mechanical components to construct bio-microactuators. We previously developed bio-micropumps powered by cardiomyocytes that utilizes glucose in the medium as chemical energy. To fabricate the pump, however, primary neonatal rat cardiomyocytes are indispensable. The operation of harvesting primary cells is inconvenient and ethically not adequate due to the need for animals sacrifice. In contrast, induced pluripotent stem (iPS) cells are obtained from subcutaneous tissue. Their most significant properties are that they proliferate indefinitely and can be differentiated into many kinds of cells, including cardiomyocytes, and also have no ethical issue differently from ES cells. By exploiting these properties of iPS cells, the above issues will be addressed. Based on this concept, we constructed a system for driving fluids as a principal component of a micropump by differentiating iPS cells into spontaneously beating cardiomyocytes. Cellular contractile force was transmitted to fluid in a microchannel by a tent-like thin membrane. The microchip was irradiated with O-2 plasma and coated with gelatin to attach the cells. Embryoid bodies (EBs) of mouse-derived iPS cells were seeded on the microchip and incubated at 37 degrees C without Leukemia Inhibitory Factor (LIF) to differentiate them into cardiomyocytes. About 2 weeks later, EB beating and periodical oscillation of fluid in a microchannel connected to a diaphragm chamber was observed. The theoretical flow rate assuming the use of ideal check valves (Q) was 6.9 nL/min. Our device presents a reasonable alternative to normal cardiomyocytes for preliminary investigations requiring bio-actuating pumps. (C) 2014 Elsevier B.V. All rights reserved.	[Tanaka, Yo; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr QBiC, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Tanaka, Yo] Osaka Univ, Grad Sch Frontier Bosci, Suita, Osaka 5650871, Japan; [Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr, WPI, Suita, Osaka 5650871, Japan	Tanaka, Y (reprint author), RIKEN, Quantitat Biol Ctr QBiC, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yo.tanaka@riken.jp	Fujita, Hideaki/B-7633-2008		Hyogo Science and Technology Agency, Japan; Japan Society for the Promotion of Science (JSPS), Japan [21681019, 25709081, 23651133]	This work was supported by Hyogo Science and Technology Agency, Japan. This work was also partially supported by the bilateral program, Grants-in-Aid for Young Scientist (A) (21681019), Young Scientist (A) (25709081), Challenging Exploratory Research (23651133), and Leading-edge Research Infrastructure Program from Japan Society for the Promotion of Science (JSPS), Japan. Y.T. thanks Dr. H.R. Ueda in RIKEN, Japan, for helpful discussions.	Akiyama Y, 2013, LAB CHIP, V13, P4870, DOI 10.1039/c3lc50490e; Hiratsuka Y, 2006, P NATL ACAD SCI USA, V103, P13618, DOI 10.1073/pnas.0604122103; Tanaka Y, 2006, LAB CHIP, V6, P362, DOI 10.1039/b515149j; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Tanaka Y, 2006, LAB CHIP, V6, P230, DOI 10.1039/b512099c; Behkam B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3040318; Chan V, 2012, LAB CHIP, V12, P88, DOI 10.1039/c1lc20688e; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Sakar MS, 2011, INT J ROBOT RES, V30, P647, DOI 10.1177/0278364910394227; Steager E, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752721; Park J, 2005, ANAL CHEM, V77, P6571, DOI 10.1021/ac0507800; Chan V, 2014, LAB CHIP, V14, P653, DOI 10.1039/c3lc50989c; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Nagai M, 2013, SENSOR ACTUAT B-CHEM, V188, P1255, DOI 10.1016/j.snb.2013.08.040; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Horiguchi H, 2009, IEEE T NANOBIOSCI, V8, P349, DOI 10.1109/TNB.2009.2035282; Kovarik ML, 2012, ANAL CHEM, V84, P516, DOI 10.1021/ac202611x; Weibel DB, 2005, P NATL ACAD SCI USA, V102, P11963, DOI 10.1073/pnas.0505481102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Kim J, 2007, LAB CHIP, V7, P1504, DOI 10.1039/b705367c; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Culbertson CT, 2014, ANAL CHEM, V86, P95, DOI 10.1021/ac403688g; Chan V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00857; Cho S., 2012, BIOMED MICRODEVICES, P1019; Fujita H, 2010, BIOTECHNOL BIOENG, V106, P482, DOI 10.1002/bit.22705; Herr H, 2004, J NEUROENG REHABIL, V1, P6, DOI DOI 10.1186/1743-0003-1-6; Itoh A, 2000, IEEE-ASME T MECH, V5, P181, DOI 10.1109/3516.847091; Kitamori T, 2004, ANAL CHEM, V76, p52A, DOI 10.1021/ac041508d; Kovarik M. L., 2013, ANAL CHEM, V85, P451; Loy CT, 1999, J MICROMECH MICROENG, V9, P341, DOI 10.1088/0960-1317/9/4/309; Martel S, 2009, INT J ROBOT RES, V28, P571, DOI 10.1177/0278364908100924; Park JY, 2007, LAB CHIP, V7, P1367, DOI 10.1039/b703900j; Pilarek M, 2011, SENSOR ACTUAT B-CHEM, V156, P517, DOI 10.1016/j.snb.2011.02.014; Tanaka Y, 2008, LAB CHIP, V8, P58, DOI 10.1039/b714252h; Tanaka Y., 2001, SENSOR ACTUAT B-CHEM, V156, P191; Zhang J., 2010, CIRC RES, V104, pe30; Zhao Y, 2006, SENSOR ACTUAT A-PHYS, V125, P398, DOI 10.1016/j.sna.2005.08.032; Zwi L., 2006, CIRCULATION, V120, P1513	44	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						267	272		10.1016/j.snb.2014.12.069		6	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000036		
J	Goya, K; Itoh, T; Seki, A; Watanabe, K				Goya, Kenji; Itoh, Toshiaki; Seki, Atsushi; Watanabe, Kazuhiro			Efficient deep-hole drilling by a femtosecond, 400 nm second harmonic Ti:Sapphire laser for a fiber optic in-line/pico-liter spectrometer	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Femtosecond laser drilling; Fiber optic spectrometer; Micro through-hole array	ABLATION; GLASS; DIELECTRICS; PULSES; MICROCHANNELS; FABRICATION; NANOSECOND; THRESHOLDS; MECHANISM; SOLIDS	A second harmonic 400-nm femtosecond laser has demonstrated efficient deep hole drilling for a pico-liter fiber optic spectrometer. A pulse train of 1 kHz with a pulse width of 350 fs and a pulse energy of 15 mu J was irradiated during 1.2 s onto an optical fiber to make a through hole that penetrates the fiber core and works to be a sample cell for a spectroscopic measurement. The spectroscopic measurement is shown using several liquids including dye of rhodamine 6G (R6G). Even with a single cell volume of approximately 20 pico-liter, the absorption spectrum is appeared in the visible range centered at 530 nm depending on the dye concentration. Discussions have also been made on the optimum arrangement of the through hole drilling to obtain sufficient performance of spectroscopic measurements. (C) 2015 Elsevier B.V. All rights reserved.	[Goya, Kenji; Itoh, Toshiaki; Watanabe, Kazuhiro] Soka Univ, Dept Informat Syst Sci, Fac Engn, Hachioji, Tokyo 1928577, Japan; [Seki, Atsushi] Soka Univ, Dept Bioinformat, Fac Engn, Hachioji, Tokyo 1928577, Japan	Goya, K (reprint author), Soka Univ, Dept Informat Syst Sci, Fac Engn, 1-236 Tangi, Hachioji, Tokyo 1928577, Japan.	ktg.research@gmail.com			JSPS KAKENHI [24510126]	This work has been supported by JSPS KAKENHI Grant Numbers 24510126.	Guan YZ, 2014, SENSOR ACTUAT B-CHEM, V198, P110, DOI 10.1016/j.snb.2014.02.098; Chen CH, 2010, MICROSYST TECHNOL, V16, P1207, DOI 10.1007/s00542-009-0945-8; Mao SS, 2004, APPL PHYS A-MATER, V79, P1695, DOI 10.1007/s00339-004-2684-0; Mlejnek M, 1998, OPT LETT, V23, P382, DOI 10.1364/OL.23.000382; Cugnet C, 2009, SENSOR ACTUAT B-CHEM, V143, P158, DOI 10.1016/j.snb.2009.07.059; Kaiser A, 2000, PHYS REV B, V61, P11437, DOI 10.1103/PhysRevB.61.11437; Chen CH, 2010, J LASER MICRO NANOEN, V5, P1; Ahsan MS, 2011, J NON-CRYST SOLIDS, V357, P851, DOI 10.1016/j.jnoncrysol.2010.11.006; Liao Y, 2013, OPT LETT, V38, P187, DOI 10.1364/OL.38.000187; Dumitru G, 2002, APPL PHYS A-MATER, V74, P729, DOI 10.1007/s003390101183; Hnatovsky C, 2006, APPL PHYS A-MATER, V84, P47, DOI 10.1007/s00339-006-3590-4; Li Y, 2001, OPT LETT, V26, P1912, DOI 10.1364/OL.26.001912; Shimotsuma Y, 2005, JPN J APPL PHYS 1, V44, P4735, DOI 10.1143/JJAP.44.4735; Barberoglou M, 2009, APPL SURF SCI, V255, P5425, DOI 10.1016/j.apsusc.2008.07.130; Duocastella M, 2010, SENSOR ACTUAT B-CHEM, V145, P596, DOI 10.1016/j.snb.2009.11.055; Lai Y, 2006, OPT LETT, V31, P2559, DOI 10.1364/OL.31.002559; Han KS, 2010, SOL ENERG MAT SOL C, V94, P583, DOI 10.1016/j.solmat.2009.12.001; Wu B, 2009, APPL SURF SCI, V256, P61, DOI 10.1016/j.apsusc.2009.07.061; Gamaly EG, 2002, PHYS PLASMAS, V9, P949, DOI 10.1063/1.1447555; Furusawa K, 1999, APPL PHYS A-MATER, V69, pS359, DOI 10.1007/s003390051417; Noack J, 1999, IEEE J QUANTUM ELECT, V35, P1156, DOI 10.1109/3.777215; Wang Y, 2010, J OPT SOC AM B, V27, P370; Borowiec A, 2005, APPL SURF SCI, V243, P129, DOI 10.1016/j.apsusc.2004.09.105; Brackmann U., 2000, LAMDACHROME LASER DY; Buividas R., 2012, P SOC PHOTO-OPT INS, V8463; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Fadeeva E., 2011, AM CHEM SOC, V27, P3012; Kanehira S., 2008, APPL PHYS LETT, V93; Sohn IB, 2010, OPT EXPRESS, V18, P19755, DOI 10.1364/OE.18.019755; Vipparty D., 2012, J APPL PHYS, V112; WANG Y, 2009, OPT LETT, V34, P3280; Yaka A. B., 2003, APPL PHYS LETT, V83, P3030; Zhao X, 2011, APPL PHYS A-MATER, V104, P713, DOI 10.1007/s00339-011-6326-z	33	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						685	691		10.1016/j.snb.2014.12.115		7	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000088		
J	Pavelko, RG; Yuasa, M; Kida, T; Shimanoe, K; Yamazoe, N				Pavelko, R. G.; Yuasa, M.; Kida, T.; Shimanoe, K.; Yamazoe, N.			Impurity level in SnO2 materials and its impact on gas sensing properties	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Gas sensor; SnO2; Precursor; Impurity; Chlorine; Humidity; Sensitivity	OXIDE ALKOXIDE POLYMERS; TIN OXIDE; LOW-TEMPERATURE; SURFACE-AREA; HYDROTHERMAL TREATMENT; RESIDUAL CHLORINE; OXIDATION; CATALYSTS; METHANE; SENSORS	Using the same protocol for precipitation of tin hydroxide and its hydrothermal treatment (HT), we synthesize SnO2 from three precursors - tin(IV) acetate, tin(IV) hydroxide acetate and tin(IV) chloride pentahydrate. After annealing on sensor substrates the materials were found to be very similar from structural point of view. However, their sensing properties (responses to CO and H-2 as a function of humidity) were discovered to be very different, which was related to different impurity level in the samples. High amount of chlorine and potassium (ca. 300 ppmw) in two samples corresponded well to notably high water vapor effect. Differences in surface areas (within 20-60 m(2)/g) and pore volumes (between 0.11 and 0.19 cm(3)/g), found for the materials in question, seem to play minor role if the impurities are present. (C) 2015 Elsevier B.V. All rights reserved.	[Pavelko, R. G.; Yuasa, M.; Kida, T.; Shimanoe, K.; Yamazoe, N.] Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Fukuoka 812, Japan	Pavelko, RG (reprint author), Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Kasugakoen 6-1, Fukuoka 812, Japan.	roman.pavelko@gmail.com			Japan Society for the Promotion of Science; JSPS [23 01343]	R.G.P. gratefully acknowledges a scholarship from the Japan Society for the Promotion of Science and financial support from JSPS grant-in-aid No. 23 01343. He is also thankful to Prof. V.G. Sevastyanov and Dr. A.V. Steblevskiy for the laser-spark mass-spectrometry.	Vuong DD, 2004, SENSOR ACTUAT B-CHEM, V103, P386, DOI 10.1016/j.sab.2004.04.122; Wagh PB, 1999, MATER CHEM PHYS, V57, P214, DOI 10.1016/S0254-0584(98)00217-X; Fujihara S, 2004, LANGMUIR, V20, P6476, DOI 10.1021/la0493060; Baik NS, 2000, J AM CERAM SOC, V83, P2983; Lin W, 2004, APPL CATAL B-ENVIRON, V50, P59, DOI 10.1016/j.apcatb.2004.03.009; Barsan N, 2007, SENSOR ACTUAT B-CHEM, V121, P18, DOI 10.1016/j.snb.2006.09.047; Hagemeyer A, 2007, APPL CATAL A-GEN, V317, P139, DOI 10.1016/j.apcata.2006.09.040; Yamazoe N, 2003, CATAL SURV ASIA, V7, P63, DOI 10.1023/A:1023436725457; Borg O, 2011, J CATAL, V279, P163, DOI 10.1016/j.jcat.2011.01.015; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; BRADLEY DC, 1989, CHEM REV, V89, P1317, DOI 10.1021/cr00096a004; Ding Y, 2001, CHEM MATER, V13, P435, DOI 10.1021/cm000607e; Balonek CM, 2010, CATAL LETT, V138, P8, DOI 10.1007/s10562-010-0366-4; Gelin P, 2002, APPL CATAL B-ENVIRON, V39, P1, DOI 10.1016/S0926-3373(02)00076-0; Pavelko RG, 2009, SENSOR ACTUAT B-CHEM, V137, P637, DOI 10.1016/j.snb.2008.12.025; HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003; Kida T, 2008, SENSOR ACTUAT B-CHEM, V134, P928, DOI 10.1016/j.snb.2008.06.044; BRADLEY DC, 1962, CAN J CHEM, V40, P15, DOI 10.1139/v62-003; BRADLEY DC, 1961, CAN J CHEM, V39, P1434, DOI 10.1139/v61-183; Brinker C.J., 1990, SOL GEL SCI PHYS CHE; Cant NW, 1998, CATAL TODAY, V44, P93, DOI 10.1016/S0920-5861(98)00177-1; Chin Y-H, 1999, CATALYSIS, V14, P1, DOI 10.1039/9781847553263-00001; Davydov A., 2003, MOL SPECTROSCOPY OXI, P27; Ertl G., 2008, HDB HETEROGENEOUS CA, P4270; HARRISON PG, 1975, J CHEM SOC FARAD T 1, V71, P1013, DOI 10.1039/f19757101013; IWASAKI I, 1956, B CHEM SOC JPN, V29, P860, DOI 10.1246/bcsj.29.860; Kakihana M, 1996, J SOL-GEL SCI TECHN, V6, P7, DOI 10.1007/BF00402588; Khaleel A, 2013, MATER RES BULL, V48, P1709, DOI 10.1016/j.materresbull.2013.01.027; Kondarides DI, 1998, J CATAL, V174, P52, DOI 10.1006/jcat.1997.1938; Lide D. R., 2004, CRC HDB CHEM PHYS; Mihaiu S, 2007, J EUR CERAM SOC, V27, P551, DOI 10.1016/j.jeurceramsoc.2006.04.070; PARK SS, 1995, THIN SOLID FILMS, V258, P268, DOI 10.1016/0040-6090(94)06404-0; Pavelko R., 2010, SNO2 BASED OXIDE SYS, P195; Pavelko R., 2012, CHEM SENSORS SIMULAT, P486; Pavelko RG, 2014, J PHYS CHEM C, V118, P2554, DOI 10.1021/jp4108766; Pavelko RG, 2012, SENSOR ACTUAT B-CHEM, V170, P51, DOI 10.1016/j.snb.2011.01.013; Pavelko R.G., UNPUB; PERI SS, 1995, J CATAL, V152, P410, DOI 10.1006/jcat.1995.1095; Sergent N, 2002, SENSOR ACTUAT B-CHEM, V84, P176, DOI 10.1016/S0925-4005(02)00022-9; SHASTRI AG, 1985, APPL CATAL, V14, P119, DOI 10.1016/S0166-9834(00)84349-3; SIMONE DO, 1991, APPL CATAL, V70, P87; Soares JMC, 2006, CATAL LETT, V109, P103, DOI 10.1007/s10562-006-0064-4; SON YM, 1991, J ELECTROCHEM SOC, V138, P2185, DOI 10.1149/1.2085947; Yamazoe N, 2005, SENSOR ACTUAT B-CHEM, V108, P2, DOI 10.1016/j.snb.2004.12.075	44	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						719	725		10.1016/j.snb.2015.01.038		7	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000093		
J	Terasawa, N; Asaka, K				Terasawa, Naohiro; Asaka, Kinji			Superior performance hybrid (electrostatic double-layer and faradaic capacitor) polymer actuators incorporating noble metal oxides and carbon black	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Polymer actuator; Hybrid capacitor; Electrostatic double-layer; Faradaic; Noble metal oxide	HYDROUS RUTHENIUM OXIDE; FULLY PLASTIC ACTUATOR; IONIC LIQUID GEL; ELECTROCHEMICAL CAPACITORS; SUPERCAPACITOR APPLICATION; ENERGY-STORAGE; BUCKY GEL; ELECTRODE; NANOTUBES; RUO2	The electrochemical and electromechanical properties of polymeric actuators prepared using iridium oxide (IrO2) or ruthenium oxide (RuO2)/carbon black (CB)/ionic liquid (IL) electrodes and formed without ultrasonication were compared with actuators prepared using solely CB or single-walled carbon nanotubes (SWCNTs) with an IL. The IrO2/CB/IL actuators surpassed the strain performance of the CB and SWCNT-only actuators. The electrode in these actuator systems appears to represent an electrochemical capacitor (EC) composed of an electrostatic double-layer (EDLC) and a faradaic capacitor (FC), the latter of which primarily determines the capacitance. The CB functions largely by increasing the electroconductivity of the actuator. The functioning mechanisms of these actuators are different from those of CB and SWCNT-only actuators, which act solely as EDLC units. Both metal oxide (MO2) and CB are required to produce high strain values that surpass the performance of SWCNT polymer actuators and are suitable for practical applications. The actuator displacement response frequency dependence could not be simulated using an electrochemical kinetic model derived for CB/VGCF/IL and SWCNT-based actuators. This model appears to apply only to EDLC-based actuator systems and thus does not pertain to the present EDLC/FC system, in which the capacitance of the electrode comes primarily from the FC effect. (C) 2015 Elsevier B.V. All rights reserved.	[Terasawa, Naohiro; Asaka, Kinji] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan	Terasawa, N (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	terasawa-naohiro@aist.go.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [24550264]	This work was supported in part by a KAKENHI Grant-in Aid for Scientific Research C (no. 24550264) from the Japan Society for the Promotion of Science (JSPS).	ZHENG JP, 1995, J ELECTROCHEM SOC, V142, P2699, DOI 10.1149/1.2050077; Chuang CM, 2010, ENERG FUEL, V24, P6476, DOI 10.1021/ef101208x; Grupioni AAF, 2002, ELECTROCHIM ACTA, V48, P407, DOI 10.1016/S0013-4686(02)00686-2; Conway BE, 1997, J POWER SOURCES, V66, P1, DOI 10.1016/S0378-7753(96)02474-3; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Pandolfo AG, 2006, J POWER SOURCES, V157, P11, DOI 10.1016/j.jpowsour.2006.02.065; Kandalkar SG, 2010, SYNTHETIC MET, V160, P1299, DOI 10.1016/j.synthmet.2010.04.003; Burke A, 2000, J POWER SOURCES, V91, P37, DOI 10.1016/S0378-7753(00)00485-7; Takeuchi I, 2009, ELECTROCHIM ACTA, V54, P1762, DOI 10.1016/j.electacta.2008.10.007; KOTZ R, 1986, ELECTROCHIM ACTA, V31, P1311, DOI 10.1016/0013-4686(86)80153-0; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Frackowiak E, 2007, PHYS CHEM CHEM PHYS, V9, P1774, DOI 10.1039/b618139m; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; Babakhani B, 2010, ELECTROCHIM ACTA, V55, P4014, DOI 10.1016/j.electacta.2010.02.030; Takeuchi I, 2009, CARBON, V47, P1373, DOI 10.1016/j.carbon.2009.01.029; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Mukai K, 2008, ELECTROCHIM ACTA, V53, P5555, DOI 10.1016/j.electacta.2008.02.113; Zhao DD, 2007, ELECTROCHEM COMMUN, V9, P869, DOI 10.1016/j.elecom.2006.11.030; Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4; Terasawa N, 2011, SENSOR ACTUAT B-CHEM, V156, P539, DOI 10.1016/j.snb.2010.09.009; Inagaki M, 2010, J POWER SOURCES, V195, P7880, DOI 10.1016/j.jpowsour.2010.06.036; Zheng JP, 1996, J POWER SOURCES, V62, P155, DOI 10.1016/S0378-7753(96)02424-X; CONWAY BE, 1991, J ELECTROCHEM SOC, V138, P1539, DOI 10.1149/1.2085829; Largeot C, 2008, J AM CHEM SOC, V130, P2730, DOI 10.1021/ja7106178; KODINTSEV IM, 1994, ELECTROCHIM ACTA, V39, P1803, DOI 10.1016/0013-4686(94)85168-9; Sugimoto W, 2004, J ELECTROCHEM SOC, V151, pA1181, DOI 10.1149/1.1765681; Shiraishi S, 2002, ELECTROCHEM COMMUN, V4, P593, DOI 10.1016/S1388-2481(02)00382-X; Shahinpoor M, 1998, SMART MATER STRUCT, V7, pR15, DOI 10.1088/0964-1726/7/6/001; Dong XP, 2006, J PHYS CHEM B, V110, P6015, DOI 10.1021/jp056754n; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Zhang Y, 2009, INT J HYDROGEN ENERG, V34, P4889, DOI 10.1016/j.ijhydene.2009.04.005; Terasawa N, 2011, SENSOR ACTUAT B-CHEM, V160, P161, DOI 10.1016/j.snb.2011.07.027; Fukushima T, 2005, ANGEW CHEM INT EDIT, V44, P2410, DOI 10.1002/anie.200462318; Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j; Hu CC, 2001, ELECTROCHIM ACTA, V46, P3431, DOI 10.1016/S0013-4686(01)00543-6; Wu MS, 2004, ELECTROCHEM SOLID ST, V7, pA123, DOI 10.1149/1.1695533; Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0; ANGELINETTA C, 1989, MATER CHEM PHYS, V22, P231, DOI 10.1016/0254-0584(89)90039-4; Bar-Cohen Y, 2004, ELECTROACTIVE POLYM; CHENG YW, 2012, J LIU NANO LETT, V12, P4206; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Lim JH, 2001, J ELECTROCHEM SOC, V148, pA275, DOI 10.1149/1.1350666; PEI QB, 1992, J PHYS CHEM-US, V96, P10507, DOI 10.1021/j100204a071; Sardngdpani S., 1996, J ELECTROCHEM SOC, V143, P3791; Terasawa N., 2014, SENSOR ACTUAT B-CHEM, V145, P775; Terasawa N, 2014, ELECTROCHIM ACTA, V123, P340, DOI 10.1016/j.electacta.2013.12.156; Terasawa N, 2009, SENSOR ACTUAT B-CHEM, V139, P624, DOI 10.1016/j.snb.2009.03.057; TRACY MMJ, 1996, NATURE, V381, P678; ZHENG JP, 1995, J ELECTROCHEM SOC, V142, pL6, DOI 10.1149/1.2043984	49	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						748	755		10.1016/j.snb.2014.12.112		8	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000097		
J	Suherman; Morita, K; Kawaguchi, T				Suherman; Morita, Kinichi; Kawaguchi, Toshikazu			Effect of alkanethiol molecular structure on sensitivity of surface plasmon resonance sensor	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Alkanethiol monolayer; Surface plasmon resonance; Clenbuterol; Indirect competitive inhibition immunoassay	SELF-ASSEMBLED MONOLAYERS; TANDEM MASS-SPECTROMETRY; IMMUNOSENSOR; BIOSENSOR; ANTIBODY; GOLD; IMMOBILIZATION; AU(111); BINDING; TNT	This work aims to find the key factor determining the detection limit for an indirect competitive inhibition immunoassay using surface plasmon resonance (SPR) sensing. In our previous work, the thiol solution concentration used in a self-assembly process highly affected the alkanethiol monolayer structure on the sensor surface (Suherman et al., 2014). It was noticed that the monolayer structure determined the immunoassay sensitivity due to the orientation and the surface concentration of antigen in domain structure of monolayer. To study the effect of orientation of antigen, we examined here three types of alkanethiol compounds: dithiobis(succinimidyl undecanoate) (DSU; straight-chain alkanethiol), carboxy-EG(6)-undecanethiol (CEG(6); flexible-chain alkanethiol), and 3,3'-dithiobis[N-(5-amino-5-carboxypentyl) propionamide-N,N'-diacetic acid] (C-2-NTA; three-branched alkanethiol). By electrochemical reductive desorption, the surface concentration of DSU, CEG(6), and C-2-NTA were estimated to be 6.6 x 10(-10), 8.5 x 10(-10), 4.6 x 10(-10) mol cm(-2), respectively. Subsequently, SPR suggested that the ratios of immobilized antigen (clenbuterol) per thiol were 0.13, 0.16, and 0.15 for DSU, CEG(6), and C-2-NTA, respectively. This suggests that the amount of immobilized clenbuterol was defined by the molecular size of clenbuterol. Sensor surface structures on a molecular scale were evaluated using high-resolution scanning tunneling microscopy (STM), which showed tilted clenbuterol with theta(DSU) > theta(CEG6) > theta(C2-NTA). For SPRsensing of clenbuterol, C-2-NTA showed the highest sensitivity (LOD = 10 ppt) among the examined alkanethiols, because clenbuterol formed a laid-on structure. Based on kinetics, the key factor for sensing performance is discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Suherman; Kawaguchi, Toshikazu] Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Div Environm Mat Sci, Sapporo, Hokkaido 0600810, Japan; [Suherman; Kawaguchi, Toshikazu] Hokkaido Univ, Fac Environm Earth Sci, Sect Mat Sci, Sapporo, Hokkaido 0600810, Japan; [Suherman] Univ Gadjah Mada, Fac Math & Nat Sci, Dept Chem, Yogyakarta 55281, Indonesia; [Morita, Kinichi] Ushio Inc, New Business Dev Off, Chiyoda Ku, Tokyo 1008150, Japan	Kawaguchi, T (reprint author), Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Div Environm Mat Sci, Sapporo, Hokkaido 0600810, Japan.	t_kawa@ees.hokudai.ac.jp			Hitachi Scholarship Foundation	Suherman wishes to thank the Hitachi Scholarship Foundation for support and facilitation during the Ph.D. program.	Aizawa H, 2006, IEEE SENS J, V6, P1052, DOI 10.1109/JSEN.2006.881368; Wheeler AR, 2004, SENSOR ACTUAT B-CHEM, V98, P208, DOI 10.1016/j.snb.2003.06.004; Li C, 2010, J CHROMATOGR A, V1217, P7873, DOI 10.1016/j.chroma.2010.10.055; Putzbach W, 2013, SENSORS-BASEL, V13, P4811, DOI 10.3390/s130404811; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9; WALCZAK MM, 1995, J ELECTROANAL CHEM, V396, P103, DOI 10.1016/0022-0728(95)04056-T; Nagatomo K, 2009, TALANTA, V79, P1142, DOI 10.1016/j.talanta.2009.02.018; Manera MG, 2014, BIOSENS BIOELECTRON, V58, P114, DOI 10.1016/j.bios.2014.02.003; Kawaguchi T, 2007, TALANTA, V72, P554, DOI 10.1016/j.talanta.2006.11.020; Sakai G, 1999, ELECTROCHIM ACTA, V44, P3849, DOI 10.1016/S0013-4686(99)00092-4; Porter MD, 2008, CHEM SOC REV, V37, P1001, DOI 10.1039/b708461g; Chaudhari V, 2011, J PHYS CHEM C, V115, P16518, DOI 10.1021/jp2042922; Matsumoto K, 2005, TALANTA, V68, P305, DOI 10.1016/j.talanta.2005.08.054; Grubor NM, 2004, BIOSENS BIOELECTRON, V19, P547, DOI 10.1016/S0956-5663(03)00274-4; Trilling AK, 2013, ANALYST, V138, P1619, DOI 10.1039/c2an36787d; Chen SF, 2000, LANGMUIR, V16, P9287, DOI 10.1021/la000417i; Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022; Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h; Arya SK, 2009, BIOSENS BIOELECTRON, V24, P2810, DOI 10.1016/j.bios.2009.02.008; Sakai G, 1998, SENSOR ACTUAT B-CHEM, V49, P5, DOI 10.1016/S0925-4005(98)00107-5; Kawaguchi T, 2008, SENSOR ACTUAT B-CHEM, V133, P467, DOI 10.1016/j.snb.2008.03.005; Brewer NJ, 2004, LANGMUIR, V20, P4109, DOI 10.1021/la036301e; Shankaran DR, 2007, SENSOR ACTUAT B-CHEM, V121, P158, DOI 10.1016/j.snb.2006.09.014; Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Chiu CW, 2013, ELECTROCHIM ACTA, V94, P42, DOI 10.1016/j.electacta.2012.12.091; Encarnacao JM, 2007, J BIOTECHNOL, V132, P142, DOI 10.1016/j.jbiotec.2007.04.010; Huang CJ, 2014, TALANTA, V122, P166, DOI 10.1016/j.talanta.2014.01.022; Joshi M, 2007, BIOSENS BIOELECTRON, V22, P2429, DOI 10.1016/j.bios.2006.08.045; Juan C, 2010, J CHROMATOGR A, V1217, P6061, DOI 10.1016/j.chroma.2010.07.034; Li Y, 2008, TALANTA, V77, P473, DOI 10.1016/j.talanta.2008.03.007; Liu M, 2012, SENSOR ACTUAT B-CHEM, V161, P124, DOI 10.1016/j.snb.2011.09.078; Lou XH, 2008, SENSOR ACTUAT B-CHEM, V129, P225, DOI 10.1016/j.snb.2007.07.130; Loureiro C. C. L., 2007, J PHYS C SER, V85, P1; Pribyl J, 2003, SENSOR ACTUAT B-CHEM, V91, P333, DOI [10.1016/S0925-4005(03)00107-2, 10.1016/S0925-4005(0300107-2]; Shankaran DR, 2006, SENSOR ACTUAT B-CHEM, V114, P71, DOI 10.1016/j.snb.2005.04.013; Shevade AV, 2001, LANGMUIR, V17, P7566, DOI 10.1021/la0108151; Shimazu K., 2002, J AM CHEM SOC, V124, P652; Shimazu K, 2002, J ELECTROANAL CHEM, V534, P163, DOI 10.1016/S0022-0728(02)01140-3; Soh N, 2003, TALANTA, V60, P733, DOI 10.1016/S0039-9140(03)00139-5; Suherman S., UNPUB; Villaverde A., 2003, FEBS LETT, V554, P167; Yeo S., 2013, APPL PHYS LETT, V102; Zhang YB, 2011, SENSOR ACTUAT B-CHEM, V159, P121, DOI 10.1016/j.snb.2011.06.059; Zhong CJ, 1997, J ELECTROANAL CHEM, V421, P9, DOI 10.1016/S0022-0728(96)01025-X	46	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	APR	2015	210						768	775		10.1016/j.snb.2015.01.026		8	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CC0BM	WOS:000350000000100		
J	Aoun, N; Matsuda, H; Sekiyama, M				Aoun, Nael; Matsuda, Hirotaka; Sekiyama, Makiko			Geographical accessibility to healthcare and malnutrition in Rwanda	SOCIAL SCIENCE & MEDICINE			English	Article						Rwanda; Geographical accessibility; Stunting; Health center; Travel time	CHILD NUTRITIONAL-STATUS; RURAL BURKINA-FASO; BIRTH-ORDER; ACCESS; MORTALITY; DISTANCE; COMMUNITY; AFRICA; GHANA	The prevalence of stunting in children less than five years of age is elevated in Rwanda. It is one of the main health challenges upon which the government is struggling to achieve progress. Health centers and district hospitals in Rwanda are expected to provide a package of health services including nutrition related activities, nutritional rehabilitation, education, and growth monitoring. They can hence play a potent role in alleviating malnutrition and stunting in Rwanda. This study tested whether travel time from household clusters to the nearest health center was significantly and negatively associated with the distribution of height-for-age z-scores of younger than five year old children in the eastern province of Rwanda. Data for 974 children was extracted from the Rwanda Demographic and Health Survey (DHS) database. However, since DHS does not contain any information on travel time to health centers, the latter was simulated using AccessMod 4.0, an extension to ArcGIS 9.3.1 that simulates health facilities' catchment areas and travel times to health facilities. Travel time was found to be negatively associated with height-for-age z-scores at the 5% level in a stepwise regression analysis that controlled for wealth index, mother's primary and secondary education, sex of the child, preceding birth interval, and birth order of the child. Field measurements are needed to validate travel time. If validated, results point to the importance of improved access to healthcare facilities as a potential pathway in reducing stunting in Rwanda. (C) 2015 Elsevier Ltd. All rights reserved.	[Aoun, Nael; Matsuda, Hirotaka; Sekiyama, Makiko] Univ Tokyo, Grad Program Sustainabil Sci, Tokyo 1138654, Japan	Aoun, N (reprint author), Room 334,Bldg Environm Studies,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	nael.aoun@sustainability.k.u-tokyo.ac.jp					Akello Beatrice, 2008, East Afr J Public Health, V5, P180; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; HART JT, 1971, LANCET, V1, P405; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Eklund P, 2007, J DEV STUD, V43, P456, DOI 10.1080/00220380701204406; Mennis J, 2003, PROF GEOGR, V55, P31; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; Rosero-Bixby L, 2004, SOC SCI MED, V58, P1271, DOI 10.1016/S0277-9536(03)00322-8; Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Mitsunaga T, 2013, SOC SCI MED, V85, P87, DOI 10.1016/j.socscimed.2013.02.033; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Byass P, 2008, PAEDIATR PERINAT EP, V22, P569, DOI 10.1111/j.1365-3016.2008.00974.x; De Stefano J., 2012, TASK ORDER 7 EARLY G; Defo BK, 1997, SOC SCI MED, V44, P1023, DOI 10.1016/S0277-9536(96)00228-6; Deaton A., 2009, Economic and Political Weekly, V44, P42; Engle PL, 1997, CARE NUTR CONCEPTS M; European Commission Joint Research Center, 2010, TRAV TIM MAJ CIT GLO; Haughton D, 1997, ECON DEV CULT CHANGE, V45, P541, DOI 10.1086/452290; HORTON S, 1988, ECON DEV CULT CHANGE, V36, P341, DOI 10.1086/451655; Imai K., 2008, Oxford Development Studies, V36, P209, DOI 10.1080/13600810701701996; Jaspars S., 2009, REV NUTR MORT IND IP; Munoz UH, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-40; Kurosaki T., 2001, INT WORKSH EC AN AGR; Lisa C.S., 2003, IMPORTANCE WOMENS ST; MILLER JE, 1994, J BIOSOC SCI, V26, P243; Ministry of Finance and Economic Planning, 2007, EC DEV POV RED STRAT; Ministry of Finance and Economic Planning Ministry of Health Macro International, 2008, RWAND SERV PROV ASS; Ministry of Health U, 2009, HLTH SECT STRAT PLAN; Mrisho M., 2008, BMC PUBLIC HLTH, V8; National Institute of Statistics of Rwanda Ministry of Health & ICH International, 2012, RWAND DEM HLTH SURV; Partners in Health, 2011, PROGR MAN GUID; Paxton W., 2012, SCH FUNDING EQUITY R; Perez-Heydrich C., 2013, SPATIAL ANAL REPORTS, V8; Prunier G., 2010, RWANDA CRISIS HIST G; Riley J.C., 2001, RISING LIFE EXPECTAN; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Rutstein S, 2004, DHS WEALTH INDEX; Sankoh OA, 2001, INT J EPIDEMIOL, V30, P485, DOI 10.1093/ije/30.3.485; Sleeter R., 2004, ANN C URB REG INF SY; VandenBroeck J, 1996, INT J EPIDEMIOL, V25, P998; Vansina J., 2012, RWANDA ANCIENT ROYAU; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wen LS, 2011, AFRICA J EMERG MED, V1, P57; World Bank, 2004, ED RWAND REB RES ACC; World Food Programme, 2012, COMPR FOOD SEC VULN; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 2013, PHYS ACC HLTH CAR PO; World Health Organization Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	57	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	APR	2015	130						135	145		10.1016/j.socscimed.2015.02.004		11	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	CE4FC	WOS:000351785500016		
J	Fejfar, A; Hyvl, M; Vetushka, A; Pikna, P; Hajkova, Z; Ledinsky, M; Kocka, J; Klapetek, P; Marek, A; Maskova, A; Vyskocil, J; Merkel, J; Becker, C; Itoh, T; Misra, S; Foldyna, M; Yu, LW; Cabarrocas, PRI				Fejfar, Antonin; Hyvl, Matej; Vetushka, Aliaksei; Pikna, Peter; Hajkova, Zdenka; Ledinsky, Martin; Kocka, Jan; Klapetek, Petr; Marek, Ales; Maskova, Andrea; Vyskocil, Jiri; Merkel, Janis; Becker, Christiane; Itoh, Takashi; Misra, Soumyadeep; Foldyna, Martin; Yu, Linwei; Roca i Cabarrocas, Pere			Correlative microscopy of radial junction nanowire solar cells using nanoindent position markers	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Radial junction solar cells; Silicon nanowires; Thin films; Structural disorder; Conductive atomic force microscopy; Nanoindentation; Correlative microscopy	ATOMIC-FORCE MICROSCOPY; SILICON THIN-FILMS; ELECTRICAL-PROPERTIES; CARBON NANOWALL; FABRICATION; OXIDATION; GROWTH; AFM	Radial junction solar cells with only similar to 100 nm thin amorphous Si absorber layer deposited on Si nanowires can be prepared by a relatively simple and low-cost thin film technology. Metal assisted Si nanowire growth leads to a disorder in nanowire orientations, lengths and shapes, which is then preserved by the conformal absorber layer. Interestingly, high conversion efficiencies are reached in spite of the disorder. In this contribution we describe microscopic methods aiming at exploring the role of structural disorder on the local electronic properties of radial junction cells. A method for locating the same nanostructure in different microscopes, using the nanoindentation marks for orientation on the sample, is described. Indents can be easily located by optical microscopy, scanning electron microscopes or scanning probe microscopes. Groups of three indents arranged in triangles can serve as coordinate systems for triangulation on samples, enabling correlative microscopy even in instruments which were not designed for it. This approach also enables localization of the same positions on samples after repeated mounting in various microscopes with a precision better than 50 nm. This is possible even on samples without any structural features, as demonstrated for flat silicon thin films prepared by solid phase crystallization, for which we have correlated crystallographic maps from electron backscattering diffraction and conductivity maps by atomic force microscopy. The technique allows observing the same locations before and after technological steps, as shown for the hot wire chemical vapor deposition of carbon nanowalls. (C) 2014 Elsevier B.V. All rights reserved.	[Fejfar, Antonin; Hyvl, Matej; Vetushka, Aliaksei; Pikna, Peter; Hajkova, Zdenka; Ledinsky, Martin; Kocka, Jan] Acad Sci Czech Republic, Inst Phys, Prague 16200 6, Czech Republic; [Klapetek, Petr] Czech Metrol Inst, Brno 63800, Czech Republic; [Marek, Ales; Maskova, Andrea; Vyskocil, Jiri] HVM Plasma Sro, Prague 5, Czech Republic; [Merkel, Janis; Becker, Christiane] Helmholtz Zentrum Berlin, Berlin, Germany; [Itoh, Takashi] Gifu Univ, Gifu 5011193, Japan; [Misra, Soumyadeep; Foldyna, Martin; Yu, Linwei; Roca i Cabarrocas, Pere] Ecole Polytech, CNRS, Lab Phys Interfaces & Couches Minces, F-91128 Palaiseau, France	Fejfar, A (reprint author), Acad Sci Czech Republic, Inst Phys, Cukrovarnicka 10, Prague 16200 6, Czech Republic.	fejfar@fzu.cz	Fejfar, Antonin/A-3347-2009; Ledinsky, Martin/H-3092-2014; Foldyna, Martin/C-5981-2014	Fejfar, Antonin/0000-0003-0988-0772; Foldyna, Martin/0000-0001-8413-0504	EU Grant (PolySiMode) of the FP7-Energy-1 [240826]; Czech Science Foundation [14-12386S]; Academy of Sciences of the Czech Republic [M100101216, M100101217]; Ministry of Education, Youth and Sports of the Czech Republic [LM2011026]	The authors would like to thank Carola Klimm for the EBSD measurements and the company Tescan Orsay Holding for the Maia 3 SEM. This work was supported by the following projects: EU Grant Agreement No. 240826 (PolySiMode) of the FP7-Energy-2009-1, 14-12386S of the Czech Science Foundation, M100101216 and M100101217 of the Academy of Sciences of the Czech Republic and LM2011026 of the Ministry of Education, Youth and Sports of the Czech Republic.	Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Teichert C, 2011, NANOSCI TECHNOL, P691, DOI 10.1007/978-3-642-10497-8_23; Fejfar A, 2013, SOL ENERG MAT SOL C, V119, P228, DOI 10.1016/j.solmat.2013.07.042; Yu LW, 2012, NANO LETT, V12, P4153, DOI 10.1021/nl3017187; Kayes B. M., 2005, Journal of Applied Physics, V97, DOI 10.1063/1.1901835; Yu LW, 2013, NANOTECHNOLOGY, V24, DOI [10.1088/0957-4484/24/27/275401, 10.1088/0957-4484/24/23/235401]; Kuang YH, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/10/106502; Beinik I, 2011, J APPL PHYS, V110, DOI 10.1063/1.3623764; Stallinga S, 2010, OPT EXPRESS, V18, P24461, DOI 10.1364/OE.18.024461; Schmidt V, 2009, ADV MATER, V21, P2681, DOI 10.1002/adma.200803754; Yu LW, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/19/194011; Misra S, 2013, SOL ENERG MAT SOL C, V118, P90, DOI 10.1016/j.solmat.2013.07.036; Becker C, 2013, SOL ENERG MAT SOL C, V119, P112, DOI 10.1016/j.solmat.2013.05.043; Merkel JJ, 2013, J CRYST GROWTH, V367, P126, DOI 10.1016/j.jcrysgro.2012.12.037; Proff C, 2010, J NUCL MATER, V404, P97, DOI 10.1016/j.jnucmat.2010.05.012; Vetushka A, 2012, J NON-CRYST SOLIDS, V358, P2545, DOI 10.1016/j.jnoncrysol.2011.12.094; Fejfar A., 2011, EU PVSEC P HAMB, P2788; Hiramatsu M, 2010, CARBON NANOWALLS: SYNTHESIS AND EMERGING APPLICATIONS, P1, DOI 10.1007/978-3-211-99718-5; Itoh T, 2006, THIN SOLID FILMS, V501, P314, DOI 10.1016/j.tsf.2005.07.216; Itoh T, 2012, J NON-CRYST SOLIDS, V358, P2548, DOI 10.1016/j.jnoncrysol.2012.01.062; Kalinin S. V., 2007, SCANNING PROBE MICRO; Keevers MJ, 2007, P 22 EUR PHOT SOL EN, P1783; Li C., 2011, 132 BRUK, V132; Markiewicz P, 1997, ULTRAMICROSCOPY, V68, P215, DOI 10.1016/S0304-3991(97)00035-1; Misra S., 2014, J PHYS APPL PHYS, V47; Pittenger B., 2010, 128 BRUK, V128; Romanus H, 2007, MICROELECTRON ENG, V84, P524, DOI 10.1016/j.mee.2006.10.076; Rumler M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4746742; Sikora A, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055401; Vetushka A, 2010, Physical Review B (Condensed Matter and Materials Physics), V81, DOI 10.1103/PhysRevB.81.237301; Vetushka A, 2010, PHYS STATUS SOLIDI C, V7, P728, DOI 10.1002/pssc.200982777; Wayne R., 2014, LIGHT VIDEO MICROSC, P219; Yu LW, 2010, SOL ENERG MAT SOL C, V94, P1855, DOI 10.1016/j.solmat.2010.06.021; Zeng L., 2011, MICROSC RES TECH	34	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	APR	2015	135				SI		106	112		10.1016/j.solmat.2014.10.027		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CE6VJ	WOS:000351976000016		
J	Zhang, P; Wang, H; Si, Q; Matsui, M; Takeda, Y; Yamamoto, O; Imanishi, N				Zhang, P.; Wang, H.; Si, Q.; Matsui, M.; Takeda, Y.; Yamamoto, O.; Imanishi, N.			High lithium ion conductivity solid electrolyte of chromium and aluminum co-doped NASICON-type LiTi2(PO4)(3)	SOLID STATE IONICS			English	Article						Solid electrolyte; Lithium ion conductor; NASICON; Lithium-air cell	PHOSPHATE; HALIDES	High lithium ion conductivity solid electrolytes of Li1+xCrxTi2 (-) (x)(PO4)(3) (x = 0-0.5) and Li1.4AlxCr0.4 - xTi1.6(PO4)(3) (x = 0-0.4) with the NASICON-type structure were synthesized using a precursor prepared by the sol-gel method. The highest total electrical conductivity of 3.55 x 10(-4) S cm(-1) at 25 C was obtained for x = 0.4 in Li1+xCrxTi2 - x(PO4)(3) (LACTP) sintered at 1120 degrees C for 6 h in air. Higher electrical conductivity was observed by the partial substitution of Cr3+ with Al3+. The highest total electrical conductivity of 1.06 x 10(-3) S cm(-1) and bulk conductivity of 1.77 x 10(-3) S cm(-1) at 25 degrees C were obtained for x = 0.3 in Li1.4AlxCr0.4 - xTi1.6(PO4)(3) sintered at 1070 degrees C for 6 h in air. The contribution of electronic conductivity to the total conductivity was negligibly small. Li1.4Al0.3Cr0.1Ti1.6(PO4)(3) was unstable in water, but stable in saturated LiOH with saturated LiCl aqueous solution. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, P.; Wang, H.; Si, Q.; Matsui, M.; Takeda, Y.; Yamamoto, O.; Imanishi, N.] Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan; [Matsui, M.] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Yamamoto, O (reprint author), Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan.	Yamamoto@chem.mie-u.ac.jp	Matsui, Masaki/O-6645-2015	Matsui, Masaki/0000-0003-1499-7457	Japan Science and Technology Agency (JST) under the Advanced Low Carbon Technology Research and Development Program	This study was supported by the Japan Science and Technology Agency (JST) under the Advanced Low Carbon Technology Research and Development Program.	Alpen U. V., 1977, APPL PHYS LETT, V30, P631; Bohnke O, 2011, SOLID STATE IONICS, V188, P144, DOI 10.1016/j.ssi.2010.09.058; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Imanishi N, 2014, MATER TODAY, V17, P24, DOI 10.1016/j.mattod.2013.12.004; WAGNER JB, 1957, J CHEM PHYS, V26, P1597, DOI 10.1063/1.1743590; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; HONG HYP, 1978, MATER RES BULL, V13, P117, DOI 10.1016/0025-5408(78)90075-2; Zhang P, 2014, SOLID STATE IONICS, V263, P27, DOI 10.1016/j.ssi.2014.04.017; AONO H, 1990, J ELECTROCHEM SOC, V137, P1023, DOI 10.1149/1.2086597; Takahashi K, 2012, J ELECTROCHEM SOC, V159, pA342, DOI 10.1149/2.018204jes; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; Shimonishi Y, 2011, J POWER SOURCES, V196, P5128, DOI 10.1016/j.jpowsour.2011.02.023; Shimonishi Y, 2010, J POWER SOURCES, V195, P6187, DOI 10.1016/j.jpowsour.2009.11.023; Murugan R, 2007, ANGEW CHEM INT EDIT, V46, P7778, DOI 10.1002/anie.200701144; Bruce P. C., 1982, J ELECTROCHEM SOC, V136, P662; Calven C., 2011, CHEM MATER, V23, P1892; Fu J., 1998, J MATER SCI, V33, P154; Hasegawa S., 2008, J POWER SOURCES, V189, P371; Ishiguro K., 2013, J ELECTROCHEM SOC, V160, pA1684; Kondo S., 1998, LITHIUM ION BATTERIE, P199, DOI 10.1002/9783527612000.ch9; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tatsumishako M., 2014, NANOSCALE TECHNOLOGY, P63; Thokchom JS, 2008, J ELECTROCHEM SOC, V155, pA915, DOI 10.1149/1.2988731; Visco S.J., 2004, 12 INT M LITH BATT N; Zhang P., 2014, SOLID STATE IONICS, V253, P175; Zhang T, 2010, J ELECTROCHEM SOC, V157, pA214, DOI 10.1149/1.3271103	26	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	APR	2015	272						101	106		10.1016/j.ssi.2015.01.004		6	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CE4KP	WOS:000351799800013		
J	Kee, Y; Dimov, N; Kobayashi, E; Kitajou, A; Okada, S				Kee, Yongho; Dimov, Nikolay; Kobayashi, Eiji; Kitajou, Ayuko; Okada, Shigeto			Structural and electrochemical properties of Fe- and Al-doped Li3V2(PO4)(3) for all-solid-state symmetric lithium ion batteries prepared by spray-drying-assisted carbothermal method	SOLID STATE IONICS			English	Article						Lithium-ion battery; All-solid-state battery; Li3V2(PO4)(3); Spray drying; NASICON; Symmetric battery	CATHODE MATERIAL; HYDROTHERMAL SYNTHESIS; VANADIUM PHOSPHATE; PERFORMANCE; TEMPERATURE; COMPOSITES; PHASE; CELL	Li3V2(PO4)(3) and Li3V1.9M0.1 (PO4)(3) (M = Fe, Al) samples were synthesized via spray-drying-assisted carbothermal solid-state reaction, and their structural and electrochemical properties were investigated by XRD, SEM, and galvanostatic charge/discharge. Li3V2(PO4)(3), Li3V1.9Fe0.1(PO4)(3), and Li3V1.9Al0.1 (PO4)(3) showed initial discharge capacities of 103.3 mAh g(-1), 107.6 mAh g(-1), and 105.6 mAh g(-1), respectively, in the all-solid-state symmetric batteries with Li1.5Al0.5Ge1.5(PO4)(3) solid-state electrolytes at a rate of 7.5 mA g(-1). The enhanced discharge capacities of Fe and Al-doped Li3V2(PO4)(3) could be attributed to the increased electrical conductivity induced by the introduction of Fe3+ or Al3+ trivalent ions into the V3+ sites and to the structural stabilization of the monoclinic Li3V2(PO4)(3) by the spray-drying process. (C) 2015 Elsevier B.V. All rights reserved.	[Kee, Yongho] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Dimov, Nikolay; Kobayashi, Eiji; Kitajou, Ayuko; Okada, Shigeto] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Okada, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	s-okada@cm.kyushu-u.ac.jp					Chang CX, 2008, ELECTROCHIM ACTA, V54, P623, DOI 10.1016/j.electacta.2008.07.038; Suzuki T, 1997, SOLID STATE IONICS, V104, P27, DOI 10.1016/S0167-2738(97)00404-9; Ko YN, 2011, J POWER SOURCES, V196, P6682, DOI 10.1016/j.jpowsour.2010.11.086; Ren MM, 2006, J POWER SOURCES, V162, P1357, DOI 10.1016/j.jpowsour.2006.08.008; Huang JS, 2010, J POWER SOURCES, V195, P5013, DOI 10.1016/j.jpowsour.2010.02.009; Sun CW, 2011, ACS APPL MATER INTER, V3, P3772, DOI 10.1021/am200987y; Deng C, 2011, J PHYS CHEM C, V115, P15048, DOI 10.1021/jp201686g; Sato M, 2000, SOLID STATE IONICS, V135, P137, DOI 10.1016/S0167-2738(00)00292-7; Pan AQ, 2011, J POWER SOURCES, V196, P3646, DOI 10.1016/j.jpowsour.2010.12.067; BYKOV AB, 1990, SOLID STATE IONICS, V38, P31, DOI 10.1016/0167-2738(90)90442-T; AONO H, 1992, B CHEM SOC JPN, V65, P2200, DOI 10.1246/bcsj.65.2200; Kee Y., 2013, ACTA CRYSTALLOGR E, VE69, pi11; Kobayashi E, 2013, J POWER SOURCES, V244, P312, DOI 10.1016/j.jpowsour.2013.01.031; Kobayashi E, 2010, ELECTROCHEM COMMUN, V12, P894, DOI 10.1016/j.elecom.2010.04.014; Patoux S, 2004, SOLID STATE SCI, V6, P1113, DOI 10.1016/j.solidstatesciences.2004.07.028; Yang G, 2010, J POWER SOURCES, V195, P5374, DOI 10.1016/j.jpowsour.2010.03.037; Zhang LL, 2013, ELECTROCHIM ACTA, V90, P433, DOI 10.1016/j.electacta.2012.11.126; Zhang LL, 2013, ELECTROCHIM ACTA, V108, P182, DOI 10.1016/j.electacta.2013.06.071; Zhang LL, 2012, J ELECTROCHEM SOC, V159, pA1573, DOI 10.1149/2.001210jes	19	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	APR	2015	272						138	143		10.1016/j.ssi.2015.01.006		6	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CE4KP	WOS:000351799800019		
J	Nishiyama, Y; Kobayashi, T; Malon, M; Singappuli-Arachchige, D; Slowing, II; Pruski, M				Nishiyama, Y.; Kobayashi, T.; Malon, M.; Singappuli-Arachchige, D.; Slowing, I. I.; Pruski, M.			Studies of minute quantities of natural abundance molecules using 2D heteronuclear correlation spectroscopy under 100 kHz MAS	SOLID STATE NUCLEAR MAGNETIC RESONANCE			English	Article						Ultrafast MAS; Indirect detection; HSQC; HMQC; Mesoporous silica nanoparticles	SOLID-STATE NMR; ANGLE-SPINNING NMR; ULTRA-FAST MAS; FUNCTIONALIZED MESOPOROUS SILICAS; CROSS-POLARIZATION; SENSITIVITY ENHANCEMENT; ROTATING SOLIDS; N-15 NMR; PROTEIN; PROTON	Two-dimensional H-1{C-13} heteronuclear correlation solid-state NMR spectra of naturally abundant solid materials are presented, acquired using the 0.75-mm magic angle spinning (MAS) probe at spinning rates up to 100 kHz. In spite of the miniscule sample volume (290 nL), high-quality HSQC-type spectra of bulk samples as well as surface-bound molecules can be obtained within hours of experimental time. The experiments are compared with those carried out at 40 kHz MAS using a 1.6-mm probe, which offered higher overall sensitivity due to a larger rotor volume. The benefits of ultrafast MAS in such experiments include superior resolution in H-1 dimension without resorting to H-1-H-1 homonuclear RE decoupling, easy optimization, and applicability to mass-limited samples. The HMQC spectra of surface-bound species can be also acquired under 100 kHz MAS, although the dephasing of transverse magnetization has significant effect on the efficiency transfer under MAS alone. Published by Elsevier Inc.	[Nishiyama, Y.; Malon, M.] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan; [Nishiyama, Y.; Malon, M.] RIKEN CLST JEOL Collaborat Ctr, Yokohama, Kanagawa 2300045, Japan; [Kobayashi, T.; Singappuli-Arachchige, D.; Slowing, I. I.; Pruski, M.] US DOE, Ames Lab, Ames, IA 50011 USA; [Singappuli-Arachchige, D.; Slowing, I. I.; Pruski, M.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA	Nishiyama, Y (reprint author), JEOL RESONANCE Inc, 3-1-2 Musashino, Akishima, Tokyo 1968558, Japan.	yunishiy@jeol.co.jp; mpruski@iastate.edu			U.S. Department of Energy; Office of Basic Energy Sciences (BES); Division of Chemical Sciences, Geosciences, and Biosciences through the Ames Laboratory; U.S. Department of Energy by Iowa State University [DE-ACO2-07CH11358]	This research was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences, and Biosciences through the Ames Laboratory (T.K., D.S.-A., I.I.S., M.P.). The Ames Laboratory is operated for the U.S. Department of Energy by Iowa State University under Contract no. DE-ACO2-07CH11358.	Agarwal V, 2014, ANGEW CHEM INT EDIT, V53, P12253, DOI 10.1002/anie.201405730; Laage S, 2008, J AM CHEM SOC, V130, P17216, DOI 10.1021/ja805926d; Demers JP, 2011, SOLID STATE NUCL MAG, V40, P101, DOI 10.1016/j.ssnmr.2011.07.002; Wickramasinghe NP, 2009, NAT METHODS, V6, P215, DOI [10.1038/nmeth.1300, 10.1038/NMETH.1300]; Ishii Y, 2000, J MAGN RESON, V142, P199, DOI 10.1006/jmre.1999.1976; Ye YQ, 2014, J MAGN RESON, V239, P75, DOI 10.1016/j.jmr.2013.12.010; Du LS, 2000, CHEM MATER, V12, P3611, DOI 10.1021/cm00355h; Wiench JW, 2007, J AM CHEM SOC, V129, P12076, DOI 10.1021/ja074746+; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Reif B, 2003, J MAGN RESON, V160, P78, DOI 10.1016/S1090-7807(02)00035-6; Ernst M, 2001, CHEM PHYS LETT, V348, P293, DOI 10.1016/S0009-2614(01)01115-0; Mao K, 2010, J MAGN RESON, V203, P144, DOI 10.1016/j.jmr.2009.12.013; Ishii Y, 2001, J AM CHEM SOC, V123, P2921, DOI 10.1021/ja015505j; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Huh S, 2003, CHEM MATER, V15, P4247, DOI 10.1021/cm0210041; Agarwal V, 2013, CHEM PHYS LETT, V583, P1, DOI 10.1016/j.cplett.2013.07.073; Zhou DH, 2007, J AM CHEM SOC, V129, P11791, DOI 10.1021/ja073462m; Ernst M, 2004, J AM CHEM SOC, V126, P4764, DOI 10.1021/ja0494510; MEIER BH, 1992, CHEM PHYS LETT, V188, P201, DOI 10.1016/0009-2614(92)90009-C; Lu XY, 2012, J MAGN RESON, V223, P219, DOI 10.1016/j.jmr.2012.07.015; Mao K, 2009, J MAGN RESON, V196, P92, DOI 10.1016/j.jmr.2008.10.010; Leskes M, 2008, CHEM PHYS LETT, V466, P95, DOI 10.1016/j.cplett.2008.10.029; Leskes M, 2009, J MAGN RESON, V199, P208, DOI 10.1016/j.jmr.2009.05.003; Kobayashi T, 2013, ANGEW CHEM INT EDIT, V52, P14108, DOI 10.1002/anie.201305475; Nishiyama Y, 2011, J MAGN RESON, V208, P44, DOI 10.1016/j.jmr.2010.10.001; Parthasarathy S, 2013, ACCOUNTS CHEM RES, V46, P2127, DOI 10.1021/ar4000482; Nishiyama Y, 2012, J MAGN RESON, V214, P151, DOI 10.1016/j.jmr.2011.10.014; Paluch P, 2013, J MAGN RESON, V233, P56, DOI 10.1016/j.jmr.2013.05.005; Kandel K, 2012, J CATAL, V291, P63, DOI 10.1016/j.jcat.2012.04.005; Lange A, 2009, CHEM PHYS LETT, V468, P100, DOI 10.1016/j.cplett.2008.11.089; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Demers JP, 2010, J MAGN RESON, V205, P216, DOI 10.1016/j.jmr.2010.04.019; Ernst M, 2003, J AM CHEM SOC, V125, P15807, DOI 10.1021/ja0369966; Kraus J. D., 1953, ELECTROMAGNETICS; Palmer A.R., 2007, APPL NOTES; PECK TL, 1995, J MAGN RESON SER B, V108, P114, DOI 10.1006/jmrb.1995.1112; Pintacuda G., 2013, MODERN NMR METHODOLO, V335, P157; Samoson A., 2002, ENCY NUCL MAGNETIC R, V9, P59; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Trebosc J, 2005, J AM CHEM SOC, V127, P7587, DOI 10.1021/ja0509127	42	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0926-2040	1527-3326		SOLID STATE NUCL MAG	Solid State Nucl. Magn. Reson.	APR-MAY	2015	66-67						56	61		10.1016/j.ssnmr.2015.02.001		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical; Physics, Condensed Matter; Spectroscopy	Chemistry; Physics; Spectroscopy	CE2SC	WOS:000351665800010		
J	Yabe, Y; Hagiwara, Y; Ando, A; Tsuchiya, M; Minowa, T; Takemura, T; Honda, M; Hatori, K; Sonofuchi, K; Kanazawa, K; Koide, M; Sekiguchi, T; Itoi, E				Yabe, Yutaka; Hagiwara, Yoshihiro; Ando, Akira; Tsuchiya, Masahiro; Minowa, Takashi; Takemura, Taro; Honda, Masahito; Hatori, Kouki; Sonofuchi, Kazuaki; Kanazawa, Kenji; Koide, Masashi; Sekiguchi, Takuya; Itoi, Eiji			Chondrogenic and Fibrotic Process in the Ligamentum Flavum of Patients With Lumbar Spinal Canal Stenosis	SPINE			English	Article						lumbar spine; canal stenosis; ligamentum flavum; histology; biology; collagen; elastin; fibrosis; chondrogenesis; proteoglycans; DNA microarray analysis	MATRIX METALLOPROTEINASES; GROWTH-FACTOR; INCREASED EXPRESSION; SCAR TISSUE; HYPERTROPHY; FIBROSIS; RAT; PATHOMECHANISM; PROTEOGLYCANS; ACCUMULATION	Study Design. A histological, biological, and immunohistochemical study of human lumbar ligamentum flavum. Objective. To analyze changes in the hypertrophied ligamentum flavum and clarify their etiology. Summary of Background Data. Hypertrophy of the ligamentum flavum has been considered a major contributor to the development of lumbar spinal canal stenosis (LSCS). Although previous studies have reported some factors related to ligamentum flavum hypertrophy, its etiology is still unclear. Methods. Ligamentum flavum samples were collected from 20 patients with LSCS (LSCS group) and 10 patients with lumbar disc herniation (LDH group) as a control. The thickness of the ligamentum flavum was measured histologically. The amounts of elastic fibers and proteoglycans were assessed by Elastica-Masson staining and alcian blue staining, respectively. Gene and protein expressions related to fibrosis, inflammation, and chondrogenesis were analyzed by quantitative reverse transcription-polymerase chain reaction and immunohistochemistry. The total genes of the 2 groups were compared by DNA microarray analysis. Results. The ligamentum flavum was significantly thicker in the LSCS group, which had a smaller amount of elastic fibers and a larger amount of proteoglycans. The gene expression related to fibrosis was significantly higher in the LSCS group; however, the immunoreactivities of collagen types I and III were weaker on the dorsal side of the ligamentum flavum in the LSCS group. The gene expression related to chondrogenesis and proteoglycan synthesis was significantly higher in the LSCS group. There was no significant difference in the gene expression related to inflammation between the 2 groups. Conclusion. Synthesis of the collagenous fibers and degradation of the elastic and collagenous fibers are both accelerated in the ligamentum flavum of patient with LSCS, which may be the reason for hypertrophy of the tissue. In addition, chondrogenesis and proteoglycan synthesis may have critical roles in the pathogenesis of the ligamentum flavum hypertrophy.	[Yabe, Yutaka; Hagiwara, Yoshihiro; Ando, Akira; Sonofuchi, Kazuaki; Kanazawa, Kenji; Koide, Masashi; Sekiguchi, Takuya; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 9808574, Japan; [Tsuchiya, Masahiro] Tohoku Univ, Grad Sch Dent, Div Aging & Geriatr Dent, Sendai, Miyagi 9808574, Japan; [Minowa, Takashi; Takemura, Taro] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki, Japan; [Honda, Masahito] Takeda Gen Hosp, Dept Otrhopaed Surg, Aizu Wakamatsu, Fukushima, Japan; [Hatori, Kouki] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan	Hagiwara, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	hagi@med.tohoku.ac.jp					Abbas J, 2010, SPINE, V35, P1225, DOI 10.1097/BRS.0b013e3181bfca15; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Hansson T, 2009, EUR SPINE J, V18, P679, DOI 10.1007/s00586-009-0919-7; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; YOSHIDA M, 1992, SPINE, V17, P1353, DOI 10.1097/00007632-199211000-00015; Altinkaya N, 2011, SPINE, V36, pE1093, DOI 10.1097/BRS.0b013e318203e2b5; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Chithra P, 1998, J ETHNOPHARMACOL, V59, P179, DOI 10.1016/S0378-8741(97)00112-8; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Viejo-Fuertes D, 1998, SURG RADIOL ANAT, V20, P171, DOI 10.1007/BF01628891; Bermpohl F, 1998, FEBS LETT, V428, P152, DOI 10.1016/S0014-5793(98)00515-8; HERNNAS J, 1992, EUR RESPIR J, V5, P404; Hagiwara Y, 2012, OSTEOARTHR CARTILAGE, V20, P241, DOI 10.1016/j.joca.2011.12.008; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Johnson LL, 1998, CURR OPIN CHEM BIOL, V2, P466, DOI 10.1016/S1367-5931(98)80122-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Herbst H, 1997, AM J PATHOL, V150, P1647; Lakemeier S, 2013, J SPINAL DISORD TECH, V26, P400, DOI 10.1097/BSD.0b013e3182495b88; Nakatani T, 2002, J ORTHOPAED RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Oh IS, 2013, CONNECT TISSUE RES, V54, P380, DOI 10.3109/03008207.2013.848199; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Park Jong-Beom, 2009, Clin Orthop Surg, V1, P81, DOI 10.4055/cios.2009.1.2.81; Park JB, 2005, J BONE JOINT SURG AM, V87A, P2750, DOI 10.2106/JBJS.E.00251; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Shafaq N, 2012, J SPINAL DISORD TECH, V25, P107, DOI 10.1097/BSD.0b013e31820bb76e; SWANN DA, 1985, J INVEST DERMATOL, V84, P527, DOI 10.1111/1523-1747.ep12273517; Zhang Y, 2010, SPINE, V35, pE1479, DOI 10.1097/BRS.0b013e3181f3d2df; Zhong ZM, 2011, J ORTHOP RES, V29, P1592, DOI 10.1002/jor.21431	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	APR 1	2015	40	7					429	435		10.1097/BRS.0000000000000795		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE5NN	WOS:000351882500012		
J	Fujimori, T; Le, H; Hu, SS; Chin, C; Pekmezci, M; Schairer, W; Tay, BK; Hamasaki, T; Yoshikawa, H; Iwasaki, M				Fujimori, Takahito; Le, Hai; Hu, Serena S.; Chin, Cynthia; Pekmezci, Murat; Schairer, William; Tay, Bobby K.; Hamasaki, Toshimitsu; Yoshikawa, Hideki; Iwasaki, Motoki			Ossification of the Posterior Longitudinal Ligament of the Cervical Spine in 3161 Patients A CT-Based Study	SPINE			English	Article						CT; ossification; posterior longitudinal ligament; cervical spine; race	IDIOPATHIC SKELETAL HYPEROSTOSIS; COMPUTED-TOMOGRAPHY; CORD COMPRESSION; JAPANESE; POPULATION; CALCIFICATION; MYELOPATHY; PREVALENCE; DISEASE; ASIANS	Study Design. A cross-sectional study. Objective. To examine the prevalence of ossification of the posterior longitudinal ligament (OPLL) and ossification of the nuchal ligament (ONL) of the cervical spine in the San Francisco area. Summary of Background Data. The prevalence of OPLL and ONL is unknown in the non-Asian population. Methods. This computed tomography-based cross-sectional study assessed the prevalence of OPLL and ONL within the cervical spine of patients treated at a level 1 trauma center between 2009 and 2012. The prevalence of both OPLL and ONL was compared between racial groups. Results. Of the 3161 patients (mean age, 51.2 +/- 21.6 yr; 66.1% male), there were 1593 Caucasians (50.4%), 624 Asians (19.7%), 472 Hispanics (14.9%), 326 African Americans (10.3%), 62 Native Americans (2.0%), and 84 Others (2.7%). The prevalence of cervical OPLL was 2.2% (95% confidence interval [CI]: 1.7-2.8). The adjusted prevalence was 1.3% in Caucasian Americans (95% CI: 0.7-2.3), 4.8% in Asian Americans (95% CI: 2.8-8.1), 1.9% in Hispanic Americans (95% CI: 0.9-4.0), 2.1% in African Americans (95% CI: 0.9-4.8), and 3.2% in Native Americans (95% CI: 0.8-12.3). The prevalence of OPLL in Asian Americans was significantly higher than that in Caucasian Americans (P = 0.005). ONL was detected in 346 patients and the prevalence was 10.9% (95% CI: 10.0-12.0). The adjusted prevalence of ONL was 7.3% in Caucasian Americans (95% CI: 5.8-9.3), 26.4% in Asian Americans (95% CI: 21.9-31.5), 7.4% in Hispanic Americans (95% CI: 5.2-10.5), 2.5% in African Americans (95% CI: 1.2-4.9), and 25.8% in Native Americans (95% CI: 16.5-37.5). ONL was significantly more common in Asian Americans than in Caucasian Americans, Hispanic Americans, and African Americans (P = 0.001). Conclusion. This study also demonstrated that OPLL and ONL were significantly more common in Asian Americans than in Caucasian Americans.	[Fujimori, Takahito; Yoshikawa, Hideki; Iwasaki, Motoki] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan; [Fujimori, Takahito; Le, Hai; Hu, Serena S.; Schairer, William; Tay, Bobby K.] Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA 94143 USA; [Fujimori, Takahito] Sumitomo Hosp, Dept Orthoped Surg, Osaka 5300005, Japan; [Chin, Cynthia] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Pekmezci, Murat] San Francisco Gen Hosp, Dept Orthoped Surg, San Francisco, CA 94110 USA; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Osaka, Japan	Fujimori, T (reprint author), Sumitomo Hosp, Dept Orthoped Surg, 5-3-20 Nakanoshima, Osaka 5300005, Japan.	takahito-f@hotmail.co.jp			Nakatomi Foundation; Investigation Committee on the Ossification of the Spinal Ligaments of the Japanese Ministry of Health, Labor, and Welfare	The Nakatomi Foundation and the Investigation Committee on the Ossification of the Spinal Ligaments of the Japanese Ministry of Health, Labor, and Welfare grant-in-aid funds were received to support this work.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Adelowo O, 2011, BMJ CASE REP 2011, V2011; Kudo H, 2013, EUR SPINE J, V22, P205, DOI 10.1007/s00586-012-2573-8; MCAFEE PC, 1987, J BONE JOINT SURG BR, V69, P569; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Mori K, 2014, SPINE, V39, P394, DOI 10.1097/BRS.0000000000000153; Shingyouchi Y, 1996, SPINE, V21, P2474, DOI 10.1097/00007632-199611010-00013; Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3; OHTSUKA K, 1987, ARCH ORTHOP TRAUM SU, V106, P89, DOI 10.1007/BF00435420; Kawaguchi Y, 2011, SPINE J, V11, P927, DOI 10.1016/j.spinee.2011.08.013; Barsony TH., 1929, ROFO FORTSCHR RONTG, V40, P809; BREIDAHL P, 1969, AUSTRALAS RADIOL, V13, P311, DOI 10.1111/j.1440-1673.1969.tb01614.x; EPSTEIN NE, 1994, SPINE, V19, P673, DOI 10.1097/00007632-199403001-00006; FIROOZNIA H, 1982, NEW YORK STATE J MED, V82, P1193; FIROOZNIA H, 1984, CT-J COMPUT TOMOGR, V8, P317; Fujimori T, 2012, J NEUROSURG-SPINE, V16, P289, DOI 10.3171/2011.11.SPINE11502; GRIFFITHS ID, 1987, ANN RHEUM DIS, V46, P166, DOI 10.1136/ard.46.2.166; HENRARD JC, 1973, REV RHUM, V40, P581; Iwasaki M, 2011, SPINE, P791; Izawa K, 1980, Nihon Seikeigeka Gakkai Zasshi, V54, P461; Jeon TS, 2012, SPINE, V37, pE1498, DOI 10.1097/BRS.0b013e31826efd89; Kawaguchi Y, 2013, SPINE, V38, pE1477, DOI 10.1097/BRS.0b013e3182a54f00; Key C., 1838, GUYS HOSP REP, V3, P17; LEE T, 1991, SURG NEUROL, V35, P40, DOI 10.1016/0090-3019(91)90200-S; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; MINAGI H, 1969, AMER J ROENTGENOL RA, V105, P365; Ohtsuka K, 1987, SEIKEIGEKA MOOK, V50, P13; ONJI Y, 1967, J BONE JOINT SURG AM, VA 49, P1314; Sohn S, 2014, CALCIFIED TISSUE INT, V94, P613, DOI 10.1007/s00223-014-9846-7; Terayama K, 1987, Nihon Seikeigeka Gakkai Zasshi, V61, P1373; Tsukahara S, 2005, SPINE, V30, P2321, DOI 10.1097/01.brs.0000182318.47343.6d; Tsukimoto H, 1960, ARCH JPN CHIR, V29, P1003; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Wang H, 2013, SPINE, V39, pE7; Wang MY, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10277; Wei W, 2014, GENET MOL RES, V13, P1794, DOI 10.4238/2014.March.17.7; Yonenobu K, 2006, OSSIFICATION POSTERI; Yoshimura N, 2014, OSTEOPOROSIS INT, V25, P1089, DOI 10.1007/s00198-013-2489-0	38	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	APR 1	2015	40	7					E394	E403		10.1097/BRS.0000000000000791		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE5NN	WOS:000351882500004		
J	Umeda, A; Saeki, N; Matsumoto, C; Nakao, M; Kawamoto, M				Umeda, Ayako; Saeki, Noboru; Matsumoto, Chikako; Nakao, Masakazu; Kawamoto, Masashi			Abdominal Aortic Injury During Vertebroplasty	SPINE			English	Article						vertebroplasty; percutaneous vertebroplasty; balloon kyphoplasty; rare complication; aortic injury; anesthetic management; needle pressure; elderly patient; prone position; conservative treatment	VERTEBRAL COMPRESSION FRACTURES; BALLOON KYPHOPLASTY; PLACEMENT	Study Design. Case report. Objective. To describe an intraoperative complication occurring from abdominal aortic penetration during a vertebroplasty procedure for vertebral fractures on Th12 and L1. Summary of Background Data. A vertebroplasty is a minimally invasive and widely performed procedure in elderly and high-risk patients, although there is a risk of life-threatening complications including aortic injury. However, little is known about the treatment of iatrogenic aortic penetration occurring during a vertebroplasty. Methods. An 80-year-old female underwent a scheduled vertebroplasty procedure. When the needle was advanced into the L1 vertebral body, arterial blood spurted out from the needle hub and fluoroscopic imaging revealed penetration of the aorta. To minimize bleeding, we depressed blood pressure and kept the needle in place. While vital signs were maintained, we prepared for blood transfusion and circulation monitoring and consulted a cardiothoracic surgeon and a cardiologist. Contrast medium injected via the needle revealed that a hematoma had formed to shift the aortic wall beyond the needle. Circulation was stable while pressure of the needle decreased, thus the hematoma was thought to have become coagulated and the needle was cautiously withdrawn. Results. After placing the patient in a supine position, aortic angiography revealed no leakage around the aorta and she was transferred to the intensive care unit. On postoperative day 1, no leakage around the aorta was confirmed on computed tomographic scans and the patient was extubated. During the 2-year follow-up period, no arterial complication was observed. Conclusion. Conservative treatment is optional for accidental aortic penetration during a vertebroplasty when a tamponade effect is expected. In cases with circulatory collapse, when the tamponade effect seems insufficient or a free wall rupture is suspected, prompt removal of the needle and surgical repair should be considered.	[Umeda, Ayako; Matsumoto, Chikako; Nakao, Masakazu] JA Hiroshima Gen Hosp, Dept Anesthesiol, Hatsukaichi City, Hiroshima 7300051, Japan; [Saeki, Noboru; Kawamoto, Masashi] Hiroshima Univ, Dept Anesthesiol & Crit Care, Hiroshima, Japan	Umeda, A (reprint author), JA Hiroshima Gen Hosp, Dept Anesthesiol, 1-3-3 Jigozen, Hatsukaichi City, Hiroshima 7300051, Japan.	kumeaya_i_hana_gogo@ybb.ne.jp					Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Taylor RS, 2006, SPINE, V31, P2747, DOI 10.1097/01.brs.0000244639.71656.7d; Bergmann M, 2012, ORTHOP REV, V4, P113; Hard JM, 2008, CARDIOVASC INTER RAD, V31, P1249, DOI 10.1007/s00270-008-9353-1; Kobayashi K, 2007, VIDEO INF MED, V39, P551; Parker SL, 2014, SPINE, V39, P683, DOI 10.1097/BRS.0000000000000221; Puri AS, 2011, J NEUROSURG-SPINE, V14, P296, DOI 10.3171/2010.10.SPINE1082; Sucato DJ, 2004, SPINE, V29, P554, DOI 10.1097/01.BRS.0000106495.91477.92	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	APR 1	2015	40	7					E439	E441		10.1097/BRS.0000000000000780		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE5NN	WOS:000351882500011		
J	Teraguchi, M; Yoshimura, N; Hashizume, H; Muraki, S; Yamada, H; Oka, H; Minamide, A; Nakagawa, H; Ishimoto, Y; Nagata, K; Kagotani, R; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Yoshida, M				Teraguchi, Masatoshi; Yoshimura, Noriko; Hashizume, Hiroshi; Muraki, Shigeyuki; Yamada, Hiroshi; Oka, Hiroyuki; Minamide, Akihito; Nakagawa, Hiroyuki; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Yoshida, Munehito			The association of combination of disc degeneration, end plate signal change, and Schmorl node with low back pain in a large population study: the Wakayama Spine Study	SPINE JOURNAL			English	Article						Disc degeneration; End plate signal change; Schmorl node; Low back pain; Large population study; ROAD study	RADIOGRAPHIC LUMBAR SPONDYLOSIS; RESONANCE-IMAGING CHANGES; ISSLS PRIZE WINNER; QUALITY-OF-LIFE; INTERVERTEBRAL DISC; MODIC CHANGES; PHYSICAL PERFORMANCE; UNITED-STATES; JAPANESE MEN; PREVALENCE	BACKGROUND CONTEXT: Disc degeneration (DD) reportedly causes low back pain (LBP) and is often observed concomitantly with end plate signal change (ESC) and/or Schmorl node (SN) on magnetic resonance imaging. PURPOSE: The purpose of this study was to examine the association between DD and LBP, considering ESC and/or SN presence, in a large population study. STUDY DESIGN/SETTING: Cross-sectional population-based study in two regions of Japan. PATIENT SAMPLE: Of 1,011 possible participants, data from 975 participants (324 men, 651 women; mean age, 66.4 years; range, 21-97 years) were included. OUTCOME MEASURES: Prevalence of DD, ESC, and SN alone and in combination in the lumbar region and the association of these prevalence levels with LBP. METHODS: Sagittal T2-weighted images were used to assess the intervertebral spaces between L1-L2 and L5-S1. Disc degeneration was classified using the Pfirrmann classification system (grades 4 and 5 indicated degeneration); ESC was defined as a diffuse high signal change along either area of the end plate, and SN was defined as a small well-defined herniation pit with a surrounding wall of hypointense signal. Logistic regression analysis was used to determine the odds ratios (ORs) and confidence intervals (CIs) for LBP in the presence of radiographic changes in the lumbar region and at each lumbar intervertebral level, compared with patients without radiographic change, after adjusting for age, body mass index, and sex. RESULTS: The prevalence of lumbar structural findings was as follows: DD alone, 30.4%; ESC alone, 0.8%; SN alone, 1.5%; DD and ESC, 26.6%; DD and SN, 12.3%; and DD, ESC, and SN, 19.1%. These lumbar structural findings were significantly associated with LBP in the lumbar region overall, as follows: DD, ESC, and SN, OR 2.17, 95% CI 1.2-3.9; L1-L2, OR 6.00, 95% CI 1.9-26.6; L4-L5, OR 2.56, 95% CI 1.4-4.9; and L5-S1, OR 2.81, 95% CI 1.1-2.3. The combination of DD and ESC was significantly associated with LBP as follows: L3-L4, OR 2.43, 95% CI 1.5-4.0; L4-L5, OR 1.82, 95% CI 1.2-2.8; and L5-S1, OR 1.60, 95% CI 1.1-2.3. CONCLUSIONS: Our data suggest that DD alone is not associated with LBP. By contrast, the combination of DD and ESC was highly associated with LBP. (C) 2015 Elsevier Inc. All rights reserved.	[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yamada, Hiroshi; Minamide, Akihito; Nakagawa, Hiroyuki; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama 6418510, Japan; [Yoshimura, Noriko; Oka, Hiroyuki; Akune, Toru] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res,Bunkyo Ku, Tokyo 1138655, Japan; [Muraki, Shigeyuki] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Clin Motor Syst Med,Bunkyo Ku, Tokyo 1138655, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, Tokyo 1608402, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, Tokorozawa, Saitama 3598555, Japan	Hashizume, H (reprint author), Wakayama Med Univ, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama 6418510, Japan.	hashizum@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan	This study was funded by the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare in Japan. The sponsors did not contribute to the study design, data collection, data analysis, data interpretation, or the writing of the manuscript.	Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MODIC MT, 1988, RADIOLOGY, V168, P177; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; Weishaupt D, 2001, RADIOLOGY, V218, P420; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Mok FPS, 2010, SPINE, V35, P1944, DOI 10.1097/BRS.0b013e3181d534f3; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; TOYONE T, 1994, J BONE JOINT SURG BR, V76B, P757; MODIC MT, 1988, RADIOLOGY, V166, P193; Muraki S, 2012, OSTEOARTHR CARTILAGE, V20, P712, DOI 10.1016/j.joca.2012.03.009; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Kuisma M, 2007, SPINE, V32, P1116, DOI 10.1097/01.brs.0000261561.12944.ff; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Kjaer P, 2006, EUR SPINE J, V15, P1312, DOI 10.1007/s00586-006-0185-x; Muraki S, 2010, MOD RHEUMATOL, V20, P444, DOI 10.1007/s10165-010-0307-5; Brown MF, 1997, J BONE JOINT SURG BR, V79B, P147, DOI 10.1302/0301-620X.79B1.6814; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Ministry of Health Labour and Welfare, OUTL RES NAT LIV SUR; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; Schmorl G., 1928, ROFO FORTSCHR RONTG, V38, P265; Wagner AL, 2000, AM J NEURORADIOL, V21, P276; Williams FMK, 2007, ARTHRIT RHEUM-ARTHR, V57, P855, DOI 10.1002/art.22789	41	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	APR 1	2015	15	4					622	628		10.1016/j.spinee.2014.11.012		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE2UX	WOS:000351676400013		
J	Okamoto, Y; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Hayashi, H; Sakamoto, J; Kawahara, N; Tsuchiya, H				Okamoto, Yoshiyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Sakamoto, Jiro; Kawahara, Norio; Tsuchiya, Hiroyuki			The effect of kyphotic deformity because of vertebral fracture: a finite element analysis of a 10 degrees and 20 degrees wedge-shaped vertebral fracture model	SPINE JOURNAL			English	Article						Osteoporotic vertebral fracture; Kyphotic deformity; Finite; element analysis; Biomechanics; Whole human model; Bimodal peaks	SPINAL FIXATION DEVICES; BIOMECHANICAL EVALUATION; WOMEN; ALENDRONATE; OSTEOTOMY; STRENGTH; RISK; MEN	BACKGROUND CONTEXT: Kyphotic deformity associated with vertebral fracture is believed to be a significant risk factor for additional vertebral fractures. However, previously published research is limited. PURPOSE: The purpose of this study was to estimate the biomechanical stresses that kyphotic deformity, with an initial vertebral fracture, place on adjacent vertebrae using three-dimensional finite element (FE) of the spine, head, and ribs. STUDY DESIGN: This study is based on the basic science. METHODS: Total Human Model for Safety, a three-dimensional FE model of the human body, was used and adjusted to represent an elderly osteoporotic woman. The 12th thoracic vertebra (T12), which is a frequent site of osteoporotic vertebral fractures, was transformed to a wedge shape at 0 degrees, 10 degrees, and 20 degrees to create a normal model, a 10 degrees kyphosis model, and a 20 degrees kyphosis model. Additionally, compensated postures were created for the 10 degrees and 20 degrees kyphosis models. Thus, five models were created: (A) a normal model, (B) a 10 degrees kyphosis model, (C) a 20 degrees kyphosis model, (D) a 10 degrees kyphosis model with compensated posture, and (E) a 20 degrees kyphosis model with compensated posture. Compressive principal stresses (CPSs) on T1-L5 in each model were calculated. RESULTS: The highest CPS value was 7.78 MPa placed on the anterior part of the T10 vertebra in the 20 degrees kyphosis model. In the 20 degrees kyphosis model, the higher CPS values showed bimodal peaks at T6 and T7 in the midthoracic spine and at T10 and T11 in the two superior adjacent vertebrae. The maximum CPS values in the A, B, C, D, and E models at T10 were 3.12, 6.74, 7.78, 6.61, and 5.78 MPa. At T11, they were 1.70, 4.41, 6.45, 4.07, and 4.79 MPa. CONCLUSIONS: The existence of an initial vertebral fracture at T12 caused an increase in stress on adjacent vertebrae. Higher CPS values showed bimodal peaks in midthoracic vertebrae and in two superior adjacent vertebrae when T12 was transformed to a wedge shape in the 20 degrees kyphosis model. (C) 2015 Elsevier Inc. All rights reserved.	[Okamoto, Yoshiyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa 9208641, Japan; [Sakamoto, Jiro] Kanazawa Univ, Fac Engn, Dept Human & Mech Syst Engn, Kanazawa, Ishikawa 9201192, Japan; [Kawahara, Norio] Kanazawa Med Univ Hosp, Dept Orthoped Surg, Kahoku, Ishikawa 9200293, Japan	Okamoto, Y (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	okamoto19780731@yahoo.co.jp					Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013; Pluijm SMF, 2000, J BONE MINER RES, V15, P1564, DOI 10.1359/jbmr.2000.15.8.1564; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; ROSS PD, 1991, ANN INTERN MED, V114, P919; LEECH JA, 1990, AM REV RESPIR DIS, V141, P68; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Nevitt MC, 2000, ARCH INTERN MED, V160, P77, DOI 10.1001/archinte.160.1.77; Kawahara N, 2001, SPINE, V26, P391, DOI 10.1097/00007632-200102150-00016; Burger H, 1997, J BONE MINER RES, V12, P152, DOI 10.1359/jbmr.1997.12.1.152; Evans FG, 1973, MECH PROPERTIES BONE, P10; Fujimoto K, 2004, ALIMENT PHARM THER, V22, P5; Hato T, 2007, J ORTHOP SCI, V12, P354, DOI 10.1007/s00776-007-1144-z; ITOI E, 1990, CALCIFIED TISSUE INT, V47, P202, DOI 10.1007/BF02555920; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; Mawatari T, 2008, ARTHRITIS RHEUM, V58, P3340, DOI 10.1002/art.23988; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; PANJABI MM, 1988, SPINE, V13, P1135, DOI 10.1097/00007632-198810000-00014; SILVA MJ, 1994, BONE, V15, P409, DOI 10.1016/8756-3282(94)90817-6; Watanabe I., 2001, JSAE REV, V36, P17	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	APR 1	2015	15	4					713	720		10.1016/j.spinee.2014.11.019		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE2UX	WOS:000351676400025		
J	Soga, M; Ishitsuka, Y; Hamasaki, M; Yoneda, K; Furuya, H; Matsuo, M; Ihn, H; Fusaki, N; Nakamura, K; Nakagata, N; Endo, F; Irie, T; Era, T				Soga, Minami; Ishitsuka, Yoichi; Hamasaki, Makoto; Yoneda, Kaori; Furuya, Hirokazu; Matsuo, Muneaki; Ihn, Hironobu; Fusaki, Noemi; Nakamura, Kimitoshi; Nakagata, Naomi; Endo, Fumio; Irie, Tetsumi; Era, Takumi			HPGCD Outperforms HPBCD as a Potential Treatment for Niemann-Pick Disease Type C During Disease Modeling with iPS Cells	STEM CELLS			English	Article						Induced pluripotent stem cells; Transgene-free; Niemann-Pick disease type C; Experimental models	PLURIPOTENT STEM-CELLS; TARGETED GENE CORRECTION; CHOLESTEROL HOMEOSTASIS; SENDAI-VIRUS; MOUSE; AUTOPHAGY; IDENTIFICATION; CYCLODEXTRINS; INDUCTION; STORAGE	Niemann-Pick disease type C (NPC) is a lysosomal storage disease characterized by abnormal accumulation of free cholesterol and glycolipids. Here, we established induced pluripotent stem cell (iPSC) lines from NPC patients. Hepatocyte-like cells (HLCs) and neural progenitors derived from the iPSC lines accumulated cholesterol and displayed impaired autophagy and ATP production. A molecular signature related to lipid metabolism was also impaired in the NPC-iPSC-derived HLCs. These findings indicate that iPSC-derived cells can phenocopy human NPC. We also newly found that 2-hydroxypropyl--cyclodextrin (HPGCD) could reduce the cholesterol accumulation and restore the functional and molecular abnormalities in the NPC patient-derived cells, and do so more effectively than 2-hydroxypropyl--cyclodextrin treatment. In addition, NPC model mice showed an improved liver status and prolonged survival with HPGCDs. Thus, iPSC lines derived from patient cells are powerful tools to study cellular models of NPC, and HPGCD is a potential new drug candidate for future treatment of this disease. Stem Cells2015;33:1075-1088	[Soga, Minami; Hamasaki, Makoto; Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto 8600811, Japan; [Ishitsuka, Yoichi; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Kumamoto 8620973, Japan; [Yoneda, Kaori; Nakamura, Kimitoshi; Endo, Fumio] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto, Japan; [Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8600811, Japan; [Nakagata, Naomi] Kumamoto Univ, Ctr Anim Resources & Dev, Div Reprod Engn, Kumamoto 8600811, Japan; [Furuya, Hirokazu] Natl Omuta Hosp, Dept Neurol, Neurouscular Ctr, Omuta, Fukuoka, Japan; [Matsuo, Muneaki] Saga Univ, Fac Med, Dept Pediat, Saga 840, Japan; [Fusaki, Noemi] DNAVEC Corp, Tsukuba, Ibaragi, Japan; [Fusaki, Noemi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Era, T (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	tirie@gpo.kuma-moto-u.ac.jp; tera@kumamoto-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO), Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	We would like to thank Toyoko Tsuru, Yumi Soejima, and Kousaku Ohno for providing NPC model mice and technical support. This study was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO), Core Research for Evolutional Science and Technology (CREST), and Japan Science and Technology Agency (JST). N.F. is currently affiliated with the Department of Ophthalmology, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan. H.F. is currently affiliated with the Department of Neurology, Kochi Medical School, Okatoyo-machi, Nangoku city, Kochi 783-8505, Japan.	Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/A1474-4422(07)70194-1; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/j1r.M700525-JLR200; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Pontikis CC, 2013, J INHERIT METAB DIS, V36, P491, DOI 10.1007/s10545-012-9583-x; Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; FRANK DW, 1976, AM J PATHOL, V83, P367; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Irie T, 1997, J PHARM SCI, V86, P147, DOI 10.1021/js960213f; Arima H., 2011, CYCLODEXTRINS PHARM, P91; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Group N-CGW, 2009, MOL GENET METAB, V98, P152; Heron B, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-36; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Liao GH, 2010, BRAIN RES, V1325, P128, DOI 10.1016/j.brainres.2010.02.019; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Schmid G, 1991, NEW TRENDS CYCLODEXT, P27; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16	48	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	APR	2015	33	4					1075	1088		10.1002/stem.1917		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CE2VD	WOS:000351677100007		
J	Katano, M; Ema, M; Nakachi, Y; Mizuno, Y; Hirasaki, M; Suzuki, A; Ueda, A; Nishimoto, M; Takahashi, S; Okazaki, Y; Okuda, A				Katano, Miyuki; Ema, Masatsugu; Nakachi, Yutaka; Mizuno, Yosuke; Hirasaki, Masataka; Suzuki, Ayumu; Ueda, Atsushi; Nishimoto, Masazumi; Takahashi, Satoru; Okazaki, Yasushi; Okuda, Akihiko			Forced Expression of Nanog or Esrrb Preserves the ESC Status in the Absence of Nucleostemin Expression	STEM CELLS			English	Article						Embryonic stem cells; Epiblast stem cells; Leukemia inhibitory factor; Pluripotency	EMBRYONIC STEM-CELLS; TUMOR-INITIATING CELLS; SELF-RENEWAL; APOPTOTIC RING; CANCER-CELLS; PLURIPOTENCY; MOUSE; MAINTAINS; MECHANISM; GENES	Nucleostemin (NS) is a nucleolar GTP-binding protein that is involved in a plethora of functions including ribosomal biogenesis and maintenance of telomere integrity. In addition to its expression in cancerous cells, the NS gene is expressed in stem cells including embryonic stem cells (ESCs). Previous knockdown and knockout studies have demonstrated that NS is important to preserve the self-renewality and high expression levels of pluripotency marker genes in ESCs. Here, we found that forced expression of Nanog or Esrrb, but not other pluripotency factors, resulted in the dispensability of NS expression in ESCs. However, the detrimental phenotypes of ESCs associated with ablation of NS expression were not mitigated by forced expression of Rad51 or a nucleolar localization-defective NS mutant that counteracts the damage associated with loss of NS expression in other NS-expressing cells such as neural stem/progenitor cells. Thus, our results indicate that NS participates in preservation of the viability and integrity of ESCs, which is distinct from that in other NS-expressing cells. Stem Cells2015;33:1089-1101	[Katano, Miyuki; Hirasaki, Masataka; Suzuki, Ayumu; Ueda, Atsushi; Nishimoto, Masazumi; Okuda, Akihiko] Saitama Med Univ, Div Dev Biol, Hidaka, Saitama 3501241, Japan; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Hidaka, Saitama 3501241, Japan; [Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Hidaka, Saitama 3501241, Japan; [Nishimoto, Masazumi] Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Hidaka, Saitama 3501241, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 305, Japan; [Okuda, Akihiko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Okuda, A (reprint author), Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Hidaka, Saitama 3501241, Japan.	akiokuda@saitama-med.ac.jp	Ueda, Atsushi/O-2099-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS) KAKENHI [25293082, 25670147, 26112512]	We thank Tomoko Okuda and Dr. Hidemasa Kato for technical assistance and helpful discussion, respectively. This study was performed as a part of the Core Research for Evolutional Science and Technology (CREST) Agency. This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and primarily by a Grant-in-Aid for the Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine. AO is the recipient of grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grants Numbers 25293082, 25670147, and 26112512).	Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Smith A, 2013, CELL STEM CELL, V13, P6, DOI 10.1016/j.stem.2013.06.016; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Meng LJ, 2013, P NATL ACAD SCI USA, V110, P11415, DOI 10.1073/pnas.1301672110; Okamoto N, 2011, P NATL ACAD SCI USA, V108, P20388, DOI 10.1073/pnas.1015171108; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Hishida T, 2012, STEM CELLS, V30, P1634, DOI 10.1002/stem.1147; Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	APR	2015	33	4					1089	1101		10.1002/stem.1918		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CE2VD	WOS:000351677100008		
J	Suzuki, NM; Niwa, A; Yabe, M; Hira, A; Okada, C; Amano, N; Watanabe, A; Watanabe, KI; Heike, T; Takata, M; Nakahata, T; Saita, MK				Suzuki, Naoya M.; Niwa, Akira; Yabe, Miharu; Hira, Asuka; Okada, Chihiro; Amano, Naoki; Watanabe, Akira; Watanabe, Ken-Ichiro; Heike, Toshio; Takata, Minoru; Nakahata, Tatsutoshi; Saita, Megumu K.			Pluripotent Cell Models of Fanconi Anemia Identify the Early Pathological Defect in Human Hemoangiogenic Progenitors	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Induced pluripotent stem cells; Fanconi anemia; Hematopoietic progenitors; Differentiation; Transcription factors	CROSS-LINK REPAIR; STEM-CELLS; HEMATOPOIETIC PROGENITORS; MICE LACKING; LEUKEMIA; FAILURE	Fanconi anemia (FA) is a disorder of genomic instability characterized by progressive bone marrow failure (BMF), developmental abnormalities, and an increased susceptibility to cancer. Although various consequences in hematopoietic stem/progenitor cells have been attributed to FA-BMF, the quest to identify the initial pathological event is still ongoing. To address this issue, we established induced pluripotent stem cells (iPSCs) from fibroblasts of six patients with FA and FANCA mutations. An improved reprogramming method yielded iPSC-like colonies from all patients, and iPSC clones were propagated from two patients. Quantitative evaluation of the differentiation ability demonstrated that the differentiation propensity toward the hematopoietic and endothelial lineages is already defective in early hemoangiogenic progenitors. The expression levels of critical transcription factors were significantly downregulated in these progenitors. These data indicate that the hematopoietic consequences in FA patients originate from the early hematopoietic stage and highlight the potential usefulness of iPSC technology for elucidating the pathogenesis of FA-BMF.	[Suzuki, Naoya M.; Niwa, Akira; Nakahata, Tatsutoshi; Saita, Megumu K.] Kyoto Univ, Dept Clin Applicat, Kyoto, Japan; [Okada, Chihiro; Amano, Naoki; Watanabe, Akira] Kyoto Univ, Dept Reprogramming Sci, Ctr Induced Pluripotent Stem Cell Res & Applicat, Kyoto, Japan; [Hira, Asuka; Takata, Minoru] Kyoto Univ, Dept Late Effects Studies, Ctr Radiat Biol, Lab DNA Damage Signaling, Kyoto, Japan; [Yabe, Miharu] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan; [Okada, Chihiro] Mitsubishi Space Software Co Ltd, Amagasaki, Hyogo, Japan; [Watanabe, Ken-Ichiro; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Watanabe, Ken-Ichiro] Shizuoka Childrens Hosp, Dept Hematol & Oncol, Shizuoka, Japan	Saita, MK (reprint author), 53 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	msaito@cira.kyoto-u.ac.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Leading Project of MEXT; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS); JSPS; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20591262]; Program for Intractable Diseases Research Utilizing Disease-Specific Induced Pluripotent Stem (iPS) Cells from the Japan Science and Technology Agency (JST); grant for Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from JST; Research Grant for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare [H-21-061]	We thank M. Yamane and S. Benno for technical assistance, H. Watanabe for administrative assistance, and M. Yoshida and K. lsoda for performing the teratoma assay. Funding was provided by grants from the Ministry of Health, Labor, and Welfare to T.N.; a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to T.N.; grants from the Leading Project of MEXT to T.N.; a grant from the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS) to T.N.; grants from the JSPS to T.N. and M.K.S.; a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant 20591262) to MY.; the Program for Intractable Diseases Research Utilizing Disease-Specific Induced Pluripotent Stem (iPS) Cells from the Japan Science and Technology Agency (JST) to T.N.; the grant for Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from JST to T.N. and M.K.S.; and a Research Grant for Intractable Diseases (H-21-061) from the Japanese Ministry of Health, Labor, and Welfare to M.Y.	Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Yung SK, 2013, STEM CELLS, V31, P1022, DOI 10.1002/stem.1308; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Kamimae-Lanning AN, 2013, BLOOD, V121, P2008, DOI 10.1182/blood-2012-06-439679; Muller LUW, 2012, CELL CYCLE, V11, P2985, DOI 10.4161/cc.21109; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Takata Minoru, 2006, Subcell Biochem, V40, P295; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243	20	2	2	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	APR	2015	4	4					333	338		10.5966/sctm.2013-0172		6	Cell & Tissue Engineering	Cell Biology	CE2NM	WOS:000351652300014		
J	Toyoda, H; Kumada, T; Tada, T; Kaneoka, Y; Maeda, A				Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi; Kaneoka, Yuji; Maeda, Atsuyuki			A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection	SURGERY			English	Article							GAMMA-CARBOXY PROTHROMBIN; SIMPLE NONINVASIVE INDEX; SIGNIFICANT FIBROSIS; ALPHA-FETOPROTEIN; LIVER FIBROSIS; UNITED-STATES; JAPAN; SURVEILLANCE; VALIDATION; CIRRHOSIS	Background. Liver fibrosis is associated with the prognosis of patients with hepatocellular carcinoma (HCC) after treatment. The laboratory marker for liver fibrosis, the FIB-4 index, is reportedly correlated with the degree of liver fibrosis. We evaluated the predictive value of FIB-4 index on the recurrence and survival of HCC patients who underwent curative hepatectomy. Methods. A total of 431 consecutive patients who underwent hepatectomy for primary, nonrecurrent HCC were analyzed. The FIB-4 index was calculated from the patient's age, serum alanine aminotransferase and aspartate aminotransferase levels, and platelet count at the time of HCC diagnosis. Postoperative recurrence and survival rates were compared according to tumor characteristics, tumor markers, Child-Pugh class, and the FIB-4 index. Results. The pretreatment FIB-4 index was associated with recurrence and survival rates, independent of HCC progression or tumor marker levels in a multivariate analysis. Recurrence rates after hepatectomy were higher in patients with a FIB-4 index >3.25 versus <= 3.25 (5-year recurrence rates 69.6% vs 54.8%; P = .0049). Survival was also worse in patients with a FIB-4 index >3.25 than those with a FIB-4 index <= 3.25 (5-year survival rates 67.1% vs 72.2%; P = .0030). Conclusion. The FIB-4 index is a predictive marker for long-term outcomes in patients with HCC treated with curative hepatic resection.	[Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan; [Kaneoka, Yuji; Maeda, Atsuyuki] Ogaki Municipal Hosp, Dept Surg, Ogaki, Gifu 5038502, Japan	Toyoda, H (reprint author), Ogaki Municipal Hosp, Dept Gastroenterol, 4-86 Minamino Kawa, Ogaki, Gifu 5038502, Japan.	tkumada@he.mirai.ne.jp					Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Gassmann P, 2010, WORLD J SURG, V34, P2442, DOI 10.1007/s00268-010-0655-5; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Umemura T, 2007, HEPATOL RES, V37, pS95, DOI 10.1111/j.1872-034X.2007.00169.x; Ko S, 2002, BRIT J SURG, V89, P57, DOI 10.1046/j.0007-1323.2001.01969.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Kaibori M, 2013, WORLD J SURG, V37, P820, DOI 10.1007/s00268-013-1902-3; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; COX DR, 1972, J R STAT SOC B, V34, P187; Aoyagi Y, 1998, CANCER, V83, P2076, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L; El-Serag H, 2003, ANN INTERN MED, V139, P817; Yoshida H, 1999, ANN INTERN MED, V131, P174; Kokudo N, 2009, J GASTROENTEROL, V44, P119, DOI 10.1007/s00535-008-2244-z; Manghisi G, 1998, HEPATOLOGY, V28, P751; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Okuda H, 2000, CANCER, V88, P544; Petro R, 1973, BIOMETRICS, V29, P579; SHIMIZU K, 1993, CLIN CHIM ACTA, V214, P3, DOI 10.1016/0009-8981(93)90297-H; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Tamaki N, 2014, J GASTROENTEROL, V49, P1495, DOI 10.1007/s00535-013-0914-y; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P1170, DOI 10.1016/j.cgh.2006.06.007; Toyoda H, 2011, J GASTROEN HEPATOL, V26, P1765, DOI 10.1111/j.1440-1746.2011.06789.x; Xiao G, 2014, HEPATOLOGY	31	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					699	707		10.1016/j.surg.2014.10.022		9	Surgery	Surgery	CE4FW	WOS:000351787500013		
J	Fujii, T; Nakao, A; Yamada, S; Suenaga, M; Hattori, M; Takami, H; Inokawa, Y; Kanda, M; Sugimoto, H; Nomoto, S; Murotani, K; Kodera, Y				Fujii, Tsutomu; Nakao, Akimasa; Yamada, Suguru; Suenaga, Masaya; Hattori, Masashi; Takami, Hideki; Inokawa, Yoshikuni; Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Murotani, Kenta; Kodera, Yasuhiro			Vein resections > 3 cm during pancreatectomy are associated with poor 1-year patency rates	SURGERY			English	Article							PORTAL-VEIN; HEAD CARCINOMA; VASCULAR RECONSTRUCTION; CANCER; PANCREATICODUODENECTOMY; GRAFT; SURGERY; INVASION; ADENOCARCINOMA; ANASTOMOSIS	Background. Resection of the superior mesenteric vein (SMV) and portal vein (PV) involved in pancreatic neoplasms improves the chances of complete tumor removal. No consensus exists, however, on the optimal reconstructive approach, and postoperative venous stenosis in the first 6 months to 1 year can cause patient morbidity. We investigated medium-term patency after direct, end-to-end venous anastomosis and evaluate predictive factors for stenosis or occlusion. Methods. We analyzed retrospectively the records of 810 patients who underwent pancreatectomy at our institution from January 2000 through April 2014, and 197 patients who underwent concurrent SMV/PV resection were selected. The venous anastomosis was assessed every 4 or 6 months postoperatively by the use of portography with computed tomography. Preoperative and intraoperative variables were evaluated for their possible association with the development of severe anastomotic stenosis (>= 70% occlusion). Results. Among patients whose cancer did not recur during the 1-year follow-up period, 18 developed severe stenosis. Univariate analyses showed that operation time >= 520 minutes and length of SMV/PV resection >= 31 mm were associated with the development of severe anastomotic stenosis. Multivariate analysis showed that length of SMV/PV resection >= 31 mm was among independent predictors of medium-term, severe anastomotic stenosis (hazard ratio, 5.96; 95% confidence interval 1.79-22.69; P = .003). Conclusion. Direct end-to-end anastomosis of the PV system is safe and offers patients with periampullary neoplasia improved chances of complete tumor excision. When tension-free anastomosis cannot be guaranteed, generally in cases requiring >= 31 mm of SMV/PV resection, venous autografting may decrease the likelihood of anastomotic stenosis.	[Fujii, Tsutomu; Nakao, Akimasa; Yamada, Suguru; Suenaga, Masaya; Hattori, Masashi; Takami, Hideki; Inokawa, Yoshikuni; Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Fujii, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	fjt@med.nagoya-u.ac.jp					Yamada S, 2013, PANCREAS, V42, P1004, DOI 10.1097/MPA.0b013e31827b2d7c; Fujisaki S, 2001, J AM COLL SURGEONS, V193, P576, DOI 10.1016/S1072-7515(01)01039-0; Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; NAKAO A, 1995, SURGERY, V117, P50, DOI 10.1016/S0039-6060(05)80229-6; Sanjay P, 2012, BRIT J SURG, V99, P1027, DOI 10.1002/bjs.8763; Zhang J, 2009, J GASTROINTEST SURG, V13, P1524, DOI 10.1007/s11605-008-0777-3; Turley RS, 2012, ANN VASC SURG, V26, P685, DOI 10.1016/j.avsg.2011.11.009; NAKAO A, 1990, SURGERY, V108, P913; Fujii T, 2014, J GASTROINTEST SURG, V18, P1108, DOI 10.1007/s11605-014-2523-3; Leach SD, 1998, BRIT J SURG, V85, P611; NAKAO A, 1993, HEPATO-GASTROENTEROL, V40, P426; Nakao A, 2012, ANN SURG, V255, P103, DOI 10.1097/SLA.0b013e318237872e; Fujii T, 2010, SURGERY, V148, P285, DOI 10.1016/j.surg.2010.03.013; Fujii T, 2012, ANN SURG ONCOL, V19, P176, DOI 10.1245/s10434-011-1901-2; Bold RJ, 1999, J GASTROINTEST SURG, V3, P233, DOI 10.1016/S1091-255X(99)80065-1; Chiu Kuan-Ming, 2007, Vasc Endovascular Surg, V41, P149, DOI 10.1177/1538574406297259; Chu CK, 2010, J AM COLL SURGEONS, V211, P316, DOI 10.1016/j.jamcollsurg.2010.04.005; de Castro SMM, 2004, J GASTROINTEST SURG, V8, P775, DOI 10.1016/j.gassur.2004.08.006; DiPerna CA, 2002, ARCH SURG-CHICAGO, V137, P901, DOI 10.1001/archsurg.137.8.901; Fuhrman GM, 1996, ANN SURG, V223, P154, DOI 10.1097/00000658-199602000-00007; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kim SM, 2013, J KOREAN SURG SOC, V84, P346, DOI 10.4174/jkss.2013.84.6.346; Lee DY, 2010, J VASC SURG, V51, P662, DOI 10.1016/j.jvs.2009.09.025; Sano T, 2008, HEPATO-GASTROENTEROL, V55, P228; STARZL TE, 1984, SURG GYNECOL OBSTET, V159, P164; Stauffer JA, 2009, BRIT J SURG, V96, P247, DOI 10.1002/bjs.6483; Suzuki T, 2006, J AM COLL SURGEONS, V202, P87, DOI 10.1016/j.jamcollsurg.2005.08.001; TAKAYAMA Y, 1995, SURG TODAY, V25, P378; Tseng JF, 2006, BEST PRACT RES CL GA, V20, P349, DOI 10.1016/j.bpg.2005.11.003; Tuech JJ, 2001, HEPATO-GASTROENTEROL, V48, P884; Weitz Jürgen, 2010, J Am Coll Surg, V210, pe1, DOI 10.1016/j.jamcollsurg.2009.10.019; Yamamoto Y, 2009, LANGENBECK ARCH SURG, V394, P1115, DOI 10.1007/s00423-009-0500-1	33	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					708	715		10.1016/j.surg.2014.12.002		8	Surgery	Surgery	CE4FW	WOS:000351787500014		
J	Hanyu, T; Matsuki, A; Kosugi, S; Ishikawa, T; Nashimoto, A; Yabusaki, H; Aizawa, M; Ichikawa, H; Shimada, Y; Hirose, Y; Wakai, T				Hanyu, Takaald; Matsuki, Atsushi; Kosugi, Shin-ichi; Ishikawa, Takashi; Nashimoto, Atsushi; Yabusaki, Hiroshi; Aizawa, Masaki; Ichikawa, Hiroshi; Shimada, Yoshifumi; Hirose, Yuki; Wakai, Toshifumi			Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis	SURGERY			English	Article							RISK-FACTORS; FOLLOW-UP; RECURRENCE; EXPERIENCE; OUTCOMES; NUMBER; TREAT	Background. The aims of this study were to identify prognostic factors of patients with submucosa-invasive (T1b) gastric cancer and to verify the validity of adjuvant chemotherapy for this disease. Methods. We retrospectively examined the cases of 1,236 consecutive patients in our prospectively maintained database with T1b gastric cancer who underwent gastrectomy in 1995-2012. We used 11 clinicopathologic characteristics to identify prognostic factors by univariate and multivariate analyses. We compared the survival of the 160 node-positive T1b gastric cancer patients with that of 133 patients in the same database who had node-positive muscularis propria-invasive (T2) gastric cancer and had undergone gastrectomy without adjuvant chemotherapy during the same period, as a reference cohort. Results. The 5-year overall survival rate was 91.4% for all 1,236 patients. Advanced age (hazard ratio [HR] 4.51; 95% confidence interval [CI] 3.26-6.24; P < .01), male sex (HR 2.26; 95% CI 1.5- 3.26; P < .01), and the presence of lymph node metastasis (HR 1.89; 95% CI 1.33-2.70; P < .01) were independent prognostic factors. The 5-year overall survival rates were 92.5 % in node-negative patients, 84.5% in patients with 1 or 2 metastatic nodes, and 80.1% in patients with 3 or more metastatic nodes (P <.01). The 5-year overall survival rates of the node-positive T1b and T2 gastric cancer patients were 83.6% and 81.2%, respectively (P = .73). Conclusion. The prognosis of node-positive T1b gastric cancer patients after curative gastrectomy was unsatisfactory. Adjuvant chemotherapy should be considered for these patients, especially those with 3 or more metastatic nodes.	[Hanyu, Takaald; Kosugi, Shin-ichi; Ishikawa, Takashi; Ichikawa, Hiroshi; Shimada, Yoshifumi; Hirose, Yuki; Wakai, Toshifumi] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata 9518510, Japan; [Matsuki, Atsushi; Nashimoto, Atsushi; Yabusaki, Hiroshi; Aizawa, Masaki] Niigata Canc Ctr Hosp, Niigata, Japan	Kosugi, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Chuou Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	sugishin@med.niigata-u.ac.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Ishikawa S, 2007, GASTRIC CANCER, V10, P35, DOI 10.1007/s10120-006-0407-2; Haruta H, 2008, J DIGEST DIS, V9, P213, DOI 10.1111/j.1751-2980.2008.00349.x; SANO T, 1993, CANCER, V72, P3174, DOI 10.1002/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H; An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Kim DY, 2004, WORLD J GASTROENTERO, V10, P737; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Folli S, 2001, JPN J CLIN ONCOL, V31, P495, DOI 10.1093/jjco/hye107; Wen L, 2005, AM J HEALTH-SYST PH, V62, P2031, DOI 10.2146/ajhp040558; Kunisaki C, 2005, J AM COLL SURGEONS, V200, P15, DOI 10.1016/j.jamcollsurg.2004.09.015; Ren G, 2013, WORLD J GASTROENTERO, V19, P3096, DOI 10.3748/wjg.v19.i20.3096; Liu CG, 2010, SURG ONCOL, V19, P4, DOI 10.1016/j.suronc.2008.10.003; Cheong JH, 2006, ANN SURG ONCOL, V13, P377, DOI 10.1245/ASO.2006.04.018; ICHIYOSHI Y, 1990, SURGERY, V107, P489; Ikeda Y, 2005, BRIT J SURG, V92, P235, DOI 10.1002/bjs.4758; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kunisaki C, 2001, HEPATO-GASTROENTEROL, V48, P294; Lee HJ, 2003, JPN J CLIN ONCOL, V33, P209, DOI 10.1093/jjco/hyg042; SHIOZAWA N, 1994, HEPATO-GASTROENTEROL, V41, P244; Sobin LH, 2009, TNM CLASSIFICATION M	22	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					716	722		10.1016/j.surg.2014.10.009		7	Surgery	Surgery	CE4FW	WOS:000351787500015		
J	Beppu, N; Matsubara, N; Noda, M; Yamano, T; Kakuno, A; Doi, H; Kamikonya, N; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagabide; Noda, Masashi; Yamano, Tomoki; Kakuno, Ayako; Doi, Hiroshi; Kamikonya, Norihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer	SURGERY			English	Article							NEOADJUVANT CHEMORADIATION; METASTATIC INFILTRATION; PROGNOSTIC-SIGNIFICANCE; SACRAL RESECTION; TUMOR-REGRESSION; LOCAL RECURRENCE; GASTRIC-CANCER; LYMPH-NODES; RADIOTHERAPY; CARCINOMA	Background. The response of positive mesorectal lymph nodes to chemoradiotherapy remains largely unstudied in patients with rectal cancer. The aim of this study was to investigate the requirements of the total regression of positive nodes treated with chemoradiotherapy. Methods. The response of the primary tumor was evaluated according to the tumor regression grade (TRG 0-4) in resected specimens, and positive lymph nodes were assessed according to the lymph node regression grade (LRG 1-3), with TRG 4 and LRG 3 indicating total regression. We investigated the relationships among TRG, LRG, and the sizes of positive lymph nodes. Results. Among 178 patients, 68 (38.2%) had 200 positive lymph nodes. We first investigated the relationship of positive nodes to TRG and LRG and found that the response of the primary tumor to chemoradiotherapy correlated with the response of positive nodes. Next, we investigated the correlation between LRG and the size of positive nodes. At TRG I and 2, LRG score was not correlated with the positive node size. In contrast, at TRG 3, LRG score was correlated with the size of positive nodes. Next, our assessment of the relationship between the sizes of positive nodes and complete degeneration to LRG 3 showed that the most accurate cut-off score on receiver-operator-characteristics curve analysis was 6 mm in maximum diameter for TRG 3. Conclusion. The requirements of the total regression of positive nodes are I) degeneration of the primary tumor to TRG 3 and 2) a positive node diameter of <6 mm.	[Beppu, Naohito; Matsubara, Nagabide; Noda, Masashi; Yamano, Tomoki; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Kakuno, Ayako] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo, Japan; [Doi, Hiroshi; Kamikonya, Norihiko] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	beppu-n@hyo-med.ac.jp					Agarwal A, 2013, CANCER, V15, P4231; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Hartley A, 2005, BRIT J RADIOL, V78, P934, DOI 10.1259/bjr/86650067; Graf W, 1997, RADIOTHER ONCOL, V43, P133, DOI 10.1016/S0167-8140(96)01867-1; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e; Martling AL, 2000, LANCET, V356, P93, DOI 10.1016/S0140-6736(00)02469-7; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Fukushima M, 2010, ONCOL REP, V24, P1307, DOI 10.3892/or_00000987; Melton GB, 2006, DIS COLON RECTUM, V49, P1099, DOI 10.1007/s10350-006-0563-9; Lim JS, 2012, EUR RADIOL, V22, P1693, DOI 10.1007/s00330-012-2416-3; Hansen MH, 2007, BRIT J SURG, V94, P113, DOI 10.1002/bjs.5576; Yeo SG, 2010, INT J RADIAT ONCOL, V78, P164, DOI 10.1016/j.ijrobp.2009.07.1682; Monig SP, 1999, ANN SURG ONCOL, V6, P579, DOI 10.1007/s10434-999-0579-1; Milne T, 2013, ANN SURG, V258, P1007, DOI 10.1097/SLA.0b013e318283a5b6; Hughes R, 2010, ACTA ONCOL, V49, P378, DOI 10.3109/02841860903483692; Park JS, 2014, DIS COLON RECTUM, V57, P32, DOI 10.1097/DCR.0000000000000004; Monig SP, 1999, AM J ROENTGENOL, V173, P365; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Doi H, 2013, J RADIAT RES, V54, P1118, DOI 10.1093/jrr/rrt058; Rullier A, 2008, AM J SURG PATHOL, V32, P45; Beddy D, 2008, ANN SURG ONCOL, V15, P3471, DOI 10.1245/s10434-008-0149-y; Chmielik E, 2006, INT J RADIAT ONCOL, V65, P182, DOI 10.1016/j.ijrobp.2005.11.039; Doll D, 2009, WORLD J SURG, V33, P340, DOI 10.1007/s00268-008-9838-8; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012; Japanese Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; MacFarlane JK, 1993, LANCET, V341, P471; Matsuoka H, 2004, ANTICANCER RES, V24, P4097; Noda N, 1998, BRIT J SURG, V85, P831; Sun W, 2013, COLORECTAL DIS, V15, P231	33	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					743	751		10.1016/j.surg.2014.10.010		9	Surgery	Surgery	CE4FW	WOS:000351787500018		
J	Ishizaki, Y; Mizuno, T; Hara, K; Kawasaki, S				Ishizaki, Yoichi; Mizuno, Tomoya; Hara, Kieko; Kawasaki, Seiji			Advanced segmental atrophy of the liver with marked elastosis	SURGERY			English	Editorial Material									[Ishizaki, Yoichi; Mizuno, Tomoya; Kawasaki, Seiji] Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo 1138421, Japan; [Hara, Kieko] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 1138421, Japan	Ishizaki, Y (reprint author), Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ishizaki@juntendo.ac.jp					Hobbs CM, 2004, AM J CLIN PATROL, V122, P231; Singhi AD, 2011, AM J SURG PATHOL, V35, P364, DOI 10.1097/PAS.0b013e31820b0603	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					826	827		10.1016/j.surg.2013.10.021		2	Surgery	Surgery	CE4FW	WOS:000351787500028		
J	Katagiri, H; Hanyuda, A; Lefor, AT; Yahara, H				Katagiri, Hideki; Hanyuda, Akiko; Lefor, Alan T.; Yahara, Hironori			Pyoderma gangrenosum after inguinal hernia repair	SURGERY			English	Editorial Material									[Katagiri, Hideki; Hanyuda, Akiko] Noguchi Hideyo Mem Int Hosp, Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Surg, Chiba, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan; [Yahara, Hironori] Noguchi Hideyo Mem Int Hosp, Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Dermatol, Chiba, Japan	Katagiri, H (reprint author), 3-4-32 Todaijima, Urayasu, Chiba 2790001, Japan.	x62h20k38@yahoo.co.jp		Lefor, Alan/0000-0001-6673-5630			Ruocco E, 2009, J EUR ACAD DERMATOL, V23, P1008, DOI 10.1111/j.1468-3083.2009.03199.x; Brooklyn T, 2006, BRIT MED J, V333, P181, DOI 10.1136/bmj.333.7560.181; Brunsting AL, 1930, ARCH DERMATOL SYPHIL, V22, P655; Kotzampassakis N, 2012, HERNIA, V15, P345	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2015	157	4					828	829		10.1016/j.surg.2013.11.011		2	Surgery	Surgery	CE4FW	WOS:000351787500029		
J	Hamada, T; Usami, A; Kishi, A; Kon, H; Takada, S				Hamada, Tomohiro; Usami, Akinobu; Kishi, Asuka; Kon, Hideki; Takada, Satoshi			Anatomical study of phrenic nerve course in relation to neck dissection	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Phrenic nerve; Posterior triangle; Supraclavian triangle; Nerve point; Erb's point	CLINICAL-IMPLICATION	The present study sought to clarify the course of the phrenic nerve and its correlation with anatomical landmarks in the neck region. We examined 17 cadavers (30 sides). In each, the phrenic nerves was dissected from the lateral side of the neck, and its position within the triangle formed by the mastoid process and sternal and acromial ends of the clavicle was determined. The point where the phrenic nerve arises in the posterior triangle was found to be similar to the point where the cutaneous blanches of the cervical plexus emerge at the middle of the posterior border of the sternocleidomastoid muscle. In the supraclavian triangle, the phrenic nerve crosses the anterior border of the anterior scalene muscle near Erb's point where the superficial point is 2-3 cm superior from the clavicle and posterior border of the sternocleidomastoid muscle. The phrenic nerve arises in the posterior triangle near the nerve point, then descends to the anterior surface of the anterior scalene muscle in the supraclavian triangle. It is necessary to be aware of the supraclavian triangle below Erb's point during neck dissection procedures.	[Hamada, Tomohiro; Kon, Hideki; Takada, Satoshi] Ohu Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Koriyama, Fukushima 9638611, Japan; [Usami, Akinobu; Kishi, Asuka] Ohu Univ, Dept Morphol Biol, Sch Dent, Koriyama, Fukushima 9638611, Japan	Hamada, T (reprint author), Ohu Univ, Dept Oral & Maxillofacial Surg, Sch Dent, 31-1 Misumido, Koriyama, Fukushima 9638611, Japan.	t-hamada@den.ohu-u.ac.jp			JSPS KAKENHI [25861973]	This work was supported by JSPS KAKENHI Grant Number 25861973.	Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Bigeleisen PE, 2003, BRIT J ANAESTH, V91, P916, DOI 10.1093/bja/aeg254; Yaddanapudi S, 1996, J LARYNGOL OTOL, V110, P281; Loukas M, 2006, ANN THORAC SURG, V82, P1870, DOI 10.1016/j.athoracsur.2006.05.098; BOCCA E, 1980, ARCH OTOLARYNGOL, V106, P524; Economou SG, 1996, RADICAL DISSECTION A, P16; Erb W, 1883, HDB ELECTROTHERAPEUT, P121; Franko OI, 2008, EMERG MED J, V25, P614, DOI 10.1136/emj.2008.059691; Liebgott B, 2011, NECK ANATOMICAL BASI, P133; Matsumura Hiroo, 1996, Acta Medica et Biologica, V44, P13; Moore KL, 2006, NERVES LATERAL CERVI, P1061; Paraskevas GK, 2011, BRIT J ANAESTH, V106, P348, DOI 10.1093/bja/aeq373; Shiozaki K, 2007, J ORAL MAXIL SURG, V65, P22, DOI 10.1016/j.joms.2005.11.091; Snell RS, 2007, CERVICAL PLEXUS CLIN, P745; Standring S, 2004, GRAYS ANATOMY, P534; Tubbs R Shane, 2005, Neurosurgery, V56, P256, DOI 10.1227/01.NEU.0000156541.78020.DA; Tubbs RS, 2007, CLIN ANAT, V20, P486, DOI 10.1002/ca.20385	17	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	APR	2015	37	3					255	258		10.1007/s00276-014-1343-1		4	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CE1QK	WOS:000351586600005		
J	Okano, N; Uchino, A; Saito, N; Maruyama, H				Okano, Nanami; Uchino, Akira; Saito, Naoko; Maruyama, Hajime			Left carotid-anterior cerebral artery anastomosis diagnosed by MR angiography: a case report	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Anterior cerebral artery; Arterial variation; Internal carotid artery; MR angiography	INFRAOPTIC COURSE	Anastomosis of the carotid-anterior cerebral artery (ACA) is a rare anomalous vessel that arises from the internal carotid artery (ICA) at the level of the ophthalmic artery and takes an infraoptic and prechiasmatic path to anastomose with the ACA. It has known right-sided predominance. We report the case of an 83-year-old man with a left carotid-ACA anastomosis that was diagnosed by magnetic resonance (MR) angiography from the neck to the head during investigation of transient left hemiplegia. The right ICA was occluded at its origin. Our literature search revealed only six reported cases of left carotid-ACA anastomoses. We believe ours is the first case diagnosed by MR angiography.	[Okano, Nanami; Uchino, Akira; Saito, Naoko] Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, Saitama 3501298, Japan; [Maruyama, Hajime] Saitama Med Univ, Int Med Ctr, Dept Neurol & Cerebrovasc Med, Saitama 3501298, Japan	Okano, N (reprint author), Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, 1397-1 Yamane, Saitama 3501298, Japan.	nanami@saitama-med.ac.jp					Uchino A, 2013, SURG RADIOL ANAT, V35, P775, DOI 10.1007/s00276-013-1085-5; ROBINSON LR, 1959, J ANAT, V93, P131; Gupta V, 2008, NEUROL INDIA, V56, P487; Kan P, 2012, NEURORADIOLOGY, V54, P181, DOI 10.1007/s00234-011-0881-z; McLaughlin N, 2007, J NEUROSURG, V107, P430, DOI 10.3171/JNS-07/08/0430; MERCIER P, 1989, SURG RADIOL ANAT, V11, P73, DOI 10.1007/BF02102250; Spinnato S, 1999, NEUROSURGERY, V44, P1315, DOI 10.1097/00006123-199906000-00087; Stevenson Charles B, 2011, Surg Neurol Int, V2, P89, DOI 10.4103/2152-7806.82371; Turkoglu E, 2011, CLIN NEUROL NEUROSUR, V113, P335, DOI 10.1016/j.clineuro.2010.12.009; Uchino A, 2012, NEURORADIOLOGY, V54, P13, DOI 10.1007/s00234-011-0847-1; Wong ST, 2008, ACTA NEUROCHIR, V150, P1087, DOI 10.1007/s00701-008-0016-4	11	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	APR	2015	37	3					311	313		10.1007/s00276-014-1358-7		3	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CE1QK	WOS:000351586600014		
J	Hashimoto, S; Nakamura, S; Saito, O; Kohsaka, R; Kamiyama, C; Tomiyoshi, M; Kishioka, T				Hashimoto, Shizuka; Nakamura, Shogo; Saito, Osamu; Kohsaka, Ryo; Kamiyama, Chiho; Tomiyoshi, Mitsuyuki; Kishioka, Tomoya			Mapping and characterizing ecosystem services of social-ecological production landscapes: case study of Noto, Japan	SUSTAINABILITY SCIENCE			English	Article						Social-ecological production landscape; Ecosystem services; Spatial variation; Landscape planning; Geographic information system (GIS); Noto Peninsula	NATURAL-RESOURCE MANAGEMENT; DECISION-MAKING; PADDY FIELDS; CONSERVATION; MULTIFUNCTIONALITY; AGRICULTURE; AREAS; ASSESSMENTS; INDICATORS; TRADEOFFS	Improving our understanding about ecosystem production, function, and services is central to balancing both conservation and development goals while enhancing human well-being. This study builds a scientific basis for conservation and development planning by exploring the types, abundance, and spatial variation in ecosystem services in the Noto Peninsula of Japan, a Globally Important Agricultural Heritage Systems. Although the Noto Peninsula is recognized as an important social-ecological production landscape, limited quantitative information about ecosystem services is available. This study evaluates and maps ecosystem services and explores their spatial variation using original data obtained through questionnaire surveys and secondary data from literature, statistics, and geographic information systems. The hilly and mountainous geography of the Noto Peninsula and its remoteness from large consumption markets work as constraints for agricultural provisioning services by limiting water resources, labor productivity, and choice of economically viable crops. However, the rich forests, and marine and coastal resources provide various economic opportunities for forest-, fishery-, and livestock-related provisioning services. Geographical conditions such as land use and cover type also play an important role in differentiating the spatial variation of regulating services, a variation that starkly differs to distribution patterns in other areas. Unlike provisioning and regulating services, natural and artificial landscape components including traditional and cultural constructions such as shrines and temples work as an anchor to help people appreciate intangible and tangible cultural services, linking different services to specific locales across the Noto Peninsula.	[Hashimoto, Shizuka; Kishioka, Tomoya] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Nakamura, Shogo] Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki, Japan; [Saito, Osamu; Kamiyama, Chiho] UNU Inst Adv Studies Sustainabil, Tokyo, Japan; [Kohsaka, Ryo; Tomiyoshi, Mitsuyuki] Kanazawa Univ, Grad Sch Human & Socioenvironm Studies, Kanazawa, Ishikawa, Japan	Hashimoto, S (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto, Japan.	hash@kais.kyoto-u.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [11303]; JSPS KAKENHI [24780230]	The authors are grateful to government officials of Ishikawa prefecture and Suzu city who devoted their time to the interview in the early stage of this study. This research was supported by the Environment Research and Technology Development Fund (11303) of the Ministry of the Environment, Japan, and by JSPS KAKENHI Grant Number 24780230.	Aizaki H, 2006, PADDY WATER ENVIRON, V4, P217, DOI 10.1007/s10333-006-0052-8; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Harrop SR, 2007, AGR ECOSYST ENVIRON, V121, P296, DOI 10.1016/j.agee.2006.12.020; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Nahuelhual L, 2014, ECOL INDIC, V40, P90, DOI 10.1016/j.ecolind.2014.01.005; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Xie J, 2011, P NATL ACAD SCI USA, V108, pE1381, DOI 10.1073/pnas.1111043108; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; Alessa L, 2008, LANDSCAPE URBAN PLAN, V85, P27, DOI 10.1016/j.landurbplan.2007.09.007; Su CH, 2012, SUSTAIN SCI, V7, P17, DOI 10.1007/s11625-011-0145-1; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Layke C, 2012, ECOL INDIC, V17, P77, DOI 10.1016/j.ecolind.2011.04.025; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Cocks M, 2006, HUM ECOL, V34, P185, DOI 10.1007/s10745-006-9013-5; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Raymond CM, 2009, ECOL ECON, V68, P1301, DOI 10.1016/j.ecolecon.2008.12.006; Barrena J, 2014, ECOSYST SERV, V7, P66, DOI 10.1016/j.ecoser.2013.12.005; Brown G, 2005, SOC NATUR RESOUR, V18, P17, DOI 10.1080/08941920590881853; Chang K, 2005, SOC SCI J, V42, P285, DOI 10.1016/j.soscij.2005.03.008; Duraiappah AK, 2012, SATOYAMA SATOUMI ECO; FAO, 2011, PROP NOT SAT SAT, P1; Greenhouse Gas Inventory Office of Japan, 2014, NATIONAL GREEN HOUSE, V674; Gu HY, 2014, ECOL SOC, V19, DOI 10.5751/ES-06283-190141; Hanewinkel M., 2010, EUR J FOREST RES, V130, P329, DOI [10.1007/s10342-010-0392-1, DOI 10.1007/S10342-010-0392-1]; Milcu AI, 2013, ECOL SOC, V18, DOI 10.5751/ES-05790-180344; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Huang CC, 2006, PADDY WATER ENVIRON, V4, P199, DOI 10.1007/s10333-006-0049-3; Ilea RC, 2008, J AGR ENVIRON ETHIC, V22, P153, DOI [10.1007/s10806-008-9136-3, DOI 10.1007/S10806-008-9136-3]; Indrawan M, 2014, ECOL ENG, V64, P77, DOI 10.1016/j.ecoleng.2013.12.038; Ishikawa Prefecture, 2013, DAMS OF ISHIKAWA; Ishikawa Prefecture, 2006, VISION OF FOOD AND A; Ishikawa Prefecture, 2007, DEVELOPMENT PLAN OF; Japan Meteorological Agency, 2014, RISK MAP OF EXTREME; Joetsu City and Research Institute for Local Government, 2013, DEVELOPMENT POLICY F; Johnson KA, 2012, ECOL ECON, V79, P71, DOI 10.1016/j.ecolecon.2012.04.020; Koohafkan P., 2011, Journal of Resources and Ecology, V2, P22; MA, 2005, ECOSYSTEMS AND HUMAN; Matsuno Y, 2006, PADDY WATER ENVIRON, V4, P189, DOI 10.1007/s10333-006-0048-4; Morri E, 2014, ECOL INDIC, V37, P210, DOI 10.1016/j.ecolind.2013.08.016; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; Ninan KN, 2013, ECOSYST SERV, V5, pE78, DOI 10.1016/j.ecoser.2013.02.006; NRIAE, 1998, Q J AGR EC, V52, P113; Qiu ZM, 2014, PADDY WATER ENVIRON, V12, P275, DOI 10.1007/s10333-013-0387-x; Riper CJ, 2012, APPL GEOGR, V35, P164, DOI [10.1016/j.apgeog.2012.06.008, DOI 10.1016/J.APGEOG.2012.06.008]; SCJ, 2001, EVALUATING THE MULTI; Shoyama K, 2014, ECOSYST SERV, V8, P25, DOI 10.1016/j.ecoser.2014.02.004; Sugito H, 2013, P JPN SOC IRRIG DRAI, P72; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Yoshida K, 2012, BIODIVERSITY OBSERVA, P27	54	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1862-4065	1862-4057		SUSTAIN SCI	Sustain. Sci.	APR	2015	10	2					257	273		10.1007/s11625-014-0285-1		17	Environmental Sciences	Environmental Sciences & Ecology	CE2UR	WOS:000351675500007		
J	Marsden, T; Farioli, F				Marsden, Terry; Farioli, Francesca			Natural powers: from the bio-economy to the eco-economy and sustainable place-making	SUSTAINABILITY SCIENCE			English	Article						Bio-economy; Eco-economy; Post-normal science; Sustainable place-making; Agri-food; Security; Rural-urban development	SCIENCE; TRANSITIONS; GOVERNMENT; INNOVATION; KNOWLEDGE; DYNAMICS; SYSTEMS; SOCIETY	The current intensification of efforts to develop post-carbon solutions to the global food/energy security problems is developing a highly contested policy/technology/production/consumption arena. The paper examines how current attempts to resolve these new productivist priorities are embedded in combinations of sustainability, security, sovereignty and resource governance concerns. These concerns are coming together with the new contested framings of the bio-economy and the eco-economy. The framings hold different implications for social and spatial development. The paper argues that it is important to apply and connect a critical 'post normal' sustainability science approach to developing the place-making properties of the eco-economy model, as well as examining the implications of the wider and more dominant bio-economic framing. The analysis shows that to achieve synergies between sustainability, security, sovereignty and effective resource governance, a more place-based eco-economic model needs to be progressed.	[Marsden, Terry] Cardiff Univ, Sustainable Places Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Farioli, Francesca] Univ Roma La Sapienza, Interuniv Res Ctr Sustainable Dev CIRPS, I-00185 Rome, Italy; [Farioli, Francesca] Univ Tokyo, IR3S, Tokyo, Japan	Marsden, T (reprint author), Cardiff Univ, Sustainable Places Res Inst, Cardiff CF10 3AX, S Glam, Wales.	MarsdenTK@Cardiff.ac.uk; Francesca.farioli@uniroma1.it					Adamson D, 2014, NEW SETTLEMENT DEEP; Alkon AH, 2008, CITY COMMUNITY, V7; Amin A., 2004, GEOGR ANN B, V86, P33, DOI DOI 10.1111/J.0435-3684.2004.00152.X; Andree P, 2013, VISUALIZATION COMMUN; Christensen CM, 2006, HARVARD BUS REV, V84, P94; Wiek A, 2014, RES EVALUAT, V23, P117, DOI 10.1093/reseval/rvt031; [Anonymous], 2010, CAMB J REG EC SO; Christen M, 2012, SUSTAIN DEV, V20, P400, DOI 10.1002/sd.518; van Kerkhoff L, 2006, ANNU REV ENV RESOUR, V31, P445, DOI 10.1146/annurev.energy.31.102405.170850; Thompson J, 2009, ENVIRON SCI POLICY, V12, P386, DOI 10.1016/j.envsci.2009.03.001; Gibbons M, 1999, NATURE, V402, pC81, DOI 10.1038/35011576; Marsden T, 2013, J RURAL STUD, V29, P123, DOI 10.1016/j.jrurstud.2011.10.001; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Pierce J, 2011, T I BRIT GEOGR, V36, P54, DOI 10.1111/j.1475-5661.2010.00411.x; Spangenberg JH, 2011, ENVIRON CONSERV, V38, P275, DOI 10.1017/S0376892911000270; McMichael P, 2013, GLOBALIZATIONS, V10, P47, DOI 10.1080/14747731.2013.760925; Geels FW, 2004, RES POLICY, V33, P897, DOI 10.1016/j.respol.2004.01.015; Sala S, 2013, INT J LIFE CYCLE ASS, V18, P1653, DOI 10.1007/s11367-012-0508-6; Talwar S, 2011, SCI PUBL POLICY, V38, P379, DOI 10.3152/030234211X12960315267615; Kitchen L, 2009, SOCIOL RURALIS, V49, P273, DOI 10.1111/j.1467-9523.2009.00489.x; Collier SJ, 2009, THEOR CULT SOC, V26, P78, DOI 10.1177/0263276409347694; Clark WC, 2007, P NATL ACAD SCI USA, V104, P1737, DOI 10.1073/pnas.0611291104; Escobar A, 2001, POLIT GEOGR, V20, P139, DOI 10.1016/S0962-6298(00)00064-0; Wiek A, 2015, SUSTAIN SCI, V10, P17, DOI 10.1007/s11625-014-0261-9; Wiek A, 2012, SUSTAIN SCI, V7, P1, DOI 10.1007/s11625-011-0154-0; Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8; Garud R, 2001, LEAS ORG MAN SERIES, P1; Robinson J, 2008, FUTURES, V40, P70, DOI 10.1016/j.futures.2007.06.007; Wiek A, 2007, GAIA, V16, P52; Arthur B., 1997, EC EVOLVING COMPLEX, VII; Benessia A, 2012, SUSTAINABILITY SC S1, V7; Bevir M., 2013, THEORY GOVERNANCE; Blay-Palmer A., 2013, Local Environment, V18, P521, DOI 10.1080/13549839.2013.797156; Cantrill J. G., 2001, ENVIRON SCI POLICY, V4, P185, DOI DOI 10.1016/S1462-9011(01)00023-5; Ceccarelli S, 2014, INT C DIV START STAR; Chatham House, 2009, FOOD FUT THINK START; Chayanov A, 1927, THEORY PAESTAT OPERA; Cooke P., 2008, REGIONAL SCI POLICY, V1, P23, DOI 10.1111/j.1757-7802.2008.00002.x; Cooke P, 2011, PROG PLAN, V76, P106; Cooke P., 2010, J KNOWLEDGE EC, V1, P239, DOI 10.1007/s13132-010-0019-2; Dovers S, 1997, J PUBLIC POLICY, V16, P303, DOI DOI 10.1017/S0143814X00007789; Dryzek J, 1997, POLITICS EARTH ENV D; Erikson A, 2010, MATRIX POSTCLUSTER I; European Commission, 2012, COMM INN SUST GROWTH; Farioli F, 2014, CULTURE SOSTENIBILLI; Folke K, 2006, GLOBAL ENVIRON CHANG, V16, P253; Foucault M, 2007, SECURITY TERRITORY P; Funtowicz S.O., 1993, FUTURES, V25, P735, DOI DOI 10.1016/0016-3287(93)90022-L; Garnet T, 2012, SUSTAINABLE INTENSIF; Goodman D, 2012, ALTERNATIVE FOOD NETWORKS: KNOWLEDGE, PRACTICE, AND POLITICS, P1; Goodman D, 1987, FARMIMG BIOTECHNOLOG; Grin J., 2010, TRANSITIONS SUSTAINA; Grunwald A., 2004, International Journal of Foresight and Innovation Policy, V1, DOI 10.1504/IJFIP.2004.004619; Gunderson LH, 2002, PANARCHY UNDERSTANDI; Hilgartner S., 2007, BIOSOCIETIES, V2, P382, DOI DOI 10.1017/S1745855207005819; Hirsch Hardon G, 2006, ECOL ECON, V60, P19; Hodson M, 2013, LOW CARBON NATION?, P1; Huttunen S, 2013, JYVASKYLA STUDIES ED; Jaeger J, 2009, BACKGROUND PAPER PRE; Jahn T, 2008, TRANSDISZIPLINARE FO, P21; Jones L, 2013, GEOFORUM, V45, P192, DOI 10.1016/j.geoforum.2012.11.003; Kasemir B., 2003, PUBLIC PARTICIPATION; Kauffman S. A., 1995, HOME UNIVERSE; Kemp R, 2000, TECHNOLOGY STUDIES S; Kitchen L., 2011, Local Environment, V16, P753, DOI 10.1080/13549839.2011.579090; Langeveld O, 2010, BIOBASED EC FUELS AN; Marsden T, 2010, ROUTL STUD HUM GEOGR, P1; Marsden TK, 2012, SUSTAIN SCI, DOI [10.1007/s11625-01200186-0, DOI 10.1007/S11625-01200186-0]; Marsden TK, 2013, HDB FOOD RES; Martin R, 2010, RGS C, V3, P225; Massey D, 2007, REV INT POLIT ECON, V86B, P5; McKibben W, 2013, SOME IT HOT REV, P59; McMichael P, 2010, J AGRAR CHANGE; Murdoch J., 2003, DIFFERENTIATED COUNT; Nowolny H, 2001, RETHINKING SCI KNOWL; OECD, 2009, BIOE 2030 DES POL AG; OECD, 2011, PREL REP; Passmore J, 2012, GEPWING BIOECONOMY; Pechlaner Gabriela, 2012, CORPORATE CROPS BIOT; Peck H., 2005, International Journal of Physical Distribution & Logistics Management, V35, DOI 10.1108/09600030510599904; Perfecto I, 2011, NATURE MATRIX LINKIN; Robinson J., 2006, SCI PUBL POLICY, V33, P151, DOI 10.3152/147154306781779064; Sayan B, 2003, LOCAL ENV, V8, P303, DOI 10.1080/13549830306657; Scholz Roland W., 2006, INT J SUSTAINABILITY, V7, P226, DOI DOI 10.1108/14676370610677829; Smil V, 2013, HARVESTING THE BIOSPHERE: WHAT WE HAVE TAKEN FROM NATURE, P1; Smith K, 2008, CHALLENGE ENV TECHNO; Spaargaren G., 2012, FOOD PRACTICES TRANS; Takeuchi K, APPL SUSTAINABILITY; Tyner W, 2012, GROWING BIOECONOMY C; Van der Pleog JD, 2013, AGRARIAN CHANGE PEAS; van der Ploeg J. D., 2008, UNFOLDING WEBS DYNAM; Vanclay F, 2008, MAKING SENSE PLACE; Waltner-Toews D, 2000, GLOBAL CHANGE HUM HL, V1, P116, DOI 10.1023/A:1010025021186; Wolf S, 2014, NEO LIBERAL REGIME A	94	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1862-4065	1862-4057		SUSTAIN SCI	Sustain. Sci.	APR	2015	10	2					331	344		10.1007/s11625-014-0287-z		14	Environmental Sciences	Environmental Sciences & Ecology	CE2UR	WOS:000351675500012		
J	Kashiwagi, Y; Rokugawa, T; Yamada, T; Obata, A; Watabe, H; Yoshioka, Y; Abe, K				Kashiwagi, Yuto; Rokugawa, Takemi; Yamada, Tomomi; Obata, Atsushi; Watabe, Hiroshi; Yoshioka, Yoshichika; Abe, Kohji			Pharmacological MRI Response to a Selective Dopamine Transporter Inhibitor, GBR12909, in Awake and Anesthetized Rats	SYNAPSE			English	Article						pharmacological MRI; GBR12909; DAT inhibitor; dopamine; isoflurane	STRIATAL DOPAMINE; BOLD CONTRAST; BRAIN; ANESTHESIA; MICRODIALYSIS; ISOFLURANE; FMRI; AUTOREGULATION; AMPHETAMINE; NOMIFENSINE	Pharmacological magnetic resonance imaging (phMRI) is a powerful tool for imaging the effects of drugs on brain activity. In preclinical phMRI studies, general anesthesia used for minimizing head movements is thought to influence the phMRI responses to drugs. In this study we investigated the phMRI responses to a selective dopamine transporter (DAT) inhibitor, GBR12909, and a dopamine (DA) releaser, D-amphetamine (AMPH), in the isoflurane anesthetized and awake rats using a relative cerebral blood volume (rCBV) method. AMPH (1 mg/kg i.p.) caused an increase in rCBV in the dopaminergic circuitry in the both anesthetized and awake rats. The striatal rCBV change was correlated with the change of the striatal DA concentration induced by AMPH in the both anesthetized and awake rats. GBR12909 (10 mg/kg i.p.) caused a positive rCBV response and showed a similar regional pattern of rCBV response to AMPH in the awake rats, and the correlation between the change of the striatal rCBV and the striatal DA concentration was observed. However, in the anesthetized rats, GBR12909 induced a widespread negative rCBV response, whereas an increase in striatal DA concentration was observed. These findings indicate that phMRI responses to activation of DA neurotransmission by GBR12909 or AMPH are overall identical in the awake state, while the phMRI response to a DAT inhibitor, GBR12909 but not to AMPH was changed by isoflurane anesthesia. For the evaluation of neuroactive drugs using phMRI, isoflurane anesthesia might be complicated the interpretation of pharmacodynamic effects of drugs in preclinical studies. (C) 2015 Wiley Periodicals, Inc	[Kashiwagi, Yuto; Rokugawa, Takemi; Yamada, Tomomi; Obata, Atsushi; Abe, Kohji] Shionogi & Co Ltd, Dept Drug Metab & Pharmacokinet, Res Lab Dev, Osaka, Japan; [Kashiwagi, Yuto; Yoshioka, Yoshichika] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Watabe, Hiroshi] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Radiat Protect & Safety Control, Sendai, Miyagi 980, Japan; [Yoshioka, Yoshichika] Osaka Univ, Immunol Frontier Res Ctr, Lab Biofunct Imaging, Osaka, Japan	Kashiwagi, Y (reprint author), Shionogi & Co Ltd, Dept Drug Metab & Pharmacokinet, Res Lab Dev, Osaka, Japan.	yuuto.kashiwagi@shionogi.co.jp					Adachi YU, 2001, BRIT J ANAESTH, V86, P837, DOI 10.1093/bja/86.6.837; OPACKAJUFFRY J, 1991, SYNAPSE, V7, P169, DOI 10.1002/syn.890070210; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Luo F, 2009, J PSYCHIATR RES, V43, P1018, DOI 10.1016/j.jpsychires.2008.11.009; Chen YCI, 2005, PSYCHOPHARMACOLOGY, V180, P705, DOI 10.1007/s00213-004-2034-0; Du CW, 2009, EUR J NEUROSCI, V30, P1565, DOI 10.1111/j.1460-9568.2009.06931.x; Wise RG, 2006, J MAGN RESON IMAGING, V23, P862, DOI 10.1002/jmri.20584; Steward CA, 2005, PSYCHOPHARMACOLOGY, V180, P687, DOI 10.1007/s00213-005-2213-7; Ren JQ, 2009, SYNAPSE, V63, P764, DOI 10.1002/syn.20659; Chen YI, 2011, EUR J NEUROSCI, V34, P800, DOI 10.1111/j.1460-9568.2011.07806.x; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Baarendse PJJ, 2012, PSYCHOPHARMACOLOGY, V219, P313, DOI 10.1007/s00213-011-2576-x; Sellers KK, 2013, J NEUROPHYSIOL, V110, P2739, DOI 10.1152/jn.00404.2013; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Chen YCI, 1997, MAGNET RESON MED, V38, P389, DOI 10.1002/mrm.1910380306; Chen YI, 1999, NEUROREPORT, V10, P2881, DOI 10.1097/00001756-199909290-00001; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Easton N, 2007, PSYCHOPHARMACOLOGY, V193, P11, DOI 10.1007/s00213-007-0756-5; FINKJENSEN A, 1994, N-S ARCH PHARMACOL, V350, P239; Fuster JM., 2008, PREFRONTAL CORTEX; Gozzi A, 2008, PSYCHOPHARMACOLOGY, V201, P273, DOI 10.1007/s00213-008-1271-z; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; Luo F, 2007, J MAGN RESON IMAGING, V26, P557, DOI 10.1002/jmri.21083; Marota JJA, 2000, NEUROIMAGE, V11, P13, DOI 10.1006/nimg.1999.0520; MCPHERSON RW, 1988, ANESTHESIOLOGY, V69, P493, DOI 10.1097/00000542-198810000-00008; Perles-Barbacaru TA, 2011, NEUROIMAGE, V55, P622, DOI 10.1016/j.neuroimage.2010.12.048; Reese T, 2000, NMR BIOMED, V13, P361, DOI 10.1002/1099-1492(200010)13:6<361::AID-NBM654>3.0.CO;2-C; Scanley BE, 2001, BRAIN RES, V913, P149, DOI 10.1016/S0006-8993(01)02771-8; Schwarz AJ, 2004, NEUROIMAGE, V23, P296, DOI 10.1016/j.neuroimage.2004.05.001; Shih YY, 2007, BIOMED ENG-APP BAS C, V19, P157, DOI 10.1142/S1016237207000203; Skoubis PD, 2006, NEUROSCIENCE, V137, P583, DOI 10.1016/j.neuroscience.2005.08.072; Summors AC, 1999, ANESTH ANALG, V88, P341, DOI 10.1097/00000539-199902000-00022; Watson C, 2007, RAT BRAIN STEREOTAXI; Zhang ZM, 2000, BRAIN RES, V852, P290, DOI 10.1016/S0006-8993(99)02243-X	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	APR	2015	69	4					203	212		10.1002/syn.21803		10	Neurosciences	Neurosciences & Neurology	CE3XH	WOS:000351762900004		
J	Nishikata, T; Ishikawa, S				Nishikata, Takashi; Ishikawa, Shingo			Challenges in the Substitution of Terminal C-C Double Bonds with Tertiary Alkyl Groups	SYNLETT			English	Article						copper; radical; tertiary alkylation; Heck; alkene	COPPER-CATALYZED TRIFLUOROMETHYLATION; HECK-TYPE REACTION; ALLYLIC ALCOHOLS; RADICAL ALKENYLATION; ORGANIC-SYNTHESIS; MILD CONDITIONS; ARYL BROMIDES; PALLADIUM; HALIDES; ALKENES	There are a few reports on the reaction of tertiary alkyl halide and alkene to produce an alkyl-substituted alkene. To establish tertiary alkylation of a C-C double bond, radical reaction is found to be one of the most promising protocols. In this paper, we highlight tertiary alkyl substitutions on C-C double bonds via atom-transfer radical substitution (ATRS) catalyzed by a copper salt and introduce the corresponding M-H reactions. 1 Alkylation via the Mizoroki-Heck Reaction 2 Tertiary Alkylative M-H-Type Reaction 3 Regioselective Double-Bond Formation 4 Summary and Perspectives	[Nishikata, Takashi; Ishikawa, Shingo] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan	Nishikata, T (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, 2-16-1 Tokiwadai, Ube, Yamaguchi 7558611, Japan.	nisikata@yamaguchi-u.ac.jp			MEXT, Japan [24750043]	Financial support provided by the Grant-in-Aid for Young Scientists (B) (24750043), and program to disseminate tenure tracking system, MEXT, Japan is gratefully acknowledgement.	Albeniz AC, 2001, J AM CHEM SOC, V123, P11504, DOI 10.1021/ja016315b; Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p; Atienza CCH, 2014, J AM CHEM SOC, V136, P12108, DOI 10.1021/ja5060884; Terao J, 2006, B CHEM SOC JPN, V79, P663, DOI 10.1246/bcsj.79.663; TAMARU Y, 1979, TETRAHEDRON, V35, P329, DOI 10.1016/0040-4020(79)80071-X; Prieto A, 2014, ORG LETT, V16, P4770, DOI 10.1021/ol5022228; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; Shibasaki M, 1997, TETRAHEDRON, V53, P7371, DOI 10.1016/S0040-4020(97)00437-7; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; Littke AF, 2001, J AM CHEM SOC, V123, P6989, DOI 10.1021/ja010988c; Bloome KS, 2011, J AM CHEM SOC, V133, P20146, DOI 10.1021/ja2091883; Gurtler C, 1999, CHEM-EUR J, V5, P3107, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3107::AID-CHEM3107>3.0.CO;2-#; Larsen CR, 2012, J AM CHEM SOC, V134, P10357, DOI 10.1021/ja3036477; Yu C, 2014, CHEM COMMUN, V50, P12884, DOI 10.1039/c4cc05467a; Eckenhoff WT, 2010, CATAL REV, V52, P1, DOI 10.1080/01614940903238759; Nishikata T, 2014, ORG LETT, V16, P5816, DOI 10.1021/ol502953w; Belhomme MC, 2013, ORG LETT, V15, P3428, DOI 10.1021/ol401483j; Liu Q, 2013, CHEM-EUR J, V19, P5120, DOI 10.1002/chem.201203694; Netherton MR, 2001, ORG LETT, V3, P4295, DOI 10.1021/ol016971g; Yang F, 2014, CHEM COMMUN, V50, P936, DOI 10.1039/c3cc48131j; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Zhang N, 2014, CHEM REV, V114, P5848, DOI 10.1021/cr400689s; Liwosz TW, 2013, ORG LETT, V15, P3034, DOI 10.1021/ol401220b; Zhang X, 2014, ORG BIOMOL CHEM, V12, P6790, DOI 10.1039/c4ob00813h; Ikeda Y, 2002, J AM CHEM SOC, V124, P6514, DOI 10.1021/ja026296l; Liu C, 2012, ANGEW CHEM INT EDIT, V51, P3638, DOI 10.1002/anie.201108350; Firmansjah L, 2007, J AM CHEM SOC, V129, P11340, DOI 10.1021/ja075245r; Nishikata T, 2013, J AM CHEM SOC, V135, P16372, DOI 10.1021/ja409661n; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; Feng C, 2013, ANGEW CHEM INT EDIT, V52, P12414, DOI 10.1002/anie.201307245; MELPOLDER JB, 1976, J ORG CHEM, V41, P265, DOI 10.1021/jo00864a017; CHO CS, 1994, J ORGANOMET CHEM, V465, P85, DOI 10.1016/0022-328X(94)87040-3; Barbero M, 2006, SYNTHESIS-STUTTGART, P3443, DOI 10.1055/s-2006-950245; Berthiol F, 2005, SYNTHESIS-STUTTGART, P3589, DOI 10.1055/s-2005-918427; Brase S, 1998, SYNTHESIS-STUTTGART, P148; Caillot G., 2014, CHEM COMMUN, P5887; CHALK AJ, 1976, J ORG CHEM, V41, P273, DOI 10.1021/jo00864a018; Chemler C R, 2001, ANGEW CHEM INT EDIT, V40, P4544; CURRAN DP, 1988, SYNTHESIS-STUTTGART, P489, DOI 10.1055/s-1988-27620; de Meijere A., 2004, METAL CATALYZED CROS; de Meijere A, 2014, METAL CATALYZED CROS, V13; FILIPPINI L, 1993, TETRAHEDRON LETT, V34, P1643, DOI 10.1016/0040-4039(93)85030-Z; JEFFERY T, 1990, TETRAHEDRON LETT, V31, P6641, DOI 10.1016/S0040-4039(00)97135-1; JEFFERY T, 1991, TETRAHEDRON LETT, V32, P2121, DOI 10.1016/S0040-4039(00)71252-4; Kauffmann T, 1996, ANGEW CHEM INT EDIT, V35, P386, DOI 10.1002/anie.199603861; Matoba K, 1999, J ORGANOMET CHEM, V574, P3, DOI 10.1016/S0022-328X(98)00974-7; McAtee JR, 2014, J AM CHEM SOC, V136, P10166, DOI 10.1021/ja505446y; Munoz-Molina JM, 2011, EUR J INORG CHEM, P3155, DOI 10.1002/ejic.201100379; Oestreich M., 2009, MIZOROKI HECK REACTI; SEN A, 1981, INORG CHEM, V20, P4036, DOI 10.1021/ic50225a101; Zhou W, 2011, ORG BIOMOL CHEM, V9, P5833, DOI 10.1039/c1ob05231d; Zou YJ, 2014, CHEM COMMUN, V50, P3725, DOI 10.1039/c4cc00297k	53	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	APR	2015	26	6					716	724		10.1055/s-0034-1379939		9	Chemistry, Organic	Chemistry	CE1PJ	WOS:000351583700002		
J	Arae, S; Ogasawara, M				Arae, Sachie; Ogasawara, Masamichi			Catalytic asymmetric synthesis of planar-chiral transition-metal complexes	TETRAHEDRON LETTERS			English	Article						Planar chiral; Transition-metal complex; Catalytic asymmetric synthesis; Enantioselective reaction; Homogenous catalysis	RING-CLOSING METATHESIS; ARENE CHROMIUM COMPLEXES; LIPASE-MEDIATED RESOLUTION; ENANTIOSELECTIVE SYNTHESIS; KINETIC RESOLUTION; ORTHO-LITHIATION; TRICARBONYLIRON FRAGMENT; FERROCENE DERIVATIVES; (DIENE)FE(CO)(3) COMPLEXES; ARYLBORONIC ACIDS	Planar-chiral transition-metal complexes are important chiral scaffolds in organic and organometallic chemistry and have been utilized as chiral ligands, chiral catalysts, or chiral building blocks. In spite of the usefulness of planar-chiral transition-metal complexes in asymmetric synthesis, enantiomerically enriched forms of these compounds are primarily obtained by rather classical methods. Examples of catalytic controlling planar-chirality in transition-metal species have been extremely rare, and this has been still a developing area in this field. In this review article, various methods of preparing enantiomerically enriched planar-chiral transition-metal complexes using substoichiometric chiral sources are surveyed. Most of the asymmetric reactions in these categories are transition-metal-catalyzed reactions, and there are a few examples of organocatalytic reactions. (C) 2015 Published by Elsevier Ltd.	[Ogasawara, Masamichi] Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan; Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Ogasawara, M (reprint author), Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan.	ogasawar@cat.hokudai.ac.jp	Ogasawara, Masamichi/B-7727-2012		MEXT, Japan [24655039]; JSPS Research Fellowship	We are grateful to Prof. Tamio Hayashi of National University of Singapore for providing us useful information regarding the historical background of the planar-chiral compounds. This work was supported by a Grant-in-Aid for Challenging Exploratory Research (24655039) from MEXT, Japan. S.A. has been a recipient of the JSPS Research Fellowship for the Young Scientists.	Akiyama M., 2014, CHEM COMMUN, P7893; Alba AN, 2009, TETRAHEDRON-ASYMMETR, V20, P1314, DOI 10.1016/j.tetasy.2009.05.011; Shi YC, 2013, BEILSTEIN J ORG CHEM, V9, P1891, DOI 10.3762/bjoc.9.222; Enders D, 1999, ANGEW CHEM INT EDIT, V38, P2421, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2421::AID-ANIE2421>3.3.CO;2-I; Ogasawara M, 2010, J AM CHEM SOC, V132, P2136, DOI 10.1021/ja910348z; Siegel S, 1997, ANGEW CHEM INT EDIT, V36, P2456, DOI 10.1002/anie.199724561; Garcia AE, 2010, ADV SYNTH CATAL, V352, P2306, DOI 10.1002/adsc.201000384; Gao DW, 2014, J AM CHEM SOC, V136, P4841, DOI 10.1021/ja500444v; Patti A, 2010, TETRAHEDRON-ASYMMETR, V21, P2631, DOI 10.1016/j.tetasy.2010.10.004; Ogasawara M, 2012, ANGEW CHEM INT EDIT, V51, P2951, DOI 10.1002/anie.201108292; Duan WL, 2007, TETRAHEDRON, V63, P8529, DOI 10.1016/j.tet.2007.05.025; Genet C, 2006, J AM CHEM SOC, V128, P9336, DOI 10.1021/ja062616f; HALTERMAN RL, 1992, CHEM REV, V92, P965, DOI 10.1021/cr00013a011; Arrayas RG, 2006, ANGEW CHEM INT EDIT, V45, P7674, DOI 10.1002/anie.200602482; Takemoto Y, 1998, TETRAHEDRON, V54, P15567, DOI 10.1016/S0040-4020(98)01010-2; RIANT O, 1993, J AM CHEM SOC, V115, P5835, DOI 10.1021/ja00066a066; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Deng RX, 2014, J AM CHEM SOC, V136, P4472, DOI 10.1021/ja500699x; Pi C, 2013, CHEM SCI, V4, P2675, DOI 10.1039/c3sc50577d; Kamikawa K, 2005, TETRAHEDRON-ASYMMETR, V16, P1419, DOI 10.1016/j.tetasy.2005.02.007; Richards CJ, 1998, TETRAHEDRON-ASYMMETR, V9, P2377, DOI 10.1016/S0957-4166(98)00251-1; Mercier A, 2010, CHEM-EUR J, V16, P6285, DOI 10.1002/chem.201000011; REBIERE F, 1993, ANGEW CHEM INT EDIT, V32, P568, DOI 10.1002/anie.199305681; Togni A, 1996, ANGEW CHEM INT EDIT, V35, P1475, DOI 10.1002/anie.199614751; Ogasawara M, 2006, ORGANOMETALLICS, V25, P5201, DOI 10.1021/om0608298; Gao DW, 2013, J AM CHEM SOC, V135, P86, DOI 10.1021/ja311082u; Fu GC, 2006, ACCOUNTS CHEM RES, V39, P853, DOI 10.1021/ar068115g; Gotov B, 2001, ORG LETT, V3, P1753, DOI 10.1021/ol0159468; UEMURA M, 1993, TETRAHEDRON LETT, V34, P107, DOI 10.1016/S0040-4039(00)60069-2; Takemoto Y, 1996, TETRAHEDRON LETT, V37, P3345, DOI 10.1016/0040-4039(96)00512-6; Pape AR, 2000, CHEM REV, V100, P2917, DOI 10.1021/cr9902852; Zhang H, 2012, ORG LETT, V14, P3012, DOI 10.1021/ol301063k; Arae S., ORGANOMETAL IN PRESS; Barbaro P, 2004, COORDIN CHEM REV, V248, P2131, DOI 10.1016/j.ccr.2004.03.022; Bueno A, 2006, ADV SYNTH CATAL, V348, P2590, DOI 10.1002/adsc.200600282; Butsugan Y, 1995, FERROCENES, P143; Canter C., 2008, PHOSPHORUS LIGANDS A, P393; Colacot T., 2003, J CHEM REV, V103, P3101; Dai L. -X., 2010, CHIRAL FERROCENES AS, P16; Dai L.-X., 2010, CHIRAL FERROCENES AS; Davies S. G., 1995, COMPREHENSIVE ORGANO, V12, P1039; Fu GC, 2000, ACCOUNTS CHEM RES, V33, P412, DOI 10.1021/ar990077w; Fu GC, 2004, ACCOUNTS CHEM RES, V37, P542, DOI 10.1021/ar030051b; Gibson SE, 2002, CHEM COMMUN, P2465, DOI 10.1039/b205479p; Hayashi T., 1995, FERROCENES, P105; HAYASHI T, 1974, TETRAHEDRON LETT, P4405; Hoveyda A. H., 1998, METALLOCENES, V2, P625; Huerlander D, 2002, EUR J INORG CHEM, P2633; IZUMI T, 1992, J CHEM TECHNOL BIOT, V55, P325; Kamikawa K., CHEM EUR J IN PRESS; Kanda K, 2014, HETEROCYCLES, V88, P1355, DOI 10.3987/COM-13-5(S)105; Kanda K, 2009, CHEM COMMUN, P1870, DOI 10.1039/b818904h; Kanda K, 2010, ORG LETT, V12, P1980, DOI 10.1021/ol100444u; Knolker HJ, 1999, SYNLETT, P421; Knolker HJ, 1999, TETRAHEDRON LETT, V40, P3547, DOI 10.1016/S0040-4039(99)00548-1; Knolker HJ, 1996, ANGEW CHEM INT EDIT, V35, P341, DOI 10.1002/anie.199603411; Knolker HJ, 2000, CHEM REV, V100, P2941, DOI 10.1021/cr990267k; Kundig P. E., 2006, ANGEW CHEM INT EDIT, V45, P1092; Lambusta D, 1996, TETRAHEDRON LETT, V37, P127, DOI 10.1016/0040-4039(95)02090-X; Laufer RS, 2000, ORG LETT, V2, P629, DOI 10.1021/ol991381s; Locke AJ, 2001, J ORGANOMET CHEM, V637, P669, DOI 10.1016/S0022-328X(01)00980-9; Marion N., 2010, CHIRAL FERROCENES AS, P307; MARQUARD.D, 1970, J AM CHEM SOC, V92, P5389, DOI 10.1021/ja00721a017; Mercier A, 2009, CHEM COMMUN, P5227, DOI 10.1039/b910977c; Murai M, 2013, J ORG CHEM, V78, P10986, DOI 10.1021/jo401893f; Murai M, 2010, ORG LETT, V12, P4788, DOI 10.1021/ol1019376; Negishi EI, 2011, ARKIVOC, P34; Nishibayashi Y, 1996, J ORG CHEM, V61, P1172, DOI 10.1021/jo9516345; Ogasawara M, 2008, ORGANOMETALLICS, V27, P6565, DOI 10.1021/om8007663; Ogasawara M, 2002, J AM CHEM SOC, V124, P9068, DOI 10.1021/ja026401r; Ogasawara M, 2011, J ORGANOMET CHEM, V696, P3987, DOI 10.1016/j.jorganchem.2011.05.006; Ogasawara M, 2003, ORGANOMETALLICS, V22, P1174, DOI 10.1021/om021058k; Ogasawara M, 2008, PURE APPL CHEM, V80, P1109, DOI 10.1351/pac200880051109; Ogasawara M, 2013, CHEM-EUR J, V19, P4151, DOI 10.1002/chem.201300116; Patti A, 1998, TETRAHEDRON-ASYMMETR, V9, P3073, DOI 10.1016/S0957-4166(98)00311-5; Richards C. J., 1995, SYNLETT, V74; Schlogl K., 1964, MONATSH CHEM, V95, P558, DOI 10.1007/BF00901323; Schlogl K., 1967, TOP STEREOCHEM, V1, P39, DOI 10.1002/9780470147108.ch2; Schlogl K., 1964, MONATSH CHEM, V95, P576, DOI 10.1007/BF00901324; Schlogl K., 1964, ANGEW CHEM INT EDIT, V3, P512; Bottcher A, 2003, SYNLETT, P1595, DOI 10.1055/s-2003-41417; Schmalz H.-G., 1998, TRANSITION METALS FI, V1; Semmelhack M. F., 1995, COMPREHENSIVE ORGANO, V12, p[979, 1017]; Shibata T, 2014, ANGEW CHEM INT EDIT, V53, P5410, DOI 10.1002/anie.201402518; Stepnicka P., 2008, FERROCENES LIGANDS M, P237; Tanaka K, 2008, TETRAHEDRON, V64, P831, DOI 10.1016/j.tet.2007.10.085; Tanaka K, 2007, J AM CHEM SOC, V129, P1522, DOI 10.1021/ja0679127; Tanaka K, 2007, ORG LETT, V9, P4881, DOI 10.1021/oI702242x; THOMSON JB, 1959, TETRAHEDRON LETT, P26; Togni A., 1998, METALLOCENES, P685; Tsukazaki M, 1996, J AM CHEM SOC, V118, P685, DOI 10.1021/ja953246q; Uemura M., 2006, ORG REACTIONS, V67, P217; UEMURA M, 1994, J ORGANOMET CHEM, V473, P129, DOI 10.1016/0022-328X(94)80113-4; Urbaneja X., 2011, CHEM COMMUN, P3739; Wagner G, 1995, FERROCENES, P173	95	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	APR 1	2015	56	14					1751	1761		10.1016/j.tetlet.2015.01.130		11	Chemistry, Organic	Chemistry	CE4HC	WOS:000351790700001		
J	Mugishima, N; Kanomata, N; Akutsu, N; Kubota, H				Mugishima, Nanako; Kanomata, Nobuhiro; Akutsu, Norihiko; Kubota, Hironobu			Remote steric effects of C-2-symmetric planar-chiral terpyridine ligands on copper-catalyzed asymmetric cyclopropanation reactions	TETRAHEDRON LETTERS			English	Article						Asymmetric cyclopropanation; Copper carbenoid; Planar chirality; Remote steric effect; Terpyridine	HIGHLY ENANTIOSELECTIVE REDUCTION; BRIDGED NADH MODELS; N-OXIDE LIGANDS; 2,2'/6',2''-TERPYRIDINE LIGANDS; SELECTIVE CYCLOPROPANATION; BIPYRIDINE-LIGAND; COMPLEXES; ALKENES; PARACYCLOPHANES; PYRIDINOPHANES	A series of enantioselective cyclopropanation reactions of substituted alkenes with diazoacetates was investigated in the presence of Cu(OTf)(2) with C-2-symmetric planar-chiral bridged 2,2':6',2 ''-terpyridines. Planar-chiral terpyridine-copper complexes exhibited moderate diastereomeric excesses with good enantioselectivities of cis-cyclopropane products in catalytic asymmetric cyclopropanation reactions of various styrene derivatives with ethyl diazoacetate. A remote steric effect was found to enhance enantioselectivity for the cyclopropanation induced by a sterically demanding substituent beyond the ansa-bridge of pyridinophane ligands on the other side of the reaction site as a relay of steric influences through flexible cyclophane bridges. (C) 2015 Elsevier Ltd. All rights reserved.	[Mugishima, Nanako; Kanomata, Nobuhiro; Akutsu, Norihiko] Waseda Univ, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan; [Kanomata, Nobuhiro; Kubota, Hironobu] Meiji Univ, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Kanomata, N (reprint author), Waseda Univ, Dept Chem & Biochem, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	kanomata@waseda.jp	Kanomata, Nobuhiro/A-4948-2011	Kanomata, Nobuhiro/0000-0002-5266-9756	Waseda University [2011B-180]	The authors acknowledge financial support through a Waseda University Grant for Special Research Projects 2011B-180.	Chen Y, 2007, J ORG CHEM, V72, P5931, DOI 10.1021/jo070997p; Charette AB, 2001, J AM CHEM SOC, V123, P12168, DOI 10.1021/ja0108382; Ishikawa S, 2004, J AM CHEM SOC, V126, P12236, DOI 10.1021/ja047896i; Chelucci G, 2002, J MOL CATAL A-CHEM, V178, P27, DOI 10.1016/S1381-1169(01)00287-4; MAXWELL JL, 1992, ORGANOMETALLICS, V11, P645, DOI 10.1021/om00038a023; Suematsu H, 2008, J AM CHEM SOC, V130, P10327, DOI 10.1021/ja802561t; Arai T, 2014, ORG LETT, V16, P2768, DOI 10.1021/ol501085y; Chelucci G, 2002, CHEM REV, V102, P3129, DOI 10.1021/cr0101914; SALOMON RG, 1973, J AM CHEM SOC, V95, P3300, DOI 10.1021/ja00791a038; van Oers MCM, 2014, CHEM COMMUN, V50, P4040, DOI 10.1039/c3cc48865a; Gao MZ, 2005, SYNTHETIC COMMUN, V35, P2665, DOI 10.1080/00397910500213948; Duan ZQ, 2014, BEILSTEIN J ORG CHEM, V10, P969, DOI 10.3762/bjoc.10.95; Bisai V, 2014, ANGEW CHEM INT EDIT, V53, P10737, DOI 10.1002/anie.201405074; White JD, 2014, ORG LETT, V16, P3880, DOI 10.1021/ol501549x; Wong WL, 2004, ORG BIOMOL CHEM, V2, P1967, DOI 10.1039/b407933g; Berkessel A, 2003, CHEM-EUR J, V9, P4746, DOI 10.1002/chem.200305045; Cortright SB, 2004, ORGANOMETALLICS, V23, P2238, DOI 10.1021/om049897p; Lyle MPA, 2004, ORG LETT, V6, P855, DOI 10.1021/ol049853c; Inoue M, 2008, CHEM REC, V8, P169, DOI 10.1002/tcr.20148; Kishimoto Y, 2009, J AM CHEM SOC, V131, P4227, DOI 10.1021/ja810032t; Niimi T, 2001, ADV SYNTH CATAL, V343, P79, DOI 10.1002/1615-4169(20010129)343:1<79::AID-ADSC79>3.3.CO;2-#; Kwong HL, 2000, TETRAHEDRON-ASYMMETR, V11, P2299, DOI 10.1016/S0957-4166(00)00182-8; YUEH W, 1995, J AM CHEM SOC, V117, P5671, DOI 10.1021/ja00126a007; Bartoli G, 2014, SYNTHESIS-STUTTGART, V46, P979, DOI 10.1055/s-0033-1340838; Kwong HL, 2007, COORDIN CHEM REV, V251, P2188, DOI 10.1016/j.ccr.2007.03.010; Morandi B, 2012, ORG LETT, V14, P2162, DOI 10.1021/ol300688p; GUPTA AD, 1994, TETRAHEDRON, V50, P13725, DOI 10.1016/S0040-4020(01)85684-2; Azoulay S, 2005, ORG LETT, V7, P4593, DOI 10.1021/ol051546z; Maeda R, 2011, J AM CHEM SOC, V133, P10379, DOI 10.1021/ja203781f; Lo MMC, 1998, J AM CHEM SOC, V120, P10270, DOI 10.1021/ja982488y; Araki T, 2011, SYNLETT, P539, DOI 10.1055/s-0030-1259539; Awata A, 2014, ANGEW CHEM INT EDIT, V53, P10462, DOI 10.1002/anie.201405223; Charette AB, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P203; Chelucci G, 2002, TETRAHEDRON LETT, V43, P8599, DOI 10.1016/S0040-4039(02)02066-X; Chelucci G, 2001, TETRAHEDRON, V57, P1099, DOI 10.1016/S0040-4020(00)01082-6; Chen Y, 2004, J ORG CHEM, V69, P2431, DOI 10.1021/jo049870f; Davi M, 2008, CHEM COMMUN, P4974, DOI 10.1039/b810708d; Desimoni G, 2011, CHEM REV, V111, pPR284, DOI 10.1021/cr100339a; Garcia JI, 2014, TETRAHEDRON-ASYMMETR, V25, P833, DOI 10.1016/j.tetasy.2014.04.017; Ishida Y, 2009, CHEM COMMUN, P3401, DOI 10.1039/b904059e; Kadzhaeva AZ, 2009, CHEM HETEROCYCL COM+, V45, P595, DOI 10.1007/s10593-009-0315-6; Kanda K, 2010, ORG LETT, V12, P1980, DOI 10.1021/ol100444u; Kanomata N, 2009, TETRAHEDRON LETT, V50, P2740, DOI 10.1016/j.tetlet.2009.03.095; Kanomata N, 2001, TETRAHEDRON LETT, V42, P1045, DOI 10.1016/S0040-4039(00)02043-8; Kanomata N, 2003, TETRAHEDRON LETT, V44, P3625, DOI 10.1016/S0040-4039(03)00699-3; Kanomata N, 2000, J AM CHEM SOC, V122, P4563, DOI 10.1021/ja992990y; Kanomata N, 2010, ADV SYNTH CATAL, V352, P2966, DOI 10.1002/adsc.201000079; Kanomata N, 2009, TETRAHEDRON LETT, V50, P409, DOI 10.1016/j.tetlet.2008.11.021; Kanomata N, 1997, ANGEW CHEM INT EDIT, V36, P1207, DOI 10.1002/anie.199712071; Kitanosono T, 2012, ORG BIOMOL CHEM, V10, P7134, DOI 10.1039/c2ob26264a; Kramer JJP, 2013, EUR J ORG CHEM, P541, DOI 10.1002/ejoc.201201286; Lee WS, 2011, POLYHEDRON, V30, P178, DOI 10.1016/j.poly.2010.10.021; Masterson DS, 2012, J MOL CATAL A-CHEM, V361, P111, DOI 10.1016/j.molcata.2012.05.009; Moberg C, 2012, ISR J CHEM, V52, P653, DOI 10.1002/ijch.201200020; Mori K, 2009, ANGEW CHEM INT EDIT, V48, P5638, DOI 10.1002/anie.200901974; Nishii Y, 2001, BIOORGAN MED CHEM, V9, P33, DOI 10.1016/S0968-0896(00)00217-0; Pezet F, 2001, EUR J INORG CHEM, P2669; Rios R., 2000, J CHEM SOC CHEM COMM; Sambasivan R, 2014, CHEM SCI, V5, P1401, DOI 10.1039/c3sc53354a; Schubert US, 2011, TERPYRIDINE BASED MATERIALS: FOR CATALYTIC, OPTOELECTRONIC AND LIFE SCIENCE APPLICATIONS, P459; Stanley L. M., 2011, PRIVILEGED CHIRAL LI, P171; Uchida T, 2000, TETRAHEDRON, V56, P3501, DOI 10.1016/S0040-4020(00)00273-8; Ueda T, 2005, ORG LETT, V7, P2365, DOI 10.1021/ol0506258; Wada K, 2013, CHEM LETT, V42, P1194, DOI 10.1246/cl.130502; Kwong HL, 2001, TETRAHEDRON-ASYMMETR, V12, P2683, DOI 10.1016/S0957-4166(01)00431-1; Wong WL, 2002, TETRAHEDRON-ASYMMETR, V13, P1485, DOI 10.1016/S0957-4166(02)00270-7; Worsdorfer U, 1999, SYNTHESIS-STUTTGART, P597; Worsdorfer U, 1999, J PRAK CHEM-CHEM ZTG, V341, P445; Xin DY, 2010, TETRAHEDRON-ASYMMETR, V21, P333, DOI 10.1016/j.tetasy.2010.02.007; Yeung CT, 2010, POLYHEDRON, V29, P1497, DOI 10.1016/j.poly.2010.01.017; Yeung CT, 2007, ORG BIOMOL CHEM, V5, P3859, DOI 10.1039/b712995e; Yeung CT, 2007, CHEM COMMUN, P5203, DOI 10.1039/b713010d; Yeung CT, 2009, INORG CHIM ACTA, V362, P3267, DOI 10.1016/j.ica.2009.02.034	73	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	APR 1	2015	56	14					1898	1903		10.1016/j.tetlet.2015.02.103		6	Chemistry, Organic	Chemistry	CE4HC	WOS:000351790700036		
J	Kamijo, S; Tao, K; Takao, G; Murooka, H; Murafuji, T				Kamijo, Shin; Tao, Keisuke; Takao, Go; Murooka, Hironori; Murafuji, Toshihiro			Ether derivatization via two-step protocol comprised of photochemical ethereal C-H bond chlorination and nucleophilic substitution	TETRAHEDRON LETTERS			English	Article						Carbon tetrachloride; Chlorination; Ether; Sulfamoyl chloride; Photoreaction	C(SP(3))-H BONDS; 2-TETRAHYDROFURANYL ETHERS; TOLUENESULFONYL CHLORIDE; RADICAL ALKYNYLATION; ALCOHOLS; TETRAHYDROFURANYLATION; CARBAMOYLATION; PROTECTION; EFFICIENT	A two-step protocol has been developed for ether derivatization introducing oxygen-, sulfur-, and carbon-functionalities. The present protocol comprises photochemical chlorination of ethereal C(sp(3))-H bond for preparation of chlorinated ethers as common synthetic intermediates, and nucleophilic substitution of the installed chlorine moiety for construction of various ether derivatives. These two reactions can be conducted sequentially in a single flask, thus the newly developed method offers a one-pot and unified procedure for ether derivatization with attachment of various functionalities at the alpha-position. (C) 2015 Elsevier Ltd. All rights reserved.	[Kamijo, Shin; Tao, Keisuke; Murooka, Hironori] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan; [Takao, Go] Yamaguchi Univ, Dept Biol & Chem, Yamaguchi 7538512, Japan; [Murafuji, Toshihiro] Yamaguchi Univ, Grad Sch Med, Yamaguchi 7538512, Japan	Kamijo, S (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan.	kamijo@yamaguchi-u.ac.jp			Naito Foundation; Iwatani Naoji Foundation's Research Grant; MEXT, Japan; Program to Disseminate Tenure Tracking System (MEXT, Japan)	This research was supported by the Naito Foundation, the Iwatani Naoji Foundation's Research Grant, a Grant-in-Aid for Scientific Research on Innovative Areas 'Advanced Molecular Transformations by Organocatalysts' (MEXT, Japan), and a Program to Disseminate Tenure Tracking System (MEXT, Japan) to S.K. We thank the Collaborative Center for Engineering Research Equipment at Yamaguchi University for assistance in obtaining some of the mass spectrometry data.	Albini A., 2010, HDB SYNTHETIC PHOTOC; Amaoka Y, 2014, CHEM SCI, V5, P4339, DOI 10.1039/c4sc01631a; Kamijo S, 2011, ORG LETT, V13, P5928, DOI 10.1021/ol202659e; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Kamijo S, 2014, TETRAHEDRON LETT, V55, P5551, DOI 10.1016/j.tetlet.2014.08.011; JUNG JC, 1993, TETRAHEDRON LETT, V34, P3581, DOI 10.1016/S0040-4039(00)73641-0; Hoshikawa T, 2013, ORG BIOMOL CHEM, V11, P164, DOI 10.1039/c2ob26785c; Yoshioka S, 2015, ORG LETT, V17, P90, DOI 10.1021/ol503291s; Hoshikawa T, 2013, SYNTHESIS-STUTTGART, V45, P874, DOI 10.1055/s-0032-1318325; Kamon T, 2011, ORG LETT, V13, P2674, DOI 10.1021/ol200772f; Troisi L, 2010, TETRAHEDRON LETT, V51, P5980, DOI 10.1016/j.tetlet.2010.09.014; [Anonymous], 2011, CHEM SOC REV, P0; Gaspar B, 2008, ANGEW CHEM INT EDIT, V47, P5758, DOI 10.1002/anie.200801760; Hoshikawa T, 2013, CHEM SCI, V4, P3118, DOI 10.1039/c3sc51080h; Kamijo S, 2011, TETRAHEDRON LETT, V52, P2885, DOI 10.1016/j.tetlet.2011.03.128; BROWN DS, 1989, TETRAHEDRON, V45, P4293, DOI 10.1016/S0040-4020(01)81323-5; Kamijo S, 2010, TETRAHEDRON LETT, V51, P872, DOI 10.1016/j.tetlet.2009.12.027; Falck JR, 2006, TETRAHEDRON LETT, V47, P5111, DOI 10.1016/j.tetlet.2006.05.081; Barks JM, 2000, TETRAHEDRON LETT, V41, P6249, DOI 10.1016/S0040-4039(00)01045-5; Ochiai M, 2004, TETRAHEDRON LETT, V45, P3557, DOI 10.1016/j.tetlet.2004.03.049; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Ishida N, 2012, ANGEW CHEM INT EDIT, V51, P11750, DOI 10.1002/anie.201206166; Atavin A. S, 1973, KHIM GETEROTSIKL, V12, P1611; Baati R, 2000, ORG LETT, V2, P485, DOI 10.1021/ol991332f; BROWN DS, 1988, TETRAHEDRON LETT, V29, P4873, DOI 10.1016/S0040-4039(00)80631-0; Cal K., 2008, TETRAHEDRON LETT, V49, P4652; Cao LD, 2011, ADV SYNTH CATAL, V353, P3467, DOI 10.1002/adsc.201100473; CHATGILIALOGLU C, 1986, J ORG CHEM, V51, P2871, DOI 10.1021/jo00365a003; CHATGILIALOGLU C, 1989, J ORG CHEM, V54, P2734, DOI 10.1021/jo00272a052; Choi H.C., 1995, SYNTHETIC COMMUN, P207; DAS B, 2007, CHIM ACTA, V90, P2163; Dyker G., 2005, HDB C H TRANSFORMATI, V1-3; Dyker G., 2005, HDB C H TRANSFORMATI, V2; Fuchs P. L, 2007, HDB REAGENTS ORGANIC, P2007; KRUSE CG, 1976, TETRAHEDRON LETT, P1725; KRUSE CG, 1979, RECL TRAV CHIM PAY B, V98, P371; Luo Y.-R, 2007, COMPREHENSIVE HDB CH, p[20, 74]; Malone A.M., 1987, SYNTHESIS-STUTTGART, P250; Nagatomo M, 2015, CHEM-ASIAN J, V10, P120, DOI 10.1002/asia.201402983; Schaffner AP, 2008, ADV SYNTH CATAL, V350, P1163, DOI 10.1002/adsc.200700531; Wang M.-K., 2013, SYNLETT, P737; Zhuk R.A., 1979, KHIM GETEROTSIKL, V2, P166	42	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	APR 1	2015	56	14					1904	1907		10.1016/j.tetlet.2015.02.102		4	Chemistry, Organic	Chemistry	CE4HC	WOS:000351790700037		
J	Tatsumi, K; Oizumi, T; Yamashiki, Y				Tatsumi, Kenichi; Oizumi, Tsutao; Yamashiki, Yosuke			Effects of climate change on daily minimum and maximum temperatures and cloudiness in the Shikoku region: a statistical downscaling model approach	THEORETICAL AND APPLIED CLIMATOLOGY			English	Article							ASSESSING UNCERTAINTIES; PRECIPITATION INDEXES; RIVER THAMES; RANGE; IMPACT; SIMULATION; TRENDS; REANALYSIS; SCENARIOS; PROJECT	In this study, we present a detailed analysis of the effect of changes in cloudiness (CLD) between a future period (2071-2099) and the base period (1961-1990) on daily minimum temperature (TMIN) and maximum temperature (TMAX) in the same period for the Shikoku region, Japan. This analysis was performed using climate data obtained with the use of the Statistical DownScaling Model (SDSM). We calibrated the SDSM using the National Center for Environmental Prediction (NCEP) reanalysis dataset for the SDSM input and daily time series of temperature and CLD from 10 surface data points (SDP) in Shikoku. Subsequently, we validated the SDSM outputs, specifically, TMIN, TMAX, and CLD, obtained with the use of the NCEP reanalysis dataset and general circulation model (GCM) data against the SDP. The GCM data used in the validation procedure were those from the Hadley Centre Coupled Model, version 3 (HadCM3) for the Special Report on Emission Scenarios (SRES) A2 and B2 scenarios and from the third generation Coupled Global Climate Model (CGCM3) for the SRES A2 and A1B scenarios. Finally, the validated SDSM was run to study the effect of future changes in CLD on TMIN and TMAX. Our analysis showed that (1) the negative linear fit between changes in TMAX and those in CLD was statistically significant in winter while the relationship between the two changes was not evident in summer, (2) the dependency of future changes in TMAX and TMIN on future changes in CLD were more evident in winter than in other seasons with the present SDSM, (3) the diurnal temperature range (DTR) decreased in the southern part of Shikoku in summer in all the SDSM projections while DTR increased in the northern part of Shikoku in the same season in these projections, (4) the dependencies of changes in DTR on changes in CLD were unclear in summer and winter. Results of the SDSM simulations performed for climate change scenarios such as those from this study contribute to local-scale agricultural and hydrological simulations and development of agricultural and hydrological models.	[Tatsumi, Kenichi] Tokyo Univ Agr & Technol, Dept Environm & Agr Engn, Fuchu, Tokyo 1838509, Japan; [Oizumi, Tsutao] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Yamashiki, Yosuke] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Kyoto, Kyoto 6068501, Japan	Tatsumi, K (reprint author), Tokyo Univ Agr & Technol, Dept Environm & Agr Engn, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	ktatsumi@cc.tuat.ac.jp					Hessami M, 2008, ENVIRON MODELL SOFTW, V23, P813, DOI 10.1016/j.envsoft.2007.10.004; Weber RO, 1997, CLIMATIC CHANGE, V36, P327, DOI 10.1023/A:1005378702066; Tatsumi K, 2014, STOCH ENV RES RISK A, V28, P1447, DOI 10.1007/s00477-014-0847-x; Raje D, 2011, HYDROL PROCESS, V25, P3575, DOI 10.1002/hyp.8083; Coulibaly P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020075; Zhou LM, 2007, P NATL ACAD SCI USA, V104, P17937, DOI 10.1073/pnas.0700290104; Hashmi MZ, 2011, STOCH ENV RES RISK A, V25, P475, DOI 10.1007/s00477-010-0416-x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Dai A, 1999, J CLIMATE, V12, P2451, DOI 10.1175/1520-0442(1999)012<2451:EOCSMP>2.0.CO;2; Wilby RL, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004065; Wilby RL, 1998, WATER RESOUR RES, V34, P2995, DOI 10.1029/98WR02577; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; PLUMMER N, 1995, ATMOS RES, V37, P79, DOI 10.1016/0169-8095(94)00070-T; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Diaz-Nieto J, 2005, CLIMATIC CHANGE, V69, P245, DOI 10.1007/s10584-005-1157-6; Prudhomme C, 2009, CLIMATIC CHANGE, V93, P177, DOI 10.1007/s10584-008-9464-3; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Dibike YB, 2005, J HYDROL, V307, P145, DOI 10.1016/j.hydrol.2004.10.012; Chu JT, 2010, THEOR APPL CLIMATOL, V99, P149, DOI 10.1007/s00704-009-0129-6; Christensen JH, 2007, CLIMATIC CHANGE, V81, P1, DOI 10.1007/s10584-006-9211-6; Dai A, 1997, NATURE, V386, P665, DOI 10.1038/386665b0; Lobell DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028726; Khan MS, 2006, J HYDROL, V319, P357, DOI 10.1016/j.jhydrol.2005.06.035; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Wise EK, 2009, INT J CLIMATOL, V29, P87, DOI 10.1002/joc.1713; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Gachon P, 2007, INT J CLIMATOL, V27, P1623, DOI 10.1002/joc.1582; HORTON B, 1995, ATMOS RES, V37, P101, DOI 10.1016/0169-8095(94)00083-P; Houghton J T, 2001, CLIM CHANG 2001 SCI; Huang J, 2012, THEOR APPL CLIMATOL, V108, P325, DOI 10.1007/s00704-011-0536-3; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; IPCC, 2001, WORK GROUP 2 IMP AD; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Mendes D, 2010, THEOR APPL CLIMATOL, V100, P413, DOI 10.1007/s00704-009-0193-y; Przybylak, 1999, POLISH POLAR RES, V20, P149; Schoof JT, 2001, INT J CLIMATOL, V21, P773, DOI 10.1002/joc.655; Soussy C.J., 2008, SETS PREDICTOR VARIA, V2008, P1; Stenchikov GL, 1995, J GEOPHYS RES-ATMOS, V100, P26211, DOI 10.1029/95JD02166; Wetterhall F, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004573; Wilby R. L., 2002, ENVIRON MODELL SOFTW, V17, P145, DOI [10.1016/51364-8152(01)00060-3, DOI 10.1016/S1364-8152(01)00060-3]; Wilby RL, 2007, SDSM 4 2 DECISION SU; Zheng XG, 1997, J CLIMATE, V10, P317, DOI 10.1175/1520-0442(1997)010<0317:TDIRMT>2.0.CO;2	42	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-798X	1434-4483		THEOR APPL CLIMATOL	Theor. Appl. Climatol.	APR	2015	120	1-2					87	98		10.1007/s00704-014-1152-9		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE5IY	WOS:000351866800009		
J	Hayase, S; Sasaki, Y; Matsubara, T; Seo, D; Miyakoshi, M; Murata, T; Ozaki, T; Kakudo, K; Kumamoto, K; Ylaya, K; Cheng, SY; Thorgeirsson, SS; Hewitt, SM; Ward, JM; Kimura, S				Hayase, Suguru; Sasaki, Yoshihito; Matsubara, Tsutomu; Seo, Daekwan; Miyakoshi, Masaaki; Murata, Tsubasa; Ozaki, Takashi; Kakudo, Kennichi; Kumamoto, Kensuke; Ylaya, Kris; Cheng, Sheue-yann; Thorgeirsson, Snorri S.; Hewitt, Stephen M.; Ward, Jerrold M.; Kimura, Shioko			Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells	THYROID			English	Article							VON-WILLEBRAND-FACTOR; EMBRYONIC STEM-CELLS; HORMONE RECEPTOR-BETA; GENE-EXPRESSION; IN-VITRO; MAMMARY-GLAND; GASTRIC-CANCER; DIFFERENTIATION; CARCINOMA; METASTASIS	Background: Mouse thyroid side population (SP) cells consist of a minor population of mouse thyroid cells that may have multipotent thyroid stem cell characteristics. However the nature of thyroid SP cells remains elusive, particularly in relation to thyroid cancer. Stanniocalcin (STC) 1 and 2 are secreted glycoproteins known to regulate serum calcium and phosphate homeostasis. In recent years, the relationship of STC1/2 expression to cancer has been described in various tissues. Method: Microarray analysis was carried out to determine genes up- and down-regulated in thyroid SP cells as compared with non-SP cells. Among genes up-regulated, stanniocalcin 1 (STC1) was chosen for study because of its expression in various thyroid cells by Western blotting and immunohistochemistry. Results: Gene expression analysis revealed that genes known to be highly expressed in cancer cells and/or involved in cancer invasion/metastasis were markedly up-regulated in SP cells from both intact as well as partial thyroidectomized thyroids. Among these genes, expression of STC1 was found in five human thyroid carcinoma-derived cell lines as revealed by analysis of mRNA and protein, and its expression was inversely correlated with the differentiation status of the cells. Immunohistochemical analysis demonstrated higher expression of STC1 in the thyroid tumor cell line and thyroid tumor tissues from humans and mice. Conclusion: These results suggest that SP cells contain a population of cells that express genes also highly expressed in cancer cells including Stc1, which warrants further study on the role of SP cells and/or STC1 expression in thyroid cancer.	[Hayase, Suguru; Sasaki, Yoshihito; Matsubara, Tsutomu; Miyakoshi, Masaaki; Murata, Tsubasa; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Hayase, Suguru; Kumamoto, Kensuke] Fukushima Med Univ, Sch Med, Dept Organ Regulatory Surg, Fukushima, Japan; [Sasaki, Yoshihito] Kuwana East Med Ctr, Kuwana, Mie, Japan; [Matsubara, Tsutomu] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 558, Japan; [Seo, Daekwan; Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; [Seo, Daekwan] Seoul Natl Univ, Sch Biol Sci, Bioinformat Core, Seoul, South Korea; [Miyakoshi, Masaaki] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Sapporo, Hokkaido, Japan; [Murata, Tsubasa] Tomakomai City Hosp, Dent & Oral Surg, Tomakomai, Hokkaido, Japan; [Ozaki, Takashi] Wakayama Med Univ, Dept Pathol, Wakayama, Japan; [Kakudo, Kennichi] Kinki Univ, Nara Hosp, Fac Med, Dept Pathol, Ikoma, Japan; [Ylaya, Kris; Hewitt, Stephen M.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Cheng, Sheue-yann] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ward, Jerrold M.] Global VetPathol, Montgomery Village, MD USA	Kimura, S (reprint author), NIH, Bldg 37,Rm 3106,9000 Rockville Pike, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov		Hewitt, Stephen/0000-0001-8283-1788	Intramural Research Program of National Cancer Institute, Center for Cancer Research [ZIABC005522, ZICBC010923]	We would like to thank Subhadra Banerjee and Karen M. Wolcott (Flow Cytometry Core Facility, Laboratory of Genome Integrity, CCR, NCI) for their help in FACS analysis. This work was supported by an Intramural Research Program of National Cancer Institute, Center for Cancer Research, ZIABC005522 (SK) and ZICBC010923 (SMH).	Liu GZ, 2010, J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Smirnov DA, 2006, CANCER RES, V66, P2918, DOI 10.1158/0008-5472.CAN-05-4003; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Eppert K, 2005, MODERN PATHOL, V18, P388, DOI 10.1038/modpathol.3800265; McCudden CR, 2004, MOL CELL ENDOCRINOL, V213, P167, DOI 10.1016/j.mce.2003.10.042; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; McCudden CR, 2002, J BIOL CHEM, V277, P45249, DOI 10.1074/jbc.M205954200; Okabe H, 2001, CANCER RES, V61, P2129; Fierabracci A, 2008, J ENDOCRINOL, V198, P471, DOI 10.1677/JOE-07-0552; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Shiozawa Y, 2013, PHARMACOL THERAPEUT, V138, P285, DOI 10.1016/j.pharmthera.2013.01.014; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43922; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Lan L, 2013, INT J ONCOL, V43, P113, DOI 10.3892/ijo.2013.1913; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V250, P252, DOI 10.1006/bbrc.1998.9300; Antoniou A, 2013, CELL CYCLE, V12, P3743, DOI 10.4161/cc.27305; Wang HX, 2012, BMB REP, V45, P629, DOI 10.5483/BMBRep.2012.45.11.086; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; DUMONT JE, 1992, PHYSIOL REV, V72, P667; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Iwatani H, 2004, KIDNEY INT, V65, P1604, DOI 10.1111/j.1523-1755.2004.00561.x; Hawkins KE, 2013, REGEN MED, V8, P771, DOI 10.2217/rme.13.71; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Zorn AM, 2007, INT REV CYTOL, V259, P49, DOI 10.1016/S0074-7696(06)59002-3; Arigami T, 2012, ONCOLOGY-BASEL, V83, P158, DOI 10.1159/000341390; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Pinto CA, 2013, CANCER LETT, V341, P56, DOI 10.1016/j.canlet.2013.06.003; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Tsai FY, 1997, BLOOD, V89, P3636; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Tohmiya Y, 2004, TOHOKU J EXP MED, V204, P125, DOI 10.1620/tjem.204.125; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005.0116; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Carina V, 2013, THYROID, V23, P829, DOI 10.1089/thy.2012.0372; Hasilo CP, 2005, AM J PHYSIOL-ENDOC M, V289, pE634, DOI 10.1152/ajpendo.00098.2005; Havekes B, 2000, J ENDOCRINOL, V167, P229, DOI 10.1677/joe.0.1670229; Hoshi N, 2007, ENDOCRINOLOGY, V148, P4251, DOI 10.1210/en.2006-0490; Hussain SZ, 2005, DIGEST DIS SCI, V50, P1755, DOI 10.1007/s10620-005-2933-x; Kao YR, 2003, CLIN CANCER RES, V9, P2807; Kim YS, 2009, FRONT BIOSCI, V14, P2845, DOI 10.2741/4017; Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Lin SJ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-26; Masson Norma, 2014, Cancer Metab, V2, P3, DOI 10.1186/2049-3002-2-3; Mittal S, 2009, AM J MED SCI, V338, P107, DOI 10.1097/MAJ.0b013e3181ad5865; Moeller LC, 2011, EXP CLIN ENDOCR DIAB, V119, P81, DOI 10.1055/s-0030-1262860; Neuhäuser Markus, 2006, Appl Bioinformatics, V5, P173, DOI 10.2165/00822942-200605030-00005; Ozaki T, 2012, ENDOCRINOLOGY, V153, P2514, DOI 10.1210/en.2011-1365; Rao AS, 2005, J CLIN ENDOCR METAB, V90, P5906, DOI 10.1210/jc.2005-0952; Shirakawa M, 2012, ONCOL REP, V27, P940, DOI 10.3892/or.2011.1607; Summer R, 2004, AM J PHYSIOL-LUNG C, V287, pL477, DOI 10.1152/ajplung.00020.2004; Tabata M, 2001, J CELL PHYSIOL, V186, P260, DOI 10.1002/1097-4652(200002)186:2<260::AID-JCP1025>3.0.CO;2-K; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Terraube V, 2007, THROMB RES, V120, pS64, DOI 10.1016/S0049-3848(07)70132-9; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Wang WS, 2005, WORLD J GASTROENTERO, V11, P2166; Wulf GG, 2003, HAEMATOLOGICA, V88, P368	80	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	APR 1	2015	25	4					425	436		10.1089/thy.2014.0464		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CF1HJ	WOS:000352295100008		
J	Thitiwuthikiat, P; Ii, M; Saito, T; Asahi, M; Kanokpanont, S; Tabata, Y				Thitiwuthikiat, Piyanuch; Ii, Masaaki; Saito, Takashi; Asahi, Michio; Kanokpanont, Sorada; Tabata, Yasuhiko			A Vascular Patch Prepared from Thai Silk Fibroin and Gelatin Hydrogel Incorporating Simvastatin-Micelles to Recruit Endothelial Progenitor Cells	TISSUE ENGINEERING PART A			English	Article							CONTROLLED-RELEASE; BONE REGENERATION; TISSUE; GRAFTS; SCAFFOLDS; STATINS; REENDOTHELIALIZATION; PROLIFERATION; BIOMATERIALS; INHIBITION	Delayed re-endothelialization is one of the major disadvantages in synthetic vascular grafts, especially in small-diameter grafts (inner diameter <6 mm), leading to thrombosis and stenosis of the grafts. Simvastatin, a serum cholesterol-lowering drug, has promotional effects on endothelial progenitor cell (EPC) mobilization from bone marrow and recruitment to sites of vascular injury exhibiting acceleration of re-endothelialization. In this study, we prepared double-layer vascular patches from Thai silk fibroin/gelatin with gelatin hydrogel incorporating simvastatin-micelles (SM) for sustained release of simvastatin to recruit circulation EPCs. To enhance simvastatin solubility, simvastatin was entrapped in micelles of l-lactic acid oligomer-grafted gelatin. The drug loading efficiency was at 4.1 +/- 0.5 mu g/mg micelles. SM had a chemoattractive effect on EPCs comparable to nonmodified simvastatin. Gelatin hydrogel incorporating SM at 100 mu M of simvastatin (GSM100) could enhance in vitro EPC activities of adhesion and proliferation. In vitro results showed the initial cell adhesion of 86%, specific growth rate of 15.33x10(-3) h(-1), and population doubling time of 46.21 h. In vivo implantation of the patches incorporating SM significantly increased the recruitment of circulating EPCs. From the results of immunofluorescence staining, they demonstrated the complete re-endothelialization on the implanted patches containing SM at 2 weeks after implantation in rat carotid arteries. The gelatin hydrogel incorporating SM could be an effective inner layer of multifunctional vascular grafts to accelerate re-endothelialization in vascular tissue engineering.	[Thitiwuthikiat, Piyanuch] Chulalongkorn Univ, Fac Engn, Biomed Engn Program, Bangkok 10330, Thailand; [Ii, Masaaki; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, Osaka, Japan; [Saito, Takashi; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto 6068507, Japan; [Kanokpanont, Sorada] Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Bangkok 10330, Thailand	Kanokpanont, S (reprint author), Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Bangkok 10330, Thailand.	sorada.k@chula.ac.th; yasuhiko@frontier.kyoto-u.ac.jp			program Strategic Scholarships for Frontier Research Network for the Join PhD Program Thai Doctoral degree from the Commission on Higher Education, Thailand; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530060-AS]	This research was supported by grants under the program Strategic Scholarships for Frontier Research Network for the Join PhD Program Thai Doctoral degree from the Commission on Higher Education, Thailand, and the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530060-AS). The Chulalongkorn University Centenary Academic Development Project (under Biomedical Engineering Development Program and Center of Innovative Nanotechnology, Chulalongkorn University) was gratefully acknowledged.	Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5; Steinmetz M, 2010, J CELL MOL MED, V14, P1645, DOI 10.1111/j.1582-4934.2009.00829.x; Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046; Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Hu XL, 2009, EXPERT OPIN DRUG DEL, V6, P1079, DOI 10.1517/17425240903158917; Vorrapakdee R, 2013, J MATER SCI-MATER M, V24, P735, DOI 10.1007/s10856-012-4830-0; Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558; LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X; Hirata M, 2010, J POLYM SCI POL CHEM, V48, P794, DOI 10.1002/pola.23827; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461; Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j; Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322; Tungtasana H, 2010, J MATER SCI-MATER M, V21, P3151, DOI 10.1007/s10856-010-4159-5; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Tanigo T, 2010, J CONTROL RELEASE, V143, P201, DOI 10.1016/j.jconrel.2009.12.027; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Marelli B, 2012, MACROMOL BIOSCI, V12, P1566, DOI 10.1002/mabi.201200195; Menu P, 2013, CLIN HEMORHEOL MICRO, V53, P117, DOI 10.3233/CH-2012-1580; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Wongputtaraksa T, 2012, J BIOMED MATER RES B, V100B, P2307, DOI 10.1002/jbm.b.32802; Vachiraroj N, 2009, INT J BIOL MACROMOL, V45, P470, DOI 10.1016/j.ijbiomac.2009.07.010; Fedel M, 2012, J BIOACT COMPAT POL, V27, P295, DOI 10.1177/0883911512446060; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.TEA.2012.0325, 10.1089/ten.tea.2012.0325]; Ii M, 2007, VASC PHARMACOL, V46, P1, DOI 10.1016/j.vph.2006.06.012; Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.TEB.2012.0577, 10.1089/ten.teb.2012.0577]; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI13131; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004; Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052; Arayne MS, 2007, J ANAL CHEM+, V62, P536, DOI 10.1134/S106193480706007X; Asakage M, 2004, ANTI-CANCER DRUG, V15, P625, DOI 10.1097/01.cad.0000131680.83518.91; Bray Laura J, 2013, J Funct Biomater, V4, P74, DOI 10.3390/jfb4020074; Ii M, 2010, METHODS MOL BIOL, V660, P9, DOI 10.1007/978-1-60761-705-1_2; Kahler CM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-50; Kanokpanont S, 2013, INT J BIOL MACROMOL, V55, P88, DOI 10.1016/j.ijbiomac.2013.01.003; KOMATSU K, 1979, JARQ-JPN AGR RES Q, V13, P64; Sadeghi M M, 2000, J Immunol, V165, P2712; Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607; Tabata Y, 1998, PURE APPL CHEM, V70, P1277, DOI 10.1351/pac199870061277; Thitiwuthikiat P, 2012, ADV MATER RES-SWITZ, V506, P381, DOI 10.4028/www.scientific.net/AMR.506.381; Thomas LV, 2013, INT J CARDIOL, V167, P1091, DOI 10.1016/j.ijcard.2012.09.069; Undas A, 2001, CIRCULATION, V103, P2248; Wang Y, 2006, LANGMUIR, V22, P4952, DOI 10.1021/la0533516; Zhu Jun-Hui, 2004, Shengli Xuebao, V56, P357	56	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	APR 1	2015	21	7-8					1309	1319		10.1089/ten.tea.2014.0237		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CF5RC	WOS:000352613600012		
J	Mori, Y; Ohshimo, J; Shimazu, T; He, HP; Takahashi, A; Yamamoto, Y; Tsunoda, H; Tojo, A; Nagamura-Inoue, T				Mori, Yuka; Ohshimo, Jun; Shimazu, Takahisa; He, Haiping; Takahashi, Atsuko; Yamamoto, Yuki; Tsunoda, Hajime; Tojo, Arinobu; Nagamura-Inoue, Tokiko			Improved Explant Method to Isolate Umbilical Cord-Derived Mesenchymal Stem Cells and Their Immunosuppressive Properties	TISSUE ENGINEERING PART C-METHODS			English	Article							THERAPY POSITION STATEMENT; INTERNATIONAL-SOCIETY; STROMAL CELLS; BONE-MARROW; TISSUE; EXPANSION	The umbilical cord (UC) has become one of the major sources of mesenchymal stem cells (MSCs). The common explant method of isolating UC-derived MSCs (UC-MSCs) involves mincing the UCs into small fragments, which are then attached to a culture dish bottom from which the MSCs migrate. However, the fragments frequently float up from the bottom of the dish, thereby reducing the cell recovery rate. To overcome this problem, we demonstrate an improved explant method for UC-MSC isolation, which involves the use of a stainless steel mesh (Cellamigo((R)); Tsubakimoto Chain Co.), to protect the tissue from floating after the minced fragments are aligned at regular intervals in culture dishes. The culture medium was refreshed every 3 days and the adherent cells and tissue fragments were harvested using trypsin. The number of UC-MSCs isolated from 1 g of UC using the explant method with Cellamigo was 2.9 +/- 1.4x10(6)/g, which was significantly higher than that obtained without Cellamigo (0.66 +/- 0.53x10(6)/g) (n=6, p<0.01) when cells reached 80-90% confluence. In addition, the processing and incubation time required to reach 80-90% confluence was reduced in the improved explant method compared with the conventional method. The UC-MSCs isolated using the improved method were positive for CD105, CD73, CD90, and HLA class I expression and negative for CD45 and HLA class II expression. The isolated UC-MSCs efficiently inhibited the responder T cells induced by allogeneic dendritic cells in a mixed lymphocyte reaction. Conclusively, we demonstrated that the use of Cellamigo improves the explant method for isolating UC-MSCs.	[Mori, Yuka; Shimazu, Takahisa; He, Haiping; Takahashi, Atsuko; Yamamoto, Yuki; Tojo, Arinobu; Nagamura-Inoue, Tokiko] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo 1088639, Japan; [Ohshimo, Jun] Tsubakimoto Chain Corp, R&D Ctr, Saitama, Japan; [He, Haiping; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Ctr Adv Med Res, Div Mol Therapy, Tokyo 1088639, Japan; [Tsunoda, Hajime] NTT Med Ctr Tokyo Hosp, Dept Obstet, Tokyo, Japan	Nagamura-Inoue, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Minato Ku, 4-6-1Shirokanedai, Tokyo 1088639, Japan.	tokikoni@ims.u-tokyo.ac.jp			Ministry of Health, Labor, and Welfare of Japan	This study was supported by the research fund (Cord Blood and Cord-derived MSC banking) of Ministry of Health, Labor, and Welfare of Japan. The authors thank the staff of the NTT Medical Center Hospital, Tokyo for assistance with collection of UC and CB tissues.	Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Han YF, 2013, CYTOTECHNOLOGY, V65, P819, DOI 10.1007/s10616-012-9528-0; Salehinejad P, 2012, IN VITRO CELL DEV-AN, V48, P75, DOI 10.1007/s11626-011-9480-x; Ishige I, 2009, INT J HEMATOL, V90, P261, DOI 10.1007/s12185-009-0377-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Tong CK, 2011, CELL BIOL INT, V35, P221, DOI 10.1042/CBI20100326; Bieback Karen, 2007, Curr Stem Cell Res Ther, V2, P310, DOI 10.2174/157488807782793763; Gruber HE, 2010, TISSUE ENG PT A, V16, P2843, DOI 10.1089/ten.TEA.2009.0709; He HP, 2014, TISSUE ENG PT A, V20, P1314, DOI [10.1089/ten.TEA.2013.0333, 10.1089/ten.tea.2013.0333]; Margossian T, 2012, BIO-MED MATER ENG, V22, P243, DOI 10.3233/BME-2012-0714; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Prasanna SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009016; Santos JM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-18	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	APR 1	2015	21	4					367	372		10.1089/ten.tec.2014.0385		6	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CF1KE	WOS:000352303200004		
J	Yuan, QY; Ariga, H; Asakura, K				Yuan, Qiuyi; Ariga, Hiroko; Asakura, Kiyotaka			An Investigation of Ni2P Single Crystal Surfaces: Structure, Electronic State and Reactivity	TOPICS IN CATALYSIS			English	Article						Single crystal surfaces; Nickel phosphide; Electronic structure; Surface structure; Scanning tunneling microscopy; Density functional theory; LEED IV	SCANNING-TUNNELING-MICROSCOPY; PHOSPHIDE HYDROPROCESSING CATALYSTS; X-RAY PHOTOELECTRON; NI2P/AL2O3 CATALYST; HYDROGEN EVOLUTION; METAL PHOSPHIDES; NICKEL PHOSPHIDE; NI2P(0001); HYDRODESULFURIZATION; DESULFURIZATION	Ni2P has demonstrated high catalytic activity for hydrodesulfurization and has recently been employed as a catalyst in a variety of other reactions. We have thoroughly reviewed the literature concerning Ni2P single crystal surfaces, with the aim of determining the relationship between surface structure and catalytic properties. Published results to date indicate that Ni2P single crystal surfaces exhibit reconstructed structures, and so the bulk terminated structure may not be stable. We have also reviewed the surface structures and electronic states of (1 x 1) and reconstructed Ni2P(0001) and (). Based on these reviews, this paper presents general rules regarding stabilization of the Ni2P surface structure and discusses the role of phosphorus in the single crystal surfaces.	[Yuan, Qiuyi; Ariga, Hiroko; Asakura, Kiyotaka] Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Asakura, K (reprint author), Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Kita 21-10, Sapporo, Hokkaido 0010021, Japan.	askr@cat.hokudai.ac.jp	Ariga, Hiroko/F-5952-2012; Asakura, Kiyotaka/G-6052-2010	Asakura, Kiyotaka/0000-0003-1077-5996			Liu P, 2005, J AM CHEM SOC, V127, P14871, DOI 10.1021/ja0540019; Liu P, 2009, J CATAL, V262, P294, DOI 10.1016/j.jcat.2009.01.006; Oyama ST, 2004, J CATAL, V221, P263, DOI 10.1016/S0021-9517(03)00017-4; Okamoto H, 2010, J PHASE EQUILIB DIFF, V31, P200, DOI 10.1007/s11669-010-9664-1; Cho A, 2014, J CATAL, V318, P151, DOI 10.1016/j.jcat.2014.07.021; Oyama ST, 2009, CATAL TODAY, V143, P94, DOI 10.1016/j.cattod.2008.09.019; Blanchard PER, 2008, CHEM MATER, V20, P7081, DOI 10.1021/cm802123a; Liu P, 2005, J PHYS CHEM B, V109, P4575, DOI 10.1021/jp044301x; Rodriguez JA, 2003, J PHYS CHEM B, V107, P6276, DOI 10.1021/jp022639q; Li QX, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035414; Prins R, 2012, CATAL LETT, V142, P1413, DOI 10.1007/s10562-012-0929-7; Zhao HY, 2015, APPL CATAL B-ENVIRON, V164, P204, DOI 10.1016/j.apcatb.2014.09.010; Oyama ST, 2012, J CATAL, V285, P1, DOI 10.1016/j.jcat.2011.08.006; Li JF, 2014, APPL CATAL A-GEN, V469, P434, DOI 10.1016/j.apcata.2013.09.047; Hernandez AB, 2011, CHEM PHYS LETT, V513, P48, DOI 10.1016/j.cplett.2011.07.055; Oyama ST, 2003, J CATAL, V216, P343, DOI 10.1016/S0021-9517(02)00069-6; Suzuki S, 2009, J NANOSCI NANOTECHNO, V9, P195, DOI 10.1166/jnn.2009.J051; VANHOVE MA, 1993, SURF SCI REP, V19, P191, DOI 10.1016/0167-5729(93)90011-D; Oyama ST, 2009, J CATAL, V268, P209, DOI 10.1016/j.jcat.2009.09.018; Alexander AM, 2010, CHEM SOC REV, V39, P4388, DOI 10.1039/b916787k; Bando KK, 2012, J CATAL, V286, P165, DOI 10.1016/j.jcat.2011.10.025; Popczun EJ, 2013, J AM CHEM SOC, V135, P9267, DOI 10.1021/ja403440e; Song CS, 2003, CATAL TODAY, V86, P211, DOI 10.1016/S0920-5861(03)00412-7; Zhao HY, 2011, APPL CATAL A-GEN, V391, P305, DOI 10.1016/j.apcata.2010.07.039; Ariga H, 2013, CHEM LETT, V42, P1481, DOI 10.1246/cl.130710; Cho KS, 2011, CATAL COMMUN, V12, P470, DOI 10.1016/j.catcom.2010.10.016; Edamoto K, 2008, SOLID STATE COMMUN, V148, P135, DOI 10.1016/j.ssc.2008.07.037; Edamoto K, 2013, APPL SURF SCI, V269, P7, DOI 10.1016/j.apsusc.2012.09.055; Edamoto Kazuyuki, 2009, e-Journal of Surface Science and Nanotechnology, V7, DOI 10.1380/ejssnt.2009.1; Edamoto K, 2010, SOLID STATE COMMUN, V150, P1120, DOI 10.1016/j.ssc.2010.03.026; Fuks D, 2010, J PHYS CHEM C, V114, P13313, DOI 10.1021/jp1031306; Guo D, 2010, SURF SCI, V604, P1347, DOI 10.1016/j.susc.2010.03.024; Kanama D., 2001, Surface Science Spectra, V8, DOI 10.1116/11.20020303; Kinoshita K, 2008, JPN J APPL PHYS, V47, P6088, DOI 10.1143/JJAP.47.6088; Kono K, 2014, J JPN SOC SURF SCI, V35, P2014; Miyamoto T, 2010, THESIS HOKKAIDO U SA; Moula MG, 2006, SURF INTERFACE ANAL, V38, P1611, DOI 10.1002/sia.2404; Moula MG, 2006, CHEM LETT, V35, P90, DOI 10.1246/cl.2006.90; Otani S, 2013, J CERAM SOC JPN, V121, P311; Ozkan U. S., 1994, J CATAL, V148, P181; RUNDQVIST S, 1962, ACTA CHEM SCAND, V16, P992, DOI 10.3891/acta.chem.scand.16-0992; Wada T, 2012, J SYNCHROTRON RADIAT, V19, P205, DOI 10.1107/S0909049512001197; Wada T, 2012, CHEM LETT, V41, P1238, DOI 10.1246/cl.2012.1238; Yoshimura Y, 2001, APPL CATAL A-GEN, V207, P303, DOI 10.1016/S0926-860X(00)00660-8	44	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	APR	2015	58	4-6			SI		194	200		10.1007/s11244-015-0360-6		7	Chemistry, Applied; Chemistry, Physical	Chemistry	CE2SR	WOS:000351668200002		
J	Oyama, ST; Onkawa, T; Takagaki, A; Kikuchi, R; Hosokai, S; Suzuki, Y; Bando, KK				Oyama, S. Ted; Onkawa, Tatsuki; Takagaki, Atsushi; Kikuchi, Ryuji; Hosokai, Sou; Suzuki, Yoshizo; Bando, Kyoko K.			Production of Phenol and Cresol from Guaiacol on Nickel Phosphide Catalysts Supported on Acidic Supports	TOPICS IN CATALYSIS			English	Article						Hydrodeoxygenation; Guaiacol; Phosphides; Ni2P; Acid supports	TRANSITION-METAL PHOSPHIDES; MAGNETIC-RESONANCE SPECTROSCOPY; RAY-ABSORPTION SPECTROSCOPY; HYDROPROCESSING CATALYSTS; MODEL-COMPOUND; BIO-OIL; HYDROTREATING CATALYSTS; NI2P/SIO2 CATALYST; SULFIDE CATALYSTS; NI2P CATALYST	Partial hydrodeoxygenation (HDO) of bio-oil derived from the pyrolysis of lignin can yield higher value added products, such as phenol derivatives. The HDO of 2-methoxyphenol (guaiacol) was studied over nickel phosphide (Ni2P) supported on various acidic substrates. The substrates were the microporous zeolite ZSM-5, a fluidized catalytic cracking (FCC) support consisting of USY zeolite embedded in a silica-alumina matrix, and an amorphous silica-alumina (ASA) material. Guaiacol was used as reactant because it is a good model compound for species derived from the lignin portion of biomass. The order of activity was Ni2P/ASA > Ni2P/FCC > Ni2P/ZSM-5. Contact time measurements indicated that the main pathway on Ni2P/ASA, the most active catalyst, was conversion of guaiacol to the primary intermediate catechol, which was then dehydroxylated to phenol.	[Oyama, S. Ted; Onkawa, Tatsuki; Takagaki, Atsushi; Kikuchi, Ryuji] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Oyama, S. Ted] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA; [Hosokai, Sou; Bando, Kyoko K.] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Suzuki, Yoshizo] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan	Oyama, ST (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	oyama@vt.edu	Takagaki, Atsushi/E-6788-2010; Kikuchi, Ryuji/H-4255-2015	Takagaki, Atsushi/0000-0002-7829-3451; 	Japan Ministry of Agriculture, Forestry, and Fisheries (MAFF); JSPS KAKENHI [26289301]; National Science Foundation [CHE-1361842]; US Department of Energy [DE-FG02-96ER14669];  [2012G655]	This work was supported by the Japan Ministry of Agriculture, Forestry, and Fisheries (MAFF) and JSPS KAKENHI Grant No. 26289301, the National Science Foundation under Grant CHE-1361842 and the US Department of Energy under Grant DE-FG02-96ER14669. The XAFS experiments were conducted under approval of PF-PAC (Project No. 2012G655).	Bui P, 2012, J CATAL, V294, P184, DOI 10.1016/j.jcat.2012.07.021; Li D, 2012, J CATAL, V290, P1, DOI 10.1016/j.jcat.2012.02.001; Mortensen PM, 2011, APPL CATAL A-GEN, V407, P1, DOI 10.1016/j.apcata.2011.08.046; Oyama ST, 2009, CATAL TODAY, V143, P94, DOI 10.1016/j.cattod.2008.09.019; Abu II, 2007, APPL CATAL A-GEN, V328, P58, DOI 10.1016/j.apcata.2007.05.018; Liu P, 2005, J PHYS CHEM B, V109, P4575, DOI 10.1021/jp044301x; Romero Y, 2010, APPL CATAL B-ENVIRON, V98, P213, DOI 10.1016/j.apcatb.2010.05.031; Bui VN, 2011, APPL CATAL B-ENVIRON, V101, P239, DOI 10.1016/j.apcatb.2010.10.025; Hayes JR, 2010, J CATAL, V276, P249, DOI 10.1016/j.jcat.2010.09.013; Gaudette AF, 2010, J CATAL, V272, P18, DOI 10.1016/j.jcat.2010.03.016; de Brimont MR, 2012, J CATAL, V286, P153, DOI 10.1016/j.jcat.2011.10.022; da Silva VT, 2011, J CATAL, V279, P88, DOI 10.1016/j.jcat.2011.01.010; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Bulushev DA, 2011, CATAL TODAY, V171, P1, DOI 10.1016/j.cattod.2011.02.005; Prins R, 2012, CATAL LETT, V142, P1413, DOI 10.1007/s10562-012-0929-7; Zhang Q, 2007, ENERG CONVERS MANAGE, V48, P87, DOI 10.1016/j.enconman.2006.05.010; Moon JS, 2014, J CATAL, V311, P144, DOI 10.1016/j.jcat.2013.11.023; Oyama ST, 2012, J CATAL, V285, P1, DOI 10.1016/j.jcat.2011.08.006; Wang XQ, 2002, J CATAL, V208, P321, DOI 10.1006/jcat.2002.3604; Chang J, 2013, CHEMCATCHEM, V5, P3041, DOI 10.1002/cctc.201300096; Serrano-Ruiz JC, 2011, ENERG ENVIRON SCI, V4, P83, DOI 10.1039/c0ee00436g; Oyama ST, 2002, J PHYS CHEM B, V106, P1913, DOI 10.1021/jp0136056; Oyama ST, 2003, J CATAL, V216, P343, DOI 10.1016/S0021-9517(02)00069-6; CENTENO A, 1995, J CATAL, V154, P288, DOI 10.1006/jcat.1995.1170; Zuzaniuk V, 2003, J CATAL, V219, P85, DOI 10.1016/S0021-9517(03)00149-0; Panwar NL, 2012, RENEW SUST ENERG REV, V16, P1801, DOI 10.1016/j.rser.2012.01.024; Lee YK, 2007, APPL CATAL A-GEN, V322, P191, DOI 10.1016/j.apcata.2007.01.007; Bowker RH, 2014, APPL CATAL A-GEN, V482, P221, DOI 10.1016/j.apcata.2014.05.026; Whiffen VML, 2012, APPL CATAL A-GEN, V419, P111, DOI 10.1016/j.apcata.2012.01.018; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Lee YK, 2006, J CATAL, V239, P376, DOI 10.1016/j.jcat.2005.12.029; Wildschut J, 2009, IND ENG CHEM RES, V48, P10324, DOI 10.1021/ie9006003; Rensel DJ, 2013, J CATAL, V305, P256, DOI 10.1016/j.jcat.2013.05.026; Shu YY, 2005, J CATAL, V236, P112, DOI 10.1016/j.jcat.2005.08.015; Sepulveda C, 2012, CATAL TODAY, V195, P101, DOI 10.1016/j.cattod.2012.05.047; Ausavasukhi A, 2012, J CATAL, V290, P90, DOI 10.1016/j.jcat.2012.03.003; Cho A, 2012, TOP CATAL, V55, P969, DOI 10.1007/s11244-012-9882-3; Janssen AH, 2001, ANGEW CHEM INT EDIT, V40, P1102, DOI 10.1002/1521-3773(20010316)40:6<1102::AID-ANIE11020>3.3.CO;2-Y; Zhao HY, 2011, APPL CATAL A-GEN, V391, P305, DOI 10.1016/j.apcata.2010.07.039; Sun FX, 2004, J CATAL, V228, P298, DOI 10.1016/j.jcat.2004.09.002; Radhakrishnan R, 2001, J PHYS CHEM B, V105, P8519, DOI 10.1021/jp0117361; Cecilia JA, 2013, APPL CATAL B-ENVIRON, V136, P140, DOI 10.1016/j.apcatb.2013.01.047; Iino A, 2014, J CATAL, V311, P17, DOI 10.1016/j.jcat.2013.11.002; Clark P, 2002, J CATAL, V210, P116, DOI 10.1006/jcat.2002.3658; Nakagawa Y, 2014, GREEN CHEM, V16, P2197, DOI 10.1039/c3gc42322k; Ariga H, 2013, CHEM LETT, V42, P1481, DOI 10.1246/cl.130710; Bando KK, 2011, J PHYS CHEM C, V115, P7466, DOI 10.1021/jp11657z; Bando KK, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012158; Bando KK, 2002, TOP CATAL, V18, P59, DOI 10.1023/A:1013882200949; Cho KS, 2011, CATAL COMMUN, V12, P470, DOI 10.1016/j.catcom.2010.10.016; Clark P, 2002, J CATAL, V207, P256, DOI 10.1006/jcat.2002.3520; Custodis YBF, 2014, J PHYS CHEM B, V118, P8524; Li W, 1998, CHEM LETT, P207; Jongerius AL, 2011, J CATAL, V285, P315; Knozinger H., 2008, HDB HETEROGENEOUS CA, V2, P1154; Koranyi TI, 2008, J PHYS CHEM A, V112, P5126, DOI 10.1021/jp711935n; Ryymin EM, 2009, APPL CATAL A-GEN, V358, P42, DOI 10.1016/j.apcata.2009.01.035; Sepulveda C, 2011, CATAL LETT, V141, P987, DOI 10.1007/s10562-011-0578-2; Zhang X, 2008, MICROPOR MESOPOR MAT, V116, P210, DOI 10.1016/j.micromeso.2008.04.004	59	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	APR	2015	58	4-6			SI		201	210		10.1007/s11244-015-0361-5		10	Chemistry, Applied; Chemistry, Physical	Chemistry	CE2SR	WOS:000351668200003		
J	Cho, A; Takagaki, A; Kikuchi, R; Oyama, ST				Cho, Ara; Takagaki, Atsushi; Kikuchi, Ryuji; Oyama, S. Ted			Active Sites in Ni2P/USY Catalysts for the Hydrodeoxygenation of 2-Methyltetrahydrofuran	TOPICS IN CATALYSIS			English	Article						Hydrodeoxygenation; 2-methyltetrahydrofuran; Ni2P; USY support	TRANSITION-METAL PHOSPHIDES; MODEL-COMPOUND; PYROLYSIS OIL; BIO-OIL; THIOPHENE HYDRODESULFURIZATION; HYDROPROCESSING CATALYSTS; NI2P/SIO2 CATALYST; SULFIDED CATALYSTS; ALIPHATIC ESTERS; BIOMASS	A series of nickel phosphide catalysts supported on ultrastable Y zeolites USY (Si/Al = 40) with microporous/mesoporous structure were prepared by impregnation and temperature-programmed reduction and were studied for the hydrodeoxygenation (HDO) of 2-methyltetrahydrofuran (2-MTHF). The loading of the active phase was varied from 0.58, 1.16, and 1.74 to 2.3 mmol (g support)(-1) and the corresponding samples were denoted as 0.5, 1.0, 1.5, and 2.0 Ni2P/USY. The two lowest loading supports did not show X-ray diffraction (XRD) lines, but X-ray absorption fine-structure spectroscopy (XAFS) indicated the formation of a Ni2P phase, with low Ni-Ni coordination, consistent with high dispersion. The two highest loading supports showed XRD patterns typical of Ni2P, and XAFS indicated similar bond distances to bulk Ni2P and high Ni-Ni coordination. Furthermore, the XAFS data indicated that the low-loading samples had shorter bond distances and more Ni in square-pyramidal coordination compared to the high loading samples and the reference Ni2P material, suggesting that there were differences in structural properties in the samples. This likely was due to preferred termination of the small crystallites with pyramidal Ni sites. The HDO of 2-MTHF was studied at 0.5 MPa and 513-593 K and the main products were n-pentane and n-butane for all catalysts. The low-loading samples showed higher turnover frequency (based on sites titrated by CO chemisorption), and this was attributed to the higher intrinsic activity of the pyramidal Ni sites. In addition, the low-loading samples showed higher selectivity to n-pentane, and this was attributed to lower C-C hydrogenolysis type reactions, which are favored by metallic ensembles as found in the high-loading samples.	[Cho, Ara; Takagaki, Atsushi; Kikuchi, Ryuji; Oyama, S. Ted] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Oyama, S. Ted] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA	Oyama, ST (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	oyama@vt.edu	Takagaki, Atsushi/E-6788-2010; Kikuchi, Ryuji/H-4255-2015	Takagaki, Atsushi/0000-0002-7829-3451; 	Development of Next-generation Technology for Strategic Utilization of Biomass Energy of New Energy and Industrial Technology Development Organization (NEDO), Japan; JSPS KAKENHI [26289301]; National Science Foundation [CHE-1361842]; US Department of Energy [DE-FG02-96ER14669];  [2012G655]	This work was supported by Development of Next-generation Technology for Strategic Utilization of Biomass Energy of New Energy and Industrial Technology Development Organization (NEDO), Japan and JSPS KAKENHI Grant Number 26289301, the National Science Foundation under Grant CHE-1361842 and the US Department of Energy under Grant DE-FG02-96ER14669. The XAFS experiments were conducted under approval of PF-PAC (Project No. 2012G655).	Bui P, 2012, J CATAL, V294, P184, DOI 10.1016/j.jcat.2012.07.021; Moraes MSA, 2012, J ANAL APPL PYROL, V98, P51, DOI 10.1016/j.jaap.2012.05.007; Gutierrez A, 2009, CATAL TODAY, V147, P239, DOI 10.1016/j.cattod.2008.10.037; Mortensen PM, 2011, APPL CATAL A-GEN, V407, P1, DOI 10.1016/j.apcata.2011.08.046; Cho A, 2014, J CATAL, V318, P151, DOI 10.1016/j.jcat.2014.07.021; Oyama ST, 2009, CATAL TODAY, V143, P94, DOI 10.1016/j.cattod.2008.09.019; Romero Y, 2010, APPL CATAL B-ENVIRON, V98, P213, DOI 10.1016/j.apcatb.2010.05.031; Bui VN, 2011, APPL CATAL B-ENVIRON, V101, P239, DOI 10.1016/j.apcatb.2010.10.025; Furimsky E, 2013, CATAL TODAY, V217, P13, DOI 10.1016/j.cattod.2012.11.008; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Yakovlev VA, 2009, CATAL TODAY, V144, P362, DOI 10.1016/j.cattod.2009.03.002; Bulushev DA, 2011, CATAL TODAY, V171, P1, DOI 10.1016/j.cattod.2011.02.005; Echeandia S, 2010, APPL CATAL B-ENVIRON, V101, P1, DOI 10.1016/j.apcatb.2010.08.018; Zhang Q, 2007, ENERG CONVERS MANAGE, V48, P87, DOI 10.1016/j.enconman.2006.05.010; Moon JS, 2014, J CATAL, V311, P144, DOI 10.1016/j.jcat.2013.11.023; Wang XQ, 2002, J CATAL, V208, P321, DOI 10.1006/jcat.2002.3604; Chang J, 2013, CHEMCATCHEM, V5, P3041, DOI 10.1002/cctc.201300096; Serrano-Ruiz JC, 2011, ENERG ENVIRON SCI, V4, P83, DOI 10.1039/c0ee00436g; Oyama ST, 2003, J CATAL, V216, P343, DOI 10.1016/S0021-9517(02)00069-6; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Bunch AY, 2007, J MOL CATAL A-CHEM, V270, P264, DOI 10.1016/j.molcata.2007.02.006; Yang YX, 2012, ACS CATAL, V2, P592, DOI 10.1021/cs200659r; Senol OI, 2007, J MOL CATAL A-CHEM, V268, P1, DOI 10.1016/j.molcata.2006.12.006; Panwar NL, 2012, RENEW SUST ENERG REV, V16, P1801, DOI 10.1016/j.rser.2012.01.024; Lee YK, 2007, APPL CATAL A-GEN, V322, P191, DOI 10.1016/j.apcata.2007.01.007; Whiffen VML, 2012, APPL CATAL A-GEN, V419, P111, DOI 10.1016/j.apcata.2012.01.018; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Lee YK, 2006, J CATAL, V239, P376, DOI 10.1016/j.jcat.2005.12.029; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Cho A, 2012, TOP CATAL, V55, P969, DOI 10.1007/s11244-012-9882-3; Janssen AH, 2001, ANGEW CHEM INT EDIT, V40, P1102, DOI 10.1002/1521-3773(20010316)40:6<1102::AID-ANIE11020>3.3.CO;2-Y; Zhao HY, 2011, APPL CATAL A-GEN, V391, P305, DOI 10.1016/j.apcata.2010.07.039; Ruddy DA, 2014, GREEN CHEM, V16, P454, DOI 10.1039/c3gc41354c; Sawhill SJ, 2005, J CATAL, V231, P300, DOI 10.1016/j.jcat.2005.01.020; Iino A, 2014, J CATAL, V311, P17, DOI 10.1016/j.jcat.2013.11.002; Oyama ST, 2008, J CATAL, V258, P393, DOI 10.1016/j.jcat.2008.06.023; Bando KK, 2011, J PHYS CHEM C, V115, P7466, DOI 10.1021/jp11657z; Boudart M., 1969, ADV CATAL, V20, P153, DOI 10.1016/S0360-0564(08)60271-0; Boullosa-Eiras S, 2014, POTENTIAL METAL CARB, V2; Chen L, 2011, J MOL CATAL A-CHEM, V351, P239; Custodis YBF, 2014, J PHYS CHEM B, V118, P8524; Li W, 1998, CHEM LETT, P207; Echeandia S, 2014, FUEL, V117, P1061, DOI 10.1016/j.fuel.2013.10.011; Eiras SB, 2014, CATAL TODAY, V223, P44; Koranyi TI, 2003, APPL CATAL A-GEN, V239, P253, DOI 10.1016/S0926-860X(02)00390-3; RUNDQVIST S, 1962, ACTA CHEM SCAND, V16, P992, DOI 10.3891/acta.chem.scand.16-0992; Ryymin EM, 2009, APPL CATAL A-GEN, V358, P42, DOI 10.1016/j.apcata.2009.01.035; Senol OI, 2007, APPL CATAL A-GEN, V326, P236, DOI 10.1016/j.apcata.2007.04.022	48	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	APR	2015	58	4-6			SI		219	231		10.1007/s11244-015-0363-3		13	Chemistry, Applied; Chemistry, Physical	Chemistry	CE2SR	WOS:000351668200005		
J	Takei, T; Suenaga, J; Ishida, T; Haruta, M				Takei, Takashi; Suenaga, Junya; Ishida, Tamao; Haruta, Masatake			Ethanol Oxidation in Water Catalyzed by Gold Nanoparticles Supported on NiO Doped with Cu	TOPICS IN CATALYSIS			English	Article						Ethanol; Oxidation; Acetic acid; Gold catalyst; Nanoparticles; Support effect	ACETIC-ACID; SELECTIVE OXIDATION; MECHANISM; OXIDES; CERIUM; SIZE	Ethanol oxidation in water by molecular oxygen on supported gold nanoparticles (NPs) has been investigated at a temperature as low as 120 A degrees C. Among various base metal oxide supports, NiO provided the highest conversion of ethanol and good selectivity to acetic acid. Furthermore Cu doping to the NiO support to enhance the semiconductivity resulted in an improvement in the selectivity to acetic acid without the depression of the conversion of ethanol. An increase in the specific surface area of the NiO support by Cu doping enabled the deposition of smaller gold NPs and, accordingly, the improvement of the catalytic activity.	[Takei, Takashi; Suenaga, Junya; Ishida, Tamao; Haruta, Masatake] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Res Ctr Gold Chem, Hachioji, Tokyo 1920397, Japan	Haruta, M (reprint author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Res Ctr Gold Chem, I-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	haruta-masatake@center.tmu.ac.jp					Greca MC, 2001, APPL CATAL A-GEN, V216, P267, DOI 10.1016/S0926-860X(01)00571-3; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Ishida T, 2012, CHEMSUSCHEM, V5, P2243, DOI 10.1002/cssc.201200324; Sun KQ, 2008, CATAL LETT, V124, P238, DOI 10.1007/s10562-008-9507-4; Ishida T, 2008, ANGEW CHEM INT EDIT, V47, P9265, DOI 10.1002/anie.200802845; Jorgensen B, 2009, TOP CATAL, V52, P253, DOI 10.1007/s11244-008-9161-5; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055; Jorgensen B, 2007, J CATAL, V251, P332, DOI 10.1016/j.jcat.2007.08.004; Takei T, 2011, NEW J CHEM, V35, P2227, DOI 10.1039/c1nj20297a; Li XB, 2007, CHEM-EUR J, V13, P9324, DOI 10.1002/chem.200700579; [Anonymous], 2014, RENEWABLES 2014 GLOB, V511, P5; Mattos LV, 2005, J POWER SOURCES, V145, P10, DOI 10.1016/j.jpowsour.2004.12.034; Tembe SM, 2009, GOLD BULL, V42, P321; Takei T, 2011, CATAL SURV ASIA, V15, P80, DOI 10.1007/s10563-011-9112-1; Lin R, 2004, CATAL LETT, V93, P139, DOI 10.1023/B:CATL.0000017067.19873.32; Christensen CH, 2006, ANGEW CHEM INT EDIT, V45, P4648, DOI 10.1002/anie.200601180; Dingerdissen U, 2008, HDB HETEROGENEOUS CA, V1, P44; Eguchi Y, 2008, MICROPOR MESOPOR MAT, V116, P44, DOI 10.1016/j.micromeso.2008.03.009; Goncalves FM, 2001, APPL CATAL A-GEN, V208, P265, DOI 10.1016/S0926-860X(00)00716-X; Ide M. S., 2013, ACCOUNTS CHEM RES, V47, P825	20	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	APR	2015	58	4-6			SI		295	301		10.1007/s11244-015-0370-4		7	Chemistry, Applied; Chemistry, Physical	Chemistry	CE2SR	WOS:000351668200012		
J	Ohkouchi, Y; Tajima, S; Nomura, M; Itoh, S				Ohkouchi, Yumiko; Tajima, Satoshi; Nomura, Masahiro; Itoh, Sadahiko			Inflammatory responses and potencies of various lipopolysaccharides from bacteria and cyanobacteria in aquatic environments and water supply systems	TOXICON			English	Article						Lipopolysaccharide (LPS); Purification; Endotoxin; Indigenous bacteria/cyanobacteria; Human monocytic cells; Cytokine secretion	AMEBOCYTE LYSATE ASSAY; HETEROTROPHIC BACTERIA; PSEUDOMONAS-AERUGINOSA; GROWTH TEMPERATURE; YERSINIA-PESTIS; TAP WATER; ENDOTOXIN; IDENTIFICATION; SPHINGOMONAS; DIVERSITY	Inflammatory substances derived from indigenous bacteria in aquatic environments or water systems are of great concern. Lipopolysaccharides (LPSs), one of the major inflammatory substances in water, are usually identified using Limurus amoebocyte lysate (LAL) assay on the basis of their endotoxic activity, but endotoxin levels do not accurately represent their inflammatory potency in humans. In this investigation, the cellular endotoxin contents of pure-cultured bacteria/cyanobacteria, Which are frequently detected in water sources and distribution systems, and of indigenous bacteria in a river and in biologically activated carbon (BAC) effluent, were investigated. The indigenous bacteria showed the highest endotoxin contents exceeding 10(-3) EU/cell. The LPSs were then purified from those samples, and their inflammatory potencies were examined using a human monocytic cell line. The LPSs from Acinetobacter lwoffii culture, the river water, and the BAC effluent sample revealed a unique cytokine secretion pattern; they induced both IL-8 and TNF-alpha. more strongly than the other tested bacterial LPSs. These results suggest that natural bacterial/cyanobacterial flora in aquatic environments and water distribution systems have the potential to induce relatively strong inflammatory responses in humans; therefore, further accumulation of data on water quality from the perspective of not just endotoxins but inflammatory potency is needed. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohkouchi, Yumiko] Kyoto Univ, Grad Sch Global Environm Studies, Dept Global Ecol, Nishikyo Ku, Kyoto 6158540, Japan; [Tajima, Satoshi; Nomura, Masahiro; Itoh, Sadahiko] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Nishikyo Ku, Kyoto 6158540, Japan	Ohkouchi, Y (reprint author), Azabu Univ, Sch Life & Environm Sci, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	okochi@azabu-u.ac.jp			GSGES Research Grant for Young Researchers, Kyoto University	This research was supported by a GSGES Research Grant for Young Researchers 2011, Kyoto University.	Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Bernardova K, 2008, J APPL TOXICOL, V28, P72, DOI 10.1002/jat.1257; Dehus O, 2006, J ENDOTOXIN RES, V12, P171, DOI 10.1179/096805106X102156; Kawahara K, 1999, J IND MICROBIOL BIOT, V23, P408, DOI 10.1038/sj.jim.2900708; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Lee J, 2010, WATER RES, V44, P5050, DOI 10.1016/j.watres.2010.07.027; Vaz-Moreira I, 2013, FEMS MICROBIOL ECOL, V83, P361, DOI 10.1111/1574-6941.12002; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Anderson WB, 2003, WATER RES, V37, P4553, DOI 10.1016/j.waters.2003.08.016; Rapala J, 2002, WATER RES, V36, P2627, DOI 10.1016/S0043-1354(01)00478-X; COYNE CP, 1993, AM J VET RES, V54, P305; Ohkouchi Y, 2012, J ENVIRON SCI HEAL A, V47, P1966, DOI 10.1080/10934529.2012.695254; Blahova L, 2013, TOXICON, V76, P187, DOI 10.1016/j.toxicon.2013.10.011; Szita G, 2007, LETT APPL MICROBIOL, V45, P42, DOI 10.1111/j.1472-765X.2007.02145.x; Can Zhang, 2013, Water Res, V47, P3591, DOI 10.1016/j.watres.2013.04.009; CARMICHAEL WW, 1981, APPL ENVIRON MICROB, V41, P1383; Dentovskaya SV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P192, DOI 10.1134/S0006297908020119; El Marghani A, 2014, SCI TOTAL ENVIRON, V488, P228, DOI 10.1016/j.scitotenv.2014.04.090; Furuhata K, 2004, J FOOD HYG SOC JPN, V45, pJ1; Furuhata K, 2006, MICROBIOL IMMUNOL, V50, P11; Hansen LA, 1999, J IMMUNOL METHODS, V226, P49, DOI 10.1016/S0022-1759(99)00047-2; HIRATA T, 1993, WATER SCI TECHNOL, V27, P155; Hoson T., 2002, J WATER WASTE, V44, P755; Kasuga I., 2011, P 4 IWA ASPIRE TOK, P141; KAWASAKI S, 1994, J BACTERIOL, V176, P284; Kelly JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098542; Merino S, 1998, RES MICROBIOL, V149, P407, DOI 10.1016/S0923-2508(98)80323-9; Ohkouchi Y., 2009, ADV ASIAN ENV ENG, V8, P13; Ohkouchi Y., 2007, ENV ENG RES, V44, P247; O'Toole J, 2008, WATER SCI TECHNOL, V58, P603, DOI 10.2166/wst.2008.428; Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5; Scott BA, 2010, J ENVIRON SCI HEAL A, V45, P890, DOI 10.1080/10934521003709115; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Suomalainen M, 2010, INFECT IMMUN, V78, P2644, DOI 10.1128/IAI.01329-09; Wichmann G, 2004, ENVIRON TOXICOL, V19, P594, DOI 10.1002/tox.20067; Yano T., 2009, JPN J ENV INFECT, V24, P303	37	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	APR	2015	97						23	31		10.1016/j.toxicon.2015.02.003		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CE4MB	WOS:000351803600003		
J	Mitsuishi, A; Yamaguchi, T				Mitsuishi, Ayato; Yamaguchi, Takao			COLLAPSING THREE-DIMENSIONAL CLOSED ALEXANDROV SPACES WITH A LOWER CURVATURE BOUND	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article							STRATIFIED SETS; MANIFOLDS; HOMEOMORPHISMS; DEFORMATION; 3-MANIFOLDS	In the present paper, we determine the topologies of three-dimensional closed Alexandrov spaces which converge to lower dimensional spaces in the Gromov-Hausdorff topology.	[Mitsuishi, Ayato] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan; [Yamaguchi, Takao] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan	Mitsuishi, A (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan.	mitsuishi@math.tohoku.ac.jp; takao@math.tsukuba.ac.jp					Petrunin A, 1998, GEOM FUNCT ANAL, V8, P123, DOI 10.1007/s000390050050; GROVE K, 1993, INVENT MATH, V112, P577, DOI 10.1007/BF01232447; Kuwae K, 2001, MATH Z, V238, P269, DOI 10.1007/s002090100252; Bridson Martin R., 1999, GRUND MATH WISS, V319; Burago D., 2001, GRADUATE STUDIES MAT, V33; Cao JG, 2011, J GEOM ANAL, V21, P807, DOI 10.1007/s12220-010-9169-5; CHEEGER J, 1972, ANN MATH, V96, P413, DOI 10.2307/1970819; EPSTEIN DBA, 1966, ACTA MATH-UPPSALA, V115, P83, DOI 10.1007/BF02392203; FUKAYA K, 1992, ANN MATH, V136, P253, DOI 10.2307/2946606; Kapovitch V., 2007, SURV DIFFER GEOM, V11, P103; Kapovitch V, 2005, MATH Z, V249, P519, DOI 10.1007/s00209-004-0715-3; Kleiner B., PREPRINT; Lytchak A., 2005, ST PETERSB MATH J, V16, p[128, 1017], DOI [10.1090/51061-0022-05-00888-5, DOI 10.1090/51061-0022-05-00888-5]; Milka A. D., 1967, UKRAIN GEOMETR SB VY, V4, P43; Mitsuishi A, 2010, GEOMETRIAE DEDICATA, V144, P101, DOI 10.1007/s10711-009-9390-1; Morgan J., PREPRINT; NATSHEH MA, 1986, ARCH MATH, V46, P179, DOI 10.1007/BF01197497; OTSU Y, 1994, J DIFFER GEOM, V39, P629; OTSU Y, 1993, AM J MATH, V115, P1229, DOI 10.2307/2374965; BURAGO Y, 1992, RUSS MATH SURV+, V47, P1, DOI 10.1070/RM1992v047n02ABEH000877; Perelman G., ARXIV MATH DG 021115; Perelman G., PREPRINT; Perelman G., ARXIV MATH DG 030310; Perelman G. Y., 1994, ST PETERSB MATH J, V5, p[232, 205]; Petrunin A., 2007, SURVEYS DIFFERENTIAL, VXI, P137; Petrunin A., 1997, MATH SCI RES I PUBL, V30, P203; Petrunin Anton, 1995, THESIS U ILLINOIS UR; Plaut C, 1996, J GEOM ANAL, V6, P113; Shioya T, 2005, MATH ANN, V333, P131, DOI 10.1007/s00208-005-0667-x; Shioya T, 2000, J DIFFER GEOM, V56, P1; SIEBENMA.LC, 1972, COMMENT MATH HELV, V47, P137; SIEBENMA.LC, 1972, COMMENT MATH HELV, V47, P123, DOI 10.1007/BF02566793; Wolf Joseph A., 1984, SPACES OF CONSTANT C; YAMAGUCHI T, 1991, ANN MATH, V133, P317, DOI 10.2307/2944340; Yamaguchi Takao, ARXIV 1205 0323V1 MA; Yamaguchi Takao, RXIV 1205 0441V1 MAT; Yamaguchi Takao, 1996, SEMIN C, V1, P601	37	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	APR	2015	367	4					2339	2410	PII S0002-9947(2014)06091-1			72	Mathematics	Mathematics	CE5GB	WOS:000351858000003		
J	Iwabuchi, T; Ogawa, T				Iwabuchi, Tsukasa; Ogawa, Takayoshi			ILL-POSEDNESS FOR THE NONLINEAR SCHRODINGER EQUATION WITH QUADRATIC NON-LINEARITY IN LOW DIMENSIONS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article							WELL-POSEDNESS; CAUCHY-PROBLEM; SPACES	We consider the ill-posedness issue for the nonlinear Schriidinger equation with a quadratic nonlinearity. We refine the Bejenaru-Tao result by constructing an example in the following sense. There exist a sequence of time T-N -> 0 and solution u(N)(t) such that u(N)(T-N) -> infinity in the Besov space B-2,sigma(-1) (R) (sigma > 2) for one space dimension. We also construct a similar ill-posed sequence of solutions in two space dimensions in the scaling critical Sobolev space H-1(R-2). We systematically utilize the modulation space M-2,1(0) for one dimension and the scaled modulation space (M-2,1(0))(N) for two dimensions.	[Iwabuchi, Tsukasa] Chuo Univ, Dept Math, Bunkyo Ku, Tokyo 1128551, Japan; Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Iwabuchi, T (reprint author), Chuo Univ, Dept Math, Bunkyo Ku, Tokyo 1128551, Japan.				JSPS [20244009, 25220702]	The work of the second author was partially supported by JSPS Grant-in-Aid, Scientific Research A #20244009 and Scientific Research S #25220702.	Colliander JE, 2001, T AM MATH SOC, V353, P3307, DOI 10.1090/S0002-9947-01-02760-X; GINIBRE J, 1979, J FUNCT ANAL, V32, P1, DOI 10.1016/0022-1236(79)90076-4; Wang BX, 2006, J FUNCT ANAL, V233, P1, DOI 10.1016/j.jfa.2005.06.018; Kenig CE, 2001, DUKE MATH J, V106, P617; Toft J, 2004, J FUNCT ANAL, V207, P399, DOI 10.1016/j.jfa.2003.10.003; Kenig CE, 1996, T AM MATH SOC, V348, P3323, DOI 10.1090/S0002-9947-96-01645-5; Bejenaru I, 2006, J FUNCT ANAL, V233, P228, DOI 10.1016/j.jfa.2005.08.004; Bejenaru I, 2008, T AM MATH SOC, V360, P5805, DOI 10.1090/S0002-9947-08-04415-2; CAZENAVE T, 1990, NONLINEAR ANAL-THEOR, V14, P807, DOI 10.1016/0362-546X(90)90023-A; Dix DB, 1996, SIAM J MATH ANAL, V27, P708, DOI 10.1137/0527038; Feichtinger H. G., 2003, P INT C WAV APPL CHE, P1; KATO T, 1987, ANN I H POINCARE-PHY, V46, P113; Kishimoto N, 2008, COMMUN PUR APPL ANAL, V7, P1123; Kishimoto N, 2009, J DIFFER EQUATIONS, V247, P1397, DOI 10.1016/j.jde.2009.06.009; la Bekiranov Daniel, 1996, DIFFER INTEGRAL EQU, V9, P1253; Molinet L, 2012, ADV MATH, V230, P1895, DOI 10.1016/j.aim.2012.03.026; Molinet Luc, 2011, ANN SC NORM SUPER PI, V10, P531; Oh S, 2012, J LOND MATH SOC, V86, P499, DOI 10.1112/jlms/jds016; Ponce Gustavo, 1993, PARTIAL DIFFERENTIAL, V18, P169, DOI [10.1080/03605309308820925, DOI 10.1080/03605309308820925]; Tsutsumi Y., 1987, FUNK EKVA, V30, P115	20	1	1	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	APR	2015	367	4					2613	2630	PII S0002-9947(2014)06000-5			18	Mathematics	Mathematics	CE5GB	WOS:000351858000011		
J	Uchiyama, K				Uchiyama, Kohei			ASYMPTOTICS OF THE DENSITIES OF THE FIRST PASSAGE TIME DISTRIBUTIONS FOR BESSEL DIFFUSIONS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						First passage time; exterior problem; uniform estimate; Bessel diffusion	BROWNIAN-MOTION; HITTING TIMES; DISC	This paper concerns the first passage times to a point a > 0, denoted by sigma(a), of Bessel processes. We are interested in the case when the process starts at x > a and we compute the densities of the distributions of sigma(a) to obtain the exact asymptotic forms of them as t -> infinity that are valid uniformly in x > a for every order of the Bessel process.	Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan	Uchiyama, K (reprint author), Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan.	uchiyama@math.titech.ac.jp					Byczkowski T, 2013, POTENTIAL ANAL, V38, P753, DOI 10.1007/s11118-012-9296-7; Byczkowski T, 2006, STUD MATH, V173, P19, DOI 10.4064/sm173-1-2; Ciesielski Z., 1962, T AM MATH SOC, V103, P434, DOI 10.2307/1993838; Erdelyi A., 1956, ASYMPTOTIC EXPANSION; Erdelyi A., 1954, TABLES OF INTEGRAL T, VI; Evans Lawrence C., 1998, GRADUATE STUDIES MAT, V19; GETOOR RK, 1979, Z WAHRSCHEINLICHKEIT, V47, P83, DOI 10.1007/BF00533253; Grigor'yan A, 2002, J MATH PURE APPL, V81, P115, DOI 10.1016/S0021-7824(01)01244-2; Hamana Y, 2013, T AM MATH SOC, V365, P5237; Hamana Y., 2012, J MATH FOR IND, V4B, P91; Ito K., 1965, DIFFUSION PROCESSES; KENT JT, 1980, Z WAHRSCHEINLICHKEIT, V52, P309, DOI 10.1007/BF00538895; Lebedev N. N., 1965, SPECIAL FUNCTIONS AN; Revuz Daniel, 1999, GRUNDLEHREN DER MATH, V293; Spitzer F., 1958, T AM MATH SOC, V87, P187, DOI 10.2307/1993096; Titchmarsh E. C., 1962, EIGENFUCTION EXPAN 1; Uchiyama K., 2013, THE EXPECTED VOLUME; Uchiyama K, 2012, J THEOR PROBAB, V25, P450, DOI 10.1007/s10959-010-0305-8; Uchiyama K, 2011, ELECTRON J PROBAB, V16, P1960; Uchiyama K, 2013, STOCH PROC APPL, V123, P191, DOI 10.1016/j.spa.2012.09.005; Watson G. N., 1944, TREATISE THEORY BESS; Watson Neil A., 2012, MATHEMATICAL SURVEYS, V182	22	1	1	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	APR	2015	367	4					2719	2742	PII S0002-9947(2014)06155-2			24	Mathematics	Mathematics	CE5GB	WOS:000351858000015		
J	Koda, Y; Ozawa, M; Gordon, C				Koda, Yuya; Ozawa, Makoto; Gordon, Cameron			ESSENTIAL SURFACES OF NON-NEGATIVE EULER CHARACTERISTIC IN GENUS TWO HANDLEBODY EXTERIORS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Knot; handlebody; essential surface	CABLING CONJECTURE; KNOTS; AUTOMORPHISMS; 3-SPHERE; PRESERVE; SURGERY; 3-MANIFOLDS; COMPLEMENTS; MANIFOLDS	We provide a classification of the essential surfaces of non-negative Euler characteristic in the exteriors of genus two handlebodies embedded in the 3-sphere.	[Koda, Yuya] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan; [Ozawa, Makoto] Komazawa univ, Dept Nat Sci, Fac Arts & Sci, Setagaya Ku, Tokyo 1548525, Japan; [Gordon, Cameron] Univ Texas Austin, Dept Math, Austin, TX 78712 USA	Koda, Y (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan.	koda@math.tohoku.ac.jp; w3c@komazawa-u.ac.jp; gordon@math.utexas.edu			Japan Society for the Promotion of Science [26800028, 23540105]; JSPS Postdoctoral Fellowships for Research Abroad	The first-named author was supported in part by Grant-in-Aid for Young Scientists (B) (No. 26800028), Japan Society for the Promotion of Science, and by JSPS Postdoctoral Fellowships for Research Abroad.; The second-named author was supported in part by Grant-in-Aid for Scientific Research (C) (No. 23540105), Japan Society for the Promotion of Science.	Akbas E, 2008, PAC J MATH, V236, P201; Ishii A, 2008, ALGEBR GEOM TOPOL, V8, P1403, DOI 10.2140/agt.2008.8.1403; THURSTON WP, 1982, B AM MATH SOC, V6, P357, DOI 10.1090/S0273-0979-1982-15003-0; Benedetti R, 2013, T AM MATH SOC, V365, P2099; Blair R., ARXIV12114787; BONAHON F, 1983, ANN SCI ECOLE NORM S, V16, P237; Burde Gerhard, 1985, DEGRUYTER STUDIES MA, V5; Cho S, 2008, P AM MATH SOC, V136, P1113; Eudave-Munoz M., 2014, B SOC MAT MEX, DOI [10.1007/s40590-014-0035-5, DOI 10.1007/S40590-014-0035-5]; Eudave-Munoz M, 2002, TOPOL APPL, V121, P119, DOI 10.1016/S0166-8641(01)00114-6; Eudave-Munoz M., 1997, AMS IP STUD ADV MATH, V2.1, P35; GABAI D, 1987, J DIFFER GEOM, V26, P479; Goeritz L., 1933, ABH MATH SEM HAMBURG, V9, P244, DOI 10.1007/BF02940650; Gonzalez-Acuna Francisco, 1986, MATH P CAMBRIDGE PHI, V99, P89, DOI 10.1017/ S0305004100063969; Gordon C. McA., 2004, COMMUN ANAL GEOM, V12, P417; Gordon C. McA., 1987, MATH P CAMBRIDGE PHI, V102, P97, DOI [10.1017/ S0305004100067086, DOI 10.1017/S0305004100067086]; Gordon C. McA., 1989, J AM MATH SOC, V2, P371; Gordon C. McA., 1987, TOPOL APPL, V27, P285, DOI [10.1016/0166-8641(87)90093-9, DOI 10.1016/0166-8641(87)90093-9]; Haken Wolfgang, 1968, STUDIES MODERN TOPOL, P39; Hayashi C, 1998, MATH PROC CAMBRIDGE, V123, P501, DOI 10.1017/S0305004197002399; Hempel John, 1976, ANN MATH STUD, V86; Hoffman JA, 1998, J KNOT THEOR RAMIF, V7, P549, DOI 10.1142/S0218216598000309; Hoffman James Allen, 1995, THESIS U TEXAS AUSTI; Ichihara K, 2000, J KNOT THEOR RAMIF, V9, P725, DOI 10.1142/S0218216500000414; Ishii A., J MATH SOC JAPAN; Jaco William, 1980, CBMS REGIONAL C SERI, V43; J.-P. OTAL, 1998, SURVEYS DIFFERENTIAL, VIII, P77; Kapovich Michael, 2001, PROGR MATH, V183; Kneser H., 1929, JBER DTSCH MATH VERE, V38, P248; KOBAYASHI T, 1984, OSAKA J MATH, V21, P437; Koda Y., ARXIV11064777; Lee JH, 2012, ALGEBR GEOM TOPOL, V12, P1059, DOI 10.2140/agt.2012.12.1059; LUFT E, 1994, MATH ANN, V298, P489, DOI 10.1007/BF01459747; McA C., 1984, TOPOL APPL, V18, P121, DOI DOI 10.1016/0166-8641(84)90005-1; MENASCO WW, 1992, J REINE ANGEW MATH, V426, P47; Morgan J. W., 1984, PURE APPL MATH, V112, P37, DOI 10.1016/S0079-8169(08)61637-2; MOTTO M, 1990, TOPOL APPL, V36, P283, DOI 10.1016/0166-8641(90)90052-4; Munoz Mario Eudave, 1992, T AM MATH SOC, V330, P463, DOI [10.2307/2153918, DOI 10.2307/2153918]; Otal J-P., 1996, ASTERISQUE, V235; PARRY W, 1990, P AM MATH SOC, V110, P871, DOI 10.2307/2047731; PRZYTYCKI JH, 1983, MICH MATH J, V30, P289; Scharlemann M, 2004, BOL SOC MAT MEX, V10, P503; SCHARLEMANN M, 1990, TOPOLOGY, V29, P481, DOI 10.1016/0040-9383(90)90017-E; Schubert H., 1949, S B HEIDELBERGER MN, V1949, P57; Tsukui Yasuyuki, 1975, YOKOHAMA MATH J, V23, P63; Waldhausen F., 1968, TOPOLOGY, V7, P195, DOI 10.1016/0040-9383(68)90027-X	46	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	APR	2015	367	4					2875	2904	PII S0002-9947(2014)06199-0			30	Mathematics	Mathematics	CE5GB	WOS:000351858000021		
J	Saomoto, H; Katagiri, J				Saomoto, Hidetaka; Katagiri, Jun			Particle Shape Effects on Hydraulic and Electric Tortuosities: A Novel Empirical Tortuosity Model Based on van Genuchten-Type Function	TRANSPORT IN POROUS MEDIA			English	Article						Particle; Hydraulic tortuosity; Electric tortuosity; Porosity; FEM	POROUS-MEDIA; UNSATURATED SOILS; FIXED-BEDS; CONDUCTIVITY; FLOW; PERMEABILITY; DIFFUSION; PATH; FORM	The tortuosity is one of the key parameters to characterize the transport properties of porous media. Since the tortuosity is strongly related with the shape of particles constituting the porous media, we need to investigate the shape effect of particles on the tortuosities. We have, respectively, performed a series of finite element simulations for the hydraulic and the electric tortuosity to reveal the relationship between the tortuosity and the particle shape. The results reveal that: (1) A concise computational expression for tortuosities proposed by Duda et al. is numerically validated through our simulations. (2) On average, the hydraulic tortuosity is 15 % greater than the electric tortuosity within the porosity range from 0.5 to 0.9. (3) The high particle aspect ratio (5.0) results in the amplifications of both the hydraulic and the electric tortuosities up to 15 % greater than the values with the low particle aspect ratio (1.0). Using the simulation results, we propose a novel tortuosity model based on the van Genuchten-type function, which can precisely describe the relationship between the tortuosities and the porosity for elliptic particle having the aspect ratio ranging from 1.0 to 5.0.	[Saomoto, Hidetaka] Natl Inst Adv Ind Sci & Technol, Inst Earthquake & Volcano Geol, Cent 7, Tsukuba, Ibaraki 3058567, Japan; [Katagiri, Jun] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki 3058569, Japan	Saomoto, H (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Earthquake & Volcano Geol, Cent 7, Higashi I-1-1, Tsukuba, Ibaraki 3058567, Japan.	h-saomoto@aist.go.jp					AHUJA LR, 1972, SOIL SCI SOC AM PRO, V36, P9; Koponen A, 1996, PHYS REV E, V54, P406, DOI 10.1103/PhysRevE.54.406; WEISSBERG HL, 1963, J APPL PHYS, V34, P2636, DOI 10.1063/1.1729783; Duda A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036319; Ewing RP, 2006, VADOSE ZONE J, V5, P731, DOI 10.2136/vzj2005.0107; Hunt AG, 2001, ADV WATER RESOUR, V24, P279, DOI 10.1016/S0309-1708(00)00058-0; Ghanbarian B, 2013, SOIL SCI SOC AM J, V77, P1461, DOI 10.2136/sssaj2012.0435; Ahmadi MM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026312; Friedman SP, 1998, WATER RESOUR RES, V34, P1703, DOI 10.1029/98WR00939; HAVERKAMP R, 1977, SOIL SCI SOC AM J, V41, P285; Archie GE, 1942, T AM I MIN MET ENG, V146, P54; COMITI J, 1989, CHEM ENG SCI, V44, P1539, DOI 10.1016/0009-2509(89)80031-4; WYLLIE MRJ, 1955, IND ENG CHEM, V47, P1379, DOI 10.1021/ie50547a037; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; Yu BM, 2004, CHINESE PHYS LETT, V21, P1569, DOI 10.1088/0256-307X/21/8/044; HAVLIN S, 1987, ADV PHYS, V36, P695, DOI 10.1080/00018738700101072; MARTYS N, 1992, PHYS REV B, V46, P6080, DOI 10.1103/PhysRevB.46.6080; Lanfrey PY, 2010, CHEM ENG SCI, V65, P1891, DOI 10.1016/j.ces.2009.11.011; Matyka M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026306; VANGENUCHTEN MT, 1985, ANN GEOPHYS, V3, P615; Barrande M, 2007, ANAL CHEM, V79, P9115, DOI 10.1021/ac071377r; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Bear J., 1972, DYNAMICS FLUIDS PORO; BEECKMAN JW, 1990, CHEM ENG SCI, V45, P2603, DOI 10.1016/0009-2509(90)80148-8; Brutsaert W., 1966, SOIL SCI, V101, P85; Carman P.C., 1937, T I CHEM ENG-LOND, V15, P150, DOI DOI 10.1016/S0263-8762(97)80003-2; Clennell M. B., 1997, GEOL SOC SPEC PUBL, V122, P299, DOI 10.1144/GSL.SP.1997.122.01.18; Coleman SW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035504; DUPLESSIS JP, 1991, TRANSPORT POROUS MED, V6, P207; Koponen A, 1997, PHYS REV E, V56, P3319, DOI 10.1103/PhysRevE.56.3319; KOSTEK S, 1992, PHYS REV B, V45, P186, DOI 10.1103/PhysRevB.45.186; Mauret E, 1997, CHEM ENG SCI, V52, P1807, DOI 10.1016/S0009-2509(96)00499-X; Maxwell J. C., 1873, TREATISE ELECT MAGNE, V1; Mota M., 2001, T FILTRATION SOC, V1, P101; Pech D., 1984, THESIS INP GRENOBLE; SAEGER RB, 1991, PHYS REV A, V44, P5087, DOI 10.1103/PhysRevA.44.5087; Schopper J.R., 1966, GEOPHYS PROSPECT, V14, P301, DOI 10.1111/j.1365-2478.1966.tb01763.x; TSAI DS, 1986, CHEM ENG COMMUN, V40, P207, DOI 10.1080/00986448608911698; van Genuchten M.T., 1978, 78WR08 PRINC U; Wong PZ, 1999, EXPTL METH PHYS SCI, V35, P119; Wyllie M.R.J., 1957, FUNDAMENTALS ELECT L; Yazdchi K., 2011, INT C PART BAS METH	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0169-3913	1573-1634		TRANSPORT POROUS MED	Transp. Porous Media	APR	2015	107	3					781	798		10.1007/s11242-015-0467-z		18	Engineering, Chemical	Engineering	CE1OL	WOS:000351581100009		
J	Matsukawa, Y; Takai, S; Funahashi, Y; Yamamoto, T; Gotoh, M				Matsukawa, Yoshihisa; Takai, Shun; Funahashi, Yasuhito; Yamamoto, Tokunori; Gotoh, Momokazu			Urodynamic Evaluation of the Efficacy of Mirabegron on Storage and Voiding Functions in Women With Overactive Bladder	UROLOGY			English	Article							URINARY-TRACT SYMPTOMS; HUMAN DETRUSOR MUSCLE; BETA(3)-ADRENOCEPTOR AGONIST; RELAXATION; INSTABILITY; SOLIFENACIN; SUBTYPES; SAFETY; PHASE; SCORE	OBJECTIVE To investigate the effects of mirabegron (50 mg once daily for 12 weeks) in treatment-naive women with overactive bladder (OAB) based on urodynamic studies. METHODS This was an open-labeled, single-center, prospective study involving 65 recruited outpatients. The OAB symptom score was used for assessing the severity of subjective symptoms. Urodynamic studies, including uroflowmetry, cystometry, and pressure flow study, were conducted to evaluate objective symptoms. The first desire to void, maximum cystometric capacity, and occurrence of detrusor overactivity were measured as storage function parameters, whereas maximum flow rate, detrusor pressure at Qmax, and postvoid residual urine volume were assessed as voiding function parameters. RESULTS A total of 60 patients with a mean age of 72.3 years (50-86 years) were included in the analysis. The subjective symptom parameter (ie, the mean OAB symptom score) decreased significantly from 9.4 to 6.2 points (P <. 001). In objective symptom parameters, both the first desire to void and maximum cystometric capacity significantly improved after treatment, and detrusor overactivity disappeared in 14 of 35 patients (40.0%) compared with that at baseline (P <. 01). The voiding function parameters (ie, mean maximum flow rate, detrusor pressure at Qmax, and postvoid residual urine volume) did not significantly change, demonstrating that mirabegron does not inhibit voiding function. CONCLUSION Mirabegron improves storage function and subjective symptoms, without influencing voiding function, in women with OAB. (C) 2015 Elsevier Inc.	[Matsukawa, Yoshihisa; Takai, Shun; Funahashi, Yasuhito; Yamamoto, Tokunori; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4668550, Japan	Matsukawa, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Urol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yoshi44@med.nagoya-u.ac.jp					Yamaguchi O, 2002, UROLOGY, V59, P25, DOI 10.1016/S0090-4295(01)01635-1; Sexton CC, 2009, BJU INT, V103, P12, DOI 10.1111/j.1464-410X.2009.08369.x; Benner JS, 2010, BJU INT, V105, P1276, DOI 10.1111/j.1464-410X.2009.09036.x; Wagg A, 2012, BJU INT, V110, P1767, DOI 10.1111/j.1464-410X.2012.11023.x; Khullar V, 2013, EUR UROL, V63, P283, DOI 10.1016/j.eururo.2012.10.016; Yamaguchi O, 2014, BJU INT, V113, P951, DOI 10.1111/bju.12649; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Igawa Y, 1999, BRIT J PHARMACOL, V126, P819, DOI 10.1038/sj.bjp.0702358; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Seckiner I, 2007, NEUROUROL URODYNAM, V26, P492, DOI 10.1002/nau.20389; Yamanishi T, 2003, NEUROUROL URODYNAM, V22, P338, DOI 10.1002/nau.10130; Nitti VW, 2013, J UROLOGY, V189, P1388, DOI 10.1016/j.juro.2012.10.017; Fujimura T, 1999, J UROLOGY, V161, P680, DOI 10.1016/S0022-5347(01)61994-3; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Nitti VW, 2013, J UROLOGY, V190, P1320, DOI 10.1016/j.juro.2013.05.062; Takeda M, 1999, J PHARMACOL EXP THER, V288, P1367; Yamaguchi O, 2009, INT J UROL, V16, P126, DOI 10.1111/j.1442-2042.2008.02177.x; Woods M, 2001, J UROLOGY, V166, P1142, DOI 10.1016/S0022-5347(05)65936-8; AWAD SA, 1983, J UROLOGY, V130, P114; Brubaker L, 2006, UROLOGY, V68, P3, DOI 10.1016/j.urology.2006.05.045; Hatanaka T, 2013, N-S ARCH PHARMACOL, V386, P71, DOI 10.1007/s00210-012-0814-3; Hsiao SM, 2011, J OBSTET GYNAECOL RE, V37, P1084, DOI 10.1111/j.1447-0756.2010.01493.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Tanaka Y, 2010, INT J UROL, V17, P796, DOI 10.1111/j.1442-2042.2010.02602.x	27	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	APR	2015	85	4					786	790		10.1016/j.urology.2015.01.002		5	Urology & Nephrology	Urology & Nephrology	CE6JZ	WOS:000351944000022		
J	Shoji, K; Takahashi, T; Kurohane, K; Iwata, K; Matsuoka, T; Tsuruta, S; Sugino, T; Miyake, M; Suzuki, T; Imai, Y				Shoji, Kentaro; Takahashi, Tadanobu; Kurohane, Kohta; Iwata, Koki; Matsuoka, Takeshi; Tsuruta, Shogo; Sugino, Takatomo; Miyake, Masaki; Suzuki, Takashi; Imai, Yasuyuki			Recombinant Immunoglobulin A Specific for Influenza A Virus Hemagglutinin: Production, Functional Analysis, and Formation of Secretory Immunoglobulin A	VIRAL IMMUNOLOGY			English	Article							LIVE-ATTENUATED INFLUENZA; IGA MONOCLONAL-ANTIBODY; SHIGA TOXIN; MUCOSAL IMMUNITY; VIRAL-INFECTION; MONOMERIC IGA; SIALIC-ACID; VACCINE; RECEPTOR; BINDING	Secretory immunoglobulin (Ig) A (SIgA), comprised of dimeric IgA and secretory component (SC), is believed to provide a defense mechanism on the mucosal surface. Influenza A virus (IAV) hemagglutinin (HA)-specific SIgA is thought to play an important role in the prevention of IAV infection. However, the topical application of preformed IAV-specific SIgA has not been shown to prevent IAV infection. This is due to the difficulty in the production of antigen-specific IgA monoclonal antibodies (mAbs) and monoclonal SIgA. Here, a recombinant hybrid IgA (HIgA) was established that utilizes variable regions of an HA-specific mouse IgG mAb and the heavy chain constant region of a mouse IgA mAb. We expressed the dimeric HIgA in Chinese hamster ovary-K1 (CHO-K1) cells. When in vitro IAV infection of Madin-Darby canine kidney (MDCK) cells was tested, 10 times lower concentrations of HIgA were able to inhibit it as compared with an HA-specific IgG with the same variable regions. A functional hybrid secretory IgA (HSIgA) was also produced through incubation of the dimeric HIgA with recombinant mouse SC in vitro. It was demonstrated that HSIgA could be separated from the dimeric HIgA on size exclusion chromatography. This study provides a basic strategy for investigating the role of SIgA upon IAV infection on the mucosal surface.	[Shoji, Kentaro; Kurohane, Kohta; Iwata, Koki; Matsuoka, Takeshi; Tsuruta, Shogo; Sugino, Takatomo; Miyake, Masaki; Imai, Yasuyuki] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka, Shizuoka 4228526, Japan; [Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka 4228526, Japan	Imai, Y (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka, Shizuoka 4228526, Japan.	imai@u-shizuoka-ken.ac.jp	Imai, Yasuyuki/E-8701-2010		Japan Society for the Promotion of Science;  [23659067];  [25670063]	The authors thank Mr. Shingo Kunugi and Mr. Yasukazu Sasanuma (University of Shizuoka) for their technical assistance. This work was supported partly by a Grant-in-aid for Challenging Exploratory Research (grant number 23659067, 25670063) to Y.I., and by research funding for the Global COE Program from the Japan Society for the Promotion of Science.	Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; CZINN SJ, 1993, VACCINE, V11, P637, DOI 10.1016/0264-410X(93)90309-L; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; Asahi Y, 2002, J IMMUNOL, V168, P2930; Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Renegar KB, 2004, J IMMUNOL, V173, P1978; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; TOMODA T, 1995, VACCINE, V13, P185, DOI 10.1016/0264-410X(95)93134-U; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Renegar KB, 1998, J IMMUNOL, V160, P1219; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Ito T, 1997, J VIROL, V71, P3357; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; OFFIT PA, 1985, J VIROL, V54, P58; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; WINNER L, 1991, INFECT IMMUN, V59, P977; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; CLEMENTS ML, 1983, INFECT IMMUN, V40, P1044; FRENCH MAH, 1995, CLIN EXP IMMUNOL, V100, P47; Higuchi R., 1990, PCR PROTOCOLS GUIDE, P177; Imai Y, 2005, J IMMUNOL METHODS, V302, P125, DOI 10.1016/j.jim.2005.05.007; Iwata K, 2014, BIOL PHARM BULL, V37, P1510; Jones RML, 1998, BBA-PROTEIN STRUCT M, V1429, P265, DOI 10.1016/S0167-4838(98)00239-8; KERR MA, 1990, BIOCHEM J, V271, P285; Lullau E, 1996, J BIOL CHEM, V271, P16300; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PERSSON E, 1988, GENITOURIN MED, V64, P373; PISKURICH JF, 1995, J IMMUNOL, V154, P1735; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; RENEGAR KB, 1991, J VIROL, V65, P2146; SUZUKI Y, 1985, J BIOL CHEM, V260, P1362; Takahashi T, 2008, BIOCHEM BIOPH RES CO, V368, P550, DOI 10.1016/j.bbrc.2008.01.145; TAMURA S, 1992, EUR J IMMUNOL, V22, P477, DOI 10.1002/eji.1830220228; Tanikawa T, 2007, HYBRIDOMA, V26, P328, DOI 10.1089/hyb.2007.0514; Tanikawa T, 2008, SCAND J IMMUNOL, V68, P414, DOI 10.1111/j.1365-3083.2008.02153.x; Tanimoto T, 2012, VIRAL IMMUNOL, V25, P433, DOI 10.1089/vim.2012.0026; Tobisawa Y, 2011, SCAND J IMMUNOL, V74, P574, DOI 10.1111/j.1365-3083.2011.02617.x	45	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0882-8245	1557-8976		VIRAL IMMUNOL	Viral Immunol.	APR 1	2015	28	3					170	178		10.1089/vim.2014.0098		9	Immunology; Virology	Immunology; Virology	CF1XG	WOS:000352340700006		
J	Koyanagi, T; Nakanishi, Y; Murayama, N; Yamaura, Y; Ikeda, K; Yano, K; Uehara, S; Utoh, M; Kim, S; Uno, Y; Yamazaki, H				Koyanagi, Takashi; Nakanishi, Yasuharu; Murayama, Norie; Yamaura, Yoshiyuki; Ikeda, Kanami; Yano, Koji; Uehara, Shotaro; Utoh, Masahiro; Kim, Soonih; Uno, Yasuhiro; Yamazaki, Hiroshi			Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation	XENOBIOTICA			English	Article						Cynomolgus monkey; hepatic clearance; in vitro-in vivo correlation; liver microsomes; P450 substrates	DRUG-METABOLISM; LIVER-MICROSOMES; PROTEIN-BINDING; PHARMACOKINETICS; HUMANS; ENZYMES; 3A; POLYMORPHISMS; (S)-WARFARIN; VARIABILITY	1. Pharmacokinetics of human cytochrome P450 probes (caffeine, racemic warfarin, omeprazole, metoprolol and midazolam) were investigated after single intravenous and oral administrations at doses of 0.20 and 1.0 mgkg(-1), respectively, in combination to three young (3-year-old) and three aged (16-year-old) cynomolgus monkeys. 2. The plasma concentrations of caffeine and R-/S-warfarin decreased slowly in a monophasic manner, but those of omeprazole, metoprolol and midazolam decreased rapidly, in a similar manner to those as reported for pharmacokinetics in humans. 3. The mean maximum concentrations of R- and S-warfarin (4.6 and 3.7 mu g/mL, respectively) in aged monkeys after oral administration were significantly higher than those in young monkeys (3.3 and 2.7 mu g/mL). The mean clearance (CL) values of midazolam in aged monkeys (9.5 mL/min/kg) were significantly lower than those in young monkeys (13 mL/min/kg). 4. Individual intrinsic CL values for omeprazole (r = 0.29) and metoprolol (r = 0.30) of individual monkey livers were inversely correlated with their ages significantly (p < 0.05) in liver microsomes prepared from 55 cynomolgus monkeys. 5. These results suggest that cynomolgus monkeys could be a good model for humans, especially with particular characteristics in reduced CLs of some human P450 substrates by aging.	[Koyanagi, Takashi; Yamaura, Yoshiyuki; Yano, Koji; Kim, Soonih] Ono Pharmaceut Co Ltd, Shimamoto, Osaka, Japan; [Nakanishi, Yasuharu; Utoh, Masahiro; Uno, Yasuhiro] Shin Nippon Biomed Labs Ltd, Wakayama, Japan; [Murayama, Norie; Ikeda, Kanami; Uehara, Shotaro; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab DMPK, Machida, Tokyo 1948543, Japan	Yamazaki, H (reprint author), Showa Pharmaceut Univ, Lab DMPK, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Takeda Science Foundation	This work was supported, in part, by the Takeda Science Foundation (H. Y.).	Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x; McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Gorski JC, 2003, CLIN PHARMACOL THER, V74, P275, DOI 10.1016/S0009-9236(03)00187-5; Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001; Corsonello A, 2010, CURR MED CHEM, V17, P571; Klotz U, 2004, BASIC CLIN PHARMACOL, V95, P2; Johnson JA, 1996, DRUG METAB DISPOS, V24, P350; VIANI A, 1992, BRIT J CLIN PHARMACO, V33, P299; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Mogi M, 2012, J TOXICOL SCI, V37, P1157; Uno Y, 2010, DRUG METAB DISPOS, V38, P1486, DOI 10.1124/dmd.110.033274; HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469; GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; HARPER KW, 1985, BRIT J ANAESTH, V57, P866, DOI 10.1093/bja/57.9.866; Hosoi Y, 2012, BIOCHEM PHARMACOL, V84, P1691, DOI 10.1016/j.bcp.2012.09.026; Ishizawa Y, 2005, CLIN PHARMACOKINET, V44, P1179, DOI 10.2165/00003088-200544110-00005; Iwasaki K, 2010, DRUG METAB PHARMACOK, V25, P388; Jensen BP, 2012, BRIT J CLIN PHARMACO, V74, P797, DOI 10.1111/j.1365-2125.2012.04259.x; Koyanagi T, 2014, XENOBIOTICA, V44, P893, DOI 10.3109/00498254.2014.903532; LARSSON M, 1984, EUR J CLIN PHARMACOL, V27, P217, DOI 10.1007/BF00544048; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; Platten HP, 1998, CLIN PHARMACOL THER, V63, P552, DOI 10.1016/S0009-9236(98)90106-0; Uehara S, 2011, J PHARMACOL EXP THER, V339, P654, DOI 10.1124/jpet.111.185009; Uno Y, 2014, DRUG METAB IN PRESS, DOI [10.1016/j.dmpk.2014.10.002, DOI 10.1016/J.DMPK.2014.10.002]; Uno Y, 2014, BIOCHEM PHARMACOL, V91, P242, DOI 10.1016/j.bcp.2014.07.004; Uno Y, 2014, DRUG METAB DISPOS, V42, P1407, DOI 10.1124/dmd.114.059220; Utoh M, 2013, XENOBIOTICA, V43, P1037, DOI 10.3109/00498254.2013.793874	31	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	APR	2015	45	4					312	321		10.3109/00498254.2014.979271		10	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CE5JQ	WOS:000351869200004		
J	Kosugi, Y; Takahashi, J				Kosugi, Yohei; Takahashi, Junzo			Species differences and substrate specificity of CYP3A heteroactivation by efavirenz	XENOBIOTICA			English	Article						CYP3A4; drug-drug interactions (DDIs); efavirenz; heteroactivation; midazolam; species differences; substrate specificity	DRUG-DRUG INTERACTION; HUMAN LIVER-MICROSOMES; IN-VITRO; CYNOMOLGUS MONKEYS; ALPHA-NAPHTHOFLAVONE; ACTIVE-SITE; HETEROTROPIC COOPERATIVITY; CYTOCHROME-P450 ISOFORMS; INTESTINAL METABOLISM; INTERACTION PATTERNS	1. The purpose of this study was to clarify species differences in the heteroactivation of CYP3A substrates by efavirenz, which is known from clinical studies to activate midazolam 1'-hydroxylation, and to assess the feasibility of an animal model. 2. In monkey and human liver microsomes, efavirenz activated CYP3A-mediated midazolam 10-hydroxylation, but had no effect in rat liver microsomes. The activating effect of efavirenz was also observed with recombinant human CYP3A4 and CYP3A5. Midazolam 4-hydroxylation, testosterone 6 beta-hydroxylation and the oxidation of nifedipine were not activated by efavirenz in any of the microsomes. 3. In an in vivo study using monkeys, the AUC ratio of midazolam/1'-hydroxymidazolam was reduced from 0.85 to 0.30 by efavirenz treatment, which was comparable to that obtained in clinical studies. However, the AUC changes of midazolam caused by efavirenz were smaller than those observed in clinical results, therefore the effect of efavirenz on monkeys was not completely consistent with that seen in humans. 4. In conclusion, this is the first report that efavirenz specifically activates midazolam 1'-hydroxylation only in monkey and human liver microsomes, revealing marked species differences and high substrate specificity in the heteroactivation. A further study is required to clarify whether this in vitro result reflects the in vivo situation.	[Kosugi, Yohei; Takahashi, Junzo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa 2518555, Japan	Kosugi, Y (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	youhei.kosugi@takeda.com					Adkins JC, 1998, DRUGS, V56, P1055, DOI 10.2165/00003495-199856060-00014; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Kuperman AV, 2001, DRUG METAB DISPOS, V29, P1403; Maenpaa J, 1998, PHARMACOGENETICS, V8, P137; Tang W, 2001, CURR DRUG METAB, V2, P185, DOI 10.2174/1389200013338658; Wang RW, 2000, DRUG METAB DISPOS, V28, P360; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Lu C, 2001, CHEM-BIOL INTERACT, V134, P271, DOI 10.1016/S0009-2797(01)00162-4; Seo KA, 2010, DRUG METAB DISPOS, V38, P2007, DOI 10.1124/dmd.110.035295; Cameron MD, 2005, BIOCHEMISTRY-US, V44, P14143, DOI 10.1021/bi051689t; Hariparsad N, 2004, J CLIN PHARMACOL, V44, P1273, DOI 10.1177/0091270004269142; Ogasawara A, 2007, DRUG METAB DISPOS, V35, P410, DOI 10.1124/dmd.106.011288; Komura H, 2008, J PHARM SCI-US, V97, P1775, DOI 10.1002/jps.21121; Keubler A, 2012, DRUG METAB DISPOS, V40, P1178, DOI 10.1124/dmd.111.043844; Blobaum AL, 2013, DRUG METAB DISPOS, V41, P2066, DOI 10.1124/dmd.113.052662; Ishigami M, 2001, DRUG METAB DISPOS, V29, P1068; Pelkonen O, 1998, XENOBIOTICA, V28, P1203, DOI 10.1080/004982598238886; Tang W, 1999, J PHARMACOL EXP THER, V291, P1068; Egnell AC, 2003, J PHARMACOL EXP THER, V305, P1251, DOI 10.1124/jpet.102.047530; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Bayer J, 2009, BASIC CLIN PHARMACOL, V104, P515; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Belanger AS, 2009, DRUG METAB DISPOS, V37, P1793, DOI 10.1124/dmd.109.027706; GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131; Emoto C, 2013, CURR DRUG METAB, V14, P239; Emoto C, 2006, XENOBIOTICA, V36, P219, DOI 10.1080/00498250500489968; HEIZMANN P, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2220; Igarashi T, 1997, ARCH BIOCHEM BIOPHYS, V339, P85, DOI 10.1006/abbi.1996.9852; Iwasaki K, 2009, XENOBIOTICA, V39, P578, DOI 10.1080/00498250903003135; Ji HY, 2012, MOLECULES, V17, P851, DOI 10.3390/molecules17010851; Kanazu T, 2004, XENOBIOTICA, V34, P391, DOI 10.1080/00498250410001685755; KERR BM, 1994, BIOCHEM PHARMACOL, V47, P1969, DOI 10.1016/0006-2952(94)90071-X; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Nakamura A, 1999, XENOBIOTICA, V29, P243, DOI 10.1080/004982599238641; Ngui JS, 2000, DRUG METAB DISPOS, V28, P1043; Niwa T, 2008, CURR DRUG METAB, V9, P453, DOI 10.2174/138920008784746364; Ogasawara A, 2009, DRUG METAB DISPOS, V37, P122, DOI 10.1124/dmd.108.022574; Ogawa K, 2013, XENOBIOTICA, V43, P468, DOI 10.3109/00498254.2012.733831; Ohtsuka T, 2010, DRUG METAB DISPOS, V38, P1806, DOI 10.1124/dmd.110.032656; Oswald S, 2012, CLIN PHARMACOL THER, V91, P506, DOI 10.1038/clpt.2011.255; Prueksaritanont T, 2006, DRUG METAB DISPOS, V34, P1546, DOI 10.1124/dmd.106.009878; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; SHARER JE, 1995, DRUG METAB DISPOS, V23, P1231; Sugiyama M, 2011, DRUG METAB DISPOS, V39, P757, DOI 10.1124/dmd.110.037853; Uno Y, 2007, ARCH BIOCHEM BIOPHYS, V466, P98, DOI 10.1016/j.abb.2007.07.003; von Moltke LL, 2001, J CLIN PHARMACOL, V41, P85, DOI 10.1177/00912700122009728; WIEBEL FJ, 1971, ARCH BIOCHEM BIOPHYS, V144, P78, DOI 10.1016/0003-9861(71)90456-5; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Zhao XJ, 1997, J PHARMACOL EXP THER, V283, P1168; Zhu B, 2008, DRUG METAB DISPOS, V36, P331, DOI 10.1124/dmd.107.017962	53	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	APR	2015	45	4					345	352		10.3109/00498254.2014.981610		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CE5JQ	WOS:000351869200007		
J	Yamamura, Y; Koyama, N; Umehara, K				Yamamura, Yoshiya; Koyama, Noriyuki; Umehara, Ken			Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies	XENOBIOTICA			English	Article						Chlorzoxazone; CYP1A2; CYP2E1; HLMs; kinetics; KOH; sucrose	HUMAN CYTOCHROME-P450 ACTIVITIES; FUNCTIONAL-CHARACTERIZATION; ORGANIC-SOLVENTS; DRUG-METABOLISM; 2E1; EXPRESSION; PROBE; P450; METHOXYFLURANE; SEVOFLURANE	1. Chlorzoxazone (CLZ) is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans. Although in CLZ 6-hydroxylation several CYPs are responsible, previous studies have presented the monophasicity of the reaction in human liver microsomes (HLMs). Furthermore, the K-m values of CYP2E1 for the 6-hydroxylation in HLMs were reported to be lower than those of its recombinant enzymes. 2. This study aimed to provide the comprehensive K-m values for the CLZ 6-hydroxylation in HLMs using CYP antibodies. The Eadie-Hofstee plots revealed a biphasic profile and indicate that the reaction was mainly mediated by CYP1A2 as well as CYP2E1. The formation of 6-hydroxychlorzoxazone was more specific for CYP2E1 activity at higher substrate concentration in HLMs. 3. Moreover, KOH as a vehicle for substrate or sucrose included in HLMs preparation had some effect on the activity of CLZ 6-hydroxylase. These constituents seemed to be casually related to the apparent monophasic kinetics and variability in K-m values for the CLZ 6-hydroxylation in HLMs. 4. The K-m of CYP1A2 and CYP2E1 in HLMs was 3.8 mu mol/L and 410 mmol/L, respectively, and the value of CYP2E1 was close to that of recombinant CYP2E1.	[Yamamura, Yoshiya; Koyama, Noriyuki; Umehara, Ken] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Drug Metab, Kawauchi Cho, Tokushima 7710192, Japan	Yamamura, Y (reprint author), Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Drug Metab, 463-10 Kagasuno, Kawauchi Cho, Tokushima 7710192, Japan.	yamamura.yoshiya@otsuka.jp					Andersson TB, 2001, DRUG METAB DISPOS, V29, P712; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; KOOP DR, 1992, FASEB J, V6, P724; Fairhead M, 2005, J BIOL INORG CHEM, V10, P842, DOI 10.1007/s00775-005-0033-1; Clarke SE, 1998, XENOBIOTICA, V28, P1167, DOI 10.1080/004982598238877; Chauret N, 1998, DRUG METAB DISPOS, V26, P1; Nelson AC, 2001, DRUG METAB DISPOS, V29, P319; Fukami T, 2008, CHEM RES TOXICOL, V21, P720, DOI 10.1021/tx700325f; Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0; Anzenbacherova E, 2005, BASIC CLIN PHARMACOL, V96, P244, DOI 10.1111/j.1742-7843.2005.pto960316.x; Shimada T, 1999, DRUG METAB DISPOS, V27, P1274; ONO S, 1995, PHARMACOGENETICS, V5, P143, DOI 10.1097/00008571-199506000-00002; Lieber CS, 1997, PHYSIOL REV, V77, P517; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311; Hickman D, 1998, DRUG METAB DISPOS, V26, P207; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; Koyama N, 2002, XENOBIOTICA, V32, P573, DOI 10.1080/00498250210130591; KHARASCH ED, 1993, ANESTHESIOLOGY, V79, P795, DOI 10.1097/00000542-199310000-00023; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Baranova J, 2005, DRUG METAB DISPOS, V33, P862, DOI 10.1124/dmd.104.003392; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131; Easterbrook J, 2001, CHEM-BIOL INTERACT, V134, P243, DOI 10.1016/S0009-2797(01)00159-4; FDA, 2006, GUID IND DRUG INT ST; Gorski JC, 1997, XENOBIOTICA, V27, P243; Hanioka N, 2010, ARCH TOXICOL, V84, P363, DOI 10.1007/s00204-009-0504-1; Hanioka N, 2003, XENOBIOTICA, V33, P575, DOI 10.1080/0049825031000086400; Johnsrud EK, 2003, J PHARMACOL EXP THER, V307, P402, DOI 10.1124/jpet.102.053124; KHARASCH ED, 1995, ANESTHESIOLOGY, V82, P689; Lucas D, 1999, PHARMACOGENETICS, V9, P377, DOI 10.1097/00008571-199906000-00013; MAPOLES J, 1993, EUR J BIOCHEM, V214, P735, DOI 10.1111/j.1432-1033.1993.tb17975.x; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Schmider J, 1996, PHARMACOLOGY, V52, P125, DOI 10.1159/000139376; Shou MG, 2000, EUR J PHARMACOL, V394, P199, DOI 10.1016/S0014-2999(00)00079-0; Umehara K, 2002, BIOL PHARM BULL, V25, P1112, DOI 10.1248/bpb.25.1112; Upadhya SC, 2000, ARCH BIOCHEM BIOPHYS, V373, P23, DOI 10.1006/abbi.1999.1477; Yin H, 2000, XENOBIOTICA, V30, P141; ZAND R, 1993, CLIN PHARMACOL THER, V54, P142	37	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	APR	2015	45	4					353	360		10.3109/00498254.2014.985760		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CE5JQ	WOS:000351869200008		
J	Sakurai, H; Odani, A				Sakurai, Hiromu; Odani, Akira			New Trend in Metal-based Drug Research Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Sakurai, Hiromu] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078414, Japan; [Odani, Akira] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Odani, A (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	odani@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011	ODANI, Akira/0000-0003-3786-6740			[Anonymous], 2010, NEWTON BESSATSU KANZ; Sakurai H., 2006, ENCY BIOELEMENTS; Sakurai H., 2013, GENSO 111 SHINCHISHI	3	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					543	544				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500001		
J	Matsumura, K				Matsumura, Kenji			Iron, Aluminum, and Lanthanum-based Drugs for Treatment of Hyperphosphatemia	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						ferric citrate; chronic kidney disease; hyperphosphatemia; transferrin; fibroblast growth factor-23	GROWTH-FACTOR 23; HEMODIALYSIS-PATIENTS; FERRIC CITRATE; SEVELAMER HYDROCHLORIDE; CONTROLLED-TRIAL; JTT-751; CKD	The control of the serum phosphorus (P) level in chronic kidney disease patients is important because elevated serum P levels are associated with progression of vascular calcification and increased mortality in these patients. In 2014, a novel phosphate binder, ferric citrate hydrate (Riona (R)), became available for the treatment of hyperphosphatemia in Japan, the first country to approve this medication. Ferric citrate hydrate, which relies upon the potent phosphate-binding capacity of ferric iron, inhibits P absorption by forming complexes between ferric iron and dietary phosphate in the gut. The active pharmaceutical ingredient in ferric citrate hydrate provides a larger specific surface area and higher water solubility; therefore, it is expected to have greater efficacy in terms of its phosphate-binding capacity. In clinical trials, ferric citrate hydrate significantly reduced the serum phosphate level and effectively maintained serum P concentrations throughout the duration of the trials. Moreover, in one clinical trial, ferric citrate hydrate significantly decreased levels of fibroblast growth factor-23 (FGF-23) in nondialysis patients. FGF-23 is an endocrine hormone that increases urinary phosphate excretion to maintain serum P at the proper level. A portion of the iron from ferric citrate hydrate is absorbed and transported throughout the body as transferrin-bound iron, where it is used for the synthesis of hemoglobin, enzymes, and others. Although safer and more effective phosphate binders are expected in the future, ferric citrate hydrate will become a new approach for the treatment of hyperphosphatemia.	Torii Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038439, Japan	Matsumura, K (reprint author), Torii Pharmaceut Co Ltd, Chuo Ku, 3-4-1 Nihonbashi Honcho, Tokyo 1038439, Japan.	kenji.matsumura@torii.co.jp					Yang WC, 2002, NEPHROL DIAL TRANSPL, V17, P265, DOI 10.1093/ndt/17.2.265; Akizawa T, 2014, THER APHER DIAL, V18, P122, DOI 10.1111/1744-9987.12068; Yokoyama K, 2014, J RENAL NUTR, V24, P261, DOI 10.1053/j.jrn.2014.03.006; Yokoyama K, 2014, NEPHROL DIAL TRANSPL, V29, P1053, DOI 10.1093/ndt/gft483; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Yokoyama K, 2012, AM J NEPHROL, V36, P478, DOI 10.1159/000344008; HEAF JG, 1984, MINER ELECTROL METAB, V10, P345	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					545	549				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500002		
J	Saji, H				Saji, Hideo			Application of Radioisotopes for Theranostics, a Combination of Diagnostics and Therapy	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						radioisotope; diagnosis; therapy; theranostics; functional unit coupling radiopharmaceutical	BISPHOSPHONATE; BONE	Radioisotopes emit radiation with various characteristics. These characteristics have been used for various applications of radioisotopes in clinical fields. For example, diagnostic nuclear medicine is a technique that uses gamma-emitted radionuclides with high permeability into the body and can visualize changes in physiological and biochemical processes throughout the distributed and interrelated systems of living tissues and organs. Therapeutic nuclear medicine is a technique that uses beta-emitted radionuclides with high radiation damage to the cell and can be used for internal radiation therapy. Therefore, a strategy in which the same ligand is labeled with beta-emitted or gamma-emitted radioisotopes, i.e., a theranostics approach, is useful because an extensive availability of diagnostics and therapeutics is possible. In this presentation, some examples of a theranostics approach for radiolabeled compounds will be reported, including the results of our recent research.	Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Saji, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hsaji@pharm.kyoto-u.ac.jp					Pene F, 2009, CRIT CARE MED, V37, pS50, DOI 10.1097/CCM.0b013e3181921349; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004; Ogawa K, 2006, J NUCL MED, V47, P2042; Ogawa K, 2007, J NUCL MED, V48, P122; Saji H., 2011, SHINHOUSHAKAGAKU HOU, P123; Saji H., 2012, NANOBIO GIJUTSU SAIS, p132 ; Watanabe T, 2005, CANCER SCI, V96, P903, DOI 10.1111/j.1349-7006.2005.00120.x	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					551	556				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500003		
J	Ohmachi, Y				Ohmachi, Yasushi			Decorporation Agents for Internal Radioactive Contamination	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						radionuclide; decontamination therapy; decorporation agent	CHELATING-AGENTS; URANIUM; RATS; DESFERRITHIOCIN; EXPOSURE; REMOVAL; MERCURY; EHBP	When radionuclides are accidentally ingested or inhaled, blood circulation or tissue/organ deposition of the radionuclides causes systemic or local radiation effects. In such cases, decorporation therapy is used to reduce the health risks due to their intake. Decorporation therapy includes reduction and/or inhibition of absorption from the gastrointestinal tract, isotopic dilution, and the use of diuretics, adsorbents, and chelating agents. For example, penicillamine is recommended as a chelating agent for copper contamination, and diethylene triamine pentaacetic acid is approved for the treatment of internal contamination with plutonium. During chelation therapy, the removal effect of the drugs should be monitored using a whole-body counter and/or bioassay. Some authorities, such as the National Council on Radiation Protection and Measurements and International Atomic Energy Agency, have reported recommended decorporation agents for each radionuclide. However, few drugs are approved by the US Food and Drug Administration, and many are off-label-use agents. Because many decontamination agents are drugs that have been available for a long time and have limited efficacy, the development of new, higher-efficacy drugs has been carried out mainly in the USA and France. In this article, in addition to an outline of decorporation agents for internal radioactive contamination, an outline of our research on decorporation agents for actinide (uranium and plutonium) contamination and for radio-cesium contamination is also presented.	Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Res Program Radiat Dosimetry, Inage Ku, Chiba 2638555, Japan	Ohmachi, Y (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Res Program Radiat Dosimetry, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	y-omachi@nirs.go.jp					Agency for Toxic Substances and Disease Registry (ATSDR), 2010, TOX PROF PLUT; Anderegg G., 1990, J CHEM SOC CHEM COMM, V17, P1194; Bergeron RJ, 2009, INT J RADIAT BIOL, V85, P348, DOI 10.1080/09553000902781089; Fukuda S, 2005, CURR MED CHEM, V12, P2765, DOI 10.2174/092986705774463012; Ansoborlo E, 2007, CR CHIM, V10, P1010, DOI 10.1016/j.crci.2007.01.015; Durbin PW, 2008, HEALTH PHYS, V95, P465, DOI 10.1097/01.HP.0000326345.41816.c2; Cassatt DR, 2008, RADIAT RES, V170, P540, DOI 10.1667/RR1485.1; Sawicki M, 2008, EUR J MED CHEM, V43, P2768, DOI 10.1016/j.ejmech.2008.01.018; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; ATSDR (Agency for Toxic Substances and Dusease Regustry, 2013, TOX PROF UR; Fukuda S, 2005, HEALTH PHYS, V89, P81, DOI 10.1097/01.HP.0000156956.42935.28; Henge-Napoli MH, 1999, INT J RADIAT BIOL, V75, P1473; IAEA, 2005, GEN PROC MED RESP NU; International Commission on Radiological Protection (ICRP), 1995, ICRP PUBL 4, V71; International Commission on Radiological Protection (ICRP), 1986, ICRP PUBL, V48; NCRP (National Council on Radiation Protection and Measurements), 2008, 161 NCRP; Sadgrove MP, 2012, DRUG DEVELOP RES, V73, P243, DOI 10.1002/ddr.21019; Sanchez DJ, 2001, BIOL TRACE ELEM RES, V84, P139, DOI 10.1385/BTER:84:1-3:139; THOMPSON RC, 1983, HEALTH PHYS, V45, P837, DOI 10.1097/00004032-198310000-00001	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					557	563				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500004		
J	Yamada, H				Yamada, Hisaharu			Front-line Research of Idiosyncratic Drug Toxicity Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									Taisho Pharmaceut Co Ltd, Senior Specialist Off, Pharmaceut Prod, Kita Ku, Saitama 3319530, Japan	Yamada, H (reprint author), Taisho Pharmaceut Co Ltd, Senior Specialist Off, Pharmaceut Prod, Kita Ku, 1-403 Yoshino Cho, Saitama 3319530, Japan.	his-yamada@so.taisho.co.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					565	566				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500005		
J	Ikeda, T				Ikeda, Toshihiko			Recent Findings Regarding the Mechanism of Idiosyncratic Drug Toxicity	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						idiosyncratic toxicity; chemically reactive metabolite; judging criteria; covalent protein binding; cytotoxic T lymphocyte; gene biomarker	INDUCED-LIVER-INJURY; TANDEM MASS-SPECTROMETRY; STEVENS-JOHNSON-SYNDROME; EXPERIMENTAL AUTOIMMUNE HEPATITIS; IMMUNE-RELATED FACTORS; LONG-QT SYNDROME; METABOLIC-ACTIVATION; REACTIVE METABOLITES; INDUCED HEPATOTOXICITY; IN-VITRO	Animal experiments cannot predict the probability of idiosyncratic drug toxicity; consequently, an important goal of the pharmaceutical industry is to develop a new methodology for preventing this form of drug reaction. Although the mechanism remains unclear, immune reactions are likely involved in the toxic processes underlying idiosyncratic drug toxicity: the drug is first activated into a chemically reactive metabolite that binds covalently to proteins and then acts as an immunogen. Therefore, screening tests to detect chemically reactive metabolites are conducted early during drug development and typically involve trapping with glutathione. More quantitative methods are then used in a later stage of drug development and frequently employ C-14- or H-3-labeled compounds. It has recently been demonstrated that a zone classification system can be used to separate risky drugs from likely safe drugs: by plotting the amount of each protein-bound reactive metabolite in vitro against the dose levels in vivo, the risk associated with each drug candidate can be assessed. A mechanism for idiosyncratic drug-induced hepatotoxicity was proposed by analogy to virus-induced hepatitis, in which cytotoxic T lymphocytes play an important role. This mechanism suggests that polymorphism in human leukocyte antigens is involved in idiosyncrasy, and a strong correlation with a specific genotype of human leukocyte antigens has been found in many cases of idiosyncratic drug toxicity. Therefore, gene biomarkers hold promise for reducing the clinical risk and prolonging the life cycle of otherwise useful drugs.	Yokohama Coll Pharm, Lab Drug Metab & Pharmacokinet, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Ikeda, T (reprint author), Yokohama Coll Pharm, Lab Drug Metab & Pharmacokinet, Totsuka Ku, 601 Matano Cho, Yokohama, Kanagawa 2450066, Japan.	toshihiko_ikeda-san@nifty.com					Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Yano A, 2012, TOXICOLOGY, V293, P107, DOI 10.1016/j.tox.2012.01.008; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Zhang H, 2000, NAT BIOTECHNOL, V18, P862, DOI 10.1038/78475; Stepan AF, 2011, CHEM RES TOXICOL, V24, P1345, DOI 10.1021/tx200168d; Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479; LOHSE AW, 1990, HEPATOLOGY, V11, P24, DOI 10.1002/hep.1840110106; Jian WY, 2012, J AM SOC MASS SPECTR, V23, P964, DOI 10.1007/s13361-012-0354-6; Hirata K, 2008, PHARMACOGENOMICS J, V8, P29, DOI 10.1038/sj.tpj.6500442; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Kaniwa N, 2008, PHARMACOGENOMICS, V9, P1617, DOI 10.2217/14622416.9.11.1617; WHITCOMB DC, 1994, JAMA-J AM MED ASSOC, V272, P1845, DOI 10.1001/jama.272.23.1845; Ostapowicz G, 2002, ANN INTERN MED, V137, P947; Kobayashi M, 2012, J APPL TOXICOL, V32, P823, DOI 10.1002/jat.2731; Xu SY, 2005, DRUG METAB DISPOS, V33, P121, DOI 10.1124/dmd.104.001842; Sasaki E, 2013, TOXICOL SCI, V136, P250, DOI 10.1093/toxsci/kft184; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Blazka ME, 1996, TOXICOL PATHOL, V24, P181; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Higuchi S, 2012, J APPL TOXICOL, V32, P815, DOI 10.1002/jat.1706; Laine JE, 2011, TOXICOL IN VITRO, V25, P411, DOI 10.1016/j.tiv.2010.11.002; Kassahun K, 2001, CHEM RES TOXICOL, V14, P62, DOI 10.1021/tx000180q; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Masubuchi N, 2007, CHEM RES TOXICOL, V20, P455, DOI 10.1021/tx060234h; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Watanabe I, 2003, CLIN PHARMACOL THER, V73, P435, DOI 10.1016/S0009-9236(03)00014-6; Yamazaki H, 1999, DRUG METAB DISPOS, V27, P1260; Gan JP, 2009, CHEM RES TOXICOL, V22, P690, DOI 10.1021/tx800368n; Manthripragada AD, 2011, PHARMACOEPIDEM DR S, V20, P819, DOI 10.1002/pds.2090; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; DAVIS DC, 1974, LIFE SCI, V14, P2099, DOI 10.1016/0024-3205(74)90092-7; Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797; Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370; Higuchi S, 2011, TOXICOL LETT, V200, P139, DOI 10.1016/j.toxlet.2010.11.006; Mutlib A, 2005, RAPID COMMUN MASS SP, V19, P3482, DOI 10.1002/rcm.2223; Temple RJ, 2002, JAMA-J AM MED ASSOC, V287, P2273, DOI 10.1001/jama.287.17.2273; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Ikeda T, 2011, DRUG METAB PHARMACOK, V26, P60, DOI 10.2133/dmpk.DMPK-10-RV-090; Argoti D, 2005, CHEM RES TOXICOL, V18, P1537, DOI 10.1021/tx0501637; Zwingmann C, 2006, HEPATOLOGY, V43, P454, DOI 10.1002/hep.21075; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; Rousu T, 2009, RAPID COMMUN MASS SP, V23, P843, DOI 10.1002/rcm.3953; Dugan CM, 2011, TOXICOL SCI, V120, P507, DOI 10.1093/toxsci/kfr005; Lee SST, 1996, J BIOL CHEM, V271, P12063; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Zhang XC, 2011, DRUG METAB PHARMACOK, V26, P47, DOI 10.2133/dmpk.DMPK-10-RV-085; Yan ZY, 2005, RAPID COMMUN MASS SP, V19, P3322, DOI 10.1002/rcm.2195; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Smith MT, 2003, CHEM RES TOXICOL, V16, P679, DOI 10.1021/tx034033e; Stachulski AV, 2013, MED RES REV, V33, P985, DOI 10.1002/med.21273; Ishida Y, 2002, FASEB J, V16, DOI 10.1096/fj.02-0046com; Kaplowitz N, 2001, DRUG SAFETY, V24, P483, DOI 10.2165/00002018-200124070-00001; Mitchell MD, 2008, CHEM RES TOXICOL, V21, P859, DOI 10.1021/tx700344m; Uetrecht JP, 1999, CHEM RES TOXICOL, V12, P387, DOI 10.1021/tx980249i; Higuchi S, 2012, TOXICOL SCI, V130, P4, DOI 10.1093/toxsci/kfs222; Chen LJ, 1997, CHEM RES TOXICOL, V10, P866, DOI 10.1021/tx9700174; LOHSE AW, 1992, J HEPATOL, V14, P48, DOI 10.1016/0168-8278(92)90130-H; Bourdi M, 1996, CHEM RES TOXICOL, V9, P1159, DOI 10.1021/tx960083q; BURK RF, 1990, RES COMMUN CHEM PATH, V69, P115; Cheng LL, 2010, BIOCHEM PHARMACOL, V80, P255, DOI 10.1016/j.bcp.2010.03.025; Dieckhaus CM, 2005, CHEM RES TOXICOL, V18, P630, DOI 10.1021/tx049741u; Dugan CM, 2010, J PHARMACOL EXP THER, V333, P364, DOI 10.1124/jpet.109.164541; He K, 2004, DRUG METAB DISPOS, V32, P639, DOI 10.1124/dmd.32.6.639; Kakuni M, 2012, TOXICOL LETT, V214, P9, DOI 10.1016/j.toxlet.2012.08.001; Kawai K, 1997, ARZNEIMITTEL-FORSCH, V47, P356; Kenna J. Gerald, 1997, Journal of Hepatology, V26, P5; Kumar S, 2008, CURR OPIN DRUG DISC, V11, P43; Kuramoto K., 1998, J CLIN THER MED, V14, P461; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Maniratanachote R, 2005, TOXICOLOGY, V216, P15, DOI 10.1016/j.tox.2005.07.012; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Meneses-Lorente G, 2006, ANAL BIOCHEM, V351, P266, DOI 10.1016/j.ab.2006.01.016; Naritomi Yoichi, 2004, Drug Metab Pharmacokinet, V19, P55, DOI 10.2133/dmpk.19.55; Njoku D, 1997, ANESTH ANALG, V84, P173, DOI 10.1097/00000539-199701000-00031; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Prabhu S, 2002, CHEM-BIOL INTERACT, V142, P83, DOI 10.1016/S0009-2797(02)00056-X; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Schmidt LE, 2002, HEPATOLOGY, V35, P876, DOI 10.1053/jhep.2002.32148; Shenton JM, 2005, CHEM RES TOXICOL, V18, P1799, DOI 10.1021/tx0501132; Takakusa H, 2009, DRUG METAB PHARMACOK, V24, P100; Toda G., 1999, J CLIN ENDOCR METAB, V9, P393; Toyoda Y, 2001, LIFE SCI, V68, P1867, DOI 10.1016/S0024-3205(01)00985-7; Uetrecht J, 2001, Curr Opin Drug Discov Devel, V4, P55; VERGANI D, 1980, NEW ENGL J MED, V303, P66, DOI 10.1056/NEJM198007103030202; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Yamamoto Y, 2002, DRUG METAB DISPOS, V30, P155, DOI 10.1124/dmd.30.2.155; Zanin-Zhorov A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00211; Zhu XC, 2012, CHEM RES TOXICOL, V25, P1839, DOI 10.1021/tx300339u	94	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					567	578				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500006		
J	Oda, S; Yokoi, T				Oda, Shingo; Yokoi, Tsuyoshi			Establishment of Animal Models of Drug-induced Liver Injury and Analysis of Possible Mechanisms	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						cytochrome P450; drug development; drug metabolism; idiosyncratic drug-induced liver injury; reactive metabolite	INFLAMMATORY-RELATED FACTORS; IMMUNE-RELATED FACTORS; INDUCED HEPATOTOXICITY; METABOLIC-ACTIVATION; RISK-ASSESSMENT; GENOME-WIDE; MOUSE MODEL; PHASE-III; MICE; INVOLVEMENT	Drug-induced liver injury (DILI) is one of leading causes of attrition during both early and late stages of drug development and postmarketing. DILI is generally classified into the intrinsic and idiosyncratic types. Intrinsic DILI is dose dependent and predictable as exemplified by acetaminophen toxicity. However, the occurrence of idiosyncratic DILI with very low incidence and severe liver damage is difficult to predict because of the complex nature of DILI and poor understanding of its mechanism. In this review, we summarize current knowledge and our accumulated experimental findings on the pathogenic mechanisms of DILI focusing on the reactive metabolites of drugs formed by drug-metabolizing enzymes and immune- and inflammation-related responses. Considering drug metabolism and pharmacokinetics, we have established nonclinical animal models of DILI for 10 types of clinical drug known to cause idiosyncratic DILI in humans. Using animal models, it has been shown that the formation of reactive metabolites and both innate and adaptive immunity are involved in the pathogenesis of drug hepatotoxicity. Based on information on biomarkers obtained from animal models, we developed a cell-based system that predicts the potential DILI risks of drugs. The results of these studies increased our understanding of the mechanisms of DILI and help to predict and prevent idiosyncratic DILI caused by drug candidates.	[Oda, Shingo; Yokoi, Tsuyoshi] Nagoya Univ, Grad Sch Med, Dept Drug Safety Sci, Showa Ku, Nagoya, Aichi 4668550, Japan	Yokoi, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Drug Safety Sci, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tyokoi@med.nagoya-u.ac.jp					Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Yano A, 2012, TOXICOLOGY, V293, P107, DOI 10.1016/j.tox.2012.01.008; Usui T, 2009, DRUG METAB DISPOS, V37, P2383, DOI 10.1124/dmd.109.028860; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Kobayashi E, 2009, TOXICOL SCI, V111, P302, DOI 10.1093/toxsci/kfp165; Wuillemin N, 2013, J IMMUNOL, V190, P4956, DOI 10.4049/jimmunol.1202949; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Hirata K, 2008, PHARMACOGENOMICS J, V8, P29, DOI 10.1038/sj.tpj.6500442; Hosomi H, 2011, DRUG METAB DISPOS, V39, P1388, DOI 10.1124/dmd.110.037077; Kobayashi M, 2012, J APPL TOXICOL, V32, P823, DOI 10.1002/jat.2731; Yano A, 2014, TOXICOL LETT, V228, P13, DOI 10.1016/j.toxlet.2014.04.005; Sasaki E, 2013, TOXICOL SCI, V136, P250, DOI 10.1093/toxsci/kft184; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Shaw PJ, 2010, TOXICOL SCI, V118, P7, DOI 10.1093/toxsci/kfq168; Higuchi S, 2012, J APPL TOXICOL, V32, P815, DOI 10.1002/jat.1706; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; Walgren JL, 2005, CRIT REV TOXICOL, V35, P325, DOI 10.1080/10408440590935620; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797; Higuchi S, 2011, TOXICOL LETT, V200, P139, DOI 10.1016/j.toxlet.2010.11.006; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Kaplowitz N, 2001, DRUG SAFETY, V24, P483, DOI 10.2165/00002018-200124070-00001; Matsuo K, 2014, TOXICOL LETT, V224, P215, DOI 10.1016/j.toxlet.2013.10.025; Higuchi S, 2012, TOXICOL SCI, V130, P4, DOI 10.1093/toxsci/kfs222; Iwamura A, 2011, DRUG METAB DISPOS, V39, P838, DOI 10.1124/dmd.110.037259; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bail lie T. A., 2003, CHEM REACTIVE METABO; Bourdi M, 1996, CHEM RES TOXICOL, V9, P1159, DOI 10.1021/tx960083q; Buchweitz JP, 2002, J PHARMACOL EXP THER, V300, P460, DOI 10.1124/jpet.300.2.460; Deng XM, 2006, J PHARMACOL EXP THER, V319, P1191, DOI 10.1124/jpet.106.110247; Kobayashi M, 2010, TOXICOLOGY, V275, P50, DOI 10.1016/j.tox.2010.05.011; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li JZ, 2010, J IMMUNOTOXICOL, V7, P157, DOI 10.3109/15476910903501748; Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338; Persson M, 2014, BASIC CLIN PHARMACOL, V115, P18, DOI 10.1111/bcpt.12200; Takai S, 2015, J APPL TOXICOL, V35, P142, DOI 10.1002/jat.3002; Tsutani K., 2007, FARUMASHIA, V43, P1097; Uetrecht J., 2003, CYTOCHROME P4K0 OTHE, P87; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425; Zou W, 2009, TOXICOL SCI, V108, P184, DOI 10.1093/toxsci/kfn259	44	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					579	588				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500007		
J	Saito, Y; Kodama, S; Sugiyama, E; Nakamura, R				Saito, Yoshiro; Kodama, Susumu; Sugiyama, Emiko; Nakamura, Ryosuke			Predictive Genomic Markers for Severe Adverse Drug Reactions	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						drug-induced liver injury; ethnic difference; genomic biomarker; Stevens-Johnson syndrome; toxic epidermal necrolysis	STEVENS-JOHNSON SYNDROME; INDUCED LIVER-INJURY; JAPANESE PATIENTS; T-CELLS; HYPERSENSITIVITY; HEPATOTOXICITY; ASSOCIATION; WIDE; HLA-A-ASTERISK-3101; SUSCEPTIBILITY	Severe adverse drug reactions are an important issue to be considered during proper drug usage in postmarketing period. Most severe adverse reactions are idiosyncratic and unrelated to their pharmacological actions via primary targets. Although these reactions were not predictable, recent developments in the field of genomics have revealed closely associated markers responsible for some severe adverse reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). This review demonstrates genomic biomarkers for SJS/TEN and drug-induced liver injury (DILI) that were found mainly in Japanese patients and reveal ethnic differences. We and other groups have found the following associations of SJS/TEN with susceptible drugs: 1) HLA-B*58:01 for allopurinol-related cases; 2) HLA-B*15:11 and HLA-A*31:01 for carbamazepine-related cases; 3) HLA-B*51:01 for phenobarbital-related cases; 4) HLA-A*02:07 for zonisamide-related cases; 5) CYP2C9*3 for phenytoin-related cases; and 6) HLA-A*02:06 for cold medicine-related cases. The allele frequencies of these related HLA types vary among Asian populations. In addition, direct (non-covalent) binding of carbamazepine or an allopurinol metabolite, oxypurinol, to the associated HLA-type proteins was suggested. Associated genomic biomarkers are also summarized for DILI in Japanese and Caucasian populations. The application of these genomic biomarkers to prevent the onset of a reaction has been utilized in a few countries. However, in Japan, the package inserts only contain precautions that cite the research findings. To overcome this limitation, the following points should be addressed: 1) factors responsible for the development of SJS/TEN should be identified in addition to the above-mentioned HLA alleles; and 2) an inexpensive genotyping strategy and assay methods should be developed to provide a pharmacoeconomical viewpoint. Further research on severe adverse reactions is warranted.	[Saito, Yoshiro; Kodama, Susumu; Sugiyama, Emiko; Nakamura, Ryosuke] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo 1588501, Japan	Saito, Y (reprint author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Kamiyoga 1-18-1, Tokyo 1588501, Japan.	yoshiro@nihs.go.jp					Kaniwa N, 2013, PHARMACOGENOMICS, V14, P1821, DOI 10.2217/pgs.13.180; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Yun J, 2013, CLIN EXP ALLERGY, V43, P1246, DOI 10.1111/cea.12184; Hirata K, 2008, PHARMACOGENOMICS J, V8, P29, DOI 10.1038/sj.tpj.6500442; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Kaniwa N, 2013, J HUM GENET, V58, P317, DOI 10.1038/jhg.2013.37; Chung WH, 2014, JAMA-J AM MED ASSOC, V312, P525, DOI 10.1001/jama.2014.7859; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Kim SH, 2011, EPILEPSY RES, V97, P190, DOI 10.1016/j.eplepsyres.2011.08.010; Ariyoshi N, 2010, DRUG METAB PHARMACOK, V25, P298; Yun J, 2014, J IMMUNOL, V192, P2984, DOI 10.4049/jimmunol.1302306; Kashiwagi M, 2008, J DERMATOL, V35, P683, DOI 10.1111/j.1346-8138.2008.00548.x; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Watanabe I, 2003, CLIN PHARMACOL THER, V73, P435, DOI 10.1016/S0009-9236(03)00014-6; Kazeem GR, 2009, PHARMACOGENET GENOM, V19, P661, DOI 10.1097/FPC.0b013e32832c347d; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Kaniwa Nahoko, 2013, Ther Adv Drug Saf, V4, P246, DOI 10.1177/2042098613499791; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					589	595				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500008		
J	Tsuda, M				Tsuda, Masaaki			Gene Regulation Involved in the Formation of Long-term Memory	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						fibroin; enhancer; transcription; brain-derived neurotrophic factor; activity-regulated cytoskeleton-associated protein	CYCLASE-ACTIVATING POLYPEPTIDE; NEUROTROPHIC FACTOR GENE; MESSENGER-RNA STABILIZATION; RAT CORTICAL-NEURONS; FIBROIN GENE; ADENYLATE-CYCLASE; CRITICAL PERIOD; BDNF GENE; PYRETHROID INSECTICIDE; PROMOTER-I	My former research focused on silk fibroin gene transcription. The in vivo transcription initiation site of the fibroin gene, which is similar to the site corresponding to the 5'-terminal of mature fibroin mRNA, was determined. By developing a cell-free transcription system prepared from silk glands, it was found that the upstream region of the fibroin gene is responsible for efficient transcription initiation, which has enhancer-like features. More recent research has switched my focus to cellular neurobiology to understand the molecular mechanisms of long-term memory at the level of gene expression in terms of cell differentiation. I first developed an experimental system to analyze promoter activity in primary cultured neuronal cells. Particularly focusing on the transcription regulation of the brain-derived neurotrophic factor (BDNF) gene (Bdnf), I found that the interaction of the cAMP response element-binding protein (CREB) with the CRE sequence is important for the activity-dependent activation of the Bdnf promoter. In addition, this activity-dependent transcriptional regulation occurs in cultured neurons stimulated with excitatory GABAergic inputs, which plays a critical role in promoting the step of neuronal differentiation. Finally, I found that stimulation of the G-protein coupled receptor (GPCR) effectively activates Bdnf promoter IV through selective activation of the calcineurin pathway, irrespective of the type of GPCR if the protein kinase A or C pathway is activated. This induction mechanism appears important to understand intracellular mechanisms evoked via simultaneous neurotransmission of excitatory and modulatory inputs into neurons of the brain.	Toyama Univ, Grad Sch Med & Pharmaceut Sci, Mol Neurobiol Lab, Toyama 9300194, Japan	Tsuda, M (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Mol Neurobiol Lab, 2630 Sugitani, Toyama 9300194, Japan.	tsuda@pha.u-toyama.ac.jp					Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Matsuya Y, 2012, BIOORGAN MED CHEM, V20, P2564, DOI 10.1016/j.bmc.2012.02.048; Hara D, 2009, BIOCHEM BIOPH RES CO, V384, P506, DOI 10.1016/j.bbrc.2009.05.007; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Fukuchi M, 2004, J BIOL CHEM, V279, P47856, DOI 10.1074/jbc.M409090200; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ishimaru N, 2007, J NEUROCHEM, V100, P520, DOI 10.1111/j.1471-4159.2006.04216.x; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Young D, 1999, NAT MED, V5, P448; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Imamura L, 2006, J PHARMACOL EXP THER, V316, P136, DOI 10.1124/jpet.105.092478; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Ihara D, 2012, NEUROPHARMACOLOGY, V62, P1091, DOI 10.1016/j.neuropharm.2011.10.023; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Fukuchi M., J NEUROSCI IN PRESS; Fukuchi M., J BIOL CHEM IN PRESS; Fukuchi M, 2010, J NEUROCHEM, V115, P1222, DOI 10.1111/j.1471-4159.2010.07016.x; Fukuchi M, 2014, J NEUROCHEM, V131, P134, DOI 10.1111/jnc.12801; Hara D., 2009, BIOCHEM BIOPH RES CO, V394, P173; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Sano K, 1996, BIOCHEM BIOPH RES CO, V229, P788, DOI 10.1006/bbrc.1996.1881; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Tabuchi A, 1998, BIOCHEM BIOPH RES CO, V253, P818, DOI 10.1006/bbrc.1998.9854; Takasaki I, 2013, BEHAV BRAIN RES, V257, P182, DOI [10.1016/j.bbr.2013.09.044, 10.1016/j.bbr.2013.09.04]; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TSUDA M, 1982, J BIOL CHEM, V257, P2367; TSUDA M, 1978, J BIOCHEM-TOKYO, V84, P1285; Tsuda M., 1983, CELL TECHNOLOGY, V2, P498; TSUDA M, 1979, P NATL ACAD SCI USA, V76, P4872, DOI 10.1073/pnas.76.10.4872; TSUDA M, 1983, P NATL ACAD SCI-BIOL, V80, P7442, DOI 10.1073/pnas.80.24.7442; TSUDA M, 1981, CELL, V27, P175, DOI 10.1016/0092-8674(81)90371-8; TSUDA M, 1986, MOL CELL BIOL, V6, P3928; TSUJIMOTO Y, 1981, P NATL ACAD SCI-BIOL, V78, P4838, DOI 10.1073/pnas.78.8.4838; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	55	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					597	617				21	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500009		
J	Kawakami, J				Kawakami, Junichi			Clinical Pharmacology and Pharmacoepidemiology for Medication Safety in Clinical Settings	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						clinical pharmacology; pharmacoepidemiology; hospital pharmacy; cancer pain; hospital information database; medication safety	PLASMA EXPOSURE; CONTAMINATION; OXYCODONE; DATABASE; JAPAN	In this review, optimization of individualized analgesic therapy in cancer-pain patients (1), pharmacoepidemiological studies using a hospital database (DB) (2), and other clinical and practical research studies (3) were summarized. (1) The aim of the analgesic study was to evaluate individual factors in the effects of pain-relief, and ADR of analgesics from the viewpoints of clinical pharmacokinetics and pharmacodynamics. Oxycodone, fentanyl, and gabapentin were used. For the dose escalation and ADR of oxycodone, the plasma disposition of noroxycodone regulated by CYP3A5 polymorphisms and cancer cachexia were found to be individual factors. The ADR and clinical response of fentanyl were affected by polymorphisms of CYP3A5 and ABCB1. In the pharmacokinetics of gabapentin, concomitant magnesium oxide reduced the intestinal absorption of gabapentin. (2) The aim of the DB study was to demonstrate a pharmacoepidemiological advantage using a hospital DB of a million-scale for post-marketing safety management. We tried to detect fluoroquinolone (FQ) -induced tendon disorders, because its risk ratio in Japan has not been clarified. The risk of a tendon disorder in FQ-prescribed patients was 0.082% (95 %CI: 0.049-0.137%), and significantly higher than that in cephalosporin-prescribed patients. The risk ratio in FQ-prescribed patients in relation to cephalosporin-prescribed patients was 6.29 (95% CI: 2.27-17.46). (3) Individual variation of plasma exposure of free linezolid and its ratio to minimum inhibitory concentration in critically ill patients, as well as three other studies, were described. In conclusion, our achievement in accurately assessing these would contribute to medication safety and the appropriate use of medicines in clinical settings.	Hamamatsu Univ Sch Med, Dept Hosp Pharm, Hamamatsu, Shizuoka 4313192, Japan	Kawakami, J (reprint author), Hamamatsu Univ Sch Med, Dept Hosp Pharm, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kawakami-ham@umin.ac.jp					Takashina Y, 2012, DRUG METAB PHARMACOK, V27, P414, DOI 10.2133/dmpk.DMPK-11-RG-134; Naito T, 2011, J CLIN PHARMACOL, V51, P1529, DOI 10.1177/0091270010388033; Hanatani T, 2014, J CLIN PHARM THER, V39, P361, DOI 10.1111/jcpt.12153; Hanatani T, 2013, J CLIN PHARM THER, V38, P423, DOI 10.1111/jcpt.12083; Hori K, 2012, PHARMACOEPIDEM DR S, V21, P886, DOI 10.1002/pds.3285; Matsumoto K, 2010, YAKUGAKU ZASSHI, V130, P431, DOI 10.1248/yakushi.130.431; Naito T., J HUM LACT IN PRESS; Naito T, 2012, BIOL PHARM BULL, V35, P2043; Naito T, 2013, J CLIN PHARMACOL, V53, P812, DOI 10.1002/jcph.112; Yagi T, 2013, INT J ANTIMICROB AG, V42, P329, DOI 10.1016/j.ijantimicag.2013.06.015; Yagi T, 2012, DRUG METAB PHARMACOK, V27, P248, DOI 10.2133/dmpk.DMPK-11-RG-108	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					619	624				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500010		
J	Kamiya, S				Kamiya, Seitaro			Preparation and Physicochemical Study of the Preservation of Nanoparticles	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						nanoparticle; saccharide; freeze-drying; normal-drying; mechanism	LIPID NANOPARTICLES; SUSPENSION; MECHANISM; STABILITY	The importance of nanoparticle formulation is increasingly recognized in supporting pharmaceutical development. Thus, maintaining nanoparticles in a constant state is a major issue. A method involving lyophilization with the addition of saccharides can be used to maintain the steady state of nanoparticles. In this study, trisaccharides, tetrasaccharides, and pentasaccharides were added to nanoparticle suspensions, followed by rehydration of the samples, which had been either dried normally or freeze-dried. The particle size after rehydration was measured. In addition, each powder was measured using a powder X-ray diffractometer and thermal analysis device to investigate the correlation between the nanoparticles' aggregation and the crystal form of saccharides. The diameter of the nanoparticles was maintained when it was freeze-dried, while particle aggregation occurred when normally dried samples were used. In addition, crystalline saccharide was not observed in the freeze-dried group, but did appear in the normally dried group.	Nagasaki Int Univ, Fac Pharmaceut Sci, Div Pharmaceut Technol, Sasebo, Nagasaki 8593298, Japan	Kamiya, S (reprint author), Nagasaki Int Univ, Fac Pharmaceut Sci, Div Pharmaceut Technol, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 8593298, Japan.	kamiya@niu.ac.jp					Kamiya S, 2014, INT J PHARMACEUT, V465, P97, DOI 10.1016/j.ijpharm.2014.02.033; Devi S, 2013, J PHARM SCI-US, V102, P4246, DOI 10.1002/jps.23736; Kamiya S, 2006, CHEM PHARM BULL, V54, P181, DOI 10.1248/cpb.54.181; Kamiya S, 2008, INT J PHARM, V354, P242, DOI 10.1016/j.ijpharm.2007.10.049; Kamiya S, 2009, DRUG DEV IND PHARM, V35, P1022, DOI 10.1080/03639040802698786; Kamiya S, 2010, EUR J PHARM BIOPHARM, V74, P461, DOI 10.1016/j.ejpb.2009.12.004; Niederquell A, 2013, INT J PHARMACEUT, V446, P70, DOI 10.1016/j.ijpharm.2013.02.005; Rampino A, 2013, INT J PHARMACEUT, V455, P219, DOI 10.1016/j.ijpharm.2013.07.034; Wang YJ, 2007, J PHARM PHARMACOL, V59, P351, DOI 10.1211/jpp.59.3.0003	9	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					625	630				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500011		
J	Sato, Y; Sugaya, N; Nakagawa, T; Morita, M				Sato, Yoshiki; Sugaya, Naeko; Nakagawa, Tomoo; Morita, Masatoshi			Analysis of Phthalates in Aromatic and Deodorant Aerosol Products and Evaluation of Exposure Risk	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						phthalate; aerosol product; ultra high performance liquid chromatography; risk evaluation	CONSUMER COSMETIC PRODUCTS; LIQUID-CHROMATOGRAPHY; BISPHENOL-A; ESTERS; MICROEXTRACTION	We established an analytical method for the detection of seven phthalates, dimethyl phthalate, diethyl phthalate (DEP), benzyl butyl phthalate, di-i-butyl phthalate, dibutyl phthalate (DBP), diethylhexyl phthalate (DEHP), and di-n-octhyl phthalate, using an ultra high performance liquid chromatograph equipped with a photodiode array detector. This method is quick, with minimal contamination, and was applied to the analysis of aromatic and deodorant aerosol products. Phthalates were detected in 15 of 52 samples purchased from 1999 to 2012 in Yokohama. Three types of phthalate (DEP, DBP, DEHP) were detected, and their concentrations ranged from 0.0085-0.23% DEP in nine samples, 0.012-0.045% DBP in four samples, and 0.012-0.033% DEHP in four samples. No other phthalate esters were detected. Furthermore, we estimated phthalate exposure via breathing in commonly used aromatic and deodorant aerosol products, then evaluated the associated risk. The estimated levels of phthalate exposure were lower than the tolerated daily limit, but the results indicated that aromatic and deodorant aerosol products could be a significant source of phthalate exposure.	[Sato, Yoshiki; Sugaya, Naeko] Yokohama City Inst Publ Hlth, Kanazawa Ku, Yokohama, Kanagawa 2360051, Japan; [Nakagawa, Tomoo] Ctr Analyt Qual Control Environm, Tsukuba, Ibaraki 3050061, Japan; [Morita, Masatoshi] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Sato, Y (reprint author), Yokohama City Inst Publ Hlth, Kanazawa Ku, 2-7-1 Tomiokahigashi, Yokohama, Kanagawa 2360051, Japan.	yo46-satou@city.yokohama.jp					Ablat M., 2013, INDOOR ENVIRON, V16, P3; Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI 2 ETH PH; Agency for Toxic Substances and Disease Registry, 2001, TOX PROF DI N BUT PH; Agency for Toxic Substances and Disease Registry, 1997, TOX PROF DI N OCT; Agency for Toxic Substances and Disease Registry, 1995, TOX PROF DIETH PHTHA; Koniecki D, 2011, ENVIRON RES, V111, P329, DOI 10.1016/j.envres.2011.01.013; Fan YY, 2014, TALANTA, V119, P291, DOI 10.1016/j.talanta.2013.11.023; De Orsi D, 2006, ANAL CHIM ACTA, V555, P238, DOI 10.1016/j.aca.2005.09.029; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Bouma K, 2002, FOOD ADDIT CONTAM, V19, P602, DOI 10.1080/02652030210125137; Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Shen HY, 2007, J SEP SCI, V30, P48, DOI 10.1002/jssc.200600215; Hubinger JC, 2006, J COSMET SCI, V57, P127; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091; David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a; EFSA, 2005, EFSA J, V243, P1; European Food Safety Authority (EFSA), 2005, EFSA J, V242, P1; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039008; Hubinger JC, 2010, J COSMET SCI, V61, P457; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b; Li SQ, 2013, ANAL BIOANAL CHEM, V405, P4307, DOI 10.1007/s00216-013-6792-6; National Institute of Technology and Evaluation Chemical Management Center, 2008, GUID CONS PROD RISK; Oka H., 2004, JPN J FOOD CHEM, V11, P106; Peters R. J. B., R2005011 TNO R IA; Pharmaceutical and Food Safety Bureau Ministry of Health Labour and Welfare, 2002, NOT NO 0207002; Saito I., 2002, J SOC INDOOR ENV JPN, V5, P13; Silva M. J., 2004, ENV HLTH PERSPECT, V112, P311; Sugaya N., 2011, J ENV CHEM, V21, P169; WHO, 2003, 52 WHO	34	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					631	642				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500012		
J	Goto, H; Tomita, T; Doki, S; Nakanishi, R; Kojima, C; Yoneshima, M; Yoshida, T; Tanaka, K; Kohda, Y				Goto, Hidekazu; Tomita, Takashi; Doki, Shotaro; Nakanishi, Rie; Kojima, Chikako; Yoneshima, Mihoko; Yoshida, Tadashi; Tanaka, Katsuya; Kohda, Yukinao			Elevated Serum Lithium Concentration Due to Switch from Parenteral Nutrition Alone to Parenteral with Enteral Nutrition	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						lithium; drug-level monitoring; sodium chloride intake; parenteral nutrition; enteral nutrition		We report a patient with elevated serum lithium concentration caused by switching from parenteral nutrition alone to parenteral with enteral nutrition. A 73-year-old female inpatient was treated with lithium carbonate 600 mg/d for manic episodes of bipolar disorder. Her serum lithium level was maintained at 0.57-0.79 mEq/L. She was administered total parenteral nutrition owing to difficulty in oral intake. Her diet contained 4.8-5.8 g/d of sodium chloride. After this, parenteral with enteral nutrition was initiated. The total sodium chloride intake decreased from 6.3 to 3.0-4.0 g/d following this change. On day 15 after initiation of parenteral with enteral nutrition, her serum lithium level increased to 1.17 mEq/L, which is closer to the upper therapeutic range limit. Therefore enteral nutrition was stopped immediately, and an electrolyte solution was administered instead of enteral nutrition. An antibiotic agent was also simultaneously administered because of infection. The total amount of sodium chloride administered was increased to 7.0 g/d during this treatment. Four days after treatment, the serum lithium level returned to 0.57 mEq/L. This case suggests that administration of appropriate sodium chloride nutrition is important during treatment with lithium carbonate, because disposition of lithium ion is paralleled to that of sodium.	[Goto, Hidekazu; Tomita, Takashi; Nakanishi, Rie; Kojima, Chikako; Yoneshima, Mihoko; Kohda, Yukinao] Hosp Bando, Dept Pharm, Bando, Ibaraki 3060515, Japan; [Doki, Shotaro; Tanaka, Katsuya] Hosp Bando, Dept Psychiat, Bando, Ibaraki 3060515, Japan; [Yoshida, Tadashi] Hosp Bando, Dept Internal Med, Bando, Ibaraki 3060515, Japan; [Kohda, Yukinao] Tsukuba Int Univ, Fac Hlth Sci, Tsuchiura, Ibaraki 3000051, Japan	Tomita, T (reprint author), Hosp Bando, Dept Pharm, 411 Kutsukake, Bando, Ibaraki 3060515, Japan.	t.tomita@hpbando.jp					[Anonymous], 2012, PACK INS LIMAS TAB 1; Ministry of Health Labour and Welfare, 2015, DIET REF INT JAP 201; Sasaki M., 2012, J JPN SOC PARENTERAL, V27, P637; Sawada Y., 1999, MED DRUG J, V35, P2896; THOMSEN K, 1968, AM J PHYSIOL, V215, P823; Thomsen K, 1999, PHARMACOPSYCHIATRY, V32, P83, DOI 10.1055/s-2007-979199	6	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	2015	135	4					643	646				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VR	WOS:000352050500013		
J	Phan, QT; Sasamoto, A; Hayashi, F				Quoc Toan Phan; Sasamoto, Akihiko; Hayashi, Fumio			Description of two new species of the genus Devadatta from northern Vietnam and central Laos (Odonata: Devadattidae)	ZOOTAXA			English	Article						Odonata; Devadattidae; Devadatta; new species; Vietnam; Laos		Two new species of the genus Devadatta Kirby, 1890, D. kompieri sp. nov. from northern Vietnam (holotype: male, Mu Cang Chai district, Yen Bai Province) and D. yokoii sp. nov. from central Laos (holotype: male, Vang Vieng, Vientiane Province) are described. These new species are allied to D. ducatrix Lieftinck, 1969, but are distinguished by specific characteristics of their wings and anal appendages. The other Indochinese species are also briefly discussed.	[Quoc Toan Phan; Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol, Hachioji, Tokyo 1920397, Japan	Phan, QT (reprint author), Tokyo Metropolitan Univ, Dept Biol, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	pqtoan84@gmail.com; akssmt@sea.plala.or.jp; fhayashi@tmu.ac.jp					Dijkstra KDB, 2014, SYST ENTOMOL, V39, P68, DOI 10.1111/syen.12035; Dow Rory A., 2012, International Dragonfly Fund Report, V54, P1; Fraser F.C, 1933, J SIAM SOC NATURAL S, P109; Hamalainen M., 2006, TOMBO, V48, P1; Kitagawa K., 2013, AESCHNA, V49, P47; LAIDLAW F. F., 1934, STYLOPS, V3, P99; LIEFTINCK M A, 1969, Deutsche Entomologische Zeitschrift, V16, P205; Sasamoto A, 2003, ODONATOLOGICA, V32, P381; Yokoi Naoto, 1999, Gekkan-Mushi, V342, P2	9	1	1	MAGNOLIA PRESS	AUCKLAND	PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND	1175-5326	1175-5334		ZOOTAXA	Zootaxa	APR 1	2015	3941	3					414	420				7	Zoology	Zoology	CE8OJ	WOS:000352102400007		
J	Matsukawa, H; Fujii, M; Uemura, A; Suzuki, K; Yamamoto, D; Takahashi, O; Niimi, Y				Matsukawa, H.; Fujii, M.; Uemura, A.; Suzuki, K.; Yamamoto, D.; Takahashi, O.; Niimi, Y.			Pathology of embolic debris in carotid artery stenting	ACTA NEUROLOGICA SCANDINAVICA			English	Article						carotid artery stenting; debris; pathology; plaque imaging	US NATIONWIDE TRENDS; CEREBRAL PROTECTION; FILTER DEVICE; PLAQUE; ANGIOPLASTY; STENOSIS; LESIONS; PLACEMENT; ISCHEMIA; REVASCULARIZATION	Background - The relationship between magnetic resonance (MR) plaque imaging and the pathology of distal embolic debris is unknown. We aimed to evaluate the relationship between the pathology of embolic debris in the embolic filter during carotid artery stenting (CAS), MR plaque imaging, and new ischemic lesions on diffusion-weighted imaging (DWI). Method - We prospectively reviewed the 36 patients who underwent CAS using a filter-type embolic protection device. Pathology of debris was categorized into thrombosis, inflammatory cells, elastic fiber, and calcification. We compared the clinical parameters, MR plaque imaging, and pathological characteristics of the embolic debris retained in the filter during CAS on univariate analysis. Results - Eleven patients had and 25 patients did not have new lesion on DWI. All of DWI-high lesions were identified in affected side middle cerebral artery territory. Embolic debris was microscopically confirmed in 28 patients (78%); thrombosis in 11 (31%), inflammatory cells in 13 (36%), elastic fiber in 12 (33%), and calcification in 9 (25%). Proportion of asymptomatic carotid stenosis, intra-operative bradycardia/hypotension, and inflammatory cells of debris were significantly higher in patients with new DWI-high lesions. There was no significant relationship between the pathological characteristics and MR plaque imaging of distal embolic debris. Conclusions - Our study showed that new DWI-high lesions might be influenced by types of debris in the filter. The need for future studies specifically examine the association of pathology of debris and findings of MR plaque imaging with new DWI-high lesions during CAS is emphasized.	[Matsukawa, H.; Fujii, M.; Yamamoto, D.] St Lukes Int Hosp, Dept Neurosurg, Tokyo 1048560, Japan; [Uemura, A.; Niimi, Y.] St Lukes Int Hosp, Dept Neuroendovasc Therapy, Tokyo 1048560, Japan; [Suzuki, K.] St Lukes Int Hosp, Dept Pathol, Tokyo 1048560, Japan; [Takahashi, O.] St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Tokyo 1048560, Japan	Matsukawa, H (reprint author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	nowornever1982@gmail.com			Japan Heart Foundation Young Investigator's Research Grant; St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research	This study was supported by the Japan Heart Foundation Young Investigator's Research Grant 2012 and St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research 2012.	Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421; Yamada K, 2011, ATHEROSCLEROSIS, V215, P399, DOI 10.1016/j.atherosclerosis.2011.01.002; Angelini A, 2002, STROKE, V33, P456, DOI 10.1161/hs0202.102337; Macdonald S, 2010, CEREBROVASC DIS, V29, P282, DOI 10.1159/000275505; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; STREIFLER JY, 1994, STROKE, V25, P1130; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Faggioli G, 2009, J VASC SURG, V49, P80, DOI 10.1016/j.jvs.2008.08.014; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yamada K, 2011, CEREBROVASC DIS, V32, P106, DOI 10.1159/000328231; Topol EJ, 2000, CIRCULATION, V101, P570; Choi JH, 2014, ACTA NEUROL SCAND, V129, P94, DOI 10.1111/ane.12152; Choi JH, 2014, ACTA NEUROL SCAND, V129, P85, DOI 10.1111/ane.12163; Finol EA, 2008, J ENDOVASC THER, V15, P177, DOI 10.1583/07-2272.1; Giannakopoulos TG, 2012, EUR J VASC ENDOVASC, V43, P627, DOI 10.1016/j.ejvs.2012.03.004; Henry M, 1999, J ENDOVASC SURG, V6, P321, DOI 10.1583/1074-6218(1999)006<0321:CSWCPF>2.0.CO;2; Hsu LC, 2013, ACTA NEUROL SCAND, V127, P46, DOI 10.1111/j.1600-0404.2012.01679.x; Jaeger HJ, 2002, AM J NEURORADIOL, V23, P200; Maleux G, 2006, AM J NEURORADIOL, V27, P1830; Martin JB, 2001, STROKE, V32, P479; Roffi M, 2008, J ENDOVASC THER, V15, P103, DOI 10.1583/07-2252.1; Rosenkranz M, 2011, CEREBROVASC DIS, V32, P163, DOI 10.1159/000328883; Rosenkranz M, 2009, CEREBROVASC DIS, V27, P443, DOI 10.1159/000209239; Schluter M, 2003, J AM COLL CARDIOL, V42, P1007, DOI 10.1016/S0735-1097(03)00901-X; Sorimachi T, 2011, AM J NEURORADIOL, V32, P288, DOI 10.3174/ajnr.A2276; Sorimachi T, 2011, ACTA NEUROCHIR, V153, P2159, DOI 10.1007/s00701-011-1093-3; Sorimachi T, 2010, NEUROSURGERY, V67, P1260, DOI 10.1227/NEU.0b013e3181ef5e85; Theron JG, 1996, RADIOLOGY, V201, P627; van Heesewijk HPM, 2002, RADIOLOGY, V224, P361, DOI 10.1148/radiol.2242011302; van Laanen JHH, 2013, J THORAC CARDIOV SUR, V146, P492, DOI 10.1016/j.jtcvs.2013.03.024; Veselka J, 2007, CIRC J, V71, P1468, DOI 10.1253/circj.71.1468; Williams DO, 2001, CIRCULATION, V104, P2, DOI 10.1161/hc2601.093272	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2015	131	4					197	202		10.1111/ane.12303		6	Clinical Neurology	Neurosciences & Neurology	CD5YS	WOS:000351165300001		
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Murakata, A				Matsukawa, H.; Shinoda, M.; Fujii, M.; Takahashi, O.; Murakata, A.			Risk factors for mortality in patients with non-traumatic pontine hemorrhage	ACTA NEUROLOGICA SCANDINAVICA			English	Article						mortality; predictor; pontine hemorrhage	BRAIN-STEM; CLINICAL-MANIFESTATIONS; 30-DAY MORTALITY; PREDICTORS	Objectives - For patients with non-traumatic pontine hemorrhage (PH) who will survive, determining prognosis is vital for appropriate therapeutic planning in the acute stage. This study aimed to determine reliable prognostic factors of mortality in patients with PH. Materials and methods - The cases of a total of 118 consecutive PH patients were reviewed. We compared clinical and radiological characteristics between patients who died and survivors by the log-rank test and performed multivariate analysis by the Cox proportional hazards model using variables that were marginally or significantly associated with PH-related death on the log-rank test (P < 0.20). Results - The median length of follow-up was 51 days (interquartile range: 7-742 days). Sixty-six patients (56%) died and 52 (44%) survived during follow-up period. Multivariate analysis showed that Glasgow Coma Scale score < 9, hyperthermia (a core temperature of >= 39 degrees C), maximum hematoma diameter more than 27 mm, and hematoma extension to midbrain and/or thalamus were significantly related to PH-related death. The Kaplan-Meier method showed that patients without these four factors had successively longer period at PH-related death (21 patients without factors: mean 2900 days; 97 patients with at least one of four factors: mean 820 days). Conclusions - Promptly identifying PH patients who are most likely die is important. The decision to stop life support in patients with PH is difficult, but factors, which are shown in this study, may be used to determine the level of care.	[Matsukawa, H.; Shinoda, M.; Fujii, M.; Murakata, A.] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, O.] St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Chuo Ku, Tokyo 1048560, Japan	Matsukawa, H (reprint author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	nowornever1982@gmail.com			St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research; Smoking Research Foundation	This article was supported by St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research 2011 and a grant from the Smoking Research Foundation 2011.	KYOSHIMA K, 1993, J NEUROSURG, V78, P987, DOI 10.3171/jns.1993.78.6.0987; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Balci K, 2005, CLIN NEUROL NEUROSUR, V108, P36, DOI 10.1016/j.clineuro.2005.02.007; CHUNG CS, 1992, NEUROLOGY, V42, P830; DELBRUTTO OH, 1987, STROKE, V18, P954; Dziewas R, 2003, CEREBROVASC DIS, V16, P224, DOI 10.1159/000071120; Erickson TC, 1939, BRAIN, V62, P172, DOI 10.1093/brain/62.2.172; GOTO N, 1980, STROKE, V11, P84; Huang KB, 2012, EUR J NEUROL, V19, P1245, DOI 10.1111/j.1468-1331.2012.03724.x; Jang JH, 2011, J KOREAN MED SCI, V26, P100, DOI 10.3346/jkms.2011.26.1.100; Jeong JH, 2002, STROKE, V33, P925, DOI 10.1161/01.STR.0000013563.73522.CB; KASE CS, 1980, NEUROLOGY, V30, P652; KUSHNER MJ, 1985, NEUROLOGY, V35, P637; Ma M, 2013, J NEUROL SCI, V15, P75; Cordeiro IM, 2013, CEREBROVASC DIS, V36, P153, DOI 10.1159/000352063; Murata Y, 1999, J NEUROL SCI, V167, P107, DOI 10.1016/S0022-510X(99)00150-1; NAKAYAMA T, 1969, J APPL PHYSIOL, V27, P848; OCHIAI C, 1979, Brain and Nerve (Tokyo), V31, P803; PORTENOY RK, 1985, ARCH NEUROL-CHICAGO, V42, P85; Rabinstein AA, 2004, CEREBROVASC DIS, V17, P66, DOI 10.1159/000073900; Wakayama A, 1986, Neurol Med Chir (Tokyo), V26, P323, DOI 10.2176/nmc.26.323; WEISBERG LA, 1986, J NEUROL NEUROSUR PS, V49, P346, DOI 10.1136/jnnp.49.4.346; Wessels T, 2004, AM J NEURORADIOL, V25, P257; Wijdicks EFM, 1997, NEUROLOGY, V49, P1342; Yagura H, 2007, CEREBROVASC DIS, V24, P369, DOI 10.1159/000106984	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2015	131	4					240	245		10.1111/ane.12312		6	Clinical Neurology	Neurosciences & Neurology	CD5YS	WOS:000351165300007		
J	van Thuijl, HF; Mazor, T; Johnson, BE; Fouse, SD; Aihara, K; Hong, CB; Malmstrom, A; Hallbeck, M; Heimans, JJ; Kloezeman, JJ; Stenmark-Askmalm, M; Lamfers, MLM; Saito, N; Aburatani, H; Mukasa, A; Berger, MS; Soderkvist, P; Taylor, BS; Molinaro, AM; Wesseling, P; Reijneveld, JC; Chang, SM; Ylstra, B; Costello, JF				van Thuijl, Hinke F.; Mazor, Tali; Johnson, Brett E.; Fouse, Shaun D.; Aihara, Koki; Hong, Chibo; Malmstrom, Annika; Hallbeck, Martin; Heimans, Jan J.; Kloezeman, Jenneke J.; Stenmark-Askmalm, Marie; Lamfers, Martine L. M.; Saito, Nobuhito; Aburatani, Hiroyuki; Mukasa, Akitake; Berger, Mitchell S.; Soderkvist, Peter; Taylor, Barry S.; Molinaro, Annette M.; Wesseling, Pieter; Reijneveld, Jaap C.; Chang, Susan M.; Ylstra, Bauke; Costello, Joseph F.			Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment	ACTA NEUROPATHOLOGICA			English	Article						Low-grade glioma; Temozolomide; Hypermutator; Mismatch repair; MGMT	MGMT PROMOTER METHYLATION; GENE O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR PROGRESSION; SEQUENCING DATA; MSH6 MUTATIONS; CELL-LINES; PHASE-II; GLIOBLASTOMAS; HYPERMETHYLATION; CHEMOTHERAPY	Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined. DNA hypermethylation of the O (6) -methylguanine-DNA methyltransferase (MGMT) promoter is associated with an improved response to TMZ treatment, while inactivation of the DNA mismatch repair (MMR) pathway is associated with therapeutic resistance and TMZ-induced mutagenesis. We previously demonstrated that TMZ treatment of LGG induces driver mutations in the RB and AKT-mTOR pathways, which may drive malignant progression to secondary GBM. To better understand the mechanisms underlying TMZ-induced mutagenesis and malignant progression, we explored the evolution of MGMT methylation and genetic alterations affecting MMR genes in a cohort of 34 treatment-na < ve LGGs and their recurrences. Recurrences with TMZ-associated hypermutation had increased MGMT methylation compared to their untreated initial tumors and higher overall MGMT methylation compared to TMZ-treated non-hypermutated recurrences. A TMZ-associated mutation in one or more MMR genes was observed in five out of six TMZ-treated hypermutated recurrences. In two cases, pre-existing heterozygous deletions encompassing MGMT, or an MMR gene, were followed by TMZ-associated mutations in one of the genes of interest. These results suggest that tumor cells with methylated MGMT may undergo positive selection during TMZ treatment in the context of MMR deficiency.	[van Thuijl, Hinke F.; Mazor, Tali; Johnson, Brett E.; Fouse, Shaun D.; Hong, Chibo; Berger, Mitchell S.; Molinaro, Annette M.; Chang, Susan M.; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [van Thuijl, Hinke F.; Heimans, Jan J.; Reijneveld, Jaap C.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [van Thuijl, Hinke F.; Wesseling, Pieter; Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Aihara, Koki; Saito, Nobuhito; Mukasa, Akitake] Univ Tokyo, Dept Neurosurg, Tokyo 113, Japan; [Aihara, Koki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Lab, Tokyo, Japan; [Malmstrom, Annika] Linkoping Univ, Dept Adv Home Care, Linkoping, Sweden; [Malmstrom, Annika; Hallbeck, Martin; Stenmark-Askmalm, Marie; Soderkvist, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Kloezeman, Jenneke J.; Lamfers, Martine L. M.] Erasmus MC, Brain Tumor Ctr, Dept Neurosurg, Rotterdam, Netherlands; [Stenmark-Askmalm, Marie] Linkoping Univ Hosp, Dept Clin Pathol & Clin Genet, S-58185 Linkoping, Sweden; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Molinaro, Annette M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Wesseling, Pieter] Radboud Univ Nijmegen, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Reijneveld, Jaap C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Costello, JF (reprint author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	joseph.costello@ucsf.edu	Ylstra, Bauke/D-2906-2012; Wesseling, P./H-8114-2014	Ylstra, Bauke/0000-0001-9479-3010; Wesseling, P./0000-0001-5453-5201	Accelerate Brain Cancer Cure; Grove Foundation; TDC Foundation; Anne and Jason Farber Foundation; UCSF Brain Tumor SPORE grant [NIH P50CA097257]; Dutch Cancer Society (KWF) [2009-4470]; foundation 'STOPHersentumoren'; Edli foundation; LiU Cancer Research Network; Medical Research Council of Southeast Sweden; National Institute Of General Medical Sciences [T32GM008568]; National Institutes of Health [1T32CA15102201]; National Cancer Institute [R01CA169316]; Sontag Foundation; NCI RO1 [R01 CA163687]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan [23134501, 24221011]	This project was generously supported by Accelerate Brain Cancer Cure; The Grove Foundation; The TDC Foundation; The Anne and Jason Farber Foundation; and a generous gift from the Dabbiere family, UCSF Brain Tumor SPORE grant (NIH P50CA097257) (A.M., J.F.C., B.T., S.M.C., M.S.B.), the Dutch Cancer Society (KWF) grant number 2009-4470 and personal travel grant (H.F.v.T), foundation 'STOPHersentumoren', Edli foundation, LiU Cancer Research Network, The Medical Research Council of Southeast Sweden. Additional support by the National Institute Of General Medical Sciences T32GM008568 (T.M.), the National Institutes of Health 1T32CA15102201, the National Cancer Institute R01CA169316 (J.F.C.), Sontag Foundation (B.T.), NCI RO1 (R01 CA163687) (A.M.). This project was supported in part by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) (A.M., N.S., and H.A.), Grant-in-Aid for Scientific Research on Innovative Areas (No. 23134501) (A.M.), and Grant-in-Aid for Scientific Research (No. 24221011) (H.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are grateful to our Dutch collaborators Guus Beute and Ruth Fleischeuer from St. Elisabeth hospital, Wimar van den Brink and Miek Havenith from Isala hospital, Hans Baayen, David Noske and Philip de Witt Hamer from VU University Medical Center and Anja M. Gijtenbeek from the Radboud University Medical Center Nijmegen for providing samples and clinical data. We thank collaborators from the South-East Sweden Brain Tumor Group for providing samples and clinical data; neurosurgeon Peter Milos, clinical oncologists Anna-Lotta Hallbeck, Linkoping Charlotte Bratthall, Kalmar and Michael Strandeus, Jonkoping.	Groenendijk FH, 2011, J NEURO-ONCOL, V101, P405, DOI 10.1007/s11060-010-0274-x; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ruda R, 2013, NEURO-ONCOLOGY, V15, P1739, DOI 10.1093/neuonc/not109; Nakamura M, 2001, CARCINOGENESIS, V22, P1715, DOI 10.1093/carcin/22.10.1715; van Thuijl HF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0471-6; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Shaw EG, 2012, J CLIN ONCOL, V30, P3065, DOI 10.1200/JCO.2011.35.8598; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Brada M, 2003, ANN ONCOL, V14, P1715, DOI 10.1093/annonc/mdg371; Esteller M, 1999, CANCER RES, V59, P793; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Pace A, 2003, ANN ONCOL, V14, P1722, DOI 10.1093/annonc/mdg502; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Taal W, 2011, NEURO-ONCOLOGY, V13, P235, DOI 10.1093/neuonc/noq177; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Silber JR, 1999, CLIN CANCER RES, V5, P807; Malley DS, 2011, ACTA NEUROPATHOL, V121, P651, DOI 10.1007/s00401-011-0803-5; Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Parkinson JF, 2008, J NEURO-ONCOL, V87, P71, DOI 10.1007/s11060-007-9486-0; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; HARRIS LC, 1994, NUCLEIC ACIDS RES, V22, P4614, DOI 10.1093/nar/22.22.4614; Quinn JA, 2003, J CLIN ONCOL, V21, P646, DOI 10.1200/JCO.2003.01.009; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Komine C, 2003, BRAIN PATHOL, V13, P176; Baumert B, 2013, 4 QUADR M WORLD FED; Bodell WJ, 2003, CANCER EPIDEM BIOMAR, V12, P545; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cankovic M, 2007, LAB INVEST, V87, P392, DOI 10.1038/labinvest.3700520; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515; COSTELLO JF, 1994, J BIOL CHEM, V269, P17228; FRITZ G, 1992, BIOCHEM BIOPH RES CO, V183, P1184, DOI 10.1016/S0006-291X(05)80315-8; Giraldo A, 2005, FAM CANCER, V4, P285, DOI 10.1007/s10689-005-4523-7; Hamilton MG, 2011, J NEURO-ONCOL, V102, P255, DOI 10.1007/s11060-010-0307-5; Koekkoek JAF, 2015, J NEUROL NEUROSUR PS, V86, P366, DOI 10.1136/jnnp-2014-308136; Nguyen SA, 2014, CLIN CANC RES; PIEPER RO, 1991, CANCER COMMUN, V3, P241; Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206; Reijneveld JC, 2013, NEUROONCOL, V15; Rodriguez-Hernandez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076401; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Shin Young-Kyoung, 2004, Hum Mutat, V24, P351, DOI 10.1002/humu.9277; Weber RG, 1996, ONCOGENE, V13, P983; Wick WG, 2013, NEUROLOGY, V81, P1515, DOI 10.1212/WNL.0b013e3182a95680	60	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	APR	2015	129	4					597	607		10.1007/s00401-015-1403-6		11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CE0ST	WOS:000351517200008		
J	Kinjyo, Y; Kudaka, W; Ooyama, T; Inamine, M; Nagai, Y; Aoki, Y				Kinjyo, Yoshino; Kudaka, Wataru; Ooyama, Takuma; Inamine, Morihiko; Nagai, Yutaka; Aoki, Yoichi			Ovarian preservation in young women with endometrial cancer of endometrioid histology	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Article						Endometrial cancer; endometrioid adenocarcinoma; ovarian presentation; young patients; hysterectomy	GYNECOLOGIC-ONCOLOGY-GROUP; PREMENOPAUSAL WOMEN; CARCINOMA; SAFETY; AGE; METAANALYSIS	ObjectiveTo clarify the frequency and risk factors of ovarian metastasis in women with endometrial cancer of endometrioid histology. DesignRetrospective observational study. SettingUniversity of the Ryukyus Japan 1990-2011. PopulationEighty-eight women 45years of age with endometrial cancer of only endometrioid histology. MethodsClinicopathological factors from the medical records were used. Fisher's exact test and logistic regression analysis were used to analyze predictive factors for ovarian metastasis. Main outcome measuresRisk factors of ovarian malignancy. ResultsAll women underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy and lymph node dissection. The median age was 39years, and FIGO stage distributions were: stage I, 63 (71.6%) women; stage II, 14 (15.9%) women; and stage III, 11 (12.5%) women. Pathologically, ovarian metastasis was observed in four (4.5%) women. Only lymph node metastasis was a significant predictive factor for ovarian metastasis (p=0.0038), and deep myometrial invasion was the only significant factor (p=0.0085) for the prediction of lymph node metastasis. No ovarian malignancy was found in 72 women with invasion 50% myometrial depth and no enlargement of the ovaries. We observed ovarian metastasis in two (14.3%) of 14 women with deep myometrial invasion without ovarian tumor. ConclusionOvarian preservation surgery might be considered in endometrial cancer of endometrioid histology with 50% myometrial depth invasion with no ovarian mass after taking into account family history.	[Kinjyo, Yoshino; Kudaka, Wataru; Ooyama, Takuma; Inamine, Morihiko; Nagai, Yutaka; Aoki, Yoichi] Univ Ryukyus, Dept Obstet & Gynecol, Grad Sch Med Sci, Nishihara, Okinawa 9030215, Japan	Aoki, Y (reprint author), Univ Ryukyus, Dept Obstet & Gynecol, Grad Sch Med Sci, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	yoichi@med.u-ryukyu.ac.jp					Lee TS, 2013, GYNECOL ONCOL, V131, P289, DOI 10.1016/j.ygyno.2013.08.024; Wright JD, 2009, J CLIN ONCOL, V27, P1214, DOI 10.1200/JCO.2008.19.8150; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Tran BN, 2000, AM J CLIN ONCOL-CANC, V23, P476, DOI 10.1097/00000421-200010000-00009; Lee TS, 2009, GYNECOL ONCOL, V115, P26, DOI 10.1016/j.ygyno.2009.06.041; Duska LR, 2001, GYNECOL ONCOL, V83, P388, DOI 10.1006/gyno.2001.6434; Evans-Metcalf ER, 1998, OBSTET GYNECOL, V91, P349, DOI 10.1016/S0029-7844(97)00668-6; GITSCH G, 1995, OBSTET GYNECOL, V85, P504, DOI 10.1016/0029-7844(95)00001-8; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Walsh C, 2005, OBSTET GYNECOL, V106, P693, DOI 10.1097/01.AOG.0000172423.64995.6f; Lee TS, 2007, GYNECOL ONCOL, V104, P52, DOI 10.1016/j.ygyno.2006.07.003; Koskas M, 2012, FERTIL STERIL, V98, P1229, DOI 10.1016/j.fertnstert.2012.07.1142; ULBRIGHT TM, 1985, HUM PATHOL, V16, P28, DOI 10.1016/S0046-8177(85)80210-0; Richter CE, 2009, GYNECOL ONCOL, V114, P99, DOI 10.1016/j.ygyno.2009.03.032; Sun CY, 2013, FERTIL STERIL, V100, P782, DOI 10.1016/j.fertnstert.2013.05.032; CRISSMAN JD, 1981, OBSTET GYNECOL, V57, P699; Connell PP, 1999, GYNECOL ONCOL, V74, P74, DOI 10.1006/gyno.1999.5415; Creasman WT, 1999, AM J OBSTET GYNECOL, V181, P31, DOI 10.1016/S0002-9378(99)70431-X; Hemminki K, 2003, CANCER, V97, P2432, DOI 10.1002/cncr.11372; Song T, 2013, GYNECOL ONCOL, V131, P624, DOI 10.1016/j.ygyno.2013.09.009; Takeshima N, 1998, GYNECOL ONCOL, V70, P183, DOI 10.1006/gyno.1998.5086	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	APR	2015	94	4					430	434		10.1111/aogs.12588		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CD6SH	WOS:000351219000014		
J	Niwa, N; Nishiyama, T; Ozu, C; Yagi, Y; Saito, S				Niwa, Naoya; Nishiyama, Toru; Ozu, Choichiro; Yagi, Yasuto; Saito, Shiro			Acute aortic dissection in a patient with metastatic renal cell carcinoma treated with axitinib	ACTA ONCOLOGICA			English	Letter									[Niwa, Naoya; Nishiyama, Toru; Ozu, Choichiro; Yagi, Yasuto; Saito, Shiro] Natl Hosp Org Tokyo Med Ctr, Dept Urol, Tokyo 1528902, Japan	Niwa, N (reprint author), Natl Hosp Org Tokyo Med Ctr, Dept Urol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	ashandjesus@gmail.com					Lenihan DJ, 2013, ONCOLOGIST, V18, P900, DOI 10.1634/theoncologist.2012-0466; Sheikh AS, 2013, CIRCULATION, V128, P1122, DOI 10.1161/CIRCULATIONAHA.112.000170; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Edeline J, 2010, ANN ONCOL, V21, P186, DOI 10.1093/annonc/mdp480; Serrano C, 2010, ANN ONCOL, V21, P181, DOI 10.1093/annonc/mdp468	5	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0284-186X	1651-226X		ACTA ONCOL	Acta Oncol.	APR	2015	54	4					561	U165		10.3109/0284186X.2014.963887		2	Oncology	Oncology	CE0XH	WOS:000351533600019		
J	Kinoshita, M; Kikkawa, YS; Sakamoto, T; Kondo, K; Ishihara, K; Konno, T; Pawsey, N; Yamasoba, T				Kinoshita, Makoto; Kikkawa, Yayoi S.; Sakamoto, Takashi; Kondo, Kenji; Ishihara, Kazuhiko; Konno, Tomohiro; Pawsey, Nick; Yamasoba, Tatsuya			Safety, reliability, and operability of cochlear implant electrode arrays coated with biocompatible polymer	ACTA OTO-LARYNGOLOGICA			English	Article						Auditory brainstem response; cochlear implantation; electrical acoustic stimulation; guinea pig; hair cell; scanning electron microscope; spiral ganglion; organ of Corti	POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); PHOSPHOLIPID POLYMERS; HEARING-LOSS; GUINEA-PIG; TRAUMA; SURFACE	Conclusion: Polymer-coated electrodes can reduce surgically-induced trauma associated with the insertion of a cochlear implant (CI) electrode array. Objectives: To evaluate if insertion trauma in CI surgery can be reduced by using electrode arrays coated with 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer. Methods: We analyzed characteristics of the Contour Advance(R) electrode arrays coated with MPC polymer. To assess surgical trauma during electrode insertion, polymer-coated or uncoated (n = 5 each) animal electrode arrays were implanted in guinea pig cochleae and operability and electrophysiological and histological changes were assessed. Results: Under light and scanning electron microscopy, polymer-coated electrodes did not appear different from uncoated electrodes, and no change was observed after mechanical stressing of the arrays. Electrode insertion was significantly easier when polymer-coated electrodes were used. Auditory brainstem response (ABR) thresholds did not differ between groups, but p1-n1 amplitudes of the coated group were larger compared with the uncoated group at 32 kHz at 28 days after surgery. The survival of outer hair cells and spiral ganglion cells was significantly greater in the polymer-coated group.	[Kinoshita, Makoto; Kikkawa, Yayoi S.; Sakamoto, Takashi; Kondo, Kenji; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138655, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Tokyo 1138655, Japan; [Ishihara, Kazuhiko; Konno, Tomohiro] Univ Tokyo, Dept Bioengn, Tokyo 1138655, Japan; [Pawsey, Nick] Cochlear Ltd, Sydney, NSW, Australia	Yamasoba, T (reprint author), Univ Tokyo, Dept Otolaryngol & Head & Neck Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	tyamasoba-tky@umin.ac.jp					Schendzielorz P, 2014, ACTA OTO-LARYNGOL, V134, P497, DOI 10.3109/00016489.2013.878809; [Anonymous], 2013, OXID MED CELL LONGEV, DOI [DOI 10.1155/2013/325702, 10.1155/2013/325702]; Adunka O, 2004, ACTA OTO-LARYNGOL, V124, P807, DOI 10.1080/00016480410018179; Fayad JN, 2006, LARYNGOSCOPE, V116, P1310, DOI 10.1097/01.mlg.0000227176.09500.28; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Matsuno R, 2011, NANO TODAY, V6, P61, DOI 10.1016/j.nantod.2010.12.009; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Kyomoto M, 2007, BIOMATERIALS, V28, P3121, DOI 10.1016/j.biomaterials.2007.03.010; von Ilberg C, 1999, ORL J OTO-RHINO-LARY, V61, P334, DOI 10.1159/000027695; Shimizu T, 2010, BIOMATERIALS, V31, P3274, DOI 10.1016/j.biomaterials.2010.01.026; Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791; Chhabra M, 2007, BIOMATERIALS, V28, P4331, DOI 10.1016/j.biomaterials.2007.06.024; Dodson HC, 1997, J NEUROCYTOL, V26, P541, DOI 10.1023/A:1015434524040; Fukazawa K, 2012, COLLOID SURFACE B, V97, P70, DOI 10.1016/j.colsurfb.2012.04.008; Hassarati RT, 2014, IEEE T NEUR SYS REH, V22, P411, DOI 10.1109/TNSRE.2014.2304559; Kikkawa YS, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0280-4; Stöver T, 2009, Laryngorhinootologie, V88 Suppl 1, pS12, DOI 10.1055/s-0028-1119552; Usami SI, 2011, ACTA OTO-LARYNGOL, V131, P405, DOI 10.3109/00016489.2010.539266; van de Water TR, 2010, ACTA OTO-LARYNGOL, V130, P308, DOI [10.1080/00016480903124655, 10.3109/00016480903124655]	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	APR	2015	135	4					320	327		10.3109/00016489.2014.990580		8	Otorhinolaryngology	Otorhinolaryngology	CD8SG	WOS:000351365500002		
J	Kaga, K; Shinjo, Y; Enomoto, C; Shindo, M				Kaga, Kimitaka; Shinjo, Yukiko; Enomoto, Chieko; Shindo, Mitsuko			A case of cortical deafness and loss of vestibular and somatosensory sensations caused by cerebrovascular lesions in bilateral primary auditory cortices, auditory radiations, and postcentral gyruses - complete loss of hearing despite normal DPOAE and ABR	ACTA OTO-LARYNGOLOGICA			English	Article						anarthria; auditory agnosia; objective audiometry; speech audiometry; vestibular function test	AGNOSIA	Conclusion: A right-handed 38-year-old man's complete loss of hearing could be diagnosed as cortical deafness caused by cerebral vascular lesions in bilateral auditory cortices. Objective: The aim of this case report was to study the pathophysiology of a particular patient who manifested deafness without residual hearing and lost somatosensory sensation, vestibular sensation, and articulation ability after a right internal carotid-posterior communicating artery (IC-PC) aneurysm and subarachnoidal hemorrhage. Methods: MRI, aphasia and neurological tests, subjective and objective audiometry, and vestibular function tests were performed. Results: The neurological test revealed system loss of somatosensory sensation with normal motor function and articulation ability. Brain imaging revealed extensive infarction in the bilateral primary auditory cortices, postcentral gyruses, and the bilateral partial third frontal gyruses. Pure-tone audiometry of both ears revealed off-the-scale results and speech audiometry demonstrated 0% maximum speech discrimination. However, objective audiometry showed normal distortion product otoacoustic emissions (DPOAE) and normal auditory brainstem response (ABR). The patient showed 0% perception of environmental, speech, and music sounds in both ears. He was unable to feel vestibular sensation despite normal caloric nystagmus. He showed no damage to his larynx or articulation organs.	[Kaga, Kimitaka; Shinjo, Yukiko; Enomoto, Chieko; Shindo, Mitsuko] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo 1528902, Japan; [Kaga, Kimitaka] Int Univ Hlth & Welf, Ctr Speech & Hearing Disorders, Nasushiobara, Tochigi, Japan	Kaga, K (reprint author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	kimikaga-tky@umin.ac.jp					Hirano S, 1973, PSYCHIAT NEUROLOGIA, V75, P94; Kaga K, 2009, CENTRAL AUDITORY PATHWAY DISORDERS, P1, DOI 10.1007/978-4-431-26920-5; Kaga K, 2000, ACTA OTO-LARYNGOL, V120, P259; Kaga K, 2003, ACTA OTO-LARYNGOL, V123, P232, DOI 10.1080/00016480310001060; Kaga K, 1997, ACTA OTO-LARYNGOL, P77; LHERMITT.F, 1971, REV NEUROL, V124, P329; TANAKA Y, 1991, BRAIN, V114, P2385, DOI 10.1093/brain/114.6.2385	7	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	APR	2015	135	4					389	394		10.3109/00016489.2014.980914		6	Otorhinolaryngology	Otorhinolaryngology	CD8SG	WOS:000351365500012		
J	Yoshie, S; Ikeda, M; Imaizumi, M; Otsuki, K; Nomoto, Y; Wada, I; Omori, K				Yoshie, Susumu; Ikeda, Masakazu; Imaizumi, Mitsuyoshi; Otsuki, Koshi; Nomoto, Yukio; Wada, Ikuo; Omori, Koichi			Visualization of mouse induced pluripotent stem cells for evaluation of tracheal regeneration	ACTA OTO-LARYNGOLOGICA			English	Article						Artificial material; tdTomato; IVIS	RESPIRATORY EPITHELIUM; RECONSTRUCTION; CARTILAGE; STENOSIS; LARYNX	Conclusion: Visualization of mouse induced pluripotent stem (iPS) cells with the use of a fluorescent protein was successfully achieved for evaluation of tracheal regeneration. Objectives: Tracheal epithelial cells derived from iPS cells are expected to be a useful cell source for tracheal regeneration. Our previous study demonstrated that mouse iPS cells differentiated into tracheal epithelial cells. However, when they are implanted into tracheal defects in experimental animals, it is difficult to determine whether the regenerated tracheal epithelium is in fact derived from iPS cells. The purpose of this study was to develop a visualization technique for iPS cells for evaluation of tracheal regeneration. Methods: Fluorescent marker tdTomato was transfected into iPS cells. Tracheal epithelial cells were generated from tdTomato-labeled iPS cells using embryoid body formation to detect the expression of tdTomato. The artificial material with tdTomato-labeled iPS cells was implanted into tracheal defects in nude rats. The survival and distribution of tdTomato-labeled iPS cell-derived cells were examined using the IVIS Imaging System and immunostaining. Results: The expression of tdTomato was detected in both undifferentiated cells and tracheal epithelial cells in vitro. tdTomato-labeled iPS cell-derived cells were successfully detected in the tracheal defects by IVIS Imaging System and immunostaining.	[Yoshie, Susumu; Ikeda, Masakazu; Imaizumi, Mitsuyoshi; Otsuki, Koshi; Nomoto, Yukio; Omori, Koichi] Fukushima Med Univ, Sch Med, Dept Otolaryngol, Fukushima 9601295, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Dept Cell Sci, Fukushima 9601295, Japan	Omori, K (reprint author), Fukushima Med Univ, Sch Med, Dept Otolaryngol, 1 Hikarigaoka, Fukushima 9601295, Japan.	omori@fmu.ac.jp			Fukushima Medical University;  [26293371]	We gratefully thank Ms Etsuko Sato for her excellent technical assistance. This study was supported by the Grant-in-Aid for Scientific Research (B) 26293371, and Fukushima Medical University.	Omori K, 2008, ANN OTO RHINOL LARYN, V117, P673; Imaizumi M, 2013, CELL TRANSPLANT, V22, P341, DOI 10.3727/096368912X653147; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Omori K, 2005, ANN OTO RHINOL LARYN, V114, P429; GRILLO HC, 1982, ANN THORAC SURG, V33, P3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Otsuki K, 2013, ANN OTO RHINOL LARYN, V122, P25; FEARON B, 1974, ANN OTO RHINOL LARYN, V83, P428; GEBAUER PW, 1950, J THORAC SURG, V19, P604; GRILLO HC, 1979, J THORAC CARDIOV SUR, V78, P860; Nakamura T, 2000, INT J ARTIF ORGANS, V23, P718; Otsuki K, 2014, LARYNGOSCOPE, V124, pE8, DOI 10.1002/lary.24201; Silva AB, 2000, ANN OTO RHINOL LARYN, V109, P343	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	APR	2015	135	4					395	401		10.3109/00016489.2014.990055		7	Otorhinolaryngology	Otorhinolaryngology	CD8SG	WOS:000351365500013		
J	Zaccone, G; Fudge, DS; Winegard, TM; Capillo, G; Kuciel, M; Funakoshi, K; Lauriano, ER				Zaccone, Giacomo; Fudge, Douglas S.; Winegard, Timothy M.; Capillo, Gioele; Kuciel, Michal; Funakoshi, Kengo; Lauriano, Eugenia Rita			Confocal imaging and phylogenetic considerations of the subcutaneous neurons in the Atlantic hagfish Myxine glutinosa	ACTA ZOOLOGICA			English	Article						subcutaneous neurons; slime glands; striated muscle; confocal immunohistochemistry; hagfish; phylogeny	SUPRAMEDULLARY CELLS; NERVOUS-SYSTEM; TAKIFUGU-NIPHOBLES; PUFFER FISH; LAMPREY; ORGANIZATION; RECEPTORS; PATTERNS; GLAND	We used confocal microscopy and immunohistochemistry to characterize the morphology of the subcutaneous neurons and the innervation of the slime glands and striated muscles in the hagfish Myxine glutinosa. A rich plexus of 5HT-, ChAT- and TH-positive neurons is described in the capsule of the slime glands. These neurons, like those of the subcutaneous plexus, receive pericellular terminations from the axons of central cells. Capsular neurons receive innervation from 5HT-positive and nNOS-positive nerve fibres. Other nerve endings belonging to two separate nerve populations are identified in the striated muscles. They contain TH and nNOS immunoreactivity. Due to the lack of any topographical labelling, the cell origin and the projections of the neurons into the cranial and spinal nerves are unknown. This study provides anatomical evidence of multiple (5HT and nNOS) peripheral innervation of the neurons. However, it does not provide information about the function of these neurons in the hagfish. We suggest that hagfish neurons have a phylogenetic relationship with the spinal group of the dorsal cells of lampreys and the supramedullary cells of teleosts.	[Zaccone, Giacomo; Capillo, Gioele; Lauriano, Eugenia Rita] Dept Environm Sci Terr Food & Hlth Secur SASTAS, I-98166 Messina, Italy; [Fudge, Douglas S.; Winegard, Timothy M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Kuciel, Michal] Jagiellonian Univ, Inst Zool, Dept Comparat Anat, PL-30387 Krakow, Poland; [Funakoshi, Kengo] Yokohama City Univ, Sch Med, Dept Neuroanat, Yokohama, Kanagawa 2360027, Japan	Zaccone, G (reprint author), Dept Environm Sci Terr Food & Hlth Secur SASTAS, Viale Stagno Alcontres 31, I-98166 Messina, Italy.	gzaccone@unime.it; gioelecapilo@hotmail.it; elauriano@unime.it			 [PAN LAB PONA3_00166 CUP JA1D11000080007]	Thanks to Professor Michael Axelsson (University of Goteborg) for providing additional fixed skin tissue samples from the hagfish (Myxine glutinosa L.) collected at the Kristineberg Marine Research Station. Grant support was provided by PAN LAB PONA3_00166 CUP JA1D11000080007.	Ahlberg W. E., 2001, MAJOR EVENTS EARLY V, V61; AHLMAN H, 1984, BIOGENIC AMINES, V1, P63; ANADON R, 1989, J COMP NEUROL, V283, P602, DOI 10.1002/cne.902830413; ANDRES KH, 1993, NEUROSCI LETT, V151, P74, DOI 10.1016/0304-3940(93)90049-Q; DOWNING SW, 1981, SCIENCE, V212, P326, DOI 10.1126/science.212.4492.326; Winegard TM, 2010, J EXP BIOL, V213, P1235, DOI 10.1242/jeb.038075; QUAY WB, 1972, AM ZOOL, V12, P95; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; HUGHES A, 1957, J ANAT, V91, P323; Nilsson S, 2011, AUTON NEUROSCI-BASIC, V165, P3, DOI 10.1016/j.autneu.2010.03.018; Funakoshi K, 2007, BRAIN BEHAV EVOLUT, V69, P105, DOI 10.1159/000095199; Ariens-Kappers C. U., 1967, COMP ANATOMY NERVOUS, V1; Bailly Y. J. R., 2009, STRUCTURE EVOLUTION, P61; BONE Q, 1963, J MAR BIOL ASSOC UK, V43, P31; Bone Q., 1961, PHILOS T R SOC B, V24B, P241; BONE Q, 1989, AM ZOOL, V29, P5; Braun CB, 1997, ACTA ZOOL-STOCKHOLM, V78, P247; Brodal F, 1963, BIOL MYXINE; Campbell G., 1970, FISH PHYSIOL, VIV, P109; CHRISTENSON J, 1988, BRAIN RES, V440, P1, DOI 10.1016/0006-8993(88)91152-3; Darian-Smith I., 1984, SENSORY PROCESSES 2, P739; Fujita T., 1988, PARANEURON; Funakoshi K, 1998, NEUROSCI LETT, V258, P171, DOI 10.1016/S0304-3940(98)00869-6; FUNAKOSHI K, 1995, J COMP NEUROL, V358, P552, DOI 10.1002/cne.903580408; Gibbins I. L., 1997, AUTONOMIC INNERVATIO, P1; Gibbins I. L., 1994, COMP PHYSL EVOLUTION, P1; Holmgren S, 2011, AUTON NEUROSCI-BASIC, V165, P102, DOI 10.1016/j.autneu.2010.10.008; JOHNELS A. G., 1956, ACTA ZOOL [STOCKHOLM], V37, P251; JOrgensen JM, 1998, BIOL HAGFISHES, V1st; Kapoor BG, 2004, ICHTHYOLOGY HDB; KOCH EA, 1991, J STRUCT BIOL, V106, P205, DOI 10.1016/1047-8477(91)90070-D; LAMETSCHWANDTNER A, 1986, ACTA ZOOL-STOCKHOLM, V67, P243; Le Douarin N.M., 1982, NEURAL CREST; Mallatt J, 2001, SYST ASSOC SPEC VOL, V61, P106; Mola L, 2002, EUR J HISTOCHEM, V46, P329; Mola L, 2004, BRAIN RES BULL, V64, P195, DOI 10.1016/j.brainresbull.2004.07.010; NAKAO T, 1982, J NEUROCYTOL, V11, P517, DOI 10.1007/BF01262422; Northcutt R. G., 1985, EVOLUTIONARY BIOL PR, P81; Peters A., 1963, BIOL MYXINE, P92; Pick J, 1970, AUTONOMIC NERVOUS SY; Retzius G., 1892, BIOL UNTERSUCH, V3, P41; Retzius G., 1890, BIOL UNTERSUCH, V1, P97; Spitzer RH, 1998, BIOLOGY OF HAGFISHES, P109; WHITEAR M, 1986, BIOL INTEGUMENT, V2, P8; WINBERG M, 1981, COMP BIOCHEM PHYS C, V69, P141, DOI 10.1016/0306-4492(81)90116-7; Winegard T. M., 2012, THESIS U GUELPH; Zaccone G., 2001, ADV MAR BIOL, P255; Zaccone G, 2015, ACTA ZOOL-STOCKHOLM, V96, P127, DOI 10.1111/azo.12059; Zachar PC, 2012, ACTA HISTOCHEM, V114, P101, DOI 10.1016/j.acthis.2011.03.006; Zardoya R, 2001, SYST ASSOC SPEC VOL, V61, P135	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-7272	1463-6395		ACTA ZOOL-STOCKHOLM	Acta Zool.	APR	2015	96	2					209	217		10.1111/azo.12068		9	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	CD5YC	WOS:000351163700010		
J	Omura, A; Ejima, KI; Honda, K; Anzai, W; Taguchi, Y; Koyabu, D; Endo, H				Omura, Ayano; Ejima, Ken-Ichiro; Honda, Kazuya; Anzai, Wataru; Taguchi, Yuki; Koyabu, Daisuke; Endo, Hideki			Locomotion pattern and trunk musculoskeletal architecture among Urodela	ACTA ZOOLOGICA			English	Article						locomotion; muscle; trunk; Urodela; vertebra	FUNCTIONAL-ROLE; PERIVERTEBRAL MUSCULATURE; HYPAXIAL MUSCULATURE; TERRESTRIAL; MORPHOLOGY; AMBYSTOMA; MUSCLES; SALAMANDERS; MECHANICS; EVOLUTION	We comparatively examined the trunk musculature and prezygapophyseal angle of mid-trunk vertebra in eight urodele species with different locomotive modes (aquatic Siren intermedia, Amphiuma tridactylum, Necturus maculosus and Andrias japonicus; semi-aquatic Cynops pyrrhogaster, Cynops ensicauda; and terrestrial Hynobius nigrescens, Hynobius lichenatus and Ambystoma tigrinum). We found that the more terrestrial species were characterized by larger dorsal and abdominal muscle weight ratios compared with those of the more aquatic species, whereas muscle ratios of the lateral hypaxial musculature were larger in the more aquatic species. The lateral hypaxial muscles were thicker in the more aquatic species, whereas the M.rectus abdominis was more differentiated in the more terrestrial species. Our results suggest that larger lateral hypaxial muscles function for lateral bending during underwater locomotion in aquatic species. Larger dorsalis and abdominal muscles facilitate resistance against sagittal extension of the trunk, stabilization and support of the ventral contour line against gravity in terrestrial species. The more aquatic species possessed a more horizontal prezygapophyseal angle for more flexible lateral locomotion. In contrast, the more terrestrial species have an increasingly vertical prezygapophyseal angle to provide stronger column support against gravity. Thus, we conclude trunk structure in urodeles differs clearly according to their locomotive modes.	[Omura, Ayano] Univ Tokyo, Univ Museum, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Omura, Ayano; Anzai, Wataru; Koyabu, Daisuke; Endo, Hideki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Ejima, Ken-Ichiro; Honda, Kazuya] Nihon Univ, Dept Oral & Maxillofacial Radiol, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Honda, Kazuya] Nihon Univ, Sch Dent, Div System Biol & Oncol, Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan; [Anzai, Wataru] Univ Tokyo, Univ Museum, Grad Sch Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Taguchi, Yuki] Hiroshima City Asa Zool Pk, Asatyou Doubutsuen, Hiroshima 7313355, Japan	Omura, A (reprint author), Univ Tokyo, Univ Museum, Grad Sch Agr & Life Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ayanodesuyoroshiku@yahoo.co.jp			Sasakawa Scientific Research Grant from The Japan Science Society	We thank Dr. Shin-ichiro Kawada of National Museum of Science and Nature, Tokyo, for giving us for valuable specimens. We also thank Dr. Yukio Aizawa of the Nippon Dental University and Dr. Kenjiro Kinebuchi of Niigata Seiryo University for providing Hynobius nigrescens specimens, and Dr. Yasuchika Misawa and Natsuhiko Yoshikawa for Cynops pyrrhogaster. We thank Dr. Takenori Sasaki of The University Museum, The University of Tokyo, for lending some equipment for functional morphological analysis. We also thank Mr. Takashi Yoshimine of Microscope Network for providing adapter of microscope. We thank Asa Zoo, Ms. Ayako Noda and Mr. Jun Hatase for encourage us and provide some specimens. The research was financially supported by the Sasakawa Scientific Research Grant from The Japan Science Society. Finally, we thank reviewers for reading our manuscript and giving useful comments.	Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Gray J, 1944, J EXP BIOL, V20, P88; FROLICH LM, 1992, J EXP BIOL, V162, P107; Schilling N, 2010, J MORPHOL, V271, P200, DOI 10.1002/jmor.10791; Deban SM, 2009, J EXP BIOL, V212, P2949, DOI 10.1242/jeb.032961; Azizi E, 2002, COMP BIOCHEM PHYS A, V133, P967, DOI 10.1016/S1095-6433(02)00223-4; CARRIER DR, 1993, J EXP BIOL, V180, P75; Simons RS, 1999, J MORPHOL, V241, P153, DOI 10.1002/(SICI)1097-4687(199908)241:2<153::AID-JMOR5>3.0.CO;2-E; O'Reilly JC, 2000, AM ZOOL, V40, P123, DOI 10.1668/0003-1569(2000)040[0123:TEOTFR]2.0.CO;2; Antipenkova T. P., 1994, ZOOGEOGRAPHY SYSTEMA, P153; ASHLEYROSS MA, 1995, J COMP PHYSIOL A, V177, P273; BARCLAY OR, 1946, J EXP BIOL, V23, P177; Bennett WO, 2001, J EXP BIOL, V204, P1979; Boszczyk B. M., 2001, ANAT REC, V247, P542; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638; Francis E.T.B., 1934, ANATOMY SALAMANDER; HILTON W. A., 1948, JOUR ENT AND ZOOL, V40, P47; Hua S, 2003, NEUES JAHRB GEOL P-A, V227, P139; Liem Karel F., 2001, FUNCTIONAL ANATOMY V; Maurer F., 1911, Jenaische Zeitschrift fuer Naturwissenschaft, V47; Maurer F., 1892, MORPHOL JB, V18, P76; Mivart G, 1870, P ZOOL SOC LOND, V1870, P260; Naylor B. G., 1978, THESIS; Preuschoft Holger, 2007, Mertensiella, V16, P59; Ratnikov Vyacheslav Yu., 2007, Russian Journal of Herpetology, V14, P177; Romer A. S., 1970, VERTEBRATE BODY, V4th; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; WORTHING.RD, 1972, J MORPHOL, V137, P257, DOI 10.1002/jmor.1051370302	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-7272	1463-6395		ACTA ZOOL-STOCKHOLM	Acta Zool.	APR	2015	96	2					225	235		10.1111/azo.12070		11	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	CD5YC	WOS:000351163700012		
J	Umedachi, T; Ito, K; Ishiguro, A				Umedachi, Takuya; Ito, Kentaro; Ishiguro, Akio			Soft-bodied amoeba-inspired robot that switches between qualitatively different behaviors with decentralized stiffness control	ADAPTIVE BEHAVIOR			English	Article						Behavioral diversity; decentralized control; biologically inspired robot; soft-bodied robot	TRUE SLIME-MOLD; PHYSARUM-POLYCEPHALUM; PLASMODIUM; MODEL; PATTERNS; ENVIRONMENT; LOCOMOTION; EMERGENCE; WAVE	The goal of this research is to understand the underlying mechanism of the behavioral diversity of animals and then use the findings to build truly adaptive robots. Behavioral diversity is an inherent feature of all animals, and it is also important for robots to perform adaptively in unknown and dynamically changing environments. This feature enables animals to select adaptive behavior from among versatile behaviors. However, most designers have avoided or ignored behavioral diversity while constructing artificial systems, with the aim of achieving highly optimized performance in specific environments for given tasks; this leads to vulnerability of these systems to environmental changes. To understand how behavioral diversity can be embedded into artificial systems, we focus on a large amoeba-like unicellular organism, i.e., the plasmodium of true slime mold (Physarum polycephalum), in this study. Despite the absence of a central nervous system, the plasmodium exhibits various types of locomotion (i.e., exploratory, taxis, and escape behaviors) and switches its behavior depending on the environment. Inspired by this primitive yet intelligent living organism, we build a modular robot that exhibits exploratory and taxis locomotions, and spontaneously switches between them in a fully decentralized manner according to the situation encountered. The results are expected to shed new light on a design scheme for lifelike robots that exhibit amazingly versatile and adaptive behaviors.	[Umedachi, Takuya] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Ito, Kentaro] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 724, Japan; [Ishiguro, Akio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan	Umedachi, T (reprint author), Tufts Univ, Dept Biol, 200 Boston Ave,Rm 2600, Medford, MA 02155 USA.	takuya.umedachi@gmail.com			Japan Science and Technology Agency (JST); CREST (JST Mathematics Program, Alliance for Breakthrough between Mathematics and Sciences: ABMS); Tateishi Science and Technology Foundation [2021005];  [23656171];  [24740066]	This research was partially supported by the Japan Science and Technology Agency (JST), CREST (JST Mathematics Program, Alliance for Breakthrough between Mathematics and Sciences: ABMS), a Grant-in-Aid for Challenging Exploratory Research (No. 23656171) a Grant-in-Aid for Young Scientists (B) (No. 24740066), and the Tateishi Science and Technology Foundation (No. 2021005).	Takamatsu A, 2009, J THEOR BIOL, V256, P29, DOI 10.1016/j.jtbi.2008.09.010; DURHAM ACH, 1976, J CELL BIOL, V69, P218, DOI 10.1083/jcb.69.1.218; Takamatsu A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228102; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Rieffel JA, 2010, J R SOC INTERFACE, V7, P613, DOI 10.1098/rsif.2009.0240; Takamatsu A, 2006, PHYSICA D, V223, P180, DOI 10.1016/j.physd.2006.09.001; Yoshiyama S, 2010, CELL BIOL INT, V34, P35, DOI 10.1042/CBI20090158; Kobayashi R, 2006, J MATH BIOL, V53, P273, DOI 10.1007/s00285-006-0007-0; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Pfeifer R, 2012, COMMUN ACM, V55, P76, DOI 10.1145/2366316.2366335; TAGA G, 1994, PHYSICA D, V75, P190, DOI 10.1016/0167-2789(94)90283-6; Ito K, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036224; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; MATSUMOTO K, 1988, J THEOR BIOL, V131, P175, DOI 10.1016/S0022-5193(88)80235-2; MATSUMOTO K, 1986, J THEOR BIOL, V122, P339, DOI 10.1016/S0022-5193(86)80125-4; Owaki D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0669; Pfeifer R., 2006, INT C SERIES, V1291, P22, DOI DOI 10.1016/J.ICS.2005.12.080; Takamatsu A, 2001, Phys Rev Lett, V87, P078102, DOI 10.1103/PhysRevLett.87.078102; Takamatsu A., 2004, SICE 2004 ANN C, V2, P1760; Tero A, 2005, PHYSICA D, V205, P125, DOI 10.1016/j.physd.2005.01.010; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, DOI 10.1080/11762320802557865; Umedachi T, 2013, ARTIF LIFE, V19, P67, DOI [10.1162/ARTL_a_00081, 10.1162/artl_a_00081]; Umedachi T, 2012, ADV ROBOTICS, V26, P693, DOI 10.1163/156855312X626316; Umedachi T, 2010, BIOL CYBERN, V102, P261, DOI 10.1007/s00422-010-0367-9; Umedachi T, 2011, INT J UNCONV COMPUT, V7, P449; Umedachi T, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/035001	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	APR	2015	23	2					97	108		10.1177/1059712314564784		12	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	CD6OP	WOS:000351208900003		
J	Umedachi, T; Horikiri, S; Kobayashi, R; Ishiguro, A				Umedachi, Takuya; Horikiri, Shunya; Kobayashi, Ryo; Ishiguro, Akio			Enhancing adaptability of amoeboid robot by synergetically coupling two decentralized controllers inspired by true slime mold	ADAPTIVE BEHAVIOR			English	Article						Autonomous decentralized control; soft robotics; coupled oscillator system; amoeboid locomotion; true slime mold	PHYSARUM-POLYCEPHALUM; MATHEMATICAL-MODEL; MEMBRANE PHENOMENA; PLASMODIUM; NETWORK; FLUID; OSCILLATION; CHEMOTAXIS; PATTERNS	Autonomous decentralized control is a key concept for understanding the adaptive and versatile behaviors of living systems. To establish a design methodology for such a controller for robotic systems, we have proposed a fully decentralized control system, inspired by biochemical oscillators in true slime mold (Physarum polycephalum), which allows a modular robot to exhibit adaptive and versatile behaviors. However, in real living systems, many adaptation mechanisms with different time constants co-exist without conflict in the body (e.g., reflex, learning, growth and evolution); this contributes to the amazingly resilient and intelligent behaviors of living systems. It is well known that in true slime mold, long time-scale morphological changes coexist with the oscillatory behavior stemming from biochemical oscillators. In the present study, we have designed a mathematical model and real physical robot in which two decentralized controllers are incorporated. Numerical and experimental results show that by combining the controllers with different time constants, a robot can use the proposed model to successfully negotiate a narrow aisle by deforming its body shape dynamically.	[Umedachi, Takuya] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Horikiri, Shunya; Ishiguro, Akio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Kobayashi, Ryo] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 724, Japan	Umedachi, T (reprint author), Tufts Univ, Dept Biol, 200 Boston Ave,Rm 2600, Medford, MA 02155 USA.	takuya.umedachi@gmail.com			Tateishi Science and Technology Foundation [2021005];  [23656171]	This research was partially supported by a Grant-in-Aid for Challenging Exploratory Research (grant number 23656171) and by the Tateishi Science and Technology Foundation (grant number 2021005).	HOOVER WG, 1971, J CHEM PHYS, V55, P1128, DOI 10.1063/1.1676196; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Yoshiyama S, 2010, CELL BIOL INT, V34, P35, DOI 10.1042/CBI20090158; Kobayashi R, 2006, J MATH BIOL, V53, P273, DOI 10.1007/s00285-006-0007-0; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; HATO M, 1979, COLLOID POLYM SCI, V257, P397, DOI 10.1007/BF01521576; HATO M, 1979, COLLOID POLYM SCI, V257, P745, DOI 10.1007/BF01474104; HATO M, 1976, Cell Structure and Function, V1, P269; Ueda T, 1995, SENSOR MATER, V7, P147; UEDA T, 1986, EXP CELL RES, V162, P486, DOI 10.1016/0014-4827(86)90352-6; Umedachi T, 2013, ARTIF LIFE, V19, P67, DOI [10.1162/ARTL_a_00081, 10.1162/artl_a_00081]; Umedachi T, 2012, ADV ROBOTICS, V26, P693, DOI 10.1163/156855312X626316; Umedachi T, 2010, BIOL CYBERN, V102, P261, DOI 10.1007/s00422-010-0367-9; Umedachi T, 2011, INT J UNCONV COMPUT, V7, P449; Umedachi T, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/035001; YOSHIMOTO Y, 1981, PROTOPLASMA, V109, P159, DOI 10.1007/BF01287637	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1059-7123	1741-2633		ADAPT BEHAV	Adapt. Behav.	APR	2015	23	2					109	121		10.1177/1059712315573334		13	Computer Science, Artificial Intelligence; Psychology, Experimental; Social Sciences, Interdisciplinary	Computer Science; Psychology; Social Sciences - Other Topics	CD6OP	WOS:000351208900004		
J	Sato, D; Seko, C; Hashitomi, T; Sengoku, Y; Nomura, T				Sato, Daisuke; Seko, Chihiro; Hashitomi, Tatsuya; Sengoku, Yasuo; Nomura, Takeo			Differential effects of water-based exercise on the cognitive function in independent elderly adults	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Water-based exercise; Cognitive function; Independent elderly adults	DAY-SERVICE FACILITY; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; OLDER-ADULTS; PERCEIVED EXERTION; AEROBIC EXERCISE; AGING HUMANS; FITNESS; HEALTH; AGE	Background Physical exercise has been reported to be the most effective method to improve cognitive function and brain health, but there is as yet no research on the effect of water-based exercise. Aims The aim of the present study was to compare the effects of water-based exercise with and without cognitive stimuli on cognitive and physical functions. Methods The design is a single-blind randomized controlled study. Twenty-one participants were randomly assigned to a normal water-based exercise (Nor-WE) group or a cognitive water-based exercise (Cog-WE) group. The exercise sessions were divided into two exercise series: a 10-min series of land-based warm-up, consisting of flexibility exercises, and a 50-min series of exercises in water. The Nor-WE consisted of 10 min of walking, 30 min of strength and stepping exercise, including stride over, and 10 min of stretching and relaxation in water. The Cog-WE consisted of 10 min of walking, 30 min of water-cognitive exercises, and 10 min of stretching and relaxation in water. Cognitive function, physical function, and ADL were measured before the exercise intervention (pre-intervention) and 10 weeks after the intervention (post-intervention). Results Participation in the Cog-WE performed significantly better on the pegboard test and the choice stepping reaction test and showed a significantly improved attention, memory, and learning, and in the general cognitive function (measured as the total score in the 5-Cog test). Participation in the Nor-WE dramatically improved walking ability and lower limb muscle strength. Conclusion Our results reveal that the benefits elderly adults may obtain from water-based exercise depend on the characteristics of each specific exercise program. These findings highlight the importance of prescription for personalized water-based exercises to elderly adults to improve cognitive function.	[Sato, Daisuke] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Seko, Chihiro] Univ Tsukuba, Sch Hlth & Phys Educ, Tsukuba, Ibaraki, Japan; [Hashitomi, Tatsuya] Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Sengoku, Yasuo] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Nomura, Takeo] Tsukuba Aqua Life Res Ctr, Tsukuba, Ibaraki, Japan	Sato, D (reprint author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	daisuke@nuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Niigata University of Health and Welfare	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported by a Grant-in-Aid for Advanced Research from the Niigata University of Health and Welfare. The authors would like to thank Enago (www.enago.jp) for the English language review.	Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Takeshima N, 2002, MED SCI SPORT EXER, V34, P544, DOI 10.1097/00005768-200203000-00024; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Hillman CH, 2004, RES Q EXERCISE SPORT, V75, P176; BORG G, 1970, ACTA MED SCAND, V187, P17; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Doi T, 2013, AGING CLIN EXP RES, V25, P539, DOI 10.1007/s40520-013-0119-5; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208; Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Larson EB, 2006, ANN INTERN MED, V144, P73; Bravo G, 1997, ARCH PHYS MED REHAB, V78, P1375, DOI 10.1016/S0003-9993(97)90313-0; Gregg EW, 2000, J AM GERIATR SOC, V48, P883; Schoppen T, 1999, ARCH PHYS MED REHAB, V80, P825, DOI 10.1016/S0003-9993(99)90234-4; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; ATWATER SW, 1990, PHYS THER, V70, P79; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166; Fauth EB, 2013, INT J GERIATR PSYCH, V28, P597, DOI 10.1002/gps.3865; Christensen James, 2000, American Journal of Medicine, V108, p3S; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; DUNCAN PW, 1990, J GERONTOL, V45, pM192; Forwood M R, 2000, Aust Fam Physician, V29, P761; HASEGAWA K, 1990, Tohoku Journal of Experimental Medicine, V161, P29; Hauer K, 2002, AGE AGEING, V31, P49, DOI 10.1093/ageing/31.1.49; Jigami H, 2012, J ORTHOP SCI, V17, P737, DOI 10.1007/s00776-012-0292-y; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; MIHEVIC PM, 1981, MED SCI SPORT EXER, V13, P150; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Nagamatsu LS, 2013, J AGING RES, V2013, DOI [DOI 10.1155/2013/861893, 10.1155/2013/861893]; Netz Y, 2011, INT PSYCHOGERIATR, V23, P114, DOI 10.1017/S1041610210000797; Predovan D., 2012, J AGING RES; Sato D, 2011, ARCH GERONTOL GERIAT, V52, P331, DOI 10.1016/j.archger.2010.05.002; Sato D, 2009, ARCH GERONTOL GERIAT, V49, P123, DOI 10.1016/j.archger.2008.05.011; Sato D, 2009, DISABIL REHABIL, V31, P84, DOI 10.1080/09638280701817552; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Sudo A, 2002, SPORT SCI, V21, P65; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; Wajima H, 2003, CHIIKI HOKEN, V34, P60; Yatomi N, 2010, JAPAN GIRIATR PSYCHI, V21, P215; Yoon JY, 2014, JPN J PHYS FIT SPORT, V59, P313	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	APR	2015	27	2					149	159		10.1007/s40520-014-0252-9		11	Geriatrics & Gerontology	Geriatrics & Gerontology	CE0WQ	WOS:000351531100006		
J	Kawamoto, R; Kohara, K; Katoh, T; Kusunoki, T; Ohtsuka, N; Abe, M; Kumagi, T; Miki, T				Kawamoto, Ryuichi; Kohara, Katsuhiko; Katoh, Tateaki; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Abe, Masanori; Kumagi, Teru; Miki, Tetsuro			Brachial-ankle pulse wave velocity is a predictor of walking distance in community-dwelling adults	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Arterial stiffness; Pulse wave velocity; Walking exercise; 6-min walk distance	PERIPHERAL ARTERIAL-DISEASE; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR RISK; NORDIC WALKING; CORONARY ATHEROSCLEROSIS; OLDER-ADULTS; STIFFNESS; EXERCISE; METAANALYSIS; POPULATION	Arterial stiffness represents the cumulative effects of cardiovascular risk factors, including aging, on the arterial wall, and has been found to be a surrogate marker of cardiovascular disease. However, it remains unknown whether baseline arterial stiffness is independently associated with improvement in functional abilities after exercise training. The subjects were 72 adults (9 men and 63 women) aged 67 +/- A 7 years from a rural village. Before and at the end of a 12-week Nordic walking program, 6-min walk distance (6MWD) as functional abilities, metabolic characteristics, and the mean of the right and left brachial-ankle pulse wave velocity (baPWV) as a marker of arterial stiffness were measured. Higher baseline mean baPWV levels correlated significantly with shorter baseline 6MWD (P < 0.001), and also with the follow-up 6MWD (P < 0.001) and change rate (P = 0.019) in 6MWD after the 12-week training program. Multivariate linear regression analysis was employed to evaluate the contribution of baseline mean baPWV for 6MWD parameters showing that baseline mean baPWV values were significantly and independently associated with follow-up 6MWD (beta = -0.523, P < 0.001) and change rate in 6MWD (beta = -0.399, P < 0.001) as well as baseline 6MWD (beta = -0.522, P < 0.001), but was not associated with change after the 12-week training program. Higher baPWV, a measurement of arterial stiffness, might be a predictor of functional abilities after exercise training, independent of confounding factors, in the general population.	[Kawamoto, Ryuichi; Abe, Masanori; Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Community Med, Toon, Ehime 7910295, Japan; [Kohara, Katsuhiko; Katoh, Tateaki; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Ehime 7910295, Japan; [Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo, Ehime 7971212, Japan	Kawamoto, R (reprint author), Ehime Univ, Grad Sch Med, Dept Community Med, Toon, Ehime 7910295, Japan.	rykawamo@m.ehime-u.ac.jp			Foundation for Development of Community	This work was supported in part by a Grant-in-Aid for Scientific Research from the Foundation for Development of Community (2013).	Amoh-Tonto CA, 2009, ATHEROSCLEROSIS, V206, P173, DOI 10.1016/j.atherosclerosis.2009.02.003; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ferreira I, 2002, EUR J CLIN INVEST, V32, P723, DOI 10.1046/j.1365-2362.2002.01066.x; Takeshima N, 2013, J SPORT SCI MED, V12, P422; Amar J, 2001, J HYPERTENS, V19, P381, DOI 10.1097/00004872-200103000-00005; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296; Gram B, 2010, CLIN J SPORT MED, V20, P355, DOI 10.1227/NEU.0b013e3181e56e0a; ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Brewer LC, 2007, ATHEROSCLEROSIS, V191, P384, DOI 10.1016/j.atherosclerosis.2006.03.038; Kim HJ, 2009, DIABETES RES CLIN PR, V85, P30, DOI 10.1016/j.diabres.2009.03.013; McDermott MM, 2002, ANN INTERN MED, V136, P873; Canoy D, 2004, J HYPERTENS, V22, P2067, DOI 10.1097/00004872-200411000-00007; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Schwameder H, 1999, J SPORT SCI, V17, P969, DOI 10.1080/026404199365362; Liu CS, 2011, J ATHEROSCLER THROMB, V18, P652; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; International Nordic Walking Federation (INWA), 2011, INWA NORD WALK PORT; Kohara K, 2004, HYPERTENS RES, V27, P471, DOI 10.1291/hypres.27.471; Morgulec-Adamowicz N, 2011, HUMAN MOVEMENT, V12, P124, DOI DOI 10.2478/V10038-011-0009-7; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Watson NL, 2011, AM J HYPERTENS, V24, P90, DOI 10.1038/ajh.2010.193; Wilkinson IB, 1998, J CARDIOVASC PHARM, V32, pS33; Xu YX, 2008, HYPERTENS RES, V31, P1079, DOI 10.1291/hypres.31.1079; Yiu KH, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-94	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	APR	2015	27	2					187	193		10.1007/s40520-014-0262-7		7	Geriatrics & Gerontology	Geriatrics & Gerontology	CE0WQ	WOS:000351531100010		
J	Izawa, KP; Watanabe, S; Oka, K; Mogamiya, T; Tada, M; Nakata, S; Nitobe, S; Yoshizawa, K; Hirano, Y; Osada, N; Omiya, K; Shimizu, H				Izawa, Kazuhiro P.; Watanabe, Satoshi; Oka, Koichiro; Mogamiya, Takuma; Tada, Mika; Nakata, Shuichi; Nitobe, Sato; Yoshizawa, Kazuya; Hirano, Yasuyuki; Osada, Naohiko; Omiya, Kazuto; Shimizu, Hiroyuki			Differences in physical performance based on the Geriatric Nutritional Risk Index in elderly female cardiac patients	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Physical performance; Geriatric Nutritional Risk Index; Elderly female cardiac inpatients	SCREENING TOOLS; HEART-FAILURE; OLDER-PEOPLE; MORTALITY; HEALTH; TESTS; HEMODIALYSIS; VALUES; ADULTS; SPEED	Background Little is known about differences in the risk of poor nutritional status as assessed by the Geriatric Nutritional Risk Index (GNRI) in relation to physical performance in elderly female cardiac inpatients. The present study aimed to determine both differences in physical performance based on the GNRI and physical performance cut-off values according to the GNRI in elderly female cardiac inpatients. Methods We enrolled 105 consecutive female Japanese inpatients aged a parts per thousand yen65 years (mean age, 74.6 years) with cardiac disease in this cross-sectional study. We divided the patients into two groups according to GNRI: high-GNRI group (a parts per thousand yen92 points) (n = 71) and low-GNRI group (< 92 points) (n = 34). Handgrip strength (HG), knee extensor muscle strength (KEMS), gait speed (GS), and one-leg standing time (OLST) were assessed as indices of hospital physical performance and compared between the two groups to determine cut-off values of physical performance. Results After adjustment for age and left ventricular ejection fraction, HG, KEMS, GS, and OLST were significantly lower in the low-GNRI versus high-GNRI group. Cut-off values by ROC curve analysis were 16.2 kgf (AUC = 0.66; p < 0.001) for HG, 34.3 % of body weight (AUC = 0.62; p = 0.04) for KEMS, 1.24 m/s (AUC = 0.72; p < 0.01) for GS, and 8.28 s (AUC = 0.62; p = 0.04) for OLST. Conclusions The risk of poor nutrition, as indicated by a low GNRI, might be a predictor of lower physical performance. Cut-off values determined in this study might be minimum target goals for physical performance that can be attained by elderly female cardiac inpatients.	[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Izawa, Kazuhiro P.; Watanabe, Satoshi; Mogamiya, Takuma; Tada, Mika; Nakata, Shuichi; Nitobe, Sato; Yoshizawa, Kazuya] St Marianna Univ, Sch Med Hosp, Dept Rehabil Med, Kanagawa, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Hirano, Yasuyuki] Tokushima Bunri Univ, Dept Phys Therapy, Tokushima, Japan; [Osada, Naohiko] St Marianna Univ, Toyoko Hosp, Div Cardiol, Kawasaki, Kanagawa, Japan; [Omiya, Kazuto] St Marianna Univ, Yokohama City Seibu Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Shimizu, Hiroyuki] St Marianna Univ, Sch Med, Dept Orthoped Surg, Kanagawa, Japan	Izawa, KP (reprint author), Kobe Univ, Grad Sch Hlth Sci, 10-2 Tomogaoka 7-Chome Suma, Kobe, Hyogo 6540142, Japan.	izawapk@ga2.so-net.ne.jp					Lomivorotov VV, 2013, NUTRITION, V29, P436, DOI 10.1016/j.nut.2012.08.006; Cereda E, 2006, J AM GERIATR SOC, V54, P1011, DOI 10.1111/j.1532-5415.2006.00754.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Muramoto A, 2013, J ORTHOP SCI, V18, P618, DOI 10.1007/s00776-013-0382-5; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Cereda E, 2007, CLIN NUTR, V26, P78, DOI 10.1016/j.clnu.2006.09.007; Cereda E, 2013, BRIT J NUTR, V110, P1903, DOI 10.1017/S0007114513001062; Chan M, 2012, J RENAL NUTR, V22, P547, DOI 10.1053/j.jrn.2011.11.002; Furuna T, 1998, J Jpn Phys Ther Assoc, V1, P1, DOI 10.1298/jjpta.1.1; Islam MM, 2004, PREV MED, V39, P1148, DOI 10.1016/j.ypmed.2004.04.048; Izawa KP, 2008, J REHABIL MED, V40, P225, DOI 10.2340/16501977-0156; Izawa KP, 2014, GERIATR GER IN PRESS; Kim MJ, 2010, GERIATR GERONTOL INT, V10, P302, DOI 10.1111/j.1447-0594.2010.00614.x; Masuda T, 2009, THEORY TECHNIQUE CAR, P165; Matos AC, 2012, NUTR HOSP, V27, P1981, DOI 10.3305/nh.2012.27.6.5891; Ochi A, 2012, THER APHER DIAL, V16, P127, DOI 10.1111/j.1744-9987.2011.01043.x; Omori Y, 2004, RIGAKU RYOHO GAKU, V31, P106; Takahashi S, 1989, RIGAKU RYOHO GAKU, V16, P261; Tsuchihashi-Makaya M, 2013, CIRC J, V77, P604, DOI 10.1253/circj.CJ-13-0028	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	APR	2015	27	2					195	200		10.1007/s40520-014-0264-5		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CE0WQ	WOS:000351531100011		
J	Nagase, K; Skelton, RE				Nagase, K.; Skelton, R. E.			Double-Helix Tensegrity Structures	AIAA JOURNAL			English	Article							DEPLOYABLE STRUCTURES; EQUILIBRIUM; FRAMEWORKS; STIFFNESS; DESIGN	This paper describes a class of tensegrity systems that are formed from a common type of connectivity, having a double-helix configuration. Structures made from such internal patterns will be called a double-helix tensegrity. This paper derives the connectivity matrix for the double-helix tensegrity class of structures. This generalized common mathematical formulation will allow efficient computations for a large class of tensegrity systems, which can have many different configurations, albeit employing the same rules for connecting components. Special cases of these configurations include torus, cylinders, paraboloids, spheres, ellipsoids, and other configurations.	[Nagase, K.] Wakayama Univ, Dept Optomechatron, Wakayama 6408510, Japan; [Skelton, R. E.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA	Nagase, K (reprint author), Wakayama Univ, Dept Optomechatron, 930 Sakaedani, Wakayama 6408510, Japan.						Aldrich J. B., 2004, THESIS U CALIFORNIA; Juan SH, 2008, MECH MACH THEORY, V43, P859, DOI 10.1016/j.mechmachtheory.2007.06.010; Sultan C, 2003, INT J SOLIDS STRUCT, V40, P4637, DOI 10.1016/S0020-7683(03)00267-1; Williamson D, 2003, INT J SOLIDS STRUCT, V40, P6347, DOI 10.1016/S0020-7683(03)00400-1; Fraternali F, 2012, J MECH PHYS SOLIDS, V60, P1137, DOI 10.1016/j.jmps.2012.02.007; Puig L, 2010, ACTA ASTRONAUT, V67, P12, DOI 10.1016/j.actaastro.2010.02.021; Guest SD, 2006, INT J SOLIDS STRUCT, V43, P842, DOI 10.1016/j.ijsolstr.2005.03.008; You Z, 1996, AIAA J, V34, P813, DOI 10.2514/3.13144; MIURA K, 1990, AIAA J, V28, P1098, DOI 10.2514/3.25172; Vera C, 2005, ANN BIOMED ENG, V33, P1387, DOI 10.1007/s10439-005-4698-y; SCHMIT LA, 1981, AIAA J, V19, P1249, DOI 10.2514/3.7859; Ingber DE, 1998, SCI AM, V278, P48; Masic M, 2005, INT J SOLIDS STRUCT, V42, P4833, DOI 10.1016/j.ijsolstr.2005.01.014; Tran HC, 2010, COMPUT STRUCT, V88, P237, DOI 10.1016/j.compstruc.2009.10.006; de Jager B, 2006, INT J SOLIDS STRUCT, V43, P1308, DOI 10.1016/j.ijsolstr.2005.06.049; Paul C, 2006, IEEE T ROBOT, V22, P944, DOI 10.1109/TRO.2006.878980; Sultan C, 2002, ENG STRUCT, V24, P671, DOI 10.1016/S0141-0296(01)00130-4; Fuller R.B., 1962, US Patent, Patent No. [no. 3,063,521, 3063521, 3,063,521]; HANAOR A, 1988, COMPUT STRUCT, V28, P757, DOI 10.1016/0045-7949(88)90416-6; HOFF NJ, 1966, AIAA J, V4, P126; Kanchanasaratool N, 2002, INT J CONTROL, V75, P123, DOI 10.1080/002071701.10070563; Masic M, 2006, INT J SOLIDS STRUCT, V43, P4687, DOI 10.1016/j.ijsolstr.2005.07.046; Mirats-Tur J., 2009, INT J MECH MACHINE T, V44, P1; MIURA K, 1988, AIAA J, V26, P995, DOI 10.2514/3.10002; Motro R., 2003, TENSEGRITY STRUCTURA, P1, DOI 10.1016/B978-190399637-9/50032-9; MOTRO R, 1987, LECT NOTES ENG, V26, P270; Murakami H, 2001, INT J SOLIDS STRUCT, V38, P3599, DOI 10.1016/S0020-7683(00)00232-8; Nagase K., 2014, J INT ASS SHELL SPAT, V55, P37; Pellegrino S, 2001, CISM COUR L, P1; Pellegrino S., 1986, THESIS U CAMBRIDGE C; PELLEGRINO S, 1990, INT J SOLIDS STRUCT, V26, P1329, DOI 10.1016/0020-7683(90)90082-7; Sadao S., 1996, INT J SPACE STRUCTUR, V11, P37; Schek H.-J., 1974, Computer Methods in Applied Mechanics and Engineering, V3, DOI 10.1016/0045-7825(74)90045-0; Skelton R. E., 2009, TENSEGRITY SYSTEMS, p[1, 157], DOI 10.1007/978-0-387-74242-7_1; Tibert A.G., 2003, INT J SPACE STRUCT, V28, P209, DOI DOI 10.1260/026635103322987940; Vassart N., 1999, INT J SPACE STRUCTUR, V14, P147, DOI DOI 10.1260/0266351991494768); Yoshimura Y., 1955, TM1390 NACA; Zhang JY, 2007, INT J SOLIDS STRUCT, V44, P3875, DOI 10.1016/j.ijsolstr.2006.10.027	38	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	APR	2015	53	4					847	862		10.2514/1.J053264		16	Engineering, Aerospace	Engineering	CE0BF	WOS:000351466300004		
J	Iwakura, N; Fujiwara, Y; Tanaka, F; Tanigawa, T; Yamagami, H; Shiba, M; Tominaga, K; Watanabe, T; Iijima, K; Koike, T; Walls, AF; Arakawa, T				Iwakura, N.; Fujiwara, Y.; Tanaka, F.; Tanigawa, T.; Yamagami, H.; Shiba, M.; Tominaga, K.; Watanabe, T.; Iijima, K.; Koike, T.; Walls, A. F.; Arakawa, T.			Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							THYMIC STROMAL LYMPHOPOIETIN; ALLERGIC INFLAMMATION; SWALLOWED FLUTICASONE; HELICOBACTER-PYLORI; IDENTIFICATION; ESOMEPRAZOLE; ENDOSCOPY; EOTAXIN-3; ASSOCIATE; DIAGNOSIS	BackgroundThe features of proton pump inhibitor-responsive oesophageal eosinophilia (PPI-REE) are similar to those of eosinophilic oesophagitis (EoE), but PPI-REE demonstrates symptomatic and histological responses to PPI therapy. Several studies have shown that basophils play a crucial role in the pathogenesis of allergic diseases. AimTo identify and compare basophil infiltration in the oesophageal epithelium in patients with EoE, PPI-REE, gastroesophageal reflux disease (GERD) and normal oesophagus (controls). MethodsBiopsy specimens from 43 patients, including 12 with EoE, 11 with PPI-REE, 10 with GERD and 10 normal oesophagus, were analysed. Immunohistochemistry was performed to quantify the number of basophils and mast cells in the oesophageal epithelium. Double immunofluorescence staining for thymic stromal lymphopoietin (TSLP) and basophils was performed. Patients with EoE were treated with swallowed fluticasone. ResultsThere were no differences in clinical, endoscopic or histological features between patients with EoE and PPI-REE. There were more basophils and mast cells in patients with EoE and PPI-REE than in patients with GERD and control subjects. Basophil infiltration of the oesophageal epithelium in patients with EoE was higher than that in patients with PPI-REE (3.62.8 per high power field vs. 1.2 +/- 0.9 per high power field respectively; P=0.02); however, there was no significant difference in mast cell infiltration between the two groups. TSLP was highly expressed in the oesophageal epithelium in areas infiltrated by basophils. Steroid therapy significantly decreased intraepithelial basophils in patients with EoE. ConclusionBasophils may play an important role in the pathogenesis of eosinophilic oesophagitis.	[Iwakura, N.; Fujiwara, Y.; Tanaka, F.; Tanigawa, T.; Yamagami, H.; Shiba, M.; Tominaga, K.; Watanabe, T.; Arakawa, T.] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 5458585, Japan; [Iijima, K.; Koike, T.] Tohoku Univ, Grad Sch Med, Dept Gastroenterol, Sendai, Miyagi 980, Japan; [Walls, A. F.] Southampton Gen Hosp, Immunopharmacol Grp, Sch Med, Southampton SO9 4XY, Hants, England	Fujiwara, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	yasu@med.osaka-cu.ac.jp			Otsuka; Eisai; Astellas; Abbott Japan; Takeda; Dainippon Sumitomo; Daiichi Sankyo	Declaration of personal interests: Tetsuo Arakawa received lecture fees from Otsuka and Eisai and research grants from Otsuka, Eisai, Astellas, Abbott Japan, Takeda, Dainippon Sumitomo and Daiichi Sankyo. The remaining authors have no conflicts of interest to disclose.	Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Francis DL, 2012, ALIMENT PHARM THER, V35, P300, DOI 10.1111/j.1365-2036.2011.04922.x; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P2015, DOI 10.1016/j.cgh.2014.06.019; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P366, DOI 10.1038/ajg.2012.443; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Lundell LR, 1999, GUT, V45, P172; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Schroeder JT, 2011, IMMUNOL REV, V242, P144, DOI 10.1111/j.1600-065X.2011.01023.x; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Peterson KA, 2010, DIGEST DIS SCI, V55, P1313, DOI 10.1007/s10620-009-0859-4; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Agis H, 2006, AM J CLIN PATHOL, V125, P273, DOI 10.1309/M9FQMQGF66167N2X; Fujiwara Y, 2012, INTERNAL MED, V51, P3235, DOI 10.2169/internalmedicine.51.8670; Suzuki H, 2007, J GASTROENTEROL, V42, P1, DOI 10.1007/s00535-006-1990-z; Dellon ES, 2011, GASTROENTEROLOGY, V141, P1586, DOI 10.1053/j.gastro.2011.06.081; Moawad FJ, 2014, ALIMENT PHARM THER, V39, P603, DOI 10.1111/apt.12636; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Abe Y, 2011, J GASTROENTEROL, V46, P25, DOI 10.1007/s00535-010-0295-4; Katzka DA, 2014, CLIN GASTROENTEROL H, V12, P1824, DOI 10.1016/j.cgh.2014.02.039; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Fujishiro H, 2011, J GASTROENTEROL, V46, P1142, DOI 10.1007/s00535-011-0435-5; IZHIZAKA T, 1972, J IMMUNOL, V108, P1000; Molina-Infante J, 2014, ALIMENT PHARM THER, V40, P955, DOI 10.1111/apt.12914; Schroeder JT, 2009, ADV IMMUNOL, V101, P123, DOI 10.1016/S0065-2776(08)01004-3; vansRhijn BD, 2014, CLIN GASTROENTEROL H, V12, P1815; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	32	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	APR	2015	41	8					776	784		10.1111/apt.13141		9	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CE0AE	WOS:000351463000007		
J	Chen, SL; Gwee, KA; Lee, JS; Miwa, H; Suzuki, H; Guo, P; Hao, YT; Chen, MH				Chen, S. L.; Gwee, K. A.; Lee, J. S.; Miwa, H.; Suzuki, H.; Guo, P.; Hao, Y. T.; Chen, M. H.			Letter: prompt endoscopy in Asians with uninvestigated dyspepsia - authors' reply	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Letter									[Chen, S. L.; Chen, M. H.] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Gwee, K. A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Lee, J. S.] Soonchunhyang Univ Hosp, Ctr Digest Dis, Inst Digest Res, Seoul, South Korea; [Miwa, H.] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo, Japan; [Suzuki, H.] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Guo, P.; Hao, Y. T.] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Chen, SL (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	chenminhu@vip.163.com	Suzuki, Hidekazu/J-4396-2013				Schmidt N, 2005, ALIMENT PHARM THERAP, V21, P813, DOI 10.1111/j.1365-2036.2005.02425.x; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Goh KL, 2007, J DIGEST DIS, V8, P179, DOI 10.1111/j.1443-9573.2007.00304.x; Chen SL, 2015, ALIMENT PHARM THER, V41, P239, DOI 10.1111/apt.13028; Mahadeva S, 2012, DIGEST DIS SCI, V57, P3205, DOI 10.1007/s10620-012-2256-7; Mahadeva S, 2015, ALIMENT PHARM THER, V41, P792, DOI 10.1111/apt.13120; Wai CT, 2002, GASTROINTEST ENDOSC, V56, P548, DOI 10.1067/mge.2002.128493	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	APR	2015	41	8					793	793		10.1111/apt.13131		1	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CE0AE	WOS:000351463000017		
J	Shibata, H; Branquinho, C; McDowell, WH; Mitchell, MJ; Monteith, DT; Tang, JW; Arvola, L; Cruz, C; Cusack, DF; Halada, L; Kopacek, J; Maguas, C; Sajidu, S; Schubert, H; Tokuchi, N; Zahora, J				Shibata, Hideaki; Branquinho, Cristina; McDowell, William H.; Mitchell, Myron J.; Monteith, Don T.; Tang, Jianwu; Arvola, Lauri; Cruz, Cristina; Cusack, Daniela F.; Halada, Lubos; Kopacek, Jiri; Maguas, Cristina; Sajidu, Samson; Schubert, Hendrik; Tokuchi, Naoko; Zahora, Jaroslav			Consequence of altered nitrogen cycles in the coupled human and ecological system under changing climate: The need for long-term and site-based research	AMBIO			English	Review						Atmospheric deposition; Biogeochemistry; Water quality; N2O; Nitrogen leaching	NORTHEASTERN UNITED-STATES; NORTH-ATLANTIC OSCILLATION; DRINKING-WATER NITRATE; SOUTH-CENTRAL ONTARIO; ON-SNOW EVENTS; FORESTED WATERSHEDS; CRITICAL LOADS; TERRESTRIAL ECOSYSTEMS; ATMOSPHERIC AMMONIA; INORGANIC NITROGEN	Anthropogenically derived nitrogen (N) has a central role in global environmental changes, including climate change, biodiversity loss, air pollution, greenhouse gas emission, water pollution, as well as food production and human health. Current understanding of the biogeochemical processes that govern the N cycle in coupled human-ecological systems around the globe is drawn largely from the long-term ecological monitoring and experimental studies. Here, we review spatial and temporal patterns and trends in reactive N emissions, and the interactions between N and other important elements that dictate their delivery from terrestrial to aquatic ecosystems, and the impacts of N on biodiversity and human society. Integrated international and long-term collaborative studies covering research gaps will reduce uncertainties and promote further understanding of the nitrogen cycle in various ecosystems.	[Shibata, Hideaki] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido 0600809, Japan; [Branquinho, Cristina; Cruz, Cristina] Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias, P-1749016 Lisbon, Portugal; [McDowell, William H.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Mitchell, Myron J.] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Monteith, Don T.] Lancaster Environm Ctr, NERC Ctr Ecol & Hydrol, Lancaster LA1 4AP, England; [Tang, Jianwu] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Arvola, Lauri] Univ Helsinki, Lammi Biol Stn, Lammi 16900, Finland; [Cusack, Daniela F.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; [Halada, Lubos] Inst Landscape Ecol SAS, Branch Nitra, Nitra 94910, Slovakia; [Kopacek, Jiri] Biol Ctr ASCR, Inst Hydrobiol, Ceske Budejovice 37005, Czech Republic; [Maguas, Cristina] Univ Lisbon, SIIAF, Ctr Environm Biol, Fac Ciencias, P-1749016 Lisbon, Portugal; [Sajidu, Samson] Univ Malawi, Dept Chem, Chancellor Coll, Zomba, Malawi; [Schubert, Hendrik] Univ Rostock, Inst Biowissensch, Lehrstuhl Okol, D-18051 Rostock, Germany; [Tokuchi, Naoko] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto 6068502, Japan; [Zahora, Jaroslav] Mendel Univ Brno, Brno 61300, Czech Republic	Shibata, H (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0600809, Japan.	shiba@fsc.hokudai.ac.jp; cmbranquinho@fc.ul.pt; bill.mcdowell@unh.edu; mitchell@syr.edu; donm@ceh.ac.uk; jtang@mbl.edu; lauri.arvola@helsinki.fi; ccruz@fc.ul.pt; dcusack@geog.ucla.edu; lubos.halada@savba.sk; jkopacek@hbu.cas.cz; cmhanson@fc.ul.pt; ssajidu@cc.ac.mw; hendrik.schubert@uni-rostock.de; tokuchi@kais.kyoto-u.ac.jp; zahora@mendelu.cz	Kopacek, Jiri/A-7373-2014; Monteith, Donald/C-1534-2008; Tang, Jianwu/K-6798-2014; Branquinho, Cristina/B-3670-2008; Cruz, Cristina/F-2643-2011; McDowell, William/E-9767-2010	Monteith, Donald/0000-0003-3219-1772; Tang, Jianwu/0000-0003-2498-9012; Branquinho, Cristina/0000-0001-8294-7924; Cruz, Cristina/0000-0003-3100-463X; McDowell, William/0000-0002-8739-9047	ILTER network; Environmental research and technology development fund of the Ministry of the Environment, Japan [S-9-3]	We thank the ILTER network for giving us this opportunity to develop the ILTER-N initiative, and for funding support to organize the workshop to develop the manuscript. We also thank all of the participants in the workshop for valuable discussions and helpful comments for this paper. This paper contributes to the synthesis of the Global Land Project (IGBP/IHDP). The synthesis activity was also partly supported by the Environmental research and technology development fund (S-9-3) of the Ministry of the Environment, Japan.	Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; Kaste O, 2008, AMBIO, V37, P29, DOI 10.1579/0044-7447(2008)37[29:MOSISH]2.0.CO;2; Monteith DT, 2014, ECOL INDIC, V37, P287, DOI 10.1016/j.ecolind.2012.08.013; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Freppaz M, 2008, J PLANT NUTR SOIL SC, V171, P672, DOI 10.1002/jpln.200700278; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Boberg JB, 2010, FUNCT ECOL, V24, P454, DOI 10.1111/j.1365-2435.2009.01616.x; Jetten MSM, 2005, BIOCHEM SOC T, V33, P119; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Jovan S, 2012, ECOL APPL, V22, P1910, DOI 10.1890/11-2075.1; Shibata H, 2013, BIOGEOCHEMISTRY, V116, P69, DOI 10.1007/s10533-013-9882-9; Shaver GR, 1998, ECOL MONOGR, V68, P75, DOI 10.1890/0012-9615(1998)068[0075:BACFIW]2.0.CO;2; Park JH, 2003, GLOBAL CHANGE BIOL, V9, P1602, DOI 10.1046/j.1529-8817.2003.00686.x; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; Oulehle F, 2008, ECOSYSTEMS, V11, P410, DOI 10.1007/s10021-008-9130-7; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Camarero L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2125; Weyer PJ, 2001, EPIDEMIOLOGY, V12, P327, DOI 10.1097/00001648-200105000-00013; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099; Collins SL, 2011, FRONT ECOL ENVIRON, V9, P351, DOI 10.1890/100068; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Blenckner T, 2007, GLOBAL CHANGE BIOL, V13, P1314, DOI 10.1111/j.1365-2486.2007.01364.x; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Cusack DF, 2011, BIOGEOCHEMISTRY, V104, P203, DOI 10.1007/s10533-010-9496-4; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; Mitchell MJ, 1996, ENVIRON SCI TECHNOL, V30, P2609, DOI 10.1021/es9600237; Driscoll CT, 2012, BIOSCIENCE, V62, P354, DOI 10.1525/bio.2012.62.4.7; Curtis CJ, 2012, BIOGEOCHEMISTRY, V111, P535, DOI 10.1007/s10533-011-9686-8; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Campbell JL, 2005, FRONT ECOL ENVIRON, V3, P314, DOI 10.2307/3868565; Zaehle S, 2011, NAT GEOSCI, V4, P601, DOI 10.1038/ngeo1207; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Tierney GL, 2001, BIOGEOCHEMISTRY, V56, P175, DOI 10.1023/A:1013072519889; Kopacek J, 2013, BIOGEOCHEMISTRY, V115, P33, DOI 10.1007/s10533-013-9892-7; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Mitchell MJ, 2011, J FOREST RES-JPN, V16, P333, DOI 10.1007/s10310-011-0278-1; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1023/A:1006152112852; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Aber JD, 2002, ECOSYSTEMS, V5, P648, DOI [10.1007/s10021-002-0203-2, 10.1007/s10021-002-0203-8]; George DG, 2004, FRESHWATER BIOL, V49, P760, DOI 10.1111/j.1365-2427.2004.01223.x; Anderson CB, 2012, AUSTRAL ECOL, V37, P529, DOI 10.1111/j.1442-9993.2011.02322.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Johansson O, 2012, GLOBAL CHANGE BIOL, V18, P2626, DOI 10.1111/j.1365-2486.2012.02723.x; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; Compton JE, 2011, ECOL LETT, V14, P804, DOI 10.1111/j.1461-0248.2011.01631.x; Chestnut TJ, 2000, J N AM BENTHOL SOC, V19, P199, DOI 10.2307/1468065; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Harris TD, 2014, LAKE RESERV MANAGE, V30, P72, DOI 10.1080/10402381.2013.876131; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Cape JN, 2009, ENVIRON POLLUT, V157, P1033, DOI 10.1016/j.envpol.2008.09.049; Billen G, 2009, AGR ECOSYST ENVIRON, V133, P234, DOI 10.1016/j.agee.2009.04.018; Groffman PM, 2009, BIOGEOCHEMISTRY, V93, P49, DOI 10.1007/s10533-008-9277-5; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Wipf S, 2010, POLAR RES, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Hogberg MN, 2007, BIOL FERT SOILS, V44, P363, DOI 10.1007/s00374-007-0215-9; Fernandez IJ, 2010, ENVIRON MONIT ASSESS, V171, P149, DOI 10.1007/s10661-010-1524-2; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Davidson EA, 2003, GLOBAL CHANGE BIOL, V9, P228, DOI 10.1046/j.1365-2486.2003.00592.x; Noe GB, 2005, ECOL APPL, V15, P1178, DOI 10.1890/04-1677; Lassaletta L, 2014, BIOGEOCHEMISTRY, V118, P225, DOI 10.1007/s10533-013-9923-4; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Rissanen AJ, 2011, AQUAT MICROB ECOL, V64, P27, DOI 10.3354/ame01506; de Wit HA, 2008, HYDROL EARTH SYST SC, V12, P393; Driscoll CT, 2003, BIOSCIENCE, V53, P357, DOI 10.1641/0006-3568(2003)053[0357:NPITNU]2.0.CO;2; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Pinho P, 2012, BIOGEOSCIENCES, V9, P1205, DOI 10.5194/bg-9-1205-2012; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Monteith DT, 2000, HYDROL PROCESS, V14, P1745, DOI 10.1002/1099-1085(200007)14:10<1745::AID-HYP116>3.0.CO;2-O; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Bobbink R., 2011, REV REVISION EMPIRIC; Boyer E.W., 2002, NITROGEN CYCLE REGIO; Casson NJ, 2010, HYDROL PROCESS, V24, P1985, DOI 10.1002/hyp.7692; Christopher SF, 2008, BIOGEOCHEMISTRY, V88, P15, DOI 10.1007/s10533-008-9189-4; Curtis CJ, 2014, ECOL INDIC, V37, P412, DOI 10.1016/j.ecolind.2013.10.012; Dias T, 2011, PLANT SOIL, V341, P125, DOI 10.1007/s11104-010-0628-3; DISE NB, 1995, FOREST ECOL MANAG, V71, P153, DOI 10.1016/0378-1127(94)06092-W; Eimers MC, 2007, APPL GEOCHEM, V22, P1105, DOI 10.1016/j.apgeochem.2007.03.046; Evans CD, 2010, BIOGEOCHEMISTRY, V101, P211, DOI 10.1007/s10533-010-9413-x; Fowler D., 2007, WATER AIR SOIL POLL, V7, P41, DOI DOI 10.1007/S11267-006-9102-X; Gupta SK, 2000, NATL MED J INDIA, V13, P58; Hedwall PO, 2013, OECOLOGIA, V173, P615, DOI 10.1007/s00442-013-2638-3; Howarth R., 2011, FRONT ECOL ENVIRON, V10, P37, DOI DOI 10.1890/100178; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Kopacek J, 2013, ENVIRON SCI TECHNOL, V47, P6400, DOI 10.1021/es400181m; Kopacek J, 2013, BIOGEOCHEMISTRY, V115, P149, DOI 10.1007/s10533-013-9825-5; Kopacek J, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003779; Kurian L.M., 2012, J AM WATER RESOUR AS, V49, P264; Landberg J.O., 2011, CARDIOVASC RES, V89, P525; Leach A. M., 2012, Environmental Development, V1, P40; Lofgren S, 2011, AMBIO, V40, P836, DOI 10.1007/s13280-011-0207-8; Makoto K., 2013, ECOLOGICAL IN PRESS; Millennium Ecosystem Assessment Board, 2005, ECOSYSTEMS HUMAN WEL, V1; Ohte N, 2001, WATER AIR SOIL POLL, V130, P649, DOI 10.1023/A:1013804728336; Piatek KB, 2005, WATER AIR SOIL POLL, V165, P13, DOI 10.1007/s11270-005-4641-8; Pinho P, 2011, J APPL ECOL, V48, P1107, DOI 10.1111/j.1365-2664.2011.02033.x; Rask M, 2014, BOREAL ENVIRON RES, V19, P1; Robertson GP, 2012, BIOSCIENCE, V62, P342, DOI 10.1525/bio.2012.62.4.6; Rogora M, 2008, HYDROL EARTH SYST SC, V12, P371; Schubert H., 2005, MEER MUSEUM, V18, P83; Schubert H, 2010, LONG-TERM ECOLOGICAL RESEARCH: BETWEEN THEORY AND APPLICATION, P163, DOI 10.1007/978-90-481-8782-9_12; Shibata H, 2004, BIOGEOCHEMISTRY, V69, P83, DOI 10.1023/B:BIOG.0000031042.90585.0a; Skiba A., 2000, CHEMOSPHERE GLOBAL C, V2, P379; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665; Stal Lucas J., 2008, P423; Stoddard JL, 1994, ENV CHEM LAKES RESER, V237, P223, DOI 10.1021/ba-1994-0237.ch008; Suddick E.C., 2012, ROLE NITROGEN CLIMAT; Sutton M.A., 2011, EUROPEAN NITROGEN AS; Urakawa R, 2012, ECOL RES, V27, P245, DOI 10.1007/s11284-012-0926-8; vanMaanen JMS, 1996, ENVIRON HEALTH PERSP, V104, P522, DOI 10.2307/3432993; Vermaat JE, 2012, ECOL SOC, V17, DOI 10.5751/ES-04889-170230; Ward MH, 1996, EPIDEMIOLOGY, V7, P465, DOI 10.1097/00001648-199609000-00002; Wright RF, 1998, ECOSYSTEMS, V1, P216, DOI 10.1007/s100219900017	126	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0044-7447	1654-7209		AMBIO	Ambio	APR	2015	44	3					178	193		10.1007/s13280-014-0545-4		16	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CD7SY	WOS:000351293600003		
J	Araki, H; Tsuzuki, T; Kimura, T; Tanaka, K; Yamada, S; Sassa, N; Yoshino, Y; Hattori, R; Gotoh, M				Araki, Hidemori; Tsuzuki, Toyonori; Kimura, Tohru; Tanaka, Kuniaki; Yamada, Shin; Sassa, Naoto; Yoshino, Yasushi; Hattori, Ryohei; Gotoh, Momokazu			Relationship of Pathologic Factors to Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma	AMERICAN JOURNAL OF CLINICAL PATHOLOGY			English	Article						Clear cell renal cell carcinoma; Metastasis; Sorafenib; Effectiveness; Growth pattern	POSTOPERATIVE PROGNOSTIC NOMOGRAM; RANDOMIZED PHASE-3 TRIAL; FACTOR-TARGETED THERAPY; SSIGN SCORE; RADICAL NEPHRECTOMY; OUTCOME PREDICTION; SURVIVAL; VALIDATION; INHIBITOR; NECROSIS	Objectives: To evaluate the predictive value of growth patterns in patients undergoing sorafenib treatment for metastatic clear cell renal cell carcinomas (CCRCCs). Methods: Forty-eight patients were analyzed, each of whom underwent nephrectomy and received sorafenib treatment for metastatic CCRCC. Progression-free survival (PFS) was predicted using pathologic parameters, including pathologic stage, Fuhrman nuclear grade (FNG), the presence of a sarcomatoid component, lymphovascular invasion, tumor necrosis, and growth pattern. Results: Three (6%) patients showed partial response, 20 (42%) patients showed stable disease, and 25 (52%) patients showed progressive disease. Univariate analyses demonstrated that FNG, the presence of a sarcomatoid component, tumor necrosis, and growth pattern were significantly associated with PFS. In the multivariate analysis, growth pattern was the only parameter that was significantly and independently predictive of PFS. Conclusions: As a novel histologic prognostic parameter, growth pattern may be useful for predicting response to sorafenib treatment.	[Araki, Hidemori] Toyohashi Municipal Hosp, Dept Urol, Toyohashi, Aichi, Japan; [Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Kimura, Tohru] Shakaihoken Chulcyo Hosp, Dept Urol, Nagoya, Aichi, Japan; [Tanaka, Kuniaki] Kariya Toyota Gen Hosp, Dept Urol, Kariya, Aichi, Japan; [Yamada, Shin] Okazaki Municipal Hosp, Dept Urol, Okazaki, Aichi, Japan; [Sassa, Naoto; Yoshino, Yasushi; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi, Japan; [Hattori, Ryohei] Japanese Red Cross Nagoya Daiichi Hosp, Dept Urol, Nagoya, Aichi, Japan	Tsuzuki, T (reprint author), Nagoya Daini Red Cross Hosp, Dept Pathol, Showa Ku, 2-9 Myoken Cho, Nagoya, Aichi 4668650, Japan.	tsuzuki@nagoya2.jrc.or.jp					Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Dall'Oglio MF, 2007, BJU INT, V100, P552, DOI 10.1111/j.1464-410X.2007.07015.x; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Choueiri TK, 2007, CANCER, V110, P543, DOI 10.1002/cncr.22827; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1097/01.ju.0000035885.91935.d5; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Sorbellini M, 2005, J UROLOGY, V173, P48, DOI 10.1097/01.ju.0000148261.19532.2c; Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6; Choueiri TK, 2013, UROL ONCOL-SEMIN ORI, V31, P1788, DOI 10.1016/j.urolonc.2012.07.004; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Zisman A, 2001, J CLIN ONCOL, V19, P1649; Golshayan AR, 2009, J CLIN ONCOL, V27, P235, DOI 10.1200/JCO.2008.18.0000; Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Motzer RJ, 2004, J CLIN ONCOL, V22, P454; Ficarra V, 2006, J UROLOGY, V175, P1235, DOI 10.1016/S0022-5347(05)00684-1; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Siddiqui SA, 2009, BJU INT, V104, P778, DOI 10.1111/j.1464-410X.2009.08499.x; Flaherty KT, 2007, CLIN CANCER RES, V13, p747S, DOI 10.1158/1078-0432.CCR-06-2063; Fukatsu A, 2013, AM J CLIN PATHOL, V140, P500, DOI 10.1309/AJCPIMPE6ZFT8AME; Ljungberg B, 2013, GUIDELINES RENAL CEL; National Comprehensive Cancer Network, 2013, KIDN CANC; Nishikimi T, 2011, PATHOL INT, V61, P116, DOI 10.1111/j.1440-1827.2010.02633.x; Thompson RH, 2007, J UROLOGY, V177, P477, DOI 10.1016/j.juro.2006.09.057; Tsuzuki T, 2014, HISTOPATHOLOGY, V64, P484, DOI 10.1111/his.12277	29	0	0	AMER SOC CLINICAL PATHOLOGY	CHICAGO	2100 W HARRISON ST, CHICAGO, IL 60612 USA	0002-9173	1943-7722		AM J CLIN PATHOL	Am. J. Clin. Pathol.	APR	2015	143	4					492	499		10.1309/AJCPM8RJ2ECAWOGQ		8	Pathology	Pathology	CD8FS	WOS:000351331200005		
J	Sugimoto, H; Nagahara, M; Bae, Y; Nakagawa, T; Ishikawa, T; Sato, T; Uetake, H; Eishi, Y; Sugihara, K				Sugimoto, Hitoshi; Nagahara, Makoto; Bae, Yuan; Nakagawa, Tsuyoshi; Ishikawa, Toshiaki; Sato, Takanobu; Uetake, Hiroyuki; Eishi, Yoshinobu; Sugihara, Kenichi			Clinicopathologic Relevance of Claudin 5 Expression in Breast Cancer	AMERICAN JOURNAL OF CLINICAL PATHOLOGY			English	Article						Claudin 5; Breast cancer; Tight junctions	TIGHT JUNCTION STRANDS; LYMPH-NODE METASTASIS; PROTEINS; THERAPY; CARCINOMA; BARRIERS; TUMORS; BLOOD	Objectives: Claudins are major adhesion molecules in tight junctions and are strongly expressed in various cancers. We thus investigated the expression of claudin 5, a member of the claudin family, in breast cancer. Methods: A total of 193 patients with breast cancer were identified based on their pathologic diagnosis. The expression of each claudin 5 was analyzed in the tumor by immunohistochemical staining. Parametric correlations were done between claudin 5 expression and the clinicopathologic findings. Results: Claudin 5 expression in patients with recurrent breast cancer was statistically significantly higher (P = .004). In addition, analysis of the correlation with other clinicopathologic factors showed statistically significant differences with respect to lymphatic invasion (P = .014), venous invasion (P = .048), estrogen receptor status (P = .002), and human epidermal growth factor 2 status (P = .007). Multivariate analysis revealed that claudin 5 expression was an independent predictive factor in the recurrence for relapse-free survival (RFS) (P = .020). Kaplan-Meier analysis showed that the RFS rate was significantly lower in the high claudin 5 expression group (P = .001). Conclusions: Patients with breast cancer with high claudin 5 expression had a significantly lower RFS rate. Our findings suggest that claudin 5 may be useful as a new biomarker of a risk factor.	[Sugimoto, Hitoshi; Nagahara, Makoto; Nakagawa, Tsuyoshi; Sato, Takanobu; Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Surg Oncol, Tokyo 1138510, Japan; [Bae, Yuan; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Tokyo 1138510, Japan; [Ishikawa, Toshiaki; Uetake, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Translat Oncol, Tokyo 1138510, Japan	Nagahara, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Surg Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nagahara.srg2@tmd.ac.jp					Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Falck AK, 2013, BREAST CANCER RES TR, V140, P93, DOI 10.1007/s10549-013-2617-8; Szasz AM, 2011, CLIN EXP METASTAS, V28, P55, DOI 10.1007/s10585-010-9357-5; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Ikari A, 2011, LIFE SCI, V88, P628, DOI 10.1016/j.lfs.2011.02.002; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Kramer F, 2000, HUM GENET, V107, P249, DOI 10.1007/s004390000375; Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Kominsky SL, 2004, AM J PATHOL, V164, P1627, DOI 10.1016/S0002-9440(10)63721-2; Chiba T, 2010, DIS ESOPHAGUS, V23, P398, DOI 10.1111/j.1442-2050.2009.01023.x; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, P1; Hewitt KJ, 2006, BMC CANCER, V6, P1; Morin PJ, CANC RES, V65, P9603; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Turunen M, 2009, ANTICANCER RES, V29, P5185	24	1	1	AMER SOC CLINICAL PATHOLOGY	CHICAGO	2100 W HARRISON ST, CHICAGO, IL 60612 USA	0002-9173	1943-7722		AM J CLIN PATHOL	Am. J. Clin. Pathol.	APR	2015	143	4					540	546		10.1309/AJCPWGBZ6D0OAIVJ		7	Pathology	Pathology	CD8FS	WOS:000351331200011		
J	Yusa, T; Hiroshima, K; Sakai, F; Kishimoto, T; Ohnishi, K; Usami, I; Morikawa, T; Wu, D; Itoi, K; Okamoto, K; Shinohara, Y; Kohyama, N; Morinaga, K				Yusa, Toshikazu; Hiroshima, Kenzo; Sakai, Fumikazu; Kishimoto, Takumi; Ohnishi, Kazuo; Usami, Ikuji; Morikawa, Tetsuyuki; Wu, Di; Itoi, Kazumi; Okamoto, Kenzo; Shinohara, Yasushi; Kohyama, Norihiko; Morinaga, Kenji			Significant Relationship Between the Extent of Pleural Plaques and Pulmonary Asbestos Body Concentration in Lung Cancer Patients With Occupational Asbestos Exposure	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						pleural plaques; asbestos bodies; asbestos exposure; chest images; workers'compensation	BODIES; POPULATION; WORKERS; CORES	BackgroundThe aim of this study was to elucidate whether there is a relationship between the extent of pleural plaques and pulmonary asbestos body concentration (PABC). MethodsThe subjects were 207 lung cancer patients with occupational asbestos exposure. We determined the plaque extent by findings on chest images using our own criteria. PABCs were measured in resected or autopsy lung specimens. ResultsThere was a significant relationship between plaque extent and PABC. Seventy-five percent of the patients determined to have extensive plaques based on our criteria had a PABC of 5,000 asbestos bodies per gram of dry lung tissue, which is one of the certification criteria of lung cancer caused by asbestos for workers' compensation in Japan. ConclusionsIn lung cancer patients, the plaque extent had a significant positive relationship with the PABC. The plaque extent would be useful as a proxy for PABC for lung cancer compensation purposes. Am. J. Ind. Med. 58:444-455, 2015. (c) 2015 Wiley Periodicals, Inc.	[Yusa, Toshikazu] Chiba Rosai Hosp, Dept Gen Thorac Surg, Ichihara, Chiba, Japan; [Yusa, Toshikazu] Chiba Rosai Hosp, Asbestos Dis Ctr, Ichihara, Chiba, Japan; [Hiroshima, Kenzo; Wu, Di] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Yachiyo, Japan; [Sakai, Fumikazu] Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, Hidaka, Japan; [Kishimoto, Takumi] Okayama Rosai Hosp, Dept Resp Med, Okayama, Japan; [Kishimoto, Takumi] Okayama Rosai Hosp, Asbestos Related Dis Res Ctr, Okayama, Japan; [Ohnishi, Kazuo] Kobe Rosai Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Ohnishi, Kazuo] Kobe Rosai Hosp, Asbestos Dis Bloc Ctr, Kobe, Hyogo, Japan; [Usami, Ikuji] Asahi Rosai Hosp, Dept Resp Med, Owariasahi, Japan; [Usami, Ikuji] Asahi Rosai Hosp, Asbestos Dis Bloc Ctr, Owariasahi, Japan; [Morikawa, Tetsuyuki] Yokohama Rosai Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan; [Morikawa, Tetsuyuki] Yokohama Rosai Hosp, Asbestos Dis Bloc Ctr, Yokohama, Kanagawa, Japan; [Itoi, Kazumi] Hyogo Kenritsu Amagasaki Hosp, Dept Gen Thorac Surg, Amagasaki, Hyogo, Japan; [Okamoto, Kenzo] Hokkaido Chuo Rosai Hosp, Dept Pathol, Iwamizawa, Japan; [Shinohara, Yasushi] Natl Inst Occupat Safety & Hlth, Work Environm Res Grp, Kawasaki, Kanagawa, Japan; [Kohyama, Norihiko] Toyo Univ, Grad Sch Econ, Dept Environm Res, Tokyo, Japan; [Morinaga, Kenji] Environm Restorat & Conservat Agcy, Dept Relief Asbestos Related Dis, Kawasaki, Kanagawa, Japan	Yusa, T (reprint author), Chiba Rosai Hosp, Dept Gen Thorac Surg, 2-16 Tatsumidai Higashi, Ichihara, Chiba, Japan.	toshikazu.yusa@chibah.rofuku.go.jp			Japanese Ministry of Environment; Japan Labour Health and Welfare Organization	We thank Dr. Satoru Shimizu and Dr. Haruo Mikami for their advice on statistical analyses. This study was a part of a study conducted under contract with the Japanese Ministry of Environment and was made possible by a research grant from this ministry. This study was supported by the Japan Labour Health and Welfare Organization.	SMITH MJ, 1972, AM J CLIN PATHOL, V58, P250; CHURG A, 1977, LAB INVEST, V37, P280; De Vuyst P, 1998, EUR RESPIR J, V11, P1416, DOI 10.1183/09031936.98.11061416; EPLER GR, 1982, JAMA-J AM MED ASSOC, V247, P617, DOI 10.1001/jama.247.5.617; HILLERDAL G, 1978, SCAND J RESPIR DIS, V59, P257; GIBBS AR, 1991, BRIT J IND MED, V48, P762; Paris C, 2009, EUR RESPIR J, V34, P72, DOI 10.1183/09031936.00094008; MOULIN E, 1988, EUR RESPIR J, V1, P818; Askergren A, 1972, SCAND J WORK ENV HEA, V4, P179; Bianchi C, 1999, AM J IND MED, V36, P360, DOI 10.1002/(SICI)1097-0274(199909)36:3<360::AID-AJIM3>3.0.CO;2-Q; deKlerk NH, 1996, AM J IND MED, V30, P579, DOI 10.1002/(SICI)1097-0274(199611)30:5<579::AID-AJIM5>3.0.CO;2-O; International Labour Office Geneva, 2000, GUID US ILO INT CLAS, V2000, P6; Karjalainen A, 1996, SCAND J WORK ENV HEA, V22, P34; Kishimoto T, 2010, CANCER SCI, V101, P1194, DOI 10.1111/j.1349-7006.2010.01509.x; KOHYAMA N, 1991, ANN NY ACAD SCI, V643, P27, DOI 10.1111/j.1749-6632.1991.tb24442.x; Larson TC, 2010, RADIOLOGY, V255, P924, DOI 10.1148/radiol.10091447; Meirelles GSP, 2006, J THORAC IMAG, V21, P8, DOI 10.1097/01.rti.0000191424.50208.bd; MORGAN A, 1985, ENVIRON RES, V38, P283, DOI 10.1016/0013-9351(85)90092-1; Morinaga K, 2011, ASBESTOS DISASTER: LESSONS FROM JAPANS EXPERIENCE, P55, DOI 10.1007/978-4-431-53915-5_4; KISHIMOTO T, 1989, CHEST, V95, P549, DOI 10.1378/chest.95.3.549; POOLEY FD, 1972, ENVIRON RES, V5, P363, DOI 10.1016/0013-9351(72)90039-4; Suganuma N, 2009, J OCCUP HEALTH, V51, P210; Takahashi Ken, 1993, Japanese Journal of Industrial Health, V35, P302; Henderson DW, 1997, SCAND J WORK ENV HEA, V23, P311; Yusa T, 2011, JPN J OCCUP MED TRAU, V59, P163	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	APR	2015	58	4					444	455		10.1002/ajim.22430		12	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CD6AF	WOS:000351169600009		
J	Matsue, Y; Yoshida, K; Hoshino, M; Yonetsu, T; Suzuki, M; Matsumura, A; Hashimoto, Y; Yoshida, M				Matsue, Yuya; Yoshida, Kazuki; Hoshino, Masahiro; Yonetsu, Taishi; Suzuki, Makoto; Matsumura, Akihiko; Hashimoto, Yuji; Yoshida, Masayuki			Clinical Features and Prognosis of Type 2 Myocardial Infarction in Vasospastic Angina	AMERICAN JOURNAL OF MEDICINE			English	Article						Prognosis; Troponin; Type 2 myocardial infarction; Vasospasm	LONG-TERM PROGNOSIS; ACUTE CORONARY SYNDROME; CALCIUM-CHANNEL BLOCKERS; COENZYME-A REDUCTASE; VARIANT ANGINA; SPASM ASSOCIATION; ARTERY SPASM; TAKO-TSUBO; CARDIOMYOPATHY; DYSFUNCTION	BACKGROUND: Although generally the prognosis of vasospastic angina is considered excellent, vasospasm has been shown to be a cause of type 2 myocardial infarction. This study was performed to investigate the clinical characteristics and prognosis of patients with vasospastic angina complicated with type 2 myocardial infarction. METHODS: We performed a retrospective analysis of 171 consecutive patients with definite vasospastic angina (median age, 64 years; 55.0% were male) who visited the Kameda Medical Center with chest pain and in whom cardiac troponin I level was measured between 2005 and 2013. The patients were divided into type 2 myocardial infarction and nonetype 2 myocardial infarction groups. A diagnosis of type 2 myocardial infarction was based on a serum cardiac troponin I value >99th percentile upper reference limit. The primary end point was a combination of nonfatal myocardial infarction or death by any cause. RESULTS: A total of 42 patients (24.6%) were diagnosed with type 2 myocardial infarction, and the type 2 myocardial infarction group had a higher incidence of combined end point than the non-type 2 myocardial infarction group during the median follow-up of 4.4 years (26.2% vs 9.3%, respectively, P = .008). Type 2 myocardial infarction remained an independent predictor of combined end point even after adjusting by the Japanese Coronary Spasm Association risk factors for combined end point (hazard ratio, 2.84; 95% confidence interval, 1.22-6.61; P = .02). CONCLUSIONS: Approximately one quarter of patients with vasospastic angina were associated with type 2 myocardial infarction, and this population should be identified as a new high-risk subgroup of those with vasospastic angina requiring an alternative treatment strategy. (C) 2015 Elsevier Inc. All rights reserved.	[Matsue, Yuya; Hoshino, Masahiro; Yonetsu, Taishi; Suzuki, Makoto; Matsumura, Akihiko; Hashimoto, Yuji] Kameda Med Ctr, Dept Cardiol, Kamogawa City, Chiba 2968602, Japan; [Matsue, Yuya; Yoshida, Masayuki] Tokyo Med & Dent Univ, Dept Life Sci & Bioeth, Tokyo, Japan; [Yoshida, Kazuki] Kameda Med Ctr, Dept Rheumatol, Chiba, Japan; [Yoshida, Kazuki] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Matsue, Y (reprint author), Kameda Med Ctr, Dept Cardiol, 929 Higashi Chou, Kamogawa City, Chiba 2968602, Japan.	yuya8950@gmail.com		Yoshida, Kazuki/0000-0002-2030-3549	Kameda Medical Center; Japan Student Services Organization; Harvard School of Public Health; Pfizer; Takeda; Bayer; PhRMA	KY was funded by a scholarship from Kameda Medical Center at the time of the current research and currently receives tuition support jointly from Japan Student Services Organization and Harvard School of Public Health (partially supported by training grants from Pfizer, Takeda, Bayer, and PhRMA).	Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Britten MB, 2004, CORONARY ARTERY DIS, V15, P259, DOI 10.1097/01.mca.0000134590.99841.81; Takagi Y, 2013, J AM COLL CARDIOL, V62, P1144, DOI 10.1016/j.jacc.2013.07.018; Ong P, 2014, CIRCULATION, V129, P1723, DOI 10.1161/CIRCULATIONAHA.113.004096; YASUE H, 1988, CIRCULATION, V78, P1; Pizzi C, 2004, CIRCULATION, V109, P53, DOI 10.1161/01.CIR.0000100722.34034.E4; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Matsue Y, 2012, J AM COLL CARDIOL, V60, P908, DOI 10.1016/j.jacc.2012.03.070; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Wang CH, 2002, AM HEART J, V144, P275, DOI 10.1067/mhj.2002.123843; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Takagi Y, 2011, CIRC-ARRHYTHMIA ELEC, V4, P295, DOI 10.1161/CIRCEP.110.959809; Dokainish H, 2005, J AM COLL CARDIOL, V45, P19, DOI 10.1016/j.jacc.2004.09.056; Group JJW, 2010, CIRC J, V74, P1745; MARK DB, 1984, CIRCULATION, V69, P880; Nishigaki K, 2010, CIRC J, V74, P1943, DOI 10.1253/circj.CJ-10-0292; Schindler TH, 2003, ARTERIOSCL THROM VAS, V23, P495, DOI 10.1161/01.ATV.0000057571.03012.F4; SEVERI S, 1980, AM J CARDIOL, V46, P226, DOI 10.1016/0002-9149(80)90062-4; Sun HT, 2002, J AM COLL CARDIOL, V39, P847, DOI 10.1016/S0735-1097(02)01690-X; Suwaidi J A, 2000, Circulation, V101, P948; WALLING A, 1987, CIRCULATION, V76, P990; WATERS DD, 1983, CIRCULATION, V68, P258	27	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	APR	2015	128	4					389	395		10.1016/j.amjmed.2014.10.055		7	Medicine, General & Internal	General & Internal Medicine	CD8SH	WOS:000351365600028		
J	Kondo, T; Uehara, T; Takada, T; Terada, K; Ikusaka, M				Kondo, Takeshi; Uehara, Takanori; Takada, Toshihiko; Terada, Kazuhiko; Ikusaka, Masatomi			Recurrent Back Pain of Eosinophilic Esophagitis	AMERICAN JOURNAL OF MEDICINE			English	Editorial Material							CHEST-PAIN		[Kondo, Takeshi; Uehara, Takanori; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba, Chiba 2608677, Japan; [Takada, Toshihiko; Terada, Kazuhiko] Kimitsu Chuo Hosp, Dept Gen Med, Kisarazu City, Chiba, Japan	Kondo, T (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	reds_liverpool_2005@yahoo.co.jp					Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Dekel R, 2003, ALIMENT PHARM THERAP, V18, P1083, DOI 10.1046/j.1365-2036.2003.01772.x; Goldberg MF, 2008, AM J ROENTGENOL, V191, P758, DOI 10.2214/AJR.07.3747; Hempel SL, 1996, CHEST, V110, P1117, DOI 10.1378/chest.110.4.1117; KRAMER P, 1955, GASTROENTEROLOGY, V29, P719	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	APR	2015	128	4					E1	E2		10.1016/j.amjmed.2014.11.008		2	Medicine, General & Internal	General & Internal Medicine	CD8SH	WOS:000351365600001		
J	Yamagami, F; Mizuno, A; Niwa, K				Yamagami, Fumi; Mizuno, Atsushi; Niwa, Koichiro			Is This Right Ventricular Infarction or Brugada Syndrome? Reply	AMERICAN JOURNAL OF MEDICINE			English	Letter							ACUTE PULMONARY-EMBOLISM; ST SEGMENT ELEVATION; PHENOCOPY		[Yamagami, Fumi; Mizuno, Atsushi; Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan	Yamagami, F (reprint author), St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan.						Yamagami F, 2014, AM J MED, V127, P820, DOI 10.1016/j.amjmed.2014.04.031; Zhan ZQ, 2014, INT J CARDIOL, V177, pE153, DOI 10.1016/j.ijcard.2014.09.046; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P396, DOI 10.1111/j.1540-8167.2000.tb00334.x; Anselm DD, 2013, AM J CARDIOL, V111, P453, DOI 10.1016/j.amjcard.2012.09.005; Cheng TO, 2009, INT J CARDIOL, V136, P251, DOI 10.1016/j.ijcard.2009.01.041; Hilliard AA, 2009, INT J CARDIOL, V132, pE51, DOI 10.1016/j.ijcard.2007.08.017; Manohar S, 2014, AM J MED, V128, pe25	7	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	APR	2015	128	4					E27	E27		10.1016/j.amjmed.2014.10.059		1	Medicine, General & Internal	General & Internal Medicine	CD8SH	WOS:000351365600014		
J	Rahman, M; Nakamura, K; Seino, K; Kizuki, M				Rahman, Mosiur; Nakamura, Keiko; Seino, Kaoruko; Kizuki, Masashi			Sociodemographic Factors and the Risk of Developing Cardiovascular Disease in Bangladesh	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							MYOCARDIAL-INFARCTION; HEART-DISEASE; HYPERTENSION; HEALTH	Background: Sociodemographic determinants of predicted 10-year risk for stroke or myocardial infarction are vital to identify patients who are at increased risk. Although some risk factors of predicted cardiovascular disease (CVD) risk are documented, further exploration is necessary considering various socioeconomic and demographic factors. Purpose: To examine risk factors for stroke or myocardial infarction according to 10-year prediction, among hypertensive patients and by sociodemographic risk differences, using a nationally representative survey. Methods: Data were obtained from the 2011 Bangladesh Demographic Health Survey and analyzed in March and July 2014. The analyses were based on responses from 1,620 hypertensive individuals. WHO guidelines for predicting 10-year risk of stroke or myocardial infarction were applied to categorize risk of CVD into low, medium, or high strata. Results: A total of 21.8% of hypertensive adults were at high risk for CVD. An adjusted ordinal logistic regression model showed that a female-versus male-headed household (AOR=1.85); an urban versus rural residence (AOR=1.32); being overweight/obese versus underweight (AOR=1.80); and being aged 55-69 years (AOR=1.95) or >= 70 years (AOR=2.87) versus 35-54 years were significantly associated with higher CVD risk. A regional difference in distribution of CVD risk strata was observed. Conclusions: Living in a female-headed household, having an urban residence, being overweight/obese, old age, and regional variations are factors associated with higher risk of CVD among hypertensive patients. (C) 2015 American Journal of Preventive Medicine	[Rahman, Mosiur; Nakamura, Keiko; Seino, Kaoruko] Tokyo Med & Dent Univ, Grad Sch Med, Div Publ Hlth, Dept Int Hlth & Med, Tokyo 1138519, Japan; [Kizuki, Masashi] Tokyo Med & Dent Univ, Grad Sch Med, Div Publ Hlth, Dept Hlth Promot, Tokyo 1138519, Japan	Rahman, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Div Publ Hlth, Dept Int Hlth & Med,Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	swaponru_2000@yahoo.com					Sowers JR, 2001, HYPERTENSION, V37, P1053; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; HADDAD L, 1990, ECON J, V100, P866, DOI 10.2307/2233663; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Estacio RO, 2000, DIABETES CARE, V23, pB54; ANDERSON JA, 1984, J ROY STAT SOC B MET, V46, P1; Jeemon P, 2010, INDIAN J MED RES, V132, P617; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Catherine K, 2010, CAN J CARDIOL, V26, p8C; Ford ES, 2013, J AM COLL CARDIOL, V61, P49; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Lioyd CB, 1995, WORKING PAPER, P74; Machu B, 2014, J M GANDHI I MED SCI, V19, P51; MEASURE DHS/ICF International, 2014, STAND DHS 2011 DAT; National Institute of Population Research and Training (NIPORT), 2013, MITR ASS MACR BANGL; Panniyammakal J, 2011, BMJ OPEN, V1; Saquib N, 2012, BMC PUBLIC HEALTH, V12, P1; The World Bank, 2011, NCDS POL BRIEF BANGL; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Zhang B, 2008, CURR MED RES OPIN, V24, P2711, DOI 10.1185/03007990802363198 	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2015	48	4					456	461		10.1016/j.amepre.2014.10.009		6	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	CD7DM	WOS:000351251000012		
J	Kobayashi, Y; Yamamoto, T; Chishima, F; Takahashi, H; Suzuki, M				Kobayashi, Yusuke; Yamamoto, Tatsuo; Chishima, Fumihisa; Takahashi, Hideki; Suzuki, Manami			Autoantibodies Isolated from Patients with Preeclampsia Induce Soluble Endoglin Production from Trophoblast Cells Via Interactions with Angiotensin II Type 1 Receptor	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Angiotensin II receptor; autoantibody; preeclampsia; soluble endoglin; trophoblast	NECROSIS-FACTOR-ALPHA; AGONISTIC AUTOANTIBODIES; CONTRIBUTES; PREGNANCY; HYPOXIA; DISEASE; SERA	ProblemThis study investigated whether angiotensin II type 1 receptor agonistic autoantibodies (AT(1)-AAs) mediate the increased release of soluble endoglin (sEng) in women with preeclampsia. Method of studySerum samples were obtained from women with normal pregnancies or with preeclampsia. Human first-trimester trophoblast cells were cultured with purified IgG derived from these sera, and the sEng protein and mRNA expression levels were measured in the supernatants. We also determined the effects of the AT(1)-AAs on these cells following treatment with an AT(1) receptor antagonist (losartan). ResultsCompared with the IgG isolated from the women with normal pregnancies, treatments of the preeclamptic patients markedly increased sEng production and mRNA expression in trophoblast cells. Co-treatment with losartan significantly attenuated the release of sEng and sEng mRNA expression in the trophoblast cells. ConclusionAT(1)-AAs may be related to the increased release of sEng observed during preeclampsia and may play important roles in the pathology of this disorder.	[Kobayashi, Yusuke; Yamamoto, Tatsuo; Chishima, Fumihisa; Takahashi, Hideki; Suzuki, Manami] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1738610, Japan	Yamamoto, T (reprint author), Nihon Univ, Sch Med, Dept Obstet & Gynecol, Itabashi Ku, 30-1 Oyaguchikamimachi, Tokyo 1738610, Japan.	tyama@med.nihon-u.ac.jp			Ministry of Education	This work was supported by the Grants-in-Aid for the High-Technology Research Center Project of the Ministry of Education.	Aoki Y, 2012, AM J REPROD IMMUNOL, V67, P413, DOI 10.1111/j.1600-0897.2011.01086.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Walther T, 2005, HYPERTENSION, V46, P1275, DOI 10.1161/01.HYP.0000190040.66563.04; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567; Zhou CC, 2007, CIRC RES, V100, P88, DOI 10.1161/01.RES.0000254703.11154.18; Hubel CA, 2007, HYPERTENSION, V49, P612, DOI 10.1161/01.HYP.0000256565.20983.d4; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Kalkunte S, 2010, AM J PATHOL, V177, P2387, DOI 10.2353/ajpath.2010.100475; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Jensen F, 2012, HYPERTENSION, V59, P861, DOI 10.1161/HYPERTENSIONAHA.111.188276; LaMarca B, 2011, CURR OPIN PHARMACOL, V11, P175, DOI 10.1016/j.coph.2011.01.003; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Siddiqui AH, 2010, HYPERTENSION, V55, P386, DOI 10.1161/HYPERTENSIONAHA.109.140061; Wei F, 2011, HEART, V97, P479, DOI 10.1136/hrt.2009.192104; Yu DC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-122; Zhou CC, 2010, CIRCULATION, V121, P436, DOI 10.1161/CIRCULATIONAHA.109.902890; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	APR	2015	73	4					285	291		10.1111/aji.12340		7	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CD7UG	WOS:000351298700001		
J	Nakagawa, K; Kwak-Kim, J; Ota, K; Kuroda, K; Hisano, M; Sugiyama, R; Yamaguchi, K				Nakagawa, Koji; Kwak-Kim, Joanne; Ota, Kuniaki; Kuroda, Keiji; Hisano, Michi; Sugiyama, Rikikazu; Yamaguchi, Koushi			Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th1/Th2 Cell Ratios	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						IVF; repeated implantation failure; tacrolimus; Th1; Th2 ratios	IN-VITRO FERTILIZATION; INTRAVENOUS IMMUNOGLOBULIN; TRANSPLANT RECIPIENTS; EMBRYO-TRANSFER; PREGNANCY; IVF; CYCLOSPORINE; METAANALYSIS; MANAGEMENT; CYTOKINES	ProblemWe evaluated the clinical efficacy of immunosuppressive treatment with tacrolimus for repeated implantation failure (RIF) patients who have elevated in T helper (Th1)/Th2 cytokine producing cell ratios. Method of studyThis was a prospective cohort study of treatment for RIF patients (n=42) with elevated peripheral blood Th1 (CD4(+)/IFN-(+))/Th2 (CD4(+)/IL-4(+)) cell ratios at the Sugiyama clinic between November 2011 and October 2013. Twenty-five patients were treated with tacrolimus (treatment group) and 17 received no treatment (control group). Treatment group received tacrolimus 2days before embryo transfer and continued until the day of the pregnancy test, for a total of 16days. The daily dose of tacrolimus (1-3mg) was determined based on the degree of the Th1/Th2 cell ratio. ResultsThe clinical pregnancy rate of the treatment group was 64.0%, which was significantly higher than that of the control group (0%) (P<0.0001). In the treatment group, the miscarriage rate was 6.3%, the live birthrate was 60.0% (P<0.0001). There was no significant side-effect from tacrolimus in treatment group. No one developed obstetrical complications during pregnancy. ConclusionAn immunosuppressive treatment using tacrolimus improved pregnancy outcome of repeated implantation failure patients with elevated Th1/Th2 ratios.	[Nakagawa, Koji; Sugiyama, Rikikazu] Sugiyama Clin, Div Reprod Med, Tokyo 1540041, Japan; [Kwak-Kim, Joanne] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Obstet & Gynecol, Reprod Med, Vernon Hills, IL USA; [Ota, Kuniaki] Keio Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Kuroda, Keiji] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan; [Hisano, Michi; Yamaguchi, Koushi] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	Nakagawa, K (reprint author), Sugiyama Clin, Div Reprod Med, Setagaya Ku, 1-53-1 Ohara, Tokyo 1540041, Japan.	koji@sugiyama.or.jp					Abou-Jaoude MM, 2005, TRANSPLANT P, V37, P3025, DOI 10.1016/j.transproceed.2005.08.040; aito S, 2010, AM J REPROD IMMUNOL, V63, P601; Winger EE, 2011, AM J REPROD IMMUNOL, V65, P610, DOI 10.1111/j.1600-0897.2010.00946.x; Ng SC, 2002, AM J REPROD IMMUNOL, V48, P77, DOI 10.1034/j.1600-0897.2002.01105.x; Ram R, 2009, BONE MARROW TRANSPL, V43, P643, DOI 10.1038/bmt.2008.373; Ostensen M, 2013, CURR OPIN PHARMACOL, V13, P470, DOI 10.1016/j.coph.2013.03.004; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; KINO T, 1987, J ANTIBIOT, V40, P1256; Wong KM, 2014, FERTIL STERIL, V102, P19, DOI 10.1016/j.fertnstert.2014.05.027; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Clark DA, 2006, J ASSIST REPROD GEN, V23, P1, DOI 10.1007/s10815-005-9013-1; Rath T, 2013, EXPERT OPIN PHARMACO, V14, P115, DOI 10.1517/14656566.2013.751374; Garrido-Gomez T, 2013, FERTIL STERIL, V99, P1078, DOI 10.1016/j.fertnstert.2012.12.005; Simon A, 2012, J ASSIST REPROD GEN, V29, P1227, DOI 10.1007/s10815-012-9861-4; Carter JD, 2009, J RHEUMATOL, V36, P635, DOI 10.3899/jrheum.080545; Sunderam S, 2013, MMWR SURVEILL SUMM, V62, P1; Tan BK, 2005, BJOG-INT J OBSTET GY, V112, P773, DOI 10.1111/j.1471-0528.2005.00523.x; Kalu E, 2008, AM J REPROD IMMUNOL, V59, P206, DOI 10.1111/j.1600-0897.2007.00565.x; Coscia L, 2010, CLIN TRANSPL, V24, P65; Goring SM, 2014, CURR MED RES OPIN, V30, P1473, DOI 10.1185/03007995.2014.898140; Graphou O, 2003, AM J REPROD IMMUNOL, V49, P21, DOI 10.1034/j.1600-0897.2003.01169.x; Liu HY, 2014, J INTERF CYTOK RES, V34, P394, DOI 10.1089/jir.2013.0062; Liu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045224; Mangubat CP, 2001, AM J REPROD IMMUNOL, V45, P24; Nakagawa Koji, 2012, Reproductive Medicine and Biology, V11, P85, DOI 10.1007/s12522-011-0110-9; Nakagawa K, 2012, J ASSIST REPROD GEN, V29, P679, DOI 10.1007/s10815-012-9758-2; Ogiwara D, 2004, TRANSPLANT NOW, V17, P451; Riley JK, 2008, IMMUNOL INVEST, V37, P395, DOI 10.1080/08820130802206066; Schjenken JE, 2012, RECENT ADV RES HUMAN, P211; Sugiyama R, 2010, J ASSIST REPROD GEN, V27, P161, DOI 10.1007/s10815-010-9390-y; Uchida K, 2006, TRANSPLANT NOW, V19, P380; Virro MR, 2012, AM J REPROD IMMUNOL, V68, P218, DOI 10.1111/j.1600-0897.2012.01169.x	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	APR	2015	73	4					353	361		10.1111/aji.12338		9	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CD7UG	WOS:000351298700007		
J	Saito, Y				Saito, Yoshihiro			70th Birthday of Professor Kiyokatsu Jinno	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Editorial Material									Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Saito, Y (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibariga Oka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	saito@ens.tut.ac.jp						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	10					2651	2651		10.1007/s00216-014-8454-8		1	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE0QQ	WOS:000351509900001		
J	Aoyagi, S; Shimanouchi, T; Kawashima, T; Iwai, H				Aoyagi, Satoka; Shimanouchi, Toshinori; Kawashima, Tomoko; Iwai, Hideo			ToF-SIMS observation for evaluating the interaction between amyloid beta and lipid membranes	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						ToF-SIMS; Amyloid beta; Lipid; Peptide structure; Ar cluster beam	ION MASS-SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS; PROTEIN FILMS; BRAIN-TISSUE; SEPARATION; SUBSTRATE; PEPTIDES	The adsorption behaviour of amyloid beta (A beta), thought to be a key peptide for understanding Alzheimer's disease, was investigated by means of time-of-flight secondary ion mass spectrometry (ToF-SIMS). A beta aggregates depending on the lipid membrane condition though it has not been fully understood yet. In this study, A beta samples on different lipid membranes, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), were observed with ToF-SIMS and the complex ToF-SIMS data of the A beta samples was interpreted using data analysis techniques such as principal component analysis (PCA), gentle-SIMS (G-SIMS) and g-ogram. DOPC and DMPC are liquid crystal at room temperature, while DPPC is gel at room temperature. As primary ion beams, Bi-3 (+) and Ar cluster ion beams were used and the effect of an Ar cluster ion for evaluating biomolecules was also studied. The secondary ion images of the peptide fragment ions indicated by G-SIMS and g-ogram were consistent with the PCA results. It is suggested that A beta is adsorbed homogeneously on the liquid-crystalline-phase lipid membranes, while it aggregates along the lipid on the gel-phase lipid membrane. Moreover, in the results using the Ar cluster, the influence of contamination was reduced.	[Aoyagi, Satoka] Skeikei Univ, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan; [Shimanouchi, Toshinori] Okayama Univ, Fac Environm Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Kawashima, Tomoko] Panason Corp, Appliances Co, Corp Engn Div, R&D Support Ctr, Seika, Kyoto 6190237, Japan; [Iwai, Hideo] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan	Aoyagi, S (reprint author), Skeikei Univ, Dept Mat & Life Sci, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	aoyagi@st.seikei.ac.jp			NIMS microstructural characterization platform as a program of "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [24686086]	The work was partly supported by NIMS microstructural characterization platform as a program of "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by a Grant-in-Aid for Scientific Research (No. 24686086) from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT).	Aoyagi S, 2013, ANAL BIOANAL CHEM, V405, P6621, DOI 10.1007/s00216-013-7139-z; Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t; Sjovall P, 2004, ANAL CHEM, V76, P4271, DOI 10.1021/ac049389p; Baio JE, 2012, LANGMUIR, V28, P2107, DOI 10.1021/la203907t; Lanekoff I, 2013, ANAL CHEM, V85, P882, DOI 10.1021/ac302308p; Vickerman JC, 2011, ANALYST, V136, P2199, DOI 10.1039/c1an00008j; Hane F, 2011, J ALZHEIMERS DIS, V26, P485, DOI 10.3233/JAD-2011-102112; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Shimanouchi T, 2013, BIOCHEM ENG J, V71, P81, DOI 10.1016/j.bej.2012.11.006; Aoyagi S, 2013, SURF INTERFACE ANAL, V45, P190, DOI 10.1002/sia.5089; Aoyagi S, 2012, RAPID COMMUN MASS SP, V26, P2815, DOI 10.1002/rcm.6409; Aoyagi S, 2008, APPL SURF SCI, V255, P1071, DOI 10.1016/j.apsusc.2008.05.086; Gilmore IS, 2000, APPL SURF SCI, V161, P465, DOI 10.1016/S0169-4332(00)00317-2; Lee JLS, 2009, SURF INTERFACE ANAL, V41, P653, DOI 10.1002/sia.3070; Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382; Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x; Ogaki R, 2011, ANAL CHEM, V83, P3627, DOI 10.1021/ac200347a; Seah M. P., 2010, J PHYS CHEM C, V114, P5531; Shimanouchi T, 2014, COLLOID SURFACE B, V116, P343, DOI 10.1016/j.colsurfb.2013.07.028; Vu HT, 2009, J COLLOID INTERF SCI, V336, P902	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	10					2859	2863		10.1007/s00216-015-8527-3		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE0QQ	WOS:000351509900019		
J	Sasaki, A; Fukuda, H; Shiida, N; Tanaka, N; Furugen, A; Ogura, J; Shuto, S; Mano, N; Yamaguchi, H				Sasaki, Ai; Fukuda, Hayato; Shiida, Narumi; Tanaka, Nobuaki; Furugen, Ayako; Ogura, Jiro; Shuto, Satoshi; Mano, Nariyasu; Yamaguchi, Hiroaki			Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC/MS/MS (vol 407, pg 1625, 2015)	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Correction									[Sasaki, Ai; Shiida, Narumi; Furugen, Ayako; Ogura, Jiro] Hokkaido Univ, Fac Pharmaceut Sci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 060, Japan; [Fukuda, Hayato; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Organ Chem Drug Dev, Sapporo, Hokkaido 060, Japan; [Tanaka, Nobuaki; Mano, Nariyasu; Yamaguchi, Hiroaki] Tohoku Univ, Lab Clin Pharm, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Mano, Nariyasu; Yamaguchi, Hiroaki] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan	Yamaguchi, H (reprint author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	yamaguchi@hosp.tohoku.ac.jp					Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	10					2939	2940		10.1007/s00216-015-8512-x		2	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE0QQ	WOS:000351509900027		
J	Zhang, M; Kokabu, S; Nakatomi, C; Sugiyama, G; Matsuo, K; Jimi, E				Zhang, Min; Kokabu, Shoichiro; Nakatomi, Chihiro; Sugiyama, Goro; Matsuo, Kou; Jimi, Eijiro			The Distinct Distributions of Immunocompetent Cells in Rat Dentin Pulp After Pulpotomy	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						immunocompetent cells; ED1; OX6; pulpotomy; immunohistochemistry	MACROPHAGE POPULATIONS; PROGENITOR CELLS	Pulpotomy involves the removal of the coronal portion of pulp, including the diseased tissue, with the intent of maintaining the vitality of the remaining pulpal tissue via a therapeutic dressing. Once odontoblasts suffer injuries, the differentiation of mesenchymal cells is induced from the precursor cell population in the dental pulp, and these cells are recruited to the injured site to differentiate into odontoblasts. However, the involvement of immunocompetent cells during pulpal regeneration remains unclear. Thus, the purpose of this study was to investigate the properties of macrophages that infiltrated wound healing sites in rats between 1 and 28 days after pulpotomy (dap). During the inflammatory phase, ED11 (CD681) macrophages significantly increased throughout root pulp, especially apical to the demarcation zone, and this population persisted until 3 dap before decreasing gradually until 28 dap. OX61 macrophages expressing class II MHC also increased in the apical pulp at 1 dap and declined thereafter. However, OX61 cells appeared prior to dentin bridge formation at 3 dap and appeared again apical to the dentin bridge during the healing stage at 14 dap. The shift from ED11 cells in the inflammation phase to OX61 cells during dentin bridge formation might contribute to wound healing. Anat Rec, 298: 741-749, 2015. (C) 2014 Wiley Periodicals, Inc.	[Zhang, Min; Matsuo, Kou] Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Kokabu, Shoichiro; Nakatomi, Chihiro; Sugiyama, Goro; Jimi, Eijiro] Kyushu Dent Univ, Div Mol Signaling & Biochem, Dept Hlth Promot, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	Zhang, M (reprint author), Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r06zhang2@fa.kyu-dent.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22592042]	Grant sponsor: Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant number: 22592042.	Tziafas D, 2010, J ENDODONT, V36, P781, DOI 10.1016/j.joen.2010.02.006; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1; Kodonas K, 2012, J ENDODONT, V38, P913, DOI 10.1016/j.joen.2012.02.005; Deonarine K, 2007, J TRANSL MED, V21, P5; Fuks A B, 2006, Eur Arch Paediatr Dent, V7, P64; Hume DA, 2008, J IMMUNOL, V181, P5829; Ide M, 2003, J COMP PATHOL, V128, P41, DOI 10.1053/jcpa.2002.0603; Jontell M, 1998, CRITICAL REV ORAL BI, V9, P199; Juniantito V, 2011, J COMP PATHOL, V145, P378, DOI 10.1016/j.jcpa.2011.01.012; Kaneko T, 2008, CELL TISSUE RES, V331, P413, DOI 10.1007/s00441-007-0539-7; Melin M, 2000, J DENT RES, V79, P1689; Ritwik Priyanshi, 2013, J Calif Dent Assoc, V41, P585; Schaffer M, 2007, J SURG RES, V138, P100, DOI 10.1016/j.jss.2006.05.029; Tziafas D, 2002, CONNECT TISSUE RES, V43, P391, DOI 10.1080/03008200290001014; Yamate J, 2001, TOXICOL PATHOL, V29, P483, DOI 10.1080/01926230152500103; Zhang M, 1999, HISTOCHEM CELL BIOL, V112, P325, DOI 10.1007/s004180050413	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	APR	2015	298	4					741	749		10.1002/ar.23087		9	Anatomy & Morphology	Anatomy & Morphology	CD9RV	WOS:000351436800013		
J	Hirata, M; Matsumoto, Y; Izumi, S; Soga, Y; Hirota, F; Tobisa, M				Hirata, M.; Matsumoto, Y.; Izumi, S.; Soga, Y.; Hirota, F.; Tobisa, M.			Seasonal and interannual variations in feeding station behavior of cattle: effects of sward and meteorological conditions	ANIMAL			English	Article						cattle; grazing; bite; step; sward condition	TROPICAL GRASSES; DYNAMICS; PATCH; DIGESTIBILITY; HERBIVORES; SELECTION; PASTURES; HEIFERS; SHEEP	A feeding station is the area of forage a grazing animal can reach without moving its forefeet. Grazing behavior can be divided into residence within feeding stations (with bites as benefits) and movement between feeding stations (with steps as costs). However, relatively little information has been reported on how grazing animals modify their feeding station behavior seasonally and interannually in response to varying environmental conditions. The feeding station behavior of beef cows (Japanese Black) stocked on a tropical grass pasture (bahiagrass dominant) was monitored for 4 years (2010 to 2013) in order to investigate the association of feeding station behavior with meteorological and sward conditions across the seasons and years. Mean air temperature during stocking often exceeded 30 degrees C during summer months. A severe summer drought in 2013 decreased herbage mass and sward height of the pasture and increased nitrogen concentration of herbage from summer to autumn. A markedly high feeding station number per unit foraging time, low bite numbers per feeding station and a low bite rate were observed in summer 2013 compared with the other seasons and years. Bite number per feeding station was explained by a multiple regression equation, where sward height and dry matter digestibility of herbage had a positive effect, whereas air temperature during stocking had a negative effect (R-2 = 0.658, P<0.01). Feeding station number per minute was negatively correlated with bite number per feeding station (r = -0.838, P<0.001). It was interpreted that cows modified bite number per feeding station in response to the sward and meteorological conditions, and this largely determined the number of feeding stations the animals visited per minute. The results indicate potential value of bite number per feeding station as an indicator of daily intake in grazing animals, and an opportunity for livestock and pasture managers to control feeding station behavior of animals through managements (e.g. fertilizer application, manipulation of stocking intensity and stocking time within the day).	[Hirata, M.; Matsumoto, Y.; Izumi, S.; Soga, Y.; Hirota, F.; Tobisa, M.] Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 8892192, Japan	Hirata, M (reprint author), Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 8892192, Japan.	m.hirata@cc.miyazaki-u.ac.jp					Hirata M, 2004, REC RES DEV CROP SCI, V1, P117; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Dumont B, 2007, ANIMAL, V1, P1042, DOI 10.1017/S1751731107000250; Hirata M, 2010, J AGR SCI, V148, P615, DOI 10.1017/S0021859610000353; Hirata M, 2008, J ETHOL, V26, P327, DOI 10.1007/s10164-007-0065-9; Hirata M, 2006, J AGRON CROP SCI, V192, P79, DOI 10.1111/j.1439-037X.2006.00182.x; Da Silva SC, 2013, J AGR SCI, V151, P727, DOI 10.1017/S0021859612000858; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Hirata M, 2000, J RANGE MANAGE, V53, P315, DOI 10.2307/4003439; Boval M, 2002, J AGR SCI, V138, P73; ELAICH A, 1989, APPL ANIM BEHAV SCI, V24, P259, DOI 10.1016/0168-1591(89)90072-5; GODDARD J, 1968, East African Wildlife Journal, V6, P1; GOTO I, 1977, ANIM FEED SCI TECH, V2, P247, DOI 10.1016/0377-8401(77)90028-1; Gregorini P, 2011, LIVEST SCI, V137, P287, DOI 10.1016/j.livsci.2010.11.017; Gregorini P, 2007, GRASS FORAGE SCI, V62, P346, DOI 10.1111/j.1365-2494.2007.00589.x; Gregorini P, 2009, J ANIM SCI, V87, P3817, DOI 10.2527/jas.2009-2094; Hirata Masahiko, 1993, Journal of Japanese Society of Grassland Science, V39, P183; Hirata Masahiko Masahiko Ueno, 1993, Journal of Japanese Society of Grassland Science, V38, P487; Hirata M, 2010, GRASSL SCI, V56, P108, DOI 10.1111/j.1744-697X.2010.00182.x; Hirata M, 2012, LIVEST SCI, V150, P209, DOI 10.1016/j.livsci.2012.09.004; Japan Meteorological Agency, 2014, CLIM DAT; JIANG Z, 1993, EVOL ECOL, V7, P488, DOI 10.1007/BF01237643; LAZO A, 1993, APPL ANIM BEHAV SCI, V36, P99, DOI 10.1016/0168-1591(93)90002-7; MURRAY MG, 1991, J ANIM ECOL, V60, P1029, DOI 10.2307/5429; National Research Council, 1987, PRED FEED INT FOOD P; Ogura Shin-ichiro, 2004, Grassland Science, V50, P147; Roguet C, 1998, APPL ANIM BEHAV SCI, V56, P187, DOI 10.1016/S0168-1591(97)00104-4; RUYLE GB, 1985, J ANIM SCI, V61, P349; Searle KR, 2005, OIKOS, V111, P417, DOI 10.1111/j.0030-1299.2005.13918.x; Shingu Y, 2010, ANIM SCI J, V81, P384, DOI 10.1111/j.1740-0929.2010.00748.x; Vallentine J.F., 1990, GRAZING MANAGEMENT	32	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1751-7311	1751-732X		ANIMAL	Animal	APR	2015	9	4					682	690		10.1017/S1751731114002869		9	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CE1DC	WOS:000351551300017		
J	Muller, MS; Massa, B; Phillips, RA; Dell'Omo, G				Mueller, Martina S.; Massa, Bruno; Phillips, Richard A.; Dell'Omo, Giacomo			Seabirds mated for life migrate separately to the same places: behavioural coordination or shared proximate causes?	ANIMAL BEHAVIOUR			English	Article						behavioural strategy; carryover effects; global location sensor; GLS logger; inbreeding; mate fidelity; movement ecology; partner coordination	SHEARWATER CALONECTRIS-DIOMEDEA; CORYS SHEARWATER; PAIR-BOND; PELAGIC SEABIRD; REPRODUCTIVE-PERFORMANCE; INDIVIDUAL CONSISTENCY; ACTIVITY PATTERNS; BREEDING SUCCESS; SELVAGEM GRANDE; PACIFIC-OCEAN	Long-term pair bonds occur in diverse animal taxa, but they are most common in birds, and can last from a few years to a lifetime. In many of these species, after the reproductive season, birds migrate to distant nonbreeding grounds where they remain for several months, and until recently, little was known about whether partners maintain contact during migration. This gap in knowledge was primarily due to past methodological difficulties in tracking long-term, large-scale movements of individuals. However, the development of new animal-borne geolocation devices has enabled researchers to track movements of individuals for a year or more. We tracked the annual migrations of both members of breeding pairs of Scopoli's shearwaters, Calonectris diomedea, breeding on Linosa Island (Italy) and found that although they did not migrate together, they did spend a similar number of days travelling to and from similar terminal nonbreeding areas. Although migration destinations were alike, they were not identical. That partners did not appear to travel or spend time together in the nonbreeding season suggests that similarities were not due to behavioural coordination. We performed additional analyses to uncover alternative, potential proximate mechanisms. First, we found that body mass of breeding adults during the chick-rearing period correlated positively with the decision to migrate further south, so conceivably pair members may migrate to similar areas because of shared reproductive costs; however, partners were not of similar body mass. Distances between nonbreeding areas for individuals that nested closer together were smaller than for individuals that nested far apart. As neighbours tend to be more closely related due to high natal philopatry, this suggests that similarities within pairs in migration behaviour may reflect the influence of shared genes on migration strategy. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Mueller, Martina S.] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Massa, Bruno] Univ Palermo, Dept Agr & Forest Sci, Palermo, Italy; [Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Dell'Omo, Giacomo] Ornis Italica, Rome, Italy	Muller, MS (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, 1 Furo Cho, Nagoya, Aichi 4648601, Japan.	martina.muller9@gmail.com			Ornis Italica; Regione Siciliana; Assessorato Risorse Agricole e Alimentari; JSPS; 'Pelagic Birds' [LIFE11 + NAT/IT/000093]	We thank Paolo Becciu for helping with fieldwork. Special thanks to Ken Yoda for comments on the manuscript and for support while it was written. Our research permit was provided by Regione Siciliana. The study was supported by Ornis Italica, Regione Siciliana and Assessorato Risorse Agricole e Alimentari with a grant to the Ringing Unit of Palermo and LIFE11 + NAT/IT/000093 'Pelagic Birds'. M.M. was funded by a JSPS postdoctoral fellowship.	Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Magnusdottir E, 2014, BIRD STUDY, V61, P301, DOI 10.1080/00063657.2014.940839; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Ramos JA, 1997, CONDOR, V99, P634, DOI 10.2307/1370475; Jovani R, 2007, P R SOC B, V274, P2465, DOI 10.1098/rspb.2007.0527; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Gunnarsson TG, 2004, NATURE, V431, P646, DOI 10.1038/431646a; Yamamoto T, 2011, MAR ECOL PROG SER, V424, P191, DOI 10.3354/meps08973; Catry P, 2013, ECOLOGY, V94, P1230; THIBAULT JC, 1994, BIRD STUDY, V41, P25; Yamamoto T, 2014, BEHAVIOUR, V151, P683, DOI 10.1163/1568539X-00003163; LESSELLS CM, 1987, AUK, V104, P116; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; SEIBT U, 1979, Z TIERPSYCHOL, V50, P166; KETTERSON ED, 1976, ECOLOGY, V57, P679, DOI 10.2307/1936182; Limmer B, 2010, OIKOS, V119, P500, DOI 10.1111/j.1600-0706.2009.16673.x; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Rayner MJ, 2012, EMU, V112, P107, DOI 10.1071/MU11066; van de Pol M, 2006, BEHAV ECOL, V17, P982, DOI 10.1093/beheco/arl036; Muller MS, 2014, CURR ZOOL, V60, P631; Black JM, 2001, BEHAV ECOL, V12, P640, DOI 10.1093/beheco/12.5.640; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.1016/J.JSPS.2012.11.002; Becciu P., 2012, ECOLOGY CONSERVATION, P16; Berthold P., 2001, BIRD MIGRATION; Black J.M., 1996, PARTNERSHIPS BIRDS S; BRADLEY JS, 1995, J ANIM ECOL, V64, P31, DOI 10.2307/5825; Bried Joel, 2002, P263; Cachia Zammit R., 1986, IL MERILL, V24, P1; Catry P, 2006, ACTA ETHOL, V9, P87, DOI 10.1007/s10211-006-0022-6; CHARDINE JW, 1987, IBIS, V129, P515, DOI 10.1111/j.1474-919X.1987.tb08239.x; Clutton-Brock T., 1991, EVOLUTION PARENTAL C; Costantini D, 2013, CURR ZOOL, V59, P697; Coulson C., 1970, J ANIM ECOL, V35, P269; Dias MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049376; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Ens B. J., 1996, PARTNERSHIPS BIRDS, P345; Faraway J. J., 2006, EXTENDING LINEAR MOD; FRICKE HW, 1986, ETHOLOGY, V73, P307; Garthe S, 2012, MAR BIOL, V159, P1907, DOI 10.1007/s00227-012-1978-6; Gauthreaux S.A.J., 1982, AVIAN BIOL, P93; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Hamer Keith C., 2002, P217; HATCH SA, 1990, AUK, V107, P750; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Korsten P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3362; Kuznetsova A., 2014, LMERTEST TESTS RANDO; Lo Valvo M, 2001, WATERBIRDS, V24, P169; Massa B., 1986, MEDITERRANEAN MARINE, P293; MILLS JA, 1973, J ANIM ECOL, V42, P147, DOI 10.2307/3409; Mougin JL, 2000, J ORNITHOL, V141, P319, DOI 10.1007/BF02462241; Mougin JL, 2000, IBIS, V142, P421, DOI 10.1111/j.1474-919X.2000.tb04438.x; Ochi D, 2010, J ETHOL, V28, P313, DOI 10.1007/s10164-009-0187-3; Ollason J.C., 1988, P263; Perez C, 2014, BEHAV ECOL, V25, P313, DOI 10.1093/beheco/art119; Peron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072713; Rabouam C, 2000, AUK, V117, P651, DOI 10.1642/0004-8038(2000)117[0651:GROCSS]2.0.CO;2; Rabouam C, 1998, AUK, V115, P483; RICKLEFS RE, 1984, ORNIS SCAND, V15, P16, DOI 10.2307/3675998; Sanchez-Macouzet O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2843; SWATSCHEK I, 1994, MOL ECOL, V3, P259, DOI 10.1111/j.1365-294X.1994.tb00059.x; Werner AC, 2014, AUK, V131, P265, DOI 10.1642/AUK-13-172.1; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213	70	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	APR	2015	102						267	276		10.1016/j.anbehav.2015.02.005		10	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CD4NC	WOS:000351058700028		
J	Tong, B; Li, GP; Sasaki, S; Muramatsu, Y; Ohta, T; Kose, H; Yamada, T				Tong, B.; Li, G. P.; Sasaki, S.; Muramatsu, Y.; Ohta, T.; Kose, H.; Yamada, T.			Association of the expression levels in the skeletal muscle and a SNP in the CDC10 gene with growth-related traits in Japanese Black beef cattle	ANIMAL GENETICS			English	Article						carcass weight; marker; rib eye area; rib thickness; septin; Wagyu	ACUTE MYELOID-LEUKEMIA; CELL-DIVISION CYCLE; SEPTIN-LIKE FUSION; MAMMALIAN SEPTINS; OVARIAN-TUMORS; MLL; MSF; REGION; FUSES; T(11/17)(Q23,Q25)	Growth performance, as well as marbling, is the main breeding objective in Japanese Black (JB) cattle, the major beef breed in Japan. The septin 7 (CDC10) gene, involved in cellular proliferation, is located within a genomic region of a quantitative trait locus for growth-related traits. In this study, we first showed that the expression levels of the CDC10 gene in the skeletal muscle were higher in JB steers with extremely high growth performance than in JB steers with extremely low growth, using real-time PCR. Further, a single nucleotide polymorphism (SNP), NC_007302.5:g.63264949G>C, was detected in the promoter region of the CDC10 gene and genotyped in three Japanese cattle breeds (known as Wagyu' in Japan) and the Brown Swiss dairy cattle breed. All four cattle populations showed a moderate genetic diversity at the SNP of the CDC10 gene. An association analysis indicated that the SNP was associated with growth-related traits in JB cattle. These findings suggest possible effects of the expression levels in the skeletal muscle and the SNP of the CDC10 gene on growth-related traits in JB cattle. The CDC10 SNP may be useful for effective marker-assisted selection to increase beef productivity in JB beef cattle.	[Tong, B.; Sasaki, S.; Yamada, T.] Niigata Univ, Fac Agr, Dept Agrobiol, Nishi Ku, Niigata 9502181, Japan; [Li, G. P.] Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Hohhot 010021, Peoples R China; [Muramatsu, Y.] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Dept Nutr Sci Well Being, Osaka 5820026, Japan; [Ohta, T.] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Kose, H.] Int Christian Univ, Div Nat Sci, Dept Life Sci, Mitaka, Tokyo 1818585, Japan	Yamada, T (reprint author), Niigata Univ, Fac Agr, Dept Agrobiol, Nishi Ku, Niigata 9502181, Japan.	tyamada@agr.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [14360166]; Japanese Livestock Technology Association	This work was supported by a Grant-in-Aid for Scientific Research (B) (no. 14360166) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the research funds of Japanese Livestock Technology Association.	NEI M, 1974, GENETICS, V76, P379; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Kamanga-Sollo E, 2011, J ANIM SCI, V89, P3473, DOI 10.2527/jas.2011-4123; Borkhardt A, 2001, GENE CHROMOSOME CANC, V32, P82, DOI 10.1002/gcc.1169; Goss R, 1986, HUMAN GROWTH, P3; Kalikin LM, 2000, GENOMICS, V63, P165, DOI 10.1006/geno.1999.6077; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Martinez C, 2004, BIOCHEM J, V382, P783; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Russell SEH, 2000, CANCER RES, V60, P4729; Takasuga A, 2007, MAMM GENOME, V18, P125, DOI 10.1007/s00335-006-0096-5; Taki T, 1999, CANCER RES, V59, P4261	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	APR	2015	46	2					200	204		10.1111/age.12274		5	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CD9HX	WOS:000351410200012		
J	Hirata, D; Doichev, VD; Raichev, EG; Palova, NA; Nakev, JL; Yordanov, YM; Kaneko, Y; Masuda, R				Hirata, D.; Doichev, V. D.; Raichev, E. G.; Palova, N. A.; Nakev, J. L.; Yordanov, Y. M.; Kaneko, Y.; Masuda, R.			Genetic variation of the East Balkan Swine (Sus scrofa) in Bulgaria, revealed by mitochondrial DNA and Y chromosomal DNA	ANIMAL GENETICS			English	Article						aboriginal pig; Asian pig; Balkan Peninsula; control region; domestic pig; domestication; European pig; haplotype	DOMESTICATION	East Balkan Swine (EBS) Sus scrofa is the only aboriginal domesticated pig breed in Bulgaria and is distributed on the western coast of the Black Sea in Bulgaria. To reveal the breed's genetic characteristics, we analysed mitochondrial DNA (mtDNA) and Y chromosomal DNA sequences of EBS in Bulgaria. Nucleotide diversity ((n)) of the mtDNA control region, including two newly found haplotypes, in 54 EBS was higher (0.014 +/- 0.007) compared with that of European (0.005 +/- 0.003) and Asian (0.006 +/- 0.003) domestic pigs and wild boar. The median-joining network based on the mtDNA control region showed that the EBS and wild boar in Bulgaria comprised mainly two major mtDNA clades, European clade E1 (61.3%) and Asian clade A (38.7%). The coexistence of two mtDNA clades in EBS in Bulgaria may be the relict of historical pig translocation. Among the Bulgarian EBS colonies, the geographical differences in distribution of two mtDNA clades (E1 and A) could be attributed to the source pig populations and/or historical crossbreeding with imported pigs. In addition, analysis of the Y chromosomal DNA sequences for the EBS revealed that all of the EBS had haplotype HY1, which is dominant in European domestic pigs.	[Hirata, D.; Masuda, R.] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Doichev, V. D.; Raichev, E. G.] Trakia Univ, Fac Agr Sci, Stara Zagora 6000, Bulgaria; [Palova, N. A.] Agr Expt Stn, Sredets 8300, Bulgaria; [Nakev, J. L.; Yordanov, Y. M.] Inst Agr, Shumen 9700, Bulgaria; [Kaneko, Y.] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan	Masuda, R (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	masudary@mail.sci.hokudai.ac.jp	Kaneko, Yayoi/G-1162-2013	Kaneko, Yayoi/0000-0002-3688-4309	Japan Society for the Promotion of Science [22405003, 26257404]	This study was conducted as international partnership agreements between Faculty of Agriculture of Trakia University and Faculty of Science of Hokkaido University, and between Trakia University and Tokyo University of Agriculture and Technology. We thank Drs. D. Pavlov, G. Mihaylova, M. Panayotov, R. Slavov and T. Fukushima for their helpful supports on this mammal project. We are also grateful to Dr. H. Tsunoda and Mr. M. Hisano for useful suggestions. This study was partly supported by Grants-in-Aid for Scientific Research (No. 22405003 and 26257404) from the Japan Society for the Promotion of Science.	Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Georgiev I., 1964, J ANIM SCI, V2, P3; Georgiev I., 1964, J ANIM SCI, V3, P15; Ivanova-Peneva S. G., 2005, SYSTEMS DEV QUALITY, P97; Jones GF, 1998, GENETICS OF THE PIG, P17	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	APR	2015	46	2					209	212		10.1111/age.12269		4	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CD9HX	WOS:000351410200014		
J	Asakura, F; Corli, A				Asakura, Fumioki; Corli, Andrea			Wave-front tracking for the equations of non-isentropic gas dynamics	ANNALI DI MATEMATICA PURA ED APPLICATA			English	Article						Hyperbolic systems of conservation laws; Gas dynamics equations; Wave-front tracking	HYPERBOLIC CONSERVATION-LAWS; MULTIPHASE FLOW; SYSTEMS; MODEL	We study the model equations of polytropic gas dynamics, which constitute a system of three hyperbolic conservation laws. Global in time BV solutions were obtained by Liu (Indiana Univ Math J 26(1):147-177, 1977) provided that (gamma - 1) times the total variation of the initial data is sufficiently small; here gamma is the adiabatic coefficient. The aim of this paper is to give an alternative proof by exploiting the Dafermos-Bressan-Risebro wave-front tracking scheme. An original feature is the use of the path decomposition method to obtain pathwise estimates of the approximate solutions; these estimates show the decay properties of the solutions and play a crucial role in proving the stability of the wave-front tracking scheme.	[Asakura, Fumioki] Osaka Electrocommun Univ, Dept Engn Sci, Neyagawa, Osaka 572, Japan; [Corli, Andrea] Univ Ferrara, Dept Math & Comp Sci, I-44100 Ferrara, Italy	Corli, A (reprint author), Univ Ferrara, Dept Math & Comp Sci, I-44100 Ferrara, Italy.	asakura@isc.osakac.ac.jp; andrea.corli@unife.it					Amadori D, 2008, SIAM J MATH ANAL, V40, P134, DOI 10.1137/07069211X; Goatin P, 2003, COMMUN PURE APPL ANA, V2, P107; DAFERMOS CM, 1972, J MATH ANAL APPL, V38, P33, DOI 10.1016/0022-247X(72)90114-X; TEMPLE JB, 1981, J DIFFER EQUATIONS, V41, P96, DOI 10.1016/0022-0396(81)90055-3; Asakura F, 2005, Q APPL MATH, V63, P20; RISEBRO NH, 1993, P AM MATH SOC, V117, P1125; Asakura F., 1993, JAPAN J IND APPL MAT, V10, P133; Asakura F, 2013, Q APPL MATH, V71, P135; Asakura F., 2013, ACTA MATH VIETNAM, V38, P487; BRESSAN A, 1992, J MATH ANAL APPL, V170, P414, DOI 10.1016/0022-247X(92)90027-B; Bressan A, 2000, HYPERBOLIC SYSTEMS C; Dafermos CM, 2010, GRUNDLEHR MATH WISS, V325, P1, DOI 10.1007/978-3-642-04048-1; Fermi E., 1956, THERMODYNAMICS; GLIMM J, 1965, COMMUN PUR APPL MATH, V18, P697, DOI 10.1002/cpa.3160180408; GLIMM J, 1970, MEM AM MATH SOC, P1; Holden H, 2009, J HYPERBOL DIFFER EQ, V6, P25, DOI 10.1142/S0219891609001757; LIU TP, 1977, INDIANA U MATH J, V26, P147, DOI 10.1512/iumj.1977.26.26011; NISHIDA T, 1968, P JPN ACAD, V44, P642; Nishida T, 1978, NONLINEAR HYPERBOLIC, P78; NISHIDA T, 1973, COMMUN PUR APPL MATH, V26, P183, DOI 10.1002/cpa.3160260205; Smoller J., 1994, SHOCK WAVES REACTION; Temple B, 1996, COMMUN MATH PHYS, V179, P417, DOI 10.1007/BF02102596	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0373-3114	1618-1891		ANN MAT PUR APPL	Ann. Mat. Pura Appl.	APR	2015	194	2					581	618		10.1007/s10231-013-0390-2		38	Mathematics, Applied; Mathematics	Mathematics	CD9AT	WOS:000351388800014		
J	Sakurada, T; Kakiuchi, S; Tajima, S; Horinouchi, Y; Okada, N; Nishisako, H; Nakamura, T; Teraoka, K; Kawazoe, K; Yanagawa, H; Nishioka, Y; Minakuchi, K; Ishizawa, K				Sakurada, Takumi; Kakiuchi, Soji; Tajima, Soichiro; Horinouchi, Yuya; Okada, Naoto; Nishisako, Hirotaka; Nakamura, Toshimi; Teraoka, Kazuhiko; Kawazoe, Kazuyoshi; Yanagawa, Hiroaki; Nishioka, Yasuhiko; Minakuchi, Kazuo; Ishizawa, Keisuke			Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer	ANNALS OF PHARMACOTHERAPY			English	Article						drug-induced interstitial lung disease; chemotherapy; lung cancer; risk factors; poor prognosis factors	IDIOPATHIC PULMONARY-FIBROSIS; JAPANESE PATIENTS; PREDICTIVE FACTORS; GEFITINIB; THERAPY; EXACERBATION; RADIATION; ERLOTINIB; SURVIVAL; COHORT	Background: Drug-induced interstitial lung disease (DILD) is generally a serious adverse effect and almost always necessitates the discontinuation of the offending drug. Cancer pharmacotherapy is strongly associated with DILD, and the risk of DILD has been suggested to be higher in patients with lung cancer because of preexisting pneumonic disease. Objective: The aim of this retrospective study was to identify the risk factors and prognostic factors for early death from interstitial lung disease (ILD) induced by chemotherapy for lung cancer. Methods: The medical records of 459 patients who underwent chemotherapy for lung cancer between April 2007 and March 2013 were analyzed with regard to patient background and DILD development, initial symptoms, and prognosis. Results: A total of 33 patients (7.2%) developed chemotherapy-induced ILD. The most frequently observed initial symptom was dyspnea (94.3%). Preexisting ILD was identified as a risk factor for DILD (odds ratio [OR] = 5.38; 95% CI = 2.47-11.73; P < 0.01). Among the 33 patients who developed DILD, 10 patients suffered an early death despite steroid therapy. Poor prognostic factors included epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) use (OR = 9.26; 95% Cl = 1.05-82.0; P < 0.05) and 2 or more prior chemotherapy regimens (OR = 6.95; 95% CI = 1.14-42.3; P < 0.05). Conclusions: Many lung cancer patients have coexisting ILD, and these patients have a high risk of developing chemotherapy-induced ILD. In addition, patients with DILD who underwent EGFR-TKI therapy and 2 or more prior chemotherapy regimens had a higher risk of fatal outcome.	[Sakurada, Takumi; Horinouchi, Yuya; Okada, Naoto; Nishisako, Hirotaka; Nakamura, Toshimi; Teraoka, Kazuhiko; Kawazoe, Kazuyoshi; Minakuchi, Kazuo; Ishizawa, Keisuke] Tokushima Univ Hosp, Dept Pharm, Tokushima 7708503, Japan; [Kakiuchi, Soji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Oncol, Tokushima, Japan; [Kakiuchi, Soji; Nishioka, Yasuhiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Resp Med & Rheumatol, Tokushima, Japan; [Tajima, Soichiro] Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan; [Kawazoe, Kazuyoshi; Minakuchi, Kazuo; Ishizawa, Keisuke] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Pharm, Tokushima, Japan; [Yanagawa, Hiroaki] Tokushima Univ Hosp, Clin Trial Ctr Dev Therapeut, Tokushima 7708503, Japan	Sakurada, T (reprint author), Tokushima Univ Hosp, Dept Pharm, 2-50-1 Kuramoto Cho, Tokushima 7708503, Japan.	sakurada@tokushima-u.ac.jp					Allen JN, 2004, CLIN CHEST MED, V25, P77, DOI 10.1016/S0272-5231(03)00141-2; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Kawasaki H, 2002, J SURG ONCOL, V81, P33, DOI 10.1002/jso.10145; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Minami-Shimmyo Y, 2012, J THORAC ONCOL, V7, P177, DOI 10.1097/JTO.0b013e31823c4c07; Umemura S, 2011, J CANCER RES CLIN, V137, P1469, DOI 10.1007/s00432-011-1013-1; Hotta K, 2010, J THORAC ONCOL, V5, P179, DOI 10.1097/JTO.0b013e3181ca12e0; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Matsushita H, 1995, PATHOL INT, V45, P925, DOI 10.1111/j.1440-1827.1995.tb03417.x; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Saito Y, 2012, INT J CLIN ONCOL, V17, P534, DOI 10.1007/s10147-012-0494-5; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; Azuma A., 2007, JMAJ - Japan Medical Association Journal, V50, P405; Azuma A, 2008, AM J RESP CRIT CARE, V177, P1397; Danson S, 2005, DRUG SAFETY, V28, P103, DOI 10.2165/00002018-200528020-00002; Goto Hisatsugu, 2011, J Med Invest, V58, P219; Hotta K, 2005, CANCER J, V11, P417, DOI 10.1097/00130404-200509000-00010; Kinoshita A, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P852; Limper AH, 2004, CLIN CHEST MED, V25, P53, DOI 10.1016/S0272-5231(03)00123-0; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063	29	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	APR	2015	49	4					398	404		10.1177/1060028014566446		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD8EQ	WOS:000351328400003		
J	Yoshitake, A; Hachiya, T; Itoh, T; Kitahara, H; Kasai, M; Kawaguchi, S; Shimizu, H				Yoshitake, Akihiro; Hachiya, Takashi; Itoh, Takahito; Kitahara, Hiroto; Kasai, Mio; Kawaguchi, Shinji; Shimizu, Hideyuki			Nonvisualized Type III Endoleak Masquerading as Endotension: A Case Report	ANNALS OF VASCULAR SURGERY			English	Article							ENDOVASCULAR ANEURYSM REPAIR; ABDOMINAL AORTIC-ANEURYSMS; SAC ENLARGEMENT; GRAFT; PRESSURE	Here, we describe a case of nonvisualized type III endoleak masquerading as endotension that was diagnosed by opening the aneurysm sac during surgery and successfully treated surgically. A 79-year-old man underwent endovascular aneurysm repair (EVAR) 4 years previously for an aneurysm that had enlarged gradually without endoleak. An open surgical operation was performed. The sac pressure was 132 mm Hgdsimilar to the preoperative systolic blood pressure-and nonpulsatile. After the aneurysm sac was opened without clamping the aorta, a type III endoleak from the suture point of the prosthetic endograft was detected. The prosthetic graft was successfully replaced with a Y-graft. The current findings suggest that nonvisualized type III endoleaks may be a potential cause of endotension.	[Yoshitake, Akihiro; Hachiya, Takashi; Itoh, Takahito; Kitahara, Hiroto; Kasai, Mio; Kawaguchi, Shinji; Shimizu, Hideyuki] Keio Univ, Sch Med, Dept Cardiovasc Surg, Tokyo, Japan	Yoshitake, A (reprint author), Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	akihiro197253@yahoo.co.jp					Golzarian J, 2006, EUR RADIOL, V16, P2849, DOI 10.1007/s00330-005-0129-6; Stolzmann P, 2008, RADIOLOGY, V249, P682, DOI 10.1148/radiol.2483080193; White GH, 1999, J ENDOVASC SURG, V6, P308, DOI 10.1583/1074-6218(1999)006<0308:EAEFCA>2.0.CO;2; Alsac JM, 2005, EUR J VASC ENDOVASC, V30, P632, DOI 10.1016/k.ejvs.2005.06.010; Gorich J, 2001, RADIOLOGY, V218, P477; Gawenda M, 2003, EUR J VASC ENDOVASC, V26, P501, DOI 10.1016/S1078-5884(03)00378-2; Goodney PP, 2007, J VASC SURG, V45, P686, DOI 10.1016/j.jvs.2006.12.025; Kar B, 2002, J ENDOVASC THER, V9, P901, DOI 10.1583/1545-1550(2002)009<0901:ASGIDT>2.0.CO;2; Kougias P, 2007, J VASC SURG, V46, P124, DOI 10.1016/j.jvs.2007.02.067; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Parodi JC, 2001, J VASC SURG, V34, P909, DOI 10.1067/mva.2001.119038; Risberg B, 2001, J ENDOVASC THER, V8, P447, DOI 10.1583/1545-1550(2001)008<0447:ASHACO>2.0.CO;2; Thoo CHC, 2004, J VASC SURG, V40, P1089, DOI 10.1016/j.jvs.2004.08.057; White GH, 2001, J ENDOVASC THER, V8, P454, DOI 10.1583/1545-1550(2001)008<0454:WATCOE>2.0.CO;2; White GH, 2000, J ENDOVASC THER, V7, P435, DOI 10.1583/1526-6028(2000)007<0435:HSEBDH>2.0.CO;2	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	APR	2015	29	3							595.e15	10.1016/j.avsg.2014.10.039		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CD4XC	WOS:000351088000032		
J	Bangash, A; Ahmed, I; Abbas, S; Kudo, T; Shahzad, A; Fujiwara, T; Ohkuma, M				Bangash, Asia; Ahmed, Iftikhar; Abbas, Saira; Kudo, Takuji; Shahzad, Armghan; Fujiwara, Toru; Ohkuma, Moriya			Kushneria pakistanensis sp nov., a novel moderately halophilic bacterium isolated from rhizosphere of a plant (Saccharum spontaneum) growing in salt mines of the Karak area in Pakistan	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Halophilic bacterium; Karak salt mines; Kushneria pakistanensis	FAMILY HALOMONADACEAE; HALOTOLERANT; AVICENNIAE; INDALININA	The taxonomic position of a Gram-stain negative, moderately halophilic bacterium, designated NCCP-934(T), was investigated using polyphasic taxonomic approach. The strain NCCP-934(T) was isolated from rhizosphere of a plant (Saccharum spontaneum, family Poaceae) growing in salt mines area in the Karak district of Khyber Pakhtunkhwa Province, Pakistan. Cells of strain NCCP-934(T) are rod shaped and motile. The bacterium is strictly aerobic, can grow at a temperature range of 10-40 A degrees C (optimum at 30-33 A degrees C) and in a pH range of 6.0-10.5 (optimum pH 7.0-9.0). The strain can tolerate 1-30 % (w/v) NaCl (optimal growth occurs in the presence of approximately 3-9 % NaCl). The phylogenetic analysis based on the 16S rRNA gene sequence, showed that strain NCCP-934(T) belongs to the genus Kushneria with the highest sequence similarity to K. marisflavi SW32(T) (98.9 %), K. indalinina CG2.1(T) (98.7 %), K. avicenniae MW2a(T) (98.4 %) and less than 97 % similarity with other related species (94.7 % with the type species of the genus, K. aurantia A10(T)). DNA-DNA relatedness between strain NCCP-934(T) and the type strains of the closely related species was lower than 18 %. The chemotaxonomic data (major respiratory quinone, Q9; predominant fatty acids, C-18:1 omega 7c and C-16:0 followed by C-12:0 3-OH and Summed features 3 (C-16:1 omega 7c/iso-C-15:0 2-OH); major polar lipids, diphosphatidylglycerol, phosphatidylglycerol, phosphatidylmonomethylethanol, phosphatidylserine, phosphatidylinositol and three polar lipid of unknown structure) supported the affiliation of strain NCCP-934(T) within the genus Kushneria. The DNA G+C content of strain NCCP-934(T) was 59.2 mol%. On the basis of phenotypic, chemotaxonomic and phylogenetic data, strain NCCP-934(T) can be distinguished from the closely related taxa and thus represents a novel species in the genus Kushneria, for which the name Kushneria pakistanensis sp. nov. is proposed, with the type strain NCCP-934(T) (=LMG 28525(T) = KCTC 42082(T) = JCM 18802(T)).	[Bangash, Asia; Ahmed, Iftikhar; Abbas, Saira; Shahzad, Armghan] NARC, NIGAB, Natl Culture Collect Pakistan, Islamabad 45500, Pakistan; [Bangash, Asia] Quaid i Azam Univ, Dept Biochem, Islamabad, Pakistan; [Ahmed, Iftikhar; Abbas, Saira; Kudo, Takuji; Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan; [Ahmed, Iftikhar; Abbas, Saira; Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Lab Plant Nutr & Fertilizers,Bunkyo Ku, Tokyo 1138657, Japan	Ahmed, I (reprint author), NARC, NIGAB, Natl Culture Collect Pakistan, Pk Rd, Islamabad 45500, Pakistan.	iftikharnarc@hotmail.com	Ohkuma, Moriya/A-8100-2011; AHMED, IFTIKHAR/B-4694-2009	AHMED, IFTIKHAR/0000-0003-0969-7927	PSDP from Pakistan Agricultural Research Council (PARC), Islamabad, Pakistan [CS-55/RADP/PARC]; Japan Society for Promotion of Science (JSPS)	This work was supported partly by financial assistance from PSDP funded Project Research for Agricultural Development Project (RADP) under a sub-project (Grant No. CS-55/RADP/PARC) entitled "Establishment of Microbial Bio-Resource Laboratories: National Culture Collection of Pakistan (NCCP)'' from Pakistan Agricultural Research Council (PARC), Islamabad, Pakistan and partially from Japan Society for Promotion of Science (JSPS) under fellowship program to I.A.	Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; Arahal DR, 2007, INT J SYST EVOL MICR, V57, P2436, DOI 10.1099/ijs.0.65430-0; Cabrera A, 2007, INT J SYST EVOL MICR, V57, P376, DOI 10.1099/ijs.0.64702-0; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Soto-Ramirez N, 2007, INT J SYST EVOL MICR, V57, P900, DOI 10.1099/ijs.0.64818-0; Roohi A, 2014, ANTON LEEUW INT J G, V105, P1163, DOI 10.1007/s10482-014-0177-5; Sorokin DY, 2005, INT J SYST EVOL MICR, V55, P1405, DOI 10.1099/ijs.0.63737-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504; Ahmed I, 2007, EXTREMOPHILES, V11, P217, DOI 10.1007/s00792-006-0027-0; Roohi A, 2014, INT J AGRIC BIOL, V16, P564; Kudo T, 2001, IDENTIFICATION MANUA, P135; LPSN, 2014, LIST PROKARYOTES STA; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Roohi A, 2012, PAK J BOT, V44, P365; Sanchez-Porro C, 2009, INT J SYST EVOL MICR, V59, P397, DOI 10.1099/ijs.0.001461-0; Sasser M., 1990, 101 MIDI; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P1171; Zou ZZ, 2010, INT J SYST EVOL MICR, V60, P1881, DOI 10.1099/ijs.0.013797-0	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	APR	2015	107	4					991	1000		10.1007/s10482-015-0391-9		10	Microbiology	Microbiology	CD7VD	WOS:000351301600014		
J	Nishikiori, H; Kanada, N; Setiawan, RA; Morita, K; Teshima, K; Fujii, T				Nishikiori, Hiromasa; Kanada, Naohiro; Setiawan, Rudi Agus; Morita, Koji; Teshima, Katsuya; Fujii, Tsuneo			Photoelectrochemical properties of dye-dispersing allophane-titania composite electrodes	APPLIED CLAY SCIENCE			English	Article						Allophane; Titania; Fluorescein; Photoelectrochemistry; Electron injection	SENSITIZED SOLAR-CELLS; TIO2 FILM PHOTOANODE; BLOCKING LAYERS; CONVERSION PROPERTIES; O-2-REDUCING CATHODE; GEL FILMS; FLUORESCEIN; DEGRADATION; INJECTION; TRICHLOROETHYLENE	Dye-dispersing allophane-titania composite electrodes were prepared from titanium alkoxide sols containing dye and allophane. The photoelectric conversion properties of the electrodes were investigated by photoelectrochemical measurements. The photocurrent values in the UV range decreased with an increase in the allophane content, whereas those in the visible range were increased by adding 1.0% (Al/Ti ratio) allophane. As a small amount of allophane nanoparticles were highly dispersed in the titania electrodes, the dye molecules were dispersed in the electrodes without decreasing the efficiency of the electron injection from the dye to the titania conduction band. The dye molecules dispersed on the titania nanoparticle surface were capped with allophane nanoparticles which prevented desorption. The dye molecules strongly interacted with the titania nanoparticle surface and efficiently injected the excited electrons into the titania conduction band. (C) 2015 Elsevier B.V. All rights reserved.	[Nishikiori, Hiromasa; Kanada, Naohiro; Setiawan, Rudi Agus; Morita, Koji; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan; [Fujii, Tsuneo] Nagano Prefectural Inst Technol, Ueda, Nagano 3861211, Japan	Nishikiori, H (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, 4-17-1 Wakasato, Nagano 3808553, Japan.	nishiki@shinshu-u.ac.jp			JSPS KAKENHI [24550153]	This work was supported by JSPS KAKENHI Grant Number 24550153.	Cameron PJ, 2003, J PHYS CHEM B, V107, P14394, DOI 10.1021/jp030790+; DISLICH H, 1971, ANGEW CHEM INT EDIT, V10, P363, DOI 10.1002/anie.197103631; Antoniadou M, 2010, SOL ENERG MAT SOL C, V94, P592, DOI 10.1016/j.solmat.2009.12.004; Asbury JB, 2003, J PHYS CHEM B, V107, P7376, DOI 10.1021/jp034148r; BRINKER CJ, 1991, THIN SOLID FILMS, V201, P97, DOI 10.1016/0040-6090(91)90158-T; FUJII T, 1992, RES CHEM INTERMEDIAT, V17, P1; Wang LL, 2001, SPECTROCHIM ACTA A, V57, P1781, DOI 10.1016/S1386-1425(01)00408-5; Ueno H, 2009, J APPL ELECTROCHEM, V39, P1897, DOI 10.1007/s10800-009-9897-z; Suarez S, 2008, ENVIRON SCI TECHNOL, V42, P5892, DOI 10.1021/es703257w; Hewer TLR, 2009, CATAL TODAY, V143, P302, DOI 10.1016/j.cattod.2009.02.001; Patrocinio AOT, 2009, J PHOTOCH PHOTOBIO A, V205, P23, DOI 10.1016/j.jphotochem.2009.04.008; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Hilgendorff M, 1998, J PHYS CHEM B, V102, P10505, DOI 10.1021/jp982210s; Kimura M, 2012, ANGEW CHEM INT EDIT, V51, P4371, DOI 10.1002/anie.201108610; Gratzel M, 2003, J PHOTOCH PHOTOBIO C, V4, P145, DOI 10.1016/S1389-5567(03)00026-1; Ramakrishna G, 2001, J PHYS CHEM B, V105, P7000, DOI 10.1021/jp011291g; Kaneko M, 2006, ELECTROCHEM COMMUN, V8, P336, DOI 10.1016/j.elecom.2005.12.004; Du LC, 2010, J PHYS CHEM C, V114, P8135, DOI 10.1021/jp911418g; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; El Mekkawi D, 2005, INT J PHOTOENERGY, V7, P95, DOI 10.1155/S1110662X05000140; Antoniadou M, 2010, APPL CATAL B-ENVIRON, V99, P307, DOI 10.1016/j.apcatb.2010.06.037; Benko G, 2002, J AM CHEM SOC, V124, P489, DOI 10.1021/ja016561n; Bergaya F, 2006, DEV CLAY SCI, V1, P1; Brinker C. J., 1991, J CERAM SOC JPN, V99, P862; Brinker C.J., 1990, SOL GEL SCI PHYS CHE; Cea M, 2007, CHEMOSPHERE, V67, P1354, DOI 10.1016/j.chemosphere.2006.10.080; Cid JJ, 2007, ANGEW CHEM INT EDIT, V46, P8358, DOI 10.1002/anie.200703106; DISLICH H, 1983, J NON-CRYST SOLIDS, V57, P371, DOI 10.1016/0022-3093(83)90425-8; Griffith MJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3576904; HALL PL, 1985, CLAY CLAY MINER, V33, P345, DOI 10.1346/CCMN.1985.0330411; Hanudin E., 1999, Clay Science, V11, P57; Hart JN, 2006, CR CHIM, V9, P622, DOI 10.1016/j.crci.2005.02.052; HENMI T, 1976, AM MINERAL, V61, P379; KITAGAWA Y, 1971, AM MINERAL, V56, P465; Kitayama Y, 1998, J POROUS MAT, V5, P121, DOI 10.1023/A:1009637219763; Kitsui T., 2006, J PHOTOCH PHOTOBIO A, V192, P220; Nishikiori H, 2012, RES CHEM INTERMEDIAT, V38, P241, DOI 10.1007/s11164-011-0343-6; Nishikiori H, 2014, PHOTOCHEM PHOTOBIOL, V90, P747, DOI 10.1111/php.12254; Nishikiori H, 2013, CATAL SCI TECHNOL, V3, P1512, DOI 10.1039/c3cy00007a; Nishikiori H, 2007, J PHYS CHEM C, V111, P9008, DOI 10.1021/jp072625q; Nishikiori H, 2012, CHEM LETT, V41, P725, DOI 10.1246/cl.2012.725; Nishikiori H, 2011, J PHYS CHEM C, V115, P2880, DOI 10.1021/jp109958z; Nishikiori H, 2011, APPL CATAL B-ENVIRON, V106, P250, DOI 10.1016/j.apcatb.2011.05.035; Nishikiori H, 2010, APPL CLAY SCI, V47, P325, DOI 10.1016/j.clay.2009.11.040; Nishikiori H, 2011, APPL CATAL B-ENVIRON, V102, P470, DOI 10.1016/j.apcatb.2010.12.028; Nishikiori H, 2013, CHEM LETT, V42, P556, DOI 10.1246/cl.130089; Nishikiori H, 2009, APPL CLAY SCI, V43, P160, DOI 10.1016/j.clay.2008.07.024; Nishikiori H, 2014, APPL CATAL B-ENVIRON, V147, P246, DOI 10.1016/j.apcatb.2013.09.003; Nishikiori H, 2012, J PHYS CHEM C, V116, P4848, DOI 10.1021/jp2094388; Ozawa H., 2011, RSC ADV, V2, P3198; Setiawan RA, 2013, J PHYS CHEM C, V117, P10308, DOI 10.1021/jp4024537; Sharma GD, 2009, MATER SCI ENG B-ADV, V162, P32, DOI 10.1016/j.mseb.2009.01.033; Tao T, 1999, ENVIRON SCI TECHNOL, V33, P74, DOI 10.1021/es980435a; VANDERGAAST SJ, 1985, CLAY CLAY MINER, V33, P237, DOI 10.1346/CCMN.1985.0330310; WADA SI, 1977, CLAY MINER, V12, P289, DOI 10.1180/claymin.1977.012.4.02; Xu SH, 1998, ENVIRON SCI TECHNOL, V32, P1199, DOI 10.1021/es9708676; YONEYAMA H, 1989, J PHYS CHEM-US, V93, P4833, DOI 10.1021/j100349a031	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	APR	2015	107						138	144		10.1016/j.clay.2015.01.015		7	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CE2KX	WOS:000351645600018		
J	Nagai, H				Nagai, Hideo			H-J-B Equations of Optimal Consumption-Investment and Verification Theorems	APPLIED MATHEMATICS AND OPTIMIZATION			English	Article						Utility maximization; Risk-sensitive stochastic control; Factor models; H-J-B equation; Infinite time horizon	RISK-SENSITIVE CONTROL; JACOBI-BELLMAN EQUATION; STOCHASTIC VOLATILITY; MARKETS; MODEL	We consider a consumption-investment problem on infinite time horizon maximizing discounted expected HARA utility for a general incomplete market model. Based on dynamic programming approach we derive the relevant H-J-B equation and study the existence and uniqueness of the solution to the nonlinear partial differential equation. By using the smooth solution we construct the optimal consumption rate and portfolio strategy and then prove the verification theorems under certain general settings.	Kansai Univ, Dept Math, Fac Engn Sci, Suita, Osaka 5648680, Japan	Nagai, H (reprint author), Kansai Univ, Dept Math, Fac Engn Sci, Suita, Osaka 5648680, Japan.	nagaih@kansai-u.ac.jp			JSPS [25400150, 23244015, 23340028]	Supported in part by a grant-in-aid for Scientific Research 25400150, 23244015, 23340028 JSPS.	KARATZAS I, 1986, MATH OPER RES, V11, P261, DOI 10.1287/moor.11.2.261; COX JC, 1989, J ECON THEORY, V49, P33, DOI 10.1016/0022-0531(89)90067-7; Liu J, 2007, REV FINANC STUD, V20, P1, DOI 10.1093/rfs/hhl001; Chacko G, 2005, REV FINANC STUD, V18, P1369, DOI 10.1093/rfs/hhi035; Hata H, 2012, SIAM J CONTROL OPTIM, V50, P2373, DOI 10.1137/110794845; Fleming WH, 2004, SIAM J CONTROL OPTIM, V43, P502, DOI 10.1137/S0363012902419060; Fleming WH, 2003, FINANC STOCH, V7, P245, DOI 10.1007/s007800200083; Kaise H, 1999, ASYMPTOTIC ANAL, V20, P279; Bensoussan A., 1992, STOCHASTIC CONTROL P; Fleming WH, 2005, APPL MATH OPT, V52, P219, DOI 10.1007/s00245-005-0826-1; Hata H, 2012, SIAM J CONTROL OPTIM, V50, P2401, DOI 10.1137/110794857; Kaise H, 2006, ANN PROBAB, V34, P284, DOI 10.1214/009117905000000431; Ladyzhenskaya O.A., 1968, LINEAR QUASILINEAR E; MERTON RC, 1971, J ECON THEORY, V3, P373, DOI 10.1016/0022-0531(71)90038-X; Nagai H, 2012, ANN APPL PROBAB, V22, P608, DOI 10.1214/11-AAP781; Nagai H, 1996, SIAM J CONTROL OPTIM, V34, P74, DOI 10.1137/S0363012993255302; NAGAI H, 1992, FORUM MATH, V4, P159, DOI 10.1515/form.1992.4.159; Parthasarathy K. P., 1967, PROBABILITY MEASURES; Pliska S.R., 1986, MATH OPER RES, V11, P239; Wachter J.A., 2002, J FINANCIAL QUANTITA, V37, P69	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-4616	1432-0606		APPL MATH OPT	Appl. Math. Optim.	APR	2015	71	2					279	311		10.1007/s00245-014-9258-0		33	Mathematics, Applied	Mathematics	CE1BP	WOS:000351546900003		
J	Xu, LH; Ikeda, H; Liu, L; Arakawa, T; Wakagi, T; Shoun, H; Fushinobu, S				Xu, Lian-Hua; Ikeda, Haruo; Liu, Ling; Arakawa, Takatoshi; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya			Structural basis for the 4'-hydroxylation of diclofenac by a microbial cytochrome P450 monooxygenase	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Diclofenac; Cytochrome P450; X-ray crystallography; Streptomyces avermitilis; Xenobiotics	STREPTOMYCES-COELICOLOR A3(2); CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; P450; HYDROXYLATION; EXPRESSION; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; DETERMINANTS; ACTIVATION; GENERATION	Diclofenac is a nonsteroidal anti-inflammatory drug. It undergoes hydroxylation by mammalian cytochrome P450 enzymes at 4'- and/or 5'-positions. A bacterial P450 enzyme, CYP105D7 from Streptomyces avermitilis, has been shown to catalyze hydroxylation of 1-deoxypentalenic acid and an isoflavone daidzein. Here, we demonstrated that CYP105D7 also catalyzes hydroxylation of diclofenac at the C4'-position. A spectroscopic analysis showed that CYP105D7 binds diclofenac in a slightly cooperative manner with an affinity of 65 mu M and a Hill coefficient of 1.16. The crystal structure of CYP105D7 in complex with diclofenac was determined at 2.2 resolution. The distal pocket of CYP105D7 contains two diclofenac molecules, illustrating drug recognition with a double-ligand-binding mode. The C3' and C4' atoms of the dichlorophenyl ring of one diclofenac molecule are positioned near the heme iron, suggesting that it is positioned appropriately for aromatic hydroxylation to yield the 4'-hydroxylated product. However, recognition of diclofenac by CYP105D7 was completely different from that of rabbit CYP2C5, which binds one diclofenac molecule with a cluster of water molecules. The distal pocket of CYP105D7 contains four arginine residues, forming a wall of the substrate-binding pocket, and the arginine residues are conserved in bacterial P450s in the CYP105 family.	[Xu, Lian-Hua; Liu, Ling] Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa 2520373, Japan; [Arakawa, Takatoshi; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Xu, LH (reprint author), Zhejiang Univ, Ocean Coll, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	lianhuaxu@zju.edu.cn; asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011	Fushinobu, Shinya/0000-0003-1346-6435	Japan Society for the Promotion of Science; fundamental research funds for the central universities [2013QNA4042]; National Natural Science Foundation [81402810]	We thank the staff of the Photon Factory for X-ray data collection. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. L-H.X. was supported by the fundamental research funds for the central universities (No. 2013QNA4042) and National Natural Science Foundation (No. 81402810).	Agematu H, 2006, BIOSCI BIOTECH BIOCH, V70, P307, DOI 10.1271/bbb.70.307; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Tsotsou GE, 2012, CHEM-EUR J, V18, P3582, DOI 10.1002/chem.201102470; OMURA T, 1964, J BIOL CHEM, V239, P2370; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Shen SJ, 1999, CHEM RES TOXICOL, V12, P214, DOI 10.1021/tx9802365; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Bates PA, 2001, PROTEINS, P39; Lamb DC, 2013, EXPERT OPIN DRUG MET, V9, P1279, DOI 10.1517/17425255.2013.806485; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Sawada N, 2004, BIOCHEM BIOPH RES CO, V320, P156, DOI 10.1016/j.bbrc.2004.05.140; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Bernhardt R, 2014, APPL MICROBIOL BIOT, V98, P6185, DOI 10.1007/s00253-014-5767-7; Fujita N, 2009, BIOSCI BIOTECH BIOCH, V73, P1825, DOI 10.1271/bbb.90199; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Guengerich FP, 2003, ARCH BIOCHEM BIOPHYS, V409, P59; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi0345561; DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813; Dickmann LJ, 2004, MOL PHARMACOL, V65, P842, DOI 10.1124/mol.65.4.842; Hayashi K, 2008, BIOCHEMISTRY-US, V47, P11964, DOI 10.1021/bi801222d; Mancy A, 1999, BIOCHEMISTRY-US, V38, P14264, DOI 10.1021/bi991195u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohyama K, 2014, XENOBIOTICA, V44, P10, DOI 10.3109/00498254.2013.806837; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey BP, 2010, BIOTECHNOL BIOENG, V105, P697, DOI 10.1002/bit.22582; Prior JE, 2010, APPL MICROBIOL BIOT, V85, P625, DOI 10.1007/s00253-009-2135-0; Ridderstrom M, 2000, BIOCHEM BIOPH RES CO, V270, P983, DOI 10.1006/bbrc.2000.2538; SERIZAWA N, 1991, BIOCHIM BIOPHYS ACTA, V1084, P35, DOI 10.1016/0005-2760(91)90052-J; Takamatsu S, 2011, J ANTIBIOT, V64, P65, DOI 10.1038/ja.2010.135; Taylor M, 1999, BIOCHEM BIOPH RES CO, V263, P838, DOI 10.1006/bbrc.1999.1427; TODD PA, 1988, DRUGS, V35, P244, DOI 10.2165/00003495-198835030-00004; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Yasutake Y, 2007, BIOCHEM BIOPH RES CO, V361, P876, DOI 10.1016/j.bbrc.2007.07.062; Zhao B, 2012, INT J MOL SCI, V13, P8500, DOI 10.3390/ijms13078500	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	APR	2015	99	7					3081	3091		10.1007/s00253-014-6148-y		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE1BW	WOS:000351547800013		
J	Tamano, K; Bruno, KS; Koike, H; Ishii, T; Miura, A; Umemura, M; Culley, DE; Baker, SE; Machida, M				Tamano, Koichi; Bruno, Kenneth S.; Koike, Hideaki; Ishii, Tomoko; Miura, Ai; Umemura, Myco; Culley, David E.; Baker, Scott E.; Machida, Masayuki			Increased production of free fatty acids in Aspergillus oryzae by disruption of a predicted acyl-CoA synthetase gene	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Acyl-CoA synthetase; Fatty acid; Biofuel; Productivity; Genetic engineering; Aspergillus oryzae	SACCHAROMYCES-CEREVISIAE; PHYLOGENOMIC ANALYSIS; SYSTEM; GROWTH	Fatty acids are attractive molecules as source materials for the production of biodiesel fuel. Previously, we attained a 2.4-fold increase in fatty acid production by increasing the expression of fatty acid synthesis-related genes in Aspergillus oryzae. In this study, we achieved an additional increase in the production of fatty acids by disrupting a predicted acyl-CoA synthetase gene in A. oryzae. The A. oryzae genome is predicted to encode six acyl-CoA synthetase genes and disruption of AO090011000642, one of the six genes, resulted in a 9.2-fold higher accumulation (corresponding to an increased production of 0.23 mmol/g dry cell weight) of intracellular fatty acid in comparison to the wild-type strain. Furthermore, by introducing a niaD marker from Aspergillus nidulans to the disruptant, as well as changing the concentration of nitrogen in the culture medium from 10 to 350 mM, fatty acid productivity reached 0.54 mmol/g dry cell weight. Analysis of the relative composition of the major intracellular free fatty acids caused by disruption of AO090011000642 in comparison to the wild-type strain showed an increase in stearic acid (7 to 26 %), decrease in linoleic acid (50 to 27 %), and no significant changes in palmitic or oleic acid (each around 20-25 %).	[Tamano, Koichi; Ishii, Tomoko; Miura, Ai; Umemura, Myco; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; [Bruno, Kenneth S.; Culley, David E.] Pacific NW Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA 99352 USA; [Baker, Scott E.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA; [Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan	Tamano, K (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.	tamano-k@aist.go.jp			Ministry of Economy, Trade, and Industry (METI), Japan; DOE EERE Office of the Biomass Program	This work was performed with support from a grant-in-aid from the Ministry of Economy, Trade, and Industry (METI), Japan. S. E. Baker and K. S. Bruno were supported by the DOE EERE Office of the Biomass Program.	Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367; Ichihara K, 2010, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Walters D, 2004, MYCOPATHOLOGIA, V157, P87, DOI 10.1023/B:MYCO.0000012222.68156.2c; Faergeman NJ, 1997, J BIOL CHEM, V272, P8531; Baker SE, 2012, MICROBIOL-SGM, V158, P147, DOI 10.1099/mic.0.053462-0; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; Chang PK, 2004, J APPL MICROBIOL, V97, P1178, DOI 10.1111/j.1365-2672.2004.02424.x; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051; GOODRIDG.AG, 1972, J BIOL CHEM, V247, P6946; HUH WK, 2003, NATURE, V0425; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; Marui J, 2010, J BIOSCI BIOENG, V110, P8, DOI 10.1016/j.jbiosc.2010.01.001; Reiser K, 2010, ARCH MICROBIOL, V192, P373, DOI 10.1007/s00203-010-0565-9; Tamano K, 2007, BIOSCI BIOTECH BIOCH, V71, P926, DOI 10.1271/bbb.60591; van Roermund CWT, 2000, J CELL BIOL, V150, P489, DOI 10.1083/jcb.150.3.489	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	APR	2015	99	7					3103	3113		10.1007/s00253-014-6336-9		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE1BW	WOS:000351547800015		
J	Liu, SX; Ishimoto, T; Koyama, M				Liu, Shixue; Ishimoto, Takayoshi; Koyama, Michihisa			First-principles study of oxygen coverage effect on hydrogen oxidation on Ni(111) surface	APPLIED SURFACE SCIENCE			English	Article						Oxygen coverage; Ni(111) surface; Oxidation reaction; Density functional theory	DENSITY-FUNCTIONAL THEORY; TOTAL-ENERGY CALCULATIONS; STEPPED NICKEL SURFACES; WAVE BASIS-SET; ELECTROCHEMICAL OXIDATION; WATER DISSOCIATION; NI(100) SURFACE; SOFC ANODE; CHEMISORPTION; ADSORPTION	The anodic oxidation reactions of solid oxide fuel cells are studied by density functional theory method under different oxygen coverage on the Ni(1 1 1) surface. Co-adsorbed atoms can change the binding energy of adsorbed species, and then affect the reaction barriers. We analyze the detailed structures and atomic charges to explain the mechanism of oxygen coverage effect. Our results indicate that higher oxygen coverage (in the range between 0 and 219) leads to lower oxidation reaction barriers. The main reason of the effect is the charge transfer between species and Ni surface was changed by the electron acceptor of co-adsorbed oxygen atoms. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Shixue; Ishimoto, Takayoshi; Koyama, Michihisa] Kyushu Univ, INAMORI Frontier Res Ctr, Fukuoka 8190395, Japan; [Liu, Shixue; Ishimoto, Takayoshi; Koyama, Michihisa] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Koyama, Michihisa] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Fukuoka 8190395, Japan	Liu, SX (reprint author), Kyushu Univ, INAMORI Frontier Res Ctr, Fukuoka 8190395, Japan.	sxliu@ifrc.kyushu-u.ac.jp; koyama@ifrc.kyushu-u.ac.jp			KYOCERA Corporation	The activities of INAMORI Frontier Research Center are supported by KYOCERA Corporation.	Jiao ZJ, 2012, J ELECTROCHEM SOC, V159, pF278, DOI 10.1149/2.056207jes; Goodwin DG, 2009, J ELECTROCHEM SOC, V156, pB1004, DOI 10.1149/1.3148331; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Gladys MJ, 2008, SURF SCI, V602, P3540, DOI 10.1016/j.susc.2008.09.031; Zhou YH, 2006, J MOL CATAL A-CHEM, V258, P203, DOI 10.1016/j.molcata.2006.04.013; Vogler M, 2009, J ELECTROCHEM SOC, V156, pB663, DOI 10.1149/1.3095477; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SIEGBAHN PEM, 1992, INT J QUANTUM CHEM, V42, P1149, DOI 10.1002/qua.560420506; Cucinotta CS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.206103; Cabrera-Sanfelix P, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155438; Mukherjee J, 2007, J ELECTROCHEM SOC, V154, pB919, DOI [10.1149/1.2752983, 10.1149/1.27529983]; Shishkin M, 2010, J PHYS CHEM C, V114, P11209, DOI 10.1021/jp1030575; Bessler WG, 2010, PHYS CHEM CHEM PHYS, V12, P13888, DOI 10.1039/c0cp00541j; Wang GC, 2006, J CATAL, V244, P10, DOI 10.1016/j.jcat.2006.07.034; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Blaylock DW, 2009, J PHYS CHEM C, V113, P4898, DOI 10.1021/jp806527q; Huang SC, 2010, J PHYS CHEM C, V114, P9826, DOI 10.1021/jp1005814; Zhu HY, 2012, J ELECTROCHEM SOC, V159, pF255, DOI 10.1149/2.046207jes; Mortensen JJ, 1998, SURF SCI, V414, P315, DOI 10.1016/S0039-6028(98)00311-2; Iwai H, 2010, J POWER SOURCES, V195, P955, DOI 10.1016/j.jpowsour.2009.09.005; Phatak AA, 2009, J PHYS CHEM C, V113, P7269, DOI 10.1021/jp810216b; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Pozzo M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2717172; Monder DS, 2010, J PHYS CHEM C, V114, P22597, DOI 10.1021/jp1076774; Mueller JE, 2009, J PHYS CHEM C, V113, P20290, DOI 10.1021/jp810555y; Shishkin M, 2009, J PHYS CHEM C, V113, P21667, DOI 10.1021/jp905615c; Bhatia B, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1902943; German ED, 2010, J PHYS CHEM C, V114, P3089, DOI 10.1021/jp910328g; Henkelman G, 2006, COMP MATER SCI, V36, P254; Klinke DJ, 1998, J CATAL, V178, P540, DOI 10.1006/jcat.1998.2175; Koyama M, 2007, ECS TRANSACTIONS, V7, P2057, DOI 10.1149/1.2729319; LI J, 1990, J PHYS CHEM-US, V94, P1554, DOI 10.1021/j100367a063; Mukherjee J., 2009, J ELECTROCHEM SOC, V156, pB1457; Pan M, 2011, CATAL TODAY, V160, P198, DOI 10.1016/j.cattod.2010.05.008; Quiller RG, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2965821; Sayago DI, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.116104; Sebastiani D, 2005, J CHEM THEORY COMPUT, V1, P78, DOI 10.1021/ct049955o; Seenivasan H, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4827641; Singhal S.C., 2003, HIGH TEMPERATURE SOL; Tao SX, 2006, J PHYS CHEM B, V110, P26045, DOI 10.1021/jp0649495; Wang SG, 2006, SURF SCI, V600, P3226, DOI 10.1016/j.susc.2006.06.008; Xing B, 2014, PHYS CHEM CHEM PHYS, V16, P2621, DOI 10.1039/c3cp53801j; YANG H, 1989, SURF SCI, V223, P131; YANG H, 1988, J CHEM PHYS, V89, P5329, DOI 10.1063/1.455624	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	APR 1	2015	333						86	91		10.1016/j.apsusc.2015.01.238		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CD1TT	WOS:000350857900011		
J	Trieu, TTN; Phong, NT				Tran Thi Ngoc Trieu; Nguyen Thanh Phong			The impact of climate change on salinity intrusion and Pangasius (Pangasianodon Hypophthalmus) farming in the Mekong Delta, Vietnam	AQUACULTURE INTERNATIONAL			English	Article						Climate change; Pangasius farming; Salinity intrusion; Scenario; Sea level rise	SEA-LEVEL RISE	The combined impact of sea level rise, changes in the upstream freshwater flow, and tidal regime on salinity intrusion that affects Pangasius (Pangasianodon hypophthalmus) farming in the Mekong Delta was assessed in this study. Salinity intrusion was simulated for the whole Mekong Delta by a 1D numerical model. The scenario derived from the SRES B2 climate change projection for Vietnam by the year 2100 (0.73 m of sea level rise and 29 % reduction of the Mekong River flow in the dry season). The simulated results suggest that the saline water will shift landward by 70-80 km which covers almost 63 % area of the Mekong Delta. Furthermore, it shows that the Pangasius farming area will be reduced by approximately 11 % with the shrinkage of the freshwater zone due to the salinity intrusion.	[Tran Thi Ngoc Trieu] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Nguyen Thanh Phong] Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan	Trieu, TTN (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	ngoctrieu1232003@yahoo.com					Anh PT, 2010, AQUAC RES, V42, P108, DOI 10.1111/j.1365-2109.2010.02578.x; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Lu XX, 2006, HYDROL EARTH SYST SC, V10, P181; Wassmann R, 2004, CLIMATIC CHANGE, V66, P89, DOI 10.1023/B:CLIM.0000043144.69736.b7; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Brown LC, 1985, EPA600385065; Chaudhry Peter, 2007, CLIMATE CHANGE HUMAN; EACC, 2010, EC ADAPTATION CLIMAT; FAO, 2010, STAT WORLD FISH AQ 1; Giang LS, 1999, S FLUID MECH NAT DIS, P124; Hang NTM, 2006, SCI TECHNOL DEV ENV, V9, P18; Hoang DC, 2005, STUDY ESTABLISHING C; Minh TH, 2009, FOC GROUP DISC STAK; Ministry of Natural Resources and Environment (MONRE), 2012, CLIM CHANG SEA LEV R; MONRE, 2009, CLIM CHANG SEA LEV R; MRC, 2005, SALTW INTR MEK RIV D; Ngo DV, 2007, J GEOL A, VA301, P7; Nguyen DK, 2008, J AGROMETEOROL, V64, P167; Parry M.L., 2007, CONTRIBUTION WORKING; Rahmstorf S, 2010, NATURE REPORTS CLIMA, V4, P44, DOI [10.1029/2010GL042947, DOI 10.1038/CLIMATE.2010.29]; SIWRR, 2011, SAL INTR MEK DELT 1; Tien V, 1993, FISHERIES MAGAZINE, P22; VASEP, 2012, IMP CLIM CHANG VIETN; VIFEP, 2009, PLANN AQ DEV VIETN M	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-6120	1573-143X		AQUACULT INT	Aquac. Int.	APR	2015	23	2					523	534		10.1007/s10499-014-9833-z		12	Fisheries	Fisheries	CD6WX	WOS:000351232200009		
J	Yokoyama, H				Yokoyama, Hisashi			Suspended culture of the sea cucumber Apostichopus japonicus below a Pacific oyster raft - potential for integrated multi-trophic aquaculture	AQUACULTURE RESEARCH			English	Article						sea cucumber; Apostichopus japonicus; Pacific oyster; co-culture; stable isotope	PARASTICHOPUS-CALIFORNICUS; STICHOPUS-JAPONICUS; GROWTH; HOLOTHUROIDEA; POLYCULTURE; SEDIMENTS; CARBON	To discuss the possibility of co-culturing Pacific oyster with the sea cucumber Apostichopus japonicus, a field experiment was conducted in an oyster farm. Apostichopus japonicus juveniles (mean wet weight, 0.08g) were cultured below an oyster raft and at a control station for 216days, and the wet weight and stable isotope ratios (C-13, N-15) were analysed together with settling organic matter (OM) collected using sediment traps. All sea cucumbers cultured below the raft survived (survival rate, 100%), while at the control station one individual disappeared (96%). During 216 days, the juveniles at the oyster and control stations grew to a mean weight of 5.5 and 2.6g, attaining respective specific growth rates of 2.0% and 1.6% (paired t-test, P<0.001). Settlement rates of carbon and nitrogen at the oyster station were similar to 5 times larger than those at the control station. The stable isotope analysis showed that settling OM at both stations originated from coastal phytoplankton and that phytoplankton represented the primary food source for A.japonicus. The rapid growth of A.japonicus at the oyster station was concluded to be due to the abundant supply of oyster biodeposits, which could be ingested by this species.	[Yokoyama, Hisashi] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan	Yokoyama, H (reprint author), Kyoto Univ, Field Sci Educ & Res Ctr, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	yokoyama.hisashi.2m@kyoto-u.ac.jp			Fisheries Research Agency	I thank Shigeya Yamamoto and Ikuo Hayashi for their assistance in the field survey. Mayumi Yamamoto assisted in the sample processing and Yuka Ishihi assisted in the isotopic analysis. Sincere thanks are also due to Shigeru Itani for his approval to use his oyster farm for the present field experiment. This study was supported by grants from Fisheries Research Agency.	Slater MJ, 2009, MAR POLLUT BULL, V58, P1123, DOI 10.1016/j.marpolbul.2009.04.008; Ahlgren MO, 1998, J WORLD AQUACULT SOC, V29, P133, DOI 10.1111/j.1749-7345.1998.tb00972.x; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Yuan XT, 2006, AQUACULTURE, V256, P457, DOI 10.1016/j.aquaculture.2006.01.029; Zhou Y, 2006, AQUACULTURE, V256, P510, DOI 10.1016/j.aquaculture.2006.02.005; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Slater MJ, 2007, AQUACULTURE, V272, P389, DOI 10.1016/j.aquaculture.2007.07.230; Slater MJ, 2009, AQUACULTURE, V292, P219, DOI 10.1016/j.aquaculture.2009.04.027; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Yokoyama H, 2013, AQUACULTURE, V372, P28, DOI 10.1016/j.aquaculture.2012.10.022; Slater MJ, 2010, AQUAC RES, V41, pe695, DOI 10.1111/j.1365-2109.2010.02607.x; Paltzat DL, 2008, AQUACULTURE, V275, P124, DOI 10.1016/j.aquaculture.2007.12.014; Chen J.X., 2004, ADV SEA CUCUMBER AQU, V463, P25; CHOE S., 1961, BULL JAPANESE SOC SCI FISH, V27, P97; GEARING JN, 1984, GEOCHIM COSMOCHIM AC, V48, P1089, DOI 10.1016/0016-7037(84)90199-6; Huiling S., 2004, ADV SEA CUCUMBER AQU, P287; Ito S., 1995, B SAGA PREFECTURAL S, V4, P1; Kang KH, 2003, AQUACULTURE, V216, P87, DOI 10.1016/S0044-8486(02)00203-X; Kusuki Y., 1981, B HIROSHIMA FISH EXP, V11, P1; Mori K., 1999, AQUACULTURE SCI, V47, P173; Pitt R., 2004, SPC BECHE DE MER INF, V20, P12; Ren Y. C., 2012, AQUAC RES, V45, P177; Ishihi Y, 2003, MAR ECOL PROG SER, V255, P303, DOI 10.3354/meps255303; Yokoyama H., 2006, PLANKTON BENTHOS RES, V1, P208, DOI DOI 10.3800/PBR.1.208; Yu ZongHe, 2013, Aquaculture Research, V44, P114	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	APR	2015	46	4					825	832		10.1111/are.12234		8	Fisheries	Fisheries	CD6DK	WOS:000351179500006		
J	Yokoyama, H; Tadokoro, D; Miura, M				Yokoyama, Hisashi; Tadokoro, Daiji; Miura, Masatsugu			Quantification of waste feed and fish faeces in sediments beneath yellowtail pens and possibility to reduce waste loading by co-culturing with sea cucumbers: an isotopic study	AQUACULTURE RESEARCH			English	Article						Apostichopus japonicus; aquaculture waste; fish farm; integrated multi-trophic aquaculture; sediment; stable isotope	APOSTICHOPUS-JAPONICUS; ORGANIC-MATTER; AQUACULTURE; MARINE; GROWTH; CARBON; JAPAN	To evaluate environmental impacts of yellowtail culture and to examine the efficiency of the sea cucumber Apostichopus japonicus in reduction of waste loading, surface sediments were sampled and A. japonicus were cultured at a yellowtail farm in Owase Bay, Japan. Waste feed- and faeces-derived organic matter (WOM, FOM) in sedimentary organic matter (SOM) was estimated based on the C-13 and N-15 of the fish feed (-21.7 parts per thousand, 9.2 parts per thousand), yellowtail faeces (-20.6 parts per thousand, 6.2 parts per thousand) and SOM reference (-24.4 parts per thousand, 4.4 parts per thousand). Small WOM (0-22% in SOM) but substantial FOM (28-61%) loadings in the fish farm area and high sulphide concentrations in the sediments (1.0 mg g(-1)) suggest that reduction in the fish stocks or mitigation of the faeces should be considered. A. japonicus juveniles were cultured in three cages deployed below a pen and growth was assessed after three different periods (62, 107, 181days). A. japonicus grew well during the first 107days (daily specific growth rate, 3.7%) and their survivorship was high (80-90%). Growth ceased after 107days, probably due to fouling on the cages. The C-13 and N-15 of their hypothetical diet (-19.7 parts per thousand, 5.5 parts per thousand) were close to the FOM values, suggesting assimilation of FOM.	[Yokoyama, Hisashi] Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Tadokoro, Daiji; Miura, Masatsugu] Owasebussan Co Ltd, Owase, Mie, Japan	Yokoyama, H (reprint author), Kyoto Univ, Field Sci Educ & Res Ctr, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	yokoyama.hisashi.2m@kyoto-u.ac.jp			Fisheries Research Agency	We thank Ikuo Hayashi for his assistance in the field survey, Yuka Ishihi for her assistance in the stable isotope analysis and Mayumi Yamamoto for her assistance in the sample processing. Sincere thanks are also due to the president of Owasebussan Co., Ltd., Hiroyuki Ono, who granted approval to conduct the investigation. This study was supported by grants from Fisheries Research Agency.	FRY B, 1984, CONTRIB MAR SCI, V27, P13; Yokoyama H, 2006, AQUACULTURE, V254, P411, DOI 10.1016/j.aquaculture.2005.10.024; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Dong SL, 2010, AQUAC RES, V41, P1170, DOI 10.1111/j.1365-2109.2009.02404.x; Yokoyama H, 2013, AQUACULTURE, V372, P28, DOI 10.1016/j.aquaculture.2012.10.022; Chen J.X., 2004, ADV SEA CUCUMBER AQU, V463, P25; CHOE S., 1961, BULL JAPANESE SOC SCI FISH, V27, P97; GOWEN RJ, 1991, NUTRITIONAL STRATEGIES & AQUACULTURE WASTE, P187; Hatanaka Hiroyuki, 1994, Suisan Zoshoku, V42, P563; Huiling S, 2004, ADV SEA CUCUMBER AQU, P327; Ito S., 1995, B SAGA PREFECTURAL S, V4, P1; Japan Fisheries Resources Conservation Association, 2005, WAT QUAL CRIT PROT A; Kuramochi Takashi, 2010, Biosphere Science, V49, P49; Liang Miao, 2010, Journal of Ocean University of China, V9, P291, DOI 10.1007/s11802-010-1739-4; Pearson TH, 2001, SHEFF BIOL SCI, P1; Sakamoto I., 1976, REPORT ENV SCI MIE U, V1, P181; Tsutsumi H, 2006, FISHERIES SCI, V72, P119, DOI 10.1111/j.1444-2906.2006.01125.x; Yamana Y., 2008, J NAT FISH U, V57, P9; Yokoyama Hisashi, 1997, Benthos Research, V52, P119; Yokoyama H, 2009, AQUACULTURE, V286, P80, DOI 10.1016/j.aquaculture.2008.09.010; Ishihi Y, 2003, MAR ECOL PROG SER, V255, P303, DOI 10.3354/meps255303; Yokoyama H, 2010, REV AQUACULT, V2, P154, DOI 10.1111/j.1753-5131.2010.01033.x	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	APR	2015	46	4					918	927		10.1111/are.12247		10	Fisheries	Fisheries	CD6DK	WOS:000351179500016		
J	Yamasaki, Y; Taga, S; Kishioka, M				Yamasaki, Yasuhiro; Taga, Shigeru; Kishioka, Masanobu			Preliminary observation of growth-promoting effects of alginate hydrolysates on juvenile Manila clams, Ruditapes philippinarum	AQUACULTURE RESEARCH			English	Article						acidic sugar; alginate hydrolysates; bivalve; growth promotion; Ruditapes philippinarum	OLIGOSACCHARIDES		[Yamasaki, Yasuhiro] Natl Fisheries Univ, Lab Environm Biol, Dept Appl Aquabiol, Yamaguchi 7596595, Japan; [Taga, Shigeru; Kishioka, Masanobu] Yamaguchi Prefectural Fisheries Res Ctr, Yamaguchi, Japan	Yamasaki, Y (reprint author), Natl Fisheries Univ, Lab Environm Biol, Dept Appl Aquabiol, 2-7-1 Nagata Honmachi, Yamaguchi 7596595, Japan.	yamasaky@fish-u.ac.jp			research and development projects for application in promoting new policy of agriculture, forestry and fisheries [23048]	We are grateful to Prof. Tsuneo Honjo of Seto Inland Sea Regional Research Center, Kagawa University for thoughtful comments. We are also grateful to anonymous reviewers and the editor for thoughtful comments. This study was supported by the research and development projects for application in promoting new policy of agriculture, forestry and fisheries. [23048].	Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V21, P261, DOI 10.1016/j.fsi.2005.12.002; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Chaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1819, DOI 10.1271/bbb.60620; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P1, DOI 10.1016/j.fsi.2004.03.002; Iwasaki K, 2000, BIOSCI BIOTECH BIOCH, V64, P1067, DOI 10.1271/bbb.64.1067; JORGENSEN CB, 1983, MAR BIOL, V73, P177, DOI 10.1007/BF00406886; Park KI, 2006, AQUACULTURE, V251, P182, DOI 10.1016/j.aquaculture.2005.06.003; Tsutsumi Hiroaki, 2006, Plankton & Benthos Research, V1, P3; Uchida M, 2010, AQUACULTURE, V302, P243, DOI 10.1016/j.aquaculture.2010.02.031; WELBORN JR, 1990, MAR ECOL PROG SER, V65, P233, DOI 10.3354/meps065233; Yamasaki Y, 2012, J BIOSCI BIOENG, V113, P112, DOI 10.1016/j.jbiosc.2011.09.009; Yokose T, 2009, BIOSCI BIOTECH BIOCH, V73, P450, DOI 10.1271/bbb.80692	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	APR	2015	46	4					1013	1017		10.1111/are.12246		5	Fisheries	Fisheries	CD6DK	WOS:000351179500028		
J	Sakamoto, M; Ha, JY; Yoneshima, S; Kataoka, C; Tatsuta, H; Kashiwada, S				Sakamoto, Masaki; Ha, Jin-Yong; Yoneshima, Shin; Kataoka, Chisato; Tatsuta, Haruki; Kashiwada, Shosaku			Free Silver Ion as the Main Cause of Acute and Chronic Toxicity of Silver Nanoparticles to Cladocerans	ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article							WATER-QUALITY GUIDELINES; DONNAN MODEL PARAMETERS; DAPHNIA-MAGNA; HUMIC SUBSTANCES; SENSITIVITY; NITRATE; COPPER; ZOOPLANKTON; TOLERANCE; EXPOSURE	We investigated the interspecific variation of silver nanoparticle (SNP) sensitivity in common cladocerans (Daphnia magna, D. galeata, and Bosmina longirostris) and the exact cause of both acute and chronic toxicity focusing on the form of silver (NPs and ions). Materials tested were non-surface-coated silver nanocolloids (SNCs) and AgNO3. The results of the acute toxicity tests support the theory that the effects of SNPs on aquatic organisms is mainly due to Ag+ released from SNPs. Among the three cladocerans, D. galeata was more sensitive to silver (as Ag+) than both D. magna and B. longirostris. Moreover, the chronic toxicity of SNCs was also derived from dissolved silver (especially Ag+). SNCs (as total silver concentration) showed far lower chronic compared with acute toxicity to daphnids because the amount of dissolved silver decreased in the presence of prey algae. The chronic end-point values (EC10 values for net reproductive rate and the probability of survival to maturation) did not differ largely from acute ones (48-h EC50 obtained from acute toxicity tests and 48-h LC50 estimated by the biotic ligand model) when the values were calculated based on Ag+ concentration. The alpha value (concentration at which intrinsic population growth rate is decreased to zero) estimated by a power function model was a reliable parameter for assessing the chronic toxicity of silver.	[Sakamoto, Masaki; Ha, Jin-Yong] Toyama Prefectural Univ, Dept Environm Engn, Fac Engn, Imizu, Toyama 9390398, Japan; [Sakamoto, Masaki; Yoneshima, Shin] Toyama Prefectural Univ, Grad Sch Engn, Imizu, Toyama 9390398, Japan; [Kataoka, Chisato; Kashiwada, Shosaku] Toyo Univ, Grad Sch Life Sci, Gunma 3740193, Japan; [Tatsuta, Haruki] Univ Ryukyus, Dept Ecol & Environm Sci, Nishihara, Okinawa 9030213, Japan	Sakamoto, M (reprint author), Toyama Prefectural Univ, Dept Environm Engn, Fac Engn, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	masaki@pu-toyama.ac.jp			Japan Society for the Promotion of Science [23510031, 23310026]	The authors thank N. Watanabe for kind assistance during the experiments. We are grateful to T. Kusui for helpful comments on this study. This study was supported by Grants-in-Aid for Scientific Research to M. Sakamoto (Grant No. 23510031) and to S. Kashiwada (Grant No. 23310026) from Japan Society for the Promotion of Science.	ALONSO M, 1991, HYDROBIOLOGIA, V225, P37, DOI 10.1007/BF00028383; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI 10.1897/1551-5028(2003)022<1361:MOASTI>2.0.CO;2; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Allen HJ, 2010, ENVIRON TOXICOL CHEM, V29, P2742, DOI 10.1002/etc.329; Stensberg MC, 2014, NANOTOXICOLOGY, V8, P833, DOI 10.3109/17435390.2013.832430; KOIVISTO S, 1992, HYDROBIOLOGIA, V248, P125, DOI 10.1007/BF00006080; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Zhao CM, 2012, ENVIRON SCI TECHNOL, V46, P11345, DOI 10.1021/es3014375; Ribeiro F, 2014, SCI TOTAL ENVIRON, V466, P232, DOI 10.1016/j.scitotenv.2013.06.101; Bianchini A, 2002, ENVIRON SCI TECHNOL, V36, P1763, DOI 10.1021/es011028t; Milne CJ, 2001, ENVIRON SCI TECHNOL, V35, P2049, DOI 10.1021/es000123j; Grosell M, 2002, COMP BIOCHEM PHYS C, V133, P287, DOI 10.1016/S1532-0456(02)00085-6; Zhao CM, 2011, ENVIRON TOXICOL CHEM, V30, P885, DOI 10.1002/etc.451; Newton KM, 2013, ENVIRON TOXICOL CHEM, V32, P2356, DOI 10.1002/etc.2300; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Milne CJ, 2003, ENVIRON SCI TECHNOL, V37, P958, DOI 10.1021/es0258879; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618; Blinova I, 2013, ENVIRON SCI POLLUT R, V20, P3456, DOI 10.1007/s11356-012-1290-5; Kashiwada S, 2012, ENVIRON SCI TECHNOL, V46, P6278, DOI 10.1021/es2045647; Baumann J., 2013, ENVIRON SCI POLLUT R, V21, P2201; Bossuyt BTA, 2005, ENVIRON POLLUT, V136, P145, DOI 10.1016/j.envpol.2004.11.023; Burchardt AD, 2012, ENVIRON SCI TECHNOL, V46, P11336, DOI 10.1021/es300989e; Case T.J., 2000, ILLUSTRATED GUIDE TH; Glover CN, 2004, COMP BIOCHEM PHYS C, V139, P273, DOI 10.1016/j.cca.2004.12.005; Hogstrand C, 1998, ENVIRON TOXICOL CHEM, V17, P572; Muyssen BTA, 2001, ENVIRON TOXICOL CHEM, V20, P2053, DOI 10.1897/1551-5028(2001)020<2053:MZAATI>2.0.CO;2; NEBEKER A V, 1983, Environmental Toxicology and Chemistry, V2, P95, DOI 10.1897/1552-8618(1983)2[95:TOSTSA]2.0.CO;2; OECD, 2012, OECD GUID TEST CHEM; OECD, 2004, OECD GUID TEST CHEM; Ritz C, 2005, J STAT SOFTW, V12, P1; Sakamoto M, 2005, B ENVIRON CONTAM TOX, V75, P28, DOI 10.1007/s00128-005-0714-z; Sakamoto Masaki, 2013, Journal of Ecology and Environment, V36, P141, DOI 10.5141/ecoenv.2013.018; Stearns S. C., 1992, EVOLUTION LIFE HIST; Stevenson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074456; Tanaka Y, 2001, ENVIRON TOXICOL CHEM, V20, P1857, DOI 10.1897/1551-5028(2001)020<1857:MSAPOT>2.0.CO;2; Vesela S, 2007, AQUAT ECOL, V41, P67, DOI 10.1007/s10452-006-9050-6; Volker C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075026	41	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-4341	1432-0703		ARCH ENVIRON CON TOX	Arch. Environ. Contam. Toxicol.	APR	2015	68	3					500	509		10.1007/s00244-014-0091-x		10	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CD6JT	WOS:000351196100008		
J	Thompson, CC; Amaral, GR; Campeao, M; Edwards, RA; Polz, MF; Dutilh, BE; Ussery, DW; Sawabe, T; Swings, J; Thompson, FL				Thompson, Cristiane C.; Amaral, Gilda R.; Campeao, Mariana; Edwards, Robert A.; Polz, Martin F.; Dutilh, Bas E.; Ussery, David W.; Sawabe, Tomoo; Swings, Jean; Thompson, Fabiano L.			Microbial taxonomy in the post-genomic era: Rebuilding from scratch?	ARCHIVES OF MICROBIOLOGY			English	Editorial Material						Bacteria; Archaea; Microbes; Taxonomy; Genomics; Evolution; Open access	AD-HOC-COMMITTEE; POPULATION GENOMICS; POLYPHASIC TAXONOMY; VIBRIO-CHOLERAE; SPECIES CONCEPT; BACTERIAL; DIVERSITY; ARCHAEA; DIFFERENTIATION; RECOMBINATION	Microbial taxonomy should provide adequate descriptions of bacterial, archaeal, and eukaryotic microbial diversity in ecological, clinical, and industrial environments. Its cornerstone, the prokaryote species has been re-evaluated twice. It is time to revisit polyphasic taxonomy, its principles, and its practice, including its underlying pragmatic species concept. Ultimately, we will be able to realize an old dream of our predecessor taxonomists and build a genomic-based microbial taxonomy, using standardized and automated curation of high-quality complete genome sequences as the new gold standard.	[Thompson, Cristiane C.; Amaral, Gilda R.; Campeao, Mariana; Edwards, Robert A.; Dutilh, Bas E.; Swings, Jean; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil; [Edwards, Robert A.] San Diego State Univ, San Diego, CA 92182 USA; [Edwards, Robert A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Polz, Martin F.] MIT, Cambridge, MA 02139 USA; [Dutilh, Bas E.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Ussery, David W.] Oak Ridge Natl Lab, BioSci Div, Oak Ridge, TN USA; [Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries Sci, Microbiol Lab, Hakodate, Hokkaido, Japan; [Swings, Jean] Univ Ghent, Lab Microbiol, B-9000 Ghent, Belgium; [Thompson, Fabiano L.] SAGE COPPE UFRJ, Rio De Janeiro, Brazil	Thompson, CC (reprint author), Univ Fed Rio de Janeiro, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil.	thompsoncristiane@gmail.com		Dutilh, Bas E./0000-0003-2329-7890; Polz, Martin/0000-0001-9296-3733			Alvarez-Perez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075797; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Sen A, 2014, INT J SYST EVOL MICR, V64, P3821, DOI 10.1099/ijs.0.063966-0; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Coenye T, 2003, MICROBIOL-SGM, V149, P3507, DOI 10.1099/mic.0.26515-0; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/ijs.0.02360-0; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Amaral GRS, 2014, INT J SYST EVOL MICR, V64, P357, DOI 10.1099/ijs.0.057927-0; De Ley J, 1970, J BACTERIOL, V101, P738; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Vandamme P, 2014, ANTON LEEUW INT J G, V106, P57, DOI 10.1007/s10482-014-0148-x; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Zhi XY, 2012, ANTON LEEUW INT J G, V101, P21, DOI 10.1007/s10482-011-9667-x; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Dutilh BE, 2013, BRIEF FUNCT GENOMICS, V12, P366, DOI 10.1093/bfgp/elt008; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; COLWELL RR, 1970, J BACTERIOL, V104, P410; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Dutilh BE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-654; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Thompson CC, 2013, MICROB ECOL, V66, P752, DOI 10.1007/s00248-013-0270-8; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; KARLIN S, 1995, TRENDS GENET, V11, P283; Huang K, 2014, NUCLEIC ACIDS RES, V42, pD617, DOI 10.1093/nar/gkt1078; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Nesbo CL, 2006, GENETICS, V172, P759, DOI 10.1534/genetics.105.049312; Ramasamy D, 2014, INT J SYST EVOL MICR, V64, P384, DOI 10.1099/ijs.0.057091-0; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Shapiro BJ, 2014, TRENDS MICROBIOL, V22, P235, DOI 10.1016/j.tim.2014.02.006; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Kampfer P, 2012, ENVIRON MICROBIOL, V14, P291, DOI 10.1111/j.1462-2920.2011.02615.x; Rossello-Mora R, 2012, ENVIRON MICROBIOL, V14, P318, DOI 10.1111/j.1462-2920.2011.02599.x; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Klenk HP, 2010, SYST APPL MICROBIOL, V33, P175, DOI 10.1016/j.syapm.2010.03.003; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bayjanov JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-170; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Cuevas DA, 2014, F1000RESEARCH, V3, P210, DOI 10.12688/f1000research.5140.1; Doi Y, 2014, ANTIMICROB AGENTS CH, V58, P5947, DOI 10.1128/AAC.03180-14; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Dykhuizen Daniel, 2005, Proceedings of the California Academy of Sciences, V56, P62; Ellegaard KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003381; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Hanage WP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-41; Konstantinidis KT, 2013, PROKARYOTES, P229; Kyrpides NC, 1999, BIOINFORMATICS, V15, P773, DOI 10.1093/bioinformatics/15.9.773; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mick E, 2014, NAT BIOTECHNOL, V32, P750, DOI 10.1038/nbt.2962; Moreira APB, 2014, PEERJ, V2, DOI 10.7717/peerj.427; Moreira APB, 2014, CURR MICROBIOL, V69, P405, DOI 10.1007/s00284-014-0600-1; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Romero P, 2005, GENOME BIOL, V6; Shiwa Y, 2014, DNA RES, V21, P369, DOI 10.1093/dnares/dsu003; Sneath PHA, 1973, NUMER TAXON; Snipen L, 2010, STAND GENOMIC SCI, V2, P135, DOI 10.4056/sigs.38923; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Stackebrandt E, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-208; Staley JT, 2009, J IND MICROBIOL BIOT, V36, P1331, DOI 10.1007/s10295-009-0642-8; Tamames J, 2012, TRENDS MICROBIOL, V20, P514, DOI 10.1016/j.tim.2012.08.012; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson CC, 2011, INFECT GENET EVOL, V11, P1798, DOI 10.1016/j.meegid.2011.07.020; Thompson Cristiane C, 2013, F1000Res, V2, P67, DOI 10.12688/f1000research.2-67.v1; Thompson FL, 2011, INT J SYST EVOL MICR, V61, P3023, DOI 10.1099/ijs.0.030015-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463; Whitman WB, 2009, J BACTERIOL, V191, P2000, DOI 10.1128/JB.00962-08; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299	101	4	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	APR	2015	197	3					359	370		10.1007/s00203-014-1071-2		12	Microbiology	Microbiology	CD9FC	WOS:000351402200001		
J	Kobayashi, S; Sasaki, M; Nakao, R; Setiyono, A; Handharyani, E; Orba, Y; Rahmadani, I; Taha, S; Adiani, S; Subangkit, M; Nakamura, I; Kimura, T; Sawa, H				Kobayashi, Shintaro; Sasaki, Michihito; Nakao, Ryo; Setiyono, Agus; Handharyani, Ekowati; Orba, Yasuko; Rahmadani, Ibnu; Taha, Siswatiana; Adiani, Sri; Subangkit, Mawar; Nakamura, Ichiro; Kimura, Takashi; Sawa, Hirofumi			Detection of novel polyomaviruses in fruit bats in Indonesia	ARCHIVES OF VIROLOGY			English	Article							MESSENGER-RNA; VIRUS; PREDICTION; SEQUENCE	Bats are an important natural reservoir for a variety of viral pathogens, including polyomaviruses (PyVs). The aims of this study were: (i) to determine which PyVs are present in bats in Indonesia and (ii) to analyze the evolutionary relationships between bat PyVs and other known PyVs. Using broad-spectrum polymerase chain reaction (PCR)-based assays, we screened PyV DNA isolated from spleen samples from 82 wild fruit bats captured in Indonesia. Fragments of the PyV genome were detected in 10 of the 82 spleen samples screened, and eight full-length viral genome sequences were obtained using an inverse PCR method. A phylogenetic analysis of eight whole viral genome sequences showed that BatPyVs form two distinct genetic clusters within the proposed genus Orthopolyomavirus that are genetically different from previously described BatPyVs. Interestingly, one group of BatPyVs is genetically related to the primate PyVs, including human PyV9 and trichodysplasia spinulosa-associated PyV. This study has identified the presence of novel PyVs in fruit bats in Indonesia and provides genetic information about these BatPyVs.	[Kobayashi, Shintaro; Sasaki, Michihito; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Nakao, Ryo] Hokkaido Univ, Res Ctr Zoonosis Control, Unit Risk Anal & Management, Sapporo, Hokkaido, Japan; [Setiyono, Agus; Handharyani, Ekowati; Subangkit, Mawar] Bogor Agr Univ, Fac Vet Med, Lab Vet Pathol, Bogor, Indonesia; [Rahmadani, Ibnu] Vet Invest & Diagnost Ctr, Bukittinggi, Indonesia; [Taha, Siswatiana] Gorontalo State Univ, Fac Agr, Gorontalo, Indonesia; [Adiani, Sri] Sam Ratulangi Univ, Fac Anim Husb, Manado, Indonesia; [Nakamura, Ichiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan; [Kimura, Takashi] Hokkaido Univ, Grad Sch Vet Med, Lab Comparat Pathol, Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan; [Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA	Sawa, H (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, N20 W10, Sapporo, Hokkaido 0010020, Japan.	tkimura@vetmed.hokudai.ac.jp; h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012		Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This study was supported by the Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Almeida FC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-281; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Halpin K, 2000, J GEN VIROL, V81, P1927; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Orba Y, 2011, J GEN VIROL, V92, P789, DOI 10.1099/vir.0.027854-0; Johne R, 2005, J VIROL, V79, P3883, DOI 10.1128/JVI.79.6.3883-3997.2005; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Fagrouch Z, 2012, J GEN VIROL, V93, P2652, DOI 10.1099/vir.0.044149-0; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Johnson EM, 2010, TRENDS MICROBIOL, V18, P215, DOI 10.1016/j.tim.2010.01.001; Khalili K, 2004, HUMAN POLYOMAVIRUSES; King A. M. Q., 2012, VIRUS TAXONOMY CLASS; Leendertz FH, 2011, J VIROL, V85, P916, DOI 10.1128/JVI.01585-10; Sasaki M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-240; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Yamaguchi H, 2013, J GEN VIROL, V94, P1357, DOI 10.1099/vir.0.050740-0	23	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	APR	2015	160	4					1075	1082		10.1007/s00705-015-2349-7		8	Virology	Virology	CE0RW	WOS:000351514100020		
J	Anindita, PD; Sasaki, M; Setiyono, A; Handharyani, E; Orba, Y; Kobayashi, S; Rahmadani, I; Taha, S; Adiani, S; Subangkit, M; Nakamura, I; Sawa, H; Kimura, T				Anindita, Paulina Duhita; Sasaki, Michihito; Setiyono, Agus; Handharyani, Ekowati; Orba, Yasuko; Kobayashi, Shintaro; Rahmadani, Ibnu; Taha, Siswatiana; Adiani, Sri; Subangkit, Mawar; Nakamura, Ichiro; Sawa, Hirofumi; Kimura, Takashi			Detection of coronavirus genomes in Moluccan naked-backed fruit bats in Indonesia	ARCHIVES OF VIROLOGY			English	Article						Bat coronavirus; Fruit bats; Indonesia	ACUTE RESPIRATORY SYNDROME; SARS-CORONAVIRUS; EMERGING VIRUSES; RECEPTOR	Bats have been shown to serve as natural reservoirs for numerous emerging viruses including severe acute respiratory syndrome coronavirus (SARS-CoV). In the present study, we report the discovery of bat CoV genes in Indonesian Moluccan naked-backed fruit bats (Dobsonia moluccensis). A partial RNA-dependent RNA polymerase gene sequence was detected in feces and tissues samples from the fruit bats, and the region between the RdRp and helicase genes could also be amplified from fecal samples. Phylogenetic analysis suggested that these bat CoVs are related to members of the genus Betacoronavirus.	[Anindita, Paulina Duhita; Sasaki, Michihito; Orba, Yasuko; Kobayashi, Shintaro; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Setiyono, Agus; Handharyani, Ekowati; Subangkit, Mawar] Bogor Agr Univ, Fac Vet Med, Lab Vet Pathol, Bogor, Indonesia; [Rahmadani, Ibnu] Vet Invest & Diagnost Ctr, Bukittinggi, Indonesia; [Taha, Siswatiana] Gorontalo State Univ, Fac Agr, Gorontalo, Indonesia; [Adiani, Sri] Sam Ratulangi Univ, Fac Anim Husb, Manado, Indonesia; [Nakamura, Ichiro] Hokkaido Univ, Res Ctr Zoonosis Control, Unit Int Cooperat, Sapporo, Hokkaido, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan; [Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA; [Kimura, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Med, Lab Comparat Pathol,Kita Ku, Sapporo, Hokkaido 0600818, Japan	Sawa, H (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, North 20 West 10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp; tkimura@vetmed.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012		Japanese Initiative of Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, and Technology (MEXT), Japan	We thank Prof. Ayato Takada for providing the Vero E6 cell line, and Prof. Ken Maeda for providing the FBKT and DemKT1 cell lines for the current study. This study was partly supported by a grant from the Japanese Initiative of Global Research Network on Infectious Diseases (J-GRID) and a grant of the Ministry of Education, Culture, Sports, and Technology (MEXT), Japan.	Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Maeda K, 2008, EMERG INFECT DIS, V14, P347, DOI 10.3201/eid1402.070932; To KKW, 2013, J THORAC DIS, V5, pS103, DOI 10.3978/j.issn.2072-1439.2013.06.02; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.108952; Gouilh MA, 2011, INFECT GENET EVOL, V11, P1690, DOI 10.1016/j.meegid.2011.06.021; Xu X, 2003, NUCLEIC ACIDS RES, V31, P7117, DOI 10.1093/nar/gkg916; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Lelli D, 2013, VIRUSES-BASEL, V5, P2679, DOI 10.3390/v5112679; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Chong HT, 2009, NEUROL ASIA, V14, P73; Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632; de Souza Luna Luciano Kleber, 2007, J Clin Microbiol, V45, P1049, DOI 10.1128/JCM.02426-06; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; King AMQ, 2012, VIRUS TAXONOMY CLASS, P809; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Nguyen ATK, 2014, EMERG INFECT DIS, V20, P161, DOI 10.3201/eid2001.130813; Sasaki M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-240; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003760; Tsuda S, 2012, ARCH VIROL, V157, P2349, DOI 10.1007/s00705-012-1410-z; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208	33	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	APR	2015	160	4					1113	1118		10.1007/s00705-015-2342-1		6	Virology	Virology	CE0RW	WOS:000351514100024		
J	Van, TTB; Yoshida, S; Miki, K; Kondo, A; Kamei, K				Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kondo, Akihiro; Kamei, Kaeko			Complete genome sequence of a filamentous bacteriophage, RS611, that infects the phytopathogen Ralstonia solanacearum (vol 160, pg 865, 2015)	ARCHIVES OF VIROLOGY			English	Correction									[Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Kondo, Akihiro] Hiyoshi Corp, Omihachiman, Shiga 5238555, Japan	Kamei, K (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	kame@kit.ac.jp					Van TTB, 2015, ARCH VIROL, V160, P865, DOI 10.1007/s00705-014-2316-8	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	APR	2015	160	4					1143	1143		10.1007/s00705-015-2369-3		1	Virology	Virology	CE0RW	WOS:000351514100029		
J	Azegami, T; Itoh, H; Kiyono, H; Yuki, Y				Azegami, Tatsuhiko; Itoh, Hiroshi; Kiyono, Hiroshi; Yuki, Yoshikazu			Novel Transgenic Rice-Based Vaccines	ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS			English	Review						Rice-based vaccine; MucoRice-CTB; Mucosal immunity; Oral vaccine	TOXIN-B-SUBUNIT; HEAT-LABILE ENTEROTOXIN; HELICOBACTER-PYLORI UREASE; INFECTIOUS BURSAL DISEASE; T-CELL EPITOPES; CHLAMYDOPHILA-PSITTACI INFECTIONS; EPIDEMIC-DIARRHEA-VIRUS; CEDAR POLLEN ALLERGENS; ORAL CHOLERA VACCINE; AMYLOID BETA-PEPTIDE	Oral vaccination can induce both systemic and mucosal antigen-specific immune responses. To control rampant mucosal infectious diseases, the development of new effective oral vaccines is needed. Plant-based vaccines are new candidates for oral vaccines, and have some advantages over the traditional vaccines in cost, safety, and scalability. Rice seeds are attractive for vaccine production because of their stability and resistance to digestion in the stomach. The efficacy of some rice-based vaccines for infectious, autoimmune, and other diseases has been already demonstrated in animal models. We reported the efficacy in mice, safety, and stability of a rice-based cholera toxin B subunit vaccine called MucoRice-CTB. To advance MucoRice-CTB for use in humans, we also examined its efficacy and safety in primates. The potential of transgenic rice production as a new mucosal vaccine delivery system is reviewed from the perspective of future development of effective oral vaccines.	[Azegami, Tatsuhiko; Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, Tokyo 1088639, Japan; [Azegami, Tatsuhiko; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Tokyo 1088639, Japan	Yuki, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yukiy@ims.u-tokyo.ac.jp					Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Agnello D, 2013, J IMMUNOL, V190, P4836, DOI 10.4049/jimmunol.1202979; Santi L, 2006, P NATL ACAD SCI USA, V103, P861, DOI 10.1073/pnas.0510014103; Wakasa Y, 2013, PLANT BIOTECHNOL J, V11, P66, DOI 10.1111/pbi.12007; Babiuk S, 2008, MICROB PATHOGENESIS, V45, P7, DOI 10.1016/j.micpath.2008.01.005; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Li JT, 2006, VIROLOGY, V356, P171, DOI 10.1016/j.virol.2006.07.045; SAIZ JC, 1994, J VIROL, V68, P4557; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Rosales-Mendoza S, 2008, PLANT CELL REP, V27, P79, DOI 10.1007/s00299-007-0439-z; Yuki Y, 2009, VACCINE, V27, P5982, DOI 10.1016/j.vaccine.2009.07.071; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Streatfield SJ, 2003, INT J PARASITOL, V33, P479, DOI 10.1016/S0020-7519(03)00052-3; ROOME AJ, 1993, JAMA-J AM MED ASSOC, V270, P2931, DOI 10.1001/jama.270.24.2931; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Harkinezhad T, 2009, J MED MICROBIOL, V58, P1207, DOI 10.1099/jmm.0.011379-0; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; OWEN RL, 1977, GASTROENTEROLOGY, V72, P440; Nojima J, 2011, VACCINE, V29, P6252, DOI 10.1016/j.vaccine.2011.06.073; Seal BS, 2000, DEV COMP IMMUNOL, V24, P257, DOI 10.1016/S0145-305X(99)00077-4; Wang YY, 2012, J VIROL METHODS, V181, P12, DOI 10.1016/j.jviromet.2012.01.004; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; FAHEY KJ, 1989, J GEN VIROL, V70, P1473, DOI 10.1099/0022-1317-70-6-1473; Kim TG, 2010, MOL BIOTECHNOL, V44, P14, DOI 10.1007/s12033-009-9200-x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Nochi T, 2009, J IMMUNOL, V183, P6538, DOI 10.4049/jimmunol.0901480; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; MARSHALL BJ, 1984, LANCET, V1, P1311; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; Thanavala Y, 2005, P NATL ACAD SCI USA, V102, P3378, DOI 10.1073/pnas.0409899102; Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Kim SH, 2010, J IMMUNOL, V185, P5787, DOI 10.4049/jimmunol.0903184; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Qian BJ, 2008, TRANSGENIC RES, V17, P621, DOI 10.1007/s11248-007-9135-6; Yuki Y, 2012, VACCINE, V30, P4160, DOI 10.1016/j.vaccine.2012.04.064; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Zhang XR, 2006, PLANT BIOTECHNOL J, V4, P419, DOI 10.1111/j.1467-7652.2006.00191.x; Mahgoub HA, 2012, ARCH VIROL, V157, P2047, DOI 10.1007/s00705-012-1377-9; ADACHI T, 1993, PLANT MOL BIOL, V21, P239, DOI 10.1007/BF00019940; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Wirz H, 2012, JALA-J LAB AUTOM, V17, P449, DOI 10.1177/2211068212460037; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; Wang YY, 2009, BIOCHEM BIOPH RES CO, V380, P292, DOI 10.1016/j.bbrc.2009.01.061; Matsumoto Y, 2009, TRANSGENIC RES, V18, P185, DOI 10.1007/s11248-008-9205-4; van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770; Jiang XL, 2007, TRANSGENIC RES, V16, P169, DOI 10.1007/s11248-006-9023-5; Moravec T, 2007, VACCINE, V25, P1647, DOI 10.1016/j.vaccine.2006.11.010; Wu JX, 2007, PLANT BIOTECHNOL J, V5, P570, DOI 10.1111/j.1467-7652.2007.00270.x; Tsuji N, 2003, INFECT IMMUN, V71, P5314, DOI 10.1128/IAI.71.9.5314-5323.2003; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Kurokawa S, 2013, J PROTEOME RES, V12, P3372, DOI 10.1021/pr4002146; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Yuki Y, 2013, PLANT BIOTECHNOL J, V11, P799, DOI 10.1111/pbi.12071; Camero M, 2007, VACCINE, V25, P1658, DOI 10.1016/j.vaccine.2006.11.002; Carlson GA, 2003, NAT NEUROSCI, V6, P328, DOI 10.1038/nn0403-328; Curtiss R, 1997, ORAL IMMUNIZATION TR; Curtiss R, 1990, World Patent Application, Patent No. [WO 90/02484, 9002484]; Das P, 2004, LANCET INFECT DIS, V4, P719, DOI 10.1016/S1473-3099(04)01222-8; FINKELST.RA, 1969, J EXP MED, V130, P185, DOI 10.1084/jem.130.1.185; Franco Elisabetta, 2012, World J Hepatol, V4, P74, DOI 10.4254/wjh.v4.i3.74; Fu N, 2009, VACCINE, V27, P5252, DOI 10.1016/j.vaccine.2009.06.053; Fujii R, 2004, BIOTECHNOL BIOENG, V86, P737, DOI 10.1002/bit.20047; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Gu Q, 2006, BIOTECHNOL LETT, V28, P1661, DOI 10.1007/s10529-006-9141-4; GUERRANT RL, 1974, INFECT IMMUN, V10, P320; Hashizume F, 2008, TRANSGENIC RES, V17, P1117, DOI 10.1007/s11248-008-9187-2; Henning J, 2008, PREV VET MED, V85, P241, DOI 10.1016/j.prevetmed.2008.01.014; Huy NX, 2012, PLANT CELL REP, V31, P1933, DOI 10.1007/s00299-012-1306-0; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ishii-Katsuno R, 2010, BIOCHEM BIOPH RES CO, V399, P593, DOI 10.1016/j.bbrc.2010.07.120; Jamal SM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-116; Jenner E, 1798, INQUIRY CAUSES EFFEC, P1876; Kajiura H, 2013, MOL BIOTECHNOL, V54, P784, DOI 10.1007/s12033-012-9626-4; Katsube T, 1999, PLANT PHYSIOL, V120, P1063, DOI 10.1104/pp.120.4.1063; Kim HD, 2005, VACCINE, V23, P2977, DOI 10.1016/j.vaccine.2004.12.015; Kim HS, 2003, PLANT SCI, V165, P1445, DOI 10.1016/j.plantsci.2003.07.007; KING CA, 1973, J INFECT DIS, V127, P639; Kirk DD, 2005, IMMUNOL CELL BIOL, V83, P248, DOI 10.1111/j.1440-1711.2005.01340.x; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunisawa J, 2005, CURR MOL MED, V5, P557, DOI 10.2174/1566524054863924; Lee J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-61; Minor P, 2012, EXPERT REV VACCINES, V11, P579, DOI [10.1586/erv.12.23, 10.1586/ERV.12.23]; Nakamura R, 1996, BIOSCI BIOTECH BIOCH, V60, P1215; Nojima J, 2011, BIOSCI BIOTECH BIOCH, V75, P396, DOI 10.1271/bbb.100861; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Petrovska L, 2003, VACCINE, V21, P1445, DOI 10.1016/S0264-410X(02)00696-5; Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P21; RODRIGUEZ A, 1994, VIROLOGY, V205, P24, DOI 10.1006/viro.1994.1616; SIDEBOTHAM RL, 1990, LANCET, V335, P193, DOI 10.1016/0140-6736(90)90279-E; Solomon T, 2003, J NEUROVIROL, V9, P274, DOI 10.1080/13550280390194037; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; STEWART TB, 1988, J ANIM SCI, V66, P1548; Suzuki K, 2009, INT ARCH ALLERGY IMM, V149, P21, DOI 10.1159/000210649; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; Tackaberry ES, 2008, MOL BIOTECHNOL, V40, P1, DOI 10.1007/s12033-007-9029-0; Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102; Takagi H, 2006, J AGR FOOD CHEM, V54, P9901, DOI 10.1021/jf061848v; Takagi H, 2008, VACCINE, V26, P6027, DOI 10.1016/j.vaccine.2008.09.019; TRENTHAM DE, 1978, NEW ENGL J MED, V299, P327, DOI 10.1056/NEJM197808172990703; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; VANHEYNI.S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vermij P, 2006, NAT BIOTECHNOL, V24, P234, DOI DOI 10.1038/NBT1106-1301; World Health Organization, 1979, GLOB COMM CERT SMALL; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289; Yang L, 2008, BIOCHEM BIOPH RES CO, V365, P334, DOI 10.1016/j.bbrc.2007.10.186; Yang XL, 2005, BIOMED ENVIRON SCI, V18, P411; Yang ZQ, 2007, VACCINE, V25, P591, DOI 10.1016/j.vaccine.2006.08.016; Yoshida T, 2011, INT J BIOL SCI, V7, P301; Yoshitomi T, 2002, IMMUNOLOGY, V107, P517, DOI 10.1046/j.1365-2567.2002.01534.x; Zhang XX, 2008, BIOLOGICALS, V36, P296, DOI 10.1016/j.biologicals.2008.04.002; Zhang XX, 2009, VACCINE, V27, P1596, DOI 10.1016/j.vaccine.2008.12.042; Zhang XX, 2013, VACCINE, V31, P698, DOI 10.1016/j.vaccine.2012.11.039	130	2	2	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0004-069X	1661-4917		ARCH IMMUNOL THER EX	Arch. Immunol. Ther. Exp.	APR	2015	63	2					87	99		10.1007/s00005-014-0303-0		13	Immunology	Immunology	CD6XA	WOS:000351232500001		
J	Sugaya, M				Sugaya, Makoto			Chemokines and Skin Diseases	ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS			English	Review						CCL17; CCR4; CCL11; CCL26; CCR3; CX3CL1	ACTIVATION-REGULATED CHEMOKINE; CUTANEOUS T-CELL; FRACTALKINE RECEPTOR CX(3)CR1; MACROPHAGE-DERIVED CHEMOKINE; MONOCLONAL-ANTIBODY KW-0761; HUMAN DERMAL FIBROBLASTS; CC-CHEMOKINE; ATOPIC-DERMATITIS; DENDRITIC CELLS; ENDOTHELIAL-CELLS	Chemokines are small molecules that induce chemotaxis and activation of certain subsets of leukocytes. The expression patterns of chemokines and chemokine receptors are specific to certain organs and cells. Therefore, chemokines are important to elucidate the mechanism of organ-specific human diseases. CCL17 expressed by Langerhans cells, blood endothelial cells, and fibroblasts plays a key role in attracting Th2 cells and tumor cells of adult T-cell leukemia/lymphoma and mycosis fungoides/S,zary syndrome into the skin, developing various Th2-type inflammatory skin diseases as well as cutaneous lymphoma. CCL11 and CCL26 expressed by skin-resident cells, such as fibroblasts, blood endothelial cells, and keratinocytes, induce infiltration of CCR3-expressing cells such as Th2 cells and eosinophils. CCL11 may also serve as an autocrine as well as a paracrine in anaplastic large cell lymphoma. CX3CL1 expressed on blood endothelial cells leads to infiltration of CX3CR1(+) immune cells, such as mast cells, neutrophils, and macrophages, playing important roles in wound healing, tumor immunity, and vasculitis. Biologics targeting chemokines and their receptors are promising strategies for various skin diseases that are resistant to the current therapy.	Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Sugaya, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sugayam-der@h.u-tokyo.ac.jp					Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; Miyagaki T, 2010, J INVEST DERMATOL, V130, P2304, DOI 10.1038/jid.2010.128; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; Yu B, 2002, J DERMATOL SCI, V30, P29, DOI 10.1016/S0923-1811(02)00046-4; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sugaya M, 2003, J DERMATOL SCI, V31, P179, DOI 10.1016/S0923-1811(03)00031-8; Tamaki K, 2006, J DERMATOL, V33, P300, DOI 10.1111/j.1346-8138.2006.00072.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Ishida Y, 2008, J IMMUNOL, V180, P569; Hasegawa M, 2005, ANN RHEUM DIS, V64, P21, DOI 10.1136/ard.2003.018705; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Sugaya M, 2010, J DERMATOL SCI, V59, P81, DOI 10.1016/j.jdermsci.2010.05.005; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048; Saeki H, 2006, J DERMATOL SCI, V43, P75, DOI 10.1016/j.jdermsci.2006.06.002; Shinkai A, 1999, J IMMUNOL, V163, P1602; Fujimura T, 2014, EUR J DERMATOL, V24, P180, DOI 10.1684/ejd.2014.2283; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Nickel R, 1999, J ALLERGY CLIN IMMUN, V104, P723; Hoeck J, 2001, J IMMUNOL, V167, P3216; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Kimura T, 2014, ACTA DERM-VENEREOL, V94, P331, DOI 10.2340/00015555-1709; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Wakugawa M, 2001, J INVEST DERMATOL, V117, P188, DOI 10.1046/j.0022-202x.2001.01430.x; Pope SM, 2005, J IMMUNOL, V175, P5341; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imai T, 1996, J BIOL CHEM, V271, P21514; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Murphy G, 2008, RHEUMATOLOGY, V47, P1446, DOI 10.1093/rheumatology/ken197; Kagami S, 2003, CLIN EXP IMMUNOL, V134, P309, DOI 10.1046/j.1365-2249.2003.02273.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; Baraniuk JN, 1997, J ALLERGY CLIN IMMUN, V99, pS763, DOI 10.1016/S0091-6749(97)70125-8; Bartels J, 1996, BIOCHEM BIOPH RES CO, V225, P1045, DOI 10.1006/bbrc.1996.1292; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beaulieu S, 2002, J IMMUNOL, V169, P2925; Berkman N, 2001, AM J RESP CELL MOL, V24, P682; Campbell EM, 1998, J IMMUNOL, V161, P7047; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Fujita H, 2005, J INVEST DERMATOL, V124, P343, DOI 10.1111/j.0022-202X.2004.23607.x; Ganzalo J A, 1996, Immunity, V4, P1; Kaburagi Y, 2001, ARCH DERMATOL RES, V293, P350, DOI 10.1007/s004030100230; Kagami S, 2012, J INVEST DERMATOL, V132, P249, DOI 10.1038/jid.2011.251; Kakinuma T, 2003, J AM ACAD DERMATOL, V48, P23, DOI 10.1067/mjd.2003.132; Kawashima T, 2010, J DERMATOL SCI, V60, P52, DOI 10.1016/j.jdermsci.2010.07.012; Kleinhans M, 2003, BLOOD, V101, P1487, DOI 10.1182/blood-2002-02-0475; Miyagaki T, 2011, CANCER RES, V71, P2056, DOI 10.1158/0008-5472.CAN-10-3764; Morimura S, 2013, AM J PATHOL, V182, P1640, DOI 10.1016/j.ajpath.2013.01.023; Nakahigashi K, 2012, J ALLERGY CLIN IMMUN, V129, P536, DOI 10.1016/j.jaci.2011.11.034; Ness TL, 2006, J IMMUNOL, V177, P7531; Nishi N, 2008, BIOCHEM BIOPH RES CO, V376, P234, DOI 10.1016/j.bbrc.2008.08.136; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Sokolowska-Wojdyo M, 2005, BRIT J DERMATOL, V152, P258, DOI 10.1111/J.1365-2133.2004.06325.X; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Tsunemi Y, 2006, EUR J IMMUNOL, V36, P2116, DOI 10.1002/eji.200535564; Xiao T, 2003, CYTOKINE, V23, P126, DOI 10.1016/S1043-4666(03)00221-7; Yagi H, 2006, AM J SURG PATHOL, V30, P1111; Yamaguchi T, 2006, BRIT J DERMATOL, V154, P904, DOI 10.1111/j.1365-2133.2005.07039.x; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812; Yawalkar N, 1999, J INVEST DERMATOL, V113, P43, DOI 10.1046/j.1523-1747.1999.00619.x; Yokobayashi H, 2013, J EUR ACAD DERMATOL, V27, pE212, DOI 10.1111/j.1468-3083.2012.04592.x; Yokobayashi H, 2008, BRIT J DERMATOL, V159, P738, DOI 10.1111/j.1365-2133.2008.08689.x	74	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0004-069X	1661-4917		ARCH IMMUNOL THER EX	Arch. Immunol. Ther. Exp.	APR	2015	63	2					109	115		10.1007/s00005-014-0313-y		7	Immunology	Immunology	CD6XA	WOS:000351232500003		
J	Giga, Y; Saal, J				Giga, Yoshikazu; Saal, Juergen			Uniform exponential stability of the Ekman spiral	ARKIV FOR MATEMATIK			English	Article							NAVIER-STOKES EQUATIONS; ROTATING FLUIDS; BOUNDARY-LAYERS; INITIAL DATA; REGULARITY; EULER	This paper studies stability of the Ekman boundary layer. We utilize a new approach, developed by the authors in a precedent paper, based on Fourier transformed finite vector Radon measures, which yields exponential stability of the Ekman spiral. By this method we can also derive very explicit bounds for solutions of the linearized and the nonlinear Ekman systems. For example, we can prove these bounds to be uniform with respect to the angular velocity of rotation, which has proved to be relevant for several aspects. Another advantage of this approach is that we obtain well-posedness in classes containing nondecaying vector fields such as almost periodic functions. These outcomes give respect to the nature of boundary layer problems and cannot be obtained by approaches in standard function spaces such as Lebesgue, Bessel-potential, Holder or Besov spaces.	[Giga, Yoshikazu] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, JP-1538914 Tokyo, Japan; [Saal, Juergen] Univ Dusseldorf, Math Inst, DE-40204 Dusseldorf, Germany	Giga, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Komaba 3-8-1, JP-1538914 Tokyo, Japan.	labgiga@ms.u-tokyo.ac.jp; juergen.saal@hhu.de			Japan Society for the Promotion of Science [26220702, 23244015, 25610025]; Japan Society for the Promotion of Science; German Research Foundation through Japanese-German Graduate Externship; German Research Foundation through IRTG 1529	The work of the first author was partly supported by the Japan Society for the Promotion of Science through grant Kiban S (26220702), Kiban A (23244015) and Houga (25610025). This work was partly supported by the Japan Society for the Promotion of Science and the German Research Foundation through Japanese-German Graduate Externship and IRTG 1529.	Babin A, 2001, INDIANA U MATH J, V50, P1; Hess M, 2010, B LOND MATH SOC, V42, P691, DOI 10.1112/blms/bdq029; Babin A, 1999, INDIANA U MATH J, V48, P1133; Babin A, 1997, ASYMPTOTIC ANAL, V15, P103; Chemin J-Y, 2006, MATH GEOPHYS; Chemin JY, 2002, ESAIM CONTR OPTIM CA, V8, P441, DOI 10.1051/cocv:2002037; Desjardins B, 1999, NONLINEARITY, V12, P181, DOI 10.1088/0951-7715/12/2/001; DIESTEL J., 1977, MATH SURVEYS, V15; Ekman V. W., 1905, ARKIV MAT ASTRON FIZ, V2, P1; Fischer A, 2013, DISCRETE CONT DYN-S, V6, P1225, DOI 10.3934/dcdss.2013.6.1225; Giga Y., 2007, ADV DIFFERENTIAL EQU, V12, P721; Giga Y, 2007, ARCH RATION MECH AN, V186, P177, DOI 10.1007/s00205-007-0053-9; Giga Y, 2013, J MATH FLUID MECH, V15, P89, DOI 10.1007/s00021-012-0094-1; Greenberg L, 2004, MATH PROC CAMBRIDGE, V136, P719, DOI 10.1017/S030500410300731X; Grenier E, 1997, COMMUN PART DIFF EQ, V22, P953; Iwabuchi T, 2012, J EVOL EQU, V12, P985, DOI 10.1007/s00028-012-0165-z; Koba H., 2012, ADV MATH SCI APPL, V22, P61; Koba H., 2014, MEM AM MATH SOC, V228; Lee S. M., PREPRINT; Mahalov A., 2003, RUSS MATH SURV, V58, P287; Marletta M, 2007, J DIFFER EQUATIONS, V243, P36, DOI 10.1016/j.jde.2007.09.002; Monin A., 1971, STAT FLUID MECH MECH, V1; Monin AS, 1971, STAT FLUID MECH MECH, VII; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; Rousset F, 2004, ARCH RATION MECH AN, V172, P213, DOI 10.1007/s00205-003-0302-5; Vishik M. I., 1988, MATH PROBLEMS STAT H; Yoneda T, 2011, ARCH RATION MECH AN, V200, P225, DOI 10.1007/s00205-010-0360-4	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0004-2080	1871-2487		ARK MAT	Ark. Mat.	APR	2015	53	1					105	126		10.1007/s11512-014-0203-x		22	Mathematics	Mathematics	CD4VW	WOS:000351084500005		
J	Ridwan, R; Rusmana, I; Widyastuti, Y; Wiryawan, KG; Prasetya, B; Sakamoto, M; Ohkuma, M				Ridwan, Roni; Rusmana, Iman; Widyastuti, Yantyati; Wiryawan, Komang G.; Prasetya, Bambang; Sakamoto, Mitsuo; Ohkuma, Moriya			Fermentation Characteristics and Microbial Diversity of Tropical Grass-legumes Silages	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Calliandra calothyrsus; Silage; Fermentation Characteristics; Diversity; Lactobacillus plantarum	FRAGMENT-LENGTH-POLYMORPHISMS; RIBOSOMAL-RNA; CALLIANDRA-CALOTHYRSUS; RUMEN FERMENTATION; METHANE PRODUCTION; COMMUNITIES; BACTERIA; 16S; DEGRADATION; INOCULANTS	Calliandra calothyrsus preserved in silage is an alternative method for improving the crude protein content of feeds for sustainable ruminant production. The aim of this research was to evaluate the quality of silage which contained different levels of C. calothyrsus by examining the fermentation characteristics and microbial diversity. Silage was made in a completely randomized design consisting of five treatments with three replications i.e.: R0, Pennisetum purpureum 100%; RI, P purpureum 75%+C. calothyrsus 25%;, R2, P purpureum 50%+C. calothyrsus 50%; R3, P purpureum 25%+C. calothyrsus 75%; and R4, C. calothyrsus 100%. All silages were prepared using plastic jar silos (600 g) and incubated at room temperature for 30 days. Silages were analyzed for fermentation characteristics and microbial diversity. Increased levels of C. calothyrsus in silage had a significant effect (p<0.01) on the fermentation characteristics. The microbial diversity index decreased and activity was inhibited with increasing levels of C. calothyrsus. The microbial community indicated that there was a population of Lactobacillus plantarum, L. casei, L. brevis, Lactococcus lactis, Chryseobacterium sp., and uncultured bacteria. The result confirmed that silage with a combination of grass and C. calothyrsus had good fermentation characteristics and microbial communities were dominated by L. plantarum.	[Ridwan, Roni] Bogor Agr Univ, Grad Sch, Study Program Microbiol, Java 16680, Indonesia; [Ridwan, Roni; Widyastuti, Yantyati; Prasetya, Bambang] Indonesian Inst Sci, Biotechnol Res Ctr, Cibinong 16911, West Java, Indonesia; [Rusmana, Iman] Bogor Agr Univ, Fac Math & Nat Sci, Dept Biol, Java 16680, Indonesia; [Wiryawan, Komang G.] Bogor Agr Univ, Fac Anim Sci, Dept Anim Nutr & Feed Technol, Java 16680, Indonesia; [Sakamoto, Mitsuo; Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Div Microbe, Tsukuba, Ibaraki 3050074, Japan	Ridwan, R (reprint author), Bogor Agr Univ, Grad Sch, Study Program Microbiol, Campus IPB Darmaga Bogor, Java 16680, Indonesia.	roni001@lipi.go.id	Ohkuma, Moriya/A-8100-2011		DIPA of the Research Center for Biotechnology-Indonesian Institute of Sciences and the Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS)	This research was supported by DIPA of the Research Center for Biotechnology-Indonesian Institute of Sciences and the Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA) as part of the Science and Technology Research Partnership for Sustainable Development (SATREPS). We thank to Japan Collection of Microorganisms-RIKEN BioResource Center for supporting T-RFLP analysis in Japan, and Ministry of Research and Technology of Indonesia Government for a graduate scholarship of Doctor Program in Bogor Agricultural University and allowances for a short research in Japan.	Jayanegara A, 2011, ANIM FEED SCI TECH, V163, P231, DOI 10.1016/j.anifeedsci.2010.11.009; Lynch JP, 2012, J DAIRY SCI, V95, P2070, DOI 10.3168/jds.2011-5013; Bodas R, 2012, ANIM FEED SCI TECH, V176, P78, DOI 10.1016/j.anifeedsci.2012.07.010; Arriola KG, 2011, J DAIRY SCI, V94, P1511, DOI 10.3168/jds.2010-3807; Salawu MB, 1999, ANIM FEED SCI TECH, V82, P243, DOI 10.1016/S0377-8401(99)00105-4; [Anonymous], 1997, OFFICIAL METHODS ANA; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Kaplan CW, 2001, APPL ENVIRON MICROB, V67, P1935, DOI 10.1128/AEM.67.4.1935-1939.2001; Jimenez N, 2013, APPL ENVIRON MICROB, V79, P4253, DOI 10.1128/AEM.00840-13; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI [10.1016/j.ijfoodmicro.2009.03.025, 10.1016/j.ijfoodmicro.2009.03.02]; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; Sakamoto M, 2003, J MED MICROBIOL, V52, P79, DOI 10.1099/jmm.0.04991-0; Iwamoto K, 2008, SYST APPL MICROBIOL, V31, P269, DOI 10.1016/j.syapm.2008.05.004; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516; Tiemann TT, 2008, ANIMAL, V2, P790, DOI 10.1017/S1751731108001791; Castro-Montoya JM, 2011, CAN J ANIM SCI, V91, P433, DOI [10.4141/CJAS2010-028, 10.4141/cjas2010-028]; Deaville ER, 2010, ANIM FEED SCI TECH, V157, P129, DOI 10.1016/j.anifeedsci.2010.02.007; Gomez-Vazquez A, 2011, TROP ANIM HEALTH PRO, V43, P215, DOI 10.1007/s11250-010-9678-z; Hess HD, 2006, AGROFOREST SYST, V68, P209, DOI 10.1007/s10457-006-9010-0; Jayanegara A, 2011, J ANIM PHYSIOL AN N, V96, P365; Kondo M, 2014, ASIAN AUSTRAL J ANIM, V27, P937, DOI 10.5713/ajas.2013.13387; Landete J. M., 2008, Food Chemistry, V107, P320, DOI 10.1016/j.foodchem.2007.08.043; Li YB, 2013, ANIM SCI J, V84, P607, DOI 10.1111/asj.12046; Magurran AE, 2004, MEASURING BIOL DIVER; Makkar H.P.S., 2003, QUANTIFICATION TANNI; McDonald P, 1991, BIOCH SILAGE; Mulrooney CN, 2008, J DAIRY SCI, V91, P236, DOI 10.3168/jds.2007-0449; Norton B. W., 1994, P177; Patra A. K., 2012, DIETARY PHYTOCHEMICA, P237; Sherman N, 2001, MICROBIOLOGY LAB MAN; Sonja N. H., 2012, ANIM FEED SCI TECHNO, V174, P201; Steurm C. D., 2007, ANIM FEED SCI TECHNO, V138, P29; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Wanapat M, 2014, TROP ANIM HEALTH PRO, V46, P185, DOI 10.1007/s11250-013-0473-5	38	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	APR	2015	28	4					511	518		10.5713/ajas.14.0622		8	Agriculture, Dairy & Animal Science	Agriculture	CD4DD	WOS:000351031900007		
J	Ito, T; Fujita, H; Tani, T; Ohte, N				Ito, Tsuyoshi; Fujita, Hiroshi; Tani, Tomomitsu; Ohte, Nobuyuki			Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent	ATHEROSCLEROSIS			English	Article						Malondialdehyde-modified low-density lipoprotein; Clinical outcomes; Drug-eluting stent	ARTERY-DISEASE; MODIFIED LDL; MYOCARDIAL-INFARCTION; IMPLANTATION; ATORVASTATIN; CHOLESTEROL; SERUM; REVASCULARIZATION; ATHEROSCLEROSIS; ATHEROGENESIS	Objective: Patients undergoing lipid-lowering therapy after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) are subject to residual risk. Malondialdehyde-modified low-density lipoprotein (MDA-LDL) is suggested as a marker of the initiation and acceleration of atherosclerosis. This study aimed to investigate the impact of MDA-LDL on clinical outcomes in patients with stable angina undergoing lipid-lowering therapy after DES implantation. Methods: In this study, 332 patients whose MDA-LDL was measured before PCI with DES were followed clinically (median 2.9 years). Lipid-lowering therapy was conducted, with the target LDL <= 100 mg/dL. We analyzed the composite of major adverse cardiac events (MACE), including cardiac death, myocardial infarction, stent thrombosis, ischemia-driven target lesion revascularization, and any revascularization. Results: MACE was observed in 64 patients (19.3%). MDA-LDL was significantly higher in the MACE group (139.1 +/- 53.2 U/L vs. 106.5 +/- 38.3 U/L, p < 0.01). Univariate Cox regression analysis indicated a significant relationship between MACE and hemodialysis (Hazard ratio (HR) 4.60; p < 0.01), MDA-LDL (per 10 U/L, HR 1.14; p < 0.01), multivessel disease (HR 1.78; p = 0.02), and high-density lipoprotein (per 10 mg/dL, HR 0.79; p = 0.03). In the multivariate model, hemodialysis (HR 4.10; p < 0.01) and MDA-LDL (per 10U/L, HR 1.10; p < 0.01) remained significant predictors of MACE. The optimal MDA-LDL threshold for predicting MACE was 114.1 U/L, identified by the receiver operating characteristic curve. Conclusions: MDA-LDL was associated with future cardiac events in patients with stable angina that underwent lipid-lowering therapy after DES-PCI. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ito, Tsuyoshi; Fujita, Hiroshi; Tani, Tomomitsu; Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi 4678601, Japan	Ito, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tuyosiito@gmail.com					Abdel-Latif A, 2010, CATHETER CARDIO INTE, V76, P942, DOI 10.1002/ccd.22562; Al Gadban MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012534; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P504, DOI 10.1016/j.jcin.2009.04.004; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; Matsuo Y, 2013, EUR HEART J-CARD IMG, V14, P43, DOI 10.1093/ehjci/jes094; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Zellweger MJ, 2012, J AM COLL CARDIOL, V59, P793, DOI 10.1016/j.jacc.2011.11.024; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Amaki T, 2004, HEART, V90, P1211, DOI 10.1136/hrt.2003.018226; Steinberg D, 1997, CIRCULATION, V95, P1062; Virella G, 2004, J LIPID RES, V45, P1859, DOI 10.1194/jlr.M400095-JLR200; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Iijima R, 2013, INT J CARDIOL, V168, P2588, DOI 10.1016/j.ijcard.2013.03.046; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Sugiuchi H, 1998, CLIN CHEM, V44, P522; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Shigematsu S, 2007, CIRC J, V71, P1697, DOI 10.1253/circj.71.1697; Holvoet P, 1999, JAMA-J AM MED ASSOC, V281, P1718, DOI 10.1001/jama.281.18.1718; Kondo A, 2004, CLIN CHIM ACTA, V339, P97, DOI 10.1016/j.cccn.2003.09.005; Lopes-Virella MF, 2012, ATHEROSCLEROSIS, V224, P526, DOI 10.1016/j.atherosclerosis.2012.08.006; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Grundy SM, 2002, CIRCULATION, V106, P3143; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tamura A, 2003, CIRC J, V67, P816, DOI 10.1253/circj.67.816; Tsai TT, 2011, J AM COLL CARDIOL, V58, P1859, DOI 10.1016/j.jacc.2011.06.056; WITZTUM JL, 1994, LANCET, V344, P793; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					311	317		10.1016/j.atherosclerosis.2015.01.026		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600005		
J	Kurokawa, H; Sugiyama, S; Nozaki, T; Sugamura, K; Toyama, K; Matsubara, J; Fujisue, K; Ohba, K; Maeda, H; Konishi, M; Akiyama, E; Sumida, H; Izumiya, Y; Yasuda, O; Kim-Mitsuyama, S; Ogawa, H				Kurokawa, Hirofumi; Sugiyama, Seigo; Nozaki, Toshimitsu; Sugamura, Koichi; Toyama, Kensuke; Matsubara, Junichi; Fujisue, Koichiro; Ohba, Keisuke; Maeda, Hirofumi; Konishi, Masaaki; Akiyama, Eiichi; Sumida, Hitoshi; Izumiya, Yasuhiro; Yasuda, Osamu; Kim-Mitsuyama, Shokei; Ogawa, Hisao			Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway	ATHEROSCLEROSIS			English	Article						Mitochondria; Endothelial function; Senescence; AMPK; eNOS	SKELETAL-MUSCLE; HEART-DISEASE; DYSFUNCTION; RECEPTOR; ATHEROSCLEROSIS; METFORMIN; IMPACT	Objective: Mitochondrial dysfunction plays an important role in cellular senescence and impaired function of vascular endothelium, resulted in cardiovascular diseases. Telmisartan is a unique angiotensin II type I receptor blocker that has been shown to prevent cardiovascular events in high risk patients. AMP-activated protein kinase (AMPK) plays a critical role in mitochondrial biogenesis and endothelial function. This study assessed whether telmisartan enhances mitochondrial function and alters cellular functions via AMPK in human coronary artery endothelial cells (HCAECs). Methods and results: In cultured HCAECs, telmisartan significantly enhanced mitochondrial activity assessed by mitochondrial reductase activity and intracellular ATP production and increased the expression of mitochondria related genes. Telmisartan prevented cellular senescence and exhibited the anti-apoptotic and pro-angiogenic properties. The expression of genes related anti-oxidant and pro-angiogenic properties were increased by telmisartan. Telmisartan increased endothelial NO synthase and AMPK phosphorylation. Peroxisome proliferator-activated receptor gamma signaling was not involved in telmisartan-induced improvement of mitochondrial function. All of these effects were abolished by inhibition of AMPK. Conclusions: Telmisartan enhanced mitochondrial activity and exhibited anti-senescence effects and improving endothelial function through AMPK in HCAECs. Telmisartan could provide beneficial effects on vascular diseases via enhancement of mitochondrial activity and modulating endothelial function through AMPK activation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kurokawa, Hirofumi; Sugiyama, Seigo; Nozaki, Toshimitsu; Sugamura, Koichi; Matsubara, Junichi; Fujisue, Koichiro; Ohba, Keisuke; Maeda, Hirofumi; Konishi, Masaaki; Akiyama, Eiichi; Sumida, Hitoshi; Izumiya, Yasuhiro; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Toyama, Kensuke; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan; [Yasuda, Osamu] Kumamoto Univ, Kumamoto Univ Hosp, Dept Cardiovasc Clin & Translat Res, Kumamoto 8608556, Japan	Sugiyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ssugiyam@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [C25461086]	This study was supported in part by a Grant-in-Aid for Scientific Research (No. C25461086 for S. Sugiyama) from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Matsuzawa Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000426; Chan SY, 2003, J AM COLL CARDIOL, V42, P1037, DOI 10.1016/S0735-1097(03)00927-6; Akiyama E, 2012, J AM COLL CARDIOL, V60, P1778, DOI 10.1016/j.jacc.2012.07.036; Siragusa M, 2013, ARTERIOSCL THROM VAS, V33, P1852, DOI 10.1161/ATVBAHA.112.300985; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074; Nozaki T, 2009, J AM COLL CARDIOL, V54, P601, DOI 10.1016/j.jacc.2009.05.022; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Feng XL, 2011, J CELL MOL MED, V15, P1572, DOI 10.1111/j.1582-4934.2010.01085.x; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Schachinger V, 2000, CIRCULATION, V101, P1899; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Bakris G, 2008, KIDNEY INT, V74, P364, DOI 10.1038/ki.2008.204; Kurtz TW, 2005, ACTA DIABETOL, V42, pS9, DOI 10.1007/s00592-005-0176-0; Lin JW, 2014, HYPERTENSION, V63, P968, DOI 10.1161/HYPERTENSIONAHA.113.02550; Myojo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096948; Scalera F, 2008, HYPERTENSION, V51, P696, DOI 10.1161/HYPERTENSIONAHA.107.104570; Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298; Sugimoto K, 2006, HYPERTENSION, V47, P1003, DOI 10.1161/01.HYP.0000215181.60228.f7; Takeuchi K, 2013, HYPERTENS RES, V36, P433, DOI 10.1038/hr.2012.199; Toba H, 2013, PHARMACOLOGY, V92, P265, DOI 10.1159/000355482; Vita JA, 2005, HEART, V91, P1278, DOI 10.1136/hrt.2005.061333; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202	31	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					375	385		10.1016/j.atherosclerosis.2015.01.037		11	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600014		
J	Zaid, M; Fujiyoshi, A; Miura, K; Abbott, RD; Okamura, T; Takashima, N; Torii, S; Saito, Y; Hisamatsu, T; Miyagawa, N; Ohkubo, T; Kadota, A; Sekikawa, A; Maegawa, H; Nakamura, Y; Mitsunami, K; Ueshima, H				Zaid, Maryam; Fujiyoshi, Akira; Miura, Katsuyuki; Abbott, Robert D.; Okamura, Tomonori; Takashima, Naoyuki; Torii, Sayuki; Saito, Yoshino; Hisamatsu, Takashi; Miyagawa, Naoko; Ohkubo, Takayoshi; Kadota, Aya; Sekikawa, Akira; Maegawa, Hiroshi; Nakamura, Yasuyuki; Mitsunami, Kenichi; Ueshima, Hirotsugu		SESSA Res Grp	High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men	ATHEROSCLEROSIS			English	Article						High-density lipoprotein (HDL) particle; High-density lipoprotein (HDL) cholesterol; Subclinical atherosclerosis; Carotid intima-media thickness (cIMT); Plaque count	INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; CHOLESTEROL EFFLUX; STATIN THERAPY; A-I; RISK; HDL; SIZE; TORCETRAPIB; PROGRESSION	Objective: The association of high-density lipoprotein particle (HDL-P) with atherosclerosis may be stronger than that of HDL-cholesterol (HDL-C) and independent of conventional cardiovascular risk factors. Whether associations persist in populations at low risk of coronary heart disease (CHD) remains unclear. This study examines the associations of HDL-P and HDL-C with carotid intima-media thickness (cIMT) and plaque counts among Japanese men, who characteristically have higher HDL-C levels and a lower CHD burden than those in men of Western populations. Methods: We cross-sectionally examined a community-based sample of 870 Japanese men aged 40-79 years, free of known clinical cardiovascular disease (CVD) and not on lipid-lowering medication. Participants were randomly selected among Japanese living in Kusatsu City in Shiga, Japan. Results: Both HDL-P and HDL-C were inversely and independently associated with cIMT in models adjusted for conventional CHD risk factors, including low-density lipoprotein cholesterol (LDL-C) and diabetes. HDL-P maintained an association with cIMT after further adjustment for HDL-C (P < 0.01), whereas the association of HDL-C with cIMT was noticeably absent after inclusion of HDL-P in the model. In plaque counts of the carotid arteries, HDL-P was significantly associated with a reduction in plaque count, whereas HDL-C was not. Conclusion: HDL-P, in comparison to HDL-C, is more strongly associated with measures of carotid atherosclerosis in a cross-sectional study of Japanese men. Findings demonstrate that, HDL-P is a strong correlate of subclinical atherosclerosis even in a population at low risk for CHD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Zaid, Maryam; Fujiyoshi, Akira; Miura, Katsuyuki; Takashima, Naoyuki; Torii, Sayuki; Saito, Yoshino; Hisamatsu, Takashi; Miyagawa, Naoko; Ohkubo, Takayoshi; Nakamura, Yasuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 5202192, Japan; [Miura, Katsuyuki; Abbott, Robert D.; Hisamatsu, Takashi; Kadota, Aya; Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 5202192, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo 1608582, Japan; [Ohkubo, Takayoshi] Teikyo Univ Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, Tokyo 1738605, Japan; [Sekikawa, Akira] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Internal Med, Div Endocrinol & Metab, Otsu, Shiga 52021, Japan; [Nakamura, Yasuyuki] Kyoto Womens Univ, Dept Cardiovasc Epidemiol, Higashiyama Ku, Kyoto 6058501, Japan; [Mitsunami, Kenichi] Shiga Univ Med Sci, Otsu, Shiga 5202192, Japan	Fujiyoshi, A (reprint author), Shiga Univ Med Sci, Dept Publ Hlth, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	afujiy@belle.shiga-med.ac.jp	Okamura, Tomonori/L-1693-2013; 	Kita, Yoshikuni/0000-0002-2366-1106	Ministry of Education, Culture, Sports, Science, and Technology Japan [13307016, 17209023, 21249043, 23249036, 25253046]; Glaxo-Smith Klein; National Institutes of Health (NIH), USA [R01HL068200]; Ichiro Kanehara Foundation Scholarship [12RY006]	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology Japan [(A) 13307016, (A) 17209023, (A) 21249043, (A) 23249036, and (A) 25253046]; Glaxo-Smith Klein; and by National Institutes of Health (NIH), USA [R01HL068200].; Research was supported in part by Ichiro Kanehara Foundation Scholarship 12RY006 for Foreign Nationals in Japan [to MZ], for the 2013 fiscal year.	Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Kadota A, 2013, J ATHEROSCLER THROMB, V20, P755; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; SUTTONTYRRELL K, 1992, STROKE, V23, P215; GORDON DJ, 1989, CIRCULATION, V79, P8; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Andrikoula M, 2008, DIABETES OBES METAB, V10, P271, DOI 10.1111/j.1463-1326.2007.00714.x; Vickers KC, 2014, J LIPID RES, V55, P4, DOI 10.1194/jlr.R035964; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; El Harchaoui K, 2009, ANN INTERN MED, V150, P84; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Emerging Risk Factors C., 2009, JAMA-J AM MED ASSOC, V302, P1993; Linsel-Nitschke P, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-14; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145; OBRIEN T, 1995, ARTERIOSCL THROM VAS, V15, P228; Otvos James D, 2002, Clin Lab, V48, P171; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; Sekikawa A, 2014, HEART, V100, P569, DOI 10.1136/heartjnl-2013-304421; Sekikawa A, 2008, METABOLISM, V57, P177, DOI 10.1016/j.metabol.2007.08.022; Tan HC, 2011, J CLIN LIPIDOL, V5, P467, DOI 10.1016/j.jacl.2011.06.016; UESHIMA H, 1982, JAMA-J AM MED ASSOC, V247, P1985, DOI 10.1001/jama.247.14.1985	36	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					444	450		10.1016/j.atherosclerosis.2015.01.031		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600024		
J	Ikura, K; Hanai, K; Shinjyo, T; Uchigata, Y				Ikura, Kazuki; Hanai, Ko; Shinjyo, Takamichi; Uchigata, Yasuko			HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot ulcers	ATHEROSCLEROSIS			English	Article						HDL cholesterol; Diabetic foot ulcer; Lower extremity amputation	HIGH-DENSITY-LIPOPROTEIN; ACUTE-PHASE RESPONSE; SURGICAL-PATIENTS; SEVERE SEPSIS; RISK-FACTORS; DISEASE; KIDNEY	Objective: We examined whether HDL cholesterol levels are a predictor for an incidence of lower-extremity amputation (LEA) and wound-related death in patients with diabetic foot ulcers (DFUs). Research design and methods: This was a single-center, observational, longitudinal historical cohort study of 163 Japanese ambulatory patients with DFUs, 45 woman and 118 men, with a mean (standard deviation) age of 62 (14) years. The primary composite endpoint was defined as the worst of the following outcomes for each individual; (1) minor amputation, defined as amputation below the ankle, (2) major amputation, defined as amputation above the ankle, and (3) wound-related death. Results: During the median follow-up period of 5.1 months, 67 patients (41.1%) reached the endpoint (43 minor amputations, 16 major amputations, and 8 wound-related deaths). In the univariate Cox proportional hazard model analysis, lower HDL cholesterol levels (mmol/L) were significantly associated with the incidence of the primary composite endpoint (hazard ratio 0.16 [ 95% CI 0.08-0.32], p < 0.001). In the multivariate Cox proportional hazard model analysis using a stepwise variable-selecting procedure, HDL cholesterol levels in addition to the presence of ankle brachial index <0.9 or >= 1.4 and serum albumin levels were selected as independent risk factors for the incidence of the endpoint (hazard ratio 0.30 [95% CI 0.14-0.63], p = 0.002). Similar results were obtained when HDL cholesterol levels were treated as a categorical variable (>= 1.03 mmol/L or less). Conclusions: HDL cholesterol levels might be a novel clinical predictor for the incidence of LEA and wound-related death in patients with DFUs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ikura, Kazuki; Hanai, Ko; Shinjyo, Takamichi; Uchigata, Yasuko] Tokyo Womens Med Univ Sch Med, Ctr Diabet, Tokyo 1628666, Japan	Hanai, K (reprint author), Tokyo Womens Med Univ Sch Med, Ctr Diabet, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	hanai@dmc.twmu.ac.jp					Alavi A., 2014, J AM ACAD DERMATOL, V70, p21e1; Alavi A., 2014, J AM ACAD DERMATOL, V70, P45; American Diabetes Association, 1999, DIABETES CARE, V22, P1354; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; CABANA VG, 1989, J LIPID RES, V30, P39; Barlage S, 2009, INTENS CARE MED, V35, P1877, DOI 10.1007/s00134-009-1609-y; Norata GD, 2011, CURR OPIN LIPIDOL, V22, P410, DOI 10.1097/MOL.0b013e32834adac3; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Oyibo SO, 2001, DIABETES CARE, V24, P84, DOI 10.2337/diacare.24.1.84; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Turner RC, 1998, BRIT MED J, V316, P823; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Leung PC, 2007, SURG-J R COLL SURG E, V5, P219; Hanai K, 2012, NEPHROL DIAL TRANSPL, V27, P1070, DOI 10.1093/ndt/gfr417; Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x; Grunfeld C, 1999, J LIPID RES, V40, P245; Canturk NZ, 2002, CLIN NUTR, V21, P431, DOI 10.1054/clnu.2002.0575; Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y; Armstrong David G, 2007, Int Wound J, V4, P286; Cabana VG, 1996, J LIPID RES, V37, P2662; DelgadoRodriguez M, 1997, INFECT CONT HOSP EP, V18, P9; Li X, 2011, DIABETES RES CLIN PR, V93, P26, DOI 10.1016/j.diabres.2011.03.014; Morton J, 2012, DIABETES CARE, V35, P2201, DOI 10.2337/dc12-0306; Pajkrt B. D., 1996, J EXP MED, V184, P1601; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					465	469		10.1016/j.atherosclerosis.2015.02.006		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600027		
J	Ueno, Y; Yamashiro, K; Tanaka, Y; Watanabe, M; Miyamoto, N; Shimada, Y; Kuroki, T; Tanaka, R; Miyauchi, K; Daida, H; Hattori, N; Urabe, T				Ueno, Yuji; Yamashiro, Kazuo; Tanaka, Yasutaka; Watanabe, Masao; Miyamoto, Nobukazu; Shimada, Yoshiaki; Kuroki, Takuma; Tanaka, Ryota; Miyauchi, Katsumi; Daida, Hiroyuki; Hattori, Nobutaka; Urabe, Takao			Rosuvastatin may stabilize atherosclerotic aortic plaque: Transesophageal echocardiographic study in the EPISTEME trial	ATHEROSCLEROSIS			English	Article						Stroke; Atheromatous aortic plaque; Rosuvastatin; Transesophageal echocardiography; Aortogenic brain embolism	LIPID-LOWERING THERAPY; TRANSIENT ISCHEMIC ATTACK; LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; CEREBRAL INFARCTION; STATIN THERAPY; ARCH PLAQUES; STROKE; RISK; CHOLESTEROL	Objective: Large atheromatous aortic plaques (AAPs) have been associated with ischemic stroke. There is little evidence to guide the therapeutic strategy for ischemic stroke associated with large AAPs. This study sought to analyze the temporal profile of AAPs after rosuvastatin therapy in Japanese patients with acute ischemic stroke. Methods: The Efficacy of Post-stroke Intensive Rosuvastatin Treatment for aortogenic Embolic stroke (EPISTEME) trial was a prospective, randomized, open-label study. Acute ischemic stroke patients with dyslipidemia and AAPs >= 4-mm-thick on transesophageal echocardiography (TEE) were enrolled and randomly allocated to either the group treated with 5 mg/day rosuvastatin or the control group. The primary endpoint was the changes in volume and composition of AAPs on repeat TEE after 6 months. High-echoic plaque area was analyzed using binary images. Results: A total of 24 Japanese patients (rosuvastatin 12; control 12) were included in the primary analysis. Rosuvastatin substantially reduced low-density lipoprotein cholesterol (LDL-C) compared to control (-42.1% vs. 1.4%, P < 0.001). Percent changes of high-echoic plaque areas were significantly increased in the rosuvastatin group, while they were decreased in the control group (65.8% vs - 14.7%, P < 0.001). There was a significant linear correlation between percent increase in high-echoic plaque area and LDL-C decrease (r = 0.434, P = 0.002). Conclusion: Treatment with 5-mg rosuvastatin for 6 months might induce atheromatous aortic plaque stabilization together with marked LDL-C reduction in Japanese patients with ischemic stroke, which could provide evidence on which to base the therapeutic strategy for aortogenic brain embolism. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ueno, Yuji; Tanaka, Yasutaka; Watanabe, Masao; Miyamoto, Nobukazu; Urabe, Takao] Juntendo Univ Urayasu Hosp, Dept Neurol, Urayasu, Chiba, Japan; [Ueno, Yuji; Yamashiro, Kazuo; Shimada, Yoshiaki; Kuroki, Takuma; Tanaka, Ryota; Hattori, Nobutaka] Juntendo Univ Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Miyauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ Sch Med, Dept Cardiol, Tokyo 1138421, Japan	Ueno, Y (reprint author), Juntendo Univ Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yuji-u@juntendo.ac.jp			AstraZeneca K.K.; Shionogi Co. Ltd.	AstraZeneca K.K. participated in the preparation of the study design. However, the investigators made the final decision on the study design, patients' selection, randomization of subjects, interpretation of data, wrote the manuscript, and decided to submit the article. Dr. Daida and Dr. Urabe have received research grants from AstraZeneca K.K., and Shionogi & Co. Ltd. Dr. Daida was an advisory member of AstraZeneca K.K. and Shionogi & Co. Ltd. Dr. Miyauchi is an advisory member of AstraZeneca K.K. Dr. Ueno, Dr. Daida, Dr. Urabe, and Dr. Miyauchi have received honoraria for lectures from AstraZeneca K.K. and Shionogi & Co. Ltd. The other authors have no conflicts of interest.	AMARENCO P, 1992, STROKE, V23, P1005; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Yogo M, 2014, ATHEROSCLEROSIS, V232, P31, DOI 10.1016/j.atherosclerosis.2013.10.007; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Di Tullio MR, 2009, CIRCULATION, V119, P2376, DOI 10.1161/CIRCULATIONAHA.108.811935; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Mono ML, 2012, CEREBROVASC DIS, V34, P343, DOI 10.1159/000343227; PEDERSEN TR, 1995, LANCET, V345, P1274; Lima JAC, 2004, CIRCULATION, V110, P2336, DOI 10.1161/01.CIR.0000145170.22652.51; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Becker DJ, 2009, ANN INTERN MED, V150, P830; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Yonemura A, 2005, J AM COLL CARDIOL, V45, P733, DOI 10.1016/j.jacc.2004.11.039; Amarenco P, 2014, STROKE, V45, P1248, DOI 10.1161/STROKEAHA.113.004251; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Choukroun EM, 2002, ANN VASC SURG, V16, P714, DOI 10.1007/s10016-001-0314-2; Crisby M, 2001, CIRCULATION, V103, P926; Nohara R, 2012, CIRC J, V76, P221, DOI 10.1253/circj.CJ-11-0887; Zhang JY, 2014, J MOL NEUROSCI, V52, P261, DOI 10.1007/s12031-013-0134-1; Hara H, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-18; Kaneko K, 2014, J STROKE CEREBROVASC, V23, P1682, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.018; Moreira FT, 2014, LIFE SCI, V98, P83, DOI 10.1016/j.lfs.2014.01.001; Napoli C, 2008, AM HEART J, V156, P1154; Negishi K., 2010, J AM SOC ECHOCARDIOG, V23, p1222 e1221; Nishiga M, 2013, J ATHEROSCLER THROMB, V20, P821; Okuzumi A, 2013, J NEUROL SCI, V326, P83, DOI 10.1016/j.jns.2013.01.019; Teramoto T, 2005, INT J CLIN PRACT, V59, P92, DOI 10.1111/j.1368-5031.2004.00346.x; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Tunick PA, 2002, AM J CARDIOL, V90, P1320, DOI 10.1016/S0002-9149(02)02870-9; Ueno Y, 2007, STROKE, V38, P2470, DOI 10.1161/STROKEAHA.107.482497; Ueno Y, 2014, CARDIOVASC DRUG THER, V28, P79, DOI 10.1007/s10557-013-6493-6; Underhill H.R., 2008, AM HEART J, V155, pe581	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					476	482		10.1016/j.atherosclerosis.2015.02.021		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600029		
J	Fukami, A; Adachi, H; Hirai, Y; Enomoto, M; Otsuka, M; Kumagai, E; Nakamura, S; Yoshimura, A; Obuchi, A; Nohara, Y; Nakao, E; Hori, K; Fukumoto, Y				Fukami, Ako; Adachi, Hisashi; Hirai, Yuji; Enomoto, Mika; Otsuka, Maki; Kumagai, Eita; Nakamura, Sachiko; Yoshimura, Ayako; Obuchi, Aya; Nohara, Yume; Nakao, Erika; Hori, Kensuke; Fukumoto, Yoshihiro			Association of serum eicosapentaenoic acid to arachidonic acid ratio with microalbuminuria in a population of community-dwelling Japanese	ATHEROSCLEROSIS			English	Article						EPA; AA; EPA/AA ratio; Microalbuminuria; Epidemiology	N-3 FATTY-ACIDS; URINARY ALBUMIN EXCRETION; CORONARY-ARTERY-DISEASE; GENERAL-POPULATION; HEART-DISEASE; CARDIOVASCULAR-DISEASE; ATHEROSCLEROTIC RISK; INSULIN-RESISTANCE; GENDER-DIFFERENCES; 10-YEAR MORTALITY	Background: Epidemiological evidence suggests that the increased intake of omega-3 polyunsaturated fatty acids can prevent atherosclerosis-related cardiovascular diseases. Recently, serum eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio has been reported to be a predictive marker of cardiovascular events. Accordingly, we examined the relationship between serum EPA/AA ratio and microalbuminuria. Methods: We enrolled 444 residents (174 males and 270 females, mean age 66.6 +/- 9.3 years) who underwent a physical examination in Uku town (fishing area) in Japan. They received blood tests including serum levels of EPA and AA, and urine test to examine microalbuminuria. Eating and drinking patterns were evaluated by a brief self-administered diet history questionnaire. Microalbuminuria was defined as a urinary albumin-to-creatinine ratio (UACR) >= 30 mg/g Cr. Results: The mean EPA/AA ratio was 0.66 +/- 0.3 in males and 0.51 +/- 0.2 in females. Multiple stepwise regression analyses revealed that systolic blood pressure (p < 0.0001), high sensitive C-reactive protein (p < 0.01), serum EPA/AA ratio (p < 0.01, inversely), and hemoglobin A(1c) (p < 0.05) were significantly associated with microalbuminuria. In the group with low serum EPA/AA ratio, the prevalence of microalbuminuria was significantly higher than the other, after the adjustments for confounding factors (odds ratio, 3.45; 95% confidence interval, 1.47-8.13; p < 0.01). Conclusion: The present study demonstrated that serum EPA/AA ratio was strongly associated with microalbuminuria. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Fukami, Ako; Hirai, Yuji; Enomoto, Mika; Otsuka, Maki; Kumagai, Eita; Nakamura, Sachiko; Yoshimura, Ayako; Obuchi, Aya; Nohara, Yume; Nakao, Erika; Hori, Kensuke; Fukumoto, Yoshihiro] Kurume Univ Sch Med, Div Cardiovasc Med, Dept Internal Med, Kurume, Fukuoka 8300011, Japan; [Adachi, Hisashi] Kurume Univ Sch Med, Dept Community Med, Kurume, Fukuoka 8300011, Japan	Fukami, A (reprint author), Kurume Univ Sch Med, Div Cardiovasc Med, Dept Internal Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	fukami_ako@kurume-u.ac.jp			Kimura Memorial Heart Foundation, Fukuoka; Ministry of Education, Culture, Sports, Science and Technology [25460783]; Foundation for Total Health Promotion, Japan	This study was supported in part by the Kimura Memorial Heart Foundation, Fukuoka, by Grant-in-Aid for Scientific Research (C), from The Ministry of Education, Culture, Sports, Science and Technology (No. 25460783), and by Foundation for Total Health Promotion, Japan. We are grateful to members of the elected officials and residents of Uku town, and the team of physicians in the Third Department of Internal Medicine, Kurume University School of Medicine for their help in performing the health examinations.	Matsuzaki M, 2009, CIRC J, V73, P1283; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Kumagai E, 2011, HYPERTENSION, V58, P1043, DOI 10.1161/HYPERTENSIONAHA.111.180521; De Caterina R, 2007, DIABETES CARE, V30, P1012, DOI 10.2337/dc06-1332; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Ninomiya T, 2013, ATHEROSCLEROSIS, V231, P261, DOI 10.1016/j.atherosclerosis.2013.09.023; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Zhao HL, 2014, J IMMUNOL, V192, P385, DOI 10.4049/jimmunol.1302021; Tsukagawa E, 2013, CLIN ENDOCRINOL, V79, P43, DOI 10.1111/j.1365-2265.2012.04496.x; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99; Malik AR, 2007, J HUM HYPERTENS, V21, P231, DOI 10.1038/sj.jhh.1002143; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Nishizaki Y, 2014, AM J CARDIOL, V113, P441, DOI 10.1016/j.amjcard.2013.10.011; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Takemoto Y, 2003, BRAIN DEV-JPN, V25, P481, DOI 10.1016/S0387-7604(03)00033-0; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S; Garman JH, 2009, AM J PHYSIOL-RENAL, V296, pF306, DOI 10.1152/ajprenal.90326.2008; HAMAZAKI T, 1990, LIPIDS, V25, P541, DOI 10.1007/BF02537161; HAMAZAKI T, 1982, PROSTAGLANDINS, V23, P557, DOI 10.1016/0090-6980(82)90116-2; Hino A, 2004, ATHEROSCLEROSIS, V176, P145, DOI 10.1016/j.atherosclerosis.2004.04.020; HIRAI A, 1982, THROMB RES, V28, P285, DOI 10.1016/0049-3848(82)90112-8; Kitagawa Y, 2014, INTERNAL MED, V53, P177, DOI 10.2169/internalmedicine.53.0618; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kumagae SI, 2010, AM J HYPERTENS, V23, P1103, DOI 10.1038/ajh.2010.125; Lauretani F, 2008, CLIN CHEM, V54, P475, DOI 10.1373/clinchem.2007.095521; Mollsten AV, 2001, DIABETES CARE, V24, P805, DOI 10.2337/diacare.24.5.805; Ogata K, 2013, ATHEROSCLEROSIS, V227, P159, DOI 10.1016/j.atherosclerosis.2012.12.023; Otsuka M., 2012, J EPIDEMIOL; Terano T, 1996, LIPIDS, V31, pS301, DOI 10.1007/BF02637096; Yokoi K, 2012, CIRC J, V76, P2779, DOI 10.1253/circj.CJ-12-0469; Yoshikawa K, 2013, J AM GERIATR SOC, V61, P467, DOI 10.1111/jgs.12083; YUDKIN JS, 1988, LANCET, V2, P530	42	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					577	582		10.1016/j.atherosclerosis.2015.02.033		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600043		
J	Hishikari, K; Kimura, S; Yamakami, Y; Kojima, K; Sagawa, Y; Otani, H; Sugiyama, T; Kuwahara, T; Hikita, H; Takahashi, A; Isobe, M				Hishikari, Keiichi; Kimura, Shigeki; Yamakami, Yosuke; Kojima, Keisuke; Sagawa, Yuichiro; Otani, Hirohumi; Sugiyama, Tomoyo; Kuwahara, Taishi; Hikita, Hiroyuki; Takahashi, Atsushi; Isobe, Mitsuaki			The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions	ATHEROSCLEROSIS			English	Article						Peripheral artery disease; Endovascular therapy; Eicosapentaenoic acid; Arachidonic acid; Femoropopliteal artery; Outcome; Prognosis	CORONARY-HEART-DISEASE; FATTY-ACIDS; TASK-FORCE; ATHEROSCLEROSIS; RISK; MANAGEMENT; PLASMA; METABOLISM; GUIDELINES; DIAGNOSIS	Background: The EPA/AA ratio has emerged as a predictor of mortality endpoints in cardiac disease; however, its prognostic value in peripheral artery disease (PAD) patients is unclear. We assessed the serum eicosapentaenoic acid (EPA) to arachidonic acid (AA) ratio in patients with PAD caused by femoropopliteal artery lesions, to determine whether it predicts clinical outcomes after endovascular therapy (EVT). Methods and results: We obtained serum EPA/AA ratios from 132 consecutive patients with PAD caused by femoropopliteal artery lesions before EVT. Patients were divided into two groups using the median value of serum EPA/AA ratios of the entire cohort; LOW group with the levels <= 0.30 (n = 66) and HIGH group > 0.30 (n = 66). The incidence of major adverse events (MAE), including major adverse limb events (MALE) and death from any cause, was determined. At a median follow-up interval of 24 months, MALE occurred in 40 patients (30.3%) and 11 patients (8.3%) died. Kaplan-Meier curve analysis demonstrated the survival probability from MAE was significantly worse in patients with EPA/AA ratio under the median (long-rank test chi(2) = 16.4; p < 0.001). Multivariate Cox regression analysis showed critical limb ischemia (hazard ratio [HR]: 3.44; 95% confidence interval [CI]: 1.84 to 6.46; p < 0.001) and the pre-procedural serum EPA/AA ratios <= 0.30 (HR: 2.74; 95% CI: 1.33 to 5.65; p = 0.006) independently predicted MAE after EVT. Conclusions: Lower serum EPA/AA ratios appear to be associated with a greater risk of MALE and death from any cause after EVT in patients with PAD caused by femoropopliteal artery lesions. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hishikari, Keiichi; Kimura, Shigeki; Yamakami, Yosuke; Kojima, Keisuke; Sagawa, Yuichiro; Otani, Hirohumi; Sugiyama, Tomoyo; Kuwahara, Taishi; Hikita, Hiroyuki; Takahashi, Atsushi] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa 2388558, Japan; [Hishikari, Keiichi; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Cardiovasc Med, Tokyo, Japan	Kimura, S (reprint author), Yokosuka Kyosai Hosp, Dept Cardiovasc Ctr, 1-16 Yonegahama Dori, Yokosuka, Kanagawa 2388558, Japan.	shigeki55@nifty.com					Rooke TW, 2011, CIRCULATION, V124, P2020, DOI 10.1161/CIR.0b013e31822e80c3; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Matsuzawa Y, 2005, ATHEROSCLEROSIS SUPP, V6, P7, DOI 10.1016/j.atherosclerosissup.2005.02.003; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Fujihara M, 2013, ANGIOLOGY, V64, P112, DOI 10.1177/0003319712437031; RANKE C, 1992, ULTRASOUND MED BIOL, V18, P433, DOI 10.1016/0301-5629(92)90082-L; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99; Ueeda M, 2011, HEART VESSELS, V26, P145, DOI 10.1007/s00380-010-0038-8; Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; BEATTY CH, 1985, ATHEROSCLEROSIS, V55, P1, DOI 10.1016/0021-9150(85)90161-3; DYERBERG J, 1978, LANCET, V2, P117; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haugen S, 2007, VASC MED, V12, P343, DOI 10.1177/1358863x07083278; HOSHI M, 1973, J LIPID RES, V14, P599; Ikeya Y, 2013, NUTRITION, V29, P127, DOI 10.1016/j.nut.2012.05.003; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Tretjakovs P, 2003, MED PRIN PRACT, V12, P10, DOI 10.1159/000068154; Venkitachalam L, 2012, CIRCULATION, V125, P1858, DOI 10.1161/CIRCULATIONAHA.111.064378; Wolfram G, 2003, EUR J MED RES, V8, P321; Yamamoto Akira, 2002, J Atheroscler Thromb, V9, P191; Yli-Jama P, 2002, J INTERN MED, V251, P19, DOI 10.1046/j.1365-2796.2002.00922.x	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					583	588		10.1016/j.atherosclerosis.2015.02.035		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600044		
J	Mori, S; Takaya, T; Kinugasa, M; Ito, T; Takamine, S; Fujiwara, S; Nishii, T; Kono, AK; Inoue, T; Satomi-Kobayashi, S; Rikitake, Y; Okita, Y; Hirata, K				Mori, Shumpei; Takaya, Tomofumi; Kinugasa, Mitsuo; Ito, Tatsuro; Takamine, Sachiko; Fujiwara, Sei; Nishii, Tatsuya; Kono, Atsushi K.; Inoue, Takeshi; Satomi-Kobayashi, Seimi; Rikitake, Yoshiyuki; Okita, Yutaka; Hirata, Ken-ichi			Three-dimensional quantification and visualization of aortic calcification by multidetector-row computed tomography: A simple approach using a volume-rendering method	ATHEROSCLEROSIS			English	Article						Vascular calcification; Aortic calcification; Agatston score; Volume-rendering method; Multidetector-row computed tomography	CORONARY-ARTERY CALCIUM; THORACIC AORTA; VASCULAR CALCIFICATION; CARDIOVASCULAR EVENTS; ASCENDING AORTA; DISEASE; ATHEROSCLEROSIS; REPRODUCIBILITY; HEMODIALYSIS; PREDICTION	Objective: Three-dimensional (3-D) visualization and quantification of vascular calcification (VC) are important to accelerate the multidisciplinary investigation of VC. Agatston scoring is the standard approach for evaluating coronary artery calcification. However, regarding aortic calcification (AC), quantification methods appear to vary among studies. The aim of this study was to introduce a simple technique of simultaneous quantification and 3-D visualization of AC and provide validation data. Methods: The main study comprised of 126 patients who underwent the thoracoabdominal plain computed tomography scan as preoperative general evaluation. AC was quantified using a volume-rendering (VR) method (VR AC volume) by extracting the volume with a density >= 130 HU within the total aorta. The concordance and reproducibility of the VR AC volume were validated in comparison with the conventional slice-by-slice voxel-based AC quantification (volumetric AC score) using the Agatston scoring software. Results: Excellent concordance between the VR AC volume and volumetric AC score was confirmed (Spearman correlation coefficient = 0.9997, mean difference = -0.05 +/- 0.23 mL, p < 0.0001). Excellent intraobserver and interobserver reliabilities were demonstrated using the Bland -Altman analysis as the mean intraobserver difference was 0.00 mL (p = 0.9863) and the mean interobserver difference was -0.01 mL (p = 0.6612). Conclusion: The VR method was validated to be feasible. This simple approach could overcome the limitation of the current method based on slice-by-slice pixel or voxel summation, which lacks 3-D visual information. Accordingly, this approach would be promising for accelerating the investigation of VC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Mori, Shumpei; Takaya, Tomofumi; Kinugasa, Mitsuo; Ito, Tatsuro; Takamine, Sachiko; Fujiwara, Sei; Satomi-Kobayashi, Seimi; Rikitake, Yoshiyuki; Hirata, Ken-ichi] Kobe Univ Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Nishii, Tatsuya; Kono, Atsushi K.] Kobe Univ Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan; [Inoue, Takeshi; Okita, Yutaka] Kobe Univ Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Kobe, Hyogo 6500017, Japan; [Rikitake, Yoshiyuki] Kobe Univ Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct, Kobe, Hyogo 6500017, Japan	Mori, S (reprint author), Kobe Univ Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shumpei_8@hotmail.com		Takaya, Tomofumi/0000-0001-5775-8072			AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Cecelja M, 2011, J AM COLL CARDIOL, V57, P1480, DOI 10.1016/j.jacc.2010.09.079; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; van der Linden J, 2001, J AM COLL CARDIOL, V38, P131, DOI 10.1016/S0735-1097(01)01328-6; Elmariah S, 2010, J AM COLL CARDIOL, V56, P1752, DOI 10.1016/j.jacc.2010.05.050; Wong ND, 2009, JACC-CARDIOVASC IMAG, V2, P319, DOI 10.1016/j.jcmg.2008.12.010; Wong ND, 2011, ATHEROSCLEROSIS, V214, P436, DOI 10.1016/j.atherosclerosis.2010.09.011; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Eisen A, 2008, CIRCULATION, V118, P1328, DOI 10.1161/CIRCULATIONAHA.107.712141; Callister TQ, 1998, RADIOLOGY, V208, P807; Bapat VN, 2012, JACC-CARDIOVASC INTE, V5, P470, DOI 10.1016/j.jcin.2012.03.006; BLAND JM, 1986, LANCET, V1, P307; Cecelja M, 2013, HYPERTENSION, V61, P609, DOI 10.1161/HYPERTENSIONAHA.111.00024; Fujiu A, 2008, CIRC J, V72, P1768, DOI 10.1253/circj.CJ-08-0308; Itani Y, 2006, CIRC J, V70, P733, DOI 10.1253/circj.70.733; Kamiura N, 2014, INT UROL NEPHROL, V46, P993, DOI 10.1007/s11255-013-0620-y; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003; Nitta K, 2011, THER APHER DIAL, V15, P513, DOI 10.1111/j.1744-9987.2011.00979.x; Ryu Y, 2013, ANN NUCL MED, V27, P239, DOI 10.1007/s12149-012-0679-z; Wang SJ, 1996, AM HEART J, V132, P550, DOI 10.1016/S0002-8703(96)90237-9	20	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	APR	2015	239	2					622	628		10.1016/j.atherosclerosis.2014.12.041		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD4NZ	WOS:000351061600049		
J	Ugurlu, B; Havoutis, I; Semini, C; Kayamori, K; Caldwell, DG; Narikiyo, T				Ugurlu, Barkan; Havoutis, Ioannis; Semini, Claudio; Kayamori, Kana; Caldwell, Darwin G.; Narikiyo, Tatsuo			Pattern generation and compliant feedback control for quadrupedal dynamic trot-walking locomotion: experiments on RoboCat-1 and HyQ	AUTONOMOUS ROBOTS			English	Article						Quadrupedal locomotion; Dynamic trot-walking; Active compliance; Pattern generation	BIPED WALKING; ROBOT; GAIT; STABILITY; TERRAIN	In this paper, we introduce a method that synergistically combines an analytical pattern generator and a feedback controller frame, which are developed for the purpose of synthesizing dynamic quadrupedal trot-walking locomotion on flat and uneven surfaces. To begin with, the pattern generator analytically produces feasible and dynamically balanced joint motions in accordance with the desired trot-walking characteristics, with no empirical parameter tuning requirements. In concurrence with the pattern generation, a two-phased controller frame is constructed for closed-loop sensory feedback: (i) virtual admittance controller via force sensing, (ii) upper torso angular momentum regulation via gyro sensing. The former controller evaluates joint force errors and generates the corresponding joint displacement for a given set of virtual spring-damper couples. Together with the position constraints, these displacements are additionally fed-back to local servos for achieving compliant quadrupedal locomotion with which the position/force trade-off is addressed. The second controller, that is simultaneously used, evaluates the upper torso angular momentum rate change error using measured and reference orientation information. It then regulates the torso orientation in a dynamically consistent way as the rotational inertia is characterized. In order to validate the proposed methodology several experiments are conducted on both flat and uneven surfaces, using two robots with distinct properties; a 7 kg cat-sized electrically actuated quadruped (RoboCat-1), and a 80 kg Alpine Ibex-sized hydraulically actuated quadruped (HyQ). As a result we demonstrate continuous, repetitive, compliant and dynamically balanced trot-walking cycles in real-robot experiments, adequately confirming the effectiveness of the proposed approach.	[Ugurlu, Barkan] Ozyegin Univ, Dept Mech Engn, TR-34794 Istanbul, Turkey; [Havoutis, Ioannis; Semini, Claudio; Caldwell, Darwin G.] IIT, Dept Adv Robot, I-16163 Genoa, Italy; [Kayamori, Kana; Narikiyo, Tatsuo] Toyota Technol Inst, Dept Adv Sci & Technol, Nagoya, Aichi 4688511, Japan	Ugurlu, B (reprint author), Ozyegin Univ, Dept Mech Engn, TR-34794 Istanbul, Turkey.	barkan.ugurlu@ozyegin.edu.tr; ioannis.havoutis@iit.it; claudio.semini@iit.it; darwin.caldwell@iit.it; n-tatsuo@toyota-ti.ac.jp			Hitech Research Center; Fondazione Istituto Italiano di Tecnologia, Genova, Italy	In this study, the RoboCat-1 related portion is partially supported by Hitech Research Center, projects for private universities, supplied by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The HyQ related portion is supported by Fondazione Istituto Italiano di Tecnologia, Genova, Italy. The authors would like to thank Takao Kawasaki, Kazuyuki Hyodo, Michihiro Kawanishi, Jesus Ortiz, Jake Goldsmith, Marco Frigero, Michele Focchi, Thiago Boaventura, Stephane Bazeille, Bilal Rehman, Hamza Khan, and the team of IIT Advanced Robotics technicians for their kind assistance and support.	Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989; Boaventura T, 2013, IEEE INT C INT ROBOT, P1458, DOI 10.1109/IROS.2013.6696541; Fujimoto Y, 1998, IEEE INT CONF ROBOT, P2030, DOI 10.1109/ROBOT.1998.680613; Boaventura T, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1889, DOI 10.1109/ICRA.2012.6224628; Maufroy C, 2010, AUTON ROBOT, V28, P331, DOI 10.1007/s10514-009-9172-5; Kajita S, 2003, IEEE INT CONF ROBOT, P1620, DOI 10.1109/ROBOT.2003.1241826; Morimoto J, 2008, IEEE T ROBOT, V24, P185, DOI 10.1109/TRO.2008.915457; Kim YD, 2007, IEEE T ROBOT, V23, P1294, DOI 10.1109/TRO.2007.906250; Kimura H, 2007, INT J ROBOT RES, V26, P475, DOI 10.1177/0278364907078089; Koolen T, 2012, INT J ROBOT RES, V31, P1094, DOI 10.1177/0278364912452673; Semini C, 2011, P I MECH ENG I-J SYS, V225, P831, DOI 10.1177/0959651811402275; Kalakrishnan M, 2011, INT J ROBOT RES, V30, P236, DOI 10.1177/0278364910388677; Ugurlu B, 2014, IEEE T IND ELECTRON, V61, P5431, DOI 10.1109/TIE.2014.2300060; Sugihara T, 2009, IEEE T ROBOT, V25, P658, DOI 10.1109/TRO.2008.2012336; Moro FL, 2013, BIOL CYBERN, V107, P309, DOI 10.1007/s00422-013-0551-9; Barasuol V., 2013, IEEE INT C ROB AUT I, P2539; Bazeille S, 2014, INTEL SERV ROBOT, V7, P67, DOI 10.1007/s11370-014-0147-9; BUSCHMANN T, 2009, IEEE INT C INT ROB S, P3019; Byl K, 2009, SPRINGER TRAC ADV RO, V54, P319; Colgate E., 1989, P IEEE INT C ROB AUT, V1, P404; COLGATE JE, 1994, J DYN SYST-T ASME, V116, P419, DOI 10.1115/1.2899237; Fasse E., 1987, THESIS MASSACHUSETTS; Focchi M., 2013, INT C CLIMB WALK ROB, P1; Galloway K. C., 2013, J MECH ROBOT, V5, P677; Havoutis I, 2013, IEEE INT C INT ROBOT, P6052, DOI 10.1109/IROS.2013.6697235; Hutter M, 2013, IEEE-ASME T MECH, V18, P449, DOI 10.1109/TMECH.2012.2222430; Hyon S.-H., 2009, IEEE T ROBOTICS, V25, P677; Kurazume R, 2002, AUTON ROBOT, V12, P157, DOI 10.1023/A:1014045326702; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Ott C., 2011, IEEE RAS INT C HUM R, P26; Raibert M H, 2008, P 17 WORLD C INT FED, V17, P10822; Rutishauser S., 2008, IEEE INT C BIOM ROB, P710; Sangok S., 2013, P IEEE C ROB AUT KAR, P3292; Semini C., 2013, IEEE INT S ROB RES I, P1; Sproewitz A., 2011, INT J ROBOT RES, V32, P932; Ugurlu B, 2013, IEEE INT C INT ROBOT, P6044, DOI 10.1109/IROS.2013.6697234; Winkler A., 2014, IEEE INT C ROB AUT I, P6476; Yamada Y, 2011, IEEE INT C INT ROBOT, P1499, DOI 10.1109/IROS.2011.6048360; Yoneda K, 1996, IEEE INT CONF ROBOT, P3002, DOI 10.1109/ROBOT.1996.509168; ZHENG Y, 1985, J ROBOTIC SYST, V2, P289, DOI 10.1002/rob.4620020307	40	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5593	1573-7527		AUTON ROBOT	Auton. Robot.	APR	2015	38	4					415	437		10.1007/s10514-015-9422-7		23	Computer Science, Artificial Intelligence; Robotics	Computer Science; Robotics	CD5UJ	WOS:000351153300005		
J	Koto, A; Mersch, D; Hollis, B; Keller, L				Koto, Akiko; Mersch, Danielle; Hollis, Brian; Keller, Laurent			Social isolation causes mortality by disrupting energy homeostasis in ants	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Social insect; Behavior tracking; Social isolation; Energy homeostasis	DIVISION-OF-LABOR; ISOLATION STRESS; COLONIES; FOOD; INDIVIDUALS; HYMENOPTERA; INTEGRATION; FORMICIDAE; PLASTICITY; DROSOPHILA	Social deprivation can have negative effects on the lives of social animals, including humans, yet little is known about the mechanisms by which social withdrawal affects animal health. Here we show that in the carpenter ant Camponotus fellah, socially isolated workers have a greatly reduced life span relative to ants kept in groups of ten individuals. By using a new tracking system, we found that social isolation resulted in important behavioral changes and greatly increased locomotor activity. The higher activity of single ants and their increased propensity to leave the nest to move along the walls suggested that the increased mortality of isolated ants might stem from an imbalance of energy income and expenditure. This view was supported by the finding that while isolated ants ingested the same amount of food as grouped ants, they retained food in the crop, hence preventing its use as an energy source. Moreover, the difference in life span between single and grouped individuals vanished when ants were not fed. This study thus underlines the role of social interactions as key regulators of energy balance, which ultimately affects aging and health in a highly social organism.	[Koto, Akiko; Mersch, Danielle; Hollis, Brian; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, Quartier UNIL Sorge, CH-1015 Lausanne, Switzerland; [Koto, Akiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, Tokyo 1130033, Japan	Koto, A (reprint author), Univ Lausanne, Dept Ecol & Evolut, Quartier UNIL Sorge, Batiment Biophore, CH-1015 Lausanne, Switzerland.	akoto@mol.f.u-tokyo.ac.jp; Laurent.Keller@unil.ch			Swiss National Science Foundation; Japan Society for the Promotion of Science; advanced ERC grant	We thank A. Hefetz for collecting queens, A. Crespi for the technical support for the tracking system, and the Swiss Institute of Bioinformatics for the data storage. We are grateful to M. Miura for the helpful discussion and O. Rueppel and two reviewers for useful comments. This work was funded by several grants from the Swiss National Science Foundation, the Japan Society for the Promotion of Science, and an advanced ERC grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nonogaki K, 2007, ENDOCRINOLOGY, V148, P4658, DOI 10.1210/en.2007-0296; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Coury DL, 2012, PEDIATRICS, V130, pS160, DOI 10.1542/peds.2012-0900N; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Karelina K, 2009, P NATL ACAD SCI USA, V106, P5895, DOI 10.1073/pnas.0810737106; HATCH A, 1963, SCIENCE, V142, P507, DOI 10.1126/science.142.3591.507; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Matsumoto K, 2005, STRESS, V8, P85, DOI 10.1080/10253890500159022; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Rozanski A, 1999, CIRCULATION, V99, P2192; ARNOLD G, 1976, CR ACAD SCI D NAT, V283, P1433; Boulay R, 1999, SOCIOBIOLOGY, V33, P111; Buffin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005919; Eisner T., 1962, Psyche Cambridge Mass, V69, P107, DOI 10.1155/1962/25068; Grasse P, 1944, REV SCI, V82, P261; Hansen L. D., 2005, CARPENTER ANTS US CA; Hodobler B, 1990, ANTS; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOWARD DF, 1981, PHYSIOL ENTOMOL, V6, P297, DOI 10.1111/j.1365-3032.1981.tb00274.x; KELLER L, 1990, INSECT SOC, V37, P116, DOI 10.1007/BF02224025; MARKIN GP, 1970, INSECT SOC, V17, P127, DOI 10.1007/BF02223074; Modlmeier AP, 2013, PHYSIOL ENTOMOL, V38, P89, DOI 10.1111/phen.12007; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Roger G, 1966, ANN ABEILLE, V9, P5; Ruan HY, 2008, P NATL ACAD SCI USA, V105, P7506, DOI 10.1073/pnas.0711127105; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; SITBON G, 1968, INSECT SOC, V15, P413, DOI 10.1007/BF02223638; SITBON G., 1967, ANN ABEILLE [PARIS], V10, P203, DOI 10.1051/apido:19670401; SITBON G, 1968, INSECT SOC, V15, P37, DOI 10.1007/BF02224892; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Yang YC, 2013, J HEALTH SOC BEHAV, V54, P182, DOI 10.1177/0022146513485244	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	APR	2015	69	4					583	591		10.1007/s00265-014-1869-6		9	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	CD6XX	WOS:000351235100008		
J	Mabbott, NA; Kobayashi, A; Sehgal, A; Bradford, BM; Pattison, M; Donaldson, DS				Mabbott, Neil A.; Kobayashi, Atsushi; Sehgal, Anuj; Bradford, Barry M.; Pattison, Mari; Donaldson, David S.			Aging and the mucosal immune system in the intestine	BIOGERONTOLOGY			English	Review						Aging; Intestine; Mucosal immune system; M cells; IgA	FOLLICULAR DENDRITIC CELLS; MONONUCLEAR PHAGOCYTE SYSTEM; SCRAPIE AGENT NEUROINVASION; EPITHELIAL M-CELLS; PATCH M-CELLS; FACTOR SPI-B; PEYERS PATCH; IMMUNOGLOBULIN-A; LYMPHOID-TISSUE; GUT MICROBIOTA	Bacterial and viral infections of the gastrointestinal tract are more common in the elderly and represent a major cause of morbidity and mortality. The mucosal immune system provides the first line of defence against pathogens acquired by ingestion and inhalation, but its function is adversely affected in the elderly. This aging-related decline in the immune function is termed immunosenescence and is associated with diminished abilities to generate protective immunity, reduced vaccine efficacy, increased incidence of cancer, inflammation and autoimmunity, and the impaired ability to generate tolerance to harmless antigens. In this review we describe our current understanding of the effects immunosenescence has on the innate and adaptive arms of the mucosal immune system in the intestine. Current estimates suggest that by the year 2050 up to 40 % of the UK population will be over 65 years old, bringing with it important health challenges. A thorough understanding of the mechanisms that contribute to the development of immunosenescence is therefore crucial to help identify novel approaches to improve mucosal immunity in the elderly.	[Mabbott, Neil A.; Sehgal, Anuj; Bradford, Barry M.; Pattison, Mari; Donaldson, David S.] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Mabbott, Neil A.; Sehgal, Anuj; Bradford, Barry M.; Pattison, Mari; Donaldson, David S.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Kobayashi, Atsushi] Tohoku Univ, Grad Sch Med, Div Neurol Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan	Mabbott, NA (reprint author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	neil.mabbott@roslin.ed.ac.uk		Mabbott, Neil/0000-0001-7395-1796	Institute Strategic Programme Grant funding from the Biotechnology and Biological Sciences Research Council; European Commission [222887];  [BB/J014672/1];  [BB/K021257/1];  [BB/L007452/1]	This work was supported by project (BB/J014672/1, BB/K021257/1 & BB/L007452/1) and Institute Strategic Programme Grant funding from the Biotechnology and Biological Sciences Research Council, and project funding from the European Commission (FP7 project 222887; PRIORITY).	Ademokun A, 2010, AGING CELL, V10, P922; Aller MA, 2006, EXP GERONTOL, V41, P564, DOI 10.1016/j.exger.2006.03.007; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Kim SH, 2011, EUR J IMMUNOL, V41, P3219, DOI 10.1002/eji.201141592; Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Westphal S, 2008, AM J PATHOL, V172, P671, DOI 10.2353/ajpath.2008.070393; Lycke N, 1999, J IMMUNOL, V163, P913; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Schiffrin EJ, 2009, BRIT J NUTR, V101, P961, DOI 10.1017/S0007114508055591; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Shikina T, 2004, J IMMUNOL, V172, P6259; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dunn-Walters DK, 2003, BIOCHEM SOC T, V31, P447, DOI 10.1042/BST0310447; Henson SM, 2010, ADV EXP MED BIOL, V684, P189; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; ARRANZ E, 1992, GUT, V33, P882, DOI 10.1136/gut.33.7.882; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Kobayashi A, 2013, MUCOSAL IMMUNOL, V6, P1027, DOI 10.1038/mi.2012.141; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Suzuki K, 2010, IMMUNOL REV, V237, P180, DOI 10.1111/j.1600-065X.2010.00941.x; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Banerjee M, 2002, EUR J IMMUNOL, V32, P1947, DOI 10.1002/1521-4141(200207)32:7<1947::AID-IMMU1947>3.0.CO;2-1; Sugawara Y, 2011, J VET MED SCI, V73, P511, DOI 10.1292/jvms.10-0269; Bradford BM, 2011, IMMUNOBIOLOGY, V216, P1228, DOI 10.1016/j.imbio.2011.08.006; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Terahara K, 2008, J IMMUNOL, V180, P7840; Gibbons DL, 2011, MUCOSAL IMMUNOL, V4, P148, DOI 10.1038/mi.2010.85; Aydar Y, 2004, AGEING RES REV, V3, P15, DOI 10.1016/j.arr.2003.08.002; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465; Glaysher BR, 2007, J IMMUNOL, V178, P3757; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Rey J, 2004, J IMMUNOL, V172, P3026; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Tiihonen K, 2008, BRIT J NUTR, V100, P130, DOI 10.1017/S000711450888871X; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-1569; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Hume DA, 2013, NAT IMMUNOL, V14, P187, DOI 10.1038/ni.2516; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; MICHETTI P, 1992, INFECT IMMUN, V60, P1786; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; Ebisawa M, 2011, INT IMMUNOL, V23, P261, DOI 10.1093/intimm/dxq478; Nakato G, 2012, J IMMUNOL, V189, P1540, DOI 10.4049/jimmunol.1103332; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Silvey KJ, 2001, J VIROL, V75, P10870, DOI 10.1128/JVI.75.22.10870-10879.2001; Kadaoui KA, 2007, J IMMUNOL, V179, P7751; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Fujihashi K, 2000, VACCINE, V18, P1675, DOI 10.1016/S0264-410X(99)00505-8; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Argues J. L., 2009, GASTROENTEROLOGY, V137, P579; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Brown KL, 2009, J IMMUNOL, V183, P5199, DOI 10.4049/jimmunol.0802695; Brown KL, 2012, J VIROL, V86, P25, DOI 10.1128/JVI.05581-11; Cerruti A, 2011, ANNU REV IMMUNOL, V29, P273; Daniels CK, 1998, GASTROENTEROLOGY, V94, P1432; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; DVORAK AM, 1980, HUM PATHOL, V11, P561; EBERSOLE JL, 1985, IMMUNOLOGY, V56, P345; FAGIOLO U, 1993, AGING-CLIN EXP RES, V5, P451; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P343; Fujimura Y, 2004, VIRCHOWS ARCH, V444, P36, DOI 10.1007/s00428-003-0898-8; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; House of Commons Library Research, 2010, AG POP; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Kato H, 2003, INT IMMUNOL, V15, P145, DOI 10.1093/intimm/dxg011; Kleinschmidt S, 2007, RES VET SCI, V84, P41; Knoop KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00084; Koga T, 2000, J IMMUNOL, V165, P5352; Krahenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; Misumi S, 2009, J IMMUNOL, V182, P6061, DOI 10.4049/jimmunol.0802928; Moretto MM, 2008, J IMMUNOL, V181, P7977; Nakato G, 2009, DNA RES, V16, P227, DOI 10.1093/dnares/dsp013; Nicoletti C, 2009, MUCOSAL IMMUNOL, V2, P462, DOI 10.1038/mi.2009.92; Ogino T, 2004, MECH AGEING DEV, V125, P191, DOI 10.1016/j.mad.2003.11.014; Ren W, 2013, AGING CLIN EXP RES, V26, P183; Rochereau N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001658; Rose St, 2006, BMC INFECT DIS, V6, P5; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Schmucker Douglas L, 2003, Clin Dev Immunol, V10, P167, DOI 10.1080/10446670310001642168; SENDA S, 1988, SCAND J IMMUNOL, V27, P157, DOI 10.1111/j.1365-3083.1988.tb02334.x; Takahashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P501, DOI 10.1016/j.bbrc.2008.01.120; Taylor DL, 1992, IMMUNOLOGY, V75, P614; Thoreux K, 2000, IMMUNOLOGY, V101, P161, DOI 10.1046/j.1365-2567.2000.00095.x; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Zidan M, 2008, ANAT REC, V291, P1023, DOI 10.1002/ar.20697	113	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1389-5729	1573-6768		BIOGERONTOLOGY	Biogerontology	APR	2015	16	2			SI		133	145		10.1007/s10522-014-9498-z		13	Geriatrics & Gerontology	Geriatrics & Gerontology	CD9BP	WOS:000351391500002		
J	Mallez, S; Castagnone, C; Espada, M; Vieira, P; Eisenback, JD; Harrell, M; Mota, M; Aikawa, T; Akiba, M; Kosaka, H; Castagnone-Sereno, P; Guillemaud, T				Mallez, Sophie; Castagnone, Chantal; Espada, Margarida; Vieira, Paulo; Eisenback, Jonathan D.; Harrell, Mark; Mota, Manuel; Aikawa, Takuya; Akiba, Mitsuteru; Kosaka, Hajime; Castagnone-Sereno, Philippe; Guillemaud, Thomas			Worldwide invasion routes of the pinewood nematode: What can we infer from population genetics analyses?	BIOLOGICAL INVASIONS			English	Article						Bursaphelenchus xylophilus; Population genetics; Diversity; Genetic structure; Microsatellite markers; Pine wilt disease	BURSAPHELENCHUS-XYLOPHILUS NEMATODA; MONOCHAMUS-ALTERNATUS COLEOPTERA; MULTILOCUS GENOTYPE DATA; WILT DISEASE; WOOD NEMATODE; BIOLOGICAL INVASIONS; UNITED-STATES; F-STATISTICS; CERAMBYCIDAE; APHELENCHOIDIDAE	Identifying the invasion routes and determining the origin of new outbreaks of invasive species are of crucial importance if we are to understand the invasion process, improve or establish regulatory measures and, potentially, limit the damage. We focused here on the invasion of Europe by the pinewood nematode (PWN), Bursaphelenchus xylophilus (Steiner & Buhrer, 1934; Nickle 1970; Nematoda: Aphelenchoididae), a major pest of forest ecosystems, native to North America and already invasive in Asia since the beginning of the twentieth century. We evaluated the genetic diversity and structure of worldwide field PWN samples by classical and Bayesian population genetics methods to determine the source of the European invasive populations and the number of introduction events in Europe. We found (1) a very strong spatial genetic structure in native PWN populations, (2) a very low level of polymorphism in each of the invaded areas and (3) contrasted results concerning the origin of European invasive populations. Our findings provide evidence for: (1) a large effect of genetic drift on the biological cycle of the PWN, due to intense demographic bottlenecks during tree infections, not compensated for by effective dispersal of its vector; (2) a single introduction event for each of the invaded areas in Japan and Europe and a small effective size for the introduced populations and (3) a mainland Portuguese origin for PWN populations from Madeira. However, more sophisticated methods of invasion route inference and broader sampling are required to conclusively determine the origin of the European outbreak.	[Mallez, Sophie; Castagnone, Chantal; Castagnone-Sereno, Philippe; Guillemaud, Thomas] INRA, Inst Sophia Agrobiotech, UMR 1355, F-06903 Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Castagnone-Sereno, Philippe; Guillemaud, Thomas] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Castagnone-Sereno, Philippe; Guillemaud, Thomas] CNRS, Inst Sophia Agrobiotech, UMR 7254, F-06903 Sophia Antipolis, France; [Espada, Margarida; Vieira, Paulo; Mota, Manuel] Univ Evora, Nucleo Mitra, NemaLab, ICAAM, P-7002554 Evora, Portugal; [Eisenback, Jonathan D.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Harrell, Mark] Univ Nebraska, Nebraska Forest Serv, Lincoln, NE 68583 USA; [Aikawa, Takuya] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate 0200123, Japan; [Akiba, Mitsuteru] Forestry & Forest Prod Res Inst, Forest Pathol Lab, Tsukuba, Ibaraki 3058687, Japan; [Kosaka, Hajime] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto 8600862, Japan	Mallez, S (reprint author), INRA, Inst Sophia Agrobiotech, UMR 1355, F-06903 Sophia Antipolis, France.	mallez.sophie@gmail.com		Espada, Margarida/0000-0002-3826-711X; Mota, Manuel/0000-0002-4145-5031	EU REPHRAME Project [KBBE.2010.1.4-09]	We would like to thank Arnaud Gaigher and Pedro Barbosa for technical support, Douglas LeDoux and Julia Thompson for American sampling and Eric Lombaert for fruitful discussions. This work was funded by the EU REPHRAME Project (KBBE.2010.1.4-09).	Akbulut S, 1999, ENVIRON ENTOMOL, V28, P1014; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Vieira P, 2007, J NEMATOL, V39, P118; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Fontaine MC, 2013, NEW PHYTOL, V198, P946, DOI 10.1111/nph.12177; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.2307/2410454; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Reed DH, 2001, EVOLUTION, V55, P1095; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Perdereau E, 2013, MOL ECOL, V22, P1105, DOI 10.1111/mec.12140; Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Steiner G, 1934, J AGRIC RES, V48, P0949; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; DROPKIN VH, 1981, PLANT DIS, V65, P1022; Kelager A, 2013, BIOL INVASIONS, V15, P1125, DOI 10.1007/s10530-012-0356-0; Zhou ZH, 2007, PHYTOPATHOLOGY, V97, P304, DOI 10.1094/PHYTO-97-3-0304; Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Rousset F, 1997, GENETICS, V145, P1219; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; TOGASHI K, 1985, APPL ENTOMOL ZOOL, V20, P246; Boucher AC, 2013, MOL PHYLOGENET EVOL, V69, P75, DOI 10.1016/j.ympev.2013.05.020; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Beaumont MA, 2002, GENETICS, V162, P2025; Naves PM, 2007, J APPL ENTOMOL, V131, P21, DOI 10.1111/j.1439-0418.2006.01111.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Falush D, 2003, GENETICS, V164, P1567; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Barun A, 2013, BIOL INVASIONS, V15, P2243, DOI 10.1007/s10530-013-0447-6; Belkhir K., 1996, GENETIX 4 05 LOGICIE, V5000, P1996; CAVALLIS.LL, 1967, AM J HUM GENET, V19, P233; Evans H. F., 1996, Bulletin OEPP, V26, P199; Figueiredo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083542; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Kiritani Keizi, 2004, Global Environmental Research, V8, P75; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115; LINIT MJ, 1988, J NEMATOL, V20, P227; Mallez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059165; MAMIYA Y, 1988, J NEMATOL, V20, P219; MAMIYA Y, 1976, JARQ, V10, P206; MAMIYA Y, 1972, Review of Plant Protection Research, V5, P46; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; Mamiya Y, 2004, NEMATOL MONOGR PERSP, V1, P9; Metge K, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P175, DOI 10.1007/978-1-4020-8455-3_15; Moon Y, 2007, J NEMATOL, V39, P87; OEPP/EPPO, 1997, OEPP B, P1; Papura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036882; Pereira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056288; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHIBATA E, 1986, APPL ENTOMOL ZOOL, V21, P184; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995, DOI DOI 10.1016/J.JBIOMECH.2012.07.028; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Strong DR, 2000, SCIENCE, V288, P1969, DOI 10.1126/science.288.5473.1969; Suzuki K., 2002, Dendrobiology, V48, P71; TARES S, 1992, HEREDITY, V68, P157, DOI 10.1038/hdy.1992.24; TOGASHI K, 1990, RES POPUL ECOL, V32, P1, DOI 10.1007/BF02512586; Valadas V, 2013, J HELMINTHOL, V87, P457, DOI 10.1017/S0022149X12000673; Valadas V, 2012, NEMATOLOGY, P1; van Wilgen BW, 2013, ENVIRON MANAGE, V52, P531, DOI 10.1007/s00267-013-0099-4; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Vincent B, 2008, NEMATOLOGY, V10, P219, DOI 10.1163/156854108783476403; Wan XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036176; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; WINGFIELD MJ, 1982, CAN J FOREST RES, V12, P71, DOI 10.1139/x82-010; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zhang KY, 2008, J NEMATOL, V40, P127	102	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-3547	1573-1464		BIOL INVASIONS	Biol. Invasions	APR	2015	17	4					1199	1213		10.1007/s10530-014-0788-9		15	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CD6KF	WOS:000351197300017		
J	Kodama, S; Nunome, M; Moriwaki, K; Suzuki, H				Kodama, Sayaka; Nunome, Mitsuo; Moriwaki, Kazuo; Suzuki, Hitoshi			Ancient onset of geographical divergence, interpopulation genetic exchange, and natural selection on the Mc1r coat-colour gene in the house mouse (Mus musculus)	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						hair; introgression; recombination; selective sweep	MITOCHONDRIAL-DNA; WILD MICE; EVOLUTIONARY; ORIGIN; INTROGRESSION; POPULATIONS; INFERENCE; RECEPTOR; MARKERS; HISTORY	We examined genetic variation in house mice from India and Pakistan, a predominant part of the predicted homeland of this species and also the territory of the subspecies Mus musculus castaneus (CAS), using a nuclear marker for seven tandemly arranged genes (Fanca-Spire2-Tcf25-Mc1r-Def8-Afg3l1-Dbndd1) and compared them with those previously determined for mice from other parts of Eurasia. Construction of a network with the concatenate sequences yielded three distinct clusters representing the three major subspecies groups: CAS, Mus musculus domesticus (DOM) and Mus musculus musculus (MUS). STRUCTURE analysis provided evidence for further subdivision of CAS into two main haplogroups within the Indian subcontinent. Single-gene networks revealed not only gene-specific architecture for subgrouping in CAS, but also allelic exchange among subspecies. These results suggest the earlier onset of allopatric divergence in the predicted homeland (the Middle East and Indian subcontinent) and subsequent intermittent admixing via gene flow across the CAS haplogroups and among the three subspecies groups. A comparison of the levels of nucleotide diversity among the gene regions revealed a less divergent state in the chromosome region containing Mc1r and its adjacent genes, indicative of a selective sweep, suggesting the involvement of natural selection in the Mc1r allelic variation.(c) 2015 The Linnean Society of London, Biological Journal of the Linnean Society, 2015, 114, 778-794.	[Kodama, Sayaka; Suzuki, Hitoshi] Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Ecol & Genet, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Nunome, Mitsuo] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Moriwaki, Kazuo] RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	Suzuki, H (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Ecol & Genet, Kita Ku, Sapporo, Hokkaido 0600810, Japan.	htsuzuki@ees.hokudai.ac.jp	Suzuki, Hitoshi/F-8539-2012	Suzuki, Hitoshi/0000-0003-4426-385X	Japan Society for the Promotion of Science (JSPS) [24405013]; Heiwa Nakajima Foundation	We wish to express our appreciation to K. Abe, K. P. Aplin, T. Takada, T. Shiroishi, K. Tsuchiya, and H. Yonekawa for their valuable advice with the present study. We also thank G. N. Chelomina, L. N. E. Dokuchaev, V. Frisman, A. Frost, S.-H. Han, N. Hanzawa, T. Hosoda, H. Igawa, H. Ikeda, M. A. Iwasa, M.-L. Jin, I. Kartavtseva, V. P. Korablev, K. K. V. Korobisyna, M. Kusayama, A. P. Kryukov, O. E. Lopatin, I. Maryanto, Y. Matsuda, H. Matsuzawa, G. Mise, N. Miyashita, P. Munclinger, I. Munechika, N. Nakajima, E. Nevo, H. Okamura, R. Palmer, M. Pavlenko, M. Sakaizumi, K. Sasaki, J. J. Sato, T. Shimada, M. H. Sinaga, A. Suyanto, S. Suzuki, M. Terashima, M. Tomozawa, H. Ueda, P. Vogel, S. P. Yasuda, K. Yokoyama, and S. Wakana for their help in collecting the animals. We are also grateful for extensive comments from anonymous reviewers. The present study was funded by a grant-in-aid for Scientific Research (B) to HS (24405013) from the Japan Society for the Promotion of Science (JSPS). We thank the Heiwa Nakajima Foundation for its generous support.	Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Jones EP, 2013, TRENDS GENET, V29, P298, DOI 10.1016/j.tig.2012.11.011; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Takada T, 2013, GENOME RES, V23, P1329, DOI 10.1101/gr.156497.113; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Suzuki H, 2013, GENES GENET SYST, V88, P155; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Martinsen GD, 2001, EVOLUTION, V55, P1325; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Pritchard JK, 2000, GENETICS, V155, P945; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Boursot P, 1996, J EVOLUTION BIOL, V9, P391, DOI 10.1046/j.1420-9101.1996.9040391.x; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119; Mullen LM, 2009, P R SOC B, V276, P3809, DOI 10.1098/rspb.2009.1146; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bonhomme F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r80; Bonhomme F, 2012, CAMBRIDGE SERIES MOR, P278; BONHOMME F, 1984, BIOCHEM GENET, V22, P275, DOI 10.1007/BF00484229; Bull V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-11; Cucchi T, 2012, CAMBRIDGE STUDIES MO, P65; Din W, 1996, J EVOLUTION BIOL, V9, P519, DOI 10.1046/j.1420-9101.1996.9050519.x; Gabriel SI, 2013, BIOL J LINN SOC, V108, P929, DOI 10.1111/bij.12015; Hoekstra HE, 2004, SCIENCE, V303, P1779, DOI 10.1126/science.1096413; Jing MD, 2014, MOL ECOL, V23, P4387, DOI 10.1111/mec.12873; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kodama S, 2015, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.kt0s8, DOI 10.5061/DRYAD.KT0S8]; Koopman WJM, 2007, MOL ECOL, V16, P243, DOI 10.1111/j.1365-294X.2006.03137.x; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Marshall JT, 1998, IDENTIFICATION SCI N; Nunome M, 2010, MOL ECOL, V19, P2474, DOI 10.1111/j.1365-294X.2010.04651.x; Patel MP, 2010, J MOL BIOL, V404, P45, DOI 10.1016/j.jmb.2010.08.054; Prager EM, 1998, GENETICS, V150, P835; Rajabi-Maham H, 2012, BIOL J LINN SOC, V107, P295, DOI 10.1111/j.1095-8312.2012.01957.x; Rambaut A, 2009, TRACER VERSION 1 5; Shimada T, 2009, GENES GENET SYST, V84, P225; SMITH J M, 1974, Genetical Research, V23, P23; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Suzuki H, 2012, CAMBRIDGE STUDIES MO, P35; Terashima M, 2006, HEREDITY, V96, P128, DOI 10.1038/sj.hdy.6800761; Teschke M, 2012, CAMBRIDGE STUDIES MO, P315; Yonekawa H, 2003, PROBLEMY EVOLYUTSII, V5, P90	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4066	1095-8312		BIOL J LINN SOC	Biol. J. Linnean Soc.	APR	2015	114	4					778	794		10.1111/bij.12471		17	Evolutionary Biology	Evolutionary Biology	CD6NT	WOS:000351206700005		
J	Han, S; Mizoi, M; Nakatani, E; Adachi, S; Miyakoshi, Y; Yanagisawa, H				Han, Soonja; Mizoi, Miho; Nakatani, Emi; Adachi, Shuichi; Miyakoshi, Yuichi; Yanagisawa, Hiroyuki			Improvement of Serum Zinc Levels in Young Japanese Women by Provision of Food Information	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Zinc; Serum; Intervention; Young women; 8-OHdG	OXIDATIVE STRESS; DIETARY-INTAKE; IRON; DEFICIENCY; AVAILABILITY; CHILDREN; RATS; DNA	We investigated whether or not an intervention of providing food information improves serum Zn levels in ninety-two 18-20-year-old Japanese women. The mean serum Zn level of the participants was 73.09 +/- 10.56 (mean +/- SD) mu g/dL, where 79 % of the participants had lower than the reference Zn level (80 mu g/dL) proposed by the Japan Society for Biomedical Research on Trace Elements. Participants were divided into food information (INF) group, supplement (SPL) group, and control (C) group, and their serum Zn levels were measured before and after 2 weeks of intervention. The results showed that changes in serum Zn levels were (expressed in mu g/dL): 71.23 +/- 8.42 to 76.83 +/- 12.22 in INF group (NS; not significant), 72.72 +/- 10.77 to 84.07 +/- 12.03 in SPL group (P < 0.01), and 72.69 +/- 9.46 to 74.52 +/- 11.44 in C group (NS). Percentage of normal subjects in serum Zn level (> 79 mg/dL) were significantly increased in INF group (16.7 to 40 %, P < 0.05) and SPL group (17.2 to 69 %, P < 0.001) by each intervention. Food information only entailed a table of food items with high Zn content (card-type) and Zn intake menu (recipes). The results suggested that providing food information is effective in improving latent low Zn in young Japanese women.	[Han, Soonja; Mizoi, Miho; Nakatani, Emi; Adachi, Shuichi] Sagami Womens Univ, Grad Sch Nutr Sci, Dept Publ Hlth, Sagamihara, Kanagawa, Japan; [Miyakoshi, Yuichi; Yanagisawa, Hiroyuki] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Fac Med,Minato Ku, Tokyo, Japan	Adachi, S (reprint author), Sagami Womens Univ, Grad Sch Nutr Sci, Dept Publ Hlth, Sagamihara, Kanagawa, Japan.	adachi_shuichi@isc.sagami-wu.ac.jp					ADACHI S, 1993, CARCINOGENESIS, V14, P265, DOI 10.1093/carcin/14.2.265; Aliani M, 2013, CRIT REV FOOD SCI, V53, P245, DOI 10.1080/10408398.2010.527023; Angeles-Agdeppa I, 2011, ASIA PAC J CLIN NUTR, V20, P535; Engle-Stone R, 2014, J NUTR, V144, P382, DOI 10.3945/jn.113.188383; Nakamura Y, 2009, BRIT J NUTR, V101, P1696, DOI 10.1017/S0007114508111503; Song Y, 2009, J NUTR, V139, P1626, DOI 10.3945/jn.109.106369; Ohtomo S, 2011, J RISK RES, V14, P85, DOI 10.1080/13669877.2010.503936; MARMOT MG, 1989, BRIT MED J, V299, P1547; Brown KH, 2007, AM J CLIN NUTR, V85, P538; Arakawa Y, 2012, BIOMED RES TRACE ELE, V23, P217; Das JK, 2013, ANN NUTR METAB, V62, P44, DOI 10.1159/000348262; EVANS GW, 1981, J NUTR, V111, P68; Ishida H., 1993, Journal of Japanese Society of Nutrition and Food Science [Nihon Eiyo Shokuryo Gakkai-shi], V46, P299; Iyengar V, 2012, J NUTR BIOCHEM, V23, P1146, DOI 10.1016/j.jnutbio.2011.06.008; Kasai H, 2005, IND HEALTH, V43, P333, DOI 10.2486/indhealth.43.333; Kogirima M, 2007, EUR J CLIN NUTR, V61, P375, DOI 10.1038/sj.ejcn.1602520; Komai M, 2010, BIOMED RES TRACE ELE, V21, P43; Murakami K, 2011, J NUTR SCI VITAMINOL, V57, P87, DOI 10.3177/jnsv.57.87; Murakami K, 2010, NUTR RES, V30, P565, DOI 10.1016/j.nutres.2010.08.002; OECD, 2013, HLTH GLANC 2013 OECD, P39; Sato Yoko, 2014, Nihon Koshu Eisei Zasshi, V61, P321; SOLOMONS NW, 1983, J NUTR, V113, P337; Suzuki K, 2008, J ANAL BIO SCI, V31, P139; The Ministry of Health Labour and Welfare of Japan, 2012, BAS DIR COMPR IMPL N; The National Health and Nutrition Survey in Japan, 2012, ENGL VERS IS AV ONL; von Arnim CAF, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-148; Yoshida M, 2013, J NUTR SCI VITAMINOL, V59, pS91	27	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	APR	2015	164	2					169	177		10.1007/s12011-014-0211-5		9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CD9SX	WOS:000351439700002		
J	Fu, Q; Guo, SX; Yamauchi, Y; Hirata, H; Ishihara, H				Fu, Qiang; Guo, Shuxiang; Yamauchi, Yasuhiro; Hirata, Hideyuki; Ishihara, Hidenori			A novel hybrid microrobot using rotational magnetic field for medical applications	BIOMEDICAL MICRODEVICES			English	Article						Multi-DOFs movement; Magnetically actuated hybrid microrobot; Rotational magnetic field; Electromagnetic actuation system; Hybrid motion	CAPSULE ENDOSCOPE; FABRICATION; DESIGN	Magnetically actuated microrobots for such tools have potential accomplish procedures in biological and medical applications. In this paper, a novel magnetically actuated hybrid microrobot with hybrid motion driven by an electromagnetic actuation system has been proposed. An o-ring type permanent magnet is embedded in the hybrid microrobot as an actuator driven by rotational magnetic field which is generated by a 3 axes Helmholtz coils. It is composed by two motion mechanisms. One is the spiral jet motion moved by rotating its body. The other one is fin motion moved by vibrating its body. Because only one permanent magnet is used inside the hybrid microrobot, two motions can be controlled separately without any interference. The hybrid microrobot can change its two motions to realize multi-DOFs movement and flexibility motion. The verified experiments are conducted in the pipe. The experimental results indicate that the moving speed can be controlled by adjusting the magnetic field changing frequency and the direction of motion can be controlled by changing the magnetic field direction.	[Fu, Qiang; Yamauchi, Yasuhiro] Kagawa Univ, Grad Sch Engn, Takamatsu, Kagawa 7610396, Japan; [Guo, Shuxiang; Hirata, Hideyuki; Ishihara, Hidenori] Kagawa Univ, Fac Engn, Takamatsu, Kagawa 7610396, Japan; [Guo, Shuxiang] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	Fu, Q (reprint author), Kagawa Univ, Grad Sch Engn, 2217-20 Hayashi Cho, Takamatsu, Kagawa 7610396, Japan.	fuqiang252@gmail.com; guo@eng.kagawa-u.ac.jp			Kagawa University Characteristic Prior Research Fund	This research was supported by Kagawa University Characteristic Prior Research Fund 2013.	Keller H, 2012, P IEEE RAS-EMBS INT, P859, DOI 10.1109/BioRob.2012.6290795; Zhang L, 2009, NANO LETT, V9, P3663, DOI 10.1021/nl901869j; Guo SX, 2008, MICROSYST TECHNOL, V14, P307, DOI 10.1007/s00542-007-0430-1; Yim S, 2012, IEEE T ROBOT, V28, P183, DOI 10.1109/TRO.2011.2163861; Yu C, 2010, SENSOR ACTUAT A-PHYS, V161, P297, DOI 10.1016/j.sna.2010.04.037; Guo SX, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P831; Guo SX, 2003, IEEE-ASME T MECH, V8, P136, DOI 10.1109/TMECH.2003.809134; Kim B, 2005, IEEE-ASME T MECH, V10, P77, DOI 10.1109/TMECH.2004.842222; Basar M.R., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1155/2012/807165]; Behkam B, 2005, IEEE ASME INT C ADV, P37; Choi H., 2009, SMART MATER STRUCT, V18, P1; Fu Q, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (IEEE ICMA 2014), P1995; Gao B., 2011, INT J MECHATRONICS A, V1, P79; Guo J., 2014, INT J ADV ROBOT SYST, V11, P1; Guo S., 2002, IEEE INT C ROB AUT, P738; Honda T., 2001, J MAGNETICS SOC JAPA, V4, P1175; Jeong S. M., 2012, IEEE INT C BIOM ROB, P482; Mir-Nasiri Nazim, 2011, International Journal of Mechatronics and Automation, V1, DOI 10.1504/IJMA.2011.040043; Moglia A, 2007, BIOMED MICRODEVICES, V9, P235, DOI 10.1007/s10544-006-9025-3; Nacci A, 2008, ACTA OTORHINOLARYNGO, V28, P206; Okada T., 2012, 2012 ICME INT C COMP, P306; Okada T., 2012, 2012 IEEE International Conference on Mechatronics and Automation (ICMA), DOI 10.1109/ICMA.2012.6285722; Pan Q., 2009, 2009 I E INT C ROB A, P2995; Pan Q., 2007, 2007 I E INT C ROB A, P187; Pan Q., 2011, INT J MECHATRONICS A, V1, P60; Wang LM, 2005, BIOMED MICRODEVICES, V7, P111, DOI 10.1007/s10544-005-1588-x; Wang X., 2011, INT J MECHATRONICS A, V1, P38; Yesin KB, 2006, INT J ROBOT RES, V25, P527, DOI 10.1177/0278364906065389; Yesin KB, 2006, SPR TRA ADV ROBOT, V21, P321	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	APR	2015	17	2								10.1007/s10544-015-9942-0		12	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CD8TT	WOS:000351369600007		
J	Kamei, K; Mashimo, Y; Koyama, Y; Fockenberg, C; Nakashima, M; Nakajima, M; Li, JJ; Chen, Y				Kamei, Ken-ichiro; Mashimo, Yasumasa; Koyama, Yoshie; Fockenberg, Christopher; Nakashima, Miyuki; Nakajima, Minako; Li, Junjun; Chen, Yong			3D printing of soft lithography mold for rapid production of polydimethylsiloxane-based microfluidic devices for cell stimulation with concentration gradients	BIOMEDICAL MICRODEVICES			English	Article						3D printing; Microfluidics; Polydimethylsiloxane; Human embryonic stem cell; Concentration gradient	THERMOREVERSIBLE GELATION; SYNTHETIC HYDROGEL; CHEMOTAXIS; DIFFUSION; GELS	Three-dimensional (3D) printing is advantageous over conventional technologies for the fabrication of sophisticated structures such as 3D micro-channels for future applications in tissue engineering and drug screening. We aimed to apply this technology to cell-based assays using polydimethylsiloxane (PDMS), the most commonly used material for fabrication of micro-channels used for cell culture experiments. Useful properties of PDMS include biocompatibility, gas permeability and transparency. We developed a simple and robust protocol to generate PDMS-based devices using a soft lithography mold produced by 3D printing. 3D chemical gradients were then generated to stimulate cells confined to a micro-channel. We demonstrate that concentration gradients of growth factors, important regulators of cell/tissue functions in vivo, influence the survival and growth of human embryonic stem cells. Thus, this approach for generation of 3D concentration gradients could have strong implications for tissue engineering and drug screening.	[Kamei, Ken-ichiro; Mashimo, Yasumasa; Koyama, Yoshie; Fockenberg, Christopher; Nakashima, Miyuki; Nakajima, Minako; Li, Junjun; Chen, Yong] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan; [Mashimo, Yasumasa] Tokyo Inst Technol, Grad Sch Interdisciplinary Sci & Engn, Environm Chem & Engn, Yokohama, Kanagawa 2268501, Japan; [Chen, Yong] UPMC, ENS, CNRS, UMR 8640, F-75005 Paris, France	Kamei, K (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan.	kkamei@icems.kyoto-u.ac.jp; yong.chen@ens.fr	Kamei, Ken-ichiro/D-1243-2010; Chen, Yong/A-1700-2009; Mashimo, Yasumasa/C-1353-2015	Kamei, Ken-ichiro/0000-0003-2948-3264; Mashimo, Yasumasa/0000-0003-2752-5440	Japan Society for the Promotion of Science (JSPS) [23681028, 26560209]; Terumo Life Science Foundation; World Premier International Research Centre Initiative (WPI), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Funding was generously provided by the Japan Society for the Promotion of Science (JSPS): Young Scientists (A) (to K.K.; 23681028) and Challenging Exploratory Research (to K.K.; 26560209); funding was also provided by Terumo Life Science Foundation. The WPI-iCeMS is supported by the World Premier International Research Centre Initiative (WPI), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Przybyla L, 2012, ANNU REV ANAL CHEM, V5, P293, DOI 10.1146/annurev-anchem-062011-143122; YOSHIOKA H, 1994, J MACROMOL SCI PURE, VA31, P121; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; YOSHIOKA H, 1994, J MACROMOL SCI PURE, VA31, P113; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0; Berthier E, 2014, LAB CHIP, V14, P3241, DOI 10.1039/c4lc00448e; Carmeliet P., 2000, NATURE, V407, P6801; Cukierman E., 2013, PLOS ONE, V10; Eom D.S., 2011, DEVELOPMENT, V138, P15; Erkal J.L., 2014, LAB CHIP, V14, P12; Fosen KM, 2014, ANTIOXID REDOX SIGN, V21, P1634, DOI 10.1089/ars.2014.5940; Haessler U., 2009, BIOMED MICRODEVICES, V11, P4; Kamei K., 2009, LAB CHIP, V9, P4; Kamei K., 2013, JALA-J LAB AUTOM, V18, P6; Keenan T.M., 2008, LAB CHIP, V8, P1; Kihara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082382; Kim B.J., 2012, ANN BIOMED ENG, V40, P6; Kolesky D.B., 2014, ADV MATER, V26, P19; Kshitiz, 2011, TRENDS BIOTECHNOL, V29, P8; Lowry W.E., 2008, P NATL ACAD SCI USA, V105, P8; Ludwig T., 2006, NAT METH, V3, P8; Ludwig T., 2006, NAT BIOTECHNOL, V24, P2; Muller A., 2001, NATURE, V410, P6824; Nauman JV, 2007, BIOPHYS J, V92, P4444, DOI 10.1529/biophysj.106.102699; Symes M.D., 2012, NAT CHEM, V4, P5; Takahashi K., 2007, CELL, V131, P5; Yu J., 2007, SCIENCE, V318, P5858	31	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	APR	2015	17	2								10.1007/s10544-015-9928-y		8	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CD8TT	WOS:000351369600012		
J	Nagai, M; Oohara, K; Kato, K; Kawashima, T; Shibata, T				Nagai, Moeto; Oohara, Kiyotaka; Kato, Keita; Kawashima, Takahiro; Shibata, Takayuki			Development and characterization of hollow microprobe array as a potential tool for versatile and massively parallel manipulation of single cells	BIOMEDICAL MICRODEVICES			English	Article						Digital cell station; Hollow microprobe array; Cell function analysis; Single-cell manipulation; Modeling of cell mechanics	ENDOTHELIAL-CELLS; OPTICAL TWEEZERS; HUMAN-LEUKOCYTES; DIELECTROPHORESIS; MICROPIPETTE; COCULTURE; PLATFORM; COMMUNICATION; LITHOGRAPHY; FABRICATION	Parallel manipulation of single cells is important for reconstructing in vivo cellular microenvironments and studying cell functions. To manipulate single cells and reconstruct their environments, development of a versatile manipulation tool is necessary. In this study, we developed an array of hollow probes using microelectromechanical systems fabrication technology and demonstrated the manipulation of single cells. We conducted a cell aspiration experiment with a glass pipette and modeled a cell using a standard linear solid model, which provided information for designing hollow stepped probes for minimally invasive single-cell manipulation. We etched a silicon wafer on both sides and formed through holes with stepped structures. The inner diameters of the holes were reduced by SiO2 deposition of plasma-enhanced chemical vapor deposition to trap cells on the tips. This fabrication process makes it possible to control the wall thickness, inner diameter, and outer diameter of the probes. With the fabricated probes, single cells were manipulated and placed in microwells at a single-cell level in a parallel manner. We studied the capture, release, and survival rates of cells at different suction and release pressures and found that the cell trapping rate was directly proportional to the suction pressure, whereas the release rate and viability decreased with increasing the suction pressure. The proposed manipulation system makes it possible to place cells in a well array and observe the adherence, spreading, culture, and death of the cells. This system has potential as a tool for massively parallel manipulation and for three-dimensional hetero cellular assays.	[Nagai, Moeto; Oohara, Kiyotaka; Kato, Keita; Kawashima, Takahiro; Shibata, Takayuki] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan	Nagai, M (reprint author), Toyohashi Univ Technol, Dept Mech Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	nagai@me.tut.ac.jp			KAKENHI [25820087]; Tokai Foundation for Technology	This work was supported by KAKENHI 25820087 and the Tokai Foundation for Technology.	Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Park S, 2009, NANO LETT, V9, P1325, DOI 10.1021/nl802962t; Peer E, 2012, ACS NANO, V6, P4940, DOI 10.1021/nn300443h; Mirsaidov U, 2008, LAB CHIP, V8, P2174, DOI 10.1039/b807987k; EVANS E, 1984, BLOOD, V64, P1028; Hsiung LC, 2008, BIOSENS BIOELECTRON, V24, P869, DOI 10.1016/j.bios.2008.07.027; Gray DS, 2004, BIOSENS BIOELECTRON, V19, P771, DOI 10.1016/j.bios.2003.08.013; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature03831; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Kodama T, 2013, BIOSENS BIOELECTRON, V47, P206, DOI 10.1016/j.bios.2013.03.022; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f; Lee PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938253; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/nmeth.1290, 10.1038/NMETH.1290]; Juan ML, 2011, NAT PHOTONICS, V5, P349, DOI [10.1038/nphoton.2011.56, 10.1038/NPHOTON.2011.56]; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Hong S, 2012, INTEGR BIOL-UK, V4, P374, DOI 10.1039/c2ib00166g; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; SCHMIDSCHONBEIN GW, 1981, BIOPHYS J, V36, P243; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190; Frimat JP, 2011, LAB CHIP, V11, P231, DOI [10.1039/c0lc00172d, 10.1039/c01c00172d]; Park H, 2010, SENSOR ACTUAT B-CHEM, V150, P167, DOI 10.1016/j.snb.2010.07.020; Yusof A, 2011, LAB CHIP, V11, P2447, DOI 10.1039/c1lc20176j; Chen YC, 2014, LAB CHIP, V14, P2941, DOI 10.1039/c4lc00391h; Chun K, 1999, JPN J APPL PHYS 2, V38, pL279, DOI 10.1143/JJAP.38.L279; Cooper G. M., 2000, CELL MOL APPROACH; Guenat OT, 2005, J MICROMECH MICROENG, V15, P2372, DOI 10.1088/0960-1317/15/12/020; Hunt TP, 2006, BIOMED MICRODEVICES, V8, P227, DOI 10.1007/s10544-006-8170-z; MITCHISON JM, 1954, J EXP BIOL, V31, P443; Shibata T, 2009, MICROELECTRON ENG, V86, P1439, DOI 10.1016/j.mee.2009.01.046; Wilson CF, 2001, ANAL CHEM, V73, P787, DOI 10.1021/ac001020m	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	APR	2015	17	2								10.1007/s10544-015-9943-z		11	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CD8TT	WOS:000351369600017		
J	Okazaki, S; Mizuhara, T; Shimura, K; Murayama, H; Ohno, H; Oishi, S; Matsuoka, M; Fujii, N				Okazaki, Shiho; Mizuhara, Tsukasa; Shimura, Kazuya; Murayama, Hiroto; Ohno, Hiroaki; Oishi, Shinya; Matsuoka, Masao; Fujii, Nobutaka			Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Anti-HIV agent; Isothiazolopyrimidine; PD 404182; Pyrimidobenzothiazine	HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; ANTIRETROVIRAL THERAPY; POTENT INHIBITORS; SMALL-MOLECULE; PD 404,182; AIDS; DISCOVERY; INFECTION; BINDING	3,4-Dihydro-2H-benzo[4,5]isothiazolo[2,3-a]pyrimidine is a newly identified antiviral agent against human immunodeficiency virus type 1 (HIV-1) infection, derived from 3,4-dihydro-2H,6H-pyrimido-[1,2-c][1,3]benzothiazin-6-imine (PD 404182). The introduction of the hydrophobic 8-aryl substituent on the benzene substructure improved its anti-HIV activity, resulting in the identification of 6-fold more potent analogs. In addition, it was demonstrated that these isothiazolopyrimidine derivatives exert anti-HIV effects at an early stage of viral infection. (C) 2015 Elsevier Ltd. All rights reserved.	[Okazaki, Shiho; Mizuhara, Tsukasa; Ohno, Hiroaki; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shimura, Kazuya; Murayama, Hiroto; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Oishi, S (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	soishi@pharm.kyoto-u.ac.jp; nfujii@pharm.kyoto-u.ac.jp		SHIMURA, Kazuya/0000-0001-7819-5184	JSPS, Japan; MEXT, Japan; Ministry of Health and Welfare of Japan; JSPS Research Fellowships for Young Scientists	This work was supported by Grants-in-Aid for Scientific Research from JSPS, Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; a Grant-in-Aid for Research on HIV/AIDS from the Ministry of Health and Welfare of Japan. T.M. is grateful for JSPS Research Fellowships for Young Scientists.	Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Siliciano JD, 2013, CURR OPIN VIROL, V3, P487, DOI 10.1016/j.coviro.2013.08.007; Ishihara M, 2007, TETRAHEDRON, V63, P1474, DOI 10.1016/j.tet.2006.11.077; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Mizuhara T, 2013, BIOORGAN MED CHEM, V21, P2079, DOI 10.1016/j.bmc.2013.01.016; Choi WT, 2012, J MED CHEM, V55, P977, DOI 10.1021/jm200568c; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008; Loo JA, 1996, J MED CHEM, V39, P4313, DOI 10.1021/jm960253w; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Birck MR, 2000, J AM CHEM SOC, V122, P9334, DOI 10.1021/ja002142z; Wang CL, 2004, J INFECT DIS, V190, P1046, DOI 10.1086/422848; Duckworth BP, 2010, ANAL BIOCHEM, V403, P13, DOI 10.1016/j.ab.2010.04.009; BABA M, 1990, J ACQ IMMUN DEF SYND, V3, P493; Carr A, 2003, NAT REV DRUG DISCOV, V2, P624, DOI 10.1038/nrd1151; Chamoun-Emanuelli AM, 2014, ANTIMICROB AGENTS CH, V58, P687, DOI 10.1128/AAC.02000-13; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Ghebremariam YT, 2014, J PHARMACOL EXP THER, V348, P69, DOI 10.1124/jpet.113.206847; Kajiwara K, 2008, J CLIN MICROBIOL, V46, P792, DOI 10.1128/JCM.01470-07; Kobayashi K., 2012, MED CHEM, V55, P2746; Mizuhara T, 2010, J ORG CHEM, V75, P265, DOI 10.1021/jo902327n; Mizuhara T, 2012, BIOORGAN MED CHEM, V20, P6434, DOI 10.1016/j.bmc.2012.08.030; Mizuhara T, 2012, ORG BIOMOL CHEM, V10, P6792, DOI 10.1039/c2ob25904d; SKOOG MT, 1992, MED RES REV, V12, P27, DOI 10.1002/med.2610120103; Vercruysse T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-95	28	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	APR 1	2015	23	7					1447	1452		10.1016/j.bmc.2015.02.015		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CD3QV	WOS:000350995500009		
J	Wada, K; Lee, JY; Hung, HY; Shi, Q; Lin, L; Zhao, Y; Goto, M; Yang, PC; Kuo, SC; Chen, HW; Lee, KH				Wada, Koji; Lee, Jen-Yi; Hung, Hsin-Yi; Shi, Qian; Lin, Li; Zhao, Yu; Goto, Masuo; Yang, Pan-Chyr; Kuo, Sheng-Chu; Chen, Hui-Wen; Lee, Kuo-Hsiung			Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Curcumin; EGFR; Gastrointestinal tract; Lung adenocarcinoma; Tyrosine kinase inhibitor	ANTITUMOR AGENTS; CELL; CANCER; APOPTOSIS; GEFITINIB; MUTATION	Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR. Thirty-seven newly synthesized curcumin analogues including dimethoxycurcumin (2, DMC) were evaluated for their effects on EGFR expression as well as phosphorylation in two gefitinib-resistant lung adenocarcinoma cell lines, CL1-5 (EGFR(wt)) and H1975 (EGFR(L858R+T790M)). Based on the identified structure-activity relationships, methoxy substitution at C-3', C-4', or both positions favored inhibitory activity (compounds 1, 2, 5, 815, 17, 36), while compounds with more polar substituents were generally less active in both cell lines. Compound 36 with a fluorine substituent at C-6' and its protonated counterpart 2 did not lose activity, suggesting halogen tolerance. In addition, a conjugated linker was essential for activity. Among all evaluated curcumin derivatives, compound 2 showed the best inhibitory effects on both wild-type and mutant EGFR by efficiently inducing gefitinib-insensitive EGFR degradation. Compound 23 also reduced gefitinib-induced gastrointestinal damage in the non-transformed intestinal epithelial cell line IEC-18. (C) 2015 Elsevier Ltd. All rights reserved.	[Wada, Koji; Shi, Qian; Lin, Li; Zhao, Yu; Goto, Masuo; Lee, Kuo-Hsiung] Univ N Carolina, Nat Prod Res Labs, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Wada, Koji] Hokkaido Pharmaceut Univ, Sch Pharm, Otaru, Hokkaido 04702, Japan; [Lee, Jen-Yi; Chen, Hui-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Hung, Hsin-Yi; Kuo, Sheng-Chu] China Med Univ, Sch Pharm, Taichung, Taiwan; [Hung, Hsin-Yi; Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	Yang, PC (reprint author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	pcyang@ntu.edu.tw; shwchen@ntu.edu.tw; khlee@unc.edu			Taiwan Ministry of Science and Technology [NSC 102-2325-B-039-005, 100-2325-B-039-006]; National Cancer Institute (USA) [CA177584]	This work was supported by Taiwan Ministry of Science and Technology (NSC 102-2325-B-039-005 and 100-2325-B-039-006) awarded to S.C. Kuo and H.W. Chen, respectively, and by National Cancer Institute Grant CA177584 (USA) awarded to K.H. Lee. Authors are thankful to Dr. Susan Morris-Natschke (UNC) for the critical editing of this manuscript.	Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Lin L, 2006, J MED CHEM, V49, P3963, DOI 10.1021/jm051043z; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Masuda T, 1998, J NAT PROD, V61, P609, DOI 10.1021/np970555g; Ishida J, 2002, BIOORGAN MED CHEM, V10, P3481, DOI 10.1016/S0968-0896(02)00249-3; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Kari C, 2003, CANCER RES, V63, P1; Chu YW, 1997, AM J RESP CELL MOL, V17, P353; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023756; Lin L, 2006, BIOORGAN MED CHEM, V14, P2527, DOI 10.1016/j.bmc.2005.11.034; Miyashita N., 1977, J ORG CHEM, V42, P3; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; PEDERSEN U, 1985, LIEBIGS ANN CHEM, P1557; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	APR 1	2015	23	7					1507	1514		10.1016/j.bmc.2015.02.003		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CD3QV	WOS:000350995500016		
J	Liau, KF; Shoji, T; Ong, YH; Chua, ASM; Yeoh, HK; Ho, PY				Liau, Kee Fui; Shoji, Tadashi; Ong, Ying Hui; Chua, Adeline Seak May; Yeoh, Hak Koon; Ho, Pei Yee			Kinetic and stoichiometric characterization for efficient enhanced biological phosphorus removal (EBPR) process at high temperatures	BIOPROCESS AND BIOSYSTEMS ENGINEERING			English	Article						Activated sludge model; Glycogen accumulating organisms; Parameter estimation; Polyphosphate-accumulating organisms; Tropical climate	ACTIVATED-SLUDGE MODEL; GLYCOGEN-ACCUMULATING ORGANISMS; PRACTICAL IDENTIFIABILITY; CARBON SOURCE; COMPETITION; SIMULATION; SYSTEMS; ASM2D; PERFORMANCE; CALIBRATION	A recently reported stable and efficient EBPR system at high temperatures around 30 degrees C has led to characterization of kinetic and stoichiometric parameters of the Activated Sludge Model no. 2d (ASM2d). Firstly, suitable model parameters were selected by identifiability analysis. Next, the model was calibrated and validated. ASM2d was found to represent the processes well at 28 and 32 degrees C except in polyhyroxyalkanoate (PHA) accumulation of the latter. The values of the kinetic parameters for PHA storage (q(PHA)), polyphosphate storage (q(PP)) and growth (mu(PAO)) of polyphosphate-accumulating organisms (PAOs) at 28 and 32 degrees C were found to be much higher than those reported by previous studies. Besides, the value of the stoichiometric parameter for the requirement of polyphosphate for PHA storage (Y-PO4) was found to decrease as temperature rose from 28 to 32 degrees C. Values of two other stoichiometric parameters, i.e. the growth yield of heterotrophic organisms (Y-H) and PAOs (Y-PAO), were high at both temperatures. These calibrated parameters imply that the extremely active PAOs of the study were able to store PHA, store polyphosphate and even utilize PHA for cell growth. Besides, the parameters do not follow the Arrhenius correlation due to the previously reported unique microbial clade at 28 and 32 degrees C, which actively performs EBPR at high temperatures.	[Liau, Kee Fui; Ong, Ying Hui; Chua, Adeline Seak May; Yeoh, Hak Koon; Ho, Pei Yee] Univ Malaya, Dept Chem Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Shoji, Tadashi] Univ Tokyo, Grad Sch Frontier Sci, Dept Sociocultural Environm Studies, Kashiwa, Chiba 2778563, Japan	Chua, ASM (reprint author), Univ Malaya, Dept Chem Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.	adeline@um.edu.my	Ho, Pei Yee/G-6841-2012; Engineering, Faculty /I-7935-2015	Engineering, Faculty /0000-0002-4848-7052	University of Malaya Research Grant [RG152-12AET]; Postgraduate Research Grant [PG023-2012B]	The authors thank Professor Takashi Mino and Dr. Hiroyasu Satoh from the University of Tokyo for their useful advice and encouragement. This work is financially supported by the University of Malaya Research Grant (RG152-12AET) and the Postgraduate Research Grant (PG023-2012B).	Panswad T, 2003, WATER RES, V37, P409, DOI 10.1016/S0043-1354(02)00286-5; Hauduc H, 2010, WATER SCI TECHNOL, V61, P825, DOI 10.2166/wst.2010.898; Brun R, 2002, WATER RES, V36, P4113, DOI 10.1016/S0043-1354(02)00104-5; Ong YH, 2014, WATER RES, V64, P102, DOI 10.1016/j.watres.2014.06.038; Brun R, 2001, WATER RESOUR RES, V37, P1015, DOI 10.1029/2000WR900350; Brdjanovic D, 1998, WATER RES, V32, P1035, DOI 10.1016/S0043-1354(97)00322-9; Lopez-Vazquez CM, 2009, WATER RES, V43, P450, DOI 10.1016/j.watres.2008.10.032; Pijuan M, 2004, BIOTECHNOL BIOENG, V85, P56, DOI 10.1002/bit.10813; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21; GUJER W, 1995, WATER SCI TECHNOL, V31, P1, DOI 10.1016/0273-1223(95)00175-M; Lopez-Vazquez CM, 2009, WATER RES, V43, P2852, DOI 10.1016/j.watres.2009.03.038; APHA, 1998, STANDARD METHODS EXA; Cao YS, 2011, BIOLOGICAL PHOSPHORUS REMOVAL ACTIVATED SLUDGE PROCESS IN WARM CLIMATES, P1; Erdal UG, 2003, WATER SCI TECHNOL, V47, P1; Garcia-Usach F, 2006, WATER SCI TECHNOL, V53, P199, DOI 10.2166/wst.2006.422; Henze M, 1999, WATER SCI TECHNOL, V39, P165, DOI 10.1016/S0273-1223(98)00829-4; Liwarska-Bizukojc E, 2011, BIOPROC BIOSYST ENG, V34, P659, DOI 10.1007/s00449-011-0515-1; Machado VC, 2014, BIOPROC BIOSYST ENG, V37, P1271, DOI 10.1007/s00449-013-1099-8; Ong YH, 2013, WATER SCI TECHNOL, V67, P340, DOI 10.2166/wst.2012.552; Satoh H, 1994, WATER SCI TECHNOL, V46, P145; Swinarski M, 2012, WATER ENVIRON RES, V84, P646, DOI 10.2175/106143012X13373550426670; Whang LM, 2006, WATER ENVIRON RES, V78, P4, DOI 10.2175/106143005X84459; Whang LM, 2007, WATER RES, V41, P1312, DOI 10.1016/j.watres.2006.12.022	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-7591	1615-7605		BIOPROC BIOSYST ENG	Bioprocess. Biosyst. Eng.	APR	2015	38	4					729	737		10.1007/s00449-014-1313-3		9	Biotechnology & Applied Microbiology; Engineering, Chemical	Biotechnology & Applied Microbiology; Engineering	CE0RR	WOS:000351513500013		
J	Kawaguchi, H; Teramura, H; Uematsu, K; Hara, KY; Hasunuma, T; Hirano, K; Sazuka, T; Kitano, H; Tsuge, Y; Kahar, P; Niimi-Nakamura, S; Oinuma, KI; Takaya, N; Kasuga, S; Ogino, C; Kondo, A				Kawaguchi, Hideo; Teramura, Hiroshi; Uematsu, Kouji; Hara, Kiyotaka Y.; Hasunuma, Tomohisa; Hirano, Ko; Sazuka, Takashi; Kitano, Hidemi; Tsuge, Yota; Kahar, Prihardi; Niimi-Nakamura, Satoko; Oinuma, Ken-Ichi; Takaya, Naoki; Kasuga, Shigemitsu; Ogino, Chiaki; Kondo, Akihiko			Phenyllactic acid production by simultaneous saccharification and fermentation of pretreated sorghum bagasse	BIORESOURCE TECHNOLOGY			English	Article						Sorghum; Lignocellulosic biomass; Phenyllactic acid; Simultaneous saccharification and fermentation; Fermentation inhibitor	ETHANOLOGENIC ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DEHYDROGENASE; METABOLITES; INHIBITION; FEEDSTOCK; TOLERANCE; PATHWAY; GROWTH	Dilute acid-pretreated sorghum bagasse, which was predominantly composed of glucan (59%) and xylose (7.2%), was used as a lignocellulosic feedstock for D-phenyllactic acid (PhLA) production by a recombinant Escherichia coli strain expressing phenylpyruvate reductase from Wickerhamia fluorescens. During fermentation with enzymatic hydrolysate of sorghum bagasse as a carbon source, the PhLA yield was reduced by 35% compared to filter paper hydrolysate, and metabolomics analysis revealed that NAD(P)H regeneration and intracellular levels of erythrose-4-phosphate and phosphoenolpyruvate for PhLA biosynthesis markedly reduced. Compared to separate hydrolysis and fermentation (SHF) with sorghum bagasse hydrolysate, simultaneous saccharification and fermentation (SSF) of sorghum bagasse under glucose limitation conditions yielded 4.8-fold more PhLA with less accumulation of eluted components, including p-coumaric acid and aldehydes, which inhibited PhLA fermentation. These results suggest that gradual enzymatic hydrolysis during SSF enhances PhLA production under glucose limitation and reduces the accumulation of fermentation inhibitors, collectively leading to increased PhLA yield. (c) 2015 Elsevier Ltd. All rights reserved.	[Kawaguchi, Hideo; Teramura, Hiroshi; Uematsu, Kouji; Kahar, Prihardi; Niimi-Nakamura, Satoko; Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hara, Kiyotaka Y.; Hasunuma, Tomohisa; Tsuge, Yota] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hirano, Ko; Sazuka, Takashi; Kitano, Hidemi] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oinuma, Ken-Ichi; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kasuga, Shigemitsu] Shinshu Univ, Fac Agr, Educ & Res Ctr Alpine Field Sci, Nagano 3994598, Japan; [Kondo, Akihiko] RIKEN Ctr Sustainable Resource Sci, Turumi Ku, Yokohama, Kanagawa 2300045, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015; Ogino, Chiaki/G-9932-2014	Hasunuma, Tomohisa/0000-0002-8382-2362; Ogino, Chiaki/0000-0002-8906-7724	NC-CARP project; Ministry of Education, Culture, Sports, Science and Technology, Japan; Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction, Kobe) from the Ministry of Education, Culture, Sports, Science and Technology, Japan	We gratefully acknowledge Kaori Sei, Tomoko Ohshima, Yoshimi Hori and Kumiko Yoshihara for technical assistance. We are also grateful to Dr. Fumio Matsuda (Osaka University, Japan) for valuable advice regarding the metabolomic analysis. This work was partly supported by Grants-in-Aid from the NC-CARP project and the Ministry of Education, Culture, Sports, Science and Technology, Japan to Kobe University, Nagoya University and the University of Tsukuba, Japan, and Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction, Kobe) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ALQUADAN F, 1981, PHYTOCHEMISTRY, V20, P961, DOI 10.1016/0031-9422(81)83007-5; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; Koma D, 2012, APPL ENVIRON MICROB, V78, P6203, DOI 10.1128/AEM.01148-12; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Fujita T, 2013, APPL MICROBIOL BIOT, V97, P8887, DOI 10.1007/s00253-013-5078-4; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.3.CO;2-R]; Modig T, 2002, BIOCHEM J, V363, P769, DOI 10.1042/0264-6021:3630769; Ordonio RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05287; Kim M, 2011, J IND MICROBIOL BIOT, V38, P803, DOI 10.1007/s10295-010-0812-8; Venuto Brad, 2008, Grassland Science, V54, P189, DOI 10.1111/j.1744-697X.2008.00123.x; Qi BK, 2011, BIORESOURCE TECHNOL, V102, P2881, DOI 10.1016/j.biortech.2010.10.092; Matsakas L, 2013, BIORESOURCE TECHNOL, V127, P202, DOI 10.1016/j.biortech.2012.09.107; BANERJEE N, 1981, EUR J APPL MICROBIOL, V11, P226, DOI 10.1007/BF00505872; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Larsson S, 1999, ENZYME MICROB TECH, V24, P151, DOI 10.1016/S0141-0229(98)00101-X; Kato H, 2012, J BIOSCI BIOENG, V113, P665, DOI 10.1016/j.jbiosc.2011.12.013; Fujii T, 2011, BBA-PROTEINS PROTEOM, V1814, P1669, DOI 10.1016/j.bbapap.2011.05.024; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; BOWEN JR, 1979, PLANT PHYSIOL, V64, P382, DOI 10.1104/pp.64.3.382; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; GUENZI WD, 1966, AGRON J, V58, P303; Kawaguchi H, 2014, BIOCHEM ENG J, V88, P188, DOI 10.1016/j.bej.2014.04.014; Mu WM, 2009, BIORESOURCE TECHNOL, V100, P5226, DOI 10.1016/j.biortech.2009.05.024; Nguyen TTM, 2014, J BIOSCI BIOENG, V118, P263, DOI 10.1016/j.jbiosc.2014.02.025; Sambrook J, 2001, MOL CLONING LAB MANU; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Sipos Bálint, 2009, Appl Biochem Biotechnol, V153, P151, DOI 10.1007/s12010-008-8423-9; Teramura H, 2013, BIORESOURCE TECHNOL, V149, P520, DOI 10.1016/j.biortech.2013.09.109; Uraji M, 2013, APPL BIOCHEM BIOTECH, V171, P1085, DOI 10.1007/s12010-013-0190-6; Wang LJ, 2013, IND CROP PROD, V42, P280, DOI 10.1016/j.indcrop.2012.06.005; WOODIN TS, 1973, BIOCHIM BIOPHYS ACTA, V309, P211, DOI 10.1016/0005-2744(73)90333-1	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	APR	2015	182						169	178		10.1016/j.biortech.2015.01.097		10	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CD5BI	WOS:000351101500022		
J	Asada, C; Sasaki, C; Hirano, T; Nakamura, Y				Asada, Chikako; Sasaki, Chizuru; Hirano, Takeshi; Nakamura, Yoshitoshi			Chemical characteristics and enzymatic saccharification of lignocellulosic biomass treated using high-temperature saturated steam: Comparison of softwood and hardwood	BIORESOURCE TECHNOLOGY			English	Article						High-temperature saturated steam; Chemical characteristics; Enzymatic saccharification; Softwood; Hardwood	EMPTY FRUIT BUNCHES; EXPLOSION PRETREATMENT; SUGARCANE BAGASSE; WOOD CHIPS; HYDROLYSIS; ETHANOL; WATER; DELIGNIFICATION; DIGESTIBILITY; POPLAR	This study investigated the effect of high-temperature saturated steam treatments on the chemical characteristics and enzymatic saccharification of softwood and hardwood. The weight loss and chemical modification of cedar and beech wood pieces treated at 25, 35, and 45 atm for 5 min were determined. Fourier transform infrared and X-ray diffraction analyses indicated that solubilization and removal of hemicellulose and lignin occurred by the steam treatment. The milling treatment of steam-treated wood enhanced its enzymatic saccharification. Maximum enzymatic saccharification (i.e., 94% saccharification rate of cellulose) was obtained using steam-treated beech at 35 atm for 5 min followed by milling treatment for 1 min. However, the necessity of the milling treatment for efficient enzymatic saccharification is dependent on the wood species. (c) 2015 Elsevier Ltd. All rights reserved.	[Asada, Chikako; Sasaki, Chizuru; Hirano, Takeshi; Nakamura, Yoshitoshi] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan	Nakamura, Y (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Life Syst, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan.	ynakamu@bio.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25281048]	This investigation was partially supported by a Grant-in-Aid for Scientific Research (B) (No. 25281048) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Davis L, 2006, BIOMASS BIOENERG, V30, P809, DOI 10.1016/j.biombioe.2005.05.003; Ehara K, 2002, J WOOD SCI, V48, P320, DOI 10.1007/BF00831354; TORGET R, 1988, APPL BIOCHEM BIOTECH, V17, P89, DOI 10.1007/BF02779148; Sannigrahi P, 2011, ENERG ENVIRON SCI, V4, P1306, DOI 10.1039/c0ee00378f; Boonstra MJ, 2006, HOLZ ROH WERKST, V64, P204, DOI 10.1007/s00107-005-0078-4; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Jonoobi M, 2011, CELLULOSE, V18, P1085, DOI 10.1007/s10570-011-9546-7; Rocha GJM, 2012, BIORESOURCE TECHNOL, V111, P447, DOI 10.1016/j.biortech.2012.02.005; OOSHIMA H, 1984, BIOTECHNOL LETT, V6, P289, DOI 10.1007/BF00129056; Xiao X, 2014, BIORESOURCE TECHNOL, V159, P41, DOI 10.1016/j.biortech.2014.02.096; Zakaria MR, 2014, APPL BIOCHEM BIOTECH, V173, P1778, DOI 10.1007/s12010-014-0964-5; UCAR G, 1990, WOOD SCI TECHNOL, V24, P171; BUNGAY HR, 1982, SCIENCE, V218, P643, DOI 10.1126/science.218.4573.643; Sasaki C, 2013, IND CROP PROD, V43, P757, DOI 10.1016/j.indcrop.2012.08.018; OVEREND RP, 1987, PHILOS T R SOC A, V321, P523, DOI 10.1098/rsta.1987.0029; Zhu L, 2008, BIORESOURCE TECHNOL, V99, P3817, DOI 10.1016/j.biortech.2007.07.033; Ando H, 2000, IND ENG CHEM RES, V39, P3688, DOI 10.1021/ie0000257; DUNLOP AP, 1948, IND ENG CHEM, V40, P204, DOI 10.1021/ie50458a006; LIPINSKY ES, 1981, SCIENCE, V212, P1465, DOI 10.1126/science.212.4502.1465; Dale BE, 1996, BIORESOURCE TECHNOL, V56, P111, DOI 10.1016/0960-8524(95)00183-2; Karp SG, 2013, BRAZ ARCH BIOL TECHN, V56, P679, DOI 10.1590/S1516-89132013000400019; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; RAMOS LP, 1992, APPL BIOCHEM BIOTECH, V34-5, P37, DOI 10.1007/BF02920532; Asada C, 2012, BIOCHEM ENG J, V60, P25, DOI 10.1016/j.bej.2011.09.013; Bahrin EK, 2012, BIORESOURCES, V7, P1784; BONN G, 1987, WOOD SCI TECHNOL, V21, P179; Hooper RJ, 1996, BIOMASS BIOENERG, V11, P469, DOI 10.1016/S0961-9534(96)00054-2; Isogai A., 1990, SEN-I GAKKAISHI, V46, P324; Mason W.H., 1926, US Patent, Patent No. [1,578,609, 1578609]; Ninomiya K, 2012, BIORESOURCE TECHNOL, V103, P259, DOI 10.1016/j.biortech.2011.10.019; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Sluiter A., 2012, NRELTP51042618; Sreenath HK, 1999, PROCESS BIOCHEM, V35, P33, DOI 10.1016/S0032-9592(99)00029-1; Wise L. E., 1946, Paper Trade Journal, V122, P35; Yu ZD, 2012, BIORESOURCE TECHNOL, V121, P335, DOI 10.1016/j.biortech.2012.06.055	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	APR	2015	182						245	250		10.1016/j.biortech.2015.02.005		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CD5BI	WOS:000351101500032		
J	Machida, K; Imataka, H				Machida, Kodai; Imataka, Hiroaki			Production methods for viral particles	BIOTECHNOLOGY LETTERS			English	Review						Bio-imaging; Capsids; Cell-free protein synthesis; Drug delivery; Production systems; Viral particles; Virus-like particles	VIRUS-LIKE PARTICLES; EPIDERMAL-GROWTH-FACTOR; BACTERIOPHAGE P22; CELL EXTRACT; PROTEIN; ENCAPSULATION; BATTERIES; VACCINE	Viral particles and virus-like particles (VLPs) or capsids are becoming important vehicles and templates in bio-imaging, drug delivery and materials sciences. Viral particles are prepared by infecting the host organism but VLPs are obtained from cells that express a capsid protein. Some VLPs are disassembled and then re-assembled to incorporate a material of interest. Cell-free systems, which are amenable to manipulating the viral assembly process, are also available for producing viral particles. Regardless of the production system employed, the particles are functionalized by genetic and/or chemical engineering. Here, we review various methods for producing and functionalizing viral particles and VLPs, and we discuss the merits of each system.	[Machida, Kodai; Imataka, Hiroaki] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712201, Japan	Imataka, H (reprint author), Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712201, Japan.	machida@eng.u-hyogo.ac.jp; imataka@eng.u-hyogo.ac.jp					Soto CM, 2010, CURR OPIN BIOTECH, V21, P426, DOI 10.1016/j.copbio.2010.07.004; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Chuan YP, 2010, J R SOC INTERFACE, V7, P409, DOI 10.1098/rsif.2009.0175; Rhee JK, 2011, BIOMACROMOLECULES, V12, P3977, DOI 10.1021/bm200983k; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Wen AM, 2012, BIOMACROMOLECULES, V13, P3990, DOI 10.1021/bm301278f; Hovlid ML, 2012, NANOSCALE, V4, P3698, DOI 10.1039/c2nr30571b; Enomoto T, 2011, VIROLOGY, V420, P1, DOI 10.1016/j.virol.2011.08.014; Strable E, 2009, CURR TOP MICROBIOL, V327, P1; Zhao QH, 2011, BIOCONJUGATE CHEM, V22, P346, DOI 10.1021/bc1002532; Rurup WF, 2014, BIOMACROMOLECULES, V15, P558, DOI 10.1021/bm4015792; Lee YJ, 2009, SCIENCE, V324, P1051, DOI 10.1126/science.1171541; Patterson DP, 2012, ACS NANO, V6, P5000, DOI 10.1021/nn300545z; Cadena-Nava RD, 2011, J PHYS CHEM B, V115, P2386, DOI 10.1021/jp1094118; Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u; Kitai Y, 2011, J BIOTECHNOL, V155, P251, DOI 10.1016/j.jbiotec.2011.06.030; Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469; Fiedler JD, 2010, ANGEW CHEM INT EDIT, V49, P9648, DOI 10.1002/anie.201005243; Lee YJ, 2010, NANO LETT, V10, P2433, DOI 10.1021/nl1005993; Nuraje N, 2012, ADV MATER, V24, P2885, DOI 10.1002/adma.201200114; Liew MWO, 2010, J BIOTECHNOL, V150, P224, DOI 10.1016/j.jbiotec.2010.08.010; Yi HJ, 2012, NANO LETT, V12, P1176, DOI 10.1021/nl2031663; Chen PY, 2013, ACS NANO, V7, P6563, DOI 10.1021/nn4014164; Chuan YP, 2013, BIOTECHNOL BIOENG, V110, P2343, DOI 10.1002/bit.24907; Kobayashi T, 2014, METHODS MOL BIOL, V1118, P149, DOI 10.1007/978-1-62703-782-2_9; Kobayashi T, 2013, BIOTECHNOL LETT, V35, P309, DOI 10.1007/s10529-012-1086-1; Kobayashi T, 2012, BIOTECHNOL LETT, V34, P67, DOI 10.1007/s10529-011-0744-z; Oh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3756; Patterson DP, 2014, ACS CHEM BIOL, V9, P359, DOI 10.1021/cb4006529; Wu Y, 2014, BIOTECHNOL LETT, V36, P515, DOI 10.1007/s10529-013-1399-8	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	APR	2015	37	4					753	760		10.1007/s10529-014-1741-9		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE0XX	WOS:000351535300002		
J	Bendzala, M; Kruzliak, P; Gaspar, L; Soucek, M; Mrdovic, I; Sabaka, P; Dukat, A; Gasparova, I; Malan, L; Takazawa, K				Bendzala, Matej; Kruzliak, Peter; Gaspar, Ludovit; Soucek, Miroslav; Mrdovic, Igor; Sabaka, Peter; Dukat, Andrej; Gasparova, Iveta; Malan, Leone; Takazawa, Kenji			Prognostic significance of dipping in older hypertensive patients	BLOOD PRESSURE			English	Article						5-year mortality; ABPM; arterial hypertension; blood pressure dipping	NOCTURNAL BLOOD-PRESSURE; HEART-RATE-VARIABILITY; ALL-CAUSE MORTALITY; DIABETIC-PATIENTS; ARTERIAL-HYPERTENSION; GUIDELINES; MANAGEMENT; SOCIETY; DECLINE; DISEASE	Background and aims. Arterial hypertension doubles the risk of coronary heart disease, heart and kidney failure, and peripheral arterial disease. Less variation in diurnal ambulatory blood pressure monitoring (ABPM) patterns may affect mortality outcome. Therefore, as hypertension occurs in over 95% of older subjects, the prognostic value of dipping status in older hypertensive patients will be assessed. Method. The retrospective study group consisted of 170 hypertensive patients, aged 75-84 years, enrolled in the years 2005 to 2007. Baseline measures included 24-h ABPM. Diurnal index and dipping status was calculated and stratified the group into dippers (40 patients, 23.5%), non-dippers (65 patients, 38.2%) and reverse-dippers (65 patients, 38.2%). Results. During a 5-year observation, after baseline we have observed 69 deaths (40.9%) from the whole group of 170 patients with 23 (35.4%) being non-dippers and 36 (55.4%) reverse-dippers. There were significant differences between the groups divided according to diurnal dipping status in survival time, number of recorded deaths and night mean blood pressure. We have identified and confirmed risk factors for the all-cause mortality: age, mean systolic and diastolic blood pressure, diurnal index and dipping status (dipping, non-dipping or reverse-dipping). Conclusion. Reverse-dippers and non-dippers revealed worse prognosis compared with dippers.	[Bendzala, Matej; Gaspar, Ludovit; Sabaka, Peter; Dukat, Andrej] Comenius Univ, Fac Med, Dept Internal Med 2, Bratislava, Slovakia; [Bendzala, Matej; Gaspar, Ludovit; Sabaka, Peter; Dukat, Andrej] Univ Hosp, Bratislava, Slovakia; [Kruzliak, Peter; Soucek, Miroslav] St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno 65691, Czech Republic; [Kruzliak, Peter; Soucek, Miroslav] Masaryk Univ, Brno, Czech Republic; [Soucek, Miroslav] St Annes Univ Hosp, Dept Internal Med 2, Brno 65691, Czech Republic; [Mrdovic, Igor] Univ Belgrade, Sch Med, Belgrade, Serbia; [Mrdovic, Igor] Emergency Hosp, Clin Ctr Serbia, Coronary Unit, Belgrade, Serbia; [Mrdovic, Igor] Cardiol Clin, Belgrade, Serbia; [Gasparova, Iveta] Comenius Univ, Fac Med, Inst Biol Genet & Med Genet, Bratislava, Slovakia; [Gasparova, Iveta] Univ Hosp, Bratislava, Slovakia; [Malan, Leone] North West Univ, Hypertens Africa Res Team HART, Mahikeng, South Africa; [Takazawa, Kenji] Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1608402, Japan	Kruzliak, P (reprint author), St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Pekarska 53, Brno 65691, Czech Republic.	peter.kruzliak@savba.sk		Malan, Leone/0000-0003-3187-2410	European Regional Development Fund - Project FNU-SA-ICRC [CZ.1.05/1.1.00/02.0123]	This study was elaborated within the grant of European Regional Development Fund - Project FNU-SA-ICRC (No.CZ.1.05/1.1.00/02.0123).	Ohkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Brotman DJ, 2008, AM J HYPERTENS, V21, P92, DOI 10.1038/ajh.2007.7; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Suzuki M, 1996, SLEEP, V19, P382; Chalmers J, 1999, J HYPERTENS, V17, P151; Kario K, 2004, CLIN EXP HYPERTENS, V26, P177, DOI 10.1081/CEH-120028556; Nakano Y, 2001, AUTON NEUROSCI-BASIC, V88, P181, DOI 10.1016/S1566-0702(01)00238-7; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; van Lill L, 2011, BLOOD PRESSURE, V20, P355, DOI 10.3109/08037051.2011.580529; Bouhanick B, 2008, DIABETES METAB, V34, P560, DOI 10.1016/j.diabet.2008.05.005; [Anonymous], 2007, J HYPERTENS, V25, P1105; Kurpesa M, 2002, INT J CARDIOL, V83, P133, DOI 10.1016/S0167-5273(02)00031-1; VERDECCHIA P, 1994, HYPERTENSION, V24, P793; Cicek Y, 2012, BLOOD PRESSURE, V22, P34; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Dukat A, 2003, CARDIOL, V12, P9; Gonzalez RE, 2012, REV MED SUISSE, V8, P1714; Gonzalez RE, 2012, REV MED SUISSE, V8, P1709; KANNEL WB, 1978, B NEW YORK ACAD MED, V54, P573; KOBRIN I, 1984, J AM GERIATR SOC, V32, P896; Kondo K, 2002, DIABETIC MED, V19, P359, DOI 10.1046/j.1464-5491.2002.00720.x; Kruzliak P, 2014, AM J HYPERTENS, V27, P3, DOI 10.1093/ajh/hpt201; Lurbe E, 2001, J HYPERTENS, V19, P1421, DOI 10.1097/00004872-200108000-00010; Malan L, 2013, ATHEROSCLEROSIS, V227, P391, DOI 10.1016/j.atherosclerosis.2013.01.001; Palmas W, 2009, HYPERTENSION, V53, P120, DOI 10.1161/HYPERTENSIONAHA.108.118398; PORTALUPPI F, 1991, AM J HYPERTENS, V4, P20; Widimsky J, 2004, HYPERTENZE, P590	29	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0803-7051	1651-1999		BLOOD PRESSURE	Blood Pressure	APR	2015	24	2					103	110		10.3109/08037051.2014.992198		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD5CT	WOS:000351106200007		
J	Michishita, S; Kim, SJ; Shimazu, K; Sota, Y; Naoi, Y; Maruyama, N; Kagara, N; Shimoda, M; Shimomura, A; Noguchi, S				Michishita, Shintaro; Kim, Seung Jin; Shimazu, Kenzo; Sota, Yoshiaki; Naoi, Yasuto; Maruyama, Naomi; Kagara, Naofumi; Shimoda, Masafumi; Shimomura, Atsushi; Noguchi, Shinzaburo			Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients	BREAST			English	Article						MRI morphology; Neoadjuvant chemotherapy; pCR; Predictor; Intrinsic subtype	SURGICAL ADJUVANT BREAST; CONTRAST-ENHANCED MRI; PREOPERATIVE CHEMOTHERAPY; TUMOR RESPONSE; INTRINSIC SUBTYPES; CYCLOPHOSPHAMIDE; THERAPY; DOXORUBICIN; PACLITAXEL; PARAMETERS	The purpose of this study was to evaluate whether the baseline breast MRI findings would be useful for the prediction for pathological complete response (pCR) by breast cancer patients to neoadjuvant chemotherapy. Primary breast cancer patients (stage II-III) preoperatively treated with sequential paclitaxel (12 cycles) and fluorouracil, epirubicin, and cyclophosphamide (4 cycles), followed by surgery were retrospectively enrolled, and 229 patients were eligible. Before chemotherapy, breast MRI studies were performed. Breast tumors were dichotomized into round + oval and irregular types based on MRI morphology. The round + oval tumors showed a significantly higher pCR rate than the irregular tumors (42.0% vs 17.3%; P < 0.001). In addition, PAM50 analysis revealed that basal and HER2-enriched tumors were significantly more prevalent among round + oval than irregular type tumors (P = 0.015). Baseline MRI morphology appears to be a significant predictor for pCR. The higher rate of the basal and HER2-enriched tumors among the round + oval tumors may explain their better chemo-sensitivity. (C) 2015 Elsevier Ltd. All rights reserved.	[Michishita, Shintaro; Kim, Seung Jin; Shimazu, Kenzo; Sota, Yoshiaki; Naoi, Yasuto; Maruyama, Naomi; Kagara, Naofumi; Shimoda, Masafumi; Shimomura, Atsushi; Noguchi, Shinzaburo] Osaka Univ, Dept Breast & Endocrine Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Kim, SJ (reprint author), Osaka Univ, Dept Breast & Endocrine Surg, Grad Sch Med, 2-2-E10 Yamadaoka, Suita, Osaka 5650871, Japan.	kimsj@onsurg.med.osaka-u.ac.jp					American College of Radiology, 2013, BREAST IM REP DAT SY; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Stoutjesdijk MJ, 2005, INVEST RADIOL, V40, P355, DOI 10.1097/01.rli.0000163741.16718.3e; Marinovich ML, 2012, BREAST, V21, P669, DOI 10.1016/j.breast.2012.07.006; Abraham DC, 1996, CANCER, V78, P91, DOI 10.1002/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO;2-2; Fisher B, 1997, J CLIN ONCOL, V15, P2483; Esserman L, 2001, ANN SURG ONCOL, V8, P549, DOI 10.1245/aso.2001.8.6.549; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Yao L, 2011, ANN ONCOL, V22, P1326, DOI 10.1093/annonc/mdq612; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; BOETES C, 1995, RADIOLOGY, V197, P743; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; Mazouni C, 2007, ANN ONCOL, V18, P874, DOI 10.1093/annonc/mdm008; Pickles MD, 2005, BREAST CANCER RES TR, V91, P1, DOI 10.1007/s10549-004-5819-2; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.200502.6187; Bollet MA, 2007, INT J RADIAT ONCOL, V69, P13, DOI 10.1016/j.ijrobp.2007.02.020; Naoi Y, 2011, CANCER-AM CANCER SOC, V117, P3682, DOI 10.1002/cncr.25953; Kang DK, 2013, J COMPUT ASSIST TOMO, V37, P432, DOI 10.1097/RCT.0b013e31828386ae; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Elloumi F, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-54; Buzdar AU, 2007, CANCER, V110, P2394, DOI 10.1002/cncr.23083; Colleoni M, 2008, ANN ONCOL, V19, P465, DOI 10.1093/annonc/mdm509; ERLEMANN R, 1993, RADIOLOGY, V186, P904; Ferriere JP, 1998, AM J CLIN ONCOL-CANC, V21, P117, DOI 10.1097/00000421-199804000-00003; Fuksa L, 2012, CANCER INVEST, V30, P663, DOI 10.3109/07357907.2012.725441; Heywang-Korunner SH, 2001, EUR RADIOL, V11, P531, DOI 10.1007/s003300000745; Kim SJ, 2009, ONCOLOGY-BASEL, V77, P134, DOI 10.1159/000229753; Makris A, 1998, ANN ONCOL, V9, P1179, DOI 10.1023/A:1008400706949; Martincich Laura, 2003, Radiol Med, V106, P51; Murata Y, 2004, ONCOL REP, V12, P1257; Nagashima T, 2006, EUR J RADIOL, V60, P270, DOI 10.1016/j.ejrad.2006.07.014; Uematsu T, 2010, EUR RADIOL, V20, P2315, DOI 10.1007/s00330-010-1813-8	33	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	APR	2015	24	2					159	165		10.1016/j.breast.2015.01.001		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE2UG	WOS:000351674100011		
J	Kamiyama, Y; Kobayashi, Y; Fukuhara, S; Morikawa, N; Munakata, W; Maeshima, AM; Maruyama, D; Kim, SW; Watanabe, T; Terauchi, T; Muramatsu, Y; Tobinai, K				Kamiyama, Yutaro; Kobayashi, Yukio; Fukuhara, Suguru; Morikawa, Noriyuki; Munakata, Wataru; Maeshima, Akiko Miyagi; Maruyama, Dai; Kim, Sung-Won; Watanabe, Takashi; Terauchi, Takashi; Muramatsu, Yukio; Tobinai, Kensei			Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						cancer screening; cancer surveillance; positron emission tomography; malignant lymphoma; mortality rate	HELICOBACTER-PYLORI INFECTION; GASTRIC-CANCER; FDG PET; PREVALENCE; JAPAN		[Kamiyama, Yutaro; Kobayashi, Yukio; Fukuhara, Suguru; Morikawa, Noriyuki; Munakata, Wataru; Maruyama, Dai; Kim, Sung-Won; Watanabe, Takashi; Tobinai, Kensei] Natl Canc Ctr, Dept Haematol & Haematopoiet Stem Cell Transplant, Tokyo, Japan; [Maeshima, Akiko Miyagi] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Terauchi, Takashi; Muramatsu, Yukio] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo, Japan	Kamiyama, Y (reprint author), Tokyo Jikei Univ, Dept Clin Oncol & Haematol, Tokyo, Japan.	ykkobaya@ncc.go.jp	Kobayahi, Yukio/F-2901-2015	Kobayahi, Yukio/0000-0003-2378-7865			Moog F, 1998, RADIOLOGY, V206, P475; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Haruma K, 2000, GASTROENTEROL CLIN N, V29, P623, DOI 10.1016/S0889-8553(05)70134-5; Moog F, 1997, RADIOLOGY, V203, P795; Karam M, 2006, CANCER, V107, P175, DOI 10.1002/cncr.21967; Senra-Varela A, 1998, EUR J EPIDEMIOL, V14, P491, DOI 10.1023/A:1007485815609; Stone MA, 1998, EUR J GASTROEN HEPAT, V10, P301, DOI 10.1097/00042737-199804000-00005	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	APR	2015	169	1					138	142		10.1111/bjh.13178		5	Hematology	Hematology	CD9VF	WOS:000351446400017		
J	Nedjai, B; Viney, JM; Li, H; Hull, C; Anderson, CA; Horie, T; Horuk, R; Vaidehi, N; Pease, JE				Nedjai, Belinda; Viney, Jonathan M.; Li, Hubert; Hull, Caroline; Anderson, Caroline A.; Horie, Tomoki; Horuk, Richard; Vaidehi, Nagarajan; Pease, James E.			CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; QUINAZOLINONE-DERIVED ANTAGONISTS; NONPEPTIDE CCR5 ANTAGONIST; CHEMOKINE RECEPTOR; SMALL-MOLECULE; DIFFERENTIAL EXPRESSION; ALLOGRAFT-REJECTION; HIGHLY POTENT; T-CELLS; OPTIMIZATION	Background and PurposeThe chemokine receptor CXCR3 is implicated in a variety of clinically important diseases, notably rheumatoid arthritis and atherosclerosis. Consequently, antagonists of CXCR3 are of therapeutic interest. In this study, we set out to characterize binding sites of the specific low MW CXCR3 antagonist VUF10085 and the broad spectrum antagonist TAK-779 which blocks CXCR3 along with CCR2 and CCR5. Experimental ApproachMolecular modelling of CXCR3, followed by virtual ligand docking, highlighted several CXCR3 residues likely to contact either antagonist, notably a conserved aspartate in helix 2 (Asp-112(2:63)), which was postulated to interact with the quaternary nitrogen of TAK-779. Validation of modelling was carried out by site-directed mutagenesis of CXCR3, followed by assays of cell surface expression, ligand binding and receptor activation. Key ResultsMutation of Asn-132(3.33), Phe-207 and Tyr-271(6.51) within CXCR3 severely impaired both ligand binding and chemotactic responses, suggesting that these residues are critical for maintenance of a functional CXCR3 conformation. Contrary to our hypothesis, mutation of Asp-112(2:63) had no observable effects on TAK-779 activity, but clearly decreased the antagonist potency of VUF 10085. Likewise, mutations of Phe-131(3.32), Ile-279(6.59) and Tyr-308(7.43) were well tolerated and were critical for the antagonist activity of VUF 10085 but not for that of TAK-779. Conclusions and ImplicationsThis more detailed definition of a binding pocket within CXCR3 for low MW antagonists should facilitate the rational design of newer CXCR3 antagonists, with obvious clinical potential.	[Nedjai, Belinda; Viney, Jonathan M.; Hull, Caroline; Anderson, Caroline A.; Horie, Tomoki; Pease, James E.] Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, Leukocyte Biol Sect, London, England; [Li, Hubert; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Horie, Tomoki] Tokyo Med & Dent Univ, Tokyo, Japan; [Horuk, Richard] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Pease, JE (reprint author), Univ London Imperial Coll Sci Technol & Med, Leukocyte Biol Sect, MRC, South Kensington Campus, London SW7 2AZ, England.	j.pease@imperial.ac.uk			Arthritis Research UK [18303]	This work was supported by an Arthritis Research UK Project Grant (#18303) to J. E. P. We are grateful to Martine Smit, Rob Leurs, Chris de Graaf and Danny Scholten (Vrie University Amsterdam) for the supply of VUF 10085 and for their helpful discussions.	Akahori T, 2006, TRANSPLANT P, V38, P3366, DOI 10.1016/j.transproceed.2006.10.115; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Hall SE, 2009, MOL PHARMACOL, V75, P1325, DOI 10.1124/mol.108.053470; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Seto M, 2006, J MED CHEM, V49, P2037, DOI 10.1021/jm0509703; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Vaidehi N, 2009, METHOD ENZYMOL, V460, P263, DOI 10.1016/S0076-6879(09)05213-6; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Meiser A, 2008, J IMMUNOL, V180, P6713; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Smit MJ, 2003, BLOOD, V102, P1959, DOI 10.1182/blood-2002-12-3945; Akashi S, 2005, TRANSPLANTATION, V80, P378, DOI 10.1097/01.tp.0000166338.99933.e1; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Pease J, 2012, J MED CHEM, V55, P9363, DOI 10.1021/jm300682j; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/imtimm/dxh284; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Gao P, 2003, J LEUKOCYTE BIOL, V73, P273, DOI 10.1189/jlb.0602269; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Chan J, 2011, J ORG CHEM, V76, P1767, DOI 10.1021/jo102399a; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; desMendonca FL, 2005, J BIOL CHEM, V280, P4808; Flier J, 2001, J PATHOL, V194, P398; Hayes ME, 2008, BIOORG MED CHEM LETT, V18, P1573, DOI 10.1016/j.bmcl.2008.01.074; Henne KR, 2012, DRUG METAB DISPOS, V40, P1429, DOI 10.1124/dmd.112.045708; Jenh CH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-2; Johnson M, 2007, BIOORG MED CHEM LETT, V17, P3339, DOI 10.1016/j.bmcl.2007.03.106; Li AR, 2008, BIOORG MED CHEM LETT, V18, P688, DOI 10.1016/j.bmcl.2007.11.060; Liu JW, 2009, BIOORG MED CHEM LETT, V19, P5114, DOI 10.1016/j.bmcl.2009.07.032; Nedjai B, 2011, BRIT J PHARMACOL, V166, P912; Pease JE, 2010, CURR TOP MED CHEM, V10, P1351; Ribeiro S, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P371, DOI 10.1002/352760779X.ch16; Ruschpler P, 2003, ARTHRITIS RES THER, V5, pR241, DOI 10.1186/ar783; Scholten DJ, 2014, MOL PHARMACOL, V85, P116, DOI 10.1124/mol.113.088633; Storelli S, 2007, ARCH PHARM, V340, P281, DOI 10.1002/ardp200700037; Vaidehi N, 2006, J BIOL CHEM, V281, P27613, DOI 10.1074/jbc.M601389200; vansWanrooij EJ, 2008, ARTERIOSCLER THROMB, V28, P251; Wijtmans M, 2011, BIOORGAN MED CHEM, V19, P3384, DOI 10.1016/j.bmc.2011.04.035; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Yang YF, 2002, EUR J IMMUNOL, V32, P2124, DOI 10.1002/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	APR	2015	172	7			SI		1822	1833		10.1111/bph.13027		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD9DP	WOS:000351398000015		
J	Ruzhansky, M; Sugimoto, M				Ruzhansky, Michael; Sugimoto, Mitsuru			On global inversion of homogeneous maps	BULLETIN OF MATHEMATICAL SCIENCES			English	Article						Inverse function theorem; Homogeneous mappings; Global inverse		In this note we prove a global inverse function theorem for homogeneous mappings on . The proof is based on an adaptation of the Hadamard's global inverse theorem which provides conditions for a function to be globally invertible on . For the latter adaptation, we give a short elementary proof assuming a topological result.	[Ruzhansky, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Sugimoto, Mitsuru] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Ruzhansky, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Math, 180 Queens Gate, London SW7 2AZ, England.	m.ruzhansky@imperial.ac.uk; sugimoto@math.nagoya-u.ac.jp			EPSRC Leadership Fellowship [EP/G007233/1]; EPSRC [EP/K039407/1]	M. Ruzhansky was supported by the EPSRC Leadership Fellowship EP/G007233/1 and by EPSRC Grant EP/K039407/1.	Ruzhansky M, 2006, COMMUN PART DIFF EQ, V31, P547, DOI 10.1080/03605300500455958; GORDON WB, 1972, AM MATH MON, V79, P755, DOI 10.2307/2316266; Asada K., 1978, JAP J MATH, V4, P299; Hadamard J., 1906, B SOC MATH FRANCE, V34, p[71, 349]; Hadamard J., 1906, CR HEBD ACAD SCI, V142, P74; Hadamard J., 1998, CORRES PONCTUELLES, P383; Nijenhuis A., 1962, MICH MATH J, V9, P173; Ruzhansky M, 2006, MATH ANN, V335, P645, DOI 10.1007/s00208-006-0757-4	8	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1664-3607	1664-3615		B MATH SCI	Bull. Math. Sci.	APR	2015	5	1					13	18		10.1007/s13373-014-0059-1		6	Mathematics	Mathematics	CD6UJ	WOS:000351224700002		
J	Maskarinec, G; Nakamura, KL; Woolcott, CG; Conroy, SM; Byrne, C; Nagata, C; Ursin, G; Vachon, CM				Maskarinec, Gertraud; Nakamura, Kaylae L.; Woolcott, Christy G.; Conroy, Shannon M.; Byrne, Celia; Nagata, Chisato; Ursin, Giske; Vachon, Celine M.			Mammographic density and breast cancer risk by family history in women of white and Asian ancestry	CANCER CAUSES & CONTROL			English	Article						Breast neoplasms; Mammographic density; Family history; Epidemiology; Risk factor; Effect modification	SUSCEPTIBILITY VARIANTS; POSTMENOPAUSAL WOMEN; PARENCHYMAL PATTERNS; MUTATION CARRIERS; PREDICTION; FEATURES; BRCA1	Mammographic density, i.e., the radiographic appearance of the breast, is a strong predictor of breast cancer risk. To determine whether the association of breast density with breast cancer is modified by a first-degree family history of breast cancer (FHBC) in women of white and Asian ancestry, we analyzed data from four case-control studies conducted in the USA and Japan. The study population included 1,699 breast cancer cases and 2,422 controls, of whom 45 % reported white (N = 1,849) and 40 % Asian (N = 1,633) ancestry. To standardize mammographic density assessment, a single observer re-read all mammograms using one type of interactive thresholding software. Logistic regression was applied to estimate odds ratios (OR) while adjusting for confounders. Overall, 496 (12 %) of participants reported a FHBC, which was significantly associated with breast cancer risk in the adjusted model (OR 1.51; 95 % CI 1.23-1.84). There was a statistically significant interaction on a multiplicative scale between FHBC and continuous percent density (per 10 % density: p = 0.03). The OR per 10 % increase in percent density was higher among women with a FHBC (OR 1.30; 95 % CI 1.13-1.49) than among those without a FHBC (OR 1.14; 1.09-1.20). This pattern was apparent in whites and Asians. The respective ORs were 1.45 (95 % CI 1.17-1.80) versus 1.22 (95 % CI 1.14-1.32) in whites, whereas the values in Asians were only 1.24 (95 % CI 0.97-1.58) versus 1.09 (95 % CI 1.00-1.19). These findings support the hypothesis that women with a FHBC appear to have a higher risk of breast cancer associated with percent mammographic density than women without a FHBC.	[Maskarinec, Gertraud; Nakamura, Kaylae L.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Woolcott, Christy G.] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3K 6R8, Canada; [Woolcott, Christy G.] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Conroy, Shannon M.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Byrne, Celia] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Nagata, Chisato] Gifu Univ, Grad Sch Med, Gifu, Gifu 5011112, Japan; [Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Vachon, Celine M.] Mayo Clin, Rochester, MN 55905 USA	Maskarinec, G (reprint author), Univ Hawaii, Ctr Canc, 701 Ilalo St, Honolulu, HI 96813 USA.	gertraud@cc.hawaii.edu	Byrne, Celia/K-2964-2015	Byrne, Celia/0000-0001-8289-4252	National Cancer Institute, US Department of Health and Human Services [R03 CA 135699];  [R25 CA 90956]	This research was supported by the National Cancer Institute, US Department of Health and Human Services, Grant no. R03 CA 135699. CGW and SMC were supported during the work on this Project by postdoctoral fellowships on grant R25 CA 90956.	Ziv E, 2003, J NATL CANCER I, V95, P556; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965-EPI-06-0034; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Nagata C, 2005, BRIT J CANCER, V92, P2102, DOI 10.1038/sj.bjc.6602643; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Varghese JS, 2012, CANCER RES, V72, P1478, DOI 10.1158/0008-5472.CAN-11-3295; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; Vachon CM, 2012, CANCER EPIDEM BIOMAR, V21, P1156, DOI 10.1158/1055-9965.EPI-12-0066; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7; Maskarinec G, 2005, AM J EPIDEMIOL, V162, P743, DOI 10.1093/aje/kwi270; Mitchell G, 2006, CANCER RES, V66, P1866, DOI 10.1158/0008-5472.CAN-05-3368; Nguyen TL, 2013, CANCER EPIDEM BIOMAR, V22, P2395, DOI 10.1158/1055-9965.EPI-13-0481; Pollan M, 2012, BREAST CANCER RES TR, V134, P823, DOI 10.1007/s10549-012-2108-3; BRISSON J, 1991, EPIDEMIOLOGY, V2, P440, DOI 10.1097/00001648-199111000-00009; Colditz GA, 2006, CANC EPIDEMIOLOGY PR, P189; Conroy SM, 2012, INT J CANCER, V130, P1915, DOI 10.1002/ijc.26205; Crest AB, 2006, CANCER CAUSE CONTROL, V17, P843, DOI 10.1007/s10552-006-0026-6; Ellingjord-Dale M, 2014, CANCER EPIDEM BIOMAR, V23, P1752, DOI 10.1158/1055-9965.EPI-13-1212; Gierach GL, 2010, BREAST CANCER RES TR, V123, P245, DOI 10.1007/s10549-010-0749-7; Helvie MA, 1997, AM J ROENTGENOL, V168, P1599; Kataoka M, 2009, CANCER EPIDEM BIOMAR, V18, P1277, DOI 10.1158/1055-9965.EPI-08-0568; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Martin LJ, 2010, CANCER EPIDEM BIOMAR, V19, P456, DOI 10.1158/1055-9965.EPI-09-0881; Ozanne EM, 2012, J GENET COUNS, V21, P547, DOI 10.1007/s10897-011-9470-x; SAFTLAS AF, 1989, AM J EPIDEMIOL, V129, P518; Sestak I, 2015, CURR OPIN OBSTET GYN, V27, P92, DOI 10.1097/GCO.0000000000000153; Ursin G, 2009, CANCER EPIDEM BIOMAR, V18, P102, DOI 10.1158/1055-9965.EPI-07-2857; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Woolcott CG, 2014, AM J EPIDEMIOL, V179, P236, DOI 10.1093/aje/kwt238; Yaghjyan L, 2012, CANCER CAUSE CONTROL, V23, P785, DOI 10.1007/s10552-012-9936-7	34	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-5243	1573-7225		CANCER CAUSE CONTROL	Cancer Causes Control	APR	2015	26	4					621	626		10.1007/s10552-015-0551-2		6	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CE0YG	WOS:000351536400012		
J	Ishiwatari, H; Hayashi, T; Yoshida, M; Ono, M; Sato, T; Miyanishi, K; Sato, Y; Takimoto, R; Kobune, M; Kato, J				Ishiwatari, Hirotoshi; Hayashi, Tsuyoshi; Yoshida, Makoto; Ono, Michihiro; Sato, Tsutomu; Miyanishi, Koji; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji			Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Biliary tract cancer; Hepatic arterial infusion; Chemotherapy; S-1; Gemcitabine; Neutropenia	ADVANCED PANCREATIC-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; INTRAARTERIAL EPIRUBICIN; UNITED-STATES; CHEMOTHERAPY; 5-FLUOROURACIL; CISPLATIN; TUMORS; CHEMOEMBOLIZATION; MONOTHERAPY	S-1 and gemcitabine (GS) combination therapy is a promising treatment for advanced biliary tract cancer (BTC). However, systemic administration of GS is associated with a high rate of grade 3 and 4 neutropenia. Hepatic arterial infusion (HAI) of gemcitabine may overcome this problem. We conducted a prospective phase 1 trial to determine the maximum tolerated dose (MTD) of S-1 and rates of dose-limiting toxicities (DLTs) associated with HAI of gemcitabine in patients with unresectable BTC. BTC patients were treated with 21-day cycles of HAI of gemcitabine (1000 mg/m(2) on days 1 and 8) and oral S-1 (60, 70, or 80 mg/m(2) on days 1-14) until disease progression occurred. Fifteen patients were enrolled in the study. Grade 3 and 4 neutropenia occurred in five of 15 (33 %) patients. Among six patients who were treated with 60 mg/m(2) S-1, one developed grade 4 neutropenia. DLTs (grade 4 neutropenia and bladder infection) occurred in two of six patients who were treated with 70 mg/m(2) S-1. Two of the three patients who were treated with 80 mg/m(2) S-1 experienced DLTs (grade 4 leukopenia and neutropenia and grade 3 febrile neutropenia). Thus, 80 mg/m(2) was defined as the MTD of S-1. The MTD of oral S-1 in GS therapy is 80 mg/m(2). Furthermore, HAI of gemcitabine may reduce the rate of grade 3 and 4 neutropenia in BTC patients receiving GS therapy.	[Ishiwatari, Hirotoshi; Hayashi, Tsuyoshi; Yoshida, Makoto; Ono, Michihiro; Sato, Tsutomu; Miyanishi, Koji; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Ishiwatari, H (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	ishihiro481019@gmail.com					Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Gusani NJ, 2008, J GASTROINTEST SURG, V12, P129, DOI 10.1007/s11605-007-0312-y; Inaba Y, 2011, AM J CLIN ONCOL-CANC, V34, P58, DOI 10.1097/COC.0b013e3181d2709a; Ben-Josef E, 2005, J CLIN ONCOL, V23, P8739, DOI 10.1200/JCO.2005.01.5354; West J, 2006, BRIT J CANCER, V94, P1751, DOI 10.1038/sj.bjc.6603127; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; McGlynn KA, 2006, CANCER EPIDEM BIOMAR, V15, P1198, DOI 10.1158/1055-99965-EPI-05-0811; ENSMINGER WD, 1983, SEMIN ONCOL, V10, P176; Ueno H, 2005, ONCOLOGY-BASEL, V69, P421, DOI 10.1159/000089997; ELLIS PA, 1995, EUR J CANCER, V31A, P1594, DOI 10.1016/0959-8049(95)00323-B; Kim JH, 2008, CANCER, V113, P1614, DOI 10.1002/cncr.23787; Hezel AF, 2008, ONCOLOGIST, V13, P415, DOI 10.1634/theoncologist.2007-0252; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Mambrini A, 2007, ANTICANCER RES, V27, P3009; Archie NT, 2009, CANCER CHEMOTH PHARM, V64, P935, DOI [10.1007/s00280-009-0945-5, DOI 10.1007/S00280-009-0945-5]; Bohuslav M, 2013, ANTICANCER RES, V33, P1201; Cantore M, 2005, CANCER-AM CANCER SOC, V103, P1402, DOI 10.1002/cncr.20964; COLLINS JM, 1984, J CLIN ONCOL, V2, P498; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P55, DOI 10.1007/s00534-007-1280-z; Hayashi T, 2012, INT J CLIN ONCOL, V17, P491, DOI 10.1007/s10147-011-0320-5; Kanai M, 2011, CANCER CHEMOTH PHARM, V67, P1429, DOI 10.1007/s00280-010-1443-5; Matsuda T, 2007, JPN J CLIN ONCOL, V37, P74, DOI 10.1093/jjco/hyl158; Matsumoto S, 2004, CANCER, V100, P2422, DOI 10.1002/cncr.20265; Miyanishi K, 2008, JPN J CLIN ONCOL, V38, P268, DOI 10.1093/jjco/hyn015; Morizane C, 2014, J CLIN ONCOL, V32, p5s; Okusaka T, 2006, CANCER CHEMOTH PHARM, V57, P647, DOI 10.1007/s00280-005-0095-3; Sasaki T, 2009, ONCOLOGY-BASEL, V77, P71, DOI 10.1159/000226214; Sawada Noriaki, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P1088; Schulz L, 1998, P AM SOC CLIN ONCOL, V17, p251a; Shamseddine AI, 2005, CLIN PHARMACOKINET, V44, P957, DOI 10.2165/00003088-200544090-00005; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; The National Cancer Institute, 2010, COMM TERM CRIT ADV E; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208; van Riel JM, 2009, EUR J CANCER, V45, P2519, DOI 10.1016/j.ejca.2009.05.025; Vogl TJ, 2006, J CANCER RES CLIN, V132, P745, DOI 10.1007/s00432-006-0138-0	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	APR	2015	75	4					805	812		10.1007/s00280-015-2704-0		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CE1CI	WOS:000351549100016		
J	Nio, K; Arita, S; Isobe, T; Kusaba, H; Kohashi, K; Kajitani, T; Tamura, S; Hirano, G; Mitsugi, K; Makiyama, A; Esaki, T; Ariyama, H; Oda, Y; Akashi, K; Baba, E				Nio, Kenta; Arita, Shuji; Isobe, Taichi; Kusaba, Hitoshi; Kohashi, Kenichi; Kajitani, Tatsuhiro; Tamura, Shingo; Hirano, Gen; Mitsugi, Kenji; Makiyama, Akitaka; Esaki, Taito; Ariyama, Hiroshi; Oda, Yoshinao; Akashi, Koichi; Baba, Eishi			Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Extrapulmonary neuroendocrine carcinoma; Chemotherapy; Amrubicin; Sensitive relapse; Topoisomerase	CELL LUNG-CANCER; PHASE-III TRIAL; CLINICOPATHOLOGICAL FEATURES; TOPOTECAN; CYCLOPHOSPHAMIDE; VINCRISTINE; CISPLATIN; ETOPOSIDE; THERAPY	Extrapulmonary neuroendocrine carcinomas (EPNEC) are rarely observed and are associated with poor outcomes. Based on the clinicopathological similarity, treatment used for small cell lung carcinoma has also been employed for EPNEC, but the response to such therapy has not been well examined. The goal of this study was to investigate amrubicin (AMR) monotherapy as a salvage therapy for EPNEC arising from digestive organs. Patients with EPNEC of the digestive organs who had prior platinum-based chemotherapy and were subsequently treated with AMR between July 2005 and December 2013 at any one of four institutions were retrospectively examined to characterize the safety and efficacy of AMR. Thirteen patients (ten males, three females; median age 64 years) were examined. Primary cancer sites included stomach (n = 6), rectum (n = 3), esophagus (n = 2), liver (n = 1) and pancreas (n = 1). Prior irinotecan- and etoposide-containing chemotherapies were used in ten and six patients, respectively. Median initial dose of AMR was 40 mg/m(2)/day for three consecutive days, and median of treatment cycles was 4 (range 1-9). The objective response rate (ORR) was 38.5 %. Median progression-free survival (PFS) and overall survival (OS) were 107 (range 22-275) and 215 days (range 71-535), respectively. Common severe adverse events (grade 3/4) were neutropenia (84.6 %) and febrile neutropenia (30.8 %). Patient with longer platinum-free interval (> 90 days) exhibited longer PFS and OS than those with shorter platinum-free interval (190 vs. 63 days and 348 vs. 145 days, respectively). AMR showed evidence of clinical activity and safety when used for the treatment of EPNEC. It might be especially useful for populations with sensitive relapse.	[Nio, Kenta; Arita, Shuji; Isobe, Taichi; Kusaba, Hitoshi; Tamura, Shingo; Ariyama, Hiroshi; Akashi, Koichi] Kyushu Univ Hosp, Dept Hematol & Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Arita, Shuji; Baba, Eishi] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Kohashi, Kenichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci,Higashi Ku, Fukuoka 8128582, Japan; [Kajitani, Tatsuhiro; Esaki, Taito] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Minami Ku, Fukuoka 8111347, Japan; [Hirano, Gen; Makiyama, Akitaka] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol & Oncol, Yahatanishi Ku, Kitakyushu, Fukuoka 8068501, Japan; [Mitsugi, Kenji] Hamanomachi Hosp, Dept Oncol, Chuo Ku, Fukuoka 8108539, Japan	Baba, E (reprint author), Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	e-baba@c-oncology.med.kyushu-u.ac.jp					O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; MATSUI K, 1991, AM J GASTROENTEROL, V86, P1167; Mitry E, 1999, BRIT J CANCER, V81, P1351, DOI 10.1038/sj.bjc.6690325; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Brenner B, 2007, SEMIN ONCOL, V34, P43, DOI 10.1053/j.seminoncol.2006.10.022; MANGUM MD, 1989, J CLIN ONCOL, V7, P607; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Ettinger DS, 2010, J CLIN ONCOL, V28, P2598, DOI 10.1200/JCO.2009.26.7682; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Murakami H, 2014, LUNG CANCER, V84, P67, DOI 10.1016/j.lungcan.2014.01.012; Asayama M, 2011, CANCER CHEMOTH PHARM, V68, P1325, DOI 10.1007/s00280-011-1619-7; Bosman FT, 2010, WHO CLASSIFICATION T, P13; Isobe T, 2009, CASE REP MED, DOI [10.1155/2009/538081, DOI 10.1155/2009/538081]; Maru DM, 2008, AM J SURG PATHOL, V32, P1404, DOI 10.1097/PAS.0b013e31816bf41f; NCCN lung, 2014, NCCN LUNG 2014 NCCN; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; SUGIMOTO Y, 1990, CANCER RES, V50, P7962; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; von Pawel J, 2003, LUNG CANCER, V41, pS235, DOI 10.1016/S0169-5002(03)92536-0	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	APR	2015	75	4					829	835		10.1007/s00280-015-2706-y		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CE1CI	WOS:000351549100019		
J	Ito, H; Ando, T; Ogiso, H; Arioka, Y; Seishima, M				Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Arioka, Yuko; Seishima, Mitsuru			Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Cancer immunotherapy; Toll-like receptor agonists; Induced nitric oxide synthase; Th1	BASAL-CELL CARCINOMA; TOLL-LIKE RECEPTORS; ALPHA-GALACTOSYLCERAMIDE; BREAST-CANCER; NKT CELLS; IMMUNITY; INFLAMMATION; LYMPHOCYTES; MODEL	Toll-like receptor (TLR) agonists have been shown to have anti-tumor activity in basic research and clinical studies. However, TLR agonist monotherapy in cancer treatment dose not sufficiently eliminate tumors. Activation of the innate immune response by TLR agonists and other pathogen-associated molecular patterns is effective for driving adaptive immunity via interleukin (IL)-12 or IL-1, but is counteracted by the simultaneous induction of immunosuppressive cytokines and other molecules, including IL-10, tumor growth factor-beta, and induced nitric oxide synthase (iNOS). In the present study, we evaluated the anticancer effect of the TLR7 agonist, imiquimod (IMQ), in the absence of iNOS. The administration of IMQ in iNOS-knockout (KO) mice implanted with tumor cells significantly suppressed tumor progression as compared to that in wild-type mice and improved the survival rate. Moreover, injection with IMQ enhanced the tumor antigen-specific Th1 response in iNOS-KO mice with tumors. The enhancement of the antigen-specific Th1 response was associated with an increase in IL-2 and IL-12b expressions in the tumor-draining lymph nodes. Combination therapy with IMQ and an iNOS inhibitor also significantly inhibited tumor growth in the established tumor model. Finally, our results indicated that the enhancement of iNOS expression through the administration with TLR agonists impairs host anti-tumor immunity, while the inhibition of iNOS could enhance the therapeutic efficacy of TLR agonists via the increase in Th1 immune response.	[Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Arioka, Yuko; Seishima, Mitsuru] Gifu Univ, Dept Informat Clin Med, Grad Sch Med, Gifu 5011194, Japan	Ito, H (reprint author), Gifu Univ, Dept Informat Clin Med, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	hito@gifu-u.ac.jp			Ministry for Education, Culture, Sports, Science and Technology of Japan [24659361]	The authors thank Dr. H. Shirota for kindly providing several of the tumor cell lines in this study. This work was supported by Grant-in-Aid for Scientific Research (C) (24659361) from the Ministry for Education, Culture, Sports, Science and Technology of Japan.	Ito H, 2005, J ENDOTOXIN RES, V11, P213, DOI 10.1179/096805105X46628; Domschke C, 2013, CANCER IMMUNOL IMMUN, V62, P1053, DOI 10.1007/s00262-013-1414-x; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Goutagny N, 2012, TARGET ONCOL, V7, P29, DOI 10.1007/s11523-012-0213-1; Ohtaki H, 2009, BIOCHEM BIOPH RES CO, V378, P579, DOI 10.1016/j.bbrc.2008.11.075; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Ito H, 2008, INT IMMUNOL, V20, P869, DOI 10.1093/intimm/dxn046; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Weber G, 2013, CLIN CANCER RES, V19, P5079, DOI 10.1158/1078-0432.CCR-13-0955; Beutner KR, 1999, J AM ACAD DERMATOL, V41, P1002, DOI 10.1016/S0190-9622(99)70261-6; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; Ito H, 2006, LAB INVEST, V86, P254, DOI 10.1038/labinvest.3700388; Stockfleth E, 2003, BRIT J DERMATOL, V149, P53, DOI 10.1046/j.0366-077X.2003.05626.x; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Mortenson ED, 2013, CLIN CANCER RES, V19, P1476, DOI 10.1158/1078-0432.CCR-12-2522; Ito H, 2009, J IMMUNOL, V182, P391; Lagares-Garcia JA, 2001, AM SURGEON, V67, P709; Lu HL, 2010, J IMMUNOL, V184, P5360, DOI 10.4049/jimmunol.0902997; Blesson S, 2002, INT IMMUNOL, V14, P1169, DOI 10.1093/intimm/dxf081; Ito H, 2014, IMMUNOLOGY, V142, P614, DOI 10.1111/imm.12274; Karlsson A, 2008, BIOCHEM BIOPH RES CO, V367, P242, DOI 10.1016/j.bbrc.2007.12.046; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Shirota H, 2011, CANCER IMMUNOL IMMUN, V60, P659, DOI 10.1007/s00262-011-0973-y	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	APR	2015	64	4					429	436		10.1007/s00262-014-1644-6		8	Oncology; Immunology	Oncology; Immunology	CE0SA	WOS:000351514500004		
J	Noguchi, M; Arai, G; Matsumoto, K; Naito, S; Moriya, F; Suekane, S; Komatsu, N; Matsueda, S; Sasada, T; Yamada, A; Kakuma, T; Itoh, K				Noguchi, Masanori; Arai, Gaku; Matsumoto, Kazumasa; Naito, Seiji; Moriya, Fukuko; Suekane, Shigetaka; Komatsu, Nobukazu; Matsueda, Satoko; Sasada, Tetsuro; Yamada, Akira; Kakuma, Tatsuyuki; Itoh, Kyogo			Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Cancer vaccine; Mixed peptide; Phase I; Prostate cancer; Immunotherapy	CYTOTOXIC T-LYMPHOCYTES; CLINICAL-TRIALS; MELANOMA; CELLS; ANTIGENS	The heterogeneity expression of tumor-associated antigens (TAA) and variability of human T cell repertoire suggest that effective cancer vaccine requires induction of a wide breadth of cytotoxic T lymphocyte (CTL) specificities. This can be achieved with vaccines targeting multiple TAA. We evaluated the safety and immune dynamics of a cancer vaccine consisting of 20 mixed peptides (KRM-20) designed to induce CTLs against 12 different TAA in patients with castration-resistant prostate cancer (CRPC). Patients received each of three different randomly assigned doses of KRM-20 (6, 20, or 60 mg) once a week for 6 weeks. KRM-20 was applicable for patients with positive human leukocyte antigen (HLA) A2, A3, A11, A24, A26, A31 or A33 alleles, which cover the majority of the global population. To evaluate the minimum immunological effective dose (MIED), peptide-specific CTL and immunoglobulin G (IgG) responses, and immune suppressive subsets were evaluated during the vaccination. Total of 17 patients was enrolled. No serious adverse drug reactions were encountered. The MIED of KRM-20 in CTL or IgG response calculated by logistic regression model was set as 16 or 1.6 mg, respectively. The frequency of immune suppressive subsets was fewer in the 20 mg cohort than that in 6 or 60 mg cohort. Clinical responses determined by prostate-specific antigen levels were two partial responses (from the 20 mg cohort), five no changes and ten progressive diseases. Twenty milligrams of KRM-20 could be recommended for further studies because of the safety and ability to augment CTL activity.	[Noguchi, Masanori] Kurume Univ, Sch Med, Div Clin Res, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Noguchi, Masanori; Suekane, Shigetaka] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka 8300011, Japan; [Arai, Gaku] Dokkyo Med Univ, Dept Urol, Koshigaya Hosp, Koshigaya, Japan; [Matsumoto, Kazumasa] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa, Japan; [Naito, Seiji] Kyushu Univ, Fac Med, Dept Urol, Fukuoka 812, Japan; [Moriya, Fukuko] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Komatsu, Nobukazu; Sasada, Tetsuro] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 8300011, Japan; [Matsueda, Satoko; Itoh, Kyogo] Kurume Univ, Sch Med, Canc Vaccine Ctr, Kurume, Fukuoka 8300011, Japan; [Yamada, Akira] Kurume Univ, Sch Med, Div Canc Vaccines, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Sch Med, Biostat Ctr, Kurume, Fukuoka 8300011, Japan	Noguchi, M (reprint author), Kurume Univ, Sch Med, Div Clin Res, Res Ctr Innovat Canc Therapy, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	noguchi@med.kurume-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Sendai Kousei Hospital	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan (M. Noguchi), and Sendai Kousei Hospital (K. Itoh).	Anderson MJ, 2007, J IMMUNOL, V178, P1268; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Komatsu N, 2012, CANCER-AM CANCER SOC, V118, P3208, DOI 10.1002/cncr.26636; Cormier JN, 1997, CANCER J SCI AM, V3, P37; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Terasaki M, 2011, J CLIN ONCOL, V29, P337, DOI 10.1200/JCO.2010.29.7499; Sasada T, 2010, EUR J CANCER, V46, P1514, DOI 10.1016/j.ejca.2010.03.013; Noguchi M, 2013, CANCER IMMUNOL IMMUN, V62, P919, DOI 10.1007/s00262-012-1379-1; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Mizukoshi E, 2011, HEPATOLOGY, V53, P1206, DOI 10.1002/hep.24149; Noguchi M, 2010, CANCER BIOL THER, V10, P1266, DOI 10.4161/cbt.10.12.13448; Chianese-Bullock KA, 2008, J IMMUNOTHER, V31, P420, DOI 10.1097/CJI.0b013e31816dad10; Komatsu N, 2004, SCAND J CLIN LAB INV, V64, P535, DOI 10.1080/00365510410007008; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Wang J, 1996, J IMMUNOL, V156, P2819; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Correale P, 1998, J IMMUNOL, V161, P3186; Gohara R, 2002, J IMMUNOTHER, V25, P439, DOI 10.1097/00002371-200209000-00008; Kim SJ, 2003, CLIN CANCER RES, V9, P1200; Minami T, 2007, CANCER IMMUNOL IMMUN, V56, P689, DOI 10.1007/s00262-006-0216-9; Noguchi M, 2011, PROSTATE, V71, P470, DOI 10.1002/pros.21261; Park SI, 2012, ENDOCR-RELAT CANCER, V19, P243, DOI 10.1530/ERC-11-0278; Peshwa MV, 1998, PROSTATE, V36, P129, DOI 10.1002/(SICI)1097-0045(19980701)36:2<129::AID-PROS8>3.0.CO;2-D; Salgaller ML, 1996, CANCER RES, V56, P4749; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Simone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044654; Tjoa B, 1996, PROSTATE, V28, P65	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	APR	2015	64	4					493	505		10.1007/s00262-015-1660-1		13	Oncology; Immunology	Oncology; Immunology	CE0SA	WOS:000351514500010		
J	Okuno, Y; Korchi, AM; Shinjo, T; Kato, S				Okuno, Yuji; Korchi, Amine Mohamed; Shinjo, Takuma; Kato, Shojiro			Transcatheter Arterial Embolization as a Treatment for Medial Knee Pain in Patients with Mild to Moderate Osteoarthritis	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Abnormal neovessels; Embolization; Osteoarthritis; Knee pain	SYNOVIAL TISSUE; ANGIOGENESIS; MANAGEMENT	Osteoarthritis is a common cause of pain and disability. Mild to moderate knee osteoarthritis that is resistant to nonsurgical options and not severe enough to warrant joint replacement represents a challenge in its management. On the basis of the hypothesis that neovessels and accompanying nerves are possible sources of pain, previous work demonstrated that transcatheter arterial embolization for chronic painful conditions resulted in excellent pain relief. We hypothesized that transcatheter arterial embolization can relieve pain associated with knee osteoarthritis. Transcatheter arterial embolization for mild to moderate knee osteoarthritis using imipenem/cilastatin sodium or 75 mu m calibrated Embozene microspheres as an embolic agent has been performed in 11 and three patients, respectively. We assessed adverse events and changes in Western Ontario and McMaster University Osteoarthritis Index (WOMAC) scores. Abnormal neovessels were identified within soft tissue surrounding knee joint in all cases by arteriography. No major adverse events were related to the procedures. Transcatheter arterial embolization rapidly improved WOMAC pain scores from 12.2 +/- A 1.9 to 3.3 +/- A 2.1 at 1 month after the procedure, with further improvement at 4 months (1.7 +/- A 2.2) and WOMAC total scores from 47.3 +/- A 5.8 to 11.6 +/- A 5.4 at 1 month, and to 6.3 +/- A 6.0 at 4 months. These improvements were maintained in most cases at the final follow-up examination at a mean of 12 +/- A 5 months (range 4-19 months). Transcatheter arterial embolization for mild to moderate knee osteoarthritis was feasible, rapidly relieved resistant pain, and restored knee function.	[Okuno, Yuji; Kato, Shojiro] Edogawa Hosp, Dept Orthoped Surg, Edogawa Ku, Tokyo 1330052, Japan; [Korchi, Amine Mohamed] Univ Hosp Geneva, Dept Diagnost & Intervent Radiol, CH-1211 Geneva, Switzerland; [Shinjo, Takuma] Keio Univ, Inst Integrated Sports Med, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Okuno, Y (reprint author), Edogawa Hosp, Dept Orthoped Surg, Edogawa Ku, 2-24-18 Higashikoiwa, Tokyo 1330052, Japan.	how_lowlow@yahoo.co.jp; amine.korchi@gmail.com; shin.takuma@a7.keio.jp; shojiro7@yahoo.co.jp					Aihara Teruhito, 1999, Kawasaki Igakkai Shi, V25, P47; Guermazi A, 2013, RHEUM DIS CLIN N AM, V39, P67, DOI 10.1016/j.rdc.2012.10.003; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Lyu SR, 2010, KNEE SURG SPORT TR A, V18, P769, DOI 10.1007/s00167-009-0946-2; Walther M, 2002, RADIOLOGY, V225, P225, DOI 10.1148/radiol.2251011272; CLAESSENS AAMC, 1990, ANN RHEUM DIS, V49, P771, DOI 10.1136/ard.49.10.771; Dye SF, 1998, AM J SPORT MED, V26, P773; Crema MD, 2013, OSTEOARTHR CARTILAGE, V21, P413, DOI 10.1016/j.joca.2012.12.006; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; HART DJ, 1991, ANN RHEUM DIS, V50, P467, DOI 10.1136/ard.50.7.467; GARDNER E, 1948, ANAT REC, V101, P109, DOI 10.1002/ar.1091010111; Okuno Y, 2014, J SHOULDER ELB SURG, V23, pE199, DOI 10.1016/j.jse.2013.12.014; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Bohnsack M, 2005, ARCH ORTHOP TRAUM SU, V125, P592, DOI 10.1007/s00402-005-0796-4; Hash TW, 2011, J ARTHROPLASTY, V26, P1357, DOI 10.1016/j.arth.2011.01.010; Okuno Y, 2013, J VASC INTERV RADIOL, V24, P787, DOI 10.1016/j.jvir.2013.02.033; Woodhams R, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-344; Wu PT, 2012, OSTEOARTHR CARTILAGE, V20, P1507, DOI 10.1016/j.joca.2012.08.021	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	APR	2015	38	2					336	343		10.1007/s00270-014-0944-8		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CD5VA	WOS:000351155100011		
J	Iguchi, T; Hiraki, T; Gobara, H; Fujiwara, H; Matsui, Y; Soh, J; Toyooka, S; Kiura, K; Kanazawa, S				Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Soh, Junichi; Toyooka, Shinichi; Kiura, Katsuyuki; Kanazawa, Susumu			Percutaneous Radiofrequency Ablation of Lung Cancer Presenting as Ground-Glass Opacity	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Radiofrequency ablation; Lung; Cancer	INTENTION-TO-TREAT; LOCAL PROGRESSION; DIAGNOSTIC-ACCURACY; PULMONARY-LESIONS; TUMORS; CT; EXPERIENCE; ADENOCARCINOMAS; MANAGEMENT; PROGNOSIS	We retrospectively evaluated the outcomes of lung cancer patients presenting with ground-glass opacity (GGO) who received radiofrequency ablation (RFA). Sixteen patients (5 men and 11 women; mean age, 72.6 years) with 17 lung cancer lesions showing GGO (mean long axis diameter, 1.6 cm) underwent a total of 20 percutaneous computed tomography (CT) fluoroscopy-guided RFA sessions, including three repeated sessions for local progression. Lung cancer with GGO was defined as a histologically confirmed malignant pulmonary lesion with a GGO component accounting for > 50 % of the lesion on high-resolution CT. Procedure outcomes were evaluated. There were no major complications. Pneumothorax occurred in 15 of 20 treatment sessions: 14 were asymptomatic, and 1 required chest tube placement but resolved satisfactorily within 48 h. Minor pulmonary hemorrhage occurred in two and mild pneumonitis in one. The median tumor follow-up period was 61.5 (range 6.1-96.6) months. The effectiveness rates of the primary and secondary techniques were 100 and 100 % at 1 year, 93.3 and 100 % at 2 years, and 78.3 and 92.3 % at 3 years, respectively. The median patient follow-up period was 65.6 (range 6.1-96.6) months. One patient died owing to recurrent other cancer 11.7 months after RFA, whereas the other 15 remained alive. Overall survival and disease-specific survival rates were 93.3 and 100 % at 1 year and 93.3 and 100 % at 5 years, respectively. RFA for lung cancer with GGO was safe and effective, and resulted in promising survival rates.	[Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Kita Ku, Okayama 7008558, Japan; [Soh, Junichi; Toyooka, Shinichi] Okayama Univ, Sch Med, Dept Gen Thorac Surg, Kita Ku, Okayama 7008558, Japan; [Toyooka, Shinichi] Okayama Univ, Sch Med, Dept Clin Genom Med, Kita Ku, Okayama 7008558, Japan; [Kiura, Katsuyuki] Okayama Univ, Sch Med, Dept Resp Med, Kita Ku, Okayama 7008558, Japan	Iguchi, T (reprint author), Okayama Univ, Sch Med, Dept Radiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	iguchi@ba2.so-net.ne.jp; takaoh@tc4.so-net.ne.jp; gobara@cc.okayama-u.ac.jp; hirofujiwar@gmail.com; wckyh140@yahoo.co.jp; soh-j@cc.okayama-u.ac.jp; shintoyooka@gmail.com; kkiura@md.okayama-u.ac.jp; susumu@cc.okayama-u.ac.jp					de Baere T, 2006, RADIOLOGY, V240, P587, DOI 10.1148/radiol.2402050807; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; Anderson EM, 2009, CARDIOVASC INTER RAD, V32, P478, DOI 10.1007/s00270-008-9482-6; Hiraki T, 2011, ACTA MED OKAYAMA, V65, P287; Simon CJ, 2007, RADIOLOGY, V243, P268, DOI 10.1148/radiol.2431060088; Nakao M, 2012, J THORAC ONCOL, V7, P1563, DOI 10.1097/JTO.0b013e3182641b5c; Kashima M, 2011, AM J ROENTGENOL, V197, pW576, DOI 10.2214/AJR.11.6408; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252; Okuma T, 2010, CARDIOVASC INTER RAD, V33, P787, DOI 10.1007/s00270-009-9770-9; Ambrogi MC, 2011, J THORAC ONCOL, V6, P2044, DOI 10.1097/JTO.0b013e31822d538d; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Kondo T, 2002, LUNG CANCER-J IASLC, V36, P49, DOI 10.1016/S0169-5002(01)00448-2; Kim YS, 2010, AM J ROENTGENOL, V195, P758, DOI 10.2214/AJR.09.2954; Hiraki T, 2006, CANCER, V107, P2873, DOI 10.1002/cncr.22333; Abtin FG, 2012, RADIOGRAPHICS, V32, P947, DOI 10.1148/rg.324105181; Yasui K, 2004, RADIOLOGY, V231, P850, DOI 10.1148/radiol.2313030347; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Yamamoto A, 2005, AM J ROENTGENOL, V185, P1299, DOI 10.2214/AJR.04.0968; Hiraki T, 2010, EUR J RADIOL, V74, P136, DOI 10.1016/j.ejrad.2009.01.026; Asamura H, 2003, ANN THORAC SURG, V76, P1016, DOI 10.1016/S0003-4975(03)00835-X; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Hamamoto Y, 2012, JPN J RADIOL, V30, P430, DOI 10.1007/s11604-012-0071-x; Hiraki T, 2011, J THORAC CARDIOV SUR, V142, P24, DOI 10.1016/j.jtcvs.2011.02.036; Hiraki T, 2008, J VASC INTERV RADIOL, V19, P706, DOI 10.1016/j.jvir.2007.12.441; Hur J, 2009, AM J ROENTGENOL, V192, P629, DOI 10.2214/AJR.08.1366; Kim KW, 2011, AM J ROENTGENOL, V196, pW565, DOI 10.2214/AJR.10.5122; Kim TJ, 2012, AM J ROENTGENOL, V198, P83, DOI 10.2214/AJR.11.6862; Kim TJ, 2008, AM J ROENTGENOL, V190, P234, DOI 10.2214/AJR.07.2441	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	APR	2015	38	2					409	415		10.1007/s00270-014-0926-x		7	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CD5VA	WOS:000351155100020		
J	Koike, Y; Nishimura, J; Hase, S; Yamasaki, M				Koike, Yuya; Nishimura, Jun-ichi; Hase, Soichiro; Yamasaki, Motoshige			Sac Angiography and Glue Embolization in Emergency Endovascular Aneurysm Repair for Ruptured Abdominal Aortic Aneurysm	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Ruptured abdominal aortic aneurysm; Endovascular aneurysm repair; N-butyl cyanoacrylate	II ENDOLEAK; MANAGEMENT; SUPERIOR; EVAR	The purpose of this study was to demonstrate a sac angiography technique and evaluate the feasibility of N-butyl cyanoacrylate (NBCA) embolization of the ruptured abdominal aortic aneurysm (AAA) sac in emergency endovascular aneurysm repair (EVAR) in hemodynamically unstable patients. A retrospective case series of three patients in whom sac angiography was performed during emergency EVAR for ruptured AAA was reviewed. After stent graft deployment, angiography within the sac of aneurysm (sac angiography) was performed by manually injecting 10 ml of contrast material through a catheter to identify the presence and site of active bleeding. In two patients, sac angiography revealed active extravasation of the contrast material, and NBCA embolization with a coaxial catheter system was performed to achieve prompt sealing. Sac angiography was successful in all three patients. In the two patients who underwent NBCA embolization for aneurysm sac bleeding, follow-up computed tomography (CT) images demonstrated the accumulation of NBCA consistent with the bleeding site in preprocedural CT images. EVAR is associated with a potential risk of ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy. Therefore, sac angiography and NBCA embolization during emergency EVAR may represent a possible technical improvement in the treatment of ruptured AAA in hemodynamically unstable patients.	[Koike, Yuya; Nishimura, Jun-ichi; Hase, Soichiro; Yamasaki, Motoshige] Kawasaki Saiwai Hosp, Dept Intervent Radiol, Saiwai Ku, Kanagawa 2120014, Japan	Koike, Y (reprint author), Kawasaki Saiwai Hosp, Dept Intervent Radiol, Saiwai Ku, 31-27 Omiya Cho, Kanagawa 2120014, Japan.	r06118@hotmail.co.jp; jun-ichi_n@nifty.com; haseman@hotmail.co.jp; genyamasaki@gmail.com					Habets J, 2013, EUR J VASC ENDOVASC, V45, P340, DOI 10.1016/j.ejvs.2012.12.014; Jonker FHW, 2009, SEMIN VASC SURG, V22, P165, DOI 10.1053/j.semvascsurg.2009.07.008; Yonemitsu T, 2009, J VASC INTERV RADIOL, V20, P1176, DOI 10.1016/j.jvir.2009.06.005; Lehmkuhl L, 2013, RADIOLOGY, V268, P890, DOI 10.1148/radiol.13120197; Ronsivalle S, 2010, J ENDOVASC THER, V17, P517, DOI 10.1583/09-3004.1; Kish JW, 2004, J VASC INTERV RADIOL, V15, P689, DOI 10.1097/01.RVI.0000133505.84588.8C; Bush RL, 2001, J VASC SURG, V34, P1119, DOI 10.1067/mva.2001.118824; Zanchetta M, 2007, J ENDOVASC THER, V14, P176, DOI 10.1583/1545-1550(2007)14[176:IITITP]2.0.CO;2; Mehta M, 2005, J VASC SURG, V42, P1047, DOI 10.1016/j.jvs.2005.08.033; Berland TL, 2013, J VASC SURG, V57, P272, DOI 10.1016/j.jvs.2012.09.001; Brandt M, 2005, J VASC INTERV RADIOL, V16, P1309, DOI 10.1097/01.RVI.0000175332.44635.49; Koike Y, 2013, J VASC INTERV RADIOL, V24, P1462, DOI 10.1016/j.jvir.2013.04.020; Rusius VC, 2011, VASC ENDOVASC SURG, V45, P198, DOI 10.1177/1538574410391821; Ten Bosch JA, 2010, J VASC SURG, V52, P13, DOI 10.1016/j.jvs.2010.02.014	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	APR	2015	38	2					457	462		10.1007/s00270-014-0873-6		6	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CD5VA	WOS:000351155100027		
J	Shimomura, K; Ando, W; Moriguchi, Y; Sugita, N; Yasui, Y; Koizumi, K; Fujie, H; Hart, DA; Yoshikawa, H; Nakamura, N				Shimomura, Kazunori; Ando, Wataru; Moriguchi, Yu; Sugita, Norihiko; Yasui, Yukihiko; Koizumi, Kota; Fujie, Hiromichi; Hart, David A.; Yoshikawa, Hideki; Nakamura, Norimasa			Next Generation Mesenchymal Stem Cell (MSC)-Based Cartilage Repair Using Scaffold-Free Tissue Engineered Constructs Generated with Synovial Mesenchymal Stem Cells	CARTILAGE			English	Article						mesenchymal stem cells; synovial cells; articular cartilage; animal models; biomaterials	AUTOLOGOUS CHONDROCYTE IMPLANTATION; THICKNESS CHONDRAL DEFECTS; AGE-RELATED-CHANGES; ARTICULAR-CARTILAGE; IN-VITRO; OSTEOCHONDRAL DEFECTS; MECHANICAL-PROPERTIES; COLLAGEN MATRIX; ALGINATE BEADS; STROMAL CELLS	Because of its limited healing capacity, treatments for articular cartilage injuries are still challenging. Since the first report by Brittberg, autologous chondrocyte implantation has been extensively studied. Recently, as an alternative for chondrocyte-based therapy, mesenchymal stem cell-based therapy has received considerable research attention because of the relative ease in handling for tissue harvest, and subsequent cell expansion and differentiation. This review summarizes latest development of stem cell therapies in cartilage repair with special attention to scaffold-free approaches.	[Shimomura, Kazunori; Ando, Wataru; Moriguchi, Yu; Sugita, Norihiko; Yasui, Yukihiko; Koizumi, Kota; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan; [Fujie, Hiromichi] Kogakuin Univ, Dept Mech Engn, Biomech Lab, Tokyo, Japan; [Fujie, Hiromichi] Tokyo Metropolitan Univ, Fac Syst Design, Div Human Mechartron Syst, Tokyo 158, Japan; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Nakamura, Norimasa] Osaka Hlth Sci Univ, Inst Med Sci Sports, Osaka, Osaka 5300043, Japan; [Nakamura, Norimasa] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Nakamura, N (reprint author), Osaka Hlth Sci Univ, Inst Med Sci Sports, Kita Ku, 1-9-27 Tenma, Osaka, Osaka 5300043, Japan.	norimasa.nakamura@ohsu.ac.jp			New Energy and Industrial Technology Development Organization, Japan; Japan Society for the Promotion of Science; Alberta Innovates Health Solutions Osteoarthritis Team Grant	We thank Kiyoto Nagai, MS, Yoshihisa Fujishima, BS, Machiko Imura, BS, and Ryosuke Nansai, MS for mechanical testing. This work is supported by a grant from the New Energy and Industrial Technology Development Organization, Japan, and a Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science. DAH was supported by the Alberta Innovates Health Solutions Osteoarthritis Team Grant.	Ando W, 2014, CYTOTHERAPY, V16, P776, DOI 10.1016/j.jcyt.2013.12.003; Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K; Peterson L, 2002, AM J SPORT MED, V30, P2; De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441; De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6; Goyal D, 2013, ARTHROSCOPY, V29, P1872, DOI 10.1016/j.arthro.2013.07.271; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Shimomura K, 2010, BIOMATERIALS, V31, P8004, DOI 10.1016/j.biomaterials.2010.07.017; DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Steinwachs M, 2007, ARTHROSCOPY, V23, P381, DOI 10.1016/j.arthro.2006.12.003; Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056; [Anonymous], 1999, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199908000-00020; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118; Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415; Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x; Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5; Huang CY, 2003, J BIOMECH ENG-T ASME, V125, P84, DOI 10.1115/1.1531656; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109; Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846; Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001; Ando W, 2012, EUR CELLS MATER, V24, P292; Kreuz PC, 2006, ARTHROSCOPY, V22, P1180, DOI 10.1016/j.arthro.2006.06.020; De Bari C, 2004, ARTHRITIS RHEUM, V50, P142, DOI 10.1002/art.11450; Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3; [Anonymous], 2003, CLN ORTHOP, DOI 10.1097/01.blo.0000072467.53786.ca; Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419; Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901; van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Masuda K, 2003, J ORTHOPAED RES, V21, P922, DOI 10.1016/S0736-0266(03)00037-8; Lahiji A, 2000, J BIOMED MATER RES, V51, P586; Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345; Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Rudert M, 2002, CELLS TISSUES ORGANS, V171, P229, DOI 10.1159/000063125; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119; Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L; Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; [Anonymous], 2005, CLIN ORHTOP; Bos PK, 2006, ADV EXP MED BIOL, V585, P297; Bright P, 2014, J SPORT REHABIL, V23, P182, DOI 10.1123/JSR.2013-0045; Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362; Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413; Hickery MS, 2003, J BIOL CHEM, V278, P53063, DOI 10.1074/jbc.M209632200; Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7; Nakamura N, 2014, OPER TECH ORTHOP, V24, P54; Nakamura N, 2004, J BONE JOINT SURG AM, V86A, P2741; Nakamura T, 2012, CYTOTHERAPY, V14, P327, DOI 10.3109/14653249.2011.638912; Niemeyer P, 2014, INT ORTHOP, V38, P2065, DOI 10.1007/s00264-014-2368-0; O'Grady JE, 2003, ADV DRUG DELIVER REV, V55, P1699, DOI 10.1016/j.addr.2003.08.006; Provenzano PP, 2002, J ORTHOPAED RES, V20, P975, DOI 10.1016/S0736-0266(02)00036-0; QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343; Shimomura K, 2014, TISSUE ENG PART B-RE, V20, P468, DOI [10.1089/ten.TEB.2013.0543, 10.1089/ten.teb.2013.0543]; Tsumaki N, 2015, BONE, V70, P48, DOI 10.1016/j.bone.2014.07.011; Yamamoto T, 2004, OSTEOARTHR CARTILAGE, V12, P636, DOI 10.1016/j.joca.2004.04.007; Yanase M, 2000, BIOCHEM BIOPH RES CO, V277, P72, DOI 10.1006/bbrc.2000.3634	84	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1947-6035	1947-6043		CARTILAGE	Cartilage	APR	2015	6	2		S			13S	29S		10.1177/1947603515571002		17	Orthopedics	Orthopedics	CE5CF	WOS:000351847000002		
J	Yanatori, I; Yasui, Y; Noguchi, Y; Kishi, F				Yanatori, Izumi; Yasui, Yumiko; Noguchi, Yumiko; Kishi, Fumio			Inhibition of iron uptake by ferristatin II is exerted through internalization of DMT1 at the plasma membrane	CELL BIOLOGY INTERNATIONAL			English	Article						divalent metal transporter 1; ferristatin II; iron uptake	DIVALENT METAL TRANSPORTER-1; SMALL-MOLECULE INHIBITORS; TRANSFERRIN RECEPTOR; CELLS; HEPCIDIN; DYNAMIN; IDENTIFICATION; ACCUMULATION; FERROPORTIN; ENDOCYTOSIS	Ferristatin II, discovered as an iron transport inhibitor, promotes the internalization and degradation of transferrin receptor 1 (TfR1). DMT1, which mediates iron transport across cell membranes, is located at the plasma membrane of enterocytes and imports dietary iron into the cytosol. TfR1 is not directly engaged in the intestinal absorption of free iron, and iron uptake by DMT1 is attenuated by ferristatin II treatment. In this study, we found another function for ferristatin II in iron uptake. Ferristatin II did not cause degradation of DMT1 but did induce DMT1 internalization from the plasma membrane. Dynasore, a small molecule inhibitor of dynamin, did not inhibit this internalization by ferristatin II, which might occur via a clathrin-independent pathway.	[Yanatori, Izumi; Yasui, Yumiko; Noguchi, Yumiko; Kishi, Fumio] Kawasaki Med Univ, Dept Mol Genet, Kurashiki, Okayama 7010192, Japan	Kishi, F (reprint author), Kawasaki Med Univ, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fkishi-ygc@umin.ac.jp			Kawasaki Medical School	This work was supported in part by a Research Project Grants from Kawasaki Medical School.	Lane DJR, 2010, BIOCHEM J, V432, P123, DOI 10.1042/BJ20101317; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/192423399; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; THORSTENSEN K, 1990, BIOCHEM J, V271, P1; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Brown JX, 2004, CHEM BIOL, V11, P407, DOI 10.1016/j.chembiol.2004.02.016; Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, pG798, DOI 10.1152/ajpgi.90342.2008; Byrne SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070199; Byrne SL, 2013, FASEB J, V27, P1024; Graham RM, 1998, EUR J BIOCHEM, V253, P139, DOI 10.1046/j.1432-1327.1998.2530139.x; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Kishi F, 1997, MOL IMMUNOL, V34, P839, DOI 10.1016/S0161-5890(97)00110-7; Kishi F, 1998, BIOCHEM BIOPH RES CO, V251, P775, DOI 10.1006/bbrc.1998.9415; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355; Thomas C, 2003, AM J PHYSIOL-GASTR L, V285, pG789, DOI 10.1152/ajpgi.00509.2002; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YOSHIMORI T, 1988, CELL STRUCT FUNCT, V13, P311, DOI 10.1247/csf1975.13.311	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	APR	2015	39	4					427	434		10.1002/cbin.10403		8	Cell Biology	Cell Biology	CE2VK	WOS:000351678000009		
J	Aoyama, K; Yamaguchi, N; Yuki, R; Morii, M; Kubota, S; Hirata, K; Abe, K; Honda, T; Kuga, T; Hashimoto, Y; Tomonaga, T; Yamaguchi, N				Aoyama, Kazumasa; Yamaguchi, Noritaka; Yuki, Ryuzaburo; Morii, Mariko; Kubota, Sho; Hirata, Kensuke; Abe, Kohei; Honda, Takuya; Kuga, Takahisa; Hashimoto, Yuuki; Tomonaga, Takeshi; Yamaguchi, Naoto			c-Abl induces stabilization of histone deacetylase 1 (HDAC1) in a kinase activity-dependent manner	CELL BIOLOGY INTERNATIONAL			English	Article						c-Abl tyrosine kinase; histone deacetylase; protein stability	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; DNA-DAMAGE; NUCLEAR-LOCALIZATION; FAMILY KINASES; EXPRESSION; CANCER; PHOSPHORYLATION; SRC; CARCINOMA	c-Abl is a non-receptor-type tyrosine kinase that regulates various cellular events, including cell proliferation, differentiation, and apoptosis, through phosphorylation of cytoplasmic and nuclear targets. Although we showed that c-Abl induces histone deacetylation, the molecular mechanisms of this phenomenon are largely unknown. Here, we analyzed the effect of c-Abl on the expression of histone deacetylase 1 (HDAC1), because c-Abl was shown to be involved in maintenance of nuclear protein levels of HDAC1. Co-transfection of HDAC1 with c-Abl increased the levels of HDAC1 protein in a kinase activity-dependent manner without affecting its mRNA levels. Treatment with the proteasome inhibitor MG132 increased protein levels of HDAC1 in cells transfected with HDAC1 but not in cells co-transfected with HDAC1 and c-Abl. Among class I HDACs, knockdown of endogenous c-Abl preferentially suppressed endogenous protein levels of HDAC1, suggesting that c-Abl stabilizes HDAC1 protein by inhibiting its proteasomal degradation. Subcellular fractionation showed that the stabilization of HDAC1 by c-Abl occurred in the nucleus. Despite the fact that HDAC1 was phosphorylated by co-expression with c-Abl, stabilization of HDAC1 by c-Abl was not affected by mutations in its sites phosphorylated by c-Abl. Co-expression with HDAC1 and nuclear-targeted c-Abl did not affect HDAC1 stabilization. Therefore, these results suggest that c-Abl induces HDAC1 stabilization possibly through phosphorylation of a cytoplasmic target that is involved in proteasomal degradation of HDAC1.	[Aoyama, Kazumasa; Yamaguchi, Noritaka; Yuki, Ryuzaburo; Morii, Mariko; Kubota, Sho; Hirata, Kensuke; Abe, Kohei; Honda, Takuya; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan; [Kuga, Takahisa; Hashimoto, Yuuki; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Yamaguchi, N (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan.	yamaguchinoritaka@chiba-u.jp; nyama@faculty.chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25460356]; Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Program for Leading Graduate Schools (Leading Graduate School Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science and Technology	We are grateful to Dr. Eli Canaani (Weizmann Institute of Science, Rehovot), Dr. Hiroyuki Miyoshi (RIKEN BRC, Tsukuba), and Dr. Toshiki Tamura (National Institute of Infectious Diseases, Tokyo) for their invaluable plasmids and antibodies. We are also grateful to Mrs. Nozomi Fujiwara for her technical assistance and secretarial work. This work was supported in part by grants-in-aid for Scientific Research C (N. Y., 25460356), Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment), and Program for Leading Graduate Schools (Leading Graduate School Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. K.A. and S.K. were G-COE Research Assistants. M.M. and T.H. are Research Assistants of Program for Leading Graduate Schools. S.K. is a Research Fellow of Japan Society for the Promotion of Science.	Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Choi JH, 2001, JPN J CANCER RES, V92, P1300; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Yamaguchi N, 2012, GENES CELLS, V17, P971, DOI 10.1111/gtc.12012; Citro S, 2013, J MOL CELL BIOL, V5, P416, DOI 10.1093/jmcb/mjt032; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Kaidi A, 2013, NATURE, V498, P70, DOI 10.1038/nature12201; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-381; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Yamaguchi N, 2001, J CELL SCI, V114, P1631	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	APR	2015	39	4					446	456		10.1002/cbin.10413		11	Cell Biology	Cell Biology	CE2VK	WOS:000351678000011		
J	Fukuda, Y; Horie, N; Satoh, K; Yamaguchi, S; Morofuji, Y; Hiu, T; Izumo, T; Hayashi, K; Nishida, N; Nagata, I				Fukuda, Yuhtaka; Horie, Nobutaka; Satoh, Katsuya; Yamaguchi, Susumu; Morofuji, Youichi; Hiu, Takeshi; Izumo, Tsuyoshi; Hayashi, Kentaro; Nishida, Noriyuki; Nagata, Izumi			Intra-Arterial Transplantation of Low-Dose Stem Cells Provides Functional Recovery Without Adverse Effects After Stroke	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Intra-arterial transplantation; Mesenchymal stem cells; Stroke; Dose	MARROW MONONUCLEAR-CELLS; CEREBRAL-ISCHEMIA; STROMAL CELLS; BRAIN-INJURY; THERAPY; DELIVERY; MODEL; RATS; PLASTICITY; INJECTION	Cell transplantation therapy for cerebral infarction has emerged as a promising treatment to reduce brain damage and enhance functional recovery. We previously reported that intra-arterial delivery of bone marrow mesenchymal stem cells (MSCs) enables superselective cell administration to the infarct area and results in significant functional recovery after ischemic stroke in a rat model. However, to reduce the risk of embolism caused by the transplanted cells, an optimal cell number should be determined. At 24 h after middle cerebral artery occlusion and reperfusion, we administered human MSCs (low dose: 1 x 10(4) cells; high dose: 1 x 10(6) cells) and then assessed functional recovery, inflammatory responses, cell distribution, and mortality. Rats treated with high-or low-dose MSCs showed behavioral recovery. At day 8 post-stroke, microglial activation was suppressed significantly, and interleukin (IL)-1 beta and IL-12p70 were reduced in both groups. Although high-dose MSCs were more widely distributed in the cortex and striatum of rats, the degree of intravascular cell aggregation and mortality was significantly higher in the high-dose group. In conclusion, selective intra-arterial transplantation of low-dose MSCs has anti-inflammatory effects and reduces the adverse effects of embolic complication, resulting in sufficient functional recovery of the affected brain.	[Fukuda, Yuhtaka; Horie, Nobutaka; Yamaguchi, Susumu; Morofuji, Youichi; Hiu, Takeshi; Izumo, Tsuyoshi; Hayashi, Kentaro; Nagata, Izumi] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki 8528501, Japan; [Satoh, Katsuya; Nishida, Noriyuki] Nagasaki Univ, Sch Med, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan	Horie, N (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nobstanford@gmail.com			Y.F 25462223	This work was supported in part by a Grant-in-Aid for Scientific Research to Y.F (No. 25462223).	Amar AP, 2003, NEUROSURGERY, V52, P402, DOI 10.1227/01.NEU.0000043698.86548.A0; Chen JL, 2001, STROKE, V32, P1005; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; Janowski M, 2013, J CEREBR BLOOD F MET, V33, P921, DOI 10.1038/jcbfm.2013.32; Boutin H, 2001, J NEUROSCI, V21, P5528; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/aw1207; Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Yang B, 2013, STROKE, V44, P3463, DOI 10.1161/STROKEAHA.111.000821; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Misra V, 2012, NEUROLOGY, V79, pS207, DOI 10.1212/WNL.0b013e31826959d2; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Ishizaka S, 2013, STROKE, V44, P720, DOI 10.1161/STROKEAHA.112.677328; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Li Y, 2001, NEUROLOGY, V56, P1666; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Horie N, 2008, J NEUROSCI METH, V173, P286, DOI 10.1016/j.jneumeth.2008.06.013; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Byun JS, 2013, J KOREAN NEUROSURG S, V54, P467, DOI 10.3340/jkns.2013.54.6.467; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Guzman Raphael, 2008, Neurosurg Focus, V24, pE15, DOI 10.3171/FOC/2008/24/3-4/E14; McGuckin CP, 2013, ARCH BIOCHEM BIOPHYS, V534, P88, DOI 10.1016/j.abb.2013.02.005; MESSINA LM, 1992, P NATL ACAD SCI USA, V89, P12018, DOI 10.1073/pnas.89.24.12018; Mitkari B, 2014, BEHAV BRAIN RES, V259, P50, DOI 10.1016/j.bbr.2013.10.030; Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735	35	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2015	35	3					399	406		10.1007/s10571-014-0135-9		8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CD6YI	WOS:000351236400010		
J	Terayama, R; Tsuchiya, H; Omura, S; Maruhama, K; Mizutani, M; Iida, S; Sugimoto, T				Terayama, Ryuji; Tsuchiya, Hiroki; Omura, Shinji; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada			Possible Involvement of Convergent Nociceptive Input to Medullary Dorsal Horn Neurons in Intraoral Hyperalgesia Following Peripheral Nerve Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Trigeminal nerve; Orofacial pain; C-Fos; ERK; Medullary dorsal horn; Immunohistochemistry	SPINAL-CORD NEURONS; C-FOS EXPRESSION; GRACILE NUCLEUS; PAIN HYPERSENSITIVITY; PROTEIN-KINASE; SCIATIC-NERVE; RAT; STIMULATION; ORGANIZATION; ACTIVATION	Previous studies demonstrated that the number of c-Fos protein-like immunoreactive (c-Fos-IR) neurons in the medullary dorsal horn (MDH) evoked by noxious stimulation was increased after peripheral nerve injury, and such increase has been proposed to reflect the development of neuropathic pain state. The aim of this study was to examine the MDH for convergent collateral primary afferent input to second order neurons deafferented by peripheral nerve injury, and to explore a possibility of its contribution to the c-Fos hyperinducibility. Double immunofluorescence labeling for c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK) was performed to detect convergent synaptic input. c-Fos expression and the phosphorylation of ERK were induced by the intraoral application of capsaicin and by electrical stimulation of the inferior alveolar nerve (IAN), respectively. The number of c-Fos-IR neurons in the MDH induced by the intraoral application of capsaicin was increased after IAN injury, whereas the number of p-ERK immunoreactive neurons remained unchanged. The number of double-labeled neurons, that presumably received convergent primary afferent input from the lingual nerve and the IAN, was significantly increased after IAN injury. These results indicated that convergent primary nociceptive input through neighboring intact nerves may contribute to the c-Fos hyperinducibility in the MDH and the pathogenesis of neuropathic pain following trigeminal nerve injury.	[Terayama, Ryuji; Tsuchiya, Hiroki; Maruhama, Kotaro; Sugimoto, Tomosada] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Okayama 7008525, Japan; [Terayama, Ryuji; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada] Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Tsuchiya, Hiroki; Omura, Shinji] ASAHI Med Coll Okayama, Okayama 7000028, Japan; [Mizutani, Masahide; Iida, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008525, Japan	Terayama, R (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	ryujit@md.okayama-u.ac.jp			Japan Society for the Promotion of Science [24592764]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24592764).	Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Ji RR, 2002, J NEUROSCI, V22, P478; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57; DEVOR M, 1983, PAIN, V16, P73, DOI 10.1016/0304-3959(83)90087-8; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Woda A, 2003, J DENT RES, V82, P764; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Fujisawa N, 2012, EXP BRAIN RES, V219, P191, DOI 10.1007/s00221-012-3078-8; Hughes AS, 2008, NEUROSCIENCE, V153, P507, DOI 10.1016/j.neuroscience.2008.01.082; Liu Y, 2004, PAIN, V109, P64, DOI 10.1016/j.pain.2004.01.010; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; Shortland P, 1998, BRAIN RES, V810, P288, DOI 10.1016/S0006-8993(98)00940-8; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; Sugimoto T, 1998, BRAIN RES, V783, P158, DOI 10.1016/S0006-8993(97)01176-1; Sugimoto T, 1997, NEUROSCI RES, V28, P361, DOI 10.1016/S0168-0102(97)00064-3; SUGIMOTO T, 1993, BRAIN RES, V621, P161, DOI 10.1016/0006-8993(93)90314-D; TAKEMURA M, 1987, EXP NEUROL, V96, P540, DOI 10.1016/0014-4886(87)90217-2; Terayama R, 2014, ARCH ORAL BIOL, V59, P1334, DOI 10.1016/j.archoralbio.2014.08.008; Tokunaga A, 1999, BRAIN RES, V847, P321, DOI 10.1016/S0006-8993(99)02074-0	24	1	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2015	35	3					417	423		10.1007/s10571-014-0137-7		7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CD6YI	WOS:000351236400012		
J	Kitamura, E; Kanazawa, N; Hamada, J				Kitamura, Eiji; Kanazawa, Naomi; Hamada, Junichi			Hyperleptinemia increases the susceptibility of the cortex to generate cortical spreading depression	CEPHALALGIA			English	Article						Chronic migraine; cortical spreading depression; episodic migraine; leptin; Zucker fatty rat	LONG-TERM POTENTIATION; RAT CEREBRAL-CORTEX; LEPTIN RECEPTOR; FATTY RAT; MIGRAINE; EXPRESSION; MEMORY; BRAIN; AURA; IDENTIFICATION	Background Obesity is a risk factor for episodic migraine to develop into chronic migraine; hence, it is speculated that obesity and hyperleptinemia are associated with migraine. We hypothesized that leptin is involved in the mechanisms of cortical spreading depression (CSD). Therefore, we examined whether leptin affected a rat model of CSD to clarify the relationship between leptin and migraine. Methods We evaluated the effect of intracerebroventricular (ICV) administration of leptin on a rat CSD model. We then examined whether once-a-day intraperitoneal administration of leptin for seven days (as a chronic hyperleptinemia model) affected rat CSD models. Finally, we induced CSD in Zucker fatty (ZF) rats, which is a well-known model of obesity. Results In the parietal cortex, the percent change in cerebral blood flow and direct current (DC) potential decreased after ICV administration of leptin. A similar decrease in DC potential was observed in rats treated with intraperitoneal leptin. The number of CSDs increased significantly in rats given intraperitoneal leptin and in ZF rats. Conclusions The present study suggests that leptin is involved in the mechanisms of CSD.	[Kitamura, Eiji; Kanazawa, Naomi; Hamada, Junichi] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 2520374, Japan	Kitamura, E (reprint author), Kitasato Univ, Sch Med, Dept Neurol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	ekitamura@med.kitasato-u.ac.jp					Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Spanswick D, 1997, NATURE, V390, P521; Bigal ME, 2006, NEUROLOGY, V67, P252, DOI 10.1212/01.wnl.0000225052.35019.f9; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Lim G, 2009, J CLIN INVEST, V119, P295, DOI 10.1172/JCI36785; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Berger M, 2008, CEPHALALGIA, V28, P558, DOI 10.1111/j.1468-2982.2008.01556.x; Chua SC, 1996, DIABETES, V45, P1141, DOI 10.2337/diabetes.45.8.1141; Vezzani A, 2011, BIOMARK MED, V5, P607, DOI [10.2217/bmm.11.61, 10.2217/BMM.11.61]; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Jequier E, 2002, ANN NY ACAD SCI, V967, P379; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Loffreda S, 1998, FASEB J, V12, P57; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Supornsilpchai W, 2006, HEADACHE, V46, P34, DOI 10.1111/j.1526-4610.2006.00310.x; Bigel ME, 2006, NEUROLOGY, V66, P545; da Silva BA, 1998, ENDOCRINOLOGY, V139, P3681, DOI 10.1210/en.139.9.3681; Horev A, 2005, HEADACHE, V45, P936, DOI 10.1111/j.1526-4610.2005.05162.x; Hsuchou Hung, 2009, Peptides, V30, P2275, DOI 10.1016/j.peptides.2009.08.023; JOHNSON PR, 1971, J LIPID RES, V12, P706; Kitamura E, 2009, J CEREBR BLOOD F MET, V29, pS225; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; Oury F, 2011, TRENDS ENDOCRIN MET, V22, P382, DOI 10.1016/j.tem.2011.04.006; Ozer C, 2006, MOL CELL BIOCHEM, V282, P187, DOI 10.1007/s11010-006-1927-0; Peres MFP, 2005, ARQ NEURO-PSIQUIAT, V63, P931, DOI 10.1590/S0004-282X2005000600005; Peterlin B Lee, 2009, J Am Osteopath Assoc, V109, P314; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Yamashita T, 1997, DIABETES, V46, P1077, DOI 10.2337/diabetes.46.6.1077; Yonekura J, 2008, KITASATO MED J, V38, P77; Zhang JY, 2011, EUR J PHARMACOL, V671, P61, DOI 10.1016/j.ejphar.2011.09.170	40	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	APR	2015	35	4					327	334		10.1177/0333102414540813		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD6YZ	WOS:000351238400006		
J	Niu, J; Suzuki, S; Yi, XM; Akiyama, T				Niu, Jing; Suzuki, Shota; Yi, Xuemei; Akiyama, Tomohiro			Fabrication of AlN particles and whiskers via salt-assisted combustion synthesis	CERAMICS INTERNATIONAL			English	Article						Combustion synthesis; AlN; Salt-assisted; Microstructure	HIGH-TEMPERATURE SYNTHESIS; NITROGEN ATMOSPHERE 2; ALUMINUM NITRIDE; FINE POWDERS; BETA-SIALON; MECHANISMS; GROWTH; MOSI2; ROUTE	High-quality AN ceramic particles and whiskers were synthesized via salt-assisted combustion with the addition of AN and NaCl, KCl, or MgCl2 to the raw Al powders. The experiments were carried out at nitrogen pressures between 0.2 and 1.0 MPa. The results show that 20-30 mass% salt is required to achieve complete nitridation of Al. The sensible and latent heats of these salts afford effective heat absorption during the reaction, which greatly reduces the amount of diluent AN required compared with the conventional combustion synthesis of AN. In addition, AN particles are obtained when NaCl or KCl is added, whereas irregular whiskers are obtained with MgCl2. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Niu, Jing; Suzuki, Shota; Yi, Xuemei; Akiyama, Tomohiro] Hokkaido Univ, Ctr Adv Res Energy & Mat, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Akiyama, T (reprint author), Hokkaido Univ, Ctr Adv Res Energy & Mat, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	takiyama@eng.hokudai.ac.jp					Liu GH, 2008, CRYST GROWTH DES, V8, P2834, DOI 10.1021/cg701130k; Mussler BH, 2000, AM CERAM SOC BULL, V79, P45; Sakurai T, 2006, MAT SCI ENG A-STRUCT, V415, P40, DOI 10.1016/j.msea.2005.09.073; SLACK GA, 1987, J PHYS CHEM SOLIDS, V48, P641, DOI 10.1016/0022-3697(87)90153-3; Bradshaw SM, 1999, J AM CERAM SOC, V82, P2293; Shi ZQ, 2013, CERAM INT, V39, P4663, DOI 10.1016/j.ceramint.2012.10.235; SELVADURAY G, 1993, MATER SCI TECH SER, V9, P463; Merzhanov AG, 1996, J MATER PROCESS TECH, V56, P222, DOI 10.1016/0924-0136(95)01837-9; Camurlu HE, 2009, J EUR CERAM SOC, V29, P1501, DOI 10.1016/j.jeurceramsoc.2008.09.006; Shi ZQ, 2009, CERAM INT, V35, P2727, DOI 10.1016/j.ceramint.2009.03.013; Aoyagi K, 2007, J AM CERAM SOC, V90, P626, DOI 10.1111/j.1551-2916.2006.01387.x; Liu GH, 2013, INT J REFRACT MET H, V39, P90, DOI 10.1016/j.ijrmhm.2012.09.002; Haber JA, 1998, CHEM MATER, V10, P4062, DOI 10.1021/cm980481+; Jiang GJ, 1999, J MATER SYNTH PROCES, V7, P1, DOI 10.1023/A:1021864828552; Jiang GJ, 2001, J MATER SYNTH PROCES, V9, P49, DOI 10.1023/A:1011338732143; LEFORT P, 1993, J AM CERAM SOC, V76, P2295, DOI 10.1111/j.1151-2916.1993.tb07767.x; Li WK, 2006, J MATER SCI, V41, P2161, DOI 10.1007/s10853-006-5334-4; Manukyan KV, 2008, CHEM ENG J, V143, P331, DOI 10.1016/j.cej.2008.06.013; MUNIR ZA, 1987, J MATER SCI, V22, P710, DOI 10.1007/BF01160792; Nersisyan HH, 2008, J AM CERAM SOC, V91, P2802, DOI 10.1111/j.1551-2916.2008.02544.x; Niu J, 2014, J ALLOY COMPD, V604, P260, DOI 10.1016/j.jallcom.2014.03.145; Niu J, 2013, INTERMETALLICS, V35, P53, DOI 10.1016/j.intermet.2012.12.003; Niu J, 2014, CERAM INT, V40, P1815, DOI 10.1016/j.cerarnint.2013.07.082; Radwan M, 2007, J AM CERAM SOC, V90, P2347, DOI 10.1111/j.1551-2916.2007.01747.x; SHEPPARD LM, 1990, AM CERAM SOC BULL, V69, P1801; Shi ZQ, 2008, J CERAM SOC JPN, V116, P975, DOI 10.2109/jcersj2.116.975; Shi ZQ, 2009, J ALLOY COMPD, V476, P360, DOI 10.1016/j.jallcom.2008.08.057; Shin J, 2000, J AM CERAM SOC, V83, P1021; Wang HB, 2001, J EUR CERAM SOC, V21, P2193, DOI 10.1016/S0955-2219(00)00313-7	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				4438	4443		10.1016/j.ceramint.2014.11.135		6	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600022		
J	Kitiwan, M; Ito, A; Goto, T				Kitiwan, Mettaya; Ito, Akihiko; Goto, Takashi			Spark plasma sintering of TiN-TiB2-hBN composites and their properties	CERAMICS INTERNATIONAL			English	Article						Spark plasma sintering; Titanium nitride; Titanium diboride; Hexagonal boronnitride	BORON-NITRIDE COMPOSITES; MECHANICAL-PROPERTIES; THERMAL-CONDUCTIVITY; MACHINABLE CERAMICS; TITANIUM DIBORIDE; MICROSTRUCTURE; SYSTEM; PHASE; BN	TiN-TiB2-hBN composites (where hBN denotes hexagonal boron nitride) were prepared by spark plasma sintering at 1973 K for 300 s under 100 MPa. The hBN content was varied from 0 to 30% of the total volume of the composite, while maintaining a TiN:TiB2 ratio of 30:70 vol%. The effects of hBN content on the densification, microstructure, mechanical properties and thermal conductivities of the composites were investigated. Regardless of hBN content, TiN-TiB2-hBN composites showed high relative densities (96-97%). At the optimal hBN content (15 vol%), the composites also showed high hardness and fracture toughness (20.1 GPa and 4.3 MPa m(1/2), respectively), and their thermal conductivity increased from 58.1 to 63.4 W m(-1) K-1 as the temperature was increased from 293 to 973 K. In contrast, the thermal conductivity of most ceramics decreases with increasing temperature. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Kitiwan, Mettaya; Ito, Akihiko; Goto, Takashi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Ito, A (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	itonium@imr.tohoku.ac.jp	Ito, Akihiko/C-2848-2011	Ito, Akihiko/0000-0002-6116-1700	Ministry of Education, Science, Sports and Culture of Japan [25289223]	This research was supported in part by the Ministry of Education, Science, Sports and Culture of Japan, Grant-in-Aid for Scientific Research (B), 25289223.	ABREAL A, 1995, J EUR CERAM SOC, V15, P841, DOI 10.1016/0955-2219(95)00056-Z; Zhang GJ, 2004, J AM CERAM SOC, V87, P296, DOI 10.1111/j.1551-2916.2004.00296.x; Munro RG, 2000, J RES NATL INST STAN, V105, P709, DOI 10.6028/jres.105.057; Basu B, 2006, INT MATER REV, V51, P352, DOI 10.1179/174328006X102529; LUTZ EH, 1992, J AM CERAM SOC, V75, P67, DOI 10.1111/j.1151-2916.1992.tb05443.x; SIMPSON A, 1971, J PHYS PART C SOLID, V4, P1710, DOI 10.1088/0022-3719/4/13/021; Kusunose T, 2002, J AM CERAM SOC, V85, P2689; Barsoum MW, 2003, FUNDAMENTALS CERAMIC; Bellosi A, 2000, KEY ENG MAT, V175-1, P139; Cho WS, 2007, J EUR CERAM SOC, V27, P1425, DOI 10.1016/j.jeurceramsoc.2006.05.044; Cho WS, 2006, MAT SCI ENG A-STRUCT, V418, P61, DOI 10.1016/j.msea.2005.11.033; CHUPOV VD, 1981, INORG MATER+, V17, P1195; DUCLAUX L, 1992, PHYS REV B, V46, P3362, DOI 10.1103/PhysRevB.46.3362; GOEURIOTLAUNAY D, 1986, J MATER SCI LETT, V5, P940, DOI 10.1007/BF01729282; Kitiwan M, 2014, J EUR CERAM SOC, V34, P197, DOI 10.1016/j.jeurceramsoc.2013.08.034; Kitiwan M, 2012, KEY ENG MATER, V508, P52, DOI 10.4028/www.scientific.net/KEM.508.52; Li YL, 2008, MAT SCI ENG A-STRUCT, V483-84, P207, DOI 10.1016/j.msea.2006.09.158; Miyoshi T., 1985, T JPN SOC MECH ENG A, V51A, P2489; MORIYAMA M, 1995, J CERAM SOC JPN, V103, P844, DOI 10.2109/jcersj.103.844; Munz D., 1999, CERAMICS MECH PROPER; Rogl P, 1992, PHASE DIAGRAMS TERNA; RUH R, 1992, J AM CERAM SOC, V75, P864, DOI 10.1111/j.1151-2916.1992.tb04152.x; RUH R, 1984, J AM CERAM SOC, V67, pC83, DOI 10.1111/j.1151-2916.1984.tb19518.x; Shobu K., 1985, J POWDER METALL SOC, V32, P215; Sun Y, 2007, J MATER PROCESS TECH, V182, P134, DOI 10.1016/j.jmatprotec.2006.07.020	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				4498	4503		10.1016/j.ceramint.2014.11.144		6	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600030		
J	Estili, M; Echeberria, J; Vleugels, J; Vanmeensel, K; Bondarchuk, OB; Rodriguez, N; Larrimbe, L; Reyes-Rojas, A; Garcia-Reyes, A; Dominguez-Rios, C; Bocanegra-Bernal, MH; Aguilar-Elguezabal, A				Estili, Mehdi; Echeberria, J.; Vleugels, J.; Vanmeensel, K.; Bondarchuk, Oleksandr B.; Rodriguez, N.; Larrimbe, L.; Reyes-Rojas, A.; Garcia-Reyes, A.; Dominguez-Rios, C.; Bocanegra-Bernal, M. H.; Aguilar-Elguezabal, A.			Sintering in a graphite powder bed of alumina-toughened zirconia/carbon nanotube composites: a novel way to delay hydrothermal degradation	CERAMICS INTERNATIONAL			English	Article						Sintering; Composites; Al2O3; Biomedical applications	LOW-TEMPERATURE DEGRADATION; CARBON NANOTUBES; MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS; STABILIZED ZIRCONIA; BIOMEDICAL IMPLANTS; RESIDUAL-STRESSES; WATER-VAPOR; CERAMICS; GROWTH	Zirconia-based ceramics have been introduced in biomedical applications, for example, in hip implants. Certain zirconia composites are prone to spontaneously transform from the tetragonal phase to the monoclinic phase during long-term storage in the presence of moisture at low temperatures. This phenomenon is time-dependent and can be accelerated by water or water vapour. Herein, we report strong experimental evidence of a delayed t -> m ZrO2 phase transformation in alumina-toughened zirconia (ATZ) and ATZ/multi-walled carbon nanotube (MWCNT) composites when pressureless sintered in air in a graphite powder bed. The m-ZrO2 phase in ATZ and ATZ/MWCNT composites sintered in a graphite powder bed after hydrothermal ageing for 20 h at 134 degrees C decreased by 81% and 87%, respectively, compared to an ATZ sample sintered in an alumina powder bed. The enhanced hydrothermal stability could be attributed to the formation of a thin continuous alumina protective layer covering the surface of the ceramic composites. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Estili, Mehdi] Natl Inst Mat Sci, ICYS, Tsukuba, Ibaraki 3050047, Japan; [Echeberria, J.; Rodriguez, N.; Larrimbe, L.] Univ Navarra, CEIT, San Sebastian 20018, Spain; [Echeberria, J.; Rodriguez, N.; Larrimbe, L.] Univ Navarra, TECNUN, San Sebastian 20018, Spain; [Echeberria, J.; Vleugels, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium; [Bondarchuk, Oleksandr B.] CIC EnergiGUNE, Minano 01510, Alava, Spain; [Reyes-Rojas, A.; Dominguez-Rios, C.; Bocanegra-Bernal, M. H.; Aguilar-Elguezabal, A.] CIMAV SC, Ctr Invest Mat Avanzados, Lab Nacl Nanotecnol, Chihuahua 31109, Chihuahua, Mexico; [Garcia-Reyes, A.] Interceramic, Dept Invest & Desarrollo, Chihuahua 31060, Mexico	Bocanegra-Bernal, MH (reprint author), CIMAV SC, Ctr Invest Mat Avanzados, Lab Nacl Nanotecnol, Miguel Cervantes 120,Complejo Ind, Chihuahua 31109, Chihuahua, Mexico.	miguel.bocanegra@cimav.edu.mx					Aguilar-Elguezabal A, 2006, DIAM RELAT MATER, V15, P1329, DOI 10.1016/j.diamond.2005.10.011; Anne G, 2005, MATER SCI FORUM, V492-493, P641; Wang DN, 1998, J MATER SCI LETT, V17, P343, DOI 10.1023/A:1006506411285; COX JH, 1963, CAN J CHEM, V41, P671, DOI 10.1139/v63-095; Tang DX, 2012, CERAM INT, V38, P2429, DOI 10.1016/j.ceramint.2011.11.009; Douillard T, 2012, J EUR CERAM SOC, V32, P1529, DOI 10.1016/j.jeurceramsoc.2012.01.003; Pezzotti G, 2010, J ORTHOP RES, V28, P762, DOI 10.1002/jor.21069; Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020; Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016; Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b; Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250; Garmendia N, 2011, J EUR CERAM SOC, V31, P1009, DOI 10.1016/j.jeurceramsoc.2010.12.029; LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S; Estili M, 2010, ADV MATER, V22, P607, DOI 10.1002/adma.200902140; Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025; Estili M, 2012, ADV MATER, V24, P4322, DOI 10.1002/adma.201201134; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3; Benzaid R, 2008, BIOMATERIALS, V29, P3636, DOI 10.1016/j.biomaterials.2008.05.021; KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7; Toschi F, 2003, J AM CERAM SOC, V86, P1547; SATO T, 1985, J MATER SCI, V20, P3988, DOI 10.1007/BF00552389; Bocanegra-Bernal M.H., 2011, CARBON, V29, P1599; CHAIM R, 1992, J MATER SCI, V27, P5597, DOI 10.1007/BF00541629; CHEN SY, 1989, J MATER SCI, V24, P453, DOI 10.1007/BF01107426; Echeberria J., 2010, INT J REFRACT MET H, V23, P399; Folomeikin YI, 2006, RUSS J GEN CHEM+, V76, P1693, DOI 10.1134/S1070363206110023; Folomeikin YI, 2004, DOKL CHEM, V399, P257, DOI 10.1007/s10631-005-0007-4; Folomeikin YK, 2006, GLASS PHYS CHEM+, V32, P191, DOI 10.1134/S1087659606020118; Garmendia N., 2010, ENCY NANOSCIENCE NAN, P1; Guo RS, 2002, MATER LETT, V56, P1014, DOI 10.1016/S0167-577X(02)00666-3; Jang P, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-152; JOHNSONWALLS D, 1986, J AM CERAM SOC, V69, P44, DOI 10.1111/j.1151-2916.1986.tb04691.x; Luo TY, 2004, MAT SCI ENG A-STRUCT, V366, P206, DOI 10.1016/j.msea.2003.09.053; Nampi PP, 2011, B MATER SCI, V34, P799, DOI 10.1007/s12034-011-0197-y; Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035; Schneider J., 2008, GLOB ROADM CER ICC2; Seyyed-Hosseinzadeh H.R., 2012, RECENT ADV ARTHROPLA, P163; Sitnikov PA, 2004, RUSS J GEN CHEM+, V74, P989, DOI 10.1023/B:RUGC.0000045852.62299.10; Spear RL, 2008, INT J MATER FORM, V1, P127, DOI 10.1007/s12289-008-0374-8; Sturgeon RE, 2012, ANAL BIOANAL CHEM, V402, P429, DOI 10.1007/s00216-011-5509-y; Vythilingum V., 2012, THESIS U WITWATERSRA; Wu Y., 2013, THESIS U ILLINOIS UR	43	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				4569	4580		10.1016/j.ceramint.2014.11.155		12	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600040		
J	Okuni, T; Miyamoto, Y; Abe, H; Naito, M				Okuni, Tomoyuki; Miyamoto, Yoshinari; Abe, Hiroya; Naito, Makio			Spark plasma sintering of tungsten/graphite joints with a SiC ceramic interlayer	CERAMICS INTERNATIONAL			English	Article						Tungsten; Graphite; Silicon carbide; Joining; Spark plasma sintering	HIGH HEAT-FLUX; SPRAYED TUNGSTEN COATINGS; SILICON-CARBIDE; GRAPHITE; PHASE; MICROSTRUCTURE; COMPOSITE; ADDITIONS; BEHAVIOR; METALS	Tungsten powders were successfully sintered and simultaneously joined to a graphite disk using an interlayer of SiC ceramic powder, which contained Al2O3 and Y2O3 as sintering aids for the SiC. The tungsten/graphite joints were prepared at 30 MPa and temperatures ranging from 1700 degrees C to 2000 degrees C for 5 min using spark plasma sintering (SPS). The tensile strength of the joints prepared at 1700 degrees C reached 21 MPa. The suggested joining mechanism of the joints prepared below 1800 degrees C is as follows: both the sintered W metal layer and the SiC ceramic interlayer are chemically bonded together accompanying reaction phases of WC, W2C and W5Si3. A physical bond is achieved between the SiC interlayer and graphite when the SiC powder fills the open pores of the graphite and is sintered there. Although a similar joining mechanism is suggested when the joining temperature exceeds 1900 degrees C, the SiC interlayer disappears, and the broad reaction layer consisting of WC, W2C and trace W5Si3 is formed. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Okuni, Tomoyuki; Miyamoto, Yoshinari] Toyo Tanso Co Ltd, Adv Carbon Technol Ctr, Nishiyodogawa Ku, Osaka 5550011, Japan; [Abe, Hiroya; Naito, Makio] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Miyamoto, Y (reprint author), Toyo Tanso Co Ltd, Adv Carbon Technol Ctr, Nishiyodogawa Ku, 5-7-12 Takeshima, Osaka 5550011, Japan.	y_miyamoto@toyotanso.co.jp					Zhang Y, 2009, FUSION ENG DES, V84, P15, DOI 10.1016/j.fusengdes.2008.07.033; SUGANUMA K, 1990, ISIJ INT, V30, P1046, DOI 10.2355/isijinternational.30.1046; KIM DH, 1990, J AM CERAM SOC, V73, P1431, DOI 10.1111/j.1151-2916.1990.tb05219.x; BROSSA F, 1992, J NUCL MATER, V191, P469; Chen WW, 2012, J NUCL MATER, V420, P136, DOI 10.1016/j.jnucmat.2011.09.022; Cho GS, 2012, SURF COAT TECH, V209, P131, DOI 10.1016/j.surfcoat.2012.08.051; Gomez E, 2004, J EUR CERAM SOC, V24, P2895, DOI 10.1016/j.jeurceramsoc.2003.09.002; Liu X, 2004, FUSION ENG DES, V70, P341, DOI 10.1016/j.fusengdes.2004.06.002; Liu X, 2004, J NUCL MATER, V329, P687, DOI 10.1016/j.jnucmat.2004.04.217; Maier H, 2001, SURF COAT TECH, V142, P733, DOI 10.1016/S0257-8972(01)01177-X; She JH, 1999, MATER RES BULL, V34, P1629, DOI 10.1016/S0025-5408(99)00172-5; Tokunaga K, 1999, J NUCL MATER, V266, P1224, DOI 10.1016/S0022-3115(98)00689-8; Tokunaga K, 2000, J NUCL MATER, V283, P1121, DOI 10.1016/S0022-3115(00)00384-6	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				4651	4655		10.1016/j.ceramint.2014.12.010		5	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600049		
J	Li, WJ; Ji, SD; Qian, K; Jin, P				Li, Wenjing; Ji, Shidong; Qian, Kun; Jin, Ping			Preparation and characterization of VO2-BaSO4 composite films with enhanced optical properties in thermochromic field	CERAMICS INTERNATIONAL			English	Article						Vanadium dioxide; Hydrothermal treatment; VO2-BaSO4 composite film; Thermochromic properties	VO2 NANOPARTICLES; LUMINOUS TRANSMITTANCE; THIN-FILMS; VISIBLE TRANSMITTANCE; INSULATOR-TRANSITION; VANADIUM DIOXIDE; PHASE-TRANSITION; MULTILAYER FILMS; THERMOLYSIS; PERFORMANCE	The application of VO2 for smart windows relies on the enhancement in both luminous transmittance (T-lum) and solar modulating ability (Delta T-sol). Achieving a sufficiently high T-lum with satisfactory Delta T-sol remains to be a challenge. In this article, VO2-BaSO4 composites were prepared by a one-step hydrothermal process and the coated films using these powders showed increased T-lum (from 30.4% to 43.5%) and Delta T-sol (from 11.2% to 12.4%). The optimized optical properties could match with those of the five-layered TiO2/VO2/TiO2/VO2/TiO2 films (T-lum,T-h=45%, T-lum,T-h=42% and Delta T-sol = 12%, from Phys. Status Solidi A 2009, 206, 2155-2160). The BaSO4 could also reduce the degradation of the optical performance for the W-doped VO2 composite film. After doping 1.0 at% W, the Delta T-sol value of the pure VO2 film deteriorated to 4.9% with T-lum,T-h=28.2%, while the VO2 BaSO4 composite film could retain a relatively high Delta T-sol of 6.5% and an obviously increased T-lum of 47.4%. The BaSO4 nanoparticles could improve the T-lum, and Delta T-sol of the VO2 films simultaneously. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Li, Wenjing; Ji, Shidong; Qian, Kun; Jin, Ping] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Li, Wenjing; Qian, Kun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Jin, Ping] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Ji, SD (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.	sdki@mail.sic.ac.cn; p-jin@mail.sic.ac.cn			high-tech project of MOST [2012AA030305]; national sci-tech support plan of the National Natural Science Foundation of China (NSFC) [51272273, 51172265, 51372264]; Science and Technology Commission of Shanghai Municipality (STCSM) [13PJ1409000, 13NM1402200]	This study was financially supported by the high-tech project of MOST (2012AA030305), the national sci-tech support plan of the National Natural Science Foundation of China (NSFC, Nos. 51272273, 51172265 and 51372264), and the Science and Technology Commission of Shanghai Municipality (STCSM, Nos. 13PJ1409000 and 13NM1402200)	Peng ZF, 2007, J PHYS CHEM C, V111, P1119, DOI 10.1021/jp066342u; Zhou JD, 2013, PHYS CHEM CHEM PHYS, V15, P7505, DOI 10.1039/c3cp50638j; Li XY, 2014, ACTA MATER, V80, P16, DOI 10.1016/j.actamat.2014.07.031; Jiang M, 2014, CERAM INT, V40, P6331, DOI 10.1016/j.ceramint.2013.10.083; Gao YF, 2012, ENERG ENVIRON SCI, V5, P8234, DOI 10.1039/c2ee21119j; Mlyuka NR, 2009, PHYS STATUS SOLIDI A, V206, P2155, DOI 10.1002/pssa.200881798; Lv WZ, 2014, CERAM INT, V40, P12661, DOI 10.1016/j.ceramint.2014.04.113; Cao X, 2014, LANGMUIR, V30, P1710, DOI 10.1021/la404666n; Li WJ, 2014, RSC ADV, V4, P13026, DOI 10.1039/c3ra47666a; Zhou M, 2013, CHEM COMMUN, V49, P6021, DOI 10.1039/c3cc42112k; Hou JW, 2013, J NANOSCI NANOTECHNO, V13, P1543, DOI 10.1166/jnn.2013.5988; Kang LT, 2011, ACS APPL MATER INTER, V3, P135, DOI 10.1021/am1011172; Chen Z, 2011, SOL ENERG MAT SOL C, V95, P2677, DOI 10.1016/j.solmat.2011.05.041; Ji SD, 2011, SOL ENERG MAT SOL C, V95, P3520, DOI 10.1016/j.solmat.2011.08.015; Shen N, 2014, J MATER CHEM A, V2, P15087, DOI 10.1039/c4ta02880e; Mlyuka NR, 2009, SOL ENERG MAT SOL C, V93, P1685, DOI 10.1016/j.solmat.2009.03.021; Du J, 2011, SOL ENERG MAT SOL C, V95, P1604, DOI 10.1016/j.solmat.2011.01.009; Du J, 2013, SOL ENERG MAT SOL C, V110, P1, DOI 10.1016/j.solmat.2012.11.011; Huang AB, 2013, J MATER CHEM A, V1, P12545, DOI 10.1039/c3ta12232h; Khalaj G, 2013, SURF COAT TECH, V225, P1, DOI 10.1016/j.surfcoat.2013.02.030; KhalaJ G, 2014, CERAM INT, V40, P5515, DOI 10.1016/j.ceramint.2013.10.141; Li SJ, 2010, MATER SCI TECHNOL, P1; Li YM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01370; Woodley SM, 2008, CHEM PHYS LETT, V453, P167, DOI 10.1016/j.cplett.2008.01.018	24	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				5049	5056		10.1016/j.ceramint.2014.12.073		8	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600103		
J	Lee, SH; Feng, L; Yin, J; Lee, JS; Zhu, X; Suzuki, TS; Sakka, Y; Tanaka, H				Lee, S. H.; Feng, L.; Yin, J.; Lee, J. S.; Zhu, X.; Suzuki, T. S.; Sakka, Y.; Tanaka, H.			Dense SiC containing strongly aligned plate-like grains by magnetic treatment	CERAMICS INTERNATIONAL			English	Article						Sintering; Microstructure-final; Mechanical properties; SiC; Magnetic treatment	SILICON-CARBIDE; THERMAL-STABILITY; AL3BC3; FIELD; ADDITIONS; AL2O3; ALN	Dense SiC having strongly aligned plate-like grains was prepared by slip casting under strong magnetic field and subsequent densification using Al3BC3 additive. Irregular-shaped 6H-SiC powders in the green body were strongly aligned by the magnetic treatment. Subsequently, Al3BC3 additive induced the formation of aligned plate-like SiC grains during densification. The hardness of SiC could be tailored up to 11% by the strong alignment of the grains. Crack deflection was also strongly affected by the direction of the aligned plate-like grains. As a result, the length of the cracks which propagated parallel to the elongated grains was 18.6% shorter compared to that formed perpendicular to the grains. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Lee, S. H.; Lee, J. S.; Zhu, X.; Suzuki, T. S.; Sakka, Y.; Tanaka, H.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Lee, S. H.; Feng, L.; Yin, J.] Korea Inst Mat Sci, Chang Won 641831, Gyeongnam, South Korea; [Lee, J. S.] Korea Inst Energy Res, Taejon 305343, South Korea	Lee, SH (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	seahoon1@kims.re.kr					Lee SH, 2010, J EUR CERAM SOC, V30, P1015, DOI 10.1016/j.jeurceramsoc.2009.09.027; Zhu XW, 2010, ACTA MATER, V58, P146, DOI 10.1016/j.actamat.2009.08.064; Suzuki TS, 2010, J EUR CERAM SOC, V30, P2813, DOI 10.1016/j.jeurceramsoc.2010.04.022; Cao JJ, 1996, J AM CERAM SOC, V79, P461, DOI 10.1111/j.1151-2916.1996.tb08145.x; ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x; FABER KT, 1983, ACTA METALL MATER, V31, P577, DOI 10.1016/0001-6160(83)90047-0; Hilmas GE, 1999, J MATER SCI, V34, P5613, DOI 10.1023/A:1004745419321; HIRAI T, 1979, J MATER SCI, V14, P2253, DOI 10.1007/BF00688433; KUO SY, 1987, J AM CERAM SOC, V70, pC125; Lee SH, 2009, J AM CERAM SOC, V92, P2831, DOI 10.1111/j.1551-2916.2009.03292.x; Lee SH, 2009, J AM CERAM SOC, V92, P2172, DOI 10.1111/j.1551-2916.2009.03171.x; Lee SH, 2011, J AM CERAM SOC, V94, P2746, DOI 10.1111/j.1551-2916.2011.04688.x; Lee SH, 2009, J AM CERAM SOC, V92, P2888, DOI 10.1111/j.1551-2916.2009.03336.x; Liang HQ, 2014, J EUR CERAM SOC, V34, P831, DOI 10.1016/j.jeurceramsoc.2013.09.015; NADEAU JS, 1973, AM CERAM SOC BULL, V52, P170; Reed J., 1995, PRINCIPLES CERAMIC P; Roh MH, 2010, MET MATER INT, V16, P891, DOI 10.1007/s12540-010-1206-1; Solozhenko VL, 2006, SOLID STATE COMMUN, V137, P533, DOI 10.1016/j.ssc.2006.01.015; Suzuki TS, 2011, J CERAM SOC JPN, V119, P667, DOI 10.2109/jcersj2.119.667; Suzuki TS, 2007, MATER TRANS, V48, P2883, DOI 10.2320/matertrans.MI200716; Tana H., 1982, J AM CERAM SOC, V65, pC27; Testing Method for Hardness of Fine Ceramics, 2003, R1610 JIS JAP STAND; Zhu X., 2008, SCI TECHNOL ADV MAT, V9, P1	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	B				5079	5084		10.1016/j.ceramint.2014.12.078		6	Materials Science, Ceramics	Materials Science	CC2MZ	WOS:000350180600107		
J	Wu, CF; Shimaoka, T; Nakayama, H; Komiya, T				Wu, Chuanfu; Shimaoka, Takayuki; Nakayama, Hirofumi; Komiya, Teppei			Kinetics of nitrous oxide production by denitrification in municipal solid waste	CHEMOSPHERE			English	Article						Municipal solid waste; Denitrification; N2O production; Different substrate concentrations; Transient condition	DENITRIFYING COMMUNITIES; N2O PRODUCTION; SOIL-MOISTURE; EMISSION; REDUCTION; NITRIFICATION; TEMPERATURE; INHIBITION; LANDFILLS; QUALITY	As one of the Nitrous Oxide (N2O) production pathways, denitrification plays an important role in regulating the emission of N2O into the atmosphere. In this study, the influences of different substrate concentrations and transient conditions on the denitrification rate and N2O-reducing activities were investigated. Results revealed that N2O production rates (i.e. denitrification rates) were stimulated by increased total organic carbon (TOC) concentration, while it was restrained under high oxygen concentrations. Moreover, the impact of nitrate concentrations on N2O production rates depended on the TOC/NO3--N ratios. All the N2O production rate data fitted well to a multiplicative Monod equation, with terms describing the influence of TOC and nitrate concentrations, and an Arrhenius-type equation. Furthermore, results demonstrated that high temperatures minimized the N2O-reducing activities in aged municipal solid waste, resulting in an accumulation of N2O. On the other hand, a transient condition caused by changing O-2 concentrations may strongly influence the N2O production rates and N2O-reducing activities in solid waste. Finally, based on the results, we believe that a landfill aeration strategy properly designed to prevent rising temperatures and to cycle air injection is the key to reducing emissions of N2O during remediation of old landfills by means of in situ aeration. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Chuanfu] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, Beijing 100083, Peoples R China; [Wu, Chuanfu] Kyushu Univ, Grad Sch Engn, Fukuoka 812, Japan; [Shimaoka, Takayuki; Nakayama, Hirofumi; Komiya, Teppei] Kyushu Univ, Fac Engn, Dept Urban & Environm Engn, Nishi Ku, Fukuoka 8190395, Japan	Wu, CF (reprint author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	wucf@ustb.edu.cn					Alinsafi A, 2008, PROCESS BIOCHEM, V43, P683, DOI 10.1016/j.procbio.2008.02.008; Ritzkowski M, 2006, WASTE MANAGE, V26, P356, DOI 10.1016/j.wasman.2005.11.009; YOSHINARI T, 1977, SOIL BIOL BIOCHEM, V9, P177, DOI 10.1016/0038-0717(77)90072-4; Holtan-Hartwig L, 2002, SOIL BIOL BIOCHEM, V34, P1797, DOI 10.1016/S0038-0717(02)00169-4; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Yanai Y, 2007, BIOL FERT SOILS, V44, P113, DOI 10.1007/s00374-007-0185-y; DUXBURY JM, 1982, NATURE, V298, P462, DOI 10.1038/298462a0; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Ruser R, 2006, SOIL BIOL BIOCHEM, V38, P263, DOI 10.1016/j.soilbio.2005.05.005; Holtan-Hartwig L, 2000, SOIL BIOL BIOCHEM, V32, P833, DOI 10.1016/S0038-0717(99)00213-8; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Oncu G, 2012, WASTE MANAGE, V32, P2374, DOI 10.1016/j.wasman.2012.07.005; Khalil K, 2004, SOIL BIOL BIOCHEM, V36, P687, DOI 10.1016/j.soilbio.2004.01.004; Meima JA, 2008, WASTE MANAGE, V28, P904, DOI 10.1016/j.wasman.2007.02.032; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003; Sole-Mauri F, 2007, BIORESOURCE TECHNOL, V98, P3278, DOI 10.1016/j.biortech.2006.07.012; Zhong JC, 2010, J ENVIRON SCI-CHINA, V22, P961, DOI 10.1016/S1001-0742(09)60205-9; ESENER AA, 1981, BIOTECHNOL BIOENG, V23, P1401, DOI 10.1002/bit.260230620; He PJ, 2011, J ENVIRON SCI-CHINA, V23, P1011, DOI 10.1016/S1001-0742(10)60574-8; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Powell J, 2006, ENVIRON SCI TECHNOL, V40, P1029, DOI 10.1021/es051114j; SAUCEDOCASTANEDA G, 1990, BIOTECHNOL BIOENG, V35, P802, DOI 10.1002/bit.260350808; Wu C., 2013, WASTE MANAGE, V34, P101; Yanai Y, 2008, GEODERMA, V146, P269, DOI 10.1016/j.geoderma.2008.06.008	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	APR	2015	125						64	69		10.1016/j.chemosphere.2015.01.025		6	Environmental Sciences	Environmental Sciences & Ecology	CE2LJ	WOS:000351646800009		
J	Yamada, SM; Tomita, Y; Murakami, H; Nakane, M				Yamada, Shoko M.; Tomita, Yusuke; Murakami, Hideki; Nakane, Makoto			Delayed post-traumatic large subgaleal hematoma caused by diastasis of rhomboid skull suture on the transverse sinus	CHILDS NERVOUS SYSTEM			English	Article						Dural sinus; Epidural hematoma; Skull fracture; Subgaleal hematoma; Trauma	EXTRADURAL HEMATOMA	This study aimed to consider an appropriate treatment for large subgaleal hematoma with skull fracture and epidural hematoma (EDH). A 6-year-old boy presented at our hospital with head trauma, and computed tomography (CT) showed a thin EDH in the right temporo-occipital area and cranial diastasis in the right lambdoidal suture. However, no neurological deficits were identified in the patient. One week after trauma, he visited our hospital again with a massive fluctuant watery mass extending from the forehead to the right temporoparietal areas, and laboratory data revealed that he was anemic. CT showed a massive subgaleal hematoma with extremely high density around the cranial diastasis. Damage of the transverse sinus was suspected, and emergent sinus repair surgery was performed. The surgery disclosed that bleeding from the transverse sinus was flowing out extracranially through the cranial diastasis. The subgaleal and epidural hematomas were removed, and bleeding from the sinus was stopped by dural tacking sutures along the transverse sinus. Postoperative CT demonstrated complete disappearance of epidural and subgaleal hematomas. The patient recovered from general fatigue without blood transfusion and was discharged 9 days after surgery. The therapeutic strategy for massive subgaleal hematoma is individualized. However, treatment for massive subgaleal hematoma with skull fracture should not be considered the same as for hematoma without skull fracture. Emergent surgery is recommended before neurological deterioration is recognized in the patient if damage to the dural sinus is suspected.	[Yamada, Shoko M.; Tomita, Yusuke; Murakami, Hideki; Nakane, Makoto] Teikyo Univ, Mizonokuchi Hosp, Dept Neurosurg, Takatsu Ku, Kawasaki, Kanagawa 2138507, Japan	Yamada, SM (reprint author), Teikyo Univ, Mizonokuchi Hosp, Dept Neurosurg, Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	merrityamada@hotmail.co.jp					ADELOYE A, 1975, INT SURG, V60, P263; Yilmazlar S, 2005, ACTA NEUROCHIR, V147, P1241, DOI 10.1007/s00701-005-0623-2; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; CHEE CP, 1991, NEURORADIOLOGY, V33, P152; Khwaja HA, 2001, EMERG MED J, V18, P496, DOI 10.1136/emj.18.6.496; Kichari JR, 2013, EMERG MED J, V30, P344, DOI 10.1136/emermed-2012-201729; MEIER U, 1992, ACTA NEUROCHIR, V119, P91, DOI 10.1007/BF01541788; POMERANZ AJ, 1995, ANN EMERG MED, V26, P752, DOI 10.1016/S0196-0644(95)70051-X; POPEPEGRAM LD, 1986, SURV OPHTHALMOL, V30, P258, DOI 10.1016/0039-6257(86)90122-0; Sillero RD, 2008, J TRAUMA, V65, P963, DOI 10.1097/TA.0b013e31809ff3ce	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2015	31	4					621	624		10.1007/s00381-014-2531-3		4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CD7VY	WOS:000351304300019		
J	Minobe, S; Takebayashi, S				Minobe, Shoshiro; Takebayashi, Shogo			Diurnal precipitation and high cloud frequency variability over the Gulf Stream and over the Kuroshio	CLIMATE DYNAMICS			English	Article						Climate process; Air-sea interaction; Western boundary currents; Mid-latitude; Scale-interaction; Observational data analysis	OCEAN-ATMOSPHERE INTERACTION; SEA-SURFACE TEMPERATURE; EAST CHINA SEA; STORM-TRACKS; SATELLITE-OBSERVATIONS; CUMULUS CONVECTION; SUMMER MONSOON; HEAT EXCHANGES; NORTH PACIFIC; IN-SITU	Recent studies show mid-latitude western boundary currents (WBCs) substantially influence the atmosphere aloft, and an important feature is enhanced rain band over the WBCs in climatological mean field. However, how such long-term, climate phenomena are related to shorter, weather timescale phenomena are generally remained to be explored. In this paper, diurnal precipitation and cloud variations are investigated global mid-latitude oceans with emphasis on air-sea interactions over WBCs using satellite-derived precipitation and outgoing longwave radiation (OLR) datasets. Strong 24-h period components of precipitations are found over the Gulf Stream in summer and over the Kuroshio in the East China Sea in early summer (Baiu-Meiyu season), respectively. Similar diurnal precipitations are not observed in WBCs in the Southern Hemisphere year around. The diurnal precipitation cycles over the Gulf Stream and the Kuroshio exhibit peak phases in the early to late morning for the Gulf Stream and late morning to early afternoon for the Kuroshio, with southeastward phase propagations. High cloud frequency derived from OLR data exhibit consistent diurnal cycles. A substantial difference of diurnal cycles between the Gulf Stream and the Kuroshio regions are associated with the large-scale Baiu-Meiyu rain and cloud bands for the latter region. Diurnal precipitation and high cloud variability is found in the vicinity of the Kuroshio itself, embedded in the Baiu-Meiyu rain and cloud bands distributing in a wider area without a strong diurnal component. The spatial and seasonal distributions of the diurnal variability over these WBCs strongly suggests that the diurnal precipitation and cloud cycles are essential aspects of deep heating mode of atmospheric response recently reported for these WBCs. These results indicate that these WBCs in the Northern Hemisphere play an important role in modulating short-term precipitation variations, and on the other hand diurnal variability can be a substantial agent for the mid-latitude air-sea interaction.	[Minobe, Shoshiro; Takebayashi, Shogo] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Minobe, S (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Kita Ku, Room 319,Rigaku Bldg 8,N10,W8, Sapporo, Hokkaido 0600810, Japan.	minobe@sci.hokudai.ac.jp			Japan Society for the Promotion of Science [22106008, 22244057]	Many thanks for Dr. C. O'Reilly for comments on the English and also on the science, and for two anonymous reviewers for their helpful and constructive comments. This work was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research 22106008 and 22244057).	ALLISS RJ, 1995, J APPL METEOROL, V34, P1578, DOI 10.1175/1520-0450(1995)034<1578:DVICFO>2.0.CO;2; Ushio T, 2009, J METEOROL SOC JPN, V87A, P137, DOI 10.2151/jmsj.87A.137; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Minobe S, 2010, J CLIMATE, V23, P3699, DOI 10.1175/2010JCLI3359.1; Zuidema P, 2003, MON WEATHER REV, V131, P780, DOI 10.1175/1520-0493(2003)131<0780:CCOTBO>2.0.CO;2; WALLACE JM, 1975, MON WEATHER REV, V103, P406, DOI 10.1175/1520-0493(1975)103<0406:DVIPAT>2.0.CO;2; NINOMIYA K, 1992, J METEOROL SOC JPN, V70, P467; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Dirmeyer PA, 2012, CLIM DYNAM, V39, P399, DOI 10.1007/s00382-011-1127-9; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rudeva I, 2011, MON WEATHER REV, V139, P1419, DOI 10.1175/2010MWR3294.1; Yang S, 2006, J CLIMATE, V19, P5190, DOI 10.1175/JCLI3883.1; Rickenbach T, 2008, MON WEATHER REV, V136, P3917, DOI 10.1175/2008MWR2441.1; Kikuchi K, 2008, J CLIMATE, V21, P2680, DOI 10.1175/2007JCLI2051.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Brayshaw DJ, 2008, J ATMOS SCI, V65, P2842, DOI 10.1175/2008JAS2657.1; HOSKINS BJ, 1990, J ATMOS SCI, V47, P1854, DOI 10.1175/1520-0469(1990)047<1854:OTEOST>2.0.CO;2; Nakamura H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034010; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Xu HM, 2011, J CLIMATE, V24, P4959, DOI 10.1175/JCLI-D-10-05034.1; Chelton DB, 2010, OCEANOGRAPHY, V23, P52; Alexander MA, 1997, J CLIMATE, V10, P2963, DOI 10.1175/1520-0442(1997)010<2963:SFVOTN>2.0.CO;2; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Dai A, 2007, CLIM DYNAM, V29, P727, DOI 10.1007/s00382-007-0260-y; Booth JF, 2010, J CLIMATE, V23, P1160, DOI 10.1175/2009JCLI3064.1; KUO YH, 1991, MON WEATHER REV, V119, P368, DOI 10.1175/1520-0493(1991)119<0368:TIBBAD>2.0.CO;2; Joyce TM, 2009, J CLIMATE, V22, P3177, DOI 10.1175/2008JCLI2690.1; JANOWIAK JE, 1994, MON WEATHER REV, V122, P2296, DOI 10.1175/1520-0493(1994)122<2296:AEOTDC>2.0.CO;2; Tao WK, 1996, J ATMOS SCI, V53, P2624, DOI 10.1175/1520-0469(1996)053<2624:MOCRII>2.0.CO;2; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Nesbitt SW, 2003, J CLIMATE, V16, P1456, DOI 10.1175/1520-0442-16.10.1456; Brayshaw DJ, 2011, J ATMOS SCI, V68, P1784, DOI 10.1175/2011JAS3674.1; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Nonaka M, 2009, J CLIMATE, V22, P6515, DOI 10.1175/2009JCLI2960.1; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Kuwano-Yoshida A, 2010, J CLIMATE, V23, P3676, DOI 10.1175/2010JCLI3261.1; Mapes BE, 2003, MON WEATHER REV, V131, P830, DOI 10.1175/1520-0493(2003)131<0830:DPORIN>2.0.CO;2; Sampe T, 2010, J CLIMATE, V23, P113, DOI 10.1175/2009JCLI3128.1; Booth JF, 2012, MON WEATHER REV, V140, P1241, DOI 10.1175/MWR-D-11-00195.1; GRAY WM, 1977, MON WEATHER REV, V105, P1171, DOI 10.1175/1520-0493(1977)105<1171:DVODCC>2.0.CO;2; Yang GY, 2001, MON WEATHER REV, V129, P784, DOI 10.1175/1520-0493(2001)129<0784:TDCITT>2.0.CO;2; Sasaki YN, 2012, J CLIMATE, V25, P6627, DOI 10.1175/JCLI-D-11-00727.1; Liu WT, 2007, J CLIMATE, V20, P5784, DOI 10.1175/2007JCLI1732.1; Hoskins BJ, 2002, J ATMOS SCI, V59, P1041, DOI 10.1175/1520-0469(2002)059<1041:NPOTNH>2.0.CO;2; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Czaja A, 2011, Q J ROY METEOR SOC, V137, P1095, DOI 10.1002/qj.814; RANDALL DA, 1991, J ATMOS SCI, V48, P40, DOI 10.1175/1520-0469(1991)048<0040:DVOTHC>2.0.CO;2; OKI T, 1994, J APPL METEOROL, V33, P1445, DOI 10.1175/1520-0450(1994)033<1445:SCOTDC>2.0.CO;2; Sui CH, 1997, J ATMOS SCI, V54, P639, DOI 10.1175/1520-0469(1997)054<0639:DVITOC>2.0.CO;2; Nakamura H, 2012, J CLIMATE, V25, P7772, DOI 10.1175/JCLI-D-12-00326.1; HOSKINS BJ, 1985, Q J ROY METEOR SOC, V111, P877, DOI 10.1256/smsqj.47001; Sampe T, 2007, B AM METEOROL SOC, V88, P1965, DOI 10.1175/BAMS-88-12-1965; Hayasaki M, 2013, GEOPHYS RES LETT, V40, P2851, DOI 10.1002/grl.50546; Inatsu M, 2004, J CLIMATE, V17, P4882, DOI 10.1175/JCLI-3232.1; Inatsu M, 2003, J CLIMATE, V16, P3314, DOI 10.1175/1520-0442(2003)016<3314:ARTZVI>2.0.CO;2; KRAUS EB, 1963, J ATMOS SCI, V20, P551, DOI 10.1175/1520-0469(1963)020<0551:TDPCOT>2.0.CO;2; Kubota M, 2007, FLUX NEWS; Shaman J, 2010, J CLIMATE, V23, P2651, DOI 10.1175/2010JCLI3269.1; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625; Stackhouse PW, 2004, GEWEX NEWS, V14, P10; Zolina O, 2003, J CLIMATE, V16, P2717, DOI 10.1175/1520-0442(2003)016<2717:SVOOTF>2.0.CO;2	64	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	APR	2015	44	7-8					2079	2095		10.1007/s00382-014-2245-y		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD9YS	WOS:000351458300022		
J	Lambert, FH; Webb, MJ; Yoshimori, M; Yokohata, T				Lambert, F. Hugo; Webb, Mark J.; Yoshimori, Masakazu; Yokohata, Tokuta			The cloud radiative effect on the atmospheric energy budget and global mean precipitation	CLIMATE DYNAMICS			English	Article							GENERAL-CIRCULATION MODELS; HYDROLOGICAL CYCLE; CLIMATE FEEDBACKS; TROPOSPHERIC ADJUSTMENT; CONSTRAINTS; SENSITIVITY; ENSEMBLES; RESPONSES; LAYER	This study seeks to explain the effects of cloud on changes in atmospheric radiative absorption that largely balance changes in global mean precipitation under climate change. The partial radiative perturbations (PRPs) due to changes in cloud and due to the effects of the pre-existing climatological cloud distribution on non-cloud changes, known as "cloud masking'', are calculated when atmospheric CO2 concentration is doubled for the HadSM3 and MIROC models and for a large ensemble of parameter perturbed models based on HadSM3. Because the effect of cloud on changes in atmospheric shortwave absorption is almost negligible, longwave fluxes are analysed alone. We find that the net effects of cloud masking and cloud PRP on atmospheric absorption are both substantial. For the tropics, our results are reviewed in light of hypotheses put forward to explain cloud and radiative flux changes. We find that the major effects of clouds on radiation change are linked to known physical processes that are quite consistently simulated by models. Cloud top height changes are quite well described by the fixed anvil temperature hypothesis of Hartmann and Larson; cloud base heights change little, remaining near the same pressure. Changes in cloud geographical location and cloud amount are significant, but play a smaller role in driving radiative flux changes. Finally, because clouds are a large source of modelling uncertainty, we consider whether resolving errors in cloud simulation could reconcile modelled global mean precipitation trends of about 1-3 %K-1 with some estimates of observed trends of 7 %K-1 or more. This would require the radiative effect of clouds to change from one that increases atmospheric radiative absorption by about 0.5 Wm(-2) K-1 to one that decreases it by -3.5Wm(-2) K-1. Based on our results, this seems difficult to achieve within our current rationale for the tropics at least.	[Lambert, F. Hugo] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Webb, Mark J.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Yoshimori, Masakazu] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Yokohata, Tokuta] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Lambert, FH (reprint author), Univ Exeter, Coll Engn Math & Phys Sci, Harrison Bldg,North Pk Rd, Exeter EX4 4QF, Devon, England.	f.h.lambert@exeter.ac.uk			Joint DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]; European Union [244067]	We are very grateful to James Manners and William Ingram for help with running the Edwards-Slingo radiation code and to Rob Chadwick, Joe Osborne and Jon Petch for helpful discussions. We thank two reviewers for thorough reviews. Mark Webb was supported by the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101) and by funding from the European Union, Seventh Framework Programme (FP7/2007-2013) under grant agreement number 244067 via the EU Cloud Intercomparison and Process Study Evaluation project (EUCLIPSE).	Allan RP, 2013, SURV GEOPHYS, DOI [10.1007/s10,712-012-9213-z, DOI 10.1007/S10,712-012-9213-Z]; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Takahashi K, 2009, J CLIMATE, V22, P5667, DOI 10.1175/2009JCLI2674.1; MITCHELL JFB, 1987, Q J ROY METEOR SOC, V113, P293, DOI 10.1256/smsqj.47516; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; Pendergrass AG, 2014, J CLIMATE, V27, P757, DOI 10.1175/JCLI-D-13-00163.1; Hegerl GC, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Colman R, 2003, CLIM DYNAM, V20, P865, DOI 10.1007/s00382-003-0310-z; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; Hartmann DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015835; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018747; Yoshimori M, 2008, J CLIMATE, V21, P4399, DOI 10.1175/2008JCLI2172.1; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; WETHERALD RT, 1988, J ATMOS SCI, V45, P1397, DOI 10.1175/1520-0469(1988)045<1397:CFPIAG>2.0.CO;2; Gregory J, 2008, J CLIMATE, V21, P58, DOI 10.1175/2007JCLI1834.1; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Chadwick R, 2013, J CLIMATE, V26, P3803, DOI 10.1175/JCLI-D-12-00543.1; Zelinka MD, 2012, J CLIMATE, V25, P608, DOI 10.1175/JCLI-D-11-00096.1; Johanson CM, 2009, J CLIMATE, V22, P2713, DOI 10.1175/2008JCLI2620.1; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Yoshimori M, 2009, J CLIMATE, V22, P3374, DOI 10.1175/2009JCLI2801.1; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Lu JH, 2009, J HYDROMETEOROL, V10, P347, DOI 10.1175/2008JHM1058.1; Colman RA, 2011, CLIM DYNAM, V36, P1649, DOI 10.1007/s00382-011-1067-4; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; PIERREHUMBERT RT, 1995, J ATMOS SCI, V52, P1784, DOI 10.1175/1520-0469(1995)052<1784:TRFATL>2.0.CO;2; Stephens GL, 2008, J CLIMATE, V21, P6141, DOI 10.1175/2008JCLI2144.1; Soden BJ, 2004, J CLIMATE, V17, P3661, DOI 10.1175/1520-0442(2004)017<3661:OTUOCF>2.0.CO;2; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Lambert FH, 2009, J CLIMATE, V22, P499, DOI 10.1175/2008JCLI2135.1; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Thuburn J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000448; Colman RA, 1997, J GEOPHYS RES-ATMOS, V102, P19383, DOI 10.1029/97JD00206; Edwards JM, 1996, Q J ROY METEOR SOC, V122, P689, DOI 10.1002/qj.49712253107; Emori S., 2004, K 1 COUPLED MODEL MI; FRIELER K, 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2010GL045; Hansen J, 2005, J GEOPHYS RES, V110, P776, DOI [10.1029/2005DJ005, DOI 10.1029/2005DJ005]; Lambert FH, 2008, EOS T, V89, DOI [10.1029/2008EO210,001, DOI 10.1029/2008EO210]; LAMBERT FH, 2008, GEOPHYS RES LETT, V35, DOI DOI 10.1029/2008GL034; Li Y, 2012, J ATMOS SCI, V69, P2317, DOI 10.1175/JAS-D-11-0158.1; LORENZ DJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI DOI 10.1029/2010JD013; MING Y, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL042; NEWELL RE, 1975, NATURE, V253, P33, DOI 10.1038/253033b0; Ogura T, 2008, J METEOROL SOC JPN, V86, P69, DOI 10.2151/jmsj.86.69; PENDERGRASS AG, 2012, GEOPHYS RES LETT, V39, DOI DOI 10.1029/2011GL050; PREVIDI M, 2010, ENVIRON RES LETT, V5, DOI DOI 10.1088/1748-9326/5/2/025; Previdi M., 2008, EOS T AGU, V89, P193, DOI DOI 10.1029/2008EO210002; RICHTER I, 2008, J GEOPHYS RES-ATMOS, V113, DOI DOI 10.1029/2008JD010; SODEN BJ, 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2011GL047; Takahashi K, 2009, J ATMOS SCI, V66, P77, DOI 10.1175/2008JAS2797.1; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL023,684, DOI 10.1029/2005GL023]; Yokohata T, 2010, J CLIMATE, V23, P1392, DOI 10.1175/2009JCLI2917.1; ZELINKA MD, 2010, J GEOPHYS RES-ATMOS, V115, DOI DOI 10.1029/2010JD013	58	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	APR	2015	44	7-8					2301	2325		10.1007/s00382-014-2174-9		25	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD9YS	WOS:000351458300034		
J	Lambert, FH; Webb, MJ; Yoshimori, M; Yokohata, T				Lambert, F. Hugo; Webb, Mark J.; Yoshimori, Masakazu; Yokohata, Tokuta			The cloud radiative effect on the atmospheric energy budget and global mean precipitation (vol 44, pg 2301, 2015)	CLIMATE DYNAMICS			English	Correction									[Lambert, F. Hugo] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Webb, Mark J.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Yoshimori, Masakazu] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Yokohata, Tokuta] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Lambert, FH (reprint author), Univ Exeter, Coll Engn Math & Phys Sci, Harrison Bldg,North Pk Rd, Exeter EX4 4QF, Devon, England.	f.h.lambert@exeter.ac.uk					Lambert FH, 2015, CLIM DYNAM, V44, P2301, DOI 10.1007/s00382-014-2174-9	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	APR	2015	44	7-8					2327	2327		10.1007/s00382-014-2311-5		1	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CD9YS	WOS:000351458300035		
J	Madhok, V; Futamura, M; Thomas, KS; Barbarot, S				Madhok, V.; Futamura, M.; Thomas, K. S.; Barbarot, S.			What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 1. Epidemiology, mechanisms of disease and methodological issues	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Review							DERMATITIS; PREVALENCE	This review provides a summary of key findings from nine systematic reviews on atopic eczema (AE) published over the 2-year period from January 2012 to 31 December 2013, focusing on epidemiology, mechanisms of disease and methodological issues. There is now reasonable evidence to suggest that antibiotic exposure in early life is associated with increased incidence of AE, but delivery by caesarean section is not. The prevalence of AE is increasing in Africa, eastern Asia, western Europe and parts of northern Europe. Autoimmunity may play a part in the development and subsequent severity of AE. For researchers conducting clinical trials and other prospective studies involving patients with AE, the two best-validated scales for capturing objective clinical signs of AE are the Eczema Assessment Severity scale (EASI) and the objective SCORing Atopic Dermatitis scale (objSCORAD). For the assessment of quality of life in children aged 0-3years, the Infant Dermatitis Quality of Life scale (IDQoL) is reasonably well validated. A standardized definition of an incident case of AE for use in prevention studies is still required. Click for the corresponding questions to this CME article.	[Madhok, V.] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland; [Futamura, M.] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo, Japan; [Thomas, K. S.; Barbarot, S.] Univ Nottingham, Sch Med, Ctr Evidence Based Dermatol, Div Rheumatol, Nottingham, England; [Barbarot, S.] Nantes Univ Hosp, Dept Dermatol, F-44093 Nantes, France	Barbarot, S (reprint author), Nantes Univ Hosp, Dept Dermatol, 1 Pl Alexis Ricordeau, F-44093 Nantes, France.	sebastien.barbarot@chu-nantes.fr			French College of Professors of Dermatology (CEDEF)	This work was supported by a grant from the French College of Professors of Dermatology (CEDEF) (to SB). VM is a UK Dermatology Clinical trial Network General Practice Fellow (2012-2015).	Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Nankervis H, 2012, J INVEST DERMATOL, V132, P2727, DOI 10.1038/jid.2012.231; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Tsakok T, 2013, BRIT J DERMATOL, V169, P983, DOI 10.1111/bjd.12476; Flohr C, 2011, CURR PROBL DERMATOL, V41, P1, DOI 10.1159/000323290; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Schmitt J, 2013, J ALLERGY CLIN IMMUN, V132, P1337, DOI 10.1016/j.jaci.2013.07.008; Basra MKA, 2013, BRIT J DERMATOL, V169, P760, DOI 10.1111/bjd.12563; Chen SZ, 2013, DERMATITIS, V24, P161, DOI 10.1097/DER.0b013e31829cb0e4; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Panduru M, 2012, GINECO RO, V8, P196; Schmitt J, 2010, Br J Dermatol, V163, P1166, DOI 10.1111/j.1365-2133.2010.10054.x; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Shams K, 2011, CLIN EXP DERMATOL, V36, P7; Simpson EL, 2012, J ALLERGY CLIN IMMUN, V130, P137, DOI 10.1016/j.jaci.2012.01.075; Torley D, 2013, CLIN EXP DERMATOL, V38, P449, DOI 10.1111/ced.12143	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	APR	2015	40	3					238	242		10.1111/ced.12578		5	Dermatology	Dermatology	CD6CN	WOS:000351176700002		
J	Sato, H; Takeuchi, M; Takahashi, K				Sato, Hiroki; Takeuchi, Manabu; Takahashi, Kazuya			Eosinophilic Infiltration of the Muscularis Propria in a Patient With Jackhammer Esophagus Treated With Per-Oral Endoscopic Myotomy	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Sato, Hiroki; Takeuchi, Manabu; Takahashi, Kazuya] Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan	Sato, H (reprint author), Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan.						Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	APR	2015	13	4					E33	E34		10.1016/j.cgh.2014.11.005		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD7UL	WOS:000351299300003		
J	Nakajima, J; Okamoto, N; Tohyama, J; Kato, M; Arai, H; Funahashi, O; Tsurusaki, Y; Nakashima, M; Kawashima, H; Saitsu, H; Matsumoto, N; Miyake, N				Nakajima, J.; Okamoto, N.; Tohyama, J.; Kato, M.; Arai, H.; Funahashi, O.; Tsurusaki, Y.; Nakashima, M.; Kawashima, H.; Saitsu, H.; Matsumoto, N.; Miyake, N.			De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy	CLINICAL GENETICS			English	Article						autistic disorder; EEF1A2; epilepsy; facial dysmorphism; intellectual disability; speech delay; whole-exome sequencing	EEF1A2; GENE; EXPRESSION; WST	Eukaryotic elongation factor 1, alpha-2 (eEF1A2) protein is involved in protein synthesis, suppression of apoptosis, and regulation of actin function and cytoskeletal structure. EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration. Until now, only one missense mutation (c.208G>A, p.Gly70Ser) in EEF1A2 has been reported in two independent patients with neurological disease. In this report, we described two patients with de novo mutations (c.754G>C, p.Asp252His and c.364G>A, p.Glu122Lys) in EEF1A2 found by whole-exome sequencing. Common clinical features are shared by all four individuals: severe intellectual disability, autistic behavior, absent speech, neonatal hypotonia, epilepsy and progressive microcephaly. Furthermore, the two patients share the similar characteristic facial features including a depressed nasal bridge, tented upper lip, everted lower lip and downturned corners of the mouth. These data strongly indicate that a new recognizable disorder is caused by EEF1A2 mutations.	[Nakajima, J.; Funahashi, O.; Tsurusaki, Y.; Nakashima, M.; Saitsu, H.; Matsumoto, N.; Miyake, N.] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Nakajima, J.; Kawashima, H.] Tokyo Med Univ, Dept Pediat, Shinjuku Ku, Tokyo 1608402, Japan; [Okamoto, N.] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, N.] Res Inst Maternal & Child Hlth, Izumi, Japan; [Tohyama, J.] Nishi Niigata Chuo Natl Hosp, Epilepsy Ctr, Dept Pediat, Niigata, Japan; [Kato, M.] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Arai, H.] Morinomiya Hosp, Dept Pediat Neurol, Osaka, Japan	Miyake, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp; nmiyake@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare; fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from Ministry of Education, Culture, Sports, Science and Technology of Japan; Strategic Research Program for Brain Sciences from Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the patients and their families for participating in this work. We also thank Ms. S. Sugimoto and K. Takabe for their technical assistance. This work was supported by research grants from the Ministry of Health, Labour and Welfare (N. M., N. M.), the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems, the Strategic Research Program for Brain Sciences (N. M.) and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (N. M., N. M.), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (H. S., N. M., N. M.), the Takeda Science Foundation (H. S., N. M., N. M.), and the Hayashi Memorial Foundation for Female Natural Scientists (N. M.).	Abbott CM, 2009, BIOCHEM SOC T, V37, P1293, DOI 10.1042/BST0371293; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; LEE S, 1992, J BIOL CHEM, V267, P24064; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; desLigt J, 2012, NEW ENGL J MED, V367, P1921; Griffiths LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041917; Lee Jonathan M, 2003, Reprod Biol Endocrinol, V1, P69, DOI 10.1186/1477-7827-1-69; Potter M, 1998, CELL IMMUNOL, V188, P111, DOI 10.1006/cimm.1998.1346; SANDBAKEN MG, 1988, GENETICS, V120, P923; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; WOLOSCHAK GE, 1987, J IMMUNOL, V138, P2493	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	APR	2015	87	4					356	361		10.1111/cge.12394		6	Genetics & Heredity	Genetics & Heredity	CE0ZN	WOS:000351540700010		
J	Miyatake, S; Tada, H; Moriya, S; Takanashi, J; Hirano, Y; Hayashi, M; Oya, Y; Nakashima, M; Tsurusaki, Y; Miyake, N; Matsumoto, N; Saitsu, H				Miyatake, S.; Tada, H.; Moriya, S.; Takanashi, J.; Hirano, Y.; Hayashi, M.; Oya, Y.; Nakashima, M.; Tsurusaki, Y.; Miyake, N.; Matsumoto, N.; Saitsu, H.			Atypical giant axonal neuropathy arising from a homozygous mutation by uniparental isodisomy	CLINICAL GENETICS			English	Letter							DIAGNOSIS		[Miyatake, S.; Moriya, S.; Nakashima, M.; Tsurusaki, Y.; Miyake, N.; Matsumoto, N.; Saitsu, H.] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Tada, H.] Chibaken Saiseikai Narashino Hosp, Dept Pediat, Narashino, Chiba, Japan; [Takanashi, J.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Yachiyo, Japan; [Hirano, Y.] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; [Hayashi, M.] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo 113, Japan; [Oya, Y.] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan	Miyatake, S (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	miyatake@yokohama-cu.ac.jp					Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; KRETZSCHMAR HA, 1987, ACTA NEUROPATHOL, V73, P138; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Bomont P, 2000, NAT GENET, V26, P370; Catarzi S, 2012, MOL GENET METAB, V105, P438, DOI 10.1016/j.ymgme.2011.11.196; van dersKnaap M, 2005, MAGNETIC RESONANCE M; van der Knaap MS, 2001, AM J NEURORADIOL, V22, P541	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	APR	2015	87	4					395	397		10.1111/cge.12455		3	Genetics & Heredity	Genetics & Heredity	CE0ZN	WOS:000351540700018		
J	Fay, AP; Xie, WLL; Lee, JL; Harshman, LC; Bjarnason, GA; Knox, JJ; Ernst, S; Wood, L; Vaishamayan, UN; Yuasa, T; Tan, MH; Rha, SY; Donskov, F; Agarwal, N; Kollmannsberger, CK; North, SA; Rini, BI; Choueiri, TK; Heng, DYC				Fay, Andre P.; Xie, Wanlin L.; Lee, Jae-Lyn; Harshman, Lauren C.; Bjarnason, Georg A.; Knox, Jennifer J.; Ernst, Scott; Wood, Lori; Vaishamayan, Ulka N.; Yuasa, Takeshi; Tan, Mm-Han; Rha, Sun-Young; Donskov, Frede; Agarwal, Neeraj; Kollmannsberger, Christian K.; North, Scott A.; Rini, Brian I.; Choueiri, Toni K.; Heng, Daniel Y. C.			Characteristics of Long-Term and Short-Term Survivors of Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: Results From the International mRCC Database Consortium	CLINICAL GENITOURINARY CANCER			English	Article						Long-term survival; Overall survival; Primary refractory disease; Prognostic factors; Renal cell carcinoma; Targeted therapies	INTERFERON-ALPHA; CLINICAL-TRIALS; SUNITINIB; PAZOPANIB	Patients with mRCC may have variable clinical courses when treated with targeted therapy. The two extremes of the survival spectrum need to be characterized. Analyzing data from a large database (International Metastatic Renal Cell Carcinoma Database Consortium - IMDC) we found that baseline prognostic criteria and absence of PD after first- and second-line targeted therapy may discriminate long-term survival. Background: Targeted therapies improve survival in metastatic renal cell carcinoma (mRCC). However, survival patterns can be divergent, and patients at the 2 extremes of the survival spectrum need to be characterized. Patients and Methods: Data from 2161 patients included in the International mRCC Database Consortium (IMDC) were analyzed. We identified patients on the basis of their duration of survival. Long-term survival (LTS) was defined as overall survival (OS) of >= 4 years, and short-term survival (STS) was defined as OS of <= 6 months from the start of targeted therapy. Baseline characteristics, including demographic, clinicopathologic, and laboratory data, were compared between LTS and STS. Treatment response by the RECIST criteria was summarized for the 2 survival groups. Results: A total of 152 patients experienced LTS and 218 experienced STS. Adverse clinical and laboratory prognostic factors previously described in the IMDC prognostic model were significantly more frequent in the STS group (P < .0001). In the LTS group, 138 patients (91%) had nonprogressive disease (non-PD) as best response to first-line targeted therapy, and 56 (60%) of 94 patients who received second-line therapy had non-PD. In the STS group, only 51 patients (23%) had non-PD on first-line therapy. None of 21 the patients who received secondline therapy had non-PD as best response. In LTS, the median duration of therapy was 23.6 months (range 0.4 to 81.8+ months) for first-line therapy and 11.5 months (range 0.6 to 45.7 months) for second-line therapy, compared to 2.0 and 0.8 months for the STS group, respectively. Conclusion: Baseline prognostic criteria and absence of PD after. first and second-line targeted therapy may characterize long-term survival.	[Fay, Andre P.; Xie, Wanlin L.; Harshman, Lauren C.; Choueiri, Toni K.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lee, Jae-Lyn] Univ Ulsan, Coll Med, Asan, South Korea; [Harshman, Lauren C.] Stanford Canc Inst, Stanford, CA USA; [Bjarnason, Georg A.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Knox, Jennifer J.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Ernst, Scott] London Hlth Sci Ctr, London, ON, Canada; [Wood, Lori] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Vaishamayan, Ulka N.] Karmanos Canc Ctr, Detroit, MI USA; [Yuasa, Takeshi] Canc Inst Hosp, Japanese Fdn Canc Res, Tokyo, Japan; [Tan, Mm-Han] Natl Canc Ctr, Singapore, Singapore; [Rha, Sun-Young] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul 120749, South Korea; [Donskov, Frede] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Agarwal, Neeraj] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Kollmannsberger, Christian K.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [North, Scott A.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Rini, Brian I.] Taussig Canc Inst, Cleveland Clin, Cleveland, OH USA; [Heng, Daniel Y. C.] Tom Baker Canc Clin, Calgary, AB, Canada; [Heng, Daniel Y. C.] Univ Calgary, Calgary, AB, Canada	Heng, DYC (reprint author), Univ Calgary, Tom Baker Canc Ctr, 1331 29th St NW, Calgary, AB T2N 4N2, Canada.	daniel.heng@albertahealthservices.ca		Donskov, Frede/0000-0002-8449-863X; Bjarnason, Georg Arnold/0000-0001-6903-5357	DF/HCC Kidney Cancer SPORE [P50 CA101942-01]; DF/HCC Kidney Cancer SPORE Fund; Trust Family Fund; Michael Brigham Fund	This work was conducted as part of the IMDC database. We thank the DF/HCC Kidney Cancer SPORE, Trust Family, and the Michael Brigham Funds for Kidney Cancer Research (T.K.C.). This work was supported in part by DF/HCC Kidney Cancer SPORE P50 CA101942-01.	Abel EJ, 2011, EUR UROL, V60, P1273, DOI 10.1016/j.eururo.2011.07.008; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Sun M, 2011, EUR UROL, V59, P135, DOI 10.1016/j.eururo.2010.10.029; Leibovich BC, 2005, J UROLOGY, V174, P1759, DOI 10.1097/01.ju.0000177487.64651.3a; Golshayan AR, 2009, J CLIN ONCOL, V27, P235, DOI 10.1200/JCO.2008.18.0000; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Choueiri TK, 2013, CLIN CANCER RES, V19, P5218, DOI 10.1158/1078-0432.CCR-13-0491; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Harshman LC, 2012, LANCET ONCOL, V13, P927, DOI 10.1016/S1470-2045(12)70285-1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Courtney KD, 2009, CURR ONCOL REP, V11, P218; Grunwald V., 2013 EUR CANC C; Molina AM, EUR J CANC IN PRESS; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	21	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1558-7673	1938-0682		CLIN GENITOURIN CANC	Clin. Genitourin. Cancer	APR	2015	13	2					150	155		10.1016/j.clgc.201.4.09.003		6	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CD8GL	WOS:000351333100007		
J	Fumuro, T; Matsumoto, R; Shimotake, A; Matsuhashi, M; Inouchi, M; Urayama, S; Sawamoto, N; Fukuyama, H; Takahashi, R; Ikeda, A				Fumuro, Tomoyuki; Matsumoto, Riki; Shimotake, Akihiro; Matsuhashi, Masao; Inouchi, Morito; Urayama, Shin-ichi; Sawamoto, Nobukatsu; Fukuyama, Hidenao; Takahashi, Ryosuke; Ikeda, Akio			Network hyperexcitability in a patient with partial reading epilepsy: Converging evidence from magnetoencephalography, diffusion tractography, and functional magnetic resonance imaging	CLINICAL NEUROPHYSIOLOGY			English	Article						Reading epilepsy; Katakana; Magnetoencephalography; Diffusion tractography; Functional magnetic resonance imaging; Japanese	KANA WORDS; FMRI; SEIZURES; LOCALIZATION; ACTIVATION; CORTEX; EEG; MEG	Objective: The pathophysiological mechanisms of partial reading epilepsy are still unclear. We delineated the spatial-temporal characteristics of reading-induced epileptic spikes and hemodynamic activation in a patient with partial reading epilepsy. Methods: Magnetoencephalography (MEG) was recorded during silent letter-by-letter reading, and the source of reading-induced spikes was estimated using equivalent current dipole (ECD) analysis. Diffusion tractography was employed to determine if the white matter pathway connected spike initiation and termination sites. Functional magnetic resonance imaging (fMRI) was employed to determine the spatial pattern of hemodynamic activation elicited by reading. Results: In 91 spike events, ECDs were clustered in the left posterior basal temporal area (pBTA) during Katakana reading. In 8 of these 91 events, when the patient continued to read >30 min, another ECD cluster appeared in the left ventral precentral gyrus/frontal operculum with a time-difference of similar to 24 ms. Probabilistic diffusion tractography revealed that the long segment of the arcuate fasciculus connected these two regions. fMRI conjunction analysis indicated that both Katakana and Kanji reading activated the left pBTA, but Katakana activated the left lateral frontal areas more extensively than Kanji. Conclusions: Prolonged reading of Katakana induced hyper-activation of the cortical network involved in normal language function, concurrently serving as the seizure onset and symptomatogenic zones. Significance: Reflex epilepsy is believed to result from intrinsic hyper-excitability in the cortical regions recruited during behavioral states that trigger seizures. Our case shows that reading epilepsy can arise from a hyperexcitable network of cortical regions. Physiological activation of this network can have cumulative effects, resulting in greater reciprocal network propagation and electroclinical seizures. These effects, in turn, may give insights into the brain networks recruited by reading. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Fumuro, Tomoyuki; Matsumoto, Riki; Shimotake, Akihiro; Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, Kyoto 6068507, Japan; [Fumuro, Tomoyuki; Matsuhashi, Masao] Res & Educ Unit Leaders Integrated Med Syst, Sakyo Ku, Kyoto 6068507, Japan; [Shimotake, Akihiro; Inouchi, Morito; Sawamoto, Nobukatsu; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Matsuhashi, Masao; Urayama, Shin-ichi; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Dept Human Brain, Res Ctr,Sakyo Ku, Kyoto 6068507, Japan; [Inouchi, Morito] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Sakyo Ku, Kyoto 6068507, Japan	Matsumoto, R (reprint author), Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	matsumot@kuhp.kyoto-u.ac.jp; akio@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [26282218, 26293209, 26330175]; Japan Epilepsy Research Foundation	This work was supported by Grants-in-Aid for Scientific Research (B) 26282218, 26293209, (C) 26330175 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and the Research Grants from the Japan Epilepsy Research Foundation. Conflict of Interest: The authors declare no competing financial interests.	Amano S, 1999, JAPANESE NTT DATABAS; Ferlazzo E, 2005, BRAIN, V128, P700, DOI 10.1093/brain/awh446; Koutroumanidis M, 1998, BRAIN, V121, P1409, DOI 10.1093/brain/121.8.1409; Vaudano AE, 2012, NEUROLOGY, V79, P249, DOI 10.1212/WNL.0b013e31825fdf3a; Taylor JSH, 2013, PSYCHOL BULL, V139, P766, DOI 10.1037/a0030266; Archer JS, 2003, NEUROLOGY, V60, P415; Matsumoto R, 2012, HUM BRAIN MAPP, V33, P2856, DOI 10.1002/hbm.21407; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Baldo JV, 2011, CORTEX, V47, P800, DOI 10.1016/j.cortex.2010.07.001; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; Oguri T, 2013, NEUROIMAGE, V78, P353, DOI 10.1016/j.neuroimage.2013.04.026; Sakurai Y, 2000, COGNITIVE BRAIN RES, V9, P111, DOI 10.1016/S0926-6410(99)00052-X; Cappa SF, 1998, NEUROIMAGE, V8, P350, DOI 10.1006/nimg.1998.0368; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; RADHAKRISHNAN K, 1995, BRAIN, V118, P75, DOI 10.1093/brain/118.1.75; Salek-Haddadi A, 2009, EPILEPSIA, V50, P256, DOI 10.1111/j.1528-1167.2008.01737.x; Commission on Classification Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Enatsu R, 2008, NEUROIMAGE, V41, P1206, DOI 10.1016/j.neuroimage.2008.03.038; Kamada K, 2007, J NEUROSURG, V106, P90, DOI 10.3171/jns.2007.106.1.90; Maillard L, 2010, EPILEPSIA, V51, P165, DOI 10.1111/j.1528-1167.2009.02247.x; Martino J, 2013, BRAIN STRUCT FUNCT, V218, P105, DOI 10.1007/s00429-012-0386-5; Price CJ, 2003, NEUROIMAGE, V20, pS30, DOI 10.1016/j.neuroimage.2003.09.012; Sakurai Y, 2008, J NEUROL SCI, V268, P48, DOI 10.1016/j.jns.2007.10.030; Sakurai Y, 2001, BRAIN RES PROTOC, V6, P167, DOI 10.1016/S1385-299X(00)00049-0; Thuy DHD, 2004, NEUROIMAGE, V23, P878, DOI 10.1016/j.neuroimage.2004.07.059; Wolf P, 1994, EPILEPTIC SEIZURES S	27	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2015	126	4					675	681		10.1016/j.clinph.2014.07.033		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD4YI	WOS:000351092100007		
J	Araki, K; Terada, K; Usui, K; Usui, N; Araki, Y; Baba, K; Matsuda, K; Tottori, T; Inoue, Y				Araki, Kunihiko; Terada, Kiyohito; Usui, Keiko; Usui, Naotaka; Araki, Yasukiyo; Baba, Koichi; Matsuda, Kazumi; Tottori, Takayasu; Inoue, Yushi			Bidirectional neural connectivity between basal temporal and posterior language areas in humans	CLINICAL NEUROPHYSIOLOGY			English	Article						Language system; Basal temporal language area; Posterior language area; Cortico-cortical evoked potential	FUNCTIONAL CONNECTIVITY; ELECTRICAL-STIMULATION; CORTICAL-STIMULATION; EPILEPSY; SYSTEM; LOBE	Objective: The basal temporal language area (BTL) is known to be involved in the semantic processing of language. To investigate the neural connectivity between BTL and the posterior language area (PL), we used cortico-cortical evoked potential (CCEP) technique. Methods: Four patients with intractable epilepsy who underwent presurgical evaluation with subdural electrodes were examined. All patients were right-handed and left language dominance by Wada test. We directly stimulated 20 pairs of electrodes placed on BTL in patient 1-3, putative BTL in patient 4, and PL in patient 1-4. In patient 4, all electrodes on the left temporal basal area were stimulated. Results: We could record 132 CCEP responses including 40 responses by the left basal temporal stimulation in patient 4. The waveforms from PL to BTL were triphasic, while those from BTL to PL were biphasic. The mean latency of the first negative peak (N1) was shorter at BTL (31.8-41.0 ms; mean 35.1 ms) than at PL (39.6-73.2 ms; mean 52.3 ms). Conclusions: We revealed the uneven bidirectional connection between BTL and PL. Significance: We speculated that the two language areas are connected mainly through subcortical fibers from PL to BTL and through cortico-cortical fibers from BTL to PL, mediated by multisynaptic transmissions. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Araki, Kunihiko; Terada, Kiyohito; Usui, Keiko; Araki, Yasukiyo] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Neurol, Shizuoka 4208688, Japan; [Usui, Naotaka; Baba, Koichi; Matsuda, Kazumi; Tottori, Takayasu] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Neurosurg, Shizuoka 4208688, Japan; [Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Psychiat, Shizuoka 4208688, Japan	Terada, K (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Neurol, Aoi Ku, 886 Urushiyama, Shizuoka 4208688, Japan.	kyht-terada@umin.net			Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health and Welfare from Japan Ministry of Health, Labour and Welfare	This study was partially supported by Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health and Welfare from Japan Ministry of Health, Labour and Welfare. All authors declare no conflict of interest. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.	Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Umeoka S, 2009, NEUROSURGERY, V64, P847, DOI 10.1227/01.NEU.0000344001.26669.92; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; LUDERS H, 1991, BRAIN, V114, P743, DOI 10.1093/brain/114.2.743; Adrian ED, 1936, J PHYSIOL-LONDON, V88, P127; Usui K, 2005, COGNITIVE BRAIN RES, V24, P274, DOI 10.1016/j.cogbrainres.2005.02.001; Binder JR, 1997, J NEUROSCI, V17, P353; Koubeissi MZ, 2012, CEREB CORTEX, V22, P918, DOI 10.1093/cercor/bhr163; Usui K, 2003, BRAIN, V126, P632, DOI 10.1093/brain/awg057; WAXMAN SG, 1977, PROG NEUROBIOL, V8, P297, DOI 10.1016/0301-0082(77)90009-0; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Terada K, 2008, J CLIN NEUROPHYSIOL, V25, P351, DOI 10.1097/WNP.0b013e31818f4fec; Kovalev D, 2005, AM J NEURORADIOL, V26, P1078; LI CL, 1962, J CELL COMPAR PHYSL, V60, P1, DOI 10.1002/jcp.1030600102; LUDERS H, 1986, NEUROLOGY, V36, P505; Bowyer SM, 2005, EPILEPSY BEHAV, V6, P229, DOI 10.1016/j.yebeh.2004.12.003; GROSSGLENN K, 1991, J CLIN EXP NEUROPSYC, V13, P531, DOI 10.1080/01688639108401069; Ishitobi M, 2000, NEUROREPORT, V11, P2997, DOI 10.1097/00001756-200009110-00034; Krauss GL, 1996, EPILEPSIA, V37, P476, DOI 10.1111/j.1528-1157.1996.tb00594.x; Lesser RP, 2000, EPILEPTIC SEIZURES P, P153; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; OCHS S, 1956, J NEUROPHYSIOL, V19, P513; OCHS S, 1965, ELECTROEN CLIN NEURO, V19, P230, DOI 10.1016/0013-4694(65)90202-6; Penfield W, 1954, EPILEPSY FUNCTIONAL; Schaffler L, 1996, EPILEPSIA, V37, P463, DOI 10.1111/j.1528-1157.1996.tb00593.x; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Terada K, 2012, HUM BRAIN MAPP, V33, P14, DOI 10.1002/hbm.21189	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2015	126	4					682	688		10.1016/j.clinph.2014.07.020		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD4YI	WOS:000351092100008		
J	Fumuro, T; Matsuhashi, M; Miyazaki, T; Inouchi, M; Hitomi, T; Matsumoto, R; Takahashi, R; Fukuyama, H; Ikeda, A				Fumuro, Tomoyuki; Matsuhashi, Masao; Miyazaki, Tomoko; Inouchi, Morito; Hitomi, Takefumi; Matsumoto, Riki; Takahashi, Ryosuke; Fukuyama, Hidenao; Ikeda, Akio			Alpha-band desynchronization in human parietal area during reach planning	CLINICAL NEUROPHYSIOLOGY			English	Article						Alpha-band desynchronization; Reaching; Parietal area; Motor planning	EVENT-RELATED DESYNCHRONIZATION; FUNCTIONAL-SIGNIFICANCE; OPTIC ATAXIA; CORTEX; SYNCHRONIZATION; MOVEMENT; TASK; EEG; PATTERNS; HAND	Objective: The symptoms with optic ataxia suggest that simple and visually guided hand movements are controlled by 2 different neural substrates. To assess the differential frequency-coded posterior parietal cortex (PPC) role in planning visuo-motor goal-directed tasks, we studied the action specificity of event-related desynchronization (ERD) in this area. Methods: We investigated cortical activity by electroencephalography, while 16 healthy subjects performed self-paced reaching or wrist extension (control) movements. Time-frequency representations were calculated for each movement during the preparatory period. Results: ERD dynamics in upper alpha-band indicated that preparing a goal-directed action activates contralateral PPC to the moving hand around 1.2 s before starting the movement, while this activation is later (around 0.7 s) in preparing a not-goal-directed action. The posterior dominant rhythm had peak frequency of lower alpha-band at bilateral parietal. Conclusions: Posterior parietal cortex encodes goal-directed movement preparation through upper alpha-band activity, whereas general attention is processed via lower alpha-band oscillations. Significance: Preparing to reach an object engages posterior parietal cortex earlier than a not-goal directed movement. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Fumuro, Tomoyuki; Matsumoto, Riki; Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, Kyoto 6068507, Japan; [Fumuro, Tomoyuki; Matsuhashi, Masao] Res & Educ Unit Leaders Integrated Med Syst, Sakyo Ku, Kyoto 6068507, Japan; [Matsuhashi, Masao; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Miyazaki, Tomoko; Inouchi, Morito; Hitomi, Takefumi; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Inouchi, Morito; Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Sakyo Ku, Kyoto 6068507, Japan; [Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, Kyoto 6068507, Japan	Ikeda, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	akio@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [26282218, 26293209, 26330175]	This work was supported by Grants-in-Aid for Scientific Research (B) 26282218, 26293209, (C) 26330175 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; DEJONG R, 1988, J EXP PSYCHOL HUMAN, V14, P682, DOI 10.1037//0096-1523.14.4.682; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; DUJARDIN K, 1993, ELECTROEN CLIN NEURO, V86, P353, DOI 10.1016/0013-4694(93)90049-2; Van der Werf J, 2010, J NEUROSCI, V30, P1402, DOI 10.1523/JNEUROSCI.3448-09.2010; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pisella L, 2000, NAT NEUROSCI, V3, P729; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; VANWINSUM W, 1984, ELECTROEN CLIN NEURO, V58, P519, DOI 10.1016/0013-4694(84)90042-7; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; ARROYO S, 1993, ELECTROEN CLIN NEURO, V87, P76, DOI 10.1016/0013-4694(93)90114-B; Courtemanche R, 2005, J NEUROPHYSIOL, V93, P2039, DOI 10.1152/jn.00080.2004; DUJARDIN K, 1995, EVOKED POTENTIAL, V96, P169, DOI 10.1016/0168-5597(94)00284-L; Fumuro T, 2013, CLIN NEUROPHYSIOL, V124, P1398, DOI 10.1016/j.clinph.2013.01.026; Inouchi M, 2013, CLIN NEUROPHYSIOL, V124, P2230, DOI 10.1016/j.clinph.2013.05.011; Kellaway P., 1990, CURRENT PRACTICE CLI, P139; Naranjo JR, 2007, NEUROIMAGE, V34, P1673, DOI 10.1016/j.neuroimage.2006.07.049; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Smid H G, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P270; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Virji-Babul N, 2010, HUM BRAIN MAPP, V31, P160, DOI 10.1002/hbm.20853	32	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2015	126	4					756	762		10.1016/j.clinph.2014.07.026		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD4YI	WOS:000351092100017		
J	Chiba, T; Konoeda, F; Higashihara, M; Kamiya, H; Oishi, C; Hatanaka, Y; Sonoo, M				Chiba, Takashi; Konoeda, Fumie; Higashihara, Mana; Kamiya, Hisao; Oishi, Chizuko; Hatanaka, Yuki; Sonoo, Masahiro			C8 and T1 innervation of forearm muscles	CLINICAL NEUROPHYSIOLOGY			English	Article						Myotome; Median nerve; Ulnar nerve; Forearm flexor muscles; True neurogenic thoracic outlet syndrome; Radiculopathy	BRACHIAL PLEXOPATHIES; CERVICAL RIB; RADICULOPATHIES; ROOT; RESPONSES	Objective: C8-dominant innervation of ulnar-innervated and T1-dominant innervation of median-innervated intrinsic hand muscles have been suggested, although less is known regarding forearm muscles. We aimed to determine myotomal innervation of the forearm muscles based on the clinical and electromyographial findings of patients with C8 or T1 lesions. Methods: Medical Research Council scale and EMG findings were retrospectively reviewed in 16 patients with C8 lesions (2 postmedian sternotomy C8 plexopathy and 14 C8 radiculopathy) and 9 patients with T1-dominant lesions (8 true neurogenic thoracic outlet syndrome and 1 T1 radiculopathy). Results: Clinical and EMG findings revealed T1-dominant innervation of the flexor digitorum superficialis, flexor digitorum profundus of the index finger, abductor pollicis brevis, and flexor pollicis longus muscles, and C8-dominant innervation of the flexor carpi ulnaris, flexor digitorum profundus of the little finger, and digit extensors innervated by the posterior interosseous nerve. The first dorsal interosseous, and abductor digiti minimi muscles seem to be innervated by both C8 and T1 roots. Conclusions: C8-dominant innervation of ulnar-innervated muscles and T1-dominant innervation of median-innervated muscles are also evident for forearm flexor muscles. Significance: Such an additional evidence for myotomal innervation will improve localization in clinical as well as electrophysiological diagnoses. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Chiba, Takashi; Kamiya, Hisao; Hatanaka, Yuki; Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Tokyo 173, Japan; [Konoeda, Fumie] Tokyo Saiseikai Cent Hosp, Dept Neurol, Tokyo, Japan; [Higashihara, Mana] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 173, Japan; [Oishi, Chizuko] Kyorin Univ, Fac Med, Dept Neurol, Tokyo, Japan	Sonoo, M (reprint author), Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Kaga 2-11-1, Tokyo 173, Japan.	sonoom@med.teikyo-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19591011, 23591285]; Ministry of Health, Labour and Welfare of Japan	This study was supported by the Grants-in-Aid for Scientific Research (19591011 and 23591285) from the Ministry of Education, Science, Sports and Culture of Japan, and by Health and Labour Sciences Research Grants for research on intractable diseases (CNS Degenerative Disease Research Committee and Neuroimmunological Disease Research Committee) from the Ministry of Health, Labour and Welfare of Japan. None of the authors have potential conflicts of interest to be disclosed.	Oh CS, 2009, MUSCLE NERVE, V39, P498, DOI 10.1002/mus.21281; Tsao BE, 2003, MUSCLE NERVE, V27, P60, DOI 10.1002/mus.10291; WILBOURN AJ, 1988, MUSCLE NERVE, V11, P1099, DOI 10.1002/mus.880111102; Ferrante MA, 2004, MUSCLE NERVE, V30, P547, DOI 10.1002/mus.20131; Chu-Andrews J, 1986, ELECTRODIAGNOSIS ANA; Dumitru D, 2002, ELECTRODIAGNOSTIC ME, P713; FERRANTE MA, 1995, MUSCLE NERVE, V18, P879, DOI 10.1002/mus.880180813; Ferrante MA, 2012, MUSCLE NERVE, V45, P780, DOI 10.1002/mus.23235; GILLIATT RW, 1970, J NEUROL NEUROSUR PS, V33, P615, DOI 10.1136/jnnp.33.5.615; Haerer AF, 1992, DEJONGS NEUROLOGIC E; Higashihara M, 2007, CLIN NEUROL TOKYO, V47, P160; Hislop HJ, 2002, DANIELS WORTHINGHAMS; Kaneko K, 2004, SPINE, V29, pE185, DOI 10.1097/00007632-200405010-00022; Kendall H. O., 1971, MUSCLES TESTING FUNC; Lauder TD, 1996, MUSCLE NERVE, V19, P662; Levin KH, 1996, NEUROLOGY, V46, P1022; Levin KH, 1998, NEUROLOGY, V50, P1407; Levin KH, 1999, NEUROLOGY, V53, P1149; London ZN, 2014, MUSCLE NERVE, V49, P570, DOI 10.1002/mus.23974; Nishida T, 1993, Electromyogr Clin Neurophysiol, V33, P285; Nomenclature Committee of American Association of Electromyography and Electrodiagnosis, 1987, MUSCLE NERVE       S, V10, pG1; Sonoo M, 2006, NEUROL MED TOKYO S4, V65, P150; Sonoo M, 2012, JPN J CLIN NEUROPHYS, V40, P131; Tsao BE, 2014, MUSCLE NERVE, V49, P724, DOI 10.1002/mus.24066; Tsuboi Y, 1995, Rinsho Shinkeigaku, V35, P147; WILBOURN AJ, 1985, NEUROL CLIN, V3, P511; Yanagi T, 1976, Rinsho Shinkeigaku, V16, P520	27	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	APR	2015	126	4					837	842		10.1016/j.clinph.2014.07.031		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD4YI	WOS:000351092100027		
J	Koizumi, H; Suzuki, H; Ohbuchi, T; Kitamura, T; Hashida, K; Nakamura, M				Koizumi, H.; Suzuki, H.; Ohbuchi, T.; Kitamura, T.; Hashida, K.; Nakamura, M.			Increased permeability of the epithelium of middle ear cholesteatoma	CLINICAL OTOLARYNGOLOGY			English	Article							CHRONIC OTITIS-MEDIA; TUMOR-NECROSIS-FACTOR; HORMONE-RELATED PROTEIN; BONE-RESORPTION; ELECTRICAL-PROPERTIES; AURAL CHOLESTEATOMA; ATOPIC-DERMATITIS; GROWTH-FACTOR; FACTOR-ALPHA; EXPRESSION	ObjectiveWe investigated the electrical impedance of and the expressions of tight junction molecules in the cholesteatoma epithelium to provide supporting evidence for the acid lysis theory of bone resorption in middle ear cholesteatoma. MethodsStudy subjects were patients with primary acquired middle ear cholesteatoma and those with non-cholesteatomatous chronic otitis media who underwent tympanomastoidectomy. The electrical impedance of the cholesteatoma epithelium was measured during tympanomastoidectomy by loading alternating currents of 320Hz and 30.7kHz. The expressions of tricellulin (MARVELD2), claudin-1 (CLDN1) and claudin-3 (CLDN3) were examined by fluorescence immunohistochemistry and quantitative reverse transcription-polymerase chain reaction. ResultsThe electrical impedance of the cholesteatoma epithelium was significantly lower than that of the post-auricular skin and external auditory canal skin at both 320Hz and 30.7kHz. Immunoreactivity for MARVELD2, CLDN1 and CLDN3 was localised mainly in the granular layer, and to lesser degree, in the horny and spinous layers in both the cholesteatoma tissue and post-auricular skin. Fluorescence intensity was moderate for MARVELD2, weak for CLDN1 and strong for CLDN3. The expressions of MARVELD2, CLDN1 and CLDN3 mRNA were significantly lower in the cholesteatoma tissue than in the post-auricular skin. ConclusionsThese results indicate the increased permeability of the cholesteatoma epithelium and suggest that this change is, at least partially, dependent on the decrease in the expressions of the tight junction molecules. This evidence supports the acid lysis hypothesis of bone resorption in cholesteatoma.	[Koizumi, H.; Suzuki, H.; Ohbuchi, T.; Kitamura, T.; Hashida, K.] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Kitakyushu, Fukuoka 8078555, Japan; [Nakamura, M.] Univ Occupat & Environm Hlth, Sch Med, Dept Dermatol, Kitakyushu, Fukuoka 8078555, Japan	Suzuki, H (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	suzuhyde@med.uoeh-u.ac.jp			Japan Society for the Promotion of Science [25462656]	This study was supported by a Grant-in-Aid for Scientific Research (C) (no. 25462656; 2013-2015) from the Japan Society for the Promotion of Science.	ABRAMSON M, 1975, ANN OTO RHINOL LARYN, V84, P425; ABRAMSON M, 1977, LARYNGOSCOPE, V87, P771; AHN JM, 1990, OTOLARYNG HEAD NECK, V103, P527; AHN JM, 1990, AM J OTOLARYNG, V11, P71, DOI 10.1016/0196-0709(90)90001-C; STAMMBERGER M, 1995, AM J OTOL, V16, P527; Akimoto R, 2000, ORL J OTO-RHINO-LARY, V62, P257, DOI 10.1159/000027756; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007; Olszewska E, 2007, ACTA BIOCHIM POL, V54, P365; Ahn H, 2012, BIOCHEM BIOPH RES CO, V418, P144, DOI 10.1016/j.bbrc.2011.12.149; KURIHARA A, 1991, ANN OTO RHINOL LARYN, V100, P989; Lawrence JN, 1997, TOXICOL IN VITRO, V11, P241, DOI 10.1016/S0887-2333(97)00015-5; Mocsai G, 2014, BRIT J DERMATOL, V170, P617, DOI 10.1111/bjd.12743; Huisman MA, 2007, ACTA OTO-LARYNGOL, V127, P424, DOI 10.1080/00016480600868430; Wanke I, 2013, EXP DERMATOL, V22, P153, DOI 10.1111/exd.12083; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Jeong JH, 2006, LARYNGOSCOPE, V116, P1180, DOI 10.1097/01.mlg.0000224345.59291.da; Brandner JM, 2006, SKIN PHARMACOL PHYS, V19, P71, DOI 10.1159/000091973; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741; BIRRELL J F, 1958, J Laryngol Otol, V72, P620, DOI 10.1017/S0022215100054414; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P252; Bujia J, 1996, LARYNGOSCOPE, V106, P217; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P152, DOI 10.1007/BF00615113; Chan Aegean, 2011, Dermatoendocrinol, V3, P84, DOI 10.4161/derm.3.2.15140; CHESHIRE IM, 1995, CLIN OTOLARYNGOL, V20, P448, DOI 10.1111/j.1365-2273.1995.tb00080.x; CHESHIRE IM, 1991, LANCET, V338, P1041, DOI 10.1016/0140-6736(91)91902-7; CHOLE RA, 1984, LARYNGOSCOPE, V94, P76; Druss JG, 1933, ARCHIV OTOLARYNGOL, V17, P484; ERGUN S, 1994, ACTA OTO-LARYNGOL, V114, P295, DOI 10.3109/00016489409126059; FUJIOKA O, 1994, EUR ARCH OTO-RHINO-L, V251, P199, DOI 10.1007/BF00628423; GANTZ BJ, 1982, AM J OTOL, V3, P279; GRIPPAUDO M, 1958, J Laryngol Otol, V72, P177, DOI 10.1017/S0022215100053810; Hamzei M, 2003, LARYNGOSCOPE, V113, P436, DOI 10.1097/00005537-200303000-00009; Hansen T, 2001, MODERN PATHOL, V14, P1226, DOI 10.1038/modpathol.3880465; HARRIS ALBERT J., 1962, LARYNGOSCOPE, V72, P954; IINO Y, 1983, ANN OTO RHINOL LARYN, V92, P91; IINO Y, 1990, ACTA OTO-LARYNGOL, V110, P410, DOI 10.3109/00016489009107462; JUNG TTK, 1988, AM J OTOL, V9, P197; KAKIUCHI H, 1992, ANN OTO RHINOL LARYN, V101, P32; KANEKO Y, 1980, LARYNGOSCOPE, V90, P1865, DOI 10.1288/00005537-198011000-00015; KARJA J, 1976, J LARYNGOL OTOL, V90, P509; Kato K, 2011, EUR J PHARMACOL, V663, P27, DOI 10.1016/j.ejphar.2011.04.062; Kim TT, 1998, OTOLARYNG HEAD NECK, V118, P324, DOI 10.1016/S0194-5998(98)70309-2; Kuczkowski J, 2010, AM J OTOLARYNG, V31, P404, DOI 10.1016/j.amjoto.2009.06.004; Lee WJ, 2011, J DERMATOL, V38, P1049, DOI 10.1111/j.1346-8138.2011.01320.x; Lim D J, 1972, Ann Otol Rhinol Laryngol, V81, P1; MANN W, 1981, ARCH OTO-RHINO-LARYN, V230, P121, DOI 10.1007/BF00456141; Marquet J, 1980, Acta Otorhinolaryngol Belg, V34, P5; Martinsen OG, 2008, SKIN RES TECHNOL, V14, P142, DOI 10.1111/j.1600-0846.2007.00267.x; Nager F. R., 1925, ANN OTO RHINOL LARYN, V34, P1249; Nguyen KH, 2014, LARYNGOSCOPE, V124, P245, DOI 10.1002/lary.23883; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Olszewska E, 2007, J INVEST MED, V55, P248, DOI 10.2310/6650.2007.00005; Schaper J, 1980, Acta Otorhinolaryngol Belg, V34, P12; SCHECHTE.G, 1969, LARYNGOSCOPE, V79, P1907, DOI 10.1288/00005537-196911000-00005; Schonermark M, 1996, ACTA OTO-LARYNGOL, V116, P451, DOI 10.3109/00016489609137872; Suzuki C, 2004, OTOL NEUROTOL, V25, P674, DOI 10.1097/00129492-200409000-00005; TANAKA K, 1980, ARCH OTO-RHINO-LARYN, V226, P85, DOI 10.1007/BF00455406; Themsen J, 1974, J Laryngol Otol, V88, P983; THOMSEN J, 1974, J LARYNGOL OTOL, V88, P975, DOI 10.1017/S0022215100079639; THOMSEN J, 1981, CLIN OTOLARYNGOL, V6, P179, DOI 10.1111/j.1365-2273.1981.tb01529.x; WALSH TE, 1951, ANN OTO RHINOL LARYN, V60, P1100	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1749-4478	1749-4486		CLIN OTOLARYNGOL	Clin. Otolaryngol.	APR	2015	40	2					106	114		10.1111/coa.12332		9	Otorhinolaryngology	Otorhinolaryngology	CD8VS	WOS:000351375100006		
J	Nakai, K; Iida, S; Tobinai, M; Hashimoto, J; Kawanishi, T				Nakai, Kiyohiko; Iida, Satofumi; Tobinai, Masato; Hashimoto, Junko; Kawanishi, Takehiko			Application of Modeling and Simulation to a Long-Term Clinical Trial: A Direct Comparison of Simulated Data and Data Actually Observed in Japanese Osteoporosis Patients Following 3-Year Ibandronate Treatment (vol 54, pg 295, 2015)	CLINICAL PHARMACOKINETICS			English	Correction									[Nakai, Kiyohiko; Iida, Satofumi; Tobinai, Masato; Kawanishi, Takehiko] Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, Tokyo 1038324, Japan; [Hashimoto, Junko] Chugai Pharmaceut Co Ltd, Primary Lifecycle Management Dept, Chuo Ku, Tokyo 1038324, Japan	Nakai, K (reprint author), Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, 2-1-1 Nihonbashi Muromachi, Tokyo 1038324, Japan.	nakaikyh@chugai-pharm.co.jp					Nakai K, 2015, CLIN PHARMACOKINET, V54, P295, DOI 10.1007/s40262-014-0206-6	1	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	APR	2015	54	4					455	455		10.1007/s40262-015-0263-5		1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE0SK	WOS:000351515900013		
J	Wakoh, H; Furuie, M; Inaba, D; Azuma, N; Nakane, K; Ogata, N; Shimizu, T; Ishimaru, O				Wakoh, Hiroshi; Furuie, Mina; Inaba, Daisuke; Azuma, Nobuto; Nakane, Koji; Ogata, Nobuo; Shimizu, Toru; Ishimaru, Osamu			Deep-colour vat dyeing of cotton knit fabric on a modified jet dyeing machine	COLORATION TECHNOLOGY			English	Article								To improve the vat dyeing of cotton knit fabric with Indanthren Black RB Coll. (CI Vat Black 9), the basic parameters of dyeing, including the concentrations of chemicals, the dyeing temperature and duration, and the apparent diffusion coefficient of the dye, were obtained by test dyeing with a stoppered Erlenmeyer flask and the cellophane film roll method. A stable vat dyeing process has been developed on a modified jet dyeing machine for the first time without using nitrogen to purge oxygen. Modifications were made to improve the airtightness of the machine and the equipment in the liquor circulating system, with a water inlet and outlet for the gentle oxidation of dyed fabric, and with monitoring by means of a sensor inserted in the liquor circulating system for insitu measurements of the redox potential and the pH of the dyeing liquors. These measurements made it possible to follow to their completion the process of dyeing and the process of gentle oxidation by overflow washing with water and final oxidation. Optimal conditions with regard to the amount of reducing agent, the dyeing temperature (80 degrees C), and oxidising processes were established with this machine. It was found that, by using the modified machine and process conditions, dyeing proceeded stably and reproducibly (at 80 degrees C) to yield grade A dyed fabric. Visual inspection confirmed that faultless deep-colour dyeing of the fabric was attained. Production has been proceeding successfully for the past 2years. Owing to its insolubility, complete removal of the dye from the wastewater has been possible.	[Wakoh, Hiroshi; Furuie, Mina; Inaba, Daisuke; Azuma, Nobuto; Nakane, Koji; Ogata, Nobuo] Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan; [Shimizu, Toru; Ishimaru, Osamu] Hisaka Works Ltd, Higashiosaka, Osaka 5780973, Japan	Wakoh, H (reprint author), Univ Fukui, Grad Sch Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	wakohknowledge@me.com					[Anonymous], 2010, 105E032010 ISO; [Anonymous], 2009, 105B072009 ISO; [Anonymous], 2014, 105B022014 ISO; [Anonymous], 2010, 105C062010 ISO; [Anonymous], 2001, 105X122001 ISO; Aspland J R, 1992, TEXT CHEM COLOR, V24, P22; ASPLAND JR, 1992, TEXT CHEM COLOR, V24, P27; Horne CM, 1995, TEXT CHEM COLOR, V27, P27; Peters R H, 1968, DIFFUSION POLYM, P338; Sekido M, 1964, SEN-I GAKKAISHI, V20, P783; Sekido M, 1964, SEN-I GAKKAISHI, V20, P786; Sekido M, 1964, SEN-I GAKKAISHI, V20, P779; Silverstein R. M., 2005, SPECTROMETRIC IDENTI; Vickerstaff T, 1954, PHYS CHEM DYEING, P313	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1472-3581	1478-4408		COLOR TECHNOL	Color. Technol.	APR	2015	131	2					136	141		10.1111/cote.12135		6	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CD9ZL	WOS:000351460600008		
J	Rouxel, PL; Heilmann, A; Aida, J; Tsakos, G; Watt, RG				Rouxel, Patrick L.; Heilmann, Anja; Aida, Jun; Tsakos, Georgios; Watt, Richard G.			Social capital: theory, evidence, and implications for oral health	COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY			English	Editorial Material						oral health; public health; social capital	QUALITY-OF-LIFE; DENTAL-CARIES; NEIGHBORHOOD CHARACTERISTICS; PSYCHOSOCIAL FACTORS; PERIODONTAL-DISEASE; MULTILEVEL ANALYSIS; POLITICAL-ECONOMY; CONCEPTUAL-MODEL; PUBLIC-HEALTH; OLDER-PEOPLE	In the last two decades, there has been increasing application of the concept of social capital in various fields of public health, including oral health. However, social capital is a contested concept with debates on its definition, measurement, and application. This study provides an overview of the concept of social capital, highlights the various pathways linking social capital to health, and discusses the potential implication of this concept for health policy. An extensive and diverse international literature has examined the relationship between social capital and a range of general health outcomes across the life course. A more limited but expanding literature has also demonstrated the potential influence of social capital on oral health. Much of the evidence in relation to oral health is limited by methodological shortcomings mainly related to the measurement of social capital, cross-sectional study designs, and inadequate controls for confounding factors. Further research using stronger methodological designs should explore the role of social capital in oral health and assess its potential application in the development of oral health improvement interventions.	[Rouxel, Patrick L.; Heilmann, Anja; Tsakos, Georgios; Watt, Richard G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Aida, Jun] Tohoku Univ, Dept Int & Community Oral Hlth, Sendai, Miyagi 980, Japan	Watt, RG (reprint author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	r.watt@ucl.ac.uk					Aida J, 2010, COMMUNITY DENT ORAL, V39, P239; McGrath C, 2002, J ORAL REHABIL, V29, P918, DOI 10.1046/j.1365-2842.2002.00931.x; Zini A, 2012, CARIES RES, V46, P368, DOI 10.1159/000338404; Whitehead M, 2001, LANCET, V358, P165, DOI 10.1016/S0140-6736(01)05398-3; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Muntaner C, 2004, INT J EPIDEMIOL, V33, P674, DOI 10.1093/ije/dyh200; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Finlayson TL, 2007, COMMUNITY DENT ORAL, V35, P439, DOI 10.1111/j.1600-0528.2006.00352.x; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; Wu B, 2011, J AGING HEALTH, V23, P267, DOI 10.1177/0898264310382135; Tellez M, 2006, J PUBLIC HEALTH DENT, V66, P30, DOI 10.1111/j.1752-7325.2006.tb02548.x; Sisson KL, 2007, COMMUNITY DENT ORAL, V35, P81, DOI 10.1111/j.1600-0528.2007.00354.x; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; Merchant AT, 2003, J AM DENT ASSOC, V134, P1591; Lee JY, 2014, J DENT RES, V93, P224, DOI 10.1177/0022034513511821; RICKARDSSON B, 1989, SWED DENT J, V13, P151; Moyses SJ, 2006, HEALTH PLACE, V12, P48, DOI 10.1016/j.healthplace.2004.10.001; Gilbert KL, 2013, J HEALTH PSYCHOL, V18, P1385, DOI 10.1177/1359105311435983; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Sanders AE, 2005, COMMUNITY DENT ORAL, V33, P370, DOI 10.1111/j.1600-0528.2005.00237.x; Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084; Nicolau B, 2007, J CLIN PERIODONTOL, V34, P844, DOI 10.1111/j.1600-051X.2007.01123.x; Pattussi MP, 2006, COMMUNITY DENT ORAL, V34, P344, DOI 10.1111/j.1600-0528.2006.00283.x; Sabbah W, 2011, J CLIN PERIODONTOL, V38, P547, DOI 10.1111/j.1600-051X.2011.01713.x; Aida J, 2011, SOC SCI MED, V73, P1561, DOI 10.1016/j.socscimed.2011.09.005; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Boyapati L, 2007, PERIODONTOL 2000, V44, P195, DOI 10.1111/j.1600-0757.2007.00211.x; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Aida J, 2008, COMMUNITY DENT ORAL, V36, P149, DOI 10.1111/j.1600-0528.2007.00380.x; Iida H, 2013, AM J PUBLIC HEALTH, V103, P480, DOI 10.2105/AJPH.2012.300845; Nyqvist F, 2013, AGING MENT HEALTH, V17, P394, DOI 10.1080/13607863.2012.742490; Arcury TA, 2013, J APPL GERONTOL, V32, P302, DOI 10.1177/0733464811420428; Avlund K, 2003, COMMUNITY DENT ORAL, V31, P454, DOI 10.1046/j.1600-0528.2003.00115.x; Bourdieu Pierre, 1986, HDB THEORY RES SOCIO, P241, DOI DOI 10.1177/0265532207083743; Brennan DS, 2012, INT J BEHAV MED, V19, P56, DOI 10.1007/s12529-010-9136-3; Burr JA, 2012, J AGING HEALTH, V20, P1; Coleman J. S., 1988, AM J SOCIOL, V94, P95, DOI DOI 10.1086/228943; Cote S, 2001, WELL BEING NATIONS R; Davey SG, 2004, INT J EPIDEMIOL, V33, P5; Davey Smith G., 2004, INT J EPIDEMIOL, V33, P691, DOI 10.1093/ije/dyh261; Furuta M, 2011, COMMUNITY DENT ORAL, V40, P97; Grootaert C., 2002, UNDERSTANDING MEASUR; HANSON BS, 1994, COMMUNITY DENT ORAL, V22, P331; Harper R., 2003, MEASURING SOCIAL CAP; Harper R, 2002, MEASUREMENT SOCIAL C; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Kawachi I, 2008, SOCIAL CAPITAL HLTH, P1, DOI 10.1007/978-0-387-71311-3_1; Kawachi I, 2013, GLOBAL PERSPECTIVE S; Lamarca GA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-5; Maupome G, 1998, J PROSTHET DENT, V80, P598, DOI 10.1016/S0022-3913(98)70038-1; McPherson KE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-971; Moore S, 2013, GLOBAL PERSPECTIVES, P189; Muntaner C, 2004, INT J EPIDEMIOL, V33, P700; Muntaner Carles, 2002, INT J EPIDEMIOL, V31, P261, DOI 10.1093/ije/31.1.261; Murayama H, 2013, GLOBAL PERSPECTIVES, P205; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1993, MAKING DEMOCRACY WOR; Rodrigues SM, 2012, INT J ENV RES PUB HE, V9, P100, DOI 10.3390/ijerph9010100; Samuel LJ, 2013, HEALTH EDUC BEHAV, V41, P359; Santiago BM, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-2; Siriphant P, 2005, J PUBLIC HEALTH DENT, V65, P36, DOI 10.1111/j.1752-7325.2005.tb02784.x; Solar O, CONCEPTUAL FRAMEWORK; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Tsakos G, 2013, PSYCHOSOM MED, V75, P1; Uphoff EP, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-54; Vyncke V, 2013, BMC PUBLIC HEALTH, V23, P65; Wilkinson RG, 2009, SPIRIT LEVEL WHY MOR; Williams D M, 2011, Adv Dent Res, V23, P198, DOI 10.1177/0022034511402014; Woolcock M, 2001, ISUMA CANADIAN J POL, V2, P11	79	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0301-5661	1600-0528		COMMUNITY DENT ORAL	Community Dentist. Oral Epidemiol.	APR	2015	43	2					97	105		10.1111/cdoe.12141		9	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	CD6BU	WOS:000351174500001		
J	Kakudate, N; Sumida, F; Matsumoto, Y; Yokoyama, Y; Riley, JL; Gilbert, GH; Gordan, VV				Kakudate, Naoki; Sumida, Futoshi; Matsumoto, Yuki; Yokoyama, Yoko; Riley, Joseph L., III; Gilbert, Gregg H.; Gordan, Valeria V.			Dentists' decisions to conduct caries risk assessment in a Dental Practice-Based Research Network	COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY			English	Article						clinical research; dental caries; dental practice-based research; dentist's practice pattern; evidence-based dentistry; risk assessments	RESTORATIVE TREATMENT THRESHOLDS	Objectives(i) To quantify the importance that dentists place on caries risk factors when developing a caries treatment plan and (ii) to test the hypothesis that the ratings of importance for specific factors are significantly associated with whether or not the dentist performs caries risk assessment (CRA). MethodsThis study used a cross-sectional study design consisting of a questionnaire survey. The study queried dentists who worked in outpatient dental practices who were affiliated with the Dental Practice-Based Research Network Japan (JDPBRN), which seeks to engage dentists in investigating research questions and sharing experiences and expertise (n=282). Participants (n=189) were asked to rate the importance of caries risk factors when developing a caries treatment plan in both adult and pediatric patients. ResultsOral hygiene status was rated as the most important risk factor when developing a treatment plan in both adult and pediatric patients, whereas the use of fluorides was rated as the least important. Results of multiple logistic regression analysis showed that the odds ratios for the decision to perform CRA in the adult patient for past caries experience and use of fluorides were 2.61 (95% confidence interval [CI]: 1.29-5.29) and 1.85 (95% CI: 1.12-3.04), respectively, whereas that for oral hygiene was 3.84 (95% CI: 1.15-12.79) and use of fluorides 1.79 (95% CI: 1.06-3.03) in the pediatric patient. ConclusionsThese results suggest that enhancing dentists' concept of the importance of current use of fluorides when developing a treatment plan may increase the percentage of dentists who conduct CRA in both adult and pediatric patients (clinicaltrials.gov registration number: NCT01680848).	[Kakudate, Naoki] Kyushu Dent Univ, Educ Cooperat Ctr, Kitakyushu, Fukuoka 8038580, Japan; [Sumida, Futoshi] Mikami Dent & Orthodont Clin, Tomakomai City, Japan; [Matsumoto, Yuki] Matsumoto Dent Clin, Okazaki, Aichi, Japan; [Yokoyama, Yoko] Japan Soc Promot Sci, Tokyo, Japan; [Yokoyama, Yoko] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa, Japan; [Riley, Joseph L., III] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Gainesville, FL USA; [Gilbert, Gregg H.] Univ Alabama Birmingham, Sch Dent, Dept Clin & Community Sci, Birmingham, AL 35294 USA; [Gordan, Valeria V.] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL USA	Kakudate, N (reprint author), Kyushu Dent Univ, Educ Cooperat Ctr, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r13kakudate@fa.kyu-dent.ac.jp			NIH [U01-DE-16746, U01-DE-16747, U19-DE-22516]; Banyu Fellowship Program - Banyu Life Science Foundation International	Certain components of this investigation were supported by NIH grants U01-DE-16746, U01-DE-16747, and U19-DE-22516. Opinions and assertions contained herein are those of the authors and are not to be construed as necessarily representing the views of the respective organizations or the National Institutes of Health. N.K. was supported by the Banyu Fellowship Program, which is sponsored by Banyu Life Science Foundation International. The authors report no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatric Dentistry, 2007, PEDIAT DENT S, V29, P29; American Dental Association, 2009, CAR RISK ASS FORMS; American Dental Association Council on Scientific Affairs, 2006, J AM DENT ASSOC, V137, P1151; Evans RW, 2008, AUST DENT J, V53, P83, DOI 10.1111/j.1834-7819.2007.00004.x; Reich E, 1999, INT DENT J, V49, P15; Twetman S, 2009, MONOGR ORAL SCI, V21, P91, DOI 10.1159/000224214; Tellez M, 2013, COMMUNITY DENT ORAL, V41, P67, DOI 10.1111/cdoe.12003; Makhija Sonia K., 2009, General Dentistry, V57, P270; Frencken JE, 2012, INT DENT J, V62, P223, DOI 10.1111/idj.12007; Teachman BA, 2012, PSYCHOTHERAPY, V49, P97, DOI 10.1037/a0027346; Gordan Valeria V., 2009, General Dentistry, V57, P654; Bratthall D, 2005, COMMUNITY DENT ORAL, V33, P256, DOI 10.1111/j.1600-0528.2005.00233.x; Gordan VV, 2010, J AM DENT ASSOC, V141, P171; [Anonymous], 2001, J DENT ED, V65, P1162; Fontana M, 2006, J AM DENT ASSOC, V137, P1231; Kakudate N, 2012, J DENT RES, V91, P1202, DOI 10.1177/0022034512464778; Featherstone John D B, 2007, J Calif Dent Assoc, V35, P703; Fontana Margherita, 2009, Dent Clin North Am, V53, P149, DOI 10.1016/j.cden.2008.10.003; Gilbert GH, 2008, J AM DENT ASSOC, V139, P74; Gordan VV, 2013, DENT MATER, V29, P3, DOI 10.1016/j.dental.2012.07.159; Kidd EAM., 2005, ESSENTIALS DENT CARI, P60; Marinho VC, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002782; Ministry of Health Labour and Welfare, 2010, SURV PHYS DENT PHARM; Riley Joseph L. III, 2010, General Dentistry, V58, P230; Riley JL, 2011, COMMUNITY DENT ORAL, V39, P564, DOI 10.1111/j.1600-0528.2011.00626.x; Young Douglas A, 2007, J Calif Dent Assoc, V35, P799	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0301-5661	1600-0528		COMMUNITY DENT ORAL	Community Dentist. Oral Epidemiol.	APR	2015	43	2					128	134		10.1111/cdoe.12127		7	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	CD6BU	WOS:000351174500004		
J	Takei, GL; Mukai, C; Okuno, M				Takei, Gen Leon; Mukai, Chinatsu; Okuno, Makoto			Regulation of salmonid fish sperm motility by osmotic shock-induced water influx across the plasma membrane	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY			English	Article						Sperm motility; Osmotic shock; Water influx; Aquaporin; AQP 1a; AQP 10; Salmonid fishes	CYCLIC-AMP; TROUT SPERMATOZOA; VOLUME REGULATION; RAINBOW-TROUT; ION CHANNELS; HUMAN TESTIS; INITIATION; INVOLVEMENT; OSMOLALITY; PROTEIN	The motility of salmonid fish sperm is initiated by a decrease in the extracellular K+ concentration. However, our previous studies revealed that salmonid fish sperm motility could be initiated in the presence of an inhibitory concentration of K+ by drastic osmotic shock induced by suspension in a hypertonic glycerol solution and subsequent dilution in a hypotonic solution (glycerol-treatment). In the present study, we examined if an osmotic shock-induced water influx is involved in the regulation of salmonid fish sperm motility. HgCl2, a common inhibitor of aquaporins (AQPs), decreased the duration of salmonid fish sperm motility. Dilution of sperm cells in a hypotonic solution increased the cellular volume, whereas HgCl2 inhibited such an increase in cellular volume. Furthermore, the expression of AQP 1a and 10 in rainbow trout testes was confirmed. In contrast, HgCl2 did not affect glycerol-treated sperm motility, indicating that AQPs are not involved in glycerol-treated sperm motility. We also explored the possibility of aquaporin-independent water influx in glycerol-treated sperm by assessing the sperm membrane permeability using propidium iodide. The plasma membrane of glycerol-treated sperm was considerably permeabilized. The cellular volume was decreased in a hypertonic glycerol solution and increased upon subsequent hypoosmotic shock, indicating an AQP-independent water flux across the plasma membrane upon glycerol-treatment. Taken together, these results showed that water influx across the plasma membrane via AQP is crucial for the maintenance of salmonid fish sperm motility under normal conditions, whereas water influx by osmotic shock-induced membrane permeation is critical for the initiation of glycerol-treated sperm motility. (C) 2014 Elsevier Inc. All rights reserved.	[Takei, Gen Leon; Mukai, Chinatsu; Okuno, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Takei, Gen Leon] Dokkyo Med Univ, Dept Regulatory Physiol, Mibu, Tochigi 3210293, Japan; [Mukai, Chinatsu] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Okuno, Makoto] Chuo Univ, Dept Biosci, Bunkyo Ku, Tokyo 1228551, Japan	Takei, GL (reprint author), Dokkyo Med Univ, Dept Regulatory Physiol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	takei@dokkyomed.ac.jp					LANSMAN JB, 1987, NATURE, V325, P811, DOI 10.1038/325811a0; TAKAI H, 1995, J CELL SCI, V108, P1175; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MORISAWA M, 1980, SCIENCE, V210, P1145, DOI 10.1126/science.7444445; Takei GL, 2012, J EXP BIOL, V215, P630, DOI 10.1242/jeb.063628; Zilli L, 2009, BIOL REPROD, V81, P880, DOI 10.1095/biolreprod.109.077933; Majhi RK, 2013, CHANNELS, V7, P483, DOI 10.4161/chan.25793; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Abascal FJ, 2007, J FISH BIOL, V70, P509, DOI 10.1111/j.1095-8649.2007.01322.x; MORISAWA M, 1982, NATURE, V295, P703, DOI 10.1038/295703a0; MORISAWA M, 1983, J EXP BIOL, V107, P105; Yeung CH, 2010, INT J ANDROL, V33, P629, DOI 10.1111/j.1365-2605.2009.00998.x; Krasznai Z, 2000, P NATL ACAD SCI USA, V97, P2052, DOI 10.1073/pnas.040558097; Alavi SMH, 2006, CELL BIOL INT, V30, P1, DOI 10.1016/j.cellbr.2005.06.004; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Yeung CH, 2009, BIOL REPROD, V80, P350, DOI 10.1095/biolreprod.108.071928; BILLARD R, 1983, CELL TISSUE RES, V228, P205; Chauvigne H., 2013, BIOL REPROD IN PRESS, V113; Cosson J, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P161; Darszon A, 2012, CELL TISSUE RES, V349, P749, DOI 10.1007/s00441-012-1397-5; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Hatef A, 2011, ENVIRON TOXICOL CHEM, V30, P905, DOI 10.1002/etc.461; HAYASHI H, 1987, J BIOL CHEM, V262, P16692; Ito J, 2008, CRYOBIOLOGY, V57, P312, DOI 10.1016/j.cryobiol.2008.09.012; Kho KH, 2001, ZOOL SCI, V18, P919, DOI 10.2108/zsj.18.919; Krasznai Z, 2003, CELL MOTIL CYTOSKEL, V55, P232, DOI 10.1002/cm.10125; Martinez-Lopez P, 2011, J CELL PHYSIOL, V226, P1620, DOI 10.1002/jcp.22493; MORISAWA M, 1985, BIOMED RES-TOKYO, V6, P181; MORISAWA M, 1987, J EXP ZOOL, V242, P199, DOI 10.1002/jez.1402420211; Morita M, 2003, J EXP BIOL, V206, P913, DOI 10.1242/jeb.00153; Morita M, 2005, J EXP BIOL, V208, P4549, DOI 10.1242/jeb.01921; ODA S, 1993, CELL MOTIL CYTOSKEL, V25, P171, DOI 10.1002/cm.970250206; Perchec Poupard G, 1997, J Reprod Fertil, V110, P315; Rossato M, 1996, Mol Hum Reprod, V2, P903, DOI 10.1093/molehr/2.12.903; Saito K, 2004, J UROLOGY, V172, P2073, DOI 10.1097/01.ju.0000141499.08650.ab; Sohara E, 2007, FERTIL STERIL, V87, P671, DOI 10.1016/j.fertnstert.2006.07.1522; Zilli L, 2011, THERIOGENOLOGY, V76, P737, DOI 10.1016/j.theriogenology.2011.04.006	41	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1095-6433	1531-4332		COMP BIOCHEM PHYS A	Comp. Biochem. Physiol. A-Mol. Integr. Physiol.	APR	2015	182						84	92		10.1016/j.cbpa.2014.12.013		9	Biochemistry & Molecular Biology; Physiology; Zoology	Biochemistry & Molecular Biology; Physiology; Zoology	CE2KV	WOS:000351645400012		
J	Matsumoto, Y; Ju, YT; Yamashiro, T; Yamashiro, A				Matsumoto, Yuki; Ju, Yu-ten; Yamashiro, Tadashi; Yamashiro, Asuka			Evidence of pre-introduction hybridization of Formosan sika deer (Cervus nippon taiouanus) on Okinoshima, Wakayama Prefecture, Japan, based on mitochondrial and nuclear DNA sequences	CONSERVATION GENETICS			English	Article						Formosan sika deer; Hybridization; Introduced deer; mtDNA; Nuclear DNA	C-ELAPHUS	To examine the origin of the Formosan sika deer (Cervus nippon taiouanus) introduced to the island of Okinoshima (Wakayama Prefecture, Japan), sixteen tissue samples from Okinoshima population were analyzed to determine sequence variation in maternal mitochondrial DNA (mtDNA) cytochrome b and nuclear DNA alpha-lactalbumin (alpha LAlb). Three cytochrome b haplotypes were found in the Okinoshima population, two Formosan sika deer haplotypes and one Formosan sambar (C. unicolor swinhoei) haplotype. Three nuclear DNA alpha LAlb sequences, i.e. Formosan sika deer, red deer (C. elaphus), and additional one unknown sequence were detected in the population. Cytonuclear disequilibrium was observed in five individuals, indicating that the Okinoshima population have occurrence of hybrid among the three deer species. The deer introduced on Okinoshima might have originated from a private deer-breeding facility in Taiwan. To avoid native Japanese sika deer (e.g. C. n. centralis) genetic introgression, the Okinoshima population should be isolated from native Japanese sika deer populations.	[Matsumoto, Yuki] Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Dept Genet, Hayama, Kanagawa 2400193, Japan; [Ju, Yu-ten] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10673, Taiwan; [Yamashiro, Tadashi] Univ Tokushima, Grad Sch Integrated Arts & Sci, Tokushima 7708502, Japan; [Yamashiro, Asuka] Univ Tokushima, Res Ctr Management Disaster & Environm, Tokushima 7708506, Japan	Yamashiro, A (reprint author), Univ Tokushima, Res Ctr Management Disaster & Environm, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	as77026@yahoo.co.jp		Ju, Yu-Ten/0000-0002-5120-6960			Osborne MJ, 2013, CONSERV GENET, V14, P637, DOI 10.1007/s10592-013-0457-z; McCullough Dale R., 2009, P549, DOI 10.1007/978-4-431-09429-6_37; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.1890/1540-9295(2005)003[0012:ISPMAF]2.0.CO;2; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Yamashiro A, 2010, CONSERV GENET RESOUR, V2, P409, DOI 10.1007/s12686-010-9281-7; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Randi E, 2001, ANIM CONSERV, V4, P1, DOI 10.1017/S1367943001001019; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Asher GW, 1999, J HERED, V90, P236, DOI 10.1093/jhered/90.1.236; Banwell D. Bruce, 2009, P643, DOI 10.1007/978-4-431-09429-6_42; Bartos Ludek, 2009, P573, DOI 10.1007/978-4-431-09429-6_39; Feldhamer George A., 2009, P615, DOI 10.1007/978-4-431-09429-6_41; Fukushima S, 1983, SCI SURVEYS TOMOGASH, P67; GEIST V, 1992, NATURE, V357, P274, DOI 10.1038/357274a0; Groves C.P., 1987, P21; Imaizumi Y, 1960, COLORED ILLUSTRATION, P187; JOY JE, 1985, J COMP PHYSIOL A, V156, P125, DOI 10.1007/BF00610673; Muir PD, 1997, J HERED, V88, P366; Ohtaishi N, 1986, MAMMAL SCI, V53, P13; Rust C. C., 1962, Journal of Mammalogy, V43, P323, DOI 10.2307/1376938; Sambrook J., 1989, MOL CLONING LAB MANU, P1659; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Senn HV, 2010, MOL ECOL, V19, P910, DOI 10.1111/j.1365-294X.2009.04497.x; Swanson Graeme M., 2009, P595, DOI 10.1007/978-4-431-09429-6_40; Tokida K, 1998, RECONNAISSANCE REPOR, P102; Tsujii H, 1988, SUSTAIN LIVEST PROD, V42, P1143; Yen S. C., 2012, J NATL PARK, V22, P27	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-0621	1572-9737		CONSERV GENET	Conserv. Genet.	APR	2015	16	2					497	502		10.1007/s10592-014-0675-z		6	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CD7RA	WOS:000351287400020		
J	Kakehi, S; Ito, S; Kuwata, A; Saito, H; Tadokoro, K				Kakehi, Shigeho; Ito, Shin-ichi; Kuwata, Akira; Saito, Hiroaki; Tadokoro, Kazuaki			Phytoplankton distribution during the winter convective season in Sendai Bay, Japan	CONTINENTAL SHELF RESEARCH			English	Article						Winter diatom bloom; Ecosystem model; Critical bottom depth; Oceanic water intrusion; Sendai Bay, Japan	SPRING DIATOM BLOOM; LIGHT-LIMITATION; DYNAMICS; ESTUARY; DEPTH; MODEL; RATIO; PHOTOSYNTHESIS; PRODUCTIVITY; TEMPERATURE	We investigated the elevated chlorophyll-a (Chl-a) zone found along the coast in winter in Sendai Bay, Japan, using hydrographic observations and a one-dimensional ecosystem model. Chlorophyll-a distribution was vertically homogeneous with a horizontal gradient and could be approximated as a power function of bottom depth; Chl-a concentration drastically increased with decreasing bottom depth, despite temperature and salinity being almost vertically and horizontally homogeneous. The observed results revealed significant correlations among Chl-a and nutrients concentrations proportional to the Redfield ratio. Diatoms accounted for more than 99% of the detected total cells, indicating the occurrence of a diato m bloom. A one-dimensional ecosystem model, which incorporated vertical mixing and the self-shading effect of phytoplankton, revealed that bottom depth was responsible for the occurrence of the bloom during the convective season in coastal area where vertical mixing reached the bottom and that there existed the critical bottom depth where the integrated Chl-a in the water column remained constant. A bloom could occur where the bottom depth is shallower than the critical bottom depth, not when the depth of the mixed layer is shallower than the classical critical depth and the stratification is established. From the observational and model results, it is suggested that the diatom bloom was induced by oceanic water intrusion, which transported nutrients to the bay and the elevated Chl-a zone was formed within a month after the intrusion. (C) 2015 Elsevier Ltd. All rights reserved.	[Kakehi, Shigeho; Ito, Shin-ichi; Kuwata, Akira; Tadokoro, Kazuaki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; [Saito, Hiroaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Kakehi, S (reprint author), Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, 3-27-5 Shinhama Cho, Shiogama, Miyagi 9850001, Japan.	kakehi@affrc.go.jp	Ito, Shin-ichi/E-2981-2012	Ito, Shin-ichi/0000-0002-3635-2580	project "Environmental Research for Damaged Fisheries Ground" - Fisheries Agency, Japan; project "Core Research for Evolutional Science and Technology (CREST)" - Japan Science and Technology Agency, Japan	We thank the captain and crew of the R/V Dainana-Kaiyo-Maru, and participating investigators, especially chief investigator K. Kawakami, of Fuyo Ocean Development 82 Engineering Co., Ltd. for data acquisition. We also thank N. Numakura and A. Izumi of the Tohoku National Fisheries Research Institute and Y. Sasaki of Hokkaido National Fisheries Research Institute for sample analysis, and members of Tohoku National Fisheries Research Institute for helping conduct the cruise. MODIS derived chlorophyll-a images were downloaded from the JAXA/EOC website (http://kuroshio.eorc.jaxa.jp/ADEOS/mod_nrt_new/index.html). Part of this research was supported by the project "Environmental Research for Damaged Fisheries Ground", funded by the Fisheries Agency, Japan and the project "Core Research for Evolutional Science and Technology (CREST)" funded by the Japan Science and Technology Agency, Japan.	BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Lucas LV, 1998, J MAR RES, V56, P375, DOI 10.1357/002224098321822357; Yoshie N, 2003, J OCEANOGR, V59, P563, DOI 10.1023/B:JOCE.0000009586.02554.d3; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Irigoien X, 1997, ESTUAR COAST SHELF S, V44, P507, DOI 10.1006/ecss.1996.0132; Shikata T, 2010, NIPPON SUISAN GAKK, V76, P34; Kakinuma M, 2008, CELL BIOL TOXICOL, V24, P629, DOI 10.1007/s10565-007-9053-7; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Findlay HS, 2006, J PLANKTON RES, V28, P209, DOI 10.1093/plankt/fbi114; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137; SHIGESADA N, 1981, J MATH BIOL, V12, P311, DOI 10.1007/BF00276919; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; HITCHCOCK GL, 1977, LIMNOL OCEANOGR, V22, P126; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Cloern James E., 1999, Aquatic Ecology, V33, P3, DOI 10.1023/A:1009952125558; CLOERN JE, 1991, J MAR RES, V49, P203, DOI 10.1357/002224091784968611; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Gohin F, 2003, CONT SHELF RES, V23, P1117, DOI 10.1016/S0278-4343(03)00088-8; IKUSIMA I, 1967, BOT MAG TOKYO, V80, P57; Kawamiya Michio, 1995, Journal of Oceanography, V51, P635, DOI 10.1007/BF02235457; Kudo H., 1971, INFLOW OPEN SEA WATE, V4, P9; Parsons T.R, 1984, MANUAL CHEM BIOL MET; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, P87; PENNOCK JR, 1985, ESTUAR COAST SHELF S, V21, P711, DOI 10.1016/0272-7714(85)90068-X; Redfield A. C., 1963, SEA, V2, P26; RILEY GA, 1957, LIMNOL OCEANOGR, V2, P252; Rousseaux S.G.C., 2012, CONT SHELF RES, V32, P22; Saito H, 2003, PROG OCEANOGR, V57, P251, DOI 10.1016/S0079-0011(03)00100-9; Sverdrup H. U., 1953, J CONS CONS PERM INT, V18, P287, DOI DOI 10.1093/ICESJMS/18.3.287; Tomas C.R., 1997, IDENTIFYING MARINE P; Watanabe K., 1985, PHYS SENDAI BAY, P263; Yamaguchi M., 1996, B NANSEI NATL FISH R, V29, P59; Yokouchi Katsumi, 1998, Bulletin of Tohoku National Fisheries Research Institute, V60, P1	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-4343	1873-6955		CONT SHELF RES	Cont. Shelf Res.	APR 1	2015	97						43	53		10.1016/j.csr.2015.02.005		11	Oceanography	Oceanography	CE4HA	WOS:000351790500005		
J	Machida, S; Kaneko, M; Kurosaka, D				Machida, Shigeki; Kaneko, Muneyoshi; Kurosaka, Daijiro			Regional Variations in Correlation between Photopic Negative Response of Focal Electoretinograms and Ganglion Cell Complex in Glaucoma	CURRENT EYE RESEARCH			English	Article						Ganglion cell complex; glaucoma; photopic negative response; PhNR	VISUAL-FIELD SENSITIVITY; FLASH ELECTRORETINOGRAM; OSCILLATORY POTENTIALS; CLINICAL PERIMETRY; HUMAN RETINA; REDUCTION; THICKNESS; TOPOGRAPHY; ATROPHY; LOSSES	Purpose: To determine regional variations in a structure-function relationship, we correlated the the photopic negative response (PhNR) of the focal electoretinogram (ERG) with the ganglion cell complex (GCC) thickness in different retinal regions in patients with open angle glaucoma (OAG). Methods: Fifty-one eyes of 51 OAG patients (OAG group) and 17 eyes of 17 normal volunteers (control group) were studied. The OAG patients had different degrees of glaucoma ranging from early to advanced stages. The focal ERGs were elicited by a white, 15 degrees hemispherical stimulus placed superior or inferior to the fovea. Focal ERGs were also elicited by a half annulus placed superior or inferior to the macular region. The diameter of the inner border of the annulus was 15 degrees and that of the outer border was 30 degrees. The average GCC thickness in areas corresponding to the location of the stimuli was measured in SD-OCT images. Results: The PhNR amplitude and PhNR/b-wave amplitude ratio were significantly correlated with the GCC thickness in the superior and inferior hemispherical areas (p<0.0001). These ERG parameters were weakly correlated with the GCC thickness in the superior and inferior semi-annular areas (p<0.05). There were significant differences in the slopes of the regression lines plotting the GCC thickness and the PhNR amplitude or the PhNR/b-wave amplitude ratio between the spherical and semi-annular areas (superior: p<0.01, inferior: p<0.0005). Conclusions: The thinning of the GCC affects the RGC function measured by the PhNR more strongly in the central retinal area than in the surrounding retinal areas.	[Machida, Shigeki; Kaneko, Muneyoshi; Kurosaka, Daijiro] Iwate Med Univ, Sch Med, Dept Ophthalmol, Morioka, Iwate 020, Japan; [Machida, Shigeki] Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, Koshigaya, Saitama 3438555, Japan	Machida, S (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	smachida57@gmail.com			JSPS KAKENHI [24592677, 24592639]	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article. This study was supported by JSPS KAKENHI Grant No. 24592677 (SM) and 24592639 (MK). Institutional Review Board of Iwate Medical University approved this research.	Anderson D. R., 1999, AUTOMATED STATIC PER; Machida S, 2004, AM J OPHTHALMOL, V137, P938, DOI 10.1016/j.ajo.2003.10.023; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P2201, DOI 10.1167/iovs.07-0887; Harwerth RS, 2006, ARCH OPHTHALMOL-CHIC, V124, P853, DOI 10.1001/archopht.124.6.853; Cho JW, 2010, INVEST OPHTH VIS SCI, V51, P6401, DOI 10.1167/iovs.09-5035; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Tan Ou, 2009, Ophthalmology, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P5044, DOI 10.1167/iovs.11-9401; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P5636, DOI 10.1167/iovs.08-1946; Machida S, 2010, BRIT J OPHTHALMOL, V94, P202, DOI 10.1136/bjo.2009.161166; Nakamura H, 2011, AM J OPHTHALMOL, V151, P494, DOI 10.1016/j.ajo.2010.09.018; Kondo M, 2008, INVEST OPHTH VIS SCI, V49, P3544, DOI 10.1167/iovs.08-1798; Harwerth RS, 2004, INVEST OPHTH VIS SCI, V45, P3152, DOI 10.1167/iovs.04-0227; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DRASDO N, 1989, VISION RES, V29, P985, DOI 10.1016/0042-6989(89)90113-2; Harwerth RS, 2005, ACTA OPHTHALMOL SCAN, V83, P448, DOI 10.1111/j.1600-0420.2005.00494.x; Kaneko M, CURR EYE RE IN PRESS; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Kondo M, 1998, INVEST OPHTH VIS SCI, V39, P574; Machida S, 2012, J OPHTHALMOL, DOI 10.1155/2012/397178; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; MIYAKE Y, 1981, JPN J OPHTHALMOL, V25, P438; MIYAKE Y, 1989, INVEST OPHTH VIS SCI, V30, P1743; Miyake Y., 1988, ACTA SOC OPHTHALMOL, V92, P1419; Miyata K, 2007, INVEST OPHTH VIS SCI, V48, P820, DOI 10.1167/iovs.06-0845; Nagata M, 1963, JPN J OPHTHALMOL, V7, P96; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117; Tamada K, 2010, CURR EYE RES, V35, P155, DOI 10.3109/02713680903447926; Ueno S, 2006, INVEST OPHTH VIS SCI, V47, P3545, DOI 10.1167/iovs.05-1481; Wang J, 2012, INVEST OPHTH VIS SCI, V53, P1315, DOI 10.1167/iovs.11-8461	36	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	APR	2015	40	4					439	449		10.3109/02713683.2014.922196		11	Ophthalmology	Ophthalmology	CD9XU	WOS:000351454800011		
J	Sakai, F				Sakai, Fumihiko			Oral Triptans in Children and Adolescents: An Update	CURRENT PAIN AND HEADACHE REPORTS			English	Review						Triptan; Placebo; Children; Adolescents; Migraine; Rizatriptan; Sumatriptan; Naproxen; Randomized controlled trial; FDA; Run-in phase; Combination drug	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PEDIATRIC MIGRAINEURS; RANDOMIZED-TRIAL; SUMATRIPTAN; RIZATRIPTAN; EFFICACY; TOLERABILITY; POPULATION; CHILDHOOD	This review evaluates the recent progress in clinical trials on oral triptans for acute migraine in children and adolescents. Randomized controlled trials (RCT) on the treatment of migraine in pediatric patients were rare and difficult to design. In particular, high placebo response in many of the trials made it difficult to prove efficacy of triptans. Using a "novel study design" for RCT, a study successfully proved the efficacy of an oral rizatriptan. This trial enrolled patients with unsatisfactory response to nonsteroidal anti-inflammatory or acetaminophen and with migraine lasting longer than 3 h. Rizatriptan was approved by Food and Drug Administration (FDA) (USA) for children and adolescents of 6-17 years. The triptan-NSAID combination drug for pediatric patients also showed efficacy.	Saitama Neuropsychiat Inst, Saitama Int Headache Ctr, Chuo Ku, Saitama, Saitama 3388577, Japan	Sakai, F (reprint author), Saitama Neuropsychiat Inst, Saitama Int Headache Ctr, Chuo Ku, 6-11-1 Honmachi Higashi, Saitama, Saitama 3388577, Japan.	fsakai@mist.dti.ne.jp					Vollono C, 2011, EXPERT REV NEUROTHER, V11, P395, DOI [10.1586/ern.10.147, 10.1586/ERN.10.147]; Sun HH, 2013, JAMA PEDIATR, V167, P243, DOI 10.1001/jamapediatrics.2013.872; Linder SL, 2008, HEADACHE, V48, P1326, DOI 10.1111/j.1526-4610.2008.01138.x; Hamalainen M, 2014, CEPHALALGIA, V34, P325, DOI 10.1177/0333102413510214; Derosier FJ, 2012, PEDIATRICS, V129, pE1411, DOI 10.1542/peds.2011-2455; Kernick D, 2009, BRIT J GEN PRACT, V59, P678, DOI 10.3399/bjgp09X454142; Ho TW, 2012, CEPHALALGIA, V32, P750, DOI 10.1177/0333102412451358; Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Hewitt DJ, 2013, HEADACHE, V53, P104, DOI 10.1111/j.1526-4610.2012.02285.x; Ahonen K, 2004, NEUROLOGY, V62, P883; Ahonen K, 2006, NEUROLOGY, V67, P1135, DOI 10.1212/01.wnl.0000238179.79888.44; Evers S, 2009, CEPHALALGIA, V29, P436, DOI 10.1111/j.1468-2982.2008.01752.x; Arruda MA, 2012, NEUROLOGY, V79, P1881, DOI 10.1212/WNL.0b013e318271f812; Eiland Lea S, 2010, Paediatr Drugs, V12, P379, DOI 10.2165/11532860-000000000-00000; Evers S, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0342-y; Fernandes R, 2008, J PEDIATR, V152, P527, DOI 10.1016/j.jpeds.2007.09.024; Fraser IP, 2012, HEADACHE, V52, P625, DOI 10.1111/j.1526-4610.2011.02069.x; Fujita M, 2014, CEPHALALGIA, V34, P365, DOI 10.1177/0333102413510213; Lewis Donald W., 2005, Headache, V45, P232, DOI 10.1111/j.1526-4610.2005.05050.x; Lindkvist J, 2011, BRIT J CLIN PHARMACO, V71, P929, DOI 10.1111/j.1365-2125.2010.03881.x; Winner P, 2006, HEADACHE, V46, P212, DOI 10.1111/j.1526-4610.2006.00339.x	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1531-3433	1534-3081		CURR PAIN HEADACHE R	Curr. Pain Headache Rep.	APR	2015	19	4							8	10.1007/s11916-015-0478-z		4	Clinical Neurology	Neurosciences & Neurology	CE0SR	WOS:000351517000004		
J	Kawai, T; Katagiri, W; Osugi, M; Sugimura, Y; Hibi, H; Ueda, M				Kawai, Takamasa; Katagiri, Wataru; Osugi, Masashi; Sugimura, Yukiko; Hibi, Hideharu; Ueda, Minoru			Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration	CYTOTHERAPY			English	Article						angiogenesis; conditioned medium; mesenchymal stromal cell; migration; paracrine effects; periodontal regeneration	ENDOTHELIAL GROWTH-FACTOR; PLATELET-RICH PLASMA; STEM-CELLS; MORPHOGENETIC PROTEIN-2; FURCATION DEFECTS; IN-VIVO; ANGIOGENESIS; MODEL; TIE2; ANGIOPOIETIN-1	Background aims. Periodontal tissue regeneration with the use of mesenchymal stromal cells (MSCs) has been regarded as a future cell-based therapy. However, low survival rates and the potential tumorigenicity of implanted MSCs could undermine the efficacy of cell-based therapy. The use of conditioned media from MSCs (MSC-CM) may be a feasible approach to overcome these limitations. The aim of this study was to confirm the effect of MSC-CM on periodontal regeneration. Methods. MSC-CM were collected during their cultivation. The concentrations of the growth factors in MSC-CM were measured with the use of enzyme-linked immunoassay. Rat MSCs (rMSCs) and human umbilical vein endothelial cells cultured in MSC-CM were assessed on wound-healing and angiogenesis. The expressions of osteogenetic- and angiogenic-related genes of rMSCs cultured in MSC-CM were quantified by means of real-time reverse transcriptase polymerase chain reaction analysis. In vivo, periodontal defects were prepared in the rat models and the collagen sponges with MSC-CM were implanted. Results. MSC-CM includes insulin-like growth factor-1, vascular endothelial growth factor, transforming growth factor-beta 1 and hepatocyte growth factor. In vitro, wound-healing and angiogenesis increased significantly in MSC-CM. The levels of expression of osteogenetic- and angiogenic-related genes were significantly upregulated in rMSCs cultured with MSC-CM. In vivo, in the MSC-CM group, 2 weeks after implantation, immunohistochemical analysis showed several CD31-, CD 105- or FLK-1 positive cells occurring frequently. At 4 weeks after implantation, regenerated periodontal tissue was observed in MSC-CM groups. Conclusions. The use of MSC-CM may be an alternative therapy for periodontal tissue regeneration because several cytokines included in MSC-CM will contribute to many processes of complicated periodontal tissue regeneration.	[Kawai, Takamasa; Katagiri, Wataru; Osugi, Masashi; Sugimura, Yukiko; Hibi, Hideharu; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan	Katagiri, W (reprint author), Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	w-kat@med.nagoya-u.ac.jp	Hibi, Hideharu/E-4443-2015	Hibi, Hideharu/0000-0003-0248-7476			Al-Khaldi A, 2003, ANN THORAC SURG, V75, P204, DOI 10.1016/S0003-4975(02)04291-1; Anitua E, 2013, J PERIODONTOL, V84, P1556, DOI 10.1902/jop.2013.120556; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Katagiri W, 2013, INT J ORAL MAX IMPL, V28, P1009, DOI 10.11607/jomi.3036; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Van Belle E, 1998, CIRCULATION, V97, P381; Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048; Nakamura Y, 2007, STEM CELLS, V25, P612, DOI 10.1634/stemcells.2006-0168; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.TEA.2011.0325, 10.1089/ten.tea.2011.0325]; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Giannobile WV, 1998, J PERIODONTOL, V69, P129; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Kawasaki K, 1998, BONE, V23, P223, DOI 10.1016/S8756-3282(98)00105-7; Perri B, 2007, SPINE J, V7, P235, DOI 10.1016/j.spinee.2006.04.010; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; SPENCER EM, 1991, BONE, V12, P21, DOI 10.1016/8756-3282(91)90050-S; LYNCH SE, 1989, J CLIN PERIODONTOL, V16, P545, DOI 10.1111/j.1600-051X.1989.tb02334.x; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Perin EC, 2009, CATHETER CARDIO INTE, V73, P281, DOI 10.1002/ccd.21807; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Di Santo S, 2009, PLOS ONE, V4, P11; Esposito M, 2009, COCHRANE DATABASE SY, V69; GANTES B, 1988, J CLIN PERIODONTOL, V15, P232, DOI 10.1111/j.1600-051X.1988.tb01576.x; Han XZ, 2003, J PERIODONTOL, V74, P1176, DOI 10.1902/jop.2003.74.8.1176; Kikuchi Takeshi, 2006, Clin Calcium, V16, P241; Kinoshita A, 1997, J PERIODONTOL, V68, P103; Mohammed S, 1998, J PERIODONTAL RES, V33, P335, DOI 10.1111/j.1600-0765.1998.tb02208.x; Shirakata Y, 2013, INT J PERIODONT REST, V33, P641, DOI 10.11607/prd.0989; Villar Cristina C, 2010, Dent Clin North Am, V54, P73, DOI 10.1016/j.cden.2009.08.011; Wislet-Gendebien S, 2012, PLOS ONE, V7, P13; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514	50	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	APR	2015	17	4					369	381		10.1016/j.jcyt.2014.11.009		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CE0IC	WOS:000351486700004		
J	Iwasaki, H				Iwasaki, H.			Bayesian belief network analysis applied to determine the progression of temporomandibular disorders using MRI	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						temporomandibular joint disorders; magnetic resonance imaging; Bayesian method; algorithms; computer simulation	BONE-TUMORS; DIAGNOSTIC-CRITERIA; MEDICAL DIAGNOSIS; DISC DISPLACEMENT; JOINT EFFUSION; MODEL; SIGNS; OSTEOARTHROSIS; ASSOCIATION; REDUCTION	Objectives: This study investigated the applicability of a Bayesian belief network (BBN) to MR images to diagnose temporomandibular disorders (TMDs). Our aim was to determine the progression of TMDs, focusing on how each finding affects the other. Methods: We selected 1.5-T MRI findings (33 variables) and diagnoses (bone changes and disc displacement) of patients with TMD from 2007 to 2008. There were a total of 295 cases with 590 sides of temporomandibular joints (TMJs). The data were modified according to the research diagnostic criteria of TMD. We compared the accuracy of the BBN using 11 algorithms (necessary path condition, path condition, greedy search-and-score with Bayesian information criterion, Chow-Liu tree, Rebane-Pearl poly tree, tree augmented naive Bayes model, maximum log likelihood, Akaike information criterion, minimum description length, K2 and C4.5), a multiple regression analysis and an artificial neural network using resubstitution validation and 10-fold cross-validation. Results: There were 191 TMJs (32.4%) with bone changes and 340 (57.6%) with articular disc displacement. The BBN path condition algorithm using resubstitution validation and 10-fold cross-validation was >99% accurate. However, the main advantage of a BBN is that it can represent the causal relationships between different findings and assign conditional probabilities, which can then be used to interpret the progression of TMD. Conclusions: Osteoarthritic bone changes progressed from condyle to articular fossa and finally to mandibular bone contours. Disc displacement was directly related to severe bone changes. Early bone changes were not directly related to disc displacement. TMJ functional factors (condylar translation, bony space and disc form) and age mediated between bone changes and disc displacement.	Univ Tokushima, Inst Hlth Biosci, Fac Dent, Support Off Frontier Oral,Grad Sch, Tokushima 770, Japan	Iwasaki, H (reprint author), Univ Tokushima, Inst Hlth Biosci, Fac Dent, Support Off Frontier Oral,Grad Sch, Tokushima 770, Japan.	iwasaki@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20592203]	This study was supported in part by a Grant-In-Aid for Scientific Research (number 20592203) provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abby LM, 1987, J DENT EDUC, V51, P475; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Alkhader M, 2010, DENTOMAXILLOFAC RAD, V39, P270, DOI 10.1259/dmfr/25151578; Aldrich J, 1997, STAT SCI, V12, P162; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; LODWICK GS, 1963, RADIOLOGY, V80, P273; Burnside ES, 2009, RADIOLOGY, V251, P663, DOI 10.1148/radiol.2513081346; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; LAURITZEN SL, 1995, COMPUT STAT DATA AN, V19, P191, DOI 10.1016/0167-9473(93)E0056-A; Bertram S, 2011, J ORAL MAXIL SURG, V69, P1898, DOI 10.1016/j.joms.2010.12.026; Busato A, 2010, ORAL SURG ORAL MED O, V110, pE34, DOI 10.1016/j.tripleo.2010.04.014; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; Classification of TMD (verification committee for the classification of TMJ disorder and RDC/TMD by Japanese Society for Temporomandibular Joints), 2013, J JPN SOC TMJ, V25, P177; COLLEN MF, 1964, AM J PUBLIC HEALTH N, V54, P741, DOI 10.2105/AJPH.54.5.741; Cormen TH, 2009, INTRO ALGORITHMS, P414; DELEEUW R, 1995, ORAL SURG ORAL MED O, V79, P382; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Gidarakou IK, 2004, ANGLE ORTHOD, V74, P684; Grundal PD, 2007, MINIMUM DESCRIPTION; Huber JS, 1990, ORAL SURG ORAL MED O, V69, P263; Kambylafkas P, 2005, ANGLE ORTHOD, V75, P305; Lejbkowicz I, 2002, COMPUT METH PROG BIO, V67, P137, DOI 10.1016/S0169-2607(01)00115-8; LODWICK GS, 1965, RADIOL CLIN N AM, V3, P487; LODWICK GS, 1966, J CHRON DIS, V19, P485, DOI 10.1016/0021-9681(66)90122-6; Manfredimi D, 2009, ORAL SURG ORAL MED O, V107, P266, DOI 10.1016/j.tripleo.2008.03.033; Matsumoto M, 2010, SIKOKU DENT RES, V22, P167; Orlando B, 2009, MED ORAL PATOL ORAL, V14, pE188; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Rebane G, 1998, P 3 C UNC ART INT 10; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, P532, DOI DOI 10.1007/978-0-387-39940-9_; SCHELLHAS KP, 1992, CRANIO, V10, P248; Seigel MA, 1993, DENT CLIN N AM, V37, P113; Sox HC, 2013, MED DECIS MAKING, P61; Spirtes P, 2000, CAUSATION PREDICTION, P84; Steck H, 1999, P 2 WORKSH DAT MIN D; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; Uemura S, 1990, DENT RADIOL, V30, P211; WARNER HR, 1961, JAMA-J AM MED ASSOC, V177, P177; WELLWOOD JM, 1989, BRIT J HOSP MED, V41, P564; White S C, 1989, Dentomaxillofac Radiol, V18, P53; White S C, 1996, J Dent Educ, V60, P47; Widmalm SE, 2006, DENTOMAXILLOFAC RAD, V35, P334, DOI 10.1259/dmfr/23427399; WIENER F, 1986, INT J ORAL MAX SURG, V15, P592; Yano K, 2009, ORAL SURG ORAL MED O, V108, pE30, DOI 10.1016/j.tripleo.2009.06.006	48	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	APR	2015	44	4							20140279	10.1259/dmfr.20140279		12	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	CE5FH	WOS:000351855800005		
J	Nagai, H; Sezaki, M; Kakiguchi, K; Nakaya, Y; Lee, HC; Ladher, R; Sasanami, T; Han, JY; Yonemura, S; Sheng, GJ				Nagai, Hiroki; Sezaki, Maiko; Kakiguchi, Kisa; Nakaya, Yukiko; Lee, Hyung Chul; Ladher, Raj; Sasanami, Tomohiro; Han, Jae Yong; Yonemura, Shigenobu; Sheng, Guojun			Cellular analysis of cleavage-stage chick embryos reveals hidden conservation in vertebrate early development	DEVELOPMENT			English	Article						Amniote; Cellularization; Chick; Cleavage; Yolk syncytium; Zygotic gene activation	PRIMITIVE STREAK FORMATION; COMPLEMENTARY NORMAL TABLE; ZYGOTIC GENE ACTIVATION; PRIMORDIAL GERM-CELLS; STEM-CELLS; 1ST STAGES; MOUSE; TRANSITION; SPECIFICATION; TROPHECTODERM	Birds and mammals, phylogenetically close amniotes with similar postgastrula development, exhibit little conservation in their post-fertilization cleavage patterns. Data from the mouse suggest that cellular morphogenesis and molecular signaling at the cleavage stage play important roles in lineage specification at later (blastula and gastrula) stages. Very little is known, however, about cleavage-stage chick embryos, owing to their poor accessibility. This period of chick development takes place before egg-laying and encompasses several fundamental processes of avian embryology, including zygotic gene activation (ZGA) and blastoderm cell-layer increase. We have carried outmorphological and cellular analyses of cleavage-stage chick embryos covering the first half of pre-ovipositional development, from Eyal-Giladi and Kochav stage (EGK-) I to EGK-V. Scanning electron microscopy revealed remarkable subcellular details of blastomere cellularization and subgerminal cavity formation. Phosphorylated RNA polymerase II immunostaining showed that ZGA in the chick starts at early EGK-III during the 7th to 8th nuclear division cycle, comparable with the time reported for other yolk-rich vertebrates (e.g. zebrafish and Xenopus). The increase in the number of cell layers after EGK-III is not a direct consequence of oriented cell division. Finally, we present evidence that, as in the zebrafish embryo, a yolk syncytial layer is formed in the avian embryo after EGK-V. Our data suggest that several fundamental features of cleavage-stage development in birds resemble those in yolk-rich anamniote species, revealing conservation in vertebrate early development. Whether this conservation lends morphogenetic support to the anamniote-to-amniote transition in evolution or reflects developmental plasticity in convergent evolution awaits further investigation.	[Nagai, Hiroki; Sezaki, Maiko; Nakaya, Yukiko; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan; [Kakiguchi, Kisa; Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Electron Microscopy Lab, Kobe, Hyogo 6500047, Japan; [Lee, Hyung Chul; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Ladher, Raj] RIKEN, Ctr Dev Biol, Lab Sensory Dev, Kobe, Hyogo 6500047, Japan; [Sasanami, Tomohiro] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Sheng, GJ (reprint author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/I-4900-2015		RIKEN Center for Developmental Biology	This work was supported by an internal grant to G.S. from RIKEN Center for Developmental Biology. Deposited in PMC for immediate release.	Alev C, 2013, METHODS MOL BIOL, V1074, P151, DOI 10.1007/978-1-62703-628-3_12; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Leichsenring M, 2013, SCIENCE, V341, P1005, DOI 10.1126/science.1242527; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Hong SK, 2011, DEVELOPMENT, V138, P787, DOI 10.1242/dev.058974; Sheng GJ, 2014, DEV DYNAM, V243, P357, DOI 10.1002/dvdy.24087; Watanabe T, 2014, DEVELOPMENT, V141, P2279, DOI 10.1242/dev.103267; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; BELLAIRS R, 1978, J EMBRYOL EXP MORPH, V43, P55; Bellier S, 1997, EMBO J, V16, P6250, DOI 10.1093/emboj/16.20.6250; Danilchik MV, 2003, J CELL SCI, V116, P273, DOI 10.1242/jcs.00217; Eyal-Giladi H., 1991, Critical Reviews in Poultry Biology, V3, P143; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; GIPSON I, 1974, J ULTRA MOL STRUCT R, V49, P331, DOI 10.1016/S0022-5320(74)90049-5; Ikenouchi J, 2013, J CELL SCI, V126, P3585, DOI 10.1242/jcs.122325; KOCHAV S, 1971, SCIENCE, V171, P1027, DOI 10.1126/science.171.3975.1027; KOCHAV S, 1980, DEV BIOL, V79, P296, DOI 10.1016/0012-1606(80)90117-7; Lee HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080631; Li WM, 2006, EXP CELL RES, V312, P3260, DOI 10.1016/j.yexcr.2006.06.028; Sun YH, 2014, DEV CELL, V28, P322, DOI 10.1016/j.devcel.2014.01.003; WATT JM, 1993, J MORPHOL, V215, P165, DOI 10.1002/jmor.1052150205	38	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	APR 1	2015	142	7					1279	1286		10.1242/dev.118604		8	Developmental Biology	Developmental Biology	CE3BB	WOS:000351698000007		
J	Shinagawa, T; Huynh, LM; Takagi, T; Tsukamoto, D; Tomaru, C; Kwak, HG; Dohmae, N; Noguchi, J; Ishii, S				Shinagawa, Toshie; Linh My Huynh; Takagi, Tsuyoshi; Tsukamoto, Daisuke; Tomaru, Chinatsu; Kwak, Ho-Geun; Dohmae, Naoshi; Noguchi, Junko; Ishii, Shunsuke			Disruption of Th2a and Th2b genes causes defects in spermatogenesis	DEVELOPMENT			English	Article						Cohesin; Histone replacement; Histone variants; Spermatogenesis; Mouse	CHROMATIN-STRUCTURE; MAMMALIAN MEIOSIS; HISTONE VARIANTS; COHESIN; TESTIS; CELLS; SUBUNIT; SPERMIOGENESIS; CHROMOSOMES; OOCYTES	The variant histones TH2A and TH2B are abundant in the testis, but their roles in spermatogenesis remain elusive. Here, we show that male mutant mice lacking both Th2a and Th2b genes were sterile, with few sperm in the epididymis. In the mutant testis, the lack of TH2B was compensated for by overexpression of H2B, whereas overexpression of H2A was not observed, indicating a decrease in the total histone level. Mutant mice exhibited two defects: incomplete release of cohesin at interkinesis after meiosis I and histone replacement during spermiogenesis. In the mutant testis, secondary spermatocytes at interkinesis accumulated and cohesin was not released normally, suggesting that the retained cohesion of sister chromatids delayed the subsequent entry into meiosis II. In addition, impaired chromatin incorporation of TNP2 and degenerated spermatids were observed in the mutant testis. These results suggest that a loss of TH2A and TH2B function in chromatin dynamics or a decrease in the total histone levels causes defects in both cohesin release and histone replacement during spermatogenesis.	[Shinagawa, Toshie; Linh My Huynh; Takagi, Tsuyoshi; Tsukamoto, Daisuke; Tomaru, Chinatsu; Ishii, Shunsuke] RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Shinagawa, Toshie; Linh My Huynh; Takagi, Tsuyoshi; Tsukamoto, Daisuke; Tomaru, Chinatsu; Ishii, Shunsuke] JST Japan Sci & Technol Agcy, CREST Res Project, Tsukuba, Ibaraki 3050074, Japan; [Shinagawa, Toshie; Linh My Huynh; Tomaru, Chinatsu; Ishii, Shunsuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Kwak, Ho-Geun; Dohmae, Naoshi] Saitama Univ, RIKEN, Grad Sch Sci & Engn, Global Res Cluster, Wako, Saitama 3510198, Japan; [Noguchi, Junko] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki 3050856, Japan	Shinagawa, T (reprint author), RIKEN, Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sinagawa@rtc.riken.jp; sishii@rtc.riken.jp	Dohmae, Naoshi/C-2040-2011		CREST Research Project from JST (Japan Science and Technology Agency)	This work was supported by the CREST Research Project from JST (Japan Science and Technology Agency).	Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Lu S, 2009, MOL HUM REPROD, V15, P373, DOI 10.1093/molehr/gap028; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Lee J, 2011, J CELL BIOL, V192, P263, DOI 10.1083/jcb.201008005; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Li A, 2005, BIOCHEMISTRY-US, V44, P2529, DOI 10.1021/bi048061n; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.0.CO;2-J; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; SHIRES A, 1976, J BIOL CHEM, V251, P4155; Bedner E, 1997, CYTOMETRY, V29, P191, DOI 10.1002/(SICI)1097-0320(19971101)29:3<191::AID-CYTO1>3.0.CO;2-F; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Hanlon SE, 2003, GENETICS, V164, P1333; HUH NE, 1991, NUCLEIC ACIDS RES, V19, P93, DOI 10.1093/nar/19.1.93; OLIVA R, 1987, J BIOL CHEM, V262, P17016; RAO BJ, 1987, J BIOL CHEM, V262, P4472; TROSTLEWEIGE PK, 1982, J BIOL CHEM, V257, P5560	29	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	APR 1	2015	142	7					1287	1292		10.1242/dev.121830		6	Developmental Biology	Developmental Biology	CE3BB	WOS:000351698000008		
J	Itoh, Y; Sato, Y				Itoh, Youki; Sato, Yoshikazu			Genetic dissection of an alien chromosomal segment may enable the production of a rice (Oryza sativa L.) genotype showing shoot developmental instability	DEVELOPMENT GENES AND EVOLUTION			English	Article						Canalization; Developmental instability; Epigenetic landscape; Phyllochron; Reproductive isolation; Shoot development	QUANTITATIVE TRAIT LOCUS; CULTIVATED RICE; PHOTOPERIOD SENSITIVITY; ARABIDOPSIS-THALIANA; FLOWERING TIME; CROSS-INCOMPATIBILITY; PHYLLOCHRON DYNAMICS; LINKAGE INTENSITY; WILD; EVOLUTION	During the course of evolutionary history, organisms have acquired genes which cooperate harmoniously and subsequently express a stable pattern of development. In an earlier study we introduced a large chromosomal segment of chromosome 6 from a rice (Oryza sativa L.) ecotype, carrying the two flowering-time genes, which showed complex epistatic interactions in relation to environmental change, into a different ecotype by successive backcrossings. Four-near-isogenic lines (NILs) with respect to these two loci were obtained by subsequent hybridization with the recurrent parent. In the study reported here, these four NILs were the major plant material used to evaluate changes in days to leaf appearance (DLA) during shoot development using a quadratic-polynomial regression. The regressions were regarded as developmental norms because of the high values of R (2). Absolute Y-residuals (AYRs) (or size of deviation) of DLA from the norms were significantly affected by genotype. Dissections of the alien chromosomal segment resulted in one NIL that showed an increased level of AYR. Since this NIL also expressed a low survival rate in a stress environment, we suggest that the increased level of AYR during development might indicate an increased level of instability in shoot development.	[Itoh, Youki; Sato, Yoshikazu] Rakunogakuen Univ, Coll Agr Food & Environm Sci, Dept Environm Symbiot Sci, Lab Wildlife Ecol, Ebetsu, Hokkaido 0698501, Japan	Itoh, Y (reprint author), Rakunogakuen Univ, Coll Agr Food & Environm Sci, Dept Environm Symbiot Sci, Lab Wildlife Ecol, Ebetsu, Hokkaido 0698501, Japan.	yoshiemetkoneko@hotmail.co.jp			Brown Bear Research Group of Hokkaido University	Youki Itoh greatly thanks to Miss Yoshie Satoh (GASTO, Fukuzumi), who provided significant insight in the present study and Dr. Hiroshi Yorozuya (Brown Bear Research Group of Hokkaido University) who provided financial support for the study and encouraged me to write the present report.	PIGLIUCCI M, 1995, J EVOLUTION BIOL, V8, P421, DOI 10.1046/j.1420-9101.1995.8040421.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.3733506; Akimoto M, 1999, GENET RESOUR CROP EV, V46, P419, DOI 10.1023/A:1008622405001; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2969, DOI 10.1073/pnas.0712210105; Wright S, 1931, GENETICS, V16, P0097; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; SANO Y, 1990, GENETICS, V125, P183; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Koide Y, 2008, NEW PHYTOL, V179, P888, DOI 10.1111/j.1469-8137.2008.02490.x; Weber K, 1999, GENETICS, V153, P773; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; MCKENZIE JA, 1988, GENETICS, V120, P213; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; DOEBLEY J, 1995, GENETICS, V141, P333; NEI M, 1967, GENETICS, V57, P625; POETHIG RS, 1988, GENETICS, V119, P959; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Hagiwara WE, 2009, MOL ECOL, V18, P1537, DOI 10.1111/j.1365-294X.2009.04119.x; Samakovli D, 2007, J EXP BOT, V58, P3513, DOI 10.1093/jxb/erm191; Dobzhansky T., 1951, GENETICS ORIGIN SPEC; Dung LV, 1998, THEOR APPL GENET, V97, P714, DOI 10.1007/s001220050947; Futuyma DJ, 1986, EVOLUTIONARY BIOL, V2nd; GRANT V, 1967, AM NAT, V101, P125, DOI 10.1086/282479; Hagiwara WE, 2006, EUPHYTICA, V150, P27, DOI 10.1007/s10681-006-9085-8; Hirano HY, 1991, PLANT CELL PHYSL, V36, P37; Hoshikawa K., 1989, GROWING RICE PLANT A; Hosoi N., 1976, Japanese Journal of Breeding, V26, P328; Iso E, 1954, RICE CROPS ITS ROTAT; Itoh Y, 2012, DEV GENES EVOL, V222, P341, DOI 10.1007/s00427-012-0419-3; Itoh Y, 2006, EUPHYTICA, V150, P87, DOI 10.1007/s10681-006-9096-5; Itoh Y, 2001, EUPHYTICA, V119, P271, DOI 10.1023/A:1017577218630; Itoh Y, 2007, EUPHYTICA, V155, P153, DOI 10.1007/s10681-006-9318-x; BAGCHI S, 1983, THEOR APPL GENET, V65, P85, DOI 10.1007/BF00276269; KIESER JA, 1993, GENETICA, V89, P219, DOI 10.1007/BF02424515; Kimura M., 1983, NEUTRAL THEORY MOL E; Koide Y, 2008, EUPHYTICA, V164, P753, DOI 10.1007/s10681-008-9707-4; Koide Y, 2008, GENETICS, V180, P409, DOI 10.1534/genetics.108.090126; Koide Yohei, 2008, V62, P247; Ladizinsky G, 1998, PLANT EVOLUTION DOME, DOI 10.1007%2F978-94-011-4429-2; Levin DA, 1978, EVOL BIOL, V11, P185; Matsubara K, 2003, GENETICS, V165, P343; Moller A.P., 1997, ASYMMETRY DEV STABIL; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Morishima H, 1992, OXFORD SURV EVOL BIO, V8, P135; Nagai M, 1968, B FAC AGR SHIZUOKA U, V18, P1; Nagano N, 2005, GENES GENET SYST, V80, P351; NEI M, 1968, NATURE, V218, P1160, DOI 10.1038/2181160a0; Noguchi Y, 1965, JPN J BREED, V15, P14; Oka H.-I., 1988, ORIGIN CULTIVATED RI; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; RIESEBERG LH, 1995, NATURE, V375, P313, DOI 10.1038/375313a0; SAKAI KI, 1965, GENETICS, V51, P801; SANO Y, 1992, JPN J BREED, V42, P561; SANO Y, 1980, JPN J GENET, V55, P19, DOI 10.1266/jjg.55.19; SANO Y, 1993, INTERNATIONAL CROP SCIENCE I, P437; SAS Institute, 1985, SAS US GUID STAT VER; SATO YI, 1987, EUPHYTICA, V36, P425, DOI 10.1007/BF00041485; Schlichting C.D., 1998, PHENOTYPIC EVOLUTION; Takahashi M, 1980, JAPANESE EXPERIENCE, V22, P1; Takami S, 2007, SCIENCE, V316, P1033; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Vaughan DA, 2005, BREEDING SCI, V55, P113, DOI 10.1270/jsbbs.55.113; Waddington C. H., 1956, PRINCIPLES EMBRYOLOG; Waddington CH., 1957, STRATEGY GENES; Waddington CH, 1961, ADV GENET, V10, P227; Weinig C, 2003, GENETICS, V165, P321; White J, 1984, PERSPECTIVES PLANT P, P15; Whyte L. L., 1964, Acta Biotheoretica, V17, P33, DOI 10.1007/BF01602054; WILHELM WW, 1995, CROP SCI, V35, P1; Wu JS, 2007, GENETICS, V176, P1187, DOI 10.1534/genetics.107.072843; YAMPOLSKY LY, 1994, EVOLUTION, V48, P1715, DOI 10.2307/2410259	81	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	APR	2015	225	2					63	78		10.1007/s00427-015-0490-7		16	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CE1XD	WOS:000351605300001		
J	Mine, J; Taketani, T; Yoshida, K; Yokochi, F; Kobayashi, J; Maruyama, K; Nanishi, E; Ono, M; Yokoyama, A; Arai, H; Tamaura, S; Suzuki, Y; Otsubo, S; Hayashi, T; Kimura, M; Kishi, K; Yamaguchi, S				Mine, Jun; Taketani, Takeshi; Yoshida, Kazushi; Yokochi, Fusako; Kobayashi, Junpei; Maruyama, Koichi; Nanishi, Etsuro; Ono, Mayumi; Yokoyama, Atsushi; Arai, Hidee; Tamaura, Shiho; Suzuki, Yasuhiro; Otsubo, Shusuke; Hayashi, Takashi; Kimura, Masahiko; Kishi, Kazuko; Yamaguchi, Seiji			Clinical and genetic investigation of 17 Japanese patients with hyperekplexia	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							STARTLE DISEASE; SUBUNIT GENE; BETA-SUBUNIT; MUTATIONS; GLRB	AimThe aim of the study was to determine clinical and genetic characteristics of Japanese patients with hyperekplexia. MethodClinical courses, responses to antiepileptic drugs, outcomes, and genetic testing were investigated in 17 Japanese patients (nine males, eight females, median age 1y, range birth-45y) with hyperekplexia. ResultsIn all patients, muscle stiffness and startle responses appeared soon after birth. Only seven patients were diagnosed with hyperekplexia before 1year of age. Seven patients had been misdiagnosed with other disorders such as epilepsy and adult-onset anxiety neurosis. Umbilical/inguinal hernias were seen in 10 patients. Life-threatening events were noted in four patients. Clonazepam was the most effective drug. Muscle stiffness completely disappeared in 12 patients before 5years of age, whereas startle responses resolved in only three patients. Mutations in the GLRA1 and GLRB genes were identified in 16 patients and one patient respectively. In 14 patients, the mutation showed autosomal dominant inheritance; in the other three, inheritance was autosomal recessive. p.R271Q of GLRA1 was the most frequent mutation, found in 10 patients. Novel mutations, p.A272P and p.A384P of GLRA1, were detected. Clinical severity and outcome varied even in the same family. InterpretationEarly correct diagnosis is essential for prevention of accidental injuries and to provide appropriate treatments for hyperekplexia. Clonazepam is effective, although the time taken for startle responses to resolve varied. What this paper adds <list list-type="bulleted" id="dmcn12617-list-0001"> This is the largest study of Japanese patients with hyperekplexia. A high frequency of misdiagnosis and delay in confirmed diagnosis was found. Examines when startle and stiffness diminish. Many patients exhibit umbilical hernias. Novel mutations (p.A272P and p.A384P), rare mutations (p. K276E), and common mutations (p.R271Q) were found. This article is commented on by Thomas on page 313 of this issue.	[Mine, Jun; Taketani, Takeshi; Kishi, Kazuko; Yamaguchi, Seiji] Shimane Univ, Fac Med, Dept Pediat, Izumo, Shimane 6938501, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane, Japan; [Yoshida, Kazushi] Matsudo City Hosp, Dept Pediat, Matsudo, Chiba, Japan; [Yokochi, Fusako; Kobayashi, Junpei] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo, Japan; [Maruyama, Koichi] Cent Hosp Kasugai, Dept Pediat Neurol, Aichi Welf Ctr Persons Dev Disabil, Kasugai, Aichi, Japan; [Nanishi, Etsuro] Yamaguchi Red Cross Hosp, Dept Pediat, Yamaguchi, Japan; [Ono, Mayumi] Sapporo Med Univ, Dept Pediat, Sapporo, Hokkaido, Japan; [Yokoyama, Atsushi] Tottori Univ, Fac Med, Div Child Neurol, Inst Neurol Sci, Yonago, Tottori 683, Japan; [Arai, Hidee] Chiba Childrens Hosp, Dept Neurol, Chiba, Japan; [Tamaura, Shiho] JA Onomichi Hosp, Dept Pediat, Onomichi, Japan; [Suzuki, Yasuhiro] Osaka Med Ctr, Dept Pediat Neurol, Izumi, Japan; [Suzuki, Yasuhiro] Res Inst Maternal & Child Hlth, Izumi, Japan; [Otsubo, Shusuke] Otsubo Kodomo Clin, Kagoshima, Japan; [Hayashi, Takashi] Nishikawa Clin, Dept Dev Med, Ube, Yamaguchi, Japan; [Kimura, Masahiko] Kimura Children & Family Clin, Izumo, Shimane, Japan	Mine, J (reprint author), Shimane Univ, Sch Med, Dept Pediat, 89-1 Enya, Izumo, Shimane 6938501, Japan.	jmine@med.shimane-u.ac.jp	Kobayashi, Junjiro/J-8547-2015				Chung SK, 2013, HUM MOL GENET, V22, P927, DOI 10.1093/hmg/dds498; Thomas RH, 2013, BRAIN, V136, P3085, DOI 10.1093/brain/awt207; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Bode A, 2014, MOL BRAIN, V7, P1; Davies JS, 2010, FRONT MOL NEUROSCI, V3, P1; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI [10.1016/j.tig.2008.06.005, 10.1016/i.tig.2008.06.005]; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Kimura M, 2006, BRAIN DEV-JPN, V28, P228, DOI 10.1016/j.braindev.2005.08.007; Mine J, 2013, BRAIN DEV-JPN, V35, P660, DOI 10.1016/j.braindev.2012.10.013; Mothersill IW, 2000, EPILEPSIA, V41, pS19, DOI 10.1111/j.1528-1157.2000.tb01530.x; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	APR	2015	57	4					372	377		10.1111/dmcn.12617		6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CD6SY	WOS:000351220900018		
J	Kamiguchi, H; Borodinsky, LN				Kamiguchi, Hiroyuki; Borodinsky, Laura N.			Introduction: Second Messengers in Neural Development	DEVELOPMENTAL NEUROBIOLOGY			English	Editorial Material									[Kamiguchi, Hiroyuki] RIKEN Brain Sci Inst Wako, Lab Neuronal Growth Mech, Saitama, Japan; [Borodinsky, Laura N.] Univ Calif Davis, Sch Med, Shriners Hosp Children Northern Calif, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA	Kamiguchi, H (reprint author), RIKEN Brain Sci Inst Wako, Lab Neuronal Growth Mech, Saitama, Japan.						Akiyama H, 2014, DEV NEUROBIOL, V75, P411; Borodinsky LN, 2014, DEV NEUROBIOL, V75, P349; Guo CL, 2014, DEV NEUROBIOL, V75, P388; Komuro Y, 2014, DEV NEUROBIOL, V75, P369; McVicker DP, 2014, DEV NEUROBIOL, V75, P423; Pal K, 2014, DEV NEUROBIOL, V75, P337; Sutherland DJ, 2014, DEV NEUROBIOL, V75, P402; Uhlen P, 2014, DEV NEUROBIOL, V75, P360	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	APR	2015	75	4					335	336		10.1002/dneu.22269		2	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CD9EZ	WOS:000351401900001		
J	Komuro, Y; Galas, L; Lebon, A; Raoult, E; Fahrion, JK; Tilot, A; Kumada, T; Ohno, N; Vaudry, D; Komuro, H				Komuro, Yutaro; Galas, Ludovic; Lebon, Alexis; Raoult, Emilie; Fahrion, Jennifer K.; Tilot, Amanda; Kumada, Tasturo; Ohno, Nobuhiko; Vaudry, David; Komuro, Hitoshi			The Role of Calcium and Cyclic Nucleotide Signaling in Cerebellar Granule Cell Migration under Normal and Pathological Conditions	DEVELOPMENTAL NEUROBIOLOGY			English	Article						granule cell migration; Ca2+ signaling; cyclic nucleotide signaling; fetal alcohol spectrum disorders; fetal Minamata disease	ALCOHOL SPECTRUM DISORDERS; INTRACELLULAR CA2+ FLUCTUATIONS; CYCLASE-ACTIVATING POLYPEPTIDE; FETAL MINAMATA DISEASE; NEURONAL MIGRATION; CEREBRAL-CORTEX; NERVOUS-SYSTEM; METHYL MERCURY; IN-VITRO; INTERNEURON MIGRATION	In the developing brain, immature neurons migrate from their sites of origin to their final destination, where they reside for the rest of their lives. This active movement of immature neurons is essential for the formation of normal neuronal cytoarchitecture and proper differentiation. Deficits in migration result in the abnormal development of the brain, leading to a variety of neurological disorders. A myriad of extracellular guidance molecules and intracellular effector molecules is involved in controlling the migration of immature neurons in a cell type, cortical layer and birth-date-specific manner. To date, little is known about how extracellular guidance molecules transfer their information to the intracellular effector molecules, which regulate the migration of immature neurons. In this article, to fill the gap between extracellular guidance molecules and intracellular effector molecules, using the migration of cerebellar granule cells as a model system of neuronal cell migration, we explore the role of second messenger signaling (specifically Ca2+ and cyclic nucleotide signaling) in the regulation of neuronal cell migration. We will, first, describe the cortical layer-specific changes in granule cell migration. Second, we will discuss the roles of Ca2+ and cyclic nucleotide signaling in controlling granule cell migration. Third, we will present recent studies showing the roles of Ca2+ and cyclic nucleotide signaling in the deficits in granule cell migration in mouse models of fetal alcohol spectrum disorders and fetal Minamata disease. (c) 2014 Wiley Periodicals, Inc. Develop Neurobiol 75: 369-387, 2015	[Komuro, Yutaro; Fahrion, Jennifer K.; Tilot, Amanda; Komuro, Hitoshi] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Galas, Ludovic; Lebon, Alexis; Raoult, Emilie; Vaudry, David] INSERM, PRIMACEN, Cell Imaging Platform Normandy, F-76821 Mont St Aignan, France; [Galas, Ludovic; Lebon, Alexis; Raoult, Emilie; Vaudry, David] Univ Rouen, IRIB, Rouen, France; [Lebon, Alexis; Raoult, Emilie; Vaudry, David] INSERM, U982, DC2N, F-76821 Mont St Aignan, France; [Lebon, Alexis; Raoult, Emilie; Vaudry, David] INSERM, INRS, Int Associated Lab Samuel Champlain, Mont St Aignan, France; [Kumada, Tasturo] Tokoha Univ, Dept Occupat Therapy, Hamamatsu, Shizuoka 4312102, Japan; [Ohno, Nobuhiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Yamanashi 4093898, Japan	Komuro, H (reprint author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hitoshikomuro@gmail.com		Tilot, Amanda/0000-0002-9107-8190			AMINZAKI L, 1974, J PEDIATR-US, V85, P81, DOI 10.1016/S0022-3476(74)80291-X; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Coriale G, 2013, RIV PSICHIATR, V48, P359, DOI 10.1708/1356.15062; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.0.CO;2-C; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Cudd TA, 2005, EXP BIOL MED, V230, P389; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Riley EP, 2005, EXP BIOL MED, V230, P357; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Komuro H, 2005, CELL CALCIUM, V37, P387, DOI 10.1016/j.ceca.2005.01.006; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Komuro H, 1998, J NEUROSCI, V18, P1478; Kunimoto M, 1997, NEUROSCI LETT, V226, P183, DOI 10.1016/S0304-3940(97)00273-5; Komuro Y, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: CELLULAR MIGRATION AND FORMATION OF NEURONAL CONNECTIONS, P281, DOI 10.1016/B978-0-12-397266-8.00030-2; Komuro H, 2001, J NEUROSCI, V21, P527; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Paintner A, 2012, J CHILD NEUROL, V27, P258, DOI 10.1177/0883073811428376; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; CHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719, DOI 10.1097/00005072-197811000-00001; Walter HJ, 1999, NEUROCHEM INT, V35, P95, DOI 10.1016/S0197-0186(99)00050-9; Marty MS, 1997, TOXICOL APPL PHARM, V147, P319, DOI 10.1006/taap.1997.8262; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; Cameron DB, 2007, NEUROSCIENCE, V146, P697, DOI 10.1016/j.neuroscience.2007.02.025; Raoult E, 2011, J NEUROCHEM, V119, P920, DOI 10.1111/j.1471-4159.2011.07486.x; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; KOMURO H, 1995, J NEUROSCI, V15, P1110; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; HARADA M, 1978, TERATOLOGY, V18, P285, DOI 10.1002/tera.1420180216; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Fahrion JK, 2012, P NATL ACAD SCI USA, V109, P5057, DOI 10.1073/pnas.1120747109; PEIFFER J, 1979, J NEUROL SCI, V41, P125, DOI 10.1016/0022-510X(79)90033-9; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Sirois JE, 2000, TOXICOL APPL PHARM, V167, P1, DOI 10.1006/taap.2000.8967; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Darcy DP, 2009, J NEUROSCI, V29, P2510, DOI 10.1523/JNEUROSCI.5333-08.2009; Cameron DB, 2009, CEREBELLUM, V8, P433, DOI 10.1007/s12311-009-0121-9; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; Chang L W, 1980, Adv Pharmacol Chemother, V17, P195, DOI 10.1016/S1054-3589(08)60011-3; CHOI BH, 1986, NEUROTOXICOLOGY, V7, P591; Clarren SK, 1978, J PEDIAT, V92, P1063; Crinnion W J, 2000, Altern Med Rev, V5, P209; Eto K., 1997, TOXICOL PATHOL, V25, P614, DOI [10.1177/ 019262339702500612., DOI 10.1177/019262339702500612]; ETO K, 1992, MOL CHEM NEUROPATHOL, V16, P171; Fahrion JK, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P211, DOI 10.1016/B978-0-12-397265-1.00042-3; Falluel-Morel A, 2011, HORMONES NEURODEGENE, P227; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; Haase A, 2003, DEVELOPMENT, V130, P3977, DOI 10.1242/dev.00612; Harada M, 1964, PSYCHIAT NEUROL JAP, V66, P426; Hutchins BI, 2013, J NEUROSCI, V33, P11361, DOI 10.1523/JNEUROSCI.3758-12.2013; Jiang L, 2008, DEV NEUROSCI, V30, P7; Kakita A, 2002, ACTA NEUROPATHOL, V104, P409, DOI 10.1007/s00401-002-0571-3; KOMURO H, 1999, IBRO HB S M, V18, P57; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Komuro Y, 2012, HDB CEREBELLUM CEREB, P107; KORNGUTH SE, 1979, BRAIN RES, V177, P347, DOI 10.1016/0006-8993(79)90785-6; Kumada T, 2011, HANDBOOK OF BEHAVIOR, FOOD AND NUTRITION, P2915, DOI 10.1007/978-0-387-92271-3_182; Kumada T, 2007, J NEUROSCI RES, V85, P465, DOI 10.1002/jnr.21149; Kumada T, 2006, J NEUROSCI, V26, P742, DOI 10.1523/JNEUROSCI.4478-05.2006; Kumado T, 2009, DEV BIOL, V326, P237, DOI 10.1016/j.ydbio.2008.11.012; Kumada T, 2010, NEUROSCIENCE, V170, P1328, DOI 10.1016/j.neuroscience.2010.07.059; Lapham LW, 1995, NEUROTOXICOLOGY, V16, P689; Li Y, 2012, P NATL ACAD SCI USA, V109, P2630, DOI 10.1073/pnas.1111326109; MARCUS JC, 1987, NEUROPEDIATRICS, V18, P158, DOI 10.1055/s-2008-1052471; MATSUMOT.H, 1965, J NEUROPATH EXP NEUR, V24, P563, DOI 10.1097/00005072-196510000-00002; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; MILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304, DOI 10.1111/j.1530-0277.1993.tb00768.x; Munck S, 2004, EUR J NEUROSCI, V19, P791, DOI 10.1111/j.1460-9568.2004.03118.x; Nakai K, 2002, TOHOKU J EXP MED, V196, P89, DOI 10.1620/tjem.196.89; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Pirrone N, 2001, ATMOS ENVIRON, V35, P2979, DOI 10.1016/S1352-2310(01)00101-7; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Raoult E, 2014, J NEUROCHEM, V130, P241, DOI 10.1111/jnc.12714; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; Sakata-Haga H, 2001, ACTA NEUROPATHOL, V102, P36; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sheng LF, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-94; Synder RD, 1971, NEW ENGL J MED, V284, P1014; TAKEUCHI T., 1962, ACTA NEURO PATHOLOGICA, V2, P40; Welch-Carre Elizabeth, 2005, Adv Neonatal Care, V5, P217, DOI 10.1016/j.adnc.2005.04.007; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yacubova E, 2002, J NEUROSCI, V22, P5966; Yacubova E, 2003, CELL BIOCHEM BIOPHYS, V37, P213; Zhu Y, 2012, DEV NEUROBIOL, V72, P1349, DOI 10.1002/dneu.22041	95	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	APR	2015	75	4					369	387		10.1002/dneu.22219		19	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CD9EZ	WOS:000351401900005		
J	Akiyama, H; Kamiguchi, H				Akiyama, Hiroki; Kamiguchi, Hiroyuki			Second Messenger Networks for Accurate Growth Cone Guidance	DEVELOPMENTAL NEUROBIOLOGY			English	Article						growth cone; calcium; cyclic nucleotide; phosphatidylinositol; signal amplification	PROTEIN-KINASE-A; PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; PLASMA-MEMBRANE INSERTION; SOLUBLE ADENYLYL-CYCLASE; NERVE GROWTH; AXON GUIDANCE; CELL POLARITY; LEADING-EDGE; CYCLIC-AMP; INTRACELLULAR CALCIUM	Growth cones are able to navigate over long distances to find their appropriate target by following guidance cues that are often presented to them in the form of an extracellular gradient. These external cues are converted into gradients of specific signaling molecules inside growth cones, while at the same time these internal signals are amplified. The amplified instruction is then used to generate asymmetric changes in the growth cone turning machinery so that one side of the growth cone migrates at a rate faster than the other side, and thus the growth cone turns toward or away from the external cue. This review examines how signal specification and amplification can be achieved inside the growth cone by multiple second messenger signaling pathways activated downstream of guidance cues. These include the calcium ion, cyclic nucleotide, and phosphatidylinositol signaling pathways. (c) 2013 Wiley Periodicals, Inc. Develop Neurobiol 75: 411-422, 2015	[Akiyama, Hiroki; Kamiguchi, Hiroyuki] RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan	Kamiguchi, H (reprint author), RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp			RIKEN Special Postdoctoral Researchers Program	H.A. was supported by the RIKEN Special Postdoctoral Researchers Program. We are grateful to C. Chan, T. Tojima, and A. T. Guy for their helpful discussions and comments on the manuscript.	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Buck KB, 2002, J NEUROSCI, V22, P9358; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Maiellaro I, 2012, J CELL MOL MED, V16, P2715, DOI 10.1111/j.1582-4934.2012.01592.x; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Nakamachi T, 2011, CURR PHARM DESIGN, V17, P973; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Hong K, 2010, NEUROSCIENTIST, V16, P65, DOI 10.1177/1073858409340702; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Zhang XF, 2012, MOL BIOL CELL, V23, P4833, DOI 10.1091/mbc.E12-10-0715; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Dudanova I, 2013, TRENDS NEUROSCI, V36, P295, DOI 10.1016/j.tins.2013.01.007; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Oinuma I, 2010, J BIOL CHEM, V285, P28200, DOI 10.1074/jbc.M110.147546; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Meinhardt H, 1999, J CELL SCI, V112, P2867; Hopker VH, 1999, NATURE, V401, P69; Hong K, 2000, NATURE, V403, P93; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Eguchi K, 2012, NEURON, V74, P517, DOI 10.1016/j.neuron.2012.03.028; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; Gao Y, 2003, J NEUROSCI, V23, P11770; Guirland C, 2003, J NEUROSCI, V23, P2274; Han JZ, 2007, J CELL BIOL, V176, P101, DOI 10.1083/jcb.200607128; Henle SJ, 2013, J BIOL CHEM, V288, P20837, DOI 10.1074/jbc.C113.487066; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; Lavigne-iessier M., 2011, COLD SPRING HARB PER, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A001727; Li L, 2014, DEV NEUROBIOL, V74, P797, DOI 10.1002/dneu.22102; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Lutz S, 2013, CELL SIGNAL, V25, P630, DOI 10.1016/j.cellsig.2012.11.016; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mintz CD, 2008, J COMP NEUROL, V510, P351, DOI 10.1002/cne.21799; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Schmidt H, 2009, P NATL ACAD SCI USA, V106, P16847, DOI 10.1073/pnas.0906571106; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamazaki M, 2013, NEUROSCI LETT, V547, P59, DOI 10.1016/j.neulet.2013.04.062; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232; Zhao Z, 2009, P NATL ACAD SCI USA, V106, P18016, DOI 10.1073/pnas.0906880106	120	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	APR	2015	75	4					411	422		10.1002/dneu.22157		12	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CD9EZ	WOS:000351401900008		
J	Takahashi, H; Shibasaki, T; Park, JH; Hidaka, S; Takahashi, T; Ono, A; Song, DK; Seino, S				Takahashi, Harumi; Shibasaki, Tadao; Park, Jae-Hyung; Hidaka, Shihomi; Takahashi, Toshimasa; Ono, Aika; Song, Dae-Kyu; Seino, Susumu			Role of Epac2A/Rap1 Signaling in Interplay Between Incretin and Sulfonylurea in Insulin Secretion	DIABETES			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; SELECTIVE CAMP ANALOG; PANCREATIC BETA-CELLS; GRANULE EXOCYTOSIS; EPAC2 ACTIVATION; CYTOSOLIC CA2+; DIRECT TARGET; MOUSE ISLETS; SENSOR EPAC2	Incretin-related drugs and sulfonylureas are currently used worldwide for the treatment of type 2 diabetes. We recently found that Epac2A, a cAMP binding protein having guanine nucleotide exchange activity toward Rap, is a target of both incretin and sulfonylurea. This suggests the possibility of interplay between incretin and sulfonylurea through Epac2A/Rap1 signaling in insulin secretion. In this study, we examined the combinatorial effects of incretin and various sulfonylureas on insulin secretion and activation of Epac2A/Rap1 signaling. A strong augmentation of insulin secretion by combination of GLP-1 and glibenclamide or glimepiride, which was found in Epac2A(+/+) mice, was markedly reduced in Epac2A(-/-) mice. In contrast, the combinatorial effect of GLP-1 and gliclazide was rather mild, and the effect was not altered by Epac2A ablation. Activation of Rap1 was enhanced by the combination of an Epac-selective cAMP analog with glibenclamide or glimepiride but not gliclazide. In diet-induced obese mice, ablation of Epac2A reduced the insulin secretory response to coadministration of the GLP-1 receptor agonist liraglutide and glimepiride. These findings clarify the critical role of Epac2A/Rap1 signaling in the augmenting effect of incretin and sulfonylurea on insulin secretion and provide the basis for the effects of combination therapies of incretin-related drugs and sulfonylureas.	[Takahashi, Harumi; Hidaka, Shihomi; Takahashi, Toshimasa; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Chuo Ku, Kobe, Hyogo 657, Japan; [Shibasaki, Tadao; Ono, Aika] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Chuo Ku, Kobe, Hyogo 657, Japan; [Park, Jae-Hyung; Song, Dae-Kyu] Keimyung Univ, Sch Med, Dept Physiol, Daegu, South Korea; [Takahashi, Toshimasa] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Chuo Ku, Kobe, Hyogo 657, Japan	Seino, S (reprint author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Chuo Ku, Kobe, Hyogo 657, Japan.	seino@med.kobe-u.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Diabetes Foundation; Korean government [NRF-2013R1A2A2A01068220]; MSD K.K.; Novo Nordisk Pharma; Sumitomo Dainippon Pharma; Takeda Pharmaceutical Company	This work was supported by a CREST grant from the Japan Science and Technology Agency, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also partly supported by research funding from the Japan Diabetes Foundation. D.-K.S. has received a grant from the Korean government (No. NRF-2013R1A2A2A01068220). S.S. has received research grants from MSD K.K., Novo Nordisk Pharma, Sumitomo Dainippon Pharma, and Takeda Pharmaceutical Company.	Kubota A, 2012, J DIABETES INVEST, V3, P503, DOI 10.1111/j.2040-1124.2012.00221.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Yasuda T, 2010, CELL METAB, V12, P117, DOI 10.1016/j.cmet.2010.05.017; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Ozaki N, 2000, NAT CELL BIOL, V2, P805; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Aaboe K, 2009, J CLIN ENDOCR METAB, V94, P603, DOI 10.1210/jc.2008-1731; Yabe D, 2014, J DIABETES INVEST, V5, P475, DOI 10.1111/jdi.12229; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gutniak MK, 1996, DIABETES CARE, V19, P857, DOI 10.2337/diacare.19.8.857; Henquin JC, 2014, ENDOCRINOLOGY, V155, P3274, DOI 10.1210/en.2014-1247; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Jarrard RE, 2013, MOL PHARMACOL, V83, P191, DOI 10.1124/mol.112.081943; Leech CA, 2010, ISLETS, V2, P72, DOI 10.4161/isl.2.2.10582; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Song WJ, 2013, DIABETES, V62, P2796, DOI 10.2337/db12-1394; Takahashi T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004581; Yaekura K, 1996, DIABETES, V45, P295, DOI 10.2337/diabetes.45.3.295	38	5	5	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	APR	2015	64	4					1262	1272		10.2337/db14-0576		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CE2CA	WOS:000351619300022		
J	Mise, K; Hoshino, J; Ueno, T; Imafuku, A; Kawada, M; Sumida, K; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Hayami, N; Suwabe, T; Sawa, N; Fujii, T; Hara, S; Ohashi, K; Takaichi, K; Ubara, Y				Mise, K.; Hoshino, J.; Ueno, T.; Imafuku, A.; Kawada, M.; Sumida, K.; Hiramatsu, R.; Hasegawa, E.; Yamanouchi, M.; Hayami, N.; Suwabe, T.; Sawa, N.; Fujii, T.; Hara, S.; Ohashi, K.; Takaichi, K.; Ubara, Y.			Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy	DIABETIC MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; UNRECOGNIZED ANEMIA; RENAL ANEMIA; HYPOXIA; PREVALENCE; MELLITUS	AimsTo investigate the relationship between the progression of anaemia and renal pathological findings in patients with diabetic nephropathy. MethodsA total of 223 patients with diabetes underwent renal biopsy from 1985 to 2010 and were confirmed to have pure diabetic nephropathy according to the recent classification, of whom 113 (baseline haemoglobin 11g/dl) were enrolled in the study. Linear regression analysis was used to estimate the changes in haemoglobin levels during the follow-up period. ResultsIn a multivariate model adjusted for clinical and histopathological variables, higher interstitial fibrosis and tubular atrophy scores were more strongly associated with a decrease in haemoglobin levels than were lower scores. Compared with an interstitial fibrosis and tubular atrophy score of 0, the standardized coefficients for interstitial fibrosis and tubular atrophy scores of 1, 2 and 3 were 0.20 (95% CI -0.31 to 0.93), 0.34 (95% CI -0.22 to 1.34) and 0.47 (95% CI 0.07 to 1.96), respectively, whereas a higher glomerular class, a higher vascular lesion score and the presence of exudative lesions were not strongly correlated with the decrease in haemoglobin. ConclusionsTubulointerstitial lesions that are more advanced are significantly associated with the progression of anaemia in patients with diabetic nephropathy after adjustment for numerous covariates. This finding suggests that tubulointerstitial lesions may be a useful prognostic indicator for anaemia in patients with diabetic nephropathy, and that decreased erythropoietin production attributable to the progression of tubulointerstitial lesions is a major cause of anaemia in these patients.	[Mise, K.; Hoshino, J.; Ueno, T.; Imafuku, A.; Kawada, M.; Sumida, K.; Hiramatsu, R.; Hasegawa, E.; Yamanouchi, M.; Hayami, N.; Suwabe, T.; Sawa, N.; Hara, S.; Takaichi, K.; Ubara, Y.] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Fujii, T.; Ohashi, K.] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Hara, S.; Takaichi, K.; Ubara, Y.] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Ohashi, K.] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan	Mise, K (reprint author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.	kokims-frz@umin.ac.jp					Thomas MC, 2006, AM J KIDNEY DIS, V48, P537, DOI 10.1053/j.ajkd.2006.06.011; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Ritz E, 2005, EUR J CLIN INVEST, V35, P66, DOI 10.1111/j.1365-2362.2005.01544.x; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; New JP, 2008, DIABETIC MED, V25, P564, DOI 10.1111/j.1464-5491.2008.02424.x; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; El-Achkar TM, 2005, KIDNEY INT, V67, P1483, DOI 10.1111/j.1523-1755.2005.00226.x; White KE, 2000, J AM SOC NEPHROL, V11, P1667; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Bosman DR, 2001, DIABETES CARE, V24, P495, DOI 10.2337/diacare.24.3.495; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Denton KM, 2002, J AM SOC NEPHROL, V13, P27; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Thomas S, 2004, ACTA DIABETOL, V41, P13, DOI 10.1007/s00592-004-0132-4; Winkler AS, 1999, DIABETIC MED, V16, P813, DOI 10.1046/j.1464-5491.1999.00172.x; Yokoyama H, 2009, CLIN J AM SOC NEPHRO, V4, P1432, DOI 10.2215/CJN.06511208	22	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	APR	2015	32	4					546	555		10.1111/dme.12633		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CD8XF	WOS:000351379100017		
J	Locke, JM; Wei, FY; Tomizawa, K; Weedon, MN; Harries, LW				Locke, Jonathan M.; Wei, Fan-Yan; Tomizawa, Kazuhito; Weedon, Michael N.; Harries, Lorna W.			A cautionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1	DIABETOLOGIA			English	Article						CDKAL1; Expression quantitative trait loci; Genome-wide association studies; Non-coding RNA; Type 2 diabetes	GENE-EXPRESSION; IDENTIFICATION	Intronic single nucleotide polymorphisms (SNPs) in the CDKAL1 gene are associated with risk of developing type 2 diabetes. A strong correlation between risk alleles and lower levels of the non-coding RNA, CDKAL1-v1, has recently been reported in whole blood extracted from Japanese individuals. We sought to replicate this association in two independent cohorts: one using whole blood from white UK-resident individuals, and one using a collection of human pancreatic islets, a more relevant tissue type to study with respect to the aetiology of diabetes. Levels of CDKAL1-v1 were measured by real-time PCR using RNA extracted from human whole blood (n = 70) and human pancreatic islets (n = 48). Expression with respect to genotype was then determined. In a simple linear regression model, expression of CDKAL1-v1 was associated with the lead type 2 diabetes-associated SNP, rs7756992, in whole blood and islets. However, these associations were abolished or substantially reduced in multiple regression models taking into account rs9366357 genotype: a moderately linked SNP explaining a much larger amount of the variation in CDKAL1-v1 levels, but not strongly associated with risk of type 2 diabetes. Contrary to previous findings, we provide evidence against a role for dysregulated expression of CDKAL1-v1 in mediating the association between intronic SNPs in CDKAL1 and susceptibility to type 2 diabetes. The results of this study illustrate how caution should be exercised when inferring causality from an association between disease-risk genotype and non-coding RNA expression.	[Locke, Jonathan M.; Weedon, Michael N.; Harries, Lorna W.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Exeter EX2 5DW, Devon, England; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan	Harries, LW (reprint author), Univ Exeter, Inst Biomed & Clin Sci, Sch Med, RILD Bldg,Barrack Rd, Exeter EX2 5DW, Devon, England.	l.w.harries@exeter.ac.uk	Tomizawa, Kazuhito/F-2405-2015	Tomizawa, Kazuhito/0000-0002-5663-2627			Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Popadin K, 2013, AM J HUM GENET, V93, P1015, DOI 10.1016/j.ajhg.2013.10.022; Zhou B, 2014, HUM MOL GENET, V23, P4639, DOI 10.1093/hmg/ddu184; Nica AC, 2013, GENOME RES, V23, P1554, DOI 10.1101/gr.150706.112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	APR	2015	58	4					745	748		10.1007/s00125-015-3508-9		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CD2BK	WOS:000350878400014		
J	Kim, SH; Kim, KH; Kim, HK; Kim, MJ; Back, SH; Konishi, M; Itoh, N; Lee, MS				Kim, Seong Hun; Kim, Kook Hwan; Kim, Hyoung-Kyu; Kim, Mi-Jeong; Back, Sung Hoon; Konishi, Morichika; Itoh, Nobuyuki; Lee, Myung-Shik			Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress	DIABETOLOGIA			English	Article						ATF4; eIF2 alpha; ER stress; FGF21; Insulin resistance; Lipid accumulation; Liver injury; Obesity	UNFOLDED PROTEIN RESPONSE; FATTY LIVER-DISEASE; INSULIN ACTION; REGULATES METABOLISM; GLUCOSE-HOMEOSTASIS; ENERGY-EXPENDITURE; FGF21; MICE; MOUSE; SENSITIVITY	Fibroblast growth factor 21 (FGF21) is an endocrine hormone that exhibits anti-diabetic and anti-obesity activity. FGF21 expression is increased in patients with and mouse models of obesity or nonalcoholic fatty liver disease (NAFLD). However, the functional role and molecular mechanism of FGF21 induction in obesity or NAFLD are not clear. As endoplasmic reticulum (ER) stress is triggered in obesity and NAFLD, we investigated whether ER stress affects FGF21 expression or whether FGF21 induction acts as a mechanism of the unfolded protein response (UPR) adaptation to ER stress induced by chemical stressors or obesity. Hepatocytes or mouse embryonic fibroblasts deficient in UPR signalling pathways and liver-specific eIF2 alpha mutant mice were employed to investigate the in vitro and in vivo effects of ER stress on FGF21 expression, respectively. The in vivo importance of FGF21 induction by ER stress and obesity was determined using inducible Fgf21-transgenic mice and Fgf21-null mice with or without leptin deficiency. We found that ER stressors induced FGF21 expression, which was dependent on a PKR-like ER kinase-eukaryotic translation factor 2 alpha-activating transcription factor 4 pathway both in vitro and in vivo. Fgf21-null mice exhibited increased expression of ER stress marker genes and augmented hepatic lipid accumulation after tunicamycin treatment. However, these changes were attenuated in inducible Fgf21-transgenic mice. We also observed that Fgf21-null mice with leptin deficiency displayed increased hepatic ER stress response and liver injury, accompanied by deteriorated metabolic variables. Our results suggest that FGF21 plays an important role in the adaptive response to ER stress- or obesity-induced hepatic metabolic stress.	[Kim, Seong Hun; Kim, Kook Hwan; Lee, Myung-Shik] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea; [Kim, Seong Hun; Kim, Kook Hwan; Lee, Myung-Shik] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Sch Med, Seoul 135710, South Korea; [Kim, Hyoung-Kyu; Kim, Mi-Jeong; Back, Sung Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Higashinada Ku, Kobe, Hyogo 658, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto, Japan	Kim, KH (reprint author), Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 135710, South Korea.	kookhwankim@gmail.com; mslee0923@skku.edu					Adams Andrew C, 2013, Mol Metab, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Li HT, 2010, J HEPATOL, V53, P934, DOI [10.1016/j.jhep.2010.05.018, 10.1016/j.jhep.2010.07.003]; So WY, 2013, DIABETES, V62, P3751, DOI 10.2337/db13-0645; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Wan XS, 2014, BIOMED RES INT, DOI 10.1155/2014/807874	37	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	APR	2015	58	4					809	818		10.1007/s00125-014-3475-6		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CD2BK	WOS:000350878400021		
J	Onduka, T; Ojima, D; Ito, K; Mochida, K; Koyama, J; Fujii, K				Onduka, Toshimitsu; Ojima, Daisuke; Ito, Katsutoshi; Mochida, Kazuhiko; Koyama, Jiro; Fujii, Kazunori			Reproductive toxicity of 1-nitronaphthalene and 1-nitropyrene exposure in the mummichog, Fundulus heteroclitus	ECOTOXICOLOGY			English	Article						Nitrated polycyclic aromatic hydrocarbons; Reproductive toxicity; Cholesterol pellet implantation techniques; No-observed-effect concentration	POLYCYCLIC AROMATIC-HYDROCARBONS; DNA STRAND BREAKS; COMET ASSAY; MODEL FISH; TROUT; JAPAN; BENZO<A>PYRENE; TUMORIGENICITY; NITROARENES; BIOASSAY	After pregnant mummichog were implanted with 1-nitronaphthalene or 1-nitropyrene via cholesterol pellet, we investigated the effects of the chemicals on embryo normality, hatchability and days to hatch of normal embryos, and growth and survival of hatched larvae from normal embryos of the implanted mummichog. Hatchability was the parameter most sensitive to the effects of both 1-nitronaphthalene and 1-nitropyrene. The 4-week lowest-observed-effect concentration (LOEC) of 1-nitronaphthalene, based on the actual concentrations in the eggs in the test, was 447 ng g(-1) wet wt.; and the LOEC and no-observed-effect concentration (NOEC) of 1-nitropyrene were 958 and 344 ng g(-1) wet wt., respectively. The 4-week LOEC of 1-nitronaphthalene, based on the concentration in the water, was estimated at 4.8 mu g L-1 by using the reported bioconcentration factor; and the LOEC and NOEC of 1-nitropyrene, based on the concentration in the water, were estimated at 3.1 and 8.6 mu g L-1, respectively. The reported environmental concentrations of 1-nitropyrene and 1-nitronaphthalene are over three magnitudes lower than the toxicity values we obtained. Therefore, the effects of environmental levels of 1-nitropyrene and 1-nitronaphthalene on fish reproduction, not including genomic effects on embryos, appear to be almost negligible. However, DNA damage has been detected in marine organisms exposed to 1-nitropyrene. Further studies of the genotoxicity of nitrated polycyclic aromatic hydrocarbons at environmental levels are therefore needed to evaluate their ecotoxicological risks.	[Onduka, Toshimitsu; Ojima, Daisuke; Ito, Katsutoshi; Mochida, Kazuhiko; Fujii, Kazunori] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 7390452, Japan; [Koyama, Jiro] Kagoshima Univ, Educ & Res Ctr Marine Resources & Environm, Fac Fisheries, Kagoshima 8900056, Japan	Onduka, T (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, 2-17-5 Maruishi, Hiroshima 7390452, Japan.	onduka@affrc.go.jp			Ministry of the Environment, Japan	We are grateful to Ms. Miki Shoda and Ms. Chiaki Hiramoto (National Research Institute of Fisheries and Environment of the Inland Sea) for their kind help. This study was supported by the development fund "Research on dynamics of nitroarenes in inner bay regions and influence on marine organisms," from the Ministry of the Environment, Japan.	ATKINSON R, 1994, ENVIRON HEALTH PERSP, V102, P117, DOI 10.2307/3431940; Manzetti S, 2012, ENVIRON CHEM LETT, V10, P349, DOI 10.1007/s10311-012-0368-0; NIELSEN T, 1984, ENVIRON SCI TECHNOL, V18, P157, DOI 10.1021/es00121a005; Uno S, 2011, MAR POLLUT BULL, V63, P477, DOI 10.1016/j.marpolbul.2011.02.044; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; Mitchelmore CL, 1998, ECOTOX ENVIRON SAFE, V41, P51, DOI 10.1006/eesa.1998.1666; ARMSTRON.PB, 1965, BIOL BULL, V128, P143, DOI 10.2307/1539545; Bacolod ET, 2013, JPN J ENV TOXICOL, V16, P79; Bacolod ET, 2013, JPN J ENV TOXICOL, V16, P91; Barmford HA, 2003, ATMOS ENVIRON, V37, P2077; BUSBY WF, 1988, CARCINOGENESIS, V9, P741, DOI 10.1093/carcin/9.5.741; CRIM LW, 1988, AQUACULTURE, V74, P87, DOI 10.1016/0044-8486(88)90089-0; CURTIS MW, 1981, J HYDROL, V51, P359, DOI 10.1016/0022-1694(81)90144-X; Edmunds JSG, 2000, ENVIRON HEALTH PERSP, V108, P219, DOI 10.2307/3454437; Ishaq R, 1999, ENVIRON TOXICOL CHEM, V18, P533, DOI 10.1897/1551-5028(1999)018<0533:OPCATT>2.3.CO;2; Kawanaka Y, 2007, J CHROMATOGR A, V1163, P312, DOI 10.1016/j.chroma.2007.06.038; Mitchelmore CL, 1998, AQUAT TOXICOL, V41, P161, DOI 10.1016/S0166-445X(97)00064-7; Murahashi T, 2001, WATER RES, V35, P3367, DOI 10.1016/S0043-1354(01)00035-5; Ohe T, 1996, SCI TOTAL ENVIRON, V181, P7, DOI 10.1016/0048-9697(95)04952-5; Onduka T, 2012, JPN J ENV TOXICOL, V15, P1; Ozaki N, 2010, WATER AIR SOIL POLL, V207, P263, DOI 10.1007/s11270-009-0134-5; Papoulias DM, 2000, AQUAT TOXICOL, V48, P37, DOI 10.1016/S0166-445X(99)00026-0; SCHULTZ TW, 1985, ENVIRON TOXICOL CHEM, V4, P353; Shimizu A, 1997, J FISH BIOL, V51, P724, DOI 10.1006/jfbi.1997.0478; WISLOCKI PG, 1986, CARCINOGENESIS, V7, P1317, DOI 10.1093/carcin/7.8.1317; Yaffe D, 2001, RISK ANAL, V21, P275, DOI 10.1111/0272-4332.212111; Yamazaki H, 2000, MUTAT RES-GEN TOX EN, V472, P129, DOI 10.1016/S1383-5718(00)00138-8	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0963-9292	1573-3017		ECOTOXICOLOGY	Ecotoxicology	APR	2015	24	3					648	656		10.1007/s10646-014-1412-6		9	Ecology; Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CD5WV	WOS:000351160300017		
J	Fang, YX; Yoshii, K; Jiang, XG; Sun, XG; Tsuda, T; Mehio, N; Dai, S				Fang, Youxing; Yoshii, Kazuki; Jiang, Xueguang; Sun, Xiao-Guang; Tsuda, Tetsuya; Mehio, Nada; Dai, Sheng			An AlCl3 based ionic liquid with a neutral substituted pyridine ligand for electrochemical deposition of aluminum	ELECTROCHIMICA ACTA			English	Article						Al-containing ionic liquid; Al electroplating; Al-containing cations; neutral ligand	CHLOROALUMINATE MOLTEN-SALTS; LEWIS ACIDITY; ELECTRODEPOSITION; AL; ALLOYS; SILVER; COMPLEXES; VISCOSITY; CATIONS; MELTS	A new ionic liquid (IL) based on a "neutral" ligand, 4-propylpyridine, is obtained via complexation with AlCl3. It is found that the asymmetric cleavage of AlCl3 generates AlCl2+ and AlCl4, and the former is coordinated by 4-propylpyridine to produce the Al-containing cations ([AlCl2(4-Pr-Py)(2)](+)). The AlCl3/4-propylpyridine IL with a molar ratio of 1.3/1 is highly fluidic with a viscosity of 42.8 mPa s and an ionic conductivity of 5.0 x 10 x S-4/cm at room temperature. In contrast to conventional ILs for electroplating aluminum in which the electrochemically active species are Al-containing anions (for example Al2Cl7), this new IL has an Al-containing cation as the electroactive species, which is beneficial to electrodeposition of aluminum. (C) 2015 Elsevier Ltd. All rights reserved.	[Yoshii, Kazuki; Sun, Xiao-Guang; Dai, Sheng] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [Fang, Youxing; Jiang, Xueguang; Mehio, Nada; Dai, Sheng] Univ Tennessee, Dept Chem, Knoxville, TN 37916 USA; [Tsuda, Tetsuya] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Dai, S (reprint author), Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA.	dais@ornl.gov	Jiang, Xueguang/J-5784-2013; Tsuda, Tetsuya/F-7234-2014; Dai, Sheng/K-8411-2015	Jiang, Xueguang/0000-0002-9937-6029; Tsuda, Tetsuya/0000-0001-9462-8066; Dai, Sheng/0000-0002-8046-3931	Strategic Environmental research and Development Program (SERDP) [WP2316]	This work was funded by the Strategic Environmental research and Development Program (SERDP) (WP2316).	Abood HMA, 2011, CHEM COMMUN, V47, P3523, DOI 10.1039/c0cc04989a; Yang YL, 2004, CHEM COMMUN, P226, DOI 10.1039/b311615h; Coleman F, 2013, ANGEW CHEM INT EDIT, V52, P12582, DOI 10.1002/anie.201306267; Liao Q, 1997, J ELECTROCHEM SOC, V144, P936, DOI 10.1149/1.1837510; Depuydt D, 2013, CHEMPLUSCHEM, V78, P578, DOI 10.1002/cplu.201300063; Li B, 2011, ELECTROCHIM ACTA, V56, P5478, DOI 10.1016/j.electacta.2011.03.047; WILKES JS, 1982, INORG CHEM, V21, P1263, DOI 10.1021/ic00133a078; Wibowo R, 2009, J PHYS CHEM B, V113, P12293, DOI 10.1021/jp906128t; Liao C, 2011, PHYS CHEM CHEM PHYS, V13, P21503, DOI 10.1039/c1cp22375e; Sniekers J, 2014, DALTON T, V43, P1589, DOI 10.1039/c3dt52416g; PARRY EP, 1963, J CATAL, V2, P371, DOI 10.1016/0021-9517(63)90102-7; Tsuda T, 2008, J ELECTROCHEM SOC, V155, pD256, DOI 10.1149/1.2833305; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; Vogel H, 1921, PHYS Z, V22, P645; Anderson TM, 2010, DALTON T, V39, P8609, DOI 10.1039/c0dt00523a; Endres F, 2002, CHEMPHYSCHEM, V3, P144, DOI 10.1002/1439-7641(20020215)3:2<144::AID-CPHC144>3.3.CO;2-R; Abbott AP, 2013, ANNU REV MATER RES, V43, P335, DOI 10.1146/annurev-matsci-071312-121640; Pratt HD, 2011, DALTON T, V40, P11396, DOI 10.1039/c1dt10973a; Huang JF, 2006, J ELECTROCHEM SOC, V153, pJ9, DOI 10.1149/1.2150161; Atwood DA, 1998, COORDIN CHEM REV, V176, P407, DOI 10.1016/S0010-8545(98)00127-1; Chang JK, 2008, T I MET FINISH, V86, P227, DOI 10.1179/174591908X327554; ELEY DD, 1952, J CHEM SOC, P1914, DOI 10.1039/jr9520001914; FANNIN AA, 1984, J PHYS CHEM-US, V88, P2614, DOI 10.1021/j150656a038; Hurley F.H., 1948, U.S. Patent, Patent No. [2446331, 2 446 331]; John S. Wilkes, 2002, IONIC LIQUIDS PERSPE, P214; Johnston M, 2005, J PHYS CHEM B, V109, P11296, DOI 10.1021/jp051243m; LIPSZTAJN M, 1985, J ELECTROCHEM SOC, V132, P1126, DOI 10.1149/1.2114026; Pitner WR, 1996, J ELECTROCHEM SOC, V143, P130, DOI 10.1149/1.1836397; Sun XG, 2013, J POWER SOURCES, V237, P5, DOI 10.1016/j.jpowsour.2013.02.061; Tammann G., 1926, ANORG ALLG CHEM, V156, P245; Tang J., 2010, ELECTROCHIM ACTA, V56, P1130; Tsuda T, 2003, J ELECTROCHEM SOC, V150, pC234, DOI 10.1149/1.1554915; Wier Jr T. P., 1948, US Patent, Patent No. 2446349; Zhu Q, 2000, ELEC SOC S, V99, P494	34	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	APR 1	2015	160						82	88		10.1016/j.electacta.2015.02.020		7	Electrochemistry	Electrochemistry	CD5GL	WOS:000351115900012		
J	Siroma, Z; Fujiwara, N; Yamazaki, S; Asahi, M; Nagai, T; Ioroi, T				Siroma, Zyun; Fujiwara, Naoko; Yamazaki, Shin-ichi; Asahi, Masafumi; Nagai, Tsukasa; Ioroi, Tsutomu			Mathematical solutions of comprehensive variations of a transmission-line model of the theoretical impedance of porous electrodes	ELECTROCHIMICA ACTA			English	Article						impedance; porous electrode; transmission-line model; mathematical solution	FILM ELECTRODES; FUEL-CELL; MEMBRANE; DIFFUSION; TRANSPORT; CATALYST; PEMFC; LAYER	Mathematical solutions were obtained for the impedance of one-dimensional transmission-line (TML) models with all possible variations of the boundary conditions and connections to an external circuit. First, three types of connection (Z-type, T-type, and E-type) were considered. A more generalized connection that includes the characteristics of both Z-type and T-type (universal-type) was also considered. All four of the resulting general solutions were versatile, but quite complicated. Next, comprehensive variations of the general solutions depending on specific boundary conditions, which are generally simpler, were also considered. Finally, an equivalent transform from a three-terminal TML model to a simple Y-circuit was calculated. This enables calculation of the serial connection of multiple TML models with different parameters, which represents a multi-layered electrode. (C) 2015 Elsevier Ltd. All rights reserved.	[Siroma, Zyun; Fujiwara, Naoko; Yamazaki, Shin-ichi; Asahi, Masafumi; Nagai, Tsukasa; Ioroi, Tsutomu] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Siroma, Z (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan.	siroma.z@aist.go.jp			JSPS KAKENHI Grant [25289363]	This work was supported by JSPS KAKENHI Grant Number 25289363.	Freger V, 2005, ELECTROCHEM COMMUN, V7, P957, DOI 10.1016/j.elecom.2005.06.020; Ren XM, 1997, J ELECTROANAL CHEM, V420, P251, DOI 10.1016/S0022-0728(96)04784-5; Jang JH, 2004, J ELECTROCHEM SOC, V151, pA571, DOI 10.1149/1.1647572; LASIA A, 1995, J ELECTROANAL CHEM, V397, P27, DOI 10.1016/0022-0728(95)04177-5; RAISTRICK ID, 1990, ELECTROCHIM ACTA, V35, P1579, DOI 10.1016/0013-4686(90)80013-E; PARK JR, 1983, CORROS SCI, V23, P295, DOI 10.1016/0010-938X(83)90063-X; Bisquert J, 2000, PHYS CHEM CHEM PHYS, V2, P4185, DOI 10.1039/b001708f; Troltzsch U, 2012, ELECTROCHIM ACTA, V75, P347, DOI 10.1016/j.electacta.2012.05.014; Bisquert J, 1999, ELECTROCHEM COMMUN, V1, P429, DOI 10.1016/S1388-2481(99)00084-3; NISHIKATA A, 1995, CORROS SCI, V37, P897, DOI 10.1016/0010-938X(95)00002-2; Prabhuram J, 2010, INT J HYDROGEN ENERG, V35, P6924, DOI 10.1016/j.ijhydene.2010.04.025; De Levie R., 1963, ELECTROCHIM ACTA, V8, P751; Diard JP, 2005, J ELECTROANAL CHEM, V578, P247, DOI 10.1016/j.jelechem.2005.01.007; Donne SW, 2004, J APPL ELECTROCHEM, V34, P477, DOI 10.1023/B:JACH.0000021927.21179.d1; Elliott J. M., 2000, PHYS CHEM CHEM PHYS, V2, P5603; Itagaki M, 2010, ELECTROCHIM ACTA, V55, P6255, DOI 10.1016/j.electacta.2009.10.016; Kim JS, 2011, J SOLID STATE ELECTR, V15, P2447, DOI 10.1007/s10008-011-1393-9; Mitsushima S, 2006, ELECTROCHEMISTRY, V74, P810; Nakamura T, 2013, J POWER SOURCES, V244, P532, DOI 10.1016/j.jpowsour.2013.02.021; Park SH, 2013, J SOLID STATE ELECTR, V17, P1247, DOI 10.1007/s10008-012-1994-y; Siroma Z, 2011, ELECTROCHEMISTRY, V79, P326; Srinivasarao M, 2012, J POWER SOURCES, V206, P197, DOI 10.1016/j.jpowsour.2012.01.135; Yoon YG, 2003, J POWER SOURCES, V118, P189, DOI 10.1016/S0378-7753(03)00092-2	23	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	APR 1	2015	160						313	322		10.1016/j.electacta.2015.02.065		10	Electrochemistry	Electrochemistry	CD5GL	WOS:000351115900042		
J	Choi, B; Panthi, D; Kwon, Y; Tsutsumi, A				Choi, Bokkyu; Panthi, Dhruba; Kwon, Yonguk; Tsutsumi, Atsushi			Chemical Charging on a MnO2 Electrode of a Fuel Cell/Battery System in a Highly O-2-Dissolved Electrolyte	ELECTROCHIMICA ACTA			English	Article						Dissolved oxygen; Manganese dioxide; Fuel cell/battery system; Alkaline electrolyte	OXYGEN REDUCTION REACTION; ALKALINE GAMMA-MNO2; MANGANESE-DIOXIDE; POSITIVE ELECTRODE; BARIUM HYDROXIDE; MECHANISM; FCB; SOLUBILITY; BATTERY; COEFFICIENT	To improve the chemical reaction rate of oxygen charging on a manganese dioxide electrode of a fuel cell/battery system, we used highly dissolved oxygen in an electrolyte. For this chemical reaction, a discharged electrode was placed in a pressure-resistant chamber containing an electrolyte and then oxygen was supplied at 0.5, 1.0, 1.5, and 2.0 MPa to the electrolyte for 20, 40, and 60 min. Electrochemical characterization and X-ray diffraction were carried out to measure the amount of charge and the changes in the crystal structure before and after the chemical charging process. The results obtained from the chemical charge/electrochemical discharge experiments indicate that the dissolved oxygen in the alkaline solution can chemically charge the discharged electrode. The charge rate and amount were found to increase with O-2 partial pressure and supply time. Additionally, X-ray diffraction confirmed that the chemical charging process with dissolved oxygen is accompanied by a crystal structure change with the emission of protons and electrons from MnOOH in the same manner as in the electrochemical charging process. (C) 2015 Elsevier Ltd. All rights reserved.	[Choi, Bokkyu; Panthi, Dhruba; Kwon, Yonguk; Tsutsumi, Atsushi] Univ Tokyo, Inst Ind Sci, Collaborat Res Ctr Energy Engn, Meguro Ku, Tokyo 1538505, Japan	Tsutsumi, A (reprint author), Univ Tokyo, Inst Ind Sci, Collaborat Res Ctr Energy Engn, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	a-tsu2mi@iis.u-tokyo.ac.jp	Tsutsumi, Atsushi/K-8988-2012	Tsutsumi, Atsushi/0000-0001-9679-4383			Erable B, 2012, CHEMSUSCHEM, V5, P975, DOI 10.1002/cssc.201100836; Cao YL, 2003, J ELECTROANAL CHEM, V557, P127, DOI 10.1016/S0022-0728(03)00355-3; Pop V, 2005, MEAS SCI TECHNOL, V16, pR93, DOI 10.1088/0957-0233/16/12/R01; Peng B, 2009, COORDIN CHEM REV, V253, P2805, DOI 10.1016/j.ccr.2009.04.008; Wager G, 2014, RENEW ENERG, V62, P303, DOI 10.1016/j.renene.2013.07.029; McCloskey BD, 2012, J PHYS CHEM C, V116, P23897, DOI 10.1021/jp306680f; GUBBINS KE, 1965, J ELECTROCHEM SOC, V112, P469, DOI 10.1149/1.2423575; Valim RB, 2012, ELECTROCHIM ACTA, V85, P423, DOI 10.1016/j.electacta.2012.08.075; Choi B, 2009, J POWER SOURCES, V194, P1150, DOI 10.1016/j.jpowsour.2009.06.039; Chen HS, 2009, PROG NAT SCI, V19, P291, DOI 10.1016/j.pnsc.2008.07.014; DAVIS RE, 1967, ELECTROCHIM ACTA, V12, P287, DOI 10.1016/0013-4686(67)80007-0; Garcia P, 2013, EXPERT SYST APPL, V40, P4791, DOI 10.1016/j.eswa.2013.02.028; Roche I, 2007, J PHYS CHEM C, V111, P1434, DOI 10.1021/jp0647986; BATTINO R, 1966, CHEM REV, V66, P395, DOI 10.1021/cr60242a003; Lima FHB, 2007, ELECTROCHIM ACTA, V52, P3732, DOI 10.1016/j.electacta.2006.10.047; Arnott JB, 2007, J ELECTROCHEM SOC, V154, pA776, DOI 10.1149/1.2745643; Bailey MR, 2012, J ELECTROCHEM SOC, V159, pA2010, DOI 10.1149/2.076212jes; Bailey MR, 2011, ELECTROCHIM ACTA, V56, P5037, DOI 10.1016/j.electacta.2011.03.095; Bailey MR, 2011, J ELECTROCHEM SOC, V158, pA802, DOI 10.1149/1.3586045; Bailey MR, 2012, J ELECTROCHEM SOC, V159, pA999, DOI 10.1149/2.047207jes; Bodenes L, 2013, J POWER SOURCES, V236, P265, DOI 10.1016/j.jpowsour.2013.02.067; Browning GJ, 2005, J APPL ELECTROCHEM, V35, P871, DOI 10.1007/s10800-005-4738-1; Choi B, 2009, INT J HYDROGEN ENERG, V34, P2058, DOI 10.1016/j.ijhydene.2008.12.032; Choi B, 2010, ELECTROCHIM ACTA, V55, P8771, DOI 10.1016/j.electacta.2010.07.090; Choi B, 2011, ELECTROCHIM ACTA, V56, P6696, DOI 10.1016/j.electacta.2011.05.057; Choi B, 2010, J CHEM ENG JPN, V43, P224; Ferreira A, 2013, CHEM ENG SCI, V100, P145, DOI 10.1016/j.ces.2013.02.020; Johansen JF, 2011, J ELECTROCHEM SOC, V158, pA6, DOI 10.1149/1.3505003; Lee S, 2008, J POWER SOURCES, V181, P177, DOI 10.1016/j.jpowsour.2008.02.083	29	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	APR 1	2015	160						323	329		10.1016/j.electacta.2015.02.023		7	Electrochemistry	Electrochemistry	CD5GL	WOS:000351115900043		
J	Yamagiwa, K; Morita, D; Yabuuchi, N; Tanaka, T; Fukunishi, M; Taki, T; Watanabe, H; Otsuka, T; Yano, T; Son, JY; Cui, YT; Oji, H; Komaba, S				Yamagiwa, Kiyofumi; Morita, Daichi; Yabuuchi, Naoaki; Tanaka, Tatsuya; Fukunishi, Mika; Taki, Takayuki; Watanabe, Hiroaki; Otsuka, Takahiro; Yano, Toru; Son, Jin-Young; Cui, Yi-Tao; Oji, Hiroshi; Komaba, Shinichi			Improved High-Temperature Performance and Surface Chemistry of Graphite/LiMn2O4 Li-Ion Cells by Fluorosilane-Based Electrolyte Additive	ELECTROCHIMICA ACTA			English	Article						Li-ion battery; Fluorosilane-based electrolyte additive; Solid electrolyte interphase; LiMn2O4	RECHARGEABLE LITHIUM BATTERIES; ELECTROCHEMICAL-BEHAVIOR; VINYLENE CARBONATE; FLUOROETHYLENE CARBONATE; ELEVATED-TEMPERATURE; CAPACITY RETENTION; INSERTION; CATHODE; ANODES; REDUCTION	For graphite/LiMn2O4 based lithium-ion batteries, we have successfully improved the charge/discharge capacity retention during high temperature cycling at 60 degrees C by addition of proper amount of 1,2-bis (difluoromethylsilyl) ethane (FSE) into the electrolyte as an additive. In addition, the additive also suppresses self-discharge in a storage test at 60 degrees C for 7 days. Detailed surface analyses of graphite negative electrodes by electron microscopy, synchrotron X-ray photoelectron spectroscopy, and time of flight secondary ion spectroscopy, indicate that silicon and fluorine-containing thin layer is formed by FSE decomposition and deposited on the graphite negative electrode surface, which effectively protects the graphite negative electrode during the high temperature cycling and storage. The silicon-and fluorine-containing surface layer suppresses the degradation of the negative electrode caused by deposition of manganese, resulting from Mn2+ dissolution from LiMn2O4, and prevents self-discharge due to excess decomposition of electrolyte on the surface. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamagiwa, Kiyofumi; Morita, Daichi; Yabuuchi, Naoaki; Tanaka, Tatsuya; Fukunishi, Mika; Komaba, Shinichi] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Taki, Takayuki; Watanabe, Hiroaki; Otsuka, Takahiro; Yano, Toru] ADEKA Corp, Tokyo 1168553, Japan; [Son, Jin-Young; Cui, Yi-Tao; Oji, Hiroshi] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Komaba, S (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	komaba@rs.kagu.tus.ac.jp	Yabuuchi, Naoaki/F-8369-2012	Yabuuchi, Naoaki/0000-0002-9404-5693	Japan Science and Technology Agency through the Advanced Low Carbon Technology Research and Development Program (JST-ALCA)	This study was in part granted by the Japan Science and Technology Agency through the Advanced Low Carbon Technology Research and Development Program (JST-ALCA). The synchrotron radiation experiments, HAXPES, were performed at the BL46XU of SPring-8 as the Priority Research Proposal with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposals 2012B1373 and 2013A1399).	Xia YY, 1996, J ELECTROCHEM SOC, V143, P825, DOI 10.1149/1.1836544; Xia Q, 2008, J POWER SOURCES, V180, P602, DOI 10.1016/j.jpowsour.2008.01.039; Aurbach D, 2002, ELECTROCHIM ACTA, V47, P1423, DOI 10.1016/S0013-4686(01)00858-1; Kobayashi K, 2003, APPL PHYS LETT, V83, P1005, DOI 10.1063/1.1595714; Song D, 1999, SOLID STATE IONICS, V117, P151, DOI 10.1016/S0167-2738(98)00258-6; DAHN JR, 1995, SCIENCE, V270, P590, DOI 10.1126/science.270.5236.590; Ryou MH, 2010, ELECTROCHIM ACTA, V55, P2073, DOI 10.1016/j.electacta.2009.11.036; Yabuuchi N, 2011, ADV ENERGY MATER, V1, P759, DOI 10.1002/aenm.201100236; Inose T, 2006, J POWER SOURCES, V161, P550, DOI 10.1016/j.jpowsour.2006.03.053; Xing LD, 2009, J PHYS CHEM B, V113, P16596, DOI 10.1021/jp9074064; OHZUKU T, 1990, J ELECTROCHEM SOC, V137, P769, DOI 10.1149/1.2086552; McMillan R, 1999, J POWER SOURCES, V81, P20, DOI 10.1016/S0378-7753(98)00201-8; Matsuoka O, 2002, J POWER SOURCES, V108, P128, DOI 10.1016/S0378-7753(02)00012-5; MIZUSHIMA K, 1980, MATER RES BULL, V15, P783, DOI 10.1016/0025-5408(80)90012-4; Myung ST, 2001, J ELECTROCHEM SOC, V148, pA482, DOI 10.1149/1.1365140; Ensling D, 2009, J MATER CHEM, V19, P82, DOI 10.1039/b813099j; PELED E, 1979, J ELECTROCHEM SOC, V126, P2047, DOI 10.1149/1.2128859; GUMMOW RJ, 1994, SOLID STATE IONICS, V69, P59, DOI 10.1016/0167-2738(94)90450-2; Winter M, 1998, ADV MATER, V10, P725, DOI 10.1002/(SICI)1521-4095(199807)10:10<725::AID-ADMA725>3.0.CO;2-Z; Mogi R, 2002, J ELECTROCHEM SOC, V149, pA1578, DOI 10.1149/1.1516770; Yabuuchi N, 2012, ELECTROCHIM ACTA, V82, P296, DOI 10.1016/j.electacta.2012.06.123; Wang YX, 2002, J AM CHEM SOC, V124, P4408, DOI 10.1021/ja017073i; Amatucci G, 1999, ELECTROCHIM ACTA, V45, P255, DOI 10.1016/S0013-4686(99)00209-1; Ogata A, 2007, J POWER SOURCES, V174, P756, DOI 10.1016/j.jpowsour.2007.06.150; Komaba S, 2002, ELECTROCHIM ACTA, V47, P1229, DOI 10.1016/S0013-4686(01)00847-7; Cho IH, 2010, ELECTROCHEM SOLID ST, V13, pA168, DOI 10.1149/1.3481711; Endo E, 2000, J ELECTROCHEM SOC, V147, P4029, DOI 10.1149/1.1394014; Inoue T, 1998, J ELECTROCHEM SOC, V145, P3704, DOI 10.1149/1.1838862; Komaba S, 2005, J ELECTROCHEM SOC, V152, pA937, DOI 10.1149/1.1885385; Markovsky B, 2004, J POWER SOURCES, V136, P296, DOI 10.1016/j.powsour.2004.04.017; Qin XY, 2013, J ZHEJIANG UNIV-SC A, V14, P514, DOI 10.1631/jzus.A1300026; Taki T., 2012, Japan patent, Patent No. [JP2012109091, 2012109090]; Trofimov BA, 2005, J POWER SOURCES, V147, P260, DOI 10.1016/j.jpowsour.2005.01.015; Walkowiak M, 2010, J SOLID STATE ELECTR, V14, P2213, DOI 10.1007/s10008-008-0710-4; Wang Z, 2013, SOLID STATE IONICS, V232, P19, DOI 10.1016/j.ssi.2012.11.017	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	APR 1	2015	160						347	356		10.1016/j.electacta.2015.02.004		10	Electrochemistry	Electrochemistry	CD5GL	WOS:000351115900046		
J	Ichinose, D; Yamamoto, M; Yoshida, Y				Ichinose, Daisuke; Yamamoto, Masashi; Yoshida, Yuichiro			The decoupling of affluence and waste discharge under spatial correlation: Do richer communities discharge more waste?	ENVIRONMENT AND DEVELOPMENT ECONOMICS			English	Article							US HAZARDOUS-WASTE; KUZNETS CURVES; MODEL; POLICY; SPECIFICATION; GENERATION; HYPOTHESIS	A number of developing countries have come to face the growing problems of municipal solid waste management caused by rapid economic growth. Although there are many studies on the environmental Kuznets curve, very few address the issue of municipal solid waste, and there is still controversy concerning the validity of the waste version of the Kuznets curve hypothesis. It is demonstrated that the turning point for household municipal solid waste is approximately 3.7 million yen per person, which is far less than the maximum income in the sample and valid evidence for absolute decoupling. The success of our study partially stems from our highly disaggregated data and use of spatial econometrics. The former aspect indicates that distinguishing between household and business waste reveals the waste-income relationship, whereas the latter indicates the importance of peer effects when municipal governments formulate waste-reduction policies.	[Ichinose, Daisuke] Rikkyo Univ, Coll Econ, Tokyo 171, Japan; [Yamamoto, Masashi] Toyama Univ, Ctr Far Eastern Studies, Toyama 9308555, Japan; [Yoshida, Yuichiro] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan	Ichinose, D (reprint author), Rikkyo Univ, Coll Econ, Tokyo 171, Japan.	d.ichinose@rikkyo.ac.jp; myam@eco.utoyama.ac.jp; yuichiro@hiroshima-u.ac.jp	YOSHIDA, YUICHIRO/M-2925-2013; 	YOSHIDA, YUICHIRO/0000-0002-3061-4594; Yamamoto, Masashi/0000-0003-1583-6882			Abrate G., 2010, 1 HERMES; Kelejian HH, 1998, J REAL ESTATE FINANC, V17, P99, DOI 10.1023/A:1007707430416; Fischer-Kowalski M, 2001, POPUL ENVIRON, V23, P7; Mazzanti M, 2012, J ENVIRON PLANN MAN, V55, P563, DOI 10.1080/09640568.2011.616582; Kinnaman TC, 2000, J URBAN ECON, V48, P419, DOI 10.1006/juec.2000.2174; Kelejian HH, 1999, INT ECON REV, V40, P509, DOI 10.1111/1468-2354.00027; Berrens RP, 1997, ECON LETT, V55, P435, DOI 10.1016/S0165-1765(97)00088-8; Mazzanti M, 2009, APPL ECON LETT, V16, P719, DOI 10.1080/13504850701221824; Managi S, 2009, ECOL ECON, V68, P1643, DOI 10.1016/j.ecolecon.2008.04.005; Mazzanti M, 2009, ENVIRON RESOUR ECON, V44, P203, DOI 10.1007/s10640-009-9280-x; Zhang DQ, 2010, J ENVIRON MANAGE, V91, P1623, DOI 10.1016/j.jenvman.2010.03.012; Mazzanti M, 2008, APPL ECON LETT, V15, P287, DOI 10.1080/13504850500407640; Florax RJGM, 2003, REG SCI URBAN ECON, V33, P557, DOI 10.1016/S0166-0462(03)00002-4; Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6; Maddison D, 2006, J ENVIRON ECON MANAG, V51, P218, DOI 10.1016/j.jeem.2005.07.002; Anselin L., 1988, SPATIAL ECONOMETRICS; Anselin L, 2001, COMPANION THEORETICA, P310; Anselin L., 1995, NEW DIRECTIONS SPATI, P21; Anselin Luc, 1991, GEOGR ANAL, V23, P110; Cole M. A., 1997, ENVIRON DEV ECON, V2, P401, DOI 10.1017/S1355770X97000211; De Jaeger S., 2011, P 18 EAERE C ROM 29; DUEIIP, 2001, DELH URB ENV INFR IM; Eyckmans J., 2009, P 17 EAERE C AMST 24; FLORAX R, 1992, REG SCI URBAN ECON, V22, P405, DOI 10.1016/0166-0462(92)90037-2; Hage O., 2008, P 16 EAERE C GOTH 25; Ham J. Y., 2009, P 17 EAERE C AMST 24; Japanese Ministry of the Environment, 2008, STAT DISCH TREATM MU; Karousakis K, 2009, ROUTL EXPLOR ENVIRON, P91; LeSage J, 2009, STAT TEXTB MONOGR, P1; Maddala G. S., 1992, INTRO ECONOMETRICS; Mazzanti M, 2011, APPL ECON, V43, P3299, DOI 10.1080/00036840903559612; Mazzanti M., 2005, ENV SCI, V3, P77; Mazzanti M., 2008, J ENVIRON DEV, V17-1, P51, DOI DOI 10.1177/1070496507312575; Ministry of Internal Affairs and Communications, 2008, SYST SOC DEM STAT JA; OECD (Organization for Economic Cooperation and Development), 2002, IND MEAS DEC ENV PRE; POIRIER DJ, 1988, J ECON PERSPECT, V2, P121; Raymond L., 2004, J PUBLIC POLICY, V24, P327, DOI 10.1017/S0143814X04000145; Ross JM, 2013, LAND ECON, V89, P449; Wang P, 1998, APPL ECON LETT, V5, P761; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	40	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-770X	1469-4395		ENVIRON DEV ECON	Environ. Dev. Econ.	APR	2015	20	2					161	184		10.1017/S1355770X14000370		24	Environmental Studies	Environmental Sciences & Ecology	CD6DH	WOS:000351179100002		
J	Kurosaki, T				Kurosaki, Takashi			Vulnerability of household consumption to floods and droughts in developing countries: evidence from Pakistan	ENVIRONMENT AND DEVELOPMENT ECONOMICS			English	Article							RISK; DISASTERS; WELFARE; IMPACT	Aggregate shocks such as droughts and floods cannot be perfectly insured by risk sharing within a village. Given this inability, what type of households are more vulnerable in terms of a decline in consumption when a village is hit by such shocks and what kind of microeconomic mechanism underlies the household heterogeneity in vulnerability? These questions are investigated using two-period panel data collected in rural Pakistan in 2001 and 2004. We compare consumption response to droughts, floods and health shocks and investigate how the response differs across different types of households. Empirical results show that the impact of droughts was negligible, younger and more landed households were less vulnerable to floods, and households with greater access to formal financial institutions were less vulnerable to idiosyncratic health shocks. The empirical pattern suggests the possibility of risk sharing among households that are heterogeneous in both risk aversion and credit access.	Hitotsubashi Univ, Inst Econ Res, Kunitachi, Tokyo 1868603, Japan	Kurosaki, T (reprint author), Hitotsubashi Univ, Inst Econ Res, 2-1 Naka, Kunitachi, Tokyo 1868603, Japan.	kurosaki@ier.hit-u.ac.jp					Noy I, 2009, J DEV ECON, V88, P221, DOI 10.1016/j.jdeveco.2008.02.005; Ligon E, 2003, ECON J, V113, pC95, DOI 10.1111/1468-0297.00117; Perrings C, 2006, ENVIRON DEV ECON, V11, P417, DOI 10.1017/S1355770X06003020; Kurosaki T, 2006, J DEV STUD, V42, P70, DOI 10.1080/00220380500356696; Kurosaki T, 2002, J DEV ECON, V67, P419, DOI 10.1016/S0304-3878(01)00188-2; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; Cavallo E., 2009, IDB WORKING PAPER NO; DEATON A, 1991, ECONOMETRICA, V59, P1221, DOI 10.2307/2938366; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; Dercon S., 2005, INSURANCE AGAINST PO; Dutta I, 2010, IED DISCUSSION PAPER; Fafchamps M., 2003, RURAL POVERTY RISK A; GLEWWE P, 1991, J DEV ECON, V35, P307, DOI 10.1016/0304-3878(91)90053-X; Government of Pakistan, PAKISTAN ECONOMIC SU; Hirashima S., 2008, ECONOMIC AND POLITIC, P41; Ito T, 2009, AM J AGR ECON, V91, P697, DOI 10.1111/j.1467-8276.2009.01270.x; Kurosaki T, 2001, HITOTSUB J ECON, V42, P103; Kurosaki T., 2013, ASIAN DEVELOPMENT RE, V30, P76; Kurosaki T., 1998, RISK AND HOUSEHOLD B; Perera J., 2003, IRRIGATION DEVELOPME; Sawada Y., 2011, RIETI DISCUSSION PAP; Sawada Y, 2007, AGR ECON-BLACKWELL, V37, P59, DOI 10.1111/j.1574-0862.2007.00235.x; Singh I., 1986, AGRICULTURAL HOUSEHO; United Nations, 2010, PAKISTAN FLOODS EMER	24	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-770X	1469-4395		ENVIRON DEV ECON	Environ. Dev. Econ.	APR	2015	20	2					209	235		10.1017/S1355770X14000357		27	Environmental Studies	Environmental Sciences & Ecology	CD6DH	WOS:000351179100004		
J	Poudel, NR; Fuwa, N; Otsuka, K				Poudel, Narayan Raj; Fuwa, Nobuhiko; Otsuka, Keijiro			The impacts of a community forestry program on forest conditions, management intensity and revenue generation in the Dang district of Nepal	ENVIRONMENT AND DEVELOPMENT ECONOMICS			English	Article							RESOURCE-MANAGEMENT; DEFORESTATION; INSTITUTIONS; POLICIES; OUTCOMES; COMMONS	A growing literature documents the positive impact of community management on non-timber forest conservation but not on the condition of timber forests, which require higher management intensity than do non-timber forests. Using ground-level data of the age composition of trees and the management activities of timber forests and applying a rigorous econometric technique to deal with the endogeneity of handing over forest use rights to the community, we find that a longer period of community management is associated with a higher density of pole-size trees, indicating that community management facilitates the rehabilitation of timber forests. We also find that population pressure leads to deforestation under state management but encourages forest management under community management.	[Poudel, Narayan Raj; Fuwa, Nobuhiko] Waseda Univ, Grad Sch Asia Pacific Studies, Tokyo, Japan; [Otsuka, Keijiro] Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1068677, Japan	Poudel, NR (reprint author), Waseda Univ, Grad Sch Asia Pacific Studies, Tokyo, Japan.	mnkpoudel@yahoo.com; nfuwa@waseda.jp; Otsuka@grips.ac.jp					Aggarwal S., 2006, ROLE PROPERTY NATURA; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Gautam KH, 2006, FORESTRY, V79, P81, DOI 10.1093/forestry/cpi063; Maskey V, 2006, J FOREST ECON, V11, P261, DOI 10.1016/j.jfe.2005.10.004; Angelsen A, 1999, J DEV ECON, V58, P185, DOI 10.1016/S0304-3878(98)00108-4; Edmonds EV, 2002, J DEV ECON, V68, P89, DOI 10.1016/S0304-3878(02)00007-X; Hayami Y, 2009, J DEV STUD, V45, P96, DOI 10.1080/00220380802468595; Tachibana T, 2009, LAND ECON, V85, P107; Gautam AP, 2007, INT J SUST DEV WORLD, V14, P574; Adhikari B, 2007, FOREST POLICY ECON, V9, P464, DOI 10.1016/j.forpol.2005.11.002; Baland JM, 2010, WORLD DEV, V38, P1642, DOI 10.1016/j.worlddev.2010.03.007; Kumar S, 2002, WORLD DEV, V30, P763, DOI 10.1016/S0305-750X(02)00004-9; Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; HARDIN G, 1968, SCIENCE, V162, P1243; Thoms CA, 2008, GEOFORUM, V39, P1452, DOI 10.1016/j.geoforum.2008.01.006; Gautam AR, 2004, INT FOREST REV, V6, P136, DOI 10.1505/ifor.6.2.136.38397; Chakraborty RN, 2001, ECOL ECON, V36, P341, DOI 10.1016/S0921-8009(00)00237-8; Banjade M. R., 2011, 112 FOR ACT NEP; Bhattacharya P, 2010, RESOUR CONSERV RECY, V54, P469, DOI 10.1016/j.resconrec.2009.10.003; Bhattarai K, 2008, HUM ECOL, V36, P81, DOI 10.1007/s10745-007-9144-3; Dang District Forest Office, 2009, YEARL PROGR REP DANG; Dhakal B, 2012, ENVIRON RESOUR ECON, V53, P73, DOI 10.1007/s10640-012-9548-4; Gerald J. G., 2001, J SUSTAINABLE FOREST, V12, P1; Gibbon H., 1996, SOME THOUGHTS NUKCFP; Gilmour D.A., 1991, VILLAGERS FORESTS FO; Hobley M., 1996, PARTICIPATORY FOREST; Kanel K. R., 2004, BANKO JANAKARI, V14, P19; Khanal Chhetri B. B., 2010, RURAL DEV POTENTIAL; Kijima Y, 2000, ECON DEV CULT CHANGE, V48, P867, DOI 10.1086/452481; Kohlin G, 2001, LAND ECON, V77, P206, DOI 10.2307/3147090; METZ JJ, 1991, WORLD DEV, V19, P805, DOI 10.1016/0305-750X(91)90134-4; Murty M. N., 1994, Environmental and Resource Economics, V4, P581, DOI 10.1007/BF00693047; Ojha H., 2009, 0913 INT FOOD POL RE; Ostrom E., 1990, GOVERNING COMMONS EV; Otsuka K., 2001, LAND TENURE NATURAL; Sakurai T, 2004, ENVIRON DEV ECON, V9, P539, DOI 10.1017/s1355770x04001457; Sapkota P., 2009, Banko Janakari, V19, P25; Shrestha K. K., 2007, Small-scale Forestry, V6, P273, DOI 10.1007/s11842-007-9020-4; Somanathan E., 1991, Economic and Political Weekly, V26, P37; Tachibana T., 2001, LAND TENURE NATURAL; World Bank, 2009, FOR SOURC PRACT GUID	41	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-770X	1469-4395		ENVIRON DEV ECON	Environ. Dev. Econ.	APR	2015	20	2					259	281		10.1017/S1355770X14000473		23	Environmental Studies	Environmental Sciences & Ecology	CD6DH	WOS:000351179100006		
J	Kritsananuwat, R; Sahoo, SK; Fukushi, M; Chanyotha, S				Kritsananuwat, Rawiwan; Sahoo, Sarata Kumar; Fukushi, Masahiro; Chanyotha, Supitcha			Distribution of rare earth elements, thorium and uranium in Gulf of Thailand's sediments	ENVIRONMENTAL EARTH SCIENCES			English	Article						Rare earth elements; Thorium; Uranium; Marine sediment; Gulf of Thailand	MARINE-SEDIMENTS; RIVER; FRACTIONATION; PHOSPHOGYPSUM; CONTAMINATION; PROVENANCE; TRACERS; ESTUARY; OCEAN; BAY	Distribution of rare earth elements (REEs), thorium and uranium in 54 marine sediments collected from five selected areas along the Gulf of Thailand is discussed in this paper. These areas have been selected as potential sites to set up thermal and nuclear power plants. Concentration of elements was determined using inductively coupled plasma mass spectrometry (ICP-MS). Absolute concentrations of REEs, Th and U show a sample-to-sample variation and may be due to different geological characteristic of area as well as grain size effect. Total REE concentrations (not including Y) range between 9.4 and 206 mu g/g. The chondrite-normalized REE patterns of all samples are similar to Post-Archean Australian Shale (PAAS) and average Upper Continental Crust, with LREEs' enrichment relative to HREEs (La-N/Yb-N = 6.5-29), fairly flat HREEs' patterns (Gd-N/Yb-N = 1.0-3.8) and ubiquitous negative Eu anomaly (Eu/Eu* = 0.3-0.7). Th concentrations (0.9-28 mu g/g) are relatively higher than those of uranium (0.4-4.0 mu g/g). Th/U ratios (1.5-9.9) are higher than the average upper crust. These results are consistent with terrigenous sediments that formed from the weathering and erosion of felsic rocks.	[Kritsananuwat, Rawiwan; Fukushi, Masahiro] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo 158, Japan; [Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, Chiba 260, Japan; [Chanyotha, Supitcha] Chulalongkorn Univ, Dept Nucl Engn, Bangkok, Thailand	Sahoo, SK (reprint author), Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan.	rawiwan@fml.nirs.go.jp; sahoo@nirs.go.jp; fukushi@hs.tmu.ac.jp; supitcha.c@chula.ac.th			Tokyo Metropolitan Government, Tokyo, Japan	One of authors (RK) is very much thankful to "Asian Human Resources Fund", Tokyo Metropolitan Government, Tokyo, Japan for the award of Doctoral fellowship at Tokyo Metropolitan University. RK would like to thank specially Chulalongkorn University team members for their kind support to collect the samples during field study.	Nyakairu GWA, 2001, GEOCHEM J, V35, P13; Das BK, 2006, J ASIAN EARTH SCI, V26, P649, DOI 10.1016/j.jseaes.2005.01.005; Munksgaard NC, 2003, ESTUAR COAST SHELF S, V57, P399, DOI 10.1016/S0272-7714(02)00368-2; Parami VK, 2010, MICROCHEM J, V95, P181, DOI 10.1016/j.microc.2009.11.008; Yang SY, 2002, EARTH PLANET SC LETT, V201, P407, DOI 10.1016/S0012-821X(02)00715-X; Ardini F, 2010, ANAL CHIM ACTA, V678, P18, DOI 10.1016/j.aca.2010.07.036; Kulaksiz S, 2011, ENVIRON INT, V37, P973, DOI 10.1016/j.envint.2011.02.018; Caccia VG, 2007, MAR CHEM, V104, P171, DOI 10.1016/j.marchem.2006.11.001; Delgado J, 2012, MAR POLLUT BULL, V64, P1799, DOI 10.1016/j.marpolbul.2012.06.001; de Oliveira SMB, 2007, APPL GEOCHEM, V22, P837, DOI 10.1016/j.apgeochem.2006.12.017; WINDOM HL, 1984, ESTUAR COAST SHELF S, V19, P133, DOI 10.1016/0272-7714(84)90060-X; Chaillou G, 2006, MAR CHEM, V100, P39, DOI 10.1016/j.marchem.2005.09.007; SHOLKOVITZ ER, 1994, GEOCHIM COSMOCHIM AC, V58, P1567, DOI 10.1016/0016-7037(94)90559-2; Li CS, 2013, J ASIAN EARTH SCI, V69, P39, DOI 10.1016/j.jseaes.2013.03.001; SHOLKOVITZ ER, 1992, EARTH PLANET SC LETT, V114, P77, DOI 10.1016/0012-821X(92)90152-L; SHOLKOVITZ ER, 1988, AM J SCI, V288, P236; BONIFORTI R, 1987, SCI TOTAL ENVIRON, V64, P181, DOI 10.1016/0048-9697(87)90130-6; Borrego J, 2004, MAR POLLUT BULL, V49, P1045, DOI 10.1016/j.marpolbul.2004.07.009; Censi P, 2007, ESTUAR COAST SHELF S, V71, P69; CHARUSIRI P, 1991, MATER SCI FORUM, V70, P105; Hannigan R, 2010, CHEM GEOL, V272, P20, DOI 10.1016/j.chemgeo.2010.01.009; Imai A, 2012, RESOUR GEOL, V63, P84; Ishihara S, 2009, B GEOL SURV JAPAN, V60, P581; Khadijehl RES, 2009, J RARE EARTH, V27, P1066, DOI 10.1016/S1002-0721(08)60390-7; Liu XD, 2011, GEOCHEM J, V45, P15; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MCLENNAN SM, 1980, CHEM GEOL, V29, P333, DOI 10.1016/0009-2541(80)90029-7; MINAI Y, 1992, P OC DRILL PROGR SCI, V0127; Sahoo SK, 2001, J RADIOANAL NUCL CH, V247, P341, DOI 10.1023/A:1006757718985; Silva PSC, 2005, J RADIOANAL NUCL CH, V264, P449, DOI 10.1007/s10967-005-0736-3; Taylor S., 1985, CONTINENTAL CRUST IT; Tranchida G, 2011, MAR POLLUT BULL, V62, P182, DOI 10.1016/j.marpolbul.2010.11.003; Wu C, 1994, J SE ASIAN EARTH SCI, V10, P81, DOI 10.1016/0743-9547(94)90010-8	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	APR	2015	73	7					3361	3374		10.1007/s12665-014-3624-8		14	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CD5XY	WOS:000351163300025		
J	Thuong, NT; Yoneda, M; Shimada, Y; Matsui, Y				Nguyen Thi Thuong; Yoneda, Minoru; Shimada, Yoko; Matsui, Yasuto			Assessment of trace metal contamination and exchange between water and sediment systems in the To Lich River in inner Hanoi, Vietnam	ENVIRONMENTAL EARTH SCIENCES			English	Article						Cluster analysis; Geochemical indices; Trace metal accumulation; Quality guidelines; Sediment	SOUTH-PLATTE RIVER; HEAVY-METALS; QUALITY GUIDELINES; ORGANIC-MATTER; INDIA; CITY; SOIL; IRRIGATION; VEGETABLES; DEPOSITION	The To Lich River (TLR), which receives considerable amounts of wastewater from the inner city of Hanoi, is used for irrigation purposes by areas further downstream. The marked increase in urbanization in recent decades has meant that considerable amounts of untreated and/or partially treated wastewater from industry and households have been discharged into the river, causing serious environmental problems. Trace metal concentrations in surface waters and in different sediment layers were analyzed at nine sample sites along the TLR. The enrichment factor, geo-accumulation index (I (geo)), cluster analysis, and quality guidelines were used to assess the current status and potential risks arising from trace metal contamination. The Mn concentration in surface water exceeded the irrigation water standards at seven of the nine sites, and I (geo) values indicated that Cd was the most abundant trace metal in sediments at six of the nine sites. Sediments at all sites contained levels of trace metals that exceeded the maximum permissible concentrations of potentially toxic trace metals for crops, and all sediments were considered to be toxic to aquatic life. Cluster analysis revealed that TLR sediments could clearly be divided into three groups based on the degree of contamination. Accumulation of trace metals in sediments was in order of Cr > Cu > Ni > Zn > Pb > As > Mn.	[Nguyen Thi Thuong; Yoneda, Minoru; Shimada, Yoko; Matsui, Yasuto] Kyoto Univ, Lab Environm Risk Anal, Dept Environm Engn, Grad Sch Engn,Nishikyo Ku, Kyoto, Japan	Thuong, NT (reprint author), Kyoto Univ, Lab Environm Risk Anal, Dept Environm Engn, Grad Sch Engn,Nishikyo Ku, C1-3-468,Kyoto Daigaku Katsura 4, Kyoto, Japan.	ngthuong.ntt@gmail.com			Kyoto University, Global COE Program	Comments from the anonymous reviewers are gratefully acknowledged. This study was financially supported by Kyoto University, Global COE Program.	Anne M, 1999, BOREAL ENVIRON RES, V4, P319; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; Long ER, 1998, ENVIRON TOXICOL CHEM, V17, P714, DOI 10.1897/1551-5028(1998)017<0714:PTIMSW>2.3.CO;2; RASHID MA, 1974, CHEM GEOL, V13, P115, DOI 10.1016/0009-2541(74)90003-5; Vallius H, 1999, CHEMOSPHERE, V38, P1959, DOI 10.1016/S0045-6535(98)00409-3; Singh A, 2010, TROP ECOL, V51, P375; BUNZL K, 1976, J SOIL SCI, V27, P32; Heiny JS, 1997, ARCH ENVIRON CON TOX, V32, P246, DOI 10.1007/s002449900182; Varol M, 2009, ENVIRON MONIT ASSESS, V159, P543, DOI 10.1007/s10661-008-0650-6; Woitke P, 2003, CHEMOSPHERE, V51, P633, DOI 10.1016/S0045-6535(03)00217-0; Croue JP, 2003, ENVIRON SCI TECHNOL, V37, P328, DOI 10.1021/es020676p; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; LIVENS FR, 1991, ENVIRON POLLUT, V70, P183, DOI 10.1016/0269-7491(91)90009-L; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Pease P, 2007, ENVIRON GEOL, V51, P1103, DOI 10.1007/s00254-006-0401-3; Sharma RK, 2007, ECOTOX ENVIRON SAFE, V66, P258, DOI 10.1016/j.ecoenv.2005.11.007; GIBBS RJ, 1973, SCIENCE, V180, P71, DOI 10.1126/science.180.4081.71; Sin SN, 2001, ENVIRON INT, V26, P297, DOI 10.1016/S0160-4120(01)00003-4; LUOMA SN, 1983, SCI TOTAL ENVIRON, V28, P1; BRADLEY SB, 1986, SCI TOTAL ENVIRON, V50, P103, DOI 10.1016/0048-9697(86)90354-2; Kiziloglu FM, 2008, AGR WATER MANAGE, V95, P716, DOI 10.1016/j.agwat.2008.01.008; Martin CW, 2000, CATENA, V39, P53, DOI 10.1016/S0341-8162(99)00080-6; Beg K R, 2008, American Journal of Environmental Sciences, V4; Bolt GH, 1976, SOIL CHEM A; British Geological Survey (BGS, 2003, WAT QUAL FACT SHEET; Doan TT, 2008, P INT VIETN LESS LEA; Dojlido JR, 1991, SEDIMENT STREAM WATE, V203, P315; Facetti J, 1998, SCI TOTAL ENVIRON, V209, P79, DOI 10.1016/S0048-9697(97)00299-4; Fairbridge R. W., 1999, ENCY GEOCHEMISTRY; Forstner U., 1979, METAL POLLUTION AQUA; Gabriela N, 2010, HUNG ELECT J SCI; Gonzalez AE, 2000, WATER AIR SOIL POLL, V121, P11; Hanoi Environment and Natural Resources Department (HENRD), 2003, ENV STAT HAN CITY 20; Ho TLT, 2000, COMMUN SOIL SCI PLAN, V31, P2901, DOI 10.1080/00103620009370637; Horowitz A.J., 1991, PRIMER SEDIMENT TRAC; HudsonEdwards K, 1997, SCI TOTAL ENVIRON, V194, P437, DOI 10.1016/S0048-9697(96)05381-8; Jonasson I, 1977, FLUVIAL TRANSPORT SE, P255; Kikuchi T, 2009, B ENVIRON CONTAM TOX, V83, P575, DOI 10.1007/s00128-009-9815-4; Maskall JE, 1998, WATER AIR SOIL POLL, V108, P391, DOI 10.1023/A:1005029310495; Memet V., 2012, CATENA, V92, P1; Mendez W, 2005, THESIS ROYAL I TECHN; Middelkoop H, 2002, IAHS-AISH P, P151; Mulligan CN, 2006, AM SOC TEST MATER, V1482, P210, DOI 10.1520/STP37689S; Nguyen TLH, 2008, PADDY WATER ENVIRON, V6, P257, DOI 10.1007/s10333-008-0125-y; Nguyen TLH, 2010, INT J SOIL SEDIMENT, V3, P1940; Nguyen VC, 2005, ESTABLISHING SCI BAS; NRIAGU JO, 1989, NATURE, V338, P47, DOI 10.1038/338047a0; Olivares-Rieumont S, 2005, WATER RES, V39, P3945, DOI 10.1016/j.watres.2005.07.011; Parthasarathy N, 2004, J CHROMATOGR A, V1025, P33, DOI 10.1016/j.chroma.2003.10.083; Purves D, 1985, TRACE ELEMENT CONTAM; Rifaat A.E., 2005, EGYPT J AQUAT RES, V31, P16; Salomons W., 1984, METALS HYDROCYCLE; SAXBY JD, 1969, REV PURE APPL CHEM, V19, P131; Singh AP, 2000, J ENVIRON QUAL, V29, P1124; Singh KP, 2005, WATER AIR SOIL POLL, V166, P321, DOI 10.1007/s11270-005-5268-5; Steve PM, 1994, TOXIC METALS SOIL PL, P247; SUBRAMANIAN V, 1987, ENVIRON GEOL WAT SCI, V9, P93, DOI 10.1007/BF02449940; Swanson V, 1966, US GEOLOGICAL SURV C, P174; Thuong NT, 2013, ENVIRON MONIT ASSESS, V185, P8065, DOI 10.1007/s10661-013-3155-x; Thuong NT, 2013, J ENV PROT, V4, P361; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; U.S. Environmental Protection Agency (USEPA), 2005, PART COEFF MET SURF; USEPA, 2006, NAT REC WAT QUAL CRI; USEPA, 2007, 3051A USEPA OFF SOL; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHO, 2006, GUID SAF US WAST EXC, V2; World Health Organization (WHO), 2004, MANG ITS COMP ENV AS	67	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	APR	2015	73	7					3925	3936		10.1007/s12665-014-3678-7		12	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CD5XY	WOS:000351163300070		
J	Fujiyoshi, R; Ohno, M; Okamoto, K; Umegaki, K				Fujiyoshi, Ryoko; Ohno, Misato; Okamoto, Kazumasa; Umegaki, Kikuo			Soil radon (Rn-222) monitoring in a forest site in Fukushima, Japan	ENVIRONMENTAL EARTH SCIENCES			English	Article						Rn-222; Soil air; Monitoring; Gas transportation; Typhoon; Fukushima	TRANSPORT; GAS; PERMEABILITY; VARIABILITY; SAPPORO; PB-210; CS-137; AIR	Soil radon (Rn-222) has been monitored since August 2013 at three different soil depths on a campus forest of Fukushima University in Japan, where a large amount of fallout nuclides were released by the accident of Fukushima Daiichi Nuclear Power Plant in March 2011. The primary purpose of this study is to evaluate Rn-222 activity level, variability and factors controlling Rn-222 concentration in soil air using data obtained from August to December 2013. Time series of Rn-222 activity concentration showed depth-dependent variability with an equilibrium value (Rn-222(eq)) during this observation period; 7.5, 14 and 23 kBq m(-3) at 0.3, 0.6 and 1.0 m in depth, respectively. Two typhoons passing over the site had a great influence on soil radon level, which was practically used for evaluating effective diffusion coefficient of Rn-222. Transport mechanism of Rn-222 in soil air was considered to be diffusion-controlled with data sets on changing Rn-222 concentration with time in selected cases that showed decreasing (or increasing) Rn-222 concentration with time at every depth. Important factors affecting soil Rn-222 variability are meteorological parameters, low-pressure front passing over the site, and subsequent precipitation. Time lags of decreasing Rn-222 concentration at different depths after rain indicate a certain relationship of Rn-222 level with moving water (and water vapor) in soil. The findings obtained in this study are important to evaluate the fate of fallout nuclides (radiocesium) in contaminated forest sites using soil radon as a tracer of moving soil air.	[Fujiyoshi, Ryoko; Ohno, Misato; Okamoto, Kazumasa; Umegaki, Kikuo] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Fujiyoshi, R (reprint author), Hokkaido Univ, Fac Engn, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	fuji@eng.hokudai.ac.jp			Japan Science and Technology Agency (JST)	The authors thank Prof. Akira Watanabe of the Fukushima University for helping with everything necessary for them to start and continue monitoring on their campus. They greatly acknowledge Mr. Toshihiko Hatano and Mr. Masato Yamakawa of North One Co. Ltd. for preparing a special instrument of micro-barometric pressure measurement in the field. They give special thanks to Dr. Claude Bertrand at Algade (France) for his useful comments and suggestions in radon field monitoring. They appreciate Prof. Emeritus Ivan Kobal of Jozef Stefan Institute in Slovenia who checked the manuscript thoroughly including English grammar. This work has been supported financially by Japan Science and Technology Agency (JST) on a research theme "Multidisciplinaryinvestigation on radiocesium fate and transport for safety assessment for interim storage and disposal of heterogeneous waste" (Tamotsu KOZAKI, Hokkaido University) from 2012 to 2014.	Perrier F, 2013, GEOPHYS J INT, V195, P945, DOI 10.1093/gji/ggt280; NAZAROFF WW, 1992, REV GEOPHYS, V30, P137, DOI 10.1029/92RG00055; Bittelli M, 2008, J HYDROL, V362, P191, DOI 10.1016/j.jhydrol.2008.08.014; Fujiyoshi R, 2006, SCI TOTAL ENVIRON, V370, P224, DOI 10.1016/j.scitotenv.2006.07.007; Zahorowski W, 2004, J ENVIRON RADIOACTIV, V76, P3, DOI 10.1016/j.jenvrad.2004.03.033; Richon P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016902; Sakoda A, 2011, APPL RADIAT ISOTOPES, V69, P1422, DOI 10.1016/j.apradiso.2011.06.009; Wells T, 2007, J GEOTECH GEOENVIRON, V133, P1577, DOI 10.1061/(ASCE)1090-0241(2007)133:12(1577); Dorr H., 1990, TELLUS B, V42B, P20, DOI 10.1034/j.1600-0889.1990.t01-1-00003.x; DORR H, 1983, J GEOPHYS RES-OC ATM, V88, P1309, DOI 10.1029/JC088iC02p01309; Fujiyoshi R, 2011, CENT EUR J GEOSCI, V3, P291, DOI 10.2478/s13533-011-0027-1; Fujiyoshi R, 2013, ENVIRON EARTH SCI, V70, P1159, DOI 10.1007/s12665-012-2203-0; Fujiyoshi R, 2004, SCI TOTAL ENVIRON, V320, P177, DOI 10.1016/j.scitotenv.2003.08.007; Fujiyoshi R, 2005, ENVIRON GEOCHEM HLTH, V27, P539, DOI 10.1007/s10653-005-7569-4; Fujiyoshi R, 2010, JPN ENV GEOCHEM HLTH, V32, P73; Hao LC, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1428-6; Hashimoto S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00416; Kurosawa T, 2010, FUKUSHIMA DAIGAKU CH, V22, P103; Neznal M, 2005, ANN GEOPHYS-ITALY, V48, P175; Science Council of Japan, 2012, REC MAK NEW STEP FOR; Vaupotic J, 2010, NAT HAZARD EARTH SYS, V10, P895; Yakovleva VS, 2005, ANN GEOPHYS-ITALY, V48, P195	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	APR	2015	73	8					4135	4142		10.1007/s12665-014-3698-3		8	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CD9XK	WOS:000351453600015		
J	Nguyen, TT; Kawamura, A; Tong, TN; Nakagawa, N; Amaguchi, H; Gilbuena, R				Thuy Thanh Nguyen; Kawamura, Akira; Thanh Ngoc Tong; Nakagawa, Naoko; Amaguchi, Hideo; Gilbuena, Romeo, Jr.			Hydrogeochemical assessment of groundwater quality during dry and rainy seasons for the two main aquifers in Hanoi, Vietnam	ENVIRONMENTAL EARTH SCIENCES			English	Article						Major ions; Holocene unconfined aquifer; Pleistocene confined aquifer; Dry and rainy seasons; Piper diagram; Hanoi	TAMIL-NADU; INDIA; WATER; MECHANISMS; EVOLUTION; BASIN; SYSTEM; CHINA; DELTA; CITY	Groundwater from the Holocene unconfined aquifer (HUA) and Pleistocene confined aquifer (PCA) is the major source of drinking and domestic water in Hanoi, Vietnam. A clear understanding of the groundwater hydrogeochemical properties, particularly their changes during the dry and rainy seasons, is invaluable for the management and protection of this important water resource. In this study, the changes in the hydrogeochemical properties of groundwater during the dry and rainy seasons were investigated by analyzing the major ions (Ca2+, Mg2+, Na+, K+, HCO3 (-), SO4 (2-), Cl-) that were recently obtained in 2011 from 13 conjunctive sampling wells for HUA and PCA in Hanoi. The hydrogeochemical assessment was carried out using the Piper and Gibbs diagrams. Based on the results, at least 30 % of the sampling wells in both aquifers exhibited changes in the hydrogeochemical facies during the dry and rainy seasons. Most of the changes occurred for the cation-type facies, while the anion type remained unchanged. Moreover, the hydrogeochemical facies of HUA was found to be different from that of PCA by approximately 50 % of the sampling wells for both the dry and rainy seasons. In addition, the Gibbs diagram showed apparent differences in the weight ratios Cl/(Cl + HCO3) between PCA and HUA. The results revealed that rock weathering is the main process involved in the evolution of chemical composition of groundwater, but agricultural activities and salty paleowater are the other important factors that affect the groundwater chemistry in some parts of the study area.	[Thanh Ngoc Tong] Minist Nat Resources & Environm, Ctr Water Resources Planning & Invest, Hanoi, Vietnam	Nguyen, TT (reprint author), Tokyo Metropolitan Univ, Dept Civil & Environm Engn, 1-1 Minami Oshawa, Hachioji, Tokyo 1920397, Japan.	nguyen-thanhthuy@ed.tmu.ac.jp			Tokyo Metropolitan Government, Japan	This study was carried out as a part of the research project, "Solutions for the water related problems in Asian Metropolitan areas" supported by the Tokyo Metropolitan Government, Japan (represented by Dr. Akira Kawamura). We would like to thank the Department of Geology and Minerals of Vietnam for supplying the necessary field data from the earlier feasibility studies.	Marghade D, 2012, ENVIRON MONIT ASSESS, V184, P2405, DOI 10.1007/s10661-011-2126-3; Umar R, 2012, ENVIRON MONIT ASSESS, V184, P2321, DOI 10.1007/s10661-011-2120-9; Ravikumar P, 2011, ENVIRON MONIT ASSESS, V179, P93, DOI 10.1007/s10661-010-1721-z; Chadha DK, 1999, HYDROGEOL J, V7, P431, DOI 10.1007/s100400050216; [Anonymous], 1984, 6777 ISO; Bui DD, 2012, HYDROGEOL J, V20, P1635, DOI 10.1007/s10040-012-0889-4; Li PY, 2013, ENVIRON EARTH SCI, V69, P2211, DOI 10.1007/s12665-012-2049-5; Magesh NS, 2013, ARAB J GEOSCI, V6, P4179, DOI 10.1007/s12517-012-0673-8; Arumugam K, 2009, ENVIRON GEOL, V58, P1509, DOI 10.1007/s00254-008-1652-y; [Anonymous], 1993, 99643 ISO; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; [Anonymous], 1984, 6659 ISO; [Anonymous], 1989, 9297 ISO; Raju NJ, 2011, ENVIRON MONIT ASSESS, V173, P279, DOI 10.1007/s10661-010-1387-6; [Anonymous], 1988, 78903 ISO; [Anonymous], 1984, 6058 ISO; Zhu GF, 2008, HYDROGEOL J, V16, P167, DOI 10.1007/s10040-007-0216-7; Baghvand A, 2010, DESALINATION, V260, P264, DOI 10.1016/j.desal.2010.02.038; Montangero A, 2007, SCI TOTAL ENVIRON, V384, P55, DOI 10.1016/j.scitotenv.2007.05.032; Nagarajan R, 2010, ENVIRON MONIT ASSESS, V171, P289, DOI 10.1007/s10661-009-1279-9; Berg M, 2008, CHEM GEOL, V249, P91, DOI 10.1016/j.chemgeo.2007.12.007; Ahmed MA, 2013, ENVIRON EARTH SCI, V68, P369, DOI 10.1007/s12665-012-1744-6; Tanabe S, 2003, QUATERNARY SCI REV, V22, P2345, DOI 10.1016/S0277-3791(03)00138-0; [Anonymous], 1986, 71502 ISO; Jalali M, 2011, ENVIRON EARTH SCI, V62, P907, DOI 10.1007/s12665-010-0576-5; [Anonymous], 2006, 22743 ISO; Asia Development Bank, 2000, FIN REP MAN STUD LAN; Bui DuongDu, 2011, Geosciences Journal, V15, P323, DOI 10.1007/s12303-011-0024-x; Bui DD, 2012, HYDROL PROCESS, V26, P932, DOI 10.1002/hyp.8305; Daughney CJ, 2005, J HYDROL, V44, P105; Dijk MV, 2012, LAND USE CHANGE FOOD, P122; Duong HA, 2003, WATER RES, V37, P3242, DOI 10.1016/S0043-1354(03)00138-6; Gurugnanam B, 2009, INDIAN J SCI TECHNOL, V2, P5; Hussein MT, 2004, HYDROGEOL J, V12, P144, DOI 10.1007/s10040-003-0265-5; James ID, 1982, GEOCHEMISTRY NATURAL, P36; Jamshidzahed Z, 2011, DESALINATION, V2070, P23; Joshi A, 2011, ENVIRON MONIT ASSESS, V174, P547, DOI 10.1007/s10661-010-1477-5; Keith ES, 2002, WATER ENVIRON RES, V74, P177; Kumar SK, 2009, ENVIRON MONIT ASSESS, V159, P341, DOI 10.1007/s10661-008-0633-7; Ministry of Natural Resources and Environment (MONRE), 2008, NAT TECHN REG UND WA; MONRE, 1956, ANN REP HYDR OBS VIE; Parasanna MV, 2011, ENVIRON EARTH SCI, V63, P31; Piper AM, 1944, T AM GEOPHYS UNION, V25, P914; Raji BA, 1997, ENVIRON GEOL, V29, P46; Richter B. C., 1993, GEOCHEMICAL TECHNIQU; Schoeller H, 1962, EAUX SOUTERRAINES, V187, P642; Subba Rao N, 2012, ENVIRON EARTH SCI, DOI [10.1007/s12665-012-1590-6, DOI 10.1007/S12665-012-1590-6]; Tatawat RK, 2008, ENVIRON MONIT ASSESS, V143, P337, DOI 10.1007/s10661-007-9936-3; Tong TN, 2007, THESIS U GEOLOGY MIN, P150; Tong T.N., 2004, NATL HYDROGEOLOGY DA, P120; William JD, 1997, GROUNDWATER GEOCHEMI; Yidana SM, 2010, J AFR EARTH SCI, V58, P220, DOI 10.1016/j.jafrearsci.2010.03.003	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	APR	2015	73	8					4287	4303		10.1007/s12665-014-3713-8		17	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CD9XK	WOS:000351453600027		
J	Liang, MC; Ning, ZG; Li, YK; Song, P; Wu, NY; Yang, PL				Liang, Ming Chao; Ning, Zi Gong; Li, Yun Kai; Song, Peng; Wu, Naiyang; Yang, Peiling			Dynamic biofilm component in reclaimed water during rapid growth period	ENVIRONMENTAL EARTH SCIENCES			English	Article						Reclaimed water; Biofilm; Roughness; Component; Growth	MICROBIAL COMMUNITIES; WASTE-WATER; ENVIRONMENT; SUBSTANCES; ADSORPTION; EXTRACTION; PERIPHYTON; SEDIMENTS; METALS	Reusing reclaimed water for the ecological water has become one of the effective ways to alleviate the water crisis in the rivers and lakes, while its impact on the river and lake ecosystems has become the focus of public attention. The microorganism is one of the most direct and effective monitoring objects, which is generally present in the form of biofilm. Therefore, three kinds of water with different water quality were chosen, which included reclaimed water treated with anaerobic-anoxic-oxic (A(2)/O) and cyclic activated sludge system process, and surface water, respectively. Glass plates with different roughness (0.1, 1.0 and 10 mu m) were used as attaching matrix. Biofilms were cultured with the help of outdoor simulation environment; and the dynamic variation of the biofilm dry weight as well as inorganic and organic components were analyzed. The results showed that the content for dry weight, iron oxide, extracellular polymeric substances (EPS) and chlorophyll a of biofilms attached on multi-media surface in three kinds of water body increased sequentially during the rapid growth period, while the activity of phosphatase fluctuated. Biofilm dry weight and chlorophyll a variation can be described double-constant rate equation (R (2) is over 0.90 and 0.91, respectively), while the iron oxide and EPS content could make use of the parabolic diffusion equation (R (2) is over 0.88 and 0.87, respectively). For the surface of the medium with different roughness, dry weight of the different biofilms with roughness 1.0 mu m has the largest content, up to 1.39 mg cm(-2). With regard to iron oxide, the content differences are little with different roughness and the maximum content is up to 0.36 mu g cm(-2), while no significant difference existed between the different water bodies. The contents of EPS, chlorophyll a and phosphatase activity in reclaimed water are higher than that in the surface water, and both of them have the highest content with the roughness 1.0 mu m medium surface. Testing phospholipid fatty acids showed that the dominant bacteria are i15: 0, bacteria under two processes of reclaimed water in biofilms were, respectively, higher by 3.7 and 3.5 % than the surface water. Biofilm EPS and chlorophyll a concentration was positively correlated with pH, total phosphorus, COD and Mg2+ concentration in the reclaimed water, and was negatively correlated with NH4+, while the phosphatase activity showed no correlation with water quality indicators. This research aimed to provide a theoretical basis and technical support for health assessment of reclaimed water as the ecological water ecosystem for urban rivers and lakes.	[Liang, Ming Chao; Ning, Zi Gong; Li, Yun Kai; Song, Peng; Wu, Naiyang; Yang, Peiling] China Agr Univ, Coll Water Resources & Civil Engn, Beijing 100083, Peoples R China; [Ning, Zi Gong] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0600809, Japan	Li, YK (reprint author), China Agr Univ, Coll Water Resources & Civil Engn, Beijing 100083, Peoples R China.	liyunkai@126.com			National Natural Science Fund of China [51321001]; Beijing Eleventh-Five Year Research Program [D090409004009004]; Special Fund for Water Conservancy scientific Research in the Public Interest [201001067]	We are grateful for financial support from the National Natural Science Fund of China (No. 51321001), Key Project of the Beijing Eleventh-Five Year Research Program (No. D090409004009004), Special Fund for Water Conservancy scientific Research in the Public Interest (NO. 201001067).	Schorer M, 1997, WATER AIR SOIL POLL, V99, P651, DOI 10.1023/A:1018384616442; Lawrence JR, 2001, CAN J MICROBIOL, V47, P634, DOI 10.1139/cjm-47-7-634; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Porsbring T, 2007, J EXP MAR BIOL ECOL, V349, P299, DOI 10.1016/j.jembe.2007.05.020; Dong DM, 2000, WATER RES, V34, P427, DOI 10.1016/S0043-1354(99)00185-2; Percival SL, 1998, WATER RES, V32, P243, DOI 10.1016/S0043-1354(97)00132-2; JAMES GA, 1995, J IND MICROBIOL, V15, P257, DOI 10.1007/BF01569978; Chinalia FA, 2006, CHEMOSPHERE, V64, P1675, DOI 10.1016/j.chemosphere.2006.01.022; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Langenheder S, 2006, AQUAT SCI, V68, P415, DOI 10.1007/s00027-006-0849-y; Pennanen T, 1999, MICROBIAL ECOL, V38, P168, DOI 10.1007/s002489900161; Liu H, 2002, J BIOTECHNOL, V95, P249, DOI 10.1016/S0168-1656(02)00025-1; Behra R, 2002, AQUAT SCI, V64, P300, DOI 10.1007/s00027-002-8074-9; CHARACKL.WG, 1973, WATER RES, V7, P1249, DOI 10.1016/0043-1354(73)90002-X; Danavaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; [董德明 Dong Deming], 2002, [应用化学, Chinese Journal of Applied Chemistry], V19, P902; Donlan R.M., 2002, EMERG INFECT DIS, V8, P9, DOI DOI 10.3201/EID0809.020063; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Fletcher M, 1988, BIODETERIORATION, V7, P31; FLETCHER M, 1988, J BACTERIOL, V170, P2027; GARCIA C, 1995, BIORESOURCE TECHNOL, V53, P79, DOI 10.1016/0960-8524(95)00073-N; Lenardos N, 2000, AQUACULUTRE, V182, P301, DOI [10.1016/S0044-8486(99)00269-0, DOI 10.1016/S0044-8486(99)00269-0]; Liu Y, 1999, ADV ENV SCI, V7, P113; MCLINTOC.IS, 1967, NATURE, V216, P1204, DOI 10.1038/2161204a0; Rao TS, 1997, BIOFOULING, V11, P265; Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002; Tage N, 1978, MAR BIOL, V49, P223, DOI 10.1007/BF00391134; Tatlor GT, 1997, BIOFOULING, V11, P31, DOI [10.1080/08927019709378319, DOI 10.1080/08927019709378319]; Villanueva L, 2007, MICROB ECOL, V54, P523, DOI 10.1007/s00248-007-9224-3; Wimpenny J, 1996, BIOFOULING, V10, P43, DOI 10.1080/08927019609386270; Yang F, 2005, THESIS JILIN U JILIN; Yang YF, 2006, MUNIC ENG TECHNOL, V24, P405; Zhao W, 2013, ENVIRON EARTH SCI, V69, P41, DOI 10.1007/s12665-012-1932-4	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	APR	2015	73	8					4325	4338		10.1007/s12665-014-3717-4		14	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CD9XK	WOS:000351453600030		
J	McIlroy, SJ; Nittami, T; Kanai, E; Fukuda, J; Saunders, AM; Nielsen, PH				McIlroy, Simon J.; Nittami, Tadashi; Kanai, Eri; Fukuda, Junji; Saunders, Aaron M.; Nielsen, Per Halkjaer			Re-appraisal of the phylogeny and fluorescence in situ hybridization probes for the analysis of the Competibacteraceae in wastewater treatment systems	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							GLYCOGEN-ACCUMULATING ORGANISMS; BIOLOGICAL PHOSPHORUS REMOVAL; 16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBES; SEQUENCING-BATCH BIOREACTOR; ACTIVATED-SLUDGE; AEROBIC GRANULES; MICROBIAL ECOLOGY; TREATMENT PLANTS; SP NOV.	Members of the family Competibacteraceae are common in wastewater treatment plants (WWTPs) designed for enhanced biological phosphorus removal (EBPR) and are putatively deleterious to the process of P removal. Their ability to accumulate large amounts of polyhydroxyalkanoates is also suggested to be of potential commercial interest for bioplastic production. In this study we have updated the 16S rRNA-based phylogeny of the Competibacter and the Plasticicumulans lineages. The former is delineated by 13 clades including two described genera; Ca.Competibacter' and Ca.Contendobacter'. The oligonucleotide probes used for detection of the family by fluorescence in situ hybridization (FISH) were re-evaluated and designed for coverage of these clades. Surveys of full-scale WWTPs based on 16S rRNA gene amplicon sequencing and FISH analysis indicate that a number of member clades always coexist, with their relative abundances varying substantially between and temporally within plants. The hypothesis that these differences are based on niche partitioning is supported by marked phenotypic differences between clades. An in-depth understanding of the ecology of the family requires further studies of the metabolism of individual clades in situ. The proposed phylogeny and FISH probes will provide the foundation for such studies.	[McIlroy, Simon J.; Saunders, Aaron M.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Ctr Microbial Communities, Aalborg, Denmark; [Nittami, Tadashi; Fukuda, Junji] Yokohama Natl Univ, Fac Engn, Div Mat Sci & Chem Engn, Yokohama, Kanagawa 240, Japan; [Kanai, Eri] Yokohama Natl Univ, Coll Engn Sci, Dept Chem Chem Engn & Life Sci, Yokohama, Kanagawa 240, Japan	McIlroy, SJ (reprint author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Ctr Microbial Communities, Aalborg, Denmark.	sjm@bio.aau.dk		Nittami, Tadashi/0000-0002-3338-7913; McIlroy, Simon Jon/0000-0003-3749-8730	Aalborg University; Danish Council for Strategic Research (EcoDesign MBR); NEDO; Japan Science and Technology Agency (ALCA); Yokohama Academic Foundation	This project was funded by Aalborg University, the Danish Council for Strategic Research (EcoDesign MBR), NEDO (Grant for Industrial Technology Research), the Japan Science and Technology Agency (ALCA) and the Yokohama Academic Foundation. The authors thank the Environmental Planning Bureau of Yokohama City Government for providing the activated sludge samples from the Japanese WWTPs. The authors declare no conflict of interest.	Seviour TW, 2011, APPL MICROBIOL BIOT, V92, P1297, DOI 10.1007/s00253-011-3385-1; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353; Thomsen TR, 2007, FEMS MICROBIOL ECOL, V60, P370, DOI 10.1111/j.1574-6941.2007.00309.x; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Daims H, 1999, SYST APPL MICROBIOL, V22, P434; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Nielsen AT, 1999, APPL ENVIRON MICROB, V65, P1251; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Johnson K, 2009, BIOMACROMOLECULES, V10, P670, DOI 10.1021/bm8013796; He S, 2007, APPL ENVIRON MICROB, V73, P5865, DOI 10.1128/AEM.01207-07; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; McIlroy S, 2009, ENV MICROBIOL REP, V1, P563, DOI 10.1111/j.1758-2229.2009.00082.x; Lemaire R, 2008, ENVIRON MICROBIOL, V10, P354, DOI 10.1111/j.1462-2920.2007.01456.x; Kong YH, 2002, ENVIRON MICROBIOL, V4, P753, DOI 10.1046/j.1462-2920.2002.00357.x; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Oehmen A, 2010, WATER RES, V44, P4992, DOI 10.1016/j.watres.2010.06.071; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bengtsson S, 2008, WATER SCI TECHNOL, V58, P323, DOI 10.2166/wst.2008.381; Bengtsson S, 2009, BIOTECHNOL BIOENG, V104, P698, DOI 10.1002/bit.22444; Daims H., 2005, MOL MICROBIAL ECOLOG, P213; Jiang Y, 2014, INT J SYST EVOL MICR, V64, P33, DOI 10.1099/ijs.0.051045-0; Jiang Y, 2011, INT J SYST EVOL MICR, V61, P2314, DOI 10.1099/ijs.0.021410-0; Kim JM, 2011, MICROBIOL-SGM, V157, P2287, DOI 10.1099/mic.0.047779-0; Kong YH, 2006, ENVIRON MICROBIOL, V8, P479, DOI 10.1111/j.1462-2920.2005.00914.x; McIlroy S. J., 2011, ENVIRON MICROBIOL, V13, P38; Meyer RL, 2003, FEMS MICROBIOL ECOL, V45, P253, DOI 10.1016/S0168-6496(03)00159-4; Nguyen Hien Thi Thu, 2011, FEMS Microbiol Ecol, V76, P256, DOI 10.1111/j.1574-6941.2011.01049.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P188; Schroeder S, 2009, FEMS MICROBIOL LETT, V297, P157, DOI 10.1111/j.1574-6968.2009.01676.x; Schroeder S, 2008, J APPL MICROBIOL, V105, P1412, DOI 10.1111/j.1365-2672.2008.03857.x; Weissbrodt D. G., 2013, FRONT MICROBIOL, V4, P1; Wong MT, 2006, WATER SCI TECHNOL, V54, P29, DOI 10.2166/wst.2006.368; Yeates C, 2003, MICROBIOL-SGM, V149, P1239, DOI 10.1099/mic.0.26112-0	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	APR	2015	7	2					166	174		10.1111/1758-2229.12215		9	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CD9GX	WOS:000351407300001		
J	Morono, Y; Terada, T; Yamamoto, Y; Xiao, N; Hirose, T; Sugeno, M; Ohwada, N; Inagaki, F				Morono, Yuki; Terada, Takeshi; Yamamoto, Yuhji; Xiao, Nan; Hirose, Takehiro; Sugeno, Masaya; Ohwada, Norio; Inagaki, Fumio			Intact preservation of environmental samples by freezing under an alternating magnetic field	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							MARINE SUBSURFACE SEDIMENTS; DEEP-SEA SEDIMENTS; MICROBIAL LIFE; MAGNETOCRYSTALLINE ANISOTROPY; SUBSEAFLOOR SEDIMENTS; THERMAL-CONDUCTIVITY; TEMPERATURE-RANGE; ESCHERICHIA-COLI; MARGIN; CRYOPRESERVATION	The study of environmental samples requires a preservation system that stabilizes the sample structure, including cells and biomolecules. To address this fundamental issue, we tested the cell alive system (CAS)-freezing technique for subseafloor sediment core samples. In the CAS-freezing technique, an alternating magnetic field is applied during the freezing process to produce vibration of water molecules and achieve a stable, super-cooled liquid phase. Upon further cooling, the temperature decreases further, achieving a uniform freezing of sample with minimal ice crystal formation. In this study, samples were preserved using the CAS and conventional freezing techniques at 4, -20, -80 and -196 (liquid nitrogen) degrees C. After 6 months of storage, microbial cell counts by conventional freezing significantly decreased (down to 10.7% of initial), whereas that by CAS-freezing resulted in minimal. When Escherichia coli cells were tested under the same freezing conditions and storage for 2.5 months, CAS-frozen E.coli cells showed higher viability than the other conditions. In addition, an alternating magnetic field does not impact on the direction of remanent magnetization in sediment core samples, although slight partial demagnetization in intensity due to freezing was observed. Consequently, our data indicate that the CAS technique is highly useful for the preservation of environmental samples.	[Morono, Yuki; Xiao, Nan; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Geomicrobiol Grp, Nankoku, Kochi 7838502, Japan; [Morono, Yuki; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geobiotechnol Grp, Res & Dev Ctr Submarine Resources, Nankoku, Kochi 7838502, Japan; [Hirose, Takehiro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Fault Mech Res Grp, Nankoku, Kochi 7838502, Japan; [Terada, Takeshi] Marine Works Japan Ltd, Yokosuka, Kanagawa 2370063, Japan; [Yamamoto, Yuhji] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi 7838502, Japan; [Sugeno, Masaya; Ohwada, Norio] ABI Co Ltd, Nagareyama, Chiba 2700133, Japan	Morono, Y (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Geomicrobiol Grp, Monobe B200, Nankoku, Kochi 7838502, Japan.	morono@jamstec.go.jp			Japan Society for the Promotion of Science (JSPS); JSPS; JSPS [24651018, 24687004]	The authors thank M. Ikehara for providing samples for the analysis of magnetic characteristics. We also thank S. Tanaka and S. Fukunaga for their technical assistance with the analytical assays. We thank the crew, drilling team and onboard scientists of the Chikyu Training Expeditions CK09-01 and CK09-03. This study was supported by the Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development (to JAMSTEC), the JSPS Funding Program for Next Generation World-Leading Researchers (NEXT Program, to F.I.), and JSPS Grants-in-Aid for Scientific Research (nos. 24651018 and 24687004 to Y.M.).	Agustini TW, 2001, FISHERIES SCI, V67, P306, DOI 10.1046/j.1444-2906.2001.00226.x; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Morono Y, 2013, ENVIRON MICROBIOL, V15, P2841, DOI 10.1111/1462-2920.12153; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; Edwards KJ, 2012, ANNU REV EARTH PL SC, V40, P551, DOI 10.1146/annurev-earth-042711-105500; Bowles MW, 2014, SCIENCE, V344, P889, DOI 10.1126/science.1249213; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; SYONO Y, 1964, J PHYS SOC JPN, V19, P1752, DOI 10.1143/JPSJ.19.1752; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Kaku M, 2010, CRYOBIOLOGY, V61, P73, DOI 10.1016/j.cryobiol.2010.05.003; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Lever MA, 2013, SCIENCE, V339, P1305, DOI 10.1126/science.1229240; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; DeLong EF, 2004, SCIENCE, V306, P2198, DOI 10.1126/science.1107241; FLETCHER EJ, 1974, J PHYS C SOLID STATE, V7, P171, DOI 10.1088/0022-3719/7/1/024; Hagiwara T, 2005, FOOD SCI TECHNOL RES, V11, P407, DOI 10.3136/fstr.11.407; Hofmann G. A., 1985, U. S. Patent, Patent No. [4,524,079, 4524079]; Kaster AK, 2014, ISME J, V8, P1831, DOI 10.1038/ismej.2014.24; Koponen HT, 2004, NUTR CYCL AGROECOSYS, V69, P213, DOI 10.1023/B:FRES.0000035172.37839.24; Lin PY, 2013, CRYOBIOLOGY, V66, P256, DOI 10.1016/j.cryobiol.2013.02.061; Masui N., 2009, SCI DRILL, V8, P35; MAZUR P, 1984, AM J PHYSIOL, V247, pC125; Morono Y, 2009, ISME J, V3, P503, DOI 10.1038/ismej.2009.1; Morono Y, 2014, APPL ENVIRON MICROB, V80, P1985, DOI 10.1128/AEM.04150-13; Orcutt BN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3539; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Pribnow D, 1996, GEOPHYS RES LETT, V23, P391, DOI 10.1029/95GL00253; Pribnow DFC, 2000, J GEOPHYS RES-SOL EA, V105, P13449, DOI 10.1029/2000JB900005; RAY B, 1972, APPL MICROBIOL, V24, P258; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; Yamazaki T, 2003, EARTH PLANETS SPACE, V55, P327	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	APR	2015	7	2					243	251		10.1111/1758-2229.12238		9	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CD9GX	WOS:000351407300011		
J	Aoyagi, T; Hanada, S; Itoh, H; Sato, Y; Ogata, A; Friedrich, MW; Kikuchi, Y; Hori, T				Aoyagi, Tomo; Hanada, Satoshi; Itoh, Hideomi; Sato, Yuya; Ogata, Atsushi; Friedrich, Michael W.; Kikuchi, Yoshitomo; Hori, Tomoyuki			Ultra-high-sensitivity stable-isotope probing of rRNA by high-throughput sequencing of isopycnic centrifugation gradients	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							MICROBIAL COMMUNITY FUNCTION; REDUCING BACTERIA; DEGRADERS; DIVERSITY; SOIL	Stable isotope probing (SIP) of rRNA directly identifies microorganisms assimilating an isotopically labelled substrate. High-throughput DNA sequencing is available for label screening at high resolution and high sensitivity, yet its effectiveness and validity remain to be clarified. Here, we investigated whether the detection sensitivity of rRNA-SIP could be improved by using Illumina sequencing in place of terminal restriction fragment length polymorphism (T-RFLP) analysis. A dilution series of C-13-labelled RNA from Escherichia coli (1-0.0001%) and unlabelled RNA from Bacillus subtilis was density separated and fractionated. Illumina sequencing of isopycnic centrifugation gradients was able to detect C-13-labelled RNA in the heaviest fraction with a buoyant density of 1.798gml(-1) even at the mixing ratio of 0.001%, whereas the detection ability of T-RFLP was not lower than 0.5%. Quantitative reverse transcription polymerase chain reaction of the density-separated RNAs showed that C-13-labelled RNAs at mixing ratios of 0.05-0.001% had definitely accumulated in the heaviest fraction. Consequently, high-throughput sequencing provided up to 500-fold higher sensitivity for screening of C-13-labelled RNA than T-RFLP. Ultra-high-sensitivity rRNA-SIP represents a clear advance towards a more complete understanding of microbial ecosystem function, including the ecophysiology of rare microorganisms in various natural environments.	[Aoyagi, Tomo; Hanada, Satoshi; Sato, Yuya; Ogata, Atsushi; Hori, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan; [Hanada, Satoshi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Itoh, Hideomi; Kikuchi, Yoshitomo] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; [Friedrich, Michael W.] Univ Bremen, Dept Microbial Ecophysiol, D-28359 Bremen, Germany	Hori, T (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Environm Management Technol, Onogawa 16-1, Tsukuba, Ibaraki 3058569, Japan.	hori-tomo@aist.go.jp	Friedrich, Michael/B-3151-2013		Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Japan Society for the Promotion of Science (JSPS) KAKENHI [24651089, 25701003]	This study was supported by the Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants Number 24651089 (Grant-in-Aid for Challenging Exploratory Research) and 25701003 [Grant-in-Aid for Young Scientists (A)]. We thank KN International Inc. for reviewing the English usage in this manuscript. The authors of the manuscript have no conflict of interest to declare.	Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Hori T, 2007, APPL ENVIRON MICROB, V73, P101, DOI 10.1128/AEM.01676-06; Akuzawa M, 2011, MICROB ECOL, V61, P595, DOI 10.1007/s00248-010-9788-1; Wang BZ, 2014, APPL ENVIRON MICROB, V80, P1684, DOI 10.1128/AEM.03633-13; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Zemb O, 2012, WATER RES, V46, P601, DOI 10.1016/j.watres.2011.10.047; Pilloni G, 2011, FEMS MICROBIOL ECOL, V78, P165, DOI 10.1111/j.1574-6941.2011.01083.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Itoh H, 2014, APPL ENVIRON MICROB, V80, P5974, DOI 10.1128/AEM.01087-14; Kleindienst S, 2014, ISME J, V8, P2029, DOI 10.1038/ismej.2014.51; Manefield M, 2002, RAPID COMMUN MASS SP, V16, P2179, DOI 10.1002/rcm.782; Shao YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085948; Vandieken V, 2012, ISME J, V6, P2078, DOI 10.1038/ismej.2012.41	18	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	APR	2015	7	2					282	287		10.1111/1758-2229.12243		6	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CD9GX	WOS:000351407300015		
J	Kawai, M; Uchiyama, I; Takami, H; Inagaki, F				Kawai, Mikihiko; Uchiyama, Ikuo; Takami, Hideto; Inagaki, Fumio			Low frequency of endospore-specific genes in subseafloor sedimentary metagenomes	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							MARINE SUBSURFACE SEDIMENTS; DEEP-SEA SEDIMENTS; BACILLUS-MEGATERIUM; MICROBIAL DIVERSITY; FORMING FIRMICUTES; STATIONARY-PHASE; SPORULATION; BIOSPHERE; PROTEINS; ARCHAEA	Spore formation is considered to be one of the microbial strategies for long-term survival in subseafloor sedimentary habitats. However, our knowledge of the genetic and physiological characteristics of subseafloor microbes is limited. Here, we studied the distribution and frequency of genes that are related to endospore formation in 10 subseafloor sedimentary metagenomes from Site C9001 off Japan and Site 1229 off Peru. None or very low frequencies of endospore-specific genes (e.g. dpaA, dpaB, sspA, spo0A, spoIIGA, spoIIM, spoIIIAB, spoIVA, spoIVB, yabP, yunB, spoVM) were observed in the subseafloor metagenomes. Based on the number of universally conserved single copy genes, the frequency ratio of putative endospore-formers was estimated to be <10%, which is consistent with the frequency of Clostridia-derived genomes (2-4%) but is lower than previous estimates based on the concentration of dipicolinic acid. Conceivable explanations for this discrepancy are as follows: the efficiency of lysis and DNA extraction of subseafloor endospore cells may have been lower than those of vegetative cells, conversion factor of dipicolinic acid content per cell may differ, and/or sporulation-related genes and other functional strategies for long-term survival in the deep subseafloor biosphere are evolutionarily distinct from known spore-forming gene repertoires.	[Kawai, Mikihiko; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geobiotechnol Grp, Res & Dev Ctr Submarine Resources, Nankoku, Kochi 7838502, Japan; [Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Uchiyama, Ikuo] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Takami, Hideto] JAMSTEC, Inst Biogeosci, Microbial Genome Res Grp, Yokosuka, Kanagawa 2370061, Japan	Inagaki, F (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Monobe B200, Nankoku, Kochi 7838502, Japan.	inagaki@jamstec.go.jp			Japan Society for the Promotion of Science (JSPS); JSPS [GR102, 26251041]	The authors thank all crews, drilling team members, and shipboard scientists for core sampling during the Chikyu Shakedown Cruise CK06-06. We thank anonymous reviewers for very helpful comments on the manuscript. This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development (to JAMSTEC and F.I.), the JSPS Funding Program for Next Generation World-Leading Researchers (NEXT Program, no. GR102, to F.I., and the JSPS Grants-in-Aid for Science Research (no. 26251041, to F.I.)). Computational resources were provided in part at the supercomputer system, JAMSTEC, and at the Data Integration and Analysis Facility, National Institute for Basic Biology.	Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Biddle JF, 2011, ISME J, V5, P1038, DOI 10.1038/ismej.2010.199; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Morono Y, 2013, ENVIRON MICROBIOL, V15, P2841, DOI 10.1111/1462-2920.12153; Ciobanu MC, 2014, ISME J, V8, P1370, DOI 10.1038/ismej.2013.250; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Hinrichs KU, 2012, SCIENCE, V338, P204, DOI 10.1126/science.1229296; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Hubert C, 2010, ENVIRON MICROBIOL, V12, P1089, DOI 10.1111/j.1462-2920.2010.02161.x; Hubert C, 2009, SCIENCE, V325, P1541, DOI 10.1126/science.1174012; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; SETLOW P, 1975, J BIOL CHEM, V250, P8168; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; JOHNSON WC, 1981, J BACTERIOL, V146, P972; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; ALEXANDER CJ, 1995, J CLIN MICROBIOL, V33, P3209; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; CHURCH BD, 1959, NATURE, V183, P124, DOI 10.1038/183124a0; D'Hondt S, 2007, SCI DRILLING, V5, P26; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Fichtel J, 2007, FEMS MICROBIOL ECOL, V61, P522, DOI 10.1111/j.1574-6941.2007.00354.x; Inagaki F., 2012, IODP PREL REPT, V337, P1, DOI [10.2204/iodp.pr.337.2012, DOI 10.2204/I0DP.PR.337.2012]; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Kaster AK, 2014, ISME J, V8, P1831, DOI 10.1038/ismej.2014.24; Kawai M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00080; Langerhuus AT, 2012, GEOCHIM COSMOCHIM AC, V99, P87, DOI 10.1016/j.gca.2012.09.023; Morono Y, 2009, ISME J, V3, P503, DOI 10.1038/ismej.2009.1; Morono Y, 2014, APPL ENVIRON MICROB, V80, P1985, DOI 10.1128/AEM.04150-13; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; R Core Team, 2013, R LANG ENV STAT COMP; Shelobolina ES, 2007, INT J SYST EVOL MICR, V57, P126, DOI 10.1099/ijs.0.64221-0; TINELLI R, 1955, ANN I PASTEUR PARIS, V88, P212; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P219; Wunderlin T, 2013, ENV MICROBIOL REP, V5, P911, DOI 10.1111/1758-2229.12094	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	APR	2015	7	2					341	350		10.1111/1758-2229.12254		10	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CD9GX	WOS:000351407300022		
J	Peerakietkhajorn, S; Tsukada, K; Kato, Y; Matsuura, T; Watanabe, H				Peerakietkhajorn, Saranya; Tsukada, Koji; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			Symbiotic bacteria contribute to increasing the population size of a freshwater crustacean, Daphnia magna	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							LIMNOHABITANS STRAINS; ACYRTHOSIPHON-PISUM; CERATITIS-CAPITATA; ESCHERICHIA-COLI; NICHE SEPARATION; FATTY-ACIDS; GLUTARALDEHYDE; LONGEVITY; GUT; CULTURE	The filter-feeding crustacean Daphnia is a key organism in freshwater ecosystems. Here, we report the effect of symbiotic bacteria on ecologically important life history traits, such as population dynamics and longevity, in Daphnia magna. By disinfection of the daphniid embryos with glutaraldehyde, aposymbiotic daphniids were prepared and cultured under bacteria-free conditions. Removal of bacteria from the daphniids was monitored by quantitative polymerase chain reaction for bacterial 16S rRNA gene. The population of aposymbiotic daphniids was reduced 10-folds compared with that of the control daphniids. Importantly, re-infection with symbiotic bacteria caused daphniids to regain bacteria and increase their fecundity to the level of the control daphniids, suggesting that symbiotic bacteria regulate Daphnia fecundity. To identify the species of symbiotic bacteria, 16S rRNA genes of bacteria in daphniids were sequenced. This revealed that 50% of sequences belonged to the Limnohabitans sp. of the Betaproteobacteria class and that the diversity of bacterial taxa was relatively low. These results suggested that symbiotic bacteria have a beneficial effect on D.magna, and that aposymbiotic Daphnia are useful tools in understanding the role of symbiotic bacteria in the environmental responses and evolution of their hosts.	[Peerakietkhajorn, Saranya; Tsukada, Koji; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Watanabe, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	watanabe@bio.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Osaka University	This study was supported through a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). One of the authors (Y.K.) acknowledges the support of the Frontier Research Base for Global Young Researchers, Osaka University, based on MEXT. We also thank Shareen J. Arnold for reviewing this manuscript.	ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Heugens EHW, 2006, ENVIRON TOXICOL CHEM, V25, P1399, DOI 10.1897/05-294R.1; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Ebert D, 2008, CURR OPIN MICROBIOL, V11, P290, DOI 10.1016/j.mib.2008.05.012; STROSS RG, 1968, BIOL BULL, V134, P176, DOI 10.2307/1539976; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; GORMAN SP, 1980, J APPL BACTERIOL, V48, P161, DOI 10.1111/j.1365-2672.1980.tb01217.x; STERNER RW, 1993, ECOLOGY, V74, P2351, DOI 10.2307/1939587; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Eckert EM, 2014, ISME J, V8, P1808, DOI 10.1038/ismej.2014.39; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; Decaestecker E, 2005, OECOLOGIA, V144, P382, DOI 10.1007/s00442-005-0083-7; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.1890/0012-9658(2001)082[2507:PFAEFN]2.0.CO;2; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Ben-Yosef M, 2008, J APPL ENTOMOL, V132, P690, DOI 10.1111/j.1439-0418.2008.01330.x; Caffrey PB, 1997, ENVIRON TOXICOL CHEM, V16, P572, DOI 10.1897/1551-5028(1997)016<0572:ROZDID>2.3.CO;2; DAGOSTIN.AS, 1970, BIOL BULL, V139, P485, DOI 10.2307/1540367; DOUGLAS AE, 1992, ENTOMOL EXP APPL, V65, P195; El-Deeb Ghazy M.M., 2011, AUST J BASIC APPL SC, V5, P1; Fink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028498; FLETCHER MG, 1990, J MED ENTOMOL, V27, P922; Ghazy M. M. E., 2009, NAT SCI, V7, P28; Gilbert S. F., 2010, DEV BIOL, P675; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Huang A., 2000, DROSOPHILA PROTOCOLS, P430; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; KEATING KI, 1985, J CRUSTACEAN BIOL, V5, P130, DOI 10.2307/1548225; Koch U, 2011, OECOLOGIA, V167, P981, DOI 10.1007/s00442-011-2047-4; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; MCGUCKEN PV, 1973, J APPL BACTERIOL, V36, P419, DOI 10.1111/j.1365-2672.1973.tb04123.x; Metchnikoff M. E., 1884, VIRCHOWS ARCH PATHOL, V9, P177; MUNTON TJ, 1971, EXPERIENTIA, V27, P109, DOI 10.1007/BF02137771; MUNTON TJ, 1973, APPL MICROBIOL, V26, P508; Oda S, 2006, CHEMOSPHERE, V63, P1477, DOI 10.1016/j.chemosphere.2005.09.026; Qi WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-172; Salvesen I, 1997, AQUACULT INT, V5, P249, DOI 10.1023/A:1018343602872; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Sison-Mangus M. P., 2014, ISME J, V9, P59; VIJVERBERG J, 1976, HYDROBIOLOGIA, V51, P99, DOI 10.1007/BF00009824; VonsElert E., 2003, P ROY SOC LOND B BIO, V270, P1209	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	APR	2015	7	2					364	372		10.1111/1758-2229.12260		9	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CD9GX	WOS:000351407300025		
J	Miftahussurur, M; Shiota, S; Suzuki, R; Matsuda, M; Uchida, T; Kido, Y; Kawamoto, F; Maimunah, U; Adi, P; Rezkitha, Y; Nasronudin; Nusi, I; Yamaoka, Y				Miftahussurur, M.; Shiota, S.; Suzuki, R.; Matsuda, M.; Uchida, T.; Kido, Y.; Kawamoto, F.; Maimunah, U.; Adi, P.; Rezkitha, Y.; Nasronudin; Nusi, I.; Yamaoka, Y.			Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests	EPIDEMIOLOGY AND INFECTION			English	Article						Helicobacter pylori; Indonesia; virulence factors	GASTRODUODENAL DISEASES; CYTOTOXIN PRODUCTION; VIRULENCE FACTORS; GASTRIC-CANCER; LOW-PREVALENCE; ASSOCIATION; CAGA; INFLAMMATION; POPULATION; GENOTYPES	The prevalence of Helicobacter pylori infection in Indonesia is controversial. We examined the H. pylori infection rate in 78 patients in a hospital in Surabaya using five different tests, including culture, histology, immunohistochemistry, rapid urease test, and urine antibody test. Furthermore, we analysed virulence factors in H. pylori strains from Indonesia. The H. pylori infection rate was only 11.5% in all patients studied, and 2.3% of Javanese patients and 18.0% of Chinese patients were infected (P=0.01). Although severe gastritis was not observed, activity and inflammation were significantly higher in patients positive for H. pylori than in patients negative for H. pylori. Among genotypes identified from five isolated strains, cagA was found in four; two were vacA s1m1. All cagA-positive strains were oipA 'on' and iceA1 positive. We confirmed both a low H. pylori infection rate and a low prevalence of precancerous lesions in dyspeptic patients in a Surabaya hospital, which may contribute to the low incidence of gastric cancer in Indonesia.	[Miftahussurur, M.; Shiota, S.; Suzuki, R.; Matsuda, M.; Kido, Y.; Kawamoto, F.; Yamaoka, Y.] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Oita 8795593, Japan; [Miftahussurur, M.; Maimunah, U.; Adi, P.; Nusi, I.] Airlangga Univ, Fac Med, Dept Internal Med, Gastroenterohepatol Div, Surabaya, Indonesia; [Miftahussurur, M.; Maimunah, U.; Adi, P.; Rezkitha, Y.; Nasronudin] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Uchida, T.] Oita Univ, Fac Med, Dept Mol Pathol, Yufu, Oita 8795593, Japan; [Yamaoka, Y.] Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA; [Yamaoka, Y.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Yamaoka, Y (reprint author), Oita Univ, Fac Med, Dept Environm & Prevent Med, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.	yyamaoka@oita-u.ac.jp			National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22390085, 22659087, 24406015, 24659200, 23790798]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST)	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (Y.Y.), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (22390085, 22659087, 24406015 and 24659200) (Y.Y.), (23790798) (S.S.). This work was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST).	Maran S, 2013, WORLD J GASTROENTERO, V19, P3615, DOI 10.3748/wjg.v19.i23.3615; Abdullah M, 2009, WORLD J GASTROENTERO, V15, P4928, DOI 10.3748/wjg.15.4928; Syam AF, 2006, WORLD J GASTROENTERO, V12, P6216; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274; Syam AF, 2005, WORLD J GASTROENTERO, V11, P386; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Takahashi A, 2013, HELICOBACTER, V18, P66, DOI 10.1111/j.1523-5378.2012.00994.x; Lee YY, 2012, HELICOBACTER, V17, P54, DOI 10.1111/j.1523-5378.2011.00917.x; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Tokudome S, 2005, CANCER LETT, V219, P57, DOI 10.1016/j.canlet.2004.09.043; Zhao Y, 2012, ASIAN PAC J CANCER P, V13, P1247, DOI 10.7314/APJCP.2012.13.4.1247; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Tokudome S, 2005, CANCER SCI, V96, P873, DOI 10.1111/j.1349-7006.2005.00122.x; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Lee YY, 2013, HELICOBACTER, V18, P338, DOI 10.1111/hel.12058; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771; Yamamoto S, 2000, HELICOBACTER, V5, P160, DOI 10.1046/j.1523-5378.2000.00025.x; Arinton I Gede, 2011, Acta Med Indones, V43, P88; Aulia Diana, 2009, Acta Med Indones, V41, P107; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Lee, 2014, PEERJ, DOI [10.7717/peerj.257, DOI 10.7717/PEERJ.257]; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Peek J. R. M., 2002, NAT REV CANCER, V2, P28; Saragih J Boas, 2007, Acta Med Indones, V39, P79; Shi RH, 2008, HELICOBACTER, V13, P157, DOI 10.1111/j.1523-5378.2008.00586.x; Yeh Lee Yeong, 2009, Indian J Gastroenterol, V28, P49, DOI 10.1007/s12664-009-0017-0	36	3	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	APR	2015	143	5					986	996		10.1017/S095026881400154X		11	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CD4NH	WOS:000351059300012		
J	Abd-Elghany, SM; Sallam, KI; Abd-Elkhalek, A; Tamura, T				Abd-Elghany, S. M.; Sallam, K. I.; Abd-Elkhalek, A.; Tamura, T.			Occurrence, genetic characterization and antimicrobial resistance of Salmonella isolated from chicken meat and giblets	EPIDEMIOLOGY AND INFECTION			English	Article						Antimicrobial resistance; chickens; PCR; Salmonella serovars; virulence genes	FIELD GEL-ELECTROPHORESIS; PREVALENCE; CONTAMINATION; CARCASSES; POULTRY; PCR; ENTERICA; SEROVARS; SUSCEPTIBILITY; IDENTIFICATION	This study was undertaken to survey the presence of Salmonella in 200 chicken samples collected from Mansoura, Egypt. Salmonella was detected in 16% (8/50), 28% (14/50), 32% (16/50) and 60% (30/50) of whole chicken carcasses, drumsticks, livers and gizzards, respectively, with an overall prevalence of 34% (68/200) among all samples. One hundred and sixty-six isolates were identified biochemically as Salmonella, and confirmed genetically by PCR, based on the presence of invA and stn genes. The spvC gene, however, was detected in only 25.3% (42/166) of the isolates. Isolates were serotyped as Salmonella Enteritidis (37.3%), S. Typhimurium (30.1%), S. Kentucky (10.8%), S. Muenster (8.4%), S. Virchow (4.8%), S. Anatum (4.8%), S. Haifa (1.2%), and four were non-typable. Antimicrobial susceptibility tests of the Salmonella isolates revealed that 100% were resistant to each of erythromycin, penicillin, and amoxicillin, while 98.8%, 96.4%, 95.2%, and 91.6% were resistant to nalidixic acid, sulphamethoxazole, oxytetracycline, and ampicillin, respectively. Multidrug resistance was evident for 92.8% of the isolates. The high contamination level of chicken meat with multidrug- resistant Salmonella can constitute a problem for public health.	[Abd-Elghany, S. M.; Sallam, K. I.; Abd-Elkhalek, A.] Mansoura Univ, Fac Vet Med, Dept Food Hyg & Control, Mansoura 35516, Egypt; [Tamura, T.] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan	Sallam, KI (reprint author), Mansoura Univ, Fac Vet Med, Dept Food Hyg & Control, Mansoura 35516, Egypt.	khsallam@hotmail.com					Alvarez-Fernandez E, 2012, INT J FOOD MICROBIOL, V153, P281, DOI 10.1016/j.ijfoodmicro.2011.11.011; de Freitas CG, 2010, INT J FOOD MICROBIOL, V139, P15, DOI 10.1016/j.ijfoodmicro.2010.02.007; Dogru AK, 2010, TROP ANIM HEALTH PRO, V42, P893, DOI 10.1007/s11250-009-9504-7; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619; Capita R, 2003, INT J FOOD MICROBIOL, V81, P169, DOI 10.1016/S0168-1605(02)00195-2; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P1134, DOI 10.4315/0362-028X.JFP-11-513; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425; Whyte P, 2002, VET MICROBIOL, V89, P53, DOI 10.1016/S0378-1135(02)00160-8; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Cetinkaya F, 2008, FOOD CONTROL, V19, P1059, DOI 10.1016/j.foodcont.2007.11.004; van Nierop W, 2005, INT J FOOD MICROBIOL, V99, P1, DOI 10.1016/j.ijfoodmicro.2004.06.009; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; Favier GI, 2013, FOOD CONTROL, V29, P49, DOI 10.1016/j.foodcont.2012.05.056; Buzby JC, 2009, GASTROENTEROLOGY, V136, P1851, DOI 10.1053/j.gastro.2009.01.074; PRAGER R, 1995, FEMS IMMUNOL MED MIC, V12, P47, DOI 10.1111/j.1574-695X.1995.tb00173.x; Parveen S, 2007, J FOOD PROTECT, V70, P2466; Cardinale E, 2005, J APPL MICROBIOL, V99, P968, DOI 10.1111/j.1365-2672.2005.02618.x; Capita R, 2013, CRIT REV FOOD SCI, V53, P11, DOI 10.1080/10408398.2010.519837; Choo E, 2007, J FOOD PROTECT, V70, P917; CHOPRA AK, 1987, J BACTERIOL, V169, P5095; Defra, UK NAT CONTR PROGR S; Foley S L, 2008, J Anim Sci, V86, pE149; Gulig PA, 1993, MOL MICROBIOL, V7, P823; ISO, 2002, 65792002 ISO; Jaowapa J, 1994, J FOOD PROTECT, V57, P808; Lestari SI, 2009, J FOOD PROTECT, V72, P1165; Molla B, 2003, REV MED VET-TOULOUSE, V154, P267; National Committee for Clinical Laboratory Standards, 2001, PERF STAND ANT SUS S; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Yildirim Y, 2011, FOOD RES INT, V44, P725, DOI 10.1016/j.foodres.2010.12.040	31	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	APR	2015	143	5					997	1003		10.1017/S0950268814001708		7	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CD4NH	WOS:000351059300013		
J	Nakatani, E; Nishimura, T; Zhou, B; Kaneda, H; Teramukai, S; Nagai, Y; Fukushima, M; Kanatani, Y				Nakatani, E.; Nishimura, T.; Zhou, B.; Kaneda, H.; Teramukai, S.; Nagai, Y.; Fukushima, M.; Kanatani, Y.			Temporal and regional variations in sporadic Creutzfeldt-Jakob disease in Japan, 2001-2010	EPIDEMIOLOGY AND INFECTION			English	Article						Creutzfeldt-Jakob disease (CJD); epidemiology; geographical information systems; spatial modelling	HUMAN PRION DISEASES; MORTALITY; EPIDEMIOLOGY; SURVEILLANCE; CITY	The objective of this study was to examine temporal and regional variations of sporadic Creutzfeldt-Jakob disease (sCJD) in a retrospective study using Japanese national surveillance data from 2001 to 2010. We calculated the incidence of sCJD by age and sex, derived the standardized incidence in each of the 47 prefectures, and performed spatial disease clustering analysis. The average annual incidence of sCJD was 1.026 per million in men (637 patients) and 1.132 per million in women (733 patients), a significant sex difference after adjustment for age (P=0.001). The ratios of familial CJD to sCJD apparently increased between 2001-2005 and 2006-2010, possibly as a result of the nationwide introduction of genetic testing after 2006. Based on the data of 2006-2010, certain geographical clusters of sCJD were identified. The incidence of sCJD was higher in several specific prefectures compared to the national average. Thus, sCJD appears to have regional variations, suggesting the existence of genetic or region-specific factors affecting the incidence of the disease.	[Nakatani, E.; Nishimura, T.; Zhou, B.; Kaneda, H.; Nagai, Y.; Fukushima, M.] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Teramukai, S.] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kanatani, Y.] Natl Inst Publ Hlth, Dept Policy Sci, Saitama, Japan	Nakatani, E (reprint author), 1-5-4 Minatojima Minamimachi,Chuo Ku, Kobe, Hyogo 6500047, Japan.	e-nakatani@tri-kobe.org					AKAI J, 1989, NEUROEPIDEMIOLOGY, V8, P32, DOI 10.1159/000110162; Doi Y, 2007, J EPIDEMIOL, V17, P133, DOI 10.2188/jea.17.133; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Chitravas N, 2011, ANN NEUROL, V70, P437, DOI 10.1002/ana.22454; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; ARAKAWA K, 1991, ACTA NEUROL SCAND, V84, P445; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Collins S, 2002, ANN NEUROL, V52, P115, DOI 10.1002/ana.10224; d'Aignaux JH, 2002, INT J EPIDEMIOL, V31, P490, DOI 10.1093/ije/31.2.490; Doi Y, 2008, NEUROEPIDEMIOLOGY, V30, P222, DOI 10.1159/000126916; FARMER PM, 1978, NEW ENGL J MED, V298, P283; Groenewold Matthew R, 2004, J Ky Med Assoc, V102, P163; Gubbels S, 2012, EUROSURVEILLANCE, V17, P20142; Holman RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008521; Infectious Disease Surveillance Centre, ANN REP INF DIS INC; KOVANEN J, 1988, ACTA NEUROL SCAND, V77, P474; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MATTHEWS WB, 1975, J NEUROL NEUROSUR PS, V38, P210, DOI 10.1136/jnnp.38.3.210; Ministry of Health Labour and Welfare Japan, REP VET PHYS BAS INF; Nakamura Y, 2007, J EPIDEMIOL, V17, P19, DOI 10.2188/jea.17.19; Nakamura Y, 1999, INT J EPIDEMIOL, V28, P130, DOI 10.1093/ije/28.1.130; Nosal R, 1991, Can Dis Wkly Rep, V17, P12; Puopolo M, 2003, J CLIN EPIDEMIOL, V56, P494, DOI 10.1016/S0895-4356(02)00606-6; RAUBERTAS RF, 1989, AM J EPIDEMIOL, V129, P146; TSUJI S, 1983, NEUROLOGY, V33, P1503; WILL RG, 1993, BRIT MED BULL, V49, P960; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235	29	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	APR	2015	143	5					1073	1078		10.1017/S0950268814001605		6	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CD4NH	WOS:000351059300023		
J	Okamura, M; Hase, Y; Furusawa, Y; Tanaka, A				Okamura, Masachika; Hase, Yoshihiro; Furusawa, Yoshiya; Tanaka, Atsushi			Tissue-dependent somaclonal mutation frequencies and spectra enhanced by ion beam irradiation in chrysanthemum	EUPHYTICA			English	Article						Chrysanthemum; Flower color; Ion-beam irradiation; Mutation breeding; Tissue source	DOUBLE-STRAND BREAKS; DIANTHUS-CARYOPHYLLUS; CHROMATIN-STRUCTURE; IONIZING-RADIATION; CROP IMPROVEMENT; PETAL EPIDERMIS; FLOWER-COLOR; X-RAYS; BIOSYNTHESIS; CULTURES	We investigated the effect of tissue source selection in combination with ion beam irradiation on generating flower-color mutants in Chrysanthemum morifolium. Flower color mutation in the chrysanthemum cultivar YoMystery (purple flowers) was used as an index to estimate mutation frequency and the spectrum of mutations. Somaclones regenerated from petal and leaf tissues and ion-beam irradiated clones derived from the two tissues were analyzed for stem length and flower color mutation. Three Gy of argon ion beams was regarded as an appropriate dose for irradiation because the resulting color mutants maintained an adequate stem length suitable for commercial use even with high mutation frequencies. Statistical analysis of 7,258 individuals from three separate experiments revealed that (1) somaclones from petal tissue had a higher mutation frequency (2.91 %, sigma = 0.55) than leaf somaclones (2.01 %, sigma = 0.26); (2) the effect of tissue source on the frequency of flower color mutations was significantly enhanced when combined with ion-beam irradiation in that the mutation frequency of ion-beam irradiated petal clones was 6.47 % (sigma = 0.77), whereas that of ion-beam irradiated leaf clones was 3.89 % (sigma = 0.52); and (3) the spectrum of carotenoid color mutations was remarkably increased by ion-beam irradiation in that both leaf and petal ion-beam irradiated clones had brown, red and yellow flowers in contrast to the somaclones that only produced yellow flowers. These results suggest that intentional or directed induction of flower color mutants with practical value is possible by combining tissue source selection with ion beam irradiation.	[Okamura, Masachika] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Hase, Yoshihiro; Tanaka, Atsushi] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gumma 3701292, Japan; [Furusawa, Yoshiya] Natl Inst Radiol Sci, Res Ctr Charged Particle, Inage Ku, Chiba 2638555, Japan	Okamura, M (reprint author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Fukuura 1-13-5, Yokohama, Kanagawa 2360004, Japan.	okamuram@kirin.co.jp			Heavy Ion Medical Accelerator in Chiba (HIMAC) co-operative research program at the National Institute of Radiological Sciences, Chiba, Japan [B340]	The authors thank Dr. Masayoshi Nakayama for useful discussions and the technical staff who established the ion beam irradiation system. This project was partly performed within the Heavy Ion Medical Accelerator in Chiba (HIMAC) co-operative research program (B340) at the National Institute of Radiological Sciences, Chiba, Japan.	Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Radulescu I, 2004, RADIAT RES, V161, P1, DOI 10.1667/RR3094; Itoh Y, 2002, PLANT CELL PHYSIOL, V43, P578, DOI 10.1093/pcp/pcf065; Kishimoto S, 2006, PHYSIOL PLANTARUM, V128, P436, DOI 10.1111/j.1399-3054.2006.00761.x; KARP A, 1995, EUPHYTICA, V85, P295; Tanaka A, 2010, J RADIAT RES, V51, P223, DOI 10.1269/jrr.09143; Torikoshi M, 2007, J RADIAT RES, V48, pA15, DOI 10.1269/jrr.48.A15; INAGAKI Y, 1994, PLANT CELL, V6, P375; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Broertjes C, 1988, APPL MUTATION BREEDI; BUSH SR, 1976, AM J BOT, V63, P729, DOI 10.2307/2442032; Chen SM, 2012, BIOL PLANTARUM, V56, P458, DOI 10.1007/s10535-012-0069-3; DEJONG J, 1986, EUPHYTICA, V35, P137; ELIA MC, 1992, CANCER RES, V52, P1580; Evans DA, 1989, TRENDS GENET, V5, P346; Hase Y, 2012, PLANT BIOTECHNOL-NAR, V29, P193, DOI 10.5511/plantbiotechnology.12.0106a; Jain SM, 2001, EUPHYTICA, V118, P153, DOI 10.1023/A:1004124519479; Ladygin VG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1113; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagatomi S, 1997, I RAD BREEDING TECHN, V60; Newman HC, 2000, INT J RADIAT BIOL, V76, P1085; Okamura M, 2003, NUCL INSTRUM METH B, V206, P574, DOI 10.1016/S0168-583X(03)00835-8; Okamura M, 2013, EUPHYTICA, V191, P45, DOI 10.1007/s10681-012-0859-x; Okamura M, 2006, FLORICULTURE ORNAMEN, V1, P619; Rout GR, 1997, SCI HORTIC-AMSTERDAM, V69, P239, DOI 10.1016/S0304-4238(97)00008-3; Salamon MH, 1980, 10446 LAWR BERK LAB; Shikazono N, 2003, GENETICS, V163, P1449; Sihver L, 1998, JPN J MED PHYS, V18, P1; SKIRVIN RM, 1976, J AM SOC HORTIC SCI, V101, P281; Stadler LJ, 1928, SCIENCE, V68, P186, DOI 10.1126/science.68.1756.186; Tanaka A, 2012, PLANT BIOTECHNOL-NAR, V29, P191, DOI 10.5511/plantbiotechnology.12.0002p; van Harten AM, 1998, MUTATION BREEDING TH; Yamaguchi H, 2008, BREEDING SCI, V58, P331, DOI 10.1270/jsbbs.58.331; Yoshida H, 2004, SCI HORTIC-AMSTERDAM, V99, P175, DOI 10.1016/S0304-4238(03)00093-1	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	APR	2015	202	3					333	343		10.1007/s10681-014-1220-3		11	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CD7SG	WOS:000351291100001		
J	Gaebel, W; Zaske, H; Zielasek, J; Cleveland, HR; Samjeske, K; Stuart, H; Arboleda-Florez, J; Akiyama, T; Baumann, AE; Gureje, O; Jorge, MR; Kastrup, M; Suzuki, Y; Tasman, A; Fidalgo, TM; Jarema, M; Johnson, SB; Kola, L; Krupchanka, D; Larach, V; Matthews, L; Mellsop, G; Ndetei, DM; Okasha, TA; Padalko, E; Spurgeoun, JA; Tyszkowska, M; Sartorius, N				Gaebel, Wolfgang; Zaske, Harald; Zielasek, Jurgen; Cleveland, Helen-Rose; Samjeske, Kathrin; Stuart, Heather; Arboleda-Florez, Julio; Akiyama, Tsuyoshi; Baumann, Anja E.; Gureje, Oye; Jorge, Miguel R.; Kastrup, Marianne; Suzuki, Yuriko; Tasman, Allan; Fidalgo, Thiago M.; Jarema, Marek; Johnson, Sarah B.; Kola, Lola; Krupchanka, Dzmytry; Larach, Veronica; Matthews, Lyndy; Mellsop, Graham; Ndetei, David M.; Okasha, Tarek A.; Padalko, Ekaterina; Spurgeoun, Joyce A.; Tyszkowska, Magdalena; Sartorius, Norman			Stigmatization of psychiatrists and general practitioners: results of an international survey	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						Stigma; Psychiatrists; Psychiatry; General practitioners; Attitude survey	MENTAL-HEALTH-SERVICES; MEDICAL-STUDENTS; PUBLIC-ATTITUDES; REDUCE STIGMA; ILLNESS; PEOPLE; DISCRIMINATION; SCHIZOPHRENIA; CAREER; QUESTIONNAIRE	The stigma of mental illness affects psychiatry as a medical profession and psychiatrists. The present study aimed to compare the extent and correlation patterns of perceived stigma in psychiatrists and general practitioners. An international multicenter survey was conducted in psychiatrists and general practitioners from twelve countries. Responses were received from N = 1,893 psychiatrists and N = 1,238 general practitioners. Aspects of stigma assessed in the questionnaire included perceived stigma, self-stigma (stereotype agreement), attitudes toward the other profession, and experiences of discrimination. Psychiatrists reported significantly higher perceived stigma and discrimination experiences than general practitioners. Separate multiple regression analyses showed different predictor patterns of perceived stigma in the two groups. Hence, in the psychiatrists group, perceived stigma correlated best with discrimination experiences and self-stigma, while in the general practitioners group it correlated best with self-stigma. About 17 % of the psychiatrists perceive stigma as a serious problem, with a higher rate in younger respondents. Against this background, psychiatry as a medical profession should set a high priority on improving the training of young graduates. Despite the number of existing antistigma interventions targeting mental health professionals and medical students, further measures to improve the image of psychiatry and psychiatrists are warranted, in particular improving the training of young graduates with respect to raising awareness of own stigmatizing attitudes and to develop a better profession-related self-assertiveness.	[Gaebel, Wolfgang; Zaske, Harald; Zielasek, Jurgen; Cleveland, Helen-Rose; Baumann, Anja E.] Univ Dusseldorf, LVR Klinikum Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, D-40629 Dusseldorf, Germany; [Samjeske, Kathrin] GESIS Leibniz Inst Social Sci, Cologne, Germany; [Stuart, Heather; Arboleda-Florez, Julio] Queens Univ, Kingston, ON, Canada; [Akiyama, Tsuyoshi] NTT Med Ctr, Tokyo, Japan; [Gureje, Oye] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Jorge, Miguel R.] Escola Paulista Med UNIFESP, Sao Paulo, Brazil; [Kastrup, Marianne] Competence Ctr Transcultural Psychiat, Hellerup, Denmark; [Suzuki, Yuriko] Natl Inst Mental Hlth, Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Tasman, Allan; Johnson, Sarah B.; Spurgeoun, Joyce A.] Univ Louisville, Louisville, KY 40292 USA; [Fidalgo, Thiago M.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Jarema, Marek] Inst Psychiat & Neurol, Dept Psychiat 3, Warsaw, Poland; [Kola, Lola] World Hlth Org UN Country Off, Abuja, Nigeria; [Krupchanka, Dzmytry; Padalko, Ekaterina] Belarusian Med Acad Postgrad Educ, Minsk, Byelarus; [Larach, Veronica] Univ Andres Bello, Santiago, Chile; [Matthews, Lyndy] Royal Australian & New Zealand Coll Psychiatrists, Wellington, New Zealand; [Mellsop, Graham] Univ Auckland, Auckland 1, New Zealand; [Ndetei, David M.] Univ Nairobi, Africa Mental Hlth Fdn, Nairobi, Kenya; [Okasha, Tarek A.] Ain Shams Univ, Inst Psychiat, Fac Med, Cairo, Egypt; [Tyszkowska, Magdalena] Inst Psychiat & Neurol, PL-02957 Warsaw, Poland; [Sartorius, Norman] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland	Gaebel, W (reprint author), Univ Dusseldorf, LVR Klinikum Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, Bergische Landstrasse 2, D-40629 Dusseldorf, Germany.	wolfgang.gaebel@uni-duesseldorf.de			World Psychiatric Association (Geneva, Switzerland); Stiftung Seelische Gesundheit (German Mental Health Foundation; Essen, Germany)	The study was funded by a grant from the World Psychiatric Association (Geneva, Switzerland) and an additional grant from the Stiftung Seelische Gesundheit (German Mental Health Foundation; Essen, Germany).	Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Corker E, 2013, BRIT J PSYCHIAT, V202, pS58, DOI 10.1192/bjp.bp.112.112912; Gaebel W, 2014, EUR PSYCHIAT, V29, P83, DOI 10.1016/j.eurpsy.2014.01.001; Lyons Z, 2013, ACAD PSYCHIATR, V37, P150, DOI 10.1176/appi.ap.11110204; Rusch N, 2005, EUR PSYCHIAT, V20, P529, DOI 10.1016/j.eurpsy.2005.04.004; Stuart H, 2001, CAN J PSYCHIAT, V46, P245; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI [10.1176/appi.ps.201100529, 10.1176/appi.ps.005292011]; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Korszun A, 2012, ACAD PSYCHIATR, V36, P197, DOI 10.1176/appi.ap.10110159; [Anonymous], 2012, LANCET, V379, P1274; Sartorius N, 2010, WORLD PSYCHIATRY, V9, P131; Lauber C, 2004, EUR PSYCHIAT, V19, P423, DOI 10.1016/j.eurpsy.2004.06.019; Svirko E, 2013, MED TEACH, V35, P365, DOI 10.3109/0142159X.2012.746450; Holmes D, 2008, FAM MED, V40, P400; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Evans-Lacko S, 2012, PSYCHOL MED, V42, P1741, DOI 10.1017/S0033291711002558; Gaebel W, 2008, SCHIZOPHR RES, V98, P184, DOI 10.1016/j.schres.2007.09.013; Gaebel W, 2011, EUR ARCH PSY CLIN N, V261, P119, DOI 10.1007/s00406-011-0252-0; Cohen J., 1988, STAT POWER ANAL BEHA; Cutler JL, 2012, ACAD PSYCHIATR, V36, P191, DOI 10.1176/appi.ap.10050081; Friedrich B, 2013, BRIT J PSYCHIAT, V202, pS89, DOI 10.1192/bjp.bp.112.114017; Gaebel W, 2002, EUR ARCH PSY CLIN N, V252, P278, DOI 10.1007/s00406-002-0393-2; Goldacre MJ, 2014, BRIT J PSYCHIAT, V202, P228; Holm-Petersen C, 2007, ACTA PSYCHIAT SCAND, V116, P308, DOI 10.1111/j.1600-0447.2007.01036.x; Kassam A, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-51; Lambert TW, 2006, PSYCHOL MED, V36, P679, DOI 10.1017/S0033291705007038; Sartorius N., 2005, REDUCING STIGMA MENT; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; Totic S, 2011, INT J SOC PSYCHIAT, V58, P455; Voderholzer U, 2012, PSYCHIATRIE, V9, P31; World Psychiatric Association, 2003, FIGHT STIGM DISCR BE; World Psychiatric Association, 1998, FIGHT STIGM DISCR BE	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0940-1334	1433-8491		EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	APR	2015	265	3					189	197		10.1007/s00406-014-0530-8		9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CD9IT	WOS:000351412500003		
J	Kishi, T; Iwata, N				Kishi, Taro; Iwata, Nakao			Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						Meta-analysis; Schizophrenia; Smoking cessation; Systematic review; Varenicline	DOUBLE-BLIND PLACEBO; SCHIZOAFFECTIVE DISORDER; RATING-SCALE; NICOTINE DEPENDENCE; NEGATIVE SYMPTOMS; BIPOLAR DISORDER; TRIAL; DEPRESSION; RECEPTOR; AGONIST	We performed an updated meta-analysis of randomized double-blind placebo-controlled trials (RCTs) on the effects of varenicline adjuvant therapy for smoking cessation in people with schizophrenia, on the basis of a previous meta-analysis (Tsoi in Cochrane Database Syst Rev 2:CD007253, 2013). We searched PubMed, the Cochrane Library databases, and PsycINFO up to August 1, 2014. RCTs comparing varenicline adjuvant therapy with placebo in schizophrenia were included. The risk ratio (RR), number needed to harm (NNH), and standardized mean differences with its 95 % confidence interval (CI) were used. Seven studies (total n = 439), including 6 with only schizophrenia (total n = 352), 1 with both schizophrenia (n = 77) and bipolar disorder (n = 10), were included. Varenicline was not superior to placebo in smoking cessation (RR = 0.79, 95 % CI 0.58-1.08, p = 0.14, 5 RCTs, n = 322). Varenicline failed to show its superiority to placebo for overall, positive, negative, and depressive symptoms. Moreover, there was no significant difference in the discontinuation rate due to all causes, clinical deterioration, or side effects between varenicline and placebo. Although varenicline caused less abnormal dreams/nightmares than placebo (RR = 0.47, 95 % CI 0.22-0.99, p = 0.05, NNH = not significant, 4 RCTs, n = 288), it caused more nausea (RR = 1.79, 95 % CI 1.20-2.67, p = 0.004, NNH = 6, p = 0.004, 6 RCTs, n = 417). We detected no significant difference in suicidal ideation and depression between varenicline and placebo. Our results suggest that although varenicline adjuvant therapy is well tolerated, varenicline is not superior to placebo for smoking cessation in people with schizophrenia. Because of the limited sample sizes of the available studies, future studies will require larger samples to ensure that these findings are generalizable.	[Kishi, Taro; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan	Kishi, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan.	tarok@fujita-hu.ac.jp					Allen MH, 2011, AM J PSYCHIAT, V168, P395, DOI 10.1176/appi.ajp.2010.10040569; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; Weiner E, 2011, SCHIZOPHR RES, V129, P94, DOI 10.1016/j.schres.2011.02.003; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; GOFF DC, 1992, AM J PSYCHIAT, V149, P1189; Smith RC, 2009, SCHIZOPHR RES, V110, P149, DOI 10.1016/j.schres.2009.02.001; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Arnulf I, 2012, MOVEMENT DISORD, V27, P677, DOI 10.1002/mds.24957; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; HUGHES JR, 1986, AM J PSYCHIAT, V143, P993; Lieberman JA, 2013, NEUROPSYCHOPHARMACOL, V38, P968, DOI 10.1038/npp.2012.259; Young JW, 2013, BIOCHEM PHARMACOL, V86, P1122, DOI 10.1016/j.bcp.2013.06.031; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dutra SJ, 2012, PSYCHOPHARMACOLOGY, V219, P25, DOI 10.1007/s00213-011-2373-6; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Fatemi SH, 2013, SCHIZOPHR RES, V146, P376, DOI 10.1016/j.schres.2013.02.015; Gupta A, 2012, AUST NZ J PSYCHIAT, V46, P1009, DOI 10.1177/0004867412444993; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Ho KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; Ismail Z, 2010, SCHIZOPHR RES, V119, P268, DOI 10.1016/j.schres.2010.01.027; Kaalund SS, 2013, MOL PSYCHIAT; Lising-Enriquez K, 2009, J PSYCHIATR NEUROSCI, V34, pE1; Liu ME, 2011, PSYCHIAT RES, V190, P79, DOI 10.1016/j.psychres.2011.04.018; Meszaros ZS, 2013, J CLIN PSYCHOPHARM, V33, P243, DOI 10.1097/JCP.0b013e3182870551; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Montoya ID, 2007, J DUAL DIAGN, V3, P113, DOI 10.1300/J374v03n03_09; Ortiz G, 2013, PSYCHIAT SERV, V64, P666, DOI 10.1176/appi.ps.201200290; Patkar AA, 2002, J NERV MENT DIS, V190, P604, DOI 10.1097/01.NMD.0000030525.40247.B9; Smith RC, 2010, SCHIZOPHR RES, V119, P269, DOI 10.1016/j.schres.2010.02.1064; Trbovic SM, 2010, MED HYPOTHESES, V74, P127, DOI 10.1016/j.mehy.2009.07.019; Tsoi DT, 2013, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD007253.pub3, DOI 10.1002/14651858.C0007253.PUB3]]; Umbricht D, 2014, NEUROPSYCHOPHARMACOL; Yousefi MK, 2011, J ADDICT RES THER, VS4; Ziedonis DM, 1997, SCHIZOPHRENIA BULL, V23, P247	45	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0940-1334	1433-8491		EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	APR	2015	265	3					259	268		10.1007/s00406-014-0551-3		10	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CD9IT	WOS:000351412500010		
J	Umemura, K; Miyabayashi, T; Taira, H; Suzuki, A; Kumashiro, Y; Okano, T; Mayama, S				Umemura, Kazuo; Miyabayashi, Toru; Taira, Hisao; Suzuki, Akira; Kumashiro, Yoshikazu; Okano, Teruo; Mayama, Shigeki			Use of a microchamber for analysis of thermal variation of the gliding phenomenon of single Navicula pavillardii cells	EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS			English	Article						Single-cell analysis; Diatom; Trajectory; Temperature; Microchamber	DIATOM LOCOMOTION; MICROPHYTOBENTHIC BIOFILMS; PHAEODACTYLUM-TRICORNUTUM; MOTILITY; MECHANISM; MOVEMENT; ACTIN	In this study, we used a microchamber to observe and analyze the gliding phenomenon of Navicula pavillardii diatom cells at different temperatures. The temperature of the culture medium was varied from 17.0 to 30.0 A degrees C to examine the effect of temperature on diatom movement. Movement of each cell at different temperatures was monitored by use of an inverted optical microscope and continuously recorded as video data, from which the velocities of each cell were calculated, by using dedicated software to perform two-dimensional trajectory analysis. The velocities of the same cell at different temperatures were thereby successfully compared. The results showed that the change in cell velocity was insignificant when the temperature was increased from 17.0 to 25.0 A degrees C. When the temperature was increased from 17.0 to 27.5 A degrees C, non-uniformly disrupted cell movement was observed. When the temperature was further increased to 30.0 A degrees C, cell movement was clearly inhibited. By use of single-cell analysis, the effects of the temperature increases on diatom movement were successfully evaluated. Finally, we characterized the experimental data by performing t tests to evaluate the effects of variations of the movement of individual cells on the data analysis.	[Umemura, Kazuo; Miyabayashi, Toru; Taira, Hisao; Suzuki, Akira] Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Kumashiro, Yoshikazu; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci TWins, Shinjuku Ku, Tokyo 1628666, Japan; [Mayama, Shigeki] Tokyo Gakugei Univ, Fac Educ, Koganei, Tokyo 1848511, Japan	Umemura, K (reprint author), Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	meicun2006@163.com			RIST TUS Research Center for Green and Safety Sciences	This work was supported by RIST TUS Research Center for Green and Safety Sciences.	Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Poulsen NC, 1999, CELL MOTIL CYTOSKEL, V44, P23, DOI 10.1002/(SICI)1097-0169(199909)44:1<23::AID-CM2>3.0.CO;2-D; COOKSEY B, 1980, PLANT PHYSIOL, V65, P129, DOI 10.1104/pp.65.1.129; EDGAR LA, 1982, PROTOPLASMA, V113, P10, DOI 10.1007/BF01283035; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P345, DOI 10.1098/rspb.1983.0043; Cartaxana P, 2008, LIMNOL OCEANOGR-METH, V6, P466; Cohn SA, 2003, DIATOM RES, V18, P225; Moroz AL, 1999, GLOB CHANGE BIOL, V5, P191, DOI 10.1046/j.1365-2486.1999.00225.x; Perkins RG, 2010, MAR ECOL PROG SER, V416, P93, DOI 10.3354/meps08787; Cohn SA, 2004, DIATOM RES, V19, P167; Underwood GJC, 1999, ADV ECOL RES, V29, P93; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Perkins RG, 2010, DEVEL APPL PHYCOL, V4, P237, DOI 10.1007/978-90-481-9268-7_12; Apoya-Horton MD, 2006, J PHYCOL, V42, P379, DOI 10.1111/j.1529-8817.2006.00194.x; Clarkson N, 1999, BIOELECTROMAGNETICS, V20, P94, DOI 10.1002/(SICI)1521-186X(1999)20:2<94::AID-BEM3>3.0.CO;2-Q; Cohn S. A., 2001, PHOTOMOVEMENT, P375; DRUM RW, 1966, PROTOPLASMA, V62, P1, DOI 10.1007/BF01254629; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P331, DOI 10.1098/rspb.1983.0042; EDGAR LA, 1982, BRIT PHYCOL J, V17, P243; EDGAR LA, 1983, PROTOPLASMA, V118, P44, DOI 10.1007/BF01284745; EDGAR LA, 1979, BRIT PHYCOL J, V14, P83; Edgar LA, 1984, PROGR PHYCOLOGICAL R, V3, P47; Falkowski P. G., 1997, AQUATIC PHOTOSYNTHES; GORDON R, 1970, P NATL ACAD SCI USA, V67, P338, DOI 10.1073/pnas.67.1.338; Harper MA, 1977, BIOL DIATOMS, P224, DOI [10.1016/0014-4827(72)90416-8, DOI 10.1016/0014-4827(72)90416-8]; IWASA K, 1972, EXP CELL RES, V74, P552, DOI 10.1016/0014-4827(72)90416-8; LEWIN JC, 1958, J GEN MICROBIOL, V18, P427; Murase A, 2011, J MICROBIOL METH, V87, P316, DOI 10.1016/j.mimet.2011.09.006; Murase A, 2012, EUR BIOPHYS J BIOPHY, V41, P545, DOI 10.1007/s00249-012-0810-z; PICKETTHEAPS J, 1991, J PHYCOL, V27, P718, DOI 10.1111/j.0022-3646.1991.00718.x; Umemura K, 2013, J MICROBIOL METH, V92, P349, DOI 10.1016/j.mimet.2013.01.006	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7571	1432-1017		EUR BIOPHYS J BIOPHY	Eur. Biophys. J. Biophys. Lett.	APR	2015	44	3					113	119		10.1007/s00249-015-1006-0		7	Biophysics	Biophysics	CD6YQ	WOS:000351237400002		
J	Sugawara, J; Komine, H; Miyazawa, T; Imai, T; Ogoh, S				Sugawara, Jun; Komine, Hidehiko; Miyazawa, Taiki; Imai, Tomoko; Ogoh, Shigehiko			Influence of single bout of aerobic exercise on aortic pulse pressure	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Dynamic exercise; Post-exercise hypotension; Wave reflection; General transfer function	CENTRAL BLOOD-PRESSURE; ARTERIAL STIFFNESS; CONTROLLED-TRIALS; CARDIAC-OUTPUT; MORTALITY; DISEASE; WOMEN; VALIDATION; MECHANISMS; HUMANS	Regular aerobic exercise has come to the forefront of non-pharmacological treatment for hypertension. In this line, post-exercise hypotension may have a potential tool for efficient blood pressure management. However, less is known about the influence of acute aerobic exercise on aortic pulse pressure (PP), an important property underlying the pathophysiology of cardiovascular disease. We tested the hypotheses that aortic PP would be attenuated with a single aerobic exercise and that its extent would be associated with the delayed return of reflected wave and the leg vasodilatory capacity. In 23 apparent healthy men (22 +/- A 4 years), hemodynamic variables and aortic pulse wave velocity (PWV) were measured before and 20 and 50 min after a 60-min bout of cycling exercise at moderate intensity (corresponding to 65-75 % heart rate reserve). Aortic pressure was estimated from applanation tonometrically measured radial arterial pressure waveform via general transfer function. Peak calf vascular dilatory capacity was measured with the ischemic exercise-induced hyperemia (via venous occlusion plethysmography). Finger, brachial, and aortic PP were significantly attenuated following the exercise. At 20 min after the exercise cessation, individual changes in aortic PWV significantly correlated with corresponding changes in aortic PP (r = 0.541, P < 0.05), but this correlation was no longer significant at 50 min after the exercise cessation. Peak calf vascular dilatory capacity was not associated with change in aortic PP. We conclude that in young men the aortic PP would be attenuated with the moderate-intensity dynamic exercise partly due to the delayed return of reflection wave from periphery.	[Sugawara, Jun; Komine, Hidehiko; Miyazawa, Taiki] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Miyazawa, Taiki; Ogoh, Shigehiko] Toyo Univ, Dept Biomed Engn, Kawagoe, Saitama, Japan; [Imai, Tomoko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Sugawara, J (reprint author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	jun.sugawara@aist.go.jp			Nakatomi Foundation; Uehara Memorial Foundation; Mizuno Sports Promotion Foundation	This study was supported by the Nakatomi Foundation (JS), the Uehara Memorial Foundation (JS) and Mizuno Sports Promotion Foundation (JS).	Sugawara J, 2010, HYPERTENSION, V56, P920, DOI 10.1161/HYPERTENSIONAHA.110.160549; LEWIS JF, 1984, CIRCULATION, V70, P425; Kingwell BA, 1997, AM J PHYSIOL-HEART C, V273, pH2186; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Glynn RJ, 2000, ARCH INTERN MED, V160, P2765, DOI 10.1001/archinte.160.18.2765; ROWELL LB, 1969, CIRC RES, V24, P711; Roman MJ, 2010, J HYPERTENS, V28, P384, DOI 10.1097/HJH.0b013e328333d228; [Anonymous], 2015, EUR J APPL PHYSL, V115, P739; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566; ROWELL LB, 1968, CIRCULATION, V37, P954; Whelton SP, 2002, ANN INTERN MED, V136, P493; HAGBERG JM, 1987, J APPL PHYSIOL, V63, P270; Sharman JE, 2006, HYPERTENSION, V47, P1203, DOI 10.1161/01.HYP.0000223013.60612.72; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Sugawara J, 2013, J PHYSIOL SCI, V63, P389, DOI 10.1007/s12576-013-0272-9; Sharman JE, 2008, HYPERTENSION, V51, P856, DOI 10.1161/HYPERTENSIONAHA.107.102558; PESCATELLO LS, 1991, CIRCULATION, V83, P1557; Sugawara J, 2003, ACTA PHYSIOL SCAND, V179, P361, DOI 10.1046/j.0001-6772.2003.01211.x; KENNEY MJ, 1993, HYPERTENSION, V22, P653; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Franklin SS, 1999, CIRCULATION, V100, P354; Doonan RJ, 2013, HYPERTENS RES, V36, P226, DOI 10.1038/hr.2012.158; Benetos A, 1998, HYPERTENSION, V32, P560; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Endo MY, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-32; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Hope SA, 2008, J HYPERTENS, V26, P4; LEVINE BD, 1991, J APPL PHYSIOL, V70, P112; Nichols W, 2005, MCDONALDS BLOOD FLOW, V5; Seals DR, 1999, AM J PHYSIOL-HEART C, V277, pH947; Segers P, 2000, AM J PHYSIOL-HEART C, V279, pH542; Sugawara J, 2012, J APPL PHYSIOL, V112, P1891, DOI 10.1152/japplphysiol.01460.2011; Yan H, 2014, AM J PHYSIOL-HEART C, V306, pH60, DOI 10.1152/ajpheart.00710.2013	37	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	APR	2015	115	4					739	746		10.1007/s00421-014-3061-0		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CD6YX	WOS:000351238200007		
J	Sano, K; Nicol, C; Akiyama, M; Kunimasa, Y; Oda, T; Ito, A; Locatelli, E; Komi, PV; Ishikawa, M				Sano, Kanae; Nicol, Caroline; Akiyama, Masanobu; Kunimasa, Yoko; Oda, Toshiaki; Ito, Akira; Locatelli, Elio; Komi, Paavo V.; Ishikawa, Masaki			Can measures of muscle-tendon interaction improve our understanding of the superiority of Kenyan endurance runners?	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Ultrasonography; Muscle-tendon interaction; Endurance running; Kenya	STRETCH-SHORTENING CYCLE; TRICEPS SURAE MUSCLE; RUNNING ECONOMY; DISTANCE RUNNERS; IN-VIVO; SCANDINAVIAN RUNNERS; GASTROCNEMIUS-MUSCLE; EXERCISE CAPACITY; HUMAN LOCOMOTION; BIOMECHANICS	Leg muscle activation profiles and muscle-tendon interaction were studied with eleven internationally high-level Kenyan and eleven national level Japanese distance runners. Ultrasonography and kinematics were applied together with surface electromyography (EMG) recordings of leg muscles when subjects ran on treadmill at 9.0 (SLOW) and 13.9 km h(-1) (MEDIUM). At each speed, both groups presented similar contact and flight times. The kinematic and ultrasound analyses revealed that, in contrast to the Japanese runners, the Kenyans demonstrated during contact smaller stretching and shortening amplitudes (p < 0.01) of the tendinous tissue of medial gastrocnemius (MG), but greater tendon contribution to the muscle-tendon unit shortening (p < 0.05). The MG fascicles of the Kenyans were shorter not only at the resting standing position, but also during the contact phase at both running speeds (p < 0.01). The EMG profiles of the Kenyans showed lower braking/preactivation ratio in both MG and tibialis anterior (p < 0.05) muscles. They were also characterized by negative relationships between the Achilles tendon moment arm and the MG fascicle shortening during contact (r = -0.54, p < 0.01). In contrast, the Japanese presented the classical stretch-shortening cycle muscle activation profile of relatively high MG EMG activity during the braking phase. These findings provide new suggestions that the Kenyans have unique structural characteristics which can result in the reduction of muscle and tendinous stretch-shortening loading together with smaller muscle activation during contact at submaximal running speed.	[Sano, Kanae; Akiyama, Masanobu; Kunimasa, Yoko; Ito, Akira; Ishikawa, Masaki] Osaka Univ Hlth & Sport Sci, Kumatori, Osaka 5900496, Japan; [Nicol, Caroline] Aix Marseille Univ, CNRS, UMR 7287, Marseille, France; [Nicol, Caroline] Norwegian Sch Sport Sci, Oslo, Norway; [Oda, Toshiaki] Hyogo Univ Teachers Educ, Kato, Hyogo, Japan; [Locatelli, Elio] Int Assoc Athlet Federat, Monaco, Monaco; [Komi, Paavo V.] Univ Jyvaskyla, NMRC, Jyvaskyla, Finland; [Komi, Paavo V.] Univ Jyvaskyla, Likes Res Ctr, Jyvaskyla, Finland	Sano, K (reprint author), Osaka Univ Hlth & Sport Sci, Asashirodai 1-1, Kumatori, Osaka 5900496, Japan.	kanae.04.dec@gmail.com; masaki@ouhs.ac.jp			MEXT/JSPS KAKENHI [20800061, 23700756, 23500729, 26702026]	The authors would like to acknowledge Mr. Kipchoge Keino and the IAAF High Performance Training Centre, Kenya for helping recruitments of subjects and providing measurement place. Also, the authors thank Mr. Julian Wayne for checking the English language. This work was supported by MEXT/JSPS KAKENHI Grant Number 20800061, 23700756, 23500729 and 26702026.	Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; Anderson T, 1996, SPORTS MED, V22, P76; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Saltin Bengt, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P222; Ishikawa M, 2008, EXERC SPORT SCI REV, V36, P193, DOI 10.1097/JES.0b013e3181878417; Sano K, 2013, EUR J APPL PHYSIOL, V113, P1395, DOI 10.1007/s00421-012-2559-6; Tam E, 2012, EUR J APPL PHYSIOL, V112, P3797, DOI 10.1007/s00421-012-2357-1; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Ishikawa M, 2007, J APPL PHYSIOL, V103, P1030, DOI 10.1152/japplphysiol.00277.2007; Arampatzis A, 2006, J EXP BIOL, V209, P3345, DOI 10.1242/jeb.02340; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; WILLIAMS KR, 1987, J APPL PHYSIOL, V63, P1236; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; CARRIER DR, 1994, SCIENCE, V265, P651, DOI 10.1126/science.8036513; Lichtwark GA, 2010, J EXP BIOL, V213, P707, DOI 10.1242/jeb.038026; Saltin B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P209; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Fletcher JR, 2010, EUR J APPL PHYSIOL, V110, P1037, DOI 10.1007/s00421-010-1582-8; Fletcher JR, 2013, EUR J APPL PHYSIOL, V113, P2313, DOI 10.1007/s00421-013-2665-0; Fukunaga T, 1996, J APPL PHYSIOL, V81, P1430; Giannakou E, 2011, J ELECTROMYOGR KINES, V21, P1081, DOI 10.1016/j.jelekin.2011.06.004; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Hunter GR, 2011, MED SCI SPORT EXER, V43, P1492, DOI 10.1249/MSS.0b013e318210464a; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; KOMI PV, 1987, INT J SPORTS MED, V8, P196, DOI 10.1055/s-2008-1025655; Komi PV, 1973, NEW DEV ELECTROMYOGR, V1, P596; Nourbakhsh MR, 2004, J ELECTROMYOGR KINES, V14, P263, DOI 10.1016/S1050-6411(03)00076-2; Kunimasa Y, 2014, SCAND J MED SCI SPOR, V24, pE269, DOI 10.1111/sms.12161; Ishikawa M, 2007, Gait Posture, V25, P380, DOI 10.1016/j.gaitpost.2006.05.002; Mademli L, 2006, J BIOMECH, V39, P426, DOI 10.1016/j.jbiomech.2004.12.016; MARTIN PE, 1992, MED SCI SPORT EXER, V24, P467; McCarthy JP, 2006, J STRENGTH COND RES, V20, P511; Mooses M, 2014, J SPORTS SCI, V11, P1; Saltin B, 2003, IAAF, V18, P15; Spiriev B, 2011, IAAF SCORING TABLES	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	APR	2015	115	4					849	859		10.1007/s00421-014-3067-7		11	Physiology; Sport Sciences	Physiology; Sport Sciences	CD6YX	WOS:000351238200018		
J	Kuwata, Y; Tanimoto, S; Sawabe, E; Shima, M; Takahashi, Y; Ushizawa, H; Fujie, T; Koike, R; Tojo, N; Kubota, T; Saito, R				Kuwata, Y.; Tanimoto, S.; Sawabe, E.; Shima, M.; Takahashi, Y.; Ushizawa, H.; Fujie, T.; Koike, R.; Tojo, N.; Kubota, T.; Saito, R.			Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							TOXIN-B; RIBOSOMAL-RNA; RESISTANCE; INFECTIONS; OUTBREAKS; SEQUENCE; EUROPE; STRAIN; GENE; PCR	Clostridium difficile infection control strategies require an understanding of its epidemiology. In this study, we analysed the toxin genotypes of 130 non-duplicate clinical isolates of C. difficile from a university hospital in Tokyo, Japan. Multilocus sequence typing (MLST) and eBURST analysis were performed for these isolates and nine strains previously analysed by polymerase chain reaction (PCR) ribotyping. Minimum inhibitory concentrations (MICs) were determined for six antibiotics, and the bacterial resistance mechanisms were investigated. Ninety-five toxigenic strains (73 %), including seven tcdA-negative, tcdB-positive and cdtA/cdtB-negative strains (A(-)B(+)CDT(-)) and three A(+)B(+)CDT(+) strains, and 35 (27 %) non-toxigenic strains, were classified into 23 and 12 sequence types, respectively. Of these, sequence type (ST)17 (21.8 %) was the most predominant. MLST and eBURST analysis showed that 139 strains belonged to seven groups and singletons, and most A(+)B(+)CDT(-) strains (98 %, 89/91) were classified into group 1. All isolates were susceptible to metronidazole, vancomycin and meropenem; the ceftriaxone, clindamycin and ciprofloxacin resistance rates were 49, 59 and 99 %, respectively. Resistance rates to ceftriaxone and clindamycin were higher in toxigenic strains than in non-toxigenic strains (P < 0.001). All ST17 and ST81 strains were resistant to these antibiotics. The clindamycin- and fluoroquinolone-resistant strains carried erm(B) and mutations in GyrA and/or GyrB, respectively. To our knowledge, this is the first MLST-based study of the molecular epidemiology of toxigenic and non-toxigenic strains in Japan, providing evidence that non-toxigenic and toxigenic strains exhibit high genetic diversity and that toxigenic strains are more likely than non-toxigenic strains to exhibit multidrug resistance.	[Kuwata, Y.; Tanimoto, S.; Kubota, T.; Saito, R.] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Microbiol & Immunol, Bunkyo Ku, Tokyo 1138510, Japan; [Sawabe, E.; Shima, M.; Takahashi, Y.; Ushizawa, H.; Fujie, T.; Koike, R.; Saito, R.] Tokyo Med & Dent Univ, Hosp Med, Infect Control Sect, Tokyo 1138510, Japan; [Sawabe, E.; Tojo, N.] Tokyo Med & Dent Univ, Hosp Med, Dept Clin Lab, Tokyo 1138510, Japan	Saito, R (reprint author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Microbiol & Immunol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	r-saito.mi@tmd.ac.jp					Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; GEORGE RH, 1978, BRIT MED J, V1, P695; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Walkty A, 2010, DIAGN MICR INFEC DIS, V66, P419, DOI 10.1016/j.diagmicrobio.2009.12.002; Liao CH, 2012, ANTIMICROB AGENTS CH, V56, P3943, DOI 10.1128/AAC.00191-12; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Kato H, 1998, J CLIN MICROBIOL, V36, P2178; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; Drudy D, 2006, J ANTIMICROB CHEMOTH, V58, P1264, DOI 10.1093/jac/dkl398; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Kato H, 2005, J MED MICROBIOL, V54, P167, DOI 10.1099/jmm.0.45807-0; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Barbut F, 2007, CLIN MICROBIOL INFEC, V13, P1048, DOI 10.1111/j.1469-0691.2007.01824.x; Oka K, 2012, J CLIN MICROBIOL, V50, P915, DOI 10.1128/JCM.05588-11; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Weber I, 2013, INT J MED MICROBIOL, V303, P128, DOI 10.1016/j.ijmm.2013.02.016; Chung WSO, 1999, J ANTIMICROB CHEMOTH, V43, P5, DOI 10.1093/jac/43.1.5; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Collins Deirdre A, 2013, Antimicrob Resist Infect Control, V2, P21, DOI 10.1186/2047-2994-2-21; Depestel Daryl D, 2013, J Pharm Pract, V26, P464, DOI 10.1177/0897190013499521; HOOPER DC, 1987, AM J MED, V82, P12; Kim J, 2012, INT J ANTIMICROB AG, V40, P24, DOI 10.1016/j.ijantimicag.2012.03.015; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Murray R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-103; Nonaka S, 2014, J MED MICROBIOL, V63, P242, DOI 10.1099/jmm.0.061788-0; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660	31	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	APR	2015	34	4					763	772		10.1007/s10096-014-2290-9		10	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CE0RU	WOS:000351513900017		
J	Harada, A; Nakamura, K; Kanno, T; Inagaki, R; Ortengren, U; Niwano, Y; Sasaki, K; Egusa, H				Harada, Akio; Nakamura, Keisuke; Kanno, Taro; Inagaki, Ryoichi; Ortengren, Ulf; Niwano, Yoshimi; Sasaki, Keiichi; Egusa, Hiroshi			Fracture resistance of computer-aided design/computer-aided manufacturing generated composite resin-based molar crowns	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						CAD/CAM; composite resin; fracture resistance; lithium disilicate; micro-CT	FREE POLYMER CROWNS; DENTAL CASTING ALLOYS; BITE FORCE; MARGINAL ADAPTATION; CERAMIC CROWNS; FRACTOGRAPHIC ANALYSES; FLEXURAL STRENGTH; SINGLE CROWNS; IN-VITRO; POROSITY	The aim of this study was to investigate whether different fabrication processes, such as the computer-aided design/computer-aided manufacturing (CAD/CAM) system or the manual build-up technique, affect the fracture resistance of composite resin-based crowns. Lava Ultimate (LU), Estenia C&B (EC&B), and lithium disilicate glass-ceramic IPS e.max press (EMP) were used. Four types of molar crowns were fabricated: CAD/CAM-generated composite resin-based crowns (LU crowns); manually built-up monolayer composite resin-based crowns (EC&B-monolayer crowns); manually built-up layered composite resin-based crowns (EC&B-layered crowns); and EMP crowns. Each type of crown was cemented to dies and the fracture resistance was tested. EC&B-layered crowns showed significantly lower fracture resistance compared with LU and EMP crowns, although there was no significant difference in flexural strength or fracture toughness between LU and EC&B materials. Micro-computed tomography and fractographic analysis showed that decreased strength probably resulted from internal voids in the EC&B-layered crowns introduced by the layering process. There was no significant difference in fracture resistance among LU, EC&B-monolayer, and EMP crowns. Both types of composite resin-based crowns showed fracture loads of >2000N, which is higher than the molar bite force. Therefore, CAD/CAM-generated crowns, without internal defects, may be applied to molar regions with sufficient fracture resistance.	[Harada, Akio; Kanno, Taro; Egusa, Hiroshi] Tohoku Univ, Div Mol & Regenerat Prosthodont, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Keisuke; Niwano, Yoshimi] Tohoku Univ, Lab Redox Regulat, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Keisuke; Ortengren, Ulf] Univ Gothenburg, Inst Odontol, Dept Prosthet Dent Dent Mat Sci, Gothenburg, Sweden; [Inagaki, Ryoichi] Tohoku Univ, Sch Dent Lab Technicians, Sendai, Miyagi 9808575, Japan; [Ortengren, Ulf] Arctic Univ Norway, Dept Clin Dent, Fac Hlth Sci, Tromso, Norway; [Sasaki, Keiichi] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Sendai, Miyagi 9808575, Japan	Nakamura, K (reprint author), Tohoku Univ, Lab Redox Regulat, Grad Sch Dent, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	keisuke@m.tohoku.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [25462981]	The authors would like to express their heartfelt gratitude to 3M ESPE for generously supplying the composite resin blocks of Lava Ultimate for bar-shaped specimens. This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 25462981, 2013.	Oilo M, 2013, DENT MATER, V29, P815, DOI 10.1016/j.dental.2013.04.026; [Anonymous], 2011, C142110 ASTM; Quinn JB, 2005, DENT MATER, V21, P920, DOI 10.1016/j.dental.2005.01.006; Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x; Wen MY, 1999, INT J PROSTHODONT, V12, P534; Attia A, 2006, J PROSTHET DENT, V95, P117, DOI 10.1016/j.prosdent.2005.11.014; WALTIMO A, 1993, SCAND J DENT RES, V101, P171; Geurtsen W, 2002, CRIT REV ORAL BIOL M, V13, P71; Reich S, 2013, CLIN ORAL INVEST, V17, P1765, DOI 10.1007/s00784-012-0868-0; Vanoorbeek S, 2010, INT J PROSTHODONT, V23, P223; BRAUN S, 1995, ANGLE ORTHOD, V65, P367; Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001; WALTIMO A, 1995, ACTA ODONTOL SCAND, V53, P254, DOI 10.3109/00016359509005982; Pieger S, 2014, J PROSTHET DENT, V112, P22, DOI 10.1016/j.prosdent.2014.01.005; FERRACANE JL, 1995, CRIT REV ORAL BIOL M, V6, P302; Oilo M, 2014, EUR J ORAL SCI, V122, P238, DOI 10.1111/eos.12127; Lehmann F, 2004, J PROSTHET DENT, V92, P258, DOI 10.1016/j.prosdent.2004.05.014; Alt V, 2011, DENT MATER, V27, P339, DOI 10.1016/j.dental.2010.11.012; Yucel MT, 2012, CLIN ORAL INVEST, V16, P1105, DOI 10.1007/s00784-011-0606-z; Rosentritt M, 2000, INT J PROSTHODONT, V13, P387; Pallis K, 2004, J PROSTHET DENT, V91, P561, DOI 10.1016/j.prosdent.2004.03.001; Kelly JR, 1999, J PROSTHET DENT, V81, P652, DOI 10.1016/S0022-3913(99)70103-4; Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5; Behr M, 2003, INT J PROSTHODONT, V16, P239; Scherrer SS, 2008, DENT MATER, V24, P1107, DOI 10.1016/j.dental.2008.01.002; [Anonymous], 2004, ISO10477; Behr M, 2001, J DENT, V29, P187, DOI 10.1016/S0300-5712(01)00007-0; Behr M, 2003, J DENT, V31, P503, DOI 10.1016/S0300-5712(03)00072-1; CHADWICK RG, 1989, J DENT, V17, P230, DOI 10.1016/0300-5712(89)90171-1; De Backer H, 2006, INT J PROSTHODONT, V19, P136; Esquivel-Upshaw J, 2013, J PROSTHODONT, V22, P166, DOI 10.1111/j.1532-849X.2012.00913.x; FANO V, 1995, BIOMATERIALS, V16, P1291, DOI 10.1016/0142-9612(95)91043-X; Kawano F, 2001, J ORAL REHABIL, V28, P703, DOI 10.1046/j.1365-2842.2001.00724.x; KELLY JR, 1995, J DENT RES, V74, P1253; Li RWK, 2014, J PROSTHODONT RES, V58, P208, DOI 10.1016/j.jpor.2014.07.003; MCCABE JF, 1987, DENT MATER, V3, P9, DOI 10.1016/S0109-5641(87)80053-2; Mormann WH, 1998, INT J PROSTHODONT, V11, P333; Nakamura K, 2015, ACTA ODONTOL SCAND, DOI [10.3109/00016357.2015.1007479, DOI 10.3109/00016357.2015.1007479]; Nakamura T, 2001, INT J PROSTHODONT, V14, P401; OGDEN AR, 1985, J DENT, V13, P331, DOI 10.1016/0300-5712(85)90030-2; Ohlmann B, 2008, J PROSTHET DENT, V100, P211, DOI 10.1016/S0022-3913(08)60180-8; Oilo M, 2013, DENT MATER, V29, pE78, DOI 10.1016/j.dental.2013.03.018; Poticny DJ, 2010, J AM DENT ASSOC, V141, p5S; Rammelsberg P, 2000, J PROSTHET DENT, V84, P303, DOI 10.1067/mpr.2000.108068; Rammelsberg P, 2005, J DENT, V33, P517, DOI 10.1016/j.jdent.2004.11.012; Sakoguchi K, 2013, DENT MATER J, V32, P433, DOI 10.4012/dmj.2012-313; Scherrer S S, 1993, Int J Prosthodont, V6, P462; Takeichi T, 2015, J PROSTHODONT RES, DOI [10.1016/j.jpor.2014.11.005, DOI 10.1016/J.JPOR.2014.11.005]; WALTIMO A, 1994, SCAND J DENT RES, V102, P92; Yilmaz H, 2007, J PROSTHET DENT, V98, P120, DOI 10.1016/S0022-3913(07)60045-6	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	APR	2015	123	2					122	129		10.1111/eos.12173		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD5ZE	WOS:000351166700010		
J	Ogawa, Y; Irikura, M; Kobaru, Y; Tomiyasu, M; Kochiyama, Y; Uriu, M; Ishitsuka, Y; Kondo, Y; Yukawa, E; Kamada, N; Ohno, H; Yamazaki, T; Irie, T				Ogawa, Yuki; Irikura, Mitsuru; Kobaru, Yuka; Tomiyasu, Mayu; Kochiyama, Yoshie; Uriu, Mamiko; Ishitsuka, Yoichi; Kondo, Yuki; Yukawa, Eiji; Kamada, Noboru; Ohno, Hitoshi; Yamazaki, Toshio; Irie, Tetsumi			Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Apnea; NONMEM; Population pharmacokinetics; Premature infants; Doxapram	IDIOPATHIC APNEA; SERUM CONCENTRATIONS; CAFFEINE THERAPY; PREMATURITY; THEOPHYLLINE; DOSAGE; AMINOPHYLLINE; METABOLITES	This study aimed to determine the population pharmacokinetics of doxapram in low-birth-weight (LBW) infants. A total of 92 serum concentration measurements that were obtained from 34 Japanese neonates were analyzed using nonlinear mixed-effect modeling (NONMEM). Estimates generated by NONMEM indicated that clearance of doxapram (CL; L/kg/h) was affected by postmenstrual age (PMA; weeks), body weight (BW; g), and aspartate aminotransferase (AST; IU/L). In addition, the volume of distribution (Vd; L/kg) was affected by gestational age (GA; weeks). The final pharmacokinetic model was as follows: CL = BW / PMA x 0.0453 x serum AST(-0.373); Vd = 2.54 (if GA > 28 weeks) and Vd = 2.54 x 2.11 (if GA a parts per thousand currency sign28 weeks). The interindividual variabilities in CL and Vd were 39.9 and 83.0 %, respectively, and the residual variability was 20.9 %. To clarify the reasons for large interindividual variations, the enzymes involved in the metabolic pathway of doxapram were also determined. We found that doxapram was metabolized by CYP3A4/5. Conclusion: We report the population pharmacokinetics of doxapram in neonates and the involvement of CYP3A4/5 in its metabolism. The final model of population pharmacokinetics may be useful for formulating a safe and effective dosage regimen and for predicting serum doxapram concentrations in neonates.	[Ogawa, Yuki; Kobaru, Yuka; Tomiyasu, Mayu; Kochiyama, Yoshie; Uriu, Mamiko; Ishitsuka, Yoichi; Kondo, Yuki; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Kumamoto 8620973, Japan; [Irikura, Mitsuru; Yukawa, Eiji] Daiichi Univ, Coll Pharmaceut Sci, Lab Evidence Based Pharmacotherapy, Fukuoka, Japan; [Kamada, Noboru; Ohno, Hitoshi] Kissei Pharmaceut Co Ltd, Pharmacokinet Res, Nagano, Japan; [Yamazaki, Toshio] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan; [Irie, Tetsumi] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan	Irie, T (reprint author), Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan.	099p1011@st.kumamoto-u.ac.jp; ikura@gpo.kumamoto-u.ac.jp; 060p1020@st.kumamoto-u.ac.jp; 059y8127@pharm.stud.kumamoto-u.ac.jp; y-kochiyama@kumamoto-med.jrc.or.jp; 044y8131@pharm.stud.kumamoto-u.ac.jp; y-zuka@gpo.kumamoto-u.ac.jp; ykondo@kumamoto-u.ac.jp; yukawa@daiichi-cps.ac.jp; noboru_kamada@pharm.kissei.co.jp; hitoshi_ohno@pharm.kissei.co.jp; tyamazak@fujita-hu.ac.jp; tirie@gpo.kumamoto-u.ac.jp			Ministry of Health, Labour and Welfare [23590189]	This study was supported by a grant-in-aid for scientific research from the Ministry of Health, Labour and Welfare (Research Project Number: 23590189) and by the doxapram group of the Neonatal Research Network. The following investigators and research staff (no particular order) contributed to the trial. Fujita Health University, Aichi, Japan: Toshio Yamazaki, Tadayoshi Hata, Shuji Hashimoto, and Hiroko Mizutani; Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan: Hiroyuki Kitajima, Masanori Fujimura, and Shinya Hirano; Kumamoto University, Kumamoto, Japan: Tetsumi Irie and Mitsuru Irikura; Kakogawa City Hospital, Hyogo, Japan: Akihito Ishida and Masanori Murase; Toyohashi Municipal Hospital, Aichi, Japan: Norihisa Koyama; Hiroshima City Hospital, Hiroshima, Japan: Michiko Hayashidani; Shiga University of Medical Science, Shiga, Japan: Hirofumi Aotani; National Center for Child Health and Development, Tokyo, Japan: Hidefumi Nakamura; Kagawa University, Kagawa, Japan: Susumu Itoh; and Kissei Pharmaceutical Co., Ltd., Nagano, Japan: Mutsuo Kanzawa. Doxapram used in this study was donated by Kissei Pharmaceutical Co. Ltd.	ALDEN ER, 1972, PEDIATRICS, V50, P40; ALPAN G, 1984, J PEDIATR-US, V104, P634, DOI 10.1016/S0022-3476(84)80568-5; Victor S, 2011, ARCH DIS CHILD-FETAL, V96, pF144, DOI 10.1136/adc.2008.152454; Barbe F, 1999, THER DRUG MONIT, V21, P547, DOI 10.1097/00007691-199910000-00011; Anderson BJ, 2006, EUR J PEDIATR, V165, P741, DOI 10.1007/s00431-006-0188-y; Mohangoo AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064869; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Hines RN, 2007, J BIOCHEM MOL TOXIC, V21, P169, DOI 10.1002/jbbt.02179; Silver LE, 2003, AM J OBSTET GYNECOL, V188, P1320, DOI 10.1067/mob.2003.270; ARANDA JV, 1988, J LIQ CHROMATOGR, V11, P2983, DOI 10.1080/01483918808076774; BAIRAM A, 1991, CLIN PHARMACOL THER, V50, P32; BAIRAM A, 1990, PEDIATR RES, V28, P142, DOI 10.1203/00006450-199028020-00013; BARRINGTON KJ, 1987, PEDIATRICS, V80, P22; BEAUDRY MA, 1988, DEV PHARMACOL THERAP, V11, P65; Brion L P, 1991, J Perinatol, V11, P359; COUTTS RT, 1991, XENOBIOTICA, V21, P1407; EYAL F, 1985, PEDIATRICS, V75, P709; Fukuda T, 2005, J CLIN PHARM THER, V30, P591, DOI 10.1111/j.1365-2710.2005.00689.x; HAYAKAWA F, 1986, J PEDIATR-US, V109, P138, DOI 10.1016/S0022-3476(86)80594-7; HIGUCHI S, 1987, J PHARMACOBIO-DYNAM, V10, P703; JAMALI F, 1991, DEV PHARMACOL THERAP, V16, P78; JAMALI F, 1988, DEV PHARMACOL THERAP, V11, P253; KUMITA H, 1991, ACTA PAEDIATR SCAND, V80, P786, DOI 10.1111/j.1651-2227.1991.tb11949.x; Lee TC, 1997, CLIN PHARMACOL THER, V61, P628, DOI 10.1016/S0009-9236(97)90097-7; Ogawa Y, 2013, JAPAN J DEV PHARM TH, V26, P97; Pediatrics CoFaNAAo, 2003, PEDIATRICS, V111, P914; PELIOWSKI A, 1990, J PEDIATR-US, V116, P648, DOI 10.1016/S0022-3476(05)81620-8; Prins SA, 2013, INT J PEDIAT, V2013; ROBINSON D, 1990, AM J PERINAT, V7, P343, DOI 10.1055/s-2007-999519; ROBSON RH, 1979, BRIT J CLIN PHARMACO, V7, P81; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; TAYUYBOCO J, 1991, BIOL NEONATE, V59, P190; Yamazaki T, 2013, PERINAT MED, V43, P603	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	APR	2015	174	4					509	518		10.1007/s00431-014-2416-1		10	Pediatrics	Pediatrics	CE0SF	WOS:000351515300012		
J	Ono, R; Hasegawa, D; Hirabayashi, S; Kamiya, T; Yoshida, K; Yonekawa, S; Ogawa, C; Hosoya, R; Toki, T; Terui, K; Ito, E; Manabe, A				Ono, Rintaro; Hasegawa, Daisuke; Hirabayashi, Shinsuke; Kamiya, Takahiro; Yoshida, Kenichi; Yonekawa, Satoko; Ogawa, Chitose; Hosoya, Ryota; Toki, Tsutomu; Terui, Kiminori; Ito, Etsuro; Manabe, Atsushi			Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						GATA1; Acute megakaryoblastic leukemia; Trisomy 21; Transient abnormal myelopoiesis	TRANSIENT MYELOPROLIFERATIVE DISORDER; COOPERATIVE-STUDY GROUP; ACUTE MYELOID-LEUKEMIA; DOWN-SYNDROME; INHERITED MUTATION; CHILDHOOD; CYTARABINE; INFANTS; RISK; GENE	GATA1 mutations are found almost exclusively in children with myeloid proliferations related to Down syndrome (DS). Here, we report two phenotypically and cytogenetically normal children with acute megakaryoblastic leukemia (AMKL) whose blasts had both acquired trisomy 21 and GATA1 mutation. Patient 1 was diagnosed with transient abnormal myelopoiesis in the neonatal period. Following spontaneous improvement of the disease, leukemic blasts increased 7 months later. He received less intensive chemotherapy, and he is now 6 years old in complete remission. Patient 2 was diagnosed with AMKL at the age of 18 months. Although he received intensive chemotherapy and a cord blood transplantation, he died without gaining remission. In both cases, trisomy 21 and GATA1 mutation were detected only in leukemic blasts, but not in germline samples. Based on a literature review, we identified reports describing 14 non-DS AMKL with GATA1 mutation and acquired trisomy 21. Of those, 12 cases were diagnosed during the neonatal period, whereas the remaining 2 cases were diagnosed at the age of 22 and 31 months, respectively. Conclusion: These cases suggest that GATA1 mutation may cooperate with the additional chromosome 21 in developing myeloid proliferations even in non-DS patients.	[Ono, Rintaro; Hasegawa, Daisuke; Hirabayashi, Shinsuke; Yoshida, Kenichi; Yonekawa, Satoko; Ogawa, Chitose; Hosoya, Ryota; Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Chuo Ku, Tokyo 1048560, Japan; [Kamiya, Takahiro] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Ogawa, Chitose] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan; [Toki, Tsutomu; Terui, Kiminori; Ito, Etsuro] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan	Hasegawa, D (reprint author), St Lukes Int Hosp, Dept Pediat, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	rin.r34@gmail.com; hasedai1313@gmail.com; hirashin@luke.ac.jp; takahirokamiya@hotmail.com; yoshiken.thk@gmail.com; satoko_y0115@ga2.so-net.ne.jp; chitoseo@qb3.so-net.ne.jp; ryhosoya@luke.ac.jp; toki0824@cc.hirosaki-u.ac.jp; teru@cc.hirosaki-u.ac.jp; eturou@cc.hirosaki-u.ac.jp; manabe-luke@umin.ac.jp					Trottestam H, 2011, BLOOD, V118, P4577, DOI 10.1182/blood-2011-06-356261; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Gamis AS, 2012, BRIT J HAEMATOL, V159, P277, DOI 10.1111/bjh.12041; Hollanda LM, 2006, NAT GENET, V38, P807, DOI 10.1038/ng1825; Massey GV, 2006, BLOOD, V107, P4606, DOI 10.1182/blood-2005-06-2448; Klusmann JH, 2008, BLOOD, V111, P2991, DOI 10.1182/blood-2007-10-118810; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Zipursky A, 2003, BRIT J HAEMATOL, V120, P930, DOI 10.1046/j.1365-2141.2003.04229.x; Kudo K, 2007, J CLIN ONCOL, V25, P5442, DOI 10.1200/JCO.2007.12.3687; Tsukimoto I, 2009, J CLIN ONCOL, V27, P4007, DOI 10.1200/JCO.2008.18.7948; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Carpenter E, 2005, BRIT J HAEMATOL, V128, P548, DOI 10.1111/j.1365-2141.2004.05342.x; Cushing T, 2006, J PEDIATR-US, V148, P687, DOI 10.1016/j.jpeds.2005.12.031; Hama A, 2012, BRIT J HAEMATOL, V156, P316, DOI 10.1111/j.1365-2141.2011.08948.x; Inaba H, 2011, J CLIN ONCOL, V29, pE230, DOI 10.1200/JCO.2010.32.3634; Kudo K, 2010, INT J HEMATOL, V91, P630, DOI 10.1007/s12185-010-0549-1; Magalhaes IQ, 2005, J PEDIAT HEMATOL ONC, V27, P50, DOI 10.1097/01.mph.0000151801.26478.03; Rozen L, 2014, EUR J PEDIATR, V173, P1643, DOI 10.1007/s00431-013-2163-8; Saida S, 2013, BLOOD, V121, P4377, DOI 10.1182/blood-2012-12-474387; Sandoval C, 2005, PEDIATR BLOOD CANCER, V44, P85, DOI 10.1002/pbc.20161; Stark B, 2002, BRIT J HAEMATOL, V118, P1082, DOI 10.1046/j.1365-2141.2002.03756.x; Tsai MH, 2011, INDIAN J PEDIATR, V78, P826, DOI 10.1007/s12098-010-0312-x; Yanase K, 2010, INT J HEMATOL, V92, P527, DOI 10.1007/s12185-010-0646-1	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	APR	2015	174	4					525	531		10.1007/s00431-014-2430-3		7	Pediatrics	Pediatrics	CE0SF	WOS:000351515300014		
J	Saida, K; Kawasaki, K; Hirabayashi, K; Akazawa, Y; Kubota, S; Kasuga, E; Kusakari, M; Ishida, T; Kitamura, M; Baba, A; Koike, K				Saida, Ken; Kawasaki, Kenji; Hirabayashi, Kanae; Akazawa, Yohei; Kubota, Seiko; Kasuga, Eriko; Kusakari, Mai; Ishida, Takefumi; Kitamura, Masatomo; Baba, Atsushi; Koike, Kenichi			Exfoliative toxin A staphylococcal scalded skin syndrome in preterm infants	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Staphylococcal scalded skin syndrome (SSSS); Exfoliative toxin A (ETA); Staphylococcus aureus; Methicillin-sensitive S. aureus (MSSA)	SYNDROME SSSS	Staphylococcal scalded skin syndrome (SSSS) demonstrates dermal symptoms due to exfoliative toxin (ET) A or ETB produced by Staphylococcus aureus. We examined the association between anti-ETA antibodies and SSSS onset in neonates. Three preterm infants carried an ETA-producing strain of S. aureus, manifesting as either SSSS or bullous impetigo; a full-term infant carrying the same strain was asymptomatic. The infants (n=106) were categorized into three groups according to their gestational age (GA) as follows: < 30 weeks, 30-37 weeks, and > 37 weeks. The measured levels of anti-ETA antibody in the three infants displaying SSSS were low before the onset of dermal symptoms; only the asymptomatic full-term infant displayed a high antibody level. Anti-ETA antibody levels in the preterm group with a GA of < 30 weeks were statistically lower than those in the term infant group; the prevalences of anti-ETA antibodies above a cutoff value in the three groups of neonates were 55 % (18/33) among preterm infants with a GA < 30 weeks, 73 % (25/34) among those with a GA of 30-37 weeks, and 90 % (35/39) among infants with a GA > 37 weeks. Conclusion: The presence of anti-ETA antibodies below a particular cutoff level might be associated with SSSS onset in preterm infants.	[Saida, Ken; Hirabayashi, Kanae; Akazawa, Yohei; Kusakari, Mai; Ishida, Takefumi; Kitamura, Masatomo; Baba, Atsushi; Koike, Kenichi] Univ Sch Med, Dept Pediat Shinshu, Matsumoto, Nagano 3908621, Japan; [Kawasaki, Kenji; Kubota, Seiko; Kasuga, Eriko] Shinshu Univ Hosp, Dept Lab Med, Nagano, Japan	Saida, K (reprint author), Univ Sch Med, Dept Pediat Shinshu, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kensai524@gmail.com; kawaken@shinshu-u.ac.jp; hika@shinshu-u.ac.jp; yohei704@hotmail.com; seikok@shinshu-u.ac.jp; erika@shinshu-u.ac.jp; mkusakar@chinshu-u.ac.jp; syouriki@chinshu-u.ac.jp; tomatomo@shinshu-u.ac.jp; baba@suwa.jrc.or.jp; koikeken@shinshu-u.ac.jp					Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398; CRIBIER B, 1994, J AM ACAD DERMATOL, V30, P319, DOI 10.1016/S0190-9622(94)70032-X; Ladhani S, 1999, CLIN MICROBIOL REV, V12, P224; Kapoor V, 2008, J PAEDIATR CHILD H, V44, P374, DOI 10.1111/j.1440-1754.2008.01316.x; Yamasaki O, 2005, J CLIN MICROBIOL, V43, P1890, DOI 10.1128/JCM.43.4.1890-1893.2005; BALLOW M, 1986, PEDIATR RES, V20, P899, DOI 10.1203/00006450-198609000-00019; GEMMELL CG, 1995, J MED MICROBIOL, V43, P318; HOFFMANN R, 1994, PATHOL RES PRACT, V190, P77; Makhoul I R, 2001, Pediatrics, V108, pE16, DOI 10.1542/peds.108.1.e16; Melish ME, 1981, ZBL BAKT S, V10, P287; Patel Girish K, 2004, Expert Rev Anti Infect Ther, V2, P575, DOI 10.1586/14787210.2.4.575; Rieger-Fackeldey E, 2002, EUR J PEDIATR, V161, P649, DOI 10.1007/s00431-002-1080-z; Tenenbaum T, 2007, EUR J PEDIATR, V166, P733, DOI 10.1007/s00431-006-0291-0	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	APR	2015	174	4					551	555		10.1007/s00431-014-2414-3		5	Pediatrics	Pediatrics	CE0SF	WOS:000351515300018		
J	Kikuchi, K; Hiwatashi, A; Togao, O; Yamashita, K; Yoneyama, M; Obara, M; Kishimoto, J; Yoshiura, T; Honda, H				Kikuchi, Kazufumi; Hiwatashi, Akio; Togao, Osamu; Yamashita, Koji; Yoneyama, Masami; Obara, Makoto; Kishimoto, Junji; Yoshiura, Takashi; Honda, Hiroshi			3D MR Sequence Capable of Simultaneous Image Acquisitions with and without Blood Vessel Suppression: Utility in Diagnosing Brain Metastases	EUROPEAN RADIOLOGY			English	Article						VISIBLE (volume isotropic simultaneous interleaved bright- and black-blood examination); Blood vessel suppression; Magnetic resonance imaging; Contrast-enhanced MRI; Metastatic brain tumor	STEREOTACTIC RADIOSURGERY; WHOLE-BRAIN; OBSERVER; 3T	Volume isotropic simultaneous interleaved bright- and black-blood examination (VISIBLE) is a recently developed 3D MR sequence that provides simultaneous acquisitions of images with blood vessel suppression (Black) and images without it (Bright). Our purpose was to evaluate the usefulness of VISIBLE in detecting brain metastases. This prospective study included patients with suspected brain metastasis imaged with both VISIBLE and MPRAGE. From a data set, we compared the number of visualized blood vessels and the lesion-to-normal contrast-to-noise ratio (CNR) in 60 patients. We also performed an observer test to compare their diagnostic performance with VISIBLE, MPRAGE and only Black in 34 patients. Diagnostic performance was evaluated using a figure of merit (FOM), sensitivity, false-positive results per case (FPs/case) and reading time. The number of vessels was significantly fewer in Black compared to MPRAGE and Bright (P < 0.0001). CNR was significantly higher with both Black and Bright than with MPRAGE (P < 0.005). In the observer test, significantly higher sensitivity (P < 0.0001) and FOM (P < 0.0001), significantly shorter reading time (P = 0.0001) and similar FPs/case were achieved with VISIBLE compared to MPRAGE. Compared to only Black, VISIBLE resulted in comparable sensitivity, but significantly fewer FPs/case (P = 0.0008). VISIBLE can improve radiologists' diagnostic performance for brain metastasis. VISIBLE can achieve higher sensitivity and shorter reading time than MPRAGE. VISIBLE can achieve lower false-positive rates than blood vessel suppressed images. Compared to MPRAGE, VISIBLE can improve diagnostic performance for brain metastasis.	[Kikuchi, Kazufumi; Hiwatashi, Akio; Togao, Osamu; Yamashita, Koji; Yoshiura, Takashi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Yoneyama, Masami] Yaesu Clin, Chuo Ku, Tokyo 1030027, Japan; [Obara, Makoto] Philips Elect Japan, Minato Ku, Tokyo 1088507, Japan; [Kishimoto, Junji] Kyushu Univ, Dept Res & Dev Next Generat Med, Fac Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Hiwatashi, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hiwatasi@radiol.med.kyushu-u.ac.jp			JSPS KAKENHI [26461826]	The scientific guarantor of this publication is Hiroshi Honda. The authors of this manuscript declare relationships with the following companies: Philips Electronics Japan. Makoto Obara is an employee of Philips Electronics Japan. He is not involved in data analysis in this study. This work was supported by JSPS KAKENHI Grant Number 26461826. One of the authors has significant statistical expertise. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, diagnostic study, performed at one institution.	Dong L, 2010, J MAGN RESON IMAGING, V32, P452, DOI 10.1002/jmri.22274; Serizawa T, 2010, J NEURO-ONCOL, V98, P163, DOI 10.1007/s11060-010-0169-x; Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Park J, 2010, MAGN RESON MED, V63, P553, DOI 10.1002/mrm.22261; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Hunter GK, 2012, INT J RADIAT ONCOL, V83, P1394, DOI 10.1016/j.ijrobp.2011.10.026; Kakeda S, 2007, EUR RADIOL, V17, P2345, DOI 10.1007/s00330-007-0599-9; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Monaco EA, 2013, CANCER-AM CANCER SOC, V119, P226, DOI 10.1002/cncr.27504; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Chakraborty DP, 2006, ACAD RADIOL, V13, P1187, DOI 10.1016/j.acra.2006.06.016; Nagao E, 2011, AM J NEURORADIOL, V32, P664, DOI 10.3174/ajnr.A2343; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; Lippitz B, 2014, CANCER TREAT REV, V40, P48, DOI 10.1016/j.ctrv.2013.05.002; Obara M, 2014, J MAGN RESON IMAGING, V40, P824, DOI 10.1002/jmri.24430; Posner J B, 1978, Adv Neurol, V19, P579; Rosner D, 1983, J Neurooncol, V1, P131; Takeda T, 2008, ACTA RADIOL, V49, P1167, DOI 10.1080/02841850802477924; Yoneyama M, 2014, MAGN RESON MED SCI, V13, P277, DOI 10.2463/mrms.2013-0065; Yoneyama Masami, 2013, Radiol Phys Technol, V6, P431, DOI 10.1007/s12194-013-0216-3; Yuan C, 2012, NEUROIMAG CLIN N AM, V22, P271, DOI 10.1016/j.nic.2012.02.011	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	APR	2015	25	4					901	910		10.1007/s00330-014-3496-z		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD6UY	WOS:000351226500001		
J	Naganawa, T; Baad-Hansen, L; Ando, T; Svensson, P				Naganawa, Takuya; Baad-Hansen, Lene; Ando, Tomohiro; Svensson, Peter			Influence of topical application of capsaicin, menthol and local anesthetics on intraoral somatosensory sensitivity in healthy subjects: temporal and spatial aspects	EXPERIMENTAL BRAIN RESEARCH			English	Article						Quantitative sensory testing; Capsaicin; Hyperalgesia; Menthol	SECONDARY HYPERALGESIA; NEUROPATHIC PAIN; MECHANICAL HYPERALGESIA; NEUROGENIC HYPERALGESIA; ATYPICAL ODONTALGIA; GRADING SYSTEM; COLD ALLODYNIA; HEAT INJURY; HUMAN-MODEL; HAIRY SKIN	The aim of this study was to investigate temporal and spatial aspects of somatosensory changes after topical application of capsaicin, menthol and local anesthetics (LA) on the gingiva with the use of intraoral palpometers and thermal devices. Sixteen healthy volunteers (eight male, eight female) participated. Four topical preparations (capsaicin, menthol, LA and Vaseline as a control) were randomly applied to the gingiva around the first premolar in the upper jaw via individual oral templates, which allowed spatial mapping of somatosensory changes at and adjacent to the site of application. The topical drugs were applied for 15 min in a randomized and balanced sequence. The perceived preparation-evoked pain intensity was recorded with the use of 0-10 visual analog scales (VAS). Standardized mechanical and thermal stimuli were applied before, during and up to 30 min after the topical applications, and numerical rating scales (NRS) were used to score the perceived intensity of the stimuli. Peak VAS, area under the curve and mean VAS preparation-evoked pain scores for capsaicin, menthol, LA and control were compared with paired t tests. NRS scores for mechanical and thermal test stimuli were analyzed with four-way repeated measurements analyses of variance. Capsaicin evoked significantly higher VAS pain parameters as well as higher NRS scores to heat stimuli than control (P < 0.029). There were no significant differences in stimulus-evoked NRS scores between the menthol and control conditions (P = 0.518), but LA caused significantly lower stimulus-evoked NRS scores compared with control (P < 0.001). Post hoc tests showed that capsaicin caused sensitization to heat stimuli at and adjacent to the application area. In conclusion, this study for the first time demonstrates the time course of capsaicin-evoked heat hyperalgesia in and outside the site of application at the oral mucosa (primary and secondary hyperalgesia).	[Naganawa, Takuya; Baad-Hansen, Lene; Svensson, Peter] Aarhus Univ, Dept Dent, Sect Clin Oral Physiol, Hlth, DK-8000 Aarhus C, Denmark; [Naganawa, Takuya; Ando, Tomohiro] Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shinjuku Ku, Tokyo 1628666, Japan; [Baad-Hansen, Lene; Svensson, Peter] SCON, Stockholm, Sweden; [Svensson, Peter] Karolinska Inst, Dept Dent Med, Huddinge, Sweden	Naganawa, T (reprint author), Aarhus Univ, Dept Dent, Sect Clin Oral Physiol, Hlth, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.	tanaganawa@gmail.com			Danish Dental Association	The Danish Dental Association is acknowledged for their support to the study.	Andersen OK, 2001, PROG PAIN RES MANAG, V22, P165; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Baad-Hansen L, 2013, PAIN, V154, P1287, DOI 10.1016/j.pain.2013.04.005; Campbell CM, 2011, EUR J PAIN, V15, P561, DOI 10.1016/j.ejpain.2010.11.014; Baad-Hansen L, 2005, PAIN, V116, P359, DOI 10.1016/j.pain.2005.05.006; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190; ARENDTNIELSEN L, 1988, ANESTH ANALG, V67, P115; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Binder A, 2011, J PAIN, V12, P764, DOI 10.1016/j.jpain.2010.12.013; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Caterina MJ, 1997, NATURE, V389, P816; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Namer B, 2008, PAIN, V139, P63, DOI 10.1016/j.pain.2008.03.007; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Baad-Hansen L, 2006, J OROFAC PAIN, V20, P107; CLIFF MA, 1994, PHYSIOL BEHAV, V56, P1021, DOI 10.1016/0031-9384(94)90338-7; Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Kosek E, 1999, SCAND J REHABIL MED, V31, P89; ARENDTNIELSEN L, 1989, ACTA ANAESTH SCAND, V33, P469; Baad-Hansen L, 2003, J OROFAC PAIN, V17, P333; BAUMANN TK, 1991, J NEUROPHYSIOL, V66, P212; Cruccu G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000045; DAHL JB, 1993, PAIN, V53, P43, DOI 10.1016/0304-3959(93)90054-S; Fluhr K, 2009, CLIN J PAIN, V25, P128, DOI 10.1097/AJP.0b013e3181817aa2; Geber C, 2009, AM J MED, V122, pS3, DOI 10.1016/j.amjmed.2009.04.005; Green BG, 1998, PHYSIOL BEHAV, V65, P517, DOI 10.1016/S0031-9384(98)00202-9; Green BG, 1996, PAIN, V68, P245, DOI 10.1016/S0304-3959(96)03211-3; Hatem S, 2006, PAIN, V122, P190, DOI 10.1016/j.pain.2006.01.026; KILO S, 1994, BRAIN, V117, P385, DOI 10.1093/brain/117.2.385; Lu SY, 2013, SOMATOSENS MOT RES, V30, P30, DOI 10.3109/08990220.2012.741631; Lu SY, 2013, EUR J ORAL SCI, V121, P29, DOI 10.1111/eos.12014; Naganawa T, 2013, J OROFAC PAIN, V27, P336, DOI 10.11607/jop.1139; Naganawa T, 2015, J ORAL FACI IN PRESS; Ngom PI, 2001, NEUROSCI LETT, V316, P149, DOI 10.1016/S0304-3940(01)02401-6; RAJA SN, 1984, BRAIN, V107, P1179, DOI 10.1093/brain/107.4.1179; Roberts K, 2011, J CLIN NEUROSCI, V18, P926, DOI 10.1016/j.jocn.2010.11.015; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Svensson P, 1992, Anesth Prog, V39, P4; Svensson P, 1998, PAIN, V74, P93, DOI 10.1016/S0304-3959(97)00156-5; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	APR	2015	233	4					1189	1199		10.1007/s00221-015-4200-5		11	Neurosciences	Neurosciences & Neurology	CD5XP	WOS:000351162400018		
J	Terayama, R; Yamamoto, Y; Kishimoto, N; Maruhama, K; Mizutani, M; Iida, S; Sugimoto, T				Terayama, Ryuji; Yamamoto, Yuya; Kishimoto, Noriko; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada			Peripheral nerve injury activates convergent nociceptive input to dorsal horn neurons from neighboring intact nerve	EXPERIMENTAL BRAIN RESEARCH			English	Article						Nerve injury; c-Fos; ERK; Spinal dorsal horn; Immunohistochemistry	SPINAL-CORD NEURONS; C-FOS EXPRESSION; SIGNAL-REGULATED KINASE; GRACILE NUCLEUS NEURONS; INDUCED ERK ACTIVATION; PROTEIN-KINASE; SCIATIC-NERVE; SOMATOTOPIC ORGANIZATION; MECHANICAL STIMULATION; PAIN HYPERSENSITIVITY	Previous studies demonstrated that peripheral nerve injury induced excessive nociceptive response of spinal cord dorsal horn neurons and such change has been proposed to reflect the development of neuropathic pain state. The aim of this study was to examine the spinal dorsal horn for convergence of nociceptive input to second-order neurons deafferented by peripheral nerve injury. Double immunofluorescence labeling for c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK) was performed to detect convergent synaptic input to spinal dorsal horn neurons after the saphenous nerve injury. c-Fos expression and the phosphorylation of ERK were induced by noxious heat stimulation of the hindpaw and by electrical stimulation of the injured or uninjured saphenous nerve, respectively. Within the central terminal field of the saphenous nerve, the number of c-Fos protein-like immunoreactive (c-Fos-IR) cell profiles was significantly decreased at 3 days and returned to the control level by 14 days after the injury. p-ERK immunoreactive (p-ERK-IR) cell profiles were distributed in the central terminal field of the saphenous nerve, and the topographic distribution pattern and number of such p-ERK-IR cell profiles remained unchanged after the nerve injury. The time course of changes in the number of double-labeled cell profiles was similar to that of c-Fos-IR cell profiles after the injury. These results indicate that convergent primary nociceptive input through neighboring intact nerves contributes to increased responsiveness of spinal dorsal horn nociceptive neurons.	[Terayama, Ryuji; Yamamoto, Yuya; Kishimoto, Noriko; Maruhama, Kotaro; Sugimoto, Tomosada] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Kita Ku, Okayama 7008525, Japan; [Terayama, Ryuji; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Yamamoto, Yuya; Kishimoto, Noriko; Mizutani, Masahide; Iida, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008525, Japan	Terayama, R (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	ryujit@md.okayama-u.ac.jp			Japan Society for the Promotion of Science [24592764]	This study was supported by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24592764).	Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Ji RR, 2002, J NEUROSCI, V22, P478; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; DEVOR M, 1983, PAIN, V16, P73, DOI 10.1016/0304-3959(83)90087-8; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; Dai Y, 2002, J NEUROSCI, V22, P7737; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; DEVOR M, 1980, BRAIN RES, V190, P17, DOI 10.1016/0006-8993(80)91156-7; FITZGERALD M, 1985, J COMP NEUROL, V240, P414, DOI 10.1002/cne.902400409; Fujisawa N, 2012, EXP BRAIN RES, V219, P191, DOI 10.1007/s00221-012-3078-8; Hughes AS, 2008, NEUROSCIENCE, V153, P507, DOI 10.1016/j.neuroscience.2008.01.082; HYLDEN JLK, 1987, BRAIN RES, V411, P341, DOI 10.1016/0006-8993(87)91086-9; LISNEY SJW, 1983, BRAIN RES, V259, P31, DOI 10.1016/0006-8993(83)91064-8; Liu Y, 2004, PAIN, V109, P64, DOI 10.1016/j.pain.2004.01.010; MARKUS H, 1984, BRAIN RES, V296, P27, DOI 10.1016/0006-8993(84)90508-0; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; MOLANDER C, 1988, J COMP NEUROL, V276, P436, DOI 10.1002/cne.902760308; SELTZER Z, 1984, BRAIN RES, V106, P31; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; Shortland P, 1998, BRAIN RES, V810, P288, DOI 10.1016/S0006-8993(98)00940-8; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; STRASSMAN AM, 1993, J NEUROPHYSIOL, V70, P1811; SUGIMOTO T, 1994, EXP NEUROL, V129, P251, DOI 10.1006/exnr.1994.1167; SUGIMOTO T, 1993, BRAIN RES, V621, P161, DOI 10.1016/0006-8993(93)90314-D; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; Terayama R, 1997, BRAIN RES, V768, P135, DOI 10.1016/S0006-8993(97)00633-1; Tokunaga A, 1999, BRAIN RES, V847, P321, DOI 10.1016/S0006-8993(99)02074-0; Wang H, 2004, EUR J NEUROSCI, V19, P884, DOI 10.1111/j.1460-9568.2004.03203.x; Yamaguchi D, 2014, INT J NEUROSCI, V124, P213, DOI 10.3109/00207454.2013.842566	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	APR	2015	233	4					1201	1212		10.1007/s00221-015-4203-2		12	Neurosciences	Neurosciences & Neurology	CD5XP	WOS:000351162400019		
J	Kuehn, E; De Havas, J; Silkoset, E; Gomi, H; Haggard, P				Kuehn, Esther; De Havas, Jack; Silkoset, Emilie; Gomi, Hiroaki; Haggard, Patrick			On the bimanual integration of proprioceptive information	EXPERIMENTAL BRAIN RESEARCH			English	Article						Hand bias; Bilateral movement; Position sense; Dancers	POSTCENTRAL SOMATOSENSORY CORTEX; RECEPTIVE-FIELD NEURONS; POSITION SENSE; PRECISION CONTACT; BALLET DANCERS; 2 HANDS; REPRESENTATION; MOVEMENTS; FMRI; SENSORIMOTOR	Proprioception can be defined as the sense for body movement and position. While most sensory information can be successfully integrated across hemispheres, little is known about the bilateral integration of proprioceptive information. In two behavioural experiments, we investigated whether estimates of the position of one hand are influenced by simultaneous proprioceptive information from the other hand. We further investigated whether such putative bimanual proprioceptive integration would differ between expert dancers and non-dancer controls. Either one hand or both hands were passively moved to novel positions, and participants indicated the perceived location of the index finger tip of the designated target hand, by orienting a visible laser beam mounted on a cap. Synchronized bimanual movements compared to unimanual movements significantly improved proprioceptive position sense. In particular, we found a bias reduction to perceive the target hand's index finger tip as shifted away from the midline in the bimanual condition, compared to the unimanual condition. Expert dancers, in contrast, did not show this change in proprioceptive position sense after bimanual movements. We suggest that bimanual movements may improve proprioception due to interhemispheric integration in controls, but not in expert dancers.	[Kuehn, Esther] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Kuehn, Esther; De Havas, Jack; Silkoset, Emilie; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Gomi, Hiroaki] NTT Commun Sci Labs, Atsugi, Kanagawa 24301, Japan	Kuehn, E (reprint author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1a, D-04103 Leipzig, Germany.	ekuehn@cbs.mpg.de			EU FP7 Project VERE WP1; ESRC Professorial Research Fellowship	This research was supported by a researchers' DAAD fellowship. Additional support was provided by EU FP7 Project VERE WP1 and by an ESRC Professorial Research Fellowship to PH.	SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schmitt H, 2005, CLIN J SPORT MED, V15, P331, DOI 10.1097/01.jsm.0000181437.41268.56; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; RYMER WZ, 1980, BRAIN, V103, P1, DOI 10.1093/brain/103.1.1; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Magalhaes FH, 2011, EXP BRAIN RES, V209, P139, DOI 10.1007/s00221-010-2529-3; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Fuentes CT, 2012, EUR J NEUROSCI, V36, P3709, DOI 10.1111/ejn.12004; Wong JD, 2014, J NEUROPHYSIOL, V111, P1362, DOI 10.1152/jn.00537.2013; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; Tame L, 2011, NEUROSCI LETT, V487, P78, DOI 10.1016/j.neulet.2010.09.078; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Blanchard C, 2011, BRAIN RES, V1382, P219, DOI 10.1016/j.brainres.2011.01.066; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Han J, 2013, NEUROSCI LETT, V542, P37, DOI 10.1016/j.neulet.2013.03.020; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Harris JA, 2001, J NEUROSCI, V21, P1056; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Harris JA, 2000, NEUROREPORT, V11, P263, DOI 10.1097/00001756-200002070-00008; HOLM S, 1979, SCAND J STAT, V6, P65; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Balslev D, 2011, HUM BRAIN MAPP, V32, P624, DOI 10.1002/hbm.21050; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457; Tame L, 2012, J COGNITIVE NEUROSCI, V24, P2306, DOI 10.1162/jocn_a_00272; SWINNEN SP, 1993, J EXP PSYCHOL LEARN, V19, P1328, DOI 10.1037/0278-7393.19.6.1328; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.netiroimage.2007.05.038; Avanzino L, 2014, CEREB CORTEX, V24, P2807, DOI 10.1093/cercor/bht139; BAIRSTOW PJ, 1980, J EXP PSYCHOL HUMAN, V6, P1; BARRACK RL, 1984, AM J PHYS MED REHAB, V63, P175; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Cordo PJ, 2000, EXP BRAIN RES, V132, P1, DOI 10.1007/s002219900319; GENTILUCCI M, 1994, EXP BRAIN RES, V102, P359; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HARVEY M, 1994, CORTEX, V30, P343; Holden M, 1994, J Vestib Res, V4, P285; Huynh H., 1976, J EDUC STATIST, V1, P69, DOI [DOI 10.2307/1164736, 10.3102/10769986002002069]; Iwamura Y, 2000, PHILOS T ROY SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Kars H J J Cojanne, 2009, J Diabetes Sci Technol, V3, P931; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Kiefer Adam W, 2013, J Dance Med Sci, V17, P126; Longo MR, 2009, CURR BIOL, V19, pR727, DOI 10.1016/j.cub.2009.07.024; Mayville JM, 2002, HUM BRAIN MAPP, V17, P214, DOI 10.1002/hbm.10065; Perez MA, 2014, J NEUROPHYSIOL, V111, P405, DOI 10.1152/jn.00322.2013; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Ramsay JRE, 2001, CLIN REHABIL, V15, P324, DOI 10.1191/026921501666288152; Ridding MC, 2000, EXP BRAIN RES, V133, P249, DOI 10.1007/s002210000428; Sakurada T, 2009, IEEE ENG MED BIO, P5922, DOI 10.1109/IEMBS.2009.5334855; Sherrington C, 1907, BRAIN, V29, P18; Staniak A, 2003, CEREB CORTEX, V13, P475, DOI 10.1093/cercor/13.5.475; Stringer EA, 2014, HUM BRAIN MAPP, V35, P4841, DOI 10.1002/hbm.22517; Taoka M, 2000, EXP BRAIN RES, V134, P139, DOI 10.1007/s002210000464; Tozakidou M, 2013, NEUROIMAGE-CLIN, V2, P221, DOI 10.1016/j.nicl.2013.01.002; Verschueren SMP, 1999, EXP BRAIN RES, V127, P182, DOI 10.1007/s002210050788; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851	65	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	APR	2015	233	4					1273	1288		10.1007/s00221-015-4205-0		16	Neurosciences	Neurosciences & Neurology	CD5XP	WOS:000351162400025		
J	Suzuki, Y; Suzuki, H; Yasutake, J; Tomino, Y				Suzuki, Yusuke; Suzuki, Hitoshi; Yasutake, Junichi; Tomino, Yasuhiko			Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Review						anti-glycan antibody; biomarker; disease activity assessment; early diagnosis; galactose-deficient IgA1; glycan engineering; IgA immune complex; IgA nephropathy	GALACTOSE-DEFICIENT IGA1; IMMUNOGLOBULIN-A NEPHROPATHY; ABERRANTLY GLYCOSYLATED IGA1; RESONANCE MASS-SPECTROMETRY; O-GLYCOSYLATION; MESANGIAL CELLS; IMMUNE-COMPLEXES; HINGE-REGION; ANTICARBOHYDRATE ANTIBODIES; FUCOSYLATED HAPTOGLOBIN	Introduction: IgA nephropathy (IgAN) is the most common glomerular disease and has a poor prognosis. Appropriate therapeutic strategies are not currently available due to the lack of information regarding IgAN pathogenesis and the absence of appropriate tools to assess disease activity in IgAN, a long-term chronic disease. However, recent evidence revealed that aberrantly glycosylated serum IgA1, mostly galactose-deficient IgA1 (Gd-IgA1) and immune complexes (ICs) with autoantibodies against glycan-containing epitopes on Gd-IgA1 are essential effector molecules. Areas covered: Assessing disease activity by urinalysis/renal biopsy has some limitations, resulting in conflicts regarding the efficacy of possible IgAN-specific therapies. We summarize the characteristics and molecular basis of Gd-IgA1 and related ICs, their clinical application for activity assessment and early diagnosis, and discuss glycan as a potent target of therapeutic agents based on glycan engineering in IgAN. Expert opinion: Recently, Gd-IgA1 and related ICs have shown clinical value for disease activity assessment and IgAN diagnosis. This suggests a paradigm shift in IgAN treatment thus allowing development of appropriate clinical trials of patients with IgAN stages and objective evaluation of the efficacy of future treatments. Early screening and diagnosis may increase therapeutic options, including quantitative regulation of nephritogenic Gd-IgA1 using therapeutic antibodies and selective depletion of Gd-IgA1-producing cells via glycan engineering.	[Suzuki, Yusuke; Suzuki, Hitoshi; Yasutake, Junichi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Div Nephrol, Dept Internal Med, Tokyo, Japan; [Yasutake, Junichi] Kyowa Hakko Kirin Co Ltd, R&D Div, Nephrol R&D Unit, Nephrol Res Labs, Machida, Tokyo 1948533, Japan	Suzuki, Y (reprint author), Juntendo Univ, Fac Med, Div Nephrol, Dept Internal Med, Tokyo, Japan.	yusuke@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgA Nephropathy in Japan; Kyowa Hakko Kirin Co., Ltd.	Y Suzuki and H Suzuki are funded by research funds from Grant-in-Aids for Progressive Renal Disease Research, Research on intractable disease, from the Ministry of Health, Labor and Welfare of Japan, a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program and a grant from the Study Group on IgA Nephropathy in Japan. J Yasutake is an employee of Kyowa Hakko Kirin Co., Ltd. Y Suzuki, H Suzuki and Y Tomino are funded by a research grant from Kyowa Hakko Kirin Co., Ltd. based on the collaboration research between Juntendo University and Kyowa Hakko Kirin Co., Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.	Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Xie YS, 2004, KIDNEY INT, V65, P1135, DOI 10.1111/j.1523-1755.2004.00486.x; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.0590031077.x; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Miyoshi E, 2008, PROTEOMICS, V8, P3257, DOI 10.1002/pmic.200800046; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; Franc V, 2013, J PROTEOMICS, V92, P299, DOI 10.1016/j.jprot.2013.07.013; Li PKT, 2006, AM J KIDNEY DIS, V47, P751, DOI 10.1053/a.ajkd.2006.01.017; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Raska M, 2007, J MOL BIOL, V369, P69, DOI 10.1016/j.jmb.2007.03.002; Maeda I, 2012, NEPHROL DIAL TRANSPL, V27, P2806, DOI 10.1093/ndt/gfs053; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Yoshizumi S, 2007, METABOLISM, V56, P420, DOI 10.1016/j.metabol.2006.10.027; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; CHAUVEAU D, 1993, CONTRIB NEPHROL, V104, P1; Chen Y, 2007, AM J NEPHROL, V27, P170, DOI 10.1159/000100431; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; Coppo R, TONSILLECTOMY TREATM; Glassock RJ, 2011, CURR OPIN NEPHROL HY, V20, P153, DOI 10.1097/MNH.0b013e3283436f5c; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai H, 2011, CLIN EXP NEPHROL, V16, P195; Japanese Society of Nephrology, 2014, CLIN EXP NEPHROL, V18, P346; Kato Y, 2014, SCI REP, V4, P1; LAITINEN L, 1990, ANAT REC, V226, P10, DOI 10.1002/ar.1092260103; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; Novak J, 2011, NEPHROL DIAL TRANSPL, V26, P3451, DOI 10.1093/ndt/gfr448; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Piccoli A, 2010, NEPHROL DIAL TRANSPL, V25, P2583, DOI 10.1093/ndt/gfq107; Rasche FM, 1999, CLIN NEPHROL, V51, P147; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Sakai K, 2007, BIOCHEMISTRY-US, V46, P253, DOI 10.1021/bi061875e; Shen Peicheng, 2007, Nephron Clin Pract, V106, pc157, DOI 10.1159/000104426; Shirato K, 2011, J CLIN BIOCHEM NUTR, V48, P20, DOI 10.3164/jcbn.11-015FR; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P770, DOI 10.1007/s10157-013-0921-6; Suzuki Y, 2014, AM SOC NEPHR ANN M; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Yanagawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098081; Yuasa N, 2010, J BIOL CHEM, V285, P30587, DOI 10.1074/jbc.M110.107284	71	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	APR	2015	15	4					583	593		10.1517/14712598.2015.1006624		11	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CD9VC	WOS:000351445900012		
J	Lipatnikov, AN; Sabelnikov, VA; Nishiki, S; Hasegawa, T; Chakraborty, N				Lipatnikov, A. N.; Sabelnikov, V. A.; Nishiki, S.; Hasegawa, T.; Chakraborty, N.			DNS Assessment of a Simple Model for Evaluating Velocity Conditioned to Unburned Gas in Premixed Turbulent Flames	FLOW TURBULENCE AND COMBUSTION			English	Article						Premixed turbulent combustion; Countergradient transport; Conditioned mean velocity; DNS; Modeling	GRADIENT SCALAR TRANSPORT; LARGE-EDDY SIMULATION; BURNING VELOCITIES; GENERATED TURBULENCE; THERMAL-EXPANSION; HIGH-PRESSURE; COMBUSTION; FLUX; COUNTERGRADIENT; TEMPERATURE	Recently, a simple model for evaluating turbulent scalar flux in premixed flames was developed and validated using six experimental data sets obtained from flames stabilized in impinging jets (Sabelnikov and Lipatnikov, Combust. Sci. Technol. 183, 588-613, 2011; Sabelnikov and Lipatnikov, Flow Turbulence Combust. 90, 387-400, 2013). The model addresses the flamelet regime of premixed turbulent combustion and yields an algebraic expression for the mean velocity conditioned to unburned mixture, while turbulent scalar flux is evaluated substituting this conditioned velocity into the well-known Bray-Moss-Libby (BML) expressions. The present work aims at further assessment of the aforementioned model against two well-known 3D DNS databases obtained from statistically planar, 1D premixed turbulent flames characterized by various density ratios (7.53, 5.0, 3.3, and 2.5). For the highest density ratio, an excellent agreement between the model and DNS data was obtained. This result is particularly encouraging, because the experimental data used earlier to test the model are associated with approximately the same (7-8) density ratios. However, the DNS data obtained for lower density ratios indicate a trend, not addressed by the original model, i.e. a model parameter is not a constant but decreases with decreasing density ratio, with the dependence of the model parameter on the density ratio being roughly linear for three flames addressed by one DNS database. Implementation of this linear fit into the model makes it consistent both with the DNS and with all experimental data used earlier to validate the original model.	[Lipatnikov, A. N.] Chalmers, Dept Appl Mech, S-41296 Gothenburg, Sweden; [Sabelnikov, V. A.] Off Natl Etud & Rech Aerosp, F-91761 Palaiseau, France; [Nishiki, S.] Kagoshima Univ, Dept Mech Engn, Kagoshima 8900065, Japan; [Hasegawa, T.] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [Chakraborty, N.] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Lipatnikov, AN (reprint author), Chalmers, Dept Appl Mech, S-41296 Gothenburg, Sweden.	lipatn@chalmers.se; vladimir.sabelnikov@onera.fr; nishiki@mech.kagoshima-u.ac.jp; t-hasegawa@esi.nagoya-u.ac.jp; nilanjan.chakraborty@newcastle.ac.uk		Chakraborty, Nilanjan/0000-0003-1690-2036	Chalmers e-Science Centre; Combustion Engine Research Center (CERC); Swedish Energy Agency; ONERA, France; EPSRC, UK	AL gratefully acknowledges the financial support provided by the Chalmers e-Science Centre, Combustion Engine Research Center (CERC), and Swedish Energy Agency. VS gratefully acknowledges the financial support provided by ONERA, France. NC gratefully acknowledges the financial support provided by EPSRC, UK.	BRAY KNC, 1977, ACTA ASTRONAUT, V4, P291, DOI 10.1016/0094-5765(77)90053-4; Marshall SP, 2011, COMBUST FLAME, V158, P1920, DOI 10.1016/j.combustflame.2011.02.016; TROUVE A, 1994, J FLUID MECH, V278, P1, DOI 10.1017/S0022112094003599; CHENG RK, 1991, COMBUST FLAME, V85, P7, DOI 10.1016/0010-2180(91)90174-A; Enaux B, 2011, P COMBUST INST, V33, P3115, DOI 10.1016/j.proci.2010.07.038; POPE SB, 1988, INT J ENG SCI, V26, P445, DOI 10.1016/0020-7225(88)90004-3; Sabelnikov VA, 2013, FLOW TURBUL COMBUST, V90, P387, DOI 10.1007/s10494-012-9409-9; Robin V, 2010, COMBUST SCI TECHNOL, V182, P449, DOI 10.1080/00102200903462896; Swaminathan N, 2001, COMBUST FLAME, V126, P1764, DOI 10.1016/S0010-2180(01)00283-8; Sabel'nikov VA, 2011, COMBUST SCI TECHNOL, V183, P588, DOI 10.1080/00102202.2010.528713; Poludnenko AY, 2010, COMBUST FLAME, V157, P995, DOI 10.1016/j.combustflame.2009.11.018; Robin V, 2011, J FLUID MECH, V689, P149, DOI 10.1017/jfm.2011.409; Tullis S, 2002, P COMBUST INST, V29, P2097, DOI 10.1016/S1540-7489(02)80255-3; MOSS JB, 1980, COMBUST SCI TECHNOL, V22, P119, DOI 10.1080/00102208008952377; Mura A, 2008, COMBUST THEOR MODEL, V12, P671, DOI 10.1080/13647830801975154; Lipatnikov AN, 2010, PROG ENERG COMBUST, V36, P1, DOI 10.1016/j.pecs.2009.07.001; Galmiche B, 2012, COMBUST FLAME, V159, P3286, DOI 10.1016/j.combustflame.2012.06.008; METGHALCHI M, 1982, COMBUST FLAME, V48, P191, DOI 10.1016/0010-2180(82)90127-4; CLAVIN P, 1979, J FLUID MECH, V90, P589, DOI 10.1017/S002211207900241X; LIBBY PA, 1981, AIAA J, V19, P205, DOI 10.2514/3.50941; Veynante D, 1997, J FLUID MECH, V332, P263; Muller UC, 1997, COMBUST FLAME, V108, P349, DOI 10.1016/S0010-2180(96)00110-1; Poludnenko AY, 2011, COMBUST FLAME, V158, P301, DOI 10.1016/j.combustflame.2010.09.002; Nishiki S, 2006, COMBUST THEOR MODEL, V10, P39, DOI 10.1080/13647830500307477; Lipatnikov AN, 2013, FLOW TURBUL COMBUST, V90, P401, DOI 10.1007/s10494-012-9425-9; Mura A, 2009, FLOW TURBUL COMBUST, V82, P339, DOI 10.1007/s10494-008-9180-0; Veynante D, 2002, PROG ENERG COMBUST, V28, P193, DOI 10.1016/S0360-1285(01)00017-X; Baumann M, 2014, FLOW TURBUL COMBUST, V92, P299, DOI 10.1007/s10494-013-9472-x; Bell J., 2006, COMMUN APPL MATH COM, V1, P29, DOI 10.2140/camcos.2006.1.29; Bray K, 2011, COMBUST FLAME, V158, P2017, DOI 10.1016/j.combustflame.2011.03.009; BRAY KNC, 1995, P R SOC-MATH PHYS SC, V451, P231, DOI 10.1098/rspa.1995.0124; Chakraborty N, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4795548; Chakraborty N, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2903846; Chakraborty N, 2011, FLOW TURBUL COMBUST, V87, P205, DOI 10.1007/s10494-010-9312-1; Chakraborty N., 2011, J COMBUST, V2011; Chakraborty N., 2013, P COMBUST INST, V34, P133; Chen J.H., 1986, P COMBUST INST, V21, P1483; Cho P., 1988, P COMBUST INST, V22, P739; Gulder OL, 1982, P COMBUST INST, V19, P275; Im YH, 2004, COMBUST FLAME, V137, P478, DOI 10.1016/j.combustflame.2004.03.006; Li S.C., 1994, P COMBUST INST, V25, P1207; LIBBY PA, 1977, AIAA J, V15, P1186, DOI 10.2514/3.60770; Lipatnikov AN, 2015, P COMBUST INST, V35, P1401, DOI 10.1016/j.proci.2014.06.081; Lipatnikov A.N., 2012, FUNDAMENTALS PREMIXE; Lipatnikov AN, 2011, FLOW TURBUL COMBUST, V86, P609, DOI 10.1007/s10494-010-9281-4; Lipatnikov AN, 2008, COMBUST FLAME, V152, P529, DOI 10.1016/j.combustflame.2007.11.004; Lipatnikov A.N., 2013, 6 EUR COMB M LUND SW, P4; Nishiki S, 2002, P COMBUST INST, V29, P2017, DOI 10.1016/S1540-7489(02)80246-2; Nishiki S., 2003, THESIS NAGOYA I TECH; Robin V, 2012, COMBUST SCI TECHNOL, V184, P1718, DOI 10.1080/00102202.2012.690628; Rutland C.J., 1994, P SUMM PROGR CTR TUR, P75; Stevens E.J., 1998, P COMBUST INST, V27, P949; Chakraborty N, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2714070; Chakraborty N, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2714076; Swaminathan N, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2186590; Swaminathan N, 1997, COMBUST SCI TECHNOL, V128, P73, DOI 10.1080/00102209708935705; Yanagi T., 1981, P COMBUST INST, V18, P1031; ZHANG SW, 1995, COMBUST FLAME, V102, P447, DOI 10.1016/0010-2180(95)00036-6	58	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-6184	1573-1987		FLOW TURBUL COMBUST	Flow Turbul. Combust.	APR	2015	94	3					513	526		10.1007/s10494-014-9588-7		14	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CD9DH	WOS:000351397100003		
J	Hossain, MZ; Goto, T				Hossain, Md. Zakir; Goto, Tetsuhisa			A Rapid Determination of Ergosterol in Grains Using Gas Chromatography-Mass Spectrometry Method Without Derivatization	FOOD ANALYTICAL METHODS			English	Article						Ergosterol; Gas chromatography-mass spectrometry (GC-MS); On-column; Mycotoxins; Grains	FUSARIUM-INFECTED WHEAT; OCHRATOXIN-A PRODUCTION; LIQUID-CHROMATOGRAPHY; GROWTH; COUNT	A simple, rapid and sensitive GC-MS method using on-column injection was developed and validated to determine ergosterol (ERG) levels in maize and wheat. In this method, ERG was extracted from grains with methanol and partitioned into hexane. The hexane layer was then directly injected onto the on-column GC-MS injection system without column-clean up or derivatization. Optimization of different GC-MS parameters was evaluated to obtain maximum sensitivity. Matrix-matched calibration curves were constructed to compensate for matrix effects in both matrices. Good recoveries in maize (98-110 %) and wheat (96-110 %) samples were obtained at three spiking levels (1, 3, and 8 mg/kg), with relative standard deviations less than 8 % in maize and 7 % in wheat. The limits of detection and quantification of ERG were less than 40 mu g/kg and 200 mu g/kg of grain sample, respectively. The method was successfully applied to 37 marketed grains, with ERG concentrations ranging from 1.0 to 14.4 mg/kg. Moreover, GC-MS analyses data were compared with an HPLC method, and no significant difference was observed. This new GC-MS method is quick and reliable for routine analysis of ERG to monitor fungal invasion and possible mycotoxin contamination in grains.	[Hossain, Md. Zakir; Goto, Tetsuhisa] Shinshu Univ, Fac Agr, Nagano 3994598, Japan	Goto, T (reprint author), Shinshu Univ, Fac Agr, Nagano 3994598, Japan.	tg_goto@shinshu-u.ac.jp					Nielsen KF, 2000, J CHROMATOGR A, V898, P227, DOI 10.1016/S0021-9673(00)00873-6; ZILL G, 1988, Z LEBENSM UNTERS FOR, V187, P246, DOI 10.1007/BF01043348; Pietri A, 2004, FOOD ADDIT CONTAM A, V21, P479, DOI 10.1080/02652030410001662020; Miyagawa H, 2009, FOOD ADDIT CONTAM A, V26, P201, DOI 10.1080/02652030802399018; SEITZ LM, 1977, CEREAL CHEM, V54, P1207; Varga J, 2002, ACTA BIOL HUNG, V53, P381, DOI 10.1556/ABiol.53.2002.3.14; ERNEY DR, 1993, J CHROMATOGR, V638, P57, DOI 10.1016/0021-9673(93)85007-T; Olsson J, 2002, INT J FOOD MICROBIOL, V72, P203, DOI 10.1016/S0168-1605(01)00685-7; Saxena J, 2001, INT J FOOD MICROBIOL, V71, P29, DOI 10.1016/S0168-1605(01)00584-0; Lamper C, 2000, CEREAL RES COMMUN, V28, P337; GOURAMA H, 1995, FOOD SCI TECHNOL-LEB, V28, P185; NAEWBANIJ M, 1984, CEREAL CHEM, V61, P385; Neuhof T, 2008, J AGR FOOD CHEM, V56, P7566, DOI 10.1021/jf800971q; Kadakal C, 2005, FOOD CHEM, V90, P95, DOI 10.1016/j.foodchem.2004.03.030; AXELSSON BO, 1995, J CHROMATOGR B, V666, P77, DOI 10.1016/0378-4347(94)00553-H; Castro MFPM, 2002, BRAZ J MICROBIOL, V33, P22, DOI DOI 10.1590/S1517-83822002000100004; Charmley Lynne L., 1995, Natural Toxins, V3, P199, DOI 10.1002/nt.2620030406; Dong YH, 2006, J AGR FOOD CHEM, V54, P4121, DOI 10.1021/jf060149f; Jeldickova L, 2008, J AGR FOOD CHEM, V56, P4092; Mayer S, 2008, Mycotoxin Res, V24, P151, DOI 10.1007/BF03032342; Ravelet C, 2001, J CHROMATOGR SCI, V39, P239; Sandra P, 1989, HIGH RESOLUT GAS CHR, P1; Sasaki A., 2011, Mycotoxins, V61, P1, DOI 10.2520/myco.61.1; Varga M, 2006, J CHROMATOGR A, V1103, P278, DOI 10.1016/j.chroma.2005.11.051; Volker EJ, 2000, J CHEM EDUC, V77, P1621; Weete J. D., 1980, LIPID BIOCH FUNGI OT	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-9751	1936-976X		FOOD ANAL METHOD	Food Anal. Meth.	APR	2015	8	4					1021	1026		10.1007/s12161-014-9983-7		6	Food Science & Technology	Food Science & Technology	CD7RR	WOS:000351289400024		
J	Miura, A; Urabe, J				Miura, Aya; Urabe, Jotaro			Spatial and seasonal changes in species diversity of epilithic fungi along environmental gradients of a river	FRESHWATER BIOLOGY			English	Article						aquatic fungal diversity; dissolved organic matter; drainage basin; river environmental gradients; water temperature	LEAF-LITTER DECOMPOSITION; 16S RIBOSOMAL-RNA; SUBSTRATE PREFERENCES; GEL-ELECTROPHORESIS; NESTEDNESS ANALYSIS; STREAMS; COMMUNITIES; TEMPERATURE; BIODIVERSITY; BACTERIAL	Fungi in stream ecosystems play a critical role in decomposing organic matter. However, despite their ecological importance, few studies have investigated spatial and seasonal variation in lotic fungi. We hypothesised that the taxonomic composition and richness of epilithic fungal assemblages would change along the longitudinal river gradient from headwaters to lower reaches. To test this hypothesis, we examined composition and richness in the Natori River, Japan, using PCR-DGGE (polymerase chain reaction-denaturing gradient gel electrophoresis). We focused on five phyla of fungi or fungus-like organisms (Ascomycota, Basidiomycota, Chytridiomycota, Zygomycota and Oomycota) that colonised cobbles to examine effects of dissolved organic matter and nutrients on fungal assemblages. We found that taxonomic richness on cobbles was as high as that on leaf litter and woody debris, suggesting that fungi can grow directly using dissolved organic matter and nutrients in the water, or indirectly via epilithic biofilms. Supporting the hypothesis, taxonomic richness increased longitudinally along the river in autumn, although the within-site variation in composition on different cobbles was higher in the upper reaches. No spatial differences were detected in spring when spatial heterogeneity in water temperature was low. With the exception of Basidiomycota, nestedness in taxonomic composition was not detected in either spring or autumn, indicating that fungal taxa in the upper reaches are generally replaced by others downstream. These results suggest that taxonomic composition and richness of epilithic fungal assemblages change along the longitudinal gradient of the river, depending on water temperature and spatial differences in abundance and composition of dissolved organic matter and nutrients.	[Miura, Aya; Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Miura, A (reprint author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	ayayaya.miu@gmail.com			MEXT Japan; Global COE Program 'Center for ecosystem management adapting to global change' from MEXT Japan [J03];  [12J07309]	We are grateful to Tomoya Iwata, Satoshi Chiba, Takao Suzuki, Wataru Makino and two anonymous reviewers for critical comments. We also thank Manabu Fukui, Hisaya Kojima and Masazumi Tsutsumi for DGGE analyses, and Seiji Ishida, Hajime Otsuki, Yasuo Mukai, Takehiro Kaszama, Hitoshi Kumagai, Mika So, Takuma Sato and Ie Ji for statistical analyses and samplings. This research was supported by a Grant-in-Aid for JPSP Fellows (12J07309) to AM, a Grant-in-Aid for Challenging Exploratory Research from MEXT Japan to JU and the Global COE Program 'Center for ecosystem management adapting to global change' (J03) from MEXT Japan to AM and JU.	Allan J.D., 2007, STREAM ECOLOGY STRUC; Richardson JS, 2005, J AM WATER RESOUR AS, V41, P921, DOI 10.1111/j.1752-1688.2005.tb04470.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Sole M, 2008, SCI TOTAL ENVIRON, V389, P557, DOI 10.1016/j.scitotenv.2007.09.010; Danger M, 2013, ECOLOGY, V94, P1604, DOI 10.1890/12-0606.1; Rice SP, 2001, CAN J FISH AQUAT SCI, V58, P824, DOI 10.1139/cjfas-58-4-824; Crites S, 1998, CAN J BOT, V76, P641; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Castella E, 2001, FRESHWATER BIOL, V46, P1811, DOI 10.1046/j.1365-2427.2001.00860.x; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Romani AM, 2004, MICROBIAL ECOL, V47, P316, DOI 10.1007/s00248-003-2019-2; Beier S, 2008, APPL ENVIRON MICROB, V74, P188, DOI 10.1128/AEM.00327-07; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; Jones AC, 2013, ENVIRON MICROBIOL, V15, P2557, DOI 10.1111/1462-2920.12151; Wong MKM, 1998, BIODIVERS CONSERV, V7, P1187, DOI 10.1023/A:1008883716975; Artigas J, 2008, AQUAT BOT, V88, P32, DOI 10.1016/j.aquabot.2007.08.005; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; HOLM S, 1979, SCAND J STAT, V6, P65; DEATH RG, 1995, ECOLOGY, V76, P1446, DOI 10.2307/1938147; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Kane DF, 2002, FUNGAL DIVERS, V10, P45; Campbell J, 2009, MYCOL RES, V113, P1322, DOI 10.1016/j.mycres.2009.09.003; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Gulis V, 2001, MYCOL RES, V105, P1088, DOI 10.1016/S0953-7562(08)61971-1; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; [Anonymous], 1998, STANDARD METHODS EXA; Townsend CR, 1997, LIMNOL OCEANOGR, V42, P938; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Dang CK, 2009, ECOLOGY, V90, P122, DOI 10.1890/07-1974.1; Jabiol J, 2013, FUNGAL ECOL, V6, P439, DOI 10.1016/j.funeco.2013.04.002; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Chauvet E, 1998, APPL ENVIRON MICROB, V64, P1522; SUBERKROPP K, 1984, T BRIT MYCOL SOC, V82, P53; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Barlocher F, 2002, FRESHWATER BIOL, V47, P1123, DOI 10.1046/j.1365-2427.2002.00836.x; Laitung B, 2005, ARCH HYDROBIOL, V164, P217, DOI 10.1127/0003-9136/2005/0164-0217; Dix NJ, 1995, FUNGAL ECOLOGY; Goh TK, 1996, J IND MICROBIOL BIOT, V17, P328, DOI 10.1007/BF01574764; Hauer F. R., 2011, METHODS STREAM ECOLO; HOLLIGAN PM, 1972, NEW PHYTOL, V71, P569, DOI 10.1111/j.1469-8137.1972.tb01267.x; Jones EBG, 2008, BR MYCOL SY, V28, P301; Jonsson BG, 2001, OECOLOGIA, V127, P309, DOI 10.1007/s004420000601; Lahav R, 2002, MICROBIAL ECOL, V43, P388, DOI 10.1007/s00248-002-2001-4; Leopold LB, 1994, VIEW RIVER; McLaughlin DJ, 2001, MYCOTA COMPREHENSI A; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Nikolcheva Liliya G., 2004, Mycological Progress, V3, P41, DOI 10.1007/s11557-006-0075-y; R Development Core Team, 2010, R LANG ENV STAT COMP; Rubin MA, 2007, MICROB ECOL, V54, P374, DOI 10.1007/s00248-007-9209-2; Strickland J.D., 1984, PRACTICAL HDB SEAWAT, Vsecond; Ward JV, 1983, DYNAMICS LOTIC ECOSY, P29, DOI DOI 10.1007/S10661-006-9218-5; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0046-5070	1365-2427		FRESHWATER BIOL	Freshw. Biol.	APR	2015	60	4					673	685		10.1111/fwb.12514		13	Marine & Freshwater Biology	Marine & Freshwater Biology	CD6QB	WOS:000351213000006		
J	Ishiyama, N; Koizumi, I; Yuta, T; Nakamura, F				Ishiyama, Nobuo; Koizumi, Itsuro; Yuta, Teru; Nakamura, Futoshi			Differential effects of spatial network structure and scale on population size and genetic diversity of the ninespine stickleback in a remnant wetland system	FRESHWATER BIOLOGY			English	Article						graph theory; landscape connectivity; landscape genetics; population conservation; wetland network	LANDSCAPE CONNECTIVITY; HABITAT FRAGMENTATION; 9-SPINED STICKLEBACK; BIODIVERSITY CONSERVATION; AGRICULTURAL LANDSCAPE; 3-SPINED STICKLEBACK; PUNGITIUS-PUNGITIUS; MICROSATELLITE LOCI; PATCH CONNECTIVITY; SPECIES RICHNESS	The management of population size and genetic diversity in fragmented landscapes is the central issue in conservation biology. Functional connectivity between remnant habitat patches affects these parameters. However, the functional connectivity for genetic diversity would be characterised by a greater spatial scale than population size even within the same habitat network. The reason for this difference is that while dispersal frequency generally decreases with increasing distance, only a few immigrants may effectively contribute to gene flow, whereas a certain number of dispersers may be required to influence population abundance. Here, we investigated the effects of habitat network structures on population abundance and genetic diversity of the ninespine stickleback, Pungitius pungitius, in remnant wetland ponds in northern Japan. We tested (i) whether both population abundance and genetic diversity are positively related not only to habitat size but also to connectivity and (ii) whether the dispersal effect extends to greater spatial scales in genetic diversity than in population size. We employed a graph theoretical index to measure the degree of pond connectivity. This index can evaluate the connectivity threshold distance above which individuals cannot disperse and clarify the difference in the spatial scale of effective dispersal between population abundance and genetic diversity. Pond connectivity significantly affected the spatial variation of both population abundance and genetic diversity. In contrast, pond size was related only to population abundance. As we predicted, the connectivity threshold distance for genetic diversity was more than two times greater than that for population abundance (12.5km versus 5km, respectively). Our findings indicate that the landscape managers should consider various spatial scales as a conservation unit for the management of a habitat network in accordance with the conservation targets that they establish. We also found that small artificial agricultural ditches and streams may play important roles in sustaining the population networks of wetland organisms.	[Ishiyama, Nobuo; Nakamura, Futoshi] Hokkaido Univ, Grad Sch Agr, Dept Forest Sci, Sapporo, Hokkaido 0608589, Japan; [Koizumi, Itsuro; Yuta, Teru] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0608589, Japan	Ishiyama, N (reprint author), Hokkaido Univ, Grad Sch Agr, Dept Forest Sci, N9 W9, Sapporo, Hokkaido 0608589, Japan.	night7mare@gmail.com	Nakamura, Futoshi/A-6696-2012		Ministry of Education, Science, and Culture, Japan [23248021]; Environment Research and Technology Development Fund from the Ministry of the Environment of Japan [S9, 4D-1201]; Ministry of Land, Infrastructure, Transport, and Tourism of Japan	We are grateful to Yuichi Yamaura, Takumi Akasaka and Masanao Sueyoshi for their conceptual and technical help. We also thank the members of the Forest Ecosystem Management Laboratory of Hokkaido University for their help in conducting the fieldwork and for productive comments regarding the study. We thank the Ikeda, Toyokoro and Urahoro town offices for their assistance in selecting the study sites. We gratefully acknowledge the comments of two anonymous reviewers. This study was supported by a Grant in Aid for Scientific Research (No. 23248021) from the Ministry of Education, Science, and Culture, Japan; a Grant of the Environment Research and Technology Development Fund (S9 and 4D-1201) from the Ministry of the Environment of Japan; and the research fund for the Tokachi River provided by the Ministry of Land, Infrastructure, Transport, and Tourism of Japan.	AAVIK T, 2013, HEREDITY O, V0112; Ahn YS, 2009, EARTH SURF PROC LAND, V34, P1650, DOI 10.1002/esp.1854; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Ishiyama N, 2014, AQUAT SCI, V76, P437, DOI 10.1007/s00027-014-0345-8; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Seymour M, 2013, ECOL EVOL, V3, P492, DOI 10.1002/ece3.476; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Sanderson EW, 2006, BIOSCIENCE, V56, P911, DOI 10.1641/0006-3568(2006)56[911:HMADWW]2.0.CO;2; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/cjfas-58-1-157; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; de Vere N, 2009, OECOLOGIA, V159, P59, DOI 10.1007/s00442-008-1203-y; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Jacobson B, 2010, LANDSCAPE ECOL, V25, P495, DOI 10.1007/s10980-009-9442-9; Kirchner F, 2006, J APPL ECOL, V43, P1011, DOI 10.1111/j.1365-2664.2006.01179.x; Association of Wildlife Research and EnVision, 2007, SEARCH SYST JAP RED; Barton K, 2012, MUMIN MULTIMODEL INF; BRISCOE D. A., 2002, INTRO CONSERVATION G; Bronmark C, 2005, BIOL LAKES PONDS; Burnham K. P., 2002, MODEL SELECTION MULT; Galat DL, 1998, BIOSCIENCE, V48, P721, DOI 10.2307/1313335; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Hanski I., 1999, METAPOPULATION ECOLO; Harvey CJ, 1997, J FISH BIOL, V50, P1133, DOI 10.1006/jfbi.1996.0384; HINCH SG, 1991, ECOLOGY, V72, P1314, DOI 10.2307/1941104; Jackson ND, 2014, ECOLOGY, V95, P871, DOI 10.1890/13-0388.1; Kawanabe Y., 1998, FRESHWATER FISHES JA; Koizumi I, 2011, ECOL FRESHW FISH, V20, P352, DOI 10.1111/j.1600-0633.2010.00480.x; Langevelde F., 2000, ECOGRAPHY, V23, P614; Largiader CR, 1999, MOL ECOL, V8, P342; Lindenmayer David. B., 2006, HABITAT FRAGMENTATIO; Makinen HS, 2007, ANN ZOOL FENN, V44, P218; Meguro Y, 2009, CONSERV GENET RESOUR, V1, P31, DOI 10.1007/s12686-009-9007-x; Merila J, 2013, ANN NY ACAD SCI, V1289, P18, DOI 10.1111/nyas.12089; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; Millet A, 2013, ECOL EVOL, V3, P3219, DOI 10.1002/ece3.712; Neel MC, 2008, BIOL CONSERV, V141, P938, DOI 10.1016/j.biocon.2007.12.031; R Development Core Team, 2008, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248; SAYER MDJ, 1993, REV FISH BIOL FISHER, V3, P95, DOI 10.1007/BF00045228; Uchida Y, 2010, FRESHWATER BIOL, V55, P983, DOI 10.1111/j.1365-2427.2009.02335.x; Virgos E, 2001, J BIOGEOGR, V28, P381, DOI 10.1046/j.1365-2699.2001.00552.x; Winemiller KO, 2000, T AM FISH SOC, V129, P451, DOI 10.1577/1548-8659(2000)129<0451:FASIRT>2.0.CO;2; Wootton R. J., 1976, BIOL STICKLEBACKS	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0046-5070	1365-2427		FRESHWATER BIOL	Freshw. Biol.	APR	2015	60	4					733	744		10.1111/fwb.12525		12	Marine & Freshwater Biology	Marine & Freshwater Biology	CD6QB	WOS:000351213000011		
J	Kodera, Y				Kodera, Yasuhiro			More than 6 months of postoperative adjuvant chemotherapy results in loss of skeletal muscle: a challenge to the current standard of care	GASTRIC CANCER			English	Editorial Material							BREAST-CANCER PATIENTS; GASTRIC-CANCER; S-1		Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Showa Ku, Nagoya, Aichi 4648601, Japan	Kodera, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4648601, Japan.	ykodera@med.nagoya-u.ac.jp					Aoyama T, 2013, ANN SURG ONCOL, V20, P2000, DOI 10.1245/s10434-012-2776-6; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Abdiev S, 2011, GASTRIC CANCER, V14, P144, DOI 10.1007/s10120-011-0021-9; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Gadea E, 2012, OBES REV, V13, P368, DOI 10.1111/j.1467-789X.2011.00957.x; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Yamaoka Y, 2014, GASTRIC CANC	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					203	204		10.1007/s10120-014-0381-z		2	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900001		
J	Fujimura, T; Fushida, S; Tsukada, T; Kinoshita, J; Oyama, K; Miyashita, T; Takamura, H; Kinami, S; Ohta, T				Fujimura, Takashi; Fushida, Sachio; Tsukada, Tomoya; Kinoshita, Jun; Oyama, Katsunobu; Miyashita, Tomoharu; Takamura, Hiroyuki; Kinami, Shinichi; Ohta, Tetsuo			A new stage of sentinel node navigation surgery in early gastric cancer	GASTRIC CANCER			English	Review						Sentinel node navigation surgery; Lymphatic basin; Selective lymphadenectomy; Function-preserving gastrectomy	PYLORUS-PRESERVING GASTRECTOMY; CONVENTIONAL DISTAL GASTRECTOMY; INDOCYANINE GREEN INJECTION; GASTROINTESTINAL CANCERS; POSTOPERATIVE EVALUATION; MULTICENTER TRIAL; LYMPH-NODES; MICROMETASTASES; BIOPSY; DISSECTION	Sentinel node (SN) navigation surgery is expected to realize organ- and function-preserving surgery with SN mapping, and has been applied in operations for breast cancer and melanoma. But there has been no definite evidence for the SN concept in gastric cancer. A prospective multicenter trial to confirm the SN concept for gastric cancer conducted by the Japan Society of Sentinel Node Navigation Surgery reported that the SN detection rate, sensitivity of positive SNs, and accuracy of nodal status are 97.5 % (387/397), 93 % (53/57), and 99 % (383/387), respectively. A detailed analysis of the trial suggested that strictly the "lymphatic basin concept" rather than the "SN concept" was confirmed in early gastric cancer. The Japan Society of Sentinel Node Navigation Surgery started a new trial of function-preserving gastrectomy with lymphatic basin dissection (LBD) for early gastric cancer without metastasis in SNs on the basis of this promising outcome of the trial. It is supposed that LBD guarantees curability in SN navigation surgery for early gastric cancer. Full-thickness resection or endoscopic submucosal dissection in combination with laparoscopic LBD will soon be a new treatment option for early gastric cancer.	[Fujimura, Takashi; Fushida, Sachio; Tsukada, Tomoya; Kinoshita, Jun; Oyama, Katsunobu; Miyashita, Tomoharu; Takamura, Hiroyuki; Ohta, Tetsuo] Kanazawa Univ, Gastroenterol Surg, Kanazawa, Ishikawa 9208641, Japan; [Kinami, Shinichi] Kanazawa Med Univ, Gen & Digest Surg, Uchinada, Ishikawa 92002, Japan	Fujimura, T (reprint author), Kanazawa Univ, Gastroenterol Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	tphuji@staff.kanazawa-u.ac.jp					Aikou T, 2001, Ann Surg Oncol, V8, p90S; Ajisaka H, 2003, BRIT J CANCER, V89, P676, DOI 10.1038/sj.bjc.6601183; Fujimura T, 2010, SURG TODAY, V40, P398, DOI 10.1007/s00595-009-4151-1; Miyashiro I, 2014, GASTRIC CANCER, V17, P316, DOI 10.1007/s10120-013-0285-3; Uenosono Y, 2005, BRIT J SURG, V92, P886, DOI 10.1002/bjs.4953; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Yoshida M, 2012, J GASTROEN HEPATOL, V27, P29, DOI 10.1111/j.1440-1746.2012.07067.x; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Kelder W, 2010, EJSO-EUR J SURG ONC, V36, P552, DOI 10.1016/j.ejso.2010.04.007; Wang Z, 2012, ANN SURG ONCOL, V19, P1541, DOI 10.1245/s10434-011-2124-2; Kusano M, 2008, DIGEST SURG, V25, P103, DOI 10.1159/000121905; Soltesz EG, 2006, ANN SURG ONCOL, V13, P386, DOI 10.1245/ASO.2006.04.025; Arigami T, 2006, ANN SURG, V243, P341, DOI 10.1097/01.sla.0000201453.65534.f1; Takeuchi H, 2011, WORLD J SURG, V35, P2463, DOI 10.1007/s00268-011-1223-3; Ohdaira H, 2009, SURG TODAY, V39, P1026, DOI 10.1007/s00595-009-3993-x; Yanagita S, 2008, SURG ONCOL, V17, P203, DOI 10.1016/j.suronc.2008.04.008; Ichikura T, 2009, ANN SURG, V249, P942, DOI 10.1097/SLA.0b013e3181a77e7e; Ryu KW, 2011, J SURG ONCOL, V104, P578, DOI 10.1002/jso.21995; Park DJ, 2008, WORLD J SURG, V32, P1029, DOI 10.1007/s00268-007-9441-4; Nimura H, 2004, BRIT J SURG, V91, P575, DOI 10.1002/bjs.4470; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; EAGON JC, 1992, SURG CLIN N AM, V72, P445; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Cooperman A M, 1981, Surg Annu, V13, P139; Cox CE, 2001, J AM COLL SURGEONS, V193, P593, DOI 10.1016/S1072-7515(01)01086-9; Fujimura T, 2012, Rozhl Chir, V91, P346; Goto O, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0358-y, DOI 10.1007/S10120-014-0358-Y]; Imada T, 1998, SURGERY, V123, P165, DOI 10.1016/S0039-6060(98)70254-5; Ishii K, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-7; Isozaki H, 1996, BRIT J SURG, V83, P266, DOI 10.1046/j.1365-2168.1996.02093.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kinami S, 2008, INT J CLIN ONCOL, V13, P320, DOI 10.1007/s10147-007-0755-x; Kitagawa Y, 2006, SCAND J SURG, V95, P256; Kitagawa Y, 2004, ANN SURG ONCOL, V11, p242S, DOI 10.1245/ASO.2004.12.914; Kitagawa Yuko, 2005, Gastric Cancer, V8, P103, DOI 10.1007/s10120-005-0326-7; Koyama T, 2007, BRIT J SURG, V94, P996, DOI 10.1002/bjs.5650; Kumagai K, 2014, GASTRIC CANCER, V17, P273, DOI 10.1007/s10120-013-0271-9; Lee J, 2005, CHEM WORLD-UK, V2, P31; Lee JH, 2010, DIGEST SURG, V26, P465; Miwa K, 2003, BRIT J SURG, V90, P178, DOI 10.1002/bjs.4031; Miyake Kunitomo, 2006, Gastric Cancer, V9, P197, DOI 10.1007/s10120-006-0378-3; Nakane Y, 2000, HEPATO-GASTROENTEROL, V47, P590; Ojima T, 2013, ONCOL REP, V30, P1067, DOI 10.3892/or.2013.2591; Ryu Keun Won, 2012, J Gastric Cancer, V12, P1, DOI 10.5230/jgc.2012.12.1.1; Shimizu Y, 2012, ANN SURG ONCOL, V19, P469, DOI 10.1245/s10434-011-2122-4; Takeuchi H, 2010, DIGESTION, V82, P187, DOI 10.1159/000309464; Yaguchi Y, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-79; Yaguchi Y, 2011, ANN SURG ONCOL, V18, P2289, DOI 10.1245/s10434-011-1591-9	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					210	217		10.1007/s10120-014-0446-z		8	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900003		
J	Kunisaki, C; Makino, H; Takagawa, R; Kimura, J; Ota, M; Ichikawa, Y; Kosaka, T; Akiyama, H; Endo, I				Kunisaki, Chikara; Makino, Hirochika; Takagawa, Ryo; Kimura, Jun; Ota, Mitsuyoshi; Ichikawa, Yasushi; Kosaka, Takashi; Akiyama, Hirotoshi; Endo, Itaru			A systematic review of laparoscopic total gastrectomy for gastric cancer	GASTRIC CANCER			English	Review						Laparoscopic total gastrectomy; Gastric cancer; Systematic review	ASSISTED TOTAL GASTRECTOMY; LONG-TERM OUTCOMES; OPEN DISTAL GASTRECTOMY; STRING SUTURE TECHNIQUE; LYMPH-NODE DISSECTION; INTRACORPOREAL ESOPHAGOJEJUNOSTOMY; SURGICAL OUTCOMES; RETROSPECTIVE COHORT; LINEAR STAPLERS; MATCHED-COHORT	Laparoscopic total gastrectomy (LTG) has been performed since 1999. Although surgical outcomes have been reported from Japan, Korea, China, and many Western countries, the effectiveness of this technique has not been conclusively established. This study therefore aimed to review the literature systematically. Our search of the research literature identified 150 studies, which were mostly retrospective and from single institutions. There has recently been a remarkable increase in the number of studies from Korea, and the number of patients included in studies has increased since 2009. In most studies, the surgical procedures were longer, blood loss was reduced, and the number of retrieved lymph nodes was the same in the LTG group as in the open total gastrectomy group. The incidence of postoperative complications and that of inflammation during postoperative recovery were the same in these two groups. During LTG, the method used for esophagojejunostomy is important for surgical reliability and to reduce postoperative complications. There has been rapid development of new techniques from the level of esophagojejunostomy through a small skin incision to the high level of intracorporeal esophagojejunostomy using various techniques. A nationwide prospective phase II study is urgently needed to establish the value of LTG.	[Kunisaki, Chikara; Makino, Hirochika; Takagawa, Ryo; Kimura, Jun; Ota, Mitsuyoshi] Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Ichikawa, Yasushi] Yokohama City Univ, Grad Sch Med, Dept Clin Oncol, Yokohama, Kanagawa 2320024, Japan; [Kosaka, Takashi; Akiyama, Hirotoshi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 2320024, Japan	Kunisaki, C (reprint author), Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	s0714@med.yokohama-cu.ac.jp					Ahn SH, 2013, GASTRIC CANCER, V16, P282, DOI 10.1007/s10120-012-0178-x; Usui S, 2005, SURG LAPARO ENDO PER, V15, P309, DOI 10.1097/01.sle.0000191589.84485.4a; Kunisaki C, 2012, SURG ENDOSC, V26, P804, DOI 10.1007/s00464-011-1956-y; Shinohara T, 2013, SURG ENDOSC, V27, P286, DOI 10.1007/s00464-012-2442-x; Wada N, 2014, GASTRIC CANCER, V17, P137, DOI 10.1007/s10120-013-0235-0; Zuiki T, 2013, SURG ENDOSC, V27, P3683, DOI 10.1007/s00464-013-2945-0; Nunobe S, 2011, J GASTROINTEST SURG, V15, P1520, DOI 10.1007/s11605-011-1489-7; Lee MS, 2013, SURG ENDOSC, V27, P2598, DOI 10.1007/s00464-013-2796-8; Eom BW, 2012, SURG ENDOSC, V26, P3273, DOI 10.1007/s00464-012-2338-9; Okabe H, 2014, ANN SURG, V259, P109, DOI 10.1097/SLA.0b013e31828dfa5d; Shen HL, 2013, J LAPAROENDOSC ADV S, V23, P832, DOI 10.1089/lap.2013.0152; Hyun MH, 2013, ANN SURG ONCOL, V20, P1258, DOI 10.1245/s10434-012-2679-6; Kim HH, 2013, J KOREAN SURG SOC, V84, P123, DOI 10.4174/jkss.2013.84.2.123; Park DJ, 2012, SURG ENDOSC, V26, P1548, DOI 10.1007/s00464-011-2065-7; Sakuramoto S, 2009, SURG ENDOSC, V23, P2416, DOI 10.1007/s00464-009-0371-0; Gordon AC, 2013, SURG ENDOSC, V27, P462, DOI 10.1007/s00464-012-2459-1; Kunisaki C, 2011, SURG ENDOSC, V25, P1300, DOI 10.1007/s00464-010-1367-5; Bo T, 2013, J GASTROINTEST SURG, V17, P1202, DOI 10.1007/s11605-013-2218-1; Jeong O, 2013, J AM COLL SURGEONS, V216, P184, DOI 10.1016/j.jamcollsurg.2012.10.014; Kim HS, 2013, J LAPAROENDOSC ADV S, V23, P323, DOI 10.1089/lap.2012.0389; Zhao YL, 2011, SURG ENDOSC, V25, P2960, DOI 10.1007/s00464-011-1652-y; Kim DG, 2013, SURG ENDOSC, V27, P3153, DOI 10.1007/s00464-013-2869-8; Kim SG, 2008, J LAPAROENDOSC ADV S, V18, P572, DOI 10.1089/lap.2007.0106; Sakuramoto S, 2013, SURG ENDOSC, V27, P1695, DOI 10.1007/s00464-012-2658-9; Shim JH, 2013, AM J SURG, V206, P346, DOI 10.1016/j.amjsurg.2012.11.011; Wang WZ, 2013, J CANCER RES CLIN, V139, P1721, DOI 10.1007/s00432-013-1462-9; Zhao XF, 2013, SURG ENDOSC, V27, P2792, DOI 10.1007/s00464-013-2809-7; Kim YW, 2013, SURG ENDOSC, V27, P4267, DOI 10.1007/s00464-013-3037-x; Shinohara T, 2009, ARCH SURG-CHICAGO, V144, P1138, DOI 10.1001/archsurg.2009.223; Kawamura H, 2009, WORLD J SURG, V33, P2389, DOI 10.1007/s00268-009-0208-y; Lee JH, 2012, WORLD J SURG, V36, P2394, DOI 10.1007/s00268-012-1669-y; Lee JH, 2014, SURGERY, V155, P154, DOI 10.1016/j.surg.2013.06.015; Son T, 2014, SURG ENDOSC, V28, P2606, DOI 10.1007/s00464-014-3511-0; Okabe H, 2007, GASTRIC CANCER, V10, P176, DOI 10.1007/s10120-007-0432-9; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Nagai E, 2013, SURGERY, V153, P732, DOI 10.1016/j.surg.2012.10.012; Lee SR, 2014, SURG LAPARO ENDO PER, V24, P277, DOI 10.1097/SLE.0b013e3182901290; Bracale U, 2010, SURG ENDOSC, V24, P2475, DOI 10.1007/s00464-010-0988-z; Huang JL, 2010, DIGEST SURG, V27, P291, DOI 10.1159/000281818; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Takiguchi S, 2013, WORLD J SURG, V37, P2379, DOI 10.1007/s00268-013-2121-7; Du JJ, 2014, J AM COLL SURGEONS, V218, pE67, DOI 10.1016/j.jamcollsurg.2013.11.023; Ebihara Y, 2013, LANGENBECK ARCH SURG, V398, P475, DOI 10.1007/s00423-013-1051-z; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukunaga T, 2013, ANN SURG ONCOL, V20, P2676, DOI 10.1245/s10434-013-2930-9; Goh PMY, 1997, SURG ENDOSC-ULTRAS, V11, P650, DOI 10.1007/s004649900413; Guan GX, 2013, SURG ENDOSC, V27, P1923, DOI 10.1007/s00464-012-2688-3; Hong L, 2013, INT J SURG, V11, P957, DOI 10.1016/j.ijsu.2013.06.010; Inaba K, 2010, J AM COLL SURGEONS, V211, pE25, DOI 10.1016/j.jamcollsurg.2010.09.005; Ito H, 2014, SURG ENDOSC, V28, P1929, DOI 10.1007/s00464-014-3417-x; Kawamura H, 2013, GASTRIC CANCER, V16, P602, DOI 10.1007/s10120-012-0212-z; Kim HI, 2013, J AM COLL SURGEONS, V216, pE11, DOI 10.1016/j.jamcollsurg.2012.10.008; Kim HS, 2012, J LAPAROENDOSC ADV S, V22, P889, DOI 10.1089/lap.2012.0238; Kim HS, 2013, SURG LAPARO ENDO PER, V23, pE209, DOI 10.1097/SLE.0b013e31828e3b79; Kim KH, 2013, DIGEST SURG, V30, P348, DOI 10.1159/000354653; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kunisaki C, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0441-4, DOI 10.1007/S10120-014-0441-4]; Lin JX, 2014, CHINESE MED J-PEKING, V127, P403, DOI 10.3760/cma.j.issn.0366-6999.20130949; Matsui H, 2002, AM J SURG, V184, P58, DOI 10.1016/S0002-9610(02)00893-0; Misawa K, 2015, GASTRIC CANCER, V18, P417, DOI 10.1007/s10120-014-0374-y; Nakata K, 2014, SURG ENDOSC, DOI [10.1007/s00464-014-3870-6, DOI 10.1007/S00464-014-3870-6]; Tsunoda S, 2014, WORLD J SURG, V38, P2662, DOI 10.1007/s00268-014-2611-2; Usui S, 2007, SURG LAPARO ENDO PER, V17, P107, DOI 10.1097/SLE.0b013e318030acd6; Uyama I, 1999, GASTRIC CANCER, V2, P230, DOI DOI 10.1007/S101209900041; Uyama I, 2001, Gastric Cancer, V4, P98, DOI 10.1007/PL00011731; Wang W, 2014, PLOS ONE, V18; Yamamoto M, 2014, HEPATO-GASTROENTEROL, V61, P543, DOI 10.5754/hge13918	67	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					218	226		10.1007/s10120-015-0474-3		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900004		
J	Nagatsuma, AK; Aizawa, M; Kuwata, T; Doi, T; Ohtsu, A; Fujii, H; Ochiai, A				Nagatsuma, Akiko Kawano; Aizawa, Masaki; Kuwata, Takeshi; Doi, Toshihiko; Ohtsu, Atsushi; Fujii, Hirofumi; Ochiai, Atsushi			Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma	GASTRIC CANCER			English	Article						Receptor protein-tyrosine kinases; Immunohistochemistry; Gene amplification; Prognosis; Molecular targeted therapy	GROWTH-FACTOR RECEPTOR; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; LABEL PHASE-3 TRIAL; GENE COPY NUMBER; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; CLINICOPATHOLOGICAL FEATURES; TRASTUZUMAB RESISTANCE; MEDIATES RESISTANCE; K-SAM	Some tyrosine kinase receptors (RTKs) play critical roles in gastric cancer progression. Not only trastuzumab, but also several other agents targeting RTKs are being investigated for gastric cancer therapy. However, the simultaneous expression of multiple RTKs, which may interfere with the effectiveness of therapeutic agents, has not been evaluated in a large cohort with gastric adenocarcinoma (GAC). We performed a tissue microarray analysis in 950 patients with GAC who underwent a gastrectomy without preoperative chemotherapy. The protein expressions of HER2, EGFR, MET and FGFR2 were evaluated using immunohistochemistry, and the gene amplifications of HER2, EGFR and MET were examined using dual-color in situ hybridization. The frequency of overexpression was 11.8 % for HER2, 23.5 % for EGFR, 24.9 % for MET and 31.1 % for FGFR2. Whereas strong staining for each of the RTKs was heterogeneous, tumors with homogeneously strong staining areas often exhibited gene amplification. Strong EGFR expression was significantly associated with a poor outcome, but no prognostic correlations were observed in other RTKs. The overexpression of single and multiple RTKs was observed in 40.4 and 22.7 % of the cases, respectively. HER2, EGFR, MET and FGFR2 predominance was observed in 10.1, 13.9, 16.1 and 22.9 % of the GACs, respectively. Approximately two-thirds of patients with GAC exhibited the expression of at least one RTK and would be candidates for targeted therapies. Moreover, one-third of at least one RTK overexspressing cases showed multiple RTKs expression. Our results may be useful for selecting the most suitable patients for each targeted therapy.	[Nagatsuma, Akiko Kawano; Kuwata, Takeshi; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Nagatsuma, Akiko Kawano; Fujii, Hirofumi] Jichi Univ, Sch Med, Div Med Oncol, Shimotsuke, Tochigi 3290498, Japan; [Aizawa, Masaki] Niigata Canc Ctr Hosp, Div Surg, Niigata, Niigata 9518566, Japan; [Doi, Toshihiko; Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Div Gastroenterol, Kashiwa, Chiba 2778577, Japan	Ochiai, A (reprint author), Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	aochiai@east.ncc.go.jp			Ministry of Health, Labor and Welfare	This work was partially supported by grants from the Third-Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare. We are grateful to Ms Sachiko Fukuda and Ms Yuka Nakamura for their technical assistance.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Nakajima M, 1999, CANCER, V85, P1894; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Sawaki A, 2012, GASTRIC CANCER, V15, P313, DOI 10.1007/s10120-011-0118-1; Kataoka Y, 2013, GASTRIC CANCER, V16, P84, DOI 10.1007/s10120-012-0150-9; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Toyokawa T, 2009, ONCOL REP, V21, P875, DOI 10.3892/or_00000297; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Jung EJ, 2012, HUM PATHOL, V43, P1559, DOI 10.1016/j.humpath.2011.12.002; Aizawa M, 2014, GASTRIC CANCER, V17, P34, DOI 10.1007/s10120-013-0239-9; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; He C, 2013, WORLD J GASTROENTERO, V19, P2171, DOI 10.3748/wjg.v19.i14.2171; Guo T, 2012, J PROTEOME RES, V11, P3405, DOI 10.1021/pr300212g; Matsubara J, 2008, CLIN CANCER RES, V14, P3022, DOI 10.1158/1078-0432.CCR-07-1898; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Kunz PL, 2012, APPL IMMUNOHISTO M M, V20, P13, DOI 10.1097/PAI.0b013e31821c821c; Cappuzzo F, 2005, J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Kim KC, 2011, ANN SURG ONCOL, V18, P2833, DOI 10.1245/s10434-011-1695-2; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Betts G, 2014, VIRCHOWS ARCH, V464, P145, DOI 10.1007/s00428-013-1517-y; Lu YH, 2001, J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Association Japanese Gastric Cancer, 2011, GASTRIC CANCER, V14, P101; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bang YJ, 2012, J CLIN ONCOL S34, V30; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Cunningham D, 2013, J CLIN ONCOL S, V31; Drescher D, 2007, WORLD J GASTROENTERO, V13, P3605; Hecht JR, 2013, J CLIN ONCOL S, V31; Kim YH, 2011, J CLIN ONCOL, V29, P4; Liang ZY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-363; Martin Amy J, 2011, BMC Res Notes, V4, P72, DOI 10.1186/1756-0500-4-72; Ministry of Health LaW, VIT STAT JAP 2010; Oliner KS, 2012, J CLIN ONCOL S, V30; Shan L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-76	48	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					227	238		10.1007/s10120-014-0360-4		12	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900005		
J	Yoshida, M; Shimoda, T; Kusafuka, K; Sugino, T; Nakajima, T; Ono, H				Yoshida, Masao; Shimoda, Tadakazu; Kusafuka, Kimihide; Sugino, Takashi; Nakajima, Takashi; Ono, Hiroyuki			Comparative study of Western and Japanese criteria for biopsy-based diagnosis of gastric epithelial neoplasia	GASTRIC CANCER			English	Article						Gastric cancer; Diagnostic accuracy; Interobserver agreement; Vienna classification; Group classification	HIGH-GRADE DYSPLASIA; REVISED VIENNA CLASSIFICATION; ENDOSCOPIC MUCOSAL RESECTION; TERM-FOLLOW-UP; DNA-INSTABILITY; FORCEPS BIOPSY; CANCER CLONES; CARCINOMA; PATHOLOGISTS; ADENOMAS	In Western countries, gastric cancer (GC) is diagnosed when there is histological evidence of invasion into the lamina propria or beyond the submucosa. In Japan and some other countries, however, diagnosis of GC is based on the degree of structural and cytological abnormality of tumor glands. The aim of the present study was to compare the accuracy of the Western and Japanese criteria for diagnosis of GC. The study included 233 consecutive patients with a postoperative diagnosis of submucosal invasive GC who underwent gastrectomy or endoscopic submucosal dissection. All pretreatment biopsy specimens were independently reviewed by two experts in gastrointestinal pathology employing both the Western and Japanese diagnostic criteria. Diagnostic agreement between pretreatment biopsy specimens and the corresponding resected specimens was evaluated, together with the interobserver agreement for each of the criteria. On the basis of the Western and Japanese criteria, the pretreatment biopsy diagnosis was noncancerous (including dysplasia) in 44 lesions and 1 lesion, respectively. Diagnostic accuracy based on biopsy was 81.1 % for the Western criteria and 99.5 % for the Japanese criteria (P < 0.001). Interobserver agreement based on the Western and Japanese criteria was 73.8 % and 96.5 %, respectively (P < 0.001). Invasion into the submucosa was detected by biopsy in only 25 cases. The Japanese criteria are significantly more accurate for pretreatment biopsy diagnosis of GC. The Western criteria could lead to underdiagnosis of a lesion as high-grade dysplasia, even if submucosal invasive cancer is present.	[Yoshida, Masao; Shimoda, Tadakazu; Kusafuka, Kimihide; Sugino, Takashi; Nakajima, Takashi] Shizuoka Canc Ctr, Div Pathol, Nagaizumi, Shizuoka 4118777, Japan; [Yoshida, Masao; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka 4118777, Japan	Yoshida, M (reprint author), Shizuoka Canc Ctr, Div Pathol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	ma.yoshida@scchr.jp			Shizuoka Cancer Center	The authors would like to thank our institutional secretaries for assisting with the collection of the specimens. This work was supported by Shizuoka Cancer Center. M.Y. and T.Sh. designed the research study. M.Y. retrieved clinical and pathological data. Biopsy specimens were reviewed and diagnosed by K.K. and T.Su. Statistical analysis was performed by M.Y. The manuscript was written by M.Y., K.K., T.Su., T.N., H.O. and T.Sh. and approved by all contributing authors.	Alberts B, 2008, MOL BIOL CELL, P1205; Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Lee CK, 2010, J GASTROEN HEPATOL, V25, P1507, DOI 10.1111/j.1440-1746.2010.006367.x; Park SY, 2008, EUR J GASTROEN HEPAT, V20, P966, DOI 10.1097/MEG.0b013e3283013d58; Kokkola A, 1996, J CLIN PATHOL, V49, P979, DOI 10.1136/jcp.49.12.979; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FERTITTA AM, 1993, ENDOSCOPY, V25, P265, DOI 10.1055/s-2007-1010311; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; HISAMICHI S, 1984, JPN J CLIN ONCOL, V14, P211; Schlemper RJ, 1997, LANCET, V349, P1725, DOI 10.1016/S0140-6736(96)12249-2; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; RUGGE M, 1994, GASTROENTEROLOGY, V107, P1288; Schlemper RJ, 2000, J GASTROEN HEPATOL, V15, pG49, DOI 10.1046/j.1440-1746.2000.02266.x; Schlemper RJ, 2001, J GASTROENTEROL, V36, P445, DOI 10.1007/s005350170067; Downs-Kelly E, 2008, AM J GASTROENTEROL, V103, P2333, DOI 10.1111/j.1572-0241.2008.02020.x; SARAGA EP, 1987, AM J SURG PATHOL, V11, P788, DOI 10.1097/00000478-198710000-00006; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Kitano S, 2004, SURG ENDOSC, V18, P182, DOI 10.1007/s00464-003-8820-7; Schlemper RJ, 2000, CANCER, V88, P996, DOI 10.1002/(SICI)1097-0142(20000301)88:5<996::AID-CNCR8>3.0.CO;2-Q; Patil DT, 2012, AM J SURG PATHOL, V36, P134, DOI 10.1097/PAS.0b013e3182354e43; Yamada H, 2004, ENDOSCOPY, V36, P390, DOI 10.1055/s-2004-814330; Kim YJ, 2010, ENDOSCOPY, V42, P620, DOI 10.1055/s-0030-1255524; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Hull MJ, 2006, AM J SURG PATHOL, V30, P114, DOI 10.1097/01.pas.0000180438.56528.a0; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; DIGREGORIO C, 1993, AM J GASTROENTEROL, V88, P1714; Jung SH, 2010, GASTRIC CANCER, V13, P123, DOI 10.1007/s10120-010-0550-7; LANSDOWN M, 1990, GUT, V31, P977, DOI 10.1136/gut.31.9.977; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Bosman FT, 2010, WHO CLASSIFICATION T, P10; Chung WC, 2010, GUT LIVER, V4, P179, DOI 10.5009/gnl.2010.4.2.179; DinisRibeiro M, 2012, ENDOSCOPY, V44, P74; Ezoe Y, 2011, GASTROENTEROLOGY, V141; Fukuda M, 2005, EUR J HISTOCHEM, V49, P11; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim JM, 2011, WORLD J GASTROENTERO, V17, P2602, DOI 10.3748/wjg.v17.i21.2602; Kushima Ryoji, 2011, J Gastric Cancer, V11, P141, DOI 10.5230/jgc.2011.11.3.141; Lewin KJ, 1996, TUMORS ESOPHAGUS STO, P245; Ming S-C, 1998, PATHOLOGY GASTROINTE, P607; Ono Hiroyuki, 2005, Chin J Dig Dis, V6, P119, DOI 10.1111/j.1443-9573.2005.00206.x; OTAKI T, 1994, EUR J HISTOCHEM, V38, P281; RUBIO CA, 1988, AM J PATHOL, V130, P485; Rubio CA, 2006, J GASTROEN HEPATOL, V21, P1697, DOI 10.1111/j.1440-1746.2006.04258.x; RUGGE M, 1991, HUM PATHOL, V22, P1002, DOI 10.1016/0046-8177(91)90008-D; Schlemper R J, 1999, Verh Dtsch Ges Pathol, V83, P62; Schlemper RJ, 1998, CANCER-AM CANCER SOC, V82, P60, DOI 10.1002/(SICI)1097-0142(19980101)82:1<60::AID-CNCR7>3.0.CO;2-O; Stolte M, 1999, VIRCHOWS ARCH, V434, P279, DOI 10.1007/s004280050342; Sun A, 2003, EUR J HISTOCHEM, V47, P111; Takahashi T, 1985, PATHOL ANNU, V20, P419; Takenawa H, 2004, BRIT J CANCER, V90, P216, DOI 10.1038/sj.bjc.6601399; Vital Statistics Japan, CANC MORT 1958 2012	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					239	245		10.1007/s10120-014-0382-y		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900006		
J	Naruke, A; Azuma, M; Takeuchi, A; Ishido, K; Katada, C; Sasaki, T; Higuchi, K; Tanabe, S; Saegusa, M; Koizumi, W				Naruke, Akira; Azuma, Mizutomo; Takeuchi, Atsuko; Ishido, Kenji; Katada, Chikatoshi; Sasaki, Tohru; Higuchi, Katsuhiko; Tanabe, Satoshi; Saegusa, Makoto; Koizumi, Wasaburo			Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer	GASTRIC CANCER			English	Article						Advanced gastric cancer; Site-specific gene expression level; Laser-captured microdissection	FACTOR THYMIDINE PHOSPHORYLASE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC FACTOR; PHENOTYPIC-EXPRESSION; CARCINOMA; TISSUE; ADENOCARCINOMA; FEATURES; MICRODISSECTION	Many malignant tumors consist of heterogeneous subpopulations of cells. This heterogeneity is associated with genetic characteristics. However, it remains unclear whether gene expression levels differ among specific sites of tumors in gastric cancer. We studied differences in gene expression levels among specific sites of primary tumors and synchronous lymph node metastases, using formalin-fixed, paraffin-embedded specimens resected surgically from 48 patients with previously untreated advanced gastric cancer. Specimens were obtained by laser-captured microdissection from five regions: (1) nonneoplastic mucosa, (2) surface layer (mucosa) of the primary tumor (surface sections), (3) middle layer (submucosa) of the primary tumor (middle sections), (4) the deepest layer of the primary tumor (muscularis propria or deeper) at the site of deepest invasion (deep sections), and (5) level 1 synchronous lymph node metastasis (lymph node metastases). Expression levels of the following target genes were determined by quantitative real-time polymerase chain reaction: thymidylate synthase (TS), thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1 alpha (HIF1 alpha). TP, DPD, EGFR, and HIF1 alpha gene expression levels were significantly higher in deep sections than in surface sections. TP, EGFR, VEGF, and HIF1 alpha gene expression levels were significantly higher in lymph node metastases than in surface sections. TP, DPD, EGFR, VEGF, and HIF1 alpha gene expression levels were positively correlated with the specific samples harvested from the tumors. Our results show that the expression levels of some genes in tumor cells can change in specific sites of tumors and can become higher in association with tumor progression.	[Naruke, Akira; Azuma, Mizutomo; Takeuchi, Atsuko; Ishido, Kenji; Katada, Chikatoshi; Sasaki, Tohru; Higuchi, Katsuhiko; Tanabe, Satoshi; Koizumi, Wasaburo] Kitasato Univ, Dept Gastroenterol, Sch Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2520374, Japan	Naruke, A (reprint author), Kitasato Univ, Dept Gastroenterol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	akira-n@kitasato-u.ac.jp					MIYADERA K, 1995, CANCER RES, V55, P1687; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Mita T, 2001, J GASTROENTEROL, V36, P661, DOI 10.1007/s005350170028; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Bohm M, 1997, AM J PATHOL, V151, P63; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; Lieto E, 2008, ANN SURG ONCOL, V15, P69, DOI 10.1245/s10434-007-9596-0; Yoshida T, 2013, LAB INVEST, V93, P1184, DOI 10.1038/labinvest.2013.111; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Endoh Y, 1999, J PATHOL, V189, P201, DOI 10.1002/(SICI)1096-9896(199910)189:2<201::AID-PATH409>3.0.CO;2-A; Fox S B, 2001, Lancet Oncol, V2, P278, DOI 10.1016/S1470-2045(00)00323-5; Han HS, 2007, ONCOL REP, V17, P61; Ichikawa Wataru, 2006, Gastric Cancer, V9, P145, DOI 10.1007/s10120-006-0373-8; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kimura H, 2002, HEPATO-GASTROENTEROL, V49, P882; Kitazono M, 1998, BIOCHEM BIOPH RES CO, V253, P797, DOI 10.1006/bbrc.1998.9852; Maeda K, 1997, INT J CANCER, V74, P545, DOI 10.1002/(SICI)1097-0215(19971021)74:5<545::AID-IJC12>3.0.CO;2-5; Nakamura J, 2009, ONCOL REP, V22, P693, DOI 10.3892/or_00000489; Nakamura T, 2005, HISTOPATHOLOGY, V47, P357, DOI 10.1111/j.1365-2559.2005.02242.x; Portera CA, 1998, SURG ONCOL, V7, P183, DOI 10.1016/S0960-7404(99)00020-1; Qiu MZ, 2011, TUMOR BIOL, V32, P159, DOI 10.1007/s13277-010-0109-6; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Semenza GL, 2007, EXP PHYSIOL, V92, P988, DOI 10.1113/expphysiol.2006.036343; Shimaoka S, 2000, CANCER, V88, P2220, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2220::AID-CNCR4>3.0.CO;2-C; Takebayashi Y, 1996, JPN J CANCER RES, V87, P288; Wang X, 2010, J SURG ONCOL, V102, P325, DOI 10.1002/jso.21644; Xie HL, 2010, J DIGEST DIS, V11, P167, DOI 10.1111/j.1751-2980.2010.00432.x; Yu EJ, 2008, MOL CANCER RES, V6, P1554, DOI 10.1158/1541-7786.MCR-08-0166	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					262	270		10.1007/s10120-014-0357-z		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900009		
J	Tsujiura, M; Komatsu, S; Ichikawa, D; Shiozaki, A; Konishi, H; Takeshita, H; Moriumura, R; Nagata, H; Kawaguchi, T; Hirajima, S; Arita, T; Fujiwara, H; Okamoto, K; Otsuji, E				Tsujiura, Masahiro; Komatsu, Shuhei; Ichikawa, Daisuke; Shiozaki, Atsushi; Konishi, Hirotaka; Takeshita, Hiroki; Moriumura, Ryo; Nagata, Hiroaki; Kawaguchi, Tsutomu; Hirajima, Shoji; Arita, Tomohiro; Fujiwara, Hitoshi; Okamoto, Kazuma; Otsuji, Eigo			Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer	GASTRIC CANCER			English	Article						Biomarker; Circulating nucleic acids; Gastric cancer; microRNA; Plasma	MICRORNA CLUSTER; EXPRESSION; CARCINOMA; CELLS; PROGRESSION; PROLIFERATION; BIOMARKERS; MIR-17-92; MARKERS; RNA	Recently, circulating microRNAs have been reported to be stably detectable in plasma/serum and to function as potent non-invasive biomarkers in various cancers. We hypothesized that miR-18a could contribute to a novel plasma biomarker in patients with gastric cancer (GC). We focused on miR-18a, which is a component of miR-17-92 cluster and has been reported as highly expressed in GC tissues. The study involved three steps: (1) confirmation of the higher miR-18a expression in primary GC tissues and GC cell lines than in normal gastric tissues and a fibroblast cell line; (2) evaluation of the plasma miR-18a assay using quantitative RT-PCR by comparing 104 GC patients and 65 healthy volunteers; (3) evaluation of monitoring tumor dynamics by the plasma miR-18a assay. (1) The miR-18a expressions were significantly higher in GC tissues than in normal gastric tissues (P = 0.0286) and higher in all examined GC cell lines than in the fibroblast cell line. (2) The plasma miR-18a concentrations were significantly higher in GC patients than in healthy controls (P < 0.0001). The value of the area under the receiver-operating characteristic curve was 0.8059. (3) The plasma miR-18a levels were significantly reduced in postoperative samples compared to in preoperative samples (P = 0.0002). In an miR-18a overexpressing cell line, the miR-18a concentration of cultured medium increased in both cell number and time-course dependent manners, suggesting microRNA might be released from cancer cells into the surrounding environment. Circulating miR-18a could be a useful biomarker for screening GC and monitoring tumor dynamics.	[Tsujiura, Masahiro; Komatsu, Shuhei; Ichikawa, Daisuke; Shiozaki, Atsushi; Konishi, Hirotaka; Takeshita, Hiroki; Moriumura, Ryo; Nagata, Hiroaki; Kawaguchi, Tsutomu; Hirajima, Shoji; Arita, Tomohiro; Fujiwara, Hitoshi; Okamoto, Kazuma; Otsuji, Eigo] Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan	Komatsu, S (reprint author), Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	skomatsu@koto.kpu-m.ac.jp					Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Ichikawa D, 2012, GASTROENTEROLOGY, V142, P1074, DOI 10.1053/j.gastro.2012.03.008; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Alencar AJ, 2011, CLIN CANCER RES, V17, P4125, DOI 10.1158/1078-0432.CCR-11-0224; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Sidransky D, 1997, SCIENCE, V278, P1054, DOI 10.1126/science.278.5340.1054; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Lamerz R, 1999, ANN ONCOL, V10, P145, DOI 10.1023/A:1008386130283; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Pritchard CC, 2011, CANC PREV RES, V5, P492; Sobin L, 2009, INT UNION CANC TNM C; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	49	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					271	279		10.1007/s10120-014-0363-1		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900010		
J	Kanda, M; Shimizu, D; Nomoto, S; Takami, H; Hibino, S; Oya, H; Hashimoto, R; Suenaga, M; Inokawa, Y; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y				Kanda, Mitsuro; Shimizu, Dai; Nomoto, Shuji; Takami, Hideki; Hibino, Soki; Oya, Hisaharu; Hashimoto, Ryoji; Suenaga, Masaya; Inokawa, Yoshikuni; Kobayashi, Daisuke; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro			Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer	GASTRIC CANCER			English	Article						Gastric cancer; DENND2D; Expression; Hypermethylation; Prognosis	HEPATOCELLULAR-CARCINOMA; RAB GTPASES; PROMOTER HYPERMETHYLATION; ADJUVANT CHEMOTHERAPY; MOLECULAR PATHOLOGY; EXCHANGE FACTORS; CLASSIFICATION; METAANALYSIS; PROGRESSION; DENND2D	Patients with advanced gastric cancer (GC) have an adverse prognosis even after curative resection. Development of novel diagnostic and therapeutic approaches for GC is urgently required. The expression and methylation status of DENN/MADD domain-containing protein 2D (DENND2D), a member of the membrane trafficking proteins, were evaluated in 12 GC cell lines and 112 pairs of surgical specimens. Subgroup analysis based on tumor differentiation, location, and morphology was also performed. Expression and distribution of DENND2D protein were determined by immunohistochemistry. The majority of GC cell lines (75 %) and tissues (79 %) showed reduced expression of DENND2D mRNA compared with noncancerous gastric tissues. GC tissues showed a significantly lower mean expression level of mRNA and a higher frequency of promoter hypermethylation of DENND2D than corresponding noncancerous tissues. No significant differences in DENND2D mRNA expression and methylation status were found between GC subtypes categorized by tumor differentiation, location, and morphology. The expression patterns of DENND2D protein were confirmed to be consistent with those of DENND2D mRNA. Downregulation of DENND2D mRNA in GC tissues was significantly associated with factors related to more advanced GC and subsequent adverse prognosis. Among 72 patients who underwent R0 resection, downregulation of DENND2D mRNA in GC tissues was an independent prognostic factor and associated with early recurrence. Our results suggested that DENND2D is a putative tumor suppressor gene regulated by promoter hypermethylation in GC. Downregulation of DENND2D can serve as a novel tumor biomarker to predict progression and early recurrence of all types of GC.	[Kanda, Mitsuro; Shimizu, Dai; Nomoto, Shuji; Takami, Hideki; Hibino, Soki; Oya, Hisaharu; Hashimoto, Ryoji; Suenaga, Masaya; Inokawa, Yoshikuni; Kobayashi, Daisuke; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Dept Gastroenterol Surg Surg 2, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Kanda, M (reprint author), Nagoya Univ, Dept Gastroenterol Surg Surg 2, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; Larsson SC, 2006, J NATL CANCER I, V98, P1078, DOI 10.1093/jnci/djj301; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Nakayama G, 2007, ANTICANCER RES, V27, P3367; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Steevens J, 2010, EUR J GASTROEN HEPAT, V22, P669, DOI 10.1097/MEG.0b013e32832ca091; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Janjigian YY, 2013, J SURG ONCOL, V107, P237, DOI 10.1002/jso.23263; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Bloethner S, 2008, GENE CHROMOSOME CANC, V47, P1076, DOI 10.1002/gcc.20598; Henderson Meredith C, 2012, Front Oncol, V2, P38, DOI 10.3389/fonc.2012.00038; Imai A, 2013, ARCH BIOCHEM BIOPHYS, V536, P31, DOI 10.1016/j.abb.2013.05.002; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P129, DOI 10.1080/0968768031000084172; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Tsai CT, 2013, ONCOTARGET	43	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					288	296		10.1007/s10120-014-0372-0		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900012		
J	Araki, I; Hosoda, K; Yamashita, K; Katada, N; Sakuramoto, S; Moriya, H; Mieno, H; Ema, A; Kikuchi, S; Mikami, T; Watanabe, M				Araki, Ippeita; Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Sakuramoto, Shinichi; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Kikuchi, Shiro; Mikami, Tetuo; Watanabe, Masahiko			Prognostic impact of venous invasion in stage IB node-negative gastric cancer	GASTRIC CANCER			English	Article						Gastric cancer; Stage IB; Prognostic factors; Venous invasion; Pattern of recurrence	ADJUVANT CHEMOTHERAPY; CARCINOMA; MICROMETASTASES; GASTRECTOMY; TRIAL; HER2; S-1	Little is known about risk factors for recurrence in stage IB gastric cancer without lymph node metastasis. The aims of this study were to determine prognostic factors associated with long-term survival and to clarify patterns of recurrence. We retrospectively reviewed the medical records of 130 patients with primary gastric cancer who underwent gastrectomy at Kitasato University East Hospital from 2001 through 2010 and analyzed clinicopathological characteristics associated with survival and patterns of recurrence. Of the 130 patients, 12 (9.2 %) had recurrence, among whom 10 (83 %) patients died. Four patients (3.1 %) died of other diseases. The 5-year overall survival rate was 89 %. Of the 12 patients with recurrence, 7 (58 %) had liver metastasis, 3 (25 %) had distant lymph-node metastasis, 2 (17 %) had peritoneal dissemination, and 1 (8.3 %) had locoregional recurrence. Patients with tumors more than 5 cm in diameter tended to have recurrence within 1 year. Patients who had recurrence more than 2 years after surgery tended to survive for longer than 5 years after recurrence. Moderate or marked venous invasion (v2 or v3) and age > 65 years were significantly associated with relapse-free and overall survival on univariate analysis. On multivariate analysis, the only independent prognostic factor for relapse-free and overall survival was venous invasion. Moderate or marked venous invasion (v2 or v3) is an independent predictor of relapse-free and overall survival in stage IB node-negative gastric cancer. Postoperative adjuvant chemotherapy, currently not given to this subgroup of patients, may improve the outcomes of patients with stage IB node-negative gastric cancer, particularly when accompanied by venous invasion.	[Araki, Ippeita; Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Ema, Akira; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Sakuramoto, Shinichi] Saitama Med Univ, Int Med Ctr, Dept Gastrointestinal Surg, Hidaka, Saitama 3501298, Japan; [Mikami, Tetuo] Toho Univ, Sch Med, Dept Pathol, Tokyo 1438540, Japan	Watanabe, M (reprint author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Kitasato1-15-1, Sagamihara, Kanagawa 2520374, Japan.	gekaw@med.kitasato-u.ac.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Morgagni P, 2001, ANN SURG ONCOL, V8, P170, DOI 10.1245/aso.2001.8.2.170; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Chua TC, 2012, INT J CANCER, V130, P2845, DOI 10.1002/ijc.26292; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Nakajo A, 2001, ANN SURG ONCOL, V8, P158, DOI 10.1245/aso.2001.8.2.158; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Bozzetti F, 2000, TUMORI, V86, P470; Feng XY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0514-y; International Agency for Research on Cancer, GLOBOCAN2008; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kunisaki C, 2004, ANTICANCER RES, V24, P3169; Kunisaki C, 2006, J SURG ONCOL, V94, P212, DOI 10.1002/jso.20601; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Yokoyama T, 2011, GASTRIC CANCER, V14, P372, DOI 10.1007/s10120-011-0051-3	21	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					297	305		10.1007/s10120-014-0362-2		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900013		
J	Terai, S; Fushida, S; Tsukada, T; Kinoshita, J; Oyama, K; Okamoto, K; Makino, I; Tajima, H; Ninomiya, I; Fujimura, T; Harada, S; Ohta, T				Terai, Shiro; Fushida, Sachio; Tsukada, Tomoya; Kinoshita, Jun; Oyama, Katsunobu; Okamoto, Koichi; Makino, Isamu; Tajima, Hidehiro; Ninomiya, Itasu; Fujimura, Takashi; Harada, Shinichi; Ohta, Tetsuo			Bone marrow derived "fibrocytes" contribute to tumor proliferation and fibrosis in gastric cancer	GASTRIC CANCER			English	Article						Fibrocytes; Bone marrow-derived cell; Cancer associated fibroblasts; Cancer stroma; Gastric cancer	CIRCULATING FIBROCYTES; CARCINOMA CELLS; TGF-BETA; PULMONARY-FIBROSIS; MYOFIBROBLASTS; FIBROBLASTS; DIFFERENTIATION; STROMA	Cancer-associated fibroblasts (CAFs) in the stroma are considered to play important roles for gastric cancer proliferation, invasion, and fibrosis, but the source of CAFs and their interaction with cancer cells in the microenvironment have not been fully determined. Here we elucidated the role of bone marrow-derived cells, fibrocytes, in development of gastric cancers, as represented by scirrhous gastric cancer. In co-culturing MKN45 gastric cancer cells and purified fibrocytes from healthy volunteers, migration and endothelial mesenchymal transition associated gene expression were evaluated using western blot analysis. Also, mouse xenograft models of MKN45 with or without fibrocytes were conducted to investigate their tumorigenicity and immunohistological differences of tumors. Co-culture of fibrocytes with MKN45 resulted in morphological changes from cobblestone-shape to spindle-shape and enhanced expression of alpha-SMA and collagen type I in fibrocytes, suggesting that co-culture with gastric cancer cells may have induced the differentiation of fibrocytes to myofibroblasts. Furthermore, enhanced expression of SDF-1 in MKN45 and CXCR4 in fibrocytes were also determined. Mouse xenograft models inoculated with MKN45 and fibrocytes revealed significantly larger tumors than those inoculated with MKN45 cells alone, and the stroma in co-inoculated tumors consisted of myofibroblasts and fibrosis. Mouse-derived cells expressing both CD45 and type I collagen were also observed in co-inoculated tumors. Fibrocytes derived from bone marrow may migrate into the microenvironment of gastric cancer by SDF-1/CXCR4 system, and enhance the tumor proliferation and fibrosis as CAFs.	[Terai, Shiro; Fushida, Sachio; Tsukada, Tomoya; Kinoshita, Jun; Oyama, Katsunobu; Okamoto, Koichi; Makino, Isamu; Tajima, Hidehiro; Ninomiya, Itasu; Fujimura, Takashi; Ohta, Tetsuo] Kanazawa Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Harada, Shinichi] Kanazawa Univ, Ctr Biomed Res & Educ, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan	Fushida, S (reprint author), Kanazawa Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	fushida@staff.kanazawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22591451]	This study was supported in part by Grants-in-Aid for Scientific Research (C; 22591451 to S.F.) from the Japan Society for the Promotion of Science (JSPS).	Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Abe R, 2001, J IMMUNOL, V166, P7556; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Semba S, 2009, BRIT J CANCER, V101, P1365, DOI 10.1038/sj.bjc.6605309; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; BUCALA R, 1994, MOL MED, V1, P71; Ishii G, 2005, INT J CANCER, V117, P212, DOI 10.1002/ijc.21199; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Tisty TD, 2001, SEMIN CANCER BIOL, V11, P97; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Wever OD, 2008, INT J CANCER, V123, P2229; Zhi KK, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-66	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					306	313		10.1007/s10120-014-0380-0		8	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900014		
J	Yamamoto, H; Gotoda, T; Nakamura, T; Yamamoto, T; Kikuchi, H; Kitamura, M; Itoi, T; Moriyasu, F				Yamamoto, Hisae; Gotoda, Takuji; Nakamura, Tetsuro; Yamamoto, Tetsuro; Kikuchi, Hitoshi; Kitamura, Masatsugu; Itoi, Takao; Moriyasu, Fuminori			Clinical impact of gastroenterologist-administered propofol during esophagogastroduodenoscopy: a randomized comparison at a single medical clinic	GASTRIC CANCER			English	Article						Esophagogastroduodenoscopy; Propofol; Recovery time; Private clinic	LOW-DOSE PROPOFOL; UPPER GASTROINTESTINAL ENDOSCOPY; REGISTERED NURSES; OUTPATIENT COLONOSCOPY; CONSCIOUS SEDATION; MIDAZOLAM; SAFETY; GUIDELINES; PROTOCOL	Although midazolam is widely used during endoscopic procedures by endoscopists, propofol has been recently favored for its rapid action and metabolism. The aim of this study is to compare the clinical advantages between propofol and midazolam use during screening esophagogastroduodenoscopy (EGD) for gastric cancer and post-procedure management at a medical clinic. One hundred six healthy patients aged 20-69 years requesting sedation for screening EGD from October 2012 to May 2013 at a single clinic in Japan were randomly assigned to propofol (n = 54) or midazolam (n = 52). Medications were given by bolus injection, and the dose was adjusted by body weight. Sedation level and tolerability during EGD and recovery time were assessed. Sedation level and tolerability were evaluated by American Society of Anesthesiologists responsiveness levels and four levels of the gag reflex, respectively. For safety purposes, endoscopists and nurses were trained in administering propofol and an anesthesiologist was on call at all times. No statistically significant differences were found between the two groups in sedation level and patient tolerability. Full recovery time in the propofol group (4.7 min) was significantly shorter than that in the midazolam group (24 min, P < 0.01). Regarding post-procedure management of patients in a medical clinic, propofol use might not necessitate a recovery room and excessive assessment tasks because of rapid recovery time without any prolonged reaction, which causes patient compliance. (Clinical trial registration number: UMIN000009142.).	[Yamamoto, Hisae; Nakamura, Tetsuro; Yamamoto, Tetsuro; Kikuchi, Hitoshi; Kitamura, Masatsugu] Tokyo East Hosp, Dept Gastroenterol, Tokyo, Japan; [Gotoda, Takuji; Itoi, Takao; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Nakamura, Tetsuro] Tokyo East Hosp, Dept Anesthesiol, Tokyo, Japan	Gotoda, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	takujigotoda@yahoo.co.jp					Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Walker JA, 2003, AM J GASTROENTEROL, V98, P1744, DOI 10.1016/S0002-9270(03)00496-9; IBER FL, 1993, GASTROINTEST ENDOSC, V39, P620; Waring JP, 2003, GASTROINTEST ENDOSC, V58, P317, DOI 10.1067/S0016-5107(03)00001-4; Horiuchi A, 2008, DIGESTION, V78, P190, DOI 10.1159/000187118; Sipe BW, 2007, CLIN GASTROENTEROL H, V5, P563, DOI 10.1016/j.cgh.2007.01.013; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Rex DK, 2005, GASTROENTEROLOGY, V129, P1384, DOI 10.1053/j.gastro.2005.08.014; Clarke AC, 2002, MED J AUSTRALIA, V176, P158; Triantafillidis JK, 2013, WORLD J GASTROENTERO, V19, P463, DOI 10.3748/wjg.v19.i4.463; Rex DK, 2002, AM J GASTROENTEROL, V97, P1159; Early DS, 1999, AM J GASTROENTEROL, V94, P1862; Vargo JJ, 2002, GASTROENTEROLOGY, V123, P8, DOI 10.1053/gast.2002.34232; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Kulling D, 2003, ENDOSCOPY, V35, P679; Heuss LT, 2012, ENDOSCOPY, V44, P504, DOI 10.1055/s-0031-1291668; CARLSSON U, 1995, ENDOSCOPY, V27, P240, DOI 10.1055/s-2007-1005678; Seifert H, 2000, ALIMENT PHARM THERAP, V14, P1207; Tohda G, 2006, ENDOSCOPY, V38, P360, DOI 10.1055/s-2005-921192; Kulling D, 2007, GASTROINTEST ENDOSC, V66, P443, DOI 10.1016/j.gie.2007.01.037; Tohda G, 2006, ENDOSCOPY, V38, P684, DOI 10.1055/s-2006-925374; Meining A, 2007, ENDOSCOPY, V39, P345, DOI 10.1055/s-2006-945195; Cohen LB, 2003, GASTROINTEST ENDOSC, V58, P725, DOI 10.1016/S0016-5107(03)02010-8; Horiuchi A, 2009, AM J GASTROENTEROL, V104, P1650, DOI 10.1038/ajg.2009.250; Heuss LT, 2003, GASTROINTEST ENDOSC, V57, P664, DOI 10.1067/mge.2003.191; Deitch K, 2011, ANN EMERG MED, V58	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					326	331		10.1007/s10120-014-0371-1		6	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900016		
J	Numata, N; Oka, S; Tanaka, S; Kagemoto, K; Sanomura, Y; Yoshida, S; Arihiro, K; Shimamoto, F; Chayama, K				Numata, Norifumi; Oka, Shiro; Tanaka, Shinji; Kagemoto, Kenichi; Sanomura, Yoji; Yoshida, Shigeto; Arihiro, Koji; Shimamoto, Fumio; Chayama, Kazuaki			Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection	GASTRIC CANCER			English	Article						Early gastric cancer; Endoscopic submucosal dissection; Horizontal margin	MUCOSAL RESECTION; LOCAL RECURRENCE; TUMORS; FEASIBILITY; NEOPLASM; FIBROSIS; OUTCOMES; KNIFE; EMR	Although endoscopic submucosal dissection (ESD) is a widely accepted treatment for early gastric cancer (EGC), there is no consensus regarding the management of positive horizontal margin (HM) despite en bloc ESD. The aim of the current study was to identify the risk factors and optimal management of positive HM in EGCs resected by en bloc ESD. A total of 890 consecutive patients with 1,053 intramucosal EGCs resected by en bloc ESD between April 2005 and June 2011. Clinicopathological data were retrieved retrospectively to assess the positive HM rate, local recurrence rate, risk factors for positive HM, and outcomes of treatment for local recurrent tumor. Positive HM was defined as a margin with direct tumor invasion (type A), the presence of cancerous cells on either end of 2-mm-thick cut sections (type B), or an unclear tumor margin resulting from crush or burn damage (type C). The positive HM rate was 2.0 % (21/1,053). The local recurrence rate was 0.3 % (3/1,053). All local recurrent tumors were intramucosal carcinomas, and were resected curatively by re-ESD. Multivariate analysis with logistic regression showed tumor location in the upper third of the stomach and lesions not matching the absolute indication to be independent risk factors for positive HM. The risk factors for HM positivity in cases of EGC resected by en bloc ESD are tumor location in the upper third of the stomach and dissatisfaction of the absolute indication for curative ESD.	[Numata, Norifumi; Kagemoto, Kenichi; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Oka, Shiro; Tanaka, Shinji; Sanomura, Yoji; Yoshida, Shigeto] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan; [Shimamoto, Fumio] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Hiroshima, Japan	Oka, S (reprint author), Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan.	nnumata@hiroshima-u.ac.jp; oka4683@hiroshima-u.ac.jp					Higashiyama M, 2011, DIGEST ENDOSC, V23, P290, DOI 10.1111/j.1443-1661.2011.01151.x; Higashimaya M, 2013, GASTRIC CANCER, V16, P404, DOI 10.1007/s10120-012-0203-0; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Okada K, 2011, SURG ENDOSC, V25, P841, DOI 10.1007/s00464-010-1279-4; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Fujishiro M, 2006, GASTROINTEST ENDOSC, V63, P243, DOI 10.1016/j.gie.2005.08.002; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Matsumoto A, 2010, SCAND J GASTROENTERO, V45, P1329, DOI 10.3109/00365521.2010.495416; Oka S, 2006, ENDOSCOPY, V38, P996, DOI 10.1055/s-2006-944780; Fujishiro M, 2006, ENDOSCOPY, V38, P1001, DOI 10.1055/s-2006-944775; Watanabe K, 2006, GASTROINTEST ENDOSC, V63, P776, DOI 10.1016/j.gie.2005.08.049; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; Takenaka R, 2008, GASTROINTEST ENDOSC, V68, P887, DOI 10.1016/j.gie.2008.03.1089; Imagawa A, 2006, ENDOSCOPY, V38, P987, DOI 10.1055/s-2006-944716; Ohkuwa M, 2001, ENDOSCOPY, V33, P221, DOI 10.1055/s-2001-12805; Asada-Hirayama I, 2013, DIGEST ENDOSC, V25, P593, DOI 10.1111/den.12043; Association Japanese Gastric Cancer, 2011, GASTRIC CANCER, V14, P101; Chonan A, 2009, STOMACH INTESTINE TO, V44, P623; Higashiyama M, 2012, GASTROINTEST ENDOSC, V77, P298; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kakushima A, 2011, DIGEST ENDOSC, V23, P227; Koide N, 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/379210, DOI 10.1155/2012/379210]; Oda I, 2005, DIGEST ENDOSC, V17, P54, DOI 10.1111/j.1443-1661.2005.00459.x; Sanomura Y, 2012, GASTRIC CANCER, V15, P97, DOI 10.1007/s10120-011-0076-7; Tonouchi H, 2007, SURG ENDOSC, V21, P1289, DOI 10.1007/s00464-007-9221-0; Urabe Y, 2011, J GASTROEN HEPATOL, V26, P275, DOI 10.1111/j.1440-1746.2010.06503.x; Yano H, 2005, SURG ENDOSC, V19, P981, DOI 10.1007/s00464-004-8172-y	29	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					332	338		10.1007/s10120-014-0368-9		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900017		
J	Kawata, N; Kakushima, N; Tokunaga, M; Tanaka, M; Sawai, H; Takizawa, K; Imai, K; Hotta, K; Yamaguchi, Y; Matsubayashi, H; Tanizawa, Y; Bando, E; Kawamura, T; Terashima, M; Ono, H				Kawata, Noboru; Kakushima, Naomi; Tokunaga, Masanori; Tanaka, Masaki; Sawai, Hiroaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Yamaguchi, Yuichiro; Matsubayashi, Hiroyuki; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Terashima, Masanori; Ono, Hiroyuki			Influence of endoscopic submucosal dissection on additional gastric resections	GASTRIC CANCER			English	Article						Endoscopic submucosal dissection; Early gastric cancer; Total gastrectomy; Distal gastrectomy; Proximal gastrectomy	CANCER; GASTRECTOMY	Widespread application of endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) results in noncurative resection in some patients. The influence of preceding ESD on additional gastric resections has not been completely evaluated. Endoscopic, surgical, and pathological records of 255 patients who underwent additional gastrectomy after noncurative ESD at a single prefectural cancer center from September 2002 to December 2010 were reviewed. The estimated gastric resection based on endoscopic images before ESD was compared with the actual gastric resection performed after ESD. Altered gastric resection was performed in 4 (1.6 %) of the 255 patients. In 3 patients, total gastrectomy was performed instead of distal gastrectomy; in 1 patient, distal gastrectomy was performed instead of pylorus-preserving gastrectomy because of an insufficient distance from the cardia or pylorus caused by contraction of the ESD scar. Standard gastrectomy including total or distal gastrectomy with D2 lymph node dissection was performed in 33 patients because of deep submucosal invasion with positive/indefinite vertical margins. The final pathology revealed pT2 or deeper in 10 patients. In conclusion, 98.4 % patients underwent the scheduled gastric resection before ESD, and the preceding gastric ESD had almost no influence on changing the gastric resection of the additional surgery. Although rare, the preceding ESD may necessitate alterations in gastric resection to widen the surgical area because of contraction of ESD scar for lesions near the cardia or pylorus. A retrospective study of additional gastrectomy after noncurative ESD showed that the preceding ESD had almost no influence on changing the gastric resection of the additional surgery.	[Kawata, Noboru; Kakushima, Naomi; Tanaka, Masaki; Sawai, Hiroaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Yamaguchi, Yuichiro; Matsubayashi, Hiroyuki; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka 4118777, Japan; [Tokunaga, Masanori; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Terashima, Masanori] Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka 4118777, Japan	Kakushima, N (reprint author), Shizuoka Canc Ctr, Div Endoscopy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	kakushin-tky@umin.ac.jp		Hotta, Kinichi/0000-0001-5608-0968; Imai, Kenichiro/0000-0002-9257-5842			Akagi T, 2010, GASTROINTEST ENDOSC, V72, P438, DOI 10.1016/j.gie.2010.03.1066; Cao Y, 2009, ENDOSCOPY, V41, P751, DOI 10.1055/s-0029-1215053; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Tanaka M, 2008, DIGESTION, V77, P23, DOI 10.1159/000111484; Ono H, 2008, GASTRIC CANCER, V11, P47, DOI 10.1007/s10120-008-0452-0; Park YM, 2011, SURG ENDOSC, V25, P2666, DOI 10.1007/s00464-011-1627-z; Hiki N, 2013, ANN SURG ONCOL, V20, P2683, DOI 10.1245/s10434-013-2931-8; Oda I, 2008, BRIT J SURG, V95, P1495, DOI 10.1002/bjs.6305; Kakushima N, 2011, DIGEST ENDOSC, V23, P227, DOI 10.1111/j.1443-1661.2010.01092.x; Jiang XH, 2011, SURG ENDOSC, V25, P1182, DOI 10.1007/s00464-010-1336-z; Song KY, 2008, J SURG ONCOL, V98, P6, DOI 10.1002/jso.21074; Tsujimoto H, 2012, ONCOL REP, V28, P2205, DOI 10.3892/or.2012.2046; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Kusano C, 2011, AM J GASTROENTEROL, V106, P1064, DOI 10.1038/ajg.2011.49; Kakushima N, 2008, WORLD J GASTROENTERO, V14, P2962, DOI 10.3748/wjg.14.2962; Kakushima N, 2006, ENDOSCOPY, V38, P412, DOI 10.1055/s-2006-925166; Jiang XH, 2011, ANN SURG, V253, P928, DOI 10.1097/SLA.0b013e3182117b24; Goto O, 2008, DIGEST LIVER DIS, V40, P293, DOI 10.1016/j.dld.2007.11.018; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jiang X, 2011, BRIT J SURG, V98, P385, DOI 10.1002/bjs.7358; Kakushima N, 2011, TECHN GASTROINTEST E, V13, P63; Kakushima N, 2013, UNITED EUR GASTROENT, V1, P453, DOI 10.1177/2050640613508550; Kakushima N, 2004, DIGEST ENDOSC, V16, P327, DOI DOI 10.1111/J.1443-1661.2004.00413.X]; Ono H, 2001, STOMACH INTEST, V3, P334; Suh YS, 2014, ANN SURG, V259, P485, DOI 10.1097/SLA.0b013e318294d142	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					339	345		10.1007/s10120-014-0379-6		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900018		
J	Kurimoto, K; Ishigure, K; Mochizuki, Y; Ishiyama, A; Matsui, T; Ito, S; Nakayama, H; Tanaka, N; Kobayashi, D; Sakamoto, J; Nakao, A; Kodera, Y				Kurimoto, Keisuke; Ishigure, Kiyoshi; Mochizuki, Yoshinari; Ishiyama, Akiharu; Matsui, Takanori; Ito, Seiji; Nakayama, Hiroshi; Tanaka, Nobutake; Kobayashi, Daisuke; Sakamoto, Junichi; Nakao, Akimasa; Kodera, Yasuhiro			A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)	GASTRIC CANCER			English	Article						Gastric cancer; S-1; CDDP; Adjuvant chemotherapy; Relative dose intensity	ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT; PLUS CISPLATIN; OXALIPLATIN; TRIAL; CAPECITABINE; SURVIVAL	The standard of care for stage II/III gastric cancer in Japan is D2 dissection followed by adjuvant S-1 monotherapy. Outcome of patients with stage III disease remains unsatisfactory, calling for a more intensive adjuvant chemotherapy regimen, for which evidence in advanced/metastatic cancer research suggests S-1/cisplatin (CDDP) as a candidate. Although S-1/CDDP was poorly tolerated postoperatively in the previous trial, compliance was dramatically improved by insertion of one cycle of S-1 monotherapy, which delayed administration of CDDP by 6 weeks. A feasibility study of post-gastrectomy S-1/CDDP was performed. Patients with stage III/IV gastric cancer were eligible. The first cycle of chemotherapy consisted of S-1 monotherapy, and intensive antiemetic drugs were prescribed when patients were administered CDDP. The primary endpoint was the completion rate of four cycles of S-1/CDDP. The secondary endpoints were the relative dose intensity, safety, progression-free survival time and overall survival time. Several criteria to skip, postpone or reduce the dose had been predetermined. Between 2010 and 2011, 33 patients were enrolled. Four patients had stage IIIA disease, 7 patients had stage IIIB disease, 11 patients had stage IIIC disease, and 11 patients had stage IV disease. The completion rate of the protocol treatment was 60.6 %. The relative dose intensity of S-1 was 77.3 % and that of CDDP was 72.3 %. The protocol-specified delay in the administration of CDDP dramatically improved the relative drug intensity in the postoperative adjuvant setting, although the completion rate did not reach the expected level.	[Kurimoto, Keisuke; Ishigure, Kiyoshi; Tanaka, Nobutake] Konan Kosei Hosp, Dept Surg, Konan, Japan; [Mochizuki, Yoshinari] Komaki Municipal Hosp, Dept Surg, Komaki, Japan; [Ishiyama, Akiharu] Okazaki City Hosp, Dept Surg, Okazaki, Aichi, Japan; [Matsui, Takanori] Aichi Canc Aichi Hosp, Dept Surg Gastroenterol, Okazaki, Aichi, Japan; [Ito, Seiji] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Nakayama, Hiroshi] Nagoya Med Ctr, Natl Hosp Org, Dept Surg, Nagoya, Aichi, Japan; [Kobayashi, Daisuke; Kodera, Yasuhiro] Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Dept Surg, Kakamigahara, Japan; [Nakao, Akimasa] Nagoya Cent Clin, Dept Surg, Nagoya, Aichi, Japan	Kodera, Y (reprint author), Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ykodera@med.nagoya-u.ac.jp					Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Takahari D, 2011, CANCER CHEMOTH PHARM, V67, P1423, DOI 10.1007/s00280-010-1432-8; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Gralla RJ, 1999, J CLIN ONCOL, V17, P2971; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Koizumi W, 2010, ANN ONCOL, V21, P1001, DOI 10.1093/annonc/mdp464; Kodera Y, 2010, GASTRIC CANCER, V13, P197, DOI 10.1007/s10120-010-0559-y; Takahari D, 2014, GASTRIC CANCER, V17, P383, DOI 10.1007/s10120-013-0264-8; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; Roila F, 2010, ANN ONCOL, V21, P232	14	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					354	359		10.1007/s10120-014-0384-9		6	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900020		
J	Hayashi, T; Yoshikawa, T; Aoyama, T; Hasegawa, S; Yamada, T; Tsuchida, K; Fujikawa, H; Sato, T; Ogata, T; Cho, H; Oshima, T; Rino, Y; Masuda, M				Hayashi, Tsutomu; Yoshikawa, Takaki; Aoyama, Toru; Hasegawa, Shinichi; Yamada, Takanobu; Tsuchida, Kazuhito; Fujikawa, Hirohito; Sato, Tsutomu; Ogata, Takashi; Cho, Haruhiko; Oshima, Takashi; Rino, Yasushi; Masuda, Munetaka			Impact of infectious complications on gastric cancer recurrence	GASTRIC CANCER			English	Article						Gastric cancer; Infectious complication; Recurrence	LONG-TERM SURVIVAL; COLORECTAL-CANCER; ANASTOMOTIC LEAKAGE; CURATIVE RESECTION; POSTOPERATIVE COMPLICATIONS; ESOPHAGECTOMY; GASTRECTOMY; ESOPHAGUS	Postoperative infectious complications increase disease recurrence in colorectal cancer patients. We herein investigated the impact of infectious complications on gastric cancer recurrence after curative surgery. In total, 502 patients who underwent R0 resection for gastric cancer were reviewed. Patients were classified into those with infectious complications (IC group) and those without infectious complications (NO group). The risk factors for recurrence-free survival (RFS) were identified. Infectious complications, which occurred in 52 patients (10.4 %), included pneumonia, ileus with a systemic inflammatory reaction, anastomotic leakage, and intraperitoneal abscess. The overall 5-year RFS rate was 83 % in the NO group and 58 % in the IC group (p = 0.000). Multivariate analysis demonstrated that age, ASA score, stage, and infectious complications were significant predictors of RFS. Infectious complications were a risk factor for gastric cancer recurrence. To avoid causing infectious complications, the surgical procedure, surgical strategy, and perioperative care should be carefully planned.	[Hayashi, Tsutomu; Yoshikawa, Takaki; Aoyama, Toru; Hasegawa, Shinichi; Yamada, Takanobu; Tsuchida, Kazuhito; Fujikawa, Hirohito; Sato, Tsutomu; Ogata, Takashi; Cho, Haruhiko] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Oshima, Takashi; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Yoshikawa, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	yoshikawat@kcch.jp					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Tsujimoto H, 2009, ANN SURG ONCOL, V16, P311, DOI 10.1245/s10434-008-0249-8; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Lagarde SM, 2008, ANN SURG, V247, P71, DOI 10.1097/SLA.0b013e31815b695e; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Miki C, 2008, SURG TODAY, V38, P579, DOI 10.1007/s00595-007-3674-6; Mynster T, 2000, BRIT J SURG, V87, P1553, DOI 10.1046/j.1365-2168.2000.01570.x; Sobin LH, 2009, INT UNION CANC UICC; Tokunaga M, 2013, ANN SURG ONCOL, V20, P1575, DOI 10.1245/s10434-012-2720-9	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					368	374		10.1007/s10120-014-0361-3		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900022		
J	Goto, H; Tokunaga, M; Miki, Y; Makuuchi, R; Sugisawa, N; Tanizawa, Y; Bando, E; Kawamura, T; Niihara, M; Tsubosa, Y; Terashima, M				Goto, Hironobu; Tokunaga, Masanori; Miki, Yuichiro; Makuuchi, Rie; Sugisawa, Norihiko; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Niihara, Masahiro; Tsubosa, Yasuhiro; Terashima, Masanori			The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients	GASTRIC CANCER			English	Article						Gastric cancer; Adenocarcinoma of the esophagogastric junction; Siewert type II; Siewert type III	RANDOMIZED CONTROLLED-TRIAL; GASTRIC-CANCER; LYMPHADENECTOMY; CLASSIFICATION; CARCINOMA; JAPAN; SPLENECTOMY; RELEVANCE; EVALUATE; CARDIA	The incidence of adenocarcinoma of the esophagogastric junction (AEG) has been increasing worldwide. We investigated the clinicopathological characteristics of patients with Siewert type II and III AEGs and clarified the optimal intra-abdominal lymph node dissection in these patients. This study included 132 patients with AEG who underwent curative resection at Shizuoka Cancer Center from September 2002 to December 2012. We used the index of estimated benefit from lymph node dissection (IEBLD) to assess the efficacy of lymph node dissection of each station. The clinicopathological characteristics and IEBLDs of each station were compared between patients with Siewert type II and III AEGs. We analyzed 92 patients with Siewert type II AEG and 40 patients with Siewert type III AEG. The incidence of lymph node metastasis was high in both groups (64.1 % in type II AEG and 75.0 % in type III AEG). The 5-year survival rates were similar for the patients with Siewert type II and III AEGs, at 54.0 and 53.4 %, respectively. The IEBLDs of stations located near the esophagogastric junction were generally high in both groups, while the IEBLDs of lower perigastric lymph nodes were higher in Siewert type III than in Siewert type II AEG cases. The IEBLDs were similar between Siewert type II and III AEGs at all stations except for lower perigastric lymph nodes. Total gastrectomy should be selected as a standard treatment for Siewert type III AEG, whereas in Siewert type II AEG, preservation of the distal part of the stomach may be an acceptable procedure.	[Goto, Hironobu; Tokunaga, Masanori; Miki, Yuichiro; Makuuchi, Rie; Sugisawa, Norihiko; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Terashima, Masanori] Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka 4118777, Japan; [Niihara, Masahiro; Tsubosa, Yasuhiro] Shizuoka Canc Ctr, Div Esophageal Surg, Nagaizumi, Shizuoka 4118777, Japan	Tokunaga, M (reprint author), Shizuoka Canc Ctr, Div Gastr Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	m.tokunaga@scchr.jp					Siewert JR, 2005, J SURG ONCOL, V90, P139, DOI 10.1002/jso.20218; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Kakeji Y, 2012, SURG TODAY, V42, P351, DOI 10.1007/s00595-011-0114-4; Biondi A, 2011, J CLIN ONCOL, V29, P4338, DOI 10.1200/JCO.2011.36.9900; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Goto H, 2013, GASTRIC CANCER, V16, P590, DOI 10.1007/s10120-012-0214-x; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Oda I, 2011, GASTRIC CANCER, V14, P22, DOI 10.1007/s10120-011-0001-0; Mine S, 2013, BRIT J SURG, V100, P261, DOI 10.1002/bjs.8967; Sano T, 2002, JPN J CLIN ONCOL, V32, P363, DOI 10.1093/jjco/hyf085; Fujita J, 2012, GASTRIC CANCER, V15, P42, DOI 10.1007/s10120-011-0058-9; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Fang WL, 2009, ANN SURG ONCOL, V16, P3237, DOI 10.1245/s10434-009-0636-9; Feith M, 2006, SURG ONCOL CLIN N AM, V15, P751, DOI 10.1016/j.soc.2006.07.015; Fujitani K, 2013, GASTRIC CANCER, V16, P301, DOI 10.1007/s10120-012-0183-0; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hasegawa S, 2009, WORLD J SURG, V33, P95, DOI 10.1007/s00268-008-9740-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kodera Y, 1999, J AM COLL SURGEONS, V189, P594, DOI 10.1016/S1072-7515(99)00201-X; Kunisaki C, 2008, J GASTROINTEST SURG, V12, P542, DOI 10.1007/s11605-007-0239-3; Miwa K, 2003, BRIT J SURG, V90, P178, DOI 10.1002/bjs.4031; Siewert JR, 2000, ANN SURG, V232, P353; Shen KR, 2006, J THORAC CARDIOV SUR, V132, P755, DOI 10.1016/j.jtcvs.2006.05.064	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					375	381		10.1007/s10120-014-0364-0		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900023		
J	Yamaoka, Y; Fujitani, K; Tsujinaka, T; Yamamoto, K; Hirao, M; Sekimoto, M				Yamaoka, Yusuke; Fujitani, Kazumasa; Tsujinaka, Toshimasa; Yamamoto, Kazuyoshi; Hirao, Motohiro; Sekimoto, Mitsugu			Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy	GASTRIC CANCER			English	Article						Total gastrectomy; Skeletal muscle loss; Adjuvant chemotherapy; S-1; Risk factor	PHASE-III TRIAL; BODY-COMPOSITION; GASTRIC-CANCER; COMPUTED-TOMOGRAPHY; PERIOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; EICOSAPENTAENOIC ACID; SURGERY; SARCOPENIA; RECONSTRUCTION	Skeletal muscle loss is associated with physical disability, nosocomial infections, postoperative complications, and decreased survival. Preventing the loss of skeletal muscle mass after gastrectomy may lead to improved outcomes. The aims of this study were to assess changes in skeletal muscle mass after total gastrectomy (TG) and to clarify the clinical factors affecting significant loss of skeletal muscle after TG. One hundred and two patients undergoing TG for primary gastric cancer underwent abdominal computed tomography before and 1 year after TG to precisely quantify postoperative changes in skeletal muscle and adipose tissue. Univariate and multivariate logistic regression analyses identified clinical factors contributing to significant loss of skeletal muscle after TG. At 1 year after TG, the mass of both skeletal muscle and adipose tissue was reduced by 6.20 +/- A 6.80 and 65.8 +/- A 36.1 % of the preoperative values, respectively, and 26 patients (25.5 %) showed a significant loss of skeletal muscle of more than 10 %. Adjuvant chemotherapy with S-1 for a parts per thousand yen6 months (hazard ratio 26.61, 95 % confidence interval, 3.487-203.1) was identified as the single independent risk factor for a significant loss of skeletal muscle. Skeletal muscle loss was exacerbated by extended adjuvant chemotherapy after TG. Further research should identify appropriate nutritional interventions for maintaining skeletal muscle mass and leading to improved outcomes.	[Yamaoka, Yusuke; Yamamoto, Kazuyoshi; Hirao, Motohiro; Sekimoto, Mitsugu] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan; [Fujitani, Kazumasa] Osaka Prefectural Gen Med Ctr, Dept Surg, Sumiyoshi Ku, Osaka 5588558, Japan; [Tsujinaka, Toshimasa] Kaizuka City Hosp, Dept Surg, Kaizuka, Japan	Fujitani, K (reprint author), Osaka Prefectural Gen Med Ctr, Dept Surg, Sumiyoshi Ku, 3-1-56 Bandaihigashi, Osaka 5588558, Japan.	yamaoka.yusuke@gmail.com; fujitani@gh.opho.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Fujitani K, 2013, DIGEST SURG, V30, P119, DOI 10.1159/000350877; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Kiyama T, 2005, J GASTROINTEST SURG, V9, P313, DOI 10.1016/j.gasseur.2004.11.008; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Englesbe MJ, 2012, ANN SURG, V256, P255, DOI 10.1097/SLA.0b013e31826028b1; Abdiev S, 2011, GASTRIC CANCER, V14, P144, DOI 10.1007/s10120-011-0021-9; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Lee JSJ, 2011, J VASC SURG, V53, P912, DOI 10.1016/j.jvs.2010.10.111; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Pichard C, 2004, AM J CLIN NUTR, V79, P613; Yoshikawa T, 2014, SURG TODAY, V44, P11, DOI 10.1007/s00595-013-0529-1; Adachi S, 2010, GASTROENTEROLOGY, V138, P1312, DOI 10.1053/j.gastro.2009.12.058; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Awad S, 2012, CLIN NUTR, V31, P74, DOI 10.1016/j.clnu.2011.08.008; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Ryan AM, 2009, ANN SURG, V249, P355, DOI 10.1097/SLA.0b013e31819a4789; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Kimyagarov S, 2012, J NUTR HEALTH AGING, V16, P432, DOI 10.1007/s12603-012-0005-4; Heymsfield SB, 2008, INT J OBES LOND, V32, P76; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KVIST H, 1986, INT J OBESITY, V10, P53; Liedman B, 1997, WORLD J SURG, V21, P416; Metter EJ, 2004, AM J CLIN NUTR, V79, P613; MIHOLIC J, 1990, SURGERY, V108, P488; Miyato H, 2012, J SURG RES, V173, P60, DOI 10.1016/j.jss.2010.08.040; Nass R, 2008, ANN INTERN MED, V149, P601; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, P1; Tanaka K, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-146; Vehmas T, 1996, INT J OBESITY, V20, P570; Yoon DY, 2007, ANZ J SURG, V77, P121, DOI 10.1111/j.1445-2197.2006.03990.x; Yoshikawa T, 2012, JPN J CLIN ONCOL, V42, P459, DOI 10.1093/jjco/hys025	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					382	389		10.1007/s10120-014-0365-z		8	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900024		
J	Namikawa, T; Hiki, N; Kinami, S; Okabe, H; Urushihara, T; Kawahira, H; Fukushima, N; Kodera, Y; Yumiba, T; Oshio, A; Nakada, K				Namikawa, Tsutomu; Hiki, Naoki; Kinami, Shinichi; Okabe, Hiroshi; Urushihara, Takashi; Kawahira, Hiroshi; Fukushima, Norimasa; Kodera, Yasuhiro; Yumiba, Takeyoshi; Oshio, Atsushi; Nakada, Koji			Factors that minimize postgastrectomy symptoms following pylorus-preserving gastrectomy: assessment using a newly developed scale (PGSAS-45)	GASTRIC CANCER			English	Article						Pylorus-preserving gastrectomy; Quality of life; Early gastric cancer; Function-preserving surgery; Postgastrectomy syndrome	EARLY GASTRIC-CANCER; POSTOPERATIVE EVALUATION; RECONSTRUCTION; QUESTIONNAIRE; OPERATION; OUTCOMES; LENGTH; ULCER	Pylorus-preserving gastrectomy (PPG) is sometimes performed as a function-preserving surgery for the treatment of early gastric cancer. The aim of this study was to use an integrated assessment scale for postgastrectomy syndrome to determine the appropriate indicators and optimal methods for PPG. The Postgastrectomy Syndrome Assessment Study (PGSAS) is a multicenter survey based on an integrated questionnaire (PGSAS-45) consisting of 45 items. Questionnaire responses were retrieved from a total of 2,520 patients, each of whom had undergone one of six different types of gastrectomy procedures; 313 responses from patients who had received PPG were analyzed here. The size of the proximal gastric remnant (less than one-quarter, about one-third, or more than one-half of the original size) significantly influenced the change in body weight, the scores for dissatisfaction at the meal, and dissatisfaction for daily life subscale (P = 0.030, P = 0.005, P = 0.034, respectively). The nausea score in patients who underwent hand-sewn anastomosis was significantly lower than in those who underwent anastomosis with a linear stapler (P = 0.006). The scores for diarrhea subscale, increased passage of stools, and sense of foods sticking differed significantly depending on the length of the preserved pyloric cuff (P = 0.047, P = 0.021, P = 0.046, respectively). The results suggest that preservation of a sufficient proximal gastric remnant is recommended when utilizing PPG as function-preserving surgery.	[Namikawa, Tsutomu] Kochi Med Sch, Dept Surg, Nankoku, Kochi 7838505, Japan; [Hiki, Naoki] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol, Tokyo, Japan; [Kinami, Shinichi] Kanazawa Med Univ, Dept Surg Oncol, Kahoku Dist, Ishikawa, Japan; [Okabe, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Urushihara, Takashi] Hiroshima Prefectural Hosp, Dept Gastroenterol Breast & Transplant Surg, Hiroshima, Japan; [Kawahira, Hiroshi] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Fukushima, Norimasa] Yamagata Prefectural Cent Hosp, Dept Surg, Yamagata, Japan; [Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan; [Yumiba, Takeyoshi] Osaka Kosei Nenkin Hosp, Dept Surg, Osaka, Japan; [Oshio, Atsushi] Waseda Univ, Fac Letters Arts & Sci, Tokyo, Japan; [Nakada, Koji] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Namikawa, T (reprint author), Kochi Med Sch, Dept Surg, Oko Cho, Nankoku, Kochi 7838505, Japan.	tsutomun@kochi-u.ac.jp		Oshio, Atsushi/0000-0002-2936-2916	Jikei University; Japanese Society for Gastro-surgical Pathophysiology	This study was supported by a grant from The Jikei University and the Japanese Society for Gastro-surgical Pathophysiology. The authors thank all physicians who participated in this study and the patients whose cooperation made this study possible.	Ikeguchi M, 2010, SURG TODAY, V40, P228, DOI 10.1007/s00595-009-4043-4; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Kumagai K, 2012, SURG TODAY, V42, P411, DOI 10.1007/s00595-012-0159-z; MAKI T, 1967, SURGERY, V61, P838; Jiang XH, 2011, SURG ENDOSC, V25, P1182, DOI 10.1007/s00464-010-1336-z; Park DJ, 2008, WORLD J SURG, V32, P1029, DOI 10.1007/s00268-007-9441-4; Hiki N, 2006, J AM COLL SURGEONS, V203, P162, DOI 10.1016/j.jamcollsurg.2006.05.003; Hiki N, 2005, LANGENBECK ARCH SURG, V390, P442, DOI 10.1007/s00423-005-0573-4; Hiki N, 2009, J AM COLL SURGEONS, V209, P297, DOI 10.1016/j.jamcollsurg.2009.05.027; Isozaki H, 1996, BRIT J SURG, V83, P266, DOI 10.1046/j.1365-2168.1996.02093.x; Japanese Gastric Cancer Association, 2010, GASTRIC CANCER, V14, P113, DOI DOI 10.1007/S10120-011-0042-4; Katai Hitoshi, 2006, Int J Clin Oncol, V11, P357, DOI 10.1007/s10147-006-0613-2; Lee SW, 2010, SURG ENDOSC, V24, P1774, DOI 10.1007/s00464-009-0803-x; Morita S, 2010, GASTRIC CANCER, V13, P109, DOI 10.1007/s10120-010-0549-0; Morita S, 2008, BRIT J SURG, V95, P1131, DOI 10.1002/bjs.6295; Nakada K, 2013, GASTROENTEROLOGY, V144, pS1111; Nakada K, 2015, GASTRIC CANCER, V18, P147, DOI 10.1007/s10120-014-0344-4; Nakane Y, 2002, BRIT J SURG, V89, P220, DOI 10.1046/j.0007-1323.2001.01984.x; Nishikawa K, 2002, SURGERY, V131, P613, DOI 10.1067/msy.2002.124630; Nomura E, 2012, HEPATO-GASTROENTEROL, V59, P1677, DOI 10.5754/hge12256; Nomura E, 2011, GASTRIC CANCER, V14, P279, DOI 10.1007/s10120-011-0046-0; Shibata C, 2012, WORLD J SURG, V36, P858, DOI 10.1007/s00268-012-1491-6; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tokuda Y, 2009, VALUE HEALTH, V12, P568, DOI 10.1111/j.1524-4733.2008.00449.x	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					397	406		10.1007/s10120-014-0366-y		10	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900026		
J	Takiguchi, N; Takahashi, M; Ikeda, M; Inagawa, S; Ueda, S; Nobuoka, T; Ota, M; Iwasaki, Y; Uchida, N; Kodera, Y; Nakada, K				Takiguchi, Nobuhiro; Takahashi, Masazumi; Ikeda, Masami; Inagawa, Satoshi; Ueda, Shugo; Nobuoka, Takayuki; Ota, Manabu; Iwasaki, Yoshiaki; Uchida, Nobuyuki; Kodera, Yasuhiro; Nakada, Koji			Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by Postgastrectomy Syndrome Assessment Scale (PGSAS-45): a nationwide multi-institutional study	GASTRIC CANCER			English	Article						Proximal gastrectomy; Total gastrectomy; Postgastrectomy syndrome; Quality of life; Stomach cancer	EARLY GASTRIC-CANCER; ESOPHAGOGASTRIC JUNCTION; PSYCHOMETRIC VALIDATION; QUESTIONNAIRE MODULE; STOMACH; ADENOCARCINOMA; RECONSTRUCTION; CARCINOMA; DIAGNOSIS; SYMPTOMS	Although proximal gastrectomy (PG) is widely accepted as a function-preserving operation for early upper-third gastric cancer, postoperative disorders, such as reflux or gastric stasis, have often been pointed out. From the perspective of postoperative disorder, the choice of total gastrectomy (TG) or PG for such cancers is still controversial. By using the newly developed Postgastrectomy Syndrome Assessment Scale (PGSAS)-45, the quality of life after TG and PG was compared. The PGSAS-45 consists of 45 items composed of the SF-8 and GSRS scales and 22 new items. The main outcomes are measured by seven subscales (SS) covering symptoms, physical and mental component summary (SF-8), meals (amount and quality), ability to work, dissatisfaction for daily life, and change in body weight. A total of 2,368 eligible questionnaires were acquired from 52 institutions. From these, 393 patients with TG and 193 patients with PG were selected and compared. The PG was better than TG in terms of body weight loss (TG 13.8 % vs. PG 10.9 %; p = 0.003), necessity for additional meals (2.4 vs. 2.0; p < 0.001), diarrhea SS (2.3 vs. 2.0; p = 0.048), and dumping SS (2.3 vs. 2.0; p = 0.043). There were no differences in the other main outcome measures. Proximal gastrectomy appears to be valuable as a function-preserving procedure for early upper-third gastric cancer.	[Takiguchi, Nobuhiro] Chiba Canc Ctr, Div Gastroenterol Surg, Chuo Ku, Chiba 2600801, Japan; [Takahashi, Masazumi] Yokohama Municipal Citizens Hosp, Div Gastroenterol Surg, Yokohama, Kanagawa, Japan; [Ikeda, Masami] Asama Gen Hosp, Dept Surg, Saku, Japan; [Inagawa, Satoshi] Univ Tsukuba, Dept Surg, Tsukuba, Ibaraki, Japan; [Ueda, Shugo] Tazuke Kofukai Med Res Inst, Kitano Hosp, Dept Surg Gastroenterol, Osaka, Japan; [Nobuoka, Takayuki] Sapporo Med Univ, Sch Med, Dept Surg 1, Sapporo, Hokkaido, Japan; [Ota, Manabu] Hamamatsu Univ, Sch Med, Dept Surg 2, Hamamatsu, Shizuoka, Japan; [Iwasaki, Yoshiaki] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Surg, Tokyo, Japan; [Uchida, Nobuyuki] Haramachi Red Cross Hosp, Dept Surg, Agatsuma, Gunma, Japan; [Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan; [Nakada, Koji] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Takiguchi, N (reprint author), Chiba Canc Ctr, Div Gastroenterol Surg, Chuo Ku, 666-2 Nitona Cho, Chiba 2600801, Japan.	ntaki@chiba-cc.jp			Jikei University; Japanese Society for Gastro-Surgical Pathophysiology	This study was supported by a grant from Jikei University and the Japanese Society for Gastro-Surgical Pathophysiology. The authors thank all physicians who participated in this study and the patients whose cooperation made this study possible.	Ahn SH, 2013, GASTRIC CANCER, V16, P282, DOI 10.1007/s10120-012-0178-x; Kaptein AA, 2005, WORLD J GASTROENTERO, V11, P3189; Kunisaki C, 2006, ANN SURG ONCOL, V13, P221, DOI 10.1245/ASO.2006.04.028; Blazeby JM, 2004, EUR J CANCER, V40, P2260, DOI 10.1016/j.ejca.2004.05.023; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Tack J, 2009, NAT REV GASTRO HEPAT, V6, P583, DOI 10.1038/nrgastro.2009.148; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; TOWERS AL, 1994, J AM GERIATR SOC, V42, P701; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Dassen AE, 2010, EUR J CANCER, V46, P1101, DOI 10.1016/j.ejca.2010.02.013; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003; Hiki N, 2013, ANN SURG ONCOL, V20, P2683, DOI 10.1245/s10434-013-2931-8; Kobayashi D, 2011, WORLD J SURG, V35, P357, DOI 10.1007/s00268-010-0860-2; An JY, 2008, AM J SURG, V196, P587, DOI 10.1016/j.amjsurg.2007.09.040; Tsujimoto H, 2010, WORLD J SURG, V34, P1840, DOI 10.1007/s00268-010-0587-0; Harari D, 1996, ARCH INTERN MED, V156, P315, DOI 10.1001/archinte.156.3.315; Kim YW, 2013, SURG ENDOSC, V27, P4267, DOI 10.1007/s00464-013-3037-x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lehnert T, 2004, BRIT J SURG, V91, P528, DOI 10.1002/bjs.4512; Nozaki I, 2013, WORLD J SURG, V37, P558, DOI 10.1007/s00268-012-1894-4; Steevens J, 2010, EUR J GASTROEN HEPAT, V22, P669, DOI 10.1097/MEG.0b013e32832ca091; Lagergren P, 2007, EUR J CANCER, V43, P2066, DOI 10.1016/j.ejca.2007.07.005; PROBERT CJS, 1993, J EPIDEMIOL COMMUN H, V47, P331, DOI 10.1136/jech.47.4.331; Pilotto A, 2008, AM J GASTROENTEROL, V103, P2816, DOI 10.1111/j.1572-0241.2008.02107.x; Tokunaga M, 2009, LANGENBECK ARCH SURG, V394, P637, DOI 10.1007/s00423-008-0442-z; Ikeguchi M, 2004, AM SURGEON, V70, P645; Wen L, 2012, HEPATO-GASTROENTEROL, V59, P633, DOI 10.5754/hge11834; Aoki T, 2012, GASTRIC CANCER, V15, P396, DOI 10.1007/s10120-011-0129-y; Bouchoucha M, 2006, Tech Coloproctol, V10, P287, DOI 10.1007/s10151-006-0295-9; Hongo M, 1999, DIAGNOSIS TREATMENT, V87, P731; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Katai Hitoshi, 2006, Int J Clin Oncol, V11, P357, DOI 10.1007/s10147-006-0613-2; Kulich KR, 2008, HEALTH QUAL LIFE OUT, V31, P12; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Takiguchi S, 2012, METHOD ENZYMOL, V514, P409, DOI 10.1016/B978-0-12-381272-8.00026-X; Vickery CW, 2000, BRIT J SURG, V87, P362, DOI 10.1046/j.1365-2168.2000.01383-9.x; Wiklund I.K., 1998, EUR J SURG S, V583, P41, DOI DOI 10.1080/11024159850191238; Yoo Chang Hak, 2004, Cancer Res Treat, V36, P50, DOI 10.4143/crt.2004.36.1.50	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					407	416		10.1007/s10120-014-0377-8		10	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900027		
J	Misawa, K; Fujiwara, M; Ando, M; Ito, S; Mochizuki, Y; Ito, Y; Onishi, E; Ishigure, K; Morioka, Y; Takase, T; Watanabe, T; Yamamura, Y; Morita, S; Kodera, Y				Misawa, Kazunari; Fujiwara, Michitaka; Ando, Masahiko; Ito, Seiji; Mochizuki, Yoshinari; Ito, Yuichi; Onishi, Eiji; Ishigure, Kiyoshi; Morioka, Yuki; Takase, Tsunenobu; Watanabe, Takuya; Yamamura, Yoshitaka; Morita, Satoshi; Kodera, Yasuhiro			Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial	GASTRIC CANCER			English	Article						Quality of life; Questionnaire; Laparoscopic surgery; Gastrectomy; Gastric cancer	EUROPEAN-ORGANIZATION; FUNCTIONAL ASSESSMENT; NODAL DISSECTION; HOSPITAL VOLUME; GENERAL MEASURE; THERAPY SCALE; PHASE-III; VALIDATION; JAPANESE; MULTICENTER	The aim of this study was to compare the postoperative health-related quality of life (HRQOL) between open and laparoscopic distal gastrectomy. A multi-institutional nonrandomized study was conducted. Patients with clinical T1 gastric cancer were prospectively enrolled and underwent distal gastrectomy by either the open or laparoscopic approach. HRQOL was measured using the European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Core 30 and the site-specific module for gastric cancer. Questionnaires were completed at baseline and at 1, 3, 6, and 12 months postoperatively. Clinicopathological characteristics and short-term outcome including postoperative morbidity and HRQOL were compared between the approaches. A total of 145 patients (open, n = 72; laparoscopic, n = 73) were enrolled between September 2008 and January 2011 and analyzed. The laparoscopic approach was associated with longer operating time, less blood loss, and a similar incidence of postoperative complications. At each time point, the questionnaires were retrieved from more than 90 % of the patients. The worst scores for most of the scales were observed at 1 month postoperatively and improved thereafter. No statistically significant differences were observed regarding physical functioning, the primary endpoint. On the other hand, role, emotional, cognitive, and social functioning scores were superior in the laparoscopic group at 6 and 12 months postoperatively. Symptom scales including fatigue, pain, eating restriction, taste problems, and anxiety were better in the laparoscopic group before 6 months but not at 12 months. The study was considered to be negative because no benefit of the laparoscopic approach was observed in terms of physical functioning. However, more favorable scores for some of the symptom scales during the first 6 months and several functioning scales at 12 months after surgery suggest a potential benefit of the laparoscopic approach.	[Misawa, Kazunari; Ito, Seiji; Ito, Yuichi] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan; [Mochizuki, Yoshinari] Komaki Municipal Hosp, Dept Surg, Komaki, Japan; [Onishi, Eiji; Morioka, Yuki] Ichinomiya Municipal Hosp, Dept Surg, Ichinomiya, Japan; [Ishigure, Kiyoshi] JA Konan Kosei Hosp, Dept Surg, Konan, Japan; [Takase, Tsunenobu] JA Kainan Hosp, Dept Surg, Yatomi, Japan; [Watanabe, Takuya] Tokai Cent Hosp, Dept Surg, Kakamigahara, Japan; [Yamamura, Yoshitaka] Nagoya Mem Hosp, Dept Surg, Nagoya, Aichi, Japan; [Morita, Satoshi] Yokohama City Univ, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	Misawa, K (reprint author), Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	misawakzn@aichi-cc.jp					AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Liu J, 2012, HEPATO-GASTROENTEROL, V59, P2207, DOI 10.5754/hge11830; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P324, DOI 10.1093/jjco/hys220; Anderson O, 2011, EUR J CANCER, V47, P2408, DOI 10.1016/j.ejca.2011.07.001; Ikenaga N, 2006, J LAPAROENDOSC ADV S, V16, P119, DOI 10.1089/lap.2006.16.119; Blazeby JM, 2004, EUR J CANCER, V40, P2260, DOI 10.1016/j.ejca.2004.05.023; Lee SS, 2012, GASTRIC CANCER, V15, P299, DOI 10.1007/s10120-011-0113-6; Etoh T, 2013, J SURG ONCOL, V107, P282, DOI 10.1002/jso.23128; CELLA DF, 1993, J CLIN ONCOL, V11, P570; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Morita S, 2008, PSYCHO-ONCOL, V17, P474, DOI 10.1002/pon.1256; Dikken JL, 2012, EUR J CANCER, V48, P1004, DOI 10.1016/j.ejca.2012.02.064; Kobayashi D, 2011, WORLD J SURG, V35, P357, DOI 10.1007/s00268-010-0860-2; Yasuda K, 2007, SURG ENDOSC, V21, P2150, DOI 10.1007/s00464-007-9322-9; Kim YW, 2013, SURG ENDOSC, V27, P4267, DOI 10.1007/s00464-013-3037-x; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Kobayashi K, 1998, EUR J CANCER, V34, P810, DOI 10.1016/S0959-8049(97)00395-X; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Hosono S, 2006, WORLD J GASTROENTERO, V12, P7676; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Fayers PM, 2001, EORTC QLQ C30 SCORIN; Fumimoto H, 2001, QUAL LIFE RES, V10, P701, DOI 10.1023/A:1013851216181; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kong Horyon, 2012, J Gastric Cancer, V12, P194, DOI 10.5230/jgc.2012.12.3.194; Nakada K, 2015, GASTRIC CANCER, V18, P147, DOI 10.1007/s10120-014-0344-4	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					417	425		10.1007/s10120-014-0374-y		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900028		
J	Yanagimoto, Y; Takahashi, T; Muguruma, K; Toyokawa, T; Kusanagi, H; Omori, T; Masuzawa, T; Tanaka, K; Hirota, S; Nishida, T				Yanagimoto, Yoshitomo; Takahashi, Tsuyoshi; Muguruma, Kazuya; Toyokawa, Takahiro; Kusanagi, Hiroshi; Omori, Takeshi; Masuzawa, Toru; Tanaka, Koji; Hirota, Seiichi; Nishida, Toshirou			Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy	GASTRIC CANCER			English	Article						Gastrointestinal stromal tumor; Risk stratification; Adjuvant therapy; Recurrence; Prognosis	IMATINIB MESYLATE; RECURRENCE; SURVIVAL; STRATIFICATION; POPULATION; GUIDELINES; VERSION; TRIAL; SIZE	A substantial number of localized gastrointestinal stromal tumor (GIST) patients have recurrences even after complete resection. The risk of recurrence after complete resection should be estimated when considering adjuvant therapy. In this study, we evaluated prognostic factors of GIST recurrence and compared several reported risk-stratification schemes for defining risk of recurrence to guide the use of adjuvant therapy using data from a large Japanese GIST population. We analyzed clinicopathological data collected retrospectively and prospectively from 712 GISTs with complete resection from 1980-2010. We evaluated possible prognostic factors and compared the National Institutes of Health consensus criteria, the Armed Forces Institute of Pathology criteria, Joensuu's modified NIH classification (J-NIHC), the American Joint Committee on Cancer staging system (AJCCS), and the Japanese modified NIH criteria for prediction of tumor recurrence in adjuvant settings. Univariate analysis suggested that the following factors were prognostic: tumor size, mitotic count, site, clinically malignant features of rupture and/or invasion, and gender. In multivariate analysis, size > 5 cm, mitotic count > 5/50 HPF, non-gastric location, and the presence of rupture and/or macroscopic invasion were independent adverse prognostic factors. When adjuvant therapy is considered for patients with high-risk GIST, the J-NIHC was the most sensitive classification system, while the AJCCS appeared to be the most accurate for predicting recurrence. Tumor size, mitotic count, tumor site, and clinical features of rupture and/or invasion were important prognostic factors for GIST recurrence. Joensuu's classification appeared to best identify candidates for adjuvant therapy.	[Yanagimoto, Yoshitomo; Omori, Takeshi; Masuzawa, Toru; Tanaka, Koji; Nishida, Toshirou] Osaka Police Hosp, Dept Surg, Tennouji Ku, Osaka 5430035, Japan; [Takahashi, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Muguruma, Kazuya] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Toyokawa, Takahiro] Osaka City Gen Hosp, Dept Surg Gastroenterol, Osaka, Japan; [Kusanagi, Hiroshi] Kameda Med Ctr, Dept Surg Gastroenterol, Chiba, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan	Nishida, T (reprint author), Natl Canc Ctr Hosp East, Dept Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	toshin@mvb.biglobe.ne.jp			Ministry of Education, Science, and Culture of Japan; Ministry of Health, Labor, and Welfare of Japan	Grant support: This work was supported in part by Grants for Scientific Research from the Ministry of Education, Science, and Culture of Japan and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan.	Rutkowski P, 2011, EJSO-EUR J SURG ONC, V37, P890, DOI 10.1016/j.ejso.2011.06.005; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Takahashi T, 2007, INT J CLIN ONCOL, V12, P369, DOI 10.1007/s10147-007-0705-7; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; von Mehren M, 2012, J NATL COMPR CANC NE, V10, P951; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Rossi S, 2011, AM J SURG PATHOL, V35, P1646, DOI 10.1097/PAS.0b013e31822d63a7; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; DeMatteo RP, 2008, CANCER, V112, P608, DOI 10.1002/cncr23199; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Casali PG, 2013, J CLIN ONCOL S, V31; Edge SB, 2010, TROTTI A AJCC STAGIN; ESMO/European Sarcoma Network Working Group, 2012, ANN ONCOL S7, pvii49; Fletcher CD, 2002, HUM PATHOL, V33, P59; Hohenberger P, 2010, BRIT J SURG, V97, P1854, DOI 10.1002/bjs.7222; Kanda T, 2013, INT J CLIN ONCOL, V18, P38, DOI 10.1007/s10147-011-0339-7; Steigen SE, 2006, APMIS, V114, P192, DOI 10.1111/j.1600-0463.2006.apm_261.x	23	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					426	433		10.1007/s10120-014-0386-7		8	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900029		
J	Goto, O; Takeuchi, H; Kawakubo, H; Sasaki, M; Matsuda, T; Matsuda, S; Kigasawa, Y; Kadota, Y; Fujimoto, A; Ochiai, Y; Horii, J; Uraoka, T; Kitagawa, Y; Yahagi, N				Goto, Osamu; Takeuchi, Hiroya; Kawakubo, Hirofumi; Sasaki, Motoki; Matsuda, Tatsuo; Matsuda, Satoru; Kigasawa, Yu; Kadota, Yoshie; Fujimoto, Ai; Ochiai, Yasutoshi; Horii, Joichiro; Uraoka, Toshio; Kitagawa, Yuko; Yahagi, Naohisa			First case of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection for early gastric cancer	GASTRIC CANCER			English	Article						Minimally invasive surgery; Local resection; Sentinel node navigation surgery; Early gastric cancer	FULL-THICKNESS RESECTION; FEASIBILITY; TUMOR	Non-exposed endoscopic wall-inversion surgery (NEWS) is a novel technique of endoscopic full-thickness resection without transluminal access mainly designed to treat gastric cancer. Here, we report a successful case of NEWS with sentinel node basin dissection (SNBD) for early gastric cancer (EGC) with the risk of lymph node metastasis. A 55-year-old female patient with a 2-cm, diffuse-type intramucosal EGC with ulceration was referred to our hospital for a less invasive gastrectomy based on sentinel node navigation surgery. After obtaining informed consent, NEWS with SNBD was applied. After placing mucosal markings, indocyanine green solution was injected endoscopically into the submucosa around the lesion to examine sentinel nodes (SNs). The SN basin (the area of the left gastric artery), including three stained SNs(#3), was dissected, and an intraoperative pathological diagnosis confirmed that no metastasis had occurred. Subsequently, NEWS was performed for the primary lesion. Serosal markings were placed laparoscopically, submucosal injection was added endoscopically, and circumferential sero-muscular incision and suturing were performed laparoscopically, with the lesion inverted toward the inside of the stomach. Finally, the circumferential mucosal incision was performed, and the lesion was retrieved perorally. The operation was finished in 270 min without complications. The patient was uneventfully discharged 10 days after the procedure. The final pathological diagnosis was coincident with the pre- and intraoperative assessment. We demonstrated the feasibility and safety of NEWS with SNBD with a favorable result. This surgical concept is expected to become a promising, minimally invasive, function-preserving surgery to cure cases of EGC that are possibly node-positive.	[Goto, Osamu; Sasaki, Motoki; Fujimoto, Ai; Ochiai, Yasutoshi; Horii, Joichiro; Uraoka, Toshio; Yahagi, Naohisa] Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc, Tokyo 1608582, Japan; [Takeuchi, Hiroya; Kawakubo, Hirofumi; Matsuda, Tatsuo; Matsuda, Satoru; Kigasawa, Yu; Kadota, Yoshie; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	htakeuchi@a6.keio.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [25860558]	O.G. was funded by a Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology in Japan in 2013-2014 (Grant No. 25860558). We thank Isamu Shinohara and Miyuki Okabe (thanks to Corporation, Saitama, Japan) for creating the illustration of the NEWS procedure.	Abe N, 2009, SURG ENDOSC, V23, P1908, DOI 10.1007/s00464-008-0317-y; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; Nimura H, 2004, BRIT J SURG, V91, P575, DOI 10.1002/bjs.4470; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; Schlag C, 2013, ENDOSCOPY, V45, P4, DOI 10.1055/s-0032-1325760; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Chiu PWY, 2014, SURG ENDOSC, V28, P319, DOI 10.1007/s00464-013-3149-3; Goto O, 2014, GASTRIC CAN IN PRESS; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Mitsui T, 2013, SURG LAPARO ENDO PER, V23, pE217, DOI 10.1097/SLE.0b013e31828e3f94; Mitsui T, 2013, GASTRIC CANC	16	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					434	439		10.1007/s10120-014-0406-7		6	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900030		
J	Goto, O; Takeuchi, H; Kawakubo, H; Matsuda, S; Kato, F; Sasaki, M; Fujimoto, A; Ochiai, Y; Horii, J; Uraoka, T; Kitagawa, Y; Yahagi, N				Goto, Osamu; Takeuchi, Hiroya; Kawakubo, Hirofumi; Matsuda, Satoru; Kato, Fumihiko; Sasaki, Motoki; Fujimoto, Ai; Ochiai, Yasutoshi; Horii, Joichiro; Uraoka, Toshio; Kitagawa, Yuko; Yahagi, Naohisa			Feasibility of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection as a new surgical method for early gastric cancer: a porcine survival study	GASTRIC CANCER			English	Article						Minimally invasive surgery; Partial resection; Sentinel node navigation surgery; Early gastric cancer; Animal study	FULL-THICKNESS RESECTION; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; TUMOR	Non-exposed endoscopic wall-inversion surgery (NEWS) has been developed as an endoscopic full-thickness resection technique without translumenal communication to avoid intraabdominal infection or tumor seeding. We aimed to investigate the feasibility and safety of NEWS with sentinel node basin dissection (SNBD), which can minimize the area of lymphadenectomy for early gastric cancer (EGC), in 10 porcine survival models. After placing laparoscopic ports and making markings on both the mucosal and serosal sides of a simulated lesion, indocyanine green fluid was endoscopically injected into the submucosa at 4 quadrants around the lesion. An SN basin including the stained SNs was dissected, and a circumferential sero-muscular incision around the lesion and sero-muscular suturing were performed laparoscopically, with the lesion inverted toward the inside of the stomach. Finally, circumferential mucosal incision and transoral retrieval were made endoscopically. In all cases, the lesion was resected in an en bloc fashion, and all pigs survived without adverse events. After 1 week of observation, pigs were sacrificed for macroscopic investigation. The average procedural duration was 170 min (range 130-253 min). Intraoperative perforation occurred in 1 case, which could be safely treated by laparoscopic suturing. The number of dissected SN basins was 1 in 9 cases and 2 in 1 case. Necropsy revealed no signs of severe complication. This animal survival study demonstrated that NEWS with SNBD was safe and feasible. It may provide patients with possibly node-positive EGC a minimally-sized local resection and minimally-ranged lymphadenectomy without the risk of tumor dissemination.	[Goto, Osamu; Sasaki, Motoki; Fujimoto, Ai; Ochiai, Yasutoshi; Horii, Joichiro; Uraoka, Toshio; Yahagi, Naohisa] Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment,Canc Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Takeuchi, Hiroya; Kawakubo, Hirofumi; Matsuda, Satoru; Kato, Fumihiko; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan	Goto, O (reprint author), Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment,Canc Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ogotou-gi@a3.keio.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [25860558]	O.G. was funded by a Grant-in-Aid for Young Scientists from The Ministry of Education, Culture, Sports, Science and Technology in Japan in 2012-2013 (Grant No. 25860558).	Abe N, 2009, SURG ENDOSC, V23, P1908, DOI 10.1007/s00464-008-0317-y; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Abe N, 2011, GASTROINTEST ENDOSC, V74, P792, DOI 10.1016/j.gie.2011.06.006; Bok GH, 2012, ENDOSCOPY, V44, P953, DOI 10.1055/s-0032-1310162; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Nakajima K, 2009, SURG ENDOSC, V23, P2650, DOI 10.1007/s00464-009-0474-7; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Mitsui T, 2013, SURG LAPARO ENDO PER, V23, pE217, DOI 10.1097/SLE.0b013e31828e3f94; Mitsui T, 2013, GASTRIC CANC; Oyama Tsuneo, 2005, Clin Gastroenterol Hepatol, V3, pS67, DOI 10.1016/S1542-3565(05)00291-0; Yahagi N, 2011, TECH GASTROINTEST EN, V13, P74	17	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					440	445		10.1007/s10120-014-0358-y		6	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900031		
J	Miwa, K; Doyama, H; Ito, R; Nakanishi, H; Hirano, K; Inagaki, S; Tominaga, K; Yoshida, N; Takemura, K; Yamada, S; Kaneko, Y; Katayanagi, K; Kurumaya, H; Okada, T; Yamagishi, M				Miwa, Kazuhiro; Doyama, Hisashi; Ito, Renma; Nakanishi, Hiroyoshi; Hirano, Katsura; Inagaki, Satoko; Tominaga, Kei; Yoshida, Naohiro; Takemura, Kenichi; Yamada, Shinya; Kaneko, Yoshibumi; Katayanagi, Kazuyoshi; Kurumaya, Hiroshi; Okada, Toshihide; Yamagishi, Masakazu			Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens? (vol 15, pg 170, 2012)	GASTRIC CANCER			English	Correction									[Miwa, Kazuhiro; Doyama, Hisashi; Ito, Renma; Nakanishi, Hiroyoshi; Hirano, Katsura; Inagaki, Satoko; Tominaga, Kei; Yoshida, Naohiro; Takemura, Kenichi; Yamada, Shinya; Kaneko, Yoshibumi] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Miwa, Kazuhiro] Kanazawa Social Insurance Hosp, Dept Gastroenterol, Kanazawa, Ishikawa 9208610, Japan; [Miwa, Kazuhiro] Kanazawa Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan; [Katayanagi, Kazuyoshi; Kurumaya, Hiroshi] Ishikawa Prefectural Cent Hosp, Dept Pathol, Kanazawa, Ishikawa, Japan; [Okada, Toshihide; Yamagishi, Masakazu] Kanazawa Univ, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan	Miwa, K (reprint author), Kanazawa Social Insurance Hosp, Dept Gastroenterol, Ha 15 Okimachi, Kanazawa, Ishikawa 9208610, Japan.	kzmiwatoureg@yahoo.co.jp					Miwa K, 2012, GASTRIC CANCER, V15, P170, DOI 10.1007/s10120-011-0093-6	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	APR	2015	18	2					446	446		10.1007/s10120-015-0470-7		1	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CE1XT	WOS:000351606900032		
J	Fernandez-del Castillo, C; Tanaka, M				Fernandez-del Castillo, Carlos; Tanaka, Masao			Management of Pancreatic Cysts: The Evidence Is Not Here Yet	GASTROENTEROLOGY			English	Editorial Material							PAPILLARY MUCINOUS NEOPLASMS; INTERNATIONAL-CONSENSUS-GUIDELINES; RESECTION; CARCINOMA; IPMN		[Fernandez-del Castillo, Carlos] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Kyushu, Japan	Fernandez-del Castillo, C (reprint author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.						Vege SS, 2015, GASTROENTEROLOGY, V148, P819, DOI 10.1053/j.gastro.2015.01.015; Sadakari Y, 2010, SURGERY, V147, P812, DOI 10.1016/j.surg.2009.11.011; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Rodriguez JR, 2007, GASTROENTEROLOGY, V133, P72, DOI 10.1053/j.gastro.2007.05.010; Fritz S, 2012, ANN SURG, V256, P313, DOI 10.1097/SLA.0b013e31825d355f; Sahora K, 2013, ANN SURG, V258, P466, DOI 10.1097/SLA.0b013e3182a18f48; Ohtsuka T, 2012, AM J SURG, V204, P44, DOI 10.1016/j.amjsurg.2011.04.007; Scheiman JM, 2015, GASTROENTEROLOGY, V148, P824, DOI 10.1053/j.gastro.2015.01.014; de Jong K, 2010, CLIN GASTROENTEROL H, V8, P806, DOI 10.1016/j.cgh.2010.05.017; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x; Sadakari Y, 2010, PANCREAS, V39, P232, DOI 10.1097/MPA.0b013e3181bab60e; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Wong J, 2013, J GASTROINTEST SURG, V17, P78, DOI 10.1007/s11605-012-2017-0; Fernandez-del Castillo C, 2010, GASTROENTEROLOGY, V139, P708, DOI 10.1053/j.gastro.2010.07.025; Hruban RH, 2007, AFIP ATLAS TUMOR P 4, V4; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Tanaka M, 2011, NAT REV GASTRO HEPAT, V8, P56, DOI 10.1038/nrgastro.2010.193	17	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	APR	2015	148	4					685	687		10.1053/j.gastro.2015.02.034		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2IJ	WOS:000351639000008		
J	Koizumi, M; Kumagi, T; Hiasa, Y				Koizumi, Mitsuhito; Kumagi, Teru; Hiasa, Yoichi			An Unusual Cause of Abdominal Pain Pancreatobiliary Fistulas Associated With Intraductal Papillary Mucinous Neoplasm	GASTROENTEROLOGY			English	Editorial Material									[Koizumi, Mitsuhito; Kumagi, Teru; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan	Koizumi, M (reprint author), Ehime Univ, Grad Sch Med, Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan.						Kurihara K, 2000, HEPATO-GASTROENTEROL, V47, P1164; Kobayashi G, 2010, J GASTROENTEROL, V45, P1080, DOI 10.1007/s00535-010-0263-z; Retter J, 2007, J GASTROINTEST LIVER, V16, P445	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	APR	2015	148	4					E1	E2		10.1053/j.gastro.2014.10.057		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2IJ	WOS:000351639000001		
J	Namikawa, T; Kobayashi, M; Hanazaki, K				Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro			Esophageal Tumor After Radical Surgery for Gastric Cancer Solitary Esophageal Metastasis Arising From Gastric Cancer	GASTROENTEROLOGY			English	Editorial Material							INTRAMURAL METASTASIS; ADENOCARCINOMA		[Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Kochi, Japan	Namikawa, T (reprint author), Kochi Med Sch, Dept Surg, Kochi, Japan.						Hashimoto T, 2013, GASTRIC CANCER, V16, P537, DOI 10.1007/s10120-012-0228-4; Ki SH, 2013, WORLD J GASTROENTERO, V19, P3699, DOI 10.3748/wjg.v19.i23.3699; Szanto I, 2002, ENDOSCOPY, V34, P418, DOI 10.1055/s-2002-25294	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	APR	2015	148	4					E9	E10		10.1053/j.gastro.2014.10.056		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2IJ	WOS:000351639000005		
J	Kim, JS; Lee, J; Seo, SG; Lee, C; Woo, SY; Kim, SH				Kim, Ji-Seong; Lee, Jeongeun; Seo, Sang-Gyu; Lee, Chanhui; Woo, Su Young; Kim, Sun-Hyung			Gene expression profile affected by volatiles of new plant growth promoting rhizobacteria, Bacillus subtilis strain JS, in tobacco	GENES & GENOMICS			English	Article						Plant growth-promoting rhizobacteria; Suppression subtractive hybridization; Volatiles; RT-PCR	SUPPRESSION SUBTRACTIVE HYBRIDIZATION; GLUTATHIONE S-TRANSFERASES; BACTERIAL VOLATILES; SYSTEMIC RESISTANCE; ARABIDOPSIS; COMPLEX; YIELD; PHOTOSYNTHESIS; TECHNOLOGY; LIBRARIES	Specific bacterial strains that promote plant growth have been investigated extensively and are characterized as plant growth-promoting rhizobacteria (PGPR). To identify the series of genes involved in PGPR-mediated enhanced plant growth, suppression subtractive hybridization was performed using cDNA from tobacco plants exposed to the PGPR strain, Bacillus subtilis strain JS. After hybridization, forward and reverse subtraction cDNA libraries containing 580 clones were obtained. Blastx search detected 170 single genes. These were classified into 14 functional categories, including metabolic processes and cellular processes implicated in growth promotion. Of the 36 responsive genes confirmed by RT-PCR, expression of 24 genes was up-regulated and 12 were down-regulated by treatment with B. subtilis JS volatile compounds. Photosynthesis pathway related genes encoding chlorophyll a/b binding protein, chloroplast sedoheptulose-1,7-bisphosphatase, and the photosynthate transport related gene were up-regulated, perhaps accounting for the volatile compound-mediated enhanced plant growth. Reactive oxygen species scavenging enzyme encoding genes as well as glutathione S-transferase and methionine-R-sulfoxide reductase were down-regulated.	[Kim, Ji-Seong; Lee, Jeongeun; Seo, Sang-Gyu; Woo, Su Young; Kim, Sun-Hyung] Univ Seoul, Dept Environm Hort, Seoul 130743, South Korea; [Kim, Ji-Seong; Lee, Jeongeun] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Lee, Chanhui] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea	Kim, SH (reprint author), Univ Seoul, Dept Environm Hort, Seoulsiripdae Ro 163, Seoul 130743, South Korea.	kimmads3327@gmail.com			Forest Science & Technology Projects, Forest Service. Republic of Korea [S211214L030210]	This work was supported by a Grant (Code# S211214L030210) from Forest Science & Technology Projects, Forest Service. Republic of Korea.	Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Kim SH, 2005, BIOTECHNOL LETT, V27, P1841, DOI 10.1007/s10529-005-3891-2; Guo JH, 2004, BIOL CONTROL, V29, P66, DOI 10.1016/S1049-9644(03)00124-5; Karlidag H, 2007, SCI HORTIC-AMSTERDAM, V114, P16, DOI 10.1016/j.scienta.2007.04.013; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Kwon YS, 2010, PLANTA, V232, P1355, DOI 10.1007/s00425-010-1259-x; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Peer W, 1996, PLANT PHYSIOL, V111, P627, DOI 10.1104/pp.111.2.627; WOODROW IE, 1993, PLANTA, V191, P421; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Oh SK, 2010, PLANT PHYSIOL, V154, P245, DOI 10.1104/pp.110.162339; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Jetiyanon K, 2002, BIOL CONTROL, V24, P285, DOI 10.1016/S1049-9644(02)00022-1; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; Epstein CB, 2000, CURR OPIN BIOTECH, V11, P36, DOI 10.1016/S0958-1669(99)00065-8; Bernard RG, 2007, EUR J PLANT PATHOL, V119, P329; Byers RJ, 2000, INT J EXP PATHOL, V81, P391, DOI 10.1046/j.1365-2613.2000.00174.x; Datta M, 2011, AUST J CROP SCI, V5, P531; deSalamone IEG, 1996, BIOL FERT SOILS, V23, P249, DOI 10.1007/s003740050168; Kandasamy S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-47; KIM Y, 1991, PHYSIOL PLANTARUM, V81, P501; LOPER JE, 1986, PHYTOPATHOLOGY, V76, P386, DOI 10.1094/Phyto-76-386; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Orhan E, 2006, SCI HORTIC-AMSTERDAM, V111, P38, DOI 10.1016/j.scienta.2006.09.002; PICHERSKY E, 1987, PLANT MOL BIOL, V9, P109, DOI 10.1007/BF00015643; Song JY, 2012, J BACTERIOL, V194, P3760, DOI 10.1128/JB.00676-12; Stein J, 2002, CELL MOL LIFE SCI, V59, P1235, DOI 10.1007/s00018-002-8501-z; vonStein OD, 1997, NUCLEIC ACIDS RES, V25, P2598, DOI 10.1093/nar/25.13.2598; Wang XL, 2005, J PLANT PHYSIOL, V162, P1254, DOI 10.1016/j.jplph.2005.01.005	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1976-9571	2092-9293		GENES GENOM	Genes Genom.	APR	2015	37	4					387	397		10.1007/s13258-015-0267-4		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CD8AB	WOS:000351316400008		
J	Bailet, P; Yoshinaga, M				Bailet, Pauline; Yoshinaga, Masahiko			Degeneration of Orlik-Solomon algebras and Milnor fibers of complex line arrangements	GEOMETRIAE DEDICATA			English	Article						Hyperplane arrangements; Milnor fibers; Aomoto complex	HOMOLOGY	We give a vanishing theorem for the monodromy eigenspaces of the Milnor fibers of complex line arrangements. By applying the modular bound of the local system cohomology groups given by Papadima-Suciu, the result is deduced from the vanishing of the cohomology of certain Aomoto complex over finite fields. In order to prove this, we introduce degeneration homomorphisms of Orlik-Solomon algebras.	[Bailet, Pauline] Univ Nice Sophia Antipolis, Lab JA Dieudonne, CNRS, UMR 7351, F-06108 Nice 02, France; [Bailet, Pauline; Yoshinaga, Masahiko] Hokkaido Univ, Dept Math, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Yoshinaga, M (reprint author), Hokkaido Univ, Dept Math, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	Pauline.BAILET@unice.fr; yoshinaga@math.sci.hokudai.ac.jp			JSPS [25400060]	The authors thank Professor Alexandru Dimca for his suggestions and encouragements. The second author is supported by JSPS Grant-in-Aid for Scientific Research (C) 25400060.	Papadima S, 2010, T AM MATH SOC, V362, P2685; Cohen DC, 2003, ANN I FOURIER, V53, P1883; COHEN DC, 1995, J LOND MATH SOC, V51, P105; Libgober A, 2002, TRENDS MATH, P141; Libgober A, 2000, COMPOS MATH, V121, P337, DOI 10.1023/A:1001826010964; Orlik P., 1992, GRUNDLEHREN MATH WIS, V300; Suciu A., 2014, ANN FAC SCI TOULOUSE, V23, P417; Williams K, 2013, TOPOL APPL, V160, P1129, DOI 10.1016/j.topol.2013.05.003; Yoshinaga M., 2014, VIETNAM J MATH, V42, P377; Yoshinaga M., 2013, J SINGUL, V7, P220	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	APR	2015	175	1					49	56		10.1007/s10711-014-0027-7		8	Mathematics	Mathematics	CE0ZD	WOS:000351539500002		
J	Kitayama, T; Terashima, Y				Kitayama, Takahiro; Terashima, Yuji			Torsion functions on moduli spaces in view of the cluster algebra	GEOMETRIAE DEDICATA			English	Article						Torsion invariant; Cluster algebra; Representation space	REIDEMEISTER TORSION; INVARIANTS; COHOMOLOGY; MANIFOLDS	We introduce non-acyclic -torsion of a -manifold with toroidal boundary as an extension of J. Porti's -torsion, and present an explicit formula of the -torsion of a mapping torus for a surface with punctures, by using the higher Teichmuler theory due to V. Fock and A. Goncharov. Our formula gives a concrete rational function which represents the torsion function and comes from a concrete cluster transformation associated with the mapping class.	[Kitayama, Takahiro] Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan; [Terashima, Yuji] Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, Tokyo 1528550, Japan	Terashima, Y (reprint author), Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	kitayama@math.titech.ac.jp; tera@is.titech.ac.jp					Menal-Ferrer P, 2012, OSAKA J MATH, V49, P741; Fomin S, 2002, J AM MATH SOC, V15, P497, DOI 10.1090/S0894-0347-01-00385-X; Kirk P, 1999, TOPOLOGY, V38, P635, DOI 10.1016/S0040-9383(98)00039-1; Fomin S, 2007, COMPOS MATH, V143, P112, DOI 10.1112/S0010437X06002521; MILNOR J, 1966, B AM MATH SOC, V72, P358, DOI 10.1090/S0002-9904-1966-11484-2; Kitano T, 1996, PAC J MATH, V174, P431; Friedl S, 2011, CONTRIB MATH COMPUT, P45, DOI 10.1007/978-3-642-15637-3_3; Fock V, 2006, PUBL MATH-PARIS, V103, P1, DOI 10.1007/s10240-006-0039-4; Dimofte T, 2013, GEOM TOPOL, V17, P1253, DOI 10.2140/gt.2013.17.1253; Menal-Ferrer P, 2014, J TOPOL, V7, P69, DOI 10.1112/jtopol/jtt024; THURSTON WP, 1982, B AM MATH SOC, V6, P357, DOI 10.1090/S0273-0979-1982-15003-0; Dubois J., 2006, CANAD MATH B, V49, P55, DOI 10.4153/CMB-2006-006-0; Garoufalidis S., ARXIV12076711; Garoufalidis S., ARXIV11112828; Lubotzky A., 1985, MEM AM MATH SOC, V58; Menal-Ferrer P., 2012, ANN MATH BLAISE PASC, V19, P107, DOI DOI 10.5802/AMBP.306.(2151); Milnor J, 1968, C TOP MAN, P115; Muller W., 2012, PROG MATH, V297; Nagao K, ARXIV11123106; Porti J., 1997, MEM AM MATH SOC, V128, px+139; Terashima Y., ARXIV13015902; Turaev V., 2002, PROGR MATH, V208; WEIL A, 1964, ANN MATH, V80, P149, DOI 10.2307/1970495	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	APR	2015	175	1					125	143		10.1007/s10711-014-0032-x		19	Mathematics	Mathematics	CE0ZD	WOS:000351539500007		
J	Watanabe, K				Watanabe, Kenta			The classification of ACM line bundles on quartic hypersurfaces in P-3	GEOMETRIAE DEDICATA			English	Article						ACM line bundle; Quartic hypersurface; K3 surface	SURFACES	In this paper, we give a complete classification of initialized and ACM line bundles on a smooth quartic hypersurface in P-3.	Osaka Univ, Dept Math Sci, Toyonaka, Osaka 5600043, Japan	Watanabe, K (reprint author), Osaka Univ, Dept Math Sci, 1-1 Machikaneyama Chou, Toyonaka, Osaka 5600043, Japan.	goo314kenta@mail.goo.ne.jp			Japan Society for the Promotion Science [25400039]	The author would like to thank Prof. Ohashi. The author would also like to thank the referee for the creative suggestions and the very helpful comments. The author is partially supported by Grant-in-Aid for Scientific Research (25400039), Japan Society for the Promotion Science.	SAINTDONAT B, 1974, AM J MATH, V96, P602, DOI 10.2307/2373709; Eisenbud D, 2003, J AM MATH SOC, V16, P537, DOI 10.1090/S0894-0347-03-00423-5; Casanellas M., 2008, J EUR MATH, V13, P709; Coskun E, 2012, DOC MATH, V17, P1003; Faenzi D, 2008, J ALGEBRA, V319, P143, DOI 10.1016/j.jalgebra.2007.10.005; KNORRER H, 1987, J INVENT MATH, V88, P153	6	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	APR	2015	175	1					347	354		10.1007/s10711-014-9950-x		8	Mathematics	Mathematics	CE0ZD	WOS:000351539500019		
J	Matsu'ura, T				Matsu'ura, Tabito			Late Quaternary uplift rate inferred from marine terraces, Muroto Peninsula, southwest Japan: Forearc deformation in an oblique subduction zone	GEOMORPHOLOGY			English	Article						Late Quaternary; Marine terrace; Muroto-Misaki (Cape Muroto); Uplift rate; Southwestem Japan; Oblique subduction zone	PLATE CONVERGENCE; NEW-ZEALAND; EARTHQUAKE; DISPLACEMENT; SEDIMENTS; PACIFIC; SUMATRA; RUPTURE; FAULTS; GROWTH	Tectonic uplift rates across the Muroto Peninsula, in the southwest Japan forearc (the overriding plate in the southwest Japan oblique subduction zone), were estimated by mapping the elevations of the inner edges of marine terrace surfaces. The uplift rates inferred from marine terraces M1 and M2, which were correlated by tephrochronology with marine isotope stages (MIS) 5e and 5c, respectively, include some vertical offset by local faults but generally decrease northwestward from 12-1.6 m ky(-1) on Cape Muroto to 0.3-0.7 m ky(-1) in the Kochi Plain. The vertical deformation of the Muroto Peninsula since MIS 5e and 5c was interpreted as a combination of regional uplift and folding related to the arc-normal offshore Muroto-Misaki fault. A regional uplift rate of 0.46 m ky(-1) was estimated from terraces on the Muroto Peninsula, and the residual deformation of these terraces was attributed to fault-related folding. A mass-balance calculation yielded a shortening rate of 0.71-0.77 m ky(-1) for the Muroto Peninsula, with the Muroto-Misaki fault accounting for 0.60-0.71 m ky(-1) but these rates may be overestimated by as much as 10% given variations of several meters in the elevation difference between the buried shoreline angles and terrace inner edges in the study area. A thrust fault model with flat (5-10 degrees dip) and ramp (60 degrees dip) components is proposed to explain the shortening rate and uplift rate of the Muroto-Misaki fault since MIS 5e. Bedrock deformation also indicates that the northern extension of this fault corresponds to the older Muroto Flexure. (C) 2015 The Author. Published by Elsevier B.V.	[Matsu'ura, Tabito] Japan Nucl Energy Safety Org JNES, Toranomon Towers Off, Minato Ku, Tokyo 1050001, Japan	Matsu'ura, T (reprint author), Secretariat Nucl Regulat Author S NRA R, Regulatory Standard & Res Dept, Minato Ku, 1-9-9 Roppongi, Tokyo 1068450, Japan.	tabito_matsuura@nsr.go.jp					ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Lowe DJ, 2011, QUAT GEOCHRONOL, V6, P107, DOI 10.1016/j.quageo.2010.08.003; MANSINHA L, 1971, B SEISMOL SOC AM, V61, P1433; Chamberlin RT, 1910, J GEOL, V18, P228; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Brandon MT, 1998, GEOL SOC AM BULL, V110, P985, DOI 10.1130/0016-7606(1998)110<0985:LCEOTC>2.3.CO;2; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Seno T, 1996, J GEOPHYS RES-SOL EA, V101, P11305, DOI 10.1029/96JB00532; McCalpin JP, 2009, INT GEOPHYS SER, V95, P315, DOI 10.1016/S0074-6142(09)95005-7; Benedetti L, 2000, J GEOPHYS RES-SOL EA, V105, P739, DOI 10.1029/1999JB900222; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; MCCAFFREY R, 1992, J GEOPHYS RES-SOL EA, V97, P8905, DOI 10.1029/92JB00483; Lay T, 2005, SCIENCE, V308, P1127, DOI 10.1126/science.1112250; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; FITCH TJ, 1972, J GEOPHYS RES, V77, P4432, DOI 10.1029/JB077i023p04432; EPARD JL, 1993, AAPG BULL, V77, P1291; Aoki K, 2008, QUATERN INT, V178, P100, DOI 10.1016/j.quaint.2007.02.005; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Bernard S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004149; Central Disaster Prevention Council, 2013, HAZ ASS LARG EARTHQ; Cronin SJ, 1996, J VOLCANOL GEOTH RES, V72, P199, DOI 10.1016/0377-0273(96)00008-X; DITULLIO L, 1990, GEOL SOC AM BULL, V102, P1420, DOI 10.1130/0016-7606(1990)102<1420:DPITSL>2.3.CO;2; DiTullio L., 1989, EARTH MONTHLY, V11, P673; Furusawa A., 2003, B VOLCANOL SOC JPN, V48, P309; Furusawa A., 2009, J GEOLOGICAL SOC JAP, V115, P544; Headquarter of Earthquake Research Project, 2013, LONG TERM ACT EV SEI; HIBBARD JP, 1990, TECTONICS, V9, P207, DOI 10.1029/TC009i002p00207; HULL AG, 1987, QUATERNARY RES, V28, P183, DOI 10.1016/0033-5894(87)90058-5; Japan Coast Guard, 2014, TABL TID HARM CONST; Kamata H., 1996, INVENTORY QUATERNARY, P299; Kamata H., 1998, B VOLCANOLOGICAL SOC, V43, P69; Kanaya A., 1978, GEOGR REV, V51, P451; Kawai S., 1999, J GEOLOGICAL SOC JAP, V105, P597; Kawamura Norihito, 2009, Quaternary Research (Tokyo), V48, P379; Keller EA, 2002, ACTIVE TECTONICS EAR; Kimura G., 2002, TECTONICS CONVERGENT; Kimura J., 1996, INVENTORY QUATERNARY, P34; Kimura S., 2001, J GEOGR, V110, P581; Koike K., ATLAS QUATERNARY MAR; Kumahara Y., 2002, QUAT RES JPN, V41, P213; lwai M., 2006, J GEOL SOC JPN, V112, P27; Machida H., 2003, ATLAS TEPHRA JAPAN; Maemoku H., 2001, J GEOGR, V110, P479; Maemoku H., 2006, J GEOL SOC JPN, V112, P17; Maemoku H., 1988, GEOGRAPHICAL REV JAP, V61, P747; Maemoku H., 1996, INVENTORY QUATERNARY; Matsu'ura T, 2011, QUATERN INT, V246, P48, DOI 10.1016/j.quaint.2011.03.017; Matsu'ura T, 2014, GEOMORPHOLOGY, V209, P1, DOI 10.1016/j.geomorph.2013.11.013; Matsu'ura T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006963; Matsu'ura T, 2009, QUATERNARY RES, V71, P227, DOI 10.1016/j.yqres.2008.12.005; Matsu'ura T, 2014, QUAT GEOCHRONOL, V23, P63, DOI 10.1016/j.quageo.2014.06.001; Morie T., 2001, QUATERNARY RES, V40, P331; Okal EA, 2007, PURE APPL GEOPHYS, V164, P325, DOI 10.1007/s00024-006-0181-4; Okamura Y., 1990, J GEOL SOC JPN, V96, P223; Okuno M., 1998, B VOLCANOLOGICAL SOC, V43, P75; Ono K., 1996, INVENTORY QUATERNARY, P33; Pinter N., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:FRFICN>2.0.C0;2; Plafker G., 1987, US GEOLOGICAL SURVEY, P146; Research Group for Active Faults of Japan, 1991, ACT FAULTS JAP SHEET, VSecond; Siddall M., 2006, CLIMATE INTERGLACIAL, V7, P75; SUPPE J, 1983, AM J SCI, V283, P684; Taira A., 1980, GEOLOGY PALEONTOLOGY, P319; ten Brink US, 2006, GEOLOGY, V34, P585, DOI 10.1130/G22173.1; WESSEL P, 1998, EOS T AGU, V0079; Yonekura N., 1975, B DEP GEOGR U TOKYO, V15, P47; Yoshikawa T., 1964, GEOGR REV JPN, V37, P627	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-555X	1872-695X		GEOMORPHOLOGY	Geomorphology	APR 1	2015	234						133	150		10.1016/j.geomorph.2015.01.012		18	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CE4IV	WOS:000351795200012		
J	Tang, HY; Liu, G; Zhu, JG; Kobayashi, K				Tang, Haoye; Liu, Gang; Zhu, Jianguo; Kobayashi, Kazuhiko			Effects of elevated ozone concentration on CH4 and N2O emission from paddy soil under fully open-air field conditions	GLOBAL CHANGE BIOLOGY			English	Article						biomass; CH4 emission; elevated ozone; FACE; N2O emission; paddy soil; rice cultivar	YANGTZE-RIVER DELTA; METHANE EMISSION; TROPOSPHERIC OZONE; RICE CULTIVARS; CARBON-DIOXIDE; JAPANESE CULTIVARS; CO2 ENRICHMENT; GLOBAL CHANGE; WATER REGIME; WINTER-WHEAT	We investigated the effects of elevated ozone concentration (E-O-3) on CH4 and N2O emission from paddies with two rice cultivars: an inbred Indica cultivar Yangdao 6 (YD6) and a hybrid one II-you 084 (IIY084), under fully open-air field conditions in China. A mean 26.7% enhancement of ozone concentration above the ambient level (A-O-3) significantly reduced CH4 emission at tillering and flowering stages leading to a reduction of seasonal integral CH4 emission by 29.6% on average across the two cultivars. The reduced CH4 emission is associated with O-3-induced reduction in the whole-plant biomass (-13.2%), root biomass (-34.7%), and maximum tiller number (-10.3%), all of which curbed the carbon supply for belowground CH4 production and its release from submerged soil to atmosphere. Although no significant difference was detected between the cultivars in the CH4 emission response to E-O-3, a larger decrease in CH4 emission with IIY084 (-33.2%) than that with YD6 (-7.0%) was observed at tillering stage, which may be due to the larger reduction in tiller number in IIY084 by E-O-3. Additionally, E-O-3 reduced seasonal mean NOx flux by 5.7% and 11.8% with IIY084 and YD6, respectively, but the effects were not significant statistically. We found that the relative response of CH4 emission to E-O-3 was not significantly different from those reported in open-top chamber experiments. This study has thus confirmed that increasing ozone concentration would mitigate the global warming potential of CH4 and suggested consideration of the feedback mechanism between ozone and its precursor emission into the projection of future ozone effects on terrestrial ecosystem.	[Tang, Haoye; Liu, Gang; Zhu, Jianguo] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China; [Tang, Haoye; Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Kobayashi, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	gliu@issas.ac.cn; aclasman@mail.ecc.u-tokyo.ac.jp			Knowledge Innovation Program of the Chinese Academy of Sciences [ISSASIP1112, KZCX2-EW-414]; National Natural Science Foundation of China [41271256]; RONPAKU Fellowship of the Japan Society for the Promotion of Science [CAS-11012]; Global Environment Research Fund of the Ministry of Environment, Japan [C-062]	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (ISSASIP1112, KZCX2-EW-414) and National Natural Science Foundation of China (Grants No. 41271256). It was also supported by the RONPAKU Fellowship (CAS-11012) of the Japan Society for the Promotion of Science and the Global Environment Research Fund (C-062) of the Ministry of Environment, Japan.	Feng ZW, 2003, J ENVIRON SCI-CHINA, V15, P360; Ren W, 2012, GLOBAL CHANGE BIOL, V18, P2945, DOI 10.1111/j.1365-2486.2012.02741.x; Grantz DA, 2006, PLANT CELL ENVIRON, V29, P1193, DOI 10.1111/j.1365-3040.2006.01521.x; Tang HY, 2011, ATMOS ENVIRON, V45, P6276, DOI 10.1016/j.atmosenv.2011.08.059; Mills G, 2011, GLOBAL CHANGE BIOL, V17, P592, DOI 10.1111/j.1365-2486.2010.02217.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Feng ZZ, 2008, GLOBAL CHANGE BIOL, V14, P2696, DOI 10.1111/j.1365-2486.2008.01673.x; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382; Feng YZ, 2011, MICROB ECOL, V62, P789, DOI 10.1007/s00248-011-9895-7; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Fiore AM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009162; Larson JL, 2002, SOIL SCI SOC AM J, V66, P1848; Feng ZZ, 2011, GLOBAL CHANGE BIOL, V17, P580, DOI 10.1111/j.1365-2486.2010.02184.x; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; Morgan PB, 2006, NEW PHYTOL, V170, P333, DOI 10.1111/j.1469-8137.2006.01679.x; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Tang HY, 2013, GLOBAL CHANGE BIOL, V19, P2739, DOI 10.1111/gcb.12252; Zeng G, 2008, ATMOS CHEM PHYS, V8, P369; Fuhrer J, 2003, ENVIRON INT, V29, P141, DOI 10.1016/S0160-4120(02)00157-5; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Avnery S, 2013, GLOBAL CHANGE BIOL, V19, P1285, DOI 10.1111/gcb.12118; Bhatia A, 2011, AGR ECOSYST ENVIRON, V144, P21, DOI 10.1016/j.agee.2011.07.003; Chen Z, 2008, J ENVIRON SCI-CHINA, V20, P320, DOI 10.1016/S1001-0742(08)60050-9; Chen Z, 2010, SOIL SCI SOC AM J, V74, P829, DOI 10.2136/sssaj2009.0258; Cheng WG, 2006, BIOGEOCHEMISTRY, V77, P351, DOI 10.1007/s10533-005-1534-2; COOLEY DR, 1987, ENVIRON POLLUT, V47, P95, DOI 10.1016/0269-7491(87)90040-6; Decock C, 2012, SOIL BIOL BIOCHEM, V51, P104, DOI 10.1016/j.soilbio.2012.04.015; FARAGE PK, 1995, PHOTOSYNTH RES, V43, P11, DOI 10.1007/BF00029457; Feng YZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03193; Grantz DA, 2000, J EXP BOT, V51, P919, DOI 10.1093/jexbot/51.346.919; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Inubushi K, 2003, GLOBAL CHANGE BIOL, V9, P1458, DOI 10.1046/j.1365-2486.2003.00665.x; Jones TG, 2009, ECOL ENG, V35, P971, DOI 10.1016/j.ecoleng.2008.08.009; KOBAYASHI K, 1995, AGR ECOSYST ENVIRON, V53, P109, DOI 10.1016/0167-8809(94)00564-U; Lou YS, 2008, GLOBAL CHANGE BIOL, V14, P2678, DOI 10.1111/j.1365-2486.2008.01665.x; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; McCrady JK, 2000, ENVIRON POLLUT, V107, P465, DOI 10.1016/S0269-7491(99)00122-0; Miller JE, 1998, CROP SCI, V38, P122; Mitra S, 1999, AGR ECOSYST ENVIRON, V73, P177, DOI 10.1016/S0167-8809(99)00015-8; NOUCHI I, 1991, ENVIRON POLLUT, V74, P149, DOI 10.1016/0269-7491(91)90111-9; NOUCHI I, 1990, PLANT PHYSIOL, V94, P59, DOI 10.1104/pp.94.1.59; Pang J, 2009, AGR ECOSYST ENVIRON, V132, P203, DOI 10.1016/j.agee.2009.03.012; Rai R, 2010, ATMOS ENVIRON, V44, P4272, DOI 10.1016/j.atmosenv.2010.06.022; Shi GY, 2009, AGR ECOSYST ENVIRON, V131, P178, DOI 10.1016/j.agee.2009.01.009; Tang HY, 2014, ATMOS ENVIRON, V86, P74, DOI 10.1016/j.atmosenv.2013.11.078; The Royal Society, 2008, 1508 ROYAL SOC; Toet S, 2011, GLOBAL CHANGE BIOL, V17, P288, DOI 10.1111/j.1365-2486.2010.02267.x; Wang B, 1997, AGR ECOSYST ENVIRON, V62, P31, DOI 10.1016/S0167-8809(96)01115-2; Wang YX, 2012, AGR ECOSYST ENVIRON, V150, P63, DOI 10.1016/j.agee.2012.01.016; Xing GX, 1998, NUTR CYCL AGROECOSYS, V52, P249, DOI 10.1023/A:1009776008840; Xu H, 2000, AUST J SOIL RES, V38, P1, DOI 10.1071/SR99026; Yamaguchi Masahiro, 2008, Journal of Agricultural Meteorology, V64, P131, DOI 10.2480/agrmet.64.3.8; Zheng FX, 2011, GLOBAL CHANGE BIOL, V17, P898, DOI 10.1111/j.1365-2486.2010.02258.x; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	APR	2015	21	4					1727	1736		10.1111/gcb.12810		10	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CD6QM	WOS:000351214100032		
J	Iwamori, H; Nakamura, H				Iwamori, Hikaru; Nakamura, Hitomi			Isotopic heterogeneity of oceanic, arc and continental basalts and its implications for mantle dynamics	GONDWANA RESEARCH			English	Review						Mantle; Isotope; Basalt; Heterogeneity; Dynamics	EARTHS INNER-CORE; INDEPENDENT COMPONENT ANALYSIS; MIDOCEAN RIDGE BASALTS; MID-ATLANTIC RIDGE; TRACE-ELEMENT; SUBDUCTION ZONES; ISLAND BASALTS; STAGNANT SLAB; GEOMAGNETIC REVERSALS; CHEMICAL GEODYNAMICS	In order to discuss material recycling within the mantle, isotopic variability of the young basalts, which reflect the composition of the mantle, has been investigated based on a large compiled data set of Sr, Nd and Pb isotopic ratios. In addition to mid-ocean ridge basalts (MORB, 2773 data), oceanic island basalts (OIB, 1515 data) and arc basalts (AB, 1049 data) that have been used in the previous studies, the new data set includes continental basalts (CB, 1517 data) to densely cover the globe and examine the geographical distribution of the mantle heterogeneity. It is found that CB are heavily concentrated in the eastern hemisphere, while MORB, OIB and AB are broadly distributed in the eastern and western hemispheres evenly. Then the independent features hidden in the data have been extracted using the multivariate analysis "Independent Component Analysis (ICA)", which provide information concerning the overall structure of the data and its origin. As a result, three independent components (ICs), which are similar to those deduced in the previous studies on the oceanic and arc basalts, are identified and account for 99% of the sample variance. Of these, the two independent components (IC1 and IC2) span a compositional plane that concentrates most of the data (95%), and the third minor component (IC3) accounts for 4%. Therefore, the oceanic, arc and continental basalts mostly plot on the same plane. The geochemical nature and the statistical properties (mean, standard deviation and skewness) of the ICs suggest that IC1 is related to variability of a long-term 'melt component' inherited in the mantle, whereas IC2 corresponds to a long-term 'aqueous fluid component' in the mantle. Numerical models for a differentiation-recycling system explain most of the statistical features of IC1 and IC2, which have likely been produced by melting and aqueous fluid-rock interactions in ridge, plume and subduction zone. Material recycling and multiple processing in these tectonic settings allow IC1 and IC2 to overlap and create a joint distribution (i.e., the major compositional plane). On the other hand, IC3 exhibits unique features (e.g., a large positive skewness), suggesting that it represents minor and incomplete mixing of continental components from outside the mantle recycling system. In addition, IC2 shows global geographical discrimination, irrespective of the type of basalts, indicating the presence of east-west geochemical hemispheres in the mantle. We have also found a striking geometrical similarity between the IC2 hemispheres and the inner core hemispheric structure: the eastern hemisphere shows positive IC2 in the mantle and high seismic velocities in the inner core. Combining these constraints, we propose top-down hemispherical dynamics involving both the mantle and the core: focused subduction towards the supercontinents has formed a fluid component-rich hemispheric domain that seems to have been anchored to the asthenosphere during the continental dispersal in the past several hundred million years, and may affect the temperature and growth rate of the inner core, resulting in the synchronized hemispherical structures in the mantle and the core. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of International Association for Gondwana Research.	[Iwamori, Hikaru; Nakamura, Hitomi] Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528550, Japan	Iwamori, H (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	hikaru@jamstec.go.jp			JSPS KAKENHI Grant [26247091]	The authors would like to thank S. Maruyama and T. Sakuyama for discussion and help, and Antonio Castro and two anonymous reviewers for constructive review. This work was supported by JSPS KAKENHI Grant Number 26247091.	Agranier A, 2005, EARTH PLANET SC LETT, V238, P96, DOI 10.1016/j.epsl.2005.07.011; Albarede F, 2005, GEOPH MONOG SERIES, V160, P27, DOI 10.1029/160GM04; ALLEGRE CJ, 1982, TECTONOPHYSICS, V81, P109, DOI 10.1016/0040-1951(82)90125-1; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P319, DOI 10.1016/0012-821X(87)90120-8; WHITE WM, 1985, GEOLOGY, V13, P115, DOI 10.1130/0091-7613(1985)13<115:SOOBRI>2.0.CO;2; Takeuchi N, 2007, GEOPHYS J INT, V169, P1153, DOI 10.1111/j.1365-246X.2007.03405.x; Wolfe CJ, 2009, SCIENCE, V326, P1388, DOI 10.1126/science.1180165; Maruyama S, 2007, GONDWANA RES, V11, P7, DOI 10.1016/j.gr.2006.06.003; KLEIN EM, 1988, NATURE, V333, P623, DOI 10.1038/333623a0; Putirka KD, 2009, J PETROL, V50, P1639, DOI 10.1093/petrology/egp045; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Karato S, 2011, EARTH PLANET SC LETT, V301, P413, DOI 10.1016/j.epsl.2010.11.038; Kogiso T, 1997, EARTH PLANET SC LETT, V148, P193, DOI 10.1016/S0012-821X(97)00018-6; MCKENZIE D, 1988, J PETROL, V29, P625; Sakuraba A, 2009, NAT GEOSCI, V2, P802, DOI 10.1038/NGEO643; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Kellogg JB, 2002, EARTH PLANET SC LETT, V204, P183, DOI 10.1016/S0012-821X(02)00981-0; ZINDLER A, 1982, NATURE, V298, P519, DOI 10.1038/298519a0; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Grand SP, 2002, PHILOS T ROY SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Helffrich G, 2010, NATURE, V468, P807, DOI 10.1038/nature09636; Albarede F, 2004, GEOCHIM COSMOCHIM AC, V68, P2725, DOI 10.1016/j.gca.2003.11.024; Wolfe CJ, 2011, EARTH PLANET SC LETT, V303, P267, DOI 10.1016/j.epsl.2011.01.004; WHITE WM, 1986, J GEOPHYS RES-SOLID, V91, P5927, DOI 10.1029/JB091iB06p05927; Zhong SJ, 2007, EARTH PLANET SC LETT, V261, P551, DOI 10.1016/j.epsl.2007.07.049; DUPRE B, 1983, NATURE, V303, P142, DOI 10.1038/303142a0; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Ito G, 2005, EARTH PLANET SC LETT, V230, P29, DOI 10.1016/j.epsl.2004.10.035; Arcay D, 2005, PHYS EARTH PLANET IN, V149, P133, DOI 10.1016/j.pepi.2004.08.020; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Monnereau M, 2010, SCIENCE, V328, P1014, DOI 10.1126/science.1186212; DZIEWONSKI AM, 1984, J GEOPHYS RES, V89, P5929, DOI 10.1029/JB089iB07p05929; Workman RK, 2005, EARTH PLANET SC LETT, V231, P53, DOI 10.1016/j.epsl.2004.12.005; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; Stracke A, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000824; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; SCHILLING JG, 1980, PHILOS T R SOC A, V297, P147; Iwamori H, 1998, EARTH PLANET SC LETT, V160, P65, DOI 10.1016/S0012-821X(98)00080-6; Kelbert A, 2009, NATURE, V460, P1003, DOI 10.1038/nature08257; Jackson MG, 2007, NATURE, V448, P684, DOI 10.1038/nature06048; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; HAGER BH, 1984, J GEOPHYS RES, V89, P6003, DOI 10.1029/JB089iB07p06003; Iwamori H, 2010, EARTH PLANET SC LETT, V299, P339, DOI 10.1016/j.epsl.2010.09.014; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; ALLEGRE CJ, 1981, EARTH PLANET SC LETT, V52, P85, DOI 10.1016/0012-821X(81)90210-7; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Yogodzinski GM, 2001, NATURE, V409, P500, DOI 10.1038/35054039; Tackley PJ, 2008, PHYS EARTH PLANET IN, V171, P7, DOI 10.1016/j.pepi.2008.08.005; Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Fukao Y, 2009, ANNU REV EARTH PL SC, V37, P19, DOI 10.1146/annurev.earth.36.031207.124224; BRENAN JM, 1995, GEOCHIM COSMOCHIM AC, V59, P3331, DOI 10.1016/0016-7037(95)00215-L; BEATTIE P, 1993, NATURE, V363, P63, DOI 10.1038/363063a0; Turner S, 1996, J PETROL, V37, P45, DOI 10.1093/petrology/37.1.45; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V132, P1, DOI 10.1016/0012-821X(95)00049-I; Cao A, 2004, EARTH PLANET SC LETT, V228, P243, DOI 10.1016/j.epsl.2004.09.032; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Gerya TV, 2003, EARTH PLANET SC LETT, V212, P47, DOI 10.1016/S0012-821X(03)00265-6; Wood BJ, 2010, NATURE, V465, P767, DOI 10.1038/nature09072; Keppler H, 1996, NATURE, V380, P237, DOI 10.1038/380237a0; Hanan BB, 1996, SCIENCE, V272, P991, DOI 10.1126/science.272.5264.991; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.earth.14.1.493; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Meyzen CM, 2007, NATURE, V447, P1069, DOI [10.1038/nature05920, 10.1038/natureO5920]; GREEN TH, 1994, CHEM GEOL, V117, P1, DOI 10.1016/0009-2541(94)90119-8; Sakuyama T, 2013, CHEM GEOL, V359, P32, DOI 10.1016/j.chemgeo.2013.09.012; Nakamura H, 2009, GONDWANA RES, V16, P431, DOI 10.1016/j.gr.2009.05.004; Deuss A, 2010, SCIENCE, V328, P1018, DOI 10.1126/science.1188596; Hofmann AW, 2013, GEOCHEM GEOPHY GEOSY, V14, P5308, DOI 10.1002/2013GC004942; BONATTI E, 1990, SCIENCE, V250, P107, DOI 10.1126/science.250.4977.107; Olson P, 2013, PHYS EARTH PLANET IN, V214, P87, DOI 10.1016/j.pepi.2012.10.003; Iwamori H, 2000, EARTH PLANET SC LETT, V181, P131, DOI 10.1016/S0012-821X(00)00182-5; Richard GC, 2010, PHYS EARTH PLANET IN, V183, P280, DOI 10.1016/j.pepi.2010.02.009; Alboussiere T, 2010, NATURE, V466, P744, DOI 10.1038/nature09257; Blichert-Toft J., 1999, SCIENCE, V285; Blichert-Toft J, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000788; Cagnioncle AM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004934; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; Clement JP, 2003, CAN J EARTH SCI, V40, P1239, DOI 10.1139/E03-046; Cooper KM, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000332; Davies GF, 2002, GEOCHIM COSMOCHIM AC, V66, P3125, DOI 10.1016/S0016-7037(02)00915-8; DUPUY C, 1993, GEOCHEM J, V27, P131; Ersoy YE, 2012, CONTRIB MINERAL PETR, V163, P379, DOI 10.1007/s00410-011-0679-3; Ferrachat S., 2001, GEOCHEM GEOPHY GEOSY, V2, P1013, DOI DOI 10.1029/2000GC000092; Hall R., 1995, GEOPHYS MONOGR SER, V88, P371; Hanyu T, 2013, CONTRIB MINERAL PETR, V166, P1285, DOI 10.1007/s00410-013-0926-x; Hawkesworth C., 2007, CEHM GEOLOGY, V241, P248; Hickey-Varagas R., 1998, J GEOPHYS RES, V103, P2096; Hofmann A.W., 2003, TREATISE GEOCHEMISTR, V2, P61; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Hyvarinen A., 2001, INDEPENDENT COMPONEN; Iwamori H., 2013, PHYS CHEM DEEP EARTH; IWAMORI H, 1995, EARTH PLANET SC LETT, V134, P253, DOI 10.1016/0012-821X(95)00122-S; Iwamori H., 2008, GEOCHEMISTRY GEOPHYS, V9; Iwamori H, 2012, GEOCHEM J, V46, pE39; KamLAND Collaboration, 2011, NATURE GEOSCIENCE, V4, P647, DOI DOI 10.1038/NGEO1205; Kellogg JB, 2007, EARTH PLANET SC LETT, V262, P328, DOI 10.1016/j.epsl.2007.06.018; Lay T, 2004, GEOPHYS MONOGR SER, V150, P25, DOI 10.1029/150GM04; MCKENZIE D, 1991, J PETROL, V32, P1021; McKenzie D, 2004, GEOCHIM COSMOCHIM AC, V68, P2699, DOI 10.1016/j.gca.2003.10.029; Meibom A., 2003, EARTH PLANET SC LETT, V217, P123; Nakagawa T, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002280; Nakamura H, 2013, CONTRIB MINERAL PETR, V165, P1107, DOI 10.1007/s00410-013-0850-0; Nasir SJ, 2010, LITHOS, V118, P35, DOI 10.1016/j.lithos.2010.03.012; Oreshin SI, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018591; Ozima M., 2002, NOBLE GAS GEOCHEMIST; Prelevic D, 2012, J PETROL, V53, P1019, DOI 10.1093/petrology/egs008; Rasskazov SV, 2002, GEOL GEOFIZ, V43, P1065; Romanowicz B, 2003, ANNU REV EARTH PL SC, V31, P303, DOI 10.1146/annurev.earth.31.091602.113555; Rudge JF, 2005, GEOCHIM COSMOCHIM AC, V69, P3873, DOI 10.1016/j.gca.2005.03.004; SCHUBERT G., 2001, MANTLE CONVECTION EA; Scotese C.R., 1997, CONTINENTAL DRIFT FL; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Takamasa A, 2009, CHEM GEOL, V260, P37, DOI 10.1016/j.chemgeo.2008.11.018; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM, VBlackwell; van Keken PE, 1998, EARTH PLANET SC LETT, V156, P19, DOI 10.1016/S0012-821X(98)00023-5; Walzer U, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005459; Waszek L, 2011, NAT GEOSCI, V4, P264, DOI [10.1038/ngeo1083, 10.1038/NGEO1083]; Wessel P., 2013, T AM GEOPHYS UNION, V94, P409; Yanagisawa T, 2003, P JPN ACAD B-PHYS, V79, P99, DOI 10.2183/pjab.79B.99	122	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1342-937X	1878-0571		GONDWANA RES	Gondwana Res.	APR	2015	27	3			SI		1131	1152		10.1016/j.gr.2014.09.003		22	Geosciences, Multidisciplinary	Geology	CD2OL	WOS:000350918800016		
J	Hsu, LT; Jan, SS; Groves, PD; Kubo, N				Hsu, Li-Ta; Jan, Shau-Shiun; Groves, Paul D.; Kubo, Nobuaki			Multipath mitigation and NLOS detection using vector tracking in urban environments	GPS SOLUTIONS			English	Article						Multipath mitigation; Vector tracking; Vector delay lock loop (VDLL); Non-line-of-sight (NLOS) detection; Urban canyon; Strobe correlator	GPS	Multipath interference and non-line-of-sight (NLOS) reception are major error sources when using global navigation satellite systems in urban environments. A promising approach to minimize the effect of multipath interference and aid NLOS detection is vector tracking. Therefore, the objective of this research was to assess vector tracking in a dense urban environment to determine its effect on multipath interference and NLOS reception. Here, a vector delay lock loop is implemented using an adaptive extended Kalman filter. This replaces the individual code-tracking loops and navigation filter, but retains conventional carrier frequency tracking. The positioning and tracking performance of the conventional and vector-tracking implementations with and without a strobe correlator are compared using intermediate frequency signals recorded in the Koto-Ku district of urban canyon Tokyo city environment. Both static and dynamic tests were performed. It is shown that vector tracking reduces the root-mean-square positioning error by about 30 % compared with an equivalent conventional receiver in urban environments and is capable of detecting long-delay NLOS reception for a GPS receiver without any external aiding .	[Hsu, Li-Ta; Jan, Shau-Shiun] Natl Cheng Kung Univ, Dept Aeronaut & Astronaut, Tainan 70101, Taiwan; [Groves, Paul D.] UCL, Fac Engn, London, England; [Kubo, Nobuaki] Tokyo Univ Marine Sci & Technol, Area GPS GNSS Syst, Tokyo, Japan	Hsu, LT (reprint author), Natl Cheng Kung Univ, Dept Aeronaut & Astronaut, Tainan 70101, Taiwan.	Qmohsu@gmail.com; p.groves@ucl.ac.uk			National Science Council of Taiwan; Japan Interchange Association	The first author acknowledges the Graduate Student Study Abroad Program (GSSAP) funded by National Science Council of Taiwan which provided financial support for his academic study in University College London. He also thanks Professor Marek Ziebart who provided him with the opportunity to work in the Space Geodesy and Navigation Laboratory (SGNL) at University College London. The authors appreciate all the useful suggestions and discussions from many members of SGNL. The first author acknowledges the Summer Program funded by Japan Interchange Association which provided financial support for his academic study in Tokyo University of Marine Science and Technology. The authors also thank Dr. Taro Suzuki, a postdoctoral researcher at Tokyo University of Marine Science and Technology, for his help of providing the open-source GNSS software receiver and preparing the experiment in Tokyo.	Lashley M, 2009, IEEE J-STSP, V3, P661, DOI 10.1109/JSTSP.2009.2023341; Groves PD, 2013, J NAVIGATION, V66, P653, DOI 10.1017/S0373463313000350; Zhao SH, 2011, PROCEEDINGS OF THE 2011 INTERNATIONAL TECHNICAL MEETING OF THE INSTITUTE OF NAVIGATION, P1293; Bhattacharyya S, 2010, PROCEEDINGS OF THE 23RD INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION (ION GNSS 2010), P3152; Bhuiyan MH, 2010, HINDAWI INT J NAVIGA, V2010, P15, DOI [10.1155/2010/412393, DOI 10.1155/2010/412393]; Braasch M. S., 1996, GLOBAL POSITIONING S; Brown R, 1996, INTRO RANDOM SIGNALS; Copps E. M., 1980, Navigation. Journal of the Institute of Navigation, V27; Dierendonck A. J. V., 1992, J I NAVIG, V39, P265; Garin L, 1996, P 9 INT TECHN M SAT, P657; Groves PD, 2013, ARTECH HSE GNSS TECH, P1; Groves Paul D., 2013, P ION GNSS 2013 SEPT, P3231; Groves P. D., 2005, Navigation. Journal of the Institute of Navigation, V52; Hernandez-Pajares M, 2009, J GEODESY, V83, P263, DOI 10.1007/s00190-008-0266-1; Hsu LT, 2013, PROCEEDINGS OF THE ION 2013 PACIFIC PNT MEETING, P498; Hsu L-T., 2013, P 26 INT TECHN M SAT, P3263; Hsu LT, 2007, P INT S GPS GNSS 200; Jiang Z, 2012, GPS SOLUT, V18, P15; Jwo D.-J., 2009, KALMAN FILTER RECENT; Kanwal N, 2010, VECTOR TRACKING LOOP, P1, DOI [10.1109/UPINLBS.2010.5654015, DOI 10.1109/UPINLBS.2010.5654015]; LaMance J, 1996, P 52 ANN M I NAV CAM, P519; Lashley M, 2011, PROCEEDINGS OF THE 24TH INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION (ION GNSS 2011), P1786; McGraw G.A., 2004, P ION NTM SAN DIEG C, P561; MEHRA RK, 1972, IEEE T AUTOMAT CONTR, VAC17, P693, DOI 10.1109/TAC.1972.1100100; Misra P, 2011, GLOBAL POSITIONING S; Mohamed AH, 1999, J GEODESY, V73, P193, DOI 10.1007/s001900050236; Pany T., 2005, P ION GNSS 2005 LONG, P1095; Petovello MG, 2006, PROCEEDINGS OF THE 19TH INTERNATIONAL TECHNICAL MEETING OF THE SATELLITE DIVISION OF THE INSTITUTE OF NAVIGATION (ION GNSS 2006), P1790; Pratt AR, 2004, P ION GNSS 2004 LONG, P43; Saastamoinen J, 1973, B GEOD, V105, P279, DOI DOI 10.1007/BF02521844; Spilker JJ, 1996, GLOBAL POSITIONING S, V1; Veitsel V. A., 1998, GPS SOLUT, V2, P38, DOI DOI 10.1007/PL00000035; Ward PW, 2006, LUNDERSTANDING GPS P	33	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1080-5370	1521-1886		GPS SOLUT	GPS Solut.	APR	2015	19	2					249	262		10.1007/s10291-014-0384-6		14	Remote Sensing	Remote Sensing	CD6VE	WOS:000351227200007		
J	Terada, T				Terada, Tadashi			Ontogenic development of nerve fibers in human fetal livers: an immunohistochemical study using neural cell adhesion molecule (NCAM) and neuron-specific enolase (NSE)	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Liver; Human; Fetus; Nerve fiber; Innervation; NCAM; NSE; Immunohistochemistry	INTRAHEPATIC BILE-DUCT; VASOACTIVE-INTESTINAL-PEPTIDE; MAMMALIAN LIVER; HEPATIC NERVES; NEUROPEPTIDE-Y; TYROSINE-HYDROXYLASE; PERIBILIARY GLANDS; ENDOCRINE-CELLS; STELLATE CELLS; SUBSTANCE-P	The aim of the study was to investigate nerve fibers (NF) in human fetal livers. An immunohistochemical study was performed. NF were classified into portal tract innervation (PoI) and parenchymal innervation (PaI). The hilum area showed many Pol NF at 7 GW, and NF increased with gestational week (GW). Direct innervations to biliary epithelium were recognized. In large portal tracts, a few NCAM-positive mesenchymal cells were seen at 8 GW and many mesenchymal cells were noted around 12 GW. Apparent NF emerged around 15 GW, and NF increased with GW. Many NF plexuses were seen in 30-40 GW. In small portal tracts, no NF were seen in 7-10 GW. A few NCAM-positive mesenchymal cells emerged in 11 GW, and they increased thereafter. Apparent NF were seen around 20 GW and NF increased with GW. At term (40 GW), PoI NF were still immature. Ductal plate (DP) was positive for NCAM, NSE, chromogranin and synaptophysin, and direct innervations to DP were seen. The direct innervations to developing bile ducts and peribiliary glands were also seen. PaI NF were first seen at 21 GW and was consistent until 40 GW in which a few NF were seen in PaI. These observations suggest that PoI NF arise from committed portal mesenchyme. PaI NF are very immature at 40 GW. There are direct innervations to bile ducts, peribiliary glands, portal veins, hepatic arteries, and DP.	Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Shizuoka 4248636, Japan	Terada, T (reprint author), Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Miyakami 1231, Shizuoka 4248636, Japan.	piyo0111jp@yahoo.co.jp					AKIYOSHI H, 1989, VIRCHOWS ARCH B, V57, P81, DOI 10.1007/BF02899068; ELSALHY M, 1993, SCAND J GASTROENTERO, V28, P809, DOI 10.3109/00365529309104014; Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658; TERADA T, 1987, LIVER, V7, P1; Terada T, 1997, TOHOKU J EXP MED, V181, P19, DOI 10.1620/tjem.181.19; TERADA T, 1989, J HEPATOL, V8, P139, DOI 10.1016/0168-8278(89)90001-9; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; BIOULACSAGE P, 1990, J HEPATOL, V10, P105, DOI 10.1016/0168-8278(90)90080-B; BURT AD, 1989, HEPATOLOGY, V9, P839, DOI 10.1002/hep.1840090608; Cassiman D, 2002, AM J PATHOL, V161, P521, DOI 10.1016/S0002-9440(10)64208-3; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Cassiman D, 2007, LIVER INT, V27, P323, DOI 10.1111/j.1478-3231.2006.01427.x; Delalande JM, 2004, ANAT REC PART A, V280A, P848, DOI 10.1002/ar.a.20090; Ding WG, 1997, MICROSC RES TECHNIQ, V39, P365, DOI 10.1002/(SICI)1097-0029(19971115)39:4<365::AID-JEMT6>3.0.CO;2-G; FEHER E, 1991, DIGESTION, V50, P194; GOEHLER LE, 1988, CELL TISSUE RES, V253, P145; GOEHLER LE, 1991, CELL TISSUE RES, V265, P287, DOI 10.1007/BF00398076; Jungermann K, 1999, HEPATO-GASTROENTEROL, V46, P1414; LEE JA, 1992, GUT, V33, P87, DOI 10.1136/gut.33.1.87; LIN YS, 1995, COMP BIOCHEM PHYS A, V110, P289, DOI 10.1016/0300-9629(94)00189-Z; McCuskey RS, 2004, ANAT REC PART A, V280A, P821, DOI 10.1002/ar.a.20087; MIYAZAWA Y, 1988, AM J GASTROENTEROL, V83, P1108; Nakatani K, 1996, CELL TISSUE RES, V283, P159; Oben JA, 2003, HEPATOLOGY, V38, P664, DOI 10.1053/jhep.2003.50371; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; Roskams T, 2004, ANAT REC PART A, V280A, P910, DOI 10.1002/ar.a.20096; SCOAZEC JY, 1993, J HISTOCHEM CYTOCHEM, V41, P899; TERADA T, 1995, GASTROENTEROLOGY, V108, P1236, DOI 10.1016/0016-5085(95)90225-2; TERADA T, 1993, HEPATOLOGY, V18, P529, DOI 10.1016/0270-9139(93)90351-M; TERADA T, 1994, HEPATOLOGY, V20, P388, DOI 10.1016/0270-9139(94)90191-0; TERADA T, 1995, AM J PATHOL, V147, P1207; TERADA T, 1988, VIRCHOWS ARCH A, V413, P167, DOI 10.1007/BF00749679; TERADA T, 1995, AM J PATHOL, V146, P67; Terada T, 1997, VIRCHOWS ARCH, V430, P37, DOI 10.1007/BF01008014; TERADA T, 1989, J HEPATOL, V9, P141, DOI 10.1016/0168-8278(89)90044-5; TERADA T, 1987, AM J GASTROENTEROL, V82, P1301; Terada T, 2005, TOHOKU J EXP MED, V206, P271, DOI 10.1620/tjem.206.271; TERADA T, 1993, LAB INVEST, V68, P261; Terada T, 2002, PATHOL INT, V52, P740, DOI 10.1046/j.1440-1827.2002.01416.x; Terada T, 1998, J HEPATOL, V28, P263, DOI 10.1016/0168-8278(88)80013-8; Tiniakos DG, 2008, VIRCHOWS ARCH, V452, P435, DOI 10.1007/s00428-007-0569-2; Ueno T, 1997, NUTRITION, V13, P141, DOI 10.1016/S0899-9007(96)00389-9; Ueno T, 2004, ANAT REC PART A, V280A, P868, DOI 10.1002/ar.a.20092; UENO T, 1991, AM J GASTROENTEROL, V86, P1633	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	APR	2015	143	4					421	429		10.1007/s00418-014-1286-y		9	Cell Biology; Microscopy	Cell Biology; Microscopy	CD6NB	WOS:000351204800006		
J	Takagi, Y; Matsuoka, Y; Shiomi, T; Nosaka, K; Takeda, C; Haruki, T; Araki, K; Taniguchi, Y; Nakamura, H; Umekita, Y				Takagi, Yuzo; Matsuoka, Yuki; Shiomi, Tatsushi; Nosaka, Kanae; Takeda, Chikako; Haruki, Tomohiro; Araki, Kunio; Taniguchi, Yuji; Nakamura, Hiroshige; Umekita, Yoshihisa			Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring < 3 cm	HISTOPATHOLOGY			English	Article						lung adenocarcinoma; maspin; micropapillary; prognosis	MICROPAPILLARY PATTERN; NUCLEAR-LOCALIZATION; BREAST-CANCER; STAGE-I; TUMOR; FEATURES; CLASSIFICATION; PROGRESSION; CARCINOMA	AimsMaspin is known to be a tumour suppressor protein, and few studies focused upon its prognostic significance in patients with small-size lung adenocarcinoma have been reported; however, its clinical significance remains controversial. We explored the prognostic value of maspin with particular reference to its subcellular localization in patients with resected lung adenocarcinoma measuring <3cm. Methods and resultsImmunohistochemical analyses were performed on resected 110 specimens of lung adenocarcinoma measuring <3cm. Maspin positivity was defined as strong expression in only the cytoplasm and was observed in 27 patients (24.5%). It correlated significantly with the presence of lymph node metastasis (P=0.009) and micropapillary component (P<0.001). The patients were followed-up for 6-88months (median: 71months), and the maspin-positive group had shorter disease-free survival (DFS) and overall survival (OS) by log-rank test (P<0.001, P<0.001, respectively). Using Cox's multivariate analysis, the status of maspin was an independent prognostic factor for DFS and OS (P=0.004, P=0.022, respectively), as well as lymph node metastasis. ConclusionsCytoplasmic maspin expression could be an independent poor prognostic indicator of patients with lung adenocarcinoma measuring <3cm.	[Takagi, Yuzo; Matsuoka, Yuki; Shiomi, Tatsushi; Nosaka, Kanae; Takeda, Chikako; Umekita, Yoshihisa] Tottori Univ, Div Organ Pathol, Dept Pathol, Fac Med, Yonago, Tottori 6838503, Japan; [Takagi, Yuzo; Matsuoka, Yuki; Haruki, Tomohiro; Araki, Kunio; Taniguchi, Yuji; Nakamura, Hiroshige] Tottori Univ, Div Gen Thorac Surg, Dept Surg, Fac Med, Yonago, Tottori 6838503, Japan	Umekita, Y (reprint author), Tottori Univ, Div Organ Pathol, Dept Pathol, Fac Med, 86 Nishicho, Yonago, Tottori 6838503, Japan.	yume@med.tottori-u.ac.jp					Endsley MP, 2011, J BIOL CHEM, V286, P24599, DOI 10.1074/jbc.M111.235788; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Bodenstine TM, 2012, CANCER METAST REV, V31, P529, DOI 10.1007/s10555-012-9361-0; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Kamiya K, 2008, MODERN PATHOL, V21, P992, DOI 10.1038/modpathol.2008.79; Takanami I, 2008, CLIN LUNG CANCER, V9, P361, DOI 10.3816/CLC.2008.n.052; Nakagawa M, 2006, ANN SURG ONCOL, V13, P1517, DOI 10.1245/s10434-006-9030-z; Frey A, 2009, HISTOPATHOLOGY, V54, P590, DOI 10.1111/j.1365-2559.2009.03260.x; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Lonardo F, 2006, LUNG CANCER-J IASLC, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Hirai K, 2005, ANN THORAC SURG, V79, P248, DOI 10.1016/j.athoracsur.2004.06.118; Kelsey CR, 2013, J THORAC CARDIOV SUR, V146, P768, DOI 10.1016/j.jtcvs.2013.05.041; Miyoshi T, 2003, AM J SURG PATHOL, V27, P101, DOI 10.1097/00000478-200301000-00011; Parkin M, 2004, WORLD HLTH ORG CLASS, P12; Sanchez-Mora N, 2008, HUM PATHOL, V39, P324, DOI 10.1016/j.humpath.2007.05.029; Tsuji T, 2009, HISTOPATHOLOGY, V55, P130, DOI 10.1111/j.1365-2559.2009.03336.x; Tsuji T, 2007, HISTOPATHOLOGY, V51, P871, DOI 10.1111/j.1365-2559.2007.02872.x; Umekita Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-36; Umekita Y, 2002, INT J CANCER, V100, P452, DOI 10.1002/ijc.10500; Umekita Y, 2006, IN VIVO, V13, P317; Umekita Y, 2003, HISTOPATHOLOGY, V42, P541, DOI 10.1046/j.1365-2559.2003.01620.x; Woenckhaus M, 2007, J CLIN PATHOL, V60, P483, DOI 10.1136/jcp.2005.033407	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	APR	2015	66	5					732	739		10.1111/his.12586		8	Cell Biology; Pathology	Cell Biology; Pathology	CD8WW	WOS:000351378200013		
J	Kawasaki, T; Bussolati, G; Sugai, T; Sapino, A				Kawasaki, Tomonori; Bussolati, Gianni; Sugai, Tamotsu; Sapino, Anna			A rare case of breast cancer showing distinct TTF-1 nuclear expression: small-cell carcinoma or not?	HISTOPATHOLOGY			English	Letter							TRANSCRIPTION FACTOR-I		[Kawasaki, Tomonori; Bussolati, Gianni; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Kawasaki, Tomonori; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan	Kawasaki, T (reprint author), Univ Turin, Dept Med Sci, Turin, Italy.						Kaufmann O, 2000, HISTOPATHOLOGY, V36, P415; Christie M, 2010, INT J CLIN EXP PATHO, V3, P629; Ersahin C, 2009, INT J SURG PATHOL, V17, P368, DOI 10.1177/1066896909340275; Kawasaki T, 2013, HISTOPATHOLOGY, V63, P739, DOI 10.1111/his.12201; Ni YB, 2014, HISTOPATHOLOGY, V64, P504, DOI 10.1111/his.12287; Shin SJ, 2000, AM J SURG PATHOL, V24, P1231, DOI 10.1097/00000478-200009000-00006	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	APR	2015	66	5					752	753		10.1111/his.12482		2	Cell Biology; Pathology	Cell Biology; Pathology	CD8WW	WOS:000351378200016		
J	Kawasaki, T; Sugai, T; Kashiwaba, M; Sapino, A				Kawasaki, Tomonori; Sugai, Tamotsu; Kashiwaba, Masahiro; Sapino, Anna			Mammary carcinomas with neuroendocrine features - correct understanding and proper use of the terminology	HISTOPATHOLOGY			English	Letter							EXPRESSION		[Kawasaki, Tomonori; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan; [Kawasaki, Tomonori; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Kashiwaba, Masahiro] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan	Kawasaki, T (reprint author), Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan.						Kwon SY, 2014, HISTOPATHOLOGY, V64, P647, DOI 10.1111/his.12306; Bussolati G, 2012, WHO CLASSIFICATION T, P62; Kawasaki T, 2014, HISTOPATHOLOGY, V64, P597, DOI 10.1111/his.12276; Sapino A, 2001, MODERN PATHOL, V14, P768, DOI 10.1038/modpathol.3880387; Tan PH, 2014, HISTOPATHOL IN PRESS	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	APR	2015	66	5					754	755		10.1111/his.12559		2	Cell Biology; Pathology	Cell Biology; Pathology	CD8WW	WOS:000351378200018		
J	Eikendal, ALM; Groenewegen, KA; Anderson, TJ; Britton, AR; Engstrom, G; Evans, GW; de Graaf, J; Grobbee, DE; Hedblad, B; Holewijn, S; Ikeda, A; Kitagawa, K; Kitamura, A; Lonn, EM; Lorenz, MW; Mathiesen, EB; Nijpels, G; Dekker, JM; Okazaki, S; O'Leary, DH; Polak, JF; Price, JF; Robertson, C; Rembold, CM; Rosvall, M; Rundek, T; Salonen, JT; Sitzer, M; Stehouwer, CDA; Hoefer, IE; Peters, SAE; Bots, ML; den Ruijter, HM				Eikendal, Anouk L. M.; Groenewegen, Karlijn A.; Anderson, Todd J.; Britton, Annie R.; Engstrom, Gunnar; Evans, Greg W.; de Graaf, Jacqueline; Grobbee, Diederick E.; Hedblad, Bo; Holewijn, Suzanne; Ikeda, Ai; Kitagawa, Kazuo; Kitamura, Akihiko; Lonn, Eva M.; Lorenz, Matthias W.; Mathiesen, Ellisiv B.; Nijpels, Giel; Dekker, Jacqueline M.; Okazaki, Shuhei; O'Leary, Daniel H.; Polak, Joseph F.; Price, Jacqueline F.; Robertson, Christine; Rembold, Christopher M.; Rosvall, Maria; Rundek, Tatjana; Salonen, Jukka T.; Sitzer, Matthias; Stehouwer, Coen D. A.; Hoefer, Imo E.; Peters, Sanne A. E.; Bots, Michiel L.; den Ruijter, Hester M.		USE-IMT Project Grp	Common Carotid Intima-Media Thickness Relates to Cardiovascular Events in Adults Aged < 45 Years	HYPERTENSION			English	Article						atherosclerosis; carotid intima-media thickness; risk factors; young adult	RISK-FACTORS; HEART-DISEASE; YOUNG-ADULTS; TASK-FORCE; ATHEROSCLEROSIS; PREDICTION; DETERMINANTS; ASSOCIATIONS; METAANALYSIS; PROGRESSION	Although atherosclerosis starts in early life, evidence on risk factors and atherosclerosis in individuals aged <45 years is scarce. Therefore, we studied the relationship between risk factors, common carotid intima-media thickness (CIMT), and first-time cardiovascular events in adults aged <45 years. Our study population consisted of 3067 adults aged <45 years free from symptomatic cardiovascular disease at baseline, derived from 6 cohorts that are part of the USE-IMT initiative, an individual participant data meta-analysis of general-population-based cohort studies evaluating CIMT measurements. Information on risk factors, CIMT measurements, and follow-up of the combined end point (first-time myocardial infarction or stroke) was obtained. We assessed the relationship between risk factors and CIMT and the relationship between CIMT and first-time myocardial infarction or stroke using a multivariable linear mixed-effects model and a Cox proportional-hazards model, respectively. During a follow-up of 16.3 years, 55 first-time myocardial infarctions or strokes occurred. Median CIMT was 0.63 mm. Of the risk factors under study, age, sex, diastolic blood pressure, body mass index, total cholesterol, and high-density lipoprotein cholesterol related to CIMT. Furthermore, CIMT related to first-time myocardial infarction or stroke with a hazard ratio of 1.40 per SD increase in CIMT, independent of risk factors (95% confidence interval, 1.11-1.76). CIMT may be a valuable marker for cardiovascular risk in adults aged <45 years who are not yet eligible for standard cardiovascular risk screening. This is especially relevant in those with an increased, unfavorable risk factor burden.	[Eikendal, Anouk L. M.] Univ Med Ctr, Dept Radiol, NL-3584 CX Utrecht, Netherlands; [Groenewegen, Karlijn A.; Grobbee, Diederick E.; Peters, Sanne A. E.; Bots, Michiel L.; den Ruijter, Hester M.] Univ Med Ctr, Dept Cardiovasc Epidemiol, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Hoefer, Imo E.; den Ruijter, Hester M.] Univ Med Ctr, Dept Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Anderson, Todd J.] Univ Calgary, Dept Cardiac Sci, Calgary, AB T2N 1N4, Canada; [Anderson, Todd J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Britton, Annie R.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Engstrom, Gunnar; Hedblad, Bo; Rosvall, Maria] Lund Univ, Dept Clin Sci Malmo, Skane Univ Hosp, Malmo, Sweden; [Evans, Greg W.] Wake Forest Sch Med, Dept Biostat Sci & Neurol, Winston Salem, NC USA; [de Graaf, Jacqueline; Holewijn, Suzanne] Radboud Univ Nijmegen, Med Ctr, Div Vasc Med, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands; [Grobbee, Diederick E.] Univ Malaya, Med Ctr, Dept Clin Epidemiol, Kuala Lumpur, Malaysia; [Ikeda, Ai; Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kitagawa, Kazuo] Tokyo Women Med Univ, Dept Neurol, Tokyo, Japan; [Lonn, Eva M.] McMaster Univ, Dept Med, Div Cardiol, Hamilton, ON, Canada; [Lonn, Eva M.] McMaster Univ, Dept Med, Populat Hlth Res Inst, Hamilton, ON, Canada; [Lorenz, Matthias W.; Sitzer, Matthias] Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, D-60054 Frankfurt, Germany; [Mathiesen, Ellisiv B.] Univ Tromso, Brain & Circulat Res Grp, Dept Clin Med, Tromso, Norway; [Nijpels, Giel; Dekker, Jacqueline M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Gen Practice, Amsterdam, Netherlands; [Okazaki, Shuhei] Osaka Univ, Dept Neurol, Stroke Ctr, Grad Sch Med, Osaka, Japan; [O'Leary, Daniel H.; Polak, Joseph F.] Tufts Med Ctr, Dept Radiol, Boston, MA USA; [Price, Jacqueline F.; Robertson, Christine] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rembold, Christopher M.] Univ Virginia, Dept Internal Med, Div Cardiol, Charlottesville, VA USA; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Coral Gables, FL 33124 USA; [Salonen, Jukka T.] MAS Metab Analyt Serv Oy, Helsinki, Finland; [Sitzer, Matthias] Klinikum Herford, Dept Neurol, Herford, Germany; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Peters, Sanne A. E.] Univ Oxford, Nuffield Dept Populat Hlth, George Inst Global Hlth, Oxford, England	Eikendal, ALM (reprint author), Univ Med Ctr, Dept Radiol, Heidelberglaan 100,POB 85500, NL-3584 CX Utrecht, Netherlands.	a.l.m.eikendal@umcutrecht.nl	Graaf, J./H-8038-2014; 	Peters, Sanne/0000-0003-0346-5412; Engstrom, Gunnar/0000-0002-8618-9152	Netherlands Organization for Health Research and Development [ZonMw 200320003]	This project was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw 200320003). The funding source had no role in design and conduct of the study; in data collection, analysis and interpretation; or preparation, review or approval of the article.	Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McGill HC, 2008, CIRCULATION, V117, P1216, DOI 10.1161/CIRCULATIONAHA.107.717033; den Ruijter HM, 2013, DIABETOLOGIA, V56, P1494, DOI 10.1007/s00125-013-2898-9; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Ali YS, 2006, ATHEROSCLEROSIS, V187, P186, DOI 10.1016/j.atherosclerosis.2005.09.003; Franklin SS, 2001, CIRCULATION, V103, P1245; Bots ML, 1997, J CLIN EPIDEMIOL, V50, P801, DOI 10.1016/S0895-4356(97)00059-0; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Dawson JD, 2009, J AM COLL CARDIOL, V53, P2273, DOI 10.1016/j.jacc.2009.03.026; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; SALONEN R, 1991, J INTERN MED, V229, P225; Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653; Akosah KO, 2003, J AM COLL CARDIOL, V41, P1475, DOI 10.1016/S0735-1097(03)00187-6; Lorenz MW, 2010, EUR HEART J, V31, P2041, DOI 10.1093/eurheartj/ehq189; [Anonymous], 2000, EUROPEAN HEART J, V21, P1502; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Plantinga Y, 2009, EUR J CARDIOV PREV R, V16, P639, DOI 10.1097/HJR.0b013e3283312ece; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Stensland-Bugge E, 2000, STROKE, V31, P574	27	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	APR	2015	65	4					707	+		10.1161/HYPERTENSIONAHA.114.04658		22	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD3IL	WOS:000350971600003		
J	Kario, K; Hoshide, S				Kario, Kazuomi; Hoshide, Satoshi			Age-Related Difference in the Sleep Pressure-Lowering Effect Between an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensives The ACS1 Study	HYPERTENSION			English	Article						ambulatory blood pressure monitoring; amlodipine; azilsartan; control rate; hypertension	AMBULATORY BLOOD-PRESSURE; SYSTOLIC HYPERTENSION; JAPANESE PATIENTS; AMLODIPINE; AZILSARTAN; MANAGEMENT; CANDESARTAN; VALSARTAN; STATEMENT; SOCIETY	Sleep blood pressure (BP), which is partly determined by salt sensitivity and intake, is an important cardiovascular risk in hypertensives. However, there have been no studies on age-related differences in the sleep BP-lowering effect between angiotensin II receptor blockers and calcium channel blockers in Asians. Azilsartan Circadian and Sleep Pressure-the 1st Study was a multicenter, randomized, open-label, 2-parallel-group study conducted to compare the efficacy of 8-week oral treatment with an angiotensin II receptor blocker (azilsartan 20 mg) or a calcium channel blocker (amlodipine 5 mg) on sleep BP as evaluated by ambulatory BP monitoring. Among the overall population, amlodipine treatment achieved significantly greater reduction in sleep BP, awake BP, and 24-hour BP than azilsartan treatment. BP reduction by amlodipine was particularly pronounced in elderly hypertensive patients aged >= 60 years old. Among patients >= 60 years old, the amlodipine group had numerically, but not significantly, higher control rate of sleep BP compared with the azilsartan group. Similar results were found for awake BP and 24-hour BP. These results suggest a greater BP reduction/control by amlodipine compared with azilsartan and that reduction/control of BP by amlodipine was also more effective in the elderly population. As recommended in the American Society of Hypertension/The international Society of Hypertension and the National Institute for Health and Clinical Excellence guidelines for differentiating treatment according to age, amlodipine should be one of the options for starting treatment in the elderly population.	Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan; Jichi Med Univ, Sch Med, Dept Sleep & Circadian Cardiol, Shimotsuke, Tochigi 3290498, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Sleep & Circadian Cardiol, Div Cardiovasc Med,Dept Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kkario@jichi.ac.jp			Takeda Pharmaceutical Company, Ltd.	This study was funded by Takeda Pharmaceutical Company, Ltd.	Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Kario K, 1996, HYPERTENSION, V27, P130; Sica D, 2011, J CLIN HYPERTENS, V13, P467, DOI 10.1111/j.1751-7176.2011.00482.x; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Nelson M, 2010, AUST PRESCR, V33, P108; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Kohara Y, 1996, J MED CHEM, V39, P5228, DOI 10.1021/jm960547h; Morgan TO, 2001, AM J HYPERTENS, V14, P241, DOI 10.1016/S0895-7061(00)01266-8; Cuspidi C, 2001, J HYPERTENS, V19, P1539, DOI 10.1097/00004872-200109000-00004; Turnbull F, 2008, BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Eguchi K, 2004, AM J HYPERTENS, V17, P112, DOI 10.1016/j.amjhyper.2003.09.008; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Kario K, 1997, AM J HYPERTENS, V10, P261, DOI 10.1016/S0895-7061(96)00409-8; Kario K, 2014, BLOOD PRESS MONIT, V19, P123, DOI 10.1097/MBP.0000000000000032; Mounier-Vehier C, 2002, FUND CLIN PHARMACOL, V16, P537, DOI 10.1046/j.1472-8206.2002.00129.x; Qiu YG, 2003, CARDIOVASC DRUG THER, V17, P335, DOI 10.1023/A:1027347723347; Rakugi H, 2013, BLOOD PRESSURE, V22, P22, DOI 10.3109/08037051.2013.818758; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Wang JG, 2011, HYPERTENS RES, V34, P423, DOI 10.1038/hr.2010.259	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	APR	2015	65	4					729	+		10.1161/HYPERTENSIONAHA.114.04935		26	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD3IL	WOS:000350971600006		
J	Matsumoto, T; Oki, K; Kajikawa, M; Nakashima, A; Maruhashi, T; Iwamoto, Y; Iwamoto, A; Oda, N; Hidaka, T; Kihara, Y; Kohno, N; Chayama, K; Goto, C; Aibara, Y; Noma, K; Liao, JK; Higashi, Y				Matsumoto, Takeshi; Oki, Kenji; Kajikawa, Masato; Nakashima, Ayumu; Maruhashi, Tatsuya; Iwamoto, Yumiko; Iwamoto, Akimichi; Oda, Nozomu; Hidaka, Takayuki; Kihara, Yasuki; Kohno, Nobuoki; Chayama, Kazuaki; Goto, Chikara; Aibara, Yoshiki; Noma, Kensuke; Liao, James K.; Higashi, Yukihito			Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism	HYPERTENSION			English	Article						aldosterone; hyperaldosteronism; hypertension; Rho-associated kinases	DEPENDENT VASCULAR RELAXATION; FLOW-MEDIATED VASODILATION; ESSENTIAL-HYPERTENSION; SMOOTH-MUSCLE; POSSIBLE INVOLVEMENT; REACTIVE HYPEREMIA; OXIDATIVE STRESS; PROTEIN-KINASE; NITRIC-OXIDE; EPLERENONE	The purpose of this study was to evaluate vascular function and activity of Rho-associated kinases (ROCKs) in patients with primary aldosteronism. Vascular function, including flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation, and ROCK activity in peripheral leukocytes were evaluated in 21 patients with aldosterone-producing adenoma (APA), 23 patients with idiopathic hyperaldosteronism (IHA), and 40 age-, sex-, and blood pressure-matched patients with essential hypertension (EHT). FMD was significantly lower in the APA group than in the IHA and EHT groups (3.2 +/- 2.0% versus 4.6 +/- 2.3% and 4.4 +/- 2.2%; P<0.05, respectively), whereas there was no significant difference in FMD between the IHA and EHT groups. There was no significant difference in nitroglycerine-induced vasodilation in the 3 groups. ROCK activity was higher in the APA group than in the IHA and EHT groups (1.29 +/- 0.57 versus 1.00 +/- 0.46 and 0.81 +/- 0.36l; P<0.05, respectively), whereas there was no significant difference in ROCK activity between the IHA and EHT groups. FMD correlated with age (r=-0.31; P<0.01), plasma aldosterone concentration (r=-0.35; P<0.01), and aldosterone: renin ratio (r=-0.34; P<0.01). ROCK activity correlated with age (r=-0.24; P=0.04), plasma aldosterone concentration (r=0.33; P<0.01), and aldosterone: renin ratio (r=0.46; P<0.01). After adrenalectomy, FMD and ROCK activity were restored in patients with APA. APA was associated with both endothelial dysfunction and increased ROCK activity compared with those in IHA and EHT. APA may have a higher risk of future cardiovascular events.	[Matsumoto, Takeshi; Kajikawa, Masato; Maruhashi, Tatsuya; Iwamoto, Yumiko; Iwamoto, Akimichi; Oda, Nozomu; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Hiroshima 7348551, Japan; [Oki, Kenji; Kohno, Nobuoki] Hiroshima Univ, Dept Mol & Internal Med, Hiroshima 7348551, Japan; [Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Aibara, Yoshiki; Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cardiovasc Regenerat & Med, Hiroshima 7348551, Japan; [Nakashima, Ayumu; Higashi, Yukihito] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan; [Goto, Chikara] Hiroshima Int Univ, Dept Phys Therapy, Hiroshima, Japan; [Liao, James K.] Univ Chicago, Med Ctr, Cardiol Sect, Chicago, IL 60637 USA	Higashi, Y (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cardiovasc Regenerat & Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yhigashi@hiroshima-u.ac.jp			Ministry of Education, Science and Culture of Japan [1859081500, 21590898]; National Institutes of Health [HL052233]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (1859081500 and 21590898) and the National Institutes of Health (HL052233).	VANHOUTTE PM, 1989, HYPERTENSION, V13, P658; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; LINDER L, 1990, CIRCULATION, V81, P1762; Macdonald JE, 2004, HEART, V90, P765, DOI 10.1136/hrt.2003.017368; Nishizaka MK, 2004, CIRCULATION, V109, P2857, DOI 10.1161/01.CIR.0000129307.26791.8E; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; TADDEI S, 1995, CIRCULATION, V91, P1981; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; Kobayashi N, 2005, HYPERTENSION, V45, P538, DOI 10.1161/01.HYP.0000157408.43807.5a; Fujimura N, 2012, CLIN PHARMACOL THER, V91, P289, DOI 10.1038/clpt.2011.227; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Fuller PJ, 2005, HYPERTENSION, V46, P1227, DOI 10.1161/01.HYP.0000193502.77417.17; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; PANZA JA, 1993, CIRCULATION, V87, P1468; Higashi Y, 1999, CIRCULATION, V100, P1194; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Hashikabe Y, 2006, J CARDIOVASC PHARM, V47, P609, DOI 10.1097/01.fjc.0000211738.63207.c3; Soga J, 2011, ARTERIOSCL THROM VAS, V31, P2353, DOI 10.1161/ATVBAHA.111.227892; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P699; Kajikawa M, 2014, HYPERTENSION, V63, P856, DOI 10.1161/HYPERTENSIONAHA.113.02296; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Sanz-Rosa D, 2005, ANTIOXID REDOX SIGN, V7, P1294, DOI 10.1089/ars.2005.7.1294; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Hao LR, 2004, AM J NEPHROL, V24, P54, DOI 10.1159/000075945; Nishikawa T, 2011, ENDOCR J, V58, P711; CREAGER MA, 1994, HYPERTENSION, V24, P499; DOHI Y, 1990, HYPERTENSION, V16, P170; Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008; Duffy SJ, 2005, HYPERTENSION, V46, P707, DOI 10.1161/01.HYP.0000184231.84465.62; FURCHGOTT RF, 1983, CIRC RES, V53, P557; Higashi Y, 2002, HYPERTENSION, V39, P513, DOI 10.1161/hy02t2.102820; Iwatsubo H, 1997, HYPERTENSION, V29, P286; LUSCHER TF, 1990, AM J HYPERTENS, V3, P317; Miyata K, 2008, HYPERTENS RES, V31, P1407, DOI 10.1291/hypres.31.1407; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Ross R, 1999, NEW ENGL J MED, V340, P115; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Sun GP, 2006, J AM SOC NEPHROL, V17, P2193, DOI 10.1681/ASN.2005121375; Wehrwein EA, 2004, J PHARMACOL EXP THER, V309, P1011, DOI 10.1124/jpet.103.062265	43	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	APR	2015	65	4					841	+		10.1161/HYPERTENSIONAHA.114.05001		15	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD3IL	WOS:000350971600020		
J	Onda, K; Tong, S; Nakahara, A; Kondo, M; Monchusho, H; Hirano, T; Kaitu'u-Lino, T; Beard, S; Binder, N; Tuohey, L; Brownfoot, F; Hannan, NJ				Onda, Kenji; Tong, Stephen; Nakahara, Anzu; Kondo, Mei; Monchusho, Hideaki; Hirano, Toshihiko; Kaitu'u-Lino, Tu'uhevaha; Beard, Sally; Binder, Natalie; Tuohey, Laura; Brownfoot, Fiona; Hannan, Natalie J.			Sofalcone Upregulates the Nuclear Factor (Erythroid-Derived 2)-Like 2/Heme Oxygenase-1 Pathway, Reduces Soluble fms-Like Tyrosine Kinase-1, and Quenches Endothelial Dysfunction Potential Therapeutic for Preeclampsia	HYPERTENSION			English	Article						heme oxygenase-1; preeclampsia; sFLT-1 protein, human; sofalcone	HEME OXYGENASE-1; PLACENTAL DEVELOPMENT; HOUSEKEEPING GENES; THIOREDOXIN GENE; NRF2; VEGF; HYPERTENSION; PREGNANCIES; ACTIVATION; ELEMENT	Preeclampsia is a severe complication of pregnancy, characterized by hypertension, oxidative stress, and severe endothelial dysfunction. Antiangiogenic factors, soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin, play key pathophysiological roles in preeclampsia. Heme oxygenase-1 (HO-1) is a cytoprotective, antioxidant enzyme reported to be downregulated in preeclampsia. Studies propose that inducing HO-1 may also decrease sFlt-1 production. Sofalcone, a gastric antiulcer agent in clinical use, is known to induce HO-1 in gastric epithelium. We aimed to investigate whether sofalcone induces HO-1 and reduces sFlt-1 release from primary human placental and endothelial cells and blocks endothelial dysfunction in vitro. We isolated human trophoblasts and endothelial cells (human umbilical vein endothelial cells) and also used uterine microvascular cells. We investigated the effects of sofalcone on (1) HO-1 production, (2) activation of the nuclear factor (erythroid-derived 2)-like 2 pathway, (3) sFlt-1 and soluble endoglin release, (4) tumor necrosis factor a-induced monocyte adhesion and vascular cell adhesion molecule upregulation, and (5) endothelial tubule formation. Sofalcone potently increased HO-1 mRNA and protein in both primary trophoblasts and human umbilical vein endothelial cells. Furthermore, sofalcone treatment caused nuclear translocation of nuclear factor (erythroid-derived 2)-like 2 and transactivation of other nuclear factor (erythroid-derived 2)-like 2 responsive genes (NQO1, TXN, and GCLC). Importantly, sofalcone significantly decreased the secretion of sFlt-1 from primary human trophoblasts. Sofalcone potently suppressed endothelial dysfunction in 2 in vitro models, blocking tumor necrosis factor a-induced monocyte adhesion and vascular cell adhesion molecule 1 expression in human umbilical vein endothelial cells. These results indicate that in primary human tissues, sofalcone can potently activate antioxidant nuclear factor (erythroid-derived 2)-like 2/HO-1 pathway, decrease sFlt-1 production, and ameliorate endothelial dysfunction. We propose that sofalcone is a novel therapeutic candidate for preeclampsia.	[Onda, Kenji; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha; Beard, Sally; Binder, Natalie; Tuohey, Laura; Brownfoot, Fiona; Hannan, Natalie J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic 3084, Australia; [Onda, Kenji; Nakahara, Anzu; Kondo, Mei; Monchusho, Hideaki; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Tokyo, Japan	Hannan, NJ (reprint author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic 3084, Australia.	nhannan@unimelb.edu.au		Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Hannan, Natalie/0000-0001-8446-2250; Tong, Stephen/0000-0002-2319-0586; Brownfoot, Fiona/0000-0002-1473-5708; Tuohey, Laura/0000-0002-4255-0196	National Health and Medical Research Council of Australia [1050765, 1062418, 628927]	The National Health and Medical Research Council of Australia provided salary support; ST no. 1050765, TKL no. 1062418, and NJH no. 628927.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Levytska K, 2013, PLACENTA, V34, P291, DOI 10.1016/j.placenta.2013.01.004; Sunderland NS, 2011, CYTOKINE, V56, P192, DOI 10.1016/j.cyto.2011.06.003; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Vanderlelie J, 2005, PLACENTA, V26, P53, DOI 10.1016/j.placenta.2004.04.002; Sahlin L, 2000, PLACENTA, V21, P603, DOI 10.1053/plac.2000.0554; Fraser R, 2012, J PATHOL, V228, P322, DOI 10.1002/path.4057; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Shibuya A, 2010, BIOCHEM BIOPH RES CO, V398, P581, DOI 10.1016/j.bbrc.2010.06.124; Gutkowska J, 2011, J HYPERTENS, V29, P1203, DOI 10.1097/HJH.0b013e3283468392; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Warrington JP, 2013, HYPERTENSION, V62, P666, DOI 10.1161/HYPERTENSIONAHA.113.00588; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Ahmed A, 2009, BIOCHEM SOC T, V37, P1237, DOI 10.1042/BST0371237; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Tanaka H, 2009, BIOCHEM BIOPH RES CO, V381, P566, DOI 10.1016/j.bbrc.2009.02.086; Chigusa Y, 2012, J CLIN ENDOCR METAB, V97, pE1862, DOI 10.1210/jc.2012-1268; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradboimed.2004.06.011; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; George EM, 2013, CURR OPIN NEPHROL HY, V22, P156, DOI 10.1097/MNH.0b013e32835d19f7; George E.M., 2012, INT J HYPERTENS, V2012, P1, DOI DOI 10.1155/2012/486053; Hawkes HJK, 2014, BBA-GEN SUBJECTS, V1840, P303, DOI 10.1016/j.bbagen.2013.09.013; Kaitu'u-Lino TJ, 2014, PLACENTA, V35, P1106, DOI 10.1016/j.placenta.2014.10.003; MATSUO Y, 1983, ARZNEIMITTEL-FORSCH, V33-1, P242; MURAKAMI S, 1988, RES COMMUN CHEM PATH, V62, P461; Ramma W, 2014, J REPROD IMMUNOL, V101, P153, DOI 10.1016/j.jri.2013.12.120; Yamada T, 1980, PHARMACOMETRICS, V19, P515; Yamada T, 1980, PHARMACOMETRICS, V19, P537; Yamada T, 1980, PHARMACOMETRICS, V19, P543; Yamada T, 1980, PHARMACOMETRICS, V19, P525	38	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	APR	2015	65	4					855	+		10.1161/HYPERTENSIONAHA.114.04781		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD3IL	WOS:000350971600022		
J	Yodoi, K; Yamashita, T; Sasaki, N; Kasahara, K; Emoto, T; Matsumoto, T; Kita, T; Sasaki, Y; Mizoguchi, T; Sparwasser, T; Hirata, K				Yodoi, Keiko; Yamashita, Tomoya; Sasaki, Naoto; Kasahara, Kazuyuki; Emoto, Takuo; Matsumoto, Takuya; Kita, Tomoyuki; Sasaki, Yoshihiro; Mizoguchi, Taiji; Sparwasser, Tim; Hirata, Ken-ichi			Foxp3(+) Regulatory T Cells Play a Protective Role in Angiotensin II-Induced Aortic Aneurysm Formation in Mice	HYPERTENSION			English	Article						aortic aneurysm, abdominal; immunology; inflammation; interleukin-2; T-lymphocytes, regulatory	E-KNOCKOUT MICE; IMMUNE-RESPONSES; DEFICIENT MICE; ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; INFLAMMATION; DEPLETION; ANTIBODY; RUPTURE; DISEASE	Although regulatory T cells (Tregs) have been shown to play a protective role in abdominal aortic aneurysm (AAA) formation, it remains unclear whether expansion of endogenous Foxp3(+) Tregs prevents AAA. In the current study, we determined the effects of endogenous Foxp3(+) Treg expansion or depletion in an experimental model of AAA. We continuously infused 12-week-old apolipoprotein E-deficient mice fed a high-cholesterol diet with angiotensin II (n=60) or normal saline (n=12) by implanting osmotic mini-pumps and evaluated AAA formation at 16 weeks. The angiotensin II-infused mice received interleukin-2/anti-interleukin-2 monoclonal antibody complex (interleukin-2 complex; n=31) or PBS (n=29). Eighty-one percent of angiotensin II-infused mice developed AAA, with 42% mortality possibly because of aneurysm rupture. Interleukin-2 complex treatment systemically increased the number of Foxp3(+) Tregs and significantly decreased the incidence (52%) and mortality (17%) of AAA. Immunohistochemical analysis showed reduced accumulation of macrophages and increased numbers of Foxp3(+) Tregs in aneurysmal tissues, suggesting that expansion of Tregs may suppress local inflammation in the vessel wall and provide protection against AAA formation. Furthermore, genetic depletion of Foxp3(+) Tregs led to a significant increase in the mortality of AAA, suggesting the protective role of Foxp3(+) Tregs against AAA. Our findings suggest that Foxp3(+) Tregs may play a protective role in AAA formation and that promotion of an endogenous regulatory immune response may be a potentially valuable therapeutic approach for preventing AAA.	[Yodoi, Keiko; Yamashita, Tomoya; Sasaki, Naoto; Kasahara, Kazuyuki; Emoto, Takuo; Matsumoto, Takuya; Kita, Tomoyuki; Sasaki, Yoshihiro; Mizoguchi, Taiji; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany	Yamashita, T (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovascular Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tomoya@med.kobe-u.ac.jp; sasakin@med.kobe-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [23790849, 25860601, 24591114]; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update; Kimura Memorial Heart Foundation Research Grant; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Global Center of Excellence; Banyu Life Science Foundation International; Suzuken Memorial Foundation; ONO Medical Research Foundation; Takeda Scientific Foundation; Kanae Medical Foundation; Mochida Memorial Foundation; Senshin Medical Research Foundation; Mitsui Life Social Welfare Foundation; Yakult Bioscience Research Foundation; Uehara Memorial Foundation; Japan Circulation Society Translational Research Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant No. 23790849 (N. Sasaki), 25860601 (N. Sasaki), and 24591114 (T. Yamashita), Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update (N. Sasaki), Kimura Memorial Heart Foundation Research Grant for 2011 (N. Sasaki), Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2012 (N. Sasaki), and research grants from the Global Center of Excellence (K. Yodoi), Banyu Life Science Foundation International (N. Sasaki), Suzuken Memorial Foundation (T. Yamashita and N. Sasaki), ONO Medical Research Foundation (N. Sasaki), Takeda Scientific Foundation (T. Yamashita and N. Sasaki), Kanae Medical Foundation (N. Sasaki), Mochida Memorial Foundation (T. Yamashita), Senshin Medical Research Foundation (T. Yamashita and N. Sasaki), Mitsui Life Social Welfare Foundation (T. Yamashita), Yakult Bioscience Research Foundation (T. Yamashita), Uehara Memorial Foundation (K.-i. Hirata and N. Sasaki), and The Japan Circulation Society Translational Research Foundation (K.-i. Hirata).	Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Meng X, 2014, HYPERTENSION, V64, P875, DOI 10.1161/HYPERTENSIONAHA.114.03950; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Sasaki N, 2012, J ATHEROSCLER THROMB, V19, P503; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Kasal DA, 2012, HYPERTENSION, V59, P324, DOI 10.1161/HYPERTENSIONAHA.111.181123; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Nakajima H, 2013, HYPERTENSION, V61, P1002, DOI 10.1161/HYPERTENSIONAHA.111.201608; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Yin MD, 2010, ARTERIOSCL THROM VAS, V30, P1825, DOI 10.1161/ATVBAHA.109.200303; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P2374, DOI 10.1161/ATVBAHA.113.301280; Emoto T, 2014, CIRC J, V78, P2935, DOI 10.1253/circj.CJ-14-0644; Kasahara K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000719; Kita T, 2014, CARDIOVASC RES, V102, P107, DOI 10.1093/cvr/cvu002; Wang YX, HDB MOUSE MODELS CAR, P125	31	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	APR	2015	65	4					889	+		10.1161/HYPERTENSIONAHA.114.04934		18	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD3IL	WOS:000350971600026		
J	Dong, L; Wei, M; Alstrom, P; Huang, X; Olsson, U; Shigeta, Y; Zhang, YY; Zheng, GM				Dong, Lu; Wei, Min; Alstroem, Per; Huang, Xi; Olsson, Urban; Shigeta, Yoshimitsu; Zhang, Yanyun; Zheng, Guangmei			Taxonomy of the Narcissus Flycatcher Ficedula narcissina complex: an integrative approach using morphological, bioacoustic and multilocus DNA data	IBIS			English	Article						DNA analysis; East Asia; Ficedula; morphology; phylogeny; vocalization	MAXIMUM-LIKELIHOOD; HAPLOTYPE RECONSTRUCTION; BAYESIAN-INFERENCE; MIXED MODELS; MUSCICAPIDAE; DISTANCE; CHINA; PHYLOGEOGRAPHY; ALGORITHM; MRBAYES	The taxonomy of the Narcissus Flycatcher Ficedula narcissina-Yellow-rumped Flycatcher Ficedula zanthopygia complex from East Asia has long been debated. Most authors recognize two species: F.narcissina, with the subspecies narcissina (most of Japan and Sakhalin Island), owstoni (south Japanese islands) and elisae (northeast China) and F.zanthopygia (monotypic), although species status has been proposed for elisae and sometimes for owstoni. Here, we revise the taxonomy of this complex based on an integrative approach utilizing morphology, songs and mitochondrial and nuclear DNA for all taxa. All taxa were diagnosably different in plumage, and there were also structural differences among them, although the northernmost populations of owstoni (sometimes recognized as jakuschima and shonis) were somewhat intermediate in plumage, structure and male plumage maturation between southern populations of owstoni and narcissina. All taxa had different songs, and a discriminant function analysis of four song variables correctly classified 100% of all songs. A strongly supported phylogeny was recovered based on three mitochondrial genes and three nuclear introns (total of 3543bp), revealing a sister relationship between F.zanthopygia and the other taxa, between F.n.narcissina and F.n.owstoni, and between F.n.elisae and F.n.narcissina+F.n.owstoni. The corrected COI distances among the three F.narcissina subspecies ranged from 2.8% (narcissina-owstoni) to 8.2% (narcissina-elisae). We suggest that the congruent differences in multiple independent traits and the deep genetic divergences among the four taxa in the F.narcissina-F.zanthopygia complex support treatment of all of these taxa as separate species. However, we acknowledge the paucity of data for F.owstoni and recommend further studies of this taxon. We suggest listing both F.elisae and F.owstoni, which have small and fragmented populations, as globally threatened.	[Dong, Lu; Wei, Min; Huang, Xi; Zhang, Yanyun; Zheng, Guangmei] Beijing Normal Univ, Key Lab Biodivers & Ecol Engn, Minist Educ, Coll Life Sci, Beijing 100875, Peoples R China; [Alstroem, Per] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Alstroem, Per] Swedish Univ Agr Sci, Swedish Species Informat Ctr, SE-75007 Uppsala, Sweden; [Olsson, Urban] Univ Gothenburg, Sect Systemat & Biodivers Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [Shigeta, Yoshimitsu] Yamashina Inst Ornithol, Abiko, Chiba 2701145, Japan	Zhang, YY (reprint author), Beijing Normal Univ, Key Lab Biodivers & Ecol Engn, Minist Educ, Coll Life Sci, Beijing 100875, Peoples R China.	zhangyy@bnu.edu.cn	Alstrom, Per/C-1619-2015	Alstrom, Per/0000-0001-7182-2763	National Natural Science Foundation of China [31472010, 30170115]; Jornvall Foundation; Chinese Academy of Sciences (CAS) [2011T2S04]	We are grateful to the National Natural Science Foundation of China (No. 31472010 & No. 30170115) for support to Z.Y.Y. & Z.G.M., Jornvall Foundation and the Chinese Academy of Sciences (CAS) Visiting Professorship for Senior International Scientists (No. 2011T2S04) for support to P.A.; Geoff Carey, Magnus Gelang, Paul Leader, Zhijun Ma, Bo Petersson, Fumin Lei, Gang Song, Johan Stallberg and Chunfa Zhou for DNA samples; Peng He and the Institute of Zoology, Chinese Academy of Sciences, Beijing, and Robert Prys-Jones and Mark Adams and The Natural History Museum, Tring, for access to the specimen collections in their care; the American Museum of Natural History for a loan of specimens; Ning Wang and Qingsong Sun for recordings; two anonymous reviewers for comments on the manuscript; and Dongsheng Guo, Pete Morris and Nial Moores/Birds of Korea for the use of their photos in Figure 2.	Alstrom P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-352; Sangster G, 2010, MOL PHYLOGENET EVOL, V57, P380, DOI 10.1016/j.ympev.2010.07.008; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Dong L, 2013, MOL ECOL, V22, P3376, DOI 10.1111/mec.12315; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Fregin S, 2012, MOL PHYLOGENET EVOL, V62, P319, DOI 10.1016/j.ympev.2011.10.003; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Austin O. L., 1953, BIRDS JAPAN THEIR ST; Avise J.C., 1994, MOL MARKERS NATURAL; Brazil M., 2009, BIRDS OF E ASIA; Brazil M. A., 1991, BIRDS JAPAN; Cai Q. K., 1987, BIRDS OF BEIJING; Cheng T-H, 1987, SYNOPSIS AVIFAUNA CH; Clements J., 2000, CHECKLIST BIRDS WORL; Delacour J., 1947, BIRDS OF MALAYSIA; *delsHoyo J., 2006, HDB BIRDS WORLD, V11; Dement'ev G. P., 1951, PTITSY SOVETSKOGO SO; Dickinson EC, 2003, HOWARD MOORE COMPLET; Eck Siegfried, 1996, Zoologische Abhandlungen (Dresden), V49, P1; Eck Siegfried, 1998, Zoologische Abhandlungen (Dresden), V50, P87; Eck S., 2005, TAP TROP VOGEL GES T, V9, P11; Flint V. E., 1984, FIELD GUIDE BIRDS US; Friesen VL, 1999, MOL ECOL, V8, P2147, DOI 10.1046/j.1365-294x.1999.00802-4.x; Gill F., 2013, IOC WORLD BIRD LIST; Hartert E., 1907, VOGEL PALAARKTISCHEN, V1, P385; Horvath M., 2004, J AVIAN BIOL, V36, P84; Inskipp T, 1996, ANNOTATED CHECKLIST; IUCN, 2001, IUCN RED LIST CAT CR; Mayr E., 1986, CHECK LIST BIRDS WOR, VXI; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Norberg UM, 1989, VERTEBRATE FLIGHT ME; Ornithological Society of Japan, 2012, CHECKL JAP BIRDS, V7th; Otani C., 2002, ORIENTAL BIRD CLUB B, V35, P26; Outlaw DC, 2006, MOL PHYLOGENET EVOL, V41, P118, DOI 10.1016/j.ympev.2006.05.004; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; Prefecture Okinawa, 1996, END WILDL OK PREF JA; Rambaut A., 2007, TRACER V1 4, V4; Robson C., 2003, GUIDE BIRDS SE ASIA; Robson C., 2000, FIELD GUIDE BIRDS S; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Severinghaus L. L., 2012, AVIFAUNA TAIWAN, V3; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W; Topfer T., 2006, ZOOL MED LEIDEN, V80, P203; Vaurie C., 1954, AM MUS NOVIT, V1694, P1; Vaurie C., 1959, BIRDS PALEARCTIC FAU; Wang N, 2008, WILSON J ORNITHOL, V120, P92, DOI 10.1676/06-164.1; Wang Ying-Yong, 2007, Acta Zootaxonomica Sinica, V32, P492; Watson G.E., 1986, CHECK LIST BIRDS WOR, V11, P295; Wei M., 2010, THESIS BEIJING NORMA; Wells DR, 2007, BIRDS THAI MALAY PEN, V2; Zhang Yan-Yun, 2006, Acta Zoologica Sinica, V52, P648; Zheng Guangmei, 2000, Journal of Beijing Normal University (Natural Science), V36, P405; Zheng GM, 2011, CHECKLIST CLASSIFICA; Zuccon Dario, 2011, Bulletin of the British Ornithologists' Club, V131, P196	64	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-1019	1474-919X		IBIS	Ibis	APR	2015	157	2					312	325		10.1111/ibi.12238		14	Ornithology	Zoology	CE1XB	WOS:000351605100009		
J	Kim, Y; Takenaka, M; Takagi, S				Kim, Younghyun; Takenaka, Mitsuru; Takagi, Shinichi			Numerical Analysis of Carrier-Depletion Strained SiGe Optical Modulators With Vertical p-n Junction	IEEE JOURNAL OF QUANTUM ELECTRONICS			English	Article						Strained SiGe; optical modulator; vertical p-n junction; Si photonics	WAVE-GUIDE; SILICON	The modulation characteristics of carrier-depletion strained SiGe optical modulators with a vertical p-n junction are numerically analyzed by technology computer-aided design simulation and finite-difference optical mode analysis. In addition to the strong optical confinement in the vertical direction for the fundamental transverse electric field mode, the vertical p-n junction effectively depletes the strained SiGe layer in which the plasma dispersion effect is enhanced owing to the mass modulation of holes by strain. We predict that a Si0.7Ge0.3 optical modulator exhibits V pi L at 1.55 mu m of as small as 0.31 V-cm at a bias voltage of -2 V, which is similar to 1.8 times smaller than that of a Si optical modulator. The product of V pi L and the phase-shifter loss (alpha V pi L) is also expected to be as low as 18.3 V-dB at -2 V, enabling optical modulation with a 5-dB extinction ratio in a symmetric Mach-Zehnder modulator.	[Kim, Younghyun; Takenaka, Mitsuru; Takagi, Shinichi] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan	Kim, Y (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan.	yhkim@mosfet.t.utokyo.ac.jp; takenaka@mosfet.t.u-tokyo.ac.jp; takagi@ee.t.utokyo.ac.jp			New Energy and Industrial Technology Development Organisation	This work was supported by the New Energy and Industrial Technology Development Organisation within the Strategic Information and Communications Research and Development Promotion Programme through the Ministry of Internal Affairs and Communications Project entitled Integrated Photonics-Electronics Convergence System Technology.	PEOPLE R, 1985, APPL PHYS LETT, V47, P322, DOI 10.1063/1.96206; Liu AS, 2004, NATURE, V427, P615, DOI 10.1038/nature02310; Tu XG, 2013, OPT EXPRESS, V21, P12776, DOI 10.1364/OE.21.012776; Reed GT, 2010, NAT PHOTONICS, V4, P518, DOI [10.1038/NPHOTON.2010.179, 10.1038/nphoton.2010.179]; Jacobsen RS, 2006, NATURE, V441, P199, DOI 10.1038/nature04706; Ding JF, 2013, J LIGHTWAVE TECHNOL, V31, P2434, DOI 10.1109/JLT.2013.2262522; Kuo YH, 2005, NATURE, V437, P1334, DOI 10.1038/nature04204; Liu AS, 2007, OPT EXPRESS, V15, P660, DOI 10.1364/OE.15.000660; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Liu J, 2008, NAT PHOTONICS, V2, P433, DOI 10.1038/nphoton.2008.99; Gardes FY, 2011, OPT EXPRESS, V19, P11804, DOI 10.1364/OE.19.011804; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; Baehr-Jones T, 2012, OPT EXPRESS, V20, P12014, DOI 10.1364/OE.20.012014; Rosenberg JC, 2012, OPT EXPRESS, V20, P26411, DOI 10.1364/OE.20.026411; Gill D. M., 2012, FIGURE MERIT BASED T; Goykhman I, 2013, OPT EXPRESS, V21, P19518, DOI 10.1364/OE.21.019518; Kim Younghyun, 2014, Sci Rep, V4, P4683, DOI 10.1038/srep04683; Kim Y, 2014, THIN SOLID FILMS, V557, P342, DOI 10.1016/j.tsf.2013.10.063; Kim Y., 2014, P IEEE PES T D C EXP, P1; Liao L., 2007, ELECT LETT, V43; Majhi P, 2008, IEEE ELECTR DEVICE L, V29, P99, DOI 10.1109/LED.2007.911987; Miura M., 2014, P OPT FIB COMM C EXB, P1; PEOPLE R, 1986, APPL PHYS LETT, V49, P229, DOI 10.1063/1.97637; Takenaka M, 2012, IEEE J QUANTUM ELECT, V48, P8, DOI 10.1109/JQE.2011.2176104; Thomson DJ, 2012, IEEE PHOTONIC TECH L, V24, DOI 10.1109/LPT.2011.2177081; Van Campenhout J, 2009, OPT EXPRESS, V17, P23793, DOI 10.1364/OE.17.023793	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9197	1558-1713		IEEE J QUANTUM ELECT	IEEE J. Quantum Electron.	APR	2015	51	4							5200107	10.1109/JQE.2015.2405931		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CD5FM	WOS:000351113300001		
J	Roy, PC; Islam, MM; Murase, K; Yao, X				Roy, Proteek Chandan; Islam, Md. Monirul; Murase, Kazuyuki; Yao, Xin			Evolutionary Path Control Strategy for Solving Many-Objective Optimization Problem	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						Evolutionary algorithm; multiobjective optimization; path control strategy; reference vector	OF-THE-ART; MULTIOBJECTIVE OPTIMIZATION; NSGA-II; ALGORITHMS; PERFORMANCE; DECOMPOSITION; SELECTION	The number of objectives in many-objective optimization problems (MaOPs) is typically high and evolutionary algorithms face severe difficulties in solving such problems. In this paper, we propose a new scalable evolutionary algorithm, called evolutionary path control strategy (EPCS), for solving MaOPs. The central component of our algorithm is the use of a reference vector that helps simultaneously minimizing all the objectives of an MaOP. In doing so, EPCS employs a new fitness assignment strategy for survival selection. This strategy consists of two procedures and our algorithm applies them sequentially. It encourages a population of solutions to follow a certain path reaching toward the Pareto optimal front. The essence of our strategy is that it reduces the number of nondominated solutions to increase selection pressure in evolution. Furthermore, unlike previous work, EPCS is able to apply the classical Pareto-dominance relation with the new fitness assignment strategy. Our algorithm has been tested extensively on several scalable test problems, namely five DTLZ problems with 5 to 40 objectives and six WFG problems with 2 to 13 objectives. Furthermore, the algorithm has been tested on six CEC09 problems having 2 or 3 objectives. The experimental results show that EPCS is capable of finding better solutions compared to other existing algorithms for problems with an increasing number of objectives.	[Roy, Proteek Chandan] Mississippi State Univ, Starkville, MS 39762 USA; [Islam, Md. Monirul] Bangladesh Univ Engn & Technol, Dhaka 1000, Bangladesh; [Murase, Kazuyuki] Univ Fukui, Fukui 9108507, Japan; [Yao, Xin] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	Roy, PC (reprint author), Mississippi State Univ, Starkville, MS 39762 USA.	proteek_buet@yahoo.com; mdmonirulis-lam@cse.buet.ac.bd; murase@u-fukui.ac.jp; x.yao@cs.bham.ac.uk					Aguirre H, 2009, LECT NOTES COMPUT SC, V5467, P407, DOI 10.1007/978-3-642-01020-0_33; Zou XF, 2008, IEEE T SYST MAN CY B, V38, P1402, DOI 10.1109/TSMCB.2008.926329; Hughes EJ, 2007, IEEE C EVOL COMPUTAT, P3944, DOI 10.1109/CEC.2007.4424985; While L, 2012, IEEE T EVOLUT COMPUT, V16, P86, DOI 10.1109/TEVC.2010.2077298; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Kollat JB, 2006, ADV WATER RESOUR, V29, P792, DOI 10.1016/j.advwatres.2005.07.010; Sato H, 2007, LECT NOTES COMPUT SC, V4403, P5; Zitzler E, 2004, LECT NOTES COMPUT SC, V3242, P832; Deb K, 2002, IEEE C EVOL COMPUTAT, P825; Drechsler N, 2001, LECT NOTES COMPUT SC, V1993, P154; Kukkonen S, 2005, IEEE C EVOL COMPUTAT, P443; ONEILL RV, 1980, ECOL MODEL, V8, P297, DOI 10.1016/0304-3800(80)90043-5; Chow CK, 2012, IEEE T EVOLUT COMPUT, V16, P149, DOI 10.1109/TEVC.2010.2098411; Adra SF, 2011, IEEE T EVOLUT COMPUT, V15, P183, DOI 10.1109/TEVC.2010.2058117; Huband S, 2003, IEEE C EVOL COMPUTAT, P2284; Purshouse RC, 2003, IEEE C EVOL COMPUTAT, P2066; Khare V, 2003, LECT NOTES COMPUT SC, V2632, P376; Purshouse RC, 2007, IEEE T EVOLUT COMPUT, V11, P770, DOI 10.1109/TEVC.2007.910138; Wang R, 2013, IEEE T EVOLUT COMPUT, V17, P474, DOI 10.1109/TEVC.2012.2204264; Thiele L, 2009, EVOL COMPUT, V17, P411, DOI 10.1162/evco.2009.17.3.411; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Ishibuchi H, 2006, LECT NOTES COMPUT SC, V4193, P493; Deb K, 2005, EVOL COMPUT, V13, P501, DOI 10.1162/106365605774666895; Adra SF, 2009, IEEE T EVOLUT COMPUT, V13, P825, DOI 10.1109/TEVC.2008.2011743; Fernandez A, 2010, IEEE T EVOLUT COMPUT, V14, P913, DOI 10.1109/TEVC.2009.2039140; Hughes EJ, 2003, IEEE C EVOL COMPUTAT, P2678; Huband S, 2006, IEEE T EVOLUT COMPUT, V10, P477, DOI 10.1109/TEVC.2005.861417; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969; Lara A, 2010, IEEE T EVOLUT COMPUT, V14, P112, DOI 10.1109/TEVC.2009.2024143; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Ishibuchi H, 2008, IEEE C EVOL COMPUTAT, P2419, DOI 10.1109/CEC.2008.4631121; Farina M, 2004, IEEE T SYST MAN CY A, V34, P315, DOI 10.1109/TSMCA.2004.824873; Demsar J, 2006, J MACH LEARN RES, V7, P1; Zitzler E, 2003, IEEE T EVOLUT COMPUT, V7, P117, DOI 10.1109/TEVC.2003.810758; Hadka D, 2013, EVOL COMPUT, V21, P231, DOI 10.1162/EVCO_a_00075; Schutze O, 2011, IEEE T EVOLUT COMPUT, V15, P444, DOI 10.1109/TEVC.2010.2064321; Yang SX, 2013, IEEE T EVOLUT COMPUT, V17, P721, DOI 10.1109/TEVC.2012.2227145; Asafuddoula M, 2013, LECT NOTES COMPUT SC, V7811, P413, DOI 10.1007/978-3-642-37140-0_32; Bader J., 2009, EVOL COMPUT, V19, P45; Coello C.A., 2007, EVOLUTIONARY ALGORIT; Corder GW, 2009, NONPARAMETRIC STAT N; Deb K, 2001, MULTIOBJECTIVE OPTIM; Deb K., 2006, P 8 ANN C GEN EV COM, P635, DOI 10.1145/1143997.1144112; Deb K., 2003, 2003002 IND I KANP G; Deb K., 2006, P 2006 IEEE C EV COM, P3353; Fleischer M, 2003, LECT NOTES COMPUT SC, V2632, P519; Gaspar-Cunhaa A., 2005, INT J COMPUT SYST SI, V6, P18; Greenwood G. W., 1997, FDN GENETIC ALGORITH, V4, P437; Knowles J., 2007, P 4 INT C EV MULT CR, P757; Koppen M, 2007, LECT NOTES COMPUT SC, V4403, P727; Miettinen K., 1999, NONLINEAR MULTIOBJEC; Praditwong K, 2007, IEEE C EVOL COMPUTAT, P3959; Schaffer J. D., 1984, THESIS VAND U NASHVI; Schaffer J.D., 1985, P 1 INT C GEN ALG, P93; Sobol I. M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.2514/1.28511; Van Veldhuizen D. A., 1999, THESIS AIR FORCE I T; WIERZBICKI AP, 1986, OR SPEKTRUM, V8, P73; WINKLER P, 1985, ORDER, V1, P317, DOI 10.1007/BF00582738; Zhang Q., 2009, CES487 U ESS SCH COM; Zitzler E., 2003, P EV METH DES OPT CO, P23	60	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	APR	2015	45	4					702	715		10.1109/TCYB.2014.2334632		14	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CE0BL	WOS:000351467400009		
J	Brscic, D; Kanda, T				Brscic, Drazen; Kanda, Takayuki			Changes in Usage of an Indoor Public Space: Analysis of One Year of Person Tracking	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Article						Distributed vision networks; modeling; predictive models; ubiquitous computing	SURVEILLANCE; PATTERNS; SENSORS; PEOPLE; MOTION; MODELS	Knowledge about space usage from variables such as density and walking speed could support a variety of service applications. However, there is not much knowledge on how the usage of space changes during extended periods of time and what affects the changes. We have installed a person tracking system in a large area of a shopping center and collected pedestrian data over a year. In this paper, we analyze the collected data to find the changes in pedestrian density and speed, percentage of children, and pedestrian trajectories. The changes from day to day, as well as during the day are examined, and a number of factors that affect them are identified. This is in turn used in the prediction of the state of the space using a Gaussian process model.	[Brscic, Drazen; Kanda, Takayuki] Adv Telecommun Res Inst Int, Kyoto 6190288, Japan	Brscic, D (reprint author), Adv Telecommun Res Inst Int, Kyoto 6190288, Japan.	drazen@atr.jp; kanda@atr.jp			Japan Science and Technology Agency, Core Research for Evolutional Science and Technology program	This work was supported by the Japan Science and Technology Agency, Core Research for Evolutional Science and Technology program. This paper was recommanded by Associate Editor R. van Paassen.	Larson JS, 2005, INT J RES MARK, V22, P395, DOI 10.1016/j.ijresmar.2005.09.005; Vasquez D, 2009, INT J ROBOT RES, V28, P1486, DOI 10.1177/0278364909342118; Kitade T, 2013, ACMIEEE INT CONF HUM, P57, DOI 10.1109/HRI.2013.6483502; Morris BT, 2008, IEEE T CIRC SYST VID, V18, P1114, DOI 10.1109/TCSVT.2008.927109; Pellegrini S, 2009, IEEE I CONF COMP VIS, P261, DOI 10.1109/ICCV.2009.5459260; Wang XG, 2011, INT J COMPUT VISION, V95, P287, DOI 10.1007/s11263-011-0459-6; Zhao HJ, 2005, IEEE T SYST MAN CY A, V35, P283, DOI 10.1109/TSMCA.2005.843396; Bennewitz M, 2005, INT J ROBOT RES, V24, P31, DOI 10.1177/0278364904048962; Aultman-Hall L, 2009, TRANSP RES RECORD, P35, DOI 10.3141/2140-0; Bauer D, 2009, PEDESTRIAN BEHAVIOR: MODELS, DATA COLLECTION AND APPLICATIONS, P325; Dee HM, 2008, MACH VISION APPL, V19, P329, DOI 10.1007/s00138-007-0077-z; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Spinello L, 2011, IEEE INT CONF ROBOT, P1304, DOI 10.1109/ICRA.2011.5980085; Stauffer C, 2000, IEEE T PATTERN ANAL, V22, P747, DOI 10.1109/34.868677; Kanda T, 2007, IEEE INT CONF ROBOT, P4846, DOI 10.1109/ROBOT.2007.364226; Brscic D, 2013, IEEE T HUM-MACH SYST, V43, P522, DOI 10.1109/THMS.2013.2283945; Ellis D., 2009, P IEEE 12 INT C COMP, P1229; Guy SJ, 2010, P 2010 ACM SIGGRAPH, P119; Helbing D., 2011, EXTREME ENV EVENTS, P697, DOI 10.1007/978-1-4419-7695-6_37; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Hillier B., 1996, TATE GALLERY MILLBAN; Hoogendoorn SP, 2004, ADV TRANSPORT, V15, P135; Kaufman L., 2009, FINDING GROUPS DATA, V344; Keni B., 2008, EURASIP J IMAGE VIDE, V2008; Kidokoro H, 2013, ACMIEEE INT CONF HUM, P259, DOI 10.1109/HRI.2013.6483597; Navarro-Serment L., 2009, 7 INT C FIELD SERV R; Nikolic M., 2013, P 13 SWISS TRANSP RE; Panangadan A., 2004, P IEEE INT C INT ROB, V3, P2136; Satake S., 2009, P 4 ACM IEEE INT C H, P109, DOI DOI 10.1145/1514095.1514117; Schadschneider A., 2011, EXTREME ENV EVENTS, P517, DOI 10.1007/978-1-4419-7695-6_29; Trautman P., 2010, P IEEE RSJ INT C INT, P797; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005	33	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	APR	2015	45	2					228	237		10.1109/THMS.2014.2374172		10	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CE0BT	WOS:000351468500007		
J	Watanabe, S; Kuzuoka, S; Tan, VYF				Watanabe, Shun; Kuzuoka, Shigeaki; Tan, Vincent Y. F.			Nonasymptotic and Second-Order Achievability Bounds for Coding With Side-Information	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Source coding; channel coding; side-information; Wyner-Ahlswede-Korner; Wyner-Ziv; Gel'fand-Pinsker; finite blocklength; non-asymptotic; second-order coding rates	RATE-DISTORTION FUNCTION; FINITE BLOCKLENGTH; OUTPUT STATISTICS; SPECTRUM APPROACH; CHANNEL CAPACITY; DATA-COMPRESSION; THEOREMS; SIMULATION; DECODER; PROOF	We present a novel nonasymptotic or finite blocklength achievability bounds for three side-information problems in network information theory. These include: 1) the Wyner-Ahlswede-Korner (WAK) problem of almost-lossless source coding with rate-limited side-information; 2) the Wyner-Ziv (WZ) problem of lossy source coding with side-information at the decoder; and 3) the Gel'fand-Pinsker (GP) problem of channel coding with noncausal state information available at the encoder. The bounds are proved using ideas from channel simulation and channel resolvability. Our bounds for all three problems improve on all previous nonasymptotic bounds on the error probability of the WAK, WZ, and GP problems-in particular those derived by Verdu. Using our novel nonasymptotic bounds, we recover the general formulas for the optimal rates of these side-information problems. Finally, we also present achievable second-order coding rates by applying the multidimensional Berry-Esseen theorem to our new nonasymptotic bounds. Numerical results show that the second-order coding rates obtained using our nonasymptotic achievability bounds are superior to those obtained using existing finite blocklength bounds.	[Watanabe, Shun] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7700855, Japan; [Watanabe, Shun] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Kuzuoka, Shigeaki] Wakayama Univ, Dept Comp & Commun Sci, Wakayama 6408441, Japan; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 119077, Singapore; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Math, Singapore 119077, Singapore	Watanabe, S (reprint author), Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7700855, Japan.	shun-wata@is.tokushimau.ac.jp; kuzuoka@ieee.org; vtan@nus.edu.sg	Watanabe, Shun/G-3384-2015		JSPS; NUS [R-263-000-A98-750/133]; A*STAR, Singapore	S. Watanabe was supported in part by the JSPS through the Post-Doctoral Fellowships for Research Abroad. V. Y. F. Tan was supported in part by the NUS startup under Grant R-263-000-A98-750/133 and in part by the A*STAR, Singapore.	Kontoyiannis I, 1997, IEEE T INFORM THEORY, V43, P1339, DOI 10.1109/18.605604; Kostina V, 2012, IEEE T INFORM THEORY, V58, P3309, DOI 10.1109/TIT.2012.2186786; Hayashi M, 2008, IEEE T INFORM THEORY, V54, P4619, DOI 10.1109/TIT.2008.928985; Hayashi M, 2009, IEEE T INFORM THEORY, V55, P4947, DOI 10.1109/TIT.2009.2030478; Tyagi H, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1- 4, P1954, DOI 10.1109/ISIT.2009.5205656; HAN TS, 1987, IEEE T INFORM THEORY, V33, P759; WYNER AD, 1975, IEEE T INFORM THEORY, V21, P294, DOI 10.1109/TIT.1975.1055374; AHLSWEDE RF, 1975, IEEE T INFORM THEORY, V21, P629, DOI 10.1109/TIT.1975.1055469; MARTON K, 1979, IEEE T INFORM THEORY, V25, P306, DOI 10.1109/TIT.1979.1056046; Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; Bentkus V, 2003, J STAT PLAN INFER, V113, P385, DOI 10.1016/S0378-3758(02)00094-0; MolavianJazi E, 2012, IEEE INT SYMP INFO, P36; Tan VYF, 2014, IEEE T INFORM THEORY, V60, P881, DOI 10.1109/TIT.2013.2291231; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Moulin P, 2007, IEEE T INFORM THEORY, V53, P1326, DOI 10.1109/TIT.2007.892789; Boucheron S, 2000, IEEE T INFORM THEORY, V46, P699, DOI 10.1109/18.825846; Bennett CH, 1999, PHYS REV LETT, V83, P3081, DOI 10.1103/PhysRevLett.83.3081; Renner R, 2005, LECT NOTES COMPUT SC, V3788, P199; Steinberg Y, 1996, IEEE T INFORM THEORY, V42, P63, DOI 10.1109/18.481779; COVER TM, 1975, IEEE T INFORM THEORY, V21, P226, DOI 10.1109/TIT.1975.1055356; Polyanskiy Y, 2010, IEEE T INFORM THEORY, V56, P2307, DOI 10.1109/TIT.2010.2043769; Gu WH, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P1456, DOI 10.1109/ISIT.2007.4557427; Cuff P, 2013, IEEE T INFORM THEORY, V59, P7071, DOI 10.1109/TIT.2013.2279330; VERDU S, 1994, IEEE T INFORM THEORY, V40, P1147, DOI 10.1109/18.335960; WYNER AD, 1976, IEEE T INFORM THEORY, V22, P1, DOI 10.1109/TIT.1976.1055508; Kelly BG, 2012, IEEE T INFORM THEORY, V58, P5086, DOI 10.1109/TIT.2012.2201346; Luo ZC, 2009, IEEE T INFORM THEORY, V55, P1331, DOI 10.1109/TIT.2008.2011424; AHLSWEDE R, 1976, Z WAHRSCHEINLICHKEIT, V34, P157, DOI 10.1007/BF00535682; Gupta A, 2010, IEEE INT SYMP INFO, P530, DOI 10.1109/ISIT.2010.5513505; WYNER AD, 1975, AT&T TECH J, V54, P1355; Tomamichel M, 2013, IEEE T INFORM THEORY, V59, P7041, DOI 10.1109/TIT.2013.2276077; Baron D, 2004, CONF REC ASILOMAR C, P1096; Bennett C. H., 2009, QUANTUM REVERSE SHAN; Bennett CH, 2002, IEEE T INFORM THEORY, V48, P2637, DOI 10.1109/TIT.2002.802612; COSTA MHM, 1983, IEEE T INFORM THEORY, V29, P439, DOI 10.1109/TIT.1983.1056659; Cuff P., 2013, P IEEE INF THEOR WOR, P1; El Gamal A., 2012, NETWORK INFORM THEOR; FEINSTEIN A, 1954, IRE T INFORM THEOR, P2; Feller W., 1971, INTRO PROBABILITY TH; Gel'fand S. I., 1980, Problems of Control and Information Theory, V9; Goetze F., 1991, ANN PROBAB, V19, P724; Haim E., 2012, P IEEEI EIL ISR NOV, P1; Han T.S., 2003, INFORM SPECTRUM METH; HEEGARD C, 1983, IEEE T INFORM THEORY, V29, P731, DOI 10.1109/TIT.1983.1056723; Huang YW, 2012, IEEE INT SYMP INFO, P831; Ingber A, 2011, IEEE DATA COMPR CONF, P53, DOI 10.1109/DCC.2011.13; Ingber A., 2010, P IEEE 26 CONV IEEEI; Iwata K, 2002, IEICE T FUND ELECTR, VE85A, P1387; Korner J., 2011, INFORM THEORY CODING; Kuzuoka Shigeaki, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6284694; MIYAKE S, 1995, IEICE T FUND ELECTR, VE78A, P1063; Nomura R, 2014, IEEE T INFORM THEORY, V60, P5553, DOI 10.1109/TIT.2014.2339231; Scarlett J., 2014, P IEEE INT S INF THE, P461; Shannon C.E., 1959, IRE National Convention Record, V7; Strassen V., 1962, P T 3 PRAG C INF THE, P689; Tan V. Y. F., 2013, P IEEE INT S INF THE, P2458; Verdu S., 2012, P 46 ANN C INF SCI S, P1; Wang D., 2011, P 49 ANN ALL C COMM, P180; Watanabe S., 2013, P IEEE INT S INF THE, P3055; Winter A., 2002, COMPRESSION SOURCES; Yassaee M. H., 2013, NONASYMPTOTIC OUTPUT; Yassaee M. H., 2013, TECHNIQUE DERIVING O; Yassaee MH, 2014, IEEE T INFORM THEORY, V60, P6760, DOI 10.1109/TIT.2014.2351812; Yu B., 1997, IEEE T INF TH, V39, P813	65	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	APR	2015	61	4					1574	1605		10.1109/TIT.2015.2400994		32	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CE0CI	WOS:000351470800005		
J	Takeuchi, K; Tanaka, T; Kawabata, T				Takeuchi, Keigo; Tanaka, Toshiyuki; Kawabata, Tsutomu			Performance Improvement of Iterative Multiuser Detection for Large Sparsely Spread CDMA Systems by Spatial Coupling	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Code-division multiple-access (CDMA) systems; sparse spreading; spatial coupling; threshold saturation; iterative multiuser detection; belief propagation; individually-optimal (IO) detection; large-system analysis; density evolution; continuum limit	MULTIPLE-ACCESS; INTERFERENCE; CAPACITY; INFORMATION; CHANNELS; GRAPH	Kudekar et al. proved that the belief-propagation (BP) performance for low-density parity check codes can be boosted up to the maximum a posteriori (MAP) performance by spatial coupling. In this paper, spatial coupling is applied to sparsely spread code-division multiple-access systems to improve the performance of iterative multiuser detection based on BP. Two iterative receivers based on BP are considered: 1) one receiver is based on exact BP and 2) the other on an approximate BP with Gaussian approximation. The performance of the two BP receivers is evaluated via density evolution (DE) in the dense limit after taking the large-system limit, in which the number of users and the spreading factor tend to infinity while their ratio is kept constant. The two BP receivers are shown to achieve the same performance as each other in these limits. Furthermore, taking a continuum limit for the obtained DE equations implies that the performance of the two BP receivers can be improved up to the performance achieved by the symbol-wise MAP detection, called individually optimal detection, via spatial coupling. Numerical simulations show that spatial coupling can provide a significant improvement in bit-error rate for finite-sized systems especially in the region of high system loads.	[Takeuchi, Keigo; Kawabata, Tsutomu] Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan; [Tanaka, Toshiyuki] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto 6068501, Japan	Takeuchi, K (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan.	ktakeuchi@uec.ac.jp; tt@i.kyotou.ac.jp; kawabata@uec.ac.jp	Tanaka, Toshiyuki/C-2749-2011; Tanaka, Toshiyuki/C-6827-2014	Tanaka, Toshiyuki/0000-0001-5962-9119; 	JSPS KAKENHI [23760329]; MEXT/JSPS KAKENHI [26709029]	K. Takeuchi was supported in part by the Grant-in-Aid for Young Scientists (B) through the JSPS KAKENHI under Grant 23760329 and in part by the Grant-in-Aid for Young Scientists (A) through the MEXT/JSPS KAKENHI under Grant 26709029. This paper was presented in part at 2011 IEEE International Symposium on Information Theory.	Amari S. I., 2000, METHODS INFORM GEOME; Kudekar S, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P2816; Ojanpera T, 1998, IEEE COMMUN MAG, V36, P82, DOI 10.1109/35.714623; Wang XD, 1999, IEEE T COMMUN, V47, P1046; Adachi F, 1998, IEEE COMMUN MAG, V36, P56, DOI 10.1109/35.714618; Schlegel C, 2013, IEEE T INFORM THEORY, V59, P2459, DOI 10.1109/TIT.2012.2232965; Guo DN, 2005, IEEE T INFORM THEORY, V51, P1983, DOI 10.1109/TIT.2005.847700; Takeuchi K, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P1489; Guo DN, 2005, IEEE T INFORM THEORY, V51, P1261, DOI 10.1109/TIT.2005.844072; Boutros J, 2002, IEEE T INFORM THEORY, V48, P1772, DOI 10.1109/TIT.2002.1013125; Verdu S, 1999, IEEE T INFORM THEORY, V45, P622, DOI 10.1109/18.749007; Uchikawa H, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P1474; MADHOW U, 1994, IEEE T COMMUN, V42, P3178, DOI 10.1109/26.339839; Guo DN, 2008, IEEE J SEL AREA COMM, V26, P421, DOI 10.1109/JSAC.2008.080402; Truhachev D, 2012, IEEE COMMUN LETT, V16, P585, DOI 10.1109/LCOMM.2012.031212.120228; Caire G, 2004, IEEE T INFORM THEORY, V50, P1950, DOI 10.1109/TIT.2004.833351; Schlegel C, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P2989; Kudekar S, 2011, IEEE T INFORM THEORY, V57, P803, DOI 10.1109/TIT.2010.2095072; LUPAS R, 1989, IEEE T INFORM THEORY, V35, P123, DOI 10.1109/18.42183; Tse DNC, 1999, IEEE T INFORM THEORY, V45, P641, DOI 10.1109/18.749008; Tanaka T, 2002, IEEE T INFORM THEORY, V48, P2888, DOI 10.1109/TIT.2002.804053; Aref V., 2011, P IEEE INF THEOR WOR, P277; Ash RB, 1999, PROBABILITY MEASURE; Dahlman E, 1998, IEEE COMMUN MAG, V36, P70, DOI 10.1109/35.714620; Donoho DL, 2013, IEEE T INFORM THEORY, V59, P7434, DOI 10.1109/TIT.2013.2274513; Felstrom J., 1999, IEEE T INFORM THEORY, V45, P2181; Hagiwara M, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P638; Hassani S. H., 2012, J STAT MECH-THEORY E, V2012; Hassani S. H., 2010, P IEEE INF THEOR WOR, P1; Ikehara T, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P2081, DOI 10.1109/ISIT.2007.4557527; Kabashima Y, 2003, J PHYS A-MATH GEN, V36, P11111, DOI 10.1088/0305-4470/36/43/030; Kasai K, 2011, IEICE T FUND ELECTR, VE94A, P2161, DOI 10.1587/transfun.E94.A.2161; Kobayashi S., 1996, FDN DIFFERENTIAL GEO, VI; Korada SB, 2011, IEEE T INFORM THEORY, V57, P2440, DOI 10.1109/TIT.2011.2112231; Krzakala F, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.021005; Kudekar S., 2011, Proceedings of the 2011 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2011.6034031; Kudekar S., 2010, P 48 ANN ALL C COMM, P347; Kudekar S., IEEE T INF IN PRESS; Lentmaier M, 2010, IEEE INT SYMP INFO, P709, DOI 10.1109/ISIT.2010.5513595; Michel AN, 2008, SYST CONTROL-FOUND A, P1; Montanari A., 2006, P IEEE INF THEOR WOR, P160; Muller RR, 2004, IEEE T INFORM THEORY, V50, P1769, DOI 10.1109/TIT.2004.831854; Pearl J., 1988, PROBABILISTIC REASON; Rathi V., 2011, Proceedings of the 2011 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2011.6033992; Raymond J, 2007, J PHYS A-MATH THEOR, V40, P12315, DOI 10.1088/1751-8113/40/41/004; Richardson T., 2008, MODERN CODING THEORY; Schlegel C., 2013, P IEEE INF THEOR WOR, P1; Strang G., 2010, CALCULUS; Takeuchi K, 2012, IEICE T FUND ELECTR, VE95A, P974, DOI 10.1587/transfun.E95.A.974; Takeuchi Keigo, 2013, IEEE Wireless Communications Letters, V2, DOI 10.1109/WCL.2013.082713.130465; Verdu S., 1998, MULTIUSER DETECTION; XIE ZH, 1990, IEEE J SEL AREA COMM, V8, P683, DOI 10.1109/49.54464; Yedla A., 2012, P 7 INT S TURB COD I, P51; Yedla A., 2011, Proceedings of the 2011 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2011.6034032; Yoshida M., 2006, P IEEE INT S INF THE, P2378	55	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	APR	2015	61	4					1768	1794		10.1109/TIT.2015.2400445		27	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CE0CI	WOS:000351470800017		
J	Mori, R				Mori, Ryuhei			Loop Calculus For Nonbinary Alphabets Using Concepts From Information Geometry	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Partition function; Bethe approximation; holographic transformation; loop calculus; information geometry	GAUSSIAN GRAPHICAL MODELS; BELIEF PROPAGATION; FREE-ENERGY; ALGORITHMS; EXPANSION	The Bethe approximation is a well-known approximation of the partition function used in statistical physics. Recently, an equality relating the partition function and its Bethe approximation was obtained for graphical models with binary variables by Chertkov and Chernyak. In this equality, the multiplicative error in the Bethe approximation is represented as a weighted sum over all generalized loops in the graphical model. In this paper, the equality is generalized to graphical models with nonbinary alphabet using concepts from information geometry.	Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Math & Comp Sci, Tokyo 1080023, Japan	Mori, R (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Math & Comp Sci, Tokyo 1080023, Japan.	mori@is.titech.ac.jp			MEXT KAKENHI [24106008]	This work was supported by MEXT KAKENHI under Grant 24106008. This paper was presented at the 2012 IEICE Symposium on Information Theory and its Application.	Amari S.-I., 2000, TRANSLATIONS MATH MO, V191; Xiao JQ, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/42/425001; Chernyak VY, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P316, DOI 10.1109/ISIT.2007.4557245; Vontobel PO, 2013, IEEE T INFORM THEORY, V59, P6018, DOI 10.1109/TIT.2013.2264715; Ikeda S, 2004, NEURAL COMPUT, V16, P1779, DOI 10.1162/0899766041336477; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Zhou HJ, 2012, J STAT PHYS, V148, P513, DOI 10.1007/s10955-012-0555-1; Malioutov DM, 2006, J MACH LEARN RES, V7, P2031; FISHER ME, 1967, PHYS REV, V162, P480, DOI 10.1103/PhysRev.162.480; Pelizzola A, 2005, J PHYS A-MATH GEN, V38, pR309, DOI 10.1088/0305-4470/38/33/R01; VONDREIFUS H, 1995, COMMUN MATH PHYS, V170, P21, DOI 10.1007/BF02099437; Al-Bashabsheh A, 2011, IEEE T INFORM THEORY, V57, P752, DOI 10.1109/TIT.2010.2094870; Weiss Y, 2001, NEURAL COMPUT, V13, P2173, DOI 10.1162/089976601750541769; Gomez V, 2007, J MACH LEARN RES, V8, P1987; Valiant LG, 2008, SIAM J COMPUT, V37, P1565, DOI 10.1137/070682575; Wainwright MJ, 2003, IEEE T INFORM THEORY, V49, P1120, DOI 10.1109/TIT.2003.810642; Vontobel PO, 2013, IEEE T INFORM THEORY, V59, P1866, DOI 10.1109/TIT.2012.2227109; Yedidia JS, 2005, IEEE T INFORM THEORY, V51, P2282, DOI 10.1109/TIT.2005.850085; Bethe H.A., 1935, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V150, DOI 10.1098/rspa.1935.0122; Chandrasekaran V, 2011, SIAM J DISCRETE MATH, V25, P1012, DOI 10.1137/090767145; Chernyak VY, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/12/P12011; Chertkov M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065102; Chertkov M., 2006, P 44 ALL C COMM CONT; Chertkov M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06009; David Forney Jr G., 2011, P IEEE INF THEOR APP; GEORGES A, 1991, J PHYS A-MATH GEN, V24, P2173, DOI 10.1088/0305-4470/24/9/024; Johnson J. K., 2009, P 26 ANN INT C MACH, P473; Macris Nicolas, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283929; Mezard M., 2009, INFORM PHYS COMPUTAT; Sessak V, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/5/055001; Mori R., 2012, P IEICE S INF THEOR; Mori R., 2011, Proceedings of the 2011 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2011.6033907; Peierls R, 1936, PROC R SOC LON SER-A, V154, P0207, DOI 10.1098/rspa.1936.0047; PLEFKA T, 1982, J PHYS A-MATH GEN, V15, P1971, DOI 10.1088/0305-4470/15/6/035; Richardson T., 2008, MODERN CODING THEORY; Rothvoss T., 2013, MATCHING POLYTOPE HA; Sudderth E. B., 2008, ADV NEURAL INFORM PR, V20, P1425; Wainwright Martin J, 2008, Foundations and Trends in Machine Learning, V1, DOI 10.1561/2200000001; Watanabe Y., 2010, THESIS GRADUATE U HA; Welling M., 2012, P 28 C UNC ART INT C, P883; Werner T., 2010, P 26 C UNC ART INT U, P651	41	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	APR	2015	61	4					1887	1904		10.1109/TIT.2015.2403239		18	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CE0CI	WOS:000351470800024		
J	Li, J; Lu, H; Guizani, M				Li, Jie; Lu, Huang; Guizani, Mohsen			ACPN: A Novel Authentication Framework with Conditional Privacy-Preservation and Non-Repudiation for VANETs	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Vehicular ad hoc network; authentication framework; privacy preservation; non-repudiation; pseudonym; identity-based cryptography	AD-HOC NETWORKS; IDENTITY-BASED SIGNATURE; VEHICULAR COMMUNICATIONS; DIGITAL-SIGNATURES; EFFICIENT; SECURE; SCHEME; CRYPTOSYSTEMS; COMMUNICATION; ALGORITHMS	In Vehicular Ad hoc NETworks (VANETs), authentication is a crucial security service for both inter-vehicle and vehicle-roadside communications. On the other hand, vehicles have to be protected from the misuse of their private data and the attacks on their privacy, as well as to be capable of being investigated for accidents or liabilities from non-repudiation. In this paper, we investigate the authentication issues with privacy preservation and non-repudiation in VANETs. We propose a novel framework with preservation and repudiation (ACPN) for VANETs. In ACPN, we introduce the public-key cryptography (PKC) to the pseudonym generation, which ensures legitimate third parties to achieve the non-repudiation of vehicles by obtaining vehicles' real IDs. The self-generated PKC-based pseudonyms are also used as identifiers instead of vehicle IDs for the privacy-preserving authentication, while the update of the pseudonyms depends on vehicular demands. The existing ID-based signature (IBS) scheme and the ID-based online/offline signature (IBOOS) scheme are used, for the authentication between the road side units (RSUs) and vehicles, and the authentication among vehicles, respectively. Authentication, privacy preservation, non-repudiation and other objectives of ACPN have been analyzed for VANETs. Typical performance evaluation has been conducted using efficient IBS and IBOOS schemes. We show that the proposed ACPN is feasible and adequate to be used efficiently in the VANET environment.	[Li, Jie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Lu, Huang] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa, Japan; [Guizani, Mohsen] Qatar Univ, Doha, Qatar	Li, J (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan.	lijie@cs.tsukuba.ac.jp; lu.huang.jp@ieee.org; mguizani@ieee.org			Japan Society for Promotion of Science (JSPS); National Institute of Informatics (NII), Japan	This work was partially supported by Grant-in-Aid for Scientific Research of Japan Society for Promotion of Science (JSPS) and Collaboration Research Grant of National Institute of Informatics (NII), Japan. Huang Lu is the corresponding author.	Wang NW, 2008, COMPUT COMMUN, V31, P2827, DOI 10.1016/j.comcom.2007.12.003; EVEN S, 1990, LECT NOTES COMPUT SC, V435, P263; Hess F, 2003, LECT NOTES COMPUT SC, V2595, P310; Kamat P, 2008, SECUR COMMUN NETW, V1, P233, DOI 10.1002/sec.27; Zhang YC, 2006, IEEE T DEPEND SECURE, V3, P386, DOI 10.1109/TDSC.2006.58; Patarin J, 1996, LECT NOTES COMPUT SC, V1070, P33; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Sun YP, 2010, IEEE T VEH TECHNOL, V59, P3589, DOI 10.1109/TVT.2010.2051468; Wu B, 2007, SIGNALS COMMUN TECHN, P103, DOI 10.1007/978-0-387-33112-6_5; Liu JK, 2010, INT J INF SECUR, V9, P287, DOI 10.1007/s10207-010-0109-y; Gerlach M, 2007, IEEE VTS VEH TECHNOL, P2521, DOI 10.1109/VETECS.2007.519; Zeadally S, 2012, TELECOMMUN SYST, V50, P217, DOI 10.1007/s11235-010-9400-5; Lin XD, 2007, IEEE T VEH TECHNOL, V56, P3442, DOI 10.1109/TVT.2007.906878; [Anonymous], 2009, 1609 IEEE; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342; Sun JY, 2010, IEEE T PARALL DISTR, V21, P1227, DOI 10.1109/TPDS.2010.14; Armknecht F., 2007, PROC ITG GI CONF COM, P1; Barreto PSLM, 2002, LECT NOTES COMPUT SC, V2442, P354; Boneh D., 2001, P 21 ANN INT CRYPT C, V2139, p[213, 27]; Choi J., 2009, P IEEE 6 CONS COMM N; Dierks T., 2008, 5246 RFC IETF; Dok H., 2010, INT J FUTURE GENERAT, V3, P17; Fuentes J. M., 2011, HDB RES MOBILITY COM, P894; Gura N., 2004, P 6 INT WORKSH CRYPT, V2004, P925; Hoffstein J., 1998, P ANTS 3 LNCS SPRING, V1423, P267, DOI DOI 10.1007/BFB0054868; Hoh B., 2009, P 14 ACM C COMP COMM, P161; Kamat P., 2006, P 3 ACM INT WORKSH V, P94, DOI 10.1145/1161064.1161083; Lin XD, 2008, IEEE T WIREL COMMUN, V7, P4987, DOI 10.1109/T-WC.2008.070773; Lu H., 2012, P COMP COMM APPL C C, P345; Lu R., 2008, P IEEE INFOCOM, P1229; Mollin R.A., 2002, DISCRETE MATH ITS AP; Raya M., 2007, Journal of Computer Security, V15; Riley M, 2011, SECUR COMMUN NETW, V4, P1137, DOI 10.1002/sec.239; Shamir A., 2001, P CRYPTO 01 SANT BAR, V2139, P355; Shamir A., 1985, P CRYPTO 84 ADV CRYP, V196, P47; Studer A, 2009, J COMMUN NETW-S KOR, V11, P574; Sun J., 2007, P IEEE MIL COMM C OC, P1, DOI DOI 10.1109/MILC0M.2007.4454834; Xu SD, 2005, LECT NOTES COMPUT SC, V3823, P854; Yu F R, 2010, IEEE Transactions on Network and Service Management, V7, DOI 10.1109/TNSM.2010.1012.0362; Zhang C., 2008, P IEEE INFOCOM, P246	40	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	APR	2015	26	4					938	948		10.1109/TPDS.2014.2308215		11	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CD9XF	WOS:000351453000003		
J	Wang, XY; Li, J				Wang, Xiaoyan; Li, Jie			Improving the Network Lifetime of MANETs through Cooperative MAC Protocol Design	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Network lifetime; cooperative communication; medium access control protocol; relay selection	AD HOC NETWORKS; WIRELESS NETWORKS; SENSOR NETWORKS; DIVERSITY; SELECTION	Cooperative communication, which utilizes nearby terminals to relay the overhearing information to achieve the diversity gains, has a great potential to improve the transmitting efficiency in wireless networks. To deal with the complicated medium access interactions induced by relaying and leverage the benefits of such cooperation, an efficient Cooperative Medium Access Control (CMAC) protocol is needed. In this paper, we propose a novel cross-layer distributed energy-adaptive location-based CMAC protocol, namely DEL-CMAC, for Mobile Ad-hoc NETworks (MANETs). The design objective of DEL-CMAC is to improve the performance of the MANETs in terms of network lifetime and energy efficiency. A practical energy consumption model is utilized in this paper, which takes the energy consumption on both transceiver circuitry and transmit amplifier into account. A distributed utility-based best relay selection strategy is incorporated, which selects the best relay based on location information and residual energy. Furthermore, with the purpose of enhancing the spatial reuse, an innovative network allocation vector setting is provided to deal with the varying transmitting power of the source and relay terminals. We show that the proposed DEL-CMAC significantly prolongs the network lifetime under various circumstances even for high circuitry energy consumption cases by comprehensive simulation study.	[Wang, Xiaoyan] Natl Inst Informat, Informat Syst Architecture Sci Res Div, Chiyoda Ku, Tokyo 1018430, Japan; [Li, Jie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan	Wang, XY (reprint author), Natl Inst Informat, Informat Syst Architecture Sci Res Div, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	wangxy@nii.ac.jp; lijie@cs.tsukuba.ac.jp			Japan Society for Promotion of Science (JSPS); National Institute of Informatics (NII), Japan	The authors would like to thank Prof. Yuguang Fang, the editor and the anonymous reviewers, whose insightful comments helped us to improve the quality of the paper. This work is partially supported by Grant-in-Aid for Scientific Research of Japan Society for Promotion of Science (JSPS) and Collaboration Research Grant of National Institute of Informatics (NII), Japan. Jie Li is the corresponding author.	Shan HG, 2011, IEEE T WIREL COMMUN, V10, P2603, DOI 10.1109/TWC.2011.060811.101196; Ibrahim AS, 2008, IEEE T WIREL COMMUN, V7, P2814, DOI 10.1109/TWC.2008.070176; Liu P, 2007, IEEE J SEL AREA COMM, V25, P340, DOI 10.1109/JSAC.2007.070210; Wu J, 2006, IEEE T PARALL DISTR, V17, P851, DOI 10.1109/TPDS.2006.103; Moh S, 2011, IEEE T PARALL DISTR, V22, P353, DOI 10.1109/TPDS.2010.99; Qin XP, 2004, IEEE INFOCOM SER, P1662; Laneman JN, 2003, IEEE T INFORM THEORY, V49, P2415, DOI 10.1109/TIT.2003.817829; [Anonymous], 1999, 80211 IEEE; Cui SG, 2004, IEEE J SEL AREA COMM, V22, P1089, DOI 10.1109/JSAC.2004.830916; Zhu H, 2006, IEEE T MOBILE COMPUT, V5, P1201; Patterson CA, 2003, IEEE PERVAS COMPUT, V2, P80, DOI 10.1109/MPRV.2003.1203757; Sendonaris A, 2003, IEEE T COMMUN, V51, P1927, DOI 10.1109/TCOMM.2003.818096; Beres E, 2010, IEEE T WIREL COMMUN, V9, P2145, DOI 10.1109/TWC.2010.07.081669; Broch J., 1998, P ACM MOBICOM; Chen L, 2011, IEEE T PARALL DISTR, V22, P758, DOI 10.1109/TPDS.2010.152; Gokturk MS, 2008, IEEE ICC, P4284, DOI 10.1109/ICC.2008.804; Goldsmith A., 2005, WIRELESS COMMUNICATI; Himsoon T., 2007, IEEE J SEL AREA COMM, V25, P307; Kadloor S., 2010, IEEE T WIREL COMMUN, V9, P1675; Laneman JN, 2004, IEEE T INFORM THEORY, V50, P3062, DOI 10.1109/TIT.2004.838089; Perkins CE, 1999, P IEEE WORKSH MOB CO; Sadek AK, 2009, ACM T SENSOR NETWORK, V6, DOI 10.1145/1653760.1653765; Savarese C., 2001, P INT C AC SPEECH SI; Shan H., 2008, P 2008 IEEE GLOB COM, P1; Wang X., 2012, P IEEE WIR COMM NETW, P1646; Zhai C., 2009, P IEEE GLOBECOM HON, P1; Zhang J, 2009, IEEE T VEH TECHNOL, V58, P1561, DOI 10.1109/TVT.2008.929219; Zhu Y., 2011, IEEE T PARALL DISTR, V23, P1480	28	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	APR	2015	26	4					1010	1020		10.1109/TPDS.2013.110		11	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CD9XF	WOS:000351453000009		
J	Han, B; Li, J; Su, JS; Guo, MY; Zhao, BK				Han, Biao; Li, Jie; Su, Jinshu; Guo, Minyi; Zhao, Baokang			Secrecy Capacity Optimization via Cooperative Relaying and Jamming for WANETs	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Cooperative communication; physical layer security; secrecy capacity; relay assignment; cooperative jamming	AMPLIFY-AND-FORWARD; WIRE-TAP CHANNEL; EMERGENCY SERVICES; NETWORKS	Cooperative wireless networking, which is promising in improving the system operation efficiency and reliability by acquiring more accurate and timely information, has attracted considerable attentions to support many services in practice. However, the problem of secure cooperative communication has not been well investigated yet. In this paper, we exploit physical layer security to provide secure cooperative communication for wireless ad hoc networks (WANETs) where involve multiple source-destination pairs and malicious eavesdroppers. By characterizing the security performance of the system by secrecy capacity, we study the secrecy capacity optimization problem in which security enhancement is achieved via cooperative relaying and cooperative jamming. Specifically, we propose a system model where a set of relay nodes can be exploited by multiple source-destination pairs to achieve physical layer security. We theoretically present a corresponding formulation for the relay assignment problem and develop an optimal algorithm to solve it in polynomial time. To further increase the system secrecy capacity, we exploit the cooperative jamming technique and propose a smart jamming algorithm to interfere the eavesdropping channels. Through extensive experiments, we validate that our proposed algorithms significantly increase the system secrecy capacity under various network settings.	[Han, Biao; Su, Jinshu; Zhao, Baokang] Natl Univ Def Technol, Sch Comp, Changsha 410073, Hunan, Peoples R China; [Li, Jie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan; [Guo, Minyi] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China	Han, B (reprint author), Natl Univ Def Technol, Sch Comp, Changsha 410073, Hunan, Peoples R China.	nudtbill@nudt.edu.cn; lijie@cs.tsukuba.ac.jp; sjs@nudt.edu.cn; guo-my@cs.sjtu.edu.cn; bkzhao@nudt.edu.cn			Japan Society for Promotion of Science (JSPS), Japan; National Natural Science Foundation of China (NSFC) [61202488, 61373156, 91438121]; Key Basic Research Project of the Science and Technology Commission of Shanghai Municipality [12JC1405400]; Shanghai Pujiang Program [13PJ1404600]; Shanghai Branch of Southwest Electron and Telecom Technology Research Institute Project [2013008]	The authors would like to thank the editor and the anonymous reviewers, whose insightful comments helped us to improve the quality of the paper. This work was partially supported by Grant-in-Aid for Scientific Research of Japan Society for Promotion of Science (JSPS), Japan. This work also is partially support by the National Natural Science Foundation of China (NSFC) with Grants no. 61202488, no. 61373156 and no. 91438121, Key Basic Research Project of the Science and Technology Commission of Shanghai Municipality no. 12JC1405400, Shanghai Pujiang Program no. 13PJ1404600, and Shanghai Branch of Southwest Electron and Telecom Technology Research Institute Project no. 2013008. An bridged version of this paper was accepted in the main conference of IEEE INFOCOM' 2013 under the title "Secrecy Capacity Maximization for Secure Cooperative Ad-hoc Networks". Jie Li is the corresponding author.	Aggarwal V, 2009, EURASIP J WIREL COMM, DOI 10.1155/2009/494696; Wang T, 2008, IEEE T INF FOREN SEC, V3, P290, DOI 10.1109/TIFS.2008.920730; Zhang JB, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P3051; Bletsas A, 2007, IEEE T WIREL COMMUN, V6, P3450, DOI 10.1109/TWC.2007.06020050; Yang DJ, 2012, IEEE J SEL AREA COMM, V30, P245, DOI 10.1109/JSAC.2012.120202; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Chen JC, 2012, IEEE T INF FOREN SEC, V7, P310, DOI 10.1109/TIFS.2011.2166386; Krikidis I, 2009, IEEE T WIREL COMMUN, V8, P5003, DOI 10.1109/TWC.2009.090323; Ren K, 2011, IEEE WIREL COMMUN, V18, P6; Tekin E, 2008, IEEE T INFORM THEORY, V54, P2735, DOI 10.1109/TIT.2008.921680; Lai LF, 2008, IEEE T INFORM THEORY, V54, P4005, DOI 10.1109/TIT.2008.928272; Dong L, 2008, 2008 46TH ANNUAL ALLERTON CONFERENCE ON COMMUNICATION, CONTROL, AND COMPUTING, VOLS 1-3, P1132; Dong L, 2009, INT CONF ACOUST SPEE, P2613, DOI 10.1109/ICASSP.2009.4960158; Zhang PY, 2009, IEEE WCNC, P1, DOI 10.1109/PLASMA.2009.5227420; Dong L, 2010, IEEE T SIGNAL PROCES, V58, P1875, DOI 10.1109/TSP.2009.2038412; Wang Q, 2011, IEEE INFOCOM SER, P1422; WYNER AD, 1975, AT&T TECH J, V54, P1355; Barros J., 2006, P 2006 IEEE INT S IN, V1, P356; Han B, 2013, IEEE INFOCOM SER, P2796; Han BA, 2012, IEEE J SEL AREA COMM, V30, P450, DOI 10.1109/JSAC.2012.120225; Han BA, 2011, IEEE INFOCOM SER, P891; Hong YWP, 2010, COOPERATIVE COMMUNICATIONS AND NETWORKING: TECHNOLOGIES AND SYSTEM DESIGN, P1, DOI 10.1007/978-1-4419-7194-4; Laneman JN, 2004, IEEE T INFORM THEORY, V50, P3062, DOI 10.1109/TIT.2004.838089; LEUNGYANCHEONG SK, 1978, IEEE T INFORM THEORY, V24, P451, DOI 10.1109/TIT.1978.1055917; Liang Y., 2008, P IEEE INF THEOR APP, P249; Liang Y., 2009, INFORM THEORETIC SEC; Liu H, 2005, OFDM-BASED BROADBAND WIRELESS NETWORKS: DESIGN AND OPTIMIZATION, P1, DOI 10.1002/0471757195; Sharma S, 2011, IEEE ACM T NETWORK, V19, P879, DOI 10.1109/TNET.2010.2091148; Shen XM, 2012, IEEE J SEL AREA COMM, V30, P241, DOI 10.1109/JSAC.2012.120201; Sun Y., 2007, NETWORK AWARE SECURI; West D. B., 2001, INTRO GRAPH THEORY; Zhao Y., 2006, P IEEE INT S INF THE, P1234	32	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	APR	2015	26	4					1117	1128		10.1109/TPDS.2014.2316155		12	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CD9XF	WOS:000351453000018		
J	Tei, K; Shimizu, R; Fukazawa, Y; Honiden, S				Tei, Kenji; Shimizu, Ryo; Fukazawa, Yoshiaki; Honiden, Shinichi			Model-Driven-Development-Based Stepwise Software Development Process for Wireless Sensor Networks	IEEE TRANSACTIONS ON SYSTEMS MAN CYBERNETICS-SYSTEMS			English	Article						Domain-specific languages (DSLs); model-driven development (MDD); software development process; wireless sensor networks (WSNs)	SYSTEM; ARCHITECTURE; MIDDLEWARE	To meet future demands for wireless sensor network (WSN) software, both experts and average software developers should be involved in WSN software development. However, WSN software development is difficult for the average software developer because data processing-related design and network-related design are tangled in the software. Here, we propose a software development process for WSN software by stepwise refinement. Our process enables stepwise refinement to separately address data processing-related and network-related concerns, reuse of well-defined designs, and implementations for network-related concerns prepared by the experts, and perform model-driven development to obtain source codes from models by model transformations. Additionally, we used case studies using actual WSN software development and user studies to evaluate how our proposed process can support actual WSN software development.	[Tei, Kenji; Honiden, Shinichi] Natl Inst Informat, Tokyo 1018430, Japan; [Shimizu, Ryo; Fukazawa, Yoshiaki] Waseda Univ, Tokyo 1698050, Japan; [Honiden, Shinichi] Univ Tokyo, Tokyo 1130033, Japan	Tei, K (reprint author), Natl Inst Informat, Tokyo 1018430, Japan.	tei@nii.ac.jp					Akbal-Delibas B, 2009, LECT NOTES BUS INF, V20, P551; Mamun Q, 2012, SENSORS-BASEL, V12, P14887, DOI 10.3390/s121114887; Wang Q, 2006, IEEE NETWORK, V20, P48; Madden SR, 2005, ACM T DATABASE SYST, V30, P122, DOI 10.1145/1061318.1061322; Losilla F, 2007, LECT NOTES COMPUT SC, V4758, P179; Doolin DM, 2005, P SOC PHOTO-OPT INS, V5765, P477, DOI 10.1117/12.605655; Bhatti S, 2005, MOBILE NETW APPL, V10, P563, DOI 10.1007/s11036-005-1567-8; Bai LS, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN 2009), P85; Boonma P, 2010, COMPUT J, V53, P1674, DOI 10.1093/comjnl/bxp129; Boonma P, 2007, COMPUT NETW, V51, P4599, DOI [10.1016/j.comnet.2007.06.006, 10.1016/j.comnet.2007.07.006]; Ceriotti M., P INT C INF PROC SEN, P277; Chen D., 2004, P INT C WIR NETW LAS, V233, P1; Cheong E., 2006, UCBEECS200615 DEP EL; Chipara O., 2010, P 8 ACM C EMB NETW S, P155, DOI [10.1145/1869983.1869999, DOI 10.1145/1869983.1869999]; Costa P, 2007, LECT NOTES COMPUT SC, V4834, P429; Dantas P, 2013, INT WORK SOFTW ENG, P7, DOI 10.1109/SESENA.2013.6612258; Doddapaneni K., 2012, 3 INT WORKSH SOFTW E; France R, 2007, P FUT SOFTW ENG FOSE, P37; Gay D., 2003, ACM SIGPLAN C PROGR; Hartung C., 2006, P 4 INT C MOB SYST A, P28, DOI DOI 10.1145/1134680.1134685; Hnat TW, 2008, SENSYS'08: PROCEEDINGS OF THE 6TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS, P225; Kim S, 2007, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS, P254, DOI 10.1145/1236360.1236395; Levis P, 2005, AMBIENT INTELLIGENCE, P115, DOI 10.1007/3-540-27139-2_7; Lim J. B., 2010, ACM T SENSOR NETWORK, V7, P71; Mottola L., 2011, ACM COMPUT SURV, V43, P191; Mozumdar M., 2008, P 5 ANN IEEE COMM SO, P515; Newton R, 2007, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS, P489, DOI 10.1109/IPSN.2007.4379709; Panta R. K., 2011, ACM T SENSOR NETWORK, V7, P301; Patil M., 2012, P 18 IEEE INT C NETW, P86; Rodrigues T, 2013, INT WORK SOFTW ENG, P43, DOI 10.1109/SESENA.2013.6612265; Rodrigues T, 2011, P 9 INT C EMB UB COM, P11, DOI [10.1109/EUC.2011.50, DOI 10.1109/EUC.2011.50]; Sadler C M, 2006, P 4 INT C EMB NETW S, P265, DOI DOI 10.1145/1182807.1182834; Sha KW, 2008, J PARALLEL DISTR COM, V68, P1207, DOI 10.1016/j.jpdc.2008.06.004; Sugihara R., 2008, ACM T SENSOR NETWORK, V4, P81; Tilaky S., 2002, P 1 ACM INT WORKSH W, P49; Turon M., 2005, P 2 IEEE WORKSH EMB, P11; Volgyesi P, 2002, EUROMICRO CONF PROC, P68, DOI 10.1109/EURMIC.2002.1046135; Wada H., 2007, P 11 IASTED INT C SO, P216; Welsh M., 2004, P 1 C S NETW SYST DE, V1, P3; Werner-Allen G., 2006, Proceedings of the 7th USENIX Symposium on Operating Systems Design and Implementation (OSDI'06); Wittenburg G, 2007, LECT NOTES COMPUT SC, V4373, P163; Xu XH, 2011, INT J NETW MANAG, V21, P300, DOI 10.1002/nem.792; Zhao J., 2003, 1 INT C EMB NETW SEN	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2216			IEEE T SYST MAN CY-S	IEEE Trans. Syst. Man Cybern. -Syst.	APR	2015	45	4					675	687		10.1109/TSMC.2014.2360506		13	Automation & Control Systems; Computer Science, Cybernetics	Automation & Control Systems; Computer Science	CE1BH	WOS:000351545900011		
J	Ichikawa, K; Ohshima, D; Sagara, H				Ichikawa, Kazuhisa; Ohshima, Daisuke; Sagara, Hiroshi			Regulation of signal transduction by spatial parameters: a case in NF-kappa B oscillation	IET SYSTEMS BIOLOGY			English	Review						cancer; cellular biophysics; genetics; biomembrane transport; oscillations; signal transduction regulation; spatial parameters; NFaEuro"B-K oscillation; transcription factor; autoimmune diseases; inflammatory diseases; viral infection; malignant cancer cells; therapeutic treatment; activating stimuli; cytokines; cell nucleus; gene expression; computational simulations; nuclear-to-cytoplasmic volume ratio; nuclear membrane; organelles; mitochondria; endoplasmic reticula; lipid droplets; intracellular space; intracellular signalling mechanism	GREEN FLUORESCENT PROTEIN; SINGLE LIVING CELLS; ENDOPLASMIC-RETICULUM; TNF-ALPHA; SENSITIVITY-ANALYSIS; NEGATIVE FEEDBACK; TEMPORAL CONTROL; GENE-EXPRESSION; IKK-ALPHA; TRANSCRIPTIONAL ACTIVITY	NF-kappa B is a transcription factor regulating expression of more than 500 genes, and its dysfunction leads to the autoimmune and inflammatory diseases. In malignant cancer cells, NF-kB is constitutively activated. Thus the elucidation of mechanisms for NF-kB regulation is important for the establishment of therapeutic treatment caused by incorrect NF-kB responses. Cytoplasmic NF-kB translocates to the nucleus by the application of extracellular stimuli such as cytokines. Nuclear NF-kB is known to oscillate with the cycle of 1.5-4.5h, and it is thought that the oscillation pattern regulates the expression profiles of genes. In this review, first we briefly describe regulation mechanisms of NF-kB. Next, published computational simulations on the oscillation of NF-kB are summarised. There are at least 60 reports on the computational simulation and analysis of NF-kB oscillation. Third, the importance of a space' for the regulation of oscillation pattern of NF-kB is discussed, showing altered oscillation pattern by the change in spatial parameters such as diffusion coefficient, nuclear to cytoplasmic volume ratio (N/C ratio), and transport through nuclear membrane. Finally, simulations in a true intracellular space (TiCS), which is an intracellular 3D space reconstructed in a computer with organelles such as nucleus and mitochondria are discussed.	[Ichikawa, Kazuhisa; Ohshima, Daisuke] Univ Tokyo, Inst Med Sci, Math Oncol, Minato Ku, Tokyo 1088639, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	Ichikawa, K (reprint author), Univ Tokyo, Inst Med Sci, Math Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kichi@ims.u-tokyo.ac.jp					Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.015; Yang Q, 2011, MATH BIOSCI, V232, P151, DOI 10.1016/j.mbs.2011.05.005; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Millot C, 2000, HISTOL HISTOPATHOL, V15, P1185; Kim JR, 2010, J CELL SCI, V123, P537, DOI 10.1242/jcs.060061; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Swaminathan R, 1997, BIOPHYS J, V72, P1900; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Cucurull-Sanchez L, 2012, DRUG DISCOV TODAY, V17, P665, DOI 10.1016/j.drudis.2012.01.015; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; NAUMANN M, 1994, EMBO J, V13, P4597; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cagalinec M, 2013, J CELL SCI, V126, P2187, DOI 10.1242/jcs.118844; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; Dayel MJ, 1999, BIOPHYS J, V76, P2843; Ninomiya-Tsuji J, 1999, NATURE, V398, P252; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Ihekwaba AEC, 2007, FEBS J, V274, P1678, DOI 10.1111/j.1742-4658.2007.05713.x; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Beinke S, 2004, BIOCHEM J, V382, P393; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Nelson G, 2002, J CELL SCI, V115, P1137; Wang YJ, 2012, J THEOR BIOL, V297, P137, DOI 10.1016/j.jtbi.2011.12.014; Kim SY, 2010, BIOCHEM BIOPH RES CO, V391, P28, DOI 10.1016/j.bbrc.2009.10.154; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Miyawaki A, 2011, NAT REV MOL CELL BIO, V12, P656, DOI 10.1038/nrm3199; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Chen HH, 2013, PROTEIN CELL, V4, P27, DOI 10.1007/s13238-012-2063-0; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; KOONG AC, 1994, CANCER RES, V54, P1425; Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156; Murata T, 2000, J GEN VIROL, V81, P401; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Nikolov S, 2009, IET SYST BIOL, V3, P59, DOI 10.1049/iet-syb.2008.0105; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Hurtley S, 2009, SCIENCE, V326, P1205, DOI 10.1126/science.326.5957.1205; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Balsa-Canto E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-11; BARKEN D, 2005, SCIENCE, V308, pA52, DOI DOI 10.1126/SCIENCE.1107904; Bola B, 2009, BIOCHEM SOC T, V37, P961, DOI 10.1042/BST0370961; Breenberg J., 1988, SOC NEUR ABSTR, V225, P16; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; CHEONG R, 2008, MOL SYST BIOL, V4, pNIL60, DOI DOI 10.1038/MSB.2008.30; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Equils O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008502; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Fujarewicz K, 2007, IEEE ACM T COMPUT BI, V4, P322, DOI 10.1109/tcbb.2007.1016; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gunel A, 2012, J THEOR BIOL, V307, P137, DOI 10.1016/j.jtbi.2012.04.026; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; Ihekwaba AEC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-203; Ihekwaba A. E. C., 2004, IEE Systems Biology, V1, DOI 10.1049/sb:20045009; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Joo J, 2007, ANN NY ACAD SCI, V1115, P221, DOI 10.1196/annals.1407.014; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kang CC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S17; KATSOULIS M, 1995, BRIT J CANCER, V72, P958, DOI 10.1038/bjc.1995.441; Kim D, 2009, FASEB J, V23, P2796, DOI 10.1096/fj.09-130369; Koh G, 2011, COMPUT BIOL MED, V41, P512, DOI 10.1016/j.compbiomed.2011.04.017; Lahav G, 2004, SCI STKE, V264, P55; Lee J, 2010, BIOCHEM BIOPH RES CO, V391, P33, DOI 10.1016/j.bbrc.2009.10.155; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; LERNBECHER T, 1994, EMBO J, V13, P4060; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; MAHAFFY JM, 1984, J MATH BIOL, V20, P39, DOI 10.1007/BF00275860; MONTIRONI R, 1990, ANAL CELL PATHOL, V2, P277; Nguyen TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055550; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; SALMON I, 1992, ANAL QUANT CYTOL, V14, P47; Schliemann M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-204; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Su JM, 2009, J INNATE IMMUN, V1, P164, DOI 10.1159/000158541; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Sung MH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00616; Takahashi N, 2008, BIOCHEM BIOPH RES CO, V374, P424, DOI 10.1016/j.bbrc.2008.06.128; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Terry AJ, 2011, J THEOR BIOL, V290, P7, DOI 10.1016/j.jtbi.2011.08.036; Tournier L, 2009, J THEOR BIOL, V260, P196, DOI 10.1016/j.jtbi.2009.06.006; Vaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027774; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50	146	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8849	1751-8857		IET SYST BIOL	IET Syst. Biol.	APR	2015	9	2					41	51		10.1049/iet-syb.2013.0020		11	Cell Biology; Mathematical & Computational Biology	Cell Biology; Mathematical & Computational Biology	CD9YY	WOS:000351459200001		
J	Nonaka, MI; Zsigmond, E; Kudo, A; Kawakami, H; Yoshida, K; Yoshida, M; Kawano, N; Miyado, K; Nonaka, M; Wetsel, RA				Nonaka, Mayumi I.; Zsigmond, Eva; Kudo, Akihiko; Kawakami, Hayato; Yoshida, Kaoru; Yoshida, Manabu; Kawano, Natsuko; Miyado, Kenji; Nonaka, Masaru; Wetsel, Rick A.			Epididymal C4b-binding protein is processed and degraded during transit through the duct and is not essential for fertility	IMMUNOBIOLOGY			English	Article						C4BP; Complement; Epididymis; Gene targeting; Processing; Reproduction; Sperm maturation	CLASSICAL PATHWAY; MOUSE SPERM; C4-BINDING PROTEIN; COMPLEMENT-SYSTEM; MOLECULAR-CLONING; BINDING-PROTEIN; CELLS; RECEPTOR; ASSOCIATION; EXPRESSION	C4b-binding protein (C4BP) is known as one of the circulating complement regulators that prevents excessive activation of the host-defense complement system. We have reported previously that C4BP is expressed abundantly in the rodent epididymis, one of the male reproductive organs connecting the testis and vas deferens, where immature spermatozoa acquire their motility and fertilizing ability during their transit through the duct. Epididymal C4BP (EpC4BP) is synthesized androgen-dependently by the epithelial cells, secreted into the lumen, and bound to the outer membrane of the passing spermatozoa. In this study, we found that EpC4BP is secreted as a large oligomer, similar to the serum C4BP, but is digested during the epididymal transit and is almost lost from both the luminal fluid and the sperm surface in the vas deferens. Such a processing pattern is not known in serum C4BP, suggesting that EpC4BP and serum C4BP might have different functional mechanisms, and that there is a novel function of EpC4BP in reproduction. In addition, the disappearance of EpC4BP from the sperm surface prior to ejaculation suggests that EpC4BP works only in the epididymis and would not work in the female reproductive tract to protect spermatozoa from complement attack. Next, we generated C4BP-deficient (C4BP-/-) mice to examine the possible role of EpC4BP in reproduction. However, the C4BP-/- mice were fertile and no significant differences were observed between the C4BP-/- and wild-type mouse spermatozoa in terms of morphology, motility, and rate of the spontaneous acrosome reaction. These results suggest that EpC4BP is involved in male reproduction, but not essential for sperm maturation. (C) 2014 Elsevier GmbH. All rights reserved.	[Nonaka, Mayumi I.; Nonaka, Masaru] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Zsigmond, Eva; Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Kudo, Akihiko; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan; [Yoshida, Kaoru] Toin Univ Yokohama, Ctr Biomed Engn, Yokohama, Kanagawa, Japan; [Yoshida, Manabu] Univ Tokyo, Misaki Marine Biol Stn, Miura, Kanagawa, Japan; [Kawano, Natsuko; Miyado, Kenji] Natl Ctr Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan	Nonaka, MI (reprint author), Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	nmayumi@bs.s.u-tokyo.ac.jp			National Institutes of Health Public Service Grant [R03AI068795]	We thank Mr. Minoru Fukuda and Ms. Sachie Matsubara for help with electron microscopic analysis. This work was supported by National Institutes of Health Public Service Grant R03AI068795 (to R.A.W.).	ABE K, 1983, ARCH HISTOL JAPON, V46, P51, DOI 10.1679/aohc.46.51; Deng XN, 1999, MOL REPROD DEV, V52, P196, DOI 10.1002/(SICI)1098-2795(199902)52:2<196::AID-MRD11>3.0.CO;2-A; HERMO L, 1991, BIOL REPROD, V44, P1113, DOI 10.1095/biolreprod44.6.1113; Bailey RW, 2002, BIOL REPROD, V66, P1042, DOI 10.1095/biolreprod66.4.1042; Andersen OM, 2003, J BIOL CHEM, V278, P23989, DOI 10.1074/jbc.M302157200; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; HESSING M, 1990, J IMMUNOL, V144, P204; Harris CL, 2003, IMMUNOLOGY, V109, P117, DOI 10.1046/j.1365-2567.2003.01628.x; Inoue N, 2003, MOL CELL BIOL, V23, P2614, DOI 10.1128/MCB.23.7.2614-2622.2003; Harris CL, 2006, MOL IMMUNOL, V43, P57, DOI 10.1016/j.molimm.2005.06.026; Qin XB, 2005, J IMMUNOL, V175, P6294; Holmberg MT, 2001, J IMMUNOL, V167, P935; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Blom AM, 2008, VACCINE, V26, pI49, DOI 10.1016/j.vaccine.2008.11.049; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Baalasubramanian S, 2004, J IMMUNOL, V173, P3684; BOZAS SE, 1993, BIOL REPROD, V48, P503, DOI 10.1095/biolreprod48.3.503; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Buffone MG, 2009, J CELL SCI, V122, P3153, DOI 10.1242/jcs.052977; CHUNG LP, 1985, BIOCHEM J, V230, P133; Cuasnicus PS, 2002, EPIDIDYMIS MOL CLIN, P389; Dacheux JL, 2002, EPIDIDYMIS MOL CLIN, P151; FERREIRA A, 1977, J EXP MED, V146, P1001, DOI 10.1084/jem.146.4.1001; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; Hillarp A, 1997, J IMMUNOL, V158, P1315; KAIDOH T, 1981, J IMMUNOL, V126, P463; KRISTENSEN T, 1987, BIOCHEMISTRY-US, V26, P4668, DOI 10.1021/bi00389a012; Li SH, 2002, BIOL REPROD, V66, P322, DOI 10.1095/biolreprod66.2.322; MATTMUELLER DR, 1992, MOL REPROD DEV, V32, P73, DOI 10.1002/mrd.1080320112; Morales CR, 1996, BIOL REPROD, V55, P676, DOI 10.1095/biolreprod55.3.676; Muro Yuko, 2012, Biol Reprod, V86, P1, DOI 10.1095/biolreprod.111.095877; Nonaka MI, 2001, J IMMUNOL, V166, P4570; Nonaka MI, 2003, BIOL REPROD, V69, P1931, DOI 10.1095/biolreprod.103.020289; OGATA RT, 1993, J IMMUNOL, V150, P2273; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Roberts KP, 2002, BIOL REPROD, V67, P525, DOI 10.1095/biolreprod67.2.525; Rutllant J, 2001, BIOL REPROD, V65, P1324, DOI 10.1095/biolreprod65.5.1324; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jcb.M102293200	44	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	APR	2015	220	4					467	475		10.1016/j.imbio.2014.11.001		9	Immunology	Immunology	CD9LO	WOS:000351420000005		
J	Ito, H; Ando, T; Arioka, Y; Saito, K; Seishima, M				Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Saito, Kuniaki; Seishima, Mitsuru			Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model	IMMUNOLOGY			English	Article						cancer immunotherapy; imiquimod; indoleamine 2; 3-dioxygenase; T helper type 1 response; Toll-like receptor	CYTOTOXIC T-LYMPHOCYTES; DRAINING LYMPH-NODES; BASAL-CELL CARCINOMA; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; FULMINANT-HEPATITIS; LIVER-INJURY; TUMORS; SUPPRESSION; IMMUNITY	Toll-like receptor (TLR) agonists have been shown to have anti-tumour activity in basic research and clinical studies. However, TLR agonist monotherapy does not sufficiently eliminate tumours. Activation of the innate immune response by TLR agonists is effective at driving adaptive immunity via interleukin-12 (IL-12) or IL-1, but is counteracted by the simultaneous induction of immunosuppressive cytokines and other molecules, including IL-10, transforming growth factor-, and indoleamine 2,3-dioxygenase (IDO). In the present study, we evaluated the anti-cancer effect of the TLR7 agonist, imiquimod (IMQ), in the absence of IDO activity. The administration of IMQ in IDO knockout (KO) mice inoculated with tumour cells significantly suppressed tumour progression compared with that in wild-type (WT) mice, and improved the survival rate. Moreover, injection with IMQ enhanced the tumour antigen-specific T helper type 1 response in IDO-KO mice with tumours. Combination therapy with IMQ and an IDO inhibitor also significantly inhibited tumour growth. Our results indicated that the enhancement of IDO expression with TLR agonists in cancer treatment might impair host anti-tumour immunity while the inhibition of IDO could enhance the therapeutic efficacy of TLR agonists via the increase of T helper type 1 immune response.	[Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Dept Internal Med 1, Gifu 5011194, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto, Japan	Ito, H (reprint author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, 1-1 Yanagido, Gifu 5011194, Japan.	hito@gifu-u.ac.jp; seishima@gifu-u.ac.jp			Ministry for Education, Culture, Sports, Science and Technology of Japan [24890080]	The authors thank Dr H. Shirota for kindly providing several of the tumour cell lines in this study. This work was supported by the Grant-in-Aid for Scientific Research (C) (24890080) from the Ministry for Education, Culture, Sports, Science and Technology of Japan.	Ando T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02559; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Domschke C, 2013, CANCER IMMUNOL IMMUN, V62, P1053, DOI 10.1007/s00262-013-1414-x; Kawarada Y, 2001, J IMMUNOL, V167, P5247; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892; Ito H, 2008, INT IMMUNOL, V20, P869, DOI 10.1093/intimm/dxn046; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Weber G, 2013, CLIN CANCER RES, V19, P5079, DOI 10.1158/1078-0432.CCR-13-0955; Stockfleth E, 2003, BRIT J DERMATOL, V149, P53, DOI 10.1046/j.0366-077X.2003.05626.x; Mortenson ED, 2013, CLIN CANCER RES, V19, P1476, DOI 10.1158/1078-0432.CCR-12-2522; Ohtaki H, 2014, BBA-MOL BASIS DIS, V1842, P1464, DOI 10.1016/j.bbadis.2014.04.015; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Lan T, 2007, P NATL ACAD SCI USA, V104, P13750, DOI 10.1073/pnas.0706059104; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Ito H, 2009, J IMMUNOL, V182, P391; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Ahlers JD, 1997, J IMMUNOL, V158, P3947; Lu HL, 2010, J IMMUNOL, V184, P5360, DOI 10.4049/jimmunol.0902997; Fallarino F., 2002, Cell Death and Differentiation, V9, P1069, DOI 10.1038/sj.cdd.4401073; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Ito H, 2014, IMMUNOLOGY, V142, P614, DOI 10.1111/imm.12274; Nakagawa Y, 2011, BIOMED RES-TOKYO, V32, P159; Ohtaki H, 2009, BIOCHEM BIOPH RES CO, V389, P229, DOI 10.1016/j.bbrc.2009.08.120; Shiratsuchi Y, 2007, J LEUKOCYTE BIOL, V81, P412, DOI 10.1189/jlb.0606399; VonsBubnoff D, 2011, J IMMUNOL, V186, P6701; Yang Y, 2012, BLOOD, V120, P4533, DOI 10.1182/blood-2012-02-407163	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	APR	2015	144	4					621	630		10.1111/imm.12413		10	Immunology	Immunology	CD9DR	WOS:000351398200008		
J	Ueno, K; Kinjo, Y; Okubo, Y; Aki, K; Urai, M; Kaneko, Y; Shimizu, K; Wang, DN; Okawara, A; Nara, T; Ohkouchi, K; Mizuguchi, Y; Kawamoto, S; Kamei, K; Ohno, H; Niki, Y; Shibuya, K; Miyazaki, Y				Ueno, Keigo; Kinjo, Yuki; Okubo, Yoichiro; Aki, Kyoko; Urai, Makoto; Kaneko, Yukihiro; Shimizu, Kiminori; Wang, Dan-Ni; Okawara, Akiko; Nara, Takuya; Ohkouchi, Kayo; Mizuguchi, Yuki; Kawamoto, Susumu; Kamei, Katsuhiko; Ohno, Hideaki; Niki, Yoshihito; Shibuya, Kazutoshi; Miyazaki, Yoshitsugu			Dendritic Cell-Based Immunization Ameliorates Pulmonary Infection with Highly Virulent Cryptococcus gattii	INFECTION AND IMMUNITY			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; T-CELLS; BRITISH-COLUMBIA; HOST-DEFENSE; MOUSE MODEL; ACTIVATION; IMMUNITY; VACCINE; MICE	Cryptococcosis due to a highly virulent fungus, Cryptococcus gattii, emerged as an infectious disease on Vancouver Island in Canada and surrounding areas in 1999, causing deaths among immunocompetent individuals. Previous studies indicated that C. gattii strain R265 isolated from the Canadian outbreak had immune avoidance or immune suppression capabilities. However, protective immunity against C. gattii has not been identified. In this study, we used a gain-of-function approach to investigate the protective immunity against C. gattii infection using a dendritic cell (DC)-based vaccine. Bone marrow-derived dendritic cells (BMDCs) efficiently engulfed acapsular C. gattii (Delta cap60 strain), which resulted in their expression of costimulatory molecules and inflammatory cytokines. This was not observed for BMDCs that were cultured with encapsulated strains. When Delta cap60 strain-pulsed BMDCs were transferred to mice prior to intratracheal R265 infection, significant amelioration of pathology, fungal burden, and the survival rate resulted compared with those in controls. Multinucleated giant cells (MGCs) that engulfed fungal cells were significantly increased in the lungs of immunized mice. Interleukin 17A (IL-17A)-, gamma interferon (IFN-gamma)-, and tumor necrosis factor alpha (TNF-alpha)-producing lymphocytes were significantly increased in the spleens and lungs of immunized mice. The protective effect of this DC vaccine was significantly reduced in IFN-gamma knockout mice. These results demonstrated that an increase in cytokine-producing lymphocytes and the development of MGCs that engulfed fungal cells were associated with the protection against pulmonary infection with highly virulent C. gattii and suggested that IFN-gamma may have been an important mediator for this vaccine-induced protection.	[Ueno, Keigo; Kinjo, Yuki; Urai, Makoto; Kaneko, Yukihiro; Okawara, Akiko; Nara, Takuya; Ohkouchi, Kayo; Mizuguchi, Yuki; Ohno, Hideaki; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Okubo, Yoichiro; Aki, Kyoko; Shibuya, Kazutoshi] Toho Univ, Sch Med, Dept Surg Pathol, Tokyo, Japan; [Kaneko, Yukihiro] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan; [Shimizu, Kiminori; Kawamoto, Susumu] Chiba Univ, Med Mycol Res Ctr, Div Mol Biol, Chiba, Japan; [Wang, Dan-Ni; Kamei, Katsuhiko] Chiba Univ, Div Clin Res, Med Mycol Res Ctr, Chiba, Japan; [Kamei, Katsuhiko] Chiba Univ Hosp, Div Control & Treatment Infect Dis, Chiba, Japan; [Ohno, Hideaki] Saitama Med Univ, Saitama Med Ctr, Dept Infect Dis & Infect Control, Saitama, Japan; [Niki, Yoshihito] Showa Univ, Sch Med, Dept Internal Med, Div Clin Infect Dis, Tokyo 142, Japan	Kinjo, Y (reprint author), Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan.	ykinjo@niid.go.jp			Ministry of Health, Labor and Welfare of Japan [H25-Shinkou-Shitei-001, H25-Shinkou-Shitei-002, H25-shinkou-Wakate-005, H25-Shinkou-Ippan-006, H26-Shinkoujitsuyouka-Ippan-010]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26860774]; Life Science Foundation of Japan	This work was supported by Health Science Research Grants for Research on Emerging and Re-emerging Infectious Diseases (H25-Shinkou-Shitei-001, H25-Shinkou-Shitei-002, H25-shinkou-Wakate-005, H25-Shinkou-Ippan-006, and H26-Shinkoujitsuyouka-Ippan-010) from the Ministry of Health, Labor and Welfare of Japan, by a grant from the Strategic Research Foundation Grant-aided Project for Private Schools at Heisei 23rd, KAKENHI (26860774), from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a grant from the Life Science Foundation of Japan.	Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Okubo Y, 2013, JPN J INFECT DIS, V66, P216; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; HUFFNAGLE GB, 1994, J LEUKOCYTE BIOL, V55, P35; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Siegemund S, 2008, FEMS IMMUNOL MED MIC, V52, P417, DOI 10.1111/j.1574-695X.2008.00391.x; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Vecchiarelli A, 2003, J LEUKOCYTE BIOL, V74, P370, DOI 10.1189/jlb.1002476; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Yamamoto H, 2014, INFECT IMMUN, V82, P1606, DOI 10.1128/IAI.01089-13; Roy RM, 2012, CELL HOST MICROBE, V11, P436, DOI 10.1016/j.chom.2012.04.005; Hardison SE, 2010, INFECT IMMUN, V78, P5341, DOI 10.1128/IAI.00845-10; Bozza S, 2003, BLOOD, V102, P3807, DOI 10.1182/blood-2003-03-0748; Murdock BJ, 2014, INFECT IMMUN, V82, P937, DOI 10.1128/IAI.01477-13; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; BCCDC, 2011, CRYPT GATT, P112; Brouwer Annemarie E, 2007, J Infect, V54, pe165, DOI 10.1016/j.jinf.2006.10.002; Carvalho NB, 2011, INFECT IMMUN, V79, P1638, DOI 10.1128/IAI.01030-10; DeBess E., 2010, Morbidity and Mortality Weekly Report, V59, P865; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104316; Einsiedel L, 2004, CLIN INFECT DIS, V39, pE78, DOI 10.1086/424746; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; FROMTLING RA, 1983, SABOURAUDIA, V21, P113; HILL JO, 1992, J EXP MED, V175, P1685, DOI 10.1084/jem.175.6.1685; Kawakami K, 1999, CLIN EXP IMMUNOL, V117, P113; Kawakami K, 2004, JPN J INFECT DIS, V57, P137; Ngamskulrungroj P, 2012, CRYPTOCOCCUS NEOFORM, V3; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Simon DM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-69; Smith RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088875; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120	42	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	APR	2015	83	4					1577	1586		10.1128/IAI.02827-14		10	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CD6WR	WOS:000351231600034		
J	Hanahara, K; Ono, H; Fujinami, T; Matsumoto, N; Sunatsuki, Y				Hanahara, Keita; Ono, Hiromasa; Fujinami, Takeshi; Matsumoto, Naohide; Sunatsuki, Yukinari			Hydrogen-bonded 2D network structure and abrupt spin transition with thermal hysteresis of iron(III) complexes [Fe-III(Him)(2) (3-MeOsalen)]center dot H2OEtOH center dot X (Him = imidazole, 3-MeOsalen = N,N '-bis (3-methoxysalicylidene)ethylenediaminato, and X = PF6, AsF6, SbF6)	INORGANICA CHIMICA ACTA			English	Article						Iron(III) complex; Spin crossover; Imidazole; N2O2 Schiff-base ligand; Hydrogen bonds; Hysteresis	QUADRIDENTATE SCHIFF-BASES; FE-III-COMPLEX; MAGNETIC-PROPERTIES; EQUILIBRIUM BEHAVIOR; CHAIN STRUCTURE; CROSSOVER; N,N'-BIS(2-HYDROXYACETOPHENYLIDENE)ETHYLENEDIAMINE; BINUCLEAR; CRYSTAL; CF3SO3	Spin crossover (SCO) iron(III) complexes exhibiting thermal hysteresis, [Fe-III(Him)(2)(3-MeOsalen)]center dot H2O center dot EtOH center dot X (Him = imidazole, 3-MeOsalen = N, N'-bis(3-methoxysalicylidene) ethylenediaminato, and X = PF6, AsF6, SbF6), were synthesized in ethanol. The FeIII ion has an octahedral coordination geometry with N2O2 donor atoms of the planar tetradentate ligand (3-MeOsalen) and two nitrogen atoms of two imidazoles at the axial positions. Through H2O and EtOH the complex-cations are assembled into a hydrogen-bonded 2D network structure and the anion X is accommodated in the void of the 2D network. The temperature dependences of the magnetic susceptibilities revealed an abrupt and two-step spin transition with thermal hysteresis for the PF6 and AsF6 salts. (C) 2015 Elsevier B.V. All rights reserved.	[Hanahara, Keita; Ono, Hiromasa; Fujinami, Takeshi; Matsumoto, Naohide] Kumamoto Univ, Fac Sci, Dept Chem, Kumamoto 8608555, Japan; [Sunatsuki, Yukinari] Okayama Univ, Fac Sci, Dept Chem, Okayama 7008530, Japan	Matsumoto, N (reprint author), Kumamoto Univ, Fac Sci, Dept Chem, Kurokami 2-39-1, Kumamoto 8608555, Japan.	naohide@aster.sci.kumamoto-u.ac.jp			Japan Society for the Promotion of Science, KAKENHI [00248556]	T. Fujinami was supported by the Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science, KAKENHI 00248556.	Gutlich P, 2013, BEILSTEIN J ORG CHEM, V9, P342, DOI 10.3762/bjoc.9.39; MATSUMOTO N, 1984, B CHEM SOC JPN, V57, P3307, DOI 10.1246/bcsj.57.3307; Ross TM, 2010, DALTON T, V39, P149, DOI 10.1039/b913234a; Fujinami T, 2014, INORG CHEM, V53, P2254, DOI 10.1021/ic402947u; [Anonymous], SPART VERS 10; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0; NISHIDA Y, 1977, B CHEM SOC JPN, V50, P119, DOI 10.1246/bcsj.50.119; Koike M, 2013, INORG CHIM ACTA, V399, P185, DOI 10.1016/j.ica.2013.01.021; Weber B, 2008, ANGEW CHEM INT EDIT, V47, P10098, DOI 10.1002/anie.200802806; KENNEDY BJ, 1987, INORG CHEM, V26, P483, DOI 10.1021/ic00251a003; Real JA, 2005, DALTON T, P2062, DOI 10.1039/b501491c; Yamada M, 2006, CHEM-EUR J, V12, P4536, DOI 10.1002/chem.200500972; Dorbes S, 2005, CHEM COMMUN, P69, DOI 10.1039/b412182a; Floquet S, 2014, POLYHEDRON, V80, P60, DOI 10.1016/j.poly.2014.01.025; Fukukai T, 2005, B CHEM SOC JPN, V78, P1484, DOI 10.1246/bcsj.78.1484; FUKUYA M, 1993, J CHEM SOC DALTON, P3277, DOI 10.1039/dt9930003277; GERLOCH M, 1969, J CHEM SOC A, P2850, DOI 10.1039/j19690002850; Gutlich P., 2004, TOP CURR CHEM, P233; Hernandez-Molina R, 1998, INORG CHEM, V37, P5102, DOI 10.1021/ic980297q; Imatomi S, 2007, B CHEM SOC JPN, V80, P2375, DOI 10.1246/bcsj.80.2375; Imatomi S, 2006, CHEM LETT, V35, P502, DOI 10.1246/cl.2006.502; Kahn O., 1993, MOL MAGNETISM; NISHIDA Y, 1975, CHEM LETT, P79, DOI 10.1246/cl.1975.79; OHTA S, 1986, B CHEM SOC JPN, V59, P155, DOI 10.1246/bcsj.59.155; Saito Y., 1980, ACS SYM SER, V119, P13; SCHUGAR HJ, 1972, J AM CHEM SOC, V94, P2683, DOI 10.1021/ja00763a022; Tanimura K, 2005, B CHEM SOC JPN, V78, P1279, DOI 10.1246/bcsj.78.1279; Weber B, 2011, EUR J INORG CHEM, P3193, DOI 10.1002/ejic.201100394; Weber B, 2009, COORDIN CHEM REV, V253, P2432, DOI 10.1016/j.ccr.2008.10.002	29	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	APR 1	2015	429						93	98		10.1016/j.ica.2015.01.047		6	Chemistry, Inorganic & Nuclear	Chemistry	CD3RD	WOS:000350996800014		
J	Fujii, T; Abe, H; Kawamoto, M; Banno, Y; Shimada, T				Fujii, T.; Abe, H.; Kawamoto, M.; Banno, Y.; Shimada, T.			Positional cloning of the sex-linked giant egg (Ge) locus in the silkworm, Bombyx mori	INSECT MOLECULAR BIOLOGY			English	Article						oogenesis; egg size; dosage effect; 2-oxoglutarate-dependent oxygenase	TRANSLUCENT LARVAL SKIN; NON-LTR RETROTRANSPOSON; SIZE DETERMINING GENE; ABC TRANSPORTER GENE; W-CHROMOSOME; IDENTIFICATION; GENOME; MUTANT; MUTATION; DIFFERENTIATION	The giant egg (Ge) locus is a Z-linked mutation that leads to the production of large eggs. Cytological observations suggest that an unusual translocation of a large fragment of the W chromosome bearing a putative egg size-determining gene, Esd, gave rise to giant egg mutants. However, there is currently no molecular evidence confirming either a W-Z translocation or the presence of Esd on the W chromosome. To elucidate the origin of giant egg mutants, we performed positional cloning. We observed that the Bombyx mori. orthologue of the human Phytanoyl-CoA dioxygenase domain containing 1 gene (PHYHD1) is disrupted in giant egg mutants. PHYHD1 is highly conserved in eukaryotes and is predicted to be a Fe(II) and 2-oxoglutarate-dependent oxygenase. Exon skipping in one of the two available Ge mutants is probably caused by the insertion of a non-long terminal repeat transposon into intron 4 in the vicinity of the 5 splice site. Segmental duplication in Ge-2, an independent allele, was caused by unequal recombination between short interspersed elements inserted into introns 3 and 5. Our results indicate that (1) Bombyx PHYHD1 is responsible for the Ge mutants and that (2) the Ge locus is unrelated to the W-linked putative Esd. To our knowledge, this is the first report describing the phenotypic defects caused by mutations in PHYHD1 orthologues.	[Fujii, T.; Banno, Y.] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Fujii, T.; Kawamoto, M.; Shimada, T.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Abe, H.] Tokyo Univ Agr & Technol, Fac Agr, Dept Biol Prod, Fuchu, Tokyo 183, Japan	Fujii, T (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	fujii.tsuguru.233@m.kyushu-u.ac.jp; shimada@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011; Abe, Hiroaki/G-1133-2013	Shimada, Toru/0000-0002-5791-0000; Abe, Hiroaki/0000-0002-2301-7097	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22128004]	This study was supported in part by a Grant-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (no. 22128004). Materials (silkworms and related information) were provided by the National Bioresource Project, MEXT. We wish to thank Yasuhiro Yamada, Field Science Center for Northern Biosphere, Hokkaido University, for the maintenance of the giant egg strain.	Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Abe H, 1998, GENES GENET SYST, V73, P353, DOI 10.1266/ggs.73.353; Abrabam EG, 2000, MOL GEN GENET, V264, P11, DOI 10.1007/s004380000283; Zhang ZH, 2011, BIOCHEM BIOPH RES CO, V408, P553, DOI 10.1016/j.bbrc.2011.04.059; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Abe H, 2008, GENETICA, V133, P269, DOI 10.1007/s10709-007-9210-1; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; PERDRIXGILLOT S, 1979, BIOCHIMIE, V61, P171, DOI 10.1016/S0300-9084(79)80066-8; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Banno Y, 2005, GUIDE SILKWORM MUTAN; Bisch-Knaden S., 2013, P R SOC B, V281; Bock S. C., 1986, DEV BIOL, V111, P215; Fujii T, 2008, INSECT BIOCHEM MOLEC, V38, P1072, DOI 10.1016/j.ibmb.2008.03.004; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Fujii T, 2013, INSECT BIOCHEM MOLEC, V43, P594, DOI 10.1016/j.ibmb.2013.03.009; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Hashimoto H, 1933, JAP J GENET, V8, P245; HIROKAWA M, 1992, Journal of Sericultural Science of Japan, V61, P59; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004; KAWAGUCHI Y, 1993, J INSECT PHYSIOL, V39, P437, DOI 10.1016/0022-1910(93)90032-M; KAWAGUCHI Y, 1988, Journal of Sericultural Science of Japan, V57, P157; KAWAGUCHI Y, 1991, JPN J APPL ENTOMOL Z, V35, P109; KAWAMURA N, 1988, GENETICA, V76, P195, DOI 10.1007/BF00140224; Kawamura N, 1979, J SERIC SCI JPN, V48, P77; KAWAMURA N, 1990, GENETICA, V81, P205, DOI 10.1007/BF00360866; Kiuchi T, 2011, INSECT BIOCHEM MOLEC, V41, P680, DOI 10.1016/j.ibmb.2011.04.011; Komoto N, 2003, INSECT BIOCHEM MOLEC, V33, P417, DOI 10.1016/S0965-1748(03)00006-7; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; OGURA T, 1994, CHROMOSOMA, V103, P311, DOI 10.1007/BF00417878; Omura S., 1943, J SERIC SCI JPN, V14, P263; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Qiao L, 2014, GENETICS, V196, P1103, DOI 10.1534/genetics.113.158766; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; Sahara Ken, 1997, Journal of Sericultural Science of Japan, V66, P261; Sahara K, 2012, CHROMOSOME RES, V20, P83, DOI 10.1007/s10577-011-9262-z; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sahara Ken, 1997, Journal of Sericultural Science of Japan, V66, P341; Sato K, 2008, GENETICS, V179, P875, DOI 10.1534/genetics.107.082784; Schofield CJ, 2007, BIOCHEM SOC T, V35, P870, DOI 10.1042/BST0350870; VARAGONA MJ, 1992, PLANT CELL, V4, P811; XU HE, 2013, DATABASE OXFORD 0725, P36463, DOI DOI 10.1093/DATABASE/BAT055; Yokoyama Takeshi, 1994, Journal of Sericultural Science of Japan, V63, P347; Yokoyama Takeshi, 1996, Journal of Sericultural Science of Japan, V65, P248	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1075	1365-2583		INSECT MOL BIOL	Insect Mol. Biol.	APR	2015	24	2					213	221		10.1111/imb.12150		9	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CD9DD	WOS:000351396600007		
J	Chen, YL; Shimizu, Y; Cai, YD; Wang, S; Ito, S; Ju, BF; Gao, W				Chen, Yuan-Liu; Shimizu, Yuki; Cai, Yindi; Wang, Shu; Ito, So; Ju, Bing-Feng; Gao, Wei			Self-evaluation of the cutting edge contour of amicrodiamond tool with a force sensor integrated fast tool servo on an ultra-precision lathe	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Diamond tool; Cutting edge contour; Self-evaluation; On-machine measurement; Force control; Fast tool servo	MICRO; FABRICATION; METROLOGY; PROFILE; SURFACE; IMAGE; SHAPE; UNIT	This paper presents a self-evaluation method for sub-micrometer accuracy measurement of the cutting edge contour of a micro diamond tool with a force sensor-integrated fast tool servo (FS-FTS) on an ultra-precision lathe without using any accurate reference artifacts and additional surface form measuring instruments. At first, a series of grooves is cut side by side along the Z-direction over the outer surface of a cylindrical artifact mounted on the lathe spindle by the micro tool of the FS-FTS, which is mounted on the X-directional cross-slide (X-slide) of the lathe, to form a number of sharp line structures. The FS-FTS is then switched to a force feedback control mode for the cutting edge of the micro tool to scan across the line structures as a measuring stylus by moving the artifact with the Z-directional carriage slide (Z-slide) of the spindle. During the scanning, the contact force between the micro tool and the line structures is maintained constant by controlling the X-directional displacement of the cutting tool with the FS-FTS so that the tool cutting edge contour can be obtained from the tool scan trace profile provided by the linear encoder of the Z-slide and the displacement sensor of the FS-FTS. Measurement experiments of a micro tool with a nominal nose radius of 120 mu m are carried out to demonstrate the feasibility of the proposed method.	[Chen, Yuan-Liu; Shimizu, Yuki; Cai, Yindi; Wang, Shu; Ito, So; Gao, Wei] Tohoku Univ, Dept Nanomech, Sendai, Miyagi 9808579, Japan; [Chen, Yuan-Liu; Ju, Bing-Feng] Zhejiang Univ, State Key Lab Fluid Power Transmiss & Control, Hangzhou 310027, Zhejiang, Peoples R China	Shimizu, Y (reprint author), Tohoku Univ, Dept Nanomech, Sendai, Miyagi 9808579, Japan.	yuki.shimizu@nano.mech.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS)	This research is supported by Japan Society for the Promotion of Science (JSPS).	[Anonymous], 1998, CIRP ANN-MANUF TECHN, DOI 10.1016/S0007-8506(07)62878-9; Chen YL, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/6/064018; Denkena B, 2013, PRECIS ENG, V37, P590, DOI 10.1016/j.precisioneng.2013.01.004; Weckenmann A, 2004, CIRP ANN-MANUF TECHN, V53, P657, DOI 10.1016/S0007-8506(07)60034-1; Gao W, 2003, PRECIS ENG, V27, P289, DOI 10.1061/S0141-6359(03)00028-X; Gao W, 2009, CIRP ANN-MANUF TECHN, V58, P451, DOI 10.1016/j.cirp.2009.03.009; Teti R, 2010, CIRP ANN-MANUF TECHN, V59, P717, DOI 10.1016/j.cirp.2010.05.010; Gao W, 2006, PRECIS ENG, V30, P396, DOI 10.1016/j.precisioneng.2005.11.008; Byrne G, 2003, CIRP ANN-MANUF TECHN, V52, P483, DOI 10.1016/S0007-8506(07)60200-5; Altintas Y, 2002, CIRP ANN-MANUF TECHN, V51, P303, DOI 10.1016/S0007-8506(07)61522-4; Shaw L, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/4/045002; Klocke F, 2005, CIRP ANN-MANUF TECHN, V54, P47, DOI 10.1016/S0007-8506(07)60046-8; Brinksmeier E, 2010, CIRP ANN-MANUF TECHN, V59, P535, DOI 10.1016/j.cirp.2010.03.037; Asai S, 1990, CIRP ANN-MANUF TECHN, V39, P85, DOI 10.1016/S0007-8506(07)61008-7; Colombi P, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/8/084015; DOIRON TD, 1989, PRECIS ENG, V11, P231, DOI 10.1016/0141-6359(89)90033-0; DRESCHER J, 1993, PRECIS ENG, V15, P112, DOI 10.1016/0141-6359(93)90346-C; Hansen HN, 2006, CIRP ANN-MANUF TECHN, V55, P721, DOI 10.1016/j.cirp.2006.10.005; Harada Y, 2008, JPN J APPL PHYS, V47, P6186, DOI 10.1143/JJAP.47.6186; Heike S, 1999, J APPL PHYS, V86, P4220, DOI 10.1063/1.371349; Lee K. W., 2011, International Journal of Precision Technology, V2, DOI 10.1504/IJPTECH.2011.039460; Lu XD, 2007, INT J MACH TOOL MANU, V47, P1362, DOI 10.1016/j.ijmachtools.2006.08.008; Lucca D.A., 1993, CIRP ANN-MANUF TECHN, V42, P83, DOI 10.1016/S0007-8506(07)62397-X; MAEDA Y, 1989, PRECIS ENG, V11, P165, DOI 10.1016/0141-6359(89)90071-8; Noh YJ, 2008, INT J PRECIS ENG MAN, V9, P32; Noh YJ, 2009, INT J SURF SCI ENG, V3, P227; Ohmori H, 2007, CIRP ANN-MANUF TECHN, V56, P569, DOI 10.1016/j.cirp.2007.05.136; Picard Y, 2003, PRECIS ENG, V27, P59, DOI 10.1016/S0141-6359(02)00188-5; SHEIKO SS, 1994, ULTRAMICROSCOPY, V53, P371, DOI 10.1016/0304-3991(94)90050-7; Storch B, 2012, INT J MACH TOOL MANU, V57, P1, DOI 10.1016/j.ijmachtools.2012.01.011	30	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	APR	2015	77	9-12					2257	2267		10.1007/s00170-014-6580-2		11	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CE0TJ	WOS:000351519100057		
J	Aritake, S; Asaoka, S; Kagimura, T; Shimura, A; Futenma, K; Komada, Y; Inoue, Y				Aritake, Sayaka; Asaoka, Shoichi; Kagimura, Tatsuo; Shimura, Akiyoshi; Futenma, Kunihiro; Komada, Yoko; Inoue, Yuichi			Internet-Based Survey of Factors Associated with Subjective Feeling of Insomnia, Depression, and Low Health-Related Quality of Life Among Japanese Adults with Sleep Difficulty	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Insomnia; Health-related quality of life; Sleep difficulty; Daytime function; Sleep latency; Internet survey	RISK; POPULATION; MEDICATION	BackgroundThis study was conducted to determine what symptom components or conditions of insomnia are related to subjective feelings of insomnia, low health-related quality of life (HRQOL), or depression. Method Data from 7,027 Japanese adults obtained using an Internet-based questionnaire survey was analyzed to examine associations between demographic variables and each sleep difficulty symptom item on the Pittsburgh Sleep Quality Index (PSQI) with the presence/absence of subjective insomnia and scores on the Short Form-8 (SF-8) and Center for Epidemiologic Studies Depression Scale (CES-D). Results Prevalence of subjective insomnia was 12.2 % (n = 860). Discriminant function analysis revealed that item scores for sleep quality, sleep latency, and sleep medication use on the PSQI and CES-D showed relatively high discriminant function coefficients for identifying positivity for the subjective feeling of insomnia. Among respondents with subjective insomnia, a low SF-8 physical component summary score was associated with higher age, depressive state, and PSQI items for sleep difficulty and daytime dysfunction, whereas a low SF-8 mental component summary score was associated with depressive state, PSQI sleep latency, sleeping medication use, and daytime dysfunction. Depressive state was significantly associated with sleep latency, sleeping medication use, and daytime dysfunction. Conclusion Among insomnia symptom components, disturbed sleep quality and sleep onset insomnia may be specifically associated with subjective feelings of the disorder. The existence of a depressive state could be significantly associated with not only subjective insomnia but also mental and physical QOL. Our results also suggest that different components of sleep difficulty, as measured by the PSQI, might be associated with mental and physical QOL and depressive status.	[Aritake, Sayaka; Asaoka, Shoichi; Shimura, Akiyoshi; Futenma, Kunihiro; Komada, Yoko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Shinjuku Ku, Tokyo 1600023, Japan; [Aritake, Sayaka] Japan Soc Promot Sci, Tokyo 1028471, Japan; [Aritake, Sayaka; Asaoka, Shoichi; Komada, Yoko; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo 1510053, Japan; [Aritake, Sayaka; Kagimura, Tatsuo; Shimura, Akiyoshi; Futenma, Kunihiro; Inoue, Yuichi] Tokyo Med Univ, Dept Psychiat, Tokyo 1600023, Japan; [Aritake, Sayaka] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan	Inoue, Y (reprint author), Tokyo Med Univ, Dept Somnol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	inoue@somnology.com			Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare	This study was supported in part by a Grantin-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study (work) was supported by the Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare.	AASM AAoSM, 2005, INT CLASS SLEEP DIS; Alonso J., 2004, ACTA PSYCHIAT SCAND, V420, P38, DOI DOI 10.1111/J.1600-0047.2004.00325.X; Buysse DJ, 2006, SLEEP, V29, P1155; Sasai T, 2010, SLEEP MED, V11, P452, DOI 10.1016/j.sleep.2009.09.011; Edinger JD, 2000, J CONSULT CLIN PSYCH, V68, P586, DOI 10.1037/0022-006X.68.4.586; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; de Zambotti M, 2011, J SLEEP RES, V20, P318, DOI 10.1111/j.1365-2869.2010.00871.x; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Morphy H, 2007, SLEEP, V30, P274; Carroll A, 2013, J YOUTH ADOLESCENCE, V42, P431, DOI 10.1007/s10964-012-9799-y; Okajima I, 2012, J CLIN PSYCHIAT, V73, P377, DOI 10.4088/JCP.10m06286; [Anonymous], 2002, SLEEP EPIDEMIOLOGICA; Fortner BV, 2002, J PAIN SYMPTOM MANAG, V24, P471, DOI 10.1016/S0885-3924(02)00500-6; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Yokoyama E, 2010, SLEEP, V33, P1693; Moul DE, 2002, SLEEP, V25, P553; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; LeBlanc M, 2009, SLEEP, V32, P1027; Aritake-Okada S, 2011, SLEEP MED, V12, P1031, DOI 10.1016/j.sleep.2011.06.014; Poulin Christiane, 2005, Chronic Dis Can, V26, P65; Enomoto M, 2006, SLEEP BIOL RHYTHMS, V4, P153, DOI 10.1111/j.1479-8425.2006.00220.x; Fukuhara S, 2005, J CLIN EXP MED, V213, P133; Komada Y, 2011, PSYCHIAT CLIN NEUROS, V65, P20, DOI 10.1111/j.1440-1819.2010.02154.x; Okawa M., 2012, Journal of the National Institute of Public Health, V61, P29; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Ustinov Y, 2010, SLEEP MED, V11, P65, DOI 10.1016/j.sleep.2009.07.009; Varkevisser Michael, 2007, Behav Sleep Med, V5, P279; Ware JE, 2001, SCORE INTERPRET SING	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	APR	2015	22	2					233	238		10.1007/s12529-014-9421-7		6	Psychology, Clinical	Psychology	CE0US	WOS:000351523600009		
J	Zheng, B; Zhao, YB; Yu, J; Ikeuchi, K; Zhu, SC				Zheng, Bo; Zhao, Yibiao; Yu, Joey; Ikeuchi, Katsushi; Zhu, Song-Chun			Scene Understanding by Reasoning Stability and Safety	INTERNATIONAL JOURNAL OF COMPUTER VISION			English	Article							SEGMENTATION; OBJECTS	This paper presents a new perspective for 3D scene understanding by reasoning object stability and safety using intuitive mechanics. Our approach utilizes a simple observation that, by human design, objects in static scenes should be stable in the gravity field and be safe with respect to various physical disturbances such as human activities. This assumption is applicable to all scene categories and poses useful constraints for the plausible interpretations (parses) in scene understanding. Given a 3D point cloud captured for a static scene by depth cameras, our method consists of three steps: (i) recovering solid 3D volumetric primitives from voxels; (ii) reasoning stability by grouping the unstable primitives to physically stable objects by optimizing the stability and the scene prior; and (iii) reasoning safety by evaluating the physical risks for objects under physical disturbances, such as human activity, wind or earthquakes. We adopt a novel intuitive physics model and represent the energy landscape of each primitive and object in the scene by a disconnectivity graph (DG). We construct a contact graph with nodes being 3D volumetric primitives and edges representing the supporting relations. Then we adopt a Swendson-Wang Cuts algorithm to partition the contact graph into groups, each of which is a stable object. In order to detect unsafe objects in a static scene, our method further infers hidden and situated causes (disturbances) in the scene, and then introduces intuitive physical mechanics to predict possible effects (e.g., falls) as consequences of the disturbances. In experiments, we demonstrate that the algorithm achieves a substantially better performance for (i) object segmentation, (ii) 3D volumetric recovery, and (iii) scene understanding with respect to other state-of-the-art methods. We also compare the safety prediction from the intuitive mechanics model with human judgement.	[Zheng, Bo; Ikeuchi, Katsushi] Univ Tokyo, Tokyo, Japan; [Zhao, Yibiao; Yu, Joey; Zhu, Song-Chun] Univ Calif Los Angeles, Los Angeles, CA USA	Zheng, B (reprint author), Univ Tokyo, Tokyo, Japan.	zheng@cvl.iis.u-tokyo.ac.jp; ybzhao@ucla.edu; chengchengyu@ucla.edu; ki@cvl.iis.u-tokyo.ac.jp; sczhu@stat.ucla.edu			MURI ONR [N00014-10-1-0933]; DARPA MSEE, USA [FA 8650-11-1-7149]; Next-generation Energies for Tohoku Recovery (NET); SCOPE Program of Ministry of Internal Affairs and Communications, Japan; Microsoft Japan	This work is supported by (1) MURI ONR N00014-10-1-0933 and DARPA MSEE grant FA 8650-11-1-7149, USA, (2) Next-generation Energies for Tohoku Recovery (NET) and SCOPE Program of Ministry of Internal Affairs and Communications, Japan, (3) and the 10-th core Project Grant of Microsoft Japan.	Anand A., 2012, IJRR; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Blane MM, 2000, IEEE T PATTERN ANAL, V22, P298, DOI 10.1109/34.841760; Attene M, 2006, VISUAL COMPUT, V22, P181, DOI 10.1007/s00371-006-0375-x; Sagawa R, 2005, IEEE T PATTERN ANAL, V27, P392, DOI 10.1109/TPAMI.2005.46; Barbu A, 2005, IEEE T PATTERN ANAL, V27, P1239, DOI 10.1109/TPAMI.2005.161; Zheng B, 2010, IEEE T PATTERN ANAL, V32, P561, DOI 10.1109/TPAMI.2009.189; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Chen X., 2009, SIGGRAPH; DARPA, 2014, ROB RESC PEOPL; Delaitre V., 2012, ECCV; Fleming RW, 2010, PERCEPTION, V39, P109; Fouhey D. F., 2012, ECCV; Furukawa Y., 2009, CVPR; Grabner H., 2011, CVPR; Guo R., 2013, ICCV; Gupta A., 2010, ECCV; Gupta A., 2011, CVPR; Hamrick J., 2011, P 33 ANN M COGN SCI; Hedau V., 2010, ECCV; Janoch A., 2011, ICCV WORKSH; Jia Z., 2013, CVPR; Jiang Y., 2013, CVPR; Jiang Y., 2013, ROBOTICS SCI SYSTEMS; Karpathy A, 2013, INT C ROB AUT ICRA; Koppula H., 2011, NIPS; Kriegman DJ, 1997, INT J ROBOT RES, V16, P448, DOI 10.1177/027836499701600402; Lee D., 2010, ESTIMATING SPATIAL L; Lee D., 2009, CVPR; McCloskey M., 1983, Scientific American, V248; Nan LL, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2366145.2366156; Newcombe R. A., 2011, ISMAR; Petti S., 2005, IROS; Phillips M., 2011, ICRA; Poppinga J., 2008, IROS; Savva M, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2661229.2661230; Shao TJ, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2366145.2366155; Shao TJ, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2661229.2661288; SHI QY, 1983, IEEE T PATTERN ANAL, V5, P472; Silberman N., 2012, ECCV; Tu ZW, 2005, INT J COMPUT VISION, V63, P113, DOI 10.1007/s11263-005-6642-x; Wales D, 2004, ENERGY LANDSCAPES AP; Wu C., 2014, ROBOTICS SCI SYSTEMS; Zhao Y., 2011, NIPS; Zheng B., 2013, CVPR; Zheng B., 2014, IEEE INT C ROB AUT I	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-5691	1573-1405		INT J COMPUT VISION	Int. J. Comput. Vis.	APR	2015	112	2			SI		221	238		10.1007/s11263-014-0795-4		18	Computer Science, Artificial Intelligence	Computer Science	CE0TD	WOS:000351518500007		
J	Sun, P; Wang, SY				Sun, Ping; Wang, Shuoyu			Redundant Input Guaranteed Cost Non-fragile Tracking Control for Omnidirectional Rehabilitative Training Walker	INTERNATIONAL JOURNAL OF CONTROL AUTOMATION AND SYSTEMS			English	Article						Cost performance index; guaranteed cost non-fragile control; omnidirectional walker; redundant input degree; rehabilitative training	FAULT-TOLERANT CONTROL; NONLINEAR-SYSTEMS; DESIGN; ROBOT	In this study, the problem of guaranteed cost non-fragile tracking control on the omnidirectional rehabilitative training walker is examined. The nonlinear redundant input method is proposed when one wheel actuator fault occurs. The aim of the study is to design an asymptotically stable controller that can guarantee the safety of the user and ensure tracking on a training path planned by a physical therapist. The guaranteed cost control and the asymptotically zero state detectable concept of the walker are presented, and the model of redundant degree is constructed. The cost performance index is defined to restrain initial oversize input forces. On the grounds of LMI, a controller with gain variations that can satisfy asymptotic stability is obtained using a common Lyapunov function for admissible uncertainties resulting from an actuator fault. Simulation results confirm the effectiveness of the proposed method and verify that the walker can provide safe sequential motion when one wheel actuator is at fault.	[Sun, Ping] Shenyang Univ Technol, Sch Informat Sci & Engn, Shenyang 110870, Peoples R China; [Wang, Shuoyu] Kochi Univ Technol, Dept Intelligent Mech Syst Engn, Kochi 7828502, Japan	Sun, P (reprint author), Shenyang Univ Technol, Sch Informat Sci & Engn, Shenyang 110870, Peoples R China.	tonglongsun@sut.edu.cn; wang.shuoyu@kochi-tech.ac.jp			Japan Society for the Program of Science KAKENHI [24300203, 23240088, 22300197]; Canon Foundation; Program for Liaoning Excellent Talents in University of China [LQJ2014013]	This research was supported by the Japan Society for the Program of Science KAKENHI Grant Numbers 24300203, 23240088, and 22300197, and the Canon Foundation, and the Program for Liaoning Excellent Talents in University of China under Grant LQJ2014013. The authors would like to thank the Associate Editor and the reviewers for their constructive comments and suggestions that have helped improve the quality and presentation of this paper.	Yang GH, 2010, IEEE T AUTOMAT CONTR, V55, P242, DOI 10.1109/TAC.2009.2036293; Cui MY, 2013, AUTOMATICA, V49, P770, DOI 10.1016/j.automatica.2012.11.013; Keel LH, 1997, IEEE T AUTOMAT CONTR, V42, P1098, DOI 10.1109/9.618239; Wang R, 2009, INT J SYST SCI, V40, P205, DOI 10.1080/00207720802145577; Che WW, 2013, INT J CONTROL AUTOM, V11, P704, DOI 10.1007/s12555-012-9108-2; Chwa D, 2012, IEEE T FUZZY SYST, V20, P587, DOI 10.1109/TFUZZ.2011.2176738; Ichalal D, 2012, INT J AP MAT COM-POL, V22, P197, DOI 10.2478/v10006-012-0015-8; Lee MH, 2012, INT J CONTROL AUTOM, V10, P117, DOI 10.1007/s12555-012-0113-2; Tan RP, 2011, INT J INNOV COMPUT I, V7, P4423; Ullah I, 2013, INT J CONTROL AUTOM, V11, P1253, DOI 10.1007/s12555-012-0057-6; Ju MS, 2005, IEEE T NEUR SYS REH, V13, P349, DOI 10.1109/TNSRE.2005.847354; Sami M, 2013, INT J CONTROL AUTOM, V11, P1149, DOI 10.1007/s12555-013-0227-1; Che W. W., 2009, J CONTROL THEORY APP, V7, P63; Chugo D, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS I-V, CONFERENCE PROCEEDINGS, P2177, DOI 10.1109/ICMA.2007.4303889; Duan ZS, 2012, AUTOMATICA, V48, P2168, DOI 10.1016/j.automatica.2012.06.001; Duan ZS, 2009, SCI CHINA SER F, V52, P1973, DOI 10.1007/s11432-009-0189-3; Ishida K., 2008, J PHYS MED, V19, P246; Khelassi A, 2011, INT J AP MAT COM-POL, V21, P431, DOI 10.2478/v10006-011-0032-z; Simon Y. X., 2012, IEEE T IND ELECTRON, V59, P3211; Tan R. P., 2011, P IEEE INT C MECH AU, P325; Tan R. P., 2010, P INT C MECH AUT ICM, P156; Wang S. Y., 2007, P JSME S WELF ENG, P176; Wang Tong, 2010, Proceedings of the 2010 International Conference on Measuring Technology and Mechatronics Automation (ICMTMA 2010), DOI 10.1109/ICMTMA.2010.204; Yang J. Y., 2007, P INT C EL MACH SYST, P2033	24	0	0	INST CONTROL ROBOTICS & SYSTEMS, KOREAN INST ELECTRICAL ENGINEERS	BUCHEON	BUCHEON TECHNO PARK 401-1506, 193 YAKDAE-DONG WONMI-GU, BUCHEON, GYEONGGI-DO 420-734, SOUTH KOREA	1598-6446	2005-4092		INT J CONTROL AUTOM	Int. J. Control Autom. Syst.	APR	2015	13	2					454	462		10.1007/s12555-013-0445-6		9	Automation & Control Systems	Automation & Control Systems	CE1GS	WOS:000351560700023		
J	Jun, JY; Nakajima, S; Yamazaki, K; Kawai, Y; Yasui, H; Konishi, Y				Jun, Joon-Young; Nakajima, Sosuke; Yamazaki, Koji; Kawai, Yuji; Yasui, Hajime; Konishi, Yasuyuki			Isolation of antimicrobial agent from the marine algae Cystoseira hakodatensis	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Algae; antimicrobial agents; Cystoseira hakodatensis; isolation procedures; pathogenic micro-organisms; polyphenols	ANTIBACTERIAL ACTIVITY; BACILLUS-CEREUS; BROWN-ALGAE; PHLOROTANNINS; EXTRACTS	Cystoseira hakodatensis is an unutilised brown algae belonging to family Sargassaceae. A crude methanol extract from the algae showed inhibitory effects on the growths of Bacillus cereus and Bacillus licheniformis. To isolate the major antimicrobial agent, a sequential active-guided isolation procedure was applied: liquid-liquid extraction, column chromatography and bio-autography. A marked antimicrobial agent (active ) was isolated in hydrophobic fraction and was determined to phenolics without carbohydrates and proteins by phytochemical test. Regarding the antimicrobial potential, the isolated active showed better inhibitory effects against B.cereus and B.licheniformis at 2 and 4 times of lower concentrations (62.5 and 31.3gmL(-1)) in comparison with epigallocatechin gallate. These results showed that C.hakodatensis is a potential source of antimicrobial agent capable of preventing the growth of the two bacteria.	[Jun, Joon-Young; Nakajima, Sosuke; Yamazaki, Koji; Kawai, Yuji; Yasui, Hajime] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Konishi, Yasuyuki] Hokkaido Ind Technol Ctr, Hakodate, Hokkaido 0410801, Japan	Jun, JY (reprint author), Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	jjy791223@nate.com			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was partly supported with the Regional Innovation Strategy Support Programme (Global type) (Formation of a sustainable marine industrial cluster utilising the ocean as a huge system to produce valuable resources) through the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Airanthi W. A. M. K., 2011, J FOOD SCI, V76, pC104; Airanthi W. A. M. K., 2011, J AGR FOOD CHEM, V59, P4156; D'Orazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604; Tan SP, 2012, J APPL PHYCOL, V24, P513, DOI 10.1007/s10811-011-9747-3; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1301/nr.2007.dee.535-543; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI [10.1002/mnfr.200400055, 10.1002/mnfr.200100055]; Nagayama K, 2002, J ANTIMICROB CHEMOTH, V50, P889, DOI 10.1093/jac/dkf222; Mellegard H, 2011, INT J FOOD MICROBIOL, V148, P48, DOI 10.1016/j.ijfoodmicro.2011.04.023; Eom SH, 2012, FOOD CHEM TOXICOL, V50, P3251, DOI 10.1016/j.fct.2012.06.028; Friedman M, 2006, J FOOD PROTECT, V69, P354; Horvath G, 2010, FLAVOUR FRAG J, V25, P178, DOI 10.1002/ffj.1993; Soberon JR, 2007, J APPL MICROBIOL, V102, P1450, DOI 10.1111/j.1365-2672.2006.03229.x; Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090; Aoki H., 2012, REPORT HOKKAIDO IND, V10, P1; Swamy MLA, 2011, ADV FOOD NUTR RES, V64, P71, DOI 10.1016/B978-0-12-387669-0.00006-5; Kim SK, 2011, ADV FOOD NUTR RES, V64, P97, DOI 10.1016/B978-0-12-387669-0.00008-9; Lopes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031145; Medigan M. T., 2006, BROCK BIOL MICROORGA, P930; Miyazaki A., 1999, SCI REPORTS HOKKAIDO, V56, P15; Panda S. K., 2012, INT J BIOTECHNOLOGY, V2, P1; ROGERS DJ, 1993, HYDROBIOLOGIA, V261, P589; Rose M, 2007, FOOD CHEM TOXICOL, V45, P1263, DOI 10.1016/j.fct.2007.01.007; Sakanaka S, 2000, J BIOSCI BIOENG, V90, P81, DOI 10.1016/S1389-1723(00)80038-9; Salkinoja-Salonen MS, 1999, APPL ENVIRON MICROB, V65, P4637; Taylor P. W., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P71, DOI 10.1616/1476-2137.14184; Wang T, 2011, HDB SEAFOOD QUALITY, P509	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	APR	2015	50	4					871	877		10.1111/ijfs.12719		7	Food Science & Technology	Food Science & Technology	CD9ZD	WOS:000351459700004		
J	Nakajima, Y; Hattori, Y; Ito, S; Ohshima, R; Kuwabara, H; Machida, S; Shirasugi, Y; Miyazaki, K; Sakai, R; Tomita, N; Ando, K; Higashihara, M; Ishigatsubo, Y; Fujisawa, S				Nakajima, Y.; Hattori, Y.; Ito, S.; Ohshima, R.; Kuwabara, H.; Machida, S.; Shirasugi, Y.; Miyazaki, K.; Sakai, R.; Tomita, N.; Ando, K.; Higashihara, M.; Ishigatsubo, Y.; Fujisawa, S.			Acute leukemia during pregnancy: an investigative survey of the past 11 years	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Acute leukemia; pregnancy; treatment; chemotherapy; fetal outcomes	HEMATOLOGICAL MALIGNANCIES; IN-UTERO; CANCER; MANAGEMENT; CHEMOTHERAPY; TRANSMISSION; POPULATION; LYMPHOMA; CHILDREN; MOTHER	IntroductionThe management of pregnant women with acute leukemia is usually challenging. We collected data concerning pregnant women with acute leukemia in the Kanagawa area in Japan. MethodsA questionnaire was sent to 24 institutions in the Kanagawa area. ResultsData were obtained for 11 patients, median age of 31years (range, 20-36). Eight patients had acute myeloid leukemia and three had acute lymphoblastic leukemia. Six patients were diagnosed in the first trimester of pregnancy, one in the second trimester, and four in the third trimester. Five of six patients diagnosed in the first trimester had abortions before chemotherapy, and one had an elective abortion after receiving chemotherapy. All patients diagnosed in the second or third trimester delivered live infants. Of the six patients diagnosed in the first trimester, two died of recurrent leukemia, and four remained in remission. Of the five patients diagnosed in the second or third trimester, four achieved complete remission and remained in remission. One patient died of sepsis 4days after cesarean section. ConclusionsCareful surveillance and monitoring of the fetus and close co-operation among hematologists, gynecologists, and pediatricians are essential to successfully treat pregnant women with acute leukemia.	[Nakajima, Y.; Ohshima, R.; Kuwabara, H.; Sakai, R.; Fujisawa, S.] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Hattori, Y.] Fujisawa City Hosp, Dept Hematol & Rheumatol, Yokohama, Kanagawa, Japan; [Ito, S.; Tomita, N.; Ishigatsubo, Y.] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2320024, Japan; [Machida, S.; Shirasugi, Y.; Ando, K.] Tokai Univ, Dept Hematol Oncol, Isehara, Kanagawa, Japan; [Miyazaki, K.; Higashihara, M.] Kitasato Univ, Sch Med, Dept Hematol, Sagamihara, Kanagawa 228, Japan	Nakajima, Y (reprint author), Yokohama City Univ, Dept Hematol, Med Ctr, Minami Ku, Urafune Chou 4-57, Yokohama, Kanagawa 2320024, Japan.	yuki1234@yokohama-cu.ac.jp					Han SN, 2013, EUR J OBSTET GYN R B, V167, P18, DOI 10.1016/j.ejogrb.2012.10.026; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Germann N, 2004, ANN ONCOL, V15, P146, DOI 10.1093/annonc/mdh009; Khashu M, 2009, PEDIATRICS, V123, P109, DOI 10.1542/peds.2007-3743; Brenner B, 2012, LANCET, V379, P580, DOI 10.1016/S0140-6736(11)61348-2; Aviles A, 2012, INT J CANCER, V131, P2678, DOI 10.1002/ijc.27560; Abadi U, 2011, HEMATOL ONCOL CLIN N, V25, P277, DOI 10.1016/j.hoc.2011.01.001; Matsuo K, 2004, GYNECOL OBSTET INVES, V58, P186, DOI 10.1159/000079814; Shapira T, 2008, BLOOD REV, V22, P247, DOI 10.1016/j.blre.2008.03.006; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Rizack T, 2009, AM J HEMATOL, V84, P830, DOI 10.1002/ajh.21547; Azim HA, 2010, CANCER TREAT REV, V36, P110, DOI 10.1016/j.ctrv.2009.11.004; El-Hemaidi I, 2012, BEST PRACT RES CL OB, V26, P149, DOI 10.1016/j.bpobgyn.2011.10.007; Greenlund LJS, 2001, LEUKEMIA LYMPHOMA, V41, P571, DOI 10.3109/10428190109060347; Isoda T, 2009, P NATL ACAD SCI USA, V106, P17882, DOI 10.1073/pnas.0904658106; KAWAMURA S, 1994, TOHOKU J EXP MED, V174, P167, DOI 10.1620/tjem.174.167; Milligan DW, 2006, BRIT J HAEMATOL, V135, P450, DOI 10.1111/j.1365-2141.2006.06314.x; Nakajima Y, 2013, INT J HEMATOL, V97, P424; Nulman I, 2001, BRIT J CANCER, V85, P1611, DOI 10.1054/bjoc.2001.2090; Pentheroudakis G, 2010, ANN ONCOL, V21, P266; Pentheroudakis G, 2008, ANN ONCOL, V19, P38, DOI 10.1093/annonc/mdn307; Schamberger S, 2013, LEUKEMIA LYMPHOMA, V54, P1811, DOI 10.3109/10428194.2012.758844; Sheikh SS, 1996, INT J GYNECOL PATHOL, V15, P363, DOI 10.1097/00004347-199610000-00010; Yagasaki H, 2011, BLOOD, V117, P6046, DOI 10.1182/blood-2010-12-327627	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	APR	2015	37	2					174	180		10.1111/ijlh.12256		7	Hematology	Hematology	CD8ON	WOS:000351355000016		
J	Inaba, T; Nomura, N; Ishizuka, K; Yoshioka, K; Takahashi, M; Yuasa, S; Saito, K; Fujitomo, Y; Nakanishi, M; Fujita, N				Inaba, T.; Nomura, N.; Ishizuka, K.; Yoshioka, K.; Takahashi, M.; Yuasa, S.; Saito, K.; Fujitomo, Y.; Nakanishi, M.; Fujita, N.			Basic evaluation of Pentra MS CRP, a new automated hematology analyzer for rapid 5-part WBC differential and CRP using a small volume of whole blood	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Laboratory automation; Pentra MS CRP; 5-part differential of leukocytes (5-Diff); C-reactive protein; whole blood sample; small sample volume	PERFORMANCE EVALUATION; DXH 800; CELL; SAPPHIRE	IntroductionPentra MS CRP is a new automated hematology analyzer that can rapidly and reliably provide 5-part differential of leukocytes (5-Diff) and C-reactive protein (CRP) within approximately 3.5min using a small volume of whole blood (35L). MethodsWe evaluated the basic performance of Pentra MS CRP and correlations with Sysmex XN-3000, manual microscopic count, and Hitachi LABOSPECT. ResultsPentra MS CRP demonstrated good repeatability and linearity without any significant carryover for all parameters examined (WBC, RBC, HGB, Hct, PLT, 5-Diff, and CRP). Complete blood cell count (CBC) data examined by Pentra MS CRP correlated well with those evaluated by Sysmex XN-3000 (R0.9880). Absolute number of NEU, LYM, and EOS also showed the good correlation (R0.9866) between the two analyzers. The correlation with the manual microscopic count was within acceptable criteria. Furthermore, when CRP was examined in hemolyzed whole blood by Pentra MS CRP and converted to plasma concentrations according to Hct, it correlated well (R=0.9964) with serum CRP examined by Hitachi LABOSPECT. ConclusionPentra MS CRP is a convenient and reliable analyzer especially in the emergency unit of hospitals in which the prompt and simultaneous measurement of CBC including 5-Diff and CRP is often necessary.	[Inaba, T.; Fujita, N.] Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kyoto 6028566, Japan; [Nomura, N.; Ishizuka, K.; Yoshioka, K.; Takahashi, M.; Yuasa, S.; Saito, K.] Horiba Ltd, Kyoto, Japan; [Ishizuka, K.; Yoshioka, K.; Takahashi, M.; Yuasa, S.; Saito, K.; Fujitomo, Y.; Nakanishi, M.] Kyoto Prefectural Univ Med, Dept Med Instrumental Res & Technol, Kyoto 6028566, Japan	Inaba, T (reprint author), Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	inaba178@koto.kpu-m.ac.jp					BERGER C, 1995, EUR J PEDIATR, V154, P138; Pfafflin A, 2009, ANAL BIOANAL CHEM, V393, P1473, DOI 10.1007/s00216-008-2561-3; Tas S, 2003, DERMATOLOGY, V206, P353, DOI 10.1159/000069956; Briggs C, 2012, J CLIN PATHOL, V65, P1024, DOI 10.1136/jclinpath-2012-200930; Volpe D, 2012, PEDIATRICS, V130, pE201, DOI 10.1542/peds.2012-0153; Tan BT, 2011, AM J CLIN PATHOL, V135, P939, DOI 10.1309/AJCP1V3UXEIQTSLE; Meintker L, 2013, AM J CLIN PATHOL, V139, P641, DOI 10.1309/AJCP7D8ECZRXGWCG; Cherian S, 2010, CYTOM PART B-CLIN CY, V78B, P319, DOI 10.1002/cyto.b.20529; Arroyo ME, 2005, AM J CLIN PATHOL, V123, P206, DOI 10.1309/6U2T6UTWK10M3NCB; Clinical and Laboratory Standards Institute, 2005, EP7A2 CLSI; CLSI, 2004, EP05A2 CLSI; CLSI, 2007, H20A2 CLSI; CLSI, 2002, EP9A2 CLSI; CLSI, 2003, EP06A CLSI; CLSI, 2010, H26A2C CLSI; Davis B H, 1999, Am Clin Lab, V18, P8; Guerti K, 2009, INT J LAB HEMATOL, V31, P132, DOI 10.1111/j.1751-553X.2007.01011.x; Inaba Tohru, 2010, Rinsho Byori, V58, P664; Lesesve JF, 2005, CLIN LAB HAEMATOL, V27, P143, DOI 10.1111/j.1365-2257.2005.00667.x; Peltola H, 1998, J PEDIAT, V113, P614; Watanabe K, 1994, Rinsho Byori, V42, P764	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	APR	2015	37	2					208	216		10.1111/ijlh.12268		9	Hematology	Hematology	CD8ON	WOS:000351355000020		
J	Tsutsumi, Y; Shimono, J; Ohhigashi, H; Ito, S; Shiratori, S; Teshima, T				Tsutsumi, Y.; Shimono, J.; Ohhigashi, H.; Ito, S.; Shiratori, S.; Teshima, T.			Analysis of the influence of dabigatran on coagulation factors and inhibitors	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Dabigatran; coagulation factors; antifactor VIII inhibitor	DIRECT THROMBIN INHIBITOR; ATRIAL-FIBRILLATION; ETEXILATE; PHARMACODYNAMICS; PHARMACOKINETICS; WARFARIN; ASSAY	IntroductionDabigatran is an oral intake thrombin inhibitor for preventive administration against stroke accompanied by atrial fibrillation. Although dabigatran causes prolonged activated partial thromboplastin time (APTT), the effect of dabigatran on each coagulation factor and coagulation factor inhibitor remains to be investigated. Our aim was to analyze the influence of dabigatran on coagulation factors and coagulation factor inhibitors. MethodsWe administered dabigatran to 40 patients. In 26 of these 40, we analyzed the activity of several coagulation factors and their inhibitors. We used Fisher's exact test to determine statistical significance. ResultsThe activities of many coagulation factors changed during the dabigatran therapy. Factor II levels decreased in all patients showing prolongation of partial thromboplastin (PT) and APTT. The antifactor VIII inhibitor was positive in the majority of patients with prolonged PT and APTT, while activities of protein C, protein S, and antifactor IX inhibitor were not associated with PT and APTT prolongation. ConclusionDabigatran affects the activities of many coagulation factors, including factors II, V, VIII, and IX, as well as the antifactor VIII inhibitor.	[Tsutsumi, Y.; Shimono, J.; Ohhigashi, H.; Ito, S.; Shiratori, S.] Hakodate Municipal Hosp, Dept Hematol, Hakodate, Hokkaido 0418680, Japan; [Teshima, T.] Hokkaido Univ, Dept Hematol, Grad Sch Med, Sapporo, Hokkaido, Japan	Tsutsumi, Y (reprint author), Hakodate Municipal Hosp, Dept Hematol, 1-10-1 Minato Cho, Hakodate, Hokkaido 0418680, Japan.	yutsutsu@shore.ocn.ne.jp					Eby C, 2013, INT J LAB HEMATOL, V35, P262, DOI 10.1111/ijlh.12065; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Stangier J, 2005, J CLIN PHARMACOL, V45, P555, DOI 10.1177/0091270005274550; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Franchini M, 2007, MED SCI MONITOR, V13, pRA55; Stangier J, 2008, CLIN PHARMACOKINET, V47, P47; [Anonymous], 2012, PROD INF PRAD DAB ET; Dager WE, 2013, CRIT CARE MED, V41, pE42, DOI 10.1097/CCM.0b013e31827caaa3; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Alikhan R, 2014, EMERG MED J, V31, P163, DOI 10.1136/emermed-2012-201976; Giles AR, 1998, THROMB HAEMOSTASIS, V79, P872; Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000; Adcock DM, 2013, AM J CLIN PATHOL, V139, P102, DOI 10.1309/AJCPY6G6ZITVKPVH; Siegal DM, 2014, BLOOD, V123, P1152, DOI 10.1182/blood-2013-09-529784; Huisman MV, 2012, THROMB HAEMOSTASIS, V107, P838, DOI 10.1160/TH11-10-0718; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Harper P, 2012, NEW ENGL J MED, V366, P864, DOI 10.1056/NEJMc1112874; Legrand M, 2011, ARCH INTERN MED, V171, P1285, DOI 10.1001/archinternmed.2011.314; Baetz BE, 2001, PHARMACOTHERAPY, V28, P1354; Baglin T, 2013, BRIT J HAEMATOL, V163, P160, DOI 10.1111/bjh.12502; eMC, 2012, SUMM PROD CHAR PRAD; Radecki RP, 2012, ANN INTERN MED, V157, P66, DOI 10.7326/0003-4819-157-1-201207030-00467; Stangier J., 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI DOI 10.1177/1076029609343004	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	APR	2015	37	2					225	230		10.1111/ijlh.12270		6	Hematology	Hematology	CD8ON	WOS:000351355000022		
J	Prasing, W; Odawara, T; Traisathit, P; Yamashiro, Y; Hattori, Y; Pornprasert, S				Prasing, W.; Odawara, T.; Traisathit, P.; Yamashiro, Y.; Hattori, Y.; Pornprasert, S.			Analysis of the Xmn1-gamma(G) polymorphism in beta-thalassemia/hemoglobin E (HbE) and homozygous HbE patients with low and high levels of HbF	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Letter									[Prasing, W.; Pornprasert, S.] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai 50000, Thailand; [Odawara, T.; Yamashiro, Y.; Hattori, Y.] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Ube, Yamaguchi 755, Japan; [Traisathit, P.] Chiang Mai Univ, Dept Stat, Fac Sci, Chiang Mai 50000, Thailand	Prasing, W (reprint author), Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai 50000, Thailand.	sakornmi001@gmail.com					STEINBERG MH, 1991, BLOOD, V78, P2165; TRAEGER J, 1980, NATURE, V288, P497, DOI 10.1038/288497a0; Ekwattanakit S, 2012, ADV HEMATOL, V2012, P1; Fucharoen S, 2000, J PEDIAT HEMATOL ONC, V22, P552, DOI 10.1097/00043426-200011000-00022; GABUZDA TG, 1963, J CLIN INVEST, V42, P1678, DOI 10.1172/JCI104854; Neishabury M, 2012, BLOOD CELL MOL DIS, V48, P1, DOI 10.1016/j.bcmd.2011.10.001; Neishabury M, 2010, BLOOD CELL MOL DIS, V44, P95, DOI 10.1016/j.bcmd.2009.10.007; Nemati H, 2010, MOL BIOL REP, V37, P159, DOI 10.1007/s11033-009-9566-7; Pornprasert S, 2010, EUR J HAEMATOL, V85, P424, DOI 10.1111/j.1600-0609.2010.01512.x; Pornprasert S, 2010, CLIN LAB, V59, P693; Premawardhena A, 2005, LANCET, V366, P1467, DOI 10.1016/S0140-6736(05)67396-5; Xu XS, 2009, J HEMATOL ONCOL, V2, P1	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	APR	2015	37	2					e25	e28		10.1111/ijlh.12273		4	Hematology	Hematology	CD8ON	WOS:000351355000004		
J	Yamada, H; Tabe, Y; Watanabe, K; Morishita, S; Yuri, M; Yokoo, M; Horii, T; Shimizu, N; Kimura, S; Ohsaka, A				Yamada, H.; Tabe, Y.; Watanabe, K.; Morishita, S.; Yuri, M.; Yokoo, M.; Horii, T.; Shimizu, N.; Kimura, S.; Ohsaka, A.			Harmonization of quantitative BCR-ABL measurements using the secondary reference material anchored to the WHO primary standards	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Letter							CHRONIC MYELOID-LEUKEMIA; MOLECULAR RESPONSE; IMATINIB; RECOMMENDATIONS; CRITERIA; SCALE; TIME; CML		[Yamada, H.; Yuri, M.; Horii, T.; Ohsaka, A.] Juntendo Univ Hosp, Div Clin Lab, Bunkyo Ku, Tokyo, Japan; [Tabe, Y.] Juntendo Univ, Sch Med, Dept Clin Lab Med, Bunkyo Ku, Tokyo 113, Japan; [Watanabe, K.; Shimizu, N.] Tokyo Med & Dent Univ, Med Res Inst, Div Med Sci, Dept Virol, Tokyo, Japan; [Morishita, S.; Ohsaka, A.] Juntendo Univ, Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 113, Japan; [Yokoo, M.; Kimura, S.] Saga Univ, Sch Med, Dept Hematol, Saga 840, Japan	Yamada, H (reprint author), Juntendo Univ Hosp, Div Clin Lab, Bunkyo Ku, Tokyo, Japan.	tabe@juntendo.ac.jp					Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Langabeer SE, 2002, LEUKEMIA, V16, P393, DOI 10.1038/sj/leu/2402392; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Marin D, 2008, BLOOD, V112, P4437, DOI 10.1182/blood-2008-06-162388; Cross NCP, 2012, LEUKEMIA, V26, P2172, DOI 10.1038/leu.2012.104; Iacobucci I, 2006, CLIN CANCER RES, V12, P3037, DOI 10.1158/1078-0432.CCR-05-2574; Branford S, 2007, CLIN CANCER RES, V13, P7080, DOI 10.1158/1078-0432.CCR-07-0844; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Zhang T, 2007, J MOL DIAGN, V9, P421, DOI 10.2353/jmoldx.2007.060134; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; White HE, 2013, CLIN CHEM, V59, P938, DOI 10.1373/clinchem.2012.196477; Kantarjian HM, 2011, CLIN CANCER RES, V17, P1674, DOI 10.1158/1078-0432.CCR-10-2922; Oehler VG, 2013, HEMATOL-AM SOC HEMAT, P176; Qin YZ, 2013, LEUKEMIA RES, V37, P1035, DOI 10.1016/j.leukres.2013.06.003; White HE, 2010, BLOOD, V116, P111; Zhen CJ, 2013, J MOL DIAGN, V15, P556, DOI 10.1016/j.jmoldx.2013.05.010	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	APR	2015	37	2					e29	e33		10.1111/ijlh.12274		5	Hematology	Hematology	CD8ON	WOS:000351355000005		
J	Futamase, T				Futamase, Toshifumi			Gravitational lensing in cosmology	INTERNATIONAL JOURNAL OF MODERN PHYSICS D			English	Review						Cosmology; gravitational lensing; strong lensing; weak lensing	DARK-MATTER HALOES; SPACE-TELESCOPE OBSERVATIONS; NONLINEAR CLUSTER INVERSION; IMAGE-ANALYSIS COMPETITION; SPREAD FUNCTION CORRECTION; RAY LUMINOUS CLUSTERS; COSMIC SHEAR ANALYSIS; GALAXY CLUSTERS; MASS-DISTRIBUTION; LENSED IMAGES	Gravitational lensing is a unique and direct probe of mass in the universe. It depends only on the law of gravity and does not depend on the dynamical state nor the composition of matter. Thus, it is used to study the distribution of the dark matter in the lensing object. Combined with the traditional observations such as optical and X-ray, it gives us useful informations of the structure formation in the universe. The lensing observables depend also on the global geometry as well as large scale structure of the universe. Therefore it is possible to withdraw useful constraints on the cosmological parameters once the distribution of lensing mass is accurately known. Since the first discovery of the lensing event by a galaxy in 1979, various kinds of lensing phenomena caused by star, galaxy, cluster of galaxies and large scale structure have been observed and are used to study mass distribution in various scales and cosmology. Thus, the gravitational lensing is now regarded as an indispensable research field in the observational cosmology. In this paper, we give an instructive introduction to gravitational lensing and its applications to cosmology.	Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan	Futamase, T (reprint author), Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan.	tof@astr.tohoku.ac.jp					Jullo E, 2010, SCIENCE, V329, P924, DOI 10.1126/science.1185759; Hamana T, 2003, ASTROPHYS J, V597, P98, DOI 10.1086/378348; KAISER N, 1993, ASTROPHYS J, V404, P441, DOI 10.1086/172297; Ofek EO, 2003, MON NOT R ASTRON SOC, V343, P639, DOI 10.1046/j.1365-8711.2003.06707.x; Saha P, 2004, ASTRON J, V127, P2604, DOI 10.1086/383544; Oguri M, 2004, MON NOT R ASTRON SOC, V355, P120, DOI 10.1111/j.1365-2966.2004.08304.x; Okura Y, 2009, ASTROPHYS J, V699, P143, DOI 10.1088/0004-637X/699/1/143; Applegate DE, 2014, MON NOT R ASTRON SOC, V439, P48, DOI 10.1093/mnras/stt2129; Diemand J, 2004, MON NOT R ASTRON SOC, V352, P535, DOI 10.1111/j.1365-2966.2004.07940.x; Hoekstra H, 2000, ASTROPHYS J, V532, P88, DOI 10.1086/308556; Maoli R, 2001, ASTRON ASTROPHYS, V368, P766, DOI 10.1051/0004-6361:20010058; Hoekstra H, 2002, MON NOT R ASTRON SOC, V333, P911, DOI 10.1046/j.1365-8711.2002.05479.x; WALSH D, 1979, NATURE, V279, P381, DOI 10.1038/279381a0; Mao SD, 1998, MON NOT R ASTRON SOC, V295, P587, DOI 10.1046/j.1365-8711.1998.01319.x; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; Bradac M, 2009, ASTROPHYS J, V706, P1201, DOI 10.1088/0004-637X/706/2/1201; Perlmutter S, 1998, NATURE, V391, P51, DOI 10.1038/34124; Bradac M, 2006, ASTROPHYS J, V652, P937, DOI 10.1086/508601; Heymans C, 2006, MON NOT R ASTRON SOC, V368, P1323, DOI 10.1111/j.1365-2966.2006.10198.x; Kneib JP, 1996, ASTROPHYS J, V471, P643, DOI 10.1086/177995; Bacon DJ, 2000, MON NOT R ASTRON SOC, V318, P625, DOI 10.1046/j.1365-8711.2000.03851.x; Broadhurst T, 2005, ASTROPHYS J, V619, pL143, DOI 10.1086/428122; PACZYNSKI B, 1994, ASTROPHYS J, V435, pL113, DOI 10.1086/187607; HEWITT JN, 1988, NATURE, V333, P537, DOI 10.1038/333537a0; Okura Y, 2007, ASTROPHYS J, V660, P995, DOI 10.1086/513135; Taylor JE, 2005, MON NOT R ASTRON SOC, V364, P515, DOI 10.1111/j.1365-2966.2005.09582.x; Seitz C, 1997, ASTRON ASTROPHYS, V318, P687; Schneider P, 2007, ASTRON ASTROPHYS, V462, P841, DOI 10.1051/0004-6361:20065532; Bernardi M, 2010, MON NOT R ASTRON SOC, V404, P2087, DOI 10.1111/j.1365-2966.2010.16425.x; SCHNEIDER P, 1995, ASTRON ASTROPHYS, V294, P411; REFSDAL S, 1994, REP PROG PHYS, V57, P117, DOI 10.1088/0034-4885/57/2/001; Williams LLR, 1998, MON NOT R ASTRON SOC, V294, P299; Bridle S, 2010, MON NOT R ASTRON SOC, V405, P2044, DOI 10.1111/j.1365-2966.2010.16598.x; Zwicky F, 1937, PHYS REV, V51, P290, DOI 10.1103/PhysRev.51.290; [Anonymous], ARXIV09120914; KAISER N, 1995, ASTROPHYS J, V449, P460, DOI 10.1086/176071; Hetterscheidt M, 2007, ASTRON ASTROPHYS, V468, P859, DOI 10.1051/0004-6361:20065885; Shaw LD, 2006, ASTROPHYS J, V646, P815, DOI 10.1086/505016; Brainerd TG, 1996, ASTROPHYS J, V466, P623, DOI 10.1086/177537; Wittman DM, 2000, NATURE, V405, P143, DOI 10.1038/35012001; Kundic T, 1997, ASTROPHYS J, V482, P75, DOI 10.1086/304147; Jullo E, 2009, MON NOT R ASTRON SOC, V395, P1319, DOI 10.1111/j.1365-2966.2009.14654.x; Taylor JE, 2004, MON NOT R ASTRON SOC, V348, P811, DOI 10.1111/j.1365-2966.2004.07395.x; Benjamin J, 2013, MON NOT R ASTRON SOC, V431, P1547, DOI 10.1093/mnras/stt276; Seitz S, 1996, ASTRON ASTROPHYS, V305, P383; Kitching TD, 2011, MON NOT R ASTRON SOC, V413, P2923, DOI 10.1111/j.1365-2966.2011.18369.x; Angulo RE, 2009, MON NOT R ASTRON SOC, V399, P983, DOI 10.1111/j.1365-2966.2009.15333.x; Gao L, 2012, MON NOT R ASTRON SOC, V425, P2169, DOI 10.1111/j.1365-2966.2012.21564.x; TYSON JA, 1990, ASTROPHYS J, V349, pL1, DOI 10.1086/185636; Zitrin A, 2009, ASTROPHYS J LETT, V703, pL132, DOI 10.1088/0004-637X/703/2/L132; Hudson MJ, 1998, ASTROPHYS J, V503, P531, DOI 10.1086/306026; Cypriano ES, 2004, ASTROPHYS J, V613, P95, DOI 10.1086/422896; SOUCAIL G, 1987, ASTRON ASTROPHYS, V172, pL14; TURNER EL, 1984, ASTROPHYS J, V284, P1, DOI 10.1086/162379; Schneider P, 2002, ASTRON ASTROPHYS, V396, P1, DOI 10.1051/0004-6361:20021341; Peacock JA, 1996, MON NOT R ASTRON SOC, V280, pL19; Van Waerbeke L, 2000, ASTRON ASTROPHYS, V358, P30; Bridle S, 2009, ANN APPL STAT, V3, P6, DOI 10.1214/08-AOAS222; Huterer D, 2006, MON NOT R ASTRON SOC, V366, P101, DOI 10.1111/j.1365-2966.2005.09782.x; Hoekstra H, 2012, MON NOT R ASTRON SOC, V427, P1298, DOI 10.1111/j.1365-2966.2012.22072.x; Massey R, 2007, MON NOT R ASTRON SOC, V376, P13, DOI 10.1111/j.1365-2966.2006.11315.x; Erben T, 2001, ASTRON ASTROPHYS, V366, P717, DOI 10.1051/0004-6361:20010013; Wayth RB, 2006, MON NOT R ASTRON SOC, V372, P1187, DOI 10.1111/j.1365-2966.2006.10922.x; FAHLMAN G, 1994, ASTROPHYS J, V437, P56, DOI 10.1086/174974; Futamase T, 1998, ASTROPHYS J, V508, pL47, DOI 10.1086/311717; Gao L, 2004, MON NOT R ASTRON SOC, V355, P819, DOI 10.1111/j.1365-2966.2004.08360.x; Taylor JE, 2005, MON NOT R ASTRON SOC, V364, P535, DOI 10.1111/j.1365-2966.2005.09581.x; Hirata CM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.063526; Matsumoto A, 2008, MON NOT R ASTRON SOC, V384, P843, DOI 10.1111/j.1365-2966.2007.12769.x; Bacon DJ, 2003, MON NOT R ASTRON SOC, V344, P673, DOI 10.1046/j.1365-8711.2003.06877.x; Hoekstra H, 2002, ASTROPHYS J, V577, P595, DOI 10.1086/342120; Giocoli C, 2010, MON NOT R ASTRON SOC, V404, P502, DOI 10.1111/j.1365-2966.2010.16311.x; Ebeling H, 1998, MON NOT R ASTRON SOC, V301, P881, DOI 10.1046/j.1365-8711.1998.01949.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307; Bacon DJ, 2001, MON NOT R ASTRON SOC, V325, P1065, DOI 10.1046/j.1365-8711.2001.04507.x; BARTELMANN M, 1995, ASTRON ASTROPHYS, V303, P643; Bhattacharya A., 2013, ASTROPHYS J, V766, P32; BLANDFORD RD, 1992, ANNU REV ASTRON ASTR, V30, P311; Blandford R. D., DARK MATTER UNIVERSE, P133; Bohringer H, 2004, ASTRON ASTROPHYS, V425, P367, DOI 10.1051/0004-6361:20034484; Bouwens RJ, 2009, ASTROPHYS J, V690, P1764, DOI 10.1088/0004-637X/690/2/1764; Cain B, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/43; Cao S, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201015940; Capelo PR, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/445; Chae KH, 2003, ASTROPHYS J, V599, pL61, DOI 10.1086/381247; Chae KH, 2010, MON NOT R ASTRON SOC, V402, P2031, DOI 10.1111/j.1365-2966.2009.16073.x; Chiba M, 2002, ASTROPHYS J, V565, P17, DOI 10.1086/324493; Chwolson O., 1924, ASTR NACHRICHTEN, V221, P329, DOI DOI 10.1002/(ISSN)1521-3994; Clowe D., 1998, ASTROPHYS J, V498, pL61; Coe, 2012, ASTROPHYS J, V757, P22; Coe D, 2008, ASTROPHYS J, V681, P814, DOI 10.1086/588250; Coe D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/32; Croom SM, 2009, MON NOT R ASTRON SOC, V399, P1755, DOI 10.1111/j.1365-2966.2009.15398.x; Cropper M, 2013, MON NOT R ASTRON SOC, V431, P3103, DOI 10.1093/mnras/stt384; DAHLE H, 1994, ASTROPHYS J, V435, pL79, DOI 10.1086/187599; Dahle H, 2002, ASTROPHYS J SUPPL S, V139, P313, DOI 10.1086/338678; DePoy D. L., 2008, SPIE, V7014; Ebeling H., 2000, VIZIER ONLINE DATA C, V730, P10881; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Ellis R. S., ARXIV0109294; Fisher P., 1997, AJ, V113, P521; Fu L, 2008, ASTRON ASTROPHYS, V479, P9, DOI 10.1051/0004-6361:20078522; Fukugita M., 1990, MNRAS, V246, P24; FUTAMASE T, 1989, MON NOT R ASTRON SOC, V237, P187; Grogin NA, 1996, ASTROPHYS J, V464, P92, DOI 10.1086/177302; Hattori M., 1999, PROG THEOR PHYS SUPP, V133, P1, DOI 10.1143/PTPS.133.1; Hoekstra H, 1998, ASTROPHYS J, V504, P636, DOI 10.1086/306102; Huudson M. J., 1998, ASTROPHYS J, V503, P531; Jee MJ, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/74; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Kaiser N., ARXIVASTROPH0003338; Kaiser N., 2010, P SOC PHOTO-OPT INS, V7733, P77330; Keeton C. R., ARXIVASTROPH0102340; Kilbinger M, 2013, MON NOT R ASTRON SOC, V430, P2200, DOI 10.1093/mnras/stt041; Kitching TD, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/2/12; Kitching TD, 2012, MON NOT R ASTRON SOC, V423, P3163, DOI 10.1111/j.1365-2966.2012.21095.x; Klypin AA, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/102; Kneib JP, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0047-3; Kneib J.-P., 1993, THESIS; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Kochanek CS, 1996, ASTROPHYS J, V466, P638, DOI 10.1086/177538; Kochanek C. S., P 33 SAAS FEE ADV CO; Lefor AT, 2013, NEW ASTRON REV, V57, P1, DOI 10.1016/j.newar.2013.05.001; Leonard A, 2011, MON NOT R ASTRON SOC, V413, P789, DOI 10.1111/j.1365-2966.2010.18171.x; Leonard A, 2007, ASTROPHYS J, V666, P51, DOI 10.1086/520109; Levinson R, 2013, PUBL ASTRON SOC PAC, V125, P1474, DOI 10.1086/674333; Liebes Jr S., 1964, PHYS REV B, V133, P835, DOI DOI 10.1103/PHYSREV.133.B835; Liesenborgs J, 2008, MON NOT R ASTRON SOC, V386, P307, DOI 10.1111/j.1365-2966.2008.13026.x; Linder EV, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.123529; Link F., 1936, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, V202; Link F., 1937, Bulletin Astronomique, V10; De Lucia G, 2004, MON NOT R ASTRON SOC, V348, P333, DOI 10.1111/j.1365-2966.2004.07372.x; Lynds R., 1986, B AM ASTRON SOC, V18, P1014; Massey R, 2013, MON NOT R ASTRON SOC, V429, P661, DOI 10.1093/mnras/sts371; Medezinski E, 2007, ASTROPHYS J, V663, P717, DOI 10.1086/518638; Narayan R., ARXIVASTROPH9606001; Newman AB, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/24; Oguri M, 2010, PUBL ASTRON SOC JPN, V62, P1017; Oguri M., 2012, MON NOT R ASTRON SOC, V420, P3214; Oguri M, 2010, MON NOT R ASTRON SOC, V405, P2579, DOI 10.1111/j.1365-2966.2010.16639.x; Oguri M, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/120; Okabe N, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/90; Okabe N, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/2/L35; Okura Y, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/112; Okura Y, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/9; Okura Y., 2012, ASTROPHYS J, V771, P37; Okura Y, 2008, ASTROPHYS J, V680, P1, DOI 10.1086/587676; Postman M, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/25; Richard J., ARXIV14053303; Richard J, 2008, ASTROPHYS J, V685, P705, DOI 10.1086/591312; Rowe B., ARXIV12110966; Schmidt M., 1998, APJ, V507, P46; Schneider P., 1992, GRAVITATIONAL LENSES, VXIV; Schrabback T., 2008, DARK MATTER ASTROPAR, P260, DOI 10.1142/9789812814357_0026; Semboloni E, 2007, MON NOT R ASTRON SOC, V375, pL6, DOI 10.1111/j.1745-3933.2006.00266.x; Soldner J., 1801, ASTRON JB JAHR, V1804, P161; Suyu SH, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/70; Suyu SH, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L35; Takada M, 2004, ASTROPHYS J, V601, pL1, DOI 10.1086/381870; TURNER EL, 1990, ASTROPHYS J, V365, pL43, DOI 10.1086/185884; Tyson J. A., 2002, P 5 INT UCLA S; Okabe N, 2008, PUBL ASTRON SOC JPN, V60, P345; Umetsu K, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/163; Umetsu K., ARXIV10023952; Umetsu K, 2008, ASTROPHYS J, V684, P177, DOI 10.1086/589683; Umetsu K., ARXIV14041375U; Umetsu K., 1999, PROG THEOR PHYS SUPP, V133, P53, DOI 10.1143/PTPS.133.53; Umetsu K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/127; Valls-Gabaud D., 2006, AIP Conference Proceedings, V861, DOI 10.1063/1.2399715; van Waerbeke, 2000, ASTRON ASTROPHYS, V429, P383; van Waerbeke L., ARXIVASTROPH0305089; van den Bosch FC, 2003, MON NOT R ASTRON SOC, V340, P771, DOI 10.1046/j.1365-8711.2003.06335.x; Verdoes Kleijn G., ARXIV11120886; Viola M., ARXIV11073920; Write C. O., ARXIV9908213; Wu HY, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/23; Zitrin A, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/117	178	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-2718	1793-6594		INT J MOD PHYS D	Int. J. Mod. Phys. D	APR	2015	24	5							1530011	10.1142/S0218271815300116		52	Astronomy & Astrophysics	Astronomy & Astrophysics	CE0OL	WOS:000351503600001		
J	Altaher, Y; Nakanishi, M; Kandeel, M				Altaher, Yousef; Nakanishi, Masayuki; Kandeel, Mahmoud			Annotation of Camel Genome for Estimation of Drug Binding Power, Evolution and Adaption of Cytochrome P450 1a2	INTERNATIONAL JOURNAL OF PHARMACOLOGY			English	Article						Camel; cytochrome P450; phylogenetics; docking; molecular modeling	DROMEDARIUS; TOXICITY	While camels. rapidly evoluted several genes to adapt their environment, contemporary studies recorded that camels are sensitive to toxicity with some drugs as monensin, narasin and maduramicin ionophores compounds, which are extensively used in veterinary medicine. Recently, camel genome was resolved, which will allow for discovery of secrets of camel life. To this end, it is not known whether camel cytochrome enzymes were specially developed or adapted to camel environment or it has been associated with increasing the susceptibility of camels to toxicity with drugs. The objectives of this work are annotation of camel genome and retrieval of camel for cytochrome P450 1A2 (CYP 1A2) for phylogenetic, molecular modeling studies, docking studies and determination of its drug binding power. Results indicated poor efficiency of camel CYP 1A2 in binding with drugs. Furthermore, despite the high evolution of many camel genes to adapt camel environment, CYP 1A2 was found to be phylogenetically retarded gene showing lower rate of evolution compared with subset of data from 100 different organisms. These results suggests the potential toxicity of camels with drugs undergoing oxidation by CYP 1A2.	[Altaher, Yousef; Kandeel, Mahmoud] King Faisal Univ, Fac Vet Med & Anim Resources, Alhofuf, Alahsa, Saudi Arabia; [Kandeel, Mahmoud] King Faisal Univ, Fac Vet Med & Anim Resources, Dept Physiol Biochem & Pharmacol, Alhofuf, Alahsa, Saudi Arabia; [Nakanishi, Masayuki] Matsuyama Univ, Fac Pharmaceut Sci, Matsuyama, Ehime, Japan	Kandeel, M (reprint author), King Faisal Univ, Fac Vet Med & Anim Resources, Dept Physiol Biochem & Pharmacol, Alhofuf, Alahsa, Saudi Arabia.				deanship of scientific research, King Faisal University, Hofuf, Alahsa, Saudi Arabia	This work is supported by grants for projects of undergraduate students to MK and YA from the deanship of scientific research, King Faisal University, Hofuf, Alahsa, Saudi Arabia.	ABUDAMIR H, 2013, COMP CLIN PATHOL, V22, P305, DOI DOI 10.1007/s00580-011-1403-4; ALI BH, 1988, VET RES COMMUN, V12, P67, DOI 10.1007/BF00396405; Alquarawi AA, 2000, VET RES COMMUN, V24, P245, DOI 10.1023/A:1006498816669; Kandeel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057140; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Kandeel M, 2013, J COMPUT AID MOL DES, V27, P605, DOI 10.1007/s10822-013-9665-3; Di Rocco F, 2009, J BIOENERG BIOMEMBR, V41, P223, DOI 10.1007/s10863-009-9221-y; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Burger PA, 2014, J HERED, V105, P839, DOI 10.1093/jhered/est005; Di Rocco F, 2006, J BIOENERG BIOMEMBR, V38, P293, DOI 10.1007/s10863-006-9048-8; El Bahri L, 1999, VET HUM TOXICOL, V41, P35; HOMEIDA AM, 1981, J COMP PATHOL, V91, P355, DOI 10.1016/0021-9975(81)90005-0; Kandeel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094538; MILLER RE, 1990, J AM VET MED ASSOC, V196, P131; MOUSA HM, 1992, DEUT TIERARZTL WOCH, V99, P464; Wu HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6188	16	0	0	ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET	FAISALABAD	308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN	1811-7775	1812-5700		INT J PHARMACOL	Int. J. Pharmacol.	APR 1	2015	11	3					243	247		10.3923/ijp.2015.243.247		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD3YM	WOS:000351019700008		
J	Nomura, T; Kanda, T				Nomura, Tatsuya; Kanda, Takayuki			Influences of Evaluation and Gaze from a Robot and Humans' Fear of Negative Evaluation on Their Preferences of the Robot	INTERNATIONAL JOURNAL OF SOCIAL ROBOTICS			English	Article						Human-robot interaction; Evaluation from a robot; Fear of negative evaluation; Gaze	SELF-DISCLOSURE	To investigate influences of evaluation from robots, gazes from the robots, and humans' fear of negative evaluation (FNE) into the humans' preferences of the robots, we conducted an experiment in which a human-sized robot is used for an advisory role, providing suggestion in foreign-language education. There were three independent variables controlled: evaluation from robot (evaluative vs. non-evaluative robot), users' FNE (low FNE vs. high FNE), and gaze from robot (refrained gazes vs. normal gazes), and dependent variables were participants' preferences of the robot as subjective measures and amount of utterances as an objective measure. The experimental results suggested that when the robot evaluated participants with a lower FNE, they preferred to use the robot with normal gaze behavior more than those with a higher FNE. While the effect of refrained gaze is not clear for people with higher FNE, for people with lower FNE, refrained gaze reduced their intention to participate when the robot evaluated them. Moreover, the experimental results suggested that persons having higher FNE tend to trust the robot more, and participants spoke more when the robot did not evaluate them and when it used the normal gaze. This paper discusses the implications for applications with potential evaluation capability, e.g. for healthcare and education.	[Nomura, Tatsuya] Ryukoku Univ, Dept Media Informat, Otsu, Shiga 5202194, Japan; [Kanda, Takayuki] ATR Intelligent Robot & Commun Labs, Kyoto 6190288, Japan	Nomura, T (reprint author), Ryukoku Univ, Dept Media Informat, I-5 Yokotani, Otsu, Shiga 5202194, Japan.	nomura@rins.ryukoku.ac.jp; kanda@atr.jp			Japan Society for the Promotion of Science [21118006]	The research was supported in part by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research No. 21118006. The authors deeply thank Dr. Michihiro Shimada and Ms. Sayaka Taniguchi in the ATR Intelligent Robotics and Communication Laboratories for their cooperation with the conduction of the experiment in this research.	Heerink M, 2010, INT J SOC ROBOT, V2, P361, DOI 10.1007/s12369-010-0068-5; Saerbeck M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1613; Stafford RQ, 2014, INT J SOC ROBOT, V6, P281, DOI 10.1007/s12369-013-0224-9; Brave S, 2005, INT J HUM-COMPUT ST, V62, P161, DOI 10.1016/j.ijhcs.2004.11.002; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; Joinson AN, 2001, EUR J SOC PSYCHOL, V31, P177, DOI 10.1002/ejsp.36; Bickmore T. W., 2005, ACM Transactions on Computer-Human Interaction, V12, DOI 10.1145/1067860.1067867; Hofmann Stefan G, 2010, Depress Anxiety, V27, P1117, DOI 10.1002/da.20759; IIZUKA Y, 1995, JPN J PSYCHOL, V66, P277; Ishikawa R, 1992, JAPANESE J BEHAV THE, V18, P10; Kang SH, 2010, COMPUT ANIMAT VIRT W, V21, P473, DOI 10.1002/cav.345; Kidd C.D., 2008, THESIS MIT; Leary M. L., 1983, UNDERSTANDING SOCIAL; Nass C., 2005, P ACM C HUM FACT COM, P1973; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Watson JB, 1969, J CONSULT CLIN PSYCH, V33, P448; Welch KC, 2010, INT J SOC ROBOT, V2, P391, DOI 10.1007/s12369-010-0063-x	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1875-4791	1875-4805		INT J SOC ROBOT	Int. J. Soc. Robot.	APR	2015	7	2					155	164		10.1007/s12369-014-0270-y		10	Robotics	Robotics	CE0CB	WOS:000351469700002		
J	Morales, Y; Satake, S; Kanda, T; Hagita, N				Morales, Yoichi; Satake, Satoru; Kanda, Takayuki; Hagita, Norihiro			Building a Model of the Environment from a Route Perspective for Human-Robot Interaction	INTERNATIONAL JOURNAL OF SOCIAL ROBOTICS			English	Article						Cognitive human-robot interaction; Service robots; Social human-robot interaction; Environment modeling; Cognitive map	SPATIAL SEMANTIC HIERARCHY; SIMULTANEOUS LOCALIZATION; MOBILE ROBOTS; COGNITIVE MAPS; DIRECTIONS; NAVIGATION; KNOWLEDGE	We built a model of the environment for human-robot interaction by learning from humans cognitive processes. Our method, which differs from previous map building techniques in terms of perspectives, is based on a route perspective that is a mental tour of the environment. The main contribution of this work is the theory and computational implementation of the concept of route with its respective visual memory. The concept of route is modeled as a three layered model composed of memory layer, survey layer and route layer. By imitating the human concept of a route, the route layer is modeled as a directional path segmented by action taking associated with visual memory taken while traveling the path. We developed a system that generates human understandable route directions which was evaluated towards two methods: one copied from the explanation of a human expert and one generated with a model without the route perspective layer. Finally, experimental results demonstrate the usefulness of the route perspective layer, since it performed better than the model without the route layer and similarly to the human expert.	[Morales, Yoichi; Satake, Satoru; Kanda, Takayuki; Hagita, Norihiro] Adv Telecommun Res Inst Int, Intelligent Robot & Commun Labs, Kyoto, Japan	Morales, Y (reprint author), Adv Telecommun Res Inst Int, Intelligent Robot & Commun Labs, Kyoto, Japan.	yoichims@atr.jp			Ministry of Internal Affairs and Communications of Japan	This research was supported by the Ministry of Internal Affairs and Communications of Japan.	Alami R., 2011, P 15 INT S ROB RES; Nuchter A, 2007, J FIELD ROBOT, V24, P699, DOI 10.1002/rob.20209; Kuipers B, 2000, ARTIF INTELL, V119, P191, DOI 10.1016/S0004-3702(00)00017-5; Konolige K, 2010, INT J ROBOT RES, V29, P941, DOI 10.1177/0278364910370376; Grisetti G, 2007, IEEE T ROBOT, V23, P34, DOI 10.1109/TRO.2006.889486; Trafton JG, 2005, IEEE T SYST MAN CY A, V35, P460, DOI 10.1109/TSMCA.2005.850592; Bosse M, 2004, INT J ROBOT RES, V23, P1113, DOI 10.1177/0278364904049393; Fox D, 1999, J ARTIF INTELL RES, V11, P391; Zender H, 2008, ROBOT AUTON SYST, V56, P493, DOI 10.1016/j.robot.2008.03.007; Beeson P, 2010, INT J ROBOT RES, V29, P428, DOI 10.1177/0278364909100586; VANETTI EJ, 1988, ENVIRON BEHAV, V20, P667, DOI 10.1177/0013916588206001; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; ELFES A, 1989, COMPUTER, V22, P46, DOI 10.1109/2.30720; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Vasudevan S, 2007, ROBOT AUTON SYST, V55, P359, DOI 10.1016/j.robot.2006.12.008; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Beeson P, 2005, IEEE INT C ROB AUT I; Berlin M, 2006, NAT C ART INT AAAI20; Brunskill E, 2007, IEEE RSJ INT C INT R; Burgard W, 1998, NAT C ART INT AAAI19; Daniel M.-P., 2003, SPAT COGN COMPUT, V3, P269, DOI 10.1207/s15427633scc0304_2; Dellaert F, 1999, ROB AUT 1999 P 1999, P1322; Denis M, 1997, CAH PSYCHOL COGN, V16, P409; Golledge RG, 1996, SPATIAL BEHAV GEOGRA; Gross H-M, 2008, IEEE INT C SYST MAN; Hato Y, 2010, ACM IEEE INT C HUM R; Kendon A., 2004, GESTURE VISIBLE ACTI; Kita S, 2003, POINTING: WHERE LANGAUAGE, CULTURE, AND COGNITON MEET, P307; Klippel A, 2005, NAT BIENN C SPAT SCI; Kollar T, 2010, ACM IEEE INT C HUM R; Konolige K, 2004, NAT C ART INT AAAI 0; Kopp S, 2008, CONVERSATIONAL INFOR, P133; Kuipers B, 1978, COGNITIVE SCI, V2, P129, DOI 10.1207/s15516709cog0202_3; Kulyukin V, 2005, IEEE RSJ INT C INT R; Levenshtein V. I., 1966, SOV PHYS DOKL, V10, P707; Levit M, 2007, IEEE T SYST MAN CY B, V37, P667, DOI 10.1109/TSMCB.2006.889809; Look G, 2008, THESIS; Lynch K., 1960, IMAGE CITY; Mandel C, 2006, IEEE RSJ INT C INT R, P205; Mozos OM, 2007, ROBOT AUTON SYST, V55, P391, DOI 10.1016/j.robot.2006.12.003; Matuszek C, 2010, ACM IEEE INT C HUM R; Montello DR, 1997, P INT C SPAT INF THE; Montemerlo M., 2002, P AAAI NAT C ART INT; Morales Y, 2011, ACM IEEE INT C HUM R; Moravec HP, 1989, CERTAINTY GRIDS SENS, P243; Morris AC, 2005, IEEE INT C ROB AUT I; Muhlbauer Q, 2009, IEEE INT C ROB AUT I; Nagatani K, 1999, IEEE RSJ INT C INT R; Nothegger C., 2004, SPAT COGN COMPUT, V4, P113, DOI [10.1207/s15427633scc0402_1, DOI 10.1207/S15427633SCC0402_]; Nuechter A, 2009, 3D ROBOTIC MAPPING; Okuno Y, 2009, ACM IEEE INT C HUM R; Olson E, 2006, IEEE INT C ROB AUT I; Ono T, 2001, ANN M COGN SCI SOC C; Pandey AK, 2010, 12 INT S EXP ROB ISE; Paul R, 2010, P IEEE INT C ROB AUT; Peltason J, 2009, IEEE INT C ROB AUT I; Remolina E, 2004, ARTIF INTELL, V152, P47, DOI 10.1016/S0004-3702(03)00114-0; Richter KF, 2004, LECT NOTES COMPUT SC, V3343, P58; Ross RJ, STRATIFIED SPATIAL M, P41; Shi H, 2005, P WOSLAD WORKSH SPAT; Shimizu N, 2009, INT JOINT C ART INT; Siegwart R, 2003, ROBOT AUTON SYST, V42, P203, DOI 10.1016/S0921-8890(02)00376-7; Smith R, 2007, 9 INT C DOC AN REC I; Striegnitz K, 2005, WORKSH SPAT LANG DIA; Thrun S., 2005, PROBABILISTIC ROBOTI; Topp EA, 2006, IEEE RSJ INT C INT R; Tversky B., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings; Vogel A, 2010, 48 ANN M ASS COMP LI; Werner S, 2000, LECT NOTES ARTIF INT, V1849, P295; Yeap W. K., 2000, Spatial Cognition and Computation, V2, DOI 10.1023/A:1011447309938; Yeap WK, 1999, ARTIF INTELL, V107, P265, DOI 10.1016/S0004-3702(98)00111-8; YEAP WK, 1988, ARTIF INTELL, V34, P297, DOI 10.1016/0004-3702(88)90064-1	72	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1875-4791	1875-4805		INT J SOC ROBOT	Int. J. Soc. Robot.	APR	2015	7	2					165	181		10.1007/s12369-014-0265-8		17	Robotics	Robotics	CE0CB	WOS:000351469700003		
J	Iio, T; Shiomi, M; Shinozawa, K; Shimohara, K; Miki, M; Hagita, N				Iio, Takamasa; Shiomi, Masahiro; Shinozawa, Kazuhiko; Shimohara, Katsunori; Miki, Mitsunori; Hagita, Norihiro			Lexical Entrainment in Human Robot Interaction	INTERNATIONAL JOURNAL OF SOCIAL ROBOTICS			English	Article						Lexical entrainment; Lexical alignment; Human robot interaction; Object reference conversation	GESTURES; CONVERSATION; COORDINATION; DIALOGUE	This paper reveals that lexical entrainment, in which a person tends to change her verbal expressions to match those said by her addressee, occurs in interactions between people and a robot when they refer to an object in a shared physical space. Many studies argue that lexical entrainment is crucial for understanding the principle of human dialogue and the development of the natural language interfaces of artificial media. However, few studies of it exist in human robot interaction in which humans and robot share a physical space. If lexical entrainment occurs in situations where a physical space is shared with a robot, such findings will contribute to the development of natural language interfaces with social robots. We designed experimental tests in which participants refer to an object and a robot confirms it and measured the extent to which the participants repeated the same verbal expressions said by the robot. Our subjects tended to adopt both the same verbal expressions and lexical categories as the robot.	[Iio, Takamasa; Shiomi, Masahiro; Shinozawa, Kazuhiko; Hagita, Norihiro] ATR Intelligent Robot & Commun Labs, Keihanna Sci City, Kyoto 6190288, Japan; [Shimohara, Katsunori; Miki, Mitsunori] Doshisha Univ, Kyotanabe 6100394, Japan	Iio, T (reprint author), ATR Intelligent Robot & Commun Labs, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	iio@atr.jp; kshimoha@mail.doshisha.ac.jp			Ministry of Internal Affairs and Communications of Japan; JSPS KAKENHI Grant [25730165]; Project for Strategic Development of Advanced Robotics Elemental Technologies of New Energy and Industrial Technology Development Organization (NEDO), Japan	This research was supported by the Ministry of Internal Affairs and Communications of Japan and JSPS KAKENHI Grant Number 25730165 and the Project for Strategic Development of Advanced Robotics Elemental Technologies of New Energy and Industrial Technology Development Organization (NEDO), Japan.	Niculescu A, 2013, INT J SOC ROBOT, V5, P171, DOI 10.1007/s12369-012-0171-x; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Shiomi M, 2011, INT J SOC ROBOT, V3, P27, DOI 10.1007/s12369-010-0077-4; Shiomi M, 2007, IEEE INTELL SYST, V22, P25, DOI 10.1109/MIS.2007.37; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Kuno Y, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P1191; Iio T, 2011, INT J SOC ROBOT, V3, P405, DOI 10.1007/s12369-011-0112-0; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; GARROD S, 1987, COGNITION, V27, P181, DOI 10.1016/0010-0277(87)90018-7; Branigan HP, 2010, J PRAGMATICS, V42, P2355, DOI 10.1016/j.pragma.2009.12.012; Bennett CC, 2014, INT J SOC ROBOT, V6, P367, DOI 10.1007/s12369-014-0237-z; Beun R.- J., 1998, PRAGMAT COGN, V6, P121, DOI 10.1075/pc.6.1-2.08beu; Branigan H, 2003, P 25 ANN C COGN SCI; Brennan S. E., 1991, User Modeling and User-Adapted Interaction, V1, DOI 10.1007/BF00158952; Brennan S.E., 1996, P INT S SPOK DIAL, P41; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76; CLARK HH, 1986, COGNITION, V22, P1, DOI 10.1016/0010-0277(86)90010-7; FURNAS GW, 1987, COMMUN ACM, V30, P964, DOI 10.1145/32206.32212; Gerwing J, 2004, GESTURE, V4; Gustafson J, 1997, P EUR RHOD GREEC, V97, P2275; Holler J, 2003, GESTURE, V3; Huttenrauch H, 2004, IEEE T SYST MAN CY C, V34, P113, DOI 10.1109/TSMCC.2004.826281; Komagome D, 2007, P IEEE INT S ROB HUM, P427; Moore C., 1995, JOINT ATTENTION ITS; Ono T., 2001, P 23 ANN M COGN SCI, P732; Pearson J, 2006, P CHI C HUM FACT COM; Reitter D., 2007, P 45 ANN M ASS COMP, P808; Shinozawa K, 2007, P 2007 7 IEEE RAS IN, V2, P558; Sugiyama O, 2006, CONNECT SCI, V18, P379, DOI 10.1080/09540090600890254; Tomko S, 2004, P 8 INT C SPOK LANG; van Dijk ET, 2013, INT J SOC ROBOT, V5, P491, DOI 10.1007/s12369-013-0214-y	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1875-4791	1875-4805		INT J SOC ROBOT	Int. J. Soc. Robot.	APR	2015	7	2					253	263		10.1007/s12369-014-0255-x		11	Robotics	Robotics	CE0CB	WOS:000351469700008		
J	Yamano, S; Horii, M; Takami, T; Sakuma, M; Morimoto, T; Okada, S; Taoka, T; Kichikawa, K; Sasamura, H; Itoh, H; Furuya, Y; Ueno, S; Imamura, T; Sugiyama, S; Ogawa, H; Saito, Y				Yamano, Shigeru; Horii, Manabu; Takami, Takeshi; Sakuma, Mio; Morimoto, Takeshi; Okada, Sadanori; Taoka, Toshiaki; Kichikawa, Kimihiko; Sasamura, Hiroyuki; Itoh, Hiroshi; Furuya, Yoshiko; Ueno, Satoshi; Imamura, Tomoaki; Sugiyama, Seigo; Ogawa, Hisao; Saito, Yoshihiko			Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology	INTERNATIONAL JOURNAL OF STROKE			English	Article						angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; asymptomatic cerebral lesion; hypertension; magnetic resonance imaging; stroke recurrence	SECONDARY PREVENTION; ROTTERDAM SCAN; POPULATION; REDUCTION; INCREASE; SUBTYPES; EVENTS	ObjectivesPatients with a history of ischemic stroke are known to develop new ischemic stroke. While asymptomatic, the presence and progression of silent brain infarcts and white matter lesions on magnetic resonance imaging are associated with an increased risk of future strokes. Both angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are recommended for the primary and secondary prevention of stroke, but there are no direct comparisons of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers regarding their cerebroprotective effects, including their effect on asymptomatic cerebral lesions detected by magnetic resonance imaging. MethodsElderly (65 years or older) patients with essential hypertension who underwent cerebral magnetic resonance imaging and were found to have any cerebral ischemic lesions, such as cerebral infarction, silent brain infarct, or white matter lesion, were enrolled in this CEREBRAL study. Patients who agreed to participate were enrolled in the randomized controlled trial portion. Patients who did not agree to participate in the randomized controlled trial were enrolled in the cohort study portion. After two-years of angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers treatment, follow-up magnetic resonance imaging examination will be performed. The primary end-point is the composite of (1) occurrence of a fatal or nonfatal cerebrovascular event or (2) progression of cerebrovascular lesions as evaluated by magnetic resonance imaging, including white matter lesions or silent brain infarcts. After enrollment, cognitive function was evaluated, if possible, using the Mini-Mental State Examination. ConclusionsOur study will clarify whether angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers are more effective for preventing primary and recurrence of ischemic stroke, including the progression of asymptomatic cerebral lesions on magnetic resonance imaging, in elderly hypertensive patients.	[Yamano, Shigeru; Horii, Manabu; Okada, Sadanori; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan; [Yamano, Shigeru] Nara Prefectural Gen Rehabil Ctr, Dept Internal Med, Shiki, Japan; [Horii, Manabu] Nara City Hosp, Dept Internal Med, Nara, Japan; [Takami, Takeshi] Clin Jingumae, Dept Internal Med, Kashihara, Nara, Japan; [Sakuma, Mio; Morimoto, Takeshi] Kinki Univ, Ctr Gen Internal Med & Emergency Care, Sayama, Osaka, Japan; [Taoka, Toshiaki; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan; [Sasamura, Hiroyuki; Itoh, Hiroshi] Keio Univ, Dept Internal Med, Grad Sch Med Sci, Tokyo, Japan; [Furuya, Yoshiko; Ueno, Satoshi] Nara Med Univ, Dept Neurol, Kashihara, Nara 6348522, Japan; [Imamura, Tomoaki] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Kashihara, Nara 6348522, Japan; [Sugiyama, Seigo; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 6348522, Japan	Saito, Y (reprint author), Nara Med Univ, Dept Internal Med 1, 840 Shijyo Cho, Kashihara, Nara 6348522, Japan.	yssaito@naramed-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	This study was supported by the Ministry of Health, Labor and Welfare of Japan. The funding source had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval the manuscript.	Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; WHITEBREAD S, 1989, BIOCHEM BIOPH RES CO, V163, P284, DOI 10.1016/0006-291X(89)92133-5; Hauser W, 1998, EUR J PHARMACOL, V348, P101, DOI 10.1016/S0014-2999(98)00134-4; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Kobayashi S, 1997, STROKE, V28, P1932; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Prins ND, 2004, NEUROLOGY, V62, P1533; Bunier M, 2000, LANCET, V355, P637; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hata J, 2005, J NEUROL NEUROSUR PS, V76, P368, DOI 10.1136/jnnp.2004.038166; Hollenberg N K, 2000, J Renin Angiotensin Aldosterone Syst, V1, P5, DOI 10.3317/jraas.2000.011; MacMahon S, 2001, LANCET, V358, P1033; The Japanese Society of Hypertension Committee for the Guidelines for Management of Hypertension, 2009, HYPERTENS RES, V32, P11; vansDijk EJ, 2008, STROKE, V39, P2712; Yusuf S, 2000, NEW ENGL J MED, V342, P145	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	APR	2015	10	3					452	456		10.1111/ijs.12085		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD9CR	WOS:000351395300037		
J	Takeda, O; Hoshino, Y; Anbo, Y; Yanagase, K; Aono, M; Sato, Y				Takeda, Osamu; Hoshino, Yosuke; Anbo, Yusuke; Yanagase, Kei-ichi; Aono, Masahiro; Sato, Yuzuru			Viscosity of Molten Alkaline-Earth Fluorides	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Alkaline-earth fluorides; BaF2; CaF2; MgF2; SrF2; Viscosity	CHLORIDES; SILICON	The viscosities of molten alkaline-earth fluorides were measured using the oscillating crucible method, which is especially suitable for measuring molten salts with low viscosity. The results showed a good Arrhenius linearity over a wide temperature range. The measured viscosities and activation energies increased in the following order: . Judging by the charge density, the viscosity of alkaline-earth fluorides should increase from molten to . However, the results indicate a different tendency, which may be explained by a Coulomb force that is very strong. The low viscosity of can be attributed to a decreased cohesive force, due to a partial loss of the Coulomb force caused by a higher charge density of the material. The viscosities were also compared to those of molten alkali fluorides and alkaline-earth chlorides. The viscosities of molten alkaline-earth fluorides were higher than those of molten alkali fluorides and alkaline-earth chlorides. The viscosity determined in this study was compared to literature values and showed a reasonable value in the relatively low-viscosity region.	[Takeda, Osamu; Hoshino, Yosuke; Anbo, Yusuke; Yanagase, Kei-ichi; Aono, Masahiro; Sato, Yuzuru] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan	Takeda, O (reprint author), Tohoku Univ, Aoba Ku, 6-6-02 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	takeda@material.tohoku.ac.jp					EJIMA T, 1987, J JPN I MET, V51, P328; Sato Y, 2000, INT J THERMOPHYS, V21, P1463, DOI 10.1023/A:1006661511770; Sato Y, 2003, J CRYST GROWTH, V249, P404, DOI 10.1016/S0022-0248(02)02153-X; Baak T., 1958, P C PHYSICAL CHEM IR, P84; Barin I., 1989, THERMOCHEMICAL DATA; Davies M.W., 1970, CHEM IND, V14, P359; EJIMA T, 1982, NIPPON KAGAKU KAISHI, P961; EJIMA T, 1977, J JPN I MET, V41, P784; Kapustin E.A., 1985, IZVESTIYA AKAD NAUK, V5, P52; Kulifeev V. F., 1968, IZV VYSSH UCHEBN ZAV, V2, P116; Mills K.C., 1995, SLAG ATLAS, V2, P359; Ogino K., 1979, NIPPON TEKKO KYOKAI, V73; Podgayetski V.V., 1956, AVTOMATICESKAJA SVAR, V9, P30; ROSCOE R, 1958, P PHYS SOC LOND, V72, P576, DOI 10.1088/0370-1328/72/4/312; SATO Y, 1990, J PHYS CHEM-US, V94, P1991, DOI 10.1021/j100368a050; Schwerin L., 1934, METALS ALLOYS, V5, P118; Stepanov V.V., 1965, AUTOMAT WELD, V18, P31; Takeda O., INT J THERMOPH UNPUB; The Iron and Steel Institute of Japan, 1972, HDB PHYS PROP MOLT I, P33; TORKLEP K, 1982, J CHEM ENG DATA, V27, P387; Vyatkin G.P., 1974, TEORIA METALLURGICHE, V1; Yanagase T., 1984, P 2 INT C MET SLAGS, P995; Zhmoidin G.I., 1969, RUSS METALL METALLY, V6, P5	23	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	APR	2015	36	4					648	657		10.1007/s10765-014-1828-5		10	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CD8ZN	WOS:000351385500004		
J	Nagao, Y; Yamada, T; Yoshida, A; Kagata, K				Nagao, Yoshiki; Yamada, Tetsuya; Yoshida, Atsumasa; Kagata, Kakeru			Study on Simultaneous Photoacoustic Measurement of Thermal Diffusivity and Thermal Effusivity of Solids	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Nondestructive method; On-site measurement; Photoacoustic measurement; Thermal diffusivity; Thermal effusivity	PROBE TECHNIQUE; FLASH METHOD; CONDUCTIVITIES	The goal of this study is the simultaneous measurement of the thermal diffusivity and thermal effusivity of thick samples using the photoacoustic method that is nondestructive, quick, and simple. In their original paper, Rosencwaig and Gersho showed that it is possible to measure thermal properties of a thermally thin sample, but it is impossible to measure those of a thermally thick sample. To improve this situation, a new method is proposed, in which the position of the sample and reference (thin plate) are exchanged, and it is analyzed theoretically whether simultaneous measurement is possible or not when samples are transparent, opaque, and semitransparent. When a sample is transparent, it absorbs little light, thereby the sample produces little photoacoustic waves. When a sample is opaque, light is totally absorbed by the sample. Therefore, thermal properties of the plate almost do not affect the phase-lag output. In these cases, it is shown that the simultaneous measurement is impossible. Hence, only the case when both the plate and sample are semitransparent is simulated. From theoretical analysis, in the case of a PVC plate, it is shown that the simultaneous measurement is likely to be possible when the ratio of the absorption coefficient of the plate to sample lies between , the thermal diffusivity between , and the thermal effusivity between .	[Nagao, Yoshiki; Yamada, Tetsuya; Yoshida, Atsumasa; Kagata, Kakeru] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Nagao, Y (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	coor_yo_shi_d@yahoo.co.jp					PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; BAESSO ML, 1994, ANALYST, V119, P561, DOI 10.1039/an9941900561; Stankus SV, 2009, THERMOPHYS AEROMECH+, V16, P585, DOI 10.1134/S0869864309040076; ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296; Barros Melo W. L., 1995, Applied Physics Letters, V67; BATTY WJ, 1984, APPL ENERG, V18, P301, DOI 10.1016/0306-2619(84)90011-4; BATTY WJ, 1984, APPL ENERG, V16, P83, DOI 10.1016/0306-2619(84)90058-8; Lipaev AA, 2012, MEAS TECH+, V54, P1264; Masoumi H., 2012, WORLD ACAD SCI ENG T, V6, P141; Mina S., 2007, THERMOCHIM ACTA, V455, P46	10	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	APR	2015	36	4					709	721		10.1007/s10765-014-1830-y		13	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CD8ZN	WOS:000351385500008		
J	Hirata, M; Nakashima, Y; Hara, D; Kanazawa, M; Kohno, Y; Yoshimoto, K; Iwamoto, Y				Hirata, Masanobu; Nakashima, Yasuharu; Hara, Daisuke; Kanazawa, Masayuki; Kohno, Yusuke; Yoshimoto, Kensei; Iwamoto, Yukihide			Optimal anterior femoral offset for functional range of motion in total hip arthroplasty-a computer simulation study	INTERNATIONAL ORTHOPAEDICS			English	Article						Stem anteversion; Sagittal stem tilt; Anterior femoral offset; Total hip arthroplasty	FEMOROACETABULAR IMPINGEMENT; HEAD; REPLACEMENT; ANTEVERSION; DISLOCATION; KINEMATICS	Purpose Compared to medial femoral offset (MFO), the role of anterior femoral offset (AFO) on range of motion (ROM) in total hip arthroplasty (THA) has not been fully examined. We therefore defined AFO as the anterior distance from the centre of the femoral head to the proximal femoral axis in the sagittal plane and determined the optimal AFO required for ROM needed for activities of daily living using a computer-simulated THA model. Methods Various AFOs were obtained by changing stem anteversion (stem-AV) and stem tilt in the sagittal plane (stem-tilt) using a CT-based simulation software. The required ROM was defined as: flexion >= 110A degrees, internal rotation at 90 degrees flexion (IR)>= 30A degrees, external rotation (ER)>= 30A degrees, and extension >= 30A degrees, and we determined AFO and MFO to satisfy required ROM. Results AFO was positively correlated with stem-AV and anterior stem-tilt. MFO was negatively correlated with stem-AV and not influenced by stem-tilt. Flexion and IR increased with both increased AFO and MFO, whereas extension and ER decreased with increased AFO. A smoothing spline curve showed the optimal AFO and MFO for required ROM to be from 15 mm to 25 mm on average and more than 32.1 mm, respectively. Conclusions This is the first study to show that AFO directly influenced ROM in THA. Optimal AFO as well as MFO should be reconstructed to achieve sufficient ROM.	[Hirata, Masanobu; Nakashima, Yasuharu; Hara, Daisuke; Kanazawa, Masayuki; Kohno, Yusuke; Yoshimoto, Kensei; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan	Nakashima, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yasunaka@ortho.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24592268]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 24592268). We thank Junji Kishimoto, a statistician from the Digital Medicine Initiative, Kyushu University, for his valuable comments and suggestions in regards to the statistical analysis.	Hemmerich A, 2006, J ORTHOP RES, V24, P770, DOI 10.1002/jor.20114; Sugano N, 2012, J ARTHROPLASTY, V27, P1562, DOI 10.1016/j.arth.2012.01.029; Kessler O, 2008, J ORTHOP RES, V26, P443, DOI 10.1002/jor.20541; Tannast M, 2007, J ORTHOP RES, V25, P122, DOI 10.1002/jor.20309; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; Nakashima Y, 2013, J ORTHOP SCI, V18, P962, DOI 10.1007/s00776-013-0456-4; Widmer KH, 2004, J ORTHOPAED RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001; Malik A, 2007, J BONE JOINT SURG AM, V89A, P1832, DOI 10.2106/JBJS.F.01313; Matsushita A, 2009, J ARTHROPLASTY, V24, P646, DOI 10.1016/j.arth.2008.02.008; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228; Jolles BM, 2002, J ARTHROPLASTY, V17, P282, DOI 10.1054/arth.2002.30286; Girard J, 2012, CLIN BIOMECH, V27, P165, DOI 10.1016/j.clinbiomech.2011.08.013; Muller M, 2011, INT ORTHOP, V35, P981, DOI 10.1007/s00264-010-1047-z; Cinotti G, 2011, INT ORTHOP, V35, P317, DOI 10.1007/s00264-010-0954-3; Pasquier G, 2010, ORTHOP TRAUMATOL-SUR, V96, P367, DOI 10.1016/j.otsr.2010.02.006; Bargar WL, 2010, CLIN ORTHOP RELAT R, V468, P527, DOI 10.1007/s11999-009-1040-2; Hirata M, 2013, J ARTHROPLASTY, V28, P1648, DOI 10.1016/j.arth.2013.03.006; Iwai S, 2014, J ORTHOP SCI, V19, P443, DOI 10.1007/s00776-014-0547-x; Lakshmanan P, 2008, ACTA ORTHOP BELG, V74, P49; Lincoln M, 2009, ARTHROSCOPY, V25, P392, DOI 10.1016/j.arthro.2008.12.002; MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865; Nadzadi ME, 2003, J BIOMECH, V36, P577, DOI 10.1016/S0021-9290(02)00232-4; Preininger Bernd, 2012, Open Orthop J, V6, P578, DOI 10.2174/1874325001206010578; Shoji T, 2013, INT ORTHOP, V37, P1897, DOI 10.1007/s00264-013-1979-1	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	APR	2015	39	4					645	651		10.1007/s00264-014-2538-0		7	Orthopedics	Orthopedics	CE0SL	WOS:000351516200005		
J	Hananouchi, T				Hananouchi, Takehito			Sagittal gap balancing with the concept of a single radius femoral component in posterior cruciate sacrificing total knee arthroplasty with patient-specific instrumentation	INTERNATIONAL ORTHOPAEDICS			English	Article						Total knee arthroplasty; Sagittal gap balancing; Patient specific instrumentation; Single radius femoral component	SOFT-TISSUE BALANCE; ROTATIONAL ALIGNMENT; EXTENSION GAP; FLEXION SPACE; REPLACEMENT; RESECTION; GUIDES; TKA; ACCURACY; SYSTEM	Purpose Sagittal gap balancing (relation between flexion and extension gaps) with placement of trial femoral components and reduction of the patella in total knee arthroplasty (TKA) is important, but it is not easy. The purpose of this study was to investigate whether (1) the flexion and extension gaps were equal when a previously suggested three-dimensional planning for a single-radius femoral component (its sagittal centre is matched with flexion-extension axis of knee movement) is executed with patient-specific instrumentation (PSI) and whether (2) PSI was done with good accuracy, which did not affect the first purpose. Methods Posterior cruciate ligament sacrificed (PS) TKA was performed on 12 joints. Using the patients' pre-operative computed tomography (CT) images, PSI was manufactured to fit on the bony surface of the knee joint and to simultaneously transfer pre-operative planning to the operating room. After osteotomy with PSI, gap measurements were calculated with the knee in flexion and extension. Angle deviations of both components were investigated with postoperative CT images. Results The flexion gap (mean, 19.1 mm) was larger than the extension gap (mean, 12.3 mm) in all cases. Angle differences between pre- and postoperative alignments were within 3 degrees in all cases. Conclusions Although PSI executed the pre-operative planning with good accuracy, the flexion gap is always larger than the extension gap. This finding suggests that surgeons may not aim for equal gaps of flexion and extension in PS-TKA.	Osaka Sangyo Univ, Med Engn Lab, Dept Mech Engn, Fac Engn, Osaka 5748530, Japan	Hananouchi, T (reprint author), Osaka Sangyo Univ, Med Engn Lab, Dept Mech Engn, Fac Engn, 3-1-1 Nakagaito Daito, Osaka 5748530, Japan.	hana-osaka@umin.net					Akagi M, 2001, CLIN ORTHOP RELAT R, P147; Stoddard JE, 2013, J ORTHOP RES, V31, P53, DOI 10.1002/jor.22170; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Matsumoto T, 2009, J BONE JOINT SURG BR, V91B, P475, DOI 10.1302/0301-620X.91B4.21862; Ng VY, 2012, CLIN ORTHOP RELAT R, V470, P99, DOI 10.1007/s11999-011-1996-6; Schnurr C, 2012, INT ORTHOP, V36, P83, DOI 10.1007/s00264-011-1295-6; Griffin FM, 2000, J ARTHROPLASTY, V15, P970, DOI 10.1054/arth.2000.6503; Krishnan SP, 2012, J BONE JOINT SURG BR, V94B, P1457, DOI 10.1302/0301-620X.94B11.29350; Muratsu H, 2010, CLIN BIOMECH, V25, P926, DOI 10.1016/j.clinbiomech.2010.06.020; Uehara K, 2002, CLIN ORTHOP RELAT R, P196; Victor J, 2014, CLIN ORTHOP RELAT R, V472, P263, DOI 10.1007/s11999-013-2997-4; Matsumoto T, 2014, INT ORTHOP, V38, P531, DOI 10.1007/s00264-013-2133-9; Barnes CL, 2011, J ARTHROPLASTY, V26, P549, DOI 10.1016/j.arth.2010.04.027; Nunley RM, 2012, CLIN ORTHOP RELAT R, V470, P895, DOI 10.1007/s11999-011-2222-2; Matsumoto T, 2013, KNEE SURG SPORT TR A, V21, P2338, DOI 10.1007/s00167-013-2376-4; Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P2227, DOI 10.1007/s00167-013-2626-5; Matsumoto T, 2011, J ARTHROPLASTY, V26, P788, DOI 10.1016/j.arth.2010.06.006; Lombardi AV, 2008, ORTHOPEDICS, V31, P927; Chaiyakit Pruk, 2009, J Med Assoc Thai, V92 Suppl 6, pS80; Chinzei N, 2014, KNEE, V21, P387, DOI 10.1016/j.knee.2013.10.005; Delport H, 2012, ARCH CLIN EXP SURG, V1, P206; Fan CY, 2010, J ARTHROPLASTY, V25, P492, DOI 10.1016/j.arth.2009.05.008; Hananouchi T, 2008, COMPUT AIDED SURG, V13, P23, DOI [10.3109/10929080701882580, 10.1080/10929080701882580]; Hananouchi T, 2012, KNEE, V19, P601, DOI 10.1016/j.knee.2011.08.001; Incavo SJ, 2004, J ARTHROPLASTY, V19, P493, DOI 10.1016/j.arth.2003.12.071; INSALL J, 1976, CLIN ORTHOP RELAT R, P149; Kadoya Y, 2001, CLIN ORTHOP RELAT R, P210; Matsumoto T, 2009, J ARTHROPLASTY, V24, P358, DOI 10.1016/j.arth.2008.01.001; Matsumoto T, 2012, J ARTHROPLASTY, V27, P1723, DOI 10.1016/j.arth.2012.02.020; Matthews J, 2014, J ORTHOP RES, V32, P627, DOI 10.1002/jor.22587; Mihalko WM, 1999, CLIN ORTHOP RELAT R, P243; Nam D, 2012, J KNEE SURG, V25, P213, DOI 10.1055/s-0032-1319785; Nishizawa Y, 2013, INT ORTHOP, V37, P421, DOI 10.1007/s00264-012-1749-5; Oka S, 2014, KNEE SURG SPORT TR A, V22, P1812, DOI 10.1007/s00167-013-2535-7; Park SJ, 2009, ORTHOPEDICS, V32, P22, DOI 10.3928/01477447-20090915-54; Tanzer M, 2002, J ARTHROPLASTY, V17, P813, DOI 10.1054/arth.2002.34814; Winemaker MJ, 2002, J ARTHROPLASTY, V17, P2, DOI 10.1054/arth.2002.29321	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	APR	2015	39	4					659	665		10.1007/s00264-014-2536-2		7	Orthopedics	Orthopedics	CE0SL	WOS:000351516200007		
J	Takayama, K; Matsumoto, T; Muratsu, H; Ishida, K; Shibanuma, N; Araki, D; Matsushita, T; Kuroda, R; Kurosaka, M				Takayama, Koji; Matsumoto, Tomoyuki; Muratsu, Hirotsugu; Ishida, Kazunari; Shibanuma, Nao; Araki, Daisuke; Matsushita, Takehiko; Kuroda, Ryosuke; Kurosaka, Masahiro			The tibia first technique with tensor measurement is useful to predict the soft tissue tension after implantation in unicompartmental knee arthroplasty	INTERNATIONAL ORTHOPAEDICS			English	Article						Unicompartmental knee arthroplasty; Tibia first technique; Tensor measurement; Soft tissue tension; Joint gap kinematics	INTRAOPERATIVE JOINT GAP; NAVIGATION SYSTEM; KINEMATICS; BALANCE	Purpose The tibia first technique in unicompartmental knee arthroplasty (UKA) may have the advantage that surgeons can obtain a balanced flexion-extension gap. However, changes of the soft tissue tension during UKA have not been elucidated yet. The purpose of this study was to examine the correlation between the soft tissue tension before the femoral osteotomy and after the femoral component is in place using the tibia first technique in UKA. Methods Thirty UKAs for isolated medial compartmental osteoarthritis or idiopathic osteonecrosis were assessed. The actual values of the proximal and posterior femoral osteotomy were calculated by adding the thickness of the bone saw blades to the thickness of the bony cut. Using a UKA tensor designed to facilitate intra-operative soft tissue tension throughout the range of motion (ROM), the original gap before the femoral osteotomy, the component gap after the femoral osteotomy, and component placement were assessed under 20-lb distraction forces. Results The mean actual thickness of the distal femoral osteotomy was 6.5 +/- 1.3 mm and the posterior femoral osteotomy was 7.4 +/- 1.3 mm. The distal thickness of the prosthesis was set to 6.5 mm and the mean posterior thickness of the prosthesis used in this study was 5.8 +/- 0.3 mm. There is a positive correlation between the original and component gap throughout the ROM (R > 0.5). The original and component gap showed the same kinematic pattern from full extension to 90 degrees of knee flexion. However, the component gap was significantly higher compared to the original gap after 120 degrees of knee flexion (P < 0.001). Conclusions Despite the fact that the component gap values were significantly higher compared to the original gap value in deep flexion, there is a positive correlation between the original and component gap throughout the ROM. The discrepancy during deep flexion was due to the posterior design of the prosthesis that is designed to be thinner than the actual thickness of the posterior osteotomy. These results suggest that the tibia first technique with the tensor have the advantage that surgeons can predict final soft tissue tension before femoral osteotomies with the prosthetic design and help restore natural knee kinematics, potentially improving implant survival and functional outcomes.	[Takayama, Koji; Matsumoto, Tomoyuki; Araki, Daisuke; Matsushita, Takehiko; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Nada Ward, Kobe, Hyogo 6570013, Japan; [Muratsu, Hirotsugu] Steel Mem Hirohata Hosp, Dept Orthopaed Surg, Himeji, Hyogo, Japan; [Ishida, Kazunari; Shibanuma, Nao] Kobe Kaisei Hosp, Dept Orthopaed Surg, Nada Ku, Kobe, Hyogo 6570065, Japan	Takayama, K (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Nada Ward, 1-1 Rokkodaicho, Kobe, Hyogo 6570013, Japan.	kojitakayama78@yahoo.co.jp; matsun@m4.dion.ne.jp					LASKIN RS, 1978, J BONE JOINT SURG AM, V60, P182; Matsumoto T, 2006, J BIOMECH ENG-T ASME, V128, P867, DOI 10.1115/1.2354201; Berger RA, 1999, CLIN ORTHOP RELAT R, P50; LAURENCIN CT, 1991, CLIN ORTHOP RELAT R, P151; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Muratsu H, 2010, CLIN BIOMECH, V25, P926, DOI 10.1016/j.clinbiomech.2010.06.020; Matsumoto T, 2012, INT ORTHOP, V36, P975, DOI 10.1007/s00264-011-1377-5; Saragaglia D, 2012, INT ORTHOP, V36, P2479, DOI 10.1007/s00264-012-1679-2; Brown NM, 2012, J ARTHROPLASTY, V27, P86, DOI 10.1016/j.arth.2012.03.022; Riddle DL, 2008, J ARTHROPLASTY, V23, P408, DOI 10.1016/j.arth.2007.04.012; Akizuki S, 2009, J ARTHROPLASTY, V24, P963, DOI 10.1016/j.arth.2008.06.013; Mercier N, 2010, INT ORTHOP, V34, P1137, DOI 10.1007/s00264-009-0869-z; Murray DW, 1998, J BONE JOINT SURG BR, V80B, P983, DOI 10.1302/0301-620X.80B6.8177; Pietschmann MF, 2013, INT ORTHOP, V37, P31, DOI 10.1007/s00264-012-1710-7; Citak M, 2014, INT ORTHOP, V38, P961, DOI 10.1007/s00264-013-2263-0; Dalury DF, 2009, ORTHOPEDICS, V32; EMERSON RH, 1992, J BONE JOINT SURG BR, V74, P807; Matsumoto T, 2013, CLIN BIOMECH, V28, P29, DOI 10.1016/j.clinbiomech.2012.09.002; Whiteside LA, 2005, J ARTHROPLASTY, V20, P2, DOI 10.1016/j.arth.2005.03.029	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	APR	2015	39	4					667	671		10.1007/s00264-014-2531-7		5	Orthopedics	Orthopedics	CE0SL	WOS:000351516200008		
J	Matsuoka, T; Fujimoto, H; Kato, Y; Fukui, K; Narumoto, J				Matsuoka, Teruyuki; Fujimoto, Hiroshi; Kato, Yuka; Fukui, Kenji; Narumoto, Jin			Late-onset psychosis in older outpatients: a retrospective chart review	INTERNATIONAL PSYCHOGERIATRICS			English	Letter							ALZHEIMERS-DISEASE; DYSFUNCTION; LOBE		[Matsuoka, Teruyuki; Fujimoto, Hiroshi; Kato, Yuka; Fukui, Kenji; Narumoto, Jin] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kamigyo Ku, Kyoto 6028566, Japan	Matsuoka, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	tmms2004@koto.kpu-m.ac.jp			NEXT KAKENHI [25893203]	This work was supported by NEXT KAKENHI Grant Number 25893203.	Matsuoka T, 2011, J NEUROPSYCH CLIN N, V23, pE29, DOI 10.1176/appi.neuropsych.23.4.e29; Matsuoka T, 2010, J NEUROPSYCH CLIN N, V22, pE8; Mitford E, 2010, INT J GERIATR PSYCH, V25, P1112, DOI 10.1002/gps.2437; Tan LL, 2012, SINGAP MED J, V53, P463; Webster J, 1998, AM J GERIAT PSYCHIAT, V6, P196	5	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	APR	2015	27	4					694	696		10.1017/S1041610214002518		4	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Psychology; Geriatrics & Gerontology; Psychiatry	CD4MX	WOS:000351058200019		
J	Hattori, K				Hattori, Keisuke			Within-group cooperation and between-group externalities in the provision of public goods	INTERNATIONAL TAX AND PUBLIC FINANCE			English	Article						Externalities; Private provision of public goods; Cooperation	RENT-SEEKING; COMPETITION; INTERGROUP; CONTESTS	Using a simple two-group model of the private provision of public goods, this paper investigates the endogenous formation of within-group cooperation. We show that the equilibrium outcomes may result in a prisoners' dilemma, depending on the characteristics of between-group externalities. If between-group externalities are strongly positive (negative), within-group cooperation does not occur in either group, which leads to Pareto-inferior (superior) outcomes for all agents. On the other hand, if between-group externalities are weakly positive or negative, each group chooses to cooperate within a group in providing public goods, but it may reduce utility of both group members. Our simple framework is applicable to a wide variety of socio-economic problems such as an arms race, advertising competition, transboundary pollution, and antiterrorism measures.	Osaka Univ Econ, Fac Econ, Higashiyodogawa Ku, Osaka 5338533, Japan	Hattori, K (reprint author), Osaka Univ Econ, Fac Econ, Higashiyodogawa Ku, 2-2-8 Osumi, Osaka 5338533, Japan.	hattori@osaka-ue.ac.jp			Special Research Aid in Osaka University of Economics	We would like to thank Amihai Glazer, Satomi Kobayashi, and two anonymous referees for helpful comments and suggestions. This work was supported by Special Research Aid in Osaka University of Economics, 2010-2011.	Bornstein G, 2002, GAME ECON BEHAV, V41, P1, DOI 10.1016/S0899-8256(02)00012-X; Sandler T, 2006, CAN J ECON, V39, P1370, DOI 10.1111/j.1540-5982.2006.00393.x; Torsvik G, 2005, J DEV ECON, V77, P503, DOI 10.1016/j.jdeveco.2004.05.008; Kitchen DM, 2007, BEHAVIOUR, V144, P1551, DOI 10.1163/156853907782512074; BORNSTEIN G, 1994, J EXP SOC PSYCHOL, V30, P52, DOI 10.1006/jesp.1994.1003; Reuben E, 2010, EUR J POLIT ECON, V26, P25, DOI 10.1016/j.ejpoleco.2009.10.002; Cornes R, 2007, J PUBLIC ECON, V91, P1684, DOI 10.1016/j.jpubeco.2007.07.007; Baik KH, 2008, SOC CHOICE WELFARE, V30, P103, DOI 10.1007/s00355-007-0226-3; Baik KH, 2000, PUBLIC CHOICE, V103, P285, DOI 10.1023/A:1005003713923; BARRETT SCOTT, 2007, WHY COOPERATE INCENT; Bergstrom T., 1986, J PUBLIC ECON, V35, P53; Bruce N., 1990, DEFENC ECON, V1, P179, DOI 10.1080/10430719008404661; Buchholz W., 1998, FINANZARCHIV, V55, P1; Cheikbossian G, 2008, EUR J POLIT ECON, V24, P133, DOI 10.1016/j.ejpoleco.2007.03.004; Cornes R., 1996, THEORY EXTERNALITIES; CORNES R, 1993, Q J ECON, V108, P259, DOI 10.2307/2118503; Harsanyi J. C., 1988, GAME THEORY EQUILIBR; Ihori T, 2000, J CONFLICT RESOLUT, V44, P854, DOI 10.1177/0022002700044006009; Ihori T, 2004, DEFENCE PEACE ECON, V15, P27, DOI 10.1080/1024269042000164478; Mascarenhas R., 2006, REV INT ORGAN, V1, P337, DOI 10.1007/s11558-006-9491-7; Niou EMS, 2005, ECON INQ, V43, P519, DOI 10.1093/ei/cbi035; SALANT SW, 1983, Q J ECON, V98, P185, DOI 10.2307/1885620; Sandler T., 1997, GLOBAL CHALLENGES; Tan JHW, 2007, ECON LETT, V96, P133, DOI 10.1016/j.econlet.2006.12.031; WARR PG, 1983, ECON LETT, V13, P207, DOI 10.1016/0165-1765(83)90087-3	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0927-5940	1573-6970		INT TAX PUBLIC FINAN	Int. Tax Public Financ.	APR	2015	22	2					252	273		10.1007/s10797-014-9308-1		22	Economics	Business & Economics	CD5NR	WOS:000351135400004		
J	Makino, T; Jimi, S; Oyama, T; Nakano, Y; Hamamoto, K; Mamishin, K; Yahiro, T; Hara, S; Takata, T; Ohjimi, H				Makino, Taro; Jimi, Shiro; Oyama, Takuto; Nakano, Yuki; Hamamoto, Kouichi; Mamishin, Kanako; Yahiro, Tomoko; Hara, Shuuji; Takata, Tohru; Ohjimi, Hiroyuki			Infection mechanism of biofilm-forming Staphylococcus aureus on indwelling foreign materials in mice	INTERNATIONAL WOUND JOURNAL			English	Article						Biofilm; Foreign materials; Immunosuppression; Mice; Staphylococcus aureus	CHRONIC WOUNDS; MOUSE SKIN; MODEL; VIRULENCE	Indwelling foreign-body infections are a critical medical problem, especially in immunocompromised patients. To examine the pathogenicity of biofilm-forming bacteria settling on foreign materials, mice implanted with plastic discs were infected with Staphylococcus aureus. After opening a wide subcutaneous pocket on the dorsal side of mice with or without temporal leukocytopenia, a plastic sheet was placed in the left subcutaneous space; subsequently, bacteria in a planktonic state were dispersed over the subcutaneous space. Bacterial numbers were examined 7days after inoculation. In subcutaneous tissue on the right, S. aureus was found only in leukocytopenic mice. Meanwhile, bacteria were detected on the plastic and neighbouring tissue in both leukocytopenic and normal mice; however, colony-forming analysis indicated that leukocytopenic mice possessed significantly more bacteria. Tissue reaction against bacteria was pathologically examined. Invading S. aureus induced severe inflammation. In transient leukocytopenic mice, bacterial microcolonies formed on the plastic as well as in the developed necrotic tissue - both of which were shielded from inflammatory cell infiltration - result in bacteraemia. These results indicate that biofilm-forming S. aureus settling on indwelling foreign material are tolerant against host immunity and assault neighbouring tissue, which may lead to chronic wound infection.	[Makino, Taro; Oyama, Takuto; Ohjimi, Hiroyuki] Fukuoka Univ, Dept Plast Reconstruct & Aesthet Surg, Fukuoka 81401, Japan; [Jimi, Shiro] Fukuoka Univ, Dept Pathol & Morphol, Fukuoka 81401, Japan; [Nakano, Yuki; Hamamoto, Kouichi; Mamishin, Kanako; Yahiro, Tomoko; Hara, Shuuji] Fukuoka Univ, Dept Pharmaceut, Fukuoka 81401, Japan; [Takata, Tohru] Fukuoka Univ, Div Med Oncol Hematol & Infect Dis, Fukuoka 81401, Japan	Jimi, S (reprint author), Fukuoka Univ, Dept Pathol & Morphol, Fukuoka 81401, Japan.	sjimi@fukuoka-u.ac.jp					Kristian SA, 2004, MICROB PATHOGENESIS, V36, P237, DOI 10.1016/j.micpath.2003.12.004; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Akiyama H, 2002, BRIT J DERMATOL, V147, P879, DOI 10.1046/j.1365-2133.2002.04962.x; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Akiyama H, 1996, J DERMATOL SCI, V11, P234, DOI 10.1016/0923-1811(95)00448-3; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Arciola Carla Renata, 2002, Expert Rev Mol Diagn, V2, P478, DOI 10.1586/14737159.2.5.478; ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573; FRAILE RJ, 1980, CANCER RES, V40, P2223; Manabe T, 2012, MED B FUKUOKA U, V39, P79	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	APR	2015	12	2					122	131		10.1111/iwj.12061		10	Dermatology; Surgery	Dermatology; Surgery	CE2EI	WOS:000351626400002		
J	Sari, Y; Minematsu, T; Huang, LJ; Noguchi, H; Mori, T; Nakagami, G; Nagase, T; Oe, M; Sugama, J; Yoshimura, K; Sanada, H				Sari, Yunita; Minematsu, Takeo; Huang, Lijuan; Noguchi, Hiroshi; Mori, Taketoshi; Nakagami, Gojiro; Nagase, Takashi; Oe, Makoto; Sugama, Junko; Yoshimura, Kotaro; Sanada, Hiromi			Establishment of a novel rat model for deep tissue injury deterioration	INTERNATIONAL WOUND JOURNAL			English	Article						Deep tissue injury; Deterioration; Finite element method; Rat; Shear stress	PRESSURE ULCERS; MODERATE COMPRESSION; SKELETAL-MUSCLE; CANCER-CELLS; IN-VITRO; HYPOXIA; DAMAGE; DEFORMATION; HIF-1-ALPHA; INHIBITION	Deep tissue injuries (DTIs) can become significant problems because of their rapid deterioration into deep pressure ulcers. Presently, no animal model of DTI deterioration has been developed. By concentrating pressure and shear stress in deep tissues while minimising pressure and shear stress in the overlying skin, we produced an effective rat model of DTI deterioration. Two-dimensional finite element method (FEM) simulated the distribution of pressure and shear stress under several pressure-loading conditions. FEM showed that concentrated shear stress in deep tissue with minimum shear stress in the overlying skin could be created by using a prominence and a cushion, respectively. On the basis of the results of FEM analysis, we selected suitable conditions for testing the rat DTI deterioration model. The compressed area was macroscopically observed until day 13, and histopathologic analysis via haematoxylin and eosin (H&E) staining was performed on days 3, 7 and 13. H&E staining showed that the distribution of tissue damage was similar to the predicted FEM results. Deep ulceration and tissue damage extending from deep tissues to the overlying skin and surrounding tissues were observed in the DTI deterioration model, which are similar to the clinical manifestations of DTI deterioration. In conclusion, a representative DTI deterioration model was established by concentrating high shear stress in deep tissues while minimising shear stress in the overlying skin. This model will allow a better understanding of the mechanisms behind DTI deterioration and the development of preventative strategies.	[Sari, Yunita; Minematsu, Takeo; Huang, Lijuan; Nakagami, Gojiro; Nagase, Takashi; Oe, Makoto; Sanada, Hiromi] Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Tokyo 1130033, Japan; [Sari, Yunita] Jenderal Soedirman Univ, Dept Nursing, Purwokerto, Indonesia; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Tokyo 1130033, Japan; [Sugama, Junko] Kanazawa Univ, Sch Hlth Sci, Dept Clin Nursing, Kanazawa, Ishikawa 9201192, Japan; [Yoshimura, Kotaro] Univ Tokyo, Grad Sch Med, Dept Plast Surg, Tokyo 1130033, Japan	Sanada, H (reprint author), Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Div Hlth Sci & Nursing, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Japan Society for the Promotion of Science	This work was supported by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science.	Ankrom Michael A, 2005, Adv Skin Wound Care, V18, P35, DOI 10.1097/00129334-200501000-00016; Linder-Ganz E, 2007, J BIOMECH, V40, P1443, DOI 10.1016/j.jbiomech.2006.06.020; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Teng BT, 2011, J PHYSIOL-LONDON, V589, P3349, DOI 10.1113/jphysiol.2011.209619; Gawlitta D, 2007, ANN BIOMED ENG, V35, P273, DOI 10.1007/s10439-006-9222-5; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Linder-Ganz E, 2007, ANN BIOMED ENG, V35, P2095, DOI [10.1007/s10439-007-9384-9, 10.1007/S10439-007-9384-9]; Aoi N, 2009, PLAST RECONSTR SURG, V124, P540, DOI 10.1097/PRS.0b013e3181addb33; Stekelenburg A, 2007, J APPL PHYSIOL, V102, P2002, DOI 10.1152/japplphysiol.01115.2006; Siu PM, 2009, J APPL PHYSIOL, V107, P1266, DOI 10.1152/japplphysiol.90897.2008; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Bennett L, 1979, B PROSTHET RES, V10-31, P14; Black Joyce, 2007, Urol Nurs, V27, P144; Black JM, 2003, WOUNDS, V15, P380; Clarke M, 2000, PROCEEDINGS OF THE TWENTIETH WORLD CONGRESS OF PHILOSOPHY, VOL 5, P75; Fontaine R, 1998, J Wound Ostomy Continence Nurs, V25, P233; Fung Y., 1993, BIOMECHANICS MECH PR; Gawlitta D, 2007, J APPL PHYSIOL, V103, P464, DOI 10.1152/japplphysiol.01374.2006; Gordon MD, 2004, J BURN CARE REHABIL, V25, P388, DOI 10.1097/01.BCR.0000138289.83335.F4; Kuhn B A, 1992, Nurs Econ, V10, P353; Kwan MPC, 2007, EXP BIOL MED, V232, P481; Lin F, 2010, J TISSUE VIABILITY, V19, P67, DOI 10.1016/j.jtv.2009.11.009; Makhsous M, 2010, PM&R, V2, P1063, DOI 10.1016/j.pmrj.2010.08.002; Nagase T, 2007, J Wound Care, V16, P365; Ohura T, 2007, WOUNDS, V19, P310; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Quintavalle Paul R, 2006, Adv Skin Wound Care, V19, P498, DOI 10.1097/00129334-200611000-00010; Sari Y, 2010, WOUNDS, V22, P45; Sari Y, 2008, INT WOUND J, V5, P674, DOI 10.1111/j.1742-481X.2008.00543.x; Sato Miwa, 2006, Int Wound J, V3, P355, DOI 10.1111/j.1742-481X.2006.00267.x; Siu PM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-58; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Sugama J, 2005, WOUNDS, V17, P157; Teng BT, 2011, ACTA PHYSIOL, V201, P239, DOI 10.1111/j.1748-1716.2010.02173.x; Wang YN, 2005, P I MECH ENG H, V219, P1, DOI 10.1243/095441105X9246; Zhu SK, 2011, MOL CARCINOGEN, V50, P770, DOI 10.1002/mc.20678	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	APR	2015	12	2					202	209		10.1111/iwj.12082		8	Dermatology; Surgery	Dermatology; Surgery	CE2EI	WOS:000351626400015		
J	Sivadevi, S; Selvasekarapandian, S; Karthikeyan, S; Sanjeeviraja, C; Nithya, H; Iwai, Y; Kawamura, J				Sivadevi, S.; Selvasekarapandian, S.; Karthikeyan, S.; Sanjeeviraja, C.; Nithya, H.; Iwai, Y.; Kawamura, J.			Proton-conducting polymer electrolyte based on PVA-PAN blend doped with ammonium thiocyanate	IONICS			English	Article						Polyvinyl alcohol; Poly acrylonitrile; XRD; FTIR; DSC; Proton battery	SOLID-STATE BATTERY; IONIC-CONDUCTIVITY; FT-IR; LITHIUM; SODIUM; TETRAHYDROFURAN; ASSOCIATION; IMPEDANCE; SPECTRA; SALT	Blending of polymers is one of the most useful methods for modulating the conductivity of solid polymer electrolytes. Blend polymer electrolytes have been prepared with polyvinyl alcohol (PVA)-polyacrylonitrile (PAN) blend doped with ammonium thiocyanate with different concentrations by solution casting technique, using dimethyl formamide (DMF) as the solvent. The prepared electrolytes are characterized by X-ray diffraction (XRD), Fourier transform infrared (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), nuclear magnetic resonance (NMR), ultraviolet (UV), and ac impedance measurement techniques. The increase in amorphous nature of the blend polymer electrolyte by the addition of salt is confirmed by XRD analysis. The complex formation between the polymers and the salt has been confirmed by FTIR analysis. The thermal behavior has been examined using DSC and TGA. The maximum conductivity has been found to be 2.4 x 10(-3) S cm(-1) for 92.5PVA/7.5PAN/25 % NH4SCN sample at room temperature. The temperature dependence of conductivity has been studied with the help of Arrhenius plot, and the activation energies are calculated. The proton conductivity is confirmed by dc polarization measurement technique. H-1 NMR studies reveal the presence of protons in the sample. A proton battery is constructed with the highest conducting sample, and its open circuit voltage is measured to be 1.2 V.	[Sivadevi, S.] Bharathiar Univ, Ctr Res & Dev, Coimbatore 641046, Tamil Nadu, India; [Sivadevi, S.] SFR Coll Women, Dept Phys, Sivakasi 626123, Tamil Nadu, India; [Sivadevi, S.; Selvasekarapandian, S.] Mat Res Ctr, Coimbatore 641045, Tamil Nadu, India; [Karthikeyan, S.] Ramco Inst Technol, Dept Phys, Rajapalayam 626117, Tamil Nadu, India; [Sanjeeviraja, C.] Alagappa Chettiar Coll Engn, Dept Phys, Karaikkudi 630002, Tamil Nadu, India; [Nithya, H.; Iwai, Y.; Kawamura, J.] Tohoku Univ, IMRAM, Sendai, Miyagi 980, Japan	Selvasekarapandian, S (reprint author), Mat Res Ctr, Coimbatore 641045, Tamil Nadu, India.	sekarapandian@yahoo.com					Ramesh S, 2001, MAT SCI ENG B-SOLID, V85, P11, DOI 10.1016/S0921-5107(01)00555-4; GARTON A, 1983, J POLYM SCI POL LETT, V21, P45, DOI 10.1002/pol.1983.130210107; Mishra R, 1998, SOLID STATE IONICS, V112, P261, DOI 10.1016/S0167-2738(98)00209-4; Samsudin AS, 2014, ELECTROCHIM ACTA, V129, P1, DOI 10.1016/j.electacta.2014.02.074; Ramesh S, 2001, J POWER SOURCES, V99, P41, DOI 10.1016/S0378-7753(00)00690-X; Hema M, 2007, IONICS, V13, P483, DOI 10.1007/s11581-007-0143-6; Kadir MFZ, 2010, ELECTROCHIM ACTA, V55, P1475, DOI 10.1016/j.electacta.2009.05.011; Hodge RM, 1996, POLYMER, V37, P1371, DOI 10.1016/0032-3861(96)81134-7; Baskaran R, 2006, SOLID STATE IONICS, V177, P2679, DOI 10.1016/j.ssi.2006.04.013; XU MZ, 1995, J PHYS CHEM-US, V99, P14589, DOI 10.1021/j100040a004; VARNELL DF, 1981, POLYMER, V22, P1324, DOI 10.1016/0032-3861(81)90230-5; Hirankumar G, 2006, J SOLID STATE ELECTR, V10, P193, DOI 10.1007/s10008-004-0612-z; BACELON P, 1980, J SOLUTION CHEM, V9, P129, DOI 10.1007/BF00644484; CAMERON GG, 1986, J ELECTROANAL CHEM, V198, P205, DOI 10.1016/0022-0728(86)90038-0; CHABANEL M, 1984, J PHYS CHEM-US, V88, P1441, DOI 10.1021/j150651a041; De Bruin H. J., 1978, J AUST CERAM SOC, V14, P20; Hiran Kumar G, 2005, CHARACTERIZATION SOL; Hirankumar G, 2004, IONICS, V10, P135, DOI 10.1007/BF02410322; Huang XL, 2012, SOLID STATE IONICS, V215, P7, DOI 10.1016/j.ssi.2012.03.009; IRISH DE, 1979, J PHYS CHEM-US, V83, P3268, DOI 10.1021/j100488a018; Kamlesh Pandey N, 1998, J POWER SOURCES, V76, P116; Ma X-H, 2010, J MEMBRANE SCI, V360, P3; Radha KP, 2013, IONICS, V760; Rajeswari N, 2011, J NON-CRYST SOLIDS, V357, P3751, DOI 10.1016/j.jnoncrysol.2011.07.037; Rajeswari N, 2014, POLYM BULL, V71, P1061, DOI 10.1007/s00289-014-1111-8; Reddy CVS, 2004, IONICS, V10, P142; SAAR D, 1986, J PHYS CHEM-US, V90, P3326, DOI 10.1021/j100406a006; Selvasekarapandian S, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJS.79SA.163; SINGH K, 1993, J POWER SOURCES, V46, P65, DOI 10.1016/0378-7753(93)80036-O; Sivadevi S, 2013, INT J SCI RES, V2; Sivadevi S, 2013, INT J ELECTROACT MAT, V1, P64; Subramania A, 2006, IONICS, V12, P175, DOI 10.1007/s11581-006-0018-2; Vijaya N, 2012, IONICS, V18, P91, DOI 10.1007/s11581-011-0589-4; Wagner JB, 1957, CHEM PHYS, V26, P1597; Zhang HC, 2003, SOLID STATE IONICS, V164, P73, DOI 10.1016/j.ssi.2003.08.051	35	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	APR	2015	21	4					1017	1029		10.1007/s11581-014-1259-0		13	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	CE0QF	WOS:000351508800014		
J	Inagaki, M; Kawashima, Y; Kawanishi, C; Yonemoto, N; Sugimoto, T; Furuno, T; Ikeshita, K; Eto, N; Tachikawa, H; Shiraishi, Y; Yamada, M				Inagaki, Masatoshi; Kawashima, Yoshitaka; Kawanishi, Chiaki; Yonemoto, Naohiro; Sugimoto, Tatsuya; Furuno, Taku; Ikeshita, Katsumi; Eto, Nobuaki; Tachikawa, Hirokazu; Shiraishi, Yohko; Yamada, Mitsuhiko			Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt: A meta-analysis	JOURNAL OF AFFECTIVE DISORDERS			English	Review						Suicide; Self-harm; Emergency department; Meta-analysis; Systematic review	RANDOMIZED CONTROLLED-TRIAL; DELIBERATE SELF-HARM; 5-YEAR FOLLOW-UP; PSYCHIATRIC-ASSESSMENT; POISONING PATIENTS; TELEPHONE CONTACT; COGNITIVE THERAPY; MENTAL-DISORDERS; RISK; CARE	Background: A huge number of patients with self-harm and suicide attempt visit emergency departments (EDs). We systematically reviewed studies and examined the effect of interventions to prevent repeat suicidal behavior in patients admitted to EDs for a suicidal attempt. Method: We searched the databases of MEDLINE, PsychoINFO, CINAHL, and EMBASE through August 2013. Eligible studies were randomized controlled trials assessing the effects on repeat suicidal behavior of interventions initiated in suicidal patients admitted to EDs. Interventions in each trial were classified into groups by consensus. Meta-analyses were performed to determine pooled relative risks (RRs) and 95% confidence intervals (Os) of repetition of suicide attempt for interventions in each group. Results: Out of 5390 retrieved articles, 24 trials were included and classified into four groups (11 trials in the Active contact and follow-up, nine in the Psychotherapy, one in the Pharmacotherapy, and three in the Miscellaneous). Active contact and follow-up type interventions were effective in preventing a repeat suicide within 12 months (n=5319; pooled RR-0,83; 95% CI: 0.71 to 0.97). However, the effect at 24 months was not confirmed (n=925; pooled RR=0.98; 95% Cl: 0.76-1.22). The effects of the other interventions on preventing a repetition of suicidal behavior remain unclear. Limitation: Caution is needed regarding the heterogeneity of the effects. Conclusion: Interventions of active contact and follow-up are recommended to reduce the risk of a repeat suicide attempt at 12 months in patients admitted to EDs with a suicide attempt. However, the long-term effect was not confirmed. (C) 2014 Elsevier B.V. All rights reserved.	[Inagaki, Masatoshi] Okayama Univ Hosp, Dept Neuropsychiat, Okayama, Japan; [Kawashima, Yoshitaka; Yonemoto, Naohiro; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo, Japan; [Kawanishi, Chiaki] Yokohama City Univ Grad Sch Med, Hlth Management & Promot Ctr, Yokohama, Kanagawa, Japan; [Sugimoto, Tatsuya] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Furuno, Taku] Natl Hosp Org Yokohama Med Ctr, Dept Psychiat, Yokohama, Kanagawa, Japan; [Ikeshita, Katsumi] Nara Med Univ, Dept Psychiat, Inst Psychiat, Nara, Japan; [Eto, Nobuaki] Fukuoka Univ, Fac Med, Dept Psychiat, Fukuoka, Japan; [Tachikawa, Hirokazu] Univ Tsukuba, Fac Med, Div Clin Med, Dept Psychiat, Tsukuba, Ibaraki 305, Japan; [Shiraishi, Yohko] Yokohama City Univ Sch Med, Dept Psychiat, Yokohama, Kanagawa, Japan	Inagaki, M (reprint author), Okayama Univ Hosp, Dept Neuropsychiat, Okayama, Japan.	masatoshiinagaki@okayama-u.ac.jp			Ministry of Health, Labor and Welfare (MHLW)	This study was supported in part by a grant for Research on Psychiatric and Neurological Disease and Mental Health from the Ministry of Health, Labor and Welfare (MHLW). The MHLW had no role in study design, data collection, analysis, interpretation of the results, or writing of the report, and had no influence over submission of the manuscript.	ALLARD R, 1992, SUICIDE LIFE-THREAT, V22, P303; Bertolote JM, 2010, CRISIS, V31, P194, DOI 10.1027/0027-5910/a000052; GIBBONS JS, 1978, BRIT J PSYCHIAT, V133, P111, DOI 10.1192/bjp.133.2.111; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Guthrie E, 2001, BRIT MED J, V323, P135, DOI 10.1136/bmj.323.7305.135; Hawton K, 1998, BRIT MED J, V317, P441; Vaiva G, 2006, BRIT MED J, V332, P1241, DOI 10.1136/bmj.332.7552.1241; O'Connor E, 2013, ANN INTERN MED, V158, P741, DOI 10.7326/0003-4819-158-10-201305210-00642; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; Hickey L, 2001, J PSYCHOSOM RES, V50, P87, DOI 10.1016/S0022-3999(00)00225-7; Hawton K, 2007, SOC PSYCH PSYCH EPID, V42, P513, DOI 10.1007/s00127-007-0199-7; Hvid M, 2011, NORD J PSYCHIAT, V65, P292, DOI 10.3109/08039488.2010.544404; Isometsa ET, 1998, BRIT J PSYCHIAT, V173, P531, DOI 10.1192/bjp.173.6.531; Carter GL, 2007, BRIT J PSYCHIAT, V191, P548, DOI 10.1192/bjp.bp.107.038406; Kapur N, 2013, BRIT J PSYCHIAT, V203, P73, DOI 10.1192/bjp.bp.113.126425; Carter GL, 2005, BRIT MED J, V331, P805, DOI 10.1136/bmj.38579.455266.E0; Beautrais AL, 2010, BRIT J PSYCHIAT, V197, P55, DOI 10.1192/bjp.bp.109.075754; Cedereke M, 2002, EUR PSYCHIAT, V17, P82, DOI 10.1016/S0924-9338(02)00632-6; DELEO D, 1995, AM J PSYCHIAT, V152, P632; Ougrin D, 2011, ARCH DIS CHILD, V96, P148, DOI 10.1136/adc.2010.188755; Beautrais AL, 2004, SUICIDE LIFE-THREAT, V34, P1, DOI 10.1521/suli.34.1.1.27772; MCLEAVEY BC, 1994, SUICIDE LIFE-THREAT, V24, P382; VANHEERINGEN C, 1995, PSYCHOL MED, V25, P963; Hawton K, 2003, AM J PSYCHIAT, V160, P1494, DOI 10.1176/appi.ajp.160.8.1494; Luxton DD, 2013, CRISIS, V34, P32, DOI 10.1027/0227-5910/a000158; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; MOTTO JA, 1976, SUICIDE LIFE-THREAT, V6, P223; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; De Leo D, 2002, BRIT J PSYCHIAT, V181, P226, DOI 10.1192/bjp.181.3.226; Fleischmann A, 2008, B WORLD HEALTH ORGAN, V86, P703, DOI 10.2471/BLT.07.046995; Kapur N, 2010, BRIT J PSYCHIAT, V197, P5, DOI 10.1192/bjp.bp.109.072496; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Carter GL, 2013, BRIT J PSYCHIAT, V202, P372, DOI 10.1192/bjp.bp.112.112664; Crawford MJ, 2007, BRIT J PSYCHIAT, V190, P11, DOI 10.1192/bip.bp.106.025437; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Bannan N., 2010, COUNSELLING PSYCHOTH, V10, P201, DOI DOI 10.1080/14733140903337292; Battaglia J, 1999, INT CLIN PSYCHOPHARM, V14, P361, DOI 10.1097/00004850-199911000-00007; Bennewith O, 2004, BRIT MED J, V328, P1108, DOI 10.1136/bmj.328.7448.1108; Bertolote José Manoel, 2004, Crisis, V25, P147, DOI 10.1027/0227-5910.25.4.147; Boudreaux ED, 2013, CONTEMP CLIN TRIALS, V36, P14, DOI 10.1016/j.cct.2013.05.008; Crawford MJ, 2010, PSYCHOL MED, V40, P1821, DOI 10.1017/S0033291709991899; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EKEBERG O, 1991, ACTA PSYCHIAT SCAND, V83, P432, DOI 10.1111/j.1600-0447.1991.tb05570.x; Ghahramanlou-Holloway M, 2012, PSYCHOL MED, V42, P1185, DOI 10.1017/S0033291711002169; Hassanian-Moghaddam H, 2011, BRIT J PSYCHIAT, V198, P309, DOI 10.1192/bjp.bp.109.067199; Hawton K., 1987, ATTEMPTED SUICIDE PR; Hawton K. K. E., 2009, COCHRANE DATABASE SY; Higgins J.P.T., COCHRANE HDB SYSTEMA; Hirayasu Y, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-364; Inagaki M., 2013, PROSPERO INT PROSPEC; Johannessen HA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-81; Kawashima Y, 2014, J AFFECT DISORDERS, V163, P33, DOI 10.1016/j.jad.2014.03.025; KURZ A, 1984, PSYCHIAT PRAX, V11, P6; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; LIBERMAN RP, 1981, ARCH GEN PSYCHIAT, V38, P1126; MOLLER HJ, 1989, J ROY SOC MED, V82, P643; Morthorst B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4972; NIELSEN B, 1990, ACTA PSYCHIAT SCAND, V81, P250, DOI 10.1111/j.1600-0447.1990.tb06490.x; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x; Olfson M., 2013, AM J PSYCHIAT; Organization WH, SUIC PREV SUPRE; Raj M. A., 2001, ACTA PSYCHIAT SCAND, V104, P340; Rihmer A, 2009, J AFFECT DISORDERS, V116, P18, DOI 10.1016/j.jad.2008.10.024; Suominen K, 1996, ACTA PSYCHIAT SCAND, V94, P234, DOI 10.1111/j.1600-0447.1996.tb09855.x; Torhorst A, 1987, Crisis, V8, P53; VanderSande R, 1997, BRIT J PSYCHIAT, V171, P35, DOI 10.1192/bjp.171.1.35; WATERHOUSE J, 1990, BRIT J PSYCHIAT, V156, P236, DOI 10.1192/bjp.156.2.236; Wei SN, 2013, CRISIS, V34, P107, DOI 10.1027/0227-5910/a000181; Yamada T, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-64	71	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	APR 1	2015	175						66	78		10.1016/j.jad.2014.12.048		13	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CD3JL	WOS:000350974300007		
J	Kimura, A; Hashimoto, T; Niitsu, T; Iyo, M				Kimura, Atsushi; Hashimoto, Tasuku; Niitsu, Tomihisa; Iyo, Masaomi			Presence of psychological distress symptoms associated with onset-related life events in patients with treatment-refractory depression	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Treatment-refractory depression; Life events; Psychological distress	POSTTRAUMATIC-STRESS-DISORDER; TREATMENT-RESISTANT DEPRESSION; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; BIPOLAR DISORDER; HIPPOCAMPAL VOLUME; MAJOR DEPRESSION; SIGMA-RECEPTORS; RATING-SCALE; FOLLOW-UP; IFENPRODIL	Background: Previous studies have reported that various non-life-threatening life events could cause psychological distress symptoms like posttraumatic stress disorder in adults and adolescents. We examined whether patients with treatment-refractory depression (TRD) perceive their experiences of life events, of which they think as triggering the onset of depression, as more serious psychological distress symptoms than remitted or mildly symptomatic patients with major depressive disorder (MOD). Methods: This study employed a cross-sectional design. We recruited 78 outpatients consisting 0131 TRD patients, 31 remitted MOD patients, and 16 mildly symptomatic MOD patients. We adopted the Impact of Event Scale-Revised (IES-R) to assess the severity of psychological distress symptoms associated with the events that patients thought as triggering the onset of depression. We also evaluated clinical features and variables including the Hamilton Depression Rating Scale (HORS). Results: The mean [+/- SD] score of the IES-R in patients with TRD (46.7 [15.11) was significantly higher than in remitted (10.3 19.91, p < 0.001) or mildly symptomatic (31.3 [17.7], p < 0.001) patients with MOD. The HORS scores showed significant correlations with those of the IES-R among all patients (r=0.811). Limitations: This study was not able to exclude the possibility that the severity of psychological distress symptoms associated with onset-related events could influence the difficult therapeutic course in patients with TRD clue to the cross-sectional design. Conclusions: This study demonstrated that patients with TRD perceive their onset-related life events as serious psychological distress symptoms. This result contributes to understanding the pathophysiology of TRD. (C) 2015 Elsevier B.V. All rights reserved.	[Kimura, Atsushi; Hashimoto, Tasuku; Niitsu, Tomihisa; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba 2608670, Japan; [Kimura, Atsushi; Hashimoto, Tasuku; Niitsu, Tomihisa; Iyo, Masaomi] Chiba Univ Hosp, Dept Psychiat, Chiba, Japan	Hashimoto, T (reprint author), Chiba Univ, Grad Sch Med, Dept Psychiat, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	t-hashimoto@faculty.chiba-u.jp					Akiskal HS, 1995, ENCEPHALE, V21, P3; Akiskal HS, 2006, J AFFECT DISORDERS, V96, P207, DOI 10.1016/j.jad.2006.03.011; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angst J, 2003, EUR NEUROPSYCHOPHARM, V13, pS43, DOI 10.1016/S0924-977X(03)00077-4; Honkalampi K, 2005, AUST NZ J PSYCHIAT, V39, P627; Correa R, 2010, J AFFECT DISORDERS, V127, P10, DOI 10.1016/j.jad.2010.06.036; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Mol SSL, 2005, BRIT J PSYCHIAT, V186, P494, DOI 10.1192/bjp.186.6.494; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037//0021-843X.87.1.49; Ghaemi SN, 2002, CAN J PSYCHIAT, V47, P125; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; BROWN GW, 1995, PSYCHOL MED, V25, P7; Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Sheline YI, 1999, J NEUROSCI, V19, P5034; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037//0022-006X.66.3.493; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Sasaki T, 2013, PSYCHOTHER PSYCHOSOM, V82, P344, DOI 10.1159/000348585; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037//0033-2909.117.2.285; Baumert J, 2004, J AFFECT DISORDERS, V82, P29, DOI 10.1016/j.jad.2003.09.006; Dudek D, 2010, J AFFECT DISORDERS, V126, P268, DOI 10.1016/j.jad.2010.03.001; Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Kishimoto A, 2012, BIOL PSYCHIAT, V71, pE7, DOI 10.1016/j.biopsych.2011.10.014; Schosser A, 2012, EUR NEUROPSYCHOPHARM, V22, P453, DOI 10.1016/j.euroneuro.2012.02.006; Hovens JGFM, 2012, ACTA PSYCHIAT SCAND, V126, P198, DOI 10.1111/j.1600-0447.2011.01828.x; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Souery D, 2006, J CLIN PSYCHIAT, V67, P16; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Angst J, 2001, J AFFECT DISORDERS, V67, P3, DOI 10.1016/S0165-0327(01)00429-3; Flynn H. A., 2011, TREATMENT RESISTANT, P193; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; HASHIMOTO K, 1995, EUR J PHARMACOL, V273, P307, DOI 10.1016/0014-2999(94)00763-W; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; HASHIMOTO K, 1993, EUR J PHARMACOL, V236, P159, DOI 10.1016/0014-2999(93)90241-9; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hosang GM, 2010, PSYCHOL MED, V40, P1829, DOI 10.1017/S003329170999225X; Marks I, 1998, ARCH GEN PSYCHIAT, V55, P317, DOI 10.1001/archpsyc.55.4.317; Meiser-Stedman R, 2012, J AFFECT DISORDERS, V137, P70, DOI 10.1016/j.jad.2011.12.020; Otto MW, 2004, BIPOLAR DISORD, V6, P470, DOI 10.1111/j.1399-5618.2004.00151.x; Parker GB, 2005, J AFFECT DISORDERS, V87, P185, DOI 10.1016/j.jad.2005.02.015; Pollack MH, 2006, J CLIN PSYCHIAT, V67, P394; Rakofsky JJ, 2012, MOL PSYCHIATR, V17, P22, DOI 10.1038/mp.2011.121; Schlaepfer T. E., 2012, J PSYCHOPHARMACOL; Thase M. E., 2013, TREATMENT RESISTANT, P183; Thase ME, 2001, J CLIN PSYCHIAT, V62, P18; Weiss Daniel S., 1997, P399	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	APR 1	2015	175						303	309				7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CD3JL	WOS:000350974300042		
J	Matsumura, K; Gaitan, CF; Sugimoto, K; Cannon, AJ; Hsieh, WW				Matsumura, K.; Gaitan, C. F.; Sugimoto, K.; Cannon, A. J.; Hsieh, W. W.			Maize yield forecasting by linear regression and artificial neural networks in Jilin, China	JOURNAL OF AGRICULTURAL SCIENCE			English	Article							RED SPRING WHEAT; CROP YIELD; SEMIARID PRAIRIE; MODEL; PREDICTION; TEMPERATURES; RESPONSES; CANADA; CORN	Forecasting the maize yield of China's Jilin province from 1962 to 2004, with climate conditions and fertilizer as predictors, was investigated using multiple linear regression (MLR) and non-linear artificial neural network (ANN) models. Yield was set to be a function of precipitation from July to August, precipitation in September and the amount of fertilizer used. Fertilizer emerged as the dominant predictor and was non-linearly related to yield in the ANN model. Given the difficulty of acquiring fertilizer data for maize, the current study was also tested using the previous year's yield in the place of fertilizer data. Forecast skill scores computed under both cross-validation and retroactive validation showed ANN models to significantly outperform MLR and persistence (i.e. forecast yield is identical to last year's observed yield). As the data were non-stationary, cross-validation was found to be less reliable than retroactive validation in assessing the forecast skill.	[Matsumura, K.] Kwansei Gakuin Univ, Sch Policy Studies, Dept Appl Informat, Nishinomiya, Hyogo 6691337, Japan; [Matsumura, K.; Gaitan, C. F.; Hsieh, W. W.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Sugimoto, K.] Nagoya Univ, Grad Sch Environm Studies, Chigusa Ku, Nagoya, Aichi 4648603, Japan; [Cannon, A. J.] Univ Victoria, Pacific Climate Impacts Consortium, Victoria, BC V8W 3R4, Canada	Matsumura, K (reprint author), Kwansei Gakuin Univ, Sch Policy Studies, Dept Appl Informat, Nishinomiya, Hyogo 6691337, Japan.	kanichi1@mbox.kyoto-inet.or.jp	Gaitan Ospina, Carlos Felipe/E-5934-2011; Hsieh, William/G-8380-2011; 	Gaitan Ospina, Carlos Felipe/0000-0003-3592-5196; Hsieh, William/0000-0003-2654-392X; Cannon, Alex/0000-0002-8025-3790	Kwansei Gakuin University; Natural Sciences and Engineering Research Council of Canada	The temperature and precipitation data were kindly provided by the Climatic Research Unit, University of East Anglia. Yield data and cropping calendar information were provided by Jilin University, which also supported K.M.'s trip to interview a maize farmer in Jilin. K.M. is supported by an overseas scholarship from Kwansei Gakuin University and W.H., by a discovery grant from the Natural Sciences and Engineering Research Council of Canada.	Liu HL, 2011, NUTR CYCL AGROECOSYS, V89, P313, DOI 10.1007/s10705-010-9396-y; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Ma LW, 2012, AGR WATER MANAGE, V103, P140, DOI 10.1016/j.agwat.2011.11.005; Kaul M, 2005, AGR SYST, V85, P1, DOI 10.1016/j.agsy.2004.07.009; Chen CQ, 2011, AGR FOREST METEOROL, V151, P1580, DOI 10.1016/j.agrformet.2011.06.013; Yang HS, 2004, FIELD CROP RES, V87, P131, DOI 10.1016/j.fcr.2003.10.003; Hsieh WW, 2004, REV GEOPHYS, V42, DOI 10.1029/2002RG000112; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Panda SS, 2010, REMOTE SENS-BASEL, V2, P673, DOI 10.3390/rs2030673; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Alvarez R, 2009, EUR J AGRON, V30, P70, DOI 10.1016/j.eja.2008.07.005; CAMPBELL CA, 1988, CAN J SOIL SCI, V68, P1; Campbell CA, 1997, CAN J PLANT SCI, V77, P53; Campbell CA, 1997, CAN J PLANT SCI, V77, P43; Chantre GR, 2014, J AGR SCI, V152, P254, DOI 10.1017/S0021859612001098; China Maize, 2012, CORN ACR YIELD CHIN; CRU (Climatic Research Unit), 2010, CRU TS3 10 CLIM RES; Dai XQ, 2011, FIELD CROP RES, V121, P441, DOI 10.1016/j.fcr.2011.01.016; Dan Foresee F., 1997, P 1997 INT JOINT C N, V3, P1930; ESRI, 2008, ESRI DAT MAPS COUNTR; FAOSTAT, 2012, FAOSTAT DAT; Fortin JG, 2011, PRECIS AGRIC, V12, P905, DOI 10.1007/s11119-011-9233-6; Gaitan CF, 2014, ATMOS OCEAN, V52, P211, DOI 10.1080/07055900.2013.857639; GHODSI R., 2012, INT J ACAD RES BUSIN, V2, P34; GILLELAND E., 2010, NCARTN479STR; Guo WW, 2012, NEURAL COMPUT APPL, V21, P109, DOI 10.1007/s00521-011-0636-0; Hill BD, 2002, CAN J PLANT SCI, V82, P7; Hsieh W.W., 2009, MACHINE LEARNING MET; Hsieh WW, 1999, AGR FOREST METEOROL, V96, P209, DOI 10.1016/S0168-1923(99)00051-9; IFA (International Fertilizer Industry Association), 2012, IFADATA STAT DAT; Ji B, 2007, J AGR SCI, V145, P249, DOI 10.1017/S0021859606006691; Jiang D, 2004, INT J REMOTE SENS, V25, P1723, DOI 10.1080/0143116031000150068; Luo QY, 2013, CLIMATIC CHANGE, V120, P249, DOI 10.1007/s10584-013-0802-8; MACKAY DJC, 1992, NEURAL COMPUT, V4, P448, DOI 10.1162/neco.1992.4.3.448; O'Neal MR, 2002, BIOSYST ENG, V83, P31, DOI 10.1006/bioe.2002.0098; Qian BD, 2009, AGR FOREST METEOROL, V149, P1022, DOI 10.1016/j.agrformet.2008.12.006; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1, P318; SHABBAR A., 2007, CLIVAR EXCHANGES, V12, P10; SUN B. J., 2013, J AGR SCI, V152, P523; Yang C, 1998, T ASAE, V41, P17	40	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0021-8596	1469-5146		J AGR SCI-CAMBRIDGE	J. Agric. Sci.	APR	2015	153	3					399	410		10.1017/S0021859614000392		12	Agriculture, Multidisciplinary	Agriculture	CD9JP	WOS:000351414900002		
J	Kanno, T; Takekawa, D; Miyakawa, Y				Kanno, T.; Takekawa, D.; Miyakawa, Y.			Analysis of the essentiality of ROM2 genes in the pathogenic yeasts Candida glabrata and Candida albicans using temperature-sensitive mutants	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						antifungal targets; Candida albicans; Candida glabrata; cell lysis; essential genes; point mutation; ROM2; temperature-sensitive mutants	INVASIVE FUNGAL-INFECTIONS; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SEPTUM FORMATION; INTENSIVE-CARE; CELL-CYCLE; SECA GENE; SYSTEM; IDENTIFICATION	AimsTo analyse the essentiality of the ROM2 genes originating from the pathogenic yeasts Candida glabrata and Candida albicans by using temperature-sensitive (ts) mutants. Methods and ResultsBased on the general concepts that ts mutations are generated by virtue of point mutation within essential genes, we have previously established a novel method (termed ETS system' for screening and identification of essential genes using ts mutants of C.glabrata). According to this ETS system, the present study successfully identified a putative C.glabrata ROM2 homologue as an essential gene that complements its point mutation (Cys-1275/Tyr substitution). The C.albicans ROM2 mutant (Cys-1281/Tyr), constructed patterned after this point mutation, also displayed ts phenotype. Both ts mutants recovered colony-forming ability, with concomitant suppression of lysis phenotype, at the elevated temperature in the presence of 1moll(-1) sorbitol as an osmotic stabilizer. Sequence alignment revealed that human genome possesses relatively low homology against Rom2 homologues, which are highly conserved among yeast species. ConclusionsROM2 genes of C.glabrata and C.albicans are essential for viability, probably involved in cell wall integrity. Significance and Impact of the StudyROM2 genes essential for both Candida species may be a potentially useful antifungal targets from chemotherapeutic viewpoint.	[Kanno, T.; Takekawa, D.; Miyakawa, Y.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Biotechnol, Kofu, Yamanashi 4008510, Japan	Miyakawa, Y (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Biotechnol, 4-4-37 Takeda, Kofu, Yamanashi 4008510, Japan.	ymiya@yamanashi.ac.jp					Cassone A, 2012, AIDS, V26, P1457, DOI 10.1097/QAD.0b013e3283536ba8; LINDAHL G, 1971, P NATL ACAD SCI USA, V68, P2407, DOI 10.1073/pnas.68.10.2407; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI [10.1016/j.molcel.2008.02.021, 10.1016/j.moicel.2008.02.021]; FONZI WA, 1993, GENETICS, V134, P717; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Ozaki K, 1996, EMBO J, V15, P2196; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Gupta AK, 2003, DERMATOL CLIN, V21, P565, DOI 10.1016/S0733-8635(03)00024-X; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; ITO H, 1983, J BACTERIOL, V153, P163; CABIB E, 1975, J BACTERIOL, V124, P1604; KAGAYA K, 1989, J IMMUNOL, V143, P3353; Kitada K, 1996, GENE, V175, P105, DOI 10.1016/0378-1119(96)00132-1; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; MIYAKAWA Y, 1981, MOL GEN GENET, V181, P207, DOI 10.1007/BF00268428; MIYAKAWA Y, 1982, J BACTERIOL, V149, P673; Miyakawa Y, 2000, YEAST, V16, P1045, DOI 10.1002/1097-0061(200008)16:11<1045::AID-YEA595>3.3.CO;2-C; Miyakawa Y, 2009, LETT APPL MICROBIOL, V49, P317, DOI 10.1111/j.1472-765X.2009.02661.x; Nakayama H, 1998, MICROBIOL-UK, V144, P2407; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896; Parize P, 2012, CURR INFECT DIS REP, V14, P668, DOI 10.1007/s11908-012-0296-y; SADAIE Y, 1991, GENE, V98, P101; Sambrook J., 1989, MOL CLONING LAB MANU; Sherman F., 1986, LAB COURSE MANUAL ME; Sipsas NV, 2012, INT J ANTIMICROB AG, V39, P464, DOI 10.1016/j.ijantimicag.2011.11.017; TAKAMATSU H, 1992, J BACTERIOL, V174, P4308; Testoni D, 2012, CLIN PERINATOL, V39, P83, DOI 10.1016/j.clp.2011.12.008	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	APR	2015	118	4					851	863		10.1111/jam.12745		13	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CD9BU	WOS:000351392200008		
J	Ando, H; Kurata, A; Kishimoto, N				Ando, H.; Kurata, A.; Kishimoto, N.			Antimicrobial properties and mechanism of volatile isoamyl acetate, a main flavour component of Japanese sake (Ginjo-shu)	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						antimicrobial activity; antimicrobial mechanism; isoamyl acetate; proteome; volatile organic compounds	ESCHERICHIA-COLI; GEL-ELECTROPHORESIS; GROWTH; IDENTIFICATION; PROTEINS; ETHANOL; STRESS; YEASTS; ACID	AimsTo evaluate the antimicrobial properties of the main Ginjo-flavour components of sake, volatile isoamyl acetate and isoamyl alcohol. Methods and ResultsVolatile isoamyl acetate and isoamyl alcohol both inhibited growth of the five yeast and 10 bacterial test strains. The minimum inhibitory dose and minimum bactericidal (fungicidal) dose of isoamyl acetate were higher than those of isoamyl alcohol. Escherichia coli and Acetobacter aceti were markedly sensitive to isoamyl acetate and isoamyl alcohol. In E.coli exposed to isoamyl acetate for 5h, changes in expression were noted in proteins involved in sugar metabolism (MalE, MglB, TalB and PtsI), tricarboxylic acid cycle (AceA, Pfl and AcnB) and protein synthesis (EF-Tu, EF-G, and GlyS). Expression of acid and alcohol stress-response proteins was altered in E.coli exposed to isoamyl acetate. Esterase activity was detected in E.coli, suggesting that isoamyl acetate was hydrolyzed to acetic acid and isoamyl alcohol. Acetic acid and isoamyl alcohol damaged E.coli cell membranes and inactivated membrane proteins, impairing respiration. ConclusionsVolatile isoamyl acetate and isoamyl alcohol were effective in inactivating various micro-organisms, and antimicrobial mechanism of volatile isoamyl acetate against E.coli was clarified based on proteome analysis. Significance and Impact of the StudyTo the best of our knowledge, this is the first report to examine the antimicrobial mechanism of volatile organic compound using proteome analysis combining two-dimensional difference gel electrophoresis with peptide mass fingerprinting.	[Ando, H.] Natl Inst Adv Ind Sci & Technol, Dept Appl Biol Chem, Ikeda, Osaka, Japan; [Kurata, A.; Kishimoto, N.] Kinki Univ, Dept Appl Biol Chem, Fac Agr, Nara, Nara 6318505, Japan	Kishimoto, N (reprint author), Kinki Univ, Dept Appl Biol Chem, Fac Agr, 3327-204 Nakamachi, Nara, Nara 6318505, Japan.	kisimoto@nara.kindai.ac.jp					SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Masoud W, 2005, YEAST, V22, P1133, DOI 10.1002/yea.1304; Huang R, 2011, PHYTOPATHOLOGY, V101, P859, DOI 10.1094/PHYTO-09-10-0255; Blankenhorn D, 1999, J BACTERIOL, V181, P2209; Fukuda K, 1998, APPL ENVIRON MICROB, V64, P4076; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.3.CO;2-R]; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Ando H, 2012, FOOD CONTROL, V26, P472, DOI 10.1016/j.foodcont.2012.02.017; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Fernando WGD, 2005, SOIL BIOL BIOCHEM, V37, P955, DOI 10.1016/j.soilbio.2004.10.021; Arikawa Y, 2000, J BIOSCI BIOENG, V90, P675, DOI 10.1016/S1389-1723(00)90016-1; Brynildsen M. P., 2009, MOL SYST BIOL, V5, P1; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057628; Fialho M. B., 2011, Biocontrol Science and Technology, V21, P797, DOI 10.1080/09583157.2011.580837; Fialho MB, 2010, WORLD J MICROB BIOT, V26, P925, DOI 10.1007/s11274-009-0255-4; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Humphris SN, 2002, FEMS MICROBIOL LETT, V210, P215, DOI 10.1111/j.1574-6968.2002.tb11183.x; Kitagaki H, 2013, ANNU REV FOOD SCI T, V4, P215, DOI 10.1146/annurev-food-030212-182545; PACAUD M, 1982, J BACTERIOL, V149, P6; Seward R, 1996, J I BREWING, V102, P439; Yoshizawa K, 1999, FOOD REV INT, V15, P83; Zhang DF, 2011, CURR MICROBIOL, V62, P777, DOI 10.1007/s00284-010-9786-z	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	APR	2015	118	4					873	880		10.1111/jam.12764		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CD9BU	WOS:000351392200010		
J	Bhunchoth, A; Phironrit, N; Leksomboon, C; Chatchawankanphanich, O; Kotera, S; Narulita, E; Kawasaki, T; Fujie, M; Yamada, T				Bhunchoth, A.; Phironrit, N.; Leksomboon, C.; Chatchawankanphanich, O.; Kotera, S.; Narulita, E.; Kawasaki, T.; Fujie, M.; Yamada, T.			Isolation of Ralstonia solanacearum-infecting bacteriophages from tomato fields in Chiang Mai, Thailand, and their experimental use as biocontrol agents	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						bacterial wilt disease; bacteriophages; biocontrol; host range; Ralstonia solanacearum	GENOMIC CHARACTERIZATION; PHAGE; EVOLUTION; SOIL	AimsTo isolate and characterize novel bacteriophages infecting the phytopathogen, Ralstonia solanacearum, and to evaluate them as resources with potential uses in the biocontrol of bacterial wilt. Methods and ResultsFourteen phages infecting R.solanacearum were isolated from soil samples collected in Chiang Mai, Thailand. The phages showed different host ranges when tested against 59 R.solanacearum strains isolated from Thailand and Japan. These phages were characterized as nine podoviruses and five myoviruses based on their morphology. Podovirus J2 in combination with another podovirus (RSB2) lysed host cells very efficiently in contaminated soil. J2 treatment prevented wilting of tomato plants infected with a highly virulent R.solanacearum strain. ConclusionsTreatment with J2 effectively reduced the amount of the bacterial wilt pathogen in contaminated soil and prevented bacterial wilt of tomato in pot experiments. Myovirus J6 possessed jumbo phage features, giving a unique opportunity to study its utilization as a biocontrol agent. Significance and Impact of the StudyAs exemplified by J2, the phages isolated in this study represent valuable resources with potential uses in biocontrol of bacterial wilt. A rare jumbo phage J6 served as a valuable subject to understand and utilize this new group of phages.	[Bhunchoth, A.; Phironrit, N.; Chatchawankanphanich, O.] NSTDA, Plant Res Lab, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Bhunchoth, A.] Kasetsart Univ, Ctr Agr Biotechnol, Nakhon Pathom, Thailand; [Bhunchoth, A.] Ctr Excellence Agr Biotechnol AG BIOPERDO CHE, Bangkok, Thailand; [Leksomboon, C.] Kasetsart Univ, Dept Plant Pathol, Nakhon Pathom, Thailand; [Kotera, S.; Narulita, E.; Kawasaki, T.; Fujie, M.; Yamada, T.] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan	Yamada, T (reprint author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	tayamad@hiroshima-u.ac.jp			Strategic Japanese-Thai Research Cooperative Program on Biotechnology (JST/BIOTEC-SICP)	This study was supported by the Strategic Japanese-Thai Research Cooperative Program on Biotechnology (JST/BIOTEC-SICP). The authors thank Yuya Sugimura and Taiki Yasuda for plant challenge assays. They also thank Likhit Maneesinthu for the guidance to tomato fields in Chiang Mai, Thailand.	Abedon ST, 2009, ADV APPL MICROBIOL, V67, P1, DOI 10.1016/S0065-2164(08)01001-0; Allen C., 2001, COMPENDIUM POTATO DI, P11; Allen C, 2005, BACTERIAL WILT DIS R; WINSTEAD NN, 1952, PHYTOPATHOLOGY, V42, P628; Hendrix RW, 2009, CURR TOP MICROBIOL, V328, P229; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Fujiwara A, 2011, APPL ENVIRON MICROB, V77, P4155, DOI 10.1128/AEM.02847-10; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897; Boonsuebsakul W., 1994, ANN REP PLANT PATHOL, P162; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fegan M., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P449; Fujiwara A, 2008, J BACTERIOL, V190, P143, DOI 10.1128/JB.01158-07; Gašič K., 2011, Journal of Plant Pathology, V93, P415; Hayward AC, 2000, ENCY MICROBIOLOGY, V4, P32; Hendrix R. W., 2006, ICTVDB UNIVERSAL VIR; HIGASHIYAMA T, 1991, NUCLEIC ACIDS RES, V19, P6191, DOI 10.1093/nar/19.22.6191; Horita M., 2002, MAFF MICROORGANISM G, P5; Janse J. D., 1996, Bulletin OEPP, V26, P679; Jones J. B., 2008, ANNU REV PHYTOPATHOL, V45, P245; Kasigumpaiboon U., 1992, P 30 KAS U ANN C PLA, P321; Kawasaki T, 2009, J BACTERIOL, V191, P422, DOI 10.1128/JB.01263-08; Makari H. K., 2013, INT RES J BIOL SCI, V2, P78; Murugaiyan S., 2010, J APPL MICROBIOL, V110, P296; Nguyen MT, 2010, J PLANT PATHOL, V92, P395; Nguyen MT, 2011, J PHYTOL, V3, P01; Prior P., 1998, BACTERIAL WILT DIS M; Sambrook J, 2001, MOL CLONING LAB MANU; Suwankeereekhan J., 2004, P 42 KAS U ANN C PLA, P429; Tan G. H., 2010, Journal of Tropical Agriculture and Food Science, V38, P123; Thammakijjawat P., 1997, AGR SCI J, V30, P35; Thaveechai N., 1997, AVRDC COLLABORATIVE, P397; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Villa Joselito E., 2005, Journal of General Plant Pathology, V71, P39, DOI 10.1007/s10327-004-0156-1; Yamada T., 2012, BACTERIOPHAGES, P113; Yamada T, 2010, VIROLOGY, V398, P135, DOI 10.1016/j.virol.2009.11.043	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	APR	2015	118	4					1023	1033		10.1111/jam.12763		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CD9BU	WOS:000351392200023		
J	Jia, LJ; Ge, HB; Suzuki, T; Luo, XQ				Jia, Liang-Jiu; Ge, Hanbin; Suzuki, Toshimitsu; Luo, Xiaoqun			Experimental Study on Cracking of Thick-Walled Welded Beam-Column Connections with Incomplete Penetration in Steel Bridge Piers	JOURNAL OF BRIDGE ENGINEERING			English	Article						Cracking; Connection; Frame; Cyclic test; Steel bridge	MOMENT CONNECTIONS; BRITTLE-FRACTURE; LOCAL DETAILS; DUCTILE CRACK; EARTHQUAKE; DAMAGE; CLASSIFICATION; PERFORMANCE; BUILDINGS; TOUGHNESS	Fracture of welded beam-column connections was observed in steel moment-resisting frame steel bridge piers during the 1995 Kobe (Hyogoken-Nanbu) Earthquake. In addition, welding defects in fillet welds and full penetration welds were recently reported in existing steel bridges. This paper aims to study the effects of incomplete penetration depth and loading histories on crack initiation and propagation of thick-walled beam-column connections during a strong earthquake event. Five specimens under three different loading histories were loaded quasi-statically, and different cracking modes were observed. The experimental results indicate that the cracking modes are closely correlated with the size of the incomplete penetration depth. (C) 2014 American Society of Civil Engineers.	[Jia, Liang-Jiu] Meijo Univ, Adv Res Ctr Nat Disaster Risk Reduct, Nagoya, Aichi 4688502, Japan; [Ge, Hanbin; Luo, Xiaoqun] Meijo Univ, Dept Civil Engn, Nagoya, Aichi 4688502, Japan; [Suzuki, Toshimitsu] Mitubishi Heavy Ind Ltd, Naka Ku, Hiroshima 7308642, Japan; [Luo, Xiaoqun] Tongji Univ, Dept Bldg Engn, Shanghai 200092, Peoples R China	Ge, HB (reprint author), Meijo Univ, Dept Civil Engn, Nagoya, Aichi 4688502, Japan.	gehanbin@meijo-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24560588]; Advanced Research Center for Natural Disaster Risk Reduction, Meijo University; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	The study is supported in part by grants from the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (C) (No. 24560588), and the Advanced Research Center for Natural Disaster Risk Reduction, Meijo University, which is supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Ricles JM, 2002, J STRUCT ENG-ASCE, V128, P429, DOI 10.1061/(ASCE)0733-9445(2002)128:4(429); Kuwamura H, 1998, ENG STRUCT, V20, P310, DOI 10.1016/S0141-0296(97)00030-8; Huang XW, 2013, J CONSTR STEEL RES, V85, P60, DOI 10.1016/j.jcsr.2013.02.014; Mahin SA, 1998, ENG STRUCT, V20, P261, DOI 10.1016/S0141-0296(97)00032-1; Mahmoud HN, 2013, J STRUCT ENG, V139, P1134, DOI 10.1061/(ASCE)ST.1943-541X.0000721; Kuwamura H, 1997, J STRUCT ENG-ASCE, V123, P729, DOI 10.1061/(ASCE)0733-9445(1997)123:6(729); Nakashima M, 1998, ENG STRUCT, V20, P271, DOI 10.1016/S0141-0296(97)00019-9; Mao CS, 2001, J STRUCT ENG-ASCE, V127, P1036, DOI 10.1061/(ASCE)0733-9445(2001)127:9(1036); Kuwamura H, 1997, J STRUCT ENG-ASCE, V123, P864, DOI 10.1061/(ASCE)0733-9445(1997)123:7(864); CHABOCHE JL, 1988, J APPL MECH-T ASME, V55, P59; Architectural Institute of Japan (AIJ), 1995, FRACT STEEL STRUCT S; Bruneau M, 1996, CAN J CIVIL ENG, V23, P678; Building Center of Japan, 2003, GUID PREV BRITTL FRA; Chi WM, 2000, J STRUCT ENG-ASCE, V126, P88, DOI 10.1061/(ASCE)0733-9445(2000)126:1(88); El-Tawil S, 2000, J STRUCT ENG-ASCE, V126, P79, DOI 10.1061/(ASCE)0733-9445(2000)126:1(79); FEMA (Federal Emergency Management Agency), 2000, FEMA350; Ge HB, 2013, J BRIDGE ENG, V18, P858, DOI 10.1061/(ASCE)BE.1943-5592.0000429; Jia LJ, 2014, J STRUCT ENG, V140, DOI 10.1061/(ASCE)ST.1943-541X.0000944; Kuwamura H, 2003, J STRUCT ENG-ASCE, V129, P1475, DOI 10.1061/(ASCE)0733-9445(2003)129:11(1475); Kuwamura H, 2003, ENG STRUCT, V25, P547, DOI 10.1016/S0141-0296(02)00166-9; Jia LJ, 2014, J STRUCT ENG, V140, DOI 10.1061/(ASCE)ST.1943-541X.0000848; Kuwamura Laboratory, 1995, FIELD SURV REP STRUC; Luo XQ, 2012, STEEL COMPOS STRUCT, V13, P383; Miki Chitoshi, 2005, International Journal of STEEL STRUCTURES, V5, P133; Morikawa H., 2002, P JSCE, V703, P177; O'Sullivan D., 1998, J PERFORM CONSTR FAC, V12, P213, DOI 10.1061/(ASCE)0887-3828(1998)12:4(213); Saiprasertkit K, 2011, PROCEDIA ENGINEER, V14, DOI 10.1016/j.proeng.2011.07.072; Schafer BW, 2000, J STRUCT ENG-ASCE, V126, P1131, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1131); Stojadinovic B, 2000, J STRUCT ENG-ASCE, V126, P40; Usami T, 2009, J EARTHQ TSUNAMI, V3, P175, DOI 10.1142/S179343110900055X	30	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0702	1943-5592		J BRIDGE ENG	J. Bridge Eng.	APR	2015	20	4							04014072	10.1061/(ASCE)BE.1943-5592.0000659		9	Engineering, Civil	Engineering	CD9OI	WOS:000351427300003		
J	Yang, X; Hoshino, A; Taga, T; Kunitsu, T; Ikeda, Y; Yasumi, T; Yoshida, K; Wada, T; Miyake, K; Kubota, T; Okuno, Y; Muramatsu, H; Adachi, Y; Miyano, S; Ogawa, S; Kojima, S; Kanegane, H				Yang, Xi; Hoshino, Akihiro; Taga, Takashi; Kunitsu, Tomoaki; Ikeda, Yuhachi; Yasumi, Takahiro; Yoshida, Kenichi; Wada, Taizo; Miyake, Kunio; Kubota, Takeo; Okuno, Yusuke; Muramatsu, Hideki; Adachi, Yuichi; Miyano, Satoru; Ogawa, Seishi; Kojima, Seiji; Kanegane, Hirokazu			A Female Patient with Incomplete Hemophagocytic Lymphohistiocytosis Caused by a Heterozygous XIAP Mutation Associated with Non-Random X-Chromosome Inactivation Skewed Towards the Wild-Type XIAP Allele	JOURNAL OF CLINICAL IMMUNOLOGY			English	Article						Hemophagocytic lymphohistiocytosis; X-chromosome inactivation; X-linked inhibitor of apoptosis; X-linked lymphoproliferative syndrome	WISKOTT-ALDRICH-SYNDROME; CHRONIC GRANULOMATOUS-DISEASE; DE-NOVO MUTATION; LINKED LYMPHOPROLIFERATIVE SYNDROME; DEFICIENCY; ASSAY; PCR	X-linked lymphoproliferative disease (XLP) is a rare inherited immunodeficiency that often leads to hemophagocytic lymphohistiocytosis (HLH). XLP can be classified as XLP1 or XLP2, caused by mutations in SH2D1A and XIAP, respectively. In women, X-chromosome inactivation (XCI) of most X-linked genes occurs on one of the X chromosomes in each cell. The choice of which X chromosome remains activated is generally random, although genetic differences and selective advantage may cause one of the X chromosomes to be preferentially inactivated. Here we describe three patients with pancytopenia, including one female patient, in a Japanese family with a novel XIAP mutation. All three patients exhibited deficient XIAP protein expression, impaired NOD2/XIAP signaling, and augmented activation-induced cell death. In the female patient, the paternally derived X chromosome was non-randomly and exclusively inactivated in her peripheral blood and hair root cells. In contrast to asymptomatic females, this patient exhibied non-random XCI skewed towards the wild-type XIAP allele. This is the first report of a female patient with incomplete HLH resulting from a heterozygous XIAP mutation in association with non-random XCI.	[Yang, Xi; Hoshino, Akihiro; Adachi, Yuichi; Kanegane, Hirokazu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Taga, Takashi; Kunitsu, Tomoaki; Ikeda, Yuhachi] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Yasumi, Takahiro] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Wada, Taizo] Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Epigenet Med, Yamanashi, Japan; [Okuno, Yusuke; Muramatsu, Hideki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Kanegane, Hirokazu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan	Kanegane, H (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	hkanegane.ped@tmd.ac.jp	Muramatsu, Hideki/I-3763-2012		Research on Measures for Intractable Disease Project; Ministry of Health, Labour, and Welfare of Japan	This study was supported by the Research on Measures for Intractable Disease Project, and grants from the Ministry of Health, Labour, and Welfare of Japan. We thank Chikako Sakai, Hitoshi Moriuchi, Dr. Yuichi Shiraishi, Dr. Kenichi Chiba, and Dr. Hiroko Tanaka for their excellent technical assistance. We are grateful to Dr. Sylvain Latour and the late Dr. Toshio Miyawaki for critical discussions.	Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, p[1131, e9]; Andreu N, 2003, BLOOD CELL MOL DIS, V31, P332, DOI 10.1016/S1079-9796(03)00168-2; Yang X, 2012, J CLIN IMMUNOL, V32, P411, DOI 10.1007/s10875-011-9638-z; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Marsh RA, 2009, CYTOM PART B-CLIN CY, V76B, P334, DOI 10.1002/cyto.b.20473; Takada H, 2004, BLOOD, V103, P185, DOI 10.1182/blood-2003-06-1964; Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Ammann S, 2014, CLIN EXP IMMUNOL, V176, P394, DOI 10.1111/cei.12306; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Orstavik KH, 2009, HUM GENET, V126, P363, DOI 10.1007/s00439-009-0670-5; Boonyawat B, 2013, J CLIN IMMUNOL, V33, P1150, DOI 10.1007/s10875-013-9927-9; Gono T, 2008, INTERNAL MED, V47, P1053, DOI 10.2169/internalmedicine.47.0919; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Lewis EM, 2008, CLIN IMMUNOL, V129, P372, DOI 10.1016/j.clim.2008.07.022; Parolini O, 1998, NEW ENGL J MED, V338, P291, DOI 10.1056/NEJM199801293380504; Wada T, 2014, CYTOKINE, V65, P74, DOI 10.1016/j.cyto.2013.09.007; WENGLER G, 1995, BLOOD, V85, P2471; Wengler GS, 1997, LIFE SCI, V61, P1405, DOI 10.1016/S0024-3205(97)00686-3	22	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0271-9142	1573-2592		J CLIN IMMUNOL	J. Clin. Immunol.	APR	2015	35	3					244	248		10.1007/s10875-015-0144-6		5	Immunology	Immunology	CE0QT	WOS:000351510200002		
J	Kato, T; Crestani, E; Kamae, C; Honma, K; Yokosuka, T; Ikegawa, T; Nishida, N; Kanegane, H; Wada, T; Yachie, A; Ohara, O; Morio, T; Notarangelo, LD; Imai, K; Nonoyama, S				Kato, Tamaki; Crestani, Elena; Kamae, Chikako; Honma, Kenichi; Yokosuka, Tomoko; Ikegawa, Takeshi; Nishida, Naonori; Kanegane, Hirokazu; Wada, Taizo; Yachie, Akihiro; Ohara, Osamu; Morio, Tomohiro; Notarangelo, Luigi D.; Imai, Kohsuke; Nonoyama, Shigeaki			RAG1 Deficiency May Present Clinically as Selective IgA Deficiency	JOURNAL OF CLINICAL IMMUNOLOGY			English	Article						RAG1 deficiency; IgA deficiency; TRECs; KRECs; primary immunodeficiency; V(D)J recombination	SEVERE COMBINED IMMUNODEFICIENCY; RECOMBINATION EXCISION CIRCLES; COMBINED IMMUNE-DEFICIENCY; T-CELL-RECEPTOR; PRE-B CELLS; OMENN-SYNDROME; GRANULOMATOUS-DISEASE; GUTHRIE CARDS; MUTATIONS; IDENTIFICATION	Background Recombination-activating gene (RAG) 1 and 2 deficiency is seen in patients with severe combined immunodeficiency (SCID) and Omenn syndrome. However, the spectrum of the disease has recently expanded to include a milder phenotype. Objective We analyzed a 4-year-old boy who was initially given the diagnosis of selective immunoglobulin A deficiency (SIgAD) based on immunoglobulin serum levels without any opportunistic infections, rashes, hepatosplenomegaly, autoimmunity or granulomas. The patient was found to be infected with varicella zoster; however, the clinical course was not serious. He produced antiviral antibodies. Methods We performed lymphocyte phenotyping, quantification of T cell receptor excision circles (TRECs) and kappa deleting recombination excision circles (KRECs), an analysis of target sequences of RAG1 and 2, a whole-genome SNP array, an in vitro V(D)J recombination assay, a spectratype analysis of the CDR3 region and a flow cytometric analysis of the bone marrow. Results Lymphocyte phenotyping demonstrated that the ratio of CD4+ to CD8+ T cells was inverted and the majority of CD4+T cells expressed CD45RO antigens in addition to the almost complete lack of B cells. Furthermore, both TRECs and KRECs were absent. Targeted DNA sequencing and SNP array revealed that the patient carried a deletion of RAG1 and RAG2 genes on the paternally-derived chromosome 11, and two maternally-derived novel RAG1 missense mutations (E455K, R764H). In vitro analysis of recombination activity showed that both RAG1 mutant proteins had low, but residual function. Conclusions The current case further expands the phenotypic spectrum of mild presentations of RAG deficiency, and suggests that TRECs and KRECs are useful markers for detecting hidden severe, as well as mild, cases.	[Kato, Tamaki; Kamae, Chikako; Honma, Kenichi; Imai, Kohsuke; Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 359, Japan; [Crestani, Elena; Notarangelo, Luigi D.] Harvard Univ, Sch Med, Div Immunol, Childrens Hosp Boston, Boston, MA USA; [Yokosuka, Tomoko] Kanagawa Childrens Med Ctr, Dept Hematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Ikegawa, Takeshi] Yokohama Rosai Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Nishida, Naonori; Kanegane, Hirokazu] Toyama Univ, Dept Pediat, Toyama 930, Japan; [Kanegane, Hirokazu; Morio, Tomohiro; Imai, Kohsuke] TMDU, Dept Pediat, Bunkyo Ku, Toyama 1138519, Japan; [Wada, Taizo; Yachie, Akihiro] Kanazawa Univ, Dept Pediat, Kanazawa, Ishikawa, Japan; [Ohara, Osamu] RIKEN Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dev Technol Dept, Kisarazu, Chiba, Japan	Imai, K (reprint author), TMDU, Dept Pediat, Bunkyo Ku, 1-5-45 Yushima, Toyama 1138519, Japan.	kimai.ped@tmd.ac.jp			NIH [P01AI076210]; Jeffrey Modell Foundation; Ministry of Defense; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	This work was supported by NIH grant P01AI076210, a grant from the Jeffrey Modell Foundation (to LDN), the Ministry of Defense; the Ministry of Education, Culture, Sports, Science, and Technology; the Ministry of Health, Labor, and Welfare; and the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics. We would like to thank Ms. Kaori Tomita and Ms. Kimiko Gasa for their skillful technical assistance.	Agematsu K, 2001, CLIN EXP IMMUNOL, V124, P461, DOI 10.1046/j.1365-2249.2001.01553.x; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Nakagawa N, 2011, J ALLERGY CLIN IMMUN, V128, P223, DOI 10.1016/j.jaci.2011.01.052; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Asai E, 2011, CLIN IMMUNOL, V138, P172, DOI 10.1016/j.clim.2010.11.005; Kamae C, 2013, J ALLERGY CLIN IMMUN, V131, P1437, DOI 10.1016/j.jaci.2012.10.059; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; Niehues T, 2010, CLIN IMMUNOL, V135, P183, DOI 10.1016/j.clim.2010.01.013; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; Currier JR, 2001, CURR PROTOC IMMUNOL; Henderson LA, 2014, J ALLERGY CLIN IMMUN, V132, P969; Kumaki S, 2001, BLOOD, V98, P1464, DOI 10.1182/blood.V98.5.1464; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Nomura K, 2000, BLOOD, V96, P610; Noordzij JG, 2002, BLOOD, V100, P2145; Sheehan WJ, 2009, J ALLERGY CLIN IMMUN, V123, P966, DOI 10.1016/j.jaci.2008.12.007	26	3	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0271-9142	1573-2592		J CLIN IMMUNOL	J. Clin. Immunol.	APR	2015	35	3					280	288		10.1007/s10875-015-0146-4		9	Immunology	Immunology	CE0QT	WOS:000351510200007		
J	Njai, HF; Shimakawa, Y; Sanneh, B; Ferguson, L; Ndow, G; Mendy, M; Sow, A; Lo, G; Toure-Kane, C; Tanaka, J; Taal, M; D'alessandro, U; Njie, R; Thursz, M; Lemoine, M				Njai, Harr Freeya; Shimakawa, Yusuke; Sanneh, Bakary; Ferguson, Lynne; Ndow, Gibril; Mendy, Maimuna; Sow, Amina; Lo, Gora; Toure-Kane, Coumba; Tanaka, Junko; Taal, Makie; D'alessandro, Umberto; Njie, Ramou; Thursz, Mark; Lemoine, Maud			Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DIAGNOSTIC-ACCURACY; LIVER FIBROSIS; C VIRUS; INFECTION; PERFORMANCE; ASSAYS; HBSAG; HIV; METAANALYSIS	Hepatitis B virus (HBV) infection is a leading cause of death in sub-Saharan Africa (SSA). Point-of-care tests for hepatitis B surface antigen (HBsAg) could be an ideal tool for a large-scale HBV screening/treatment program in SSA. Using data from the PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa) program, we conducted a cross-sectional study to assess the diagnostic accuracy of three point-of-care tests (Determine, Vikia, and Espline) for the detection of HBsAg in the field or a laboratory setting in the Gambia. In the field, we used finger-prick whole blood for the Determine and Vikia tests and dried blood spots for the reference standard test (AxSYM HBsAg enzyme-linked immunosorbent assay [ELISA]). In the laboratory we used serum for the Determine, Espline, and reference test (Architect chemiluminescent microparticle immunoassay). Of 773 participants recruited at the community and 227 known chronic HBV carriers (1,000 subjects in total), 293 were positive for HBsAg. The sensitivity and specificity of the Determine test were 88.5% and 100% in the field and 95.3% and 93.3% in the laboratory setting, respectively. The sensitivity and specificity were 90.0% and 99.8% for the Vikia test (in the field) and 93.9% and 94.7% for the Espline test (in the laboratory). There was no evidence that one kit was better than another. Most of the patients with false-negative results (18/19) were classified as inactive chronic carriers. In summary, the three point-of-care tests had acceptable ranges of diagnostic accuracy. These tests may represent accurate, rapid, and inexpensive alternatives to serology testing for the screening of HBV infection at field level in SSA.	[Njai, Harr Freeya; Shimakawa, Yusuke; Ferguson, Lynne; Ndow, Gibril; D'alessandro, Umberto; Njie, Ramou; Lemoine, Maud] MRC Unit, Banjul, Gambia; [Shimakawa, Yusuke; Tanaka, Junko] Hiroshima Univ, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan; [Sanneh, Bakary; Taal, Makie] Natl Publ Hlth Lab, Banjul, Gambia; [Mendy, Maimuna; Njie, Ramou] Int Agcy Res Canc, Lab Serv & Biobank Grp, F-69372 Lyon, France; [Sow, Amina; Lo, Gora; Toure-Kane, Coumba] Univ Cheikh Anta Diop, CHU Le Dantec, Lab Bacteriol Virol, Dakar, Senegal; [Thursz, Mark; Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, Div Med, London, England	Lemoine, M (reprint author), MRC Unit, Banjul, Gambia.	m.lemoine@imperial.ac.uk			Medical Research Council Laboratories in the Gambia,; Ministry of Health and Social Welfare; European commission (EC FP7) [P34114]	We thank the Medical Research Council Laboratories in the Gambia, the local Ministry of Health and Social Welfare for supporting the project, all the study participants, and the PROLIFICA team, in particular, Ignatius Baldeh, Famara Bojang, Amie Ceesay, Mavis Foster-Nyarko, Debbo Jallow, Abdoulie Jatta, Adam Jeng, Sheriff Kolley, Yamundow Jallow Samba, Alagie Sanneh, Demba Sonko, Penda Suso, and Saydiba Tamba. We also thank Debbie Garside, the project manager of the PROLIFICA project.; This study is part of the PROLIFICA program funded by the European commission (EC FP7, P34114).	Akanmu A S, 2006, Afr J Med Med Sci, V35, P5; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Lien TX, 2000, AM J TROP MED HYG, V62, P301; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016; Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561; Thursz M, 2012, NAT REV GASTRO HEPAT, V9, P492, DOI 10.1038/nrgastro.2012.155; Villar LM, 2011, J MED VIROL, V83, P1522, DOI 10.1002/jmv.22138; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Bossuyt PM, 2003, ANN INTERN MED, V138, P40; Davies J, 2010, T ROY SOC TROP MED H, V104, P162, DOI 10.1016/j.trstmh.2009.10.010; WHITTLE H, 1990, J INFECT DIS, V161, P1112; Lin YH, 2008, J CLIN MICROBIOL, V46, P3319, DOI 10.1128/JCM.00498-08; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Papatheodoridis G, 2012, J HEPATOL, V57, P167; FARGHALY AM, 1990, FARMACO, V45, P431; Franzeck FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058468; Hoffmann C J, 2012, Int J STD AIDS, V23, pe10, DOI 10.1258/ijsa.2009.009340; Honge BL, 2014, HIV MED, V15, P571, DOI 10.1111/hiv.12158; Hwang SH, 2008, KOR J LAB MED, V28, P160, DOI 10.3343/kjlm.2008.28.2.160; Kania D, 2013, CLIN MICROBIOL INFEC, V19, pE533, DOI 10.1111/1469-0691.12292; Mvere D, 1996, B WORLD HEALTH ORGAN, V74, P19; Palmer CJ, 1999, 39 INT C ANT AG CHEM; Randrianirina F, 2008, J VIROL METHODS, V151, P294, DOI 10.1016/j.jviromet.2008.03.019; Shibahara K, 1997, JPN J MED PHARM SCI, V38, P343; Shivkumar S, 2012, AM J GASTROENTEROL, V107, P1306, DOI 10.1038/ajg.2012.141; Thursz M, 2010, TROP MED INT HEALTH, V15, P2, DOI 10.1111/j.1365-3156.2009.02410.x; WHITTLE HC, 1983, LANCET, V1, P1203; World Health Organization, 2014, CALL ACT SCAL GLOB H	33	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	APR	2015	53	4					1156	1163		10.1128/JCM.02980-14		8	Microbiology	Microbiology	CD8QA	WOS:000351359500016		
J	Ozawa, M; Matsuu, A; Yonezawa, K; Igarashi, M; Okuya, K; Kawabata, T; Ito, K; Tsukiyama-Kohara, K; Taneno, A; Deguchi, E				Ozawa, Makoto; Matsuu, Aya; Yonezawa, Kouki; Igarashi, Manabu; Okuya, Kosuke; Kawabata, Toshiko; Ito, Kimihito; Tsukiyama-Kohara, Kyoko; Taneno, Akira; Deguchi, Eisaburo			Efficient Isolation of Swine Influenza Viruses by Age-Targeted Specimen Collection	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							PANDEMIC H1N1 2009; A VIRUSES; GENETIC-CHARACTERIZATION; UNITED-STATES; AVIAN-LIKE; PIGS; REASSORTMENT; TRANSMISSION; JAPAN; INFECTIONS	The control of swine influenza virus (SIV) infection is paramount for increasing the productivity of pig farming and minimizing the threat of pandemic outbreaks. Thus, SIV surveillance should be conducted by region and on a regular basis. Here, we established a microneutralization assay specific for SIV seroprevalence surveillance by using reporter gene-expressing recombinant influenza viruses. Growth-based SIV seroprevalence revealed that most sows and piglets were positive for neutralizing antibodies against influenza viruses. In contrast, the 90-day-old growing pigs exhibited limited neutralizing activity in their sera, suggesting that this particular age of population is most susceptible to SIV infection and thus is an ideal age group for SIV isolation. From nasal swab specimens of healthy pigs in this age population, we were able to isolate SIVs at a higher incidence (5.3%) than those of previous reports. Nucleotide sequencing and phylogenetic analysis of the hemagglutinin (HA) genes revealed that the isolated SIVs have circulated and evolved in pigs but not have been recently introduced from humans, implying that a large number of SIV lineages may remain "undiscovered" in the global porcine populations. Wepropose that the 90-day-old growing pig-targeted nasal swab collection presented in this study facilitates global SIV surveillance and contributes to the detection and control of SIV infection.	[Ozawa, Makoto; Okuya, Kosuke; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Lab Anim Hyg, Joint Fac Vet Med, Kagoshima 890, Japan; [Ozawa, Makoto; Matsuu, Aya; Kawabata, Toshiko; Tsukiyama-Kohara, Kyoko; Deguchi, Eisaburo] Kagoshima Univ, Transboundary Anim Dis Ctr, Joint Fac Vet Med, Kagoshima 890, Japan; [Ozawa, Makoto; Matsuu, Aya; Tsukiyama-Kohara, Kyoko; Deguchi, Eisaburo] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Yonezawa, Kouki] Nagahama Inst Biosci & Technol, Dept Comp Biosci, Nagahama, Japan; [Igarashi, Manabu; Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Igarashi, Manabu; Ito, Kimihito] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan; [Taneno, Akira] Vaxxinova Japan KK, Tokyo, Japan; [Deguchi, Eisaburo] Kagoshima Univ, Lab Farm Anim Prod Med, Joint Fac Vet Med, Kagoshima 890, Japan	Ozawa, M (reprint author), Kagoshima Univ, Lab Anim Hyg, Joint Fac Vet Med, Kagoshima 890, Japan.	mozawa@vet.kagoshima-u.ac.jp			Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science (JSPS) (JSPS Kakenhi) [26670227]; Institute of Medical Science; University of Tokyo	This work was supported by a grant-in-aid for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labor and Welfare, Japan; by a grant-in-aid for challenging exploratory research from the Japan Society for the Promotion of Science (JSPS) (JSPS Kakenhi grant 26670227), and by a grant for a joint research project of the Institute of Medical Science, the University of Tokyo.	Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; VanReeth K, 1996, VET MICROBIOL, V48, P325, DOI 10.1016/0378-1135(95)00145-X; Zhu HC, 2011, J VIROL, V85, P10432, DOI 10.1128/JVI.05352-11; Kitikoon P, 2011, VIRUS GENES, V43, P1, DOI 10.1007/s11262-011-0597-5; Van Reeth K, 2007, VET RES, V38, P243, DOI 10.1051/vetres:2006062; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Fan XH, 2012, J VIROL, V86, P2375, DOI 10.1128/JVI.06824-11; Kanehira K, 2014, MICROBIOL IMMUNOL, V58, P327, DOI 10.1111/1348-0421.12152; CASTRUCCI MR, 1994, J GEN VIROL, V75, P371, DOI 10.1099/0022-1317-75-2-371; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid/1706.101886, 10.3201/eid1706.101886]; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI [10.3201/eid1709.110338, 10.3201/1709.110338]; Zhou NN, 1999, J VIROL, V73, P8851; Ozawa M, 2011, J GEN VIROL, V92, P2879, DOI 10.1099/vir.0.037648-0; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; DIMMOCK NJ, 1995, REV MED VIROL, V5, P165, DOI 10.1002/rmv.1980050306; Fonseca W, 2014, ARCH VIROL, V159, P1067, DOI 10.1007/s00705-013-1932-z; GOURREAU JM, 1994, ARCH VIROL, V135, P365, DOI 10.1007/BF01310021; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Jung K, 2004, ARCH VIROL, V149, P1415, DOI 10.1007/s00705-004-0324-9; Loeffen WLA, 2003, VET MICROBIOL, V91, P295, DOI 10.1016/S0378-1135(02)00306-1; Matsuu A, 2012, MICROBIOL IMMUNOL, V56, P792, DOI 10.1111/j.1348-0421.2012.00501.x; NARDELLI L, 1978, ZBL VET MED B, V25, P853; OTTIS K, 1982, ARCH VIROL, V73, P103, DOI 10.1007/BF01314719; Ouchi A, 1996, J GEN VIROL, V77, P1751, DOI 10.1099/0022-1317-77-8-1751; Ozawa M, 2013, ANNU REV ANIM BIOSCI, V1, P21, DOI 10.1146/annurev-animal-031412-103733; POPOVICI V, 1972, ACTA VIROL, V16, P363; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Su S, 2012, J VIROL, V86, P9542, DOI 10.1128/JVI.01475-12; Takemae N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-537; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yazawa S, 2004, VET MICROBIOL, V98, P221, DOI 10.1016/j.vetmic.2003.11.005; Yonezawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057684	41	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	APR	2015	53	4					1331	1338		10.1128/JCM.02941-14		8	Microbiology	Microbiology	CD8QA	WOS:000351359500041		
J	Nishimura, T; Fujita-Suzuki, Y; Yonemaru, M; Ohkusu, K; Sakagami, T; Carpenter, SM; Otsuka, Y; Namkoong, H; Yano, I; Hasegawa, N				Nishimura, Tomoyasu; Fujita-Suzuki, Yukiko; Yonemaru, Makoto; Ohkusu, Kiyofumi; Sakagami, Takuro; Carpenter, Stephen M.; Otsuka, Yoshihito; Namkoong, Ho; Yano, Ikuya; Hasegawa, Naoki			Recurrence of Disseminated Mycobacterium avium Complex Disease in a Patient with Anti-Gamma Interferon Autoantibodies by Reinfection	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							INFECTION	We report a case of recurrent disseminated Mycobacterium avium complex (DMAC) disease with anti-gamma interferon auto-antibodies. To our knowledge, this is the first reported case caused by reinfection with a separate isolate of M. avium. DMAC disease activity was monitored using serum IgG antibody titers against lipid antigens extracted from a MAC strain.	[Nishimura, Tomoyasu] Keio Univ, Ctr Hlth, Shinjuku Ku, Tokyo, Japan; [Fujita-Suzuki, Yukiko; Yano, Ikuya] Japan BCG Cent Lab, Tokyo, Japan; [Yonemaru, Makoto] Isehara Kyodo Hosp, Isehara, Kanagawa, Japan; [Ohkusu, Kiyofumi] Tokyo Med Univ, Dept Microbiol, Shinjuku Ku, Tokyo 1608402, Japan; [Sakagami, Takuro] Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, Niigata, Niigata, Japan; [Carpenter, Stephen M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Carpenter, Stephen M.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Otsuka, Yoshihito] Kameda Med Ctr, Chiba, Japan; [Namkoong, Ho] Keio Univ, Sch Med, Dept Med, Div Pulm Med,Shinjuku Ku, Tokyo 160, Japan; [Hasegawa, Naoki] Keio Univ, Sch Med, Ctr Infect Dis & Infect Control, Shinjuku Ku, Tokyo, Japan	Hasegawa, N (reprint author), Keio Univ, Sch Med, Ctr Infect Dis & Infect Control, Shinjuku Ku, Tokyo, Japan.	n-hasegawa@z8.keio.jp			Japan Society of the Promotion of Science KAKENHI [26860772]; Ohyama Health Foundation	T.N. received Japan Society of the Promotion of Science KAKENHI grant no. 26860772 and a grant from the Ohyama Health Foundation.	Wallace RJ, 2014, CHEST, V146, P276, DOI 10.1378/chest.13-2538; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Nishimura T, 2009, CLIN INFECT DIS, V49, P529, DOI 10.1086/600888; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Fujita Kohei, 2014, Ann Am Thorac Soc, V11, P45, DOI 10.1513/AnnalsATS.201309-297OC; Ishii T, 2013, J INFECT CHEMOTHER, V19, P1152, DOI 10.1007/s10156-013-0572-2; Inagaki T, 2009, J CLIN MICROBIOL, V47, P2156, DOI 10.1128/JCM.02373-08; Ohkusu K, 2004, J INFECT DIS, V190, P1347, DOI 10.1086/424488; Taga S, 2014, JMM CASE REPORTS	11	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	APR	2015	53	4					1436	1438		10.1128/JCM.03339-14		3	Microbiology	Microbiology	CD8QA	WOS:000351359500068		
J	Takahashi, T; Masuya, Y; Ueno, K; Watanabe, K; Takahashi, M; Morita, M; Higashima, M; Wada, Y				Takahashi, Tetsuya; Masuya, Yasuhiro; Ueno, Kanji; Watanabe, Kyohei; Takahashi, Masahiro; Morita, Machiyo; Higashima, Masato; Wada, Yuji			Clozapine-Related Negative Myoclonus Associated With Urinary Tract Infection A Case Report	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							DRUG-INTERACTION; ASTERIXIS		[Takahashi, Tetsuya; Masuya, Yasuhiro; Ueno, Kanji; Higashima, Masato; Wada, Yuji] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Fukui 910, Japan; [Watanabe, Kyohei] Univ Fukui Hosp, Dept Pharm, Fukui, Japan; [Takahashi, Masahiro; Morita, Machiyo] Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga 52021, Japan; [Morita, Machiyo] Shiga Univ Med Sci Hosp, Ctr Canc, Otsu, Shiga, Japan	Takahashi, T (reprint author), Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Fukui 910, Japan.	takahash@u-fukui.ac.jp					Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302; Li W, 2013, THER CLIN RISK MANAG, V9, P259, DOI 10.2147/TCRM.S43151; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Praharaj SK, 2010, PROG NEURO-PSYCHOPH, V34, P242, DOI 10.1016/j.pnpbp.2009.10.006; Hagg S, 2001, J CLIN PSYCHOPHARM, V21, P382, DOI 10.1097/00004714-200108000-00005; Palmer SE, 2008, J CLIN PSYCHIAT, V69, P759; de Leon J, 2003, PROG NEURO-PSYCHOPH, V27, P1059, DOI 10.1016/S0278-5846(03)00148-9; ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Essali A, 2009, COCHRANE DB SYST REV, V21; Hiemke C, 2011, PHARMACOPSYCHIATRY, V2011, P44195; Kwak YT, 2014, J CLIN PSYCHOPHARM, V34, P165, DOI 10.1097/JCP.0b013e3182a5959b; Liang Chih-Sung, 2011, J Psychiatry Neurosci, V36, pE1, DOI 10.1503/jpn.100133; Nayak R, 2012, J NEUROPSYCH CLIN N, V24, pE26, DOI 10.1176/appi.neuropsych.10110266; Rittmannsberger H, 1996, CLIN NEUROPHARMACOL, V19, P349, DOI 10.1097/00002826-199619040-00008; Sajatovic M, 1996, BIOL PSYCHIAT, V39, P367, DOI 10.1016/0006-3223(95)00499-8; Viikki M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-50	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	APR	2015	35	2					205	206		10.1097/JCP.0000000000000290		2	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CD6YO	WOS:000351237100023		
J	Takahashi, K; Kitamura, N; Suzuki, Y; Yamanaka, Y; Shinohara, H; Shibuya, I				Takahashi, Keita; Kitamura, Naoki; Suzuki, Yuki; Yamanaka, Yuko; Shinohara, Hikaru; Shibuya, Izumi			Activation of muscarinic acetylcholine receptors elevates intracellular Ca2+ concentrations in accessory lobe neurons of the chick	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Article						Bird; Fura-2; Muscarinic receptor; Atropine; Intracellular Ca2+ store	SPINAL-CORD; BEHAVIORAL EVIDENCE; MARGINAL NUCLEI; SENSE ORGAN; SPECIALIZATIONS; GENE; PIGEON; EQUILIBRIUM; CHANNELS; BIRDS	Accessory lobes are protrusions located at the lateral sides of the spinal cord of chicks and it has been proposed that they play a role as a sensory organ for equilibrium during walking. We have reported that functional neurons exist in the accessory lobe. As there is histological evidence that synaptic terminals of cholinergic nerves exist near the somata of accessory lobe neurons, we examined the effects of acetylcholine on changes in intracellular Ca2+ concentrations ([Ca2+](i)), as an index of cellular activities. Acetylcholine (0.1-100 A mu M) caused a transient rise in the [Ca2+](i). Acetylcholine-evoked [Ca2+](i) rises were observed in the absence of extracellular Ca2+, and they were abolished in the presence of cyclopiazonic acid, an inhibitor of Ca2+-ATPase of intracellular Ca2+ stores or atropine, a muscarinic receptor antagonist. mRNAs coding M-3 and M-5 isoforms of the muscarinic receptors were detected in accessory lobes by the RT-PCR. These results indicate that chick accessory lobe neurons express functional muscarinic acetylcholine receptors, and that acetylcholine stimulates Ca2+ mobilization from intracellular Ca2+ stores, which elevates the [Ca2+](i) in the somata of accessory lobe neurons, through activation of these receptors. Cholinergic synaptic transmission to the accessory lobe neurons may regulate some cellular functions through muscarinic receptors.	[Takahashi, Keita; Kitamura, Naoki; Suzuki, Yuki; Yamanaka, Yuko; Shinohara, Hikaru; Shibuya, Izumi] Tottori Univ, Fac Agr, Joint Dept Vet Med, Vet Physiol Lab, Tottori 6808553, Japan; [Kitamura, Naoki; Yamanaka, Yuko; Shibuya, Izumi] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 16771, Japan	Kitamura, N (reprint author), Tottori Univ, Fac Agr, Joint Dept Vet Med, Vet Physiol Lab, 4-101 Koyama Cho Minami, Tottori 6808553, Japan.	nakit@muses.tottori-u.ac.jp			KAKENHI - Japan Society for the Promotion of Science [25450463, 25450464]	We are grateful to Dr. Sam Kongsamut for critical reading of the manuscript. The animal experiments were performed in accordance with the guidelines stipulated by the ethical committee of Tottori University. This work is supported by KAKENHI provided by Japan Society for the Promotion of Science; Grant #: 25450463, 25450464.	Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Necker R, 2000, J COMP PHYSIOL A, V186, P409, DOI 10.1007/s003590050440; Necker R, 1997, J COMP NEUROL, V377, P95, DOI 10.1002/(SICI)1096-9861(19970106)377:1<95::AID-CNE9>3.0.CO;2-E; Necker R, 1999, EUR J MORPHOL, V37, P211, DOI 10.1076/ejom.37.2.211.4758; Yin GC, 2004, MOL VIS, V10, P787; CLAGUE RU, 1985, BRIT J PHARMACOL, V86, P163; Creason S, 2000, J NEUROCHEM, V74, P882, DOI 10.1046/j.1471-4159.2000.740882.x; GADBUT AP, 1994, J BIOL CHEM, V269, P25823; GAGNON J, 1992, GEN COMP ENDOCR, V85, P193, DOI 10.1016/0016-6480(92)90003-3; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147; Kayano T, 2010, J VET MED SCI, V72, P1531, DOI 10.1292/jvms.10-0196; Komori Y, 2010, CELL CALCIUM, V48, P324, DOI 10.1016/j.ceca.2010.10.002; Milinski T, 2001, BRAIN RES BULL, V56, P15, DOI 10.1016/S0361-9230(01)00587-1; Necker R, 2005, ANAT EMBRYOL, V210, P59, DOI 10.1007/s00429-005-0016-6; Necker R, 2006, J COMP PHYSIOL A, V192, P439, DOI 10.1067/s00359-006-0105-x; Necker R, 2004, ANAT EMBRYOL, V208, P169, DOI 10.1007/s00429-004-0383-4; Necker R, 2004, J CHEM NEUROANAT, V27, P109, DOI 10.1016/j.jchemneu.2004.01.003; Ozaki Y, 2009, CELL CALCIUM, V45, P209, DOI 10.1016/j.ceca.2008.10.002; Suzuki Y, 2014, J COMP PHYSIOL A, V200, P739, DOI 10.1007/s00359-014-0917-z; TIETJE KM, 1990, J BIOL CHEM, V265, P2828; TIETJE KM, 1991, J BIOL CHEM, V266, P17382; Yamanaka Y, 2012, J COMP PHYSIOL A, V198, P229, DOI 10.1007/s00359-011-0703-0; Yamanaka Y, 2013, J COMP PHYSIOL A, V199, P35, DOI 10.1007/s00359-012-0766-6; Yamanaka Y, 2008, BIOMED RES-TOKYO, V29, P205, DOI 10.2220/biomedres.29.205	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	APR	2015	201	4					385	394		10.1007/s00359-014-0971-6		10	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	CE0SQ	WOS:000351516700004		
J	Shimizu, S; Momozawa, Y; Takahashi, A; Nagasawa, T; Ashikawa, K; Terada, Y; Izumi, Y; Kobayashi, H; Tsuji, M; Kubo, M; Furuichi, Y				Shimizu, S.; Momozawa, Y.; Takahashi, A.; Nagasawa, T.; Ashikawa, K.; Terada, Y.; Izumi, Y.; Kobayashi, H.; Tsuji, M.; Kubo, M.; Furuichi, Y.			A Genome-wide Association Study of Periodontitis in a Japanese Population	JOURNAL OF DENTAL RESEARCH			English	Article						periodontal disease; disease susceptibility; SNPs; gene-environment interaction; tobacco; Asians	AGGRESSIVE PERIODONTITIS; SUSCEPTIBILITY LOCI; GENETIC-BASIS; DISEASE; RISK; VISUALIZATION; CHANNELS; LINKAGE; HEALTH	Periodontitis is a multifactorial disease in which bacterial, lifestyle, and genetic factors are involved. Although previous genetic association studies identified several susceptibility genes for periodontitis in European populations, there is little information for Asian populations. Here, we conducted a genome-wide association study and a replication study consisting of 2,760 Japanese periodontitis patients and 15,158 Japanese controls. Although single-nucleotide polymorphisms that surpassed a stringent genome-wide significance threshold (P < 5 x 10(-8)) were not identified, we found 2 suggestive loci for periodontitis: KCNQ5 on chromosome 6q13 (rs9446777, P = 4.83 x 10(-6), odds ratio = 0.82) and GPR141-NME8 at chromosome 7p14.1 (rs2392510, P = 4.17 x 10(-6), odds ratio = 0.87). A stratified analysis indicated that the GPR141-NME8 locus had a strong genetic effect on the susceptibility to generalized periodontitis in Japanese individuals with a history of smoking. In conclusion, this study identified 2 suggestive loci for periodontitis in a Japanese population. This study should contribute to a further understanding of genetic factors for enhanced susceptibility to periodontitis.	[Shimizu, S.; Momozawa, Y.; Ashikawa, K.; Kubo, M.] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Shimizu, S.; Furuichi, Y.] Hlth Sci Univ Hokkaido, Div Periodontol & Endodontol, Dept Oral Rehabil, Sch Dent, Tobetsu, Hokkaido 0610293, Japan; [Takahashi, A.] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Nagasawa, T.] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Tobetsu, Hokkaido 0610293, Japan; [Terada, Y.] Hlth Sci Univ Hokkaido, Univ Hosp, Div Gen Dent, Sapporo, Hokkaido, Japan; [Izumi, Y.; Kobayashi, H.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Tsuji, M.] Hlth Sci Univ Hokkaido, Univ Hosp, Div Internal Med, Sapporo, Hokkaido, Japan	Furuichi, Y (reprint author), Hlth Sci Univ Hokkaido, Div Periodontol & Endodontol, Dept Oral Rehabil, Sch Dent, 1757 Kanazawa, Tobetsu, Hokkaido 0610293, Japan.	furuichi@hoku-iryo-u.ac.jp			BioBank Japan project - Japanese government's Ministry of Education, Sports, Science and Technology	We thank all the individuals who participated in the study. We thank the staff of the Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN; the staff of the BioBank Japan project; and the members of the Rotary Club of Osaka-Midosuji District 2660, Rotary International, Japan. This study was supported in part by the BioBank Japan project funded by the Japanese government's Ministry of Education, Sports, Science and Technology. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Divaris K, 2013, HUM MOL GENET, V22, P2312, DOI 10.1093/hmg/ddt065; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Bosshardt DD, 2005, J DENT RES, V84, P9; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Albandar JM, 2002, PERIODONTOL 2000, V29, P153, DOI 10.1034/j.1600-0757.2002.290108.x; MICHALOWICZ BS, 1991, J PERIODONTOL, V62, P293; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Armitage GC, 2010, PERIODONTOL 2000, V53, P12, DOI 10.1111/j.1600-0757.2010.00353.x; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Teumer A, 2013, J CLIN PERIODONTOL, V40, P977, DOI 10.1111/jcpe.12154; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Stabholz A, 2010, PERIODONTOL 2000, V53, P138, DOI 10.1111/j.1600-0757.2010.00340.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Nakib SA, 2004, J PERIODONTOL, V75, P505, DOI 10.1902/jop.2004.75.4.505; Purkey MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089329; Shaffer JR, 2014, G3-GENES GENOM GENET, V4, P307, DOI 10.1534/g3.113.008755; Shiau HJ, 2010, J PERIODONTOL, V81, P1379, DOI 10.1902/jop.2010.100044; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Vaithilingam RD, 2014, J PERIODONTAL RES, V49, P683, DOI 10.1111/jre.12167	34	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	APR	2015	94	4					555	561		10.1177/0022034515570315		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE2HO	WOS:000351636500007		
J	Nagaoka, Y; Kajiya, H; Ozeki, S; Ikebe, T; Okabe, K				Nagaoka, Y.; Kajiya, H.; Ozeki, S.; Ikebe, T.; Okabe, K.			Mevalonates Restore Zoledronic Acid-induced Osteoclastogenesis Inhibition	JOURNAL OF DENTAL RESEARCH			English	Article						osteonecrosis; osteoclasts; bone remodeling; oral surgery; geranylgeranyl pyrophosphate; DC-STAMP	STIMULATORY TRANSMEMBRANE PROTEIN; BODY GIANT-CELLS; JAW-LIKE DISEASE; BONE-RESORPTION; IN-VITRO; OSTEOSARCOMA CELLS; BISPHOSPHONATES; OSTEONECROSIS; DIFFERENTIATION; RECEPTOR	Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is likely to be caused by continuous imperfection of bone healing after surgical treatments in patients with long-term administration of nitrogen-containing bisphosphonates (NBPs). NBPs inhibit osteoclastic bone resorption by impairing the mevalonic acid sterol pathway in osteoclasts. Thus, we hypothesized that exogenous mevalonic acid metabolites restore the inhibitory effects of NBPs on osteoclastogenesis and bone remodeling. To clarify the effects of mevalonic acid metabolites, especially geranylgeranyl pyrophosphate (GGPP) and geranylgeranyl transferase substrate geranylgeranyl acid (GGOH), we examined the effects of zoledronic acid with or without GGOH or GGPP on osteoclast differentiation, multinucleation, and bone mineral deposition in tooth-extracted sockets. Zoledronic acid decreased the number of tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cells derived from mouse osteoclast precursors treated with receptor activator of nuclear factor-B ligand and macrophage colony-stimulating factor. Zoledronic acid simultaneously suppressed not only the expressions of osteoclastic differentiation-related molecules such as TRAP, cathepsin K, calcitonin receptor, and vacuolar H-ATPase but also those of multinucleation-related molecules such as dendrocyte-expressed 7 transmembrane proteins and osteoclast stimulatory transmembrane protein. Treatment with GGOH or GGPP, but not farnesyl acid, restored the zoledronic acid-inhibited number of TRAP-positive multinuclear cells together with the expressions of these molecules. Although intraperitoneal administration of zoledronic acid and lipopolysaccharide into mice appeared to induce BRONJ-like lesions with empty bone lacunae and decreased mineral deposition in tooth-extracted socket, both GGOH and GGPP partially restored the inhibitory effects on zoledronic acid-related mineral deposition. These results suggest the potential of mevalonic acid metabolites as therapeutic agents for BRONJ.	[Nagaoka, Y.; Kajiya, H.; Okabe, K.] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka 8140193, Japan; [Nagaoka, Y.; Ozeki, S.; Ikebe, T.] Fukuoka Dent Coll, Dept Oral & Maxillofacial Surg, Fukuoka 8140193, Japan	Kajiya, H (reprint author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, Tamura 2-15-1, Fukuoka 8140193, Japan.	kajiya@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592823, 23390468]; Japan Society for the Promotion of Science [S1001059]	This work was supported by grant-in-aids for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 24592823 and 23390468) and by a grant-in-aid for strategic study base formation support business (S1001059) from the Japan Society for the Promotion of Science. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Allegra A, 2010, ACTA HAEMATOL-BASEL, V124, P79, DOI 10.1159/000313787; Ziebart T, 2011, ORAL ONCOL, V47, P195, DOI 10.1016/j.oraloncology.2010.12.003; Abe K, 2012, INT J MOL MED, V29, P1007, DOI 10.3892/ijmm.2012.952; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Baron R, 2012, NAT REV ENDOCRINOL, V8, P76, DOI 10.1038/nrendo.2011.207; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Benassi MS, 2007, CANCER LETT, V250, P194, DOI 10.1016/j.canlet.2006.10.004; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Mori K, 2007, J PATHOL, V211, P555, DOI 10.1002/path.2140; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Kimachi K, 2011, N-S ARCH PHARMACOL, V383, P297, DOI 10.1007/s00210-010-0596-4; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Reid IR, 2007, BONE, V41, P318, DOI 10.1016/j.bone.2007.04.196; Kim RH, 2011, J DENT RES, V90, P810, DOI 10.1177/0022034511402995; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Benford HL, 2001, BONE, V28, P465, DOI 10.1016/S8756-3282(01)00412-4; Fusco V, 2011, J CLIN ONCOL, V29, pE521, DOI 10.1200/JCO.2011.35.1551; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Nishimura M, 1999, KIDNEY INT, V55, P520, DOI 10.1046/j.1523-1755.1999.00292.x; Reszka AA, 2001, MOL PHARMACOL, V59, P193; Tatsuno I, 1997, BIOCHEM BIOPH RES CO, V241, P376, DOI 10.1006/bbrc.1997.7825; Yoshida T, 2006, FEBS LETT, V580, P5203, DOI 10.1016/j.febslet.2006.08.060; Zafar S, 2014, J ORAL PATHOL MED, V43, P711, DOI 10.1111/jop.12181	40	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	APR	2015	94	4					594	601		10.1177/0022034514564187		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE2HO	WOS:000351636500012		
J	Kitasako, Y; Sasaki, Y; Takagaki, T; Sadr, A; Tagami, J				Kitasako, Yuichi; Sasaki, Yoshiyuki; Takagaki, Tomohiro; Sadr, Alireza; Tagami, Junji			Age-specific prevalence of erosive tooth wear by acidic diet and gastroesophageal reflux in Japan	JOURNAL OF DENTISTRY			English	Article						Dental erosion; Tooth wear; Prevalence; Diet; Gastric disease	DENTAL EROSION; 12-YEAR-OLD CHILDREN; RISK INDICATORS; IN-VITRO; ADULTS; INDEX; HAGUE	Objectives: To evaluate the age-specific prevalence of erosive tooth wear in Japanese adults. Methods: The study sample consisted of a total of 1108 adults aged 15-89 yrs in Tokyo, Japan. The subjects were asked to complete a self-administered nutrition-related questionnaire. Two examiners evaluated tooth wear in a full-mouth recording, using a modified tooth wear index developed based on the Smith and Knight Tooth Wear index. Subjects who had frequent acid consumption or gastric reflux and at least one tooth with an initial enamel wear were placed in an erosive wear positive group, and the rest of subjects were placed in the erosive wear negative group. Results: The median (IQR) prevalence of erosion was 19.1 (1.8) at enamel level and 6.5 (3.7) with dentin exposure. There were statistical differences in prevalence of erosive wear among different age groups (p < 0.05). Dietary habits found to be frequent in erosive wear positive group included acidic juices for younger subjects (15-39 yrs), and acidic fruits for older subjects (60-89 yrs). The prevalence of gastroesophageal reflux and eating disorder was 3.5%. A severe loss of dental tissue was observed on labial and incisal surfaces of anterior teeth in the erosive wear positive group. Conclusions: In the studied sample of Japanese adults, 26.1% had signs of erosive wear. Clinical significance: Erosive wear, in combination with abrasion and attrition, results in severe loss of tooth tissue. Frequent consumption of acidic fruits and drinks was significantly associated with erosive tooth wear at different age groups. (C) 2015 Elsevier Ltd. All rights reserved.	[Kitasako, Yuichi; Takagaki, Tomohiro; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Restorat Sci, Cariol & Operat Dent, Tokyo 1138549, Japan; [Sasaki, Yoshiyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial & Neck Reconstruct, Maxillofacial Orthognath, Tokyo 1138549, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Tokyo 1138549, Japan	Kitasako, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Restorat Sci, Cariol & Operat Dent,Bunkyo Ku, 5-45 Yushima 1-Chome, Tokyo 1138549, Japan.	kitasako.ope@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [25462946]	We thank the subjects who took part in this study. This study was supported by a Grant-in-Aid for Scientific Research (No. 25462946) from the Japan Society for the Promotion of Science (JSPS).	Al-Dlaigan YH, 2001, BRIT DENT J, V190, P258; tenCate JM, 1996, EUR J ORAL SCI, V104, P241; van Rijkom HM, 2002, CARIES RES, V36, P147, DOI 10.1159/000057874; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Dugmore CR, 2004, BRIT DENT J, V196, P279, DOI 10.1038/sj.bdj.4811040; Bartlett DW, 2013, J DENT, V41, P1007, DOI 10.1016/j.jdent.2013.08.018; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Johansson AK, 2012, EUR J ORAL SCI, V120, P61, DOI 10.1111/j.1600-0722.2011.00922.x; El Aidi H, 2011, CARIES RES, V45, P303, DOI 10.1159/000328671; Mantonanaki M, 2013, CLIN ORAL INVEST, V17, P585, DOI 10.1007/s00784-012-0730-4; Mulic A, 2012, EUR J ORAL SCI, V120, P531, DOI 10.1111/j.1600-0722.2012.00997.x; Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Huysmans MCDNJM, 2011, CARIES RES, V45, P60, DOI 10.1159/000325947; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Smith BGN, 1996, J ORAL REHABIL, V23, P232, DOI 10.1111/j.1365-2842.1996.tb00846.x; Bartlett DW, 2001, J ORAL REHABIL, V28, P1045, DOI 10.1046/j.1365-2842.2001.00780.x; Truin GJ, 2005, CARIES RES, V39, P2, DOI 10.1159/000081650; Barbour Michele E, 2014, Monogr Oral Sci, V25, P143, DOI 10.1159/000359941; El Aidi H, 2011, J DENT, V39, P558, DOI 10.1016/j.jdent.2011.06.001; Fares J, 2009, CARIES RES, V43, P119, DOI 10.1159/000209344; Ganss C, 2008, CLIN ORAL INVEST, V12, pS1, DOI 10.1007/s00784-007-0182-4; Ganss Carolina, 2014, Monogr Oral Sci, V25, P22, DOI 10.1159/000359935; Jaeggi Thomas, 2014, Monogr Oral Sci, V25, P55, DOI 10.1159/000360973; LUSSI A, 1991, COMMUNITY DENT ORAL, V19, P286, DOI 10.1111/j.1600-0528.1991.tb00169.x; Lussi A., 2004, Caries Research, V38, P34, DOI 10.1159/000074360; Lussi Adrian, 2014, Monogr Oral Sci, V25, P220, DOI 10.1159/000360612; Lussi Adrian, 2014, Monogr Oral Sci, V25, P1, DOI 10.1159/000360380; Margaritis Vasileios, 2014, Monogr Oral Sci, V25, P46, DOI 10.1159/000359937; Schlueter Nadine, 2014, Monogr Oral Sci, V25, P74, DOI 10.1159/000359938; Shellis R Peter, 2014, Monogr Oral Sci, V25, P32, DOI 10.1159/000359936; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; West NX, 2000, J ORAL REHABIL, V27, P875, DOI 10.1046/j.1365-2842.2000.00583.x; XHONGA FA, 1983, J ORAL REHABIL, V10, P269, DOI 10.1111/j.1365-2842.1983.tb00121.x	33	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	APR	2015	43	4					418	423		10.1016/j.jdent.2015.02.004		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE3EN	WOS:000351708700004		
J	Nakamura, T; Hashizume, M; Ueda, K; Kubo, T; Shimizu, A; Okamura, T; Nishiwaki, Y				Nakamura, Takahiro; Hashizume, Masahiro; Ueda, Kayo; Kubo, Tatsuhiko; Shimizu, Atsushi; Okamura, Tomonori; Nishiwaki, Yuji			The Relationship Between Asian Dust Events and Out-of-Hospital Cardiac Arrests in Japan	JOURNAL OF EPIDEMIOLOGY			English	Article						Asian dust; Utstein-Style data; out-of-hospital cardiac arrest; case crossover analysis	AIR-POLLUTION; DAILY MORTALITY; CASE-CROSSOVER; WESTERN JAPAN; STORM EVENTS; SAND DUST; ASSOCIATION; STROKE; KOREA	Background: Asian dust events are caused by dust storms that originate in the deserts of China and Mongolia and drift across East Asia. We hypothesized that the dust events would increase incidence of out-of-hospital cardiac arrests by triggering acute events or exacerbating chronic diseases. Methods: We analyzed the Utstein-Style data collected in 2005 to 2008 from seven prefectures covering almost the entire length of Japan to investigate the effect of Asian dust events on out-of-hospital cardiac arrests. Asian dust events were defined by the measurement of light detection and ranging. A time-stratified case-crossover analysis was performed. The strength of the association between Asian dust events and out-of-hospital cardiac arrests was shown by odds ratios and 95% confidence intervals in two conditional logistic models. A pooled estimate was obtained from area-specific results by random-effect meta-analysis. Results: The total number of cases of out-of-hospital cardiac arrest was 59 273, of which 35 460 were in men and 23 813 were in women. The total number of event days during the study period was smallest in Miyagi and Niigata and largest in Shimane and Nagasaki. There was no significant relationship between Asian dust events and out-of-hospital cardiac arrests by area in either of the models. In the pooled analysis, the highest odds ratios were observed at lag day 1 in both model 1 (OR 1.07; 95% CI, 0.97-1.19) and model 2 (OR 1.08; 95% CI, 0.97-1.20). However, these results were not statistically significant. Conclusions: We found no evidence of an association between Asian dust events and out-of-hospital cardiac arrests.	[Nakamura, Takahiro; Nishiwaki, Yuji] Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Tokyo 1438540, Japan; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Paediat Infect Dis, Nagasaki 852, Japan; [Ueda, Kayo] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Kyoto, Japan; [Kubo, Tatsuhiko] Univ Occupat & Environm Hlth, Dept Publ Hlth, Fukuoka, Japan; [Shimizu, Atsushi] Natl Inst Environm Studies, Ctr Reg Environm Res, Reg Atmospher Environm Sect, Tsukuba, Ibaraki, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Heath, Tokyo, Japan	Nishiwaki, Y (reprint author), Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	yuuji.nishiwaki@med.toho-u.ac.jp	Okamura, Tomonori/L-1693-2013				[Anonymous], 2004, J GEOPHYS RES, DOI [10.1029/2002JD003253, DOI 10.1029/2002JD003253]; Kashima S, 2012, OCCUP ENVIRON MED, V69, P908, DOI 10.1136/oemed-2012-100797; Mar TF, 2000, ENVIRON HEALTH PERSP, V108, P347, DOI 10.2307/3454354; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Kwon HJ, 2002, ENVIRON RES, V90, P1, DOI 10.1006/enrs.2002.4377; Honda A, 2014, J APPL TOXICOL, V34, P250, DOI 10.1002/jat.2871; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.edu.0000181315.18836.9d; Kamouchi M, 2012, STROKE, V43, P3085, DOI 10.1161/STROKEAHA.112.672501; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Kang JH, 2012, ANN EPIDEMIOL, V22, P257, DOI 10.1016/j.annepidem.2012.02.008; Yamazaki S, 2013, ENVIRON HEALTH PREV, V18, P401, DOI 10.1007/s12199-013-0339-5; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Hashizume Masahiro, 2010, Nihon Eiseigaku Zasshi, V65, P413; Hashizume M, 2014, EAROZORU KENKYU, V29, P225; Hwang Seung-Sik, 2005, J Prev Med Public Health, V38, P197; Lee S, 2009, SCI TOTAL ENVIRON, V407, P5308, DOI 10.1016/j.scitotenv.2009.06.052; Matsukawa R, 2014, CIRC-CARDIOVASC QUAL, V7, P743, DOI 10.1161/CIRCOUTCOMES.114.000921; Ueda K, 2014, EAROZORU KENKYU, V29, P230	21	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					289	296		10.2188/jea.JE20140179		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100004		
J	Kabeya, Y; Kato, K; Tomita, M; Katsuki, T; Oikawa, Y; Shimada, A				Kabeya, Yusuke; Kato, Kiyoe; Tomita, Masuomi; Katsuki, Takeshi; Oikawa, Yoichi; Shimada, Akira			Association Between Diabetes and Increased Prevalence of Paranasal Sinus Disease: A Cross-Sectional Study in Japanese Adults	JOURNAL OF EPIDEMIOLOGY			English	Article						diabetes; glycemic status; paranasal sinus disease	PARA-NASAL SINUSES; INCIDENTAL ABNORMALITIES; COMMON INFECTIONS; MELLITUS; MRI; PNEUMONIA; SYMPTOMS; PROGRAM; BRAIN; LUNG	Background: The association between diabetes and paranasal sinus disease has not been thoroughly investigated. Methods: We cross-sectionally investigated the association between diabetes and the presence of paranasal sinus disease, which was confirmed by a head MRI scan in 1350 adults who underwent a health screening program focusing on brain diseases and metabolic syndrome. Logistic regression, which was adjusted for age, sex, body mass index, waist-to-hip ratio, hypertension, smoking status, alcohol intake, and white blood cell count, was performed to calculate the odds ratio (OR) of having paranasal sinus disease among adults with diabetes in relation to those without. The dose-response relationship between hemoglobin A1c (HbA1c) levels and the presence of paranasal sinus disease was also investigated. Results: Of the 1350 participants (mean age, 61.6 +/- 10.0 years; 71.6% men), 220 diabetes cases were identified. Paranasal sinus disease was diagnosed in 151 adults. The adjusted OR of having paranasal sinus disease was 1.74 (95% confidence interval [CI], 1.12-2.71) in those with diabetes. The odds of having paranasal sinus disease increased with HbA1c levels. Compared to those with HbA1c of <= 5.4%, those with HbA1c of 5.5%-6.4%, 6.5%-7.9%, and >= 8.0% were more likely to have paranasal sinus disease, with adjusted ORs of 1.32 (95% CI, 0.88-1.98), 1.63 (95% CI, 0.86-3.09) and 2.71 (95% CI, 1.12-6.61), respectively (P for trend = 0.019). Conclusions: Diabetes may be significantly associated with higher prevalence of paranasal sinus disease in Japanese adults. We should keep this increased risk in mind when a diabetic patient is suspected of having paranasal sinus disease.	[Kabeya, Yusuke; Kato, Kiyoe; Tomita, Masuomi; Katsuki, Takeshi; Oikawa, Yoichi; Shimada, Akira] Tokyo Saiseikai Cent Hosp, Dept Internal Med, Tokyo 1080073, Japan	Kabeya, Y (reprint author), Tokyo Saiseikai Cent Hosp, Dept Internal Med, Minato Ku, 1-4-17 Mita, Tokyo 1080073, Japan.	ykabeyan@yahoo.co.jp					Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; HAVAS TE, 1988, ARCH OTOLARYNGOL, V114, P856; Weynand B, 1999, RESPIRATION, V66, P14, DOI 10.1159/000029331; RAK KM, 1991, AM J ROENTGENOL, V156, P381; OFULUE AF, 1988, AM REV RESPIR DIS, V138, P284; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; KOZIEL H, 1995, INFECT DIS CLIN N AM, V9, P65; CONNER BL, 1989, ANN ALLERGY, V62, P457; COOKE LD, 1991, J LARYNGOL OTOL, V105, P278, DOI 10.1017/S0022215100115609; del Rio A, 2012, RHINOLOGY, V50, P319, DOI 10.4193/Rhino11.270; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; FLEMING DM, 1991, J EPIDEMIOL COMMUN H, V45, P73, DOI 10.1136/jech.45.1.73; Hashimoto Yoshiaki, 2010, Diabetes Care, V33, pe143, DOI 10.2337/dc10-1338; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kabeya Y, 2014, J EPIDEMIOL, V24, P410, DOI 10.2188/jea.JE20140016; Kabeya Y, 2013, DIABETOL INT, V4, P106; Ljubic Spomenka, 2005, Diabetologia Croatica, V33, P115; MALY PV, 1995, NEURORADIOLOGY, V37, P471; Marvisi M, 2001, RESPIRATION, V68, P268, DOI 10.1159/000050509; MOSER FG, 1991, CLIN RADIOL, V43, P252, DOI 10.1016/S0009-9260(05)80249-1; Tarp B, 2000, RHINOLOGY, V38, P33; Wani MK, 2001, J OTOLARYNGOL, V30, P257, DOI 10.2310/7070.2001.19676; Watanakunakorn C, 1997, ARCH INTERN MED, V157, P1965, DOI 10.1001/archinte.157.17.1965	24	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					297	302		10.2188/jea.JE20140163		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100005		
J	Higashiyama, A; Kubota, Y; Marumo, M; Konishi, M; Yamashita, Y; Nishimura, K; Fukuda, Y; Okamura, T; Wakabayashi, I				Higashiyama, Aya; Kubota, Yoshimi; Marumo, Mikio; Konishi, Masami; Yamashita, Yoshiko; Nishimura, Kunihiro; Fukuda, Yoshihiro; Okamura, Tomonori; Wakabayashi, Ichiro			Association Between Serum Long-Chain n-3 and n-6 Polyunsaturated Fatty Acid Profiles and Glomerular Filtration Rate Assessed by Serum Creatinine and Cystatin C Levels in Japanese Community-Dwellers	JOURNAL OF EPIDEMIOLOGY			English	Article						epidemiology; (EPA plus DHA):AA; population-based study	CHRONIC KIDNEY-DISEASE; ARACHIDONIC-ACID; NITRIC-OXIDE; FISH INTAKE; EVENTS; RISK; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PREVALENCE; BETA	Background: Plasma concentration of n-3 polyunsaturated fatty acids ( PUFAs) has been reported to be associated with renal function in Western populations. However, few studies have investigated the association between serum long-chain n-3 and n-6 PUFA profiles and renal function in a Japanese population with high marine-derived longchain n-3 PUFA intake. Methods: A cross-sectional study was performed in 549 Japanese rural community-dwellers aged 40 to 64 years. In adjusted analysis of covariance, we assessed the relationship between estimated glomerular filtration rate ( eGFR) and tertiles of serum long-chain n-3 and n-6 PUFA profiles ([ eicosapentaenoic acid {EPA} + docosahexaenoic acid {DHA}]: arachidonic acid [ AA]). GFR was estimated by Japanese specific equations using serum creatinine and cystatin C ( eGFR(cre) and eGFR(cys)). Using multivariate-adjusted linear regression models, we also assessed the relationships between eGFRs and several n-3 and n-6 PUFAs, which have been suggested to be associated with renal function. Results: In all participants, higher dietary fish intake as assessed by a semi-quantitative questionnaire was associated with higher serum value of ( EPA+ DHA): AA. Participants in the higher ( EPA+ DHA): AA tertiles had non-significantly higher eGFRcre and significantly higher eGFRcys ( P = 0.016). In addition, eGFRcys in T2+ T3 of ( EPA+ DHA): AA was significantly higher than that in T1 ( adjusted mean eGFRcys, T1: 87 ml/ min/ 1.73m2, T2+ T3: 91 ml/ min/ 1.73m2; P < 0.01). Among the PUFAs, only ( EPA+ DHA) was significantly associated with eGFRcys. Conclusions: Serum ( EPA+ DHA): AA, which reflects an individual's fish intake, might be associated with eGFRcys in Japanese community-dwellers.	[Higashiyama, Aya; Kubota, Yoshimi; Marumo, Mikio; Wakabayashi, Ichiro] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Higashiyama, Aya; Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Kubota, Yoshimi] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat, Dept Res & Dev Preempt & Prevent Med, Kobe, Hyogo, Japan; [Konishi, Masami; Yamashita, Yoshiko] Sasayama City Off, Sasayama, Hyogo, Japan; [Fukuda, Yoshihiro] Hyogo Coll Med, Dept Gen Med & Community Hlth Sci, Sasayama, Hyogo, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Higashiyama, A (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ahigashi@hyo-med.ac.jp	Okamura, Tomonori/L-1693-2013				Shoji T, 2013, AM J KIDNEY DIS, V62, P568, DOI 10.1053/j.ajkd.2013.02.362; Serikawa T, 2014, J CARDIOL, V63, P35, DOI 10.1016/j.jjcc.2013.06.016; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Manger MS, 2010, AM J CLIN NUTR, V92, P244, DOI 10.3945/ajcn.2010.29175; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Nakamura Y, 2005, AM J MED, V118, P239, DOI 10.1016/j.amjmed.2004.12.016; Das UN, 2004, EUR J CLIN NUTR, V58, P195, DOI 10.1038/sj.ejcn.1601766; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Nurk E, 2007, AM J CLIN NUTR, V86, P1470; ISO H, 1989, INT J EPIDEMIOL, V18, P374, DOI 10.1093/ije/18.2.374; Cicero AFG, 2010, CLIN EXP HYPERTENS, V32, P137, DOI 10.3109/10641960903254448; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; DONADIO JV, 1994, NEW ENGL J MED, V331, P1194, DOI 10.1056/NEJM199411033311804; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S; deJonge HW, 1996, MOL CELL BIOCHEM, V157, P199; Gopinath B, 2011, BRIT J NUTR, V105, P1361, DOI 10.1017/S0007114510005040; Grande JP, 2000, KIDNEY INT, V57, P1027, DOI 10.1046/j.1523-1755.2000.00930.x; Hsu CC, 2014, CLIN NUTR, V33, P98, DOI 10.1016/j.clnu.2013.04.010; Japan Nephrology Society, 2012, NIHON JINZO GAKKAI S, V54, P1034; Kashiyama T, 2011, CIRC J, V75, P2432, DOI 10.1253/circj.CJ-11-0352; Kielar ML, 2003, J AM SOC NEPHROL, V14, P389, DOI 10.1097/01.ASN.0000045047.44107.0B; Lauretani F, 2008, CLIN CHEM, V54, P475, DOI 10.1373/clinchem.2007.095521; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; OZAWA A, 1982, BUNSEKI KAGAKU, V31, P87; Statistics and Information Department Minister Secretariat Ministry of Health Labor and Welfare, VIT STAT JAP TRENDS; Tanaka M, 2004, CLIN BIOCHEM, V37, P27, DOI 10.1016/j.clinbiochem.2003.08.001; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431	32	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					303	311		10.2188/jea.JE20140093		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100006		
J	Ma, EB; Ren, LP; Wang, WS; Takahashi, H; Wagatsuma, Y; Ren, YL; Gao, F; Gao, FF; Wang, WR; Bi, LF				Ma, Enbo; Ren, Liping; Wang, Wensheng; Takahashi, Hideto; Wagatsuma, Yukiko; Ren, Yulin; Gao, Fei; Gao, Fangfang; Wang, Wenrui; Bi, Lifu			Demographic and Socioeconomic Disparity in Knowledge About Tuberculosis in Inner Mongolia, China	JOURNAL OF EPIDEMIOLOGY			English	Article						tuberculosis; knowledge; ethnic groups; media source; China	PERCEPTIONS; POPULATION; STIGMA; RISK	Background: The aim of this study is to evaluate the awareness status, attitudes, and care-seeking behaviors concerning tuberculosis (TB) and associated factors among the public in Inner Mongolia, China. Methods: A five-stage sampling was conducted, in which counties as the primary survey units and towns, villages, and households as sub-survey units were selected progressively. A standardized questionnaire was used to collect TB information. Complex survey analysis methods, including the procedures of survey frequency and survey logistic regression, were applied for analysis of TB knowledge and associated factors. The sample was weighted by survey design, non-respondent, and post-stratification adjustment. Results: Among 10 581 respondents, awareness that TB is an infectious disease was 86.7%. Knowing that a cough lasting >= 3 weeks is suggestive of TB was 26.9%. Knowledge about TB dispensaries in county administrative areas was reported by 68.3% of respondents, and knowledge about the free TB detection/treatment policy was reported by 57.5% of respondents. About 52.5% of participants would stigmatize TB patients. Compared with the majority Han ethnic group, Mongolians and other minorities were 1.52-2.18 times more likely to know about TB curability, TB symptoms, the free detection/ treatment policy, and TB dispensaries' locations, but were less likely to know about the TB transmission mode (odds ratio, 0.74; 95% confidence interval, 0.65-0.84). The main sources of TB information were TV (65.6%) and other persons (47.2%). In the past year, 19.7% of TB knowledge was from acquaintances, and 16.1% was from TB institutes. Conclusions: Improvement in knowledge about TB risk (symptoms and transmission), the free treatment policy, and facilities is necessary and should be provided through effective multimedia for different target populations.	[Ma, Enbo; Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Ren, Liping; Ren, Yulin; Gao, Fei; Gao, Fangfang] Inner Mongolia Ctr TB Control & Prevent, Hohhot, Peoples R China; [Wang, Wensheng; Gao, Fei; Gao, Fangfang] Inner Mongolia Fourth Hosp, Hohhot, Peoples R China; [Takahashi, Hideto] Fukushima Med Univ, Sch Med, Fukushima, Japan; [Wang, Wenrui] Inner Mongolia Ctr Dis Control & Prevent, Hohhot, Peoples R China; [Bi, Lifu] Inner Mongolia Autonomous Reg Dept Hlth, Hohhot, Peoples R China	Ma, EB (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mae@md.tsukuba.ac.jp					Suleiman MMA, 2013, INT J TUBERC LUNG D, V17, P388, DOI 10.5588/ijtld.12.0654; Ailinger RL, 2003, PUBLIC HEALTH NURS, V20, P211, DOI 10.1046/j.0737-1209.2003.20308.x; Getahun H, 1999, ETHIOPIAN MED J, V37, P147; Chen XY, 2004, LANCET, V364, P417; Zhang TH, 2007, HEALTH POLICY, V81, P155, DOI 10.1016/j.healthpol.2005.12.009; [Anonymous], 1992, CHIN J TUBERC RESP D, V15, P39; Christodoulou M, 2011, LANCET INFECT DIS, V11, P663; Chee CBE, 2012, SINGAP MED J, V53, P505; Cheng SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067516; Gan P, 2008, CHINA TUBERCULOSIS C, V30, P194; Godfrey-Faussett P, 2002, Int J Tuberc Lung Dis, V6, P796; Hoa Nguyen Phuong, 2009, Health Policy, V90, P8, DOI 10.1016/j.healthpol.2008.08.006; Inner Mongolia Statistical Bureau, 2001, INN MONG CENS 2000; Inner Mongolia Tuberculosis Research Institute, 2008, YB TUB CONTR PREV IN, V2008, P6; Kurspahić-Mujčić Amira, 2013, Med Glas (Zenica), V10, P272; Li X, 2009, CHINA TUBERCULOSIS C, V31, P126; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Lu SH, 2009, INT J TUBERC LUNG D, V13, P1493; Marks SM, 2008, INT J TUBERC LUNG D, V12, P1261; Marks SM, 2008, AM J PUBLIC HEALTH, V98, P1068, DOI 10.2105/AJPH.2006.096123; RAO K, 1992, HEAT TRANSFER ENG, V13, P9; Shetty N, 2004, Commun Dis Public Health, V7, P77; Stop TB Partnership and World Health Organization, 2011, GLOBAL PLAN STOP TB; Strand Mark A, 2010, Int Q Community Health Educ, V31, P279, DOI 10.2190/IQ.31.3.f; Tobe RG, 2011, BIOSCI TRENDS, V5, P226, DOI 10.5582/bst.2011.v5.6.226; Vukovic D, 2008, EUR J CLIN MICROBIOL, V27, P761, DOI 10.1007/s10096-008-0511-9; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Zhang X, 2008, CHINA TUBERCULOSIS C, V30, P2	29	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					312	320		10.2188/jea.JE20140033		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100007		
J	Zhu, B; Haruyama, Y; Muto, T; Yamazaki, T				Zhu, Bing; Haruyama, Yasuo; Muto, Takashi; Yamazaki, Takako			Association Between Eating Speed and Metabolic Syndrome in a Three-Year Population-Based Cohort Study	JOURNAL OF EPIDEMIOLOGY			English	Article						eating speed; metabolic syndrome; cohort study; risk factor; epidemiology	AGED JAPANESE MEN; TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; INTERVENTION PROGRAM; INSULIN-RESISTANCE; HEART-DISEASE; LIFE-STYLE; FAST LEADS; PREVALENCE; RISK	Background: Metabolic syndrome has received increased global attention over the past few years. Eating behaviors, particularly eating speed, have long been of interest as factors that contribute to the development of obesity and diabetes. The aim of this study was to assess the relationship between eating speed and incidence of metabolic syndrome among middle-aged and elderly Japanese people. Methods: A total of 8941 community residents from Soka City in Saitama Prefecture, aged from 40 to 75 years and without a diagnosis of metabolic syndrome, participated in the baseline survey in 2008 and were followed until 2011. Anthropometric measurements and lifestyle factors were measured at baseline and follow-up. The association between eating speed and incidence of metabolic syndrome was evaluated using Cox proportional hazards models adjusted for potential confounding variables. Results: During the 3-year follow-up, 647 people were diagnosed with metabolic syndrome (25.0 cases/1000 person-years). The incidence rates of metabolic syndrome among non-fast-eating and fast-eating participants were 2.3% and 3.1%, respectively. The multivariate-adjusted hazard ratio for incidence of metabolic syndrome in the fast-eating group compared to the not-fast-eating group was 1.30 (95% confidence interval [CI], 1.05-1.60) after adjustment for the potential confounding factors. Eating speed was significantly correlated with waist circumference and high-density lipoprotein cholesterol (HDL-C) components of metabolic risk factors. Hazard ratios in the fast-eating group compared with the reference group were 1.35 (95% CI, 1.10-1.66) for waist circumference and 1.37 (95% CI, 1.12-1.67) for HDL-C. Conclusions: Eating speed was associated with the incidence of metabolic syndrome. Eating slowly is therefore suggested to be an important lifestyle factor for preventing metabolic syndrome among the Japanese.	[Zhu, Bing] Anhui Prov Ctr Dis Control & Prevent, Dept Hlth Educ, Hefei, Peoples R China; [Haruyama, Yasuo; Muto, Takashi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi 3210293, Japan; [Yamazaki, Takako] Hlth Ctr Soka City, Div Hlth Promot, Soka, Saitama, Japan	Haruyama, Y (reprint author), Dokkyo Med Univ, Sch Med, Dept Publ Hlth, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	yasuo-h@dokkyomed.ac.jp			Soka City	This study was supported by grants from Soka City.	Kral JG, 2001, INT J OBESITY, V25, P258, DOI 10.1038/sj.ijo.0801469; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Hsieh SD, 2011, PUBLIC HEALTH NUTR, V14, P1266, DOI 10.1017/S1368980010003824; Sakurai M, 2012, METABOLISM, V61, P1566, DOI 10.1016/j.metabol.2012.04.005; Shigeta H, 2001, DIABETES CARE, V24, P608, DOI 10.2337/diacare.24.3.608; Tanihara S, 2011, APPETITE, V57, P179, DOI 10.1016/j.appet.2011.04.017; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Meigs JB, 2003, DIABETES, V52, P2160, DOI 10.2337/diabetes.52.8.2160; Shiwaku K, 2005, J OCCUP HEALTH, V47, P126, DOI 10.1539/joh.47.126; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Takayama S, 2002, J INT MED RES, V30, P442; Gerace TA, 1996, PREV MED, V25, P593, DOI 10.1006/pmed.1996.0094; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; DUNCAN KH, 1983, AM J CLIN NUTR, V37, P763; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haruyama Y, 2009, TOHOKU J EXP MED, V217, P259, DOI 10.1620/tjem.217.259; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Lee Hye Ah, 2011, J Prev Med Public Health, V44, P226, DOI 10.3961/jpmph.2011.44.5.226; Maruyama K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2002; Ministry of Education Culture Sports Science and Technology; Ministry of Health Labour and Welfare of Japan, 2014, ETH GUID EPID RES; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Radzeviciene L, 2013, CLIN NUTR, V32, P232, DOI 10.1016/j.clnu.2012.06.013; Sugimori H, 2004, PEDIATR INT, V46, P302, DOI 10.1111/j.1442-200x.2004.01895.x; Zhu B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-219	26	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					332	336		10.2188/jea.JE20140131		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100009		
J	Yoneoka, D; Saito, E				Yoneoka, Daisuke; Saito, Eiko			A Statistical Note on Analyzing and Interpreting Individual-Level Epidemiological Data	JOURNAL OF EPIDEMIOLOGY			English	Editorial Material							LOGISTIC-REGRESSION MODELS; COX REGRESSION; LIKELIHOOD		[Yoneoka, Daisuke] SOKENDAI Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tachikawa, Tokyo, Japan; [Saito, Eiko] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Yoneoka, D (reprint author), Grad Univ Adv Studies, Dept Stat Sci, Sch Adv Sci, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	yoneoka.daisuke@ism.ac.jp		Yoneoka, Daisuke/0000-0002-3525-5092			ALBERT A, 1984, BIOMETRIKA, V71, P1; Amemiya T, 1985, ADV ECONOMETRICS; Zamar D, 2007, J STAT SOFTW, V21, P1; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; TSIATIS AA, 1981, ANN STAT, V9, P93, DOI 10.1214/aos/1176345335; Armstrong JS, 2008, WHY WE DONT REALLY K; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Heinze G, 2002, COMPUT METH PROG BIO, V67, P217, DOI 10.1016/S0169-2607(01)00149-3; Lin M, 2013, TOO BIG FAIL LARGE S; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1	13	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					337	338		10.2188/jea.JE20140265		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100010		
J	Noda, H				Noda, Hiroyuki			The Japanese Government's "Good Sleep" Challenge: Sleep Guidelines for Health Promotion 2014	JOURNAL OF EPIDEMIOLOGY			English	Editorial Material							SHIFT WORK; METAANALYSIS; RISK		[Noda, Hiroyuki] Minist Hlth Labour & Welf, Hlth Serv Bur, Canc Control & Hlth Promot Div, Tokyo 1008916, Japan; [Noda, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Suita, Osaka, Japan	Noda, H (reprint author), Minist Hlth Labour & Welf, Hlth Serv Bur, Canc Control & Hlth Promot Div, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	noda-hiroyukiaa@mhlw.go.jp					Dong JY, 2013, ATHEROSCLEROSIS, V229, P489, DOI 10.1016/j.atherosclerosis.2013.04.026; Fukuda K, 2001, PSYCHIAT CLIN NEUROS, V55, P231, DOI 10.1046/j.1440-1819.2001.00837.x; Ikehara S, 2009, SLEEP, V32, P295; Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283; Yoshiike T, 2014, PSYCHOPHYSIOLOGY, V51, P396, DOI 10.1111/psyp.12180; Ministry of Health Labour and Welfare, 2002, SURV HLTH WELF TREND; Ministry of Health Labour and Welfare Health Service Bureau, 2014, SLEEP GUID HLTH PROM; Tanigawa Takeshi, 2011, EPMA J, V2, P83, DOI 10.1007/s13167-011-0073-2; Vyas MV, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4800; World Health Organisation, 2013, GLOB ACT PLAN PREV C	10	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	APR	2015	25	4					339	340		10.2188/jea.JE20140217		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE4AP	WOS:000351773100011		
J	Anderson, W; Barros, JM; Christensen, KT; Awasthi, A				Anderson, William; Barros, Julio M.; Christensen, Kenneth T.; Awasthi, Ankit			Numerical and experimental study of mechanisms responsible for turbulent secondary flows in boundary layer flows over spanwise heterogeneous roughness	JOURNAL OF FLUID MECHANICS			English	Article						turbulent boundary layers; turbulent flows	LARGE-EDDY SIMULATION; SCALE 3-DIMENSIONAL STRUCTURES; SURFACE-ROUGHNESS; WALL TURBULENCE; VORTEX PACKETS; CHANNEL FLOW; ORGANIZATION; VORTICITY; CURRENTS; REGION	We study the dynamics of turbulent boundary layer flow over a heterogeneous topography composed of roughness patches exhibiting relatively high and low correlation in the streamwise and spanwise directions, respectively (i.e. the roughness appears as streamwise-aligned 'strips'). It has been reported that such roughness induces a spanwise-wall normal mean secondary flow in the form of mean streamwise vorticity associated with counter-rotating boundary-layer-scale circulations. Here, we demonstrate that this mean secondary flow is Prandtl's secondary flow of the second kind, both driven and sustained by spatial gradients in the Reynolds-stress components, which cause a subsequent imbalance between production and dissipation of turbulent kinetic energy that necessitates secondary advective velocities. In reaching this conclusion, we study (i) secondary circulations due to spatial gradients of turbulent kinetic energy, and (ii) the production budgets of mean streamwise vorticity by gradients of the Reynolds stresses. We attribute the secondary flow phenomena to extreme peaks of surface stress on the relatively high-roughness regions and associated elevated turbulence production in the fluid immediately above. An optimized state is attained by entrainment of fluid exhibiting the lowest turbulent stresses - from above - and subsequent lateral ejection in order to preserve conservation of mass.	[Anderson, William; Awasthi, Ankit] Univ Texas Dallas, Mech Engn Dept, Richardson, TX 75080 USA; [Barros, Julio M.] US Naval Acad, Dept Mech Engn, Annapolis, MD 21402 USA; [Christensen, Kenneth T.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Christensen, Kenneth T.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA; [Christensen, Kenneth T.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Anderson, W (reprint author), Univ Texas Dallas, Mech Engn Dept, Richardson, TX 75080 USA.	wca140030@utdallas.edu	Christensen, Kenneth/B-1123-2009		Air Force Office of Scientific Research [FA9550-07-1-0129, FA9550-10-1-0372, FA9550-14-1-0101]; Air Force Office of Scientific Research, Young Investigator Program [FA9550-14-1-0394]	This work was supported by the Air Force Office of Scientific Research (Program Managers: Drs J. Schmisseur and R. Ponnappan) under grant nos FA9550-07-1-0129 (K.T.C.), FA9550-10-1-0372 (K.T.C.) and FA9550-14-1-0101 (W.A., K.T.C.). W.A. was also supported by the Air Force Office of Scientific Research, Young Investigator Program, grant no. FA9550-14-1-0394 (Program Managers: Drs J. Schmisseur and E. Montgomery). Computational resources were provided by Academic and Research Computing Services at Baylor University. W.A. thanks Ms Dina Caplinger (UT Dallas Office of Sponsored Projects) for internal administering of supporting grants. We thank the anonymous reviewers and Professor Ron Adrian for insightful comments made on this work.	Adrian RJ, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2717527; Anderson W, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013005; Anderson W, 2010, BOUND-LAY METEOROL, V137, P397, DOI 10.1007/s10546-010-9537-5; Anderson W, 2012, BOUND-LAY METEOROL, V144, P263, DOI 10.1007/s10546-012-9722-9; Fishpool GM, 2009, FLOW TURBUL COMBUST, V83, P323, DOI 10.1007/s10494-009-9209-z; Reynolds RT, 2007, EXP FLUIDS, V42, P311, DOI 10.1007/s00348-006-0243-5; Zhou J, 1999, J FLUID MECH, V387, P353, DOI 10.1017/S002211209900467X; Tomkins CD, 2003, J FLUID MECH, V490, P37, DOI 10.1017/S0022112003005251; GESSNER FB, 1973, J FLUID MECH, V58, P1, DOI 10.1017/S0022112073002090; Colebrook CF, 1937, PROC R SOC LON SER-A, V161, P367, DOI 10.1098/rspa.1937.0150; MADABHUSHI RK, 1991, PHYS FLUIDS A-FLUID, V3, P2734, DOI 10.1063/1.858163; Piomelli U, 2002, ANNU REV FLUID MECH, V34, P349, DOI 10.1146/annurev.fluid.34.082901.144919; Flack KA, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4001492; Bou-Zeid E, 2007, J ATMOS SCI, V64, P216, DOI 10.1175/JAS3826.1; Mejia-Alvarez R, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4832377; Dennis DJC, 2011, J FLUID MECH, V673, P218, DOI 10.1017/S0022112010006336; Hutchins N, 2007, J FLUID MECH, V579, P1, DOI 10.1017/S0022112006003946; HINZE JO, 1973, APPL SCI RES, V28, P453; Anderson W, 2013, ENVIRON FLUID MECH, V13, P479, DOI 10.1007/s10652-013-9272-9; Bons JP, 2001, J TURBOMACH, V123, P739, DOI 10.1115/1.1400115; Elsinga GE, 2010, J FLUID MECH, V644, P35, DOI 10.1017/S0022112009992047; Adrian RJ, 2000, EXP FLUIDS, V29, P275, DOI 10.1007/s003489900087; Mejia-Alvarez R, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3291076; BRUNDRETT E, 1964, J FLUID MECH, V19, P375, DOI 10.1017/S0022112064000799; Chester S, 2007, J COMPUT PHYS, V225, P427, DOI 10.1016/j.jcp.2006.12.009; Wu Y, 2010, J FLUID MECH, V655, P380, DOI 10.1017/S0022112010000960; Best J, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000218; BRADSHAW P, 1987, ANNU REV FLUID MECH, V19, P53, DOI 10.1146/annurev.fluid.19.1.53; Belcher SE, 2012, ANNU REV FLUID MECH, V44, P479, DOI 10.1146/annurev-fluid-120710-101036; ORSZAG SA, 1970, J ATMOS SCI, V27, P890, DOI 10.1175/1520-0469(1970)027<0890:TMFTCO>2.0.CO;2; Wu Y, 2006, J FLUID MECH, V568, P55, DOI 10.1017/S002211200600259X; Schultz MP, 2007, BIOFOULING, V23, P331, DOI 10.1080/08927010701461974; Adrian RJ, 2000, J FLUID MECH, V422, P1, DOI 10.1017/S0022112000001580; Bou-Zeid E, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002475; Wang ZQ, 2005, ADV WATER RESOUR, V28, P441, DOI 10.1016/j.advwatres.2004.12.008; Jimenez J, 2004, ANNU REV FLUID MECH, V36, P173, DOI 10.1146/annurev.fluid.36.050802.122103; Livingstone I, 2007, EARTH-SCI REV, V80, P239, DOI 10.1016/j.earscirev.2006.09.004; Dennis DJC, 2011, J FLUID MECH, V673, P180, DOI 10.1017/S0022112010006324; Volino RJ, 2007, J FLUID MECH, V592, P263, DOI 10.1017/S0022112007008518; Anderson W, 2011, J FLUID MECH, V679, P288, DOI 10.1017/jfm.2011.137; Hong J, 2012, J FLUID MECH, V712, P92, DOI 10.1017/jfm.2012.403; Christensen KT, 2001, J FLUID MECH, V431, P433, DOI 10.1017/S0022112001003512; Wu Y, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2741256; Castro IP, 2007, J FLUID MECH, V585, P469, DOI 10.1017/S0022112007006921; Porte-Agel F, 2000, J FLUID MECH, V415, P261, DOI 10.1017/S0022112000008776; BARROS J., 2014, THESIS U ILLINOIS UR; Barros JM, 2014, J FLUID MECH, V748, DOI 10.1017/jfm.2014.218; Bou-Zeid E, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1839152; Brutsaert W. H., 1982, EVAPORATION ATMOSPHE; Calaf M, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3663376; Calaf M, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3291077; Coceal O, 2007, J FLUID MECH, V589, P375, DOI 10.1017/S002211200700794X; Ganapathisubramani B, 2003, J FLUID MECH, V478, P35, DOI 10.1017/S0022112002003270; Graham J, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4772074; HIGGINS C., 2004, ATMOSPHERIC TURBULEN, P51, DOI 10.1017/CBO9780511735035.005; HINZE JO, 1967, PHYS FLUIDS, V10, pS122, DOI 10.1063/1.1762429; HOAGLAND L., 1960, THESIS MIT; Laufer J., 1954, 1174 NACA; MEJIA-ALVAREZ R., 2013, COHERENT FLOW STRUCT, P25; Monin A. S., 1971, STAT FLUID MECH MECH; Monin A.S., 1954, T AKAD NAUK SSSR GEO, V151, P163; Nikuradse J, 1933, 1292 NACA; Nikuradse J., 1930, ING ARCH, V1, P306, DOI 10.1007/BF02079937; NUGROHO B., 2014, P AM I AER ASTR 52 A; Nugroho B, 2013, INT J HEAT FLUID FL, V41, P90, DOI 10.1016/j.ijheatfluidflow.2013.04.003; Palmer JA, 2012, EXP FLUIDS, V52, P809, DOI 10.1007/s00348-011-1104-4; Perkins H.J., 1970, J FLUID MECH, V44, P721, DOI DOI 10.1017/S0022112070002112; Pope S. B., 2000, TURBULENT FLOWS; PRANDTL L, 1952, ESSENTIALS FLUID DYN; Raupach M.R., 1991, APPL MECH REV, V44, P1, DOI DOI 10.1115/1.3119492; Schlichting H., 1937, 823 NACA; Schultz MP, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3059630; Sheng J, 2009, J FLUID MECH, V633, P17, DOI 10.1017/S0022112009006934; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Tokgoz S, 2012, EXP FLUIDS, V53, P561, DOI 10.1007/s00348-012-1311-7; Townsend A. A., 1976, STRUCTURE TURBULENT; Vermaas DA, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010138; Westerweel J., 2011, PARTICLE IMAGE VELOC; WILLINGHAM D., 2013, PHYS FLUIDS, V26; Zhou JG, 1996, PHYS FLUIDS, V8, P288, DOI 10.1063/1.868838	80	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	APR	2015	768									10.1017/jfm.2015.91		32	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CD6VZ	WOS:000351229500017		
J	Itaka, S; Yoshida, S; Mizoue, N; Ota, T; Takashima, A; Kajisa, T				Itaka, Shizu; Yoshida, Shigejiro; Mizoue, Nobuya; Ota, Tetsuji; Takashima, Atsushi; Kajisa, Tsuyoshi			Comparing 30-year diameter censuses and tree-ring chronologies in natural old-growth Cryptomeria japonica forest on Yakushima Island, Japan	JOURNAL OF FOREST RESEARCH			English	Article						Dendrochronology; Diameter growth; Measurement error; Monitoring; Ring widths	HEIGHT	The quality of diameter measurements for natural old-growth forest was evaluated by comparing repeated field measurements in a diameter census and tree-ring chronologies. The diameter census was repeated three times from 1973 at 10- to 19-year intervals in old-growth Cryptomeria japonica forests on Yakushima Island, Japan. The diameter growth in the three intervals between (1) first and second measurement (15-19 years), (2) second and third measurement (10-13 years), and (3) first and third measurement (28-30 years) were calculated. The diameter growth of each interval was also measured using tree-ring chronologies as a control. There were significant differences in paired t tests for diameter growth calculated from the diameter census data and from the tree-ring chronologies when the interval was < 20 years. Conversely, no significant differences were observed when the measurement interval was > 27 years. The average percentage differences (APDs) were relatively high for every interval and for all diameter classes, but the APDs for the 28- to 30-year intervals were better than the 10- to 19-year intervals. The APDs followed a rising trend with increasing diameter at breast height for every interval. In conclusion, data from an interval of > 27 years is required for accurate estimation of diameter growth. Furthermore, extra care should be taken when measuring large diameter trees. The results from this study demonstrated the difficulty of using a diameter census in natural old-growth forest.	[Itaka, Shizu; Yoshida, Shigejiro; Mizoue, Nobuya; Ota, Tetsuji] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan; [Takashima, Atsushi] Univ Ryukyus, Subtrop Field Sci Ctr, Fac Agr, Kunigam 9051427, Japan; [Kajisa, Tsuyoshi] Kagoshima Univ, Fac Agr, Kagoshima 8908580, Japan	Itaka, S (reprint author), Kyushu Univ, Fac Agr, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	shizu@kyudai.jp			"Evaluation and Prediction of Effects on Forest Ecosystems in Southwestern Japan Caused by Air Pollution"; Career Center for Women Researchers at Kyushu University	Permission was obtained from Kagoshima Prefecture authorities, the Forestry Agency, and the Ministry of the Environment, Japan, for the collection of sample cores within permanent study plots located in protected areas. The present study was supported by the "Evaluation and Prediction of Effects on Forest Ecosystems in Southwestern Japan Caused by Air Pollution" project administered by the Environment Ministry of Japan and headed by S. Kanetani. We are grateful for support from the Career Center for Women Researchers at Kyushu University. We also would like to thank H. Yamada, S. Ushijima, and Y. Kawasoe for preceding research and the members of the Institute for Forest Management Laboratory (Kyushu University).	Vesala T, 2000, TREE PHYSIOL, V20, P633; Matsuzaki J, 2006, ANN BOT-LONDON, V98, P573, DOI 10.1093/aob/mcl127; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Matsuzaki J, 2007, PLANT CELL ENVIRON, V30, P646, DOI 10.1111/j.1365-3040.2007.01656.x; Zurcher E, 1998, NATURE, V392, P665, DOI 10.1038/33570; Biondi F, 1999, ECOL APPL, V9, P216; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Barker JR, 2002, ENVIRON MONIT ASSESS, V75, P51, DOI 10.1023/A:1014259902449; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; Furuono T, 1994, WOOD SCI SERIES, V2, P190; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Itaka S, 2013, J FOR PLAN, V19, P1; Itaka S, 2013, J FOR PLAN, V19, P9; Kanetani S, 2007, ASPECT FOREST YAKUSH, P11; Kitahara F, 2010, SILVA FENN, V44, P657, DOI 10.14214/sf.133; Kitahara F, 2009, ENVIRON MONIT ASSESS, V159, P331, DOI 10.1007/s10661-008-0632-8; Kyushu Regional Forest Office/Yaku-shima Environment Conservation Centre, 1996, FOR YAK SHIM; Lapin M, 2005, OLD GROWTH FORESTS L; Makinen A, 2012, SILVA FENN, V46, P211, DOI 10.14214/sf.55; Miyawaki A, 1980, VEGETATION JAPAN YAK, P376; Nakamura T, 2000, Biol Sci Space, V14, P123, DOI 10.2187/bss.14.123; Pastur GM, 2007, FORESTRY, V80, P83, DOI 10.1093/forestry/cpl047; Spies TA, 1996, DIVERSITY MAINTENANC, P296; SUZUKI E, 1987, BOT MAG TOKYO, V100, P223, DOI 10.1007/BF02492832; Takahara H, 2002, J GEOGR, V111, P726; Takashima A, 2009, THESIS KYUSHU U; Takashima A, 2009, ECOL RES, V24, P1003, DOI 10.1007/s11284-008-0574-1; Togo S, 1981, THESIS KAGOSHIMA U; Ueda M, 2006, J FOR RES, V1, P139, DOI 10.1007/BF02348191; Yoshida S., 1990, Journal of the Japanese Forestry Society, V72, P131	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	APR	2015	20	2					255	262		10.1007/s10310-014-0476-8		8	Forestry	Forestry	CD5XH	WOS:000351161600001		
J	Osono, T				Osono, Takashi			Decomposing ability of diverse litter-decomposer macrofungi in subtropical, temperate, and subalpine forests	JOURNAL OF FOREST RESEARCH			English	Article						Acid-unhydrolyzable residue; Climate; Lignin decomposition; Ligninolytic fungi; Selective delignification	JAPONICA LEAF-LITTER; NEEDLE-LITTER; LIGNIN DECOMPOSITION; FUNGAL SUCCESSION; ENZYME-ACTIVITIES; DEGRADATION; DYNAMICS; NITROGEN; LEAVES; COLONIZATION	An integrative survey was conducted on the ability of litter-decomposing macrofungi (LDM) from forests of different climatic regions to decompose litter materials and recalcitrant compounds in the litter under pure culture conditions. A total of 75 isolates in six families of LDM from subtropical, cool temperate (CT), and subalpine (SA) forests in Japan were tested for their ability to decompose a total of eight litter types that are major substrates for macrofungi at each site. The mass loss of the litter (% original mass) during incubation for 12 weeks at 20 A degrees C ranged from -3.1 % to 54.5 %. Macrofungi originated from forests of different climatic regions exhibited similar decomposing abilities, but the SA isolates caused negligible mass loss of Abies needles, possibly due to inhibitory compounds. Decomposing activity for recalcitrant compounds (as acid-unhydrolyzable residues, AUR) was found in many macrofungal isolates. The isolates of Marasmiaceae were generally more able to cause selective decomposition of AUR than those of Mycenaceae and to decompose AUR in partly decomposed materials. The isolates of Xylariaceae had lower ligninolytic activity than those of Basidiomycetes. The AUR mass loss caused by CT isolates was significantly lower in nitrogen-rich beech litter than in its nitrogen-poor counterpart, suggesting a retarding effect of nitrogen on AUR decomposition, which was obvious for Mycenaceae. The effect of fungal family was generally more significant than that of litter type, suggesting that possible changes in the composition of fungal assemblages influence their functioning more than changes in the quality of substrates.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19780114]; National Institute of Agrobiologial Sciences (NIAS) Japan; Sumitomo Foundation; Nissan Global Foundation; Nippon Life Inst. Foundation; Grants for Excellent Graduate Schools, MEXT, Japan [12-01]	I thank Ms. K. Koide for help with pure culture tests and Dr. Elizabeth Nakajima for critical reading of the manuscript. This study received partial financial support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (No. 19780114), National Institute of Agrobiologial Sciences (NIAS) Japan, The Sumitomo Foundation, Nissan Global Foundation, Nippon Life Inst. Foundation, and the Grants for Excellent Graduate Schools, MEXT, Japan (12-01) to Kyoto University.	ADASKAVEG JE, 1995, APPL ENVIRON MICROB, V61, P138; Osono T, 2006, PROCEEDINGS OF THE 8TH INTERNATIONAL MYCOLOGICAL CONGRESS, P111; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Osono T, 2009, MYCOSCIENCE, V50, P52, DOI 10.1007/s10267-008-0442-4; Sinsabaugh RL, 2005, BIOGEOCHEMISTRY, V75, P201, DOI 10.1007/s10533-004-7112-1; Osono T, 2011, MYCOSCIENCE, V52, P327, DOI 10.1007/s10267-011-0112-9; Osono T, 2009, FUNGAL DIVERS, V36, P101; NILSSON T, 1989, HOLZFORSCHUNG, V43, P11, DOI 10.1515/hfsg.1989.43.1.11; Lindahl B, 2008, BR MYCOL SY, V28, P183; Osono T, 2001, EUR J SOIL BIOL, V37, P17, DOI 10.1016/S1164-5563(01)01066-4; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Osono T, 2011, FOREST PATHOL, V41, P156, DOI 10.1111/j.1439-0329.2010.00648.x; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Osono T, 2011, FUNGAL ECOL, V4, P210, DOI 10.1016/j.funeco.2010.11.003; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; FENN P, 1981, ARCH MICROBIOL, V130, P66, DOI 10.1007/BF00527074; Hagiwara Y, 2012, J FOREST RES-JPN, V17, P51, DOI 10.1007/s10310-011-0265-6; Osono T, 2008, ECOL RES, V23, P909, DOI 10.1007/s11284-007-0455-z; Boberg JB, 2011, FUNGAL ECOL, V4, P110, DOI 10.1016/j.funeco.2010.09.002; Fukasawa Y, 2009, ECOL RES, V24, P1067, DOI 10.1007/s11284-009-0582-9; Hirobe M, 2004, J FOREST RES-JPN, V9, P347, DOI 10.1007/s10310-004-0088-9; Koide K, 2005, ECOL RES, V20, P599, DOI 10.1007/s11284-005-0077-2; Bagci E, 1996, FLAVOUR FRAG J, V11, P251, DOI 10.1002/(SICI)1099-1026(199607)11:4<251::AID-FFJ577>3.0.CO;2-K; Berg B., 2006, LITTER DECOMPOSITION; Imazeki R, 1987, COLORED ILLUSTRATION; KING HGC, 1967, PEDOBIOLOGIA, V7, P192; Miura K., 1970, T MYCOLOGICAL SOC JA, V11, P116; Miyamoto Toshizumi, 2000, Mycoscience, V41, P105, DOI 10.1007/BF02464317; Osono T, 2015, J FOREST RES-JPN, V20, P60, DOI 10.1007/s10310-014-0459-9; Osono T, 2003, MYCOLOGIA, V95, P820, DOI 10.2307/3762010; Osono T, 2015, J FOREST RES-JPN, V20, P69, DOI 10.1007/s10310-014-0461-2; Osono T, 2011, EUR J SOIL BIOL, V47, P114, DOI 10.1016/j.ejsobi.2010.12.002; Osono T, 2015, J FOREST RES-JPN, V20, P77, DOI 10.1007/s10310-014-0462-1; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Preston CM, 1997, CAN J BOT, V75, P1601; REID ID, 1991, CAN J BOT, V69, P156; Tateno R, 2010, OECOLOGIA, V163, P793, DOI 10.1007/s00442-009-1561-0; Zifcakova L, 2011, FUNGAL ECOL, V4, P427, DOI 10.1016/j.funeco.2011.04.002	40	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	APR	2015	20	2					272	280		10.1007/s10310-014-0475-9		9	Forestry	Forestry	CD5XH	WOS:000351161600003		
J	Suzuki, K; Liston, GE; Kodama, Y				Suzuki, Kazuyoshi; Liston, Glen E.; Kodama, Yuji			Variations of winter surface net shortwave radiation caused by land-use change in northern Hokkaido, Japan	JOURNAL OF FOREST RESEARCH			English	Article						Canopy snow load; Land use; Regional scale; Spatial distribution	SNOW-ALBEDO FEEDBACK; TRANSPORT MODEL; UPPER TREELINE; CANOPY SNOW; CLIMATE; BOREAL; SYSTEM; REDISTRIBUTION; DISTRIBUTIONS; VEGETATION	To evaluate changes in surface albedo and net shortwave radiation caused by land-use changes, we developed a simple model using the MicroMet/SnowModel. Simulated results were compared with plot-scale observations and verified with reasonable agreement, following which we simulated surface albedo and net shortwave radiation over a large domain (0.5A degrees A xA 0.5A degrees, 100-m resolution). We found that the histogram of spatial distribution of net shortwave radiation could assume a Gaussian distribution in the case of uniform land use, despite complex topography. However, complex land use within the domain caused two histogram peaks with large standard deviation, meaning that a Gaussian distribution could not be assumed. For such complex land use, the spatial distribution of net shortwave radiation was determined by surface albedo, which was found to be strongly related to land use. For natural forest cover within the domain, the spatial distribution of net shortwave radiation was found to be related to slope azimuth angle, but surface albedo had only minor effect. For regenerated forest, net shortwave radiation was influenced by surface albedo rather than slope azimuth angle. Simulated results for bare ground within the domain were related to surface albedo and altitude, because higher altitudes had longer periods of snow cover and much greater snow accumulation. Overall, land-use changes were more important than orographic effects in the evaluation of net shortwave radiation.	[Suzuki, Kazuyoshi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa 2360001, Japan; [Liston, Glen E.] Colorado State Univ, Cooperat Inst Res Atmosphere, Ft Collins, CO 80523 USA; [Kodama, Yuji] Natl Inst Polar Res, Arctic Observat Ctr, Tachikawa, Tokyo, Japan	Suzuki, K (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Environm Geochem Cycle Res, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	skazu@jamstec.go.jp			JAXA (Japan Aerospace Exploration Agency) [25550048]; GRENE Arctic Climate Change Research Project: The role of Arctic Cryosphere in global change	This study was partially supported by JAXA (Japan Aerospace Exploration Agency), a Challenging Exploratory Research Grant (Research Project Number 25550048), and the GRENE Arctic Climate Change Research Project: The role of Arctic Cryosphere in global change (PI: Prof. H. Enomoto). We acknowledge the valuable comments from the two anonymous reviewers and logistical support for field observation from the Northern Biosphere Field Center of Hokkaido University. Additionally, the study was performed as a Joint Research Program of the Institute of Low Temperature Science, Hokkaido University.	Qu X, 2006, J CLIMATE, V19, P2617, DOI 10.1175/JCLI3750.1; Houldcroft CJ, 2009, J HYDROMETEOROL, V10, P183, DOI 10.1175/2008JHM1021.1; Qu X, 2007, J CLIMATE, V20, P3971, DOI 10.1175/JCLI4186.1; Liston GE, 2006, J HYDROMETEOROL, V7, P1259, DOI 10.1175/JHM548.1; Mernild SH, 2007, HYDROL PROCESS, V21, P3249, DOI 10.1002/hyp.6500; Harding RJ, 1996, J CLIMATE, V9, P2778, DOI 10.1175/1520-0442(1996)009<2778:TEBOTW>2.0.CO;2; Liston GE, 1998, J GLACIOL, V44, P498; Hiemstra CA, 2002, ARCT ANTARCT ALP RES, V34, P262, DOI 10.2307/1552483; Prasad R, 2001, WATER RESOUR RES, V37, P1341, DOI 10.1029/2000WR900317; Yang FL, 2001, J CLIMATE, V14, P4245, DOI 10.1175/1520-0442(2001)014<4245:SAFASC>2.0.CO;2; YASUNARI T, 1991, J METEOROL SOC JPN, V69, P473; Fernandes R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040057; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Kuusinen N, 2012, AGR FOREST METEOROL, V164, P53, DOI 10.1016/j.agrformet.2012.05.009; Hiemstra CA, 2006, ECOL MODEL, V197, P35, DOI 10.1016/j.ecolmodel.2006.03.005; Barnes CA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001428; Pomeroy JW, 1996, HYDROL PROCESS, V10, P1591; Boisier JP, 2013, BIOGEOSCIENCES, V10, P1501, DOI 10.5194/bg-10-1501-2013; Bruland O, 2004, NORD HYDROL, V35, P191; Greene EM, 1999, COLD REG SCI TECHNOL, V30, P135, DOI 10.1016/S0165-232X(99)00008-7; Liston GE, 2006, J HYDROMETEOROL, V7, P217, DOI 10.1175/JHM486.1; Liston GE, 1999, J GEOPHYS RES-ATMOS, V104, P19559, DOI 10.1029/1999JD900055; Liston GE, 2007, J GLACIOL, V53, P241, DOI 10.3189/172756507782202865; Liston GE, 2008, J HYDROMETEOROL, V9, P989, DOI 10.1175/2008JHM871.1; Liston GE, 2002, J HYDROMETEOROL, V3, P646, DOI 10.1175/1525-7541(2002)003<0646:WPPIAA>2.0.CO;2; Matsumoto K, 2008, AGR FOREST METEOROL, V148, P1978, DOI 10.1016/j.agrformet.2008.09.008; Mernild SH, 2008, J HYDROMETEOROL, V9, P1191, DOI 10.1175/2008JHM957.1; Pyke CR, 2007, CLIMATIC CHANGE, V80, P239, DOI 10.1007/s10584-006-9110-x; STURM M, 1995, J CLIMATE, V8, P1261, DOI 10.1175/1520-0442(1995)008<1261:ASSCCS>2.0.CO;2; Suzuki K, 2008, BOREAL ENVIRON RES, V13, P403; Suzuki K, 2011, HYDROLOG SCI J, V56, P443, DOI 10.1080/02626667.2011.565008; Suzuki K, 2008, J HYDROL, V352, P126, DOI 10.1016/j.jhydrol.2008.01.007; YAMAZAKI T, 1995, J APPL METEOROL, V34, P511, DOI 10.1175/1520-0450-34.2.511	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	APR	2015	20	2					281	292		10.1007/s10310-015-0478-1		12	Forestry	Forestry	CD5XH	WOS:000351161600004		
J	Islam, MS; Lian, CL; Kameyama, N; Hogetsu, T				Islam, Md Sajedul; Lian, Chunlan; Kameyama, Norikazu; Hogetsu, Taizo			Analysis of the mating system, reproductive characteristics, and spatial genetic structure in a natural mangrove tree (Bruguiera gymnorrhiza) population at its northern biogeographic limit in the southern Japanese archipelago	JOURNAL OF FOREST RESEARCH			English	Article						Bruguiera gymnorrhiza; Genetic diversity; Mangrove; Mating system and reproductive characteristics; SSR or microsatellite marker	MICROSATELLITE MARKERS; RHIZOPHORA-STYLOSA; KANDELIA-CANDEL; CHLOROPLAST; ISLAND; DISPERSAL; SHRUB; CHAIN; L.	We examined the mating system, reproductive characteristics, and spatial genetic structure in a population of Bruguiera gymnorrhiza located at its northern biogeographic limit on the Iriomote Island of the southern Japanese archipelago. Nuclear and chloroplast simple sequence repeat (nSSR and cpSSR) markers were used to analyze adult trees, seedlings and propagule samples in the Urauchi river basin. Low genetic diversity was detected at the nSSR and a predominant haplotype was identified at the cpSSR. The mean multilocus outcrossing rate (0.855) significantly differed from 1.0, suggesting a relatively higher selfing rate. Substantial inbreeding was suggested from biparental inbreeding rates and significant F (IS) within the adult and seedling cohorts. A wide coverage of pollen and propagule dispersal was inferred within the study population based on a paternity analysis of the propagules and a parentage analysis of the seedlings; moreover, a lack of spatial genetic structure was observed. Our results suggest that B. gymnorrhiza in the Urauchi river basin was most likely established from a few founders and formed a homogeneous population due to limited gene flow from southern or central populations.	[Islam, Md Sajedul; Hogetsu, Taizo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Forest Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo 1880002, Japan; [Kameyama, Norikazu] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan	Islam, MS (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Forest Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	M.sajed@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank Prof. Tokushiro Takaso (University of the Ryukyus) and Mr. Naoya Miyashita (University of Tokyo) for helping collect samples. We greatly thank Dr. Raul Ruiz-Arce of USDA-APHIS-CPHST and three anonymous reviewers for suggesting constructive improvements to the manuscript.	Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Islam MS, 2006, MOL ECOL NOTES, V6, P30, DOI 10.1111/j.1471-8286.2005.01127.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Minobe S, 2010, CONSERV GENET, V11, P301, DOI 10.1007/s10592-009-9806-3; TOMLINSON PB, 1979, BIOTROPICA, V11, P256, DOI 10.2307/2387918; Maguire TL, 2000, MOL ECOL, V9, P1853, DOI 10.1046/j.1365-294x.2000.01089.x; Islam MS, 2014, PLANT SYST EVOL, V300, P1123, DOI 10.1007/s00606-013-0950-3; Goudet J, 1995, J HERED, V86, P485; Franceschinelli EV, 2000, HEREDITY, V84, P116, DOI 10.1046/j.1365-2540.2000.00636.x; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj/hdy/6800029; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Ge JP, 2005, J EXP MAR BIOL ECOL, V326, P48, DOI 10.1016/j.jembe.2005.05.015; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; Giang LH, 2006, INT J PLANT SCI, V167, P291, DOI 10.1086/499611; Islam MS, 2008, CONSERV GENET, V9, P989, DOI 10.1007/s10592-007-9424-x; Islam MS, 2012, TREE GENET GENOMES, V8, P1247, DOI 10.1007/s11295-012-0512-9; Islam MS, 2006, MOL ECOL NOTES, V6, P1111, DOI 10.1111/j.1471-8286.2006.01453.x; Islam MS, 2004, MOL ECOL NOTES, V4, P110, DOI 10.1046/j.1471-8286.2003.00585.x; KONDO K, 1987, BIOTROPICA, V19, P377, DOI 10.2307/2388639; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Nakasuga T, 1979, SCI B COLL AGR U RYU, V26, P413; RAYMOND M, 1995, J HERED, V86, P248; Takayama K, 2009, CONSERV GENET RESOUR, V1, P175, DOI 10.1007/s12686-009-9042-7; Takeuchi T, 2001, J FOREST RES, V6, P157, DOI 10.1007/BF02767087; Tomlinson P. B., 1986, BOT MANGROVES	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	APR	2015	20	2					293	300		10.1007/s10310-014-0473-y		8	Forestry	Forestry	CD5XH	WOS:000351161600005		
J	Iwazumi, MG; Aizawa, M; Watanabe, A; Goto, S				Iwazumi, Masakazu G.; Aizawa, Mineaki; Watanabe, Atsushi; Goto, Susumu			Highly polymorphic nuclear microsatellite markers reveal detailed patterns of genetic variation in natural populations of Yezo spruce in Hokkaido	JOURNAL OF FOREST RESEARCH			English	Article						Afforestation; Genetic structure; Nuclear microsatellites; Picea jezoensis; Seed zone	CRYPTOMERIA-JAPONICA; DISPERSED SEEDS; F-STATISTICS; FLOW; DIFFERENTIATION; DIVERSITY; SOFTWARE; JAPAN	The Yezo spruce (Picea jezoensis) has attracted attention as a species commonly used for afforestation in Hokkaido. However, there is no information available for assessing appropriate seed and planting zones for this species. We developed 21 nuclear microsatellite markers for P. jezoensis and used them to examine the genetic structure of nine natural populations (288 trees). Based on the 31 samples, the 21 markers were highly polymorphic, with an average expected heterozygosity greater than 0.84. When we applied ten effective markers to nine populations in Hokkaido, no clear regional differences in genetic diversity were detected. STRUCTURE analysis revealed that, aside from certain geographically isolated or peripheral populations, the populations within planting zones belonged to a single cluster. Thus, based on our marker data, with a few exceptions, there appears to be a single seed zone within the planting zones in Hokkaido.	[Iwazumi, Masakazu G.] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Kansai Reg Breeding Off, Katsuta, Okayama 7094335, Japan; [Aizawa, Mineaki] Utsunomiya Univ, Dept Forest Sci, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; [Watanabe, Atsushi] Kyushu Univ, Dept Forest Environm Sci, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Goto, Susumu] Univ Tokyo, Univ Forests, Grad Sch Agr & Life Sci, Div Res, Tokyo 1138657, Japan	Iwazumi, MG (reprint author), Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Kansai Reg Breeding Off, 1043 Uetsukinaka, Katsuta, Okayama 7094335, Japan.	ganchan@affrc.go.jp					Aizawa M, 2009, J BIOGEOGR, V36, P996, DOI 10.1111/j.1365-2699.2008.02074.x; Lian C, 2008, MOL ECOL, V17, P2948, DOI 10.1111/j.1365-294X.2008.03802.x; Pritchard JK, 2000, GENETICS, V155, P945; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Rousset F, 1997, GENETICS, V145, P1219; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Fukatsu E, 2005, MOL ECOL NOTES, V5, P378, DOI 10.1111/j.1471-8286.2005.00933.x; Goto S, 2013, FOR TREE BREED HOKKA, V56, P1; Goto S, 2005, SILVAE GENET, V54, P69; Goudet J, 2002, FSTAT VERSION 2 9 3; Handa T, 2004, FOR TREE BREED HOKKA, V47, P16; Hatakeyama S, 1981, B HOKKAIDO FOREST EX, V19, P1; Hirao T., 2006, Journal of the Japanese Forest Society, V88, P202, DOI 10.4005/jjfs.88.202; Ide Y, 1996, B TOKYO U FOR, V95, P65; Iwaizumi MG, 2013, FOREST ECOL MANAG, V304, P407, DOI 10.1016/j.foreco.2013.05.026; Iwaizumi MG, 2013, AM J BOT, V100, P1896, DOI 10.3732/ajb.1200563; Iwaizumi MG, 2010, J HERED, V101, P144, DOI 10.1093/jhered/esp089; Kisanuki H, 1999, T MTG HOKKAIDO BREED, V47, P58; Koshika K, 1996, JPN J FOR PLAN, V26, P73; Koshika K, 1995, JPN J FOR PLAN, V24, P33; Krestov PV, 2002, FOLIA GEOBOT, V37, P441, DOI 10.1007/BF02803257; Matsumoto A, 2010, J PLANT RES, V123, P689, DOI 10.1007/s10265-009-0299-4; Moriguchi Y, 2005, TREE GENET GENOMES, V1, P174, DOI 10.1007/s11295-005-0023-z; Nagasaka K., 1997, Forest Genetics, V4, P43; Ogasawara S, 2001, BULL TOKYO UNIV FOR, V106, P49; Pritchard JK, 2009, STRUCTURE VERSION 2; RAYMOND M, 1995, J HERED, V86, P248; Rozen S, 2000, Methods Mol Biol, V132, P365; Takahashi I, 1991, B TOKYO U FOR, V86, P201; Watanabe S, 1985, TREE SOCIOLOGICAL ST; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; White TL, 2007, FOREST GENETICS	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	APR	2015	20	2					301	307		10.1007/s10310-014-0477-7		7	Forestry	Forestry	CD5XH	WOS:000351161600006		
J	Bez, N; Sugimoto, M				Bez, Neal; Sugimoto, Mitsuru			Optimal Forward and Reverse Estimates of Morawetz and Kato-Yajima Type with Angular Smoothing Index	JOURNAL OF FOURIER ANALYSIS AND APPLICATIONS			English	Article						Smoothing estimates; Optimal constants; Extremisers	SCHRODINGER-EQUATIONS; INITIAL DATA; REGULARITY; DECAY; CONSTANTS; PROPERTY	For the solution of the free Schrodinger equation, we obtain the optimal constants and characterise extremisers for forward and reverse smoothing estimates which are global in space and time, contain a homogeneous and radial weight in the space variable, and incorporate a certain angular regularity. This will follow from a more general result which permits analogous sharp forward and reverse smoothing estimates and a characterisation of extremisers for the solution of the free Klein-Gordon and wave equations. The nature of extremisers is shown to be sensitive to both the dimension and the size of the smoothing index relative to the dimension. Furthermore, in four spatial dimensions and certain special values of the smoothing index, we obtain an exact identity for each of these evolution equations.	[Bez, Neal] Saitama Univ, Grad Sch Sci & Engn, Dept Math, Saitama 3388570, Japan; [Sugimoto, Mitsuru] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Bez, N (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Math, Saitama 3388570, Japan.	nealbez@mail.saitama-u.ac.jp; sugimoto@math.nagoya-u.ac.jp			JSPS Kakenhi grant [26887008]	The first author was partially supported by JSPS Kakenhi grant number 26887008.	Ozawa T, 2013, J ANAL MATH, V121, P163, DOI 10.1007/s11854-013-0031-0; SJOLIN P, 1987, DUKE MATH J, V55, P699, DOI 10.1215/S0012-7094-87-05535-9; VEGA L, 1988, P AM MATH SOC, V102, P874, DOI 10.2307/2047326; Atkinson K., 2012, LECT NOTES MATH, V2044; Barcelo JA, 2006, J FOURIER ANAL APPL, V12, P269, DOI 10.1007/s00041-006-6003-3; BENARTZI M, 1992, J ANAL MATH, V58, P25, DOI 10.1007/BF02790356; Bez N., 2014, FOURIER ANAL, P1; Bez N., J ANAL MATH IN PRESS; Chen X., 2012, CONT MATH, V581, P63; Constantin P., 1988, J AM MATH SOC, V1, P413, DOI 10.2307/1990923; Fang DY, 2011, FORUM MATH, V23, P181, DOI 10.1515/FORM.2011.009; Hoshiro T, 1997, J ANAL MATH, V72, P127, DOI 10.1007/BF02843156; Kato T., 1989, REV MATH PHYS, V1, P481, DOI 10.1142/S0129055X89000171; MORAWETZ CS, 1968, PROC R SOC LON SER-A, V306, P291, DOI 10.1098/rspa.1968.0151; Ruzhansky M, 2006, MATH ANN, V335, P645, DOI 10.1007/s00208-006-0757-4; Ruzhansky M, 2012, COMMUN MATH PHYS, V314, P281, DOI 10.1007/s00220-012-1524-x; Shimakura N., 1992, TRANSLATIONS MATH MO, V99; SIMON B, 1992, J FUNCT ANAL, V107, P66, DOI 10.1016/0022-1236(92)90100-W; Stein E.M., 1971, INTRO FOURIER ANAL E; Sugimoto M, 2003, J ANAL MATH, V89, P15, DOI 10.1007/BF02893075; Sugimoto M, 1998, J ANAL MATH, V76, P191, DOI 10.1007/BF02786935; Vega L., 2006, P AM MATH SOC, V135, P119, DOI 10.1090/S0002-9939-06-08732-6; Vilela MC, 2001, ILLINOIS J MATH, V45, P361; Walther BG, 2002, J FUNCT ANAL, V189, P325, DOI 10.1006/jfan.2001.3863; Watanabe K., 1991, TOKYO J MATH, V14, P239; Whittaker E. T., 1996, COURSE MODERN ANAL	26	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1069-5869	1531-5851		J FOURIER ANAL APPL	J. Fourier Anal. Appl.	APR	2015	21	2					318	341		10.1007/s00041-014-9371-0		24	Mathematics, Applied	Mathematics	CD6BW	WOS:000351174800004		
J	Kawakubo, K; Kawakami, H; Kuwatani, M; Sakamoto, N				Kawakubo, K.; Kawakami, H.; Kuwatani, M.; Sakamoto, N.			Hepatobiliary and Pancreatic: A splenic artery aneurysm presenting as a calcified pancreatic mass	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Kawakubo, K.; Kawakami, H.; Kuwatani, M.; Sakamoto, N.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan	Kawakubo, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.		Kawakubo, Kazumichi/F-2937-2011					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	APR	2015	30	4					655	655		10.1111/jgh.12848		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD9FL	WOS:000351403200010		
J	Harimoto, N; Wang, H; Ikegami, T; Takeishi, K; Itoh, S; Yamashita, YI; Yoshizumi, T; Aishima, S; Shirabe, K; Oda, Y; Maehara, Y				Harimoto, N.; Wang, H.; Ikegami, T.; Takeishi, K.; Itoh, S.; Yamashita, Y-I; Yoshizumi, T.; Aishima, S.; Shirabe, K.; Oda, Y.; Maehara, Y.			Hepatology: Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Harimoto, N.; Wang, H.; Ikegami, T.; Takeishi, K.; Itoh, S.; Yamashita, Y-I; Yoshizumi, T.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Oda, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan; [Aishima, S.] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Harimoto, N (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	APR	2015	30	4					656	656		10.1111/jgh.12849		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD9FL	WOS:000351403200011		
J	Sato, H; Tamura, C; Narimatsu, K; Shimizu, M; Takajyo, T; Yamashita, M; Inoue, Y; Ozaki, H; Furuhashi, H; Maruta, K; Yasutake, Y; Yoshikawa, K; Watanabe, C; Komoto, S; Tomita, K; Nagao, S; Miura, S; Shinmoto, H; Hokari, R				Sato, Hirokazu; Tamura, Chiharu; Narimatsu, Kazuyuki; Shimizu, Motonori; Takajyo, Takeshi; Yamashita, Masataka; Inoue, Yasushi; Ozaki, Hayato; Furuhashi, Hirotaka; Maruta, Koji; Yasutake, Yuichi; Yoshikawa, Kenichi; Watanabe, Chikako; Komoto, Shunsuke; Tomita, Kengo; Nagao, Shigeaki; Miura, Soichiro; Shinmoto, Hiroshi; Hokari, Ryota			Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn's disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						colonic inflammation; Crohn's disease; endoscopy; MR enterocolonography	ULCERATIVE-COLITIS; ACTIVITY INDEX; MR ENTEROGRAPHY; VALIDATION; INFLAMMATION; SEVERITY; MANAGEMENT; ACCURACY; FEATURES; THERAPY	Background and AimIn Crohn's disease (CD), assessment of disease activity and extension is important for clinical management. Endoscopy is the most reliable tool for evaluating disease activity in these patients and it distinguishes between lesions based on ulcer, erosion, and redness. Magnetic resonance imaging (MRI) is less invasive than endoscopy; however, the sensitivity of MRI in detecting lesions is believed to be lower, and whether MRI can detect milder lesions has not been studied. The aim of this study was to compare the detection ability of magnetic resonance enterocolonography (MREC) with ileocolonic endoscopy in patients with CD. MethodsA total of 27 patients with CD underwent both MREC and ileocolonoscopy. There were 55 lesions (18 ileum and 37 colon) endoscopically detected, and the findings of MREC were compared with each ileocolonoscopic finding to determine sensitivity and specificity. ResultsFor a positive lesion defined as having at least one of the following: wall thickness, edema, diffusion-weighted imaging (DWI) high intensity and relative contrast enhancement (RCE) on MREC, the sensitivities were 100% for ulcer, 84.6% for erosion, and 52.9% for redness, suggesting an ability to detect milder lesions such as erosion or redness. Moreover, RCE values were well correlated with the severity of endoscopically identified active lesions. ConclusionMREC findings may be useful not only for evaluation of ulcers, but also for detection of endoscopically identified milder lesions in CD, suggesting a clinical usefulness of MREC for disease detection and monitoring.	[Sato, Hirokazu; Narimatsu, Kazuyuki; Shimizu, Motonori; Takajyo, Takeshi; Yamashita, Masataka; Inoue, Yasushi; Ozaki, Hayato; Furuhashi, Hirotaka; Maruta, Koji; Yasutake, Yuichi; Yoshikawa, Kenichi; Watanabe, Chikako; Komoto, Shunsuke; Tomita, Kengo; Nagao, Shigeaki; Miura, Soichiro; Hokari, Ryota] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama 3598513, Japan; [Tamura, Chiharu; Shinmoto, Hiroshi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3598513, Japan	Hokari, R (reprint author), Natl Def Med Coll, Dept Internal Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ryota@ndmc.ac.jp			National Defense Medical College; Smoking Research Foundation; Ministry of Health, Labour and Welfare	This research was supported by grants from National Defense Medical College, the Smoking Research Foundation and by Intractable Diseases, the Health and Labour Sciences Research Grants from Ministry of Health, Labour and Welfare.	ANDRE C, 1981, GUT, V22, P571, DOI 10.1136/gut.22.7.571; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; Leyendecker JR, 2009, RADIOGRAPHICS, V29, P1827, DOI 10.1148/rg.296095510; Makanyanga JC, 2013, AM J ROENTGENOL, V201, P56, DOI 10.2214/AJR.12.10406; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Oussalah A, 2010, GUT, V59, P1056, DOI 10.1136/gut.2009.197665; Macari M, 2001, AM J ROENTGENOL, V176, P1105; Yeomans ND, 2008, ALIMENT PHARM THERAP, V27, P465, DOI 10.1111/j.1365-2036.2008.03610.x; Punwani S, 2009, RADIOLOGY, V252, P712, DOI 10.1148/radiol.2523082167; Maccioni F, 2005, ABDOM IMAGING, V30, P584, DOI 10.1007/s00261-004-0284-2; Gore RM, 1996, AM J ROENTGENOL, V167, P3; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Hordonneau C, 2014, AM J GASTROENTEROL, V109, P89, DOI 10.1038/ajg.2013.385; Girometti R, 2008, ACAD RADIOL, V15, P153, DOI 10.1016/j.acra.2007.08.010; Van Assche G, 2013, J CROHNS COLITIS, V7, P950, DOI 10.1016/j.crohns.2013.01.011; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Oto A, 2009, ACAD RADIOL, V16, P597, DOI 10.1016/j.acra.2008.11.009; WINSHIP DH, 1979, GASTROENTEROLOGY, V77, P829; Ordas I, 2013, GUT, V62, P1566, DOI 10.1136/gutjnl-2012-303240; Zappa M, 2011, INFLAMM BOWEL DIS, V17, P984, DOI 10.1002/ibd.21414; Tolan DJM, 2010, RADIOGRAPHICS, V30, P367, DOI 10.1148/rg.302095028; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Grand DJ, 2012, EUR J RADIOL, V81, P763; Kakkar Aarti, 2011, Gastroenterol Hepatol (N Y), V7, P374; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Stange EF, 2006, GUT               S1, V55, pi1, DOI DOI 10.1136/GUT.2005.081950A	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	APR	2015	30	4					667	673		10.1111/jgh.12851		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD9FL	WOS:000351403200013		
J	Miyaki, D; Kawaoka, T; Aikata, H; Kan, H; Fujino, H; Fukuhara, T; Kobayashi, T; Naeshiro, N; Honda, Y; Tsuge, M; Hiramatsu, A; Imamura, M; Hyogo, H; Kawakami, Y; Yoshimatsu, R; Yamagami, T; Awai, K; Chayama, K				Miyaki, Daisuke; Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Honda, Yohji; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Hyogo, Hideyuki; Kawakami, Yoshiiku; Yoshimatsu, Rika; Yamagami, Takuji; Awai, Kazuo; Chayama, Kazuaki			Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of Response Evaluation Criteria in Solid Tumors and tumor markers	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						early response; hepatic arterial infusion chemotherapy; hepatocellular carcinoma; RECIST; tumor marker	PERCUTANEOUS ETHANOL INJECTION; RADIOFREQUENCY ABLATION; INTRAARTERIAL 5-FLUOROURACIL; INTERFERON-ALPHA; SURVIVAL; SORAFENIB; PREDICTOR; THERAPY; CANCER	Background and AimTo assess the early response and outcome of hepatic arterial infusion chemotherapy (HAIC) in patients with advanced hepatocellular carcinoma (HCC). MethodsOne hundred sixty-five HCC patients treated with HAIC were reviewed retrospectively. The early response to one course of HAIC treatment was evaluated by the Response Evaluation Criteria in Solid Tumors (RECIST) and changes in -fetoprotein (AFP) and des--carboxy prothrombin (DCP). ResultsThe median survival time (MST) for all patients was 9.5 months. The early imaging response by RECIST was assessed as partial response (PR), stable disease (SD), and progressive disease (PD) in 32 (19.3%), 86 (52.1%), and 47 (28.4%) patients, respectively. Survival correlated with early imaging response (MST in PR, 20.6; SD, 11.4; PD, 5.0 months; P<0.0001). The MST was also significantly different in patients with AFP ratio of 1 or >1 and DCP ratio of 1 or >1 (worst MST, 6.5 months in patients with AFP ratio of >1 and DCP ratio of >1). Among patients with SD early imaging response, patients with AFP ratio of >1 and DCP ratio of >1 had significantly poorer survival than others (MST 7.4 vs 12.6 months, P=0.014). The decrease in AFP and DCP in the early stage treatment with HAIC were identified as significant and independent factors associated with survival of not only all patients, but also patients with SD early imaging response. ConclusionThe use of the combination of RECIST and tumor marker ratio could be useful for assessment of the early response to HAIC and prognosis of patients with advanced HCC.	[Miyaki, Daisuke; Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Honda, Yohji; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Hyogo, Hideyuki; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Yoshimatsu, Rika; Yamagami, Takuji; Awai, Kazuo] Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan	Aikata, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Miyaki D, 2013, J GASTROEN HEPATOL, V28, P1834, DOI 10.1111/jgh.12311; Ando E, 2002, CANCER, V95, P588, DOI 10.1002/cncr.10694; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kamada K, 2002, AM J SURG, V184, P284, DOI 10.1016/S0002-9610(02)00933-9; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Katamura Y, 2009, J GASTROENTEROL, V44, P492, DOI 10.1007/s00535-009-0033-y; Kobayashi M, 2009, CANCER, V115, P571, DOI 10.1002/cncr.24031; Uka K, 2007, LIVER INT, V27, P1209, DOI 10.1111/j.1478-3231.2007.01554.x; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; LIVRAGHI T, 1995, RADIOLOGY, V197, P101; GOLDSTEIN HM, 1976, RADIOLOGY, V120, P539; Miyaki D, 2012, J GASTROEN HEPATOL, V27, P1850, DOI 10.1111/j.1440-1746.2012.07276.x; Tsai MC, 2010, J GASTROEN HEPATOL, V25, P605, DOI 10.1111/j.1440-1746.2009.06115.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Livraghi T, 1999, RADIOLOGY, V210, P655; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; CHUANG VP, 1981, RADIOLOGY, V140, P51; DOCI R, 1988, CANCER, V61, P1983, DOI 10.1002/1097-0142(19880515)61:10<1983::AID-CNCR2820611009>3.0.CO;2-V; Memon K, 2012, J HEPATOL, V56, P1112, DOI 10.1016/j.jhep.2011.11.020; Nagaoka S, 2003, CANCER, V98, P2671, DOI 10.1002/cncr.11839; Niizeki T, 2012, J GASTROENTEROL, V47, P686, DOI 10.1007/s00535-012-0555-6; STEHLIN JS, 1988, ANN SURG, V208, P23, DOI 10.1097/00000658-198807000-00004	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	APR	2015	30	4					726	732		10.1111/jgh.12821		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD9FL	WOS:000351403200020		
J	Noji, T; Tsuchikawa, T; Okamura, K; Nakamura, T; Tamoto, E; Shichinohe, T; Hirano, S				Noji, Takehiro; Tsuchikawa, Takahiro; Okamura, Keisuke; Nakamura, Toru; Tamoto, Eiji; Shichinohe, Toshiaki; Hirano, Satoshi			Resection and Reconstruction of the Hepatic Artery for Advanced Perihilar Cholangiocarcinoma: Result of Arterioportal Shunting	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Perihilar cholangiocarcinoma; Concomitant hepatic artery resection; Arterioportal shunting; Microvascular reconstruction	PORTAL-VEIN ARTERIALIZATION; HILAR BILE-DUCT; COMMUNICATING ARCADE; LIVER-REGENERATION; BLOOD-FLOW; HEPATECTOMY; CARCINOMA; STRATEGY; FAILURE	The clinical impact of concomitant arterial resection and reconstruction for perihilar cholangiocarcinoma remains unclear. Microvascular anastomosis is typically used for arterial reconstruction, but we have proposed arterioportal shunting (APS) as an alternative procedure. The aims of this retrospective study were to evaluate concomitant arterial resection and reconstruction for perihilar cholangiocarcinoma patients, to evaluate the safety and survival impact of APS, and to evaluate whether APS offers a good alternative to microvascular reconstruction. Thirty-nine patients with perihilar cholangiocarcinoma who required arterial reconstructions were retrospectively evaluated. No significant difference was seen in overall incidence of postoperative complications between groups, but the incidence of liver abscess formation was significantly higher in the APS group. The cumulative 5-year survival rate was 15 % in patients undergoing concomitant arterial resection and reconstruction for perihilar cholangiocarcinoma. No significant differences in survival were identified between the microvascular (MV) and APS groups. Cumulative 5-year survival rates were 18 % in the MV group and 11 % in the APS group. Concomitant arterial resection and reconstruction are feasible for patients with perihilar cholangiocarcinoma. Microvascular reconstruction should be used as the first-line strategy for these patients, with APS indicated only when the artery is unable to be microscopically anastomosed.	[Noji, Takehiro; Tsuchikawa, Takahiro; Okamura, Keisuke; Nakamura, Toru; Tamoto, Eiji; Shichinohe, Toshiaki; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Noji, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol 2, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	drnoji@med.hokudai.ac.jp					Hirano S, 2010, J HEPATO-BIL-PAN SCI, V17, P455, DOI 10.1007/s00534-009-0208-1; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Ebata T, 2009, BRIT J SURG, V96, P926, DOI 10.1002/bjs.6655; Tohma T, 2005, RADIOLOGY, V237, P361, DOI 10.1148/radiol.2371040919; Nardo B, 2008, TRANSPL P, V40, P2046, DOI 10.1016/j.transproceed.2008.05.026; Shimada H, 2003, WORLD J SURG, V27, P1137, DOI 10.1007/s00268-003-6801-6; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; REDMAN HC, 1970, RADIOLOGY, V94, P575; Clavien PA, 2009, ANN SURG, V250, P197, DOI 10.1097/SLA.0b013e3181b6dcab; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Hirano S, 2009, J HEPATO-BILIARY-PAN, V16, P502, DOI 10.1007/s00534-009-0093-7; Gunji H, 2006, AM J SURG, V192, P276, DOI 10.1016/j.amjsurg.2006.01.046; Madariaga JR, 1998, ANN SURG, V227, P70, DOI 10.1097/00000658-199801000-00011; Hemming AW, 2006, AM SURGEON, V72, P599; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Chen YL, 2012, CHINESE MED J-PEKING, V125, P2302, DOI 10.3760/cma.j.issn.0366-6999.2012.13.011; Chen YL, 2010, CHINESE MED J-PEKING, V123, P3217, DOI 10.3760/cma.j.issn.0366-6999.2010.22.008; Gupta N, 1998, ARCH SURG-CHICAGO, V133, P176, DOI 10.1001/archsurg.133.2.176; Hidalgo E, 2008, EJSO-EUR J SURG ONC, V34, P787, DOI 10.1016/j.ejso.2007.10.005; Hirano S, 2007, J HEPATO-BILIARY-PAN, V14, P429, DOI 10.1007/s00534-006-1190-5; Kondo S, 2004, BRIT J SURG, V91, P248, DOI 10.1002/bjs.4428; Lee S G, 2000, J Hepatobiliary Pancreat Surg, V7, P135, DOI 10.1007/s005340050167; Miyazaki M, 2000, HEPATO-GASTROENTEROL, V47, P1526; Sakamoto Y, 2006, LANGENBECK ARCH SURG, V391, P203, DOI 10.1007/s00423-006-0026-8; Schleimer K, 2008, J SURG RES, V149, P250, DOI 10.1016/j.jss.2008.01.021; Suzuki O, 1999, EUR SURG RES, V31, P324, DOI 10.1159/000008709; Tsuge H, 1995, HEPATO-GASTROENTEROL, V42, P966; Yamanaka N, 2001, LANGENBECK ARCH SURG, V386, P364, DOI 10.1007/s004230100225	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	APR	2015	19	4					675	681		10.1007/s11605-015-2754-y		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CD9US	WOS:000351444700013		
J	Kaneoka, Y; Maeda, A; Isogai, M				Kaneoka, Yuji; Maeda, Atsuyuki; Isogai, Masatoshi			En Bloc Resection of the Hepatoduodenal Ligament for Advanced Biliary Malignancy	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Hepatoduodenal ligament; Biliary malignancy; En bloc resection	PORTAL-VEIN RESECTION; HILAR CHOLANGIOCARCINOMA; BILE-DUCT; FOLLOW-UP; HEPATECTOMY; CANCER	En bloc resection of the hepatoduodenal ligament (HDL) for advanced biliary malignancy by hepato-ligamento-pancreatoduodenectomy (HLPD) or hepatoligamentectomy (HL) remains challenging, and only short-term outcomes have been reported. We showed our surgical technique of HLPD and HL, and retrospectively investigated surgical outcomes of the patients. Between 2003 and 2014, we performed four HLPD and three HL including major hepatectomy with concomitant caudate lobectomy. Portal vein reconstruction (PVR) was performed with a right external iliac vein graft, and hepatic artery reconstruction (HAR) was accomplished with the heterogeneous artery using the continuous suturing method. Mean operation time and blood loss were 575 +/- 111 min and 1539 +/- 950 mL, respectively, and patency of the reconstructed vessels was confirmed postoperatively in all cases. Histologically, negative surgical margins (R0) were achieved in 57 % of patients, while the resected vascular invasion was confirmed in all patients. Overall morbidity was high at 57 %, but we have achieved no postoperative mortality. Overall median survival time of the patients was 36 months, and a patient of HL survived over 5 years. En bloc resection of the HDL based on steady vascular reconstruction can improve the surgical outcome of biliary cancer in selected patients.	[Kaneoka, Yuji; Maeda, Atsuyuki; Isogai, Masatoshi] Ogaki Municipal Hosp, Dept Surg, Ogaki 5038502, Japan	Kaneoka, Y (reprint author), Ogaki Municipal Hosp, Dept Surg, 4-86 Minaminokawa, Ogaki 5038502, Japan.	y-kaneoka@omh.ogaki.gifu.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Hemming AW, 2011, J AM COLL SURGEONS, V212, P604, DOI 10.1016/j.jamcollsurg.2010.12.028; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Neuhaus P, 2012, ANN SURG ONCOL, V19, P1602, DOI 10.1245/s10434-011-2077-5; de Jong MC, 2012, CANCER-AM CANCER SOC, V118, P4737, DOI 10.1002/cncr.27492; Nagino M, 1996, RADIOLOGY, V200, P559; Nuzzo G, 2012, ARCH SURG-CHICAGO, V147, P26, DOI 10.1001/archsurg.2011.771; Bachellier P, 2011, ANN SURG, V253, P173, DOI 10.1097/SLA.0b013e3181f193ba; BOERMA EJ, 1990, SURGERY, V108, P572; BOERMA EJ, 1985, SURG GYNECOL OBSTET, V161, P223; Hanyu F, 1988, GEKA CHIRYO, V59, P12; Kaneoka Y, 2013, SURG TODAY, V43, P1254, DOI 10.1007/s00595-012-0406-3; Kaneoka Y, 2012, J GASTROINTEST SURG, V16, P1590, DOI 10.1007/s11605-012-1933-3; MIMURA H, 1991, HEPATO-GASTROENTEROL, V38, P561; Sobin HL, 2010, TNM CLASSIFICATION M	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	APR	2015	19	4					708	714		10.1007/s11605-014-2731-x		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CD9US	WOS:000351444700017		
J	Seishima, R; Okabayashi, K; Hasegawa, H; Tsuruta, M; Shigeta, K; Matsui, S; Yamada, T; Kitagawa, Y				Seishima, Ryo; Okabayashi, Koji; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shigeta, Kohei; Matsui, Shimpei; Yamada, Toru; Kitagawa, Yuko			Is laparoscopic Colorectal Surgery Beneficial for Elderly Patients? A Systematic Review and Meta-Analysis	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Laparoscopic surgery; Colorectal; Elderly	POSTOPERATIVE COMPLICATIONS; COLONIC SURGERY; MATCHED-CONTROL; CANCER-SURGERY; OPEN COLECTOMY; RESECTION; OCTOGENARIANS; ADVANTAGES; PNEUMOPERITONEUM; MORTALITY	Elderly patients who undergo major abdominal surgery are potentially at a higher risk of perioperative mortality and postoperative complications. Although laparoscopic surgery has been widely accepted as a less invasive surgical procedure for colorectal diseases, the benefits for elderly patients have not been validated. To compare postoperative outcomes and long-term survival between laparoscopic and open colorectal surgery in the elderly population. A literature search was electronically performed to identify all studies comparing postoperative outcomes between laparoscopic and open colorectal resections in the elderly population. Primary outcomes were postoperative mortality and complications, and the secondary outcome was long-term survival. Overall, 30 studies (70,946 patients) met our inclusion criteria. Laparoscopic surgery was significantly associated with a decreased risk of perioperative mortality [odds ratio (OR), 0.55; 95 % confidence interval (CI), 0.45-0.68; P < 0.01] and postoperative complications (OR, 0.55; 95 % CI, 0.48-0.63; P < 0.01) compared with open surgery. There was no significant difference in long-term survival between the two procedures (OR, 0.89; 95 % CI, 0.72-1.07; P = 0.31). Laparoscopic colorectal surgery in the elderly population has significant advantages in terms of short-term outcomes. Aggressive application of laparoscopic colorectal surgery should be considered for the elderly population.	[Seishima, Ryo; Okabayashi, Koji; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shigeta, Kohei; Matsui, Shimpei; Yamada, Toru; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Okabayashi, K (reprint author), Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	okabayashikoji@gmail.com		Shigeta, Kohei/0000-0003-1596-4200			Allardyce RA, 2010, BRIT J SURG, V97, P86, DOI 10.1002/bjs.6785; Altuntas YE, 2012, TECH COLOPROCTOL, V16, P213, DOI 10.1007/s10151-012-0817-6; Chautard J, 2008, J AM COLL SURGEONS, V206, P255, DOI 10.1016/j.jamcollsurg.2007.06.316; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Whelan RL, 2003, SURG ENDOSC, V17, P972, DOI 10.1007/s00464-001-8263-y; EVERS BM, 1994, SURG CLIN N AM, V74, P23; Lian L, 2010, SURG ENDOSC, V24, P2039, DOI 10.1007/s00464-010-0900-x; ZUCKER KA, 1994, SURG ENDOSC-ULTRAS, V8, P12, DOI 10.1007/BF02909486; Harris SN, 1996, ANESTH ANALG, V83, P482, DOI 10.1097/00000539-199609000-00007; Russo A, 2009, EUR J ANAESTH, V26, P923, DOI 10.1097/EJA.0b013e32832cb3c9; Law WL, 2002, J AM COLL SURGEONS, V195, P768, DOI 10.1016/S1072-7515(02)01483-7; Grailey K, 2013, SURG ENDOSC, V27, P19, DOI 10.1007/s00464-012-2414-1; Faiz O, 2011, COLORECTAL DIS, V13, P779, DOI 10.1111/j.1463-1318.2010.02290.x; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Stocchi L, 2000, DIS COLON RECTUM, V43, P326, DOI 10.1007/BF02258297; Robinson CN, 2011, J SURG RES, V166, P182, DOI 10.1016/j.jss.2010.05.053; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Wichmann MW, 2005, ARCH SURG-CHICAGO, V140, P692, DOI 10.1001/archsurg.140.7.692; Dhoste K, 1996, CAN J ANAESTH, V43, P783; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tan WS, 2012, INT J COLORECTAL DIS, V27, P773, DOI 10.1007/s00384-011-1375-5; Story DA, 2008, CURR OPIN ANESTHESIO, V21, P375, DOI 10.1097/ACO.0b013e3282f889f8; Akiyoshi T, 2009, J GASTROINTEST SURG, V13, P1614, DOI 10.1007/s11605-009-0961-0; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; Kennedy GD, 2011, ANN SURG, V253, P508, DOI 10.1097/SLA.0b013e3181f19518; Senagore AJ, 2003, ARCH SURG-CHICAGO, V138, P252, DOI 10.1001/archsurg.138.3.252; Frasson M, 2008, DIS COLON RECTUM, V51, P296, DOI 10.1007/s10350-007-9124-0; Al-Refaie WB, 2011, ANN SURG, V253, P947, DOI 10.1097/SLA.0b013e318216f56e; Antoniou SA, 2014, SURG ENDOSC; Bo M, 2007, ARCH GERONTOL GERIAT, V44, P215, DOI 10.1016/j.archger.2006.05.007; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Castillo JJ, 2010, BLOOD, V116, P2897, DOI 10.1182/blood-2010-03-276683; Cummings LC, 2012, WORLD J SURG ONCOLOG, V10; Delgado S, 2000, SURG ENDOSC-ULTRAS, V14, P22, DOI 10.1007/s004649900004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Feng B, 2006, AGING CLIN EXP RES, V18, P191; Fleshman J, 2007, ANN SURG, V246, P662, DOI DOI 10.1097/SLA.0B013E318155A762; Fujii S, 2013, SURG ENDOSC; Gebhardt H, 1997, SURG ENDOSC-ULTRAS, V11, P864, DOI 10.1007/s004649900473; Huang C, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-127; Issa N, 2011, J GASTROINTEST SURG, V15, P2011, DOI 10.1007/s11605-011-1671-y; Miyasaka Y, 2013, SURG TODAY; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Person B, 2008, SURG ENDOSC, V22, P401, DOI 10.1007/s00464-007-9412-8; Pinto RA, 2011, SURG ENDOSC, V25, P2692, DOI 10.1007/s00464-011-1631-3; She WH, 2013, SURG ENDOSC, V27, P308, DOI 10.1007/s00464-012-2466-2; Sklow B, 2003, SURG ENDOSC, V17, P923, DOI 10.1007/s00464-002-8949-9; Stewart BT, 1999, BRIT J SURG, V86, P938, DOI 10.1046/j.1365-2168.1999.01160.x; Suto T, 2011, NIPPON RONEN IGAKKAI, V48, P655; Tei M, 2009, SURG LAPARO ENDO PER, V19, P488, DOI 10.1097/SLE.0b013e3181bd9562; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tomimaru Y, 2011, Asian J Endosc Surg, V4, P1, DOI 10.1111/j.1758-5910.2010.00061.x; Tuech JJ, 2000, SURG ENDOSC-ULTRAS, V14, P1031, DOI 10.1007/s004640000267; United Nations. Department of Economic and Social Affairs.Population Division, 2014, WORLD POP PROSP 2012; Vignali A, 2005, DIS COLON RECTUM, V48, P2070, DOI 10.1007/s10350-005-0147-0; White SI, 2012, COLORECTAL DIS, V14, pE395, DOI 10.1111/j.1463-1318.2012.02963.x; Yamamoto S, 2003, SURG LAPARO ENDO PER, V13, P95, DOI 10.1097/00129689-200304000-00007	57	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	APR	2015	19	4					756	765		10.1007/s11605-015-2748-9		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CD9US	WOS:000351444700024		
J	Otsubo, T; Sherwood, RA; Appleby, GM; Neubert, R				Otsubo, Toshimichi; Sherwood, Robert A.; Appleby, Graham M.; Neubert, Reinhart			Center-of-mass corrections for sub-cm-precision laser-ranging targets: Starlette, Stella and LARES	JOURNAL OF GEODESY			English	Article						Satellite laser ranging; Optical response; Starlette; Stella; LARES	SATELLITE; AJISAI	To realize the full potential of satellite laser ranging for accurate geodesy, it is crucial that all systematic effects in the measurements are taken into account. This paper derives new values for the so-called center-of-mass corrections for three geodetic satellites that are regularly tracked and used in geodetic studies. Optical responses of the twin satellites, Starlette and Stella, and the LARES satellite are retrieved from kHz single-photon laser-ranging data observed at Herstmonceux and Potsdam. The detection timing inside single-photon systems, C-SPAD-based systems and photomultiplier-based systems is numerically simulated, and the center-of-mass corrections are derived to be in the range of 74 to 82 mm for Starlette and Stella, and 127-135 mm for LARES. The system dependence is below 1 cm, but should not be ignored for millimeter accuracy. The longtime standard center-of-mass correction 75 mm of Starlette and Stella is revealed to be too small for the current laser-ranging stations on average, which is considered to have resulted in a non-negligible systematic error in geodetic products.	[Otsubo, Toshimichi] Hitotsubashi Univ, Tokyo 1868601, Japan; [Sherwood, Robert A.; Appleby, Graham M.] NERC Space Geodesy Facil, Hailsham BN27 1RN, E Sussex, England; [Neubert, Reinhart] Deutsch GeoForschungsZentrum, D-14473 Potsdam, Germany	Otsubo, T (reprint author), Hitotsubashi Univ, 2-1 Naka, Tokyo 1868601, Japan.	t.otsubo@r.hit-u.ac.jp			JSPS KAKENHI [26400449]	This work was supported by JSPS KAKENHI Grant Number 26400449.	Ciufolini I, 2013, NUCL PHYS B-PROC SUP, V243, P180, DOI 10.1016/j.nuclphysbps.2013.09.005; Chen JL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005397; Paolozzi A, 2011, ACTA ASTRONAUT, V69, P127, DOI 10.1016/j.actaastro.2011.03.005; Sosnica K, 2014, J GEODESY, V88, P789, DOI 10.1007/s00190-014-0722-z; Matsuo K, 2013, GEOPHYS RES LETT, V40, P4662, DOI 10.1002/grl.50900; Appleby G, 1996, THESIS U ASTON BIRMI; Appleby GM, 1992, P 8 INT WORKSH LAS R, P21; Arnold DA, 2013, P 18 INT WORKSH LAS; Arnold DA, 1975, 1610602 RTOP SMITHS; DEGNAN JJ, 1985, IEEE T GEOSCI REMOTE, V23, P398, DOI 10.1109/TGRS.1985.289430; Gibbs P, 2006, P 15 INT WORKSH LAS, P250; Grunwaldt L, 2013, P 18 INT WORKSH LAS, P13; ILRS, 2012, MISS LARES; Kirchner G, 1998, P 11 INT WORKSH LAS, P245; Kirchner G., 2004, P 14 INT WORKSH LAS, P501; Kral L, 2005, OPT LETT, V30, P1767, DOI 10.1364/OL.30.001767; Kucharski D, 2010, ADV SPACE RES, V46, P251, DOI 10.1016/j.asr.2010.03.029; Kucharski D, 2014, ADV SPACE RES, V53, P90, DOI 10.1016/j.asr.2013.10.020; Kucharski D, 2014, IEEE GEOSCI REMOTE S, V11, P646, DOI 10.1109/LGRS.2013.2273561; Neubert R, 1994, P 9 INT WORKSH LAS R, P82; Otsubo T, 2000, IEEE T GEOSCI REMOTE, V38, P1417, DOI 10.1109/36.843036; Otsubo T, 2003, J GEOPHYS RES, V109, P91; Otsubo T, 1999, IEEE T GEOSCI REMOTE, V37, P2011, DOI 10.1109/36.774712; Parkhomenko N, 2013, P 18 INT WORKSH LAS, P13; Ries J, 2008, GGOS GROUND NETW COM; SCHWARTZ JA, 1990, APPL OPTICS, V29, P3590, DOI 10.1364/AO.29.003590; Vasiliev VP, 2007, ILRS FALL 2007 WORKS	27	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-7714	1432-1394		J GEODESY	J. Geodesy	APR	2015	89	4					303	312		10.1007/s00190-014-0776-y		10	Geochemistry & Geophysics; Remote Sensing	Geochemistry & Geophysics; Remote Sensing	CD7AW	WOS:000351243600001		
J	Moriya, A; Iwasaki, Y; Ohguchi, S; Kayashima, E; Mitsumune, T; Taniguchi, H; Ando, M; Yamamoto, K				Moriya, Akio; Iwasaki, Yoshiaki; Ohguchi, Souhei; Kayashima, Eizo; Mitsumune, Tadahiko; Taniguchi, Hideaki; Ando, Masaharu; Yamamoto, Kazuhide			Roles of alcohol consumption in fatty liver: A longitudinal study	JOURNAL OF HEPATOLOGY			English	Article						Non-alcoholic fatty liver disease; Drinking pattern; Generalized estimating equation; Ultrasonography	CORONARY-HEART-DISEASE; METABOLIC SYNDROME; NONALCOHOLIC STEATOHEPATITIS; ALDEHYDE DEHYDROGENASE; DECREASED PREVALENCE; GENERAL-POPULATION; HEPATIC STEATOSIS; DRINKING; RISK; LIGHT	Background & Aims: Roles of alcohol consumption in non-alcoholic fatty liver disease are still controversial, although several cross-sectional studies have suggested the beneficial effect of light to moderate drinking on fatty liver. We analyzed the longitudinal relationship between drinking pattern and fatty liver. Methods: We included 5297 Japanese individuals (3773 men and 1524 women) who underwent a baseline study in 2003 and follow-up at least once from 2004 to 2006. Generalized estimating equation was used to estimate any association between drinking pattern and fatty liver assessed by ultrasonography. Results: At baseline, 1179 men (31.2%) and 235 women (15.4%) had fatty liver; 2802 men (74.2%) and 436 women (28.6%) reported alcohol consumption. At the latest follow-up, 348 of 2594 men (13.4%) and 101 of 1289 women (7.8%) had newly developed fatty liver; 285 of 1179 men (24.2%) and 70 of 235 women (29.8%) demonstrated a remission of fatty liver. In men, drinking 0.1-69.9 g/week (odds ratio, 0.79 [95% confidence interval, 0.68-0.90]), drinking 70.0-139.9 g/week (0.73 [0.63-0.84]), drinking 140.0-279.9 g/week (0.69 [0.60-0.79]), and drinking >= 280.0 g/week (0.68 [0.58-0.79]) were inversely associated with fatty liver after adjusting for obesity, exercise, and smoking. In women, drinking 0.1-69.9 g/week (0.71 [0.52-0.96]) and drinking 70.0-139.9 g/week (0.67 [0.45-0.98]) were inversely associated with fatty liver after the adjustment. Conclusions: Light to moderate alcohol consumption, or even somewhat excessive amounts especially in men, was likely to protect most individuals against fatty liver over time. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Moriya, Akio; Ando, Masaharu] Mitoyo Gen Hosp, Dept Med, Kanonji, Japan; [Iwasaki, Yoshiaki] Okayama Univ, Hlth Serv Ctr, Okayama 7008558, Japan; [Iwasaki, Yoshiaki; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Ohguchi, Souhei; Kayashima, Eizo; Mitsumune, Tadahiko] Junpukai Hlth Maintenance Ctr, Okayama, Japan; [Taniguchi, Hideaki] Tottori Municipal Hosp, Dept Med, Tottori, Japan	Iwasaki, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	yiwasaki@cc.okayama-u.ac.jp					Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; SINGH S, 1989, HUM GENET, V83, P119, DOI 10.1007/BF00286702; Zelber-Sagi S, 2012, J HEPATOL, V56, P1145, DOI 10.1016/j.jhep.2011.12.011; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Hiramine Y, 2011, J GASTROENTEROL, V46, P519, DOI 10.1007/s00535-010-0336-z; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Tolstrup J, 2006, BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; Charlton M, 2001, LIVER TRANSPLANT, V7, P608, DOI 10.1053/jlts.2001.25453; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Suzuki A, 2007, AM J GASTROENTEROL, V102, P1912, DOI 10.1111/j.1572-0241.2007.01274.x; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Bellentani S, 1997, GUT, V41, P845; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Hojsgaard S., 2006, J STAT SOFTW, V15, P1; Khashab Mouen A, 2008, Curr Gastroenterol Rep, V10, P73, DOI 10.1007/s11894-008-0012-0; Machado M, 2006, CURR OPIN CLIN NUTR, V9, P637, DOI 10.1097/01.mco.0000241677.40170.17; MENDELOFF AI, 1954, J CLIN INVEST, V33, P1298, DOI 10.1172/JCI103005; Palasciano G, 2007, CURR PHARM DESIGN, V13, P2193; R Core Team, 2014, R LANG ENV STAT COMP; Matsuzawa Y, 2002, CIRC J, V66, P987; Yamada T, 2010, DIGEST DIS SCI, V55, P176, DOI 10.1007/s10620-008-0693-0; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004	42	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	APR	2015	62	4					921	927		10.1016/j.jhep.2014.11.025		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD7WH	WOS:000351305300024		
J	Nakanuma, Y; Sasaki, M; Harada, K				Nakanuma, Yasuni; Sasaki, Motoko; Harada, Kenichi			Autophagy and senescence in fibrosing cholangiopathies	JOURNAL OF HEPATOLOGY			English	Review						Fibrosing cholangiopathy; Cellular senescence; Autophagy; Innate immunity; Senescence-associated secretory phenotype	PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; ONCOGENE-INDUCED SENESCENCE; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; SMALL BILE-DUCTS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INDUCED CELLULAR SENESCENCE; RIBOSOMAL-RNA GENE; NF-KAPPA-B	Fibrosing cholangiopathy such as primary sclerosing cholangitis (PSC) and biliary atresia (BA) is characterized by biliary epithelial injuries and concentric fibrous obliteration of the biliary tree together with inflammatory cell infiltration. In these diseases, inappropriate innate immunity is reported to contribute more to bile duct pathology as compared with various aspects of "classical'' autoimmune diseases. Primary biliary cirrhosis (PBC) is characterized by chronic cholangitis with bile duct loss and classical autoimmune features. Cellular senescence of cholangiocytes and a senescence-associated secretory phenotype lead to the production of proinflammatory cytokines and chemokines that may modify the milieu of the bile duct and then trigger fibroinflammatory responses in PSC and PBC. Furthermore, deregulated autophagy might be involved in cholangiocyte senescence and possibly in the autoimmune process in PBC, and the deregulated innate immunity against enteric microbes or their products that is associated with cholangiocyte senescence might result in the fibrosing cholangitis that develops in PBC and PSC. In BA, innate immunity against double-stranded RNA viruses might be involved in cholangiocyte apoptosis and also in the development of the epithelial-mesenchymal transition of cholangiocytes that results in fibrous obliteration of bile ducts. These recent advances in the understanding of immune-mediated biliary diseases represent a paradigm shift: the cholangiocyte is no longer viewed merely as a passive victim of injury; it is now also considered to function as a potential effector in bile duct pathology. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Diagnost Pathol, Shizuoka 4118777, Japan; [Nakanuma, Yasuni; Sasaki, Motoko; Harada, Kenichi] Kanazawa Univ, Grad Sch Med Sci, Dept Pathol, Kanazawa, Ishikawa 9201192, Japan	Nakanuma, Y (reprint author), Shizuoka Canc Ctr, Dept Diagnost Pathol, Sunto Nagaizumi 1007, Shizuoka 4118777, Japan.	pbcpsc@kenroku.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X			Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Hiramatsu K, 2000, J HEPATOL, V33, P9, DOI 10.1016/S0168-8278(00)80153-1; O'Mahony CA, 2006, SEMIN LIVER DIS, V26, P3, DOI 10.1055/s-2006-933559; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Sasaki M, 2013, LIVER INT, V33, P312, DOI 10.1111/liv.12049; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Chen XM, 2005, J IMMUNOL, V175, P7447; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Strozyk E, 2013, INT J MOL SCI, V14, P15260, DOI 10.3390/ijms140815260; Nakanuma Y, 2010, HISTOL HISTOPATHOL, V25, P223; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Harada K, 2007, HEPATOLOGY, V46, P1146, DOI 10.1002/hep.21797; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Sasatomi K, 1998, J HEPATOL, V29, P409, DOI 10.1016/S0168-8278(98)80058-5; Tabibian JH, 2014, SCAND J GASTROENTERO, V49, P901, DOI 10.3109/00365521.2014.913189; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Kalimuthu S, 2013, INT J MOL SCI, V14, P2334, DOI 10.3390/ijms14022334; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Harada K, 2009, J PATHOL, V217, P654, DOI 10.1002/path.2488; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Isse K, 2005, HEPATOLOGY, V41, P506, DOI 10.1002/hep.20582; Seidel D, 2014, HEPATOLOGY, V59, P601, DOI 10.1002/hep.26702; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Parikh-Patel A, 2001, HEPATOLOGY, V33, P16, DOI 10.1053/jhep.2001.21165; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Xu B, 2002, GUT, V51, P120, DOI 10.1136/gut.51.1.120; Shimoda S, 2010, HEPATOLOGY, V51, P567, DOI 10.1002/hep.23318; Brain JG, 2013, AM J TRANSPLANT, V13, P1688, DOI 10.1111/ajt.12271; Poupon R, 2008, J HEPATOL, V49, P1038, DOI 10.1016/j.jhep.2008.07.027; Mack CL, 2007, GASTROENTEROLOGY, V133, P278, DOI 10.1053/j.gastro.2007.04.032; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x; Hohenester S, 2012, HEPATOLOGY, V55, P173, DOI 10.1002/hep.24691; Zhu BK, 2014, J BIOL CHEM, V289, P20102, DOI 10.1074/jbc.M114.551069; Mueller T, 2011, LIVER INT, V31, P1574, DOI 10.1111/j.1478-3231.2011.02635.x; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Bowlus CL, 2011, CLIN REV ALLERG IMMU, V41, P139, DOI 10.1007/s12016-010-8221-3; Bansi DS, 1996, GUT, V38, P384, DOI 10.1136/gut.38.3.384; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Nitta T, 2014, INT J CLIN EXP PATHO, V7, P4913; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Terjung B, 2010, GUT, V59, P808, DOI 10.1136/gut.2008.157818; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Trivedi PJ, 2013, J AUTOIMMUN, V46, P97, DOI 10.1016/j.jaut.2013.06.013; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Aron JH, 2009, SEMIN IMMUNOPATHOL, V31, P383, DOI 10.1007/s00281-009-0154-7; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Tkach M, 2012, J IMMUNOL, V189, P1162, DOI 10.4049/jimmunol.1102538; Shimoda S, 2008, HEPATOLOGY, V47, P958, DOI 10.1002/hep.22102; Wall M, 2013, CANCER DISCOV, V3, P82, DOI 10.1158/2159-8290.CD-12-0404; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; Shimoda S, 2011, HEPATOLOGY, V53, P1270, DOI 10.1002/hep.24194; Brodsky W Y, 1977, Int Rev Cytol, V50, P275; Gotthardt D, 2008, HEPATOLOGY, V48, P1157, DOI 10.1002/hep.22485; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Harada K, 2003, LAB INVEST, V83, P1657, DOI 10.1097/01.LAB.0000097190.56734.FE; LaRusso NF, 2006, HEPATOLOGY, V44, P746, DOI 10.1002/hep.21337; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; POKORNY CS, 1994, J GASTROEN HEPATOL, V9, P40, DOI 10.1111/j.1440-1746.1994.tb01214.x; Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8; Yasoshima M, 1998, LAB INVEST, V78, P89; Beuers U, 2008, J HEPATOL, V49, P881, DOI 10.1016/j.jhep.2008.09.010; Broome U, 1997, J HEPATOL, V26, P527; Chuang Jiin-Haur, 2006, Chang Gung Med J, V29, P240; de Graaf EL, 2014, MOL CELL PROTEOMICS, V13, P2089, DOI 10.1074/mcp.M113.035436; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EASL Clinical Practice Guidelines, 2009, J HEPATOL, V51, P237; Feldman AG, 2012, SEMIN PEDIATR SURG, V21, P192, DOI 10.1053/j.sempedsurg.2012.05.003; Gitenay D, 2014, ONCOTARGET, V5, P5845; Glaser SS, 2008, LIVER INT, V28, P587, DOI 10.1111/j.1478-3231.2008.01752.x; Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231; Harada K, 2006, J CLIN PATHOL, V59, P184, DOI 10.1136/jcp.2004.023507; Harada K, 2011, LIVER INT, V31, P245, DOI 10.1111/j.1478-3231.2010.02367.x; Harada K, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/373878; Harada K, 2005, HEPATOLOGY, V41, P1329, DOI 10.1002/hep.20705; Harada K, 2001, HEPATOLOGY, V33, P530, DOI 10.1053/jhep.2001.22653; Harada Kenichi, 2012, Inflammation & Allergy Drug Targets, V11, P478; Harada K, 1997, HEPATOLOGY, V26, P1399; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Harada K, 2008, LIVER INT, V28, P614, DOI 10.1111/j.1478-3231.2008.01740.x; Harada K, 2011, J CLIN PATHOL, V64, P660, DOI 10.1136/jclinpath-2011-200040; Ikeda H, 2007, LAB INVEST, V87, P559, DOI 10.1038/labinvest.3700556; Karrar A, 2007, GASTROENTEROLOGY, V132, P1504, DOI 10.1053/j.gastro.2007.01.039; Kisseleva T, 2011, HEPATOLOGY, V53, P1433, DOI 10.1002/hep.24312; Kullak-Ublick GA, 2000, J HEPATOL, V32, P3, DOI 10.1016/S0168-8278(00)80411-0; Kumar M, 2014, AM J RESP CELL MOL, V51, P323, DOI 10.1165/rcmb.2013-0382PS; Laish I, 2013, GENE, V529, P245, DOI 10.1016/j.gene.2013.07.098; Marzioni M, 2002, SEMIN LIVER DIS, V22, P227, DOI 10.1055/s-2002-34501; MATSUMOTO K, 1994, HEPATOLOGY, V20, P376; Matsushita H, 2014, J GASTROENTEROL HEPA; NAKANUMA Y, 1995, HUM PATHOL, V26, P92, DOI 10.1016/0046-8177(95)90120-5; Nakanuma Y, 1999, J Hepatobiliary Pancreat Surg, V6, P333, DOI 10.1007/s005340050127; Nakanuma Y, 2014, HISTOL HISTOPATHOL, V29, P1; Nakanuma Y, 2012, MACSWEENS PATHOLOGY, P491; Nakanuma Y, 2012, INT J HEPATOL, V2012; O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Okamura A, 2013, J CLIN PATHOL, V66, P99, DOI 10.1136/jclinpath-2012-201097; Okamura A, 2013, CLIN EXP IMMUNOL, V173, P268, DOI 10.1111/cei.12103; PRIETO J, 1993, GASTROENTEROLOGY, V105, P572; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sasaki M, 2014, J CLIN PATHOL, V67, P470, DOI 10.1136/jclinpath-2013-201917; Sasaki M, 2012, INT J HEPATOL, V2012; Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6; Sasaki M, 2012, DIGEST DIS SCI, V57, P660, DOI 10.1007/s10620-011-1929-y; Sasaki M, 2010, HEPAT RES TREAT, V2010; Schwarze C, 2003, CLIN EXP IMMUNOL, V133, P283, DOI 10.1046/j.1365-2249.2003.02195.x; Selmi C, 2010, GASTROENTEROLOGY, V139, P1461, DOI 10.1053/j.gastro.2010.09.020; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260; Szavay PO, 2002, EUR J PEDIATR SURG, V12, P48; Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Tsuneyama K, 2001, J PATHOL, V193, P102, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH725>3.0.CO;2-P; Yasoshima M, 2000, J PATHOL, V190, P93, DOI 10.1002/(SICI)1096-9896(200001)190:1<93::AID-PATH507>3.0.CO;2-A	141	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	APR	2015	62	4					934	945				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD7WH	WOS:000351305300026		
J	Oh, CH; Saito, E				Oh, Chu Hyang; Saito, Emiko			Comparison of Eating Habits in Obese and Non-obese Filipinas Living in an Urban Area of Japan	JOURNAL OF IMMIGRANT AND MINORITY HEALTH			English	Article						Filipinas living in Japan; Obesity; Eating habits; Acculturation	BODY-MASS INDEX; WOMEN; RISK; HYPERTENSION; POPULATION; OVERWEIGHT; WEIGHT; HEALTH	This study compares eating habits among obese and non-obese Filipinas living in an urban area of Japan. We used self-report questionnaires to study 635 Filipinos. Body mass index (BMI) and eating/lifestyle habits were noted. Obesity was defined as BMI a parts per thousand yen25 kg/m(2). Seventeen percent (24/140) were obese. Results of the age-adjusted multiple logistic regression analysis show that the following responses were associated with obesity: "frequency of eating high green and yellow vegetables" (every day: 0, not every day: 1) [OR 4.9; 95 % confidence interval (CI) 1.6-14.8] and "frequency of eating high fruits" (every day: 0, not every day: 1) (OR .2; 95 % CI .1-.7). We suggest strategies to prevent obesity and improve eating habits among this Filipina population.	[Oh, Chu Hyang; Saito, Emiko] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Nursing Sci, Arakawa City, Tokyo 1168551, Japan	Oh, CH (reprint author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Nursing Sci, 7-2-10 Higashiogu, Arakawa City, Tokyo 1168551, Japan.	oh-chuhyang@ed.tmu.ac.jp			Japan Society for the Promotion of Science (JSPS)	This study was conducted as part of the Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS). Thank you to those who participants, leaders of the Filipino communities, church representatives, and Mr. Hiroyuki Arakawa for assisting us during the course of our study.	Adair LS, 2004, OBES RES, V12, P1335, DOI 10.1038/oby.2004.168; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Araneta MRG, 2002, DIABETES CARE, V25, P494, DOI 10.2337/diacare.25.3.494; Greenwood DC, 2000, EUR J CLIN NUTR, V54, P314, DOI 10.1038/sj.ejcn.1600941; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0; Newbold KB, 2003, SOC SCI MED, V57, P1981, DOI 10.1016/S0277-9536(03)00064-9; Cairney J, 1999, CAN J PUBLIC HEALTH, V90, P120; Desmond EMW, 2000, BR J NUTR, V83, P257; Dineros H, 2007, OBES SURG, V17, P82, DOI 10.1007/s11695-007-9010-9; Gill Tim, 2006, Asia Pac J Clin Nutr, V15 Suppl, P3; Higuchi M., 2006, J INT HLTH, V21, P33; Hirano Y, 1997, COLLECTION RES AID P, P139; Hirano Y., 1997, KENKO BUNKA KENKYU J, V3, P139; Hirano-Ohara Y., 1998, MEM KYUSHU U SCH HLT, V25, P11; Immigrant Bureau of Japan, 2007, HEIS 18 NEN MAT GENZ; Immigrant Bureau of Japan, 2002, HEIS 14 NEN NI OK NY; Immigrant Bureau of Japan, 2007, DAI 2 HYOU KOK SHUSS, P32; International Obesity Task Force/ World Health Organization, 2000, AS PERSP RED OB ITS, P17; Japan Ministry of Health Labor and Welfare, 2007, HEIS 19 NEN KOK KENK; Kido T, 2001, JPN J HLTH HUM ECOL, V67, P229; Kobayashi M, 2006, J HLTH WELF STAT, V53, P7; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; McKay L, 2003, 12 U GLASG MCR SOC P; Okuda M, 2010, J EPIDEMIOL, V20, P46, DOI 10.2188/jea.JE20090036; Pedro MRA, 2006, FOOD AGR ORG, V84, P205; Tan E A, 1993, Asian Pac Migr J, V2, P303; Tashiro M, 2005, B NAGANO COLL NURS, V7, P41; Tokyo General Affairs Bureau Statistics Department, 2007, DAI 1 HYOU KUSH BET; Tuekpe MKN, 2006, IND HEALTH, V44, P258, DOI 10.2486/indhealth.44.258; Urashima M., 2005, JMAJ - Japan Medical Association Journal, V48, P441; World Health Organization, 2000, WHO TECHN REP SER, V894, P5; Yuki T, 2005, J CHILD HLTH, V64, P279	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1912	1557-1920		J IMMIGR MINOR HEALT	J. Immigr. Minor. Health	APR	2015	17	2					467	473		10.1007/s10903-014-0024-9		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE0UW	WOS:000351524000019		
J	Saito, K; Ohara, K; Kimura, M; Motoda, H				Saito, Kazumi; Ohara, Kouzou; Kimura, Masahiro; Motoda, Hiroshi			Change point detection for burst analysis from an observed information diffusion sequence of tweets	JOURNAL OF INTELLIGENT INFORMATION SYSTEMS			English	Article						Social networks; Information diffusion; Change point detection; Burst detection	MODEL; NETWORKS	We propose a method of detecting the period in which a burst of information diffusion took place from an observed diffusion sequence data over a social network and report the results obtained by applying it to the real Twitter data. We assume a generic information diffusion model in which time delay associated with the diffusion follows the exponential distribution and the burst is directly reflected to the changes in the time delay parameter of the distribution. The shape of the parameter's change is approximated by a step function and the problem of detecting the change points and finding the values of the parameter is formulated as an optimization problem of maximizing the likelihood of generating the observed diffusion sequence. Time complexity of the search is almost proportional to the number of observed data points and has been shown to be very efficient. We first demonstrated that the proposed method can detect the burst using a synthetic data and showed that it performs better than one of the representative state-of-the-art methods, confirming that the proposed method covers a wider range of change patterns. Then, we extended our evaluation on synthetic data to show that it is efficient and effective comparing it with a naive exhaustive search and a simple greedy method. We then apply the method to the real Twitter data of the 2011 To-hoku earthquake and tsunami, and reconfirmed its efficiency and effectiveness. Two interesting discoveries are that a burst period detected by the proposed method tends to contain massive homogeneous tweets on a specific topic even if the observed diffusion sequence consists of heterogeneous tweets on various topics, and that assuming the information diffusion path to be a line shape tree can give a good approximation of the maximum likelihood estimator when the actual diffusion path is not known.	[Saito, Kazumi] Univ Shizuoka, Sch Adm & Informat, Shizuoka 4228526, Japan; [Ohara, Kouzou] Aoyama Gakuin Univ, Dept Integrated Informat Technol, Sagamihara, Kanagawa 2298558, Japan; [Kimura, Masahiro] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan; [Motoda, Hiroshi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Motoda, Hiroshi] Univ Tasmania, Sch Comp & Informat Syst, Hobart, Tas 7005, Australia	Saito, K (reprint author), Univ Shizuoka, Sch Adm & Informat, Shizuoka 4228526, Japan.	k-saito@u-shizuoka-ken.ac.jp; ohara@it.aoyama.ac.jp; kimura@rins.ryukoku.ac.jp; motoda@ar.sanken.osaka-u.ac.jp			Asian Office of Aerospace Research and Development; Air Force Office of Scientific Research [AOARD-13-4042]; JSPS [23500194]	The Twitter data we used in this paper were provided by Prof. Fujio Toriumi of Tokyo University and Prof. Kazuhiro Kazama of Wakayama University. This work was partly supported by Asian Office of Aerospace Research and Development, Air Force Office of Scientific Research under Grant No. AOARD-13-4042, and JSPS Grant-in-Aid for Scientific Research (C) (No. 23500194).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Saito K, 2009, LECT NOTES ARTIF INT, V5828, P322, DOI 10.1007/978-3-642-05224-8_25; Goldenberg J, 2001, MARKET LETT, V12, P211, DOI 10.1023/A:1011122126881; Kimura M, 2010, DATA MIN KNOWL DISC, V20, P70, DOI 10.1007/s10618-009-0150-5; Saito K, 2010, LECT NOTES ARTIF INT, V6323, P180, DOI 10.1007/978-3-642-15939-8_12; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; [Anonymous], 1953, PSYCHOMETRIKA; Araujo L, 2006, LECT NOTES COMPUT SC, V4193, P302; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Ebina R, 2011, PROC INT C TOOLS ART, P1040, DOI 10.1109/ICTAI.2011.177; Kempe D., 2003, P 9 ACM SIGKDD INT C, P137, DOI DOI 10.1145/956750.956769; Kleinberg J., 2002, P 8 ACM SIGKDD INT C, P91, DOI DOI 10.1023/A:1024940629314; Rissanen J., 1989, STOCHASTIC COMPLEXIT; Sadikov E., 2011, P 4 ACM INT C WEB SE, P55, DOI [10.U45/1935826.1935844, DOI 10.1145/1935826.1935844]]; Sun A, 2010, IEEE T SYST MAN CY C, V40, P258, DOI 10.1109/TSMCC.2009.2037311; Wasserman S., 1994, SOCIAL NETWORK ANAL; Zhang X., 2006, THESIS NEW YORK U; Zhu Y., 2003, P 9 ACM SIGKDD INT C, P336	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9902	1573-7675		J INTELL INF SYST	J. Intell. Inf. Syst.	APR	2015	44	2			SI		243	269		10.1007/s10844-013-0283-2		27	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	CE0QW	WOS:000351510500004		
J	Nakamizo, S; Egawa, G; Tomura, M; Sakai, S; Tsuchiya, S; Kitoh, A; Honda, T; Otsuka, A; Nakajima, S; Dainichi, T; Tanizaki, H; Mitsuyama, M; Sugimoto, Y; Kawai, K; Yoshikai, Y; Miyachi, Y; Kabashima, K				Nakamizo, Satoshi; Egawa, Gyohei; Tomura, Michio; Sakai, Shunsuke; Tsuchiya, Soken; Kitoh, Akihiko; Honda, Tetsuya; Otsuka, Atsushi; Nakajima, Saeko; Dainichi, Teruki; Tanizaki, Hideaki; Mitsuyama, Masao; Sugimoto, Yukihiko; Kawai, Kazuhiro; Yoshikai, Yasunobu; Miyachi, Yoshiki; Kabashima, Kenji			Dermal V gamma 4(+) gamma delta T Cells Possess a Migratory Potency to the Draining Lymph Nodes and Modulate CD8(+) T-Cell Activity through TNF-alpha Production	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; IMMUNE-RESPONSE; SKIN; DERMATITIS; INFLAMMATION; PROTECTION; MICE; TUBERCULOSIS; INFECTION	A large number of gamma delta T cells (gamma delta T cells) are located within epithelial tissues including the skin. In mice, epidermal and dermal gamma delta T cells consist of distinct subsets and have specific roles in cutaneous immune responses. A recent study demonstrated that gamma delta T cells and cutaneous dendritic cells migrate from the skin to the draining lymph nodes (LNs). However, it remains unclear whether they regulate the antigen-specific immune response within the LNs. Herein, we investigated their properties and role in the LNs using the Mycobacterium bovis bacille Calmette-Guerin (BCG) infection model. In vivo cell labeling analysis, revealed that most of the migratory subset comprised dermal V gamma 4(+) cells. This population transmigrated from the skin to the LNs in a Gi-coupled chemokine receptor independent manner. By depleting V gamma 4(+) cells, the intranodal expansion of CD8(+) T cell against BCG was significantly attenuated. In addition, in vitro analysis revealed that V gamma 4(+) cells produced TNF-alpha and enhanced IL-12 production by dendritic cells. Taken together, these findings suggest that dermal V gamma 4(+) cells are a unique subset that possesses a migratory potency to the skin-draining LNs and enhances the dendritic cell function therein.	[Nakamizo, Satoshi; Egawa, Gyohei; Kitoh, Akihiko; Honda, Tetsuya; Otsuka, Atsushi; Nakajima, Saeko; Dainichi, Teruki; Tanizaki, Hideaki; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Tomura, Michio; Honda, Tetsuya] Kyoto Univ, Grad Sch Med, Ctr Innovat lmmunoregulat Technol & Therapeut, Kyoto 6068507, Japan; [Sakai, Shunsuke; Mitsuyama, Masao] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto 6068507, Japan; [Tsuchiya, Soken; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan; [Kawai, Kazuhiro] Kido Hosp, Dept Dermatol, Niigata, Japan; [Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Div Host Def, Fukuoka 812, Japan; [Kabashima, Kenji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kabashima, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	gyohei@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Kawai, Kazuhiro/D-4998-2011	Kawai, Kazuhiro/0000-0001-9375-0713	Japan Society for the Promotion of Science of Japan; Precursory Research for Embryonic Science and Technology	We thank Dr Takaharu Okada for critical reading of our manuscript. This work was supported in part by Grants-in-Aid for Japan Society for the Promotion of Science of Japan and Precursory Research for Embryonic Science and Technology.	Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Wilson DC, 2008, J IMMUNOL, V180, P5935; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; TAKAGAKI Y, 1989, NATURE, V339, P712, DOI 10.1038/339712a0; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Vrieling M, 2012, J IMMUNOL, V188, P578, DOI 10.4049/jimmunol.1101972; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Saito K, 2006, J IMMUNOL, V176, P2496; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Hahn YS, 2004, J IMMUNOL, V172, P2894; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Conti L, 2005, J IMMUNOL, V174, P252; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Okamoto Y. Y., 2010, J IMMUNOL, V184, P4414, DOI DOI 10.4049/JIMMUNOL.0903332; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Rakasz E, 1998, INT IMMUNOL, V10, P1509, DOI 10.1093/intimm/10.10.1509	35	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	APR	2015	135	4					1007	1015		10.1038/jid.2014.516		9	Dermatology	Dermatology	CD6GW	WOS:000351188600016		
J	Yajima, I; Kumasaka, MY; Ohnuma, S; Ohgami, N; Naito, H; Shekhar, HU; Omata, Y; Kato, M				Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Ohgami, Nobutaka; Naito, Hisao; Shekhar, Hossain U.; Omata, Yasuhiro; Kato, Masashi			Arsenite-Mediated Promotion of Anchorage-Independent Growth of HaCaT Cells through Placental Growth Factor	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							TRANSCRIPTION FACTOR MTF-1; METALLOTHIONEIN-I; ADHESION KINASE; DOSE-ESCALATION; PHASE-I; CANCER; GROUNDWATER; BANGLADESH; ANGIOGENESIS; EXPRESSION	Various cancers including skin cancer are increasing in 45 million people exposed to arsenic above the World Health Organization's guideline value of 10 mu gl(-1). However, there is limited information on key molecules regulating arsenic-mediated carcinogenesis. Our fieldwork in Bangladesh demonstrated that levels of placental growth factor (PIGF) in urine samples from residents of cancer-prone areas with arsenic-polluted drinking water were higher than those in urine samples from residents of an area that was not polluted with arsenic. Our experimental study in human nontumorigenic HaCaT skin keratinocytes showed that arsenite promoted anchorage-independent growth with increased expression and secretion of PIGF, a ligand of vascular endothelial growth factor receptor1 (VEGFR1), and increased VEGFR1/mitogen-activated protein kinase/ERK kinase (MEK)/extracellular signal-regulated kinase (ERK) activities. The arsenite-mediated promotion of anchorage-independent growth was strongly inhibited by PIGF depletion with decreased activities of the PIGF/VEGFR1/MEK/ERK pathway. Moreover, arsenite proteasome-dependently degrades metal-regulatory transcription factor-1 (MTF-1) protein, resulting in a decreased amount of MTF-1 protein binding to the PIGF promoter. MTF-1 negatively controlled PIGF transcription in HaCaT cells, resulting in increased PIGF transcription. These results suggest that arsenite-mediated MTF-1 degradation enhances the activity of PIGF/VEGFR1/MEK/ERK signaling, resulting in promotion of the malignant transformation of keratinocytes. Thus, this study proposed a molecular mechanism for arsenite-mediated development of skin cancer.	[Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohgami, Nobutaka; Naito, Hisao; Omata, Yasuhiro; Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi 4668550, Japan; [Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohgami, Nobutaka; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Ohgami, Nobutaka; Kato, Masashi] Voluntary Body Int Hlth Care Univ, Nagoya, Aichi, Japan; [Shekhar, Hossain U.; Kato, Masashi] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka 1000, Bangladesh	Kato, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	katomasa@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24390157, 24406002, 25340052, 25460178, 26460798, 23650241, 26670525, 25-40080, 24108001]; AEON Environmental Foundation; Cosmetology Research Foundation; TOYOAKI Scholarship Foundation; Aichi Health Promotion Foundation; Mitsui & Co., Ltd. Environment Fund; Lydia O'Leary Memorial Foundation; Foundation from Center for Advanced Medical and Clinical Research Nagoya University Hospital; Kurita Water and Environment Foundation	This work was supported in part by Grants-in-Aid for Scientific Research (B) (grant numbers 24390157 and 24406002) and (C) (grant number 25340052, 25460178, and 26460798); Grant-in-Aid for Challenging Exploratory Research (grant number 23650241 and 26670525); Grant-in-Aid for Restart Postdoctoral Fellowship (grant number 25-40080); and Grant-in-Aid for Scientific Research on Innovative Areas (grant number 24108001) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); AEON Environmental Foundation; the Cosmetology Research Foundation; TOYOAKI Scholarship Foundation, the Aichi Health Promotion Foundation; the Mitsui & Co., Ltd. Environment Fund; the Lydia O'Leary Memorial Foundation; Foundation from Center for Advanced Medical and Clinical Research Nagoya University Hospital; and Kurita Water and Environment Foundation.	Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Gault AG, 2008, SCI TOTAL ENVIRON, V393, P168, DOI 10.1016/j.scitotenv.2007.12.028; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Yajima I, 2012, ARCH TOXICOL, V86, P961, DOI 10.1007/s00204-012-0848-9; Cheng SJ, 2010, HEAD NECK-J SCI SPEC, V32, P1363, DOI 10.1002/hed.21335; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; Matsui M, 1999, J INVEST DERMATOL, V113, P26, DOI 10.1046/j.1523-1747.1999.00630.x; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Hinwood AL, 2003, ENVIRON HEALTH PERSP, V111, P187, DOI 10.1289/ehp.5455; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Li CZ, 2011, CANCER PREV RES, V4, P2101, DOI 10.1158/1940-6207.CAPR-11-0343; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; LANSDOWN ABG, 1995, CRIT REV TOXICOL, V25, P397, DOI 10.3109/10408449509049339; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Parr C, 2005, EUR J CANCER, V41, P2819, DOI 10.1016/j.ejca.2005.07.022; He XQ, 2009, J BIOL CHEM, V284, P12609, DOI 10.1074/jbc.M901204200; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Joshi B, 2005, ONCOGENE, V24, P2204, DOI 10.1038/sj.onc.1208206; Bi YY, 2006, J BIOCHEM MOL TOXIC, V20, P57, DOI 10.1002/jbt.20116; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Hata Akihisa, 2012, Environmental Health and Preventive Medicine, V17, P235, DOI 10.1007/s12199-011-0247-5; IARC, 1980, MONOGR EVAL CARCINOG, V23, P37; IARC, 2004, IARC MONOGR EVAL CAR, V84, P1; Kato M, 2002, CANCER RES, V62, P2414; Kato M., 2010, Toxicological and Environmental Chemistry, V92, P1609, DOI 10.1080/02772241003707454; Kumasaka MY, 2012, ARCH TOXICOL, V87, P439; Kurokawa M, 2001, ARCH DERMATOL, V137, P102; Lassen U, 2012, BRIT J CANCER, V106, P678, DOI 10.1038/bjc.2011.609; Loges S, 2009, CLIN CANCER RES, V15, P3648, DOI 10.1158/1078-0432.CCR-08-2276; Martinsson-Niskanen T, 2011, CLIN THER, V33, P1142, DOI 10.1016/j.clinthera.2011.08.007; Matsumoto Y, 2002, J IMMUNOL, V168, P5824; National Research Council, 1999, ARS DRINK WAT; Nishimoto F, 2009, ENDOCRINOLOGY, V150, P1801, DOI 10.1210/en.2008-0949; Roy H, 2005, HUM GENE THER, V16, P1422, DOI 10.1089/hum.2005.16.1422; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Tareq SM, 2003, SCI TOTAL ENVIRON, V313, P213, DOI 10.1016/S0048-9697(03)00266-3; Thang ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025636; Yancy SL, 2005, TOXICOL SCI, V84, P278, DOI 10.1093/toxsci/kfi032; Yokota H, 2002, WATER SCI TECHNOL, V46, P375	46	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	APR	2015	135	4					1147	1156		10.1038/jid.2014.514		10	Dermatology	Dermatology	CD6GW	WOS:000351188600031		
J	Uchiyama, A; Yamada, K; Perera, B; Ogino, S; Yokoyama, Y; Takeuchi, Y; Ishikawa, O; Motegi, S				Uchiyama, Akihiko; Yamada, Kazuya; Perera, Buddhini; Ogino, Sachiko; Yokoyama, Yoko; Takeuchi, Yuko; Ishikawa, Osamu; Motegi, Sei-ichiro			Protective Effect of MFG-E8 after Cutaneous Ischemia-Reperfusion Injury	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							PRESSURE ULCER; MOUSE MODEL; FACTOR-VIII; MILK; GROWTH; ANGIOGENESIS; POLARIZATION; EXPRESSION; INTEGRIN; DOMAINS	We recently demonstrated that the secreted glycoprotein and integrin-ligand MFG-E8 promotes cutaneous wound healing by enhancing angiogenesis. Several studies have identified potential roles for MFG-E8 in regulation of ischemia-reperfusion (I/R) injury in the brain, kidney, and liver. Our objective was to assess the role of MFG-E8 in the formation of skin ulcers using a murine model of cutaneous I/R injury cutaneous pressure ulcers. Cutaneous I/R was performed by trapping the dorsal skin between two magnetic plates for 12 hours, followed by plate removal. Expression of MFG-E8 increased in the dermis during ischemia, and then decreased after reperfusion. Administration of recombinant (r)MFG-E8 in I/R areas at the beginning of reperfusion significantly inhibited the formation of cutaneous pressure ulcers, and the number of CD31(+) vessel and NG2(+) pericytes in wounds were increased in I/R mice treated with rMFG-E8. The number of M1 macrophages and the amount of proinflammatory mediators monocyte chemotactic protein-1,induced nitric oxide synthase, IL-6, tumor necrosis factor-alpha; and IL-1 beta in the wound area were reduced by the administration of rMFG-E8. We conclude that MFG-E8 may inhibit the formation of pressure ulcers induced by cutaneous I/R injury by regulating angiogenesis and inflammation. Exogenous application of MFG-E8 might have therapeutic potential for cutaneous I/R injuries, including decubitus ulcers and Raynaud's phenomenon induced digital ulcers.	[Uchiyama, Akihiko; Yamada, Kazuya; Perera, Buddhini; Ogino, Sachiko; Yokoyama, Yoko; Takeuchi, Yuko; Ishikawa, Osamu; Motegi, Sei-ichiro] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showamachi, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp			Adaptable and Seamless Technology transfer Program (A-STEP), Japan Science and Technology Agency	This work was supported by a Grant from the Adaptable and Seamless Technology transfer Program (A-STEP), Japan Science and Technology Agency.	Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Wu RQ, 2012, INT J MOL MED, V30, P593, DOI 10.3892/ijmm.2012.1044; Stadler I, 2004, J INVEST SURG, V17, P221, DOI 10.1080/08941930490472046; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Saito Y, 2008, J INVEST DERMATOL, V128, P1838, DOI 10.1038/sj.jid.5701258; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Motegi S, 2011, ARTERIOSCL THROM VAS, V31, P2024, DOI 10.1161/ATVBAHA.111.232587; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Matsuda A, 2011, CRIT CARE MED, V39, P2039, DOI 10.1097/CCM.0b013e3182227a3d; Carmo-Araujo EM, 2007, INT J EXP PATHOL, V88, P147, DOI 10.1111/j.1365-2613.2007.00526.x; Ferrante C. J., 2011, ADV WOUND CARE NEW R, V1, P10; Kasuya A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04173; Matsuda A, 2013, J SURG RES, V180, pE37, DOI 10.1016/j.jss.2012.03.021; Motegi S, 2011, ARTERIOSCL THROM VAS, V31, P2653, DOI 10.1161/ATVBAHA.111.233619; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Ogura K, 1996, BIOCHEM BIOPH RES CO, V225, P932, DOI 10.1006/bbrc.1996.1274; Peirce SM, 2000, WOUND REPAIR REGEN, V8, P68, DOI 10.1046/j.1524-475x.2000.00068.x; PRETTO EA, 1991, TRANSPLANT P, V23, P1912; Reid RR, 2004, J SURG RES, V116, P172, DOI 10.1016/S0022-4804(03)00227-0; Salcido R, 1994, Adv Wound Care, V7, P23; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; Uchiyama A, 2014, AM J PATHOL, V184, P1981, DOI 10.1016/j.ajpath.2014.03.017; Vitoriano-Souza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040745; WOOLFSON RG, 1994, NEPHROL DIAL TRANSPL, V9, P1529	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	APR	2015	135	4					1157	1165		10.1038/jid.2014.515		9	Dermatology	Dermatology	CD6GW	WOS:000351188600032		
J	Koike-Akino, T; Kojima, K; Millar, DS; Parsons, K; Kametani, S; Sugihara, T; Yoshida, T; Ishida, K; Miyata, Y; Matsumoto, W; Mizuochi, T				Koike-Akino, Toshiaki; Kojima, Keisuke; Millar, David S.; Parsons, Kieran; Kametani, Soichiro; Sugihara, Takashi; Yoshida, Tsuyoshi; Ishida, Kazuyuki; Miyata, Yoshikuni; Matsumoto, Wataru; Mizuochi, Takashi			Han-Kobayashi and Dirty-Paper Coding for Superchannel Optical Communications	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Dirty-paper coding; Han-Kobayashi coding; joint decoding; superchannel optical communications	FASTER-THAN-NYQUIST; INTERFERENCE CHANNEL; CAPACITY; MODEL; EQUALIZATION; PROPAGATION	Superchannel transmission is a candidate to realize Tb/s-class high-speed optical communications. In order to achieve higher spectrum efficiency, the channel spacing shall be as narrow as possible. However, densely allocated channels can cause non-negligible inter-channel interference (ICI) especially when the channel spacing is close to or below the Nyquist bandwidth. In this paper, we consider joint decoding to cancel the ICI in dense superchannel transmission. To further improve the spectrum efficiency, we propose the use of Han-Kobayashi superposition coding. In addition, for the case when neighboring subchannel transmitters can share data, we introduce dirty-paper coding for pre-cancelation of the ICI. We analytically evaluate the potential gains of these methods when ICI is present for sub-Nyquist channel spacing.	[Koike-Akino, Toshiaki; Kojima, Keisuke; Millar, David S.; Parsons, Kieran] Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA; [Kametani, Soichiro; Sugihara, Takashi; Yoshida, Tsuyoshi; Miyata, Yoshikuni; Matsumoto, Wataru] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Kamakura, Kanagawa 2478501, Japan; [Ishida, Kazuyuki] Mitsubishi Electr Corp, Commun Networks Ctr, Amagasaki, Hyogo 6618661, Japan; [Mizuochi, Takashi] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan	Koike-Akino, T (reprint author), Mitsubishi Elect Res Labs, Cambridge, MA 02139 USA.	koike@merl.com; kojima@merl.com; millar@merl.com; parsons@merl.com; Kametani.Soichiro@ap.MitsubishiElectric.co.jp; sugihara.takashi@ak.mitsubishielectric.co.jp; Yoshida.Tsuyoshi@ah.MitsubishiElectric.co.jp; Ishida.Kazuyuki@dy.MitsubishiElectric.co.jp; Matsumoto.Wataru@aj.MitsubishiElectric.co.jp; mizuochi.takashi@df.mitsubishielectric.co.jp			Lambda Reach Project of the National Institute of Information and Communications Technology, under a Program of the Ministry of Internal Affairs and Communications of Japan	This work was supported in part by the Lambda Reach Project of the National Institute of Information and Communications Technology, under a Program of the Ministry of Internal Affairs and Communications of Japan.	Agrawal GP, 2010, WILEY MICRO, V222, P1, DOI 10.1002/9780470918524; Agrell E., 2013, J LIGHTW TECHNOL, V32, P2862; Etkin RH, 2008, IEEE T INFORM THEORY, V54, P5534, DOI 10.1109/TIT.2008.2006447; Sun Y, 2009, IEEE T INFORM THEORY, V55, P3013, DOI 10.1109/TIT.2009.2021319; Tuchler M, 2002, IEEE T COMMUN, V50, P754, DOI 10.1109/TCOMM.2002.1006557; Rusek F, 2009, IEEE T INFORM THEORY, V55, P764, DOI 10.1109/TIT.2008.2009832; Poggiolini P, 2012, J LIGHTWAVE TECHNOL, V30, P3857, DOI 10.1109/JLT.2012.2217729; Colavolpe G, 2011, OPT EXPRESS, V19, P26600, DOI 10.1364/OE.19.026600; Ke JH, 2014, OPT EXPRESS, V22, P71, DOI 10.1364/OE.22.000071; Zhao Y, 2012, IEEE T INFORM THEORY, V58, P3798, DOI 10.1109/TIT.2012.2190040; Carena A, 2014, OPT EXPRESS, V22, P16335, DOI 10.1364/OE.22.016335; CHAN AM, 2002, P GLOB TEL C TAIP TA, P297; Chung H.-S., 2012, P OPT FIB COMM LOS A; COSTA MHM, 1983, IEEE T INFORM THEORY, V29, P439, DOI 10.1109/TIT.1983.1056659; Cover T. M., 2006, ELEMENTS INFORM THEO; Erez U, 2005, IEEE T INFORM THEORY, V51, P3417, DOI 10.1109/TIT.2005.855586; Hamaoka F., 2014, P EUR C OPT COMM CAN; HAN TS, 1981, IEEE T INFORM THEORY, V27, P49; Koike-Akino T., 2014, P EUR C OPT COMM CAN; Kojima K., 2014, P EUR C OPT COMM CAN; Li J., 2012, P EUR C OPT COMM AMS; Liu X., 2012, P EUR C OPT COMM AMS; Mazo E., 1975, BELL SYST TECH J, V54, P1450; Mehanna O., 2010, P ALL C COMM CONTR C, P1273; Olsson B.-E., 2010, P OPT FIB COMM SAN D; QURESHI SUH, 1985, P IEEE, V73, P1349, DOI 10.1109/PROC.1985.13298; Renaudier J., 2014, P EUR C OPT COMM CAN; Serena P., 2014, P EUR C OPT COMM CAN; Serena P, 2013, J LIGHTWAVE TECHNOL, V31, P3489, DOI 10.1109/JLT.2013.2284499; Sleiffer V., 2012, P OPT FIB COMM LOS A; Vassilieva O., 2014, P EUR C OPT COMM CAN	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	APR 1	2015	33	7					1292	1299		10.1109/JLT.2015.2397435		8	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CD8NF	WOS:000351351300004		
J	Umeki, T; Kazama, T; Tadanaga, O; Enbutsu, K; Asobe, M; Miyamoto, Y; Takenouchi, H				Umeki, Takeshi; Kazama, Takushi; Tadanaga, Osamu; Enbutsu, Koji; Asobe, Masaki; Miyamoto, Yutaka; Takenouchi, Hirokazu			PDM Signal Amplification Using PPLN-Based Polarization-Independent Phase-Sensitive Amplifier	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Nonlinear optics; optical amplifiers	NOISE-FIGURE; REGENERATION; CONVERSION	We demonstrate the first polarization-independent phase-sensitive amplification of a polarization-division multiplexing (PDM) signal. A novel polarization-diversity loop configuration using periodically poled LiNbO3 wave guides is proposed to achieve the polarization-independent amplification of both a single-polarized signal and a PDM signal. The proposed configuration provides two independent optical parametric amplification processes for two orthogonal polarization components in the loop, while preventing the amplification of the reflection noise by a counter-propagating pump. Polarization-independent error-free operation was confirmed with a bit-error-rate measurement for a 40-Gb/s quadrature phase-shift keying (QPSK) signal. We then demonstrated the phase regenerative amplification of an 80-Gb/s PDM-QPSK signal with artificial phase noise.	[Umeki, Takeshi; Kazama, Takushi; Tadanaga, Osamu; Enbutsu, Koji; Takenouchi, Hirokazu] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan; [Umeki, Takeshi; Miyamoto, Yutaka; Takenouchi, Hirokazu] NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan; [Asobe, Masaki] Tokai Univ, Dept Engn, Hiratsuka, Kanagawa 2591292, Japan	Umeki, T (reprint author), NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan.	umeki.takeshi@lab.ntt.co.jp; kazama.takushi@lab.ntt.co.jp; tadanaga.osamu@lab.ntt.co.jp; enbutsu.koji@lab.ntt.co.jp; asobe@tokai-u.jp; miyamoto.yutaka@lab.ntt.co.jp; takenouchi.hirokazu@lab.ntt.co.jp					Umeki T, 2014, OPT EXPRESS, V22, P2473, DOI 10.1364/OE.22.002473; Umeki T, 2013, OPT EXPRESS, V21, P18170, DOI 10.1364/OE.21.018170; Imajuku W, 1999, ELECTRON LETT, V35, P1954, DOI 10.1049/el:19991343; Croussore K, 2007, IEEE PHOTONIC TECH L, V19, P864, DOI 10.1109/LPT.2007.897501; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Asobe M, 2012, OPT EXPRESS, V20, P13164, DOI 10.1364/OE.20.013164; Hu H, 2010, OPT EXPRESS, V18, P9961, DOI 10.1364/OE.18.009961; Inoue T., 2013, OPTOELECTRON COMM C; Jazayerifar M., EUR C EXH OPT COMM C; Olsson S. L. I., 2014, OPT FIB COMM C SAN F; Olsson S. L. I., 2014, EUR C EXH OPT COMM C; Song HB, 2010, OPT EXPRESS, V18, P15332, DOI 10.1364/OE.18.015332; Umeki Takeshi, 2011, Opt Express, V19, P6326, DOI 10.1364/OE.19.006326; Yang J- Y., 2013, EUR C EXH OPT COMM L	14	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	APR 1	2015	33	7					1326	1332		10.1109/JLT.2014.2385867		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CD8NF	WOS:000351351300009		
J	Gu, XD; Suzuki, K; Ikuma, Y; Seno, K; Tanobe, H; Matsutani, A; Koyama, F				Gu, Xiaodong; Suzuki, Kenya; Ikuma, Yuichiro; Seno, Kazunori; Tanobe, Hiromasa; Matsutani, Akihiro; Koyama, Fumio			Compact Wavelength Selective Switch Using a Bragg Reflector Waveguide Array With Ultra-Large Number (> 100) of Output Ports	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Slow light; wavelength routing; WDM networks		A wavelength selective switch (WSS) is proposed based on a Bragg reflector waveguide array, which has a footprint of only 2 x 6 mm(2). We demonstrated arbitrary switching among 182 output ports by using a liquid crystal on silicon as a switching engine. The proposed WSS module length is only 10 cm, taking an advantage of the large angular dispersion in the Bragg reflector waveguide. Wavelength selective switching of 60 channels is carried out, exhibiting the device's excellent capability in providing ultra-large number of port count and wavelength channel operations at the same time. The crosstalk between adjacent ports are below -20 dB by a suitable alignment, which can be further improved by optimizing the module optics and alignments. The flexible lithography defined waveguide array design also reveals versatile potentials in integrating with other functional components.	[Gu, Xiaodong; Koyama, Fumio] Tokyo Inst Technol, Precis & Intelligence Lab, Photon Integrat Syst Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Suzuki, Kenya; Ikuma, Yuichiro; Tanobe, Hiromasa] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Seno, Kazunori] NTT Corp, NTT Photon Labs, Atsugi, Kanagawa 2430198, Japan; [Matsutani, Akihiro] Tokyo Inst Technol, Semicond & MEMS Proc Ctr, Tech Dept, Yokohama, Kanagawa 2268503, Japan; [Koyama, Fumio] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia	Gu, XD (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Photon Integrat Syst Res Ctr, Yokohama, Kanagawa 2268503, Japan.	gu.xiaodong@ms.pi.titech.ac.jp; s.kenya@lab.ntt.co.jp; yuichiro@lab.ntt.co.jp; seno.kazunori@lab.ntt.co.jp; tanobe.hiromasa@lab.ntt.co.jp; matsutani.a.aa@m.titech.ac.jp; koyama@pi.titech.ac.jp			JSPS KAKENHI in Japan [S22226008]	This work was supported by JSPS KAKENHI in Japan under Grant S22226008.	Gringeri S, 2010, IEEE COMMUN MAG, V48, P40, DOI 10.1109/MCOM.2010.5496877; Marom DM, 2005, J LIGHTWAVE TECHNOL, V23, P1620, DOI 10.1109/JLT.2005.844213; Okamoto K, 1996, ELECTRON LETT, V32, P1471, DOI 10.1049/el:19960981; Baxter G., 2006, OPT FIB COMM C AN CA; Feuer M. D., 2013, OPT FIB COMM C AN CA; Gu X, 2012, IEEE PHOTONICS J, V4, P1712, DOI 10.1109/JPHOT.2012.2214206; Gu X., 2013, J APPL PHYS, V114; Gu XD, 2011, OPT EXPRESS, V19, P22675, DOI 10.1364/OE.19.022675; Ishii Y., 2009, EUR C OPT COMM VIENN, pPD1 9; Okuno M., 2003, P OPT FIB COMM C ATL, V1, P169; Sakamaki Y, 2011, OPT EXPRESS, V19, P1, DOI 10.1364/OE.19.0000B1; Sorimoto K, 2013, OPT EXPRESS, V21, P17131, DOI 10.1364/OE.21.017131; YAMADA Y, 1995, ELECTRON LETT, V31, P1366, DOI 10.1049/el:19950938	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	APR 1	2015	33	7					1358	1364		10.1109/JLT.2014.2386324		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CD8NF	WOS:000351351300013		
J	Sato, M; Maher, R; Lavery, D; Shi, K; Thomsen, BC; Bayvel, P				Sato, Masaki; Maher, Robert; Lavery, Domanic; Shi, Kai; Thomsen, Benn C.; Bayvel, Polina			Frequency Diversity MIMO Detection for DP- QAM Transmission	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Coherent; digital signal processing (DSP); multi channel equalizer; multi-input-multi-output (MIMO); optical transmission; quadrature amplitude modulation (QAM); spectral efficiency (SE); wavelength division multiplexing (WDM)	EQUALIZATION; SYSTEM	Dual-carrier 10-GBaud DP-16QAM transmission system with frequency diversity multiple-input multiple-output (FD-MIMO) detection is described. In transmission over 800 km of standard single-mode fiber, with a dual-carrier spacing of 0.8x symbol rate, a Q(2)-factor penalty of only 1.7 dB, relative to single-carrier performance, is achieved. The performance of FD-MIMO for linear crosstalk mitigation is experimentally demonstrated by varying the channel spacing from 0.4 to 1.2x symbol rate in a dual-carrier DP-16QAM and DP-QPSK back-to-back configuration. Three-channel FD-MIMO equalization for both modulation formats is also studied in the same configuration. In addition, the combination of optical filtering and FD-MIMO indicates that a guard band of 10% of the symbol rate is sufficient to avoid additional linear crosstalk from neighboring WDM channels.	[Sato, Masaki] NEC Corp Ltd, Converged Network Div, Chiba 2701198, Japan; [Maher, Robert; Lavery, Domanic; Shi, Kai; Thomsen, Benn C.; Bayvel, Polina] UCL, Dept Elect & Elect Engn, Opt Networks Grp, London WC1E 7JE, England	Sato, M (reprint author), NEC Corp Ltd, Converged Network Div, Chiba 2701198, Japan.	m-satou@kj.jp.nec.com; r.maher@ucl.ac.uk; d.lavery@ee.ucl.ac.uk; k.shi@ucl.ac.uk; b.thomsen@ucl.ac.uk; p.bayvel@ucl.ac.uk	Lavery, Domanic/D-9172-2011	Lavery, Domanic/0000-0003-4494-4786	U.K. EPSRC Program UNLOC (UNLocking the Capacity of Optical Communications) [EP/J017582/1]	This work was supported by the U.K. EPSRC Program UNLOC (UNLocking the Capacity of Optical Communications) under Grant EP/J017582/1.	Fatadin I, 2009, J LIGHTWAVE TECHNOL, V27, P3042, DOI 10.1109/JLT.2009.2021961; Ip E, 2007, J LIGHTWAVE TECHNOL, V25, P2033, DOI 10.1109/JLT.2007.900889; Cai JX, 2012, J LIGHTWAVE TECHNOL, V30, P651, DOI 10.1109/JLT.2011.2179975; Darwazeh I, 2014, IEEE PHOTONIC TECH L, V26, P352, DOI 10.1109/LPT.2013.2293874; Kaneda N., 2013, EUR C OPT COMM LOND; Kaneda N., 2014, P OPT COMM C JUL, P1051; Koike-Akino T., 2014, EUR C OPT COMM CANN; Maher R., 2014, OPTOELECTRONICS COMM; Pan J, 2012, J LIGHTWAVE TECHNOL, V30, P3993, DOI 10.1109/JLT.2012.2208732; Ready M. J., 1990, IEEE INT C SPEECH SI, V3, P1699; Sato M., 2014, EUR C OPT COMM CANN; Zeng T, 2013, OPT EXPRESS, V21, P14799, DOI 10.1364/OE.21.014799; Zhang JW, 2014, J LIGHTWAVE TECHNOL, V32, P3239, DOI 10.1109/JLT.2014.2343016	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	APR 1	2015	33	7					1388	1394		10.1109/JLT.2015.2388860		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CD8NF	WOS:000351351300017		
J	Takara, H; Mizuno, T; Kawakami, H; Miyamoto, Y; Masuda, H; Kitamura, K; Ono, H; Asakawa, S; Amma, Y; Hirakawa, K; Matsuo, S; Tsujikawa, K; Yamada, M				Takara, Hidehiko; Mizuno, Takayuki; Kawakami, Hiroto; Miyamoto, Yutaka; Masuda, Hiroji; Kitamura, Kokoro; Ono, Hirotaka; Asakawa, Shuichiro; Amma, Yoshimichi; Hirakawa, Keisuke; Matsuo, Shoichiro; Tsujikawa, Kyozo; Yamada, Makoto			120.7-Tb/s MCF-ROPA Unrepeatered Transmission of PDM-32QAM Channels Over 204 km	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Optical fiber amplifiers; optical fiber communication; space division multiplexing		We demonstrate the unrepeatered transmission of over 100 Tb/s by employing a multicore-fiber-based remote optically pumped amplifier. We establish 120.7-Tb/s, 204-km sevencore fiber transmission with the aggregate spectral efficiency (SE) of 53.6 b/s/Hz, a record capacity per fiber and the highest SE for unrepeatered transmission. We also realized the highest capacity per core of 17.2 Tb/s (180 x 95.8 Gb/s) and SE of 7.6 b/s/Hz by using the polarization-division-multiplexed 32-quadrature amplitude modulation format for unrepeatered transmission.	[Takara, Hidehiko; Mizuno, Takayuki; Kawakami, Hiroto; Miyamoto, Yutaka] NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan; [Masuda, Hiroji; Kitamura, Kokoro] Shimane Univ, Matsue, Shimane 6908504, Japan; [Ono, Hirotaka; Asakawa, Shuichiro] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan; [Amma, Yoshimichi; Hirakawa, Keisuke; Matsuo, Shoichiro] Fujikura Ltd, Opt & Elect Lab, Chiba 2858550, Japan; [Tsujikawa, Kyozo] NTT Corp, Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan; [Yamada, Makoto] Osaka Prefecture Univ, Sakai, Osaka 5998531, Japan	Takara, H (reprint author), NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan.	takara.hidehiko@lab.ntt.co.jp; mizuno.takayuki@lab.ntt.co.jp; kawakami.hiroto@lab.ntt.co.jp; miyamoto.yutaka@lab.ntt.co.jp; masuda@ecs.shimane-u.ac.jp; kitamura@ecs.shimane-u.ac.jp; ono.hirotaka@lab.ntt.co.jp; asakawa.shuichiro@lab.ntt.co.jp; yoshimichi.amma@jp.fujikura.com; keisuke.hirakawa@jp.fujikura.com; shoichiro.matsuo@jp.fujikura.com; tujikawa.kyouzou@lab.ntt.co.jp; myamada@eis.osakafu-u.ac.jp					Igarashi K, 2014, OPT EXPRESS, V22, P1220, DOI 10.1364/OE.22.001220; Chang D., 2012, OPT FIB COMM C LOS A; Chang D., 2013, OPT FIB COMM C AN CA; Kobayashi T., 2010, OPT FIB COMM C SAN D; Kobayashi T., 2013, EUR C EXH OPT COMM L; Masuda H., 2013, IEEE PHOT SOC SUMM T; Mongardien D., 2013, EUR C EXH OPT COMM L; Morioka T., 2012, OPTOELECTRONICS COMM; Oda S., 2011, EUR C EXH OPT COMM G; Takara H., 2014, EUR C EXH OPT COMM C; Takara H., 2012, EUR C EXH OPT COMM A; Takenaga K., 2013, OPTOELECTRON COMM C; Winzer P. J., 2011, EUR C EXH OPT COMM G; Zhu B., 2014, OPT FIB COMM C SAN F	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	APR 1	2015	33	7					1473	1478		10.1109/JLT.2015.2397009		6	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CD8NF	WOS:000351351300028		
J	Hayashi, S; Fujioka, M; Ikoma, K; Saito, M; Ueshima, K; Ishida, M; Kuribayashi, M; Ikegami, A; Mazda, O; Kubo, T				Hayashi, Shigeki; Fujioka, Mikihiro; Ikoma, Kazuya; Saito, Masazumi; Ueshima, Keiichiro; Ishida, Masashi; Kuribayashi, Masaaki; Ikegami, Akira; Mazda, Osam; Kubo, Toshikazu			Evaluation of Femoral Perfusion in a Rabbit Model of Steroid-Induced Osteonecrosis by Dynamic Contrast-Enhanced MRI with a High Magnetic Field MRI System	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						steroid-induced osteonecrosis; evaluation of femoral perfusion; dynamic contrast-enhanced MRI; high magnetic field MRI system	CORTICOSTEROID-INDUCED OSTEONECROSIS; HEAD; HETEROGENEITY; NECROSIS	PurposeTo evaluate perfusion during the early phase after steroid administration in vivo using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with a high magnetic field MRI system. The main pathogenesis of steroid-induced osteonecrosis is considered to be ischemia. Materials and MethodsA single dose of methylprednisolone (MPSL) was injected into nine rabbits. DCE-MRI was performed for these rabbits before MPSL administration and 1, 5, 10, and 14 days after administration. Time-signal intensity curves were created for each femur based on the signal intensity to evaluate perfusion. Enhancement ratio (ER), initial slope (IS), and area under the curve (AUC) were calculated and the value before MPSL administration and the minimal value after administration were compared statistically. ResultsER, IS, and AUC values after MPSL administration significantly decreased (P < 0.05, P < 0.01, and P < 0.01, respectively). All of them decreased by the 5th day in 56% of the femora and by the 14th day in 83%, and some femora even showed a decrease from the 1st day. ConclusionIn this study, decreased perfusion in the femora after steroid administration was proven. Additionally, we could show that it occurred from the early days after steroid administration. J. Magn. Reson. Imaging 2015;41:935-940. (c) 2014 Wiley Periodicals, Inc.	[Hayashi, Shigeki; Fujioka, Mikihiro; Ikoma, Kazuya; Saito, Masazumi; Ueshima, Keiichiro; Ishida, Masashi; Kuribayashi, Masaaki; Ikegami, Akira; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan; [Mazda, Osam] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Immunol, Kyoto 6028566, Japan	Fujioka, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan.	fujioka@koto.kpu-m.ac.jp			Research on Rare and Intractable Diseases, Health and Labour Sciences Research [H24-nanchi-ippan-001]; Hip Joint Foundation of Japan	Contract grant sponsor: Research on Rare and Intractable Diseases, Health and Labour Sciences Research; Contract grant number: H24-nanchi-ippan-001; Contract grant sponsor: Hip Joint Foundation of Japan.	Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; Johansen R, 2009, J MAGN RESON IMAGING, V29, P1300, DOI 10.1002/jmri.21778; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; Kuribayashi M, 2010, ACTA ORTHOP, V81, P154, DOI [10.3109/17453671003628772, 10.3109/17453671003587101]; Jia G, 2008, RADIOLOGY, V248, P901, DOI 10.1148/radiol.2491071936; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Byun J, 2013, STAT MED, V32, P4924, DOI 10.1002/sim.5887; Ichiseki T, 2006, RHEUMATOLOGY, V45, P287, DOI 10.1093/rheumatology/kei149; Kabata T, 2008, J RHEUMATOL, V35, P2383, DOI 10.3899/jrheum.070838; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kiessling F, 2004, EUR RADIOL, V14, P1793, DOI 10.1007/s00330-004-2386-1; Liney GP, 1999, JMRI-J MAGN RESON IM, V10, P945, DOI 10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.3.CO;2-9; Mussurakis S, 1998, RADIOLOGY, V206, P465; Nakamura T, 1997, CLIN ORTHOP RELAT R, P68	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	APR	2015	41	4					935	940		10.1002/jmri.24632		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE0UD	WOS:000351521700011		
J	Fujima, N; Kudo, K; Tsukahara, A; Yoshida, D; Sakashita, T; Homma, A; Tha, KK; Shirato, H				Fujima, Noriyuki; Kudo, Kohsuke; Tsukahara, Akiko; Yoshida, Daisuke; Sakashita, Tomohiro; Homma, Akihiro; Tha, Khin Khin; Shirato, Hiroki			Measurement of Tumor Blood Flow in Head and Neck Squamous Cell Carcinoma by Pseudo-Continuous Arterial Spin Labeling: Comparison With Dynamic Contrast-Enhanced MRI	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						tumor blood flow; pseudo-continuous arterial spin labeling; dynamic contrast-enhanced perfusion; head and neck squamous cell carcinoma	PERFUSION MRI; CT PERFUSION; CANCER	PurposeTo investigate the feasibility of tumor blood flow (TBF) measurement in head and neck squamous cell carcinoma (HNSCC) using pseudo-continuous arterial spin labeling (pCASL) in a comparison with dynamic contrast-enhanced (DCE) perfusion. Materials and MethodsWe prospectively scanned 18 patients with HNSCC using 3T magnetic resonance imaging (MRI) with both pCASL and DCE perfusion. Quantitative TBF value in the whole-tumor region of interest (ROI), and regional TBF in the ROIs of the central and peripheral areas in the tumor were respectively measured. Relative TBF value in the whole-tumor ROI was also calculated. We determined the correlation and agreement between each measured TBF by pCASL and DCE perfusion using Pearson's correlation coefficients, intraclass correlation coefficients (ICC), and Bland-Altman analysis. ResultsIn the whole-tumor ROIs, significant correlation was observed between the absolute TBF values (r=0.72, P<0.01), with an ICC of 0.72; moreover, higher correlation was observed in the relative TBF (r=0.79). The correlation was higher in the peripheral ROI (r=0.70) than the central ROI (r=0.65), with an ICC of 0.62 and 0.54, respectively. Bland-Altman plots revealed the underestimation of TBF by pCASL in central ROIs. ConclusionTBF measurement by pCASL was feasible in patients with HNSCC. J. Magn. Reson. Imaging 2015;41:983-991. (c) 2014 Wiley Periodicals, Inc.	[Fujima, Noriyuki; Kudo, Kohsuke; Tsukahara, Akiko; Yoshida, Daisuke] Hokkaido Univ Hosp, Dept Radiol, Sapporo, Hokkaido 0608638, Japan; [Sakashita, Tomohiro; Homma, Akihiro] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Tha, Khin Khin; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan	Fujima, N (reprint author), Hokkaido Univ Hosp, Dept Radiol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	Noriyuki.Fujima@mb9.seikyou.ne.jp	Tha, Khin/A-4762-2012	Tha, Khin/0000-0002-9072-4509	Ministry of Education, Culture, Sports, Science and Technology, Japan [25861047]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology, Japan; Contract grant number: 25861047..	Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; Razek AAKA, 2011, EUR J RADIOL, V77, P73, DOI 10.1016/j.ejrad.2009.07.022; Hirasawa S, 2007, ACAD RADIOL, V14, P312, DOI 10.1016/j.acra.2006.12.017; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Agrawal S, 2012, CLIN RADIOL, V67, pE1, DOI 10.1016/j.crad.2012.03.005; WHEELER RH, 1986, CANCER RES, V46, P4200; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Bisdas S, 2010, AM J NEURORADIOL, V31, P576, DOI 10.3174/ajnr.A1852; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Barrett T, 2007, J MAGN RESON IMAGING, V26, P235, DOI 10.1002/jmri.20991; Lin SP, 2007, J MAGN RESON IMAGING, V25, P884, DOI 10.1002/jmri.20955; Wong EC, 2007, MAGN RESON MED, V58, P1086, DOI 10.1002/mrm.21293; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Wu WC, 2011, RADIOLOGY, V261, P845, DOI 10.1148/radiol.11110668; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Faggioni L, 2010, AM J ROENTGENOL, V194, P62, DOI 10.2214/AJR.09.3187; Fujima N., 2014, J MAGN RESON IMAGING; Parkes LM, 2005, J MAGN RESON IMAGING, V22, P732, DOI 10.1002/jmri.20456; Srinivasan A, 2012, AM J NEURORADIOL, V33, P586, DOI 10.3174/ajnr.A2535; Talagala SL, 2004, MAGNET RESON MED, V52, P131, DOI 10.1002/mrm.20124; Thomassin-Naggara I, 2012, EUR RADIOL, V22, P738, DOI 10.1007/s00330-011-2329-6; Truong MT, 2011, AM J NEURORADIOL, V32, P1195, DOI 10.3174/ajnr.A2501; vansOsch MJP, 2009, MAGN RESON MED, V62, P165; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong AM, 2014, J MAGN RESON IMAGING, V39, P427, DOI 10.1002/jmri.24178; Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026	28	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	APR	2015	41	4					983	+		10.1002/jmri.24637		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE0UD	WOS:000351521700001		
J	Mohapatra, JN; Kamada, Y				Mohapatra, J. N.; Kamada, Y.			Magnetic Hysteresis Loop as a Tool for the Evaluation of Spheroidization of Cementites in Pearlitic Steels	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						coercivity; magnetic hysteresis loop; microhardness; NDE; pearlitic steel; spheroidization	BARKHAUSEN NOISE; CARBON STEELS; MICROSTRUCTURES; EVOLUTION	Pearlitic Fe-0.76wt.% C binary alloy was isothermally annealed at 700 A degrees C up to 100 h to study the spheroidization of cementites and its effect on both the mechanical and magnetic properties with the aim to use the magnetic techniques for the evaluation of spheroidization in steels. Micro-Vickers hardness, magnetic hysteresis loop (MHL) measurements, optical and scanning electron microscopy studies were carried out at various lengths of time by interrupting the test. Microhardness and coercivity were decreased with increase in annealing time due to reduction in dislocation pinning and magnetic domain wall pinning for the breaking of cementite lamella and their subsequent transformation to spheroidal form. The microhardness and coercivity showed a very good correlation with the change in microstructure indicating that MHL would be a suitable non-destructive evaluation tool for the evaluation of spheroidized pearlitic steels.	[Mohapatra, J. N.] JSW Steel Ltd, R&D & SS, Toranagallu 583275, Bellary, India; [Kamada, Y.] Iwate Univ, NDE & SRC, Fac Engn, Morioka, Iwate 0208551, Japan	Mohapatra, JN (reprint author), JSW Steel Ltd, R&D & SS, Toranagallu 583275, Bellary, India.	jitendra.mohapatra@jsw.in					Agren J., 1980, MET T A, V17, P617; TIAN YL, 1987, METALL TRANS A, V18, P1403, DOI 10.1007/BF02646654; Byeon JW, 2003, MATER TRANS, V44, P2184, DOI 10.2320/matertrans.44.2184; ATASOY OE, 1989, J MATER SCI, V24, P281, DOI 10.1007/BF00660968; Henager CH, 2013, ACTA MATER, V61, P3285, DOI 10.1016/j.actamat.2013.02.017; Batista L, 2014, J MAGN MAGN MATER, V354, P248, DOI 10.1016/j.jmmm.2013.11.019; Davut K, 2010, J NONDESTRUCT EVAL, V29, P241, DOI 10.1007/s10921-010-0082-4; GOGIA AK, 1980, METALL TRANS A, V11, P1077, DOI 10.1007/BF02654725; Gupta N, 2006, DEFENCE SCI J, V56, P665; Jiles D.C., 1991, INTRO MAGNETISM MAGN, V2nd, P179; Kahrobaee S., 2010, INT J INT SPACE SCI, V7, P29; Krauss G., 1989, STEELS HEAT TREATMEN; Luzginova NV, 2008, METALL MATER TRANS A, V39A, P513, DOI 10.1007/s11661-007-9403-3; Mohapatra JN, 2007, NDT&E INT, V40, P173, DOI 10.1016/j.ndteint.2006.08.001; Nutal N, 2010, IMAGE ANAL STEREOL, V29, P91; OBrien JM, 1997, J MATER ENG PERFORM, V6, P69, DOI 10.1007/s11665-997-0034-z; Saha A, 2011, J MATER ENG PERFORM, V20, P114, DOI 10.1007/s11665-010-9653-x; Schastlivtsev VM, 2002, DOKL PHYS, V47, P451, DOI 10.1134/1.1493385; Thelning K.E., 1984, STEEL ITS HEAT TREAT, P207; TIAN YL, 1987, METALL TRANS A, V18, P1359, DOI 10.1007/BF02646650	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	APR	2015	24	4					1551	1557		10.1007/s11665-015-1385-5		7	Materials Science, Multidisciplinary	Materials Science	CD7SH	WOS:000351291200017		
J	Arthi, G; Archana, J; Navaneethan, M; Ponnusamy, S; Hayakawa, Y; Muthamizhchelvan, C				Arthi, G.; Archana, J.; Navaneethan, M.; Ponnusamy, S.; Hayakawa, Y.; Muthamizhchelvan, C.			Solvothermal growth of diethylamine capped TiO2 nanoparticles and functional properties	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							SENSITIZED SOLAR-CELLS; EFFICIENCY; ANATASE; PERFORMANCE; NANOTUBES; NANORODS; ARRAYS	Size controlled anatase titanium dioxide (TiO2) nanoparticles with high surface area were prepared using diethylamine (DEA) as a passivating agent by simple hydrothermal growth. X-ray diffraction pattern revealed the formation of anatase crystal phase of TiO2. There is no phase transformation for capped and uncapped TiO2 nanoparticles. Ligand passivation on TiO2 nanoparticles were confirmed by Fourier transform infra red studies. Significant UV-visible absorption is shown by absorption analysis. Uncapped and DEA capped TiO2 nanoparticles were synthesized and compared. Monodispersed cubic like morphology of DEA capped TiO2 nanoparticles with an average size of 13 nm is observed by transmission electron microscope (TEM) analysis. TEM analysis confirms that agglomerations were restricted by adding DEA as a capping agent. DEA capped TiO2 nanoparticles showed surface area of 65 m(2)/g and it is higher than uncapped TiO2 nanoparticles as confirmed by Brunauer-Emmett-Teller method. Prepared materials can be used as photoanodes in dye-sensitized solar cell application.	[Arthi, G.; Ponnusamy, S.; Muthamizhchelvan, C.] SRM Univ, Dept Phys, Kanchipuram 603203, Tamil Nadu, India; [Archana, J.; Navaneethan, M.; Hayakawa, Y.] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Muthamizhchelvan, C (reprint author), SRM Univ, Dept Phys, Kanchipuram 603203, Tamil Nadu, India.	selvancm@gmail.com					Zhang QF, 2012, PHYS CHEM CHEM PHYS, V14, P14982, DOI 10.1039/c2cp43089d; Laskova B, 2012, J SOLID STATE ELECTR, V16, P2993, DOI 10.1007/s10008-012-1729-0; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Liao MY, 2014, MAT SCI SEMICON PROC, V24, P1, DOI 10.1016/j.mssp.2014.02.037; Archana J, 2013, J POWER SOURCES, V242, P803, DOI 10.1016/j.jpowsour.2013.05.126; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Navaneethan M, 2012, PHYS STATUS SOLIDI-R, V6, P120, DOI 10.1002/pssr.201105517; Shao F, 2012, J MATER CHEM, V22, P6824, DOI 10.1039/c2jm15442k; Giannakas AE, 2013, APPL CATAL B-ENVIRON, V140, P636, DOI 10.1016/j.apcatb.2013.04.052; Shalan AE, 2013, APPL PHYS A-MATER, V110, P111, DOI 10.1007/s00339-012-7368-6; Chen D, 2013, ENERG ENVIRON SCI, V6, P1362, DOI 10.1039/c3ee23586f; Kandiel TA, 2010, J PHYS CHEM C, V114, P4909, DOI 10.1021/jp912008k; Lee SH, 2015, SOL ENERG MAT SOL C, V132, P47, DOI 10.1016/j.solmat.2014.08.007; Lee CS, 2014, ACS APPL MATER INTER, V6, P20842, DOI 10.1021/am505217k; Arthi G, 2013, SCRIPTA MATER, V68, P396, DOI 10.1016/j.scriptamat.2012.10.049; Kim WR, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-93; Lei BX, 2014, ELECTROCHIM ACTA, V149, P264, DOI 10.1016/j.electacta.2014.10.115; Mira N., 2013, ELECTROCHIM ACTA, V102, P274; Park H, 2012, J NANOSCI NANOTECHNO, V12, P1535, DOI 10.1166/jnn.2012.4620; Park H, 2012, J POWER SOURCES, V216, P36, DOI 10.1016/j.jpowsour.2012.05.060; Qi LH, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0907-4; Xiuquan Gu, 2013, Journal of Materials Science: Materials in Electronics, V24, DOI 10.1007/s10854-012-0939-7; Yao PC, 2014, SOL ENERGY, V108, P322, DOI 10.1016/j.solener.2014.07.020; Ye MD, 2014, GREEN ENERGY TECHNOL, P9, DOI 10.1007/978-1-4471-6473-9_2; Yea M., 2012, J NANOSCI LETT, V2, P1; Zhang L., 2012, SCI CHINA CHEM, V55, P1308	26	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	APR	2015	26	4					2380	2383		10.1007/s10854-015-2694-z		4	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CD5ZB	WOS:000351166400054		
J	Oh, C; Nagao, S; Suganuma, K				Oh, Chulmin; Nagao, Shijo; Suganuma, Katsuaki			Silver stress migration bonding driven by thermomechanical stress with various substrates	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							AL THIN-FILMS; THERMAL-EXPANSION; POWER DEVICES; ELASTIC-CONSTANTS; SILICON-CARBIDE; HILLOCK GROWTH; DIE-ATTACHMENT; TEMPERATURES; MODEL; H-4	In recent years, the requirement for environmentally friendly power electronics such as light-emitting diodes and integrated power modules has led to substantial efforts in electronic packaging. The high operating temperatures of advanced power devices particularly require alternative bonding materials to replace the high-temperature solders that contain much Pb. Without limiting the conventional soldering processes that use melting alloys, several candidate materials have been developed, along with the development of devices. In this study, we demonstrate Ag stress migration bonding with various substrate materials to address the intrinsic mechanisms underlying the bonding process. Varying the substrate material changes the thermal expansion mismatch between the sputtered Ag films and the substrate, resulting in different bonding properties, in particular the die shear strength. It has been revealed that a low bonding temperature process can be achieved with a high thermal stress, suggesting that stress migration and resulting stress relaxation at the bonding temperature play key roles in controlling the Ag stress migration bonding. This Ag stress migration bonding opens up a novel opportunity to access wide band-gap devices by realizing low-temperature processes without any application of pressure.	[Oh, Chulmin] Osaka Univ, Dept Adapt Machine Syst, Osaka 5670047, Japan; [Oh, Chulmin; Nagao, Shijo; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Nagao, S (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Osaka 5670047, Japan.	shijo.nagao@sanken.osaka-u.ac.jp	Nagao, Shijo/E-4870-2012	Nagao, Shijo/0000-0002-2764-3458	Japan Society for the Promotion of Science [24226017]	The authors are grateful for the support from the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (Grant No. 24226017).	Albert A.D., 2011, ACTA MAT, V56, P1820; Chin HS, 2010, METALL MATER TRANS B, V41, P824, DOI 10.1007/s11663-010-9365-5; LI Z, 1986, J APPL PHYS, V60, P612, DOI 10.1063/1.337456; Sakamoto S, 2013, J MATER SCI-MATER EL, V24, P2593, DOI 10.1007/s10854-013-1138-x; Chinmulgund M, 1995, THIN SOLID FILMS, V270, P260, DOI 10.1016/0040-6090(95)06990-9; Kim S, 2009, J ELECTRON MATER, V38, P2668, DOI 10.1007/s11664-009-0928-7; Zhang W, 2008, J ELECTRON MATER, V37, P1095, DOI 10.1007/s11664-008-0487-3; Mustain HA, 2010, IEEE T COMPON PACK T, V33, P563, DOI 10.1109/TCAPT.2010.2046901; Park SW, 2012, J ALLOY COMPD, V542, P236, DOI 10.1016/j.jallcom.2012.07.040; Chidambaram V, 2011, MICROELECTRON ENG, V88, P981, DOI 10.1016/j.mee.2010.12.072; COWAN JA, 1968, CRYOGENICS, V8, P155, DOI 10.1016/0011-2275(68)90092-1; Daniel R, 2011, ACTA MATER, V59, P6631, DOI 10.1016/j.actamat.2011.07.018; Hwang SJ, 2007, ACTA MATER, V55, P5297, DOI 10.1016/j.actamat.2007.05.046; Kamitani K, 1997, J APPL PHYS, V82, P3152, DOI 10.1063/1.366100; KARMANN S, 1989, J APPL PHYS, V66, P3922, DOI 10.1063/1.344477; Kim DK, 2001, J APPL PHYS, V90, P781, DOI 10.1063/1.1381045; Kim S, 2009, J ELECTRON MATER, V38, P873, DOI 10.1007/s11664-009-0770-y; Oh C, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872320; Oh C, 2014, MATER LETT, V137, P170, DOI 10.1016/j.matlet.2014.09.006; Sakamoto S, 2013, J MATER SCI-MATER EL, V24, P1332, DOI 10.1007/s10854-012-0929-9; Villain P, 2002, THIN SOLID FILMS, V406, P185, DOI 10.1016/S0040-6090(01)01779-5; WHITE GK, 1978, CRYOGENICS, V18, P301, DOI 10.1016/0011-2275(78)90068-1; Zwilsky K.M., 2011, ASM HDB, P2969	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	APR	2015	26	4					2525	2530		10.1007/s10854-015-2717-9		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CD5ZB	WOS:000351166400075		
J	Kurakawa, T; Ogata, K; Tsuji, H; Kado, Y; Takahashi, T; Kida, Y; Ito, M; Okada, N; Nomoto, K				Kurakawa, Takashi; Ogata, Kiyohito; Tsuji, Hirokazu; Kado, Yukiko; Takahashi, Takuya; Kida, Yumi; Ito, Masahiro; Okada, Nobuhiko; Nomoto, Koji			Establishment of a sensitive system for analysis of human vaginal microbiota on the basis of rRNA-targeted reverse transcription-quantitative PCR	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Lactobacillus; RT-qPCR; Vaginal microbiota	B STREPTOCOCCAL COLONIZATION; REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SPECIES-SPECIFIC PRIMERS; BACTERIAL VAGINOSIS; GARDNERELLA-VAGINALIS; PREDOMINANT BACTERIA; JAPANESE WOMEN; HUMAN FECES; INFECTION	Ten specific primer sets, for Lactobacillus gasseri, Lactobacillus crispatus, Atopobium vaginae, Gardnerella vaginalis, Mobiluncus curtisii, Chlamydia trachomatis/muridarum, Bifidobacterium longum subsp. longum, Bifidobacterium longum subsp. infantis, Bifidobacterium adolescentis, and Bifidobacterium angulatum, were developed for quantitative analysis of vaginal microbiota. rRNA-targeted reverse transcription-quantitative PCR (RT-qPCR) analysis of the vaginal samples from 12 healthy Japanese volunteers using the new primer sets together with 25 existing primer sets revealed the diversity of their vaginal microbiota: Lactobacilli such as L crispatus, L gasseri, Lactobacillus jensenii, Lactobacillus iners, and Lactobacillus vaginalis, as the major populations at 10(7) cells/ml vaginal fluid, were followed by facultative anaerobes such as Streptococcus and strict anaerobes at lower population levels of 10(4) cells/ml or less. Certain bacterial vaginosis (BV)-related bacteria, such as G. vaginalis, A. vaginae, M. curtisii, and Prevotella, were also detected in some subjects. Especially in one subject, both G. vaginalis and A. vaginae were detected at high population levels of 10(8.8) and 10(8.9) cells/ml vaginal fluid, suggesting that she is an asymptomatic BV patient. These results suggest that the RT-qPCR system is effective for accurate analysis of major vaginal commensals and diagnosis of several vaginal infections. (C) 2015 Elsevier B.V. All rights reserved.	[Kurakawa, Takashi; Ogata, Kiyohito; Tsuji, Hirokazu; Kado, Yukiko; Takahashi, Takuya; Nomoto, Koji] Yakult Cent Inst, Tokyo 1868650, Japan; [Kida, Yumi; Ito, Masahiro; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Dept Microbiol, Tokyo 1088641, Japan	Kurakawa, T (reprint author), Yakult Cent Inst, 5-11 Izumi, Tokyo 1868650, Japan.	takashi-kurakawa@yakult.co.jp					Altoparlak U, 2004, INT J GYNECOL OBSTET, V87, P245, DOI 10.1016/j.ijgo.2004.08.003; AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Kurakawa T, 2013, J MICROBIOL METH, V92, P213, DOI 10.1016/j.mimet.2012.12.008; Rampersaud R, 2011, J BACTERIOL, V193, P1034, DOI 10.1128/JB.00694-10; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Tyrrell GJ, 2000, J INFECT DIS, V182, P168, DOI 10.1086/315699; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V174, P1618, DOI 10.1016/S0002-9378(96)70617-8; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Plitt SS, 2005, SEX TRANSM DIS, V32, P446, DOI 10.1097/01.olq.0000154567.21291.59; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Poppert S, 2002, APPL ENVIRON MICROB, V68, P4081, DOI 10.1128/AEM.68.8.4081-4089.2002; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; El Aila N. A., 2009, BMC INFECT DIS, V9, P167; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Fujimori M, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-53; Kubota T, 1998, OBSTET GYNECOL, V92, P926, DOI 10.1016/S0029-7844(98)00309-3; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; MacPhee RA, 2013, APPL ENVIRON MICROB, V79, P1835, DOI 10.1128/AEM.02908-12; Meltzer MC, 2008, SEX TRANSM DIS, V35, P611, DOI 10.1097/OLQ.0b013e318167b105; Mizuno T, 2010, ANN SURG, V252, P1013, DOI 10.1097/SLA.0b013e3181f3f355; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297; Razzak Mohammad Sabri A, 2011, N Am J Med Sci, V3, P185, DOI 10.4297/najms.2011.3185; Schwebke JR, 2014, SEX TRANSM INFECT, V90, P61, DOI 10.1136/sextrans-2013-051232; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Verhelst R, 2005, BMC MICROBIOL, V5, P5; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Watanabe K., 1998, Japan patent application, Patent No. 260041; Wilks M, 2004, J CLIN MICROBIOL, V42, P713, DOI 10.1128/JCM.42.2.713-717.2004; Winn HN, 2007, CLIN PERINATOL, V34, P387, DOI 10.1016/j.clp.2007.03.012; Wyrick P.B., 2010, J INFECT DIS S2, V201, P588; Yan DH, 2009, CHINESE MED J-PEKING, V122, P2748, DOI 10.3760/cma.j.issn.0366-6999.2009.22.014; YANCEY MK, 1994, OBSTET GYNECOL, V84, P816	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	APR	2015	111						93	104		10.1016/j.mimet.2015.01.021		12	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CE4JN	WOS:000351797000014		
J	Yoshino, Y; Okugawa, S; Kimura, S; Makita, E; Seo, K; Koga, I; Matsunaga, N; Kitazawa, T; Ota, Y				Yoshino, Yusuke; Okugawa, Shu; Kimura, Satoshi; Makita, Eiko; Seo, Kazunori; Koga, Ichiro; Matsunaga, Naohisa; Kitazawa, Takatoshi; Ota, Yasuo			Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION			English	Article						Cephalosporin resistant; Enterobacter cloacae; Infective endocarditis; Management option	INTERNATIONAL COLLABORATION; MERGED DATABASE; CIRRHOSIS; SURGERY	We report the case of using a long-term combination of meropenem and amikacin to treat infective endocarditis caused by Enterobacter cloacae resistant to third-and fourth-generation cephalosporins. Multi-drug resistant Gram-negative bacilli, such as the E. cloacae in our study, may become possible pathogens of infective endocarditis. Our experience with this case indicates that long-term use of a combination of beta-lactam and aminoglycosides might represent a suitable management option for future infective endocarditis cases due to non-Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella spp. (HACEK group) Gram-negative bacilli such as ours. Copyright (C) 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.	[Yoshino, Yusuke; Kimura, Satoshi; Makita, Eiko; Seo, Kazunori; Koga, Ichiro; Matsunaga, Naohisa; Kitazawa, Takatoshi; Ota, Yasuo] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 1738606, Japan; [Okugawa, Shu] Tokyo Univ Hosp, Dept Infect Control & Prevent, Bunkyo Ku, Tokyo 1138655, Japan	Yoshino, Y (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.	yyoshino@med.teikyo-u.ac.jp					Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Miro JM, 2005, CLIN INFECT DIS, V41, P507, DOI 10.1086/431979; Morpeth S, 2007, ANN INTERN MED, V147, P829; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Hayashida Nobuhiko, 2004, Ann Thorac Cardiovasc Surg, V10, P140; Lin CH, 2005, ANN THORAC SURG, V79, P1551, DOI 10.1016/j.athoracsur.2004.11.004; Masterton RG, 2006, INT J ANTIMICROB AG, V27, P69, DOI 10.1016/j.ijantimicag.2005.09.011; McDonald JR, 2005, AM J MED, V118, P759, DOI 10.1016/j.amjmed.2005.02.020; Moon J, 2012, J INFECT CHEMOTHER; National Committee for Clinical Laboratory Standards, 2009, M100S19 CLSI NAT COM; Paterson DL., 2006, AM J INFECT CONTROL, V34, P20, DOI DOI 10.1016/J.AJIC.2006.05.175; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS64	12	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1684-1182	1995-9133		J MICROBIOL IMMUNOL	J. Microbiol. Immunol. Infect.	APR	2015	48	2					226	228		10.1016/j.jmii.2012.07.015		3	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CD4PY	WOS:000351067100015		
J	Kee, JY; Inujima, A; Andoh, T; Tanaka, K; Li, F; Kuraishi, Y; Sakurai, H; Shibahara, N; Saiki, I; Koizumi, K				Kee, Ji-Ye; Inujima, Akiko; Andoh, Tsugunobu; Tanaka, Ken; Li, Feng; Kuraishi, Yasushi; Sakurai, Hiroaki; Shibahara, Naotoshi; Saiki, Ikuo; Koizumi, Keiichi			Inhibitory effect of Moutan Cortex aqueous fraction on mast cell-mediated allergic inflammation	JOURNAL OF NATURAL MEDICINES			English	Article						Moutan Cortex; Aqueous fraction; Allergic inflammation; RBL-2H3; TNF-alpha	HISTAMINE-RELEASE; PAEONIA-SUFFRUTICOSA; TNF-ALPHA; TRANSCRIPTION; AZELASTINE; ACTIVATION	Moutan Cortex and its major compounds have been shown to possess various biological activities, including anti-inflammatory properties. However, the effects of Moutan Cortex aqueous fraction (MCA) and its molecular mechanisms have yet to be elucidated. In this study, we attempted to evaluate the effects of MCA on mast cell-mediated allergy inflammation in vitro and in vivo compared with major Moutan Cortex compounds. Thus, we examined the anti-inflammatory effects of a water extract of Moutan Cortex by comparing the inhibition of beta-hexosaminadase and tumor necrosis factor-alpha (TNF-alpha) release in an aqueous fraction with other major compounds of Moutan Cortex. The inhibitory mechanism of MCA was investigated by western blotting in IgE-mediated DNP-BSA-stimulated RBL-2H3 cells. We confirmed the pharmacological effects of MCA on compound 48/80-induced allergic reactions in a mouse model by assessing scratching behavior and passive cutaneous anaphylaxis (PCA)-like reaction. Consequently, MCA inhibited IgE-mediated DNP-BSA-induced beta-hexosaminadase and TNF-alpha release via inactivation of p38, ERK, Akt, and NF-kappa B in RBL-2H3 cells. MCA reduced compound 48/80-induced PCA reaction and scratching behavior in mice. This inhibitory effect of MCA is more potent than major compounds of Moutan Cortex. In conclusion, our results suggest that MCA has more potential in the treatment of allergic inflammatory diseases compared to other major compounds of Moutan Cortex.	[Kee, Ji-Ye; Saiki, Ikuo; Koizumi, Keiichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Div Pathogen Biochem, Toyama 9300194, Japan; [Inujima, Akiko; Shibahara, Naotoshi; Koizumi, Keiichi] Toyama Univ, Inst Nat Med, Grad Sch Med & Pharmaceut Sci, Div Kampo Diagnost, Toyama 9300194, Japan; [Andoh, Tsugunobu; Kuraishi, Yasushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 9300194, Japan; [Tanaka, Ken] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Div Pharmacognosy, Toyama 9300194, Japan; [Li, Feng] Res Ctr Sci Based Nat Med Res Promot Off, Toyama, Japan; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan	Koizumi, K (reprint author), Toyama Univ, Inst Nat Med, Grad Sch Med & Pharmaceut Sci, Div Kampo Diagnost, 2630 Sugitani, Toyama 9300194, Japan.	kkoizumi@inm.u-toyama.ac.jp		Sakurai, Hiroaki/0000-0003-0657-9570	Institute of Natural Medicine, University of Toyama	This study was supported by a Grant-in-Aid for Health Labour Sciences Research Grant and a Grant-in-Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama.	Alfonso A, 2000, CELL SIGNAL, V12, P343, DOI 10.1016/S0898-6568(00)00070-X; Shakoory B, 2004, J INTERF CYTOK RES, V24, P271, DOI 10.1089/107999004323065057; Kim SH, 2004, INT IMMUNOPHARMACOL, V4, P279, DOI 10.1016/j.intimp.2003.12.013; Lee B, 2008, ARCH PHARM RES, V31, P445, DOI 10.1007/s12272-001-1177-6; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; Chun SC, 2007, EVID-BASED COMPL ALT, V4, P327, DOI 10.1093/ecam/nel093; Fujiwara H, 2009, J NEUROCHEM, V109, P1648, DOI 10.1111/j.1471-4159.2009.06069.x; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Wong CK, 2005, CLIN EXP IMMUNOL, V139, P90, DOI 10.1111/j.1365-2249.2005.02678.x; CHAND N, 1985, INT ARCH ALLER A IMM, V77, P451; Choi Yun Ho, 2010, Anat Cell Biol, V43, P317, DOI 10.5115/acb.2010.43.4.317; Hide I, 1997, J IMMUNOL, V159, P2932; Hong MH, 2010, BIOSCI BIOTECH BIOCH, V74, P1152, DOI 10.1271/bbb.90676; Huang KC, 1999, PHARM CHINESE HERBS, P403; Jiang S, 2007, BIOL PHARM BULL, V30, P1707, DOI 10.1248/bpb.30.1707; Kageyama-Yahara N, 2009, FEBS LETT, V584, P111; KALINER M, 1974, J IMMUNOL, V112, P664; Kim YH, 2013, FEBS OPEN BIO, V3, P341, DOI [10.1016/j.fob.2013.07.008, 10.1016/j.fob.2013.08.008]; Lee SW, 2001, KOREAN J ORIENT PHYS, V15, P631; Pawankar R, 2012, WAO WHITE BOOK ALLER; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Yamasaki S, 2005, CHEM IMMUNOL ALLERGY, V87, P22	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-3443	1861-0293		J NAT MED-TOKYO	J. Nat. Med.	APR	2015	69	2					209	217		10.1007/s11418-014-0880-6		9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD5XV	WOS:000351163000006		
J	Hiki, Y; Hori, H; Yamamoto, K; Yamamoto, Y; Yuzawa, Y; Kitaguchi, N; Takahashi, K				Hiki, Yoshiyuki; Hori, Hideo; Yamamoto, Kouichiro; Yamamoto, Yoshihiro; Yuzawa, Yukio; Kitaguchi, Nobuya; Takahashi, Kazuo			Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region	JOURNAL OF NEPHROLOGY			English	Article						IgA nephropathy; IgA1 hinge region; N-acetylgalactosamine; Galactose; Monoclonal antibody	CIRCULATING IMMUNE-COMPLEXES; O-GLYCOSYLATION; NEPHROPATHY; PEPTIDE; EPITOPE; IGG	Increased levels of hypo-galactosylated immunoglobulin (Ig)A1 (HG-IgA1) in IgA nephropathy (IgAN) have been detected using a Helix aspersa agglutinin lectin enzyme-linked immunosorbent assay (ELISA). In this study, we developed monoclonal antibodies to evaluate the HG-IgA1 in IgA nephropathy, aiming to gain a more consistent and reproducible assay. As an analogue to the HG-IgA1 hinge region, a 19 mer synthetic peptide with five GalNAc (sHGP) residues at positions 4, 7, 9, 11 and 15 [VPST(GalNAc)PPT(GalNAc)PS(GalNAc)PS(GalNAc)TPPT (GalNAc)PSPS-NH2] was synthesized. Two monoclonal antibodies against sHGP (35A12 and 44H8) that reacted with human IgA were developed. Also, their reactivities to serum IgA from IgAN patients (n = 49), patients with other forms of kidney diseases (OKD, n = 48), and healthy controls (HC, n = 41) were evaluated using ELISA assays. The binding levels of the two monoclonal antibodies against serum IgA were significantly higher (all comparisons, p < 0.0001, Steel-Dwass non-parametric test) in IgAN patients compared to HC and OKD patients. In each individual, there was a close correlation of IgA binding levels between 35A12 and 44H8 (R (2) = 0.737). These results indicate that the monoclonal antibodies recognize similar epitopes in HG IgA1, which is found predominantly in IgAN patients. The developed antibodies are proposed as a clinically useful tool for IgAN screening.	[Hiki, Yoshiyuki; Hori, Hideo; Kitaguchi, Nobuya] Fujita Hlth Univ, Sch Hlth Sci, Dept Clin Engn, Toyoake, Aichi 4701192, Japan; [Yamamoto, Kouichiro; Yamamoto, Yoshihiro; Yuzawa, Yukio; Takahashi, Kazuo] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 4701192, Japan	Hiki, Y (reprint author), Fujita Hlth Univ, Sch Hlth Sci, Dept Clin Engn, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	yoshi-cake@mtj.biglobe.ne.jp			Fujita Health University Research Foundation; New Energy and Industrial Technology Organization (NEDO) by Japanese Government	The authors thank Dr. T. Tomiyama for producing the monoclonal antibodies. We also thank Ms. M. Sakata, Ms. A. Kamiya and Mr. H. Itoh for their superb technical assistance and data analyses. This work was supported by grants from Fujita Health University Research Foundation and by New Energy and Industrial Technology Organization (NEDO) supported by Japanese Government. The monoclonal antibody is the subject of a patent application (Domestic patent reception No.: 51302302502).	Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.0590031077.x; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; CZERKINSKY C, 1986, J CLIN INVEST, V77, P1931, DOI 10.1172/JCI112522; HIKI Y, 1991, NEPHRON, V59, P552; Hiki Y, 1996, J AM SOC NEPHROL, V7, P955; IWASE H, 1992, ANAL BIOCHEM, V206, P202, DOI 10.1016/S0003-2697(05)80034-X; Kokubo T, 2000, NEPHROL DIAL TRANSPL, V15, P28, DOI 10.1093/ndt/15.1.28; Nakamura I, 2004, NEPHROLOGY, V9, P26, DOI 10.1111/j.1440-1797.2003.00225.x; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Yamamoto K, 2012, J GLYCOBIOLOGY, V1, P2	16	0	0	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	APR	2015	28	2					181	186		10.1007/s40620-014-0118-4		6	Urology & Nephrology	Urology & Nephrology	CE5JE	WOS:000351867600006		
J	Eriguchi, R; Taniguchi, M; Ninomiya, T; Hirakata, H; Fujimi, S; Tsuruya, K; Kitazono, T				Eriguchi, Rieko; Taniguchi, Masatomo; Ninomiya, Toshiharu; Hirakata, Hideki; Fujimi, Satoru; Tsuruya, Kazuhiko; Kitazono, Takanari			Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study	JOURNAL OF NEPHROLOGY			English	Article						Hemodialysis; ESA responsiveness; Mortality; Major cardiovascular events	CHRONIC-RENAL-FAILURE; ANEMIA MANAGEMENT; DIALYSIS PATIENTS; KIDNEY-DISEASE; MORTALITY; HEMOGLOBIN; SURVIVAL; RESPONSIVENESS; INFLAMMATION; OUTCOMES	Previous epidemiological evidence has suggested that responsiveness to erythropoiesis-stimulating agents (ESAs) is related to prognosis in hemodialysis (HD) patients. We investigated the effects of hyporesponsiveness to ESA on mortality and cardiovascular events in Japanese HD patients, taking modifying factors into account. A total of 2,905 Japanese HD patients aged a parts per thousand yen18 years who received ESA treatment were prospectively followed up for 4 years. Responsiveness to ESA was estimated using an erythropoietin resistance index (ERI), defined as erythropoietin dosage per week divided by post-HD weight and hemoglobin value (U/kg/week/g/dl). Patients were divided into three groups by tertiles of ERI levels: low ERI, a parts per thousand currency sign5.10; intermediate ERI, 5.11-9.43; high ERI, a parts per thousand yen9.44. Risk estimates were calculated by a Cox proportional hazards model, adjusting for potential confounders. During follow-up, 482 patients died from any causes. The 4-year survival rate decreased linearly with higher ERI levels, being 87.5, 82.9, and 72.0 % for low, intermediate, and high ERI group (p for trend < 0.001). Compared with the low ERI group, the multivariate-adjusted hazard ratio (mHR) was significantly higher in the high ERI group [mHR, 1.64 (95 % confidence interval, 1.27-2.11)]. In the high ERI group, patients with Kt/V a parts per thousand yen 1.57 had a significantly lower risk of death from any causes compared with those with Kt/V a parts per thousand currency sign 1.56 [mHR, 0.73 (0.54-0.98)]. Our findings suggest that ESA responsiveness can be considered a significant prognostic factor in Japanese HD patients.	[Eriguchi, Rieko; Fujimi, Satoru] Fukuoka Renal Clin, Fukuoka, Japan; [Eriguchi, Rieko; Taniguchi, Masatomo; Ninomiya, Toshiharu; Tsuruya, Kazuhiko; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Fukuoka 8128582, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp			Kidney Foundation [H19 JKFB 07-13, H20 JKFB 08-8, H23 JKFB 11-11]; Japan Dialysis Outcome Research Foundation [H19-076-02, H20-003]	We thank the participants in the Q-Cohort Study, members of the Society for the Study of Kidney Disease, and all personnel at participating institutions involved in the study. The following personnel (institutions) participated in the study: Takashi Ando (Hakozaki Park Internal Medicine Clinic); Takashi Ariyoshi (Ariyoshi Clinic); Koichiro Goto (Goto Clinic); Fumitada Hattori (Nagao Hospital); Harumichi Higashi (St Mary's Hospital); Tadashi Hirano (Hakujyuji Hospital); Kei Hori (Munakata Medical Association Hospital); Takashi Inenaga (Ekisaikai Moji Hospital); Hidetoshi Kanai (Kokura Memorial Hospital); Shigemi Kiyama (Kiyama Naika); Tetsuo Komota (Komota Clinic); Hiromasa Kuma (Kuma Clinic); Toshiro Maeda (Kozenkai-Maeda Hospital); Junichi Makino (Makino Clinic); Dai Matsuo (Hirao Clinic); Chiaki Miishima (Miishima Clinic); Koji Mitsuiki (Japanese Red Cross Fukuoka Hospital); Kenichi Motomura (Motomura Naika Clinic); Sadatoshi Nakamura (Kokura Daiichi Hospital); Hidetoshi Nakamura (Kokura Daiichi Hospital); Koichi Nakashima (Ohashi Internal Circulatory Clinic); Nobumitsu Okita (Shiroishi Kyoritsu Hospital); Shinichiro Osato (Osato Jin Clinic); Sakura Sakamoto (Fujiyamato Spa Hospital); Keiko Shigematsu (Shigematsu Clinic); Kazumasa Shimamatsu (Shimamatsu Naika Iin); Yoshito Shogakiuchi (Shin-Ai Clinic); Hiroaki Takamura (Hara Hospital); Kazuhito Takeda (Iizuka Hospital); Asuka Terai (Chidoribashi Hospital); Hideyoshi Tanaka (Mojiko-Jin Clinic); Suguru Tomooka (Hakozaki Park Internal Medicine Clinic); Jiro Toyonaga (Fukuoka Renal Clinic); Hiroshi Tsuruta (Steel Memorial Yawata Hospital); Ryutaro Yamaguchi (Shiseikai Hospital); Taihei Yanagida (Saiseikai Yahata General Hospital); Tetsuro Yanase (Yanase Internal Medicine Clinic); Tetsuhiko Yoshida (Hamanomachi Hospital); Takahiro Yoshimitsu (Gofukumachi Kidney Clinic, Harasanshin Hospital); Koji Yoshitomi (Yoshitomi Medical Clinic). This study was supported by the Kidney Foundation (H19 JKFB 07-13, H20 JKFB 08-8, H23 JKFB 11-11) and the Japan Dialysis Outcome Research Foundation (H19-076-02, H20-003).	Ramirez SPB, 2012, CLIN J AM SOC NEPHRO, V7, P1977, DOI 10.2215/CJN.00390112; Kilpatrick RD, 2008, CLIN J AM SOC NEPHRO, V3, P1077, DOI 10.2215/CJN.04601007; Port FK, 2002, J AM SOC NEPHROL, V13; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Stenvinkel P, 2002, SEMIN DIALYSIS, V15, P329, DOI 10.1046/j.1525-139X.2002.00083.x; Kalantar-Zadeh K, 2009, AM J KIDNEY DIS, V53, P823, DOI 10.1053/j.ajkd.2008.12.040; Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; DAUGIRDAS JT, 1989, INT J ARTIF ORGANS, V12, P420; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Streja E, 2008, AM J KIDNEY DIS, V52, P727, DOI 10.1053/j.ajkd.2008.05.029; Mallick S, 2012, BLOOD PURIFICAT, V33, P238, DOI 10.1159/000335256; Locatelli F, 2006, NEPHROL DIAL TRANSPL, V21, P991, DOI 10.1093/ndt/gfk011; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Kaysen GA, 2006, AM J KIDNEY DIS, V47, P157, DOI 10.1053/j.ajkd.2005.09.013; Locatelli Francesco, 2004, Am J Kidney Dis, V44, P27, DOI 10.1016/S0272-6386(04)01102-3; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; National Kidney Foundation, 2006, AM J KIDNEY DIS S, V47, pS16; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Rattanasompattikul M, 2013, NEPHROL DIAL TRANSPL, V28, P1936, DOI 10.1093/ndt/gfs368; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Taniguchi M, 2009, THER APHER DIAL, V13, pS15, DOI 10.1111/j.1744-9987.2009.00770.x	27	1	1	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	APR	2015	28	2					217	225		10.1007/s40620-014-0121-9		9	Urology & Nephrology	Urology & Nephrology	CE5JE	WOS:000351867600011		
J	Nishimura, M; Okamoto, Y; Takatani, T; Sato, N; Nishida, M; Hashimoto, T; Yamazaki, S; Kobayashi, H; Ono, T				Nishimura, Masato; Okamoto, Yu; Takatani, Toru; Sato, Nodoka; Nishida, Masaya; Hashimoto, Tetsuya; Yamazaki, Satoru; Kobayashi, Hiroyuki; Ono, Toshihiko			Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease	JOURNAL OF NEPHROLOGY			English	Article						ATP-sensitive potassium channel; Cardiac event; Fatty acids; Hemodialysis; Microcirculation	CARDIAC DEATH; HEART; RISK	We investigated the potential of oral nicorandil to improve myocardial fatty acid metabolism assessed by single-photon emission computed tomography (SPECT) using I-123-beta-methyliodophenyl pentadecanoic acid (BMIPP) in hemodialysis patients without obstructive coronary artery disease (CAD). This study was based on a cohort study of 155 hemodialysis patients with angiographic absence of obstructive CAD, with analysis performed in 100 propensity-matched patients (54 men and 46 women, 64 +/- A 10 years); 50 with oral administration of nicorandil (15 mg/d, nicorandil group) and 50 without (control). BMIPP SPECT was performed every year after angiography. Uptake on SPECT was graded in 17 segments on a five-point scale (0 normal, 4 absent) and assessed as BMIPP summed scores (SS). Over a mean follow-up period of 5.3 +/- A 1.9 years, we observed 25 cardiac deaths among 100 propensity-matched patients. Myocardial uptake of BMIPP in SPECT improved in the nicorandil group compared with the control group from 2 years of administration. In Kaplan-Meier survival analyses, free survival rate from cardiac death was higher in patients with a BMIPP SS improvement rate of a parts per thousand yen20 % compared to those with a parts per thousand yen0 % < 20 % or with < 0 % BMIPP SS improvement rate. At multiple logistic analysis, a a parts per thousand yen20 % BMIPP SS improvement rate was positively associated with serum albumin concentration and oral nicorandil. Long-term oral nicorandil may inhibit cardiac death by improving myocardial fatty acid metabolism in hemodialysis patients without obstructive CAD.	[Nishimura, Masato] Toujinkai Hosp, Div Cardiovasc, Fushimi Ku, Kyoto 6128026, Japan; [Okamoto, Yu] Toujinkai Hosp, Div Anesthesiol, Kyoto 6128026, Japan; [Takatani, Toru] Toujinkai Hosp, Div Nephrol, Kyoto 6128026, Japan; [Sato, Nodoka; Nishida, Masaya; Hashimoto, Tetsuya; Yamazaki, Satoru; Kobayashi, Hiroyuki; Ono, Toshihiko] Toujinkai Hosp, Div Urol, Kyoto 6128026, Japan	Nishimura, M (reprint author), Toujinkai Hosp, Div Cardiovasc, Fushimi Ku, 83-1 Iga,Momoyama Cho, Kyoto 6128026, Japan.	mnishimura@tea.ocn.ne.jp					AKAI K, 1995, J CARDIOVASC PHARM, V26, P541, DOI 10.1097/00005344-199510000-00006; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Moroi M, 2013, AM J KIDNEY DIS, V61, P466, DOI 10.1053/j.ajkd.2012.09.017; ARNETT EN, 1979, ANN INTERN MED, V91, P350; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; Kasama S, 2005, AM HEART J, V150, DOI DOI 10.1016/J.AHJ.2005.06.030; KUKOVETZ WR, 1991, J CARDIOVASC PHARM, V17, P627, DOI 10.1097/00005344-199104000-00016; Kuwabara Y, 2000, J NUCL CARDIOL, V7, P320, DOI 10.1067/mnc.2000.105382; Nishimura M, 2008, J AM COLL CARDIOL, V51, P139, DOI 10.1016/j.jacc.2007.08.057; Nishimura M, 2009, NEPHRON CLIN PRACT, V111, pC212, DOI 10.1159/000203074; Nishimura M, 2011, NEPHRON CLIN PRACT, V119, pC301, DOI 10.1159/000329112; Nishimura M, 2009, AM J KIDNEY DIS, V54, P307, DOI 10.1053/j.ajkd.2009.03.025; Nishimura M, 2011, KIDNEY INT, V79, P363, DOI 10.1038/ki.2010.392; Nishimura M, 2006, J NEPHROL, V19, P481; Nishimura M, 2008, KIDNEY INT, V74, P513, DOI 10.1038/ki.2008.211; Nishimura M, 2014, NEPHRON CLIN PRACT, V126, P24, DOI 10.1159/000357579; PORTER TR, 1993, J AM COLL CARDIOL, V22, P1858; Rubin DB, 1997, ANN INTERN MED, V127, P757; TAIRA N, 1979, CLIN EXP PHARMACOL P, V6, P301, DOI 10.1111/j.1440-1681.1979.tb01252.x; Workgroup K/DOQI, 2005, AM J KIDNEY DIS S, V45, pS1	20	1	1	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	APR	2015	28	2					227	234		10.1007/s40620-014-0125-5		8	Urology & Nephrology	Urology & Nephrology	CE5JE	WOS:000351867600012		
J	Meguro, R; Hishida, R; Tsukano, H; Yoshitake, K; Imamura, R; Tohmi, M; Kitsukawa, T; Hirabayashi, T; Yagi, T; Takebayashi, H; Shibuki, K				Meguro, Reiko; Hishida, Ryuichi; Tsukano, Hiroaki; Yoshitake, Kohei; Imamura, Ryota; Tohmi, Manavu; Kitsukawa, Takashi; Hirabayashi, Takahiro; Yagi, Takeshi; Takebayashi, Hirohide; Shibuki, Katsuei			Impaired clustered protocadherin-alpha leads to aggregated retinogeniculate terminals and impaired visual acuity in mice	JOURNAL OF NEUROCHEMISTRY			English	Article						aggregated terminals; lateral geniculate nucleus; protocadherin; retinal terminals; visual acuity	GAMMA-GENE-CLUSTER; NERVOUS-SYSTEM; SELF-AVOIDANCE; NEURONS; PATHWAY; SYNAPSE; FAMILY; MOUSE; EXPRESSION; DIVERSITY	Clustered protocadherins (cPcdhs) comprising cPcdh-, -, and -, encode a large family of cadherin-like cell-adhesion molecules specific to neurons. Impairment of cPcdh- results in abnormal neuronal projection patterns in specific brain areas. To elucidate the role of cPcdh- in retinogeniculate projections, we investigated the morphological patterns of retinogeniculate terminals in the lateral geniculate (LG) nucleus of mice with impaired cPcdh-. We found huge aggregated retinogeniculate terminals in the dorsal LG nucleus, whereas no such aggregated terminals derived from the retina were observed in the olivary pretectal nucleus and the ventral LG nucleus. These aggregated terminals appeared between P10 and P14, just before eye opening and at the beginning of the refinement stage of the retinogeniculate projections. Reduced visual acuity was observed in adult mice with impaired cPcdh-, whereas the orientation selectivity and direction selectivity of neurons in the primary visual cortex were apparently normal. These findings suggest that cPcdh- is required for adequate spacing of retinogeniculate projections, which may be essential for normal development of visual acuity.	[Meguro, Reiko; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata 9518518, Japan; [Hishida, Ryuichi; Tsukano, Hiroaki; Yoshitake, Kohei; Imamura, Ryota; Tohmi, Manavu; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata 9518518, Japan; [Yoshitake, Kohei; Kitsukawa, Takashi; Hirabayashi, Takahiro; Yagi, Takeshi; Shibuki, Katsuei] Osaka Univ, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Suita, Osaka, Japan; [Kitsukawa, Takashi; Hirabayashi, Takahiro; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, KOKORO Biol Grp, Osaka, Japan	Meguro, R (reprint author), Niigata Univ, Fac Med, Sch Hlth Sci, Chuo Ku, 2-746 Asahi Machi, Niigata 9518518, Japan.	meguror@clg.niigata-u.ac.jp	Tsukano, Hiroaki/G-5053-2013	Tsukano, Hiroaki/0000-0001-8511-7256	JSPS KAKENHI [23659091]; JST-CREST	This work was supported by JSPS KAKENHI Grant Number 23659091 and JST-CREST. The authors declare no competing financial interests.	Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Budisantoso T, 2012, J NEUROSCI, V32, P2357, DOI 10.1523/JNEUROSCI.5243-11.2012; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Hooks BM, 2008, J NEUROSCI, V28, P4807, DOI 10.1523/JNEUROSCI.4667-07.2008; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Golding B, 2014, NEURON, V81, P1057, DOI 10.1016/j.neuron.2014.01.032; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Phillips GR, 2003, J NEUROSCI, V23, P5096; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Chen WV, 2012, NEURON, V75, P402, DOI 10.1016/j.neuron.2012.06.039; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Guido W, 2008, J PHYSIOL-LONDON, V586, P4357, DOI 10.1113/jphysiol.2008.157115; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Honma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068113; Horie M, 2013, NEUROSCIENCE, V228, P382, DOI 10.1016/j.neuroscience.2012.10.047; Liu XJ, 2008, J NEUROPHYSIOL, V99, P629, DOI 10.1152/jn.01171.2007; Morishita H, 2004, NEUROREPORT, V15, P2595, DOI 10.1097/00001756-200412030-00007; Prasad T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00054; Tohmi M, 2014, CURR BIOL, V24, P587, DOI 10.1016/j.cub.2014.01.061; Wu HH, 2000, J COMP NEUROL, V426, P651, DOI 10.1002/1096-9861(20001030)426:4<651::AID-CNE11>3.0.CO;2-X; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; Yamashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035676; Yoshitake K, 2013, CELL REP, V5, P1365, DOI 10.1016/j.celrep.2013.11.006	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2015	133	1					66	72		10.1111/jnc.13053		7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CD9CJ	WOS:000351393900006		
J	Sandhu, KV; Yanagawa, Y; Stork, O				Sandhu, K. V.; Yanagawa, Y.; Stork, O.			Transcriptional Regulation of Glutamic Acid Decarboxylase in the Male Mouse Amygdala by Dietary Phyto-Oestrogens	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						Phyto-oestrogens; glutamic acid decarboxylase; neuropeptide Y; gene expression; basolateral amygdala; anxiety; male mice	ADULT-RAT HIPPOCAMPUS; NEUROPEPTIDE-Y; BASOLATERAL AMYGDALA; SOY-PHYTOESTROGENS; RECEPTOR-BETA; INHIBITORY NEUROTRANSMISSION; STRUCTURAL PLASTICITY; TESTOSTERONE LEVELS; ANDROGEN RECEPTOR; LATERAL AMYGDALA	Phyto-oestrogens are biologically active components of many human and laboratory animal diets. In the present study, we investigated, in adult male mice with C57BL/6 genetic background, the effects of a reduced phyto-oestrogens intake on anxiety-related behaviour and associated gene expression in the amygdala. After 6weeks on a low-phyto-oestrogen diet (<20g/g cumulative phyto-oestrogen content), animals showed reduced centre exploration in an open-field task compared to their littermates on a soybean-based standard diet (300g/g). Freezing behaviour in an auditory fear memory task, in contrast, was not affected. We hypothesised that this mildly increased anxiety may involve changes in the function of GABAergic local circuit neurones in the amygdala. Using GAD67(+/GFP) mice, we could demonstrate reduced transcription of the GAD67 gene in the lateral and basolateral amygdala under the low-phyto-oestrogen diet. Analysis of mRNA levels in microdissected samples confirmed this regulation and demonstrated concomitant changes in expression of the second glutamic acid decarboxylase (GAD) isoform, GAD65, as well as the anxiolytic neuropeptide Y. These molecular and behavioural alterations occurred without apparent changes in circulating oestrogens or testosterone levels. Our data suggest that expression regulation of interneurone-specific gene products in the amygdala may provide a mechanism for the control of anxiety-related behaviour through dietary phyto-oestrogens.	[Sandhu, K. V.; Stork, O.] Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39120 Magdeburg, Germany; [Yanagawa, Y.] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 371, Japan; [Yanagawa, Y.] JST, CREST, Maebashi, Gumma, Japan; [Stork, O.] Ctr Behav Brain Sci, Magdeburg, Germany	Sandhu, KV (reprint author), Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39120 Magdeburg, Germany.	kv.sandhu7@gmail.com			German Research Foundation [CRC779]; MEXT, Japan	We thank Dr A. Schuhmacher for information on diet composition and for valuable comments on the manuscript. We are grateful to F. Webers for expert technical assistance and to T. Porzucek for excellent animal care. This work was supported by the German Research Foundation (CRC779 project B5 to OS) and Grant-in-Aids for Scientific Research from the MEXT, Japan (YY).	Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Pihlajamaa P, 2011, ENDOCRINOLOGY, V152, P4395, DOI 10.1210/en.2011-0221; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Gilabert-Juan J, 2011, EXP NEUROL, V232, P33, DOI 10.1016/j.expneurol.2011.07.009; Marowsky A, 2012, J NEUROSCI, V32, P8611, DOI 10.1523/JNEUROSCI.4404-11.2012; Lange MD, 2014, NEUROPSYCHOPHARMACOL, V39, P2211, DOI 10.1038/npp.2014.72; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Donner J, 2012, AM J MED GENET B, V159B, P316, DOI 10.1002/ajmg.b.32029; Lussier AL, 2013, NEUROSCIENCE, V231, P38, DOI 10.1016/j.neuroscience.2012.11.037; Setchell KDR, 2011, AM J CLIN NUTR, V94, P1284, DOI 10.3945/ajcn.111.019638; Noriega NC, 2010, BRAIN RES, V1307, P28, DOI 10.1016/j.brainres.2009.10.011; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Bergado-Acosta JR, 2014, BEHAV BRAIN RES, V260, P92, DOI 10.1016/j.bbr.2013.11.042; Domschke K, 2013, PROG NEURO-PSYCHOPH, V46, P189, DOI 10.1016/j.pnpbp.2013.07.014; Bergado-Acosta JR, 2008, LEARN MEMORY, V15, P163, DOI 10.1101/lm.705408; Marowsky A, 2004, EUR J NEUROSCI, V20, P1281, DOI 10.1111/j.1460-9568.2004.03574.x; Nakamura NH, 2005, NEUROSCIENCE, V136, P357, DOI 10.1016/j.neuroscience.2005.07.056; Weber KS, 2001, J ENDOCRINOL, V170, P591, DOI 10.1677/joe.0.1700591; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858; Hudgens ED, 2009, J NEUROSCI, V29, P8790, DOI 10.1523/JNEUROSCI.1289-09.2009; Tasan RO, 2010, J NEUROSCI, V30, P6282, DOI 10.1523/JNEUROSCI.0430-10.2010; Lund TD, 2004, BIOL REPROD, V70, P1188, DOI 10.1095/biolreprod.103.023713; Blurton-Jones M, 2002, J COMP NEUROL, V452, P276, DOI 10.1002/cne.10393; Tian Z, 2013, PSYCHONEUROENDOCRINO, V38, P2218, DOI 10.1016/j.psyneuen.2013.04.011; Tan XJ, 2012, P NATL ACAD SCI USA, V109, P1708, DOI 10.1073/pnas.1121162109; Belsham DD, 2007, MOL NEUROBIOL, V35, P182, DOI 10.1007/s12035-007-0010-5; Curran-Rauhut MA, 2002, J NEUROENDOCRINOL, V14, P310, DOI 10.1046/j.1365-2826.2002.00780.x; Dunne EL, 1998, MOL CELL NEUROSCI, V12, P300, DOI 10.1006/mcne.1998.0717; Gilabert-Juan J, 2012, BRAIN RES, V1448, P129, DOI 10.1016/j.brainres.2012.01.073; Guerra-Araiza C, 2008, NEUROCHEM RES, V33, P1568, DOI 10.1007/s11064-008-9665-1; Hadad-Ophir O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00003; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Jacobs C, 2006, J VET MED A, V53, P334, DOI 10.1111/j.1439-0442.2006.00840.x; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Lephart ED, 2005, BRAIN RES BULL, V65, P193, DOI 10.1016/j.brainresbull.2004.11.022; Lephart ED, 2000, BRAIN RES, V859, P123, DOI 10.1016/S0006-8993(00)01968-5; Lephart ED, 2001, NEUROREPORT, V12, P3451, DOI 10.1097/00001756-200111160-00015; Lund TD, 2001, BRAIN RES, V913, P180, DOI 10.1016/S0006-8993(01)02793-7; Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-20; MCDONALD AJ, 1989, BRAIN RES, V500, P37, DOI 10.1016/0006-8993(89)90297-7; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Obata K, 2013, P JPN ACAD B-PHYS, V89, P139, DOI 10.2183/pjab.89.139; Pan Zhizhong Z, 2012, Transcription, V3, P68, DOI 10.4161/trns.19511; PESOLD C, 1995, BRAIN RES, V671, P213, DOI 10.1016/0006-8993(94)01318-C; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P999; Rana ZA, 2005, J PHYSIOL-LONDON, V562, P815, DOI 10.1113/jphysiol.2004.075333; Stanic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090451; Sumien N, 2013, BRAIN RES, V1514, P123, DOI 10.1016/j.brainres.2013.02.013; Thorsell Annika, 1999, Neuroreport, V10, P3003, DOI 10.1097/00001756-199909290-00024; Thorsell A, 1998, REGUL PEPTIDES, V75-6, P247, DOI 10.1016/S0167-0115(98)00075-5; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Tzanoulinou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094666; Unschuld PG, 2009, AM J MED GENET B, V150B, P1100, DOI 10.1002/ajmg.b.30938; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Ward WE, 2005, J NUTR BIOCHEM, V16, P743, DOI 10.1016/j.jnutbio.2005.04.002; Weber H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037651; Weber KS, 1999, P SOC EXP BIOL MED, V221, P131, DOI 10.1046/j.1525-1373.1999.d01-66.x	64	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	APR	2015	27	4					285	292		10.1111/jne.12262		8	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CD9VG	WOS:000351446600005		
J	Inoue, A; Tagawa, M; Kumon, Y; Watanabe, H; Shoda, D; Sugiu, K; Ohnishi, T				Inoue, Akihiro; Tagawa, Masahiko; Kumon, Yoshiaki; Watanabe, Hideaki; Shoda, Daisuke; Sugiu, Kenji; Ohnishi, Takanori			Ethmoidal dural arteriovenous fistula with unusual drainage route treated by transarterial embolization	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article							ANTERIOR CRANIAL FOSSA; MANAGEMENT	Ethmoidal dural arteriovenous fistulas (AVFs) are rare intracranial lesions associated with a high risk of intracranial hemorrhage. In particular, this entity with reflux drainage directly into the ophthalmic vein is extremely rare. We report a case of ethmoidal dural AVF with direct drainage of the superior ophthalmic vein (SOV) and inferior ophthalmic vein (IOV), successfully treated by endovascular surgery. A 58-year-old man presented with progressive diplopia. Angiography and contrast-enhanced CT showed an ethmoidal dural AVF supplied via the bilateral anterior ethmoidal arteries and venous drainage through the left SOV and IOV. A transarterial approach through the bilateral anterior ethmoidal arteries was used to place the microcatheter close to the fistula site. After intra-arterial embolization with 20% N-butyl cyanoacrylate, the dural AVF was completely occluded. In patients with good vascular access, endovascular transarterial embolization may be an effective and less invasive treatment strategy for ethmoidal dural AVF.	[Inoue, Akihiro; Tagawa, Masahiko; Kumon, Yoshiaki; Watanabe, Hideaki; Ohnishi, Takanori] Ehime Univ, Sch Med, Dept Neurosurg, Toon, Ehime 7910295, Japan; [Shoda, Daisuke] Uwajima City Hosp, Dept Neurosurg, Uwajima, Ehime, Japan; [Sugiu, Kenji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosurg, Okayama 7008530, Japan	Inoue, A (reprint author), Ehime Univ, Sch Med, Dept Neurosurg, Toon, Ehime 7910295, Japan.	iakihiro3@gmail.com		inoue, akihiro/0000-0002-7438-2369			Abrahams JM, 2002, SURG NEUROL, V58, P410, DOI 10.1016/S0090-3019(02)00871-6; Akasaka K, 1974, J TOKYO WOM MED U, V44, P271; Kakarla UK, 2007, NEUROSURGERY, V61, P447, DOI 10.1227/01.NEU.0000280007.72190.F1; Agid R, 2009, J NEUROSURG, V110, P79, DOI 10.3171/2008.6.17601; Nelson PK, 2003, J NEUROSURG, V98, P498, DOI 10.3171/jns.2003.98.3.0498; Lawton MT, 1999, NEUROSURGERY, V45, P805, DOI 10.1097/00006123-199910000-00014; Defreyne L, 2000, AM J NEURORADIOL, V21, P761; Deshmukh VR, 2005, NEUROSURGERY, V57, P809; Jamous MA, 2004, NEUROL MED-CHIR, V44, P516, DOI 10.2176/nmc.44.516; Mishra SS, 2013, SURG NEUROL INT, V23, P107	10	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	APR	2015	7	4					E15	U17		10.1136/neurintsurg-2013-011098.rep		4	Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	CE2CB	WOS:000351619400003		
J	Noto, Y; Shiga, K; Tsuji, Y; Mizuta, I; Higuchi, Y; Hashiguchi, A; Takashima, H; Nakagawa, M; Mizuno, T				Noto, Yu-ichi; Shiga, Kensuke; Tsuji, Yukiko; Mizuta, Ikuko; Higuchi, Yujiro; Hashiguchi, Akihiro; Takashima, Hiroshi; Nakagawa, Masanori; Mizuno, Toshiki			Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CARPAL-TUNNEL-SYNDROME; CROSS-SECTIONAL AREA; HEREDITARY MOTOR; MEDIAN NERVE; NEUROPATHY; CONDUCTION; FEATURES; ULTRASONOGRAPHY; POLYNEUROPATHY; RELIABILITY	Objective To elucidate the ultrasound (US) features of peripheral nerves including nerve roots in patients with different types of Charcot-Marie-Tooth disease (CMT), and the association between US findings, clinical features and parameters of nerve conduction studies (NCS) in CMT1A. Methods US of median, sural and great auricular nerves and the C6 nerve root was performed in patients with CMT1A (n=20), MPZ-associated CMT (n=3), NEFL-associated CMT (n=4), EGR2-associated CMT (n=1), ARHGEF10-associated CMT (n=1) and in controls (n=30). In patients with CMT1A, we analysed the correlations between US findings and the following parameters: age, CMT Neuropathy Score (CMTNS) and NCS indices of the median nerve. Results Cross-sectional areas (CSAs) of all the nerves were significantly increased in patients with CMT1A compared with that in controls. In MPZ-associated CMT, increased CSAs were found in the median nerve at wrist and in the great auricular nerve, whereas it was not increased in patients with NEFL-associated CMT. In patients with CMT1A, there was a positive correlation between CMTNS and the CSAs in the median nerves or great auricular nerves. In median nerves in patients with CMT1A, we found a negative correlation between the nerve conduction velocity and the CSA. Conclusions Nerve US may aid in differentiating among the subtypes of CMT in combination with NCS. In CMT1A, the median nerve CSA correlates with the disease severity and peripheral nerve function.	[Noto, Yu-ichi; Tsuji, Yukiko; Mizuta, Ikuko; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kyoto 6020841, Japan; [Shiga, Kensuke] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Med Educ & Primary Care, Kyoto 6020841, Japan; [Higuchi, Yujiro; Hashiguchi, Akihiro; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, North Med Ctr, Kyoto 6020841, Japan	Noto, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	y-noto@koto.kpu-m.ac.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Applying Health and Technology of Ministry of Health, Welfare and Labour, Japan; Research Committee of Charcot-Marie-Tooth Disease, Ministry of Health, Labour and Welfare of Japan	The work was partly funded by the Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Applying Health and Technology of Ministry of Health, Welfare and Labour, Japan and Grants-in-Aid from the Research Committee of Charcot-Marie-Tooth Disease, the Ministry of Health, Labour and Welfare of Japan.	Zaidman CM, 2013, J NEUROL, V260, P3115, DOI 10.1007/s00415-013-7123-8; Cartwright MS, 2009, MUSCLE NERVE, V40, P98, DOI 10.1002/mus.21292; Tsukamoto H, 2014, CLIN NEUROPHYSIOL, V125, P1491, DOI 10.1016/j.clinph.2013.11.041; Hattori N, 2003, BRAIN, V126, P134, DOI 10.1093/brain/awg012; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Watanabe T, 2010, J ULTRAS MED, V29, P697; Zhao Z, 2012, NEUROLOGY, V78, P1644, DOI 10.1212/WNL.0b013e3182574f8f; Nakamichi KI, 2002, MUSCLE NERVE, V26, P798, DOI 10.1002/mus.10276; Cartwright MS, 2012, MUSCLE NERVE, V46, P287, DOI 10.1002/mus.23389; Zaidman CM, 2009, MUSCLE NERVE, V40, P960, DOI 10.1002/mus.21431; Heinemeyer O, 1999, ULTRASOUND MED BIOL, V25, P481, DOI 10.1016/S0301-5629(98)00187-2; Schreiber S, 2013, MUSCLE NERVE, V47, P385, DOI 10.1002/mus.23681; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Shy ME, 2005, NEUROLOGY, V64, P1209; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; De Jonghe P, 1999, ARCH NEUROL-CHICAGO, V56, P1283, DOI 10.1001/archneur.56.10.1283; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; Cartwright MS, 2013, MUSCLE NERVE, V47, P515, DOI 10.1002/mus.23621; Matsuoka N, 2004, J NEUROL SCI, V219, P15, DOI 10.1016/j.jns.2003.11.011; Martinoli C, 2002, AM J ROENTGENOL, V178; Miltenberger-Miltenyi G, 2007, ARCH NEUROL-CHICAGO, V64, P966, DOI 10.1001/archneur.64.7.966; Pazzaglia C, 2013, CLIN NEUROPHYSIOL, V124, P1695, DOI 10.1016/j.clinph.2013.02.020; Robaglia-Schlupp A, 2002, BRAIN, V125, P2213, DOI 10.1093/brain/awf230; Scheidl E, 2012, NEUROMUSCULAR DISORD, V22, P627, DOI 10.1016/j.nmd.2012.03.005; Shiga K, 2012, J PERIPHER NERV SYST, V17, P206, DOI 10.1111/j.1529-8027.2012.00403.x; Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d; Sugimoto T, 2013, J NEUROL, V260, P2580, DOI 10.1007/s00415-013-7021-0	27	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2015	86	4					378	384		10.1136/jnnp-2014-308211		7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CD3SK	WOS:000351000800007		
J	Nishino, I; Carrillo-Carrasco, N; Argov, Z				Nishino, Ichizo; Carrillo-Carrasco, Nuria; Argov, Zohar			GNE myopathy: current update and future therapy	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Review							INCLUSION-BODY MYOPATHY; RIMMED VACUOLES DMRV; DISTAL MYOPATHY; N-ACETYLMANNOSAMINE; MOUSE MODEL; MISSENSE MUTATION; KEY ENZYME; GENE; MUSCLE; PHENOTYPE	GNE myopathy is an autosomal recessive muscle disease caused by biallelic mutations in GNE, a gene encoding for a single protein with key enzymatic activities, UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase, in sialic acid biosynthetic pathway. The diagnosis should be considered primarily in patients presenting with distal weakness (foot drop) in early adulthood (other onset symptoms are possible too). The disease slowly progresses to involve other lower and upper extremities' muscles, with marked sparing of the quadriceps. Characteristic findings on biopsies of affected muscles include 'rimmed' (autophagic) vacuoles, aggregation of various proteins and fibre size variation. The diagnosis is confirmed by sequencing of the GNE gene. Note that we use a new mutation nomenclature based on the longest transcript (GenBank: NM_001128227), which encodes a 31-amino acid longer protein than the originally described one (GenBank: NM_005476), which has been used previously in most papers. Based upon the pathophysiology of the disease, recent clinical trials as well as early gene therapy trials have evaluated the use of sialic acid or N-acetylmannosamine (a precursor of sialic acid) in patients with GNE myopathy. Now that therapies are under investigation, it is critical that a timely and accurate diagnosis is made in patients with GNE myopathy.	[Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; [Carrillo-Carrasco, Nuria] NIH, Therapeut Rare & Neglected Dis, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Argov, Zohar] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel	Nishino, I (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878502, Japan.	nishino@ncnp.go.jp			NCNP, Tokyo, Japan [23-5]; Ministry of Health, Labour and Welfare, Japan; Neuromuscular Disease Foundation (NDF) of Los Angeles; Therapeutics for Rare and Neglected Diseases (TRND) Program of the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, Maryland, USA; Hadassah Southern California groups	Studies reported in this review have been supported partly by Intramural Research Grant 23-5 for Neurological and Psychiatric Disorders of NCNP, Tokyo, Japan; Research on rare and intractable diseases from the Ministry of Health, Labour and Welfare, Japan; the Neuromuscular Disease Foundation (NDF) of Los Angeles; the Therapeutics for Rare and Neglected Diseases (TRND) Program of the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, Maryland, USA; Hadassah Southern California groups (Malka and Haifa) and numerous patients' support groups.	Amouri R, 2005, NEUROMUSCULAR DISORD, V15, P361, DOI 10.1016/j.nmd.2005.01.012; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Malicdan MCV, 2012, J BIOL CHEM, V287, P2689, DOI 10.1074/jbc.M111.297051; Nemunaitis G, 2011, HUM GENE THER, V22, P1331, DOI 10.1089/hum.2010.192; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Tasca G, 2012, J NEUROL, V259, P1358, DOI 10.1007/s00415-011-6357-6; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Argov Z, 2003, NEUROLOGY, V60, P1519; Argov Z, 2008, NEUROTHERAPEUTICS, V5, P633, DOI 10.1016/j.nurt.2008.07.004; Boyden SE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-87; Chai YH, 2011, MUSCLE NERVE, V43, P133, DOI 10.1002/mus.21839; Chaouch A, 2014, J NEUROL NEUROSUR PS, V85, P1359, DOI 10.1136/jnnp-2013-306314; Cho A, 2014, J NEUROL NEUROSUR PS, V85, P912, DOI 10.1136/jnnp-2013-305587; Darvish D, 2002, MOL GENET METAB, V77, P252, DOI 10.1016/S1096-7192(02)00141-5; Del Bo R, 2003, MUSCLE NERVE, V28, P113, DOI 10.1002/mus.10391; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; Fischer C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-24; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Huizing M, 2014, NEUROMUSCULAR DISORD, V24, P387, DOI 10.1016/j.nmd.2014.03.004; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Kaback M, 2010, GENET MED, V12, P628, DOI 10.1097/GIM.0b013e3181edef5b; Kalaydjieva Luba, 2005, Neuromuscul Disord, V15, P65, DOI 10.1016/j.nmd.2004.09.008; Kannan MA, 2012, NEUROL INDIA, V60, P631, DOI 10.4103/0028-3886.105199; Khademian H, 2013, CLIN GENET, V84, P589, DOI 10.1111/cge.12086; Kim BJ, 2006, J HUM GENET, V51, P137, DOI 10.1007/s10038-005-0338-5; Krause S, 2003, NEUROMUSCULAR DISORD, V13, P830, DOI 10.1016/S0960-8966(03)00140-8; Lamark T., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/736905; Liewluck T, 2006, MUSCLE NERVE, V34, P775, DOI 10.1002/mus.20583; Lu XH, 2011, NEUROL RES, V33, P1025, DOI 10.1179/1743132811Y.0000000070; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; MAYHEW JE, 2013, 18 INT C WORLD MUSCL, V23, P755; Mitrani-Rosenbaum S, 2012, NEUROMUSCULAR DISORD, V22, P1015, DOI 10.1016/j.nmd.2012.03.013; Mori-Yoshimura M, 2012, J NEUROL SCI, V318, P100, DOI 10.1016/j.jns.2012.03.016; Mori-Yoshimura M, 2013, NEUROMUSCULAR DISORD, V23, P84, DOI 10.1016/j.nmd.2012.09.007; Nakamura H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-60; Nalini A, 2013, NEUROL INDIA, V61, P371, DOI 10.4103/0028-3886.117609; Nishino I, 2002, NEUROLOGY, V59, P1689; Park YE, 2012, J NEUROL SCI, V321, P77, DOI 10.1016/j.jns.2012.07.061; Saechao C, 2010, GENET TEST MOL BIOMA, V14, P157, DOI 10.1089/gtmb.2009.0157; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Sela I, 2012, PLOS ONE, V7; Sela I, 2013, NEUROMOL MED, V15, P180, DOI 10.1007/s12017-012-8209-7; Sparks S, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-3; Tal-Goldberg T., 2013, NEUROMOL MED, V16, P322; Tomimitsu H, 2004, NEUROLOGY, V62, P1607; Vasconcelos OM, 2002, NEUROLOGY, V59, P1776; Weihl CC, 2011, NEUROMUSCULAR DISORD, V21, P102, DOI 10.1016/j.nmd.2010.11.002; Yardeni T, 2011, BIOCHEMISTRY-US, V50, P8914, DOI 10.1021/bi201050u	50	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2015	86	4					385	392		10.1136/jnnp-2013-307051		8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CD3SK	WOS:000351000800008		
J	Kanbara, S; Yukawa, Y; Ito, K; Machino, M; Kato, F				Kanbara, Shunsuke; Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Kato, Fumihiko			Surgical outcomes of modified lumbar spinous process-splitting laminectomy for lumbar spinal stenosis	JOURNAL OF NEUROSURGERY-SPINE			English	Article						lumbar spinous process-splitting laminectomy; laminoplasty; lumbar spinal stenosis; decompression surgery; spinous process; paravertebral muscle	SURGERY; MULTIFIDUS; LAMINOTOMY; STABILITY	The lumbar spinous process splitting laminectomy (LSPSL) procedure was developed as an alternative to lumbar laminectomy. In the LSPSL procedure, the spinous process is evenly split longitudinally and then divided at its base from the posterior arch, leaving the bilateral paravertebral muscle attached to the lateral aspects. This procedure allows for better exposure of intraspinal nerve tissues, comparable to that achieved by conventional laminectomy while minimizing damage to posterior supporting structures. In this study, the authors make some modifications to the original LSPSL procedure (modified LSPSL), in which laminoplasty is performed instead of laminectomy. The purpose of this study was to compare postoperative outcomes in modified LSPSL with those in conventional laminectomy (CL) and to evaluate bone unions between the split spinous process and residual laminae following modified LSPSL. Forty-seven patients with lumbar spinal stenosis were enrolled in this study. Twenty-six patients underwent modified LSPSL and 21 patients underwent CL. Intraoperative blood loss and surgical duration were evaluated. The Japanese Orthopaedic Association (JOA) scale scores were used to assess parameters before surgery and 12 months after surgery. The recovery rates were also-evaluated. Postoperative paravertebral muscle atrophy was assessed using MRI. Bone union rates between The split spinous process and residual laminae were also examined. The mean surgical time and intraoperative blood loss were 25.7 minutes and 42.4 ml per 1 level in modified LSPSL, respectively, and 22.7 minutes and 29.5 ml in CL, respectively. The recovery rate of the JOA score was 64.2% in modified LSPSL and 68.7% in CL. The degree of paravertebral muscle atrophy was 7.8% in modified LSPSL and 22.2% in CL at 12 months after surgery (p < 0.05). The fusion rates of the spinous process with the arcus vertebrae at 6 and 12 months in modified LSPSL were 56.3% and 81.3%, respectively. The modified LSPSL procedure was less invasive to the paravertebral muscles and could be a laminoplasty; therefore, the modified LSPSL procedure presents an effective alternative to lumbar laminectomy.	[Kanbara, Shunsuke] Chutoen Gen Med Ctr, Dept Orthoped Surg, Shizuoka 4368555, Japan; [Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Kato, Fumihiko] Chubu Rosai Hosp, Dept Orthoped Surg, Nagoya, Aichi, Japan	Kanbara, S (reprint author), Chutoen Gen Med Ctr, Dept Orthoped Surg, 1-1 Shobugaike, Shizuoka 4368555, Japan.	shunaly@live.jp					ABUMI K, 1990, SPINE, V15, P1142, DOI 10.1097/00007632-199011010-00011; Watanabe K, 2005, J NEUROSURG-SPINE, V3, P405, DOI 10.3171/spi.2005.3.5.0405; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Katz JN, 1999, SPINE, V24, P2229, DOI 10.1097/00007632-199911010-00010; Gille O, 2007, SPINE, V32, P1236, DOI 10.1097/BRS.0b013e31805471fe; Cho DY, 2007, J NEUROSURG-SPINE, V6, P229, DOI 10.3171/spi.2007.6.3.229; Gejo R, 1999, SPINE, V24, P1023, DOI 10.1097/00007632-199905150-00017; Kawaguchi Y, 2001, J SPINAL DISORD, V14, P404, DOI 10.1097/00002517-200110000-00006; KATZ JN, 1991, J BONE JOINT SURG AM, V73A, P809; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; Crock HV, 1995, NEURO-ORTHOPEDICS, V17, P151; Inoue S, 1986, J JPN ORTHOP ASSOC, V60, P391; Katz JN, 1996, SPINE, V21, P92, DOI 10.1097/00007632-199601010-00022; Kojima M, 2013, J SPINE RES, V4, P1393; MACINTOSH JE, 1986, CLIN BIOMECH, V1, P205, DOI 10.1016/0268-0033(86)90147-6; MACINTOSH JE, 1986, CLIN BIOMECH, V1, P196, DOI 10.1016/0268-0033(86)90146-4; POLETTI CE, 1995, NEUROSURGERY, V37, P343; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011	18	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	APR	2015	22	4					353	357		10.3171/2014.9.SPINE1457		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2PY	WOS:000351658700004		
J	Imajo, Y; Kanchiku, T; Yoshida, Y; Nishida, N; Taguchi, T				Imajo, Yasuaki; Kanchiku, Tsukasa; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko			Large spinal intraosseous arteriovenous fistula: case report	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal intraosseous arteriovenous fistula; surgical treatment; lumbar spine; oncology	BODY	Here the authors report the case of a fresh vertebral body fracture with a large spinal intraosseous arteriovenous fistula (AVF). A 74-year-old woman started to experience low-back pain following a rear-end car collision. Plain radiography showed diffuse idiopathic skeletal hyperostosis (DISH). Sagittal CT sections revealed a transverse fracture of the L-4 vertebral body with a bone defect. Sagittal fat-suppressed T2-weighted MRI revealed a flow void in the fractured vertebra. Spinal angiography revealed an intraosseous AVF with a feeder from the right L-4 segmental artery. A fresh fracture of the L-4 vertebral body with a spinal intraosseous AVF was diagnosed. Observation of a flow void in the vertebral body on fat-suppressed 12-weighted MRI was important for the diagnosis of the spinal intraosseous AVE Because conservative treatment was ineffective, surgery was undertaken. The day before surgery, embolization through the right L-4 segmental artery was performed using 2 coils to achieve AVF closure. Poster lateral fusion with instrumentation at the T12 S2 vertebral levels was performed without L-4 vertebroplasty. The spinal intraosseous AVF had disappeared after 4 months. At 24 months after surgery, the bone defect was completely replaced by bone and the patient experienced no limitations in daily activities. Given their experience with the present case, the authors believe that performing vertebroplasty or anterior reconstruction may not be necessary in treating spinal intraosseous AVE	[Imajo, Yasuaki; Kanchiku, Tsukasa; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Orthopaed Surg, Yamaguchi, Japan	Imajo, Y (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Orthopaed Surg, 1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	i-yasuak@yamaguchi-u.ac.jp					Kiyosue H, 2013, NEURORADIOLOGY, V55, P327, DOI 10.1007/s00234-012-1130-9; Iwakura T, 2012, J MAGN RESON IMAGING, V36, P1231, DOI 10.1002/jmri.23732; Jin YJ, 2010, AM J NEURORADIOL, V31, P688, DOI 10.3174/ajnr.A1780; Papadoulas S, 2002, EUR J VASC ENDOVASC, V24, P189, DOI 10.1052/ejvs.2002.1682	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	APR	2015	22	4					406	408		10.3171/2014.10.SPINE1487		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2PY	WOS:000351658700012		
J	Ueno, M; Sakai, R; Tanaka, K; Inoue, G; Uchida, K; Imura, T; Saito, W; Nakazawa, T; Takahira, N; Mabuchi, K; Takaso, M				Ueno, Masaki; Sakai, Rina; Tanaka, Kensei; Inoue, Gen; Uchida, Kentaro; Imura, Takayuki; Saito, Wataru; Nakazawa, Toshiyuki; Takahira, Naonobu; Mabuchi, Kiyoshi; Takaso, Masashi			Should we use cortical bone screws for cortical bone trajectory?	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cortical bone trajectory; screw thread; spinal fusion; pedicle screw; technique	MINERAL DENSITY; SPINE; FIXATION	OBJECT In 2009, Santoni et al. reported cortical bone trajectory (CBT) as a method of inserting pedicle screws to obtain more solid fixation, and proposed the use of cortical trajectory screws with a more closely placed thread (cortical screws) for CBT. Since the entry trajectory in CBT differs from that in the traditional trajectory, it is unclear whether the increased strength derives from the specific trajectory or the shape of the screw thread in contact with the cortical bone. Whether the use of cortical screws is always required with CBT thus remains unclear. The authors therefore investigated the relationship between screw entry trajectory and screw thread characteristics and pullout strength in animal experiments. METHODS Lumbar vertebrae (L1-L4) from 4-month-old female pigs were randomly assigned to one of 4 groups, with cancellous screws or cortical screws inserted via the traditional trajectory or CBT. For pullout strength testing, the screw wasiDulled out vertically against the direction of insertion. Rod pullout testing (toggle testing) was also performed, and the peak breaking strength was measured. RESULTS The maximum pullout strength was significantly greater for CBT using cortical screws than for the traditional trajectory using cancellous screws. Pullout strength tended to be higher when cortical screws were used in both CBT and the traditional trajectory, although the difference was not significant. Toggle testing showed no significant differences among the 4 groups. CONCLUSIONS The specific unconventional trajectory seemed to have a major impact on the increased strength obtained with CBT.	[Ueno, Masaki; Inoue, Gen; Uchida, Kentaro; Imura, Takayuki; Saito, Wataru; Nakazawa, Toshiyuki; Takahira, Naonobu; Takaso, Masashi] Kitasato Univ, Sch Med, Dept Orthopaed Surg, Sagamihara, Kanagawa 228, Japan; [Sakai, Rina; Tanaka, Kensei; Mabuchi, Kiyoshi] Kitasato Univ, Sch Allied Hlth Sci, Dept Biomed Engn, Sagamihara, Kanagawa 228, Japan; [Takahira, Naonobu] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa 228, Japan	Ueno, M (reprint author), Machida Keisen Hosp, Dept Orthopaed Surg, 1546-2 Ogawa, Machida, Tokyo 1940003, Japan.	masaki.ueno00@gmail.com					OKUYAMA K, 1993, SPINE, V18, P2240, DOI 10.1097/00007632-199311000-00016; HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008; WITTENBERG RH, 1991, SPINE, V16, P647, DOI 10.1097/00007632-199106000-00009; Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008; Asnis SE, 1996, J ORTHOP TRAUMA, V10, P462, DOI 10.1097/00005131-199610000-00003; SOSHI S, 1991, SPINE, V16, P1335, DOI 10.1097/00007632-199111000-00015	6	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	APR	2015	22	4					416	421		10.3171/2014.9.SPINE1484		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2PY	WOS:000351658700014		
J	Nakazato, R; Slomka, PJ; Fish, M; Schwartz, RG; Hayes, SW; Thomson, LEJ; Friedman, JD; Lemley, M; Mackin, ML; Peterson, B; Schwartz, AM; Doran, JA; Germano, G; Berman, DS				Nakazato, Ryo; Slomka, Piotr J.; Fish, Mathews; Schwartz, Ronald G.; Hayes, Sean W.; Thomson, Louise E. J.; Friedman, John D.; Lemley, Mark, Jr.; Mackin, Maria L.; Peterson, Benjamin; Schwartz, Arielle M.; Doran, Jesse A.; Germano, Guido; Berman, Daniel S.			Quantitative high-efficiency cadmium-zinc-telluride SPECT with dedicated parallel-hole collimation system in obese patients: Results of a multi-center study	JOURNAL OF NUCLEAR CARDIOLOGY			English	Article						Myocardial perfusion imaging; obesity; cadmium-zinc-telluride; parallel-hole collimation; quantification	MYOCARDIAL-PERFUSION; PROGNOSTIC VALUE; CAMERA; FEASIBILITY; RESERVE; SUPINE; PET	Obesity is a common source of artifact on conventional SPECT myocardial perfusion imaging (MPI). We evaluated image quality and diagnostic performance of high-efficiency (HE) cadmium-zinc-telluride parallel-hole SPECT MPI for coronary artery disease (CAD) in obese patients. 118 consecutive obese patients at three centers (BMI 43.6 +/- A 8.9 kg center dot m(-2), range 35-79.7 kg center dot m(-2)) had upright/supine HE-SPECT and invasive coronary angiography > 6 months (n = 67) or low likelihood of CAD (n = 51). Stress quantitative total perfusion deficit (TPD) for upright (U-TPD), supine (S-TPD), and combined acquisitions (C-TPD) was assessed. Image quality (IQ; 5 = excellent; < 3 nondiagnostic) was compared among BMI 35-39.9 (n = 58), 40-44.9 (n = 24) and a parts per thousand yen45 (n = 36) groups. ROC curve area for CAD detection (a parts per thousand yen50% stenosis) for U-TPD, S-TPD, and C-TPD were 0.80, 0.80, and 0.87, respectively. Sensitivity/specificity was 82%/57% for U-TPD, 74%/71% for S-TPD, and 80%/82% for C-TPD. C-TPD had highest specificity (P = .02). C-TPD normalcy rate was higher than U-TPD (88% vs 75%, P = .02). Mean IQ was similar among BMI 35-39.9, 40-44.9 and a parts per thousand yen45 groups [4.6 vs 4.4 vs 4.5, respectively (P = .6)]. No patient had a nondiagnostic stress scan. In obese patients, HE-SPECT MPI with dedicated parallel-hole collimation demonstrated high image quality, normalcy rate, and diagnostic accuracy for CAD by quantitative analysis of combined upright/supine acquisitions.	[Nakazato, Ryo; Slomka, Piotr J.; Hayes, Sean W.; Thomson, Louise E. J.; Friedman, John D.; Germano, Guido; Berman, Daniel S.] Cedars Sinai Med Ctr, Dept Imaging, Los Angeles, CA 90048 USA; [Nakazato, Ryo] St Lukes Int Hosp, Cardiovasc Ctr, Tokyo, Japan; [Fish, Mathews; Lemley, Mark, Jr.] Peacehealth Sacred Heart Med Ctr, Dept Cardiol, Springfield, OR USA; [Schwartz, Ronald G.; Mackin, Maria L.; Peterson, Benjamin; Schwartz, Arielle M.; Doran, Jesse A.] Univ Rochester, Med Ctr, Dept Med, Cardiol Div, Rochester, NY 14642 USA; [Schwartz, Ronald G.; Mackin, Maria L.; Peterson, Benjamin; Schwartz, Arielle M.; Doran, Jesse A.] Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14642 USA	Berman, DS (reprint author), Cedars Sinai Med Ctr, Dept Imaging, 8700 Beverly Blvd,Taper Bldg Suite 1258, Los Angeles, CA 90048 USA.	bermand@cshs.org					Gambhir SS, 2009, J NUCL MED, V50, P635, DOI 10.2967/jnumed.108.060020; Gimelli A, 2012, EUR J NUCL MED MOL I, V39, P1254, DOI 10.1007/s00259-012-2161-5; Gimelli A, 2011, CIRC-CARDIOVASC IMAG, V4, P51, DOI 10.1161/CIRCIMAGING.110.957399; Thompson RC, 2005, J NUCL CARDIOL, V12, P195, DOI 10.1016/j.nuclcard.2004.12.298; Einstein AJ, 2014, J NUCL MED, V55, P1430, DOI 10.2967/jnumed.114.138222; Fiechter M, 2012, J NUCL MED, V53, P1401, DOI 10.2967/jnumed.111.102434; Ben-Haim S, 2013, J NUCL MED, V54, P873, DOI 10.2967/jnumed.112.109652; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Slomka PJ, 2014, SEMIN NUCL MED, V44, P232, DOI 10.1053/j.semnuclmed.2014.04.003; Nakazato R, 2010, J NUCL MED, V51, P1724, DOI 10.2967/jnumed.110.078782; Verger A, 2014, EUR J NUCL MED MOL I, V41, P522, DOI 10.1007/s00259-013-2617-2; Ben-Haim S, 2014, J NUCL CARDIOL, V21, P478, DOI 10.1007/s12350-014-9853-0; Blankstein R, 2010, NAT REV CARDIOL, V7, P226, DOI 10.1038/nrcardio.2010.15; Chow BJW, 2014, JACC-CARDIOVASC IMAG, V7, P278, DOI 10.1016/j.jcmg.2013.12.008; Mouden M, 2014, EUR J NUCL MED MOL I, V41, P956, DOI 10.1007/s00259-013-2630-5; Nakazato R, 2015, J NUCL CARDIOL, V22, P266, DOI 10.1007/s12350-014-9984-3; Shah RV, 2014, JACC-CARDIOVASC IMAG, V7, P462, DOI 10.1016/j.jcmg.2013.11.011; Supariwala A, 2014, ECHOCARDIOGR-J CARD, V31, P879, DOI 10.1111/echo.12481; van Dijk JD, 2014, J NUCL CARDIOL, V21, P1158, DOI 10.1007/s12350-014-9942-0	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-3581	1532-6551		J NUCL CARDIOL	J. Nucl. Cardiol.	APR	2015	22	2					266	278		10.1007/s12350-014-9984-3		13	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CD4YJ	WOS:000351092200005		
J	Shimizu, M; Fujii, H; Yamawake, N; Nishizaki, M				Shimizu, Masato; Fujii, Hiroyuki; Yamawake, Noriyoshi; Nishizaki, Mitsuhiro			Cardiac function changes with switching from the supine to prone position: Analysis by quantitative semiconductor gated single-photon emission computed tomography	JOURNAL OF NUCLEAR CARDIOLOGY			English	Article						Prone position; cardiac function tests; cardiac-gated SPECT	LEFT-VENTRICULAR VOLUMES; RESPIRATORY-DISTRESS-SYNDROME; EJECTION FRACTION; MECHANICAL DYSSYNCHRONY; PHASE-ANALYSIS; HEART-RATE; SPECT; ECHOCARDIOGRAPHY; CONTRACTION; PRESSURE	Prone positioning is required in certain operations such as spinal surgery. Changes in cardiac function in the prone position have been studied with various methodologies. Few studies have investigated changes in left ventricular diastolic function and rhythm in subjects turned prone. Cardiac function was evaluated in the supine and prone positions in 90 patients without atrial fibrillation who underwent Tc-99m-tetrofosmin quantitative gated single-photon emission computed tomography. Three groups of 30 patients each were classified as "no history of myocardial ischemia or cardiomyopathy" (Group A), "history of myocardial infarction" (Group B), and "ischemic heart disease without myocardial infarction history" (Group C). Upon assuming the prone position, the cardiac index and any dyssynchrony worsened in all groups. Ejection fraction changes occurred only in Group B, and diastolic function changes occurred in Groups B and C, but not in Group A. The changes caused by prone positioning were more severe in the patients with poor cardiac function. Prone positioning induces significant changes in systolic and diastolic function, as well as dyssynchrony. The negative effects of prone positioning are more severe in patients with poor baseline cardiac function.	[Shimizu, Masato; Fujii, Hiroyuki; Yamawake, Noriyoshi; Nishizaki, Mitsuhiro] Yokohama Minami Kyosai Hosp, Kanazawa Ku, Yokohama, Kanagawa 2360037, Japan	Shimizu, M (reprint author), Yokohama Minami Kyosai Hosp, Kanazawa Ku, 1-21-1 Mutsuura Higashi, Yokohama, Kanagawa 2360037, Japan.	mst-smz@my.email.ne.jp					Pump B, 2002, AM J PHYSIOL-REG I, V283, pR174, DOI 10.1152/ajpregu.00619.2001; GILBERT JC, 1989, CIRC RES, V64, P827; Yoshida K, 2001, SLEEP, V24, P538; Chen J, 2005, J NUCL CARDIOL, V12, P687, DOI 10.1016/j.nuclcard.2005.06.088; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Kubitz JC, 2006, EUR J CARDIO-THORAC, V30, P90, DOI 10.1016/j.ejcts.2006.04.008; Levine MG, 1999, J NUCL CARDIOL, V6, P389, DOI 10.1016/S1071-3581(99)90004-1; Esteves FP, 2009, J NUCL CARDIOL, V16, P927, DOI 10.1007/s12350-009-9137-2; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Yap K, 2012, J MED IMAG RADIAT ON, V56, P525, DOI 10.1111/j.1754-9485.2012.02438.x; Berman D, 1998, J NUCL CARDIOL, V5, P40, DOI 10.1016/S1071-3581(98)80009-3; YOKOYAMA M, 1991, ACTA ANAESTH SCAND, V35, P741; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Caracciolo G, 2013, CIRC J, V77, P2526, DOI 10.1253/circj.CJ-12-1230; Chen J, 2008, ECHOCARDIOGR-J CARD, V25, P1186, DOI 10.1111/j.1540-8175.2008.00782.x; Chiumello D, 2006, CRIT CARE, V10, DOI 10.1186/cc4933; Hirakawa M, 1988, Masui, V37, P1314; Ioannidis JPA, 2002, J AM COLL CARDIOL, V39, P2059, DOI 10.1016/S0735-1097(02)01882-X; Kato T, 2010, TOHOKU J EXP MED, V222, P175, DOI 10.1620/tjem.222.175; Nakae I, 2005, ANN NUCL MED, V19, P447, DOI 10.1007/BF02985571; Paeng JC, 2001, J NUCL MED, V42, P695; PEARCE DJ, 1957, P ROY SOC MED, V50, P109; Schaefer WM, 2004, J NUCL MED, V45, P2016; Soliman DE, 1998, CAN J ANAESTH, V45, P925; Tiotiu Angelica, 2011, Pneumologia, V60, P216	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-3581	1532-6551		J NUCL CARDIOL	J. Nucl. Cardiol.	APR	2015	22	2					301	307		10.1007/s12350-014-0058-3		7	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CD4YJ	WOS:000351092200008		
J	Yasui, S				Yasui, Shojiro			250 mSv: Temporary Increase in the Emergency Exposure Dose Limit in Response to the TEPCO Fukushima Daiichi NPP Accident and Its Decision Making Process	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE			English	Article						emergency radiation dose limit; emergency response; Fukushima Daiichi NPP accident; radiation exposure	WORKERS	The Great East Japan Earthquake on March 11, 2011, led to an accident at the Fukushima Daiichi Nuclear Power Plant of the Tokyo Electric Power Company (TEPCO). In response to this accident, on March 14, 2011, the Ministry of Health, Labour, andWelfare (MHLW) of Japan enforced an ordinance that temporarily increased the radiation exposure dose limit allowed to 250 mSv during the emergency. This article explains the processes of a) temporarily increasing emergency dose limits, b) controlling for the combined emergency and normal exposure doses, and c) reducing the limit back to 100 mSv. Major issues addressed when deliberating the reduction of the emergency limits includes the following: a) political initiative, b) a phased reduction of dose limits, and c) transitional measures for workers who were exposed to more than 100 mSv. This article also identifies key challenges that need further deliberation to be resolved. These include: a) establishing a pre-defined protocol for applying pre-accident emergency dose limits and/or amending post-accident limits; b) designating the conditions in which to apply or amend emergency dose limits; c) selecting methods of radiation control for individuals who are exposed to more than the normal exposure dose limit during emergency work; and d) designating the conditions under which to terminate or reduce emergency dose limits after the accident.	[Yasui, Shojiro] Minist Hlth Labour & Welf, Tokyo, Japan	Yasui, S (reprint author), 1-2-2 Kasumigaseki,Chiyoda Ku, Tokyo 1008988, Japan.	syasui@st.rim.or.jp					[Anonymous], 2011, ORD EX ORD PREV ION, V23; [Anonymous], 2011, ORD PART REV SPEC EX; [Anonymous], 2011, COND PSEC MIN MHLW B; [Anonymous], 1972, ORD PREV ION RAD HAZ; ICRP, 2008, ANN ICRP, V37; ICRP, 1991, ANN ICRP, V21; Labour Policy Council, 2011, PROP OUTL MIN ORD PA; Labour Policy Council, 2011, OV DRAFT MIN ORD AB; Ministry of Health Labour and Welfare, 2011, OV OUTL DRAFT MIN OR; Ministry of Health Labour and Welfare, 2011, CONS REC LAB POL COU; Ministry of Health Labour and Welfare, 2012, FUT ACT BAS EXP SUCH; Ministry of Health Labour and Welfare, 2014, RES ADD REEV COMM EM; Ministry of Health Labour and Welfare, 2011, PUBL ENF MIN ORD AB; Ministry of Health Labour and Welfare, ACT LIN GREAT E JAP; Ministry of Health Labour and Welfare, 2011, OV DRAFT MIN ORD AB; Ministry of Health Labour and Welfare, 2013, PERSP ACT TAK MIN HL; Nuclear and Industrial Safety Agency (NISA), REG EXP DOS LIM RAD; Nuclear Emergency Response Headquarters, 2011, ROADM SETTL ACC FUK; Yamada T., 2001, BIOL EFFECTS LOW DOS; Yasui S, 2014, J OCCUP ENVIRON HYG, V11, pD49, DOI 10.1080/15459624.2014.880445; Yasui S, 2013, J OCCUP ENVIRON HYG, V10, pD163, DOI 10.1080/15459624.2013.831988; Yonei S., 2002, J JAPAN SOC RADIOL T, V58, P1328	22	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1545-9624	1545-9632		J OCCUP ENVIRON HYG	J. Occup. Environ. Hyg.	APR	2015	12	4					D35	D42		10.1080/15459624.2014.989366		8	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CD4OF	WOS:000351062200002		
J	Ishizaka, J				Ishizaka, Joji			Message from the new Editor-in-Chief	JOURNAL OF OCEANOGRAPHY			English	Editorial Material									Nagoya Univ, Hydrospher Atmospher Res Ctr HyARC, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Ishizaka, J (reprint author), Nagoya Univ, Hydrospher Atmospher Res Ctr HyARC, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	jishizak@hyarc.nagoya-u.ac.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					161	161		10.1007/s10872-015-0278-4		1	Oceanography	Oceanography	CE0SE	WOS:000351515200001		
J	Shimanaga, M; Maenaka, A; Misonou, T; Masuda, T; Henmi, Y				Shimanaga, Motohiro; Maenaka, Akiyo; Misonou, Toshiharu; Masuda, Tatsuya; Henmi, Yasuhisa			Spatiotemporal changes in meiofaunal composition on soft substrates in the semi-enclosed inner section of the northern Yatsushiro Sea	JOURNAL OF OCEANOGRAPHY			English	Article						Yatsushiro Sea; Meiofauna; Environmental factors; Spatiotemporal change; Sulfide; Community structure	HARPACTICOID COPEPODS	The Yatsushiro Sea is an inland sea in the southwestern part of Kyushu Island, covering an area of 1,200 km(2), and is partly connected to the Ariake Sea to the north and the east China Sea to the south. The innermost part of the sea is semi-enclosed by the Shiranui reclaimed land, which was created in 1967. Coastal fishery operators in the region have suggested that fish stocks have declined due to the accumulation of 'hedoro' (sludge) on the sea floor, which increased after the land was reclaimed. This project analyzed spatiotemporal changes in the community structure of the meiofauna, which represent ideal organisms for environment assays and in the environmental factors in sediments at four fixed stations around the inner part of the northern Yatsushiro Sea over 3 years (May 2010-February 2013). The results confirm the site of local deposits in the narrow sub tidal section off the Shiranui reclaimed land, where rich organic matter has accumulated and highly sulfidic conditions above the standard criterion value for fisheries were present, along with clear and significant decreases in meiofaunal abundance during the summer. Multivariate analyses, however, did not reveal any strong association between the meiofaunal composition and any environmental factor in sediments, suggesting the organic and sulfidic conditions were not driving the temporal changes in meiofaunal structure in the area. Instead, the meiofaunal changes could be directly related to the low continuous decline in dissolved oxygen and salinity in the water on the sea floor in summer.	[Shimanaga, Motohiro; Maenaka, Akiyo; Henmi, Yasuhisa] Kumamoto Univ, Ctr Marine Environm Studies, Aitsu Marine Stn, Kumamoto 8616102, Japan; [Misonou, Toshiharu; Masuda, Tatsuya] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Kumamoto 8608555, Japan	Shimanaga, M (reprint author), Kumamoto Univ, Ctr Marine Environm Studies, Aitsu Marine Stn, Kumamoto 8616102, Japan.	motohiro@gpo.kumamoto-u.ac.jp			"Enhancing various Academic Research Functions with using Characteristics of University Research" - Ministry of Education, Sports, Culture, Science, and Technology of Japan	We thank Mr. Hideyuki Shimasaki, the captain of the research vessel "Dolphin II", and the students at the Aitsu Marine Station, Kumamoto University, who helped with our sampling. Special thanks to two anonymous reviewers, who kindly checked our manuscript. This study was partly supported by "Enhancing various Academic Research Functions with using Characteristics of University Research" granted by the Ministry of Education, Sports, Culture, Science, and Technology of Japan (represented by Dr. Kiyoshi Takikawa).	Akimoto K, 2006, KAIYO MON, V38, P97; Anderson M.J., 2008, PERMANOVA PRIMER GUI, P214; HICKS GRF, 1983, OCEANOGR MAR BIOL, V21, P67; COULL BC, 1992, OCEANOGR MAR BIOL, V30, P191; De Troch M, 2013, BIOGEOSCIENCES, V10, P4259, DOI 10.5194/bg-10-4259-2013; Clarke KR, 2001, CHANGE MARINE COMMUN, P162; Danovaro R, 2010, METHODS STUDY DEEP S, P428; Giere O, 2009, MEIOBENTHOLOGY MICRO, V2, P527; Henmi Y, 2005, KAIYO MON, V37, P53; Itaoka Mutsumi, 1993, Benthos Research, V45, P19; Japan Fisheries Resource Conservation Association, 2005, SHIS YOUS KIJ; Kumamoto Port and Airport Construction Office Kyusyu Regional Development Bureau Ministry of Land Infrastructure Kumamoto Port and Airport Construction Office Kyusyu Regional Development Bureau Ministry of Land Infrastructure Transport and Tourism, 2012, HEIS 23 NEND KANK SE, P94; Kumamoto Port and Airport Construction Office Kyusyu Regional Development Bureau Ministry of Land Infrastructure Transport and Tourism, 2013, HEIS 24 NEND KANK SE, P123; Ohwada K, 2006, KAIYO MON, V38, P73; Ohwada K, 2005, KAIYO MON, V37, P3; Sato M, 2000, ARIAKEKAI NO IKIMONO, P396; Sougawa Hiroshi, 2008, Japanese Journal of Benthology, V63, P11; Takikawa K, 2005, KAIYO MON, V37, P12; The Committee for recovering tidal flats and other ecosystems in the Marine Coastal area in the Ariake and Yatsushiro Seas, 2006, AR KAI YATS KAI HIG; Transport and Tourism, 2012, HEIS 22 NEND KANK SE, P93; Tsujino Mutsumi, 2008, Japanese Journal of Benthology, V63, P35; Tsujino Mutsumi, 2011, Japanese Journal of Benthology, V65, P90; Tsutsumi Hiroaki, 2006, Plankton & Benthos Research, V1, P3; Tsutsumi H, 2003, ECOLOGY MARINE BENTH, P407; Yoshino Kenji, 2014, Plankton & Benthos Research, V9, P57	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					177	186		10.1007/s10872-015-0274-8		10	Oceanography	Oceanography	CE0SE	WOS:000351515200003		
J	Yoshizawa, E; Shimada, K; Ha, HK; Kim, TW; Kang, SH; Chung, KH				Yoshizawa, Eri; Shimada, Koji; Ha, Ho Kyung; Kim, Tae Wan; Kang, Sung Ho; Chung, Kyung Ho			Delayed responses of the oceanic Beaufort Gyre to winds and sea ice motions: influences on variations of sea ice cover in the Pacific sector of the Arctic Ocean	JOURNAL OF OCEANOGRAPHY			English	Article						Arctic Ocean; Oceanic Beaufort Gyre; Sea ice motion; Sea ice reduction; Pacific Summer Water	VARIABILITY	In the late 2000s, the dominant sea ice type in the Arctic Ocean changed from multi-year ice to first-year ice. In this condition, winter growth of first-year ice and resultant ice thickness at the melt onset are key preconditions on whether sea ice can survive or will disappear during the following summer. The growth rate strongly depends on upper ocean thermal conditions. In the Pacific sector of the Arctic Ocean, the warm Pacific Summer Water, which is a major heat source affecting the sea ice growth, is transported toward the basin by the oceanic Beaufort Gyre, driven by winds and sea ice motions, but the response time scale of the oceanic Beaufort Gyre to surface forcing has been unclear until now. In the present study, we examine the relationship between the ocean dynamic height near the Northwind Ridge as a proxy of the northward volume transport and curls of winds and sea ice velocities, using multiple regression models that evaluate relative contributions of past surface forcing to the current state of the oceanic Beaufort Gyre. As a result, the time scale of the delayed oceanic response in 2006-2012 was estimated to be about 3 years. Taking into account the response time scale, the multiple regression model using the satellite-derived sea ice motion data successfully reconstructed the observed variations of ocean dynamic heights within an accuracy of 0.2 dynamic cm, which corresponded to about 2 % of the amplitude of the observed variations.	[Yoshizawa, Eri; Shimada, Koji] Tokyo Univ Marine Sci & Technol, Grad Sch, Minato Ku, Tokyo 1088477, Japan; [Ha, Ho Kyung] Inha Univ, Dept Ocean Sci, Inchon 402751, South Korea; [Kim, Tae Wan; Kang, Sung Ho; Chung, Kyung Ho] Korea Polar Res Inst, Inchon 406840, South Korea	Yoshizawa, E (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	d122018@kaiyodai.ac.jp	SHIMADA, Koji/O-1913-2014; Yoshizawa, Eri/L-7230-2015		JAXA research projects (IARC-JAXA Information System, GCOM-W); Green Network of Excellence (GRENE) Program; Ministry of Oceans and Fisheries, Korea [PM13020]	This work was supported by JAXA research projects (IARC-JAXA Information System, GCOM-W), and the Green Network of Excellence (GRENE) Program. This research was a part of the project titled "K-PORT (KOPRI, PM13020)", funded by the Ministry of Oceans and Fisheries, Korea. We greatly appreciate the efforts of Takashi Kamoshida in developing the sea ice motion data set. We wish to express our appreciation to Dr. Kohei Mizobata and Dr. Daisuke Hirano for their efforts in carrying out hydrographic observations. We also thank the crews of the IBR/V Araon, the CCGS Louis S. St Laurent and R/V Mirai, and the science parties on board, for their cooperation.	CAVALIERI DJ, 1984, J GEOPHYS RES-ATMOS, V89, P5355, DOI 10.1029/JD089iD04p05355; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fluid.23.1.261; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; Kimura N, 2000, GEOPHYS RES LETT, V27, P3735, DOI 10.1029/2000GL011495; Wu BY, 2006, J CLIMATE, V19, P210, DOI 10.1175/JCLI3619.1; Polyakov IV, 2012, B AM METEOROL SOC, V93, P145, DOI 10.1175/BAMS-D-11-00070.1; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Maslanik J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047735; Proshutinsky A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015847; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Yang JY, 2006, J CLIMATE, V19, P5366, DOI 10.1175/JCLI3892.1; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Markus T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005436; Kwok R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046063; Kwok R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044678; Kamoshida T, 2010, P 2 INT S ARCT RES T, P125; Shimada K, 2001, GEOPHYS RES LETT, V28, P3441, DOI 10.1029/2001GL013168; STEELE M, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/200; Sumata K, 2007, J OCEANOGR, V63, P363; Watanabe E, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028112	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					187	197		10.1007/s10872-015-0276-6		11	Oceanography	Oceanography	CE0SE	WOS:000351515200004		
J	Suzuki, N; Donelan, MA; Komori, S; Takagaki, N				Suzuki, Naoya; Donelan, Mark A.; Komori, Satoru; Takagaki, Naohisa			Estimation of the global air-sea CO2 gas flux considering wave breaking	JOURNAL OF OCEANOGRAPHY			English	Article						Air-sea CO2 gas transfer velocity; Air-sea CO2 gas flux; Air-sea interaction; Wave breaking; Whitecap coverage	WATER-INTERFACE; MASS-TRANSFER; WIND-SPEED; EXCHANGE	We propose a new model with microbreaking and linear dependence on wind speed in the whitecap-free area and linear dependence on the fractional area of whitecaps, based on the whitecap model proposed by Monahan and Spillane (The role of oceanic whitecap in air-sea gas exchange. In: Brutsaert W, Jirka GH (eds) Gas transfer at water surfaces. Reidel, Dordrecht, 495-503, 1984). The relationship between whitecap coverage and wind-sea Reynolds number proposed by Zhao and Toba (J Oceanogr 57:603-616, 2001) provides the link among waves, wind, and whitecap coverage. This model yields a mass transfer velocity that is linear in wind speed at light winds and smoothly transitions with increasing wind to approximately cubic in wind speed and linear in wave age.	[Suzuki, Naoya] Kinki Univ, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Donelan, Mark A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Ocean Sci, Miami, FL 33149 USA; [Komori, Satoru; Takagaki, Naohisa] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan	Suzuki, N (reprint author), Kinki Univ, Fac Sci & Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	nsuzuki@mech.kindai.ac.jp; mdonelan@rsmas.miami.edu; komori@mech.kyoto-u.ac.jp; takagaki@me.kyoto-u.ac.jp					Alaee M, 1995, AIR WATER GAS TRANSF, P617; Zhao D, 2003, TELLUS B, V55, P478, DOI 10.1034/j.1600-0889.2003.00055.x; OCAMPOTORRES FJ, 1994, TELLUS B, V46, P16, DOI 10.1034/j.1600-0889.1994.00002.x; Donelan MA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007787; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; KADER BA, 1972, INT J HEAT MASS TRAN, V15, P2329, DOI 10.1016/0017-9310(72)90131-7; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Edson JB, 2013, J PHYS OCEANOGR, V43, P1589, DOI 10.1175/JPO-D-12-0173.1; JAHNE B, 1987, J GEOPHYS RES-OCEANS, V92, P1937, DOI 10.1029/JC092iC02p01937; Woolf DK, 2005, TELLUS B, V57, P87, DOI 10.1111/j.1600-0889.2005.00139.x; Jeong D, 2012, J ATMOS SCI, V69, P2733, DOI 10.1175/JAS-D-11-0260.1; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; DEACON EL, 1977, TELLUS, V29, P363; Donelan MA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005238; Iwano K, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.21341; Kitaigorodskii SA, 1984, GAS TRANSFER WATER S, P147; Liss SP, 1986, ROLE AIR SEA EXCHANG, P113; Monahan EC, 1984, GAS TRANSFER WATER S, P495; Toba Y, 1986, OCEANIC WHITECAPS, P37; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Weiss R., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Wu J, 1988, J ATMOS OCEAN TECH, V5, P885, DOI 10.1175/1520-0426(1988)005<0885:WSCALW>2.0.CO;2; Zhao D., 2001, J OCEANOGR, V57, P603, DOI DOI 10.1023/A:1021215904955	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					199	204		10.1007/s10872-015-0271-y		6	Oceanography	Oceanography	CE0SE	WOS:000351515200005		
J	Hosoda, K; Kawamura, H; Sakaida, F				Hosoda, Kohtaro; Kawamura, Hiroshi; Sakaida, Futoki			Improvement of New Generation Sea Surface Temperature for Open ocean (NGSST-O): a new sub-sampling method of blending microwave observations	JOURNAL OF OCEANOGRAPHY			English	Article						Sea surface temperature; Remote sensing; Gridded data; Sub-sampling method	WAVE-NUMBER SPECTRA; NORTH PACIFIC; AMSR-E; DIFFERENCE; PROFILES; ENERGY; SSTS	An improved version (version 1.6) of the blended optimum interpolation sea surface temperature (SST), obtained by use of infrared (IR) and microwave (MW) data of the New Generation SST for Open ocean (NGSST-O) product, has been developed. A major improvement is the introduction of a sub-sampling scheme for MW-SST with a finer grid; this has resulted in reduction of the blocky patterning occasionally found in blended SST products with finer grids. Spectral comparison of along-track sea surface height and NGSST-O suggests that mesoscale turbulence was reproduced in the updated NGSST-O in a wide wavelength range.	[Hosoda, Kohtaro; Kawamura, Hiroshi; Sakaida, Futoki] Tohoku Univ, Grad Sch Sci, Ctr Atmospher & Ocean Studies, Aoba Ku, Sendai, Miyagi 9808578, Japan	Hosoda, K (reprint author), Tohoku Univ, Grad Sch Sci, Ctr Atmospher & Ocean Studies, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	hosoda@ocean.caos.tohoku.ac.jp			JAXA [JX-PSPC-400142]	The AMSR-E and MODIS data were provided by the Japan Aerospace Exploration Agency (JAXA) Earth Observation Research Center (EORC). Remote Sensing Systems (RSS) distributed the Windsat data and RSS MW+IR blended SST data set. The IMS (ice mapping system) daily Northern Hemisphere snow and ice analysis was provided by the Nathinal Snow and Ice Data Center (NSIDC). The GTS buoy SST database was maintained by the National Center for Environmental Prediction (NCEP) and the Canadian Marine Environmental Data Service (MEDS). The sea surface height data sets were provided by Archiving, Validation, and Interpretation of Satellite Oceanographic data (AVISO). Two anonymous reviewers and an editor made valuable comments and suggestions for improving the manuscript. The authors would like to express gratitude to members of physical oceanographic and satellite oceanographic groups in Tohoku University for their helpful comments and advice. This research was funded by the JAXA under JX-PSPC-400142.	Fujii Y, 2003, J OCEANOGR, V59, P173, DOI 10.1023/A:1025539104750; Guan L, 2004, J OCEANOGR, V60, P905, DOI 10.1007/s10872-004-5782-x; Wentz FJ, 2000, SCIENCE, V288, P847, DOI 10.1126/science.288.5467.847; BRETHERTON FP, 1976, DEEP-SEA RES, V23, P559, DOI 10.1016/0011-7471(76)90001-2; Wiebe H, 2008, IEEE T GEOSCI REMOTE, V46, P3098, DOI 10.1109/TGRS.2008.919272; Le Traon PY, 2008, J PHYS OCEANOGR, V38, P1137, DOI 10.1175/2007JPO3806.1; Scharffenberg MG, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005242; Reynolds RW, 2010, J CLIMATE, V23, P3545, DOI 10.1175/2010JCLI3294.1; Sasaki H, 2012, J PHYS OCEANOGR, V42, P1233, DOI 10.1175/JPO-D-11-0180.1; CHARNEY JG, 1971, J ATMOS SCI, V28, P1087, DOI 10.1175/1520-0469(1971)028<1087:GT>2.0.CO;2; Kawanishi T, 2003, IEEE T GEOSCI REMOTE, V41, P184, DOI 10.1109/TGRS.2002.808331; Scott RB, 2005, J PHYS OCEANOGR, V35, P1650, DOI 10.1175/JPO2771.1; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Qiu CH, 2012, J OCEANOGR, V68, P417, DOI 10.1007/s10872-012-0106-z; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Cavalieri D, 2003, TECHNICAL REPORT; Emery WJ, 2001, DATA ANAL METHODS PH, P640; Eyre J, 2009, ESA PUBLICATION, V2, DOI [10.5270/OceanObs09.cwp.26, DOI 10.5270/OCEANOBS09.CWP.26]; Gandin LS, 1965, OBJECTIVE ANAL METEO, V242; Gentemann C, 2011, 2 NASA SEA SURF TEMP; Hosoda K, 2013, J OCEANOGR, V69, P631, DOI 10.1007/s10872-013-0194-4; Hosoda K, 2010, J OCEANOGR, V66, P439; Hosoda K, 2011, J OCEANOGR, V67, P135, DOI 10.1007/s10872-011-0007-6; Hosoda K, 2007, J OCEANOGR, V63, P267, DOI 10.1007/s10872-007-0027-4; Hosoda K, 2006, J OCEANOGR, V62, P339, DOI 10.1007/s10872-006-0059-1; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; Imaoka K, 2003, INT GEOSCI REMOTE SE, P666; Japan Aerospace Exploration Agency, 2009, AMSR E DAT US HDB DA; Locarnini R.A., 2010, NOAA ATLAS NESDIS, V68, P184; National Ice Center, 2008, TECHNICAL REPORT; Rogachev KA, 2000, J OCEANOGR, V56, P439, DOI 10.1023/A:1011132507144; Sakaida F, 2009, J OCEANOGR, V65, P859; Sakaida F, 2000, J OCEANOGR, V56, P707, DOI 10.1023/A:1011181918048; Shibata A, 1999, UMI NO KENKYU, V8, P135; Shibata A, 2007, J OCEANOGR, V63, P863, DOI 10.1007/s10872-007-0073-y; Shibata A, 2006, J OCEANOGR, V62, P321, DOI 10.1007/s10872-006-0057-3; Shibata A., 2004, ITALIAN J REMOTE SEN, V30, P131; Xu YS, 2011, J PHYS OCEANOGR, V41, P802, DOI 10.1175/2010JPO4558.1	38	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					205	220		10.1007/s10872-015-0272-x		16	Oceanography	Oceanography	CE0SE	WOS:000351515200006		
J	Abe, K; Tsujino, M; Nakagawa, N; Abo, K				Abe, Kazuo; Tsujino, Mutsumi; Nakagawa, Norihisa; Abo, Katsuyuki			Effect of nutrient release from sea floor on Si:P ratio in the Buzen-Kai, western Seto Inland Sea, in summer	JOURNAL OF OCEANOGRAPHY			English	Article						Nutrient release; Si:P ratio; Stratified condition; Buzen-Kai; Western Seto Inland Sea	JAPAN; SEDIMENT; WATER; ECOSYSTEM; SILICA; FLUXES; OXYGEN; RATES; DAM	The concentrations of silicic acid [Si(OH)(4)] and phosphate (PO4) in the Buzen-Kai (southwestern Seto Inland Sea) increased by a rate of 93:1 from April through July 2013. Using the core incubation method, the Si(OH)(4):PO4 ratio of the release rate and the release amount from the sediment were estimated to be 92:1 and 86:1, which generally agreed with the increased ratio in seawater (93:1). These findings indicate that the Si(OH)(4):PO4 ratio in seawater in the Buzen-Kai is considered to reflect the nutrient release ratio from the sea floor, probably much influenced by the temperature or redox state in summer.	[Abe, Kazuo; Tsujino, Mutsumi; Nakagawa, Norihisa; Abo, Katsuyuki] Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi 7390452, Japan	Abe, K (reprint author), Natl Res Inst Fisheries & Environm Inland Sea, 2-17-5 Maruishi, Hatsukaichi 7390452, Japan.	abek@fra.affrc.go.jp					Abe K, 2014, J OCEANOGR, V70, P267, DOI 10.1007/s10872-014-0229-5; Berelson WM, 2013, CONT SHELF RES, V55, P66, DOI 10.1016/j.csr.2013.01.009; Miyazono A, 2012, HARMFUL ALGAE, V16, P81, DOI 10.1016/j.hal.2012.02.001; FOURNIER RO, 1977, AM MINERAL, V62, P1052; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Zhang L, 2013, ESTUAR COAST SHELF S, V133, P182, DOI 10.1016/j.ecss.2013.08.028; Date E, 2008, B HIROSHIMA PRETECHN, V16, P41; Harashima A, 2005, B COAST OCEANOGR, V43, P39; Hayashi M, 2000, UMI NO KENKYU, V9, P83; Isobe A, 1993, B COAST OCEANOGR, V31, P109; Jin G, 2013, ESTUAR COAST SHELF S, V135, P191, DOI 10.1016/j.ecss.2013.10.009; Kamizono M, 1996, B COASTAL OCEANOGRAP, V33, P179; Kamizono M, 1995, B COAST OCEANOGR, V32, P167; Katayama S, 2002, B FUKUOKA FISH MAR T, V12, P67; Ministry of the Environment Environmental Management Bureau Water Environment Field, 2003, REP NUTR REL FLUX SE, P137; Montani S, 2002, B COAST OCEANOGR, V39, P171; OCHI T, 1986, Journal of the Oceanographical Society of Japan, V42, P1, DOI 10.1007/BF02109187; Sarker MJ, 2005, FISHERIES SCI, V71, P593, DOI 10.1111/j.1444-2906.2005.01003.x; Seiki T, 2008, NIPPON SUISAN GAKK, V74, P678, DOI 10.2331/suisan.74.678; Senjyu T, 2001, J OCEANOGR, V57, P15, DOI 10.1023/A:1011166418573; Srithongouthai S, 2003, MAR POLLUT BULL, V47, P10, DOI 10.1016/S0025-326X(02)00406-X; Suzumura M, 2003, UMI NO KENKYU, V12, P501; Tsukamoto H, 1998, OCEANOGR JPN, V7, P11; Yamamoto Tamiji, 2002, Bulletin of the Japanese Society of Fisheries Oceanography, V66, P102; Yamamoto T, 1998, OCEANOGR JPN, V7, P151	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	APR	2015	71	2					221	227		10.1007/s10872-015-0277-5		7	Oceanography	Oceanography	CE0SE	WOS:000351515200007		
J	Shindo, M; Manaka, T; Shudo, K				Shindo, Masako; Manaka, Tomohiro; Shudo, Ken-ichi			Clusterization modes of Ti on TiO2(110)-1 x 1 due to stablization by catalytic suboxide formation	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Article						TiO2 surface; oxidation; STM; STS	TITANIUM; SILICON; OXIDES; NANOPARTICLES; DIELECTRICS; EPOXIDATION; OVERLAYERS; PROPYLENE; DIOXIDE	The electronic states of individual clusters formed from Ti deposition on a TiO2(1 1 0)-1 x 1 surface were measured using scanning tunneling spectroscopy (STS). The results of scanning tunneling microscopy (STM) suggests that as the amount of deposited Ti increased, at a critical height of 1.4 nm, the cluster growth changes from vertical oxide formation to lateral growth. Based on the STS spectra, the relation between the band-gap and cluster size was revealed. In the first oxide-formation mode, the band gaps decreased smoothly in response to the increase of the cluster size, while a band-gap-free (metallic) phase appears when the clusters are thicker than similar to 1.4 nm. This result indicates that Ti adatoms initially diffuse on the oxide surface and are stabilized by oxygen atoms from the substrate to form a suboxide interfacial layer. This catalytic suboxide formation promotes the vertical granular growth of the deposited Ti atoms.	[Shindo, Masako; Manaka, Tomohiro; Shudo, Ken-ichi] Yokohama Natl Univ, Fac Engn Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Shindo, M (reprint author), Yokohama Natl Univ, Fac Engn Sci, Hodogaya Ku, Tokiwadai 79-5, Yokohama, Kanagawa 2408501, Japan.	ken1@ynu.ac.jp					FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Haruta M, 2001, APPL CATAL A-GEN, V222, P427, DOI 10.1016/S0926-860X(01)00847-X; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; MAYER JT, 1995, J ELECTRON SPECTROSC, V73, P1, DOI 10.1016/0368-2048(94)02258-5; Minato T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082408; Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055; Kadoshima M, 2003, THIN SOLID FILMS, V424, P224, DOI 10.1016/S0040-6090(02)01105-7; SHANNON RD, 1993, J APPL PHYS, V73, P348, DOI 10.1063/1.353856; Visokay MR, 2002, APPL PHYS LETT, V80, P3183, DOI 10.1063/1.1476397; Yoshida S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026802; Hubbard KJ, 1996, J MATER RES, V11, P2757, DOI 10.1557/JMR.1996.0350; Kingon AI, 2000, NATURE, V406, P1032, DOI 10.1038/35023243; Seo M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3605527; Tien TC, 2012, THIN SOLID FILMS, V520, P1745, DOI 10.1016/j.tsf.2011.08.057; Batzill M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.235401; Panda D, 2013, THIN SOLID FILMS, V531, P1, DOI 10.1016/j.tsf.2013.01.004; Houssa M, 2006, MAT SCI ENG R, V51, P37, DOI 10.1016/j.mser.2006.04.001; Hayashi T, 1998, J CATAL, V178, P566, DOI 10.1006/jcat.1998.2157; Biswas A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/19/195601; Iida T, 2007, SURF SCI, V601, P4444, DOI 10.1016/j.susc.2007.04.214; Kiyota Y, 2010, ECS TRANSACTIONS, V33, P339, DOI 10.1149/1.3481622; Ogawa S, 2007, JPN J APPL PHYS 1, V46, P3244, DOI 10.1143/JJAP.46.3244; Ohno S, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/30/305001; Rathee D, 2011, WORLD J NANOSCIENCE, V1, P84; ROCKER G, 1987, SURF SCI, V181, P530, DOI 10.1016/0039-6028(87)90204-4; Shindo M, 2015, J PHYS CHEM C UNPUB; Sinha AK, 2003, APPL CATAL A-GEN, V240, P243, DOI 10.1016/S0926-860X(02)00451-9	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-8984	1361-648X		J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	APR 1	2015	27	12							122001	10.1088/0953-8984/27/12/122001		5	Physics, Condensed Matter	Physics	CD7TG	WOS:000351294700001		
J	Lawrence, J; Yamashita, K; Yamaguchi, T				Lawrence, Jimmy; Yamashita, Koichi; Yamaguchi, Takeo			Correlating electronic structure and chemical durability of sulfonated poly(arylene ether sulfone)s	JOURNAL OF POWER SOURCES			English	Article						Polymer electrolyte membrane; Accelerated test; Electronic structure; Molecular orbital; Degradation mechanism; Fuel cell	PROTON-EXCHANGE MEMBRANES; FUEL-CELL APPLICATIONS; POLYMER ELECTROLYTE; DEGRADATION MITIGATION; MECHANISMS; SPECTROSCOPY; TEMPERATURE; COPOLYMERS; KETONES; PEMFCS	Many different proton-conducting polymeric materials have been developed for polymer electrolyte membrane fuel cells (PEMFCs). The development of perfluorosulfonic acid-based, polymer electrolyte membranes (PFSA-PEMs) was followed by aromatic hydrocarbon-based PEMs (HC-PEMs), which allow for tailored design and optimization of their molecular structures. Although many new PFSA-PEMs and HC-PEMs have shown promising proton conductivity and thermal stability, chemical degradation of these materials in an oxidizing environment remains a significant technical barrier in PEMFC development. Here, we used accelerated degradation tests and electronic structure analysis to examine the chemical stability of sulfonated poly(arylene ether sulfone) (SPES) copolymers, a highly thermally stable HC-PEM. HOMO levels, the presence of main chain-protecting steric groups, and HOMO LUMO location along the main chain have significant effects on the chain scission modes and degradation rate of SPES copolymers. Rational design of HC-PEMs to suppress midpoint scission can open many opportunities in the development of highly robust polymer electrolytes for fuel cell and other energy storage applications. (C) 2015 Elsevier B.V. All rights reserved.	[Lawrence, Jimmy; Yamashita, Koichi; Yamaguchi, Takeo] Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138656, Japan; [Lawrence, Jimmy] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01375 USA; [Yamaguchi, Takeo] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Yamaguchi, T (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, R1-17,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yamag@reslitech.ac.jp	Yamaguchi, Takeo/H-1607-2011; LAWRENCE, JIMMY/G-4181-2010	Yamaguchi, Takeo/0000-0001-9043-4408; LAWRENCE, JIMMY/0000-0003-4455-6177	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), Japan; New Energy and Industrial Technology Development Organization, Japan; Kanagawa Academy of Science and Technology, Japan	The authors thank the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), Japan, the New Energy and Industrial Technology Development Organization, Japan, and the Kanagawa Academy of Science and Technology, Japan, for their support of this research.	Pozio A, 2003, ELECTROCHIM ACTA, V48, P1543, DOI 10.1016/S0013-4686(03)00026-4; Kerres J, 2004, FUEL CELLS, V4, P105, DOI 10.1002/fuce.200400013; Collier A, 2006, INT J HYDROGEN ENERG, V31, P1838, DOI 10.1016/j.ijhydene.2006.05.006; Cheng ZY, 2002, BIOORGAN MED CHEM, V10, P4067, DOI 10.1016/S0968-0896(02)00267-5; Kim YS, 2003, MACROMOLECULES, V36, P6281, DOI 10.1021/ma0301451; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Lawrence J, 2008, J MEMBRANE SCI, V325, P633, DOI 10.1016/j.memsci.2008.08.027; Kim YS, 2006, POLYMER, V47, P4026, DOI 10.1016/j.polymer.2006.02.032; Kim DS, 2009, MACROMOLECULES, V42, P957, DOI 10.1021/ma802192y; Wu JF, 2008, J POWER SOURCES, V184, P104, DOI 10.1016/j.jpowsour.2008.06.006; Harrison WL, 2003, J POLYM SCI POL CHEM, V41, P2264, DOI 10.1002/pola.10755; Paddison SJ, 2003, ANNU REV MATER RES, V33, P289, DOI 10.1146/annurev.matsci.33.022702.155102; Yang SJ, 2004, SYNTHETIC MET, V141, P171, DOI 10.1016/j.synthmet.2003.08.019; Miyatake K, 2003, CHEM COMMUN, P368, DOI 10.1039/b210296j; Endoh E, 2004, ELECTROCHEM SOLID ST, V7, pA209, DOI 10.1149/1.1739314; Chandan A, 2013, J POWER SOURCES, V231, P264, DOI 10.1016/j.jpowsour.2012.11.126; Miyatake K, 2012, J POWER SOURCES, V204, P74, DOI 10.1016/j.jpowsour.2011.12.039; Stewart JJP, 2004, J MOL MODEL, V10, P155, DOI 10.1007/s00894-004-0183-z; Zhang HW, 2012, CHEM REV, V112, P2780, DOI 10.1021/cr200035s; RAGHAVAN NV, 1980, J AM CHEM SOC, V102, P3495, DOI 10.1021/ja00530a031; LEE J, 1984, J POLYM SCI POL CHEM, V22, P295, DOI 10.1002/pol.1984.170220202; Schuster M, 2007, MACROMOLECULES, V40, P598, DOI 10.1021/ma062324z; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Wang Y, 2011, APPL ENERG, V88, P981, DOI 10.1016/j.apenergy.2010.09.030; Mattsson B, 2000, ELECTROCHIM ACTA, V45, P1405, DOI 10.1016/S0013-4686(99)00351-5; Prabhakaran V, 2012, P NATL ACAD SCI USA, V109, P1029, DOI 10.1073/pnas.1114672109; SCHERER GG, 1990, BER BUNSEN PHYS CHEM, V94, P1008; Park CH, 2011, PROG POLYM SCI, V36, P1443, DOI 10.1016/j.progpolymsci.2011.06.001; Aoki M, 2006, ELECTROCHEM COMMUN, V8, P1412, DOI 10.1016/j.elecom.2006.06.028; FUKUI K, 1952, J CHEM PHYS, V20, P722, DOI 10.1063/1.1700523; Gross M., 2010, HDB FUEL CELLS, P1; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709; HOWARD EG, 1967, J AM CHEM SOC, V89, P1422, DOI 10.1021/ja00982a026; Liu H., 2006, ECS T, V1, P283, DOI 10.1149/1.2214561; Marusawa H, 2002, BIOORGAN MED CHEM, V10, P2283, DOI 10.1016/S0968-0896(02)00048-2; Miyatake K, 2003, MACROMOLECULES, V36, P9691, DOI 10.1021/ma035452l; Okada T, 1999, J ELECTROANAL CHEM, V465, P1, DOI 10.1016/S0022-0728(99)00065-0; Parra S, 2002, APPL CATAL B-ENVIRON, V36, P75, DOI 10.1016/S0926-3373(01)00283-1; Roduner E., 2006, ADV ESR METHODS POLY, P197, DOI 10.1002/047005350X.ch8; Trogadas P, 2008, ELECTROCHEM SOLID ST, V11, pB113, DOI 10.1149/1.2916443; U.S. Department of Energy (U.S. DOE), FUEL CELL TECHN OFF; Yu J., 2002, PHYS CHEM CHEM PHYS, V5, P611	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						48	54		10.1016/j.jpowsour.2014.12.155		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600002		
J	Fujii, K; Ito, M; Sato, Y; Takenaka, S; Kishida, M				Fujii, Keitaro; Ito, Mizuki; Sato, Yasushi; Takenaka, Sakae; Kishida, Masahiro			Performance and durability of carbon black-supported Pd catalyst covered with silica layers in membrane-electrode assemblies of proton exchange membrane fuel cells	JOURNAL OF POWER SOURCES			English	Article						Proton exchange membrane fuel cells; Non-Pt electrocatalyst; Durability; Silica-coating; Oxygen reduction reaction; Palladium	OXYGEN REDUCTION REACTION; POROUS SILICA; PERFLUORINATED IONOMER; ENERGY-CONVERSION; PORE STRUCTURE; GEL; CONDUCTION; DIFFUSION; GLASSES; SIO2	Pd metal particles supported on a high surface area carbon black (Pd/CB) were covered with silica layers to improve the durability under severe cathode condition of proton exchange membrane fuel cells (PEMFCs). The performance and the durability of the silica-coated Pd/CB (SiO2/Pd/CB) were investigated by rotating disk electrode (RDE) in aqueous HClO4 and single cell test of the membrane-electrode assemblies (MEAs). SiO2/Pd/CB showed excellent durability exceeding Pt/CB during potential cycle in single cell test as well as in RDE measurement while Pd/CB significantly degraded. Furthermore, the MEA using SiO2/Pd/CB as the cathode catalyst showed higher performance than that using Pd/CB even in the initial state. The catalytic activity of SiO2/Pd/CB was higher than that of Pd/CB, and the drop of the cell performances due to the inhibition of electron conduction, proton conduction, and oxygen diffusion by the silica layer was not significant. It has been shown that the silica-coating is a very practical technique that can stabilize metal species originally unstable in the cathode condition of PEMFCs without a decrease in the cell performance. (C) 2015 Elsevier B.V. All rights reserved.	[Fujii, Keitaro; Ito, Mizuki; Sato, Yasushi] JX Nippon Oil & Energy Co, Cent Tech Res Lab, Naka Ku, Yokohama, Kanagawa 2310815, Japan; [Takenaka, Sakae; Kishida, Masahiro] Kyushu Univ, Grad Sch Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan	Fujii, K (reprint author), JX Nippon Oil & Energy Co, Cent Tech Res Lab, Naka Ku, Chidoricho 8, Yokohama, Kanagawa 2310815, Japan.	keitaro.fujii@noe.jx-group.co.jp; mizuki.ito@noe.jx-group.co.jp; yasushi.satou@noe.jx-group.co.jp; takenaka@chem-eng.kyushu-u.ac.jp; kishida@chem-eng.kyushu-u.ac.jp					Cheng NC, 2010, J POWER SOURCES, V195, P7246, DOI 10.1016/j.jpowsour.2010.05.039; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Daiko Y, 2002, CHEM MATER, V14, P4624, DOI 10.1021/cm020323p; JASINSKI R, 1964, NATURE, V201, P1212, DOI 10.1038/2011212a0; Ohma A, 2010, ELECTROCHIM ACTA, V55, P8829, DOI 10.1016/j.electacta.2010.08.005; Kinumoto T, 2006, J POWER SOURCES, V158, P1222, DOI 10.1016/j.jpowsour.2005.10.043; MIKKELSEN JC, 1984, APPL PHYS LETT, V45, P1187, DOI 10.1063/1.95086; Grden M, 2008, ELECTROCHIM ACTA, V53, P7583, DOI 10.1016/j.electacta.2008.05.046; Takenaka S, 2010, CHEM COMMUN, V46, P8950, DOI 10.1039/c0cc04055j; Higuchi E, 2005, J ELECTROANAL CHEM, V583, P69, DOI 10.1016/j.jelechem.2005.01.041; Ohgi Y, 2012, ELECTROCHIM ACTA, V68, P192, DOI 10.1016/j.electacta.2012.02.059; Okada T, 2001, J PHYS CHEM B, V105, P6980, DOI 10.1021/jp010822y; Omura J, 2011, LANGMUIR, V27, P6464, DOI 10.1021/la200694a; VANTE NA, 1986, NATURE, V323, P431, DOI 10.1038/323431a0; Kajihara K, 2008, J NON-CRYST SOLIDS, V354, P224, DOI 10.1016/j.jnoncrysol.2007.07.038; Jiang L, 2009, J ELECTROCHEM SOC, V156, pB643, DOI 10.1149/1.3098478; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Kunimatsu K, 2006, J ELECTROANAL CHEM, V587, P299, DOI 10.1016/j.jelechem.2005.11.026; Zhang L, 2006, J POWER SOURCES, V156, P171, DOI 10.1016/j.jpowsour.2005.05.069; Cooper KR, 2006, J POWER SOURCES, V160, P1088, DOI 10.1016/j.jpowsour.2006.02.086; Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020; Lee J, 2013, CURR APPL PHYS, V13, P309, DOI 10.1016/j.cap.2012.08.008; Colomer MT, 2001, J NON-CRYST SOLIDS, V290, P93, DOI 10.1016/S0022-3093(01)00815-8; Daiko Y, 2004, MICROPOR MESOPOR MAT, V69, P149, DOI 10.1016/j.micromeso.2004.02.005; Garcia-Rodriguez FJ, 1999, SOLID STATE COMMUN, V111, P717, DOI 10.1016/S0038-1098(99)00237-9; Guilminot E., 2007, J ELECTROCHEM SOC, V154, P896; Kajihara K, 2007, J NON-CRYST SOLIDS, V353, P514, DOI [10.1016/j.jnoncrysol.2006.10.038, 10.1016/j.noncrysol.2006.10.038]; Li HB, 2006, MICROPOR MESOPOR MAT, V97, P42, DOI 10.1016/j.micromeso.2006.08.001; Liu RL, 2010, ANGEW CHEM, V122, P2619, DOI DOI 10.1002/ANGE.200907289; MEADOWCR.DB, 1970, NATURE, V226, P847, DOI 10.1038/226847a0; Nam KD, 2010, ELECTROCHIM ACTA, V55, P7290, DOI 10.1016/j.electacta.2010.07.048; Nogami M, 1998, J PHYS CHEM B, V102, P5772, DOI 10.1021/jp981059j; SATOH S, 1995, J NON-CRYST SOLIDS, V190, P206, DOI 10.1016/0022-3093(95)00275-8; Takako T., 1999, J ELECTROCHEMICAL SO, V146, P3750; Takenaka S, 2011, J CATAL, V279, P381, DOI 10.1016/j.jcat.2011.02.008	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						100	106		10.1016/j.jpowsour.2014.12.144		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600009		
J	Aydin, O; Koshiyama, T; Nakajima, H; Kitahara, T				Aydin, Ozgur; Koshiyama, Takahiro; Nakajima, Hironori; Kitahara, Tatsumi			In-situ diagnosis and assessment of longitudinal current variation by electrode-segmentation method in anode-supported microtubular solid oxide fuel cells	JOURNAL OF POWER SOURCES			English	Article						In-situ; Segmentation; Current; Variation; Microtubular; SOFC	TUBULAR SOFC; PERFORMANCE; TRANSPORT; STACKS	Electrochemical performance of Solid Oxide Fuel Cells (SOFC) is highly dependent on the spatial distribution of the reactant and product species. The structure degradation processes are also associated with the spatial quantities. In fact, spatially measured current variations provide profound information about the local processes. Due to the geometry of microtubular SOFCs (mt-SOFC), notable current variations can develop along the cells and cause temperature variations. By applying the electrode-segmentation method, the longitudinal current variation is thus experimentally investigated in an anode-supported mt-SOFC for various cell voltage and fuel flow rates. As a result, a remarkable current variation is shown among the segments for various flow rates. The current of the downstream segment rapidly decreases with the declining cell voltage implying the fuel starvation while the other segments continue to increase their currents. The conventional polarization curve drawn for the whole cell overlaps with the midstream polarization curve, considerably differing from the other segments. The higher N-2 flow rate with the identical H-2 flow enhances the overall performance. In comparison with the estimated practical power generation capacity of the whole cell, a notable performance-loss is found due to the inhomogeneity. (C) 2015 Elsevier B.V. All rights reserved.	[Aydin, Ozgur] Kyushu Univ, Int Res Ctr Hydrogen Energy, Nishi Ku, Fukuoka 8190395, Japan; [Aydin, Ozgur; Koshiyama, Takahiro] Kyushu Univ, Grad Sch Engn, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan; [Nakajima, Hironori; Kitahara, Tatsumi] Kyushu Univ, Fac Engn, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nakajima, Hironori; Kitahara, Tatsumi] Kyushu Univ, I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Nakajima, H (reprint author), Kyushu Univ, Fac Engn, Dept Mech Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nakajima@mech.kyushu-u.ac.jp		Nakajima, Hironori/0000-0003-2335-4226	JSPS (Japanese Society for Promotion of Science) [25820064]	The authors acknowledge the contributions of graduate students, K. Kiyama, K. Ueyama and A. Shimizu to the development of the experimental setup through the valuable discussions with Profs. K. Ito and K. Sasaki for the longitudinal characterization of mt-SOFCs in Fuel Cell Systems Laboratory at Kyushu University. The authors also declare their gratitude to the JSPS (Japanese Society for Promotion of Science) for Grant-in-Aid for Young Scientists (B) 25820064.	Zamel N, 2013, FUEL CELLS, V13, P910, DOI 10.1002/fuce.201200223; Campanari S, 2004, J POWER SOURCES, V132, P113, DOI 10.1016/j.jpowsour.2004.01.043; Nishino T, 2006, J FUEL CELL SCI TECH, V3, P33, DOI 10.1115/1.2133804; Suzuki M, 2008, J POWER SOURCES, V180, P29, DOI 10.1016/j.jpowsour.2008.02.039; Costamagna P, 1998, J ELECTROCHEM SOC, V145, P3995, DOI 10.1149/1.1838904; Howe KS, 2011, J POWER SOURCES, V196, P1677, DOI 10.1016/j.jpowsour.2010.09.043; Andersson M, 2013, ELECTROCHIM ACTA, V109, P881, DOI 10.1016/j.electacta.2013.08.018; Morita H, 2002, J POWER SOURCES, V112, P509, DOI 10.1016/S0378-7753(02)00468-8; Bessler WG, 2010, FUEL CELLS, V10, P411, DOI 10.1002/fuce.200900083; Faes Antonin, 2012, Membranes (Basel), V2, P585, DOI 10.3390/membranes2030585; Hanasaki M, 2014, J ELECTROCHEM SOC, V161, pF850, DOI 10.1149/2.0421409jes; Hemmes K., 2004, MODERN ASPECTS ELECT, V37; KANAMURA K, 1991, B CHEM SOC JPN, V64, P1828, DOI 10.1246/bcsj.64.1828; Lockett M, 2004, J POWER SOURCES, V131, P243, DOI 10.1016/j.jpowsour.2003.11.082; Nakajima H, 2009, ECS TRANSACTIONS, V25, P359, DOI 10.1149/1.3205544; Nakajima H., 2011, MASS TRANSFER ADV AS, P285; Shimizu A, 2013, ECS TRANSACTIONS, V57, P727, DOI 10.1149/05701.0727ecst; Yamamoto O, 2000, ELECTROCHIM ACTA, V45, P2423, DOI 10.1016/S0013-4686(00)00330-3	18	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						218	223		10.1016/j.jpowsour.2014.12.156		6	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600024		
J	Lim, J; Lee, S; Suzuki, K; Kim, K; Kim, S; Taminato, S; Hirayama, M; Oshima, Y; Takayanagi, K; Kanno, R				Lim, Jaemin; Lee, Soyeon; Suzuki, Kota; Kim, KyungSu; Kim, Sangryun; Taminato, Sou; Hirayama, Masaaki; Oshima, Yoshifumi; Takayanagi, Kunio; Kanno, Ryoji			Synthesis, structure and electrochemical properties of novel Li-Co-Mn-O epitaxial thin-film electrode using layer-by-layer deposition process	JOURNAL OF POWER SOURCES			English	Article						Epitaxial thin film; Lithium battery; Layer-by-layer deposition; Pulsed laser deposition	RECHARGEABLE LITHIUM BATTERIES; SOLID-STATE BATTERY; FABRICATION; INTERFACE; ORIENTATION; MULTILAYER; LICOMNO4; SPINEL	A novel epitaxial thin-film electrode for lithium batteries, with a composition of Li0.92Co0.65Mn1.35O4 and a cubic spinel structure, is fabricated on a SrTiO3(111) single-crystal substrate. Fabrication is carried out by layer-by-layer pulsed laser deposition of LiCoO2 with a layered rock-salt structure and LiMn2O4 with a spinel structure. The electrode is found to exhibit unique disordering of the lithium (8a) and transition-metal (16d) sites, leading to a higher rate capability and cycle retention ratio than those for a thin-film electrode with the same composition prepared by a conventional single-step deposition process. The proposed layer-by-layer deposition method allows an expanded range of compositional and structural variations for lithium battery electrode materials. (C) 2015 Published by Elsevier B.V.	[Lim, Jaemin; Suzuki, Kota; Kim, KyungSu; Kim, Sangryun; Taminato, Sou; Hirayama, Masaaki; Kanno, Ryoji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Lee, Soyeon] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 1528551, Japan; [Lee, Soyeon; Oshima, Yoshifumi; Takayanagi, Kunio] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Oshima, Yoshifumi] Japan Adv Inst Sci & Technol, Sch Mat Sci 1, Nomi, Ishikawa 9231292, Japan; [Takayanagi, Kunio] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan	Kanno, R (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	kanno@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [25106009, 25248051]	Sample preparation for STEM observation was supported by the NIMS microstructural characterization platform as a program of "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The synchrotron radiation experiments were performed as projects approved by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2014A1801). This study was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Exploration of nanostructure-property relationships for materials innovation" (No. 25106009) and Grant-in-Aid for scientific Research (A) (No. 25248051) from the Japan Society for the Promotion of Science.	Zheng YM, 2012, J POWER SOURCES, V208, P447, DOI 10.1016/j.jpowsour.2012.02.044; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; Tang DC, 2014, CHEM MATER, V26, P3535, DOI 10.1021/cm501125e; Koksbang R, 1996, SOLID STATE IONICS, V84, P1, DOI 10.1016/S0167-2738(96)83001-3; Sata N, 2000, NATURE, V408, P946, DOI 10.1038/35050047; Kawai H, 1998, ELECTROCHEM SOLID ST, V1, P212; Sakamoto K, 2010, PHYS CHEM CHEM PHYS, V12, P3815, DOI 10.1039/b920271d; Takahashi K, 2014, SOLID STATE IONICS, V262, P179, DOI 10.1016/j.ssi.2013.10.028; Sawada H, 2009, J ELECTRON MICROSC, V58, P357, DOI 10.1093/jmicro/dfp030; Shiraki S, 2014, J POWER SOURCES, V267, P881, DOI 10.1016/j.jpowsour.2014.05.133; Shigemura H, 2002, J MATER CHEM, V12, P1882, DOI 10.1039/b200690c; Yamamoto K, 2010, ANGEW CHEM INT EDIT, V49, P4414, DOI 10.1002/anie.200907319; Goodenough JB, 2013, ACCOUNTS CHEM RES, V46, P1053, DOI 10.1021/ar2002705; Chung SY, 2009, ANGEW CHEM INT EDIT, V48, P543, DOI 10.1002/anie.200803520; Mangalam RVK, 2013, ADV MATER, V25, P1761, DOI 10.1002/adma.201204240; Suzuki K, 2013, J POWER SOURCES, V226, P340, DOI 10.1016/j.jpowsour.2012.11.008; Meducin F, 2004, AM MINERAL, V89, P981; Kato T, 2014, J POWER SOURCES, V260, P292, DOI 10.1016/j.jpowsour.2014.02.102; Bhardwaj C, 2012, MATER LETT, V87, P172, DOI 10.1016/j.matlet.2012.07.102; Yu XH, 1997, J ELECTROCHEM SOC, V144, P524, DOI 10.1149/1.1837443; Melot BC, 2013, ACCOUNTS CHEM RES, V46, P1226, DOI 10.1021/ar300088q; Kim K, 2012, ELECTROCHEMISTRY, V80, P800, DOI 10.5796/electrochemistry.80.800; Hirayama M, 2007, J ELECTROCHEM SOC, V154, pA1065, DOI 10.1149/1.2778853; Hirayama M, 2010, J AM CHEM SOC, V132, P15268, DOI 10.1021/ja105389t; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; BATES JB, 1995, J POWER SOURCES, V54, P58, DOI 10.1016/0378-7753(94)02040-A; Mishra R, 2014, NANO LETT, V14, P2694, DOI 10.1021/nl500601d; Bates JB, 2000, J ELECTROCHEM SOC, V147, P59, DOI 10.1149/1.1393157; Mercey B, 1999, J MATER CHEM, V9, P233, DOI 10.1039/a804929g; Chen B. B., 2014, APPL PHYS LETT, V104; Das S., 2014, J APPL PHYS, V115; Gupta A, 1997, CURR OPIN SOLID ST M, V2, P23, DOI 10.1016/S1359-0286(97)80101-5; Huang R, 2012, MATER CHEM PHYS, V133, P1101, DOI 10.1016/j.matchemphys.2012.02.022; Kuwata N, 2014, SOLID STATE IONICS, V262, P165, DOI 10.1016/j.ssi.2013.09.054; Norton DP, 1996, MAT SCI ENG B-SOLID, V41, P374, DOI 10.1016/S0921-5107(96)01891-0; JESSON DE, 1993, P ROY SOC LOND A MAT, V441, P261, DOI 10.1098/rspa.1993.0060; Yonemura M, 2004, MATER TRANS, V45, P2048, DOI 10.2320/matertrans.45.2048	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						502	509		10.1016/j.jpowsour.2014.12.152		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600056		
J	Tabuchi, M; Kitta, M; Kageyama, H; Shibuya, H; Imaizumi, J				Tabuchi, Mitsuharu; Kitta, Mitsunori; Kageyama, Hiroyuki; Shibuya, Hideka; Imaizumi, Junichi			Mn source effects on electrochemical properties of Fe -and Ni-substituted Li2MnO3 positive electrode material	JOURNAL OF POWER SOURCES			English	Article						Lithium-ion battery; Cathode material; Analytical TEM; Full-cell performance	HIGH-CAPACITY; ION BATTERIES; REDUCTION; CATHODES; BEHAVIOR	This study examined Mn source effects on the electrochemical properties of Fe-substituted and Ni-substituted Li2MnO3 (Li1+x(Fe0.2Ni0.2Mn0.6)(1-x)O-2, 0 < x < 1/3). Manganese sources of two kinds were selected: MnCl2 center dot 4H(2)O and KMnO4. Given the same preparation conditions, the chemical composition, transition metal distribution, and electrochemical properties of the two samples were compared. The sample obtained from KMnO4 exhibited better electrochemical performance, except for high-rate discharge characteristics, than that obtained from MnCl2. The origin of the different electrochemical performance was discussed to ascertain the unknown factor responsible for it. The full-cell performance was assessed using a single-layer laminate cell and mesocarbon microbead (MCMB) anode. (C) 2015 Elsevier B.V. All rights reserved.	[Tabuchi, Mitsuharu; Kitta, Mitsunori; Kageyama, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Shibuya, Hideka; Imaizumi, Junichi] Tanaka Chem Corp, Fukui 9103131, Japan	Tabuchi, M (reprint author), Natl Inst Adv Ind Sci & Technol, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-tabuchi@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was financially supported by the New Energy and Industrial Technology Development Organization (NEDO) as a national project named "Li-ion and Excellent Advanced Battery Development" and "Advanced Technology Development Project for Lithium-ion Battery Application."	Abouimrane A, 2011, ELECTROCHEM SOLID ST, V14, pA126, DOI 10.1149/1.3597655; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Tabuchi M, 2013, J POWER SOURCES, V221, P427, DOI 10.1016/j.jpowsour.2012.08.055; Jiang M, 2009, CHEM MATER, V21, P2733, DOI 10.1021/cm900279u; West WC, 2011, J ELECTROCHEM SOC, V158, pA883, DOI 10.1149/1.3597319; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA778, DOI 10.1149/1.1471541; STROBEL P, 1988, J SOLID STATE CHEM, V75, P90, DOI 10.1016/0022-4596(88)90305-2; Wu Y, 2006, ELECTROCHEM SOLID ST, V9, pA221, DOI 10.1149/1.2180528; Thackeray MM, 2007, J MATER CHEM, V17, P3112, DOI 10.1039/b702425h; Yu DYW, 2009, J ELECTROCHEM SOC, V156, pA417, DOI 10.1149/1.3110803; Johnson CS, 2008, CHEM MATER, V20, P6095, DOI 10.1021/cm801245r; Robertson AD, 2003, CHEM MATER, V15, P1984, DOI 10.1021/cm030047u; Tabuchi M, 2011, J POWER SOURCES, V196, P3611, DOI 10.1016/j.jpowsour.2010.12.060; Fell CR, 2010, J ELECTROCHEM SOC, V157, pA1202, DOI 10.1149/1.3473830; Izumi F, 2000, MATER SCI FORUM, V321-3, P198; Kikkawa J., 2007, APPL PHYS LETT, V91; Kikkawa J, 2008, ELECTROCHEM SOLID ST, V11, pA183, DOI 10.1149/1.2968956; Smit J., 1965, FERRITES; Tabuchi M, 2010, J POWER SOURCES, V195, P834, DOI 10.1016/j.jpowsour.2009.08.059	19	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						510	516		10.1016/j.jpowsour.2015.01.045		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600057		
J	Utaka, Y; Okabe, A; Omori, Y				Utaka, Yoshio; Okabe, Akira; Omori, Yasuyuki			Proposal and examination of method of water removal from gas diffusion layer by applying slanted microgrooves inside gas channel in separator to improve polymer electrolyte fuel cell performance	JOURNAL OF POWER SOURCES			English	Article						Polymer electrolyte fuel cell; Separator; Gas channel; Water management; Slanted microgrooves; LIF method	OXYGEN DIFFUSIVITY; MICROPOROUS MEDIA; WETTABILITY; MOISTURE	The objective of this study was to improve the management of moisture from the gas diffusion layer (GDL) in the gas channel of a separator for PEFC. At the cathode-side, oxygen is transported as reactant gas from gas channel through GDL. When large quantity of moisture is generated during high power generation, moisture blocks transport of oxygen, and the cell voltage drops drastically. Narrow microgrooves with axes at tilt angle to the air flow were arranged inside channel walls. The water from GDL was discharged along microgrooves to facing top of GDL by forces of capillary and air flow shearing. Laser induced fluorescence method was used to measure water velocity in microgrooves. The effect of air velocity in the gas channel on water velocity in microgrooves was investigated. It was shown microgrooves manufactured inside gas channel worked properly. Water velocity in microgrooves increased with increasing air velocity, and moisture could be discharged from GDL by applying microgrooves. Furthermore, effective length of the microgrooves needed to remove water from the GDL surface increased with decreasing inclination angle of microgrooves in the range of 20 degrees-45 degrees. An effective length of approximately 200 mm was attained, which was overall length of experimental apparatus. (C) 2015 Elsevier B.V. All rights reserved.	[Utaka, Yoshio] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Okabe, Akira] Suzuki Motor Co, Minami Ku, Hamamatsu, Shizuoka 4328611, Japan; [Omori, Yasuyuki] Toyota Motor Co, Toyota, Aichi 4718571, Japan	Utaka, Y (reprint author), Yokohama Natl Univ, Fac Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	utaka@ynu.ac.jp			Japan Society for the Promotion of Science (JSPS) [20360096]; Strategic International Collaborative Research Program of the Japan Science and Technology Agency (JST)	This work was supported in part by a Grant-in-Aid for Scientific Research [(B) 20360096] from the Japan Society for the Promotion of Science (JSPS) and the Strategic International Collaborative Research Program of the Japan Science and Technology Agency (JST). The authors would like to thank Professor Yasushi Yokoyama at Yokohama National University for his valuable instruction on the synthesis of photochromic dye.	Zhang FY, 2006, J ELECTROCHEM SOC, V153, pA225, DOI 10.1149/1.2138675; Kruger P, 2011, J POWER SOURCES, V196, P5250, DOI 10.1016/j.jpowsour.2010.09.042; Maeda S, 1999, T APPL CHEM, V1, P85; Utaka Y, 2011, INT J HYDROGEN ENERG, V36, P9128, DOI 10.1016/j.ijhydene.2011.04.152; Koresawa R, 2014, J POWER SOURCES, V271, P16, DOI 10.1016/j.jpowsour.2014.05.151; Palan V, 2006, J POWER SOURCES, V161, P1116, DOI 10.1016/j.jpowsour.2006.06.021; Konomi T., 2008, T JPN SOC MECH ENG-B, V74, P11; Konomi T., 2008, T JPN SOC MECH ENG-B, V74, P3; Koresawa R, 2014, INT J HEAT MASS TRAN, V76, P549, DOI 10.1016/j.ijheatmasstransfer.2014.05.005; Kumbur E.C., 2006, J POWER SOURCES, V161, P245; Tanigawa H., 2009, T JPN SOC MECH ENG-B, V75, P192; Tanigawa H., 2009, T JPN SOC MECH ENG-B, V75, P186; Turuhan A., 2010, ELECTROCHIM ACTA, V55, P2734; Utaka Y, 2009, INT J HEAT MASS TRAN, V52, P3685, DOI 10.1016/j.ijheatmasstransfer.2009.02.032; Wood DL, 1998, ELECTROCHIM ACTA, V43, P3795, DOI 10.1016/S0013-4686(98)00139-X	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						533	539		10.1016/j.jpowsour.2015.01.050		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600061		
J	Matsui, Y; Yamagata, M; Murakami, S; Saito, Y; Higashizaki, T; Ishiko, E; Kono, M; Ishikawa, M				Matsui, Yukiko; Yamagata, Masaki; Murakami, Satoshi; Saito, Yasuteru; Higashizaki, Tetsuya; Ishiko, Eriko; Kono, Michiyuki; Ishikawa, Masashi			Design of an electrolyte composition for stable and rapid charging discharging of a graphite negative electrode in a bis(fluorosulfonyl)imide-based ionic liquid	JOURNAL OF POWER SOURCES			English	Article						Lithium-ion battery; Ionic liquids; Bis(fluorosulfonyl)imide; Graphite negative electrode	LITHIUM SALT ELECTROLYTES; THICK-FILM ANODES; ROOM-TEMPERATURE; SUPERCONCENTRATED ELECTROLYTES; POLYMER ELECTROLYTES; LOW-VISCOSITY; BATTERIES; INTERCALATION; STABILITY; FUTURE	We evaluate the effects of lithium salt on the charge-discharge performance of a graphite negative electrode in 1-ethyl-3-methylimidazolium bis(fluorosulfonyl)imide (EMImFSI) ionic liquid-based electrolytes. Although the graphite negative electrode exhibits good cyclability and rate capability in both 0.43 mol dm(-3) LiFSI/EMImFSI and LiTFSI/EMImFSI (TFSI- = bis(trifluoromethylsulfonyl)imide) at room temperature, only the LiFSI/EMImFSI system enables the graphite electrode to be operated with sufficient discharge capacity at the low temperature of 0 degrees C, even though there is no noticeable difference in ionic conductivity, compared with LiTFSI/EMImFSI. Furthermore, a clear difference in the low-temperature behaviors of the two cells composed of EMImFSI with a high-concentration of lithium salts is observed. Additionally, charge-discharge operation of the graphite electrode at C-rate of over 5.0 can be achieved using of the high-concentration LiFSI/EMImFSI electrolyte. Considering the low-temperature characteristics in both high-concentration electrolytes, the stable and rapid charge-discharge operation in the high-concentration LiFSI/EMImFSI is presumably attributed to a suitable electrode/electrolyte interface with low resistivity. These results suggest that optimization of the electrolyte composition can realize safe and high-performance lithium-ion batteries that utilize ionic liquid-based electrolytes. (C) 2015 Elsevier B.V. All rights reserved.	[Matsui, Yukiko; Yamagata, Masaki; Ishikawa, Masashi] Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan; [Murakami, Satoshi; Saito, Yasuteru] Dai Ichi Kogyo Seiyaku Co Ltd, Minami Ku, Kyoto 6018391, Japan; [Higashizaki, Tetsuya; Ishiko, Eriko] Elexcel Co Ltd, Lab Wing 13F, Kyoto 6190237, Japan; [Yamagata, Masaki; Kono, Michiyuki; Ishikawa, Masashi] iElectrolyte LLC, Osaka 5300011, Japan	Yamagata, M (reprint author), Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	yamagata@kansai-u.ac.jp	Yamagata, Masaki/A-7501-2012	Yamagata, Masaki/0000-0001-7565-8251	MEXT [S0901043]	This work was supported, in part, by a MEXT-supported Program for the Strategic Research Foundation at Private Universities (S0901043), 2009-2014.	Dias FB, 2000, J POWER SOURCES, V88, P169, DOI 10.1016/S0378-7753(99)00529-7; Van Mierlo J, 2007, FUEL CELLS, V7, P165, DOI 10.1002/fuce.200600052; Zheng HH, 2006, CARBON, V44, P203, DOI 10.1016/j.carbon.2005.07.038; Yamada Y, 2014, ACS APPL MATER INTER, V6, P10892, DOI 10.1021/am5001163; Li LF, 2011, J ELECTROCHEM SOC, V158, pA74, DOI 10.1149/1.3514705; Sato T, 2004, J POWER SOURCES, V138, P253, DOI 10.1016/j.jpowsour.2004.06.027; Wagner FT, 2010, J PHYS CHEM LETT, V1, P2204, DOI 10.1021/jz100553m; Matsui Y, 2012, ELECTROCHEMISTRY, V80, P808, DOI 10.5796/electrochemistry.80.808; Han HB, 2011, J POWER SOURCES, V196, P3623, DOI 10.1016/j.jpowsour.2010.12.040; Seki S, 2006, CHEM COMMUN, P544, DOI 10.1039/b514681j; Yamagata M, 2013, ELECTROCHEMISTRY, V81, P857, DOI 10.5796/electrochemistry.81.857; Sugimoto T, 2010, J POWER SOURCES, V195, P6153, DOI 10.1016/j.jpowsour.2010.01.011; Appetecchi GB, 2009, J POWER SOURCES, V192, P599, DOI 10.1016/j.jpowsour.2008.12.095; Yamagata M, 2013, J POWER SOURCES, V227, P60, DOI 10.1016/j.jpowsour.2012.11.013; Song JY, 1999, J POWER SOURCES, V77, P183, DOI 10.1016/S0378-7753(98)00193-1; Usui H, 2012, CHEM LETT, V41, P521, DOI 10.1246/cl.2012.521; Chakrapani V, 2011, J PHYS CHEM C, V115, P22048, DOI 10.1021/jp207605w; Matsumoto H, 2006, J POWER SOURCES, V160, P1308, DOI 10.1016/j.jpowsour.2006.02.018; Tsuzuki S, 2010, J PHYS CHEM B, V114, P16329, DOI 10.1021/jp106870v; Yamada Y, 2013, CHEM COMMUN, V49, P11194, DOI 10.1039/c3cc46665e; Holzapfel M, 2005, CARBON, V43, P1488, DOI 10.1016/j.carbon.2005.01.030; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Usui H, 2013, J POWER SOURCES, V235, P29, DOI 10.1016/j.jpowsour.2013.01.188; Li GC, 2008, PURE APPL CHEM, V80, P2553, DOI 10.1351/pac200880112553; Yamada Y, 2014, J AM CHEM SOC, V136, P5039, DOI 10.1021/ja412807w; Lux SF, 2009, J POWER SOURCES, V192, P606, DOI 10.1016/j.jpowsour.2009.02.066; Scheers J, 2012, ELECTROCHEMISTRY, V80, P18, DOI 10.5796/electrochemistry.80.18; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; SCROSATI B, 1995, NATURE, V373, P557, DOI 10.1038/373557a0; Guerfi A, 2008, J POWER SOURCES, V175, P866, DOI 10.1016/j.jpowsour.2007.09.030; Appetecchi GB, 2001, SOLID STATE IONICS, V143, P73, DOI 10.1016/S0167-2738(01)00835-9; CARLIN RT, 1994, J ELECTROCHEM SOC, V141, pL21, DOI 10.1149/1.2054823; Galinski M, 2006, ELECTROCHIM ACTA, V51, P5567, DOI 10.1016/j.electacta.2006.03.016; Holzapfel M, 2004, CHEM COMMUN, P2098, DOI 10.1039/b407526a; Katayama Y., 2003, SOLID STATE LETT, V6, pA96; Koura N, 2001, CHEM LETT, P1320; MEGAHED S, 1994, J POWER SOURCES, V51, P79, DOI 10.1016/0378-7753(94)01956-8; Nadherna M, 2011, J POWER SOURCES, V196, P7700, DOI 10.1016/j.jpowsour.2011.04.033; Reiter J, 2012, J POWER SOURCES, V205, P402, DOI 10.1016/j.jpowsour.2012.01.003; Reiter J., 2012, ELECTROCHIM ACTA, V71, P22; Seki S., 2005, SOLID STATE LETT, V8, pA577; Vreeke MS, 1998, J ELECTROCHEM SOC, V145, P3668, DOI 10.1149/1.1838858; Wakihara M., 2001, MAT SCI ENG R, V33, P109; Yamagata M., 2013, ELECTROCHIM ACTA, V110, P181	44	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	APR 1	2015	279						766	773		10.1016/j.jpowsour.2015.01.070		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CD2OT	WOS:000350919600087		
J	Yoshida, J; Sugiura, A				Yoshida, Jiro; Sugiura, Ayako			The Effects of Multiple Green Factors on Condominium Prices	JOURNAL OF REAL ESTATE FINANCE AND ECONOMICS			English	Article						Sustainability; Green buildings; Hedonic pricing; Property price; Residential real estate; Japan	HOUSING-MARKET; ENERGY LABELS; REAL-ESTATE; DEPRECIATION; MAINTENANCE; RETURNS	This paper analyzes the transaction prices of green buildings assessed on the basis of multiple green factors. Our theoretical model demonstrates that the initial green premium can be negative but becomes positive as the building ages if a green building has a higher life-cycle cost and a longer economic life. Our empirical analysis of green condominiums in Tokyo confirms this prediction. We additionally find that the longer-life design is associated with a price premium, but the use of renewable energy and recycled materials and water is associated with price discounts. The price discounts are interpreted as the capitalization of a greater life-cycle user cost.	[Yoshida, Jiro] Penn State Univ, University Pk, PA 16802 USA; [Sugiura, Ayako] Tokyo Assoc Real Estate Appraisers, Shinjuku Ku, Tokyo 1620845, Japan	Yoshida, J (reprint author), Penn State Univ, 368 Business Bldg, University Pk, PA 16802 USA.	jiro@psu.edu			MLIT; Institute for Real Estate Studies at the Pennsylvania State University	We thank John Quigley, Piet Eichholtz, Nils Kok, Austin Jaffe, Brent Ambrose, Ed Coulson, Joshua Graff-Zivin, Jenny Schuetz, Kerry Vandell, Patrick McAllister, Erin Mansur, James Conklin, Moussa Diop, Sun Young Park, and the participants of seminars at the Ministry of Land, Infrastructure, Transport, and Tourism (MLIT); the AREUEA Denver conference; the Berkeley-Maastricht Conference on Green Buildings; and 2013 NBER Japan Meeting for their comments. We also thank the members of the Tokyo Association of Real Estate Appraisers for their valuable comments and support in configuring the data. We gratefully acknowledge the grants from MLIT and the Institute for Real Estate Studies at the Pennsylvania State University that have supported this research.	Wilhelmsson M, 2008, J HOUS ECON, V17, P88, DOI 10.1016/j.jhe.2007.09.001; Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651; ROSENBAUM PR, 1985, BIOMETRICS, V41, P103, DOI 10.2307/2530647; Dastrup SR, 2012, EUR ECON REV, V56, P961, DOI 10.1016/j.euroecorev.2012.02.006; Kitzmueller M, 2012, J ECON LIT, V50, P51, DOI 10.1257/jel.50.1.51; DINAN TM, 1989, J URBAN ECON, V25, P52, DOI 10.1016/0094-1190(89)90043-0; Fuerst F, 2011, REAL ESTATE ECON, V39, P45, DOI 10.1111/j.1540-6229.2010.00286.x; Eichholtz P, 2010, AM ECON REV, V100, P2492, DOI 10.1257/aer.100.5.2492; ROSEN S, 1974, J POLIT ECON, V82, P34, DOI 10.1086/260169; Brounen D, 2011, J ENVIRON ECON MANAG, V62, P166, DOI 10.1016/j.jeem.2010.11.006; Fuerst F, 2011, ENERG POLICY, V39, P6608, DOI 10.1016/j.enpol.2011.08.005; Architectural Institute of Japan, 2000, ARCH CHART GLOB ENV; Aroul RR, 2012, J REAL ESTATE RES, V34, P27; Borenstein S., 2008, 176 UCEI CSEM WP; Deng YH, 2012, REG SCI URBAN ECON, V42, P506, DOI 10.1016/j.regsciurbeco.2011.04.004; GILMER RW, 1989, ENERG ECON, V11, P213, DOI 10.1016/0140-9883(89)90026-1; Jaffee D., 2011, WORKING PAPER; Knight JR, 1996, J HOUS ECON, V5, P369, DOI 10.1006/jhec.1996.0019; Komatsu Y., 2010, LIFE SPAN BUILDING P; Lancaster K., 1971, CONSUMER DEMAND NEW; LAQUATRA J, 1986, ENERG ECON, V8, P134, DOI 10.1016/0140-9883(86)90011-3; Leuven E, 2003, PSMATCH2 STATA MODUL; Matsushita H., 2006, J JSCE DIV E, V62, P230; Miller N., 2008, DOES GREEN PAY UNPUB; Pivo G, 2010, J REAL ESTATE RES, V32, P243; Stewart E. A., 2010, STAT SCI, V25, P1; van Garderen K. J., 2002, ECONOMET J, V5, P149, DOI 10.1111/1368-423X.00078; Zheng SQ, 2012, EUR ECON REV, V56, P974, DOI 10.1016/j.euroecorev.2012.02.012	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0895-5638	1573-045X		J REAL ESTATE FINANC	J. Real Estate Financ. Econ.	APR	2015	50	3					412	437		10.1007/s11146-014-9462-3		26	Business, Finance; Economics; Urban Studies	Business & Economics; Urban Studies	CD5BD	WOS:000351100800006		
J	Nozaki, T; Nimura, A; Fujishiro, H; Mochizuki, T; Yamaguchi, K; Kato, R; Sugaya, H; Akita, K				Nozaki, Taiki; Nimura, Akimoto; Fujishiro, Hitomi; Mochizuki, Tomoyuki; Yamaguchi, Kumiko; Kato, Ryuichi; Sugaya, Hiroyuki; Akita, Keiichi			The anatomic relationship between the morphology of the greater tubercle of the humerus and the insertion of the infraspinatus tendon	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Greater tubercle; lateral impression; highest impression; middle impression; infraspinatus; micro-CT	SUPRASPINATUS	Background: The objective of this study was to evaluate the topographic relationship between the morphology of the greater tubercle and the insertion of the tendon of the infraspinatus. Materials and methods: First, we defined an impression of the greater tubercle, which has not been recognized in classic textbooks, as the "lateral impression'' and then measured the dimensions of the "lateral impression'' of the greater tubercle in 71 samples of dry bone of humeri. Next, we examined 16 cadaveric humeri with rotator cuff tendons by micro-computed tomography to analyze the positional relationship between the lateral impression and the infraspinatus tendon. Results: In all samples of dry bones, the lateral impression could be identified as a triangle shape. The lateral impression was composed of the border with the highest impression (mean, 6.3 mm), the border with the middle impression (mean, 5.0 mm), and the border with the lateral wall of the greater tubercle (mean, 8.5 mm). In all samples of humeri with rotator cuffs, we could confirm the lateral impression, and the border between the highest impression and the lateral impression corresponded to the anterior border of the insertion of the infraspinatus tendon. Conclusion: We propose a new anatomic concept of the lateral impression that could enable the precise diagnosis of and facilitate repair techniques for infraspinatus tear, according to specific anatomic characteristics, by applying 3-dimensional computed tomography assessment preoperatively. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Nozaki, Taiki; Nimura, Akimoto; Fujishiro, Hitomi; Yamaguchi, Kumiko; Akita, Keiichi] Tokyo Med & Dent Univ, Dept Clin Anat, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan; [Nozaki, Taiki] St Lukes Int Hosp, Dept Radiol, Tokyo, Japan; [Mochizuki, Tomoyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Reconstruct, Tokyo 1138519, Japan; [Kato, Ryuichi] Nokyo Kyosai Res Inst, Tokyo, Japan; [Sugaya, Hiroyuki] Funabashi Orthopaed Sports Med Ctr, Shoulder & Elbow Serv, Funabashi, Chiba, Japan	Nimura, A (reprint author), Tokyo Med & Dent Univ, Dept Clin Anat, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	a-nim@sol.dti.ne.jp			Ministry of Education, Culture, Sports [24791525]; NokyoKyosai Research Institute (Agricultural Cooperative Insurance Research Institute)	This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports (C) (No. 24791525) and also by a grant from NokyoKyosai Research Institute (Agricultural Cooperative Insurance Research Institute).	Minagawa H, 1998, ARTHROSCOPY, V14, P302, DOI 10.1016/S0749-8063(98)70147-1; Mochizuki T, 2009, J BONE JOINT SURG AM, V91A, P1, DOI 10.2106/JBJS.H.01426; Mochizuki T, 2008, J BONE JOINT SURG AM, V90A, P962, DOI 10.2106/JBJS.G.00427; Clemente C, 1985, GRAYS ANATOMY OFTHE, P233; Curtis AS, 2006, ARTHROSCOPY, V22, P603, DOI 10.1016/j.arthro.2006.04.001; Fick R, 1904, HDB ANATOMIE MECH GE, P141; Gray H, 1901, GRAYS ANATOMY, P1; Kopsch F, 1933, LEHRBUCH ATLAS ANATO, P1	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	APR	2015	24	4					555	560		10.1016/j.jse.2014.09.038		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CD6UK	WOS:000351224800015		
J	Shimogaki, T; Tokoro, H; Tabuchi, M; Koike, N; Yamashina, Y; Takahashi, M				Shimogaki, Tomoyo; Tokoro, Hiroki; Tabuchi, Minoru; Koike, Nobuyuki; Yamashina, Yohzoh; Takahashi, Masahide			Large-scale synthesis of monodisperse microporous silica nanoparticles by gradual injection of reactants	JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY			English	Article						Porous silica; Nanoparticle; Monodisperse; Modified Stober method; Sol-Gel reaction	PARTICLE-SIZE CONTROL; MESOPOROUS SILICA; FORMATION MECHANISM; SURFACTANT SYSTEM; SPHERES; RANGE; DIAMETERS; MICRON	Monodisperse microporous silica particles were prepared in high yield, by the gradual injection of tetramethoxysilane (TMOS) and template molecules into the reaction system. This resulted in continuous nucleation. The dilute TMOS concentration suppressed silica particle aggregation. The diameters of the microporous silica particles were 100-130 nm. The narrow size distribution resulted from larger particles experiencing smaller growth rates, despite the continuous nucleation occurring during TMOS injection. This method has potential in the industrial-scale preparation of monodisperse silica particles.	[Shimogaki, Tomoyo; Takahashi, Masahide] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Shimogaki, Tomoyo; Tokoro, Hiroki; Tabuchi, Minoru; Koike, Nobuyuki; Yamashina, Yohzoh] DIC Corp, Tech Div 2, Polymer Tech Grp 10, Polymer, Ichihara, Chiba 2908585, Japan	Takahashi, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	masa@photomater.com	Takahashi, Masahide/C-3326-2009	Takahashi, Masahide/0000-0001-7273-1660			STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Mizutani M, 2008, CHEM MATER, V20, P4777, DOI 10.1021/cm702792e; Yano K, 2004, J MATER CHEM, V14, P1579, DOI 10.1039/b313712k; Nakamura T, 2007, J PHYS CHEM C, V111, P1093, DOI 10.1021/jp0648240; Yano K, 2003, J MATER CHEM, V13, P2577, DOI 10.1039/b304867p; Zhang K, 2013, J AM CHEM SOC, V135, P2427, DOI 10.1021/ja3116873; Yamada Y, 2006, MICROPOR MESOPOR MAT, V93, P190, DOI 10.1016/j.micromeso.2006.02.013; Suzuki K, 2004, J AM CHEM SOC, V126, P462, DOI 10.1021/ja038250d; Nooney RI, 2002, CHEM MATER, V14, P4721, DOI 10.1021/cm0204371; Qiao ZA, 2009, CHEM MATER, V21, P3823, DOI 10.1021/cm901335k; Ikari K, 2004, LANGMUIR, V20, P11504, DOI 10.1021/la0483717; Unger KK, 2000, J CHROMATOGR A, V892, P47, DOI 10.1016/S0021-9673(00)00177-1; Kuroda K, 2014, CHEM MATER, V26, P211, DOI 10.1021/cm4023387; Yamada H, 2012, CHEM MATER, V24, P1462, DOI 10.1021/cm3001688; Ikari K, 2006, LANGMUIR, V22, P802, DOI 10.1021/la0525527; Shiratori Y, 2002, J CERAM SOC JPN, V110, P304, DOI 10.2109/jcersj.110.304; Shiratori Y, 2003, J CERAM SOC JPN, V111, P104, DOI 10.2109/jcersj.111.104; Unger KK, 2000, CHARACTERISATION POR, VV, P155; Urata C, 2009, CHEM COMMUN, V34, P5094; Yano K, 2002, B CHEM SOC JPN, V75, P1977, DOI 10.1246/bcsj.75.1977; Yano K, 2014, J COLLOID INTERF SCI, V418, P61, DOI 10.1016/j.jcis.2013.11.049	21	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0928-0707	1573-4846		J SOL-GEL SCI TECHN	J. Sol-Gel Sci. Technol.	APR	2015	74	1					109	113		10.1007/s10971-014-3583-2		5	Materials Science, Ceramics	Materials Science	CE0ZQ	WOS:000351541200013		
J	Yanagida, S; Nakagawa, T; Kishi, T; Yasumori, A				Yanagida, Sayaka; Nakagawa, Tomohiro; Kishi, Tetsuo; Yasumori, Atsuo			Preparation and characterization of gold nanoparticle-loaded silica-gel films for localized surface plasmon resonance sensing	JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY			English	Article						Silica gel; Thick film; Porous material; Gold nanoparticle; LSPR; Sensing	SILVER NANOPARTICLES; REFRACTIVE-INDEX; SIZE; GLASS; SHAPE; POLYSTYRENE; TEMPERATURE; ABSORPTION; DEPENDENCE; PARTICLES	Gold nanoparticles (AuNPs) were investigated as a sensing material because their absorption wavelength due to localized surface plasmon resonance (LSPR) shifts depending on the surrounding environment. For accurate sensing, the immobilization of dispersed AuNPs on a substrate is desirable. However, attaching AuNPs to smooth surfaces is difficult because the adhesion forces between AuNPs and most substrates are very weak. In this study, thick and porous silica-gel films were prepared via a dip-coating method using polyvinylpyrrolidone-containing silica sols. The AuNPs were precipitated in the silica-gel films by immersion in HAuCl4 solution followed by heating. The effects of the silica-gel film calcination temperature and the silica-sol aging conditions on sample structures, LSPR peak wavelengths, and LSPR sensing abilities against the change in refractive index were investigated. When the calcination temperature decreased, the intensity of LSPR absorption increased significantly because the silica gel calcined at low temperatures had a sparse structure and a significant quantity of AuNPs in the silica gel pores. The aging conditions of the silica sol also affected the structures of the AuNP-loaded silica gel films and their LSPR sensing abilities. The sample prepared from a silica sol aged at 25 A degrees C contained much larger AuNPs and exhibited a higher sensing ability than the sample prepared from a silica sol aged at 40 A degrees C. The high sensing ability of the sample prepared from the silica sol aged at 25 A degrees C was considered to result from both the large size of the AuNPs and the low silica gel density around them.	[Yanagida, Sayaka; Nakagawa, Tomohiro; Yasumori, Atsuo] Tokyo Univ Sci, Dept Mat Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Yanagida, Sayaka; Yasumori, Atsuo] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan; [Kishi, Tetsuo] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528550, Japan	Yasumori, A (reprint author), Tokyo Univ Sci, Dept Mat Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	YANAGIDA.Sayaka@nims.go.jp; yasumori@rs.noda.tus.ac.jp					Anderson ML, 1999, LANGMUIR, V15, P674, DOI 10.1021/la980784i; Malinsky MD, 2001, J PHYS CHEM B, V105, P2343, DOI 10.1021/jp002906x; Karakouz T, 2008, ADV MATER, V20, P3893, DOI 10.1002/adma.200703092; Tabor C, 2009, J PHYS CHEM A, V113, P1946, DOI 10.1021/jp807904s; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Zeng SW, 2011, PLASMONICS, V6, P491, DOI 10.1007/s11468-011-9228-1; Westcott SL, 1998, LANGMUIR, V14, P5396, DOI 10.1021/la980380q; Yamamoto Y, 2005, ELECTROANAL, V17, P2224, DOI 10.1002/elan.200503354; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Okamoto T, 2000, OPT LETT, V25, P372, DOI 10.1364/OL.25.000372; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282; UNDERWOOD S, 1994, LANGMUIR, V10, P3427, DOI 10.1021/la00022a011; Kozuka H, 2000, J SOL-GEL SCI TECHN, V19, P205, DOI 10.1023/A:1008780120351; Novo C, 2008, J PHYS CHEM C, V112, P3, DOI 10.1021/jp709606u; Link S, 1999, J PHYS CHEM B, V103, P4212, DOI 10.1021/jp984796o; Zhong ZY, 2004, J PHYS CHEM B, V108, P4046, DOI 10.1021/jp037056a; Jain PK, 2007, NANO LETT, V7, P2080, DOI 10.1021/nl071008a; Lee KS, 2006, J PHYS CHEM B, V110, P19220, DOI 10.1021/jp062536y; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Vogel N, 2010, SMALL, V6, P104, DOI 10.1002/smll.200900497; Brinker C.J., 1990, SOL GEL SCI PHYS CHE; Cheng S, 2003, CHEM MATER, V15, P1560, DOI 10.1021/cm0202106; HENGLEIN A, 1993, J PHYS CHEM-US, V97, P5457, DOI 10.1021/j100123a004; KAMIYA K, 1987, J NON-CRYST SOLIDS, V93, P407, DOI 10.1016/S0022-3093(87)80185-0; Kim CY, 2008, J SOL-GEL SCI TECHN, V48, P336, DOI 10.1007/s10971-008-1814-0; Satija Jitendra, 2010, Nanotechnol Sci Appl, V3, P171, DOI 10.2147/NSA.S8981; Wang T, 2010, J MATER SCI, V45, P4539, DOI 10.1007/s10853-010-4648-4; Yanagida S, 2014, J SOL-GEL SCI TECHN, V71, P1, DOI 10.1007/s10971-014-3317-5; YASUMORI A, 1988, J NON-CRYST SOLIDS, V100, P215, DOI 10.1016/0022-3093(88)90020-8; Zhang ZY, 2010, J COLLOID INTERF SCI, V347, P215, DOI 10.1016/j.jcis.2010.03.052	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0928-0707	1573-4846		J SOL-GEL SCI TECHN	J. Sol-Gel Sci. Technol.	APR	2015	74	1					227	233		10.1007/s10971-014-3603-2		7	Materials Science, Ceramics	Materials Science	CE0ZQ	WOS:000351541200027		
J	Thein, MT; Pung, SY; Aziz, A; Itoh, M				Thein, Myo Thuya; Pung, Swee-Yong; Aziz, Azizan; Itoh, Mitsuru			Stacked ZnO nanorods synthesized by solution precipitation method and their photocatalytic activity study	JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY			English	Article						ZnO; Solution precipitation; Photocatalytic study; Nanorods	LOW-TEMPERATURE; NANOSTRUCTURES; COMPLEX; GROWTH; NANOPARTICLES; DEGRADATION; WATER; IRRADIATION; MORPHOLOGY; MECHANISM	ZnO has been considered as a promising photocatalyst for wastewater treatment. Although many works have been done to enhance the photocatalytic activity of ZnO particles, it is difficult to synthesize well-controlled morphology of ZnO particles having high photocatalytic activity. In this work, stacked ZnO nanorods were synthesized at different growth time via solution precipitation method. Their length and diameter of stacked ZnO nanorods increased with growth time. The formation of stacked ZnO nanorods was attributed to the joining of (002) polar surfaces at the tips of a smaller ZnO nanorods during the synthesis process. A small amount of PVP was added to minimize the agglomeration and to reduce the secondary nucleation of ZnO nanorods. The photocatalytic study showed that the photodegradation of RhB solution by stacked ZnO nanorods under UV light followed first-order kinetic. The results also indicated that a larger effective surface area of stacked ZnO nanorods leads to a higher adsorption of organic molecules, causing a better photocatalytic activity for RhB dye removal. Stacked ZnO nanorods synthesized by solution precipitation method and their photocatalytic activity study.	[Thein, Myo Thuya; Pung, Swee-Yong; Aziz, Azizan] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Sci & Engn Nanomat Team, George Town, Malaysia; [Itoh, Mitsuru] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan	Pung, SY (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Sci & Engn Nanomat Team, Engn Campus,14300 Nibong Tebal, George Town, Malaysia.	sypung@usm.my	ITOH, Mitsuru/E-3481-2014; Pung, Swee/C-6249-2011	ITOH, Mitsuru/0000-0001-6457-9152; 	AUN/SEED-Net under Collaborative Research Program (CR) [304/PBAHAN/6050277/A119]; USM Research University Grant (RU) [1001/PBAHAN/814200]	The authors would like to thank AUN/SEED-Net under Collaborative Research Program (CR) (304/PBAHAN/6050277/A119) and USM Research University Grant (RU) (1001/PBAHAN/814200) for providing the research funding to conduct this project.	Abd Aziz SNQA, 2014, APPL PHYS A-MATER, V116, P1801, DOI 10.1007/s00339-014-8333-3; Zhang LN, 2010, APPL PHYS A-MATER, V100, P1061, DOI 10.1007/s00339-010-5737-6; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Arnold MS, 2003, J PHYS CHEM B, V107, P659, DOI 10.1021/jp0271054; Tian ZRR, 2003, NAT MATER, V2, P821, DOI 10.1038/nmat1014; Zhang YL, 2009, J SOL-GEL SCI TECHN, V51, P198, DOI 10.1007/s10971-009-1959-5; Zak AK, 2011, CERAM INT, V37, P393, DOI 10.1016/j.ceramint.2010.08.017; Ba-Abbad MM, 2013, J ALLOY COMPD, V550, P63, DOI 10.1016/j.jallcom.2012.09.076; Gao XD, 2005, J PHYS CHEM B, V109, P1155, DOI 10.1021/jp046267s; KAWAI T, 1979, NATURE, V282, P283, DOI 10.1038/282283a0; Wang M, 2008, J CRYST GROWTH, V310, P1213, DOI 10.1016/j.jcrysgro.2008.01.001; KAWAI T, 1980, NATURE, V286, P474, DOI 10.1038/286474a0; Krishnan D, 2009, J CRYST GROWTH, V311, P3889, DOI 10.1016/j.jcrysgro.2009.06.019; Lim JH, 2006, ADV MATER, V18, P2720, DOI 10.1002/adma.200502633; Wei A, 2006, NANOTECHNOLOGY, V17, P1740, DOI 10.1088/0957-4484/17/6/033; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Aarthi T, 2007, IND ENG CHEM RES, V46, P7, DOI 10.1021/ie060948n; Kumar V, 1999, OPT MATER, V12, P115, DOI 10.1016/S0925-3467(98)00052-4; Zhang H, 2006, J PHYS CHEM B, V110, P827, DOI 10.1021/jp055351k; SATO S, 1980, CHEM PHYS LETT, V72, P83, DOI 10.1016/0009-2614(80)80246-6; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; Kuriakose S, 2013, BEILSTEIN J NANOTECH, V4, P763, DOI 10.3762/bjnano.4.87; Cong Y, 2007, J PHYS CHEM C, V111, P6976, DOI 10.1021/jp0685030; Bhatkhande DS, 2002, J CHEM TECHNOL BIOT, V77, P102, DOI 10.1002/jctb.532; Djurisic AB, 2004, ADV FUNCT MATER, V14, P856, DOI 10.1002/adfm.200305082; Mclaren A, 2009, J AM CHEM SOC, V131, P12540, DOI 10.1021/ja9052703; Cho S, 2008, J PHYS CHEM C, V112, P12769, DOI 10.1021/jp803783s; Jang ES, 2006, ADV MATER, V18, P3309, DOI 10.1002/adma.200601455; Tonto P, 2008, CERAM INT, V34, P57, DOI 10.1016/j.ceramint.2006.08.003; Cai XY, 2014, CERAM INT, V40, P57, DOI 10.1016/j.ceramint.2013.05.103; Dhara S, 2011, APPL NANOSCI, V1, P165; Fujishima A, 1969, J CHEM SOC JAPAN, V72, P108; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Gao P, 2006, J NANOPART RES, V8, P131, DOI 10.1007/s11051-005-5130-0; Hassan NK, 2012, ECS J SOLID STATE SC, V1, pP86, DOI 10.1149/2.018202jss; Jiang H, 2009, J ALLOY COMPD, V478, P550, DOI 10.1016/j.jallcom.2008.11.086; Lansdown A. B. G., 1997, International Journal of Cosmetic Science, V19, P167, DOI 10.1046/j.1467-2494.1997.171712.x; Lee JRI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146803; Mohammad MT, 2006, MATER CHEM PHYS, V99, P382, DOI 10.1016/j.matchemphys.2005.11.009; Pung S.Y., 2012, INT J INORG CHEM, V2012, P1; Rodriguez-Paez JE, 2001, J EUR CERAM SOC, V21, P925, DOI 10.1016/S0955-2219(00)00283-1; Ryu Y, 2006, APPL PHYS LETT, V88; Thein MT, 2015, J EXP NANOSCI, V10, P1068, DOI 10.1080/17458080.2014.953609; Thirugnanam T, 2013, J NANOMATER, V2013, P1; Vernardou D, 2007, THIN SOLID FILMS, V515, P8764, DOI 10.1016/j.tsf.2007.03.108; Xia JA, 2011, J ELECTROCHEM SOC, V158, pD244, DOI 10.1149/1.3556647; Zhang X, 2014, SCI REP, V4, P1	48	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0928-0707	1573-4846		J SOL-GEL SCI TECHN	J. Sol-Gel Sci. Technol.	APR	2015	74	1					260	271		10.1007/s10971-015-3646-z		12	Materials Science, Ceramics	Materials Science	CE0ZQ	WOS:000351541200032		
J	Katori, M				Katori, Makoto			Determinantal Martingales and Correlations of Noncolliding Random Walks	JOURNAL OF STATISTICAL PHYSICS			English	Article						Noncolliding random walk; Discrete Ito's formula; Martingales; Determinantal processes; Random matrix theory; Infinite particle systems; Invariance principle	RANDOM POINT FIELDS; RANDOM MATRICES; BROWNIAN-MOTION; ENSEMBLES	We study the noncolliding random walk (RW), which is a particle system of one-dimensional, simple and symmetric RWs starting from distinct even sites and conditioned never to collide with each other. When the number of particles is finite, , this discrete process is constructed as an -transform of absorbing RW in the -dimensional Weyl chamber. We consider Fujita's polynomial martingales of RW with time-dependent coefficients and express them by introducing a complex Markov process. It is a complexification of RW, in which independent increments of its imaginary part are in the hyperbolic secant distribution, and it gives a discrete-time conformal martingale. The -transform is represented by a determinant of the matrix, whose entries are all polynomial martingales. From this determinantal-martingale representation (DMR) of the process, we prove that the noncolliding RW is determinantal for any initial configuration with , and determine the correlation kernel as a function of initial configuration. We show that noncolliding RWs started at infinite-particle configurations having equidistant spacing are well-defined as determinantal processes and give DMRs for them. Tracing the relaxation phenomena shown by these infinite-particle systems, we obtain a family of equilibrium processes parameterized by particle density, which are determinantal with the discrete analogues of the extended sine-kernel of Dyson's Brownian motion model with . Following Donsker's invariance principle, convergence of noncolliding RWs to the Dyson model is also discussed.	Chuo Univ, Dept Phys, Fac Sci & Engn, Bunkyo Ku, Kasuga, Tokyo 1128551, Japan	Katori, M (reprint author), Chuo Univ, Dept Phys, Fac Sci & Engn, Bunkyo Ku, Kasuga, Tokyo 1128551, Japan.	katori@phys.chuo-u.ac.jp			Japan Society for the Promotion of Science [21540397, 26400405]	The present author would like to thank T. Shirai, H. Osada, H. Tanemura, and S. Esaki for useful discussions. This work is supported in part by the Grant-in-Aid for Scientific Research (C) (Nos. 21540397 and 26400405) of Japan Society for the Promotion of Science.	ANDREWS G. E., 1999, SPECIAL FUNCTIONS; DYSON FJ, 1962, J MATH PHYS, V3, P1191, DOI 10.1063/1.1703862; Shirai T, 2003, J FUNCT ANAL, V205, P414, DOI 10.1016/S0022-1236(03)00171-X; Katori M, 2013, ELECTRON COMMUN PROB, V18, P1, DOI 10.1214/ECP.v18-2554; Osada H, 2013, ANN PROBAB, V41, P1, DOI 10.1214/11-AOP736; Osada H, 2012, PROBAB THEORY REL, V153, P471, DOI 10.1007/s00440-011-0352-9; Katori M, 2014, STOCH PROC APPL, V124, P3724, DOI 10.1016/j.spa.2014.06.002; Katori M, 2004, J MATH PHYS, V45, P3058, DOI 10.1063/1.1765215; Johansson K, 2001, COMMUN MATH PHYS, V215, P683, DOI 10.1007/s002200000328; Katori M, 2007, J STAT PHYS, V129, P1233, DOI 10.1007/s10955-007-9421-y; Eynard B, 1998, J PHYS A-MATH GEN, V31, P4449, DOI 10.1088/0305-4470/31/19/010; Katori M, 2011, J STAT PHYS, V142, P592, DOI 10.1007/s10955-011-0117-y; Katori M, 2009, J STAT PHYS, V136, P1177, DOI 10.1007/s10955-009-9829-7; Johansson K, 2002, PROBAB THEORY REL, V123, P225, DOI 10.1007/s004400100187; Nagao T, 1998, PHYS LETT A, V247, P42, DOI 10.1016/S0375-9601(98)00602-1; FISHER ME, 1984, J STAT PHYS, V34, P667, DOI 10.1007/BF01009436; Soshnikov A, 2000, RUSS MATH SURV+, V55, P923, DOI 10.1070/RM2000v055n05ABEH000321; Graczyk P, 2013, J MATH PHYS, V54, DOI 10.1063/1.4790507; Osada H, 2013, STOCH PROC APPL, V123, P813, DOI 10.1016/j.spa.2012.11.002; Baik J, 2007, ANN PROBAB, V35, P1807, DOI 10.1214/009117906000001105; Baik J, 2000, COMMUN PUR APPL MATH, V53, P1385, DOI 10.1002/1097-0312(200011)53:11<1385::AID-CPA3>3.3.CO;2-K; Ben Hough J., 2009, ZEROS GAUSSIAN ANAL; Billingsley P., 1968, CONVERGENCE PROBABIL; Cardy J, 2003, J PHYS A-MATH GEN, V36, P609, DOI 10.1088/0305-4470/36/3/302; Eichelsbacher P, 2008, ELECTRON J PROBAB, V13, P1307; Erdelyi A., 1955, BATEMAN MANUSCRIPT P, V3; Esaki S., 2014, PAC J MATH IND, V6, P1; Feierl T, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/9/095003; Feller W., 1966, INTRO PROBABILITY TH, VII; Forrester PJ, 2010, LOND MATH SOC MONOGR, V34, P1; Fujita T., 2002, STOCHASTIC CALCULUS; Fujita T, 2008, STUD SCI MATH HUNG, V45, P125, DOI 10.1556/SScMath.2007.1043; Grabiner DJ, 1999, ANN I H POINCARE-PR, V35, P177, DOI 10.1016/S0246-0203(99)80010-7; HARKNESS WL, 1968, J AM STAT ASSOC, V63, P329, DOI 10.2307/2283852; Johansson K, 2005, ANN I FOURIER, V55, P2129; Katori M, 2010, COMMUN MATH PHYS, V293, P469, DOI 10.1007/s00220-009-0912-3; Katori M., 2011, SUGAKU EXPO, V24, P263; Katori M, 2015, PROBAB THEORY REL, V162, P637, DOI 10.1007/s00440-014-0581-9; Katori M., 2003, STOCH STOCH REP, V75, P369, DOI 10.1080/10451120310001633711; Konig W, 2002, WIRTSCHAFTSINF, V44, P1; Konig W, 2005, PROBABILITY SURVEYS, V2, P385, DOI [DOI 10.1214/154957805100000177.(1387), 10.1214/154957805100000177]; Krattenthaler C, 2006, J PHYS CONF SER, V42, P179, DOI 10.1088/1742-6596/42/1/017; Levin B.Ya., 1996, TRANSLATIONS MATH MO, V150; Mehta M. L., 2004, RANDOM MATRICES; Nagao T, 2002, NUCL PHYS B, V620, P551, DOI 10.1016/S0550-3213(01)00561-2; Perez-Abreu V., 2007, COMM STOCHAST ANAL, V1, P415; Privault N, 2009, LECT NOTES MATH, V1982, P1, DOI 10.1007/978-3-642-02380-4; Revuz D., 2005, CONTINUOUS MARTINGAL; Sato K.-I., 1999, LEVY PROCESSES INFIN; Schoutens W., 2000, LECT NOTES STAT, V146; Spohn H., 1987, IMA VOLUMES MATH ITS, V9, P151; Tao T, 2012, TOPICS RANDOM MATRIX	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	APR	2015	159	1					21	42		10.1007/s10955-014-1179-4		22	Physics, Mathematical	Physics	CD7TJ	WOS:000351295100002		
J	Mori, T				Mori, Takashi			Quasi-Equilibrium Nonadditivity	JOURNAL OF STATISTICAL PHYSICS			English	Article						Nonadditivity; Long-range interactions; Quasi-equilibrium states	RELAXATION; SYSTEMS; MODEL	The possibility that a short-range interacting system exhibits nonadditivity is investigated. After the discussion on the precise definition of additivity and its consequence, we show that it is possible when the system is in a quasi-equilibrium state by examining the specific model, in which the spin degrees of freedom are coupled to the motional degrees of freedom and which exhibits a type of structural phase transitions. In this model, the interactions are local but the system evolves under the global constraint, i.e., the triangular lattice structure, which effectively plays the role of long-range interactions and causes the nonadditivity. The triangular lattice structure is just a metastable structure, and hence this nonadditivity is not an equilibrium property but a property in a quasi-equilibrium state.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Mori, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	mori@spin.phys.s.u-tokyo.ac.jp			Sumitomo Foundation [120753]	The author is grateful to Seiji Miyashita for the discussions and warm encouragement. The author also would like to thank Stefano Ruffo and Hugo Touchette for suggestive comments and discussions. This work was supported by the Sumitomo Foundation (Grant No. 120753). The computation in this work has been partially done using the facilities of the Supercomputer Center, Institute for Solid State Physics, the University of Tokyo.	Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Kastner M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130601; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Campa A, 2009, PHYS REP, V480, P57, DOI 10.1016/j.physrep.2009.07.001; Levin Y, 2014, PHYS REP, V535, P1, DOI 10.1016/j.physrep.2013.10.001; GUTLICH P, 1994, ANGEW CHEM INT EDIT, V33, P2024, DOI 10.1002/anie.199420241; THIRRING W, 1970, Z PHYS, V235, P339, DOI 10.1007/BF01403177; Berges J, 2004, Phys Rev Lett, V93, P142002, DOI 10.1103/PhysRevLett.93.142002; ANTONI M, 1995, PHYS REV E, V52, P2361, DOI 10.1103/PhysRevE.52.2361; Yamaguchi YY, 2004, PHYSICA A, V337, P36, DOI 10.1016/j.physa.2004.01.041; Mori T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031128; KAC M, 1963, J MATH PHYS, V4, P216, DOI 10.1063/1.1703946; Baldovin F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011102; CREUTZ M, 1983, PHYS REV LETT, V50, P1411, DOI 10.1103/PhysRevLett.50.1411; Feynman R.P., 1972, STAT MECH SET LECT; Gupta S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040602; Kastner M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/07/P07006; Landau LD, 1980, STAT PHYS 1; Mori T, 2012, J STAT PHYS, V147, P1020, DOI 10.1007/s10955-012-0511-0; Mori T, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/10/P10003; Mori T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.020601; Mori T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021132; Mori T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.060103; Nishino M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247203; Ruelle D., 1999, STAT MECH RIGOROUS R; Touchette H, 2002, PHYSICA A, V305, P84, DOI 10.1016/S0378-4371(01)00644-6; Touchette H., 2014, ARXIV14036608; Truesdell C., 1961, ERGODIC THEORY	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	APR	2015	159	1					172	194		10.1007/s10955-014-1177-6		23	Physics, Mathematical	Physics	CD7TJ	WOS:000351295100010		
J	Goto, Y; Ebisawa, T; Lu, XL; Lu, WS				Goto, Yoshiaki; Ebisawa, Takemasa; Lu, Xilin; Lu, Wensheng			Ultimate State of Thin-Walled Circular Steel Columns Subjected to Biaxial Horizontal Forces and Biaxial Bending Moments Caused by Bidirectional Seismic Accelerations	JOURNAL OF STRUCTURAL ENGINEERING			English	Article						Steel column; Seismic effects; Limit state; Seismic design; Structural stability; Nonlinear analysis	DUCTILITY; STABILITY; BEHAVIOR	To check the safety of thin-walled circular steel columns used for bridge piers of elevated-girder bridges, a versatile interaction equation is derived to specify the ultimate state of the columns under the coupling of bidirectional horizontal seismic accelerations. These bidirectional seismic accelerations generally cause biaxial horizontal force components and biaxial bending moment components to act at the top of the columns. Therefore, the interaction equation is derived in this paper in terms of these force and moment components. In this interaction equation, the bending moment components are converted to equivalent horizontal force components. The accuracy of the ultimate interaction equation is first investigated by carrying out a bidirectional shaking table test and an advanced dynamic analysis on single-column models in which a mass with translational and rotational inertias is fixed at the top of the columns. As an application to actual problems, an advanced dynamic response analysis is used to examine the validity of the interaction equation when applied to a column of a two-span simply supported elevated-girder bridge model under bidirectional seismic accelerations. In this model, the center of a superstructure is supported by a single circular steel column, whereas both ends of the superstructure are supported by abutments. The numerical analysis showed that the proposed ultimate interaction equation considering the effects of the biaxial horizontal force components and biaxial bending moment components accurately predicts the ultimate state of the column. The biaxial bending moment components have some large effect on the ultimate state of the column. (C) 2014 American Society of Civil Engineers.	[Goto, Yoshiaki; Ebisawa, Takemasa] Nagoya Inst Technol, Dept Civil Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Lu, Xilin; Lu, Wensheng] Tongji Univ, State Key Lab Disaster Reduct Civil Engn, Shanghai 200092, Peoples R China	Goto, Y (reprint author), Nagoya Inst Technol, Dept Civil Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	goto.yoshiaki@nitech.ac.jp; ebisawa@nitech.ac.jp; lxlst@mail.tongji.edu.cn; wenshenglu@vip.163.com			JSPS KAKENHI [23246084]	This work is partly supported by JSPS KAKENHI Grant No. 23246084.	Jiao H, 2004, THIN WALL STRUCT, V42, P1257, DOI 10.1016/j.tws.2004.03.020; Gao SB, 1998, J ENG MECH-ASCE, V124, P260, DOI 10.1061/(ASCE)0733-9399(1998)124:3(260); [Anonymous], 2007, ABAQUS STANDARD US M; D'Aniello M, 2012, J CONSTR STEEL RES, V78, P144, DOI 10.1016/j.jcsr.2012.07.003; HILL R, 1958, J MECH PHYS SOLIDS, V6, P236, DOI 10.1016/0022-5096(58)90029-2; Nishikawa K, 1998, ENG STRUCT, V20, P540; Goto Y, 2009, J STRUCT ENG-ASCE, V135, P1481, DOI 10.1061/(ASCE)ST.1943-541X.0000076; Goto Y, 2006, J STRUCT ENG-ASCE, V132, P1621, DOI 10.1061/(ASCE)0733-9445(2006)132:10(1621); Goto Y, 1998, J STRUCT ENG-ASCE, V124, P1290, DOI 10.1061/(ASCE)0733-9445(1998)124:11(1290); Japan Road Association, 2002, SPEC HIGHW BRIDG, V5; Obata M, 2007, J STRUCT ENG-ASCE, V133, P638, DOI 10.1061/(ASCE)0733-9445(2007)133:5(638); Public Work Research Institute, 1997, REP COOP RES LIM STA	12	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9445	1943-541X		J STRUCT ENG	J. Struct. Eng.	APR	2015	141	4							04014122	10.1061/(ASCE)ST.1943-541X.0001067		12	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CE0DP	WOS:000351475000008		
J	Kataoka, K; Kanazawa, A; Nakajima, A; Yamaguchi, A; Arimoto, A				Kataoka, Kozo; Kanazawa, Akiyoshi; Nakajima, Akio; Yamaguchi, Ayane; Arimoto, Akira			Prognostic value of biomarkers in metastatic colorectal cancer patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Colorectal cancer; Liver metastases; Prognostic marker; TP; DPD	5-FLUOROURACIL-RELATED GENE-EXPRESSION; THYMIDINE PHOSPHORYLASE EXPRESSION; MESSENGER-RNA EXPRESSION; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE; LIVER METASTASES; REG-IV; GROWTH-FACTOR; CHEMOTHERAPY; CAPECITABINE	Backgrounds: The prognostic value of biomarkers in metastatic colorectal cancer (mCRC) patients with liver metastases remains unclear. We assessed the difference of expression of biomarkers between primary tumors and liver metastases treated with chemotherapy in mCRC patients, as well as the prognostic value of these markers. Methods: Forty-three mCRC patients with liver-limited disease from January 2007-November 2011 were analyzed. They all received resection of primary tumors followed by oxaliplatin-based chemotherapy. After chemotherapy, they all received hepatic resection. Forty-three paired primary and metastatic tumor specimens were collected to measure the messenger RNA expression of six biomarkers by the Danenberg tumor profile method (thymidylate synthase, dihydropyrimidine dehydrogenase [DPD], excision repair cross-complementing gene1, thymidine phosphorylase [TP], folylpolyglutamate synthase, and regenerating islet-derived family, member 4). Results: Thirty-six patients' messenger RNA was used for analysis. All markers showed similar expression between primary and metastatic sites. The low-expression group of Danenberg tumor profile and TP in the primary tumor showed significantly higher overall survival than the high-expression group (P < 0.001 and P = 0.033), but for DPD and TP in liver metastases, there were no significant differences of overall survival between the two groups. The ratios of marker expression in liver metastatic site to that in primary site of DPD and TP were significantly higher in chemo-responders than in non-chemo-responders (P = 0.034 and P = 0.022). Conclusions: Biomarkers' expressions in liver metastases were similar to those in the primary tumor. DPD and TP in the primary lesion may be a prognostic factor in chemotherapy-naive mCRC patients with liver-limited disease, but those in liver tumor were not. Further validated analysis to our results would be warranted. (C) 2015 Elsevier Inc. All rights reserved.	[Kataoka, Kozo; Nakajima, Akio; Yamaguchi, Ayane; Arimoto, Akira] Osaka Red Cross Hosp, Dept Surg, Osaka 5438555, Japan; [Kanazawa, Akiyoshi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Gastroenterol Surg & Oncol, Osaka, Japan	Kataoka, K (reprint author), Osaka Red Cross Hosp, Dept Surg, Tennoji Ku, 5-30 Fudegasaki, Osaka 5438555, Japan.	kozokataoka@hotmail.co.jp					Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Sadahiro S, 2010, CANCER CHEMOTH PHARM, V65, P735, DOI 10.1007/s00280-009-1079-5; Koopman M, 2009, EUR J CANCER, V45, P1999, DOI 10.1016/j.ejca.2009.04.017; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Calascibetta A, 2004, ANTICANCER RES, V24, P3875; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Shirota Y, 2001, J CLIN ONCOL, V19, P4298; Soong R, 2008, ANN ONCOL, V19, P915, DOI 10.1093/annonc/mdm599; Braun MS, 2008, J CLIN ONCOL, V26, P2690, DOI 10.1200/JCO.2007.15.5580; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Jemal A, 2005, CA-CANCER J CLIN, V55, P10; ETIENNE MC, 1995, J CLIN ONCOL, V13, P1663; Kuramochi H, 2006, CLIN CANCER RES, V12, P29, DOI 10.1158/1078-0432.CCR-05-1275; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Meropol NJ, 2006, J CLIN ONCOL, V24, P4069, DOI 10.1200/JCO.2005.05.2084; Leonard GD, 2005, J CLIN ONCOL, V23, P2038, DOI 10.1200/JCO.2005.00.0349; Takechi T, 1998, JPN J CANCER RES, V89, P1144; Boskos CS, 2010, J SURG ONCOL, V102, P408, DOI 10.1002/jso.21423; Ciaparrone M, 2006, ONCOLOGY-BASEL, V70, P366, DOI 10.1159/000098110; Etienne MC, 1996, ANN ONCOL, V7, P283; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; HARAGUCHI M, 1993, CANCER RES, V53, P5680; Kuramochi H, 2006, INT J CANCER, V119, P522, DOI 10.1002/ijc.21692; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Nagano Hiroto, 2004, Gan To Kagaku Ryoho, V31, P889; Numata M, 2011, J SURG ONCOL, V104, P205, DOI 10.1002/jso.21906; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Sameshima S, 2008, ANTICANCER RES, V28, P1477; Sasaki S, 2013, J ONCOL, V2013; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Takenoue T, 2000, ANN ONCOL, V11, P273, DOI 10.1023/A:1008337913456; Tokunaga Y, 2007, SURGERY, V141, P346, DOI 10.1016/j.surg.2006.06.025; Uchida K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-386	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					343	350		10.1016/j.jss.2014.10.006		8	Surgery	Surgery	CD4OC	WOS:000351061900005		
J	Ota, Y; Kumamoto, T; Ishibe, A; Watanabe, K; Mori, R; Taniguchi, K; Matsuyama, R; Makino, H; Ueda, M; Kubota, T; Akiyama, H; Tanaka, K; Ichikawa, Y; Endo, I				Ota, Yohei; Kumamoto, Takafumi; Ishibe, Atsushi; Watanabe, Kazuteru; Mori, Ryutarou; Taniguchi, Koichi; Matsuyama, Ryusei; Makino, Hirochika; Ueda, Michio; Kubota, Toru; Akiyama, Hirotoshi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru			Thrombomodulin improves rat survival after extensive hepatectomy	JOURNAL OF SURGICAL RESEARCH			English	Article						Ninety-five percent hepatectomy; Apoptosis; Liver regeneration; Thrombomodulin; Hepatoprotective effect; Protease-activator receptor 1	ACTIVATED PROTEIN-C; DISSEMINATED INTRAVASCULAR COAGULATION; EXCESSIVE HEPATECTOMY; LIVER-REGENERATION; PROTEOLYTIC CLEAVAGE; HEPATIC-FAILURE; GROWTH-FACTOR; EXPRESSION; APOPTOSIS; CELLS	Background: Recombinant human soluble thrombomodulin (rTM) protects against disseminated intravascular coagulopathy by inhibiting coagulation, inflammation, and apoptosis. This study tests the hypothesis that rTM is hepatoprotective after extensive hepatectomy (Hx) and investigates the mechanisms underlying this effect. Materials and methods: Experiment 1: rats (15 per group) were injected with rTM (1.0 or 2.0 mg/kg) or saline just before 95% Hx and their 7-d survival assessed. Experiment 2: rats were assigned to either a treated (2.0 mg/kg rTM just before Hx) or control group (n = 5 per group). Five rats per group were euthanized immediately after surgery, and at 1, 3, 6, 12, and 24 h postoperatively; serum and liver remnant samples were collected for biochemical and histologic analysis, as well as reverse-transcription polymerase chain reaction and Western blotting. Results: All saline-injected rats died within 52 h of Hx, whereas injection of 2.0 mg/kg rTM prolonged survival (P = 0.003). rTM increased the number of Ki67-positive cells and reduced the number of terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cells. The number of myeloperoxidase-positive cells and the expression of high-mobility group box 1 protein did not differ. Reverse-transcription polymerase chain reaction revealed that rTM significantly enhanced protease-activated receptor-1 and sphingosine kinase 1 messenger RNA expression and significantly reduced plasminogen activator inhibitor-1 and Bax messenger RNA expression. Immunohistochemistry and Western blotting demonstrated that protease-activated receptor-1 expression 24 h after Hx was significantly higher in rTM-treated than in control rats. Conclusions: rTM may improve survival after extensive Hx by inhibiting apoptosis and promoting liver regeneration. (C) 2015 Elsevier Inc. All rights reserved.	[Ota, Yohei; Kumamoto, Takafumi; Ishibe, Atsushi; Watanabe, Kazuteru; Mori, Ryutarou; Taniguchi, Koichi; Matsuyama, Ryusei; Makino, Hirochika; Ueda, Michio; Kubota, Toru; Akiyama, Hirotoshi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Ota, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	y.ota1029@gmail.com			Yokohama City University, Yokohama, Japan	This study was supported by a grant-in-aid from the 2010 Strategic Research Project of Yokohama City University, Yokohama, Japan.	Esmon CT, 2000, THROMB HAEMOSTASIS, V83, P639; Riewald M, 2008, ARTERIOSCL THROM VAS, V28, P1, DOI 10.1161/ATVBAHA.107.157321; Takano K, 2010, SHOCK, V34, P573, DOI 10.1097/SHK.0b013e3181df0433; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Higgins GM, 1931, ARCH PATHOL, V12, P186; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Tsuruta K, 2011, J CLIN PHARMACOL, V51, P1276, DOI 10.1177/0091270010381900; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; NALDINI L, 1992, EMBO J, V11, P4825; Kuriyama N, 2009, LIVER INT, V29, P299, DOI 10.1111/j.1478-3231.2008.01796.x; Macias WL, 2005, CRIT CARE, V9, pS38, DOI 10.1186/cc3747; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; CONWAY EM, 1993, BLOOD, V81, P726; DEMETRIOU AA, 1988, HEPATOLOGY, V8, P1006, DOI 10.1002/hep.1840080505; Fausto N, 1996, HEPATOLOGY TXB LIVER, P32; GAUB J, 1984, HEPATOLOGY, V4, P902, DOI 10.1002/hep.1840040519; GIMENEZ A, 1995, HEPATOLOGY, V22, P1259, DOI 10.1016/0270-9139(95)90637-1; Hasegawa S, 1999, TRANSPLANT P, V31, P558, DOI 10.1016/S0041-1345(98)01554-1; Iino S, 2004, CLIN CANCER RES, V10, P6179, DOI 10.1158/1078-0432.CCR-03-0750; Ishibe A, 2009, WOUND REPAIR REGEN, V17, P62, DOI 10.1111/j.1524-475X.2008.00442.x; Iwata M, 2008, BIOCHEM BIOPH RES CO, V377, P642, DOI 10.1016/j.bbrc.2008.10.049; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Koyama S, 2003, HEPATO-GASTROENTEROL, V50, P37; Kubota T, 1997, J HEP BIL PANCR SURG, V4, P398, DOI 10.1007/BF02488972; Kumamoto T, 2008, LIVER INT, V28, P865, DOI 10.1111/j.1478-3231.2008.01712.x; LEE SS, 1987, GASTROENTEROLOGY, V93, P157; Makino H, 2005, J SURG RES, V127, P171, DOI 10.1016/j.jss.2005.04.029; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Matsuyama T, 2000, J PERIODONTAL RES, V35, P146, DOI 10.1034/j.1600-0765.2000.035003146.x; MOCHIDA S, 1990, GASTROENTEROLOGY, V99, P771; Morita Tomoyuki, 2002, J Hepatobiliary Pancreat Surg, V9, P352, DOI 10.1007/s005340200039; Shimizu S, 2003, AM J RESP CRIT CARE, V167, P1416, DOI 10.1164/rccm.200206-515OC; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; THORNTON AJ, 1994, CANCER RES, V54, P1337; Watanabe K, 2007, J SURG RES, V143, P13, DOI 10.1016/j.jss.2007.04.041	39	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					375	382		10.1016/j.jss.2014.10.048		8	Surgery	Surgery	CD4OC	WOS:000351061900009		
J	Kamiya, K; Unno, N; Miyazaki, S; Sano, M; Kikuchi, H; Hiramatsu, Y; Ohta, M; Yamatodani, T; Mineta, H; Konno, H				Kamiya, Kinji; Unno, Naoki; Miyazaki, Shinichiro; Sano, Masaki; Kikuchi, Hirotoshi; Hiramatsu, Yoshihiro; Ohta, Manabu; Yamatodani, Takashi; Mineta, Hiroyuki; Konno, Hiroyuki			Quantitative assessment of the free jejunal graft perfusion	JOURNAL OF SURGICAL RESEARCH			English	Article						Indocyanine green; Fluorescence angiography; Free jejunal graft; Pharyngoesophagectomy; Esophageal cancer	INDOCYANINE GREEN; FREE-FLAP; FLUORESCENCE LYMPHOGRAPHY; PRELIMINARY EXPERIENCE; CERVICAL ESOPHAGUS; RECONSTRUCTION; ANGIOGRAPHY; ISCHEMIA; HYPOPHARYNGEAL; OBSTRUCTION	Background: Reconstruction with free jejunal graft (FJG) is often performed for patients with hypopharyngeal or cervical esophageal cancer. During reconstruction with an FJG after pharyngoesophagectomy, it is critical to intraoperatively detect venous anastomotic failure and subsequent venous malperfusion to avoid postoperative FJG necrosis. This study introduces a novel method for assessing blood perfusion in FJGs by using indocyanine green (ICG) fluorescence angiography. Methods: We used ICG fluorescence angiography to quantitatively assess FJG blood perfusion in archived fluorescence video files from 26 patients who had undergone FJG transfer. A software program "ROIs", was used to create a time-fluorescence intensity curve. We retrospectively measured the maximum fluorescence intensity at the terminal ileum and the duration (T1/2max) between when the intensity began rising and when it reached half of the maximum. Results: Among the 26 patients, 5 patients suffered venous anastomotic failure. In three of these cases, anastomosis was corrected intraoperatively; the other two patients underwent a second FJG transfer. Retrospective assessment showed that the mean T1/2max at the FJG serosae was significantly longer in these five patients than that in FJGs with good blood perfusion. Our analysis revealed that a T1/2max >9.6 s may be a good indicator of FJG venous malperfusion. Conclusions: Quantitative analysis of ICG fluorescence angiography proved useful for detecting venous anastomotic failure of FJG, and may help to reduce vascular problems in FJG reconstruction. (C) 2015 Elsevier Inc. All rights reserved.	[Kamiya, Kinji; Unno, Naoki; Miyazaki, Shinichiro; Sano, Masaki; Kikuchi, Hirotoshi; Hiramatsu, Yoshihiro; Ohta, Manabu; Konno, Hiroyuki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Yamatodani, Takashi; Mineta, Hiroyuki] Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Hamamatsu, Shizuoka 4313192, Japan	Unno, N (reprint author), Hamamatsu Univ Sch Med, Dept Surg 2, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	unno@hama-med.ac.jp			 [24591938];  [20291958]	This work was supported by Grant-in-Aid for Scientific Research (C) (24591938) (K.K.) and Grant-in-Aid for Scientific Research (B) (20291958) (N.U.).	ANGEL MF, 1990, PLAST RECONSTR SURG, V85, P789, DOI 10.1097/00006534-199005000-00021; Angel MF, 1990, PLAST RECONSTR SURG, V85, P94, DOI 10.1097/00006534-199005000-00022; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Pacheco PE, 2013, AM J SURG, V205, P349, DOI 10.1016/j.amjsurg.2012.11.005; SEIDENBERG B, 1959, ANN SURG, V149, P162, DOI 10.1097/00000658-195902000-00002; Newman MI, 2009, J RECONSTR MICROSURG, V25, P21, DOI 10.1055/s-0028-1090617; Perez-Smith D, 2013, J PLAST RECONSTR AES, V66, P9, DOI 10.1016/j.bjps.2012.08.033; Unno N, 2008, EUR J VASC ENDOVASC, V35, P205, DOI 10.1016/j.ejvs.2007.09.001; Ott K, 2009, BRIT J SURG, V96, P258, DOI 10.1002/bjs.6437; Shimada Y, 2011, ESOPHAGUS-TOKYO, V8, P259, DOI 10.1007/s10388-011-0291-7; Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Mirzabeigi MN, 2012, PLAST RECONSTR SURG, V130, P579, DOI 10.1097/PRS.0b013e31825dbfb7; Disa JJ, 2003, PLAST RECONSTR SURG, V111, P652, DOI 10.1097/01.PRS.0000041987.53831.23; BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017; Sarukawa S, 2006, SCAND J PLAST RECONS, V40, P148, DOI 10.1080/02844310600652894; Balacumaraswami L, 2005, J THORAC CARDIOV SUR, V130, P315, DOI 10.1016/j.jtcvs.2004.11.033; Cho BC, 2002, PLAST RECONSTR SURG, V110, P1249; HAUGHEY BH, 1994, OTOLARYNG CLIN N AM, V27, P1159; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P1083, DOI 10.1097/00006534-199206000-00014; HJORTDAL VE, 1994, PLAST RECONSTR SURG, V93, P366, DOI 10.1097/00006534-199402000-00023; Kamiya K, 2007, DIGEST SURG, V24, P214, DOI 10.1159/000102902; Kim KW, 2007, AM J ROENTGENOL, V188, pW239, DOI 10.2214/AJR.05.1761; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Sekijima M, 2004, TRANSPLANT P, V36, P2188, DOI 10.1016/j.transproceed.2004.09.001; Shirakawa Y, 2004, LANGENBECK ARCH SURG, V389, P387, DOI 10.1007/s00423-004-0501-z; Taggart DP, 2003, ANN THORAC SURG, V75, P870, DOI 10.1016/S0003-4975(02)04669-6; Yamana I, 2014, ANN THORAC CARDIOVAS, V20, P1, DOI 10.5761/atcs.oa.12.02041	28	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					394	399		10.1016/j.jss.2014.10.049		6	Surgery	Surgery	CD4OC	WOS:000351061900012		
J	Sugimoto, M; Takahashi, S; Kobayashi, T; Kojima, M; Gotohda, N; Satake, M; Ochiai, A; Konishi, M				Sugimoto, Motokazu; Takahashi, Shinichiro; Kobayashi, Tatsushi; Kojima, Motohiro; Gotohda, Naoto; Satake, Mitsuo; Ochiai, Atsushi; Konishi, Masaru			Pancreatic perfusion data and post-pancreaticoduodenectomy outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article						Pancreatic CT perfusion; Postoperative pancreatic fistula; Pancreaticoduodenectomy; Fibrosis	DYNAMIC COMPUTED-TOMOGRAPHY; 320-DETECTOR ROW CT; ANASTOMOTIC LEAKAGE; EMISSION-TOMOGRAPHY; RISK-FACTORS; FISTULA; LIVER; EXPRESSION; FIBROSIS; DISEASES	Background: Precise risk assessment for postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) may be facilitated using imaging modalities. Computed tomography perfusion (CTP) of the pancreas may represent histologic findings. This study aimed to evaluate the utility of CTP data for the risk of POPF after PD, in relation to histologic findings. Methods: Twenty patients who underwent preoperative pancreatic CTP measurement using 320-detector row CT before PD were investigated. Clinicopathologic findings, including CTP data, were analyzed to assess the occurrence of POPF. In addition, the correlation between CTP data and histologic findings was evaluated. Results: POPF occurred in 11 cases (grade A, 6; grade B, 5; and grade C, 0). In CTP data, both high arterial flow (AF) and shortmeantransit time (MTT) were related to POPF occurrence (P = 0.001, P = 0.001). AF was negatively correlated with fibrosis in the pancreatic parenchyma (r = -0.680), whereas MTT was positively correlated with fibrosis (r = 0.725). AF >80 mL/min/100 mL and MTT <16 s showed high sensitivity, specificity, positive predictive value, and negative predictive value (80.0%, 100.0%, 100.0%, and 83.3%, respectively) for the occurrence of POPF. Conclusions: CTP data for the pancreas were found to be correlated with the occurrence of POPF after PD. Alterations in the blood flow to the remnant pancreas may reflect histological changes, including fibrosis in the pancreatic stump, and influence the outcome after PD. CTP may thus facilitate objective and quantitative risk assessment of POPF after PD. (C) 2015 Elsevier Inc. All rights reserved.	[Sugimoto, Motokazu; Takahashi, Shinichiro; Gotohda, Naoto; Konishi, Masaru] Natl Canc Ctr Hosp East, Dept Hepatobiliary Pancreat Surg, Kashiwa, Chiba 2778577, Japan; [Sugimoto, Motokazu; Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Kobayashi, Tatsushi; Satake, Mitsuo] Natl Canc Ctr Hosp East, Dept Radiol, Kashiwa, Chiba 2778577, Japan	Takahashi, S (reprint author), Natl Canc Ctr Hosp East, Dept Hepatobiliary Pancreat Surg, 6-5-1 Kashiwa No Ha, Kashiwa, Chiba 2778577, Japan.	shtakaha@east.ncc.go.jp			Health and Labor Sciences Research grants for Third-term Comprehensive Control Research for Cancer [General-025]; Health and Labor Sciences Research grants for Research on Applying Health Technology	The authors express special thanks to So Tsushima of the Application Development Group and Shinsuke Tsukagoshi of the CT Systems Development Department of Toshiba Medical Systems Corporation for their technical assistance with 320-detector row perfusion CT. This work was supported in part by Health and Labor Sciences Research grants for Third-term Comprehensive Control Research for Cancer (General-025) and Health and Labor Sciences Research grants for Research on Applying Health Technology.	Aizawa M, 2012, PANCREAS, V41, P512, DOI 10.1097/MPA.0b013e31823ca3e0; Goshima S, 2011, RADIOLOGY, V260, P139, DOI 10.1148/radiol.11101459; Hashimoto K, 2006, ONCOL REP, V16, P677; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Friess H, 1996, PANCREAS, V13, P202; Bize PE, 2006, AM J ROENTGENOL, V186, P114, DOI 10.2214/AJR.04.1416; Tsuji Y, 2007, CLIN GASTROENTEROL H, V5, P1484, DOI 10.1016/j.cgh.2007.07.014; Xiong JJ, 2014, BRIT J SURG, V101, P1196, DOI 10.1002/bjs.9553; Tajima Y, 2004, BRIT J SURG, V91, P595, DOI 10.1002/bjs.4461; Ziegler SI, 1996, EUR J NUCL MED, V23, P169, DOI 10.1007/BF01731841; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Callery MP, 2013, J AM COLL SURGEONS, V216, P1, DOI 10.1016/j.jamcollsurg.2012.09.002; Ronot M, 2010, RADIOLOGY, V256, P135, DOI 10.1148/radiol.10091295; Ammann RW, 1996, GASTROENTEROLOGY, V111, P224, DOI 10.1053/gast.1996.v111.pm8698203; Hashimoto Y, 2011, J GASTROINTEST SURG, V15, P2193, DOI 10.1007/s11605-011-1687-3; MILES KA, 1995, BRIT J RADIOL, V68, P471; Nasis A, 2013, EUR RADIOL, V23, P1812, DOI 10.1007/s00330-013-2788-z; Dinter DJ, 2009, J GASTROINTEST SURG, V13, P735, DOI 10.1007/s11605-008-0765-7; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Allen PJ, 2014, NEW ENGL J MED, V370, P2014, DOI 10.1056/NEJMoa1313688; Hayashibe A, 2007, J SURG ONCOL, V95, P106, DOI 10.1002/jso.20608; Frozanpor F, 2012, WORLD J SURG, V36, P1858, DOI 10.1007/s00268-012-1567-3; Arikawa S, 2012, PANCREAS, V41, P530; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Kojima M, 2005, ONCOLOGY-BASEL, V68, P230, DOI 10.1159/000086779; Kuehn R, 1999, PANCREAS, V18, P96, DOI 10.1097/00006676-199901000-00012; Materne R, 2000, CLIN SCI, V99, P517, DOI 10.1042/CS20000080; Menahem B, 2014, ANN SURG; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Rzepko R, 2003, FOLIA HISTOCHEM CYTO, V41, P237; Shinohara Y, 2010, J COMPUT ASSIST TOMO, V34, P830, DOI 10.1097/RCT.0b013e3181ebd16a; Sugimoto M, 2013, J GASTROINTEST SURG, V17, P1744, DOI 10.1007/s11605-013-2320-4; Sugimoto M, 2014, SURGERY, V156, P1204, DOI 10.1016/j.surg.2014.05.015; Tajima Y, 2006, J AM COLL SURGEONS, V202, P723, DOI 10.1016/j.jamcollsurg.2006.01.008; Tobin NP, 2012, HUM PATHOL, V43, P2053, DOI 10.1016/j.humpath.2012.02.015	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					441	449		10.1016/j.jss.2014.11.046		9	Surgery	Surgery	CD4OC	WOS:000351061900018		
J	Ikeda, T; Kumashiro, R; Oki, E; Taketani, K; Ando, K; Aishima, S; Akahoshi, T; Morita, M; Maehara, Y				Ikeda, Tetsuo; Kumashiro, Ryuichi; Oki, Eiji; Taketani, Kenji; Ando, Koji; Aishima, Shinichi; Akahoshi, Tomohiko; Morita, Masaru; Maehara, Yoshihiko			Evaluation of techniques to prevent colorectal anastomotic leakage	JOURNAL OF SURGICAL RESEARCH			English	Article						Colorectal anastomosis; Anastomotic leakage; Low anterior resection; DST; Bursting pressure; Porcine rectum; Experimental study	STAPLE-LINE REINFORCEMENT; LOW ANTERIOR RESECTION; CIRCULAR STAPLER; SEAMGUARD; SURGERY; RECTUM	Background: Anastomotic leakage is a major complication after anterior resection for rectal cancer. The double-stapling technique (DST) is the main method for creating a colorectal anastomosis. However, the rate of anastomotic leakage after DST remains high, and the technical risk factors have not been well established. Materials and methods: Five methods of colorectal anastomosis were performed on the porcine rectum and colon: single-stapled double-purse-string (SSDP), DST, side-to-side with a linear stapler (SS-L), side-to-side with a circular stapler (SS-C), and SS-C with hand-sewn reinforcement (n = 6 for each method). In each group, burst pressures were tested, paying special attention to the locations of the first disruptions. The anastomosis line, including staples, was embedded in polyester resin, and polished sections were examined histologically. Results: Burst pressures were significantly higher in the SS-L and SS-C than those in the SSDP and DST groups (P < 0.001) and were higher in the SS-C with hand-sewn reinforcement than those in the SS-L and SS-C groups (P < 0.001). Remarkably, in the SSDP, DST, and SS-C groups, the first disruptions occurred on the staple line created by the circular stapler. Conclusions: The experimentally strongest colorectal anastomosis created with instruments currently in use was a SS-C. This anastomosis does not overlap staple lines and does not require a purse-string suture. Hand-sewn reinforcement was effective in increasing the anastomotic strength. (C) 2015 Elsevier Inc. All rights reserved.	[Ikeda, Tetsuo; Kumashiro, Ryuichi; Oki, Eiji; Taketani, Kenji; Ando, Koji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Aishima, Shinichi] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Akahoshi, Tomohiko] Kyushu Univ, Dept Integrat Adv Med Life Sci & Innovat Technol, Fukuoka 812, Japan	Ikeda, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	t-ikeda@surg2.med.kyushu-u.ac.jp			Scientific Research Fund of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	No financial support was received for this work from any company. This study was supported in part by a grant from the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	De Nardi P, 2008, TECH COLOPROCTOL, V12, P69, DOI 10.1007/s10151-008-0401-2; Fajardo AD, 2012, SURG INNOV, V19, P288, DOI 10.1177/1553350611429025; Franklin ME, 2006, SURG LAPARO ENDO PER, V16, P411, DOI 10.1097/SLE.0b013e31802b68fe; Ikeda T, 2015, J SURG RES, V193, P126, DOI 10.1016/j.jss.2014.07.009; Kim HJ, 2013, INT J COLORECTAL DIS, V28, P149, DOI 10.1007/s00384-012-1582-8; KYZER S, 1992, INT J COLORECTAL DIS, V7, P125, DOI 10.1007/BF00360351; Marecik SJ, 2007, AM J SURG, V193, P395, DOI 10.1016/j.amjsurg.2006.12.008; Moore JWE, 1996, AUST NZ J SURG, V66, P820, DOI 10.1111/j.1445-2197.1996.tb00757.x; Pantelis D, 2010, LANGENBECK ARCH SURG, V395, P1039, DOI 10.1007/s00423-010-0703-5; Portillo G, 2010, J LAPAROENDOSC ADV S, V20, P323, DOI 10.1089/lap.2009.0201; Roumen RMH, 2000, DIS COLON RECTUM, V43, P522, DOI 10.1007/BF02237198; Storer EH, 1994, PRINCIPLES SURG, V26, p[1191, 1204]	12	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					450	457		10.1016/j.jss.2014.11.045		8	Surgery	Surgery	CD4OC	WOS:000351061900019		
J	Uchiyama, M; Tojo, K; Yazawa, T; Ota, S; Goto, T; Kurahashi, K				Uchiyama, Munehito; Tojo, Kentaro; Yazawa, Takuya; Ota, Shuhei; Goto, Takahisa; Kurahashi, Kiyoyasu			Edaravone prevents lung injury induced by hepatic ischemia-reperfusion	JOURNAL OF SURGICAL RESEARCH			English	Article						Lung injury; Hepatic ischemia-reperfusion; Reactive oxygen species; Free radical-scavenger; Cytokine; Liver injury	FREE-RADICAL SCAVENGER; LIVER-TRANSPLANTATION; LIPID-PEROXIDATION; PULMONARY-EDEMA; RAT-LIVER; MCI-186; INDEXES; DAMAGE	Background: Lung injury is a major clinical concern after hepatic ischemia-reperfusion (I/R), due to the production of reactive oxygen species in the reperfused liver. We investigated the efficacy of edaravone, a potent free-radical scavenger, for attenuating lung injury after hepatic I/R. Materials and methods: Adult male Sprague-Dawley rats were assigned to sham + normal saline (NS), I/R + NS, or I/R + edaravone group. Rats in the I/R groups were subjected to 90 min of partial hepatic I/R. Five minutes before reperfusion, 3 mg/kg edaravone was administered to the I/R + edaravone group. After 6 h of reperfusion, we evaluated lung histopathology and wet-to-dry ratio. We also measured malondialdehyde (MDA), an indicator of oxidative stress, in the liver and the lung, as well as cytokine messenger RNA expressions in the reperfused liver and plasma cytokine concentrations. Results: Histopathology revealed lung damages after 6 h reperfusion of partial ischemic liver. Moreover, a significant increase in lung wet-to-dry ratio was observed. MDA concentration increased in the reperfused liver, but not in the lungs. Edaravone administration attenuated the lung injury and the increase of MDA in the reperfused liver. Edaravone also suppressed the reperfusion-induced increase of interleukin-6 messenger RNA expressions in the liver and plasma interleukin-6 concentrations. Conclusions: Edaravone administration before reperfusion of the ischemic liver attenuates oxidative stress in the reperfused liver and the subsequent lung injury. Edaravone may be beneficial for preventing lung injury induced by hepatic I/R. (C) 2015 Elsevier Inc. All rights reserved.	[Uchiyama, Munehito] Yokohama City Univ, Dept Emergency Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Tojo, Kentaro; Goto, Takahisa; Kurahashi, Kiyoyasu] Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Yazawa, Takuya] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan; [Ota, Shuhei] Kanagawa Canc Ctr, Dept Palliat Care Med, Yokohama, Kanagawa 2410815, Japan	Kurahashi, K (reprint author), Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	kiyok@med.yokohama-cu.ac.jp			Japan Society for the Promotion of Science [23592303]	This work was supported by Grants-in-Aid for Scientific Research (No. 23592303) from the Japan Society for the Promotion of Science to K.K. The authors thank Ms Keiko Yaba Clinical laboratory, Yokohama City University Hospital, Yokohama, Japan) and Ms Yuki Yuba (Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine) for technical assistance.	Aduen JF, 2003, LIVER TRANSPLANT, V9, P764, DOI 10.1053/jlts.2003.50103; Taniguchi M, 2007, J SURG RES, V137, P69, DOI 10.1016/j.jss.2006.06.033; Snowden CP, 2000, LIVER TRANSPLANT, V6, P466, DOI 10.1053/jlts.2000.7580; Meagher EA, 2000, FREE RADICAL BIO MED, V28, P1745, DOI 10.1016/S0891-5849(00)00232-X; Schroeder RA, 2006, ANN SURG, V243, P373, DOI 10.1097/01.sla.0000201483.95911.08; Ahuja N, 2012, AM J PHYSIOL-RENAL, V303, pF864, DOI 10.1152/ajprenal.00025.2012; COLLETTI LM, 1995, J CLIN INVEST, V95, P134, DOI 10.1172/JCI117630; NISHI H, 1989, STROKE, V20, P1236; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Okatani Y, 2003, EUR J PHARMACOL, V465, P163, DOI 10.1016/S0014-2999(03)01463-8; Zhang H, 2013, J CLIN INVEST, V123, P1019, DOI 10.1172/JCI64931; Brenner T, 2010, ANESTHESIOL RES PRAC, V2010, P1, DOI DOI 10.1155/2010/586425; Castro Angela Potter de, 2012, Acta Cir Bras, V27, P49; Chan KC, 2008, ANESTH ANALG, V107, P1284, DOI 10.1213/ane.0b013e318181f4e6; Chiu MH, 2012, TRANSPL P, V44, P962, DOI 10.1016/j.transproceed.2012.01.097; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Komatsu T, 1996, YAKUBUTSUDOUTAI, V11, P463; Kono H, 2006, FREE RADICAL RES, V40, P579, DOI 10.1080/10715760600606374; Nielsen VG, 1996, AM J RESP CRIT CARE, V154, P1364; Ota S, 2007, AM J PHYSIOL-LUNG C, V292, pL625, DOI 10.1152/ajplung.00151.2006; Suzuki F, 2005, TRANSPLANT INT, V18, P844, DOI 10.1111/j.1432-2277.2005.00094.x	24	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					551	557		10.1016/j.jss.2014.11.011		7	Surgery	Surgery	CD4OC	WOS:000351061900032		
J	Tanaka, M; Shinoda, M; Takayanagi, A; Oshima, G; Nishiyama, R; Fukuda, K; Yagi, H; Hayashida, T; Masugi, Y; Suda, K; Yamada, S; Miyasho, T; Hibi, T; Abe, Y; Kitago, M; Obara, H; Itano, O; Takeuchi, H; Sakamoto, M; Tanabe, M; Maruyama, I; Kitagawa, Y				Tanaka, Masayuki; Shinoda, Masahiro; Takayanagi, Atsushi; Oshima, Go; Nishiyama, Ryo; Fukuda, Kazumasa; Yagi, Hiroshi; Hayashida, Tetsu; Masugi, Yohei; Suda, Koichi; Yamada, Shingo; Miyasho, Taku; Hibi, Taizo; Abe, Yuta; Kitago, Minoru; Obara, Hideaki; Itano, Osamu; Takeuchi, Hiroya; Sakamoto, Michiie; Tanabe, Minoru; Maruyama, Ikuro; Kitagawa, Yuko			Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model	JOURNAL OF SURGICAL RESEARCH			English	Article						Acute liver failure; High-mobility group box 1; Adenovirus vectors; Box-A; Gene delivery	INTERLEUKIN-1 RECEPTOR ANTAGONIST; ISCHEMIA-REPERFUSION INJURY; HEPATIC ISCHEMIA; IMMUNE-RESPONSES; HMGB1; ACTIVATION; PROTEIN; RAGE; MICE; INFLAMMATION	Background: High-mobility group box 1 (HMGB1) has recently been identified as an important mediator of various kinds of acute and chronic inflammation. The protein encoded by the box-A domain of the HMGB1 gene is known to act as a competitive inhibitor of HMGB1. In this study, we investigated whether box-A gene transfer results in box-A protein production in rats and assessed therapeutic efficacy in vivo using an acute liver failure (ALF) model. Materials and methods: Three types of adenovirus vectors were constructed-a wild type and two mutants-and a mutant vector was then selected based on the secretion from HeLa cells. The secreted protein was subjected to a tumor necrosis factor (TNF) production inhibition test in vitro. The vector was injected via the portal vein in healthy Wistar rats to confirm box-A protein production in the liver. The vector was then injected via the portal vein in rats with ALF. Results: Western blot analysis showed enhanced expression of box-A protein in HeLa cells transfected with one of the mutant vectors. The culture supernatant from HeLa cells transfected with the vector inhibited TNF-alpha production from macrophages. Expression of box-A protein was confirmed in the transfected liver at 72 h after transfection. Transfected rats showed decreased hepatic enzymes, plasma HMGB1, and hepatic TNF-alpha messenger RNA levels, and histologic findings and survival were significantly improved. Conclusions: HMGB1 box-A gene transfer results in box-A protein production in the liver and appears to have a beneficial effect on ALF in rats. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Masayuki; Shinoda, Masahiro; Oshima, Go; Nishiyama, Ryo; Fukuda, Kazumasa; Yagi, Hiroshi; Hayashida, Tetsu; Suda, Koichi; Hibi, Taizo; Abe, Yuta; Kitago, Minoru; Obara, Hideaki; Itano, Osamu; Takeuchi, Hiroya; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Takayanagi, Atsushi] Keio Univ, Dept Mol Biol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Masugi, Yohei; Sakamoto, Michiie] Keio Univ, Dept Pathol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Shingo] Shino Test Corp, Cent Inst, Sagamihara, Kanagawa, Japan; [Miyasho, Taku] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Sci, Ebetsu, Hokkaido 069, Japan; [Tanabe, Minoru] Tokyo Med & Dent Univ, Dept Surg, Bunkyo Ku, Tokyo, Japan; [Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan	Shinoda, M (reprint author), Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	masa02114@yahoo.co.jp	Sakamoto, Michiie/N-2917-2015		Ministry of Education, Science, and Culture of Japan [23591875]	This work was partially supported by grants-in-aid from the Ministry of Education, Science, and Culture of Japan (#23591875). The authors thank the late Dr Akitoshi Ishizaka for his invaluable advice during the investigation and Ms Katsuko Sano for her technical assistance.	Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Watanabe T, 2005, J SURG RES, V124, P59, DOI 10.1016/j.jss.2004.10.019; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Tsung A, 2007, J LEUKOCYTE BIOL, V81, P119, DOI 10.1189/jlb.0706468; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Fan J, 2007, J IMMUNOL, V178, P6573; Takano K, 2010, SHOCK, V34, P573, DOI 10.1097/SHK.0b013e3181df0433; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI [10.1016/j.bbagrm.2009.11.019, 10.1016/j.bbagrm.2009.11.049]; Kikuchi H, 2014, J SURG RES, V190, P134, DOI 10.1016/j.jss.2014.02.047; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Kuhla A, 2013, BRIT J SURG, V100, P1229, DOI 10.1002/bjs.9188; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Apetoh L, 2007, REV IMMUNOL, V220, P47; Edward A, 2000, J IMMUNOL, V165, P2950; Harada H, 2002, TRANSPLANTATION, V74, P1434, DOI 10.1097/01.TP.0000034711.92003.EC; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nishiyama R, 2013, EUR SURG RES, V51, P181, DOI 10.1159/000357563; Ono S, 2012, J SURG RES, V176, P293, DOI 10.1016/j.jss.2011.07.053; Oshima G, 2012, EUR SURG RES, V48, P154, DOI 10.1159/000338363; Shinoda M, 2006, TISSUE ENG, V12, P1313, DOI 10.1089/ten.2006.12.1313; Suda K, 2006, WORLD J SURG, V30, P1755, DOI 10.1007/s00268-005-0369-2	36	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					571	580		10.1016/j.jss.2014.11.022		10	Surgery	Surgery	CD4OC	WOS:000351061900035		
J	Kimura, T; Nojiri, T; Hosoda, H; Ishikane, S; Shintani, Y; Inoue, M; Miyazato, M; Okumura, M; Kangawa, K				Kimura, Toru; Nojiri, Takashi; Hosoda, Hiroshi; Ishikane, Shin; Shintani, Yasushi; Inoue, Masayoshi; Miyazato, Mikiya; Okumura, Meinoshin; Kangawa, Kenji			C-type natriuretic peptide attenuates lipopolysaccharide-induced acute lung injury in mice	JOURNAL OF SURGICAL RESEARCH			English	Article						C-type natriuretic peptide; Acute lung injury; Pulmonary inflammation; Anti-inflammation	ENDOTHELIAL-CELLS; KAPPA-B; INFLAMMATION; CNP; MECHANISMS; DELIVERY; RATS	Background: C-type natriuretic peptide (CNP), secreted by vascular endothelial cells, belongs to a family of peptides that includes atrial and brain natriuretic peptides. CNP exhibits many vasoprotective effects against pulmonary hypertension and pulmonary fibrosis. The objective of this study was to investigate the prophylactic effects of CNP in a mouse model of lipopolysaccharide (LPS)-induced acute lung injury (ALI). Materials and methods: C57BL/6 mice were divided into three groups as follows: normal control mice (n = 13), LPS mice treated with vehicle (n = 12), and LPS mice treated with CNP (n = 12). Twenty-four hours after tail vein injection of LPS, histopathologic, gene expression, and bronchoalveolar lavage fluid (BALF) assessments were performed on the lungs. To examine the neutrophils in the lungs, cells positive for myeloperoxidase staining were detected by immunohistochemistry. BALF cytokine levels were analyzed by enzyme-linked immunosorbent assays. Gene expression in lung tissue was analyzed by real-time polymerase chain reaction. Results: CNP significantly attenuated the elevation of leukocyte cell counts and levels of tumor necrosis factor-alpha, macrophage inflammatory protein-2, monocyte chemoattractant protein1, interleukin-6, and keratinocyte-derived chemokine in the BALF after LPS injection. Furthermore, there were significantly fewer myeloperoxidase-positive cells in lungs treated with CNP after LPS injection. In lungs of CNP-treated mice, expression of the monocyte chemoattractant protein-1, S100A8, and E-selectin geneswas significantly lower than that in vehicle-treated mice. Conclusions: CNP had a protective effect on ALI induced by LPS by reducing inflammatory cell infiltration. CNP may hold promise in therapeutic strategies for ALI after pulmonary resection surgery. (C) 2015 Elsevier Inc. All rights reserved.	[Kimura, Toru; Nojiri, Takashi; Ishikane, Shin; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Kimura, Toru; Nojiri, Takashi; Shintani, Yasushi; Inoue, Masayoshi; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka, Japan; [Hosoda, Hiroshi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan	Nojiri, T (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, 5-7-1 Fujishir Odai, Suita, Osaka 5658565, Japan.	kimura@thoracic.med.osaka-u.ac.jp			 [90580796]	This work was supported in part by a grant-in-aid for Scientific Research (90580796).	Alam N, 2007, ANN THORAC SURG, V84, P91; Jubeli E, 2012, J CONTROL RELEASE, V158, P194, DOI 10.1016/j.jconrel.2011.09.084; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Vandal K, 2003, J IMMUNOL, V171, P2602; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524; Alam N, 2007, ANN THORAC SURG, V84, P1085, DOI 10.1016/j.athoracsur.2007.05.053; Nojiri T, 2014, PULM PHARMACOL THER, V29, P24, DOI 10.1016/j.pupt.2014.01.003; Ahluwalia A, 2004, BASIC RES CARDIOL, V99, P83, DOI 10.1007/s00395-004-0459-6; Shenkar R, 1999, J IMMUNOL, V163, P954; Liu F, 2013, J SURG RES, V185, P300, DOI 10.1016/j.jss.2013.05.083; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; Del Ry S, 2013, PEPTIDES, V40, P93, DOI 10.1016/j.peptides.2012.12.010; Feng XS, 2014, INFLAMMATION, V37, P1091, DOI 10.1007/s10753-014-9833-1; Itoh T, 2004, AM J RESP CRIT CARE, V170, P1204, DOI 10.1164/rccm.200404-455OC; Kiemer AK, 2002, ENDOCRINOLOGY, V143, P846, DOI 10.1210/en.143.3.846; Murakami S, 2004, AM J PHYSIOL-LUNG C, V287, pL1172, DOI 10.1152/ajplung.00087.2004; Obata H, 2007, BIOCHEM BIOPH RES CO, V356, P60, DOI 10.1016/j.bbrc.2007.02.085; Ogino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092710; Rautureau Y., 2010, Autonomic & Autacoid Pharmacology, V30, P185, DOI 10.1111/j.1474-8673.2009.00449.x; Schachner T, 2004, EUR J CARDIO-THORAC, V25, P585, DOI 10.1016/j.ejcts.2003.07.013; Soeki Takeshi, 2005, J Am Coll Cardiol, V45, P608, DOI 10.1016/j.jacc.2004.10.067; SUGA S, 1993, ENDOCRINOLOGY, V133, P3038, DOI 10.1210/en.133.6.3038	26	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					631	637		10.1016/j.jss.2014.11.023		7	Surgery	Surgery	CD4OC	WOS:000351061900041		
J	Onodera, N; Yoshikane, F				Onodera, Natsuo; Yoshikane, Fuyuki			Factors Affecting Citation Rates of Research Articles	JOURNAL OF THE ASSOCIATION FOR INFORMATION SCIENCE AND TECHNOLOGY			English	Article							SCIENTIFIC COLLABORATION; BIBLIOMETRIC INDICATORS; INFORMATION-SCIENCE; SELF-CITATIONS; JOURNAL IMPACT; CO-AUTHORSHIP; QUALITY; COUNTS; PUBLICATIONS; REFERENCES	This study examines whether there are some general trends across subject fields regarding the factors affecting the number of citations of articles, focusing especially on those factors that are not directly related to the quality or content of articles (extrinsic factors). For this purpose, from 6 selected subject fields (condensed matter physics, inorganic and nuclear chemistry, electric and electronic engineering, biochemistry and molecular biology, physiology, and gastroenterology), original articles published in the same year were sampled (n=230-240 for each field). Then, the citation counts received by the articles in relatively long citation windows (6 and 11 years after publication) were predicted by negative binomial multiple regression (NBMR) analysis for each field. Various article features about author collaboration, cited references, visibility, authors' achievements (measured by past publications and citedness), and publishing journals were considered as the explanatory variables of NBMR. Some generality across the fields was found with regard to the selected predicting factors and the degree of significance of these predictors. The Price index was the strongest predictor of citations, and number of references was the next. The effects of number of authors and authors' achievement measures were rather weak.	[Onodera, Natsuo; Yoshikane, Fuyuki] Univ Tsukuba, Fac Lib Informat & Media Sci, Tsukuba, Ibaraki 3058550, Japan	Onodera, N (reprint author), Univ Tsukuba, Fac Lib Informat & Media Sci, 1-2 Kasuga, Tsukuba, Ibaraki 3058550, Japan.	nt.onodera@y5.dion.ne.jp; fuyuki@slis.tsukuba.ac.jp		Onodera, Natsuo/0000-0002-2052-4712	JSPS [18300080]	This work was supported by JSPS KAKENHI Grant Number 18300080. We appreciate useful discussions with the members of the research group, in addition to their support for data acquisition and processing. We express our gratitude for helpful advice from the reviewers regarding the bias that was possibly brought on by sampling, the possibility of differences in citation tendency among subfields, and the description of Literature Review.	Akcan D, 2013, SCIENTOMETRICS, V96, P297, DOI 10.1007/s11192-013-0949-0; Aksnes DW, 2006, J AM SOC INF SCI TEC, V57, P169, DOI 10.1002/asi.20262; MacRoberts MH, 2010, J AM SOC INF SCI TEC, V61, P1, DOI 10.1002/asi.21228; Figg WD, 2006, PHARMACOTHERAPY, V26, P759, DOI 10.1592/phco.26.6.759; Chen CM, 2012, J AM SOC INF SCI TEC, V63, P431, DOI 10.1002/asi.21694; Glanzel W, 2004, SCIENTOMETRICS, V61, P395, DOI 10.1023/B:SCIE.0000045117.13348.b1; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P424, DOI 10.1002/asi.21232; Aksnes DW, 2003, SCIENTOMETRICS, V56, P235, DOI 10.1023/A:1021919228368; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P1841, DOI 10.1002/asi.20901; Bornmann L, 2006, SCIENTOMETRICS, V68, P427, DOI 10.1007/s11192-006-0121-1; Lokker C, 2008, BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Glanzel W, 2004, SCIENTOMETRICS, V59, P63; MacRoberts MH, 1996, SCIENTOMETRICS, V36, P435, DOI 10.1007/BF02129604; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; SEGLEN PO, 1994, J AM SOC INFORM SCI, V45, P1, DOI 10.1002/(SICI)1097-4571(199401)45:1<1::AID-ASI1>3.0.CO;2-Y; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Davis PM, 2009, J AM SOC INF SCI TEC, V60, P3, DOI 10.1002/asi.20965; Hsu JW, 2011, SCIENTOMETRICS, V86, P317, DOI 10.1007/s11192-010-0265-x; Bookstein A, 1999, SCIENTOMETRICS, V46, P337, DOI 10.1007/BF02464782; Pasterkamp G, 2007, SCIENTOMETRICS, V70, P153, DOI 10.1007/s11192-007-0109-5; Danell R, 2011, J AM SOC INF SCI TEC, V62, P50, DOI 10.1002/asi.21454; CHUBIN DE, 1975, SOC STUD SCI, V5, P423, DOI 10.1177/030631277500500403; Aksnes DW, 2003, RES EVALUAT, V12, P159, DOI 10.3152/147154403781776645; Schubert A, 2006, SCIENTOMETRICS, V69, P409, DOI 10.1007/s11192-006-0160-7; Rinia EJ, 1998, RES POLICY, V27, P95, DOI 10.1016/S0048-7333(98)00026-2; Abramo G, 2011, SCIENTOMETRICS, V89, P929, DOI 10.1007/s11192-011-0459-x; MORAVCSIK MJ, 1975, SOC STUD SCI, V5, P86, DOI 10.1177/030631277500500106; Basu A, 2005, ASLIB PROC, V57, P232, DOI 10.1108/00012530510599190; Bordons M, 2013, SCIENTOMETRICS, V96, P443, DOI 10.1007/s11192-012-0890-7; Bornmann L, 2011, J AM SOC INF SCI TEC, V62, P61, DOI 10.1002/asi.21418; Cronin B, 1999, J DOC, V55, P402, DOI 10.1108/EUM0000000007153; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; Didegah F, 2013, J AM SOC INF SCI TEC, V64, P1055, DOI 10.1002/asi.22806; Fanelli D, 2013, SCIENTOMETRICS, V94, P701, DOI 10.1007/s11192-012-0757-y; Fu LD, 2010, SCIENTOMETRICS, V85, P257; Haslam N, 2008, SCIENTOMETRICS, V76, P169, DOI 10.1007/s11192-007-1892-8; He ZL, 2009, J AM SOC INF SCI TEC, V60, P2151, DOI 10.1002/asi.21150; van Dalen HP, 2005, SCIENTOMETRICS, V64, P209, DOI 10.1007/s11192-005-0248-5; Honekopp J, 2012, SCIENTOMETRICS, V90, P843, DOI 10.1007/s11192-011-0551-2; Ibanez A., 2013, SCIENTOMETRICS, V95, P689; Krampen G, 2007, SCIENTOMETRICS, V71, P191, DOI 10.1007/s11192-007-1659-2; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Levitt JM, 2009, J AM SOC INF SCI TEC, V60, P434, DOI 10.1002/asi.21000; Davis PM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a568; Long J. S., 1997, REGRESSION MODELS CA; Lortie CJ, 2013, SCIENTOMETRICS, V94, P675, DOI 10.1007/s11192-012-0822-6; MACROBERTS MH, 1987, SCIENTOMETRICS, V12, P293, DOI 10.1007/BF02016665; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Moed H. F., 2005, CITATION ANAL RES EV; MOED HF, 1989, SCIENTOMETRICS, V15, P473, DOI 10.1007/BF02017066; Mryglod O, 2013, SCIENTOMETRICS, V95, P115, DOI 10.1007/s11192-012-0874-7; Onodera N, 2011, J AM SOC INF SCI TEC, V62, P677, DOI 10.1002/asi.21491; Oppenheim C, 1997, J DOC, V53, P477, DOI 10.1108/EUM0000000007207; Patterson MS, 2009, SCIENTOMETRICS, V80, P343, DOI 10.1007/s11192-008-2064-1; Peclin S, 2012, SCIENTOMETRICS, V93, P937, DOI 10.1007/s11192-012-0768-8; Peng TQ, 2012, J AM SOC INF SCI TEC, V63, P1789, DOI 10.1002/asi.22649; PETERS HPF, 1994, J AM SOC INFORM SCI, V45, P39, DOI 10.1002/(SICI)1097-4571(199401)45:1<39::AID-ASI5>3.0.CO;2-Q; Rigby J, 2013, SCIENTOMETRICS, V94, P57, DOI 10.1007/s11192-012-0779-5; Sin S. C. J., 2011, J AM SOC INFORM SCI, V62, P1770; Slyder JB, 2011, SCIENTOMETRICS, V89, P955, DOI 10.1007/s11192-011-0467-x; Sooryamoorthy R, 2009, SCIENTOMETRICS, V81, P177, DOI 10.1007/s11192-009-2126-z; STEWART JA, 1983, SOC FORCES, V62, P166, DOI 10.2307/2578354; van Dalen HP, 2001, SCIENTOMETRICS, V50, P455, DOI 10.1023/A:1010510831718; vansRaan A. F. J., 1996, SCIENTOMETRICS, V36, P397; vansRaan A. F. J., 1998, SCIENTOMETRICS, V42, P423; Walters GD, 2006, SCIENTOMETRICS, V69, P499, DOI 10.1007/s11192-006-0166-1; Wang MY, 2012, SCIENTOMETRICS, V93, P635, DOI 10.1007/s11192-012-0766-x; Wang MY, 2011, SCIENTOMETRICS, V87, P695, DOI 10.1007/s11192-011-0366-1	71	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2330-1635	2330-1643		J ASSOC INF SCI TECH		APR	2015	66	4					739	764		10.1002/asi.23209		26	Computer Science, Information Systems; Information Science & Library Science	Computer Science; Information Science & Library Science	CD9CW	WOS:000351395800007		
J	Yamamoto, S; Shiraishi, S; Suzuki, S				Yamamoto, S.; Shiraishi, S.; Suzuki, S.			Are cyclic lipopeptides produced by Bacillus amyloliquefaciens S13-3 responsible for the plant defence response in strawberry against Colletotrichum gloeosporioides?	LETTERS IN APPLIED MICROBIOLOGY			English	Article						Bacillus amyloliquefaciens; iturin A; lipopeptide; plant defence response; surfactin	INDUCED SYSTEMIC RESISTANCE; SUBTILIS; BIOCONTROL; SURFACTIN; PATHOGENS; INSIGHTS; GROWTH; AGENT	The antagonistic strain Bacillus amyloliquefaciens strain S13-3 decreased the severity of strawberry anthracnose caused by Colletotrichum gloeosporioides. The foliar application of S13-3 triggered the expression of pathogenesis-related proteins, chitinase and -1,3-glucanase, in strawberry leaves. We identified lipopeptide antibiotics, including iturin A, fengycin, mixirin, pumilacidin and surfactin, produced and secreted by S13-3. Iturin A and surfactin elicited the gene expression of the pathogenesis-related proteins in strawberry leaves, suggesting that antagonistic strain S13-3 confers resistance to strawberry leaves through the production of lipopeptide antibiotics. In fact, iturin A and surfactin triggered induced systemic resistance on strawberry plants, resulting in the reduction of the severity of anthracnose disease caused by Colletotrichum gloeosporioides. The bifunctional activity of S13-3, which consists of the antagonistic effect and the induction of plant defence response by the antibiotics produced by it, may make S13-3 an innovative biological control agent against phytopathogens in strawberry. Significance and Impact of the StudyThis study tries to determine whether biocontrol of phytopathogens by Bacillus amyloliquefaciens in strawberry can be connected to induced plant resistance. The results suggested that the antagonistic strain B.amyloliquefaciens S13-3 confers resistance to strawberry through the production of lipopeptide antibiotics.	[Yamamoto, S.] IAI Corp, Eco Farm Dept, Shizuoka, Japan; [Shiraishi, S.; Suzuki, S.] Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan	Suzuki, S (reprint author), Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan.	suzukis@yamanashi.ac.jp					Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Zhang HL, 2004, CHEM PHARM BULL, V52, P1029, DOI 10.1248/cpb.52.1029; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Garcia-Gutierrez L, 2013, MICROB BIOTECHNOL, V6, P264, DOI 10.1111/1751-7915.12028; Nagorska K, 2007, ACTA BIOCHIM POL, V54, P495; Jourdan E, 2009, MOL PLANT MICROBE IN, V22, P456, DOI 10.1094/MPMI-22-4-0456; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; From C, 2007, INT J FOOD MICROBIOL, V115, P319, DOI 10.1016/j.ijfoodmicro.2006.11.005; Arguelles-Arias A., 2009, MICROB CELL FACT, V8, P63; European Food Safety Authority, 2013, EFSA J, V11, P3042; Furuya S, 2011, BIOCONTROL SCI TECHN, V21, P705, DOI 10.1080/09583157.2011.574208; Jacques P, 2011, MICROBIOL MONOGR, V20, P57, DOI 10.1007/978-3-642-14490-5_3; Mochizuki M, 2012, BIOCONTROL SCI TECHN, V22, P697, DOI 10.1080/09583157.2012.679644; Park KyungSeok, 2013, Recent advances in biofertilizers and biofungicides (PGPR) for sustainable agriculture. Proceedings of 3rd Asian Conference on Plant Growth-Promoting Rhizobacteria (PGPR) and other Microbials, Manila, Philippines, 21-24 April, 2013, P342; Saito S, 2011, J PLANT BIOCHEM BIOT, V20, P47, DOI 10.1007/s13562-010-0025-2; Tan SY, 2013, PEST MANAG SCI, V69, P1245, DOI 10.1002/ps.3491	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	APR	2015	60	4					379	386		10.1111/lam.12382		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CD9CP	WOS:000351395000012		
J	Kimura-Sakai, S; Sako, Y; Yoshida, T				Kimura-Sakai, S.; Sako, Y.; Yoshida, T.			Development of a real-time PCR assay for the quantification of Ma-LMM01-type Microcystis cyanophages in a natural pond	LETTERS IN APPLIED MICROBIOLOGY			English	Article						cyanobacteria; cyanophage-infected cells; cyanophages; Microcystis aeruginosa; real-time PCR	FRESH-WATER; DEFENSE SYSTEMS; AERUGINOSA; CRISPR; VIRUSES; LAKE; DIVERSIFICATION; POPULATION; RESISTANCE; BACTERIAL	Microcystis aeruginosa forms toxic cyanobacterial blooms throughout the world where its infectious phages are thought to influence host population dynamics. To assess the cyanophage impact on the host dynamics, we previously monitored Ma-LMM01-type phage abundance using a real-time PCR with a primer set designed based on the sequence of Microcystis phage Ma-LMM01; and we estimated the phage-infected host cell abundance. However, a recent study shows the Ma-LMM01g91 gene sequence belongs to the smallest group, group III, of the three genotype groups, suggesting Ma-LMM01-type phage abundance was underestimated. Therefore, to re-evaluate the effect of Ma-LMM01-type phages on their hosts, we monitored the abundance of Ma-LMM01-type phages using real-time PCR with a new primer set designed based on the sequences of genotype groups I-III. We found phage abundance between 10(3) and 10(4)ml(-1) using the new primer set in samples where previously these phages were not detected using the old primer set. The frequency of Ma-LMM01-type phage-infected cells to Ma-LMM01-type phage-susceptible host cells may be as high as 30%, suggesting the phages may occasionally affect not only shifts in the genetic composition but also the dynamics of Ma-LMM01-type phage-susceptible host populations. Significance and Impact of the StudyPhages are one of the factors that may control the ecology of their host blooms. Therefore, it is essential to estimate phage abundance to understand phage impact on host populations. A real-time PCR assay was improved to detect a larger range of Microcystis cyanophages in natural surroundings where no phages were detected using a previous method by re-designing a new primer set based on sequences from three Ma-LMM01-type phage genetic groups. The new method allows us to determine the distribution, dynamics and infection cycle of the phage to help understand the interaction between the phages and the hosts.	[Kimura-Sakai, S.; Sako, Y.; Yoshida, T.] Kyoto Univ, Lab Marine Microbiol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Yoshida, T (reprint author), Kyoto Univ, Lab Marine Microbiol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	yoshiten@kais.kyoto-u.ac.jp			JSPS [233313];  [20310045];  [26281031]	This study was partially supported by Grant-in-Aid for Scientific Research (B) (grant 20310045 and 26281031) and by the JSPS Research Fellowships for Young Scientists (grant 233313). We thank Prof. Syuhei Ban, Prof. Misako Urabe and Dr Shoko Hosoi-Tanabe for experiments. We thank Mika Uehara and Maho Masuda for sequence analyses. We thank Dr Shoko Hosoi-Tanabe and Ginji Nakamura for providing samples from Lake Yogo and Lake Shinji, respectively. We thank Yusuke Matsui and Yoko Matsui for sampling help.	Yoshida M, 2008, APPL ENVIRON MICROB, V74, P3269, DOI 10.1128/AEM.02240-07; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082; Okello W, 2010, ENVIRON TOXICOL, V25, P367, DOI 10.1002/tox.20522; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P6723, DOI 10.1128/AEM.69.11.6730.2003; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Rozon RM, 2013, FRESHWATER BIOL, V58, P2648, DOI 10.1111/fwb.12241; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Cao HS, 2010, J FRESHWATER ECOL, V25, P331, DOI 10.1080/02705060.2010.9664375; Codd G. A., 2005, HARMFUL CYANOBACTERI; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Kimura S, 2013, APPL ENVIRON MICROB, V79, P2789, DOI 10.1128/AEM.03751-12; Kimura S, 2012, APPL ENVIRON MICROB, V78, P5805, DOI 10.1128/AEM.00571-12; Kuno S, 2014, MICROBIOL-SGM, V160, P903, DOI 10.1099/mic.0.073494-0; Kuno S, 2012, APPL ENVIRON MICROB, V78, P5353, DOI 10.1128/AEM.00626-12; Takashima Y, 2007, MICROBES ENVIRON, V22, P207, DOI 10.1264/jsme2.22.207; Yoshida T, 2003, MICROB ENV, V18, P16; Yoshida T, 2006, APPL ENVIRON MICROB, V72, P1239, DOI 10.1128/AEM.72.2.1239-1247.2006	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	APR	2015	60	4					400	408		10.1111/lam.12387		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CD9CP	WOS:000351395000015		
J	Nagao, H				Nagao, Hidehito			The Pad, Interpolation Method Applied to q-Painlev, Equations	LETTERS IN MATHEMATICAL PHYSICS			English	Article						Pade method; Pade interpolation; q-Painleve equation	HYPERGEOMETRIC SOLUTIONS; ANALOG	We establish interpolation problems related to all the q-Painlev, equations of types from to . By solving those problems, we can derive the evolution equations, the scalar Lax pairs and the determinant formulae of special solutions for the corresponding q-Painlev, equations.	Kobe Univ, Dept Math, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	Nagao, H (reprint author), Kobe Univ, Dept Math, Grad Sch Sci, Kobe, Hyogo 6578501, Japan.	hnagao@math.kobe-u.ac.jp					Van Assche W, 2007, DIFFERENCE EQUATIONS, SPECIAL FUNCTIONS AND ORTHOGONAL POLYNOMIALS, P687, DOI 10.1142/9789812770752_0058; Yamada Y, 2011, INT MATH RES NOTICES, P3823, DOI 10.1093/imrn/rnq232; Ikawa Y, 2013, LETT MATH PHYS, V103, P743, DOI 10.1007/s11005-013-0610-0; Kajiwara K, 2004, INT MATH RES NOTICES, P2497; Hamamoto T, 2007, J PHYS A-MATH THEOR, V40, P12509, DOI 10.1088/1751-8113/40/42/S01; Sakai H, 1998, NONLINEARITY, V11, P823, DOI 10.1088/0951-7715/11/4/004; MAGNUS AP, 1995, J COMPUT APPL MATH, V57, P215, DOI 10.1016/0377-0427(93)E0247-J; Sakai H, 2001, COMMUN MATH PHYS, V220, P165, DOI 10.1007/s002200100446; Yamada Y, 2009, FUNKC EKVACIOJ-SER I, V52, P83; Jimbo M, 1996, LETT MATH PHYS, V38, P145, DOI 10.1007/BF00398316; Grammaticos B, 1999, PHYS LETT A, V257, P288, DOI 10.1016/S0375-9601(99)00296-0; Ramani A, 2001, COMPUT MATH APPL, V42, P603, DOI 10.1016/S0898-1221(01)00180-8; Clarkson Peter A, 2013, J PHYS A, V46, P18; Gasper G., 1990, ENCY MATH ITS APPL, V35; Grammaticos B., 1999, CRM SERIES MATH PHYS, P413; Jacobi C.G, 1846, J REINE ANGEW MATH, V30, P127, DOI 10.1515/crll.1846.30.127; Kajiwara K, 2001, J PHYS A-MATH GEN, V34, P8563, DOI 10.1088/0305-4470/34/41/312; Kruskal MD, 2000, REGUL CHAOTIC DYN, V5, P273, DOI 10.1070/RD2000v005n03ABEH000149; Masuda T., 2009, SIGMA, V5, P30; Murata M., 2009, J PHYS A, V42, P17; Nakazono N., 2010, SIGMA, V6, P16; Noumi M., 2013, SYMMETRIES INTEGRABL, V40, P463; Sakai H., 2006, J PHYS A, V39, P1203; Sakai H., 2005, FUNKC EKVACIOJ-SER I, V48, P273, DOI 10.1619/fesi.48.273; Witte N.S., 2012, SIGMA, V8, P27; Yamada Y., 2014, RIMS KOKYUR IN PRESS, V47; Yoshioka R., 2010, THESIS; Zhedanov A.S., 2005, ROKKO LECT MATH, V18, P323	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0377-9017	1573-0530		LETT MATH PHYS	Lett. Math. Phys.	APR	2015	105	4					503	521		10.1007/s11005-015-0749-y		19	Physics, Mathematical	Physics	CE0ZW	WOS:000351541900003		
J	Yamamoto, H; Kawada, T; Shimizu, S; Kamiya, A; Turner, MJ; Miyazaki, S; Sugimachi, M				Yamamoto, Hiromi; Kawada, Toru; Shimizu, Shuji; Kamiya, Atsunori; Turner, Michael J.; Miyazaki, Shunichi; Sugimachi, Masaru			Acute effects of intravenous nifedipine or azelnidipine on open-loop baroreflex static characteristics in rats	LIFE SCIENCES			English	Article						Nifedipine; Azelnidipine; Carotid sinus baroreflex; Open-loop system analysis; Sympathetic nerve activity	SPONTANEOUSLY HYPERTENSIVE-RATS; ROSTRAL VENTROLATERAL MEDULLA; CALCIUM-CHANNEL BLOCKER; SYMPATHETIC ARTERIAL-PRESSURE; CAROTID-SINUS BAROREFLEX; BARORECEPTOR REGIONS; NERVE ACTIVITY; HEART-RATE; ADULT-RAT; DIHYDROPYRIDINES	Aims: To assess the acute effects of intravenous azelnidipine, a third-generation L-type calcium channel blocker, on sympathetic outflow from the central nervous system and to compare the effects of intravenous azelnidipine with those of intravenous nifedipine. Main methods: In anesthetized Wistar Kyoto rats, carotid sinus baroreceptor regions were isolated. Changes in sympathetic nerve activity (SNA) and arterial pressure (AP) in response to a stepwise baroreceptor pressure input were examined before and during intravenous nifedipine or azelnidipine (for each: 100 mu g/kg bolus followed by 300 mu g/kg/h infusion, n = 6). Key findings: Nifedipine significantly reduced the range of the AP response from 76.8 +/- 7.4 to 45.4 +/- 7.0 mm Hg (P <0.01) but did not affect the range of the SNA response (from 84.4 +/- 5.1 to 85.9 +/- 10.2%) or the SNA maximum gain (from 2.26 +/- 0.28 to 2.35 +/- 0.55%/mm Hg). Similarly, azelnidipine significantly reduced the range of the AP response from 62.4 +/- 3.9 to 31.4 +/- 4.1 mm Hg (P <0.01) but did not affect the range of the SNA response (from 71.2 +/- 5.5 to 74.9 +/- 7.2%) or the SNA maximum gain (from 1.64 +/- 0.17 to 2.08 +/- 0.26%/mm Hg). Significance: A depressor dose of nifedipine or azelnidipine does not have an acute sympathoinhibitory effect in normotensive Wistar Kyoto rats even when the level of SNA was varied over the entire operating range of the carotid sinus baroreflex. (C) 2015 Elsevier Inc. All rights reserved.	[Yamamoto, Hiromi; Miyazaki, Shunichi] Kinki Univ, Fac Med, Dept Med, Div Cardiol, Osaka 5898511, Japan; [Kawada, Toru; Shimizu, Shuji; Kamiya, Atsunori; Turner, Michael J.; Sugimachi, Masaru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Osaka 5658565, Japan	Yamamoto, H (reprint author), Kinki Univ, Fac Med, Dept Med, Div Cardiol, Osaka 5898511, Japan.	hiromi@med.kindai.ac.jp			JSPS KAKENHI [23592319, 25350909]; JSPS Fellows (JSPS KAKENHI) [23.01705]; Hiroshi and Aya Irisawa Memorial Award for Excellent Papers on Research in Circulation in The Journal of Physiological Sciences	This study was supported ( i) by a Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant Number 23592319, 25350909), (ii) by a Grant-in-Aid for JSPS Fellows (JSPS KAKENHI Grant Number 23.01705), and (iii) by Hiroshi and Aya Irisawa Memorial Award for Excellent Papers on Research in Circulation in The Journal of Physiological Sciences.	Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH326; Kawada T, 2011, LIFE SCI, V89, P498, DOI 10.1016/j.lfs.2011.07.026; Abe C, 2011, J APPL PHYSIOL, V111, P1614, DOI 10.1152/japplphysiol.00501.2011; Hayashi Koichi, 2010, Keio Journal of Medicine, V59, P84; SHOUKAS AA, 1991, AM J PHYSIOL, V260, pH300; Naito Y, 2006, EUR J PHARMACOL, V546, P11, DOI 10.1016/j.ejphar.2006.07.030; Yamamoto H, 2013, LIFE SCI, V92, P1202, DOI 10.1016/j.lfs.2013.05.004; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Kawada T, 2009, J PHYSIOL SCI, V59, P447, DOI 10.1007/s12576-009-0055-5; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH2251; Kawada T, 2002, JPN J PHYSIOL, V52, P21, DOI 10.2170/jjphysiol.52.21; Miyawaki T, 2003, NEUROSCIENCE, V116, P455, DOI 10.1016/S0306-4522(02)00705-4; Kawada T, 2010, J PHYSIOL SCI, V60, P283, DOI 10.1007/s12576-010-0096-9; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Kamiya A, 2005, J PHYSIOL-LONDON, V566, P237, DOI 10.1113/jphysiol.2005.086512; Meredith PA, 2004, J HYPERTENS, V22, P1641, DOI 10.1097/00004872-200409000-00002; Fujisawa M, 2009, J CARDIOVASC PHARM, V53, P325, DOI 10.1097/FJC.0b013e31819f1be1; Furukawa T, 2009, EUR J PHARMACOL, V613, P100, DOI 10.1016/j.ejphar.2009.04.036; Glantz S.A., 2002, PRIMER BIOSTATISTICS; Grassi G, 2003, HYPERTENSION, V41, P558, DOI 10.1161/01.HYP.0000058003.27729.5A; JANICKI PK, 1988, PHARMACOLOGY, V36, P183, DOI 10.1159/000138382; Kase M, 1999, NEUROSCI LETT, V268, P77, DOI 10.1016/S0304-3940(99)00385-7; KLEINBLOESEM CH, 1984, CLIN PHARMACOL THER, V35, P742; Konno S, 2008, J CARDIOVASC PHARM, V52, P555, DOI 10.1097/FJC.0b013e318192690e; LAURENT S, 1989, FUNDAM CLIN PHARM, V3, pS47; MIDDLEMISS DN, 1985, NATURE, V314, P94, DOI 10.1038/314094a0; Murzenok PP, 2000, HYPERTENSION, V35, P631; OIZUMI K, 1989, JPN J PHARMACOL, V51, P57, DOI 10.1254/jjp.51.57; Shinomiya K, 2004, J INT MED RES, V32, P170; Shokoji T, 2005, HYPERTENS RES, V28, P1017, DOI 10.1291/hypres.28.1017; Takahara A, 2002, EUR J PHARMACOL, V434, P43, DOI 10.1016/S0014-2999(01)01521-7; Yamamoto K, 2004, AM J PHYSIOL-HEART C, V286, pH1382, DOI 10.1152/ajpheart.00801.2003	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	APR 1	2015	126						37	41		10.1016/j.lfs.2015.01.024		5	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CE4OK	WOS:000351809700005		
J	Chien, MT; Nakazato, H				Chien, Mao-Ting; Nakazato, Hiroshi			Singular points of the algebraic curves of symmetric hyperbolic	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Singular point; Hyperbolic form; Numerical range	WEIGHTED SHIFT MATRICES; RANK NUMERICAL RANGES; FLAT PORTIONS; 3X3 MATRICES; DETERMINANTAL REPRESENTATION; BOUNDARY; POLYNOMIALS	We investigate singular points of the algebraic curve defined by a hyperbolic form satisfying some symmetric properties. We show that all singular points of such a curve are real nodes. (C) 2014 Elsevier Inc. All rights reserved.	[Chien, Mao-Ting] Soochow Univ, Dept Math, Taipei 11102, Taiwan; [Nakazato, Hiroshi] Hirosaki Univ, Fac Sci & Technol, Dept Math Sci, Hirosaki, Aomori 0368561, Japan	Chien, MT (reprint author), Soochow Univ, Dept Math, Taipei 11102, Taiwan.	mtchien@scu.edu.tw; nakahr@cc.hirosaki-u.ac.jp			Taiwan National Science Council [NSC102-2115-M-031-001]; Japan Society for Promotion of Science [23540180]	The authors are grateful to an anonymous referee for many valuable suggestions and comments on an earlier version of the paper. This work was carried out while the second author was visiting the Department of Mathematics, Soochow University. The supports of this visit from Taiwan Mathematics Research Promotion Center and Soochow University are gratefully acknowledged. The first author was partially supported by Taiwan National Science Council under NSC102-2115-M-031-001, and the second author expresses thanks for the partial support by Japan Society for Promotion of Science, Project Number 23540180.	Chien MT, 2011, LINEAR ALGEBRA APPL, V435, P2971, DOI 10.1016/j.laa.2011.05.020; Chien MT, 2013, OPER MATRICES, V7, P197, DOI 10.7153/oam-07-11; Helton JW, 2007, COMMUN PUR APPL MATH, V60, P654, DOI 10.1002/cpa.20155; Keeler DS, 1997, LINEAR ALGEBRA APPL, V252, P115, DOI 10.1016/0024-3795(95)00674-5; Lewis AS, 2005, P AM MATH SOC, V133, P2495, DOI 10.1090/S0002-9939-05-07752-X; Rodman L, 2005, LINEAR ALGEBRA APPL, V397, P193, DOI 10.1016/j.laa.2004.10.014; ATIYAH MF, 1970, ACTA MATH-UPPSALA, V124, P109, DOI 10.1007/BF02394570; Bebiano N, 2008, LINEAR ALGEBRA APPL, V428, P2863, DOI 10.1016/j.laa.2008.01.017; Chien MT, 2013, LINEAR ALGEBRA APPL, V439, P4090, DOI 10.1016/j.laa.2013.10.012; Chien MT, 2014, BANACH J MATH ANAL, V8, P269; Chien M.T., 2013, PREPRINT; Chien MT, 2008, LINEAR MULTILINEAR A, V56, P143, DOI 10.1080/03081080701217745; Chien MT, 2011, LINEAR ALGEBRA APPL, V435, P1277, DOI 10.1016/j.laa.2011.03.012; Eldred J, 2012, LINEAR MULTILINEAR A, V60, P1295, DOI 10.1080/03081087.2011.634415; FIEDLER M, 1990, LINEAR ALGEBRA APPL, V141, P53, DOI 10.1016/0024-3795(90)90308-Y; FIEDLER M, 1981, LINEAR ALGEBRA APPL, V37, P81, DOI 10.1016/0024-3795(81)90169-5; GARDING L, 1951, ACTA MATH-DJURSHOLM, V85, P1; Gau HL, 2013, LINEAR ALGEBRA APPL, V438, P3054, DOI 10.1016/j.laa.2012.11.017; Gau HL, 2013, LINEAR ALGEBRA APPL, V438, P498, DOI 10.1016/j.laa.2012.08.018; Kippenhahn R., 1951, MATH NACHR, V6, P193, DOI 10.1002/mana.19510060306; LAX PD, 1958, COMMUN PUR APPL MATH, V11, P175, DOI 10.1002/cpa.3160110203; Namba M., 1984, GEOMETRY PROJECTIVE; Plaumann D., 2012, OPER THEORY ADV APPL, V222; Tsai MC, 2011, LINEAR ALGEBRA APPL, V435, P243, DOI 10.1016/j.laa.2011.01.025; Tsai MC, 2011, LINEAR ALGEBRA APPL, V435, P2296, DOI 10.1016/j.laa.2011.04.028; Walker R, 1950, ALGEBRAIC CURVES	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	APR 1	2015	470				SI		40	50		10.1016/j.laa.2014.02.006		11	Mathematics, Applied; Mathematics	Mathematics	CD7EF	WOS:000351252900003		
J	Sattari, M; Moslehian, MS; Yamazaki, T				Sattari, Mostafa; Moslehian, Mohammad Sal; Yamazaki, Takeaki			Some generalized numerical radius inequalities for Hilbert space operators	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Heinz means; Numerical radius; Positive operator; Operator norm		We generalize several inequalities involving powers of the numerical radius for product of two operators acting on a Hilbert space. For any A, B, X is an element of B(H) such that A, B are positive, we establish some numerical radius inequalities for A(alpha)XB(alpha) and A(alpha)XB(1-alpha) (0 <= alpha <= 1) and Heinz means under mild conditions. (C) 2014 Elsevier Inc. All rights reserved.	[Sattari, Mostafa; Moslehian, Mohammad Sal] Ferdowsi Univ Mashhad, Ctr Excellence Anal Algebra Struct, Dept Pure Math, Mashhad 91775, Iran; [Yamazaki, Takeaki] Toyo Univ, Dept Elect Elect & Comp Engn, Kawagoe, Saitama, Japan	Moslehian, MS (reprint author), Ferdowsi Univ Mashhad, Ctr Excellence Anal Algebra Struct, Dept Pure Math, POB 1159, Mashhad 91775, Iran.	msattari.b@gmail.com; moslehian@ferdowsi.um.ac.ir; t-yamazaki@toyo.jp					Yamazaki T, 2007, STUD MATH, V178, P83, DOI 10.4064/sm178-1-5; Dragomir S. S., 2008, TAMKANG J MATH, V39, P1; Dragomir S. S., 1985, S MAT APL TIM ROM 1, V1-2, P13; Dragomir S. S., 2009, SARAJEVO J MATH, V5, P269; Dragomir SS, 2006, B AUST MATH SOC, V73, P255; Hardy G. H., 1988, INEQUALITIES; Kaur R, 2014, LINEAR ALGEBRA APPL, V447, P26, DOI 10.1016/j.laa.2013.01.012; KITTANEH F, 1988, PUBL RES I MATH SCI, V24, P283, DOI 10.2977/prims/1195175202; Omidvar M., 2009, INVOLVE J MATH, V2, P469; Salemi A, 2013, MATH INEQUAL APPL, V16, P783, DOI 10.7153/mia-16-59	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	APR 1	2015	470				SI		216	227		10.1016/j.laa.2014.08.003		12	Mathematics, Applied; Mathematics	Mathematics	CD7EF	WOS:000351252900011		
J	Fujii, M; Seo, Y; Zuo, HL				Fujii, Masatoshi; Seo, Yuki; Zuo, Hongliang			Zhan's inequality on A-G mean inequalities	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Heinz inequality; Zhan's inequality; Hadamard product; Unitarily invariant norm	UNITARILY-INVARIANT NORMS; MATRIX MONOTONE-FUNCTIONS	In this paper, we show some generalizations of Zhan's inequality by virtue of Hadamard product as follows: Let A, B, X be n x n matrices such that A, B are positive definite, and f, g be two continuous functions on (0, infinity), k = max{f(lambda)g(lambda)/lambda vertical bar lambda is an element of sigma(A) U sigma(B)}, where sigma(A) is the spectrum of A. If f(x)/g(x) is Kwong, i.e., the matrix (f/g(lambda(i)) + f/g(lambda(j))/lambda(i) + lambda(j)) is positive semidefinite for any positive numbers lambda(1),...., lambda(n), then for any beta > 0, i. vertical bar vertical bar vertical bar A(1/2) (f(A)Xg(B) + g(A)Xf(B))B-1/2 vertical bar vertical bar vertical bar <= k vertical bar vertical bar vertical bar 2(1 -2 beta + 2 beta r(0))AXB +4 beta(1 - r(0))/t + 2 (A(2)X + tAXB + XB2)vertical bar vertical bar vertical bar holds for -2 < t <= 2 beta - 2, where r(0) = min{1/2 + vertical bar 1 - r vertical bar, 1 - vertical bar 1-r vertical bar}. ii. vertical bar vertical bar vertical bar A(1/2) [f (A)Xg(B) + g(A)Xf(B)]B-1/2 vertical bar vertical bar vertical bar <= 2k/t + 2 vertical bar vertical bar vertical bar A(2)X + tAXB + XB2 vertical bar vertical bar vertical bar holds for any -2 < t <= 2, where vertical bar vertical bar vertical bar . vertical bar vertical bar vertical bar is any unitarily invariant norm. (C) 2014 Elsevier Inc. All rights reserved.	[Fujii, Masatoshi; Seo, Yuki] Osaka Kyoiku Univ, Dept Math, Kashiwara, Osaka 5828582, Japan; [Zuo, Hongliang] Henan Normal Univ, Coll Math & Informat Sci, Xinxiang 453007, Henan, Peoples R China	Zuo, HL (reprint author), Henan Normal Univ, Coll Math & Informat Sci, Xinxiang 453007, Henan, Peoples R China.	mfujii@cc.osaka-kyoiku.ac.jp; yukis@cc.osaka-kyoiku.ac.jp; zuodke@yahoo.com			National Natural Science Foundation of China [10471085]	This research was partially supported by the National Natural Science Foundation of China (10471085).	KWONG MK, 1988, LINEAR ALGEBRA APPL, V108, P177, DOI 10.1016/0024-3795(88)90187-5; BHATIA R, 1993, SIAM J MATRIX ANAL A, V14, P132, DOI 10.1137/0614012; Audenaert KMR, 2011, P AM MATH SOC, V139, P4217; Fu XH, 2013, J MATH INEQUAL, V7, P727, DOI 10.7153/jmi-07-66; Gradshteyn IS, 1994, TABLES INTEGRALS SER; Horn R. A., 1990, TOPICS MATRIX ANAL; Kaur R, 2014, LINEAR ALGEBRA APPL, V447, P26, DOI 10.1016/j.laa.2013.01.012; Kittaneh F, 2010, INTEGR EQUAT OPER TH, V68, P519, DOI 10.1007/s00020-010-1807-6; KWONG MK, 1989, LINEAR ALGEBRA APPL, V118, P129, DOI 10.1016/0024-3795(89)90577-6; Najafi H, 2013, LINEAR ALGEBRA APPL, V439, P2634, DOI 10.1016/j.laa.2013.06.018; Pecaric J. E., 1992, CONVEX FUNCTIONS PAR; Singh M, 2004, MATH INEQUAL APPL, V7, P621; Tan M., 2011, J NANOMATER, V1-8, p2011b; Zhan XZ, 1998, SIAM J MATRIX ANAL A, V20, P466, DOI 10.1137/S0895479898323823	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	APR 1	2015	470				SI		241	251		10.1016/j.laa.2014.10.019		11	Mathematics, Applied; Mathematics	Mathematics	CD7EF	WOS:000351252900013		
J	Hosaka, T; Suzuki, F; Kobayashi, M; Fukushima, T; Kawamura, Y; Sezaki, H; Akuta, N; Suzuki, Y; Saitoh, S; Arase, Y; Ikeda, K; Kobayashi, M; Kumada, H				Hosaka, Tetsuya; Suzuki, Fumitaka; Kobayashi, Masahiro; Fukushima, Taito; Kawamura, Yusuke; Sezaki, Hitomi; Akuta, Norio; Suzuki, Yoshiyuki; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu			HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy	LIVER INTERNATIONAL			English	Article						hepatitis B surface antigen; HLA-DP; lamivudine; nucleot(s)ide analogue	TENOFOVIR DISOPROXIL FUMARATE; GENOME-WIDE ASSOCIATION; TERM-FOLLOW-UP; ADEFOVIR DIPIVOXIL; PEGINTERFERON ALPHA-2B; POSITIVE PATIENTS; VIRUS-INFECTION; HBSAG LOSS; LAMIVUDINE; HBEAG	Background & AimsGenome-wide association studies (GWAS) recently indicated that polymorphisms in the human leucocyte antigen (HLA)-DP genes were associated with risk of persistent hepatitis B virus (HBV) infection and clearance of HBV, but the effect of HLA-DP gene polymorphisms on the effect of antiviral therapy was unknown. We here investigated whether such polymorphisms were associated with decreases in HBsAg levels and seroclearance in patients who received long-term lamivudine (LAM) treatment. MethodsJapanese patients (202) who were hepatitis B e antigen positive at baseline, received LAM as first-line treatment, and consented to HLA-DP genotyping (HLA-DPA1 rs3077 and HLA-DPB1 rs9277535) were categorized into two cohorts, viz., a cohort who achieved virological response without rescue therapy (cohort 1) and those who did so with rescue therapy (cohort 2). ResultsSerum HBsAg levels declined significantly between year 3 and 9 from baseline among cohort 1 patients possessing 2 A-alleles at rs3077 and rs9277535. The percentages of such patients in cohort 1 patients with decreases in HBsAg 0.5 log IU/ml were higher than those with <2 A-alleles (71.8% [28/39] vs. 38.9% [23/59]; P=0.004). However, there was no significant difference in cumulative HBsAg seroclearance rates between patients with 2 and those with <2 A-alleles in cohort 1. In cohort 2, HBsAg seroclearance rates were higher in patients with 2 A-alleles than in those with <2 A-alleles (P=0.003). ConclusionWe found an association between HLA-DP polymorphisms and decreases in HBsAg levels and seroclearance among HBeAg-positive patients treated with LAM.	[Hosaka, Tetsuya; Suzuki, Fumitaka; Kobayashi, Masahiro; Fukushima, Taito; Kawamura, Yusuke; Sezaki, Hitomi; Akuta, Norio; Suzuki, Yoshiyuki; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo 1058470, Japan; [Kobayashi, Mariko] Toranomon Gen Hosp, Res Inst Hepatol, Tokyo 1058470, Japan	Hosaka, T (reprint author), Toranomon Gen Hosp, Dept Hepatol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	hosa-p@toranomon.gr.jp			Ministry of Health, Labour and Welfare of Japan	This research was partly supported by grants from the Ministry of Health, Labour and Welfare of Japan.	Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Hosaka T, 2013, J GASTROENTEROL, V48, P930, DOI 10.1007/s00535-012-0688-7; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Nair S, 2001, HEPATOLOGY, V34, P1021, DOI 10.1053/jhep.2001.28459; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Wursthorn K, 2010, HEPATOLOGY, V52, P1611, DOI 10.1002/hep.23905; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Tseng TC, 2011, ANTIVIR THER, V16, P629, DOI 10.3851/IMP1841; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Flink HJ, 2005, GUT, V54, P1604, DOI 10.1136/gut.2004.062208; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Buster EHCJ, 2009, AM J GASTROENTEROL, V104, P2449, DOI 10.1038/ajg.2009.371; DisMarco V, 2004, HEPATOLOGY, V40, P883; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Seto WK, 2013, HEPATOLOGY, V58, P923, DOI 10.1002/hep.26376; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	APR	2015	35	4					1290	1302		10.1111/liv.12652		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD5TN	WOS:000351151100019		
J	Korenaga, M; Nishina, S; Korenaga, K; Tomiyama, Y; Yoshioka, N; Hara, Y; Sasaki, Y; Shimonaka, Y; Hino, K				Korenaga, Masaaki; Nishina, Sohji; Korenaga, Keiko; Tomiyama, Yasuyuki; Yoshioka, Naoko; Hara, Yuichi; Sasaki, Yusuke; Shimonaka, Yasushi; Hino, Keisuke			Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice	LIVER INTERNATIONAL			English	Article						hepatitis C virus; hepatic mitochondrial dysfunction; hepcidin-25; iron metabolic disorder; reactive oxygen species	CHRONIC LIVER-DISEASE; SUPPLEMENTATION IMPROVES; HEPATOCELLULAR-CARCINOMA; HEPCIDIN TRANSCRIPTION; VIROLOGICAL RESPONSE; SIGNAL-TRANSDUCTION; ALBUMIN SYNTHESIS; PROTEIN; CIRRHOSIS; STEATOSIS	Background & AimsBranched-chain amino acids (BCAA) reduce the incidence of hepatocellular carcinoma (HCC) in patients with cirrhosis. However, the mechanisms that underlie these effects remain unknown. Previously, we reported that oxidative stress in male transgenic mice that expressed hepatitis C virus polyprotein (HCVTgM) caused hepatic iron accumulation by reducing hepcidin transcription, thereby leading to HCC development. This study investigated whether long-term treatment with BCAA reduced hepatic iron accumulation and oxidative stress in iron-overloaded HCVTgM and in patients with HCV-related advanced fibrosis. MethodsMale HCVTgM were fed an excess-iron diet that comprised either casein or 3.0% BCAA, or a control diet, for 6months. ResultsFor HCVTgM, BCAA supplementation increased the serum hepcidin-25 levels and antioxidant status [ratio of biological antioxidant potential (BAP) relative to derivatives of reactive oxygen metabolites (dROM)], decreased the hepatic iron contents, attenuated reactive oxygen species generation, and restored mitochondrial superoxide dismutase expression and mitochondrial complex I activity in the liver compared with mice fed the control diet. After 48weeks of BCAA supplementation in patients with HCV-related advanced fibrosis, BAP/dROM and serum hepcidin-25 increased and serum ferritin decreased compared with the pretreatment levels. ConclusionsBCAA supplementation reduced oxidative stress by restoring mitochondrial function and improved iron metabolism by increasing hepcidin-25 in both iron-overloaded HCVTgM and patients with HCV-related advanced fibrosis. These activities of BCAA may partially account for their inhibitory effects on HCC development in cirrhosis patients.	[Korenaga, Masaaki; Nishina, Sohji; Korenaga, Keiko; Tomiyama, Yasuyuki; Yoshioka, Naoko; Hara, Yuichi; Hino, Keisuke] Kawasaki Med Univ, Dept Hepatol & Pancreatol, Okayama, Japan; [Korenaga, Masaaki] Natl Ctr Global Hlth & Med NCGM, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Sasaki, Yusuke; Shimonaka, Yasushi] Chugai Pharmaceut Co Ltd, Prod Res Dept, Yokohama, Kanagawa, Japan	Korenaga, M (reprint author), Natl Ctr Global Hlth & Med NCGM, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai, Ichikawa, Chiba, Japan.	dmkorenaga@hospk.ncgm.go.jp			Ministry of Education, Culture, Sports, Science, and Technology [22590750]; Liver Forum in Kyoto; Kawasaki Medical School Projects; Ministry of Health, Labor, and Welfare, Japan	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (No. 22590750), a research award from the Liver Forum in Kyoto, research funding from Kawasaki Medical School Projects, and partly by the Ministry of Health, Labor, and Welfare, Japan.	Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Ohno T, 2008, HEPATOL RES, V38, P683, DOI 10.1111/j.1872-034X.2008.00319.x; Kawaguchi T, 2014, CLIN GASTROENTEROL H, V12, P1012, DOI 10.1016/j.cgh.2013.08.050; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Michitaka K, 2010, HEPATOL RES, V40, P393, DOI 10.1111/j.1872-034X.2009.00614.x; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Kohjima M, 2008, INT J MOL MED, V21, P507; Yoshiji H, 2010, J GASTROENTEROL, V45, P443, DOI 10.1007/s00535-009-0158-z; Cesarone MR, 1999, INT ANGIOL, V18, P127; Kato J, 2001, CANCER RES, V61, P8697; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Oettl K, 2013, J HEPATOL, V59, P978, DOI 10.1016/j.jhep.2013.06.013; Nishina S, 2010, LIVER INT, V30, P683, DOI 10.1111/j.1478-3231.2010.02210.x; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1053/S1542-3565(05)00017-0; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Beard MR, 1999, HEPATOLOGY, V30, P316, DOI 10.1002/hep.510300137; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; Fukushima H, 2007, HEPATOL RES, V37, P765, DOI 10.1111/j.1872-034X.2007.00123.x; Hofer H, 2004, J HEPATOL, V40, P1018, DOI 10.1016/j.jhep.2004.02.030; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Iwasa M, 2013, PLOS ONE, V25; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kitase A, 2005, J GASTROENTEROL, V40, P617, DOI 10.1007/s00535-005-1596-x; Korenaga M, 2011, LIVER INT, V31, P552, DOI 10.1111/j.1478-3231.2011.02469.x; Kuwahata M, 2008, J NUTR BIOCHEM, V19, P438, DOI 10.1016/j.jnutbio.2007.05.01; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Nishitani S, 2002, BIOCHEM BIOPH RES CO, V299, P693, DOI 10.1016/S0006-291X(02)02717-1; Rulyak SJ, 2005, AM J GASTROENTEROL, V100, P332, DOI 10.1111/j.1572-0241.2005.41112.x; Suzuki K, 2008, HEPATOL RES, V38, P267, DOI 10.1111/j.1872-034X.2007.00268.x; YAMATO M, 1995, INT HEPATOL COMMUN, V3, P91, DOI 10.1016/0928-4346(94)00159-3	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	APR	2015	35	4					1303	1314		10.1111/liv.12675		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD5TN	WOS:000351151100020		
J	Wang, PF; Sugo, M; Adachi, K				Wang, Pengfei; Sugo, Masakatsu; Adachi, Koshi			Stable and super-low friction of amorphous carbon nitride coatings in nitrogen gas by using two-step ball-on-disk friction test	LUBRICATION SCIENCE			English	Article						carbon nitride; nitrogen gas; friction coefficient; running-in; pre-sliding	SLIDING STEEL SURFACES; RUN-IN; WEAR; ENVIRONMENTS; BEHAVIOR; GRAPHENE; LAYER; AIR	Effect of running-in process on friction behaviour of carbon nitride (CNx) coating in N-2 gas stream was investigated with a newly introduced two-step ball-on-disk friction test, where the rubbed Si3N4 ball in the pre-sliding (step 1) was replaced by a new CNx-coated Si3N4 ball in the subsequent sliding stage under N-2 gas (step 2). The two-step friction test is clarified to be a simple but effective technique for obtaining contact material combination of self-mated CNx coatings and for achieving stable and low frictions of CNx coatings. Friction coefficients of CNx/CNx in N-2 gas stream decrease greatly from 0.07 without pre-sliding to less than 0.025 in two-step friction tests. The minimum friction coefficient of 0.004 was obtained by introducing 500 cycles of pre-sliding in ambient air. These stable and low frictions are attributed to the generation of self-mated CNx coatings and the formation of a lubricious layer on the disk surface. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Wang, Pengfei] Shenzhen Univ, Coll Mechatron & Control Engn, Inst Nanosurface Sci & Engn, Shenzhen 518060, Peoples R China; [Wang, Pengfei; Adachi, Koshi] Tohoku Univ, Div Mech Engn, Lab Nanointerface Engn, Sendai, Miyagi 980, Japan; [Sugo, Masakatsu] Nissan Motor Co Ltd, Yokohama, Kanagawa, Japan	Wang, PF (reprint author), Shenzhen Univ, Coll Mechatron & Control Engn, Inst Nanosurface Sci & Engn, Shenzhen 518060, Peoples R China.	wangpf@szu.edu.cn	Wang, Pengfei/D-9366-2012				Adachi K, 2008, TRIBOLOGY DIAMOND LI, P339, DOI 10.1007/978-0-387-49891-1_13; Adachis K, 2005, P 31 LEEDS LYON S TR, P673; Adachi K, 2006, J JPN SOC TRIBOLOGIS, V51, P861; Fontaine J, 2005, THIN SOLID FILMS, V482, P99, DOI 10.1016/j.tsf.2004.11.126; Tokoroyama T, 2006, TRIBOL LETT, V22, P215, DOI 10.1007/s11249-006-9084-x; Sanchez-Lopez JC, 2002, SURF COAT TECH, V160, P138, DOI 10.1016/S0257-8972(02)00397-3; Berman D, 2013, CARBON, V59, P167, DOI 10.1016/j.carbon.2013.03.006; Scharf TW, 2009, TRIBOL LETT, V36, P43, DOI 10.1007/s11249-009-9457-z; Kato K, 2003, WEAR, V254, P1062, DOI 10.1016/S0043-1648(03)00334-X; Berman D, 2013, CARBON, V54, P454, DOI 10.1016/j.carbon.2012.11.061; Zhou F, 2005, TRIBOL LETT, V18, P153, DOI 10.1007/s11249-004-1771-x; Marino MJ, 2011, LANGMUIR, V27, P12702, DOI 10.1021/la202927v; Wang PF, 2013, SURF COAT TECH, V221, P163, DOI 10.1016/j.surfcoat.2013.01.045; Bryant P.J., 1964, WEAR, V7, P118, DOI 10.1016/0043-1648(64)90083-3; Kato K., 2007, SUPERLUBRICITY, P341, DOI 10.1016/B978-044452772-1/50051-2; Konca E, 2005, WEAR, V259, P795, DOI 10.1016/j.wear.2005.02.034; Masripans NAB, 2013, TRIBOLOGY ONLINE, V8, P219; Tokoroyama T, 2012, LUBR SCI, V24, P129, DOI 10.1002/ls.1168; Umehara N, 1998, P INT C MET COAT THI, P151; Wang P., 2011, TRIBOL ONLINE, V6, P265	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-0075	1557-6833		LUBR SCI	Lubr. Sci.	APR	2015	27	3					137	149		10.1002/ls.1258		13	Engineering, Chemical; Engineering, Mechanical	Engineering	CD9XI	WOS:000351453400002		
J	Nagata, N; Wakamatsu, K; Kumazoe, H; Miyazaki, H; Akagi, T; Kawasaki, M; Watanabe, K				Nagata, Nobuhiko; Wakamatsu, Kentaro; Kumazoe, Hiroyuki; Miyazaki, Hiroyuki; Akagi, Takanori; Kawasaki, Masayuki; Watanabe, Kentaro			Clinical Significance of Intra-alveolar Fibrin Deposition in Transbronchial Lung Biopsy in Patients with Organizing Pneumonia	LUNG			English	Article						Organizing pneumonia; Cryptogenic organizing pneumonia; Collagen vascular disease; Fibrin; Relapse	SECONDARY	This study examined the clinical significance of intra-alveolar fibrin deposition (IAFD) in transbronchial lung biopsy specimens obtained from patients with organizing pneumonia. Pathological reports of transbronchial lung biopsies performed between 2004 and 2012 were reviewed to identify cases of intra-alveolar organization with or without fibrin deposition. Clinical charts, computed tomography images, and transbronchial lung biopsy specimens from these cases were examined retrospectively. Diagnosis of organizing pneumonia was reevaluated based upon the consensus of a respiratory physician, a radiologist, and a pathologist. Transbronchial lung biopsy results of the reviewed patients with organizing pneumonia found seven patients who had IAFD, and 34 who did not. Seven patients' conditions were associated with collagen vascular disease (CVD), and 34 were cryptogenic. IAFD was significantly associated with high C-reactive protein (CRP) values (> 5 mg/dl) (p = 0.0012) and underlying CVD (p = 0.0099). Multivariate analysis revealed that IAFD was independently associated with high CRP values (p = 0.0184). Three of 31 patients and six of 27 patients experienced a relapse of organizing pneumonia within 6 months and 1 year, respectively. IAFD (p = 0.0044) and high CRP values (p = 0.0207) were significantly related to relapse within 6 months, while only CRP was significantly related to relapse within 1 year (p = 0.0007). In patients with organizing pneumonia, IAFD was significantly associated with high CRP values. High CRP values and/or IAFD predicted relapse of organizing pneumonia within 6 months to 1 year.	[Nagata, Nobuhiko; Kumazoe, Hiroyuki; Akagi, Takanori] Fukuoka Univ, Chikushi Hosp, Dept Resp Med, Chikushino, Fukuoka 8188502, Japan; [Nagata, Nobuhiko; Wakamatsu, Kentaro; Kawasaki, Masayuki] Natl Hosp Org, Omuta Hosp, Dept Clin Res & Resp Med, Omuta, Japan; [Kumazoe, Hiroyuki] Natl Hosp Org, Omuta Hosp, Dept Radiol, Omuta, Japan; [Watanabe, Kentaro] Fukuoka Univ, Fac Med, Dept Resp Med, Fukuoka, Japan	Nagata, N (reprint author), Fukuoka Univ, Chikushi Hosp, Dept Resp Med, 1-1-1 Zokumyoin, Chikushino, Fukuoka 8188502, Japan.	nbnagata@fukuoka-u.ac.jp					Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Sveinsson OA, 2007, INT J TUBERC LUNG D, V11, P689; Lazor R, 2000, AM J RESP CRIT CARE, V162, P571; Drakopanagiotakis F, 2011, CHEST, V139, P893, DOI 10.1378/chest.10-0883; Fukuoka J, 2011, PRACTICAL PULMONARY, P213; Travis WD, 2002, NONNEOPLASTIC DISORD, P49; Watanabe K, 1998, CHEST, V114, P1599, DOI 10.1378/chest.114.6.1599; Yoo JW, 2011, RHEUMATOLOGY, V50, P932, DOI 10.1093/rheumatology/keq410; YOSHINOUCHI T, 1995, RESP MED, V89, P271, DOI 10.1016/0954-6111(95)90087-X	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	APR	2015	193	2					203	208		10.1007/s00408-015-9689-7		6	Respiratory System	Respiratory System	CE0RZ	WOS:000351514400007		
J	Matsumoto, N; Miki, K; Tsubouchi, H; Sakamoto, A; Arimura, Y; Yanagi, S; Iiboshi, H; Yoshida, M; Souma, R; Ishimoto, H; Yamamoto, Y; Yatera, K; Yoshikawa, M; Sagara, H; Iwanaga, T; Mukae, H; Maekura, R; Kimura, H; Nakazato, M; Kangawa, K				Matsumoto, Nobuhiro; Miki, Keisuke; Tsubouchi, Hironobu; Sakamoto, Akihiro; Arimura, Yasuji; Yanagi, Shigehisa; Iiboshi, Hirotoshi; Yoshida, Makoto; Souma, Ryosuke; Ishimoto, Hiroshi; Yamamoto, Yoshifumi; Yatera, Kazuhiro; Yoshikawa, Masanori; Sagara, Hironori; Iwanaga, Tomoaki; Mukae, Hiroshi; Maekura, Ryoji; Kimura, Hiroshi; Nakazato, Masamitsu; Kangawa, Kenji			Ghrelin Administration for Chronic Respiratory Failure: A Randomized Dose-Comparison Trial	LUNG			English	Article						Ghrelin; Chronic respiratory failure; Cachexia; 6MWD; Peak VO2	OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEART-FAILURE; EXERCISE CAPACITY; GROWTH-HORMONE; REHABILITATION; CACHEXIA; COPD	Repeated ghrelin administration leads to improvements in symptoms, muscle wasting and exercise tolerance in cachectic patients with pulmonary disease. We investigated the optimal ghrelin dose for underweight patients with chronic respiratory failure. In this multicenter, randomized, dose-comparison exploratory study, 44 cachectic patients with chronic respiratory failure were randomly assigned pulmonary rehabilitation with intravenous twice-daily administration of 1 or 2 mu g/kg ghrelin for 3 weeks. The primary endpoint was improvement in 6-min walking distance (6MWD). The secondary endpoint was change in peak O-2. Twenty-one patients were assigned to the 1 mu g/kg ghrelin group and 23 to the 2 mu g/kg ghrelin group. Change from baseline 6MWD after treatment was similar between groups(1 mu g/kg: 53.9 m, 2 mu g/kg: 53.9 m, p = 0.99). Mean change in peak O-2 was significantly greater in the 2 mu g/kg group (63.1 ml/min) than in the 1 mu g/kg group (-63.8 ml/min, p = 0.048). Food intake and lean body mass significantly increased in both groups, and the St. George Respiratory Questionnaire score, body weight, and body mass index were remarkably improved in only the 2 mu g/kg group, although there was no significant difference between groups. No treatment-related serious events were reported for either group. Improvements in the oxygen uptake capacity were greater in patients receiving 2 mu g/kg ghrelin twice daily for 3 weeks than in those receiving 1 mu g/kg, although exercise tolerance was similar between groups at the end of the 3-week treatment period. Thus, a twice daily dose of 2 mu g/kg ghrelin is recommended over 1 mu g/kg ghrelin for patients with chronic respiratory failure and weight loss.	[Matsumoto, Nobuhiro; Tsubouchi, Hironobu; Sakamoto, Akihiro; Arimura, Yasuji; Yanagi, Shigehisa; Iiboshi, Hirotoshi; Yoshida, Makoto] Miyazaki Univ, Fac Med, Neurol Respirol Endocrinol & Metab Internal Med, Kiyotake, Miyazaki 8891692, Japan; [Miki, Keisuke; Maekura, Ryoji] Natl Hosp Org Toneyama Natl Hosp, Dept Internal Med, Toyonaka, Osaka 5608552, Japan; [Yoshida, Makoto; Iwanaga, Tomoaki] Natl Hosp Org Fukuoka Natl Hosp, Minami Ku, Fukuoka 8111394, Japan; [Ishimoto, Hiroshi; Yatera, Kazuhiro; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Yamamoto, Yoshifumi; Yoshikawa, Masanori; Kimura, Hiroshi] Nara Med Univ, Dept Internal Med 2, Kashihara, Nara 6348521, Japan; [Sagara, Hironori] Showa Univ, Sch Med, Div Allergol & Resp Med, Shinagawa Ku, Tokyo 1428555, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka 5658565, Japan	Matsumoto, N (reprint author), Miyazaki Univ, Fac Med, Neurol Respirol Endocrinol & Metab Internal Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	nobuhiro@med.miyazaki-u.ac.jp			Research Grant from Health and Labour Sciences Research Grants, Clinical Research [H20-translational research-general-002]	The authors thank Sumie Tajiri and Keiko Sakaguchi for technical assistance. This study was supported by the Research Grant from Health and Labour Sciences Research Grants, Clinical Research (H20-translational research-general-002).	FLETCHER CM, 1959, BRIT MED J, V2, P257; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; CASABURI R, 1991, AM REV RESPIR DIS, V143, P9; Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000034395.51441.10; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Nagaya N, 2001, AM J PHYSIOL-REG I, V280, pR1483; Akamizu T, 2004, EUR J ENDOCRINOL, V150, P447, DOI 10.1530/eje.0.1500447; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Baatar D, 2011, MOL CELL ENDOCRINOL, V340, P44, DOI 10.1016/j.mce.2011.04.019; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Rabinovich RA, 2006, RESPIRATION, V73, P757, DOI 10.1159/000094395; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Rabinovich RA, 2001, AM J RESP CRIT CARE, V164, P1114; Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Miki K, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-37; Schols AMWJ, 2002, INT J CARDIOL, V85, P101, DOI 10.1016/S0167-5273(02)00238-3; Woo M A, 1997, Am J Crit Care, V6, P348	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	APR	2015	193	2					239	247		10.1007/s00408-015-9685-y		9	Respiratory System	Respiratory System	CE0RZ	WOS:000351514400012		
J	Watanabe, K; Ikeda, S				Watanabe, Kazuho; Ikeda, Shiro			Entropic risk minimization for nonparametric estimation of mixing distributions	MACHINE LEARNING			English	Article						Mixture models; Nonparametric estimation; Entropic risk measure; Rate-distortion theory	DIVERGENCE; GEOMETRY; DISTORTION; ROBUST	We discuss a nonparametric estimation method for the mixing distributions in mixture models. The problem is formalized as a minimization of a one-parameter objective functional, which becomes the maximum likelihood estimation or the kernel vector quantization in special cases. Generalizing the theorem for the nonparametric maximum likelihood estimation, we prove the existence and discreteness of the optimal mixing distribution and provide an algorithm to calculate it. It is demonstrated that with an appropriate choice of the parameter, the proposed method is less prone to overfitting than the maximum likelihood method. We further discuss the connection between the unifying estimation framework and the rate-distortion problem.	[Watanabe, Kazuho] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan; [Ikeda, Shiro] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan	Watanabe, K (reprint author), Toyohashi Univ Technol, Dept Comp Sci & Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	wkazuho@cs.tut.ac.jp; shiro@ism.ac.jp			JSPS KAKENHI [23700175, 24560490, 25120008, 25120014]	The authors are grateful for helpful comments and suggestions by anonymous reviewers. This work was supported by JSPS KAKENHI Grant Numbers 23700175, 24560490, 25120008, and 25120014.	AMARI S, 1992, NEURAL COMPUT, V4, P605, DOI 10.1162/neco.1992.4.4.605; Banerjee A, 2005, J MACH LEARN RES, V6, P1705; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Murata N, 2004, NEURAL COMPUT, V16, P1437, DOI 10.1162/089976604323057452; Basu A, 1998, BIOMETRIKA, V85, P549, DOI 10.1093/biomet/85.3.549; Fujisawa H, 2008, J MULTIVARIATE ANAL, V99, P2053, DOI 10.1016/j.jmva.2008.02.004; Arikan E, 1998, IEEE T INFORM THEORY, V44, P1041, DOI 10.1109/18.669158; Barber David, 2012, BAYESIAN REASONING M; Barron A. R., 2014, P 2014 IEEE INT S IN, P1667; Berger T., 1971, RATE DISTORTION THEO; Boyd S, 2004, CONVEX OPTIMIZATION; Eguchi S, 2011, ENTROPY-SWITZ, V13, P1746, DOI 10.3390/e13101746; Eguchi S, 2010, ENTROPY-SWITZ, V12, P262, DOI 10.3390/e12020262; Hartigan J. A, 1985, P BERKELEY C HONOR J, V2, P807; Lashkari D., 2007, ADV NEURAL INFORM PR, V19; Lindsay B., 1995, MIXTURE MODELS THEOR; LINDSAY BG, 1983, ANN STAT, V11, P86, DOI 10.1214/aos/1176346059; Nowozin S., 2008, P 24 INT C MACH LEAR; Renyi A., 1961, P 4 BERK S MATH STAT, V1, P547; ROSE K, 1994, IEEE T INFORM THEORY, V40, P1939, DOI 10.1109/18.340468; Rudloff B., 2008, FESTSCHRIFT CELEBRAT, P149; Scholkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Tipping M., 2001, P INT C ART INT STAT; Tsallis C, 2009, INTRO NONEXTENSIVE S; Watanabe S, 2005, NEUROCOMPUTING, V67, P198, DOI 10.1016/j.neucom.2004.11.037	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0885-6125	1573-0565		MACH LEARN	Mach. Learn.	APR	2015	99	1					119	136		10.1007/s10994-014-5467-7		18	Computer Science, Artificial Intelligence	Computer Science	CE1DQ	WOS:000351552700004		
J	Hua, CS; Makihara, Y; Yagi, Y; Iwasaki, S; Miyagawa, K; Li, B				Hua, Chunsheng; Makihara, Yasushi; Yagi, Yasushi; Iwasaki, Shun; Miyagawa, Keisuke; Li, Bo			Onboard monocular pedestrian detection by combining spatio-temporal hog with structure from motion algorithm	MACHINE VISION AND APPLICATIONS			English	Article						Spatio-temporal HOG; Pedestrian detection; Onboard monocular camera; Structure from motion	STEREO VISION SYSTEM; ORIENTED GRADIENTS; DRIVER ASSISTANCE; HISTOGRAMS; TRACKING; FLOW	In this paper, we brought out a novel pedestrian detection framework for the advanced driver assistance system of mobile platform under the normal urban street environment. Different from the conventional systems that focus on the pedestrian detection at near distance by interfusing multiple sensors (such as radar, laser and infrared camera), our system has achieved the pedestrian detection at all (near, middle and long) distance on a normally driven vehicle (1-40 km/h) with monocular camera under the street scenes. Since pedestrians typically exhibit not only their human-like shape but also the unique human movements generated by their legs and arms, we use the spatio-temporal histogram of oriented gradient (STHOG) to describe the pedestrian appearance and motion features. The shape and movement of a pedestrian will be described by a unique feature produced by concatenating the spatial and temporal histograms. A STHOG detector trained by the AdaBoost algorithm will be applied to the images stabilized by the structure from motion (SfM) algorithm with geometric ground constraint. The main contributions of this work include: (1) ground constraint with monocular camera to reduce the computational cost and false alarms; (2) preprocessing by stabilizing the successive images captured from mobile camera with the SfM algorithm; (3) long-distance (maximum 100 m) pedestrian detection at various velocities (1-40 km/h). Through the extensive experiments under different city scenes, the effectiveness of our algorithm has been proved.	[Hua, Chunsheng] Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang 110045, Liaoning, Peoples R China; [Makihara, Yasushi; Yagi, Yasushi] Osaka Univ, Dept Intelligent Multimedia, ISIR, Osaka 5600023, Japan; [Iwasaki, Shun] Honda Res & Dev Co Ltd, Dev Safety Technol, Wako, Saitama, Japan; [Miyagawa, Keisuke; Li, Bo] Honda Res & Dev Co Ltd, Wako, Saitama, Japan	Hua, CS (reprint author), Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang 110045, Liaoning, Peoples R China.	huachunsheng@gmail.com; makihara@am.sanken.osaka-u.ac.jp; yagi@am.sanken.osaka-u.ac.jp; Shun_Iwasaki@n.t.rd.honda.co.jp; Keisuke_Miyagawa@n.t.rd.honda.co.jp; snakeie@gmail.com			National Natural Science Foundation of China [61433016]; JSPS KEKENHI [21220003]; R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society; Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology; Japanese Government; JST CREST	This work was partly supported by the National Natural Science Foundation of China project 61433016, JSPS KEKENHI Grant Number 21220003, "R&D Program for Implementation of Anti-Crime and Anti-Terrorism Technologies for a Safe and Secure Society", Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government, and the JST CREST "Behavior Understanding based on Intention-Gait Model" project.	Agawal S., 2002, EUROPEAN CONFERENCE; Andriluka M., 2008, IEEE CONFERENCE ON C; Papageorgiou C, 2000, INT J COMPUT VISION, V38, P15, DOI 10.1023/A:1008162616689; Munder S, 2006, IEEE T PATTERN ANAL, V28, P1863, DOI 10.1109/TPAMI.2006.217; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Ess A, 2009, IEEE T PATTERN ANAL, V31, P1831, DOI 10.1109/TPAMI.2009.109; Keller CG, 2011, IEEE T INTELL TRANSP, V12, P1292, DOI 10.1109/TITS.2011.2158424; Gandhi T, 2007, IEEE T INTELL TRANSP, V8, P413, DOI 10.1109/TITS.2007.903444; Wu B, 2007, INT J COMPUT VISION, V75, P247, DOI 10.1007/s11263-006-0027-7; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Breitenstein MD, 2011, IEEE T PATTERN ANAL, V33, P1820, DOI 10.1109/TPAMI.2010.232; Bertozzi M, 2006, 2006 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P231, DOI 10.1109/IVS.2006.1689633; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Geronimo D, 2010, IEEE T PATTERN ANAL, V32, P1239, DOI 10.1109/TPAMI.2009.122; Dalal N, 2005, PROC CVPR IEEE, P886; Enzweiler M, 2009, IEEE T PATTERN ANAL, V31, P2179, DOI 10.1109/TPAMI.2008.260; Gavrila DM, 2007, INT J COMPUT VISION, V73, P41, DOI 10.1007/s11263-006-9038-7; Barinova O., 2009, IEEE CONFERENCE ON C; Bourdev L., 2010, EURO CONF COMPUTER V; Broggi A, 2001, IEEE INT CONF ROBOT, P3698; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428; Dang T., 2004, IEEE INT VEH S PARM, P268, DOI 10.1109/IVS.2004.1336393; Daniel W., 2010, EUROPEAN CONFERENCE, P635; Dollar P., 2011, IEEE TRANS PATT ANAL; Dollar P., 2009, IEEE CONFERENCE ON C; Dollar P., 2010, BRITI MACH VISI CONF; Ess A., 2007, IEEE INTERNATIONAL C; Ess A., 2008, IEEE CONFERENCE ON C; Fardi B., 2005, IEEE INT VEH S, P18, DOI 10.1109/IVS.2005.1505071; Felzenszwalb P. F., 2010, IEEE CONFERENCE ON C; Gavrila D, 2004, IEEE INT VEH S, P13, DOI 10.1109/IVS.2004.1336348; Goubet E., 2006, P SOC PHOTO-OPT INS, V6206, P797; Harris C., 1988, P 4 ALV VIS C, V15, P147; Hartley R., 1992, IEEE C COMP VIS PATT, P761; Hoiem D., 2006, CVPR, V2, P2137; Hua CS, 2013, IEICE T INF SYST, VE96D, P1376, DOI 10.1587/transinf.E96.D.1376; Keller C., 2011, PROC OF THE IEEE INT; Klaser A., 2010, TECHNICAL REPORT; Klaser A., 2008, BRIT MACH VIS C, P995; Knoll PM, 2007, SPR SER ADV MICROELE, V26, P123; Labayrade R., 2002, IEEE INT VEH S, V2, P17; Laptev I., 2007, IEEE INTERNATIONAL C; Leibe B., 2007, IEEE CONFERENCE ON C; Liu Y., 2010, EUROPEAN CONFERENCE; Lucas B. D., 1981, P 7 INT JOINT C ART, V2, P674; Marchal P., 2005, FINAL REPORT; Marin J., 2010, IEEE CONFERENCE ON C; Milch S., 2001, PROCEEDINGS OF THE C; Murai Y., 2009, AS C COMP VIS, P915; Park D., 2010, EUROPEAN CONFERENCE; Richar H., 2003, MULTIPLE VIEW GEOMET; Rodriguez M., 2011, IEEE INTERNATIONAL C; Roth P. M., 2009, IEEE CONFERENCE ON C; Rozenfeld B., 2008, IEEE CONFERENCE ON C; Ryan K., ARXIV 1309 6964; Sappa AD, 2008, IEEE T INTELL TRANSP, V9, P476, DOI 10.1109/TITS.2008.928237; Scovanner P., 2007, INT C MULT, P357; Sternig S., 2010, INTERN CONFER ON ADV; Sun J., 2009, IEEE CONFERENCE ON C; Triggs B., 2000, LNCS, P1883; Tuzel O., 2007, IEEE CONFERENCE ON C; Viola P., 2005, INT J COMPU VISION, V63, P13; Viola P., 2001, INT J COMPUT VIS; Walk S., 2010, IEEE CONFERENCE ON C; Wang H., 2009, BRITISH MACH VISI CO; Wang H. Z., 2009, IEEE INTERNATIONAL C; Wang M., 2011, IEEE CONFERENCE ON C; Yamauchi Y., 2008, INTERNATIONAL CONFER; Zhu Q., 2006, IEEE COMP SOC C COMP, V2, P1491	71	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-8092	1432-1769		MACH VISION APPL	Mach. Vis. Appl.	APR	2015	26	2-3					161	183		10.1007/s00138-014-0653-y		23	Computer Science, Artificial Intelligence; Computer Science, Cybernetics; Engineering, Electrical & Electronic	Computer Science; Engineering	CE0AD	WOS:000351462900002		
J	Nishizawa, B; Ochi, D; Minami, H; Yokawa, K; Saitoh, SI; Watanuki, Y				Nishizawa, Bungo; Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro; Saitoh, Sei-Ichi; Watanuki, Yutaka			Habitats of two albatross species during the non-breeding season in the North Pacific Transition Zone	MARINE BIOLOGY			English	Article							FORAGING DESTINATIONS; 1ST-PASSAGE TIME; INDIAN-OCEAN; MARINE; ASSOCIATIONS; SEAMOUNT; FRONTS; CONSERVATION; PREDATORS; SEABIRDS	The North Pacific Transition Zone (NPTZ) is one of the most productive offshore regions. To identify important habitats for pelagic top predators within this region, we investigated the at-sea distributions of black-footed (Phoebastria nigripes) and Laysan albatrosses (P. immutabilis) by vessel-based surveys during their non-breeding season (July and October in 2010 and September and October in 2011). We developed statistical models using satellite-based oceanographic data at spatial scales of 4, 20 and 80 km to explain their densities. For both species, sea surface temperatures (SST) and distance to the Emperor Seamounts emerged as important factors in the better-fitting models at all spatial scales. In addition, black-footed albatrosses were widely distributed in the NPTZ (SST 17.7-27.4 A degrees C), whereas Laysan albatrosses favoured northern and colder waters (13.6-25.4 A degrees C). Our results also indicated that the Emperor Seamounts, where trawling and longline fishing occur, were an important habitat for both species in the NPTZ. Therefore, careful attention should be paid to interactions between fisheries and albatross species in this region.	[Nishizawa, Bungo; Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro] Natl Res Inst Far Seas Fisheries, Tuna & Skipjack Resources Div, Shimizu, Shizuoka 4248633, Japan; [Saitoh, Sei-Ichi] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Bioresource & Environm Sensing, Hakodate, Hokkaido 0418611, Japan	Nishizawa, B (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	nishizawa@salmon.fish.hokudai.ac.jp					TASKER ML, 1984, AUK, V101, P567; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.015; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; WOLANSKI E, 1988, SCIENCE, V241, P177, DOI 10.1126/science.241.4862.177; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Sullivan BJ, 2006, BIOL CONSERV, V131, P495, DOI 10.1016/j.biocon.2006.02.007; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; RODEN GI, 1982, J GEOPHYS RES-OC ATM, V87, P9537, DOI 10.1029/JC087iC12p09537; Hazen EL, 2013, MAR ECOL PROG SER, V487, P177, DOI 10.3354/meps10477; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; CAYULA JF, 1992, J ATMOS OCEAN TECH, V9, P67, DOI 10.1175/1520-0426(1992)009<0067:EDAFSI>2.0.CO;2; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; KAWAMURA H, 1986, DEEP-SEA RES, V33, P1617, DOI 10.1016/0198-0149(86)90070-1; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; Burnham K. P., 2010, MODEL SELECTION MULT; Duffy D, 2006, PELAG FISH RES PROG, V11, P1; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; HANEY JC, 1995, MAR BIOL, V123, P1, DOI 10.1007/BF00350317; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Haury LR, 1978, PATTERN PLANKTON COM, P277; Holland KN, 1999, FISH B-NOAA, V97, P392; Hunt G.L. Jr, 1987, P7; Hyrenbach KD, 2006, MAR ECOL PROG SER, V324, P271, DOI 10.3354/meps324271; International Union for Conservation of Nature (IUCN), 2013, IUCN RED LIST THREAT; KAWAI H, 1986, DEEP-SEA RES, V33, P1487, DOI 10.1016/0198-0149(86)90064-6; KURODA N, 1988, Journal of the Yamashina Institute for Ornithology, V20, P1; Mizuno K, 1983, J PHYS OCEANOGR, V13, P1848; Moore Sue E., 2002, Oceanography, V15, P20; Naughton MB, 2007, CONSERVATION ACTION; Pearcy WG, 1996, FISH OCEANOGR, V5, P1, DOI 10.1111/j.1365-2419.1996.tb00013.x; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; R Development Core Team, 2014, R LANG ENV STAT COMP; Roden G. I., 1991, BIOL OCEANOGRAPHY FI, V105, P1; Roden G.I., 1986, NOAA TECHNICAL REPOR, V43, P3; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; SAITOH S, 1986, DEEP-SEA RES, V33, P1601, DOI 10.1016/0198-0149(86)90069-5; Sasaki T, 1986, NATL MARINE FISHERIE, V43, P21; Schneider D.C., 1990, Polar Research, V8, P89, DOI 10.1111/j.1751-8369.1990.tb00379.x; Stafford KM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040724; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; WAHL TR, 1979, CONDOR, V81, P390, DOI 10.2307/1366965; Yasui M, 1986, NOAA TECH REP NMFS, V43, P37; Young LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007623; Zuur A., 2009, MIXED EFFECTS MODELS; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	58	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	APR	2015	162	4					743	752		10.1007/s00227-015-2620-1		10	Marine & Freshwater Biology	Marine & Freshwater Biology	CD6VK	WOS:000351227900002		
J	Yasumuro, H; Nakatsuru, S; Ikeda, Y				Yasumuro, Haruhiko; Nakatsuru, Shogo; Ikeda, Yuzuru			Cuttlefish can school in the field	MARINE BIOLOGY			English	Article							SEPIA-OFFICINALIS; SEPIOTEUTHIS-LESSONIANA; DISRUPTIVE COLORATION; LOLIGO-OPALESCENS; MALE CHIMPANZEES; SOCIAL-BEHAVIOR; BODY PATTERNS; FISH SCHOOLS; OVAL SQUID; CEPHALOPODA	Cuttlefish (Sepiidae) are usually solitary in nature, but we have found evidence that the broadclub cuttlefish (Sepia latimanus) forms schools. S. latimanus groups of various sizes were observed for 145 min in Okinawa, Japan. The groups were comprised of 2-9 members that were usually of similar body sizes. The groups continuously changed shape, forming either clusters or lines. The groups were regarded as schools and had characteristic structures such as synchronized and polarized swimming with similar distances apart from each other (similar to 4.0 mantle length), and swam in parallel (under 20A degrees or over 110A degrees in angle) to their nearest neighbours, regardless of the numbers of members in the group. Small members sometimes followed larger members within the school. These characteristics were similar to those observed in schools of Teuthoidea squid. Schools comprising large numbers of members frequently exhibited hunting behaviour for small crustaceans and fish. This is the first observation of schooling behaviour in wild Sepiidae.	[Yasumuro, Haruhiko] Univ Ryukyus, Grad Sch Engn & Sci, Dept Marine & Environm Sci, Nishihara, Okinawa 9030213, Japan; [Nakatsuru, Shogo; Ikeda, Yuzuru] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan	Ikeda, Y (reprint author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan.	ikeda@sci.u-ryukyu.ac.jp					Adamo SA, 1999, J MOLLUS STUD, V65, P377, DOI 10.1093/mollus/65.3.377; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; DeBlois EM, 1996, OECOLOGIA, V108, P192, DOI 10.1007/BF00333231; SHAW E, 1978, AM SCI, V66, P166; Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741; Chiao CC, 2010, J EXP BIOL, V213, P187, DOI 10.1242/jeb.030247; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hunt JC, 2000, J MAR BIOL ASSOC UK, V80, P873, DOI 10.1017/S002531540000285X; Hall KC, 2002, MAR BIOL, V140, P533; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Sugimoto C, 2012, FISHERIES SCI, V78, P287, DOI 10.1007/s12562-011-0464-2; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Chiao CC, 2005, BIOL BULL-US, V208, P7, DOI 10.2307/3593095; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Rocha F, 2001, BIOL REV, V76, P291, DOI 10.1017/S1464793101005681; Mathger LM, 2006, VISION RES, V46, P1746, DOI 10.1016/j.visres.2005.09.035; Zylinski S, 2009, PHILOS T R SOC B, V364, P439, DOI 10.1098/rstb.2008.0264; BLAXTER J. H. S., 1965, INT COMM NORTHWEST ATLANTIC FISH SPEC PUBLICATION, V6, P647; Boal JG, 2006, VIE MILIEU, V56, P69; Boal JG, 1999, CONTEMP TOP LAB ANIM, V38, P49; Boal JG, 1998, ETHOLOGY, V104, P161; Boletzky SV, 2014, CEPHALOPOD CULTURES, P3, DOI [10.1007/978-94-017-8648-5_1, DOI 10.1007/978-94-017-8648-5_1]; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; BREDER CM, 1967, ZOOLOGICA-N Y, V52, P25; CHOE S, 1966, B MAR SCI, V16, P330; Corner B.D., 1980, Micronesica, V16, P235; Goodall Jane, 1968, ANIM BEHAV MONOGR, V1, P163; Hanlon RT, 2005, NATURE, V433, P212, DOI 10.1038/433212a; Hanlon RT, 1996, CEPHALOPOD BEHAV; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; HAYAKI H, 1989, PRIMATES, V30, P187, DOI 10.1007/BF02381303; Huang KL, 2013, ANIM COGN, V16, P313, DOI 10.1007/s10071-012-0573-z; HURLEY AC, 1978, FISH B-NOAA, V76, P433; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Mangold K., 1987, P157; MATHER JA, 1984, MAR BEHAV PHYSIOL, V10, P259; MATHER JA, 1995, ADV STUD BEHAV, V24, P317, DOI 10.1016/S0065-3454(08)60398-8; MESSENGE.JB, 1968, ANIM BEHAV, V16, P342, DOI 10.1016/0003-3472(68)90020-1; Moynihan M, 1985, COMMUNICATION NONCOM; Moynihan M., 1982, ADV ETHOL, V25, P1; Nabhitabhata Jaruwat, 1997, Phuket Marine Biological Center Special Publication, V17, P289; Pitcher T. J., 1993, BEHAV TELEOST FISHES, V7, P363; Pitcher TJ, 1983, PREDATORS PREY FISHE, P193; Ruxton G.D., 2002, LIVING GROUPS; Segawa Susumu, 1993, Venus the Japanese Journal of Malacology, V52, P101; SEGAWA S, 1987, Journal of the Tokyo University of Fisheries, V74, P67; Sugimoto Chikatoshi, 2013, Marine Biodiversity Records, V6, pe34, DOI 10.1017/S1755267213000067; Ueda K, 1985, B NANSEI REG FISH RE, V19, P1; Wells M.J., 1962, BRAIN BEHAV CEPHALOP; Wilson E.O., 1975, SOCIOBIOLOGY NEW SYN	52	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	APR	2015	162	4					763	771		10.1007/s00227-015-2622-z		9	Marine & Freshwater Biology	Marine & Freshwater Biology	CD6VK	WOS:000351227900004		
J	Onitsuka, T; Niwa, K; Unuma, T; Umezu, Y				Onitsuka, Toshihiro; Niwa, Kentaro; Unuma, Tatsuya; Umezu, Yuya			Dietary shifts in the juvenile sea urchin Strongylocentrotus intermedius associated with the development of digestive enzymes	MARINE BIOLOGY			English	Article							HALIOTIS-DISCUS-HANNAI; SPINY LOBSTER; KELP BED; GROWTH; ABALONE; DIATOMS; GUT; DEGRADATION; LARVAE	This study investigated a causal association between dietary change and digestive enzyme production of the sea urchin Strongylocentrotus intermedius. Urchins were fed microalgae (Achnanthes longipes, Cocconeis sublittoralis or Saccharina longissima gametophyte), macroalgae (S. longissima sporophyte or Ulva pertusa), or starved, and their growth rate (GR) was examined to identify the size at which sea urchins' diet shifts from microalgae to macroalgae. Changes in specific activity of seven enzymes (amylase, glycogen hydrolase, carboxymethyl cellulase (CMCase), laminarinase, alginate lyase, protease and lipase) were investigated in urchins of test diameters (TDs) 1.0-3.5, 3.0-4.5 and 6.0-9.2 mm to elucidate ontogenetic and diet-responsive changes. GRs were generally higher in urchins of < 6 mm TD fed microalgae than in those fed macroalgae. However, GRs of urchins fed macroalgae increased linearly for a TD of a parts per thousand 3 mm to a TD of a parts per thousand 6 mm. Activity for every enzyme was low in urchins < 3 mm in TD. Development of enzyme production capacity and increased ability to regulate enzyme activity in response to ingested diets were observed for urchins > 3 mm in TD. Our results suggest that the primary nutrient source of S. intermedius shifts from microalgae to macroalgae at a parts per thousand 6 mm TD, and that macroalgae digestion efficiency in urchins a parts per thousand yen3 mm TD gradually improves because of activation of the enzymes. Highly activated enzymes enable sea urchins to efficiently digest nutrients stored in the bodies of macroalgae, allowing the primary nutrient source of S. intermedius to shift from microalgae to macroalgae.	[Onitsuka, Toshihiro; Unuma, Tatsuya] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido 0850802, Japan; [Niwa, Kentaro] Fisheries Res Agcy, Natl Res Inst Aquaculture, Yokosuka Stn, Yokosuka, Kanagawa 2380316, Japan; [Umezu, Yuya] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Onitsuka, T (reprint author), Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, 116 Katsurakoi, Kushiro, Hokkaido 0850802, Japan.	onitsuka@affrc.go.jp					Agatsuma Y, 2009, UNI GAKU, P249; ANDREW NL, 1985, MAR ECOL PROG SER, V27, P155, DOI 10.3354/meps027155; Garcia-Esquivel Z, 2006, AQUACULTURE, V261, P615, DOI 10.1016/j.aquaculture.2006.08.022; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Jones DA, 1997, AQUACULTURE, V155, P285, DOI 10.1016/S0044-8486(97)00129-4; Agatsuma Y, 2000, FISHERIES SCI, V66, P467, DOI 10.1046/j.1444-2906.2000.00075.x; Kim D, 2013, INT J SYST EVOL MICR, V63, P3697, DOI 10.1099/ijs.0.047951-0; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Suman K, 2012, BOT MAR, V55, P289, DOI 10.1515/bot-2011-0076; Johnston DJ, 2003, MAR BIOL, V143, P1071, DOI 10.1007/s00227-003-1154-0; Johnston D, 2004, MAR ECOL PROG SER, V275, P219, DOI 10.3354/meps275219; Takami H, 1998, J SHELLFISH RES, V17, P723; Knauer J, 1996, AQUACULTURE, V140, P75, DOI 10.1016/0044-8486(95)01193-5; SAWABE T, 1995, MICROBIAL ECOL, V30, P193, DOI 10.1007/BF00172574; Johnston D, 2005, AQUACULTURE, V250, P341, DOI 10.1016/j.aquaculture.2005.03.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Azad AK, 2010, REV AQUACULT, V2, P121, DOI 10.1111/j.1753-5131.2010.01030.x; de Vicose GC, 2012, J APPL PHYCOL, V24, P1427, DOI 10.1007/s10811-012-9799-z; HASSETT RP, 1994, J PLANKTON RES, V16, P413, DOI 10.1093/plankt/16.4.413; JORGENSEN EG, 1962, PHYSIOL PLANTARUM, V15, P530, DOI 10.1111/j.1399-3054.1962.tb08056.x; Kawamura K., 1973, Scientific Rep Hokkaido Fish Exp Stn, VNo. 16, P1; Kawamura K, 1964, SCI REP HOKKAIDO FIS, V2, P39; Labarta U, 2002, MAR BIOL, V140, P669, DOI 10.1007/s00227-001-0742-0; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Machiguchi Y, 2012, AQUAC SCI, V60, P313; Onitsuka T, 2014, AQUAC RES, V45, P1; Rotllant G, 2010, MAR BIOL, V157, P2215, DOI 10.1007/s00227-010-1487-4; ROWLEY RJ, 1989, MAR BIOL, V100, P485, DOI 10.1007/BF00394825; ROWLEY RJ, 1990, MAR ECOL PROG SER, V62, P229, DOI 10.3354/meps062229; Sakai Y, 2004, HOKUSUISHI DAYORI, V66, P8; Sano Minoru, 1998, Benthos Research, V53, P79; Scholz B, 2014, EUR J PHYCOL, V49, P97, DOI 10.1080/09670262.2014.893589; Takami H, 2003, JARQ-JPN AGR RES Q, V37, P89; Trenzado CE, 2012, AQUACULTURE, V344, P174, DOI 10.1016/j.aquaculture.2012.03.027; Wangensteen OS, 2011, MAR ECOL PROG SER, V441, P117, DOI 10.3354/meps09359	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	APR	2015	162	4					869	880		10.1007/s00227-015-2630-z		12	Marine & Freshwater Biology	Marine & Freshwater Biology	CD6VK	WOS:000351227900012		
J	Kawasaki, H; Okada, H; Roppongi, T; Soma, D; Sato, I; Kawamata, Y; Arakui, K; Tsuge, A				Kawasaki, Hiroyoshi; Okada, Hiroshi; Roppongi, Takahiro; Soma, Daisuke; Sato, Isamu; Kawamata, Yuji; Arakui, Koji; Tsuge, Akihiko			Improvement of dispersion of pure indium particles by forming indium-complex covering	MATERIALS LETTERS			English	Article						Indium particles; Soldering; Indium-complex; Covering	SOLDER JOINTS; CU	No agglomeration of pure indium particles by the treatment with soaking in the solvent such as acetone or MEK has achieved. This is due to formation of indium-complex covering on the surface of particles. Furthermore we also have found out that a new pure indium particle works as well as conventional materials in terms of soldering properties. (C) 2014 Elsevier B.V. All rights reserved.	[Kawasaki, Hiroyoshi; Okada, Hiroshi; Roppongi, Takahiro; Soma, Daisuke; Sato, Isamu; Kawamata, Yuji] Senju Met Ind Co Ltd, Moka, Tochigi 3214346, Japan; [Kawasaki, Hiroyoshi; Arakui, Koji; Tsuge, Akihiko] Kyushu Inst Technol, Dept Appl Chem, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Kawasaki, H (reprint author), Senju Met Ind Co Ltd, 1 Matsuyama, Moka, Tochigi 3214346, Japan.	hikawasaki@senju.com					Ohata M, 2014, ANAL CHIM ACTA, V837, P23, DOI 10.1016/j.aca.2014.06.023; MEI Z, 1992, J ELECTRON MATER, V21, P599, DOI 10.1007/BF02655427; Suganuma K, 2001, CURR OPIN SOLID ST M, V5, P55, DOI 10.1016/S1359-0286(00)00036-X; Kim KS, 2003, J ALLOY COMPD, V352, P226, DOI 10.1016/S0925-8388(02)01166-0; Chuang TH, 2006, SCRIPTA MATER, V55, P983, DOI 10.1016/j.scriptamat.2006.08.024; Lee BJ, 1997, ACTA MATER, V45, P1867, DOI 10.1016/S1359-6454(96)00325-4; FELTON LE, 1993, JOM-J MIN MET MAT S, V45, P28; Islam MN, 2005, J ALLOY COMPD, V396, P217, DOI 10.1016/j.jallcom.2005.01.001; Katoh R, 2005, Jpn. Patent, Patent No. 3753168; Ladou J, 2008, INT J OCCUP ENV HEAL, V14, P1; Lee BJ, 1996, J ELECTRON MATER, V25, P983, DOI 10.1007/BF02666734; Munekata O, 2004, Jpn. Patent, Patent No. 3622788; Tabe N, 1993, Jpn. Patent, Patent No. 3027441; Tachibana K, 2014, Jpn. Patent, Patent No. 5578301; Ueshima M, 2010, Jpn. Patent, Patent No. 4618089	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	APR 1	2015	144						36	38		10.1016/j.matlet.2014.12.039		3	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CD2UZ	WOS:000350935800011		
J	Fujishige, S; Massberg, J				Fujishige, Satoru; Massberg, Jens			Dual consistent systems of linear inequalities and cardinality constrained polytopes	MATHEMATICAL PROGRAMMING			English	Article						Dual consistency; Linear inequalities; Cardinality constrained polytopes; Matroids		We introduce a concept of dual consistency of systems of linear inequalities with full generality. We show that a cardinality constrained polytope is represented by a certain system of linear inequalities if and only if the systems of linear inequalities associated with the cardinalities are dual consistent. Typical dual consistent systems of inequalities are those which describe polymatroids, generalized polymatroids, and dual greedy polyhedra with certain choice functions. We show that the systems of inequalities for cardinality-constrained ordinary bipartite matching polytopes are not dual consistent in general, and give additional inequalities to make them dual consistent. Moreover, we show that ordinary systems of inequalities for the cardinality-constrained (poly)matroid intersection are not dual consistent, which disproves a conjecture of Maurras, Spiegelberg, and Stephan about a linear representation of the cardinality-constrained polymatroid intersection.	[Fujishige, Satoru] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan; [Massberg, Jens] Univ Ulm, Inst Optimizat & Operat Res, D-89069 Ulm, Germany	Massberg, J (reprint author), Univ Ulm, Inst Optimizat & Operat Res, D-89069 Ulm, Germany.	fujishig@kurims.kyoto-u.ac.jp; jens.massberg@uni-ulm.de			JSPS [25280004]; Hausdorff Center for Mathematics, University of Bonn; Research Institute for Mathematical Sciences, Kyoto University	The first author's research was supported by JSPS Grant-in-Aid for Scientific Research (B) 25280004. The second author's research was done when he was working at the Research Institute for Discrete Mathematics, University of Bonn. The present research was partly supported due to the "General Agreement for Cooperation between Hausdorff Center for Mathematics, University of Bonn and Research Institute for Mathematical Sciences, Kyoto University". The authors thank the two anonymous referees for their useful comments that improved the presentation of this paper.	Edmonds J, 2003, LECT NOTES COMPUT SC, V2570, P11; Camion P., 1982, CAHIERS CTR ETUDES R, V24, P107; Fujishige S, 2005, ANN DISCR MATH, V58, P1; Fujishige S., 2004, DISCRETE OPTIM, V1, P41, DOI 10.1016/j.disopt.2004.03.004; Grotschel M., 2004, MPS SIAM SERIES OPTI, V4, P199; Kaibel V, 2010, MATH PROGRAM, V123, P371, DOI 10.1007/s10107-008-0257-2; Maurras JF, 2014, DISCRETE APPL MATH, V164, P237, DOI 10.1016/j.dam.2011.10.007; Maurras J.F., 1977, ANN DISCRETE MATH, V1, P391; Maurras JF, 2011, NETWORKS, V57, P240, DOI 10.1002/net.20430; Santos F., 2011, ARXIV10062814V3MATHC; Stephan R, 2010, DISCRETE OPTIM, V7, P99, DOI 10.1016/j.disopt.2010.03.002; Stephan R., 2010, ELECT NOTES DISCRETE, V36, P1017	12	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5610	1436-4646		MATH PROGRAM	Math. Program.	APR	2015	150	1					35	48		10.1007/s10107-014-0748-2		14	Computer Science, Software Engineering; Operations Research & Management Science; Mathematics, Applied	Computer Science; Operations Research & Management Science; Mathematics	CD6VO	WOS:000351228300004		
J	Uematsu, T				Uematsu, Tetsuya			Zero-cycles on diagonal cubic surfaces over -adic fields	MATHEMATISCHE ZEITSCHRIFT			English	Article						Zero-cycles; Diagonal cubic surfaces; Brauer groups	CHOW GROUP	By using symbolic generators of the Brauer group of diagonal cubic surfaces, we compute the degree-zero part of the Chow group of zero-cycles on some diagonal cubic surfaces over -adic fields. We also find that the Chow group of zero-cycles on them are generated by the classes of rational points.	[Uematsu, Tetsuya] Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Uematsu, T (reprint author), Toyota Natl Coll Technol, Dept Gen Educ, 2-1 Eisei Cho, Toyota, Aichi 4718525, Japan.	utetsuya@08alumni.u-tokyo.ac.jp			MEXT; JSPS [23340003]	This work was supported by MEXT Grant-in-Aid for the Global COE Program 'The research and training center for new development in mathematics' at Graduate School of Mathematical Sciences, the University of Tokyo, and by JSPS Grant-in-Aid for Scientific Research (B) Grant Number 23340003 (Kanetomo Sato).	COLLIOTTHELENE JL, 1987, LECT NOTES MATH, V1290, P1; BLOCH S, 1986, PUBL MATH-PARIS, P107; Colliot-Thelene J.L., 1996, INT MATH RES NOTICES, V4, P151; COLLIOTTHELENE JL, 1983, INVENT MATH, V71, P1, DOI 10.1007/BF01393336; Dalawat CS, 2000, INDAGAT MATH NEW SER, V11, P173; Madore DA, 2008, J NUMBER THEORY, V128, P926, DOI 10.1016/j.jnt.2007.03.009; Manin Y. I., 1986, N HOLLAND MATH LIB, V4; Manin Yu. I., 1970, ACTES C INT MATH NIC, V1, P401; Pisolkar S, 2008, INDAGAT MATH NEW SER, V19, P427; Saito S, 2014, ANN SCI ECOLE NORM S, V47, P505; Uematsu T., 2012, RIMS KOKYUR IN PRESS; Uematsu T, 2014, Q J MATH, V65, P677, DOI 10.1093/qmath/hat013	12	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	APR	2015	279	3-4					1047	1066		10.1007/s00209-014-1402-7		20	Mathematics	Mathematics	CD2AI	WOS:000350875500018		
J	Yasufuku, Y				Yasufuku, Yu			Integral points and relative sizes of coordinates of orbits in	MATHEMATISCHE ZEITSCHRIFT			English	Article						Integral points; Orbits; Higher-dimensional dynamics; Vojta's conjecture	DIOPHANTINE APPROXIMATION; SEMIABELIAN VARIETIES; ENDOMORPHISMS; CONJECTURE; MAPS	We give a generalization to higher dimensions of Silverman's result on finiteness of integer points in orbits. Assuming Vojta's conjecture, we prove a sufficient condition for morphisms on so that -integral points in each orbit are Zariski-non-dense. This condition is geometric, and for dimension 1 it corresponds precisely to Silverman's hypothesis that the second iterate of the map is not a polynomial. In fact, we will prove a more precise formulation comparing local heights outside to the global height. For hyperplanes, this amounts to comparing logarithmic sizes of the coordinates, generalizing Silverman's precise version in dimension 1. We also discuss a variant where we can conclude that integral points in orbits are finite, rather than just Zariski-non-dense. Further, we show unconditional results and examples, using Schmidt's subspace theorem and known cases of Lang-Vojta conjecture. We end with some extensions to the case of rational maps and to the case when the arithmetic of the orbit under one map is controlled by the geometric properties of another. We include many explicit examples to illustrate different behaviors of integral points in orbits in higher dimensions.	Nihon Univ, Dept Math, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan	Yasufuku, Y (reprint author), Nihon Univ, Dept Math, Coll Sci & Technol, Chiyoda Ku, 1-8-14 Kanda Surugadai, Tokyo 1018308, Japan.	yasufuku@math.cst.nihon-u.ac.jp			JSPS [23740033]; Nihon University College of Science and Technology	Supported in part by JSPS Grants-in-Aid 23740033 and by Nihon University College of Science and Technology Grants-in-Aid for Fundamental Science Research.	FALTINGS G, 1983, INVENT MATH, V73, P349, DOI 10.1007/BF01388432; SILVERMAN JH, 1993, DUKE MATH J, V71, P793, DOI 10.1215/S0012-7094-93-07129-3; Evertse JH, 2008, DEV MATH, V16, P175, DOI 10.1007/978-3-211-74280-8_9; Benedetto RL, 2010, COMPOS MATH, V146, P1056, DOI 10.1112/S0010437X09004667; Bombieri E., 2006, NEW MATH MONOGRAPHS, V4; Briend JY, 2004, MATH ANN, V330, P39, DOI 10.1007/s00208-004-0532-3; Corvaja P., 2012, J REINE ANGEW MATH; Dinh TC, 2002, MATH ANN, V324, P33, DOI 10.1007/s00208-002-0328-2; Ghioca D, 2011, INT MATH RES NOTICES, P5109, DOI 10.1093/imrn/rnq283; Ghioca D, 2011, J THEOR NOMBR BORDX, V23, P645; Lang S., 1983, FUNDAMENTALS DIOPHAN, DOI 10.1007/978-1-4757-1810-2; Lee C.G., 2010, ARXIV10023357; Scanlon T, 2014, INT MATH RES NOTICES, P4357, DOI 10.1093/imrn/rnt081; Silverman JH, 2013, J NUMBER THEORY, V133, P2948, DOI 10.1016/j.jnt.2013.03.005; Vojta P, 1996, INVENT MATH, V126, P133, DOI 10.1007/s002220050092; Vojta P., 1987, LECT NOTES MATH, V1239; Vojta P, 2000, AM J MATH, V122, P843, DOI 10.1353/ajm.2000.0031; Yasufuku Y., 2011, RIMS KOKYUROKU BES B, VB25, P75; Yasufuku Y., 2014, B I MATH ACAD SIN, V9, P603; Zhang S., 2006, SURVEY DIFFERENTIAL, V10, P381, DOI DOI 10.4310/SDG.2005.V10.NL.A9.(904)	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	APR	2015	279	3-4					1121	1141		10.1007/s00209-015-1406-y		21	Mathematics	Mathematics	CD2AI	WOS:000350875500022		
J	Mori, I				Mori, Izuru			Regular modules over 2-dimensional quantum Beilinson algebras of Type	MATHEMATISCHE ZEITSCHRIFT			English	Article						Regular modules; Beilinson algebras; AS-regular algebras; Representation infinite algebras; Preprojective algebras	CO-POINT MODULES; GRADED ALGEBRAS; KOSZUL ALGEBRAS; EQUIVALENCES; DIMENSION-3; COMPLEXES; PLANES; RINGS; P-3	In the study of a finite dimensional hereditary algebra of infinite representation type, understanding regular modules is essential. Recently, Herschend, Iyama and Oppermann introduced the notions of -representation infinite algebra and -regular module, extending the above notions to finite dimensional algebras of global dimension . Since the Beilinson algebras of AS-regular algebras of dimension are typical examples of -representation infinite algebras, the purpose of this paper is to study the behavior of -regular modules over such algebras. In particular, we will show that the isomorphism classes of simple 2-regular modules over a 2-representation tame quantum Beilinson algebra of Type are parameterized by .	Shizuoka Univ, Grad Sch Sci, Dept Math, Shizuoka 4228529, Japan	Mori, I (reprint author), Shizuoka Univ, Grad Sch Sci, Dept Math, Shizuoka 4228529, Japan.	simouri@ipc.shizuoka.ac.jp			 [25400037]	This work was supported by Grant-in-Aid for Scientific Research (C) 25400037.	Ajitabh K, 1996, P LOND MATH SOC, V72, P567; Stephenson DR, 1997, P AM MATH SOC, V125, P1593, DOI 10.1090/S0002-9939-97-03752-0; ALEV J, 1994, J ALGEBRA, V170, P229, DOI 10.1006/jabr.1994.1336; vandenBergh M, 1997, J ALGEBRA, V195, P662, DOI 10.1006/jabr.1997.7052; BAER D, 1987, COMMUN ALGEBRA, V15, P425, DOI 10.1080/00927878708823425; Jorgensen P, 2000, ADV MATH, V151, P313, DOI 10.1006/aima.1999.1897; Zhang JJ, 1996, P LOND MATH SOC, V72, P281; Keller B, 2011, J REINE ANGEW MATH, V654, P125, DOI 10.1515/CRELLE.2011.031; Jorgensen P, 1997, COMMUN ALGEBRA, V25, P575, DOI 10.1080/00927879708825875; ARTIN M, 1991, INVENT MATH, V106, P335, DOI 10.1007/BF01243916; Bondal A, 2003, MOSC MATH J, V3, P1; Herschend M, 2014, ADV MATH, V252, P292, DOI 10.1016/j.aim.2013.09.023; ARTIN M., 1992, CONT MATH, V124, P1; ARTIN M, 1987, ADV MATH, V66, P171, DOI 10.1016/0001-8708(87)90034-X; ARTIN M, 1994, ADV MATH, V109, P228, DOI 10.1006/aima.1994.1087; Artin M., 1990, GROTHENDIECK FESTSCH, VI, P33; Assem I., 2006, LOND MATH SOC STUD T, V1, P65, DOI DOI 10.1017/CB09780511614309; LEVASSEUR T, 1993, J PURE APPL ALGEBRA, V86, P181, DOI 10.1016/0022-4049(93)90102-Y; Minamoto H, 2012, INT MATH RES NOTICES, P67, DOI 10.1093/imrn/rnr001; Minamoto H, 2011, ADV MATH, V226, P4061, DOI 10.1016/j.aim.2010.11.004; Mori I, 2013, COMMUN ALGEBRA, V41, P2071, DOI 10.1080/00927872.2011.653463; Mori I, 2001, J PURE APPL ALGEBRA, V157, P279, DOI 10.1016/S0022-4049(00)00012-8; Mori I, 2008, COMMUN ALGEBRA, V36, P4659, DOI 10.1080/00927870802186847; Mori I, 2013, J LOND MATH SOC, V88, P97, DOI 10.1112/jlms/jdt005; Mori I, 1998, J ALGEBRA, V204, P15, DOI 10.1006/jabr.1997.7358; Mori I., 2006, ALGEBRAS RINGS THEIR, P215, DOI 10.1142/9789812774552_0014; Mori I, 2013, GLASGOW MATH J, V55, P241, DOI 10.1017/S001708951200047X; Mori I, 2006, J LOND MATH SOC, V74, P639, DOI 10.1112/S002461070602326X; Mori I, 2009, J ALGEBRA, V322, P2235, DOI 10.1016/j.jalgebra.2009.02.027; Shelton B, 1999, COMMUN ALGEBRA, V27, P2877, DOI 10.1080/00927879908826599; Simson D., 2007, LONDON MATH SOC STUD, V71; Smith S.P., 1999, LECT NOTES; Smith S.P., 1994, LECT NOTES; Vancliff M, 1997, J ALGEBRA, V195, P93, DOI 10.1006/jabr.1997.7077	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	APR	2015	279	3-4					1143	1174		10.1007/s00209-015-1407-x		32	Mathematics	Mathematics	CD2AI	WOS:000350875500023		
J	Akatsu, T; Numata, S; Demura, T; Shinoda, Y; Wakai, F				Akatsu, Takashi; Numata, Shingo; Demura, Takamitsu; Shinoda, Yutaka; Wakai, Fumihiro			Representative indentation elastic modulus evaluated by unloading of nanoindentation made with a point sharp indenter	MECHANICS OF MATERIALS			English	Article						Nanoindentation; Elastic modulus; Finite element method	LOAD; MICROINDENTATION; HARDNESS; CURVES; SOLIDS	The conventional method to extract elastic modulus from the nanoindentation on isotropic linearly elastic solids is based on Sneddon's solution (1965). However, it is known that the solution is valid only for incompressive elastic solids with the Poisson's ratio nu of 0.5. This paper first proposes the modification of the solution in a wide range of nu from 0 to 0.5 through the numerical analysis on the unloading behavior of a simulated conical nanoindentation with a finite element method. As a result of the modification, the coefficient of linearity between the indentation elastic parameter k(e) and Young's modulus E is empirically given as a function of nu and the inclined face angle of the indenter, beta, where k(e) is defined as k(e) equivalent to P/h(2) with the indentation load P and penetration depth of the indenter h. According to the linear relationship between k(e) and E, it is found that elastic rebound during unloading of a nanoindentation is uniquely characterized by a representative indentation elastic modulus E* defined in terms of E, nu and beta, and that the value of E* can be evaluated from the P-h relationship with k(e) and beta. For an isotropic elastoplastic solid, the indentation unloading parameter k(2) defined as k(2) equivalent to (h-h(r))(2) for a residual depth h(r) different from k(e) even though a linearly elastic solid with k(e) and elastoplastic solid with k(2) have a common E*. In order to evaluate E* of an elastoplastic solid, the corresponding k(e) is estimated from k(2) with an empirical equation as a function of the relative residual depth xi defined as xi equivalent to h(r)/h(max) for the maximum penetration depth h(max). A nanoindentation experiment confirmed the validity of the numerical analysis for evaluating the elastic modulus. (C) 2014 Elsevier Ltd. All rights reserved.	[Akatsu, Takashi; Numata, Shingo; Demura, Takamitsu; Shinoda, Yutaka; Wakai, Fumihiro] Tokyo Inst Technol, Secure Mat Ctr, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan	Akatsu, T (reprint author), Tokyo Inst Technol, Secure Mat Ctr, Mat & Struct Lab, R3-24 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	akatsu.t.aa@m.titech.ac.jp	WAKAI, Fumihiro/C-9658-2009; Shinoda, Yutaka/F-7502-2014	WAKAI, Fumihiro/0000-0002-8391-139X; 	Nippon Sheet Glass Foundation for Materials Science and Engineering;  [18560652];  [13750622]	Financial support for this research was provided in the form of a Grant-In-Aid for Scientific Research (C) (No. 18560652), Encouragement of Scientists (No. 13750622) and the Nippon Sheet Glass Foundation for Materials Science and Engineering.	Akatsu T, 2005, FRACT MECH, V14, P13; Sakai M, 2002, J MATER RES, V17, P2161, DOI 10.1557/JMR.2002.0318; Bolshakov A, 1998, J MATER RES, V13, P1049, DOI 10.1557/JMR.1998.0146; Poon B, 2008, INT J SOLIDS STRUCT, V45, P6018, DOI 10.1016/j.ijsolstr.2008.07.021; Wang TH, 2007, MAT SCI ENG A-STRUCT, V447, P244, DOI 10.1016/j.msea.2006.10.077; Cheng YT, 1999, J MATER RES, V14, P3493, DOI 10.1557/JMR.1999.0472; Pharr GM, 2002, J MATER RES, V17, P2660, DOI 10.1557/JMR.2002.0386; Nakamura T, 2007, MECH MATER, V39, P340, DOI 10.1016/j.mechmat.2006.06.004; Guo WC, 2010, J COMPUT APPL MATH, V234, P2183, DOI 10.1016/j.cam.2009.08.072; Giannakopoulos AE, 1997, INT J SOLIDS STRUCT, V34, P2357, DOI 10.1016/S0020-7683(96)00171-0; Hay JC, 1999, J MATER RES, V14, P2296, DOI 10.1557/JMR.1999.0306; Love A. E. H., 1939, Q J MATH, V10, P161, DOI 10.1093/qmath/os-10.1.161; Mann AB, 1999, J MATER RES, V14, P2195, DOI 10.1557/JMR.1999.0643; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Sakai M, 2003, J MATER RES, V18, P2087, DOI 10.1557/JMR.2003.0293; Sakai M, 2004, ACTA MATER, V52, P2359, DOI 10.1016/j.actamat.2004.01.027; Sakai M, 2003, J MATER RES, V18, P1631, DOI 10.1557/JMR.2003.0224; Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6636	1872-7743		MECH MATER	Mech. Mater.	APR	2015	83						66	71		10.1016/j.mechmat.2014.12.009		6	Materials Science, Multidisciplinary; Mechanics	Materials Science; Mechanics	CD8BN	WOS:000351320300005		
J	Kosumi, K; Baba, Y; Ishimoto, T; Harada, K; Miyake, K; Izumi, D; Tokunaga, R; Murata, A; Eto, K; Sugihara, H; Shigaki, H; Iwagami, S; Sakamoto, Y; Miyamoto, Y; Yoshida, N; Watanabe, M; Komohara, Y; Takeya, M; Baba, H				Kosumi, Keisuke; Baba, Yoshifumi; Ishimoto, Takatsugu; Harada, Kazuto; Miyake, Keisuke; Izumi, Daisuke; Tokunaga, Ryuma; Murata, Asuka; Eto, Kojiro; Sugihara, Hidetaka; Shigaki, Hironobu; Iwagami, Shiro; Sakamoto, Yasuo; Miyamoto, Yuji; Yoshida, Naoya; Watanabe, Masayuki; Komohara, Yoshihiro; Takeya, Motohiro; Baba, Hideo			Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae	MEDICAL ONCOLOGY			English	Article						Infection of Helicobacter pylori; LINE-1; Hypomethylation; Gastric mucosae; Epigenetic field defect	EPIGENETIC FIELD DEFECT; SQUAMOUS-CELL CARCINOMA; BLOOD LEUKOCYTE DNA; CANCER-RISK; PERIPHERAL-BLOOD; POOR-PROGNOSIS; COLON-CANCER; METHYLATION; CARCINOGENESIS; INVOLVEMENT	The DNA methylation alterations occurring in human cancers have two types: global DNA hypomethylation and site-specific CpG island promoter hypermethylation. Recently, to assess global DNA methylation, long interspersed nucleotide element 1 (LINE-1) retrotransposons, constituting a substantial portion of the human genome, attracts much attention. The aim of the current study was to clarify the significance of LINE-1 methylation level for epigenetic field defects and the relationships among LINE-1 methylation level in gastric mucosae, clinical and pathological features, including infection by Helicobacter pylori (H. pylori), a bacterium implicated in gastric cancer. By bisulfite-PCR pyrosequencing, we quantified the LINE-1 methylation levels in noncancerous gastric mucosae and cancer tissues from 87 gastric cancer patients, in gastric mucosae from 17 autopsied individuals without gastric cancers and in 20 gastric fresh frozen samples from non-gastric cancer patients. LINE-1 methylation in the noncancerous gastric mucosae of gastric cancer patients was significantly higher than in cancer tissues (P = 0.0006), but significantly lower than in the gastric mucosae of the autopsied individuals (P = 0.026), suggesting the formation of epigenetic field defect in noncancerous gastric mucosae. Moreover, LINE-1 hypomethylation of noncancerous gastric mucosae in gastric cancer patients significantly correlated with H. pylori infection (P = 0.037). We prospectively confirmed the similar result in 20 non-gastric cancer patients (P = 0.010). LINE-1 hypomethylation of gastric mucosae significantly correlated with H. pylori infection, supporting the potential of LINE-1 methylation level as a surrogate marker of epigenetic field defects for gastric cancer cancerization, particularly induced by H. pylori.	[Kosumi, Keisuke; Baba, Yoshifumi; Ishimoto, Takatsugu; Harada, Kazuto; Miyake, Keisuke; Izumi, Daisuke; Tokunaga, Ryuma; Murata, Asuka; Eto, Kojiro; Sugihara, Hidetaka; Shigaki, Hironobu; Iwagami, Shiro; Sakamoto, Yasuo; Miyamoto, Yuji; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, Kumamoto 8608556, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Chuo Ku, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Iwagami S, 2012, ANN SURG ONCOL, V19, P2726, DOI 10.1245/s10434-011-2176-3; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Bae JM, 2012, INT J CANCER, V131, P1323, DOI 10.1002/ijc.27369; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Takamaru H, 2012, CANCER PREV RES, V5, P1203, DOI 10.1158/1940-6207.CAPR-12-0056; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Shigaki H, 2013, GASTRIC CANCER, V16, P480, DOI 10.1007/s10120-012-0209-7; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Zhang FF, 2011, EPIGENETICS-US, V6, P623; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Yuasa Y, 2012, INT J CANCER, V131, P2596, DOI 10.1002/ijc.27554; Baba Y, 2010, GASTROENTEROLOGY, V139, P1855, DOI 10.1053/j.gastro.2010.07.050; McShane LM, 2005, J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Baba Y, 2014, CLIN CANCER RES, V20, P1114, DOI 10.1158/1078-0432.CCR-13-1645; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Compare D, 2011, J CLIN PATHOL, V64, P677, DOI 10.1136/jcp.2010.087858; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI [10.2217/epi.09.33, 10.2217/EPI.09.33]; Ferrari F, 2013, WORLD J GASTROENTERO, V19, P9383, DOI 10.3748/wjg.v19.i48.9383; Gerhard M, 2002, HELICOBACTER, V7, P17, DOI 10.1046/j.1523-5378.7.s1.3.x; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; Nakajima Takeshi, 2008, Environmental Health and Preventive Medicine, V13, P8, DOI 10.1007/s12199-007-0005-x; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Yamamoto Eiichiro, 2012, Rinsho Byori, V60, P637	44	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	APR	2015	32	4							117	10.1007/s12032-015-0571-5		9	Oncology	Oncology	CE0DG	WOS:000351474100031		
J	Osawa, K; Shigemura, K; Shimizu, R; Kato, A; Kusuki, M; Jikimoto, T; Nakamura, T; Yoshida, H; Arakawa, S; Fujisawa, M; Shirakawa, T				Osawa, Kayo; Shigemura, Katsumi; Shimizu, Rika; Kato, Ayaka; Kusuki, Mari; Jikimoto, Takumi; Nakamura, Tatsuya; Yoshida, Hiroyuki; Arakawa, Soichi; Fujisawa, Masato; Shirakawa, Toshiro			Molecular Characteristics of Extended-Spectrum beta-Lactamase-Producing Escherichia coli in a University Teaching Hospital	MICROBIAL DRUG RESISTANCE			English	Article							UNITED-STATES; E.-COLI; VIRULENCE FACTORS; RESISTANCE; PREVALENCE; STRAINS; ENTEROBACTERIACEAE; EPIDEMIOLOGY; DISSEMINATION; EMERGENCE	The prevalence of extended-spectrum beta-lactamases (ESBLs) has been increasing worldwide. Recently, a pandemic clone of Escherichia coli O25:H4, sequence type 131 (ST131), producing ESBL-type CTX-M-15 has been reported as a major problem. In this study, we investigated the molecular characteristics of 72 ESBL-producing E. coli isolates. We detected the ESBL bla(CTX-M) gene and nine virulence factor genes (papC, papEF, fimH, hlyA, iutA, sfa, eaeA, bfpA, and aggR) by PCR and DNA sequencing, plasmid replicon typing, phylogenetic grouping, repetitive-sequence-based PCR (rep-PCR), and multilocus sequence typing. All strains were positive for bla(CTX-M). Twenty-two (30.6%) strains in CTX-M-1 group included 9 (12.5%) of CTX-M-15, 3 (4.2%) in CTX-M-2 group, and 47 (65.3%) strains in CTX-M-9 group. The CTX-M-15-producing E. coli O25:H4 ST131 was derived from phylogenetic group B2 and rep-PCR pattern d. The most prevalent virulence factor was fimH (72 strains; 100%) and the most common replicon type was the IncF type (65 strains; 90.3%). The CTX-M-9 group was significantly associated with the presence of papC and papEF [OR (95% CI)=9.22 (1.32-64.7), p=0.025] or hlyA [OR (95% CI)=5.57 (1.17-26.4), p=0.031]. In conclusion, we confirmed that CTX-M-15-producing E. coli O25:H4 ST131 has emerged in Japan and found significant virulence factors with CTX-M-9 group.	[Osawa, Kayo; Shimizu, Rika; Kato, Ayaka; Shirakawa, Toshiro] Kobe Univ, Grad Sch Med, Dept Int Hlth, Div Infect Dis, Kobe, Hyogo 6500017, Japan; [Shigemura, Katsumi; Arakawa, Soichi; Fujisawa, Masato; Shirakawa, Toshiro] Kobe Univ, Grad Sch Med, Fac Med, Div Urol,Dept Organs Therapeut, Kobe, Hyogo 6500017, Japan; [Kusuki, Mari; Jikimoto, Takumi; Nakamura, Tatsuya] Kobe Univ Hosp, Clin Lab, Kobe, Hyogo, Japan; [Yoshida, Hiroyuki; Arakawa, Soichi] Kobe Univ Hosp, Dept Infect Control & Prevent, Kobe, Hyogo, Japan; [Shirakawa, Toshiro] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo 6500017, Japan	Shirakawa, T (reprint author), Kobe Univ, Grad Sch Med, Ctr Infect Dis, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	toshiro@med.kobe-u.ac.jp			JSPS KAKENHI [24590610]	This work was supported by JSPS KAKENHI grant number 24590610.	ANDERSON ES, 1977, J HYG-CAMBRIDGE, V79, P425; Cao V, 2002, ANTIMICROB AGENTS CH, V46, P3739, DOI 10.1128/AAC.46.12.3739-3743.2002; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Elhani D, 2010, CLIN MICROBIOL INFEC, V16, P157, DOI 10.1111/j.1469-0691.2009.03057.x; Kuroda H, 2012, DIAGN MICR INFEC DIS, V74, P201, DOI 10.1016/j.diagmicrobio.2012.06.011; NOVICK RP, 1987, MICROBIOL REV, V51, P381; Villegas MV, 2008, CLIN MICROBIOL INFEC, V14, P154, DOI 10.1111/j.1469-0691.2007.01869.x; Jouini A, 2013, J FOOD PROTECT, V76, P323, DOI 10.4315/0362-028X.JFP-12-251; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Lucet JC, 1996, CLIN INFECT DIS, V22, P430; Picard B, 1999, INFECT IMMUN, V67, P546; Vidal R, 2004, J CLIN MICROBIOL, V42, P1787, DOI 10.1128/JCM.42.4.1787-1789.2004; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Bhusal Y, 2011, CHEMOTHERAPY, V57, P335, DOI 10.1159/000329661; JARLIER V, 1988, REV INFECT DIS, V10, P867; JOHNSON JR, 1989, ANN INTERN MED, V111, P906; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Olesen B, 2013, J CLIN MICROBIOL, V51, P1779, DOI 10.1128/JCM.00346-13; COUTURIER M, 1988, MICROBIOL REV, V52, P375; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Lavollay M, 2006, ANTIMICROB AGENTS CH, V50, P2433, DOI 10.1128/AAC.00150-06; Boll EJ, 2013, INFECT IMMUN, V81, P1164, DOI 10.1128/IAI.01376-12; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Woodford N, 2004, J ANTIMICROB CHEMOTH, V54, P735, DOI 10.1093/jac/dkh424; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; BERNARD H, 1992, J ANTIMICROB CHEMOTH, V29, P590, DOI 10.1093/jac/29.5.590; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269; Livermore D. M., 2007, J ANTIMICROB CHEMOTH, V59, P65; Mnif B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-147; Moyo S. J., 2007, BMC INFECT DIS, V7, P92; Nakamura T., 2011, AM J CLIN PATHOL, V137, P620; Narciso A, 2012, EUR J CLIN MICROBIOL, V31, P1211, DOI 10.1007/s10096-011-1431-7; Pobiega M, 2013, MED SCI MONITOR, V19, P317, DOI 10.12659/MSM.883898; Rajendran P, 2010, DIAGN MICR INFEC DIS, V68, P117, DOI 10.1016/j.diagmicrobio.2010.06.003; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Yano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064359	47	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1076-6294	1931-8448		MICROB DRUG RESIST	Microb. Drug Resist.	APR 1	2015	21	2					130	139		10.1089/mdr.2014.0083		10	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CE5BD	WOS:000351843800002		
J	Kawaguchiya, M; Urushibara, N; Kobayashi, N				Kawaguchiya, Mitsuyo; Urushibara, Noriko; Kobayashi, Nobumichi			High Prevalence of Genotype 6E (Putative Serotype 6E) Among Noninvasive/Colonization Isolates of Streptococcus pneumoniae in Northern Japan	MICROBIAL DRUG RESISTANCE			English	Article							MOLECULAR EPIDEMIOLOGY; CLONES; PNEUMOCOCCI; PENICILLIN; IDENTIFICATION; RESISTANCE; EVOLUTION; ICELAND; PERIOD; LOCUS	Serogroup 6 of Streptococcus pneumoniae contains four established serotypes (6A-6D). Recently, putative serotype 6E (genotype 6E) was proposed as a novel type, which is cross-reactive with 6B-specific antiserum, but its capsular polysaccharide synthesis (cps) locus is genetically distinct from those of serotypes 6A and 6B. In the present study, prevalence of genotype 6E was analyzed by a newly designed multiplex polymerase chain reaction (PCR) for noninvasive or colonizing S. pneumoniae isolates in northern Japan assigned to serogroup 6 in our previous study by the sequential multiplex PCR developed by Pai et al. Among the isolates previously assigned to 6A and 6B, 2.2% (1/45) and 77.3% (140/181) of isolates, respectively, were revealed to have cps genes of genotype 6E. Eight 6E isolates selected for further analysis were found to have identical or highly similar sequences of cps genes (wzg, wzh, wze, wciN, wciP, and wzy) to those of strains previously reported as putative serotype 6E, and all the isolates were classified into sequence type 90 (ST90). Reanalysis of genetic traits on penicillin and macrolide resistance clarified significantly higher rates of three pbp mutations (gPRSP) and ermB in genotype 6E than in serotypes 6A and 6B. These findings suggested a need for detection of genotype 6E in the surveillance of S. pneumoniae serotypes.	[Kawaguchiya, Mitsuyo; Urushibara, Noriko; Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido 0608556, Japan	Kawaguchiya, M (reprint author), Sapporo Med Univ, Sch Med, Dept Hyg, Chuo Ku, S-1 W-17, Sapporo, Hokkaido 0608556, Japan.	kawaguchiya@sapmed.ac.jp			Japan Society for the Promotion of Science (JSPS) [26893212]	This work was supported by the Grant-in-Aid for Scientific Research (KAKENHI) (No. 26893212) from Japan Society for the Promotion of Science (JSPS).	Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Song JH, 2011, J CLIN MICROBIOL, V49, P1758, DOI 10.1128/JCM.02628-10; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; VERSALOVIC J, 1993, J INFECT DIS, V167, P850; Chiba N, 2013, MICROB DRUG RESIST, V19, P308, DOI 10.1089/mdr.2012.0180; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Gherardi G, 2007, J CLIN MICROBIOL, V45, P306, DOI 10.1128/JCM.01229-06; Kawaguchiya M, 2014, MICROB DRUG RESIST, V20, P456, DOI 10.1089/mdr.2013.0196; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Otsuka T, 2013, J MED MICROBIOL, V62, P1868, DOI 10.1099/jmm.0.066316-0; Parra EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084993; Rolo D, 2011, J CLIN MICROBIOL, V49, P2328, DOI 10.1128/JCM.02545-10; Sa-Leao R, 2002, J INFECT DIS, V186, P966, DOI 10.1086/343769; SOARES S, 1993, J INFECT DIS, V168, P158; Zhuo F, 2011, CLIN MICROBIOL INFEC, V17, P1246, DOI 10.1111/j.1469-0691.2010.03404.x	23	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1076-6294	1931-8448		MICROB DRUG RESIST	Microb. Drug Resist.	APR 1	2015	21	2					209	214		10.1089/mdr.2014.0181		6	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CE5BD	WOS:000351843800012		
J	Nagasaka, Y; Kimura, K; Yamada, K; Wachino, JI; Jin, WC; Notake, S; Yanagisawa, H; Arakawa, Y				Nagasaka, Yukiko; Kimura, Kouji; Yamada, Keiko; Wachino, Jun-Ichi; Jin, Wanchun; Notake, Shigeyuki; Yanagisawa, Hideji; Arakawa, Yoshichika			Genetic Profiles of Fluoroquinolone-Nonsusceptible Klebsiella pneumoniae Among Cephalosporin-Resistant K. pneumoniae	MICROBIAL DRUG RESISTANCE			English	Article							BETA-LACTAMASE GENES; REPUBLIC-OF-CHINA; ESCHERICHIA-COLI; QUINOLONE RESISTANCE; MOLECULAR EPIDEMIOLOGY; MULTIPLEX PCR; UNITED-STATES; ENTEROBACTERIACEAE; INFECTIONS; JAPAN	The rate of fluoroquinolone (FQ) resistance among the cephalosporin-resistant Klebsiella pneumoniae is considerably high, however, their genetic profiles have not been well investigated. We selected 61 ciprofloxacin-nonsusceptible isolates from 102 K. pneumoniae isolates judged to be "resistant" to some cephalosporins during 2009 and 2012 throughout Japan. Pulsed-field gel electrophoresis excluded clonal isolates, and 29 isolates were subjected to multilocus sequence typing (MLST), detection of the amino acid substitutions in the quinolone resistance determining regions (QRDRs) of GyrA and ParC, beta-lactamase typing, and identification of plasmid-mediated quinolone resistance (PMQR) genes. PCR-based replicon typing was performed, after PMQR gene transfer. Four major sequence types (STs) or clonal complexes (CCs), that is, ST37, CC17 (consisting of ST17 and ST20), ST11, and CC528 (consisting of ST528 and ST1130), were found, and they accounted for 48.2% of the isolates tested. Amino acid substitutions in the QRDRs and the presence of PMQR genes were identified in 20 (68.9%) and 18 (62.0%) isolates, respectively. The replicon type of three PMQR-carrying plasmids was IncN, but others were nontypable. Fifteen (83.3%) of the 18 PMQR-harboring isolates coharbored bla(CTX-M) and/or bla(DHA-1). Ciprofloxacin-nonsusceptible K. pneumoniae clinical isolates demonstrating cephalosporin resistance often belong to the global epidemic lineages and possess PMQR and/or QRDR substitutions.	[Nagasaka, Yukiko; Kimura, Kouji; Yamada, Keiko; Wachino, Jun-Ichi; Jin, Wanchun; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi 4660065, Japan; [Notake, Shigeyuki; Yanagisawa, Hideji] Miroku Med Lab Co Ltd, Saku, Nagano, Japan	Arakawa, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4660065, Japan.	yarakawa@med.negoya-u.ac.jp	Kimura, Kouji/C-1847-2015; Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labour and Welfare, Japan [H24-Shinko-Ippan-010]	Tigecycline was kindly provided by Pfizer Japan, Inc., Tokyo, Japan. This study was supported by a research grant from the Ministry of Health, Labour and Welfare, Japan (H24-Shinko-Ippan-010).	Aathithan S, 2011, EUR J CLIN MICROBIOL, V30, P745, DOI 10.1007/s10096-010-1147-0; Yagi T, 2000, FEMS MICROBIOL LETT, V184, P53, DOI 10.1111/j.1574-6968.2000.tb08989.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915; Garau J, 1999, ANTIMICROB AGENTS CH, V43, P2736; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Bedenic B, 2012, J CHEMOTHERAPY, V24, P237, DOI 10.1179/1973947812Y.0000000017; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Damjanova I, 2008, J ANTIMICROB CHEMOTH, V62, P978, DOI 10.1093/jac/dkn287; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; KADO CI, 1981, J BACTERIOL, V145, P1365; Paltansing S, 2013, J ANTIMICROB CHEMOTH, V68, P40, DOI 10.1093/jac/dks365; Chanawong A, 2002, ANTIMICROB AGENTS CH, V46, P630, DOI 10.1128/AAC.46.3.630-637.2002; Johnson JR, 2010, ANTIMICROB AGENTS CH, V54, P546, DOI 10.1128/AAC.01089-09; Yamane K, 2008, ANTIMICROB AGENTS CH, V52, P1564, DOI 10.1128/AAC.01137-07; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Bialek-Davenet S, 2013, ANTIMICROB AGENTS CH, V57, P672, DOI 10.1128/AAC.01410-12; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Illiaquer M, 2012, DIAGN MICR INFEC DIS, V74, P95, DOI 10.1016/j.diagmicrobio.2012.05.023; Ling TKW, 2006, ANTIMICROB AGENTS CH, V50, P374, DOI 10.1128/AAC.50.1.374-378.2006; Peirano G, 2012, J ANTIMICROB CHEMOTH, V67, P1114, DOI 10.1093/jac/dks026; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10	37	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1076-6294	1931-8448		MICROB DRUG RESIST	Microb. Drug Resist.	APR 1	2015	21	2					224	233		10.1089/mdr.2014.0150		10	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CE5BD	WOS:000351843800015		
J	Kuroda, K; Hatamoto, M; Nakahara, N; Abe, K; Takahashi, M; Araki, N; Yamaguchi, T				Kuroda, Kyohei; Hatamoto, Masashi; Nakahara, Nozomi; Abe, Kenichi; Takahashi, Masanobu; Araki, Nobuo; Yamaguchi, Takashi			Community Composition of Known and Uncultured Archaeal Lineages in Anaerobic or Anoxic Wastewater Treatment Sludge	MICROBIAL ECOLOGY			English	Article						Archaeal community composition; Uncultured lineages; 16S rRNA gene sequencing; Diversity analysis; Anaerobic wastewater treatment sludge	METHANOGENIC ARCHAEA; SP NOV.; METHANOMASSILIICOCCUS-LUMINYENSIS; MOLECULAR ANALYSIS; GEN. NOV.; FAM. NOV; DIVERSITY; METHANE; BACTERIAL; SEDIMENTS	Microbial systems are widely used to treat different types of wastewater from domestic, agricultural, and industrial sources. Community composition is an important factor in determining the successful performance of microbial treatment systems; however, a variety of uncultured and unknown lineages exist in sludge that requires identification and characterization. The present study examined the archaeal community composition in methanogenic, denitrifying, and nitrogen-/phosphate-removing wastewater treatment sludge by Archaea-specific 16S rRNA gene sequencing analysis using Illumina sequencing technology. Phylotypes belonging to Euryarchaeota, including methanogens, were most abundant in all samples except for nitrogen-/phosphate-removing wastewater treatment sludge. High levels of Deep Sea Hydrothermal Vent Group 6 (DHVEG-6), WSA2, Terrestrial Miscellaneous Euryarchaeotal Group, and Miscellaneous Crenarchaeotic Group were also detected. Interestingly, DHVEG-6 was dominant in nitrogen-/phosphate-removing wastewater treatment sludge, indicating that unclear lineages of Archaea still exist in the anaerobic wastewater treatment sludges. These results reveal a previously unknown diversity of Archaea in sludge that can potentially be exploited for the development of more efficient wastewater treatment strategies.	[Kuroda, Kyohei; Hatamoto, Masashi; Nakahara, Nozomi; Abe, Kenichi; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Environm Syst Engn, Nagaoka, Niigata 9402188, Japan; [Abe, Kenichi; Takahashi, Masanobu] Tohoku Univ, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Araki, Nobuo] Nagaoka Natl Coll Technol, Dept Civil Engn, Nagaoka, Niigata 9408532, Japan	Yamaguchi, T (reprint author), Nagaoka Univ Technol, Dept Environm Syst Engn, 1603-1 Kami Tomioka, Nagaoka, Niigata 9402188, Japan.	s115043@stn.nagaokaut.ac.jp; hatamoto@vos.nagaokaut.ac.jp; ecoya@vos.nagaokaut.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Science and Technology Research Partnership for Sustainable Development (SATREPS)	This research was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), the Japan Society for the Promotion of Science (JSPS), and the Science and Technology Research Partnership for Sustainable Development (SATREPS). The authors thank Aqua and Soil Environmental laboratory members of Aida A. A. and Maharajan N. for the critical reading of the manuscript; Furukawa A., Ohtsuki K., Chosei T., Okabe Y., Sakamoto K. and Watari T. for the assistance with the reactor operation; and Sato T. and Yamamoto M. for supporting the experiment and stimulating discussions.	Alonso-Saez L, 2011, ENV MICROBIOL REP, V3, P689, DOI 10.1111/j.1758-2229.2011.00282.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Ionescu D, 2009, FEMS MICROBIOL ECOL, V69, P425, DOI 10.1111/j.1574-6941.2009.00721.x; Onodera T, 2013, BIORESOURCE TECHNOL, V131, P295, DOI [10.1016/j.biortech.2012.12.126, 10.1016/j.biortech.2013.12.126]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Sekiguchi Y, 1998, MICROBIOL-UK, V144, P2655; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Tabatabaei M, 2010, PROCESS BIOCHEM, V45, P1214, DOI 10.1016/j.procbio.2010.05.017; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Narihiro T, 2009, MICROBES ENVIRON, V24, P88, DOI 10.1264/jsme2.ME08561; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Shi Y, 2013, ENVIRON SCI TECHNOL, V47, P11577, DOI 10.1021/es402775z; Iino T, 2013, MICROBES ENVIRON, V28, P244, DOI 10.1264/jsme2.ME12189; Bandara WMKRTW, 2012, WATER RES, V46, P5756, DOI 10.1016/j.watres.2012.07.061; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Pender S, 2004, WATER RES, V38, P619, DOI 10.1016/j.watres.2003.10.055; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Imachi H, 2008, INT J SYST EVOL MICR, V58, P294, DOI 10.1099/ijs.0.65394-0; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Auguet JC, 2008, ENVIRON MICROBIOL, V10, P1080, DOI 10.1111/j.1462-2920.2007.01498.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Kendall MM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P244, DOI 10.1007/0-387-30743-5_12; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Sakai S, 2012, INT J SYST EVOL MICR, V62, P1389, DOI 10.1099/ijs.0.035048-0; Garcia JL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P208, DOI 10.1007/0-387-30743-5_10; Hugoni M, 2013, P NATL ACAD SCI USA, V110, P6004, DOI 10.1073/pnas.1216863110; Dridi B, 2012, APMIS, V120, P773, DOI 10.1111/j.1600-0463.2012.02899.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Nunoura T, 2012, MICROBES ENVIRON, V27, P382, DOI 10.1264/jsme2.ME12032; Balcazar JL, 2013, PLOS ONE, V8; Borrel G, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00453-13, DOI 10.1128/GENOMEA.00453-13]; Casamayor EO, 2013, FEMS MICROBIOL ECOL, V85, P503, DOI 10.1111/1574-6941.12139; Chen JQ, 2013, INDIAN J MICROBIOL, V53, P432, DOI 10.1007/s12088-013-0397-9; Chouari R, 2010, MICROB ECOL, V60, P272, DOI 10.1007/s00248-009-9632-7; Ghanimeh SA, 2013, WASTE MANAGE, V33, P2211, DOI 10.1016/j.wasman.2013.06.011; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; Luo G, 2013, ENVIRON SCI TECHNOL, V47, P10685, DOI 10.1021/es401018d; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mori K, 2011, INT J SYST EVOL MICR, V61, P138, DOI 10.1099/ijs.0.022723-0; Nunoura T, 2009, APPL ENVIRON MICROB, V76, P1198; Ritari J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-121; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535	58	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	APR	2015	69	3					586	596		10.1007/s00248-014-0525-z		11	Ecology; Marine & Freshwater Biology; Microbiology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	CD6VT	WOS:000351228900012		
J	Wang, JP; Zou, BJ; Rui, JZ; Song, QX; Kajiyama, T; Kambara, H; Zhou, GH				Wang, Jianping; Zou, Bingjie; Rui, Jianzhong; Song, Qinxin; Kajiyama, Tomoharu; Kambara, Hideki; Zhou, Guohua			Exponential amplification of DNA with very low background using graphene oxide and single-stranded binding protein to suppress non-specific amplification	MICROCHIMICA ACTA			English	Article						Exponential amplification reaction; Graphene oxide; Single-stranded binding protein; Nicking enzyme	ROLLING CIRCLE AMPLIFICATION; SEQUENCE-BASED AMPLIFICATION; SIGNAL AMPLIFICATION; ISOTHERMAL AMPLIFICATION; SENSITIVE DETECTION; ESCHERICHIA-COLI; NUCLEOTIDE POLYMORPHISMS; GOLD NANOPARTICLES; PLATFORM; ASSAY	The high background signal caused by non-specific amplification (NSA) is a serious issue when using the conventional exponential amplification reaction (EXPAR). We describe a novel method of suppressing NSA using 10 mg L-1 graphene oxide (GO) to prevent non-specific binding of DNA polymerase to the template, resulting in ultra-low background. A side effect of the use of GO is the slow release of ssDNA from the GO surface, with the positive signal decreasing accordingly. The problem of low signal intensity is addressed by applying a 2 mu M solution of single-stranded binding protein (SSB) to accelerate the release of template for EXPAR. The use of GO and SSB in EXPAR can substantially suppress NSA, but it does not compromise the performance of the quantification step. The improved EXPAR presented here can detect concentration as low as 5 aM of trigger, which is approximately four orders of magnitude lower than that of conventional EXPAR under the same experimental conditions.	[Wang, Jianping; Song, Qinxin; Zhou, Guohua] China Pharmaceut Univ, Nanjing 210009, Peoples R China; [Wang, Jianping; Zou, Bingjie; Rui, Jianzhong; Zhou, Guohua] Nanjing Univ, Dept Pharmacol, Jinling Hosp, Sch Med, Nanjing 210002, Peoples R China; [Kajiyama, Tomoharu; Kambara, Hideki] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858601, Japan	Zhou, GH (reprint author), Nanjing Univ, Dept Pharmacol, Jinling Hosp, Sch Med, Nanjing 210002, Peoples R China.	ghzhou@nju.edu.cn			National Key Basic Research Program of China [2014CB744501]; National Natural Science Foundation of China [21275161, 31200638, 31300704]; National Key Science & Technology Special Project [2013ZX10004103]	This work was supported by the National Key Basic Research Program of China (2014CB744501), the National Natural Science Foundation of China (Grant numbers: 21275161, 31200638, and 31300704), and National Key Science & Technology Special Project (2013ZX10004103).	Hu P, 2012, BIOSENS BIOELECTRON, V34, P83, DOI 10.1016/j.bios.2012.01.022; Jia HN, 2011, ANALYST, V136, P5229, DOI 10.1039/c1an15766c; Nagamine K, 2001, CLIN CHEM, V47, P1742; De M, 2011, J AM CHEM SOC, V133, P17524, DOI 10.1021/ja208427j; Qin XY, 2011, CHINESE MED J-PEKING, V124, P2301, DOI 10.3760/cma.j.issn.0366-6999.2011.15.011; Lyamichev VI, 2000, BIOCHEMISTRY-US, V39, P9523, DOI 10.1021/bi0007829; Hsu TM, 2001, CLIN CHEM, V47, P1373; Tan E, 2005, ANAL CHEM, V77, P7984, DOI 10.1021/ac051364i; Tan E, 2008, BIOCHEMISTRY-US, V47, P9987, DOI 10.1021/bi800746p; Mahmoudian L, 2008, ANAL CHEM, V80, P2483, DOI 10.1021/ac702289j; Tan YN, 2011, ANAL CHEM, V83, P4251, DOI 10.1021/ac200525a; Zou BJ, 2012, ANALYST, V137, P729, DOI 10.1039/c1an15886d; Zhang Y, 2012, ANAL CHEM, V84, P9544, DOI 10.1021/ac3024087; Sato K, 2010, LAB CHIP, V10, P1262, DOI 10.1039/b927460j; Liu XQ, 2012, ACS NANO, V6, P3553, DOI 10.1021/nn300598q; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Xu ZN, 2014, MICROCHIM ACTA, V181, P471, DOI 10.1007/s00604-013-1141-1; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Zou BJ, 2011, ANGEW CHEM INT EDIT, V50, P7395, DOI 10.1002/anie.201001529; Jang H, 2010, ANGEW CHEM INT EDIT, V49, P5703, DOI 10.1002/anie.201001332; Li CP, 2011, CHEM COMMUN, V47, P2595, DOI 10.1039/c0cc03957h; Jia HX, 2010, ANGEW CHEM INT EDIT, V49, P5498, DOI 10.1002/anie.201001375; Cao XY, 2014, MICROCHIM ACTA, V181, P1133, DOI 10.1007/s00604-014-1301-y; Huang PJJ, 2012, SMALL, V8, P977, DOI 10.1002/smll.201102156; Zhou M, 2009, ANAL CHEM, V81, P5603, DOI 10.1021/ac900136z; Zhao XH, 2011, ANAL CHEM, V83, P5062, DOI 10.1021/ac200843x; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Zhang ZZ, 2012, ANAL CHEM, V84, P1623, DOI 10.1021/ac2029002; Huang YY, 2007, BIOSENS BIOELECTRON, V22, P980, DOI 10.1016/j.bios.2006.04.017; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Guo YS, 2011, CHEM COMMUN, V47, P725, DOI 10.1039/c0cc03266b; Tan E, 2007, CLIN CHEM, V53, P2017, DOI 10.1373/clinchem.2007.091116; Zhang Y, 2012, ANAL CHEM, V84, P224, DOI 10.1021/ac202405q; Inoue J, 2011, J BIOL CHEM, V286, P6720, DOI 10.1074/jbc.M110.164210; Kozlov AG, 2011, BIOPHYS CHEM, V159, P48, DOI 10.1016/j.bpc.2011.05.005; MEYER RR, 1990, MICROBIOL REV, V54, P342; Murakami T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1014; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Qian JF, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks230; SIGAL N, 1972, P NATL ACAD SCI USA, V69, P3537, DOI 10.1073/pnas.69.12.3537; Souverijn JHM, 2014, NEW ENGL J MED, V371, P187, DOI 10.1056/NEJMc1405215#SA4; Tang YW, 2007, J CLIN VIROL, V40, P129, DOI 10.1016/j.jcv.2007.07.007	42	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-3672	1436-5073		MICROCHIM ACTA	Microchim. Acta	APR	2015	182	5-6					1095	1101		10.1007/s00604-014-1426-z		7	Chemistry, Analytical	Chemistry	CD7NB	WOS:000351276100024		
J	Kotari, H; Motosuke, M				Kotari, Hideharu; Motosuke, Masahiro			Simple applications of microparticle transportation by tender optical scattering force	MICROFLUIDICS AND NANOFLUIDICS			English	Article						Particle sorting; Optical scattering force; Microfluidics; Large-area irradiation; Low energy density	PINCHED FLOW FRACTIONATION; MICROFLUIDIC DEVICES; PARTICLE SEPARATION; BEAM; CHROMATOGRAPHY; MANIPULATION; ELECTRODES; SYSTEMS; REGIME; CELLS	This paper provides a novel application of the optical radiation pressure for microfluidic particle transportation without precise focusing or alignment of the laser beam to the device and target. An optical manipulation of particles in a microfluidic platform is highly exploited in life science or biomedical analysis using optical tweezers with the use of a gradient force of the optical radiation pressure. Our method utilizes the other term of the radiation pressure, namely scattering force, to manipulate particles in a microchannel. The migration distance of particle depends on the amount of light received by the particle. Therefore, particle movement with long retention distance can be achieved by large-area irradiation even with low energy density. In our experiments, two proof-of-concept microfluidic chips were designed and investigated; one was a lateral particle sorting using a monolithic microfluidic chip integrated with a planar SU-8 waveguide and beam expander, the other was a vertical sorting using a 10-cm-long polydimethylsiloxane channel with whole-area irradiation. Experimental results show that 1, 2 and 5 mu m polystyrene beads can be transported by the optical scattering force and that particle migration is achieved with the irradiated energy density < 10 mW/mm(2). The present method has practical potential for simple and fuss-free use of the optical radiation pressure without spot focusing or precise alignment process of the laser beam and damage to the device and sample.	[Kotari, Hideharu; Motosuke, Masahiro] Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, Tokyo 1258585, Japan; [Motosuke, Masahiro] Tokyo Univ Sci, Res Inst Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan	Motosuke, M (reprint author), Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	mot@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25709013]	This work is partially supported by Grant-in-Aid for Young Scientists (A) No. 25709013 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. A part of microfabrication was performed in Center for Nano Lithography and Analysis, The University of Tokyo, supported by MEXT, Japan.	Airoudj A, 2008, TALANTA, V77, P1590; Yamada M, 2004, ANAL CHEM, V76, P5465, DOI 10.1021/ac049863r; Hou HW, 2011, MICROMACHINES-BASEL, V2, P319, DOI 10.3390/mi2030319; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; RUSSEL WB, 1981, ANNU REV FLUID MECH, V13, P425, DOI 10.1146/annurev.fl.13.010181.002233; Kim SB, 2006, J OPT SOC AM B, V23, P897, DOI 10.1364/JOSAB.23.000897; Hoeb M, 2007, BIOPHYS J, V93, P1032, DOI 10.1529/biophysj.106.101188; ASHKIN A, 1980, SCIENCE, V210, P1081, DOI 10.1126/science.210.4474.1081; Lee KH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801951; Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; ASHKIN A, 1992, BIOPHYS J, V61, P569; Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h; Nussbaum P, 1997, PURE APPL OPT, V6, P617, DOI 10.1088/0963-9659/6/6/004; Yalcin SE, 2010, ELECTROPHORESIS, V31, P3711, DOI 10.1002/elps.201000330; Sajeesh P, 2014, MICROFLUID NANOFLUID, V17, P1, DOI 10.1007/s10404-013-1291-9; Gascoyne PRC, 2002, ELECTROPHORESIS, V23, P1973, DOI 10.1002/1522-2683(200207)23:13<1973::AID-ELPS1973>3.0.CO;2-1; Peterman EJG, 2003, BIOPHYS J, V84, P1308; Yamada M, 2005, LAB CHIP, V5, P1233, DOI 10.1039/b509386d; Seo J, 2004, SENSOR ACTUAT B-CHEM, V99, P615, DOI 10.1016/j.snb.2003.11.014; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Ozkan M, 2003, BIOMED MICRODEVICES, V5, P61, DOI 10.1023/A:1024467417471; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Friend J, 2010, BIOMICROFLUIDICS, V4; Hart SJ, 2003, APPL PHYS LETT, V83, P5316, DOI 10.1063/1.1635984; IMASAKA T, 1995, ANAL CHEM, V67, P1763, DOI 10.1021/ac00107a003; Ishida A, 2012, J THERM SCI TECH-JPN, V7, P475, DOI 10.1299/jtst.7.475; Janasek D, 2006, NATURE, V442; JOHNSON FS, 1954, J METEOROL, V11, P431, DOI 10.1175/1520-0469(1954)011<0431:TSC>2.0.CO;2; Kayani AA, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4736796; Kim SB, 2008, ANAL CHEM, V80, P6023, DOI 10.1021/ac800740b; Kuntaegowdanahalli SS, 2009, LAB CHIP, V9, P2973, DOI 10.1039/b908271a; Lairell T, 2007, CHEM SOC REV, V36, P492; Lee KH, 2011, LAB CHIP, V11, P354, DOI 10.1039/c0lc00225a; Liu CX, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2736278; Mogensen KB, 2003, APPL OPTICS, V42, P4072, DOI 10.1364/AO.42.004072; Motosuke M, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005714; Motosuke M, 2010, INT J HEAT FLUID FL, V31, P1005, DOI 10.1016/j.ijheatfluidflow.2010.05.005; Neuman KC, 2004, REV SCI INSTRUM, V75, P2785; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Viana NB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021914; Zhbanov A, 2011, P INT C QUANT NAN MI, P103	43	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1613-4982	1613-4990		MICROFLUID NANOFLUID	Microfluid. Nanofluid.	APR	2015	18	4					549	558		10.1007/s10404-014-1459-y		10	Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Fluids & Plasmas	Science & Technology - Other Topics; Instruments & Instrumentation; Physics	CE1AF	WOS:000351542900002		
J	Matsumoto, T; Endo, J; Hashida, K; Ichikawa, H; Kojima, S; Takashimizu, S; Watanabe, N; Yamagami, T; Hasebe, T				Matsumoto, Tomohiro; Endo, Jun; Hashida, Kazunobu; Ichikawa, Hitoshi; Kojima, Seiichiro; Takashimizu, Shinji; Watanabe, Norihito; Yamagami, Takuji; Hasebe, Terumitsu			Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial microballoon catheter for hepatocellular carcinoma: Technical and safety considerations	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Interventional radiology; catheter interventions; minimally invasive procedures; balloon-occluded transarterial chemoembolization; hepatocellular carcinoma; microballoon catheter	TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CISPLATIN-LIPIODOL SUSPENSION; OILY CHEMOEMBOLIZATION; CHEMOTHERAPY; EMBOLIZATION; DOXORUBICIN; RECURRENCE; SM-11355; EMULSION; AGENT	Objective: To evaluate the technical feasibility and safety considerations of balloon-occluded transarterial chemoembolization (B-TACE) using a newly developed 1.8-French (Fr) tip microballoon catheter for hepatocellular carcinoma (HCC). Material and methods: Between February 2013 and May 2013, 31 patients (20 males, 11 females; age range 56-85 years) underwent B-TACE using a 1.8-Fr tip microballoon catheter for unresectable HCC. The technical success rate, procedural complications, and adverse events of B-TACE were retrospectively investigated. Results: A total of 31 patients were subjected to 70 sessions of B-TACE using a 1.8-Fr tip microballoon catheter. The level of B-TACE was sub-subsegmental in 11, subsegmental in 35, segmental in 14, lobar in five, and right inferior phrenic artery in five sessions. The overall technical success rate was 99% (69 out of 70 sessions). As procedural complications, rupturing of the microballoon (n = 3) and aneurysmal dilatation at the site of balloon occlusion (n = 2) were encountered. There were no significant differences in any parameters between blood biochemical examination before and between two to four weeks after the procedure. Conclusion: A 1.8-Fr tip microballoon catheter enables selective catheterization in patients with HCC and B-TACE using the 1.8-Fr tip microballoon catheter is a safe procedure.	[Matsumoto, Tomohiro; Endo, Jun; Hashida, Kazunobu; Yamagami, Takuji; Hasebe, Terumitsu] Tokai Univ, Hachioji Hosp, Sch Med, Dept Radiol, Hachioji, Tokyo 1920032, Japan; [Ichikawa, Hitoshi; Kojima, Seiichiro; Takashimizu, Shinji; Watanabe, Norihito] Tokai Univ, Hachioji Hosp, Sch Med, Dept Gastroenterol, Hachioji, Tokyo 1920032, Japan; [Yamagami, Takuji] Hiroshima Univ Hosp, Inst & Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan	Hasebe, T (reprint author), Tokai Univ, Hachioji Hosp, Sch Med, Dept Radiol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	hasebe@tokai-u.jp					MONDAZZI L, 1994, HEPATOLOGY, V19, P1115, DOI 10.1016/0270-9139(94)90857-5; Takayasu K, 2001, AM J ROENTGENOL, V176, P681; Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Ikeda M, 2004, ONCOLOGY-BASEL, V66, P24, DOI 10.1159/000076331; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Hanada M, 2009, CANCER CHEMOTH PHARM, V64, P473, DOI 10.1007/s00280-008-0895-3; Ikeda Kenji, 2010, Gan To Kagaku Ryoho, V37, P271; Ikeda M, 2010, J GASTROENTEROL, V45, P60, DOI 10.1007/s00535-009-0109-8; Kamada K, 2001, J VASC INTERV RADIOL, V12, P847, DOI 10.1016/S1051-0443(07)61510-3; Kawamura Y, 2009, HEPATOL RES, V39, P346, DOI 10.1111/j.1872-034X.2008.00466.x; Kishimoto S, 2000, BIOL PHARM BULL, V23, P637; Kora S, 2013, HEPATOL RES, V43, P1100, DOI 10.1111/hepr.12050; Kora S, 2013, CARDIOVASC INTER RAD, V36, P1023, DOI 10.1007/s00270-012-0537-3; Okusaka T, 2004, INVEST NEW DRUG, V22, P169, DOI 10.1023/B:DRUG.0000011793.72775.d1; Ono Y, 2000, AM J CLIN ONCOL-CANC, V23, P564, DOI 10.1097/00000421-200012000-00006; Yodono H, 2011, ANTI-CANCER DRUG, V22, P277, DOI 10.1097/CAD.0b013e328342231d	17	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	APR	2015	24	2					94	100		10.3109/13645706.2014.951657		7	Surgery	Surgery	CD8RT	WOS:000351364200005		
J	Toyoizumi, H; Imazu, H; Ikeda, K; Mori, N; Kanazawa, K; Chiba, M; Ang, TL; Tajiri, H				Toyoizumi, Hirobumi; Imazu, Hiroo; Ikeda, Keiichi; Mori, Naoki; Kanazawa, Keisuke; Chiba, Masafumi; Ang, Tiing Leong; Tajiri, Hisao			A novel second-generation multibending backward-oblique viewing duodenoscope in ERCP	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Endoscopic retrograde cholangiopancreatography; multi-bending backward-oblique viewing duodenoscope; biliary cannulation; en face view of the papilla	BILE-DUCT CANNULATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; RANDOMIZED CONTROLLED-TRIALS; RISK-FACTORS; SELECTIVE CANNULATION; PANCREATITIS; METAANALYSIS; COMPLICATIONS; PAPILLOTOME; MULTICENTER	Introduction: Successful access to the papilla and cannulation of the desired duct can be technically challenging. A novel second-generation multi-bending backward-oblique viewing duodenoscope (2nd M-D scope) was developed to overcome this difficulty. The aim of the present study was to evaluate the utility of 2nd M-D scope during biliary ERCP. Material and methods: This was a retrospective review of 53 patients with native papilla who underwent biliary ERCP with the 2nd M-D scope. Results: Biliary cannulation and interventional procedures were successfully completed in all patients. In two of these patients, ERCP was initially attempted with a conventional single bending duodenoscope, but biliary cannulation was unsuccessful; one had Billroth-I gastrectomy, and the other had a Type III choledochal cyst. However, with the 2nd M-D scope, biliary cannulation and interventional procedures were successfully achieved. Finally, in nine patients, upward or downward angulation of the proximal bending portion in addition to the distal bending portion was used during ERCP, and the operator's comments demonstrated that it was helpful for obtaining an appropriate en face view to look up to the papilla and facilitate successful biliary cannulation. Conclusion: The newly developed 2nd M-D scope could safely facilitate biliary cannulation in selected patients during ERCP.	[Toyoizumi, Hirobumi; Imazu, Hiroo; Ikeda, Keiichi; Mori, Naoki; Kanazawa, Keisuke; Chiba, Masafumi] Jikei Univ, Sch Med, Dept Endoscopy, Minato Ku, Tokyo 1058461, Japan; [Ang, Tiing Leong] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore; [Tajiri, Hisao] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1058461, Japan	Imazu, H (reprint author), Jikei Univ, Sch Med, Dept Endoscopy, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	himazu21@aol.com					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Cheng CL, 2006, AM J GASTROENTEROL, V101, P139, DOI 10.1111/j.1572-0241.2006.00380.x; Cotton PB, 2009, GASTROINTEST ENDOSC, V70, P80, DOI 10.1016/j.gie.2008.10.039; Cennamo V, 2009, AM J GASTROENTEROL, V104, P2343, DOI 10.1038/ajg.2009.269; Binmoeller KF, 1996, GASTROINTEST ENDOSC, V44, P689, DOI 10.1016/S0016-5107(96)70053-6; Cennamo V, 2010, ENDOSCOPY, V42, P381, DOI 10.1055/s-0029-1243992; Catalano MF, 2004, GASTROINTEST ENDOSC, V60, P557, DOI 10.1016/S0016-5107(04)01877-2; Koo HC, 2009, GASTROINTEST ENDOSC, V69, P931, DOI 10.1016/j.gie.2008.10.053; Isshi K, 2004, ENDOSCOPY, V36, P294, DOI 10.1055/s-2004-814203; Cheung J, 2009, GASTROINTEST ENDOSC, V70, P1211, DOI 10.1016/j.gie.2009.08.007; Gotoh Y, 2001, GASTROINTEST ENDOSC, V53, P820, DOI 10.1067/mge.2001.113387; Cortas GA, 1999, GASTROINTEST ENDOSC, V50, P775, DOI 10.1016/S0016-5107(99)70157-4; Cotton BB, 1972, LANCET, V1, P53; Dumonceau JM, 1998, ENDOSCOPY, V30, pS30; HUIBREGTSE K, 1986, GASTROINTEST ENDOSC, V32, P403, DOI 10.1016/S0016-5107(86)71921-4; Imazu H, 2012, ENDOSCOPY, V44, P99, DOI 10.1055/s-0031-1291445; Larkin C J, 2001, Curr Gastroenterol Rep, V3, P147, DOI 10.1007/s11894-001-0012-9; Santiago I, 2012, AM J ROENTGENOL, V198, P825, DOI 10.2214/AJR.11.7294; Schwacha H, 2000, GASTROINTEST ENDOSC, V52, P387, DOI 10.1067/mge.2000.107909; TAKAGI K, 1970, GASTROENTEROLOGY, V59, P445	21	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	APR	2015	24	2					101	107		10.3109/13645706.2014.955030		7	Surgery	Surgery	CD8RT	WOS:000351364200006		
J	Shimohira, M; Hashizume, T; Ohta, K; Honda, J; Shibamoto, Y				Shimohira, Masashi; Hashizume, Takuya; Ohta, Kengo; Honda, Junichi; Shibamoto, Yuta			Triaxial transarterial embolization for lower gastrointestinal bleeding: A retrospective case series	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Embolization; triaxial; catheter interventions	TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; ENDOSCOPIC TREATMENT; MICROCATHETER; COLONOSCOPY; HEMORRHAGE; SYSTEM	Objective: Superselective transcatheter arterial embolization (TAE) is important for lower gastrointestinal (GI) bleeding. A new 1.9-Fr. no-taper microcatheter has recently become available and can be inserted into a 2.7-Fr. microcatheter. We assessed the applicability of this new triple co-axial (triaxial) system to TAE for lower GI bleeding. Material and methods: Five patients with lower GI bleeding underwent TAE with the triaxial system. The approach was via the femoral artery with a 4-Fr. sheath in all cases. The 4-Fr. catheter and triaxial system were inserted into the artery in which extravasation had occurred. Coil embolization was performed with 0.010-inch coils. We evaluated technical success rate, clinical success rate and complications. Results: All five cases of bleeding occurred at the ascending colon, and were caused by diverticulosis in four cases, and an injury to the artery during polypectomy in one case. The 1.9-Fr. no-taper microcatheter could be inserted into the site of extravasation, the vasa recta, in all procedures and TAE was performed successfully. The disappearance of extravasation was confirmed in all cases following TAE. No patients exhibited any signs of recurrent bleeding or complication. Conclusion: The triaxial system appears to be effective and useful in superselective TAE for lower GI bleeding.	[Shimohira, Masashi; Hashizume, Takuya; Ohta, Kengo; Honda, Junichi; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan	Shimohira, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan.	mshimohira@gmail.com					Angtuaco TL, 2001, AM J GASTROENTEROL, V96, P1782, DOI 10.1016/S0002-9270(01)02434-0; Manta R, 2013, SURG ENDOSC, V27, P3162, DOI 10.1007/s00464-013-2871-1; Schuetz A, 2001, LANGENBECK ARCH SURG, V386, P17, DOI 10.1007/s004230000192; Shimohira M, 2013, J ENDOVASC THER, V20, P200, DOI 10.1583/1545-1550-20.2.200; Eisen GM, 2001, GASTROINTEST ENDOSC, V53, P859; d'Othee BJ, 2006, CARDIOVASC INTER RAD, V29, P49, DOI 10.1007/s00270-004-0301-4; Shimohira M, 2011, BRIT J RADIOL, V84, P184, DOI 10.1259/bjr/26974088; Nitta N, 2013, MINIM INVASIV THER, V22, P157, DOI 10.3109/13645706.2012.719909; Bandi R, 2001, J VASC INTERV RADIOL, V12, P1399, DOI 10.1016/S1051-0443(07)61697-2; Chaudhry V, 1998, AM SURGEON, V64, P723; Koganemaru M, 2012, AM J ROENTGENOL, V198, pW370, DOI 10.2214/AJR.11.7295; Komemushi A, 2014, MINIM INVASIV THER, V23, P52, DOI 10.3109/13645706.2013.831107; Peter DJ, 1999, EMERG MED CLIN N AM, V17, P239, DOI 10.1016/S0733-8627(05)70055-9; Rozycki GS, 2002, ANN SURG, V235, P681, DOI 10.1097/00000658-200205000-00010; Shimohira M, 2012, ACTA RADIOL, V53, P857, DOI 10.1258/ar.2012.120044	15	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	APR	2015	24	2					119	122		10.3109/13645706.2014.951656		4	Surgery	Surgery	CD8RT	WOS:000351364200009		
J	Tsuda, Y; Nakao, K; Ide, Y; Tsumura, Y				Tsuda, Y.; Nakao, K.; Ide, Y.; Tsumura, Y.			The population demography of Betula maximowicziana, a cool-temperate tree species in Japan, in relation to the last glacial period: its admixture-like genetic structure is the result of simple population splitting not admixing	MOLECULAR ECOLOGY			English	Article						approximate Bayesian computation; Betula maximowicziana; demographic history; forest conservation and management; last glacial maximum; northern persistence	APPROXIMATE BAYESIAN COMPUTATION; MULTILOCUS GENOTYPE DATA; NUCLEOTIDE POLYMORPHISM; EVOLUTIONARY PROCESSES; CLIMATE-CHANGE; HISTORY; REFUGIA; CONSERVATION; FOREST; RANGE	Conservation of the local genetic variation and evolutionary integrity of economically and ecologically important trees is a key aspect of studies involving forest genetics, and a population demographic history of the target species provides valuable information for this purpose. Here, the genetic structure of 48 populations of Betula maximowicziana was assessed using 12 expressed sequence tag-simple sequence repeat (EST-SSR) markers. Genetic diversity was lower in northern populations than southern ones and structure analysis revealed three groups: northern and southern clusters and an admixed group. Eleven more genomic-SSR loci were added and the demographic history of these three groups was inferred by approximate Bayesian computation (ABC). The ABC revealed that a simple split scenario was much more likely than isolation with admixture, suggesting that the admixture-like structure detected in this species was due to ancestral polymorphisms. The ABC analysis suggested that the population growth and divergence of the three groups occurred 96800 (95% CI, 20500-599000) and 28300 (95% CI, 8700-98400) years ago, respectively. We need to be aware of several sources of uncertainty in the inference such as assumptions about the generation time, overlapping of generations, confidence intervals of the estimated parameters and the assumed model in the ABC. However, the results of the ABC together with the model-based maps of reconstructed past species distribution and palaeoecological data suggested that the modern genetic structure of B.maximowicziana originated prior to the last glacial maximum (LGM) and that some populations survived in the northern range even during the LGM.	[Tsuda, Y.] Uppsala Univ, Dept Ecol & Genet, Program Plant Ecol & Evolut, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Tsuda, Y.; Tsumura, Y.] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 3058687, Japan; [Nakao, K.] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Ide, Y.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Ecosyst Studies, Lab Forest Ecosyst Studies,Bunkyo Ku, Tokyo 1138657, Japan	Tsuda, Y (reprint author), Chiba Univ, Lab Plant Systemat, Dept Biol, Grad Sch Sci,Inage Ku, 1-33 Yayoi Cho, Chiba, Chiba 2638522, Japan.	ytsuda.gt@gmail.com			Ministry of Environment, Japan; Japan Society for the Promotion of Science (JSPS)	We greatly appreciated for the comments of the subject editor, Myriam Hueuertz, and three reviewers when revising and improving this manuscript. We thank Saneyoshi Ueno, Shinya Yamada, Tetsuji Hakamada and Hiroki Nishikawa for their help in sampling the plant material and Yuriko Taguchi, Misako Koshiba and Akihiro Komatsu for help with the experimental work. We also thank the staff of the University Forests, University of Tokyo, for collecting samples from the Furano population in the University Forest in Hokkaido, and the Chichibu population in the University Forest in Chichibu. We are grateful to Katsuhiro Osumi for a valuable discussion about the life history and generation time of B. maximowicziana and Leanne Faulks and Federico Sebastiani for their help in editing the figures and the manuscript. This study was supported by a grant for Research on Genetic Guidelines for Restoration Programs using Genetic Diversity Information from the Ministry of Environment, Japan, and a grant for overseas research from the Japan Society for the Promotion of Science (JSPS).	Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Lian CL, 2001, HEREDITY, V87, P88, DOI 10.1046/j.1365-2540.2001.00913.x; Kimura MK, 2014, ANN BOT-LONDON, V114, P1687, DOI 10.1093/aob/mcu197; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Mathiasen P, 2010, MOL ECOL, V19, P371, DOI 10.1111/j.1365-294X.2009.04456.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Nevill PG, 2014, ANN BOT-LONDON, V113, P55, DOI 10.1093/aob/mct253; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Semerikov VL, 2013, MOL ECOL, V22, P4958, DOI 10.1111/mec.12433; Pritchard JK, 2000, GENETICS, V155, P945; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Mellick R, 2012, J BIOGEOGR, V39, P2292, DOI 10.1111/j.1365-2699.2012.02747.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sakaguchi S, 2011, HEREDITY, V107, P338, DOI 10.1038/hdy.2011.20; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FRANKEL OH, 1974, GENETICS, V78, P53; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Osumi K, 2005, J BIOGEOGR, V32, P2057, DOI 10.1111/j.1365-2699.2005.01368.x; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Falush D, 2003, GENETICS, V164, P1567; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bodare S, 2013, ECOL EVOL, V3, P3233, DOI 10.1002/ece3.669; Breiman L., 1984, CLASSIFICATION REGRE; Bucci G, 2000, MOL ECOL, V9, P923, DOI 10.1046/j.1365-294x.2000.00946.x; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Cavers S, 2004, FOREST ECOL MANAG, V197, P285, DOI 10.1016/j.foreco.2004.05.019; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Fujii N, 2006, TAXON, V55, P43; Goudet J, 2001, FSTAT VERSIOIN 2 9 3; HEUSSER LE, 1985, QUATERNARY RES, V24, P60, DOI 10.1016/0033-5894(85)90083-3; IGARASHI Y, 1994, QUATERNARY SCI REV, V13, P335, DOI 10.1016/0277-3791(94)90111-2; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Japan Forestry Investigation Committee, 2009, JAP FOR INV COMM; Japan Map Center, 1998, NUM MAP U SGUID; Kado E, 2002, B TOKYO U FORESTS, V107, P93; Lascoux M, 2008, PLANT ECOL DIVERS, V1, P209, DOI 10.1080/17550870802328439; Lefevre F, 2004, FOREST ECOL MANAG, V197, P257, DOI 10.1016/j.foreco.2004.05.017; Liu CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087187; McCallum KP, 2014, AUSTRAL ECOL, V39, P17, DOI 10.1111/aec.12041; Morgenstern E.K., 1996, GEOGRAPHIC VARIATION; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2009, STRUCTURE VER 2 3; R Development Core Team, 2012, R LANG ENV STAT COMP; R Development Core Team, 2008, R LANG ENV STAT COMP; Schorr G, 2012, ECOL EVOL, V2, P1260, DOI 10.1002/ece3.100; Sousa VC, 2012, HEREDITY, V108, P521, DOI 10.1038/hdy.2011.116; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Tani N, 1996, CAN J FOREST RES, V26, P1454, DOI 10.1139/x26-162; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Tsuda Y, 2010, J PLANT RES, V123, P343, DOI 10.1007/s10265-009-0280-2; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Tsuda Y, 2004, SILVAE GENET, V53, P234; Tsuda Y, 2009, CONSERV GENET, V10, P661, DOI 10.1007/s10592-008-9608-z; TSUKADA M, 1983, QUATERNARY RES, V19, P212, DOI 10.1016/0033-5894(83)90006-6; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Whittaker R.H., 1975, COMMUNITIES ECOSYSTE	81	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	APR	2015	24	7					1403	1418		10.1111/mec.13123		16	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CE2GC	WOS:000351631500002		
J	Fekih, R; Tamiru, M; Kanzaki, H; Abe, A; Yoshida, K; Kanzaki, E; Saitoh, H; Takagi, H; Natsume, S; Undan, JR; Undan, J; Terauchi, R				Fekih, Rym; Tamiru, Muluneh; Kanzaki, Hiroyuki; Abe, Akira; Yoshida, Kentaro; Kanzaki, Eiko; Saitoh, Hiromasa; Takagi, Hiroki; Natsume, Satoshi; Undan, Jerwin R.; Undan, Jesusa; Terauchi, Ryohei			The rice (Oryza sativa L.) LESION MIMIC RESEMBLING, which encodes an AAA-type ATPase, is implicated in defense response	MOLECULAR GENETICS AND GENOMICS			English	Article						ATPase; Defense response; Lesion mimic; Cell death; Oryza sativa	BROAD-SPECTRUM RESISTANCE; PROGRAMMED CELL-DEATH; ENHANCED RESISTANCE; DISEASE RESISTANCE; BACTERIAL-BLIGHT; PROTEIN; GENE; MUTANTS; ARABIDOPSIS; PLANTS	Lesion mimic mutants (LMMs) provide a useful tool to study defense-related programmed cell death (PCD) in plants. Although a number of LMMs have been identified in multiple species, most of the candidate genes are yet to be isolated. Here, we report the identification and characterization of a novel rice (Oryza sativa L.) lesion mimic resembling (lmr) mutant, and cloning of the corresponding LMR gene. The LMR locus was initially delineated to 1.2 Mb region on chromosome 6, which was further narrowed down to 155-kb using insertions/deletions (INDELs) and cleavage amplified polymorphic sequence markers developed in this study. We sequenced the open reading frames predicted within the candidate genomic region, and identified a G-A base substitution causing a premature translation termination in a gene that encodes an ATPase associated with various cellular activities type (AAA-type) protein. RNA interference transgenic lines with reduced LMR transcripts exhibited the lesion mimic phenotype similar to that of lmr plants. Furthermore, expression of the wild-type LMR in the mutant background complemented the lesion phenotype, confirming that the mutation identified in LMR is responsible for the mutant phenotype. The pathogenesis-related (PR) genes PBZ1 and PR1 were induced in lmr, which also showed enhanced resistance to rice blast (Magnaporthe oryzae) and bacterial blight (Xanthomonas oryzae pv. oryzae), suggesting LMR is a negative regulator of cell death in rice. The identification of lmr and cloning of the corresponding LMR gene provide an additional resource for the study of PCD in plants.	[Fekih, Rym; Tamiru, Muluneh; Kanzaki, Hiroyuki; Abe, Akira; Yoshida, Kentaro; Kanzaki, Eiko; Saitoh, Hiromasa; Takagi, Hiroki; Natsume, Satoshi; Undan, Jerwin R.; Undan, Jesusa; Terauchi, Ryohei] Iwate Agr Res Ctr, Kitakami, Iwate 0240003, Japan; [Abe, Akira] Iwate Agr Res Ctr, Kitakami, Iwate 0240003, Japan	Tamiru, M (reprint author), Iwate Agr Res Ctr, Narita 22-174-4, Kitakami, Iwate 0240003, Japan.	olimt@ibrc.or.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; MEXT [23113009]; JSPS KAKENHI [24248004]	This project was partially supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Grant-in-aid for MEXT (Scientific Research on Innovative Areas 23113009), and JSPS KAKENHI (Grant No. 24248004) to RT. RF is a postdoctoral fellow of the Japanese Society for the Promotion of Sciences (JSPS). We thank D. Baulcombe of Sainsbury Laboratory, John Innes Center, for providing us the 35S-p19 vector.	Abe A, 2012, NAT BIOTECHNOL, V30, P74; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Glazebrook J, 1997, GENETICS, V146, P381; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Kanzaki H, 2002, THEOR APPL GENET, V105, P809, DOI 10.1007/s00122-001-0817-9; Wang LJ, 2005, MOL PLANT MICROBE IN, V18, P375, DOI 10.1094/MPMI-18-0375; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Dangl JL, 1996, PLANT CELL, V8, P1793; Feng BH, 2013, J INTEGR PLANT BIOL, V55, P473, DOI 10.1111/jipb.12021; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Abbink TEM, 2002, VIROLOGY, V295, P307, DOI 10.1006/viro.2002.1332; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Undan JR, 2012, GENES GENET SYST, V87, P169; Mori M, 2007, PLANT MOL BIOL, V63, P847, DOI 10.1007/s11103-006-9130-y; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Qiao Y, 2010, NEW PHYTOL, V185, P258, DOI 10.1111/j.1469-8137.2009.03047.x; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Wu CJ, 2008, MOL GENET GENOMICS, V279, P605, DOI 10.1007/s00438-008-0337-2; Mizobuchi R, 2002, PLANT SCI, V163, P345, DOI 10.1016/S0168-9452(02)00134-6; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Midoh N, 1997, J PESTIC SCI, V22, P45; Takahashi A, 1999, PLANT J, V17, P535, DOI 10.1046/j.1365-313X.1999.00405.x; JOHAL GS, 1995, BIOESSAYS, V17, P685, DOI 10.1002/bies.950170805; Sun CH, 2011, J GENET GENOMICS, V38, P29, DOI [10.1016/j.jcg.2010.12.001, 10.1016/j.jgg.2011.12.001]; Beyer A, 1997, PROTEIN SCI, V6, P2043; Buaboocha T, 2001, PLANTA, V212, P774, DOI 10.1007/s004250000440; Bussemer J, 2009, FEBS J, V276, P4294, DOI 10.1111/j.1742-4658.2009.07102.x; Jian-yang M, 2012, RICE SCI, V19, P1; Kinoshita CT, 1995, RICE GENET NEWSLETT, V12, P9; KIYOSAWA S., 1970, Bull. natn. Inst. agric. Sci., Tokyo, V21, P61; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; Liu G, 2004, MOL GENET GENOMICS, V272, P108, DOI 10.1007/s00438-004-1040-6; Matin MN, 2010, PLANT PATHOLOGY J, V26, P159, DOI 10.5423/PPJ.2010.26.2.159; Miki D, 2004, PLANT CELL PHYSL, V45, P445; Mittler R, 2000, PLANT MOL BIOL, V44, P335, DOI 10.1023/A:1026544625898; Mizobuchi K, 2003, BREEDING SCI, V53, P93; Moeder W, 2008, PLANT SIGNAL BEHAV, V10, P764; Nagao S, 1964, MEM FAC AGR HOKKAIDO, V5, P89; Sujay Rakshit, 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P187; Sekiguchi Y, 1965, ANN PHYTOPATH SOC JA, V30, P71; Sugimoto M, 2004, PLANT MOL BIOL, V56, P973, DOI 10.1007/s11103-004-6459-y; Takahashi A, 2007, PLANT CELL, V19, P2940, DOI 10.1105/tpc.106.047142; Takahashi Y, 2009, MOL PLANT MICROBE IN, V22, P31, DOI 10.1094/MPMI-22-1-0031; Terauchi R, 2012, J PLANT BIOCHEM BIOT, V21, pS10, DOI 10.1007/s13562-012-0133-2; Urantowka A, 2005, PLANT MOL BIOL, V59, P239, DOI 10.1007/s11103-005-8766-3	60	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	APR	2015	290	2					611	622		10.1007/s00438-014-0944-z		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CD9GE	WOS:000351405200019		
J	Ueno, H; Urasaki, N; Natsume, S; Yoshida, K; Tarora, K; Shudo, A; Terauchi, R; Matsumura, H				Ueno, Hiroki; Urasaki, Naoya; Natsume, Satoshi; Yoshida, Kentaro; Tarora, Kazuhiko; Shudo, Ayano; Terauchi, Ryohei; Matsumura, Hideo			Genome sequence comparison reveals a candidate gene involved in male-hermaphrodite differentiation in papaya (Carica papaya) trees	MOLECULAR GENETICS AND GENOMICS			English	Article						Carica papaya; Sex chromosome; Y-h chromosome; Y chromosome; Short Vegetative Phase like	SEX-CHROMOSOMES; FLORAL DEVELOPMENT; ARABIDOPSIS; DIVERGENCE; EVOLUTION; PLANTS	The sex type of papaya (Carica papaya) is determined by the pair of sex chromosomes (XX, female; XY, male; and XYh, hermaphrodite), in which there is a non-recombining genomic region in the Y and Y-h chromosomes. This region is presumed to be involved in determination of males and hermaphrodites; it is designated as the male-specific region in the Y chromosome (MSY) and the hermaphrodite-specific region in the Y-h chromosome (HSY). Here, we identified the genes determining male and hermaphrodite sex types by comparing MSY and HSY genomic sequences. In the MSY and HSY genomic regions, we identified 14,528 nucleotide substitutions and 965 short indels with a large gap and two highly diverged regions. In the predicted genes expressed in flower buds, we found no nucleotide differences leading to amino acid changes between the MSY and HSY. However, we found an HSY-specific transposon insertion in a gene (SVP like) showing a similarity to the Short Vegetative Phase (SVP) gene. Study of SVP-like transcripts revealed that the MSY allele encoded an intact protein, while the HSY allele encoded a truncated protein. Our findings demonstrated that the SVP-like gene is a candidate gene for male-hermaphrodite determination in papaya.	[Ueno, Hiroki] Shinshu Univ, Dept Biosci & Text Technol, Ueda, Nagano 3868567, Japan; [Urasaki, Naoya; Tarora, Kazuhiko; Shudo, Ayano] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa 9010336, Japan; [Natsume, Satoshi; Yoshida, Kentaro; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano 3868567, Japan	Matsumura, H (reprint author), Shinshu Univ, Ctr Gene Res, Ueda, Nagano 3868567, Japan.	hideoma@shinshu-u.ac.jp			JSPS (Japan Society for the Promotion of Science) [25450004]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (PROBRAIN); MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan	This work is supported by JSPS (Japan Society for the Promotion of Science) Grant no. 25450004, and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (PROBRAIN). This work was also supported in part by Grants for Excellent Graduate Schools, MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan.	CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Song YP, 2013, PLANT MOL BIOL, V83, P559, DOI 10.1007/s11103-013-0108-2; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Urasaki N, 2002, THEOR APPL GENET, V104, P281, DOI 10.1007/s001220100693; Gregis V, 2009, PLANT J, V60, P626, DOI 10.1111/j.1365-313X.2009.03985.x; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; VanBuren R, 2013, MOL GENET GENOMICS, V288, P277, DOI 10.1007/s00438-013-0747-7; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Gschwend AR, 2013, EUPHYTICA, V189, P461, DOI 10.1007/s10681-012-0815-9; Ming R, 2007, SEMIN CELL DEV BIOL, V18, P401, DOI 10.1016/j.semcdb.2006-11.013; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Carvalho FA, 2012, MOL PHYLOGENET EVOL, V65, P46, DOI 10.1016/j.ympev.2012.05.019; Carvalho FA, 2013, GENETICS GENOMICS PA, P81; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Jaudal M, 2014, J EXP BOT, V65, P429, DOI 10.1093/jxb/ert384; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Matsumura H, 2006, NAT METHODS, V3, P469, DOI 10.1038/NMETH882; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Na JK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-176; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Urasaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040904; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Wu RM, 2012, J EXP BOT, V63, P797, DOI 10.1093/jxb/err304; Yu Q. Y., 2008, Tropical Plant Biology, V1, P49, DOI 10.1007/s12042-007-9005-7; Zhang W, 2008, GENOME RES, V18, P1	28	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	APR	2015	290	2					661	670		10.1007/s00438-014-0955-9		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CD9GE	WOS:000351405200023		
J	Kanno, T; Tanaka, A; Nishizaki, T				Kanno, Takeshi; Tanaka, Akito; Nishizaki, Tomoyuki			Linoleic Acid Derivative DCP-LA Ameliorates Stress-Induced Depression-Related Behavior by Promoting Cell Surface 5-HT1A Receptor Translocation, Stimulating Serotonin Release, and Inactivating GSK-3 beta	MOLECULAR NEUROBIOLOGY			English	Article						DCP-LA; Serotonin; 5-HT1A receptor; GSK-3 beta; Depression; Antidepressant	ALPHA-7 ACETYLCHOLINE-RECEPTORS; GLYCOGEN-SYNTHASE KINASE-3; ACTIVATES PKC-EPSILON; MEMBRANE; NEURONS	Impairment of serotonergic neurotransmission is the major factor responsible for depression and glycogen synthase kinase 3 beta (GSK-3 beta) participates in serotonergic transmission-mediated signaling networks relevant to mental illnesses. In the forced-swim test to assess depression-like behavior, the immobility time for mice with restraint stress was significantly longer than that for nonstressed control mice. Postsynaptic cell surface localization of 5-HT1A receptor, but not 5-HT2A receptor, in the hypothalamus for mice with restraint stress was significantly reduced as compared with that for control mice, which highly correlated to prolonged immobility time, i.e., depression-like behavior. The linoleic acid derivative 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) restored restraint stress-induced reduction of cell surface 5-HT1A receptor and improved depression-like behavior in mice with restraint stress. Moreover, DCP-LA stimulated serotonin release from hypothalamic slices and cancelled restraint stress-induced reduction of GSK-3 beta phosphorylation at Ser9. Taken together, the results of the present study indicate that DCP-LA could ameliorate depression-like behavior by promoting translocation of 5-HT1A receptor to the plasma membrane on postsynaptic cells, stimulating serotonin release, and inactivating GSK-3 beta.	[Kanno, Takeshi; Nishizaki, Tomoyuki] Hyogo Coll Med, Div Bioinformat, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan; [Tanaka, Akito] Hyogo Univ Hlth Sci, Adv Med Res Ctr, Biol Chem Lab, Kobe, Hyogo, Japan	Nishizaki, T (reprint author), Hyogo Coll Med, Div Bioinformat, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan.	tomoyuki@hyo-med.ac.jp					Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Cowen DS, 2005, J NEUROCHEM, V93, P910, DOI 10.1111/j.1471-4159.2005.03107.x; Kanno T, 2012, CELL PHYSIOL BIOCHEM, V30, P1014, DOI 10.1159/000341478; Lesch KP, 2004, INT J NEUROPSYCHOPH, V7, P381, DOI 10.1017/S1461145704004845; Latapy C, 2012, PHILOS T R SOC B, V367, P2460, DOI 10.1098/rstb.2012.0094; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Kanno T, 2009, J CELL PHYSIOL, V221, P183, DOI 10.1002/jcp.21838; Kanno T, 2013, BIOCHEM J, V450, P303, DOI 10.1042/BJ20121348; Kanno T, 2005, J NEUROCHEM, V95, P695, DOI 10.1111/j.1471-4159.2005.03398.x; Kanno T, 2012, CELL PHYSIOL BIOCHEM, V30, P75, DOI 10.1159/000339049; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; Shimizu T, 2011, CELL PHYSIOL BIOCHEM, V27, P149, DOI 10.1159/000325217; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; Yamamoto S, 2005, NEUROSCIENCE, V130, P207, DOI 10.1016/j.neuroscience.2004.09.016; Zarate C, 2003, ANN NY ACAD SCI, V1292, P21	22	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2015	51	2					523	532		10.1007/s12035-014-8718-5		10	Neurosciences	Neurosciences & Neurology	CD7YL	WOS:000351311800008		
J	Moriguchi, S; Nishi, M; Sasaki, Y; Takeshima, H; Fukunaga, K				Moriguchi, Shigeki; Nishi, Miyuki; Sasaki, Yuzuru; Takeshima, Hiroshi; Fukunaga, Kohji			Aberrant Behavioral Sensitization by Methamphetamine in Junctophilin-Deficient Mice	MOLECULAR NEUROBIOLOGY			English	Article						Junctophilin; Behavioral sensitization; Calcium/calmodulin-dependent protein kinase II; Calcineurin; Long-termpotentiation; Striatum	PROTEIN-KINASE-II; RECEPTOR STIMULATION INCREASES; NUCLEUS-ACCUMBENS NEURONS; LONG-TERM POTENTIATION; LOCOMOTOR SENSITIZATION; CALCINEURIN INHIBITOR; NMDA RECEPTORS; AMPA RECEPTORS; PHOSPHORYLATION; DOPAMINE	Junctophilins (JPs) expressed in the endoplasmic/sarcoplasmic reticulum (ER/SR) interact with the plasma membrane, thereby constructing junctional membrane complexes (JMC). We here reported that double-knockout mice lacking both JP3 and JP4 (JP-DKO mice) exhibit aberrant synaptic plasticity in the corticostriatal circuits and irregular methamphetamine (METH)-induced behavioral sensitization when METH (1.0 mg/kg) was administrated six consecutive days and assessed the striatal glutamatergic population spike (PS) by stimulation of cortical white matter. When we assessed the striatal PS by stimulation of cortical white matter, the long-term depression (LTD) was observed in JP-DKO mouse striatum similar to that in control (JP-double hetero mice (JP-DHE mice)). Importantly, LTD converted to long-term potentiation (LTP) following chronic METH treatment concomitant with behavioral sensitization in JP-DHE mice. LTD in JP-DKO mice, however failed to convert to LTP with lacks of behavioral sensitization. LTP impairment in JP-DKO mice was restored by pretreatment with FK506, calcineurin (CaN) inhibitor, but not with apamin, SK channel inhibitor. In immunoblotting analyses, calcium/calmodulin-dependent protein kinase II (CaMKII) autophosphorylation was significantly increased following METH treatment in the striatum of JP-DHE mice. However, CaMKII autophosphorylation did not changed by METH treatment in the striatum of JP-DKO mouse. The increased CaMKII autophosphorylation was closely associated with elevated CaN activity in JP-DKO mice. The lack of increased CaMKII activity in JP-DKO mice was correlated with the impaired METH-induced behavioral sensitization. Thus, elevated CaN and aberrant CaMKII activities in the striatum of JP-DKO mice likely accounts for lack of METH-induced behavioral sensitization.	[Moriguchi, Shigeki; Sasaki, Yuzuru; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto, Japan	Moriguchi, S (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	shigeki@m.tohoku.ac.jp; kfukunaga@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health and Welfare of Japan [24659024, 24102505, 20790398]; Smoking Research Foundation; Takeda Science Foundation; Suzuken Memorial Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health and Welfare of Japan (24659024 and 24102505 to K.F.; 20790398 to S.M.), the Smoking Research Foundation (to K.F.), the Takeda Science Foundation (to S.M.), and the Suzuken Memorial Foundation (to S.M.). Authors have no conflict of interest in this work.	Addy NA, 2007, J NEUROSCI, V27, P8571, DOI 10.1523/JNEUROSCI.2601-07.2007; Addy NA, 2008, PSYCHOPHARMACOLOGY, V200, P129, DOI 10.1007/s00213-008-1189-5; Alexander E, 1990, TREND NEUROSCI, V13, P266; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; POZZAN T, 1994, PHYSIOL REV, V74, P595; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Moriguchi S, 2006, P NATL ACAD SCI USA, V103, P10811, DOI 10.1073/pnas.0509863103; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Sun X, 2008, J NEUROSCI, V28, P4216, DOI 10.1523/JNEUROSCI.0258-08.2008; Wei Q, 2002, CELL MOL NEUROBIOL, V22, P13, DOI 10.1023/A:1015385527187; Moriguchi S, 2002, EXP BRAIN RES, V144, P238, DOI 10.1007/s00221-002-1039-3; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Poncer JC, 2002, J NEUROSCI, V22, P4406; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Rusnak F, 2000, PHYSIOL REV, V80, P1483; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; Choe ES, 2005, NEUROSCI LETT, V384, P38, DOI 10.1016/j.neulet.2005.04.044; ROBINSON TE, 1984, PSYCHOPHARMACOLOGY, V84, P466, DOI 10.1007/BF00431451; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Cattaneda E, 1988, LIFE SCI, V42, P2447; Facchin F, 2008, GENE, V407, P159, DOI 10.1016/j.gene.2007.10.006; HIRABAYASHI M, 1981, PHARMACOL BIOCHEM BE, V15, P925, DOI 10.1016/0091-3057(81)90056-3; Kuczenski T, 1989, J NEUROSCI, V9, P2051; LAU LF, 1995, J BIOL CHEM, V270, P20036; Loweth JA, 2010, J NEUROSCI, V30, P939, DOI 10.1523/JNEUROSCI.4383-09.2010; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Moriguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060863; Nishi M, 2002, BIOCHEM BIOPH RES CO, V292, P318, DOI 10.1006/bbrc.2002.6649; OHNO M, 1994, BRAIN RES, V665, P135, DOI 10.1016/0006-8993(94)91163-0; PATRICK SL, 1991, BRAIN RES, V538, P343, DOI 10.1016/0006-8993(91)90453-3; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Ris L, 2014, LEARNING ME IN PRESS; Singer BF, 2010, EUR J NEUROSCI, V31, P1243, DOI 10.1111/j.1460-9568.2010.07155.x; Tsukamoto T, 2001, PSYCHOPHARMACOLOGY, V158, P107, DOI 10.1007/s002130100870; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Wang J, 2012, PSYCHOPHARMACOLOGY, V220, P117, DOI 10.1007/s00213-011-2461-7	54	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2015	51	2					533	542		10.1007/s12035-014-8737-2		10	Neurosciences	Neurosciences & Neurology	CD7YL	WOS:000351311800009		
J	Aoki, Y; Watanabe, T; Abe, O; Kuwabara, H; Yahata, N; Takano, Y; Iwashiro, N; Natsubori, T; Takao, H; Kawakubo, Y; Kasai, K; Yamasue, H				Aoki, Y.; Watanabe, T.; Abe, O.; Kuwabara, H.; Yahata, N.; Takano, Y.; Iwashiro, N.; Natsubori, T.; Takao, H.; Kawakubo, Y.; Kasai, K.; Yamasue, H.			Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial	MOLECULAR PSYCHIATRY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; RECEPTOR GENE OXTR; LIKELIHOOD ESTIMATION METAANALYSIS; SPECTRUM DISORDERS; INTRANASAL OXYTOCIN; SOCIAL-BEHAVIOR; N-ACETYLASPARTATE; HUMANS; ADULTS; POLYMORPHISM	The neuropeptide oxytocin may be an effective therapeutic strategy for the currently untreatable social and communication deficits associated with autism. Our recent paper reported that oxytocin mitigated autistic behavioral deficits through the restoration of activity in the ventromedial prefrontal cortex (vmPFC), as demonstrated with functional magnetic resonance imaging (fMRI) during a socio-communication task. However, it is unknown whether oxytocin exhibited effects at the neuronal level, which was outside of the specific task examined. In the same randomized, double-blind, placebo-controlled, within-subject cross-over clinical trial in which a single dose of intranasal oxytocin (24 IU) was administered to 40 men with high-functioning autism spectrum disorder (UMIN000002241/000004393), we measured N-acetylaspartate (NAA) levels, a marker for neuronal energy demand, in the vmPFC using H-1-magnetic resonance spectroscopy (H-1-MRS). The differences in the NAA levels between the oxytocin and placebo sessions were associated with oxytocin-induced fMRI signal changes in the vmPFC. The oxytocin-induced increases in the fMRI signal could be predicted by the NAA differences between the oxytocin and placebo sessions (P = 0.002), an effect that remained after controlling for variability in the time between the fMRI and H-1-MRS scans (P = 0.006) and the order of administration of oxytocin and placebo (P = 0.001). Furthermore, path analysis showed that the NAA differences in the vmPFC triggered increases in the task-dependent fMRI signals in the vmPFC, which consequently led to improvements in the socio-communication difficulties associated with autism. The present study suggests that the beneficial effects of oxytocin are not limited to the autistic behavior elicited by our psychological task, but may generalize to other autistic behavioral problems associated with the vmPFC.	[Aoki, Y.; Watanabe, T.; Yahata, N.; Takano, Y.; Iwashiro, N.; Natsubori, T.; Kasai, K.; Yamasue, H.] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1138655, Japan; [Watanabe, T.] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1138655, Japan; [Abe, O.; Takao, H.] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo 1138655, Japan; [Abe, O.] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Kuwabara, H.; Kawakubo, Y.] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Tokyo 1138655, Japan; [Yamasue, H.] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Yamasue, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1138655, Japan.	yamasue-tky@umin.ac.jp		Watanabe, Takamitsu/0000-0002-8104-6873	KAKENHI [22689034]; Japan Society for the Promotion of Science Research Foundation [222882]	HY had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of data analysis. We thank Drs Hideyuki Inoue, Yasumasa Nippashi, Motomu Suga, Yoshitsugu Yanagihara and Miho Kuroda for their support of this study. A part of this study is a result of the 'Development of biomarker candidates for social behavior' project under the Strategic Research Program for Brain Sciences by the MEXT. We acknowledge the support provided by KAKENHI (22689034 to HY) and a grant from the Japan Society for the Promotion of Science Research Foundation for Young Scientists (222882 to TW).	Anagnostou E, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-16; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Watanabe T, 2014, JAMA PSYCHIAT, V71, P166, DOI 10.1001/jamapsychiatry.2013.3181; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Baslow MH, 2007, J MOL NEUROSCI, V32, P235, DOI 10.1007/s12031-007-0049-9; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Gomez R, 2012, BIOL PSYCHIAT, V71, P239, DOI 10.1016/j.biopsych.2011.06.026; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Yamasue H, 2011, BIOL PSYCHIAT, V70, pE41, DOI 10.1016/j.biopsych.2011.06.034; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Cauda F, 2011, J NEUROL NEUROSUR PS, V82, P1304, DOI 10.1136/jnnp.2010.239111; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; Watanabe T, 2014, SOC COGN AFFECT NEUR, V9, P767, DOI 10.1093/scan/nst046; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Hutcheson NL, 2012, SCHIZOPHR RES, V140, P136, DOI 10.1016/j.schres.2012.06.039; Kleinhans NM, 2007, BRAIN RES, V1162, P85, DOI 10.1016/j.brainres.2007.04.081; Striepens N, 2012, P NATL ACAD SCI USA, V109, P18144, DOI 10.1073/pnas.1208852109; Yamasue H, 2013, BRAIN DEV-JPN, V35, P111, DOI 10.1016/j.braindev.2012.08.010; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Skuse DH, 2014, P NATL ACAD SCI USA, V111, P1987, DOI 10.1073/pnas.1302985111; Miller G, 2013, SCIENCE, V339, P267, DOI 10.1126/science.339.6117.267; Veening JG, 2013, NEUROSCI BIOBEHAV R, V37, P1445, DOI 10.1016/j.neubiorev.2013.04.012; Sauer C, 2012, NEUROPSYCHOPHARMACOL, V37, P1474, DOI 10.1038/npp.2011.333; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Tachibana M, 2013, J CHILD ADOL PSYCHOP, V23, P123, DOI 10.1089/cap.2012.0048; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Domes G, 2013, BIOL PSYCHIAT, V74, P164, DOI 10.1016/j.biopsych.2013.02.007; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.65; Bethlehem RAI, 2013, PSYCHONEUROENDOCRINO, V38, P962, DOI 10.1016/j.psyneuen.2012.10.011; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.108; Bakermans-Kranenburg MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.34; Baslow MH, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00005; Chen FS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00200; Guastella Adam J, 2012, Horm Behav, V61, P410, DOI 10.1016/j.yhbeh.2012.01.002; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; Natsubori T, 2013, SCHIZOPHR B; Perlman SB, 2011, SOC NEUROSCI-UK, V6, P22, DOI 10.1080/17470911003683185; Sager TN, 2000, J CEREBR BLOOD F MET, V20, P780; Van IMH, 2012, PSYCHONEUROENDOCRINO, V37, P438, DOI DOI 10.1016/J.PSYNEUEN.2011.07.008; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561	54	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	APR	2015	20	4					447	453		10.1038/mp.2014.74		7	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CE4DK	WOS:000351780800005		
J	Ito, H; Shiwaku, H; Yoshida, C; Homma, H; Luo, H; Chen, X; Fujita, K; Musante, L; Fischer, U; Frints, SGM; Romano, C; Ikeuchi, Y; Shimamura, T; Imoto, S; Miyano, S; Muramatsu, S; Kawauchi, T; Hoshino, M; Sudol, M; Arumughan, A; Wanker, EE; Rich, T; Schwartz, C; Matsuzaki, F; Bonni, A; Kalscheuer, VM; Okazawa, H				Ito, H.; Shiwaku, H.; Yoshida, C.; Homma, H.; Luo, H.; Chen, X.; Fujita, K.; Musante, L.; Fischer, U.; Frints, S. G. M.; Romano, C.; Ikeuchi, Y.; Shimamura, T.; Imoto, S.; Miyano, S.; Muramatsu, S-i; Kawauchi, T.; Hoshino, M.; Sudol, M.; Arumughan, A.; Wanker, E. E.; Rich, T.; Schwartz, C.; Matsuzaki, F.; Bonni, A.; Kalscheuer, V. M.; Okazawa, H.			In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells	MOLECULAR PSYCHIATRY			English	Article							OUTER SUBVENTRICULAR ZONE; MAMMALIAN CEREBRAL-CORTEX; LINKED MENTAL-RETARDATION; RADIAL GLIAL-CELLS; WW DOMAIN; CENTROSOMAL PROTEIN; POLYGLUTAMINE TRACT; RENPENNING SYNDROME; MISSENSE MUTATION; BASAL PROGENITORS	Human mutations in PQBP1, a molecule involved in transcription and splicing, result in a reduced but architecturally normal brain. Examination of a conditional Pqbp1-knockout (cKO) mouse with microcephaly failed to reveal either abnormal centrosomes or mitotic spindles, increased neurogenesis from the neural stem progenitor cell (NSPC) pool or increased cell death in vivo. Instead, we observed an increase in the length of the cell cycle, particularly for the M phase in NSPCs. Corresponding to the developmental expression of Pqbp1, the stem cell pool in vivo was decreased at E10 and remained at a low level during neurogenesis (E15) in Pqbp1-cKO mice. The expression profiles of NSPCs derived from the cKO mouse revealed significant changes in gene groups that control the M phase, including anaphase-promoting complex genes, via aberrant transcription and RNA splicing. Exogenous Apc4, a hub protein in the network of affected genes, recovered the cell cycle, proliferation, and cell phenotypes of NSPCs caused by Pqbp1-cKO. These data reveal a mechanism of brain size control based on the simple reduction of the NSPC pool by cell cycle time elongation. Finally, we demonstrated that in utero gene therapy for Pqbp1-cKO mice by intraperitoneal injection of the PQBP1-AAV vector at E10 successfully rescued microcephaly with preserved cortical structures and improved behavioral abnormalities in Pqbp1-cKO mice, opening a new strategy for treating this intractable developmental disorder.	[Ito, H.; Shiwaku, H.; Yoshida, C.; Homma, H.; Luo, H.; Chen, X.; Fujita, K.; Okazawa, H.] Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Tokyo 1138510, Japan; [Ito, H.; Shiwaku, H.; Yoshida, C.; Homma, H.; Luo, H.; Chen, X.; Fujita, K.; Okazawa, H.] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138510, Japan; [Musante, L.; Fischer, U.; Kalscheuer, V. M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Frints, S. G. M.] Univ Hosp azM Maastricht, Dept Clin Genet, Maastricht, Netherlands; [Frints, S. G. M.] Maastricht Univ, GROW, Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Romano, C.] IRCCS Assoc Oasi Maria Santissima, Unita Operat Complessa Pediat & Genet Med, Troina, Enna, Italy; [Ikeuchi, Y.; Bonni, A.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Ikeuchi, Y.; Bonni, A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Shimamura, T.; Imoto, S.; Miyano, S.] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan; [Muramatsu, S-i] Jichi Med Univ, Dept Neurol, Shimotsuke, Tochigi, Japan; [Kawauchi, T.] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan; [Hoshino, M.] Natl Ctr Neurol & Psychiat, Dept Biochem & Cellular Biol, Tokyo, Japan; [Sudol, M.] Weis Ctr Res, Geisinger Clin, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Arumughan, A.; Wanker, E. E.] Max Delbruck Ctr Mol Med, Dept Neurogenet, Berlin, Germany; [Rich, T.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Schwartz, C.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Matsuzaki, F.] RIKEN, Ctr Dev Biol, Lab Cell Asymmetry, Chuo Ku, Kobe, Hyogo, Japan	Okazawa, H (reprint author), Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	okazawa-tky@umin.ac.jp		Kalscheuer, Vera/0000-0001-6898-3259	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22110001, 22110002]; Japan Society for the Promotion of Science (JSPS) [18390254]; Japan Science and Technology Agency (JST); Deutsche Forschungsgemeinschaft [SFB577]; Department of Health, Pennsylvania, USA [RFA60707, RFA09200903]; NIH grant [NS084393]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Foundation of Synapse and Neurocircuit Pathology' (22110001, 22110002), Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (18390254), CREST from Japan Science and Technology Agency (JST) to HO, the Deutsche Forschungsgemeinschaft, SFB577 to VMK and HHR, research grants from the Department of Health, Pennsylvania, USA, RFA60707 and RFA09200903 to MS and NIH grant NS084393 to AB. We thank Drs Kazuhiko Tagawa, Takuya Tamura, Masaki Sone, Naoyuki Kataoka, Miho Soma, Koichi Tanaka, and Ms Tayoko Tajima (TMDU) for technical assistance and critical discussion. We appreciate the technical support of Drs Yoshiaki V Nishimura, Daijiro Konno, Shigeaki Kanatani and Kazunori Nakajima (Keio University), Mss Mami Terao and Mimi Adachi (Kyoto University), and critical advice from Dr Shigetaka Kitajima (TMDU) and continuous encouragement from Professor Ichiro Kanazawa (National Center for Neurology and Psychiatry).	Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Tapia VE, 2010, J BIOL CHEM, V285, P19391, DOI 10.1074/jbc.M109.084525; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Wang QQ, 2013, GENE DEV, V27, P615, DOI 10.1101/gad.212308.112; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Berry LD, 1999, MOL CELL BIOL, V19, P2535; Berry LD, 1997, J CELL BIOL, V137, P1337, DOI 10.1083/jcb.137.6.1337; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Driskell RA, 2003, ANNU REV PHYSIOL, V65, P585, DOI 10.1146/annurev.physiol.65.092101.142426; Fichera M, 2005, CLIN GENET, V67, P446, DOI 10.1111/j.1399-0004.2005.00436.x; Germanaud D, 2011, CLIN GENET, V79, P225, DOI 10.1111/j.1399-0004.2010.01551.x; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Ikeuchi Y, 2013, CELL REP, V4, P879, DOI 10.1016/j.celrep.2013.07.042; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068627; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Lubs H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037556; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Sheen VL, 2010, AM J MED GENET A, V152A, P2888, DOI 10.1002/ajmg.a.33507; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Tamura T, 2010, J NEUROSCI, V30, P14091, DOI 10.1523/JNEUROSCI.1319-10.2010; Wagner AM, 2009, ADV DRUG DELIVER REV, V61, P813, DOI 10.1016/j.addr.2009.04.011; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	70	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	APR	2015	20	4					459	471		10.1038/mp.2014.69		13	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CE4DK	WOS:000351780800007		
J	Sawada, K; Kobayashi, M; Satoh, K				Sawada, Kiyoshi; Kobayashi, Midori; Satoh, Keiichi			Complex formation of phthalocyanine derivatives substituted by polyethylene oxide with alkali metal ions in methanol	MONATSHEFTE FUR CHEMIE			English	Article						Crown compounds; Complex formation; Coordination chemistry; Polyether compounds; Fluorescence spectroscopy; Phthalocyanines	CROWN-ETHER; OCTASUBSTITUTED PHTHALOCYANINE; POLY(OXYETHYLENE) DERIVATIVES; PHOTODYNAMIC THERAPY; PICRATE ION; AGGREGATION; WATER; CHROMATOGRAPHY; SURFACTANTS; ELECTRODES	Amphiphilic bifunctional phthalocyanine (Pc) derivatives (protonated compound: EO-H2Pc and copper(II) complex: EO-CuPc) having methylhexaethylene oxide (EO: -O(CH2CH2O)(6)-CH3) have been synthesized. Dimerization equilibria of EO-H2Pc in alcohols and complex formation with alkali metal ion (Li+, Na+, and K+) in methanol have been studied by means of absorption and fluorescence spectrophotometry. EO-H2Pc in methanol exists predominantly as a dimer, (EO-H2Pc)(2). By the reaction with alkali metal hydroxide, the dimer dissociates to monomer and forms complexes at the Pc moiety and/or EO moiety. Lithium ion is captured inside the cavity of the Pc ring and forms a stable complex, EO-LiPc-. Sodium ion and potassium ion, the ion sizes of which are larger than the cavity size of Pc, form "sitting a top" (SAT) complex, that is, the metal ion in the complex with Pc moiety is located on the outside of the Pc ring. By the reaction with NaOH, sodium ion is inserted between the dimeric Pc ring, (EO-Na1/2Pc)(2) at the first step, then forms a monomeric 1:1 complex, EO-NaPc-. In the case of reaction with KOH, the monomeric complex, in which potassium ion is coordinated at the EO moiety, (KEO)+H2Pc, is formed as the first step. Then, the Pc moiety coordinates to the potassium ion, (KEO)(+)-KPc-. The structures of complexes were confirmed by the reaction of EO-CuPc. The order of stability of alkali metal ion complex is obtained as Li+ > > Na+ > K+ for Pc moiety and Li+ < Na+ < < K+ for EO moiety.	[Sawada, Kiyoshi; Kobayashi, Midori; Satoh, Keiichi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan	Sawada, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	sawada@sc.niigata-u.ac.jp					Ahsen V, 1988, J CHEM SOC DA, V1988, P401; VACUS J, 1992, J MATER CHEM, V2, P1065, DOI 10.1039/jm9920201065; Kobayashi M, 2012, J PORPHYR PHTHALOCYA, V16, P183, DOI 10.1142/S1088424612004513; KOBAYASHI N, 1987, J AM CHEM SOC, V109, P7433, DOI 10.1021/ja00258a030; Hayashi H, 2011, J AM CHEM SOC, V133, P10736, DOI 10.1021/ja203822q; O'Flaherty SM, 2003, ADV MATER, V15, P19, DOI 10.1002/adma.200390002; Hofman JW, 2007, J MED CHEM, V50, P1485, DOI 10.1021/jm061136w; George RD, 1998, J PORPHYR PHTHALOCYA, V2, P1, DOI 10.1002/(SICI)1099-1409(199801/02)2:1<1::AID-JPP43>3.0.CO;2-L; Pietrangeli D, 2011, INORG CHEM, V50, P4680, DOI 10.1021/ic200458k; Dumoulin F, 2010, COORDIN CHEM REV, V254, P2792, DOI 10.1016/j.ccr.2010.05.002; OKADA T, 1991, J CHROMATOGR, V586, P277, DOI 10.1016/0021-9673(91)85133-Z; Martinez-Diaz MV, 2010, CHEM COMMUN, V46, P7090, DOI 10.1039/c0cc02213f; Dhami S, 1996, J PHOTOCH PHOTOBIO A, V100, P77, DOI 10.1016/S1010-6030(96)04438-3; ARNOLD J, 1993, J AM CHEM SOC, V115, P2707, DOI 10.1021/ja00060a020; Charlot G, 1969, CHEM REACTIONS SOLVE; Cissell JA, 2007, INORG CHEM, V46, P4360, DOI 10.1021/ic070254m; Cook MJ, 2000, CHEM COMMUN, P969, DOI 10.1039/b001783n; Cook MJ, 2011, J PORPHYR PHTHALOCYA, V15, P149, DOI 10.1142/S1088424611003100; FAVRETTO L, 1976, ANALYST, V101, P198, DOI 10.1039/an9760100198; FUJITA H, 1980, ANAL CHEM, V52, P869, DOI 10.1021/ac50056a023; Garcia-Frutos EM, 2003, J MATER CHEM, V13, P749, DOI 10.1039/b210707d; Giovanna DL, 2009, INORG CHEM, V48, P8493; Gurol I, 2000, J PORPHYR PHTHALOCYA, V4, P620; Hirohashi R, 2004, PHTHALOCYANINES FUNC; Horn D, 1974, 12 FAT K, P181; Kadish K., 2003, PORPHYRIN HDB, V17; KIMURA K, 1984, ANAL CHEM, V56, P2369, DOI 10.1021/ac00277a025; Kobayashi M, 2012, J PORPHYR PHTHALOCYA, V18, P359; Leznoff C.C., 1996, PHTHALOCYANINES PROP, V1-4; Mitzel F, 2003, CHEM-EUR J, V9, P1233, DOI 10.1002/chem.200390140; MOHITE BS, 1987, ANAL CHEM, V59, P1200, DOI 10.1021/ac00135a027; NAKAGAWA T, 1985, J CHROMATOGR, V330, P43, DOI 10.1016/S0021-9673(01)81960-9; NAKAMURA T, 1992, B CHEM SOC JPN, V65, P19, DOI 10.1246/bcsj.65.19; Oeztuerk ZZ, 2009, J PORPHYR PHTHALOCYA, V13, P1179; PIECHOCKI C, 1985, NOUV J CHIM, V9, P159; Richards RA, 1996, INORG CHEM, V35, P1940, DOI 10.1021/ic941434w; SAMEC Z, 1990, ANAL CHEM, V62, P1010, DOI 10.1021/ac00209a009; Sawada K, 2007, J PHYS CHEM B, V111, P4361, DOI 10.1021/jp0688411; Sawada K, 1999, PHYS CHEM CHEM PHYS, V1, P2737, DOI 10.1039/a901431d; Sawada K, 1997, J CHEM SOC FARADAY T, V93, P1903, DOI 10.1039/a700056a; Sawada K, 2005, J MOL LIQ, V119, P171, DOI 10.1016/j.molliq.2004.10.029; SCHUTTE WJ, 1993, J PHYS CHEM-US, V97, P6069, DOI 10.1021/j100124a047; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shirai H, 1997, PHTHALOCYANINES CHEM; TOEI K, 1982, TALANTA, V29, P103, DOI 10.1016/0039-9140(82)80028-3	45	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-9247	1434-4475		MONATSH CHEM	Mon. Chem.	APR	2015	146	4					547	558		10.1007/s00706-014-1398-z		12	Chemistry, Multidisciplinary	Chemistry	CD7OJ	WOS:000351279800004		
J	Hiruma, J; Kano, R; Harada, K; Monod, M; Hiruma, M; Hasegawa, A; Tsuboi, R				Hiruma, Junichiro; Kano, Rui; Harada, Kazutoshi; Monod, Michel; Hiruma, Masataro; Hasegawa, Atsuhiko; Tsuboi, Ryoji			Occurrence of Arthroderma benhamiae Genotype in Japan	MYCOPATHOLOGIA			English	Article						Arthroderma benhamiae; Genotype; White type; Yellow type; Zoophilic	TRICHOPHYTON-MENTAGROPHYTES; MATING-BEHAVIOR; EPIDEMIOLOGY; INFECTION	In this study, we epidemiologically investigated on clinical isolates of Arthroderma benhamiae from humans and animals in Japan by internal transcribed spacer (ITS) region sequence analysis and mating type (MAT)-specific PCR. Seven of 8 A. benhamiae isolates from a human, rabbits and guinea pigs were identified as group I (white phenotype) by morphological characters and ITS region sequence analysis. One strain isolated from a degus (Octodon degus) produced colonies with few irregular folds and yellow velvety mycelium without macro- and microconidia. This strain resembled to group II (yellow phenotype) strain. ITS sequence analysis was also 100 % identical to that of group II. MAT-specific PCR indicated that 6 of these 7 isolates of group I contained an alpha-box gene and that one strain contained high-mobility-group (HMG) gene. One strain of group II was revealed to have an alpha-box gene and no HMG gene. To our knowledge, it is the first A. benhamiae isolate of group II found in Japan. The A. benhamiae may be more widespread in worldwide than our surpassing what is common or usual or expected.	[Hiruma, Junichiro; Harada, Kazutoshi; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan; [Monod, Michel] CHU Vaudois, Dept Dermatol, CH-1011 Lausanne, Switzerland; [Hiruma, Masataro] Ochanomizu Inst Med Mycol & Allergol, Bunkyo Ku, Tokyo 1130033, Japan; [Hasegawa, Atsuhiko] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo 1920395, Japan	Kano, R (reprint author), Nihon Univ, Dept Pathobiol, Sch Vet Med, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	kanou.rui@nihon-u.ac.jp			Health, Labor and Welfare Sciences Research Grants for Research on Measures for Intractable Diseases from the Japanese Government [H25 shinko-ippan 006]	This study was partly funded by Health, Labor and Welfare Sciences Research Grants for Research on Measures for Intractable Diseases (H25 shinko-ippan 006) from the Japanese Government.	AJELLO L., 1967, SABOURAUDIA J INT SOC HUM ANIM MYCOL, V5, P230; Symoens F, 2013, J MED MICROBIOL, V62, P377, DOI [10.1099/jmm.0.053223-0, 10.1099/mm.0.053223-0]; Nenoff P, 2014, J DTSCH DERMATOL GES, V12, P571, DOI 10.1111/ddg.12390; Nenoff P, 2014, J DTSCH DERMATOL GES, V12, P188, DOI [10.1111/ddg.12245, 10.1111/ddg.12245_suppl]; Kano R, 1998, MICROBIOL IMMUNOL, V42, P575; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Kano R, 2012, MYCOPATHOLOGIA, V173, P103, DOI 10.1007/s11046-011-9487-6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hata Y, 2000, Nihon Ishinkin Gakkai Zasshi, V41, P269; HIRONAGA M, 1980, MYCOLOGIA, V72, P1159, DOI 10.2307/3759570; Hiruma J, 2014, J DERMATOL, V41, P743, DOI 10.1111/1346-8138.12575; Kano R, 2008, MED MYCOL, V46, P739, DOI 10.1080/13693780801975584; Kawasaki Masako, 2002, Nihon Ishinkin Gakkai Zasshi, V43, P103; Kwon-Chung KJ, 1992, DERMATOPHYTOSES MED, p[130, 816]; Mochizuki T, 2001, J DERMATOL SCI, V27, P14, DOI 10.1016/S0923-1811(01)00101-3; Saito K, 2001, J VET MED SCI, V63, P929, DOI 10.1292/jvms.63.929; Shiraki Y, 2006, J DERMATOL, V33, P504, DOI 10.1111/j.1346-8138.2006.00120.x; Stockdale MP, 1967, SABOURAUDIA, V4, P112; Takashio M., 1977, Recent advances in medical and veterinary mycology., P271; TAKASHIO M, 1974, INT J DERMATOL, V13, P94, DOI 10.1111/j.1365-4362.1974.tb01774.x	21	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-486X	1573-0832		MYCOPATHOLOGIA	Mycopathologia	APR	2015	179	3-4					219	223		10.1007/s11046-014-9839-0		5	Mycology	Mycology	CD5ZX	WOS:000351168800006		
J	Iwanaga, T; Anzawa, K; Mochizuki, T				Iwanaga, Tomoyuki; Anzawa, Kazushi; Mochizuki, Takashi			Quantification of Dermatophyte Viability for Evaluation of Antifungal Effect by Quantitative PCR (vol 177, pg 241, 2014)	MYCOPATHOLOGIA			English	Correction									[Iwanaga, Tomoyuki] Pola Pharma Inc, R&D Labs, Totuka Ku, Yokohama, Kanagawa 2440812, Japan; [Iwanaga, Tomoyuki; Anzawa, Kazushi; Mochizuki, Takashi] Kanazawa Med Univ, Dept Dermatol, Uchinada, Ishikawa 92002, Japan	Iwanaga, T (reprint author), Pola Pharma Inc, R&D Labs, Totuka Ku, 560 Kashio Cho, Yokohama, Kanagawa 2440812, Japan.	t-iwanaga@pola-pharma.co.jp					Iwanaga Tomoyuki, 2014, Mycopathologia, V177, P241, DOI 10.1007/s11046-014-9745-5	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-486X	1573-0832		MYCOPATHOLOGIA	Mycopathologia	APR	2015	179	3-4					335	335		10.1007/s11046-014-9846-1		1	Mycology	Mycology	CD5ZX	WOS:000351168800024		
J	Murata, H; Yamada, A; Maruyama, T; Neda, H				Murata, Hitoshi; Yamada, Akiyoshi; Maruyama, Tsuyoshi; Neda, Hitoshi			Ectomycorrhizas in vitro between Tricholoma matsutake, a basidiomycete that associates with Pinaceae, and Betula platyphylla var. japonica, an early-successional birch species, in cool-temperate forests	MYCORRHIZA			English	Article						Abies; Betulaceae; Pinus; Somatic plants; Symbiosis; Tsuga	INCOMPATIBLE INTERACTIONS; EXOGENOUS CARBOHYDRATE; MICROBIAL ECOLOGY; HOSTS INVITRO; S-ITO; SHIRO; ALLEGHANIENSIS; ULTRASTRUCTURE; GROWTH	Tricholoma matsutake is an ectomycorrhizal basidiomycete that associates with Pinaceae in the Northern Hemisphere and produces prized "matsutake" mushrooms. We questioned whether the symbiont could associate with a birch that is an early-successional species in boreal, cool-temperate, or subalpine forests. In the present study, we demonstrated that T. matsutake can form typical ectomycorrhizas with Betula platyphylla var. japonica; the associations included a Hartig net and a thin but distinct fungal sheath, as well as the rhizospheric mycelial aggregate "shiro" that is required for fruiting in nature. The in vitro shiro also emitted a characteristic aroma. This is the first report of an ectomycorrhizal formation between T. matsutake and a deciduous broad-leaved tree in the boreal or cool-temperate zones that T. matsutake naturally inhabits.	[Murata, Hitoshi; Neda, Hitoshi] Forestry & Forest Prod Res Inst, Dept Appl Microbiol & Mushroom Sci, Tsukuba, Ibaraki 3058687, Japan; [Yamada, Akiyoshi] Shinshu Univ, Fac Agr, Dept Biosci & Biotechnol, Minami Minowa, Nagano 3994598, Japan; [Maruyama, Tsuyoshi] Forestry & Forest Prod Res Inst, Dept Mol & Cell Biol, Tsukuba, Ibaraki 3058687, Japan	Murata, H (reprint author), Forestry & Forest Prod Res Inst, Dept Appl Microbiol & Mushroom Sci, Matsunosato 1, Tsukuba, Ibaraki 3058687, Japan.	murmur@ffpri.affrc.go.jp			Forestry and Forest Products Research Institute of Japan	This work was supported by grants from the Forestry and Forest Products Research Institute of Japan.	Amaranthus MP, 2000, PSWGTR178 USDA FOR S; Murata H, 2014, MYCORRHIZA, V24, P315, DOI 10.1007/s00572-013-0534-7; Murata H, 2013, MYCORRHIZA, V23, P235, DOI 10.1007/s00572-012-0466-7; Murata H, 1999, MYCOLOGIA, V91, P766, DOI 10.2307/3761530; Yamada A, 2006, MYCORRHIZA, V16, P111, DOI 10.1007/s00572-005-0021-x; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; DUDDRIDGE JA, 1986, NEW PHYTOL, V103, P465, DOI 10.1111/j.1469-8137.1986.tb02884.x; DUDDRIDGE JA, 1986, NEW PHYTOL, V103, P457, DOI 10.1111/j.1469-8137.1986.tb02883.x; Guerin-Laguette A, 2004, MYCORRHIZA, V14, P397, DOI 10.1007/s00572-004-0322-5; Guerin-Laguette A, 2005, MYCORRHIZA, V15, P301, DOI 10.1007/s00572-005-0355-4; Harley JL, 1983, MYCORRHIZAL SYMBIOSI, P1; Hashimoto Y, 1998, THESIS GIFU U; Hosford D, 1997, PNWGTR412 USDA FOR S; Kobayashi H, 2007, MUSH SCI TECH, V15, P151; MASSICOTTE HB, 1989, AM J BOT, V76, P1654, DOI 10.2307/2444403; MASSICOTTE HB, 1990, CAN J BOT, V68, P579; Masui K, 1927, MEM COLL SCI KYOTO I, V3, P151; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OGAWA M, 1977, T MYCOL SOC JPN, V18, P20; Ogawa M, 1978, BIOL MATSUTAKE; OGAWA M, 1977, T MYCOL SOC JPN, V18, P34; Ogawa M., 1975, B GOVT FOREST EXP ST, V272, P79; Sasse J, 1998, THE FORESTS OF JAPAN, P1; SMITH SE, 2008, MYC SYMB 3 ED, P1; Vaario LM, 2010, MYCORRHIZA, V20, P511, DOI 10.1007/s00572-010-0304-8; Vaario LM, 2012, MYCORRHIZA, V22, P409, DOI 10.1007/s00572-011-0416-9; Yamada Akiyoshi, 1999, Mycoscience, V40, P455, DOI 10.1007/BF02461022; Yamada Akiyoshi, 1999, Mycoscience, V40, P193, DOI 10.1007/BF02464298; Yamada A, 2014, MYCOSCIENCE, V55, P27, DOI 10.1016/j.myc.2013.05.004; Yamada A, 1998, MANUAL CONCISE DESCR; Yamada A, 2010, MYCORRHIZA, V20, P333, DOI 10.1007/s00572-009-0286-6; Yamanaka T, 2014, MYCOLOGIA, V106, P397, DOI 10.3852/13-197	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6360	1432-1890		MYCORRHIZA	Mycorrhiza	APR	2015	25	3					237	241		10.1007/s00572-014-0606-3		5	Mycology	Mycology	CD7OL	WOS:000351280000007		
J	Uratsuji, H; Nakamura, A; Yamada, Y; Hashimoto, K; Matsumoto, T; Ikeda, F; Ishii, R				Uratsuji, Hideya; Nakamura, Aki; Yamada, Yoshihito; Hashimoto, Kei; Matsumoto, Tatsumi; Ikeda, Fumiaki; Ishii, Ritsuko			Anti-inflammatory activity of lanoconazole, a topical antifungal agent	MYCOSES			English	Article						Lanoconazole; topical antifungal agent; dermatomycoses; anti-inflammatory activity; irritant dermatitis; contact dermatitis	HUMAN EPIDERMAL-KERATINOCYTES; SERTACONAZOLE NITRATE; TINEA-PEDIS; INFLAMMATION	Topical antifungal agents which have anti-inflammatory effects have the potential to provide additional clinical benefits. Therefore, an anti-inflammatory activity of lanoconazole (LCZ), a topical antifungal agent, was investigated against in vitro and in vivo models of inflammation. The release of interleukin-8 (IL-8) from human epidermal keratinocytes stimulated by the addition of 100gml(-1) -glucan of Saccharomyces cerevisiae was significantly inhibited by LCZ at the concentration of 10(-5)moll(-1). The release of interferon- and IL-2 from human peripheral blood mononuclear cells stimulated by the addition of 30 and 100gml(-1) phytohemagglutinin was significantly inhibited by LCZ at the concentrations of 10(-7) and 10(-6)moll(-1), respectively. The increase in the ear thickness induced by topical application of 0.01% 12-O-tetradecanoyl phorbol-13-acetate and 1% 2,4,6-trinitrochlorobenzene (TNCB) after sensitisation with 3% TNCB were established as the mouse models of irritant and contact dermatitis, respectively. Application of 1% and 3% LCZ showed a significant anti-inflammatory activity against both the irritant and contact dermatitis models. These findings suggest that LCZ possesses an anti-inflammatory activity, which may be partially helpful in the treatment of dermatomycoses.	[Uratsuji, Hideya; Nakamura, Aki; Yamada, Yoshihito; Hashimoto, Kei; Matsumoto, Tatsumi; Ikeda, Fumiaki; Ishii, Ritsuko] Maruho Co Ltd, Kyoto R&D Ctr, Res Labs, Kyoto 6008815, Japan	Uratsuji, H (reprint author), Maruho Co Ltd, Kyoto R&D Ctr, Res Labs, Shimogyo Ku, 93 Awata Cho, Kyoto 6008815, Japan.	uratsuji_cpv@mii.maruho.co.jp					Weinstein A, 2002, AM FAM PHYSICIAN, V65, P2095; Tani K, 2007, ARCH DERMATOL RES, V299, P381, DOI 10.1007/s00403-007-0780-7; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Mori T, 2008, J INVEST DERMATOL, V128, P1719, DOI 10.1038/jid.2008.5; Bell-Syer SE, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003584.17; Hau CS, 2011, J INVEST DERMATOL, V131, P2255, DOI 10.1038/jid.2011.201; Hsieh CY, 2012, J PHARMACOL EXP THER, V343, P125, DOI 10.1124/jpet.112.194100; MAIBACH HI, 1962, ARCH DERMATOL, V85, P233; Koga Tetsuya, 2009, Nihon Ishinkin Gakkai Zasshi, V50, P151; Koga T, 2001, MED MYCOL, V39, P87, DOI 10.1080/714030994; Koga Tetsuya, 1993, Journal of Dermatology (Tokyo), V20, P441; Liebel F, 2006, ARCH DERMATOL RES, V298, P191, DOI 10.1007/s00403-006-0679-8; Merlos M, 1996, INFLAMM RES, V45, P20, DOI 10.1007/BF02263500; Nakajima Hiroshi, 2005, Nihon Ishinkin Gakkai Zasshi, V46, P5; Nakamura Y, 2002, CLIN DIAGN LAB IMMUN, V9, P935, DOI 10.1128/CDLI.9.4.935-937.2002; Nishimoto Katsutaro, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P103; Niwano Yoshimi, 1995, Japanese Journal of Antibiotics, V48, P140; Niwano Yoshimi, 1995, Japanese Journal of Antibiotics, V48, P146; OHMI T, 1991, ARZNEIMITTEL-FORSCH, V41-2, P847; Patel A, 1999, Australas J Dermatol, V40, P197, DOI 10.1046/j.1440-0960.1999.00360.x; Rubin Adam I, 2002, Am J Clin Dermatol, V3, P71, DOI 10.2165/00128071-200203020-00001; Sadakane C, 1996, CLIN REPORT, V30, P2319; Sur R, 2008, J INVEST DERMATOL, V128, P336, DOI 10.1038/sj.jid.5700972; Takeuchi S, 2010, J DERMATOL SCI, V57, P44, DOI 10.1016/j.jdermsci.2009.09.008; Tanuma H, 2001, MYCOSES, V44, P181, DOI 10.1046/j.0933-7407.2001.00607.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	APR	2015	58	4					197	202		10.1111/myc.12297		6	Dermatology; Mycology	Dermatology; Mycology	CD9FS	WOS:000351404000001		
J	Kano, R; Okubo, M; Siew, HH; Kamata, H; Hasegawa, A				Kano, Rui; Okubo, Miki; Siew, Han Hock; Kamata, Hiroshi; Hasegawa, Atsuhiko			Molecular typing of Sporothrix schenckii isolates from cats in Malaysia	MYCOSES			English	Article						Feline sporotrichosis; molecular typing; mating type; MAT 1-1-1; Sporothrix schenckii	MATING TYPES; SPOROTRICHOSIS; BRASILIENSIS; GLOBOSA; COMPLEX	Epidemiological data on the aetiologic agents of feline sporotrichosis in Malaysia have not been reported, though human sporotrichosis in Malaysia is reported to be transmitted primarily via cat scratch. To the best of our knowledge, the present report is the first study of the molecular epidemiology of Sporothrix schenckii isolates from cats with sporotrichosis in Malaysia. In the present work, we characterised 18 clinical isolates from cats in Malaysia based on molecular properties, including sequence analyses of the calmodulin gene and the rDNA ITS region and selective PCR of mating type (MAT) loci. In this study, isolates from feline sporotrichosis were identified as a S. schenckii sensu stricto by sequence analyses of the calmodulin gene and the internal transcribed spacer (ITS) region. Notably, phylogenetic analysis of the ITS confirmed assignment to clinical clade D (and not C) of S. schenckii sensu stricto. Therefore, clinical clade D of S. schenckii sensu stricto appeared to be the prevailing source of feline sporotrichosis in Malaysia. The ratio of MAT1-1-1:MAT1-2-1 in these Malaysian isolates was found to be 1:0. This result suggested that a clonal strain of S. schenckii is the prevailing causative agent of feline sporotrichosis in Malaysia.	[Kano, Rui; Okubo, Miki; Kamata, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Pathobiol, Fujisawa, Kanagawa 2520880, Japan; [Siew, Han Hock] Han Vet Surg, Johor Baharu, Johor, Malaysia; [Hasegawa, Atsuhiko] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo, Japan	Kano, R (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Vet Pathobiol, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	kanou.rui@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; Nihon University	This study was supported by a grant ('International joint research and training of young researchers for zoonosis control in the globalized world') from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan, and by a Nihon University Multidisciplinary Research Grant (2013-2014).	Schubach A, 2005, EMERG INFECT DIS, V11, P1952; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Rodrigues AM, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.33; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337; Zhou X, 2014, FUNGAL DIVERS, V66, P153, DOI 10.1007/s13225-013-0220-2; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Kano R, 2012, MYCOPATHOLOGIA, V173, P103, DOI 10.1007/s11046-011-9487-6; Kano R, 2014, MYCOPATHOLO IN PRESS; Kano R, 2013, J DERMATOL, V40, P726, DOI 10.1111/1346-8138.12226; Kwon-Chung K, 1992, MED MYCOL, P707; KWONCHUNG KJ, 1984, SABOURAUDIA, V22, P155; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Romeo O, 2011, MYCOPATHOLOGIA, V172, P179, DOI 10.1007/s11046-011-9420-z; Tang MM, 2012, INT J DERMATOL, V51, P702, DOI 10.1111/j.1365-4632.2011.05229.x; Teixeira MD, 2014, EUKARYOT CELL, V14, P158	19	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	APR	2015	58	4					220	224		10.1111/myc.12302		5	Dermatology; Mycology	Dermatology; Mycology	CD9FS	WOS:000351404000005		
J	Rantakari, P; Auvinen, K; Jappinen, N; Kapraali, M; Valtonen, J; Karikoski, M; Gerke, H; Iftakhar-E-Khuda, I; Keuschnigg, J; Umemoto, E; Tohya, K; Miyasaka, M; Elima, K; Jalkanen, S; Salmi, M				Rantakari, Pia; Auvinen, Kaisa; Jappinen, Norma; Kapraali, Maria; Valtonen, Joona; Karikoski, Marika; Gerke, Heidi; Iftakhar-E-Khuda, Imtiaz; Keuschnigg, Johannes; Umemoto, Eiji; Tohya, Kazuo; Miyasaka, Masayuki; Elima, Kati; Jalkanen, Sirpa; Salmi, Marko			The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes	NATURE IMMUNOLOGY			English	Article							FENESTRAL DIAPHRAGMS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; AFFERENT LYMPH; T-CELLS; B-CELLS; MIGRATION; BLOOD; DIFFERENTIATION; DIAPEDESIS	In the lymphatic sinuses of draining lymph nodes, soluble lymph-borne antigens enter the reticular conduits in a size-selective manner and lymphocytes transmigrate to the parenchyma. The molecular mechanisms that control these processes are unknown. Here we unexpectedly found that PLVAP, a prototypic endothelial protein of blood vessels, was synthesized in the sinus-lining lymphatic endothelial cells covering the distal conduits. In PLVAP-deficient mice, both small antigens and large antigens entered the conduit system, and the transmigration of lymphocytes through the sinus floor was augmented. Mechanistically, the filtering function of the lymphatic sinus endothelium was dependent on diaphragms formed by PLVAP fibrils in transendothelial channels. Thus, in the lymphatic sinus, PLVAP forms a physical sieve that regulates the parenchymal entry of lymphocytes and soluble antigens.	[Rantakari, Pia; Auvinen, Kaisa; Jappinen, Norma; Kapraali, Maria; Valtonen, Joona; Karikoski, Marika; Iftakhar-E-Khuda, Imtiaz; Keuschnigg, Johannes; Miyasaka, Masayuki; Elima, Kati; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland; [Umemoto, Eiji; Miyasaka, Masayuki] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Tohya, Kazuo] Kansai Univ Hlth Sci, Dept Anat, Osaka, Japan; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Jalkanen, Sirpa; Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	Salmi, M (reprint author), Univ Turku, MediCity Res Lab, Turku, Finland.	marko.salmi@utu.fi		Rantakari, Pia/0000-0003-1638-5075	Finnish Academy and Sigrid Juselius Foundation	We thank E. Butcher (Stanford University) for antibody MECA-367; The Cell Imaging Core at the Centre of Biotechnology and Laboratory of Electron Microscopy in University of Turku for help in imaging; E.-L. Vaananen, R. Sjoroos, S. Maki and M. Pohjansalo for technical assistance; and A. Sovikoski-Georgieva for secretarial assistance. This work benefitted from data assembled by the Immunological Genome Project consortium. Supported by the Finnish Academy and Sigrid Juselius Foundation.	Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinelli R, 2014, J CELL SCI, V127, P3720, DOI 10.1242/jcs.148619; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; HALLMANN R, 1995, DEV DYNAM, V202, P325; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Razani B, 2001, J BIOL CHEM, V276, P38121; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Stan RV, 2012, DEV CELL, V23, P1203, DOI [10.1016/j.devcel.2012.11.003, 10.1016/j.deycel.2012.11.003]; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Baluk R, 2008, ANN NY ACAD SCI, V1131, P1; BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Noannidou S., 2006, P NATL ACAD SCI USA, V103, P16770; Nourshargh S., 2011, NAT REV MOL CELL BIO, V11, P366; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; SAINTEMARIE G, 1982, AM J ANAT, V164, P275, DOI 10.1002/aja.1001640402; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; SCHNITZER JE, 1990, EUR J CELL BIOL, V52, P241; Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593; Tkachenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032655	43	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					386	396		10.1038/ni.3101		11	Immunology	Immunology	CD8GR	WOS:000351333700011		
J	Woessner, A; Lundeberg, MB; Gao, Y; Principi, A; Alonso-Gonzaolez, P; Carrega, M; Watanabe, K; Taniguchi, T; Vignale, G; Polini, M; Hone, J; Hillenbrand, R; Koppens, FHL				Woessner, Achim; Lundeberg, Mark B.; Gao, Yuanda; Principi, Alessandro; Alonso-Gonzaolez, Pablo; Carrega, Matteo; Watanabe, Kenji; Taniguchi, Takashi; Vignale, Giovanni; Polini, Marco; Hone, James; Hillenbrand, Rainer; Koppens, Frank H. L.			Highly confined low-loss plasmons in graphene-boron nitride heterostructures	NATURE MATERIALS			English	Article							TERAHERTZ; METAMATERIALS; SPECTROSCOPY; POLARITONS; MICROSCOPY	Graphene plasmons were predicted to possess simultaneous ultrastrong field confinement and very low damping, enabling new classes of devices for deep-subwavelength metamaterials, single-photon nonlinearities, extraordinarily strong light-matter interactions and nano-optoelectronic switches. Although all of these great prospects require low damping, thus far strong plasmon damping has been observed, with both impurity scattering and many-body effects in graphene proposed as possible explanations. With the advent of van der Waals heterostructures, new methods have been developed to integrate graphene with other atomically flat materials. In this Article we exploit near-field microscopy to image propagating plasmons in high-quality graphene encapsulated between two films of hexagonal boron nitride (h-BN). We determine the dispersion and plasmon damping in real space. We find unprecedentedly low plasmon damping combined with strong field confinement and confirm the high uniformity of this plasmonic medium. The main damping channels are attributed to intrinsic thermal phonons in the graphene and dielectric losses in the h-BN. The observation and in-depth understanding of low plasmon damping is the key to the development of graphene nanophotonic and nano-optoelectronic devices.	[Woessner, Achim; Lundeberg, Mark B.; Koppens, Frank H. L.] ICFO, Inst Ciencies Foton, Barcelona 08860, Spain; [Gao, Yuanda; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Principi, Alessandro; Vignale, Giovanni] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Alonso-Gonzaolez, Pablo; Hillenbrand, Rainer] CIC nanoGUNE, Donostia San Sebastian 20018, Spain; [Carrega, Matteo] CNR, NEST, Ist Nanosci, I-56126 Pisa, Italy; [Carrega, Matteo] Scuola Normale Superi, I-56126 Pisa, Italy; [Carrega, Matteo] CNR, SPIN, I-16146 Genoa, Italy; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Polini, Marco] Ist Italiano Tecnol, Graphene Labs, I-16163 Genoa, Italy; [Hillenbrand, Rainer] Univ Basque Country, Donostia San Sebastian 20018, Spain; [Hillenbrand, Rainer] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Koppens, FHL (reprint author), ICFO, Inst Ciencies Foton, Mediterranean Technol Pk, Barcelona 08860, Spain.	frank.koppens@icfo.eu	Polini, Marco/L-3419-2013; Hone, James/E-1879-2011; nanoGUNE, CIC/A-2623-2015; WATANABE, Kenji/H-2825-2011; Alonso-Gonzalez, Pablo/B-8101-2013; 	Hone, James/0000-0002-8084-3301; WATANABE, Kenji/0000-0003-3701-8119; Koppens, Frank/0000-0001-9764-6120	Fundacio Cellex Barcelona; ERC Career integration grant (GRANOP) [294056]; ERC starting grant [307806]; EU project GRASP [FP7-ICT-2013-613024-GRASP]; EU under Graphene Flagship [CNECT-ICT-604391]; DOE [DE-FG02-05ER46203]; Research Board Grant at the University of Missouri; Italian Ministry of Education, Universities and Research (MIUR) through the programme 'FIRB - Futuro in Ricerca', Project PLASMOGRAPH [RBFR10M5BT]; Project HybridNanoDev [RBFR1236VV]; MIUR through the programme 'Progetti Premiali' - Project ABNANOTECH; ERC starting grant (TERATOMO) [258461]; Spanish Ministry of Economy and Competitiveness [MAT2012-36580]; US Office of Naval Research [N00014-13-1-0662]	It is a great pleasure to thank J. D. Caldwell, J. Garcia de Abajo, A. Tomadin and L. Levitov for many useful discussions. This work used open source software (www.matplotlib.org,www.python.org). F.H.L.K. acknowledges support by the Fundacio Cellex Barcelona, the ERC Career integration grant 294056 (GRANOP), the ERC starting grant 307806 (CarbonLight), and support by EU project GRASP (FP7-ICT-2013-613024-GRASP). F.H.L.K., M.P. and R.H. acknowledge support by the EU under Graphene Flagship (contract no. CNECT-ICT-604391). A.P. and G.V. acknowledge DOE grant DE-FG02-05ER46203 and a Research Board Grant at the University of Missouri. M.P. and M.C. acknowledge support by the Italian Ministry of Education, Universities and Research (MIUR) through the programme 'FIRB - Futuro in Ricerca', Project PLASMOGRAPH (Grant No. RBFR10M5BT) and Project HybridNanoDev (Grant No. RBFR1236VV). M.P. also acknowledges support by the MIUR through the programme 'Progetti Premiali 2012' - Project ABNANOTECH. R.H. acknowledges support by the ERC starting grant 258461 (TERATOMO) and the Spanish Ministry of Economy and Competitiveness (National Project MAT2012-36580). Y.G. and J.H. acknowledge support from the US Office of Naval Research N00014-13-1-0662.	Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Yankowitz M, 2012, NAT PHYS, V8, P382, DOI [10.1038/nphys2272, 10.1038/NPHYS2272]; Low T, 2014, ACS NANO, V8, P1086, DOI 10.1021/nn406627u; Chen JN, 2013, NANO LETT, V13, P6210, DOI 10.1021/nl403622t; Alonso-Gonzalez P, 2014, SCIENCE, V344, P1369, DOI 10.1126/science.1253202; Fang ZY, 2014, NANO LETT, V14, P299, DOI 10.1021/nl404042h; Brar VW, 2014, NANO LETT, V14, P3876, DOI 10.1021/nl501096s; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Fei Z, 2013, NAT NANOTECHNOL, V8, P821, DOI [10.1038/nnano.2013.197, 10.1038/NNANO.2013.197]; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/nphoton.2013.243, 10.1038/NPHOTON.2013.243]; Nikitin AY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.161407; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Christensen J, 2012, ACS NANO, V6, P431, DOI 10.1021/nn2037626; Li YL, 2014, NANO LETT, V14, P1573, DOI 10.1021/nl404824w; Keilmann F, 2004, PHILOS T R SOC A, V362, P787, DOI 10.1098/rsta.2003.1347; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Principi A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075418; Huidobro PA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155438; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781; Yan HG, 2012, NAT NANOTECHNOL, V7, P330, DOI [10.1038/nnano.2012.59, 10.1038/NNANO.2012.59]; Brar VW, 2013, NANO LETT, V13, P2541, DOI 10.1021/nl400601c; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Tassin P, 2013, SCIENCE, V341, P620, DOI 10.1126/science.1242253; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI 10.1038/NPHOTON.2013.57; Nikitin AY, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081405; Gullans M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.247401; Mak KF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196405; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; de Abajo FJG, 2014, ACS PHOTONICS, V1, P135, DOI 10.1021/ph400147y; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Cai YQ, 2007, SOLID STATE COMMUN, V141, P262, DOI 10.1016/j.ssc.2006.10.040; Caldwell JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6221; Gerber JA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055502; Jang MS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165409; Principi A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.121405; Principi A., 2014, PHYS REV B, V90; Principi A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.195405; Schnell M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4499; Thongrattanasiri S., PHYS REV LETT, V108; Tomadin A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161406; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318; Zhang L, 2014, COMMUN THEOR PHYS, V61, P751	51	25	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	APR	2015	14	4					421	425		10.1038/NMAT4169		5	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CE3VN	WOS:000351757800017		
J	Isomura, T; Ogawa, Y; Kotani, K; Jimbo, Y				Isomura, Takuya; Ogawa, Yutaro; Kotani, Kiyoshi; Jimbo, Yasuhiko			Accurate Connection Strength Estimation Based on Variational Bayes for Detecting Synaptic Plasticity	NEURAL COMPUTATION			English	Article							INTEGRATE-AND-FIRE; CORTICAL-NEURONS; FUNCTIONAL CONNECTIVITY; SPIKING NEURONS; NETWORKS; MODEL; MICROCIRCUITS; DEPENDENCE; DYNAMICS	Connection strength estimation is widely used in detecting the topology of neuronal networks and assessing their synaptic plasticity. A recently proposed model-based method using the leaky integrate-and-fire model neuron estimates membrane potential from spike trains by calculating the maximum a posteriori (MAP) path. We further enhance the MAP path method using variational Bayes and dynamic causal modeling. Several simulations demonstrate that the proposed method can accurately estimate connection strengths with an error ratio of less than 20%. The results suggest that the proposed method can be an effective tool for detecting network structure and synaptic plasticity.	[Isomura, Takuya; Ogawa, Yutaro] Univ Tokyo, Dept Human & Engn Environm Studies, Grad Sch Frontier Sci, Kashiwa, Chiba 1138656, Japan; [Isomura, Takuya; Ogawa, Yutaro] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kotani, Kiyoshi; Jimbo, Yasuhiko] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1538904, Japan	Isomura, T (reprint author), Univ Tokyo, Dept Human & Engn Environm Studies, Grad Sch Frontier Sci, Kashiwa, Chiba 1138656, Japan.	isomura@neuron.t.u-tokyo.ac.jp; ogawa@neuron.t.u-tokyo.ac.jp; kotani@neuron.t.u-tokyo.ac.jp; jimbo@neuron.t.u-tokyo.ac.jp					Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Shahaf G, 2001, J NEUROSCI, V21, P8782; Song S, 2000, NAT NEUROSCI, V3, P919; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Bi GQ, 1998, J NEUROSCI, V18, P10464; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Koyama S, 2010, J COMPUT NEUROSCI, V29, P89, DOI 10.1007/s10827-009-0150-x; Eytan D, 2003, J NEUROSCI, V23, P9349; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Beal M. J., 2003, BAYESIAN STAT; Bear M. F., 2006, NEUROSCIENCE; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Field G. D., 2010, NATURE, V467, P672; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gerstner W., 2002, SPIKING NEURON MODEL; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gilson M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002584; Isomura T., 2012, IEEJ T C, V132, P1581; Sporns O., 2007, SCHOLARPEDIA, V2, P4695; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653	39	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	APR	2015	27	4					819	844		10.1162/NECO_a_00721		26	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CE1WO	WOS:000351603800002		
J	Hagino, Y; Kasai, S; Fujita, M; Setogawa, S; Yamaura, H; Yanagihara, D; Hashimoto, M; Kobayashi, K; Meltzer, HY; Ikeda, K				Hagino, Yoko; Kasai, Shinya; Fujita, Masayo; Setogawa, Susumu; Yamaura, Hiroshi; Yanagihara, Dai; Hashimoto, Makoto; Kobayashi, Kazuto; Meltzer, Herbert Y.; Ikeda, Kazutaka			Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice	NEUROPSYCHOPHARMACOLOGY			English	Article							PARKINSONS-DISEASE; PEDUNCULOPONTINE NUCLEUS; BASAL GANGLIA; SCHIZOPHRENIA; DISORDERS; AMPHETAMINE; RECEPTORS; NEURONS; REWARD; MOTOR	Dopaminergic systems have been known to be involved in the regulation of locomotor activity and development of psychosis. However, the observations that some Parkinson's disease patients can move effectively under appropriate conditions despite low dopamine levels (eg, kinesia paradoxia) and that several psychotic symptoms are typical antipsychotic resistant and atypical antipsychotic sensitive indicate that other systems beyond the dopaminergic system may also affect locomotor activity and psychosis. The present study showed that dopamine-deficient (DD) mice, which had received daily L-DOPA injections, could move effectively and even be hyperactive 72 h after the last L-DOPA injection when dopamine was almost completely depleted. Such hyperactivity was ameliorated by clozapine but not haloperidol or ziprasidone. Among multiple actions of clozapine, muscarinic acetylcholine (ACh) activation markedly reduced locomotor activity in DD mice. Furthermore, the expression of choline acetyltransferase, an ACh synthase, was reduced and extracellular ACh levels were significantly reduced in DD mice. These results suggest that the cholinergic system, in addition to the dopaminergic system, may be involved in motor control, including hyperactivity and psychosis. The present findings provide additional evidence that the cholinergic system may be targeted for the treatment of Parkinson's disease and psychosis.	[Hagino, Yoko; Kasai, Shinya; Fujita, Masayo; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 1568506, Japan; [Setogawa, Susumu; Yamaura, Hiroshi; Yanagihara, Dai] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Yanagihara, Dai] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; [Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Parkinsons Dis Project, Tokyo 1568506, Japan; [Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan; [Meltzer, Herbert Y.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Ikeda, K (reprint author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	ikeda-kz@igakuken.or.jp			BioLine Rx; Cephalon; Dainippon Sumitomo; Eli Lilly; En Vivo; Janssen; Otsuka; Pfizer; Sunovion	The authors declare no conflict of interest. Over the past 3 years, KI has received support from Eisai, Taisho Pharmaceutical, and Nobelpharma for a project unrelated to this research and speaker's fees from Shionogi, Taisho Pharmaceutical, and Japan Tobacco. Over the past 3 years, KK has received support from Novartis Pharma and Ono Pharmaceutical for a project unrelated to this research. Herbert Y Meltzer is a stockholder of ACADIA and Sure Gene. He has received grant support in the past 3 years from BioLine Rx, Cephalon, Dainippon Sumitomo, Eli Lilly, En Vivo, Janssen, Otsuka, Pfizer, and Sunovion. He is, or has been, a consultant to ACADIA, Alkemes, Astellas, Boehringer Mannheim, Bristol Myers Squibb, Cypress, Janssen, Lundbeck, Ovation, Merck, Novartis, Pfizer, Teva, and Valeant (BioVail).	Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Hornykiewicz O, 1987, Adv Neurol, V45, P19; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Giladi N, 2001, ADV NEUROL, V86, P273; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Meltzer HY, 2013, ANNU REV MED, V64, P393, DOI 10.1146/annurev-med-050911-161504; Meltzer HY, 2010, NEUROPSYCHOPHARMACOL, V35, P881, DOI 10.1038/npp.2009.176; Ninan I, 1998, EUR J PHARMACOL, V358, P111, DOI 10.1016/S0014-2999(98)00591-3; Ziauddeen H, 2010, CURR OPIN PSYCHIATR, V23, P91, DOI 10.1097/YCO.0b013e328336661b; Arnt J, 1998, NEUROPSYCHOPHARMACOL, V18, P63, DOI 10.1016/S0893-133X(97)00112-7; Salomon L, 2007, PSYCHOPHARMACOLOGY, V194, P11, DOI 10.1007/s00213-007-0810-3; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Devos D, 2010, FUND CLIN PHARMACOL, V24, P407, DOI 10.1111/j.1472-8206.2009.00798.x; Rinne JO, 2008, PARKINSONISM RELAT D, V14, P553, DOI 10.1016/j.parkreldis.2008.01.006; Au WL, 2010, EXP BRAIN RES, V202, P553, DOI 10.1007/s00221-010-2156-z; Avale ME, 2004, J NEUROSCI RES, V78, P289, DOI 10.1002/jnr.20245; Barak S, 2009, BEHAV BRAIN RES, V204, P335, DOI 10.1016/j.bbr.2009.04.006; BERENDSEN HHG, 1990, BRIT J PHARMACOL, V101, P667; BERTORELLI R, 1992, J NEUROCHEM, V59, P353, DOI 10.1111/j.1471-4159.1992.tb08911.x; Calabresi P, 2008, NEURON, V60, P4, DOI 10.1016/j.neuron.2008.09.031; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; HEAL DJ, 1987, PSYCHOPHARMACOLOGY, V92, P219; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; Huot P, 2011, J PHARMACOL EXP THER, V339, P2, DOI 10.1124/jpet.111.184093; McKinzie D. L., 2012, HDB EXP PHARM, V213, P233, DOI DOI 10.1007/978-3-642-25758-2_9; Meltzer HY, 2008, PROG BRAIN RES, V172, P177, DOI 10.1016/S0079-6123(08)00909-6; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Nishii K, 1998, J NEUROSCI RES, V54, P450, DOI 10.1002/(SICI)1097-4547(19981115)54:4<450::AID-JNR3>3.0.CO;2-B; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; YEOMANS JS, 1995, NEUROPSYCHOPHARMACOL, V12, P3, DOI 10.1016/0893-133X(94)00054-4	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	APR	2015	40	5					1141	1150		10.1038/npp.2014.295		10	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CD3ZR	WOS:000351022900010		
J	Nakano, Y; Wittsten, J				Nakano, Yushi; Wittsten, Jens			On the spectra of quenched random perturbations of partially expanding maps on the torus	NONLINEARITY			English	Article						random dynamical system; transfer operator; partially expanding map; semiclassical analysis; decay rate of correlations	CONTACT ANOSOV-FLOWS; TRANSFER OPERATORS; THERMODYNAMIC FORMALISM; STABILITY	We consider quenched random perturbations of skew products of rotations on the unit circle over uniformly expanding maps on the unit circle. It is known that if the skew product satisfies a certain condition (shown to be generic in the case of linear expanding maps), then the transfer operator of the skew product has a spectral gap. Using semiclassical analysis we show that the spectral gap is preserved under small random perturbations. This implies exponential decay of quenched random correlation functions for smooth observables at small noise levels.	[Nakano, Yushi; Wittsten, Jens] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Nakano, Y (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	nakano.yushi.88m@st.kyoto-u.ac.jp; jensw@maths.lth.se			JSPS Kakenhi, Japan Society for the Promotion of Science [11J01842, 24-02782]	We would like to express our profound gratitude to Frederic Faure, Masato Tsujii, Yoshinori Morimoto, Nils Dencker and Shigehiro Ushiki for many fruitful discussions and valuable comments. We are also deeply grateful to the anonymous referee for the many suggestions, all of which substantially improved the paper. The research of YN was supported in part by JSPS Kakenhi Grant No. 11J01842, Japan Society for the Promotion of Science. The research of JW was supported in part by JSPS Kakenhi Grant No. 24-02782, Japan Society for the Promotion of Science.	Ando H, 2002, OSAKA J MATH, V39, P123; Baladi V, 2012, COMMUN MATH PHYS, V314, P689, DOI 10.1007/s00220-012-1538-4; Blank M, 2002, NONLINEARITY, V15, P1905, DOI 10.1088/0951-7715/15/6/309; Ruzhansky M, 2010, J FOURIER ANAL APPL, V16, P943, DOI 10.1007/s00041-009-9117-6; Butterley O, 2007, J MOD DYN, V1, P301; Faure F, 2011, COMMUN MATH PHYS, V308, P325, DOI 10.1007/s00220-011-1349-z; Bogenschutz T, 2000, ERGOD THEOR DYN SYST, V20, P663, DOI 10.1017/S0143385700000353; Faure F, 2013, CR MATH, V351, P385, DOI 10.1016/j.crma.2013.04.022; Tsujii M, 2010, NONLINEARITY, V23, P1495, DOI 10.1088/0951-7715/23/7/001; Arnold L., 1998, RANDOM DYNAMICAL SYS; Arnoldi J., 2013, ARXIV13023087; Arnoldi J-F, 2012, NONLINEARITY, V25, P1671; Avila A, 2006, DISCRETE CONT DYN S, V15, P21; Baillif M, 2005, ERGOD THEOR DYN SYST, V25, P1437, DOI 10.1017/S014338570500012X; Baladi V, 2008, CONT MATH, V469; BALADI V, 1993, COMMUN MATH PHYS, V156, P355, DOI 10.1007/BF02098487; Baladi V., 1996, Random and Computational Dynamics, V4; Bonatti C., 2004, DYNAMICS UNIFORM HYP; Bowen R, 2008, LECT NOTES MATH, V470, P1, DOI 10.1007/978-3-540-77695-6; Dolgopyat D, 2002, ISRAEL J MATH, V130, P157, DOI 10.1007/BF02764076; Dyatlov S, 2013, ARXIV13064203; Eslami P, 2014, ARXIV14056981; Faure F, 2006, NONLINEARITY, V19, P1233, DOI 10.1088/0951-7715/19/6/002; Faure F, 2011, NONLINEARITY, V24, P1473, DOI 10.1088/0951-7715/24/5/005; Faure F, 2013, ARXIV12060282; Gonzalez-Tokman C, 2014, ERGOD THEOR DYN SYST, V34, P1230, DOI 10.1017/etds.2012.189; Hormander L., 1985, ANAL LINEAR PARTIAL, VIV; Hormander L., 1985, ANAL LINEAR PARTIAL; Kifer Y, 2008, STOCH DYNAM, V8, P77, DOI 10.1142/S0219493708002238; Kumano-go H., 1981, PSEUDODIFFERENTIAL O; Liverani C, 2004, ANN MATH, V159, P1275; Mane R, 1987, ERGODIC THEORY DIFFE, V8; RUELLE D, 1989, COMMUN MATH PHYS, V125, P239, DOI 10.1007/BF01217908; RUELLE D, 1990, PUBL MATH IHES, V72, P175, DOI 10.1007/BF02699133; Tsujii M, 2012, ERGOD THEOR DYN SYST, V32, P2083, DOI 10.1017/S0143385711000605; Tsujii M, 2008, ERGOD THEOR DYN SYST, V28, P291, DOI 10.1017/S0143385707000430; Tsujii M, 2014, COMMUNICATION; Yosida K., 1980, FUNCTIONAL ANAL; Zworski M, 2012, GRADUATE STUDIES MAT, V138	39	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	APR	2015	28	4					951	1002		10.1088/0951-7715/28/4/951		52	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CD2NU	WOS:000350915900005		
J	Chen, CN; Jimbo, S; Morita, Y				Chen, Chao-Nien; Jimbo, Shuichi; Morita, Yoshihisa			Spectral comparison and gradient-like property in the FitzHugh-Nagumo type equations	NONLINEARITY			English	Article						FitzHugh-Nagumo equations; spectral comparison; linearized stability; Morse index; min-max principle; Lyapunov function	REACTION-DIFFUSION SYSTEM; STABILITY	In the study of stationary problems of the FitzHugh-Nagumo activator-inhibitor system, based on a variational structure, the associated Euler-Lagrange equation is an elliptic equation with a non-local term. We are concerned with the influence of such a variational structure on the local or global dynamics of the system. With the aid of spectral comparison, it will be shown that the dimension of the unstable manifold of an equilibrium solution to the system can actually be determined by the Morse index of the corresponding critical point. Also, some estimates for the eigenvalues concerned with the linearized stability are established. Besides the local structure near the equilibrium solutions, the existence of a Lyapunov function leads to a gradient-like property in the global dynamics. The case under consideration is when, in the equation for the inhibitor, the rate of degradation is relatively higher than that of production due to the activator.	[Chen, Chao-Nien] Natl Changhua Univ Educ, Dept Math, Changhua 500, Taiwan; [Jimbo, Shuichi] Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan; [Morita, Yoshihisa] Ryukoku Univ, Dept Appl Math & Informat, Seta 5202194, Japan	Chen, CN (reprint author), Natl Changhua Univ Educ, Dept Math, Changhua 500, Taiwan.	chen@math.nthu.edu.tw; jimbo@math.sci.hokudai.ac.jp; morita@rins.ryukoku.ac.jp			Ministry of Science and Technology, Taiwan, ROC; JSPS [22540216, 22340022, 26287025, 24654044]	The first author is supported in part by the Ministry of Science and Technology, Taiwan, ROC. The second author was supported in part by the Grant-in-Aid for Scientific Research (C) No. 22540216, JSPS. The third author was partially supported by the Grant-in-Aid for Scientific Research (B) No. 22340022, 26287025 and Challenging Exploratory Research No. 24654044, JSPS.	Jimbo S, 2013, J DIFFER EQUATIONS, V255, P1657, DOI 10.1016/j.jde.2013.05.021; Fiedler B, 1996, J DIFFER EQUATIONS, V125, P239, DOI 10.1006/jdeq.1996.0031; Fiedler B, 2000, T AM MATH SOC, V352, P257, DOI 10.1090/S0002-9947-99-02209-6; BATES PW, 1990, PHYSICA D, V43, P335, DOI 10.1016/0167-2789(90)90141-B; Chen CN, 2008, COMMUN PART DIFF EQ, V33, P189, DOI 10.1080/03605300601188755; Chen CN, 2014, SIAM J MATH ANAL, V46, P657, DOI 10.1137/130907793; CONLEY C, 1986, J DIFFER EQUATIONS, V63, P389, DOI 10.1016/0022-0396(86)90062-8; Dancer EN, 2004, ANN I H POINCARE-AN, V21, P237, DOI 10.1016/j.anihpc.2003.02.001; DAVIES E. B., 1995, SPECTRAL THEORY DIFF; Freitas P, 2001, J DIFFER EQUATIONS, V169, P208, DOI 10.1006/jdeq.2000.3901; Hale J. K., 1988, MATH SURVEYS MONOGRA, V25; KLAASEN GA, 1986, SIAM J MATH ANAL, V17, P74, DOI 10.1137/0517009; Kokubu H, 1997, J DIFFER EQUATIONS, V140, P309, DOI 10.1006/jdeq.1997.3317; LAZER AC, 1982, NONLINEAR ANAL-THEOR, V6, P523, DOI 10.1016/0362-546X(82)90045-1; Morita Y, 2012, J APPL ANAL COMPUT, V2, P57; Rabinowitz P.H, 1986, CBMS REGIONAL C SERI, V65; Ren XF, 2005, J DIFFER EQUATIONS, V209, P266, DOI 10.1016/j.jde.2004.08.019; Smoller J., 1994, SHOCK WAVES REACTION; Temam R., 1988, INFINITE DIMENSIONAL; Wei JC, 2005, J DIFFER EQUATIONS, V213, P121, DOI 10.1016/j.jde.2004.09.009	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	APR	2015	28	4					1003	1016		10.1088/0951-7715/28/4/1003		14	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CD2NU	WOS:000350915900006		
J	Yamagishi, Y; Sushida, T; Hizume, A				Yamagishi, Yoshikazu; Sushida, Takamichi; Hizume, Akio			Voronoi spiral tilings	NONLINEARITY			English	Article						phyllotaxis; Voronoi tiling; spiral tiling; continued fraction; golden section	SELF-ORGANIZING PROCESS; PHYLLOTAXIS; LATTICES; MODELS	The parameter set of Voronoi spiral tilings gives a dual of van Iterson's bifurcation diagram for phyllotactic spirals. We study the Voronoi tilings for the Bernoulli spiral site sets, as the simplest spirals in the centric representation with similarity symmetry. Their parameter set is composed of a family of real algebraic curves in the complex plane, with the Farey sequence structure. This naturally extends to the parameter set for multiple tilings, i.e., the tilings of the covering spaces of the punctured plane. We show the denseness of the parameters z = re(i theta) for quadrilateral Voronoi spiral multiple tilings. The techniques of dynamical systems are applied to the group of similarity symmetry. The parastichy numbers and the distortion of the Voronoi regions depend on the rational approximations of theta/2 pi. We consider the limit set of the shapes of the quadrilateral tiles by taking the limit as r -> 1, with theta fixed. If theta/2 pi is a quadratic irrational number, then the limit set is a finite set of rectangles. In particular, if theta/2 pi is linearly equivalent to the golden section, then the limit is the square.	[Yamagishi, Yoshikazu; Sushida, Takamichi; Hizume, Akio] Ryukoku Univ, Dept Appl Math & Informat, Otsu, Shiga 5202194, Japan	Yamagishi, Y (reprint author), Ryukoku Univ, Dept Appl Math & Informat, Otsu, Shiga 5202194, Japan.	yg@rins.ryukoku.ac.jp			JSPS Kakenhi [24654029]; Ryukoku University Science and Technology Fund; Joint Research Center for Science and Technology of Ryukoku University	The authors would like to thank the referees for helpful comments and recommendations. This work is partially supported by JSPS Kakenhi Grant No 24654029, Ryukoku University Science and Technology Fund, and the Joint Research Center for Science and Technology of Ryukoku University.	van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; [Anonymous], 1991, ACM COMPUT SURV, DOI DOI 10.1145/116873.116880; Atela P, 2002, J NONLINEAR SCI, V12, P641, DOI 10.1007/s00332-002-0513-1; Atela P, 2011, MATH MODEL NAT PHENO, V6, P173, DOI 10.1051/mmnp/20116207; Baake M., 2013, MATH INVITATION, V1; Bravais L., 1837, ANN SCI NAT BOT BIOL, V7, P42; Bravais L, 1837, ANN SCI NATURELLES B, V7, P291; Bravais L, 1837, ANN SCI NAT BOT BIOL, V8, P11; Bravais L, 1837, ANN SCI NAT BOT BIOL, V7, P193; Cheng S., 2012, DELAUNAY MESH GENERA; DEMELO W, 1993, ONE DIMENSIONAL DYNA; Dixon R, 1998, SYMMETRY PLANTS SERI, V4, P313, DOI 10.1142/9789814261074_0013; Douady S, 1996, J THEOR BIOL, V178, P275, DOI 10.1006/jtbi.1996.0025; Douady S, 1996, J THEOR BIOL, V178, P295, DOI 10.1006/jtbi.1996.0026; Douady S, 1996, J THEOR BIOL, V178, P255, DOI 10.1006/jtbi.1996.0024; Grunbaum B., 1987, TILINGS PATTERNS; Hardy G.H., 2008, INTRO THEORY NUMBERS; Hizume A, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/1/015202; Hotton S., 1999, THESIS U CALIFORNIA; Jean R V, 1994, PHYLLATAXIS SYSTEMAT; Jean R V, 1998, SERIES MATH BIOL MED, V4; JEAN RV, 1988, J NUMBER THEORY, V29, P206, DOI 10.1016/0022-314X(88)90100-X; LeVeque W J, 1977, FUNDAMENTALS NUMBERN; LEVITOV LS, 1991, PHYS REV LETT, V66, P224, DOI 10.1103/PhysRevLett.66.224; LEVITOV LS, 1991, EUROPHYS LETT, V14, P533, DOI 10.1209/0295-5075/14/6/006; Reick CH, 2012, J THEOR BIOL, V313, P181, DOI 10.1016/j.jtbi.2012.08.009; Reick CH, 2002, J THEOR BIOL, V215, P263, DOI 10.1006/jtbi.2002.2527; Rothen F, 1989, J PHYS, P633; Sadoc JF, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/29/295202; Shipman PD, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031905; Shubnikov AV, 1961, SOV PHYS-CRYSTALLOGR, V5, P-76; Shubnikov AV, 1988, CRYSTAL SYMMETRIES S, P365; Sushida T, 2014, RIMS KOKYUROKU BES B, VB47, P23; Van Iterson G., 1907, MATH MIKROSKOPISCH A	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	APR	2015	28	4					1077	1102		10.1088/0951-7715/28/4/1077		26	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CD2NU	WOS:000350915900009		
J	Sumi, H				Sumi, Hiroki			Random complex dynamics and devil's coliseums	NONLINEARITY			English	Article						complex dynamical system; random complex dynamical system; random dynamical system; rational semigroup; fractal geometry	HYPERBOLIC RATIONAL SEMIGROUPS; JULIA SETS; RANDOM ITERATIONS; MAPS; CONNECTEDNESS; POLYNOMIALS	We investigate the random dynamics of polynomial maps on the Riemann sphere (C) over cap and the dynamics of semigroups of polynomial maps on (C) over cap. In particular, the dynamics of a semigroup G of polynomials whose planar postcritical set is bounded and the associated random dynamics are studied. In general, the Julia set of such aGmaybe disconnected. We showthat if G is such a semigroup, then regarding the associated random dynamics, the chaos of the averaged system disappears in the C-0 sense, and the function T-infinity of probability of tending to infinity is an element of (C) over cap is Holder continuous on (C) over cap and varies only on the Julia set of G. Moreover, the function T-infinity has a kind of monotonicity. It turns out that T infinity is a complex analogue of the devil's staircase, and we call T-infinity a 'devil's coliseum'. We investigate the details of T-infinity when G is generated by two polynomials. In this case, T-infinity varies precisely on the Julia set of G, which is a thin fractal set. Moreover, under this condition, we investigate the pointwise Holder exponents of T-infinity.	Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Sumi, H (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	sumi@math.sci.osaka-u.ac.jp			JSPS KAKENHI [24540211]	The author thanks Rich Stankewitz for valuable comments. The author also thanks the referee for checking the manuscript carefully and giving the author some valuable comments. This research was partially supported by JSPS KAKENHI 24540211.	MATSUMOTO K, 1983, J STAT PHYS, V31, P87, DOI 10.1007/BF01010923; Beardon A. F., 1991, GRADUATE TEXTS MATH, V132; Brjuno A. D., 1965, DOKL AKAD NAUK SSSR, V165, P987; Bruck R, 1999, ERGOD THEOR DYN SYST, V19, P1221, DOI 10.1017/S0143385799141658; Devaney R. L., 1989, INTRO CHAOTIC DYNAMI; Falconer K., 1997, TECHNIQUES FRACTAL G; FORNAESS JE, 1991, ERGOD THEOR DYN SYST, V11, P687; Gong Z., 1996, J FUDAN U, V35, P387; Gong ZM, 2003, ERGOD THEOR DYN SYST, V23, P1807, DOI 10.1017/S0143385703000129; Hinkkanen A, 1996, P LOND MATH SOC, V73, P358; Jonsson M, 2000, ARK MAT, V38, P281, DOI 10.1007/BF02384321; Sester O, 2001, ERGOD THEOR DYN SYST, V21, P915; Sumi H, 2011, DISCRETE CONT DYN-A, V29, P1205, DOI 10.3934/dcds.2011.29.1205; Sumi H, 2010, AM MATH SOC TRANSL, V230, P161; Sumi H, 1997, J MATH KYOTO U, V37, P717; Sumi H, 2005, KODAI MATH J, V28, P390, DOI 10.2996/kmj/1123767019; Sumi H, 2001, ERGOD THEOR DYN SYST, V21, P563; Sumi H, 2013, ADV MATH, V234, P697, DOI 10.1016/j.aim.2012.10.020; Sumi H, 2011, P LOND MATH SOC, V102, P50, DOI 10.1112/plms/pdq013; Sumi H, 2010, ERGOD THEOR DYN SYST, V30, P1869, DOI 10.1017/S0143385709000923; Sumi H, 2013, ADV MATH, V245, P137, DOI 10.1016/j.aim.2013.05.023; Sumi H, 2013, J LOND MATH SOC, V88, P294, DOI 10.1112/jlms/jdt017; Sumi H, 2012, DISCRETE CONT DYN-A, V32, P2591, DOI 10.3934/dcds.2012.32.2591; Sumi H, 2006, ERGOD THEOR DYN SYST, V26, P893, DOI 10.1017/S0143385705000532; Sumi H, 1998, KODAI MATH J, V21, P10, DOI 10.2996/kmj/1138043831; Sumi H, 2000, NONLINEARITY, V13, P995, DOI 10.1088/0951-7715/13/4/302; Sumi H, 2009, ADV MATH, V222, P729, DOI 10.1016/j.aim.2009.04.007; Yamaguti M, 1997, TRANSLATIONS MATH MO, V167; YOCCOZ JC, 1988, CR ACAD SCI I-MATH, V306, P55	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	APR	2015	28	4					1135	1161		10.1088/0951-7715/28/4/1135		27	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CD2NU	WOS:000350915900011		
J	Yuan, Y; Makita, N; Cao, DL; Mihara, K; Kadomatsu, K; Takei, Y				Yuan, Yuan; Makita, Naoki; Cao, Dongliang; Mihara, Keichiro; Kadomatsu, Kenji; Takei, Yoshifumi			Atelocollagen-Mediated Intravenous siRNA Delivery Specific to Tumor Tissues Orthotopically Xenografted in Prostates of Nude Mice and Its Anticancer Effects	NUCLEIC ACID THERAPEUTICS			English	Article							SMALL INTERFERING RNA; IN-VIVO; CANCER-THERAPY; VASCULAR-PERMEABILITY; COLLAGEN RECEPTOR; SYSTEMIC DELIVERY; GROWTH-FACTOR; CELL-DEATH; MIDKINE; THERAPEUTICS	Successful short interfering RNA (siRNA)-based therapy for cancers depends on functional siRNA delivery specific to tumors. In our previous report, we have shown systemic siRNA delivery specific to human prostate cancer cell line PC-3 subcutaneous tumors in nude mice by atelocollagen, a collagen derivative, for formulating a complex with siRNA. We used an siRNA for human Bcl-xL as a model target. In the present study, we examined the antitumor effect on PC-3 orthotopic tumors in nude mice, as these tumors resemble the human clinical situation. The systemic intravenous administration of the complex (siRNA, 50 mu g/shot) significantly reduced Bcl-xL expression and induced apoptosis in the tumors, and suppressed their growth. Liver metastasis was also inhibited in the orthotopic model. We successfully showed tumor-specific accumulation of the siRNA by Cy3-labeled siRNA and the direct quantification of the siRNA via reverse-phase high-performance liquid chromatography. The tumor-specific delivery was achieved by the enhanced permeability and retention effect, which is characteristic of macromolecular drugs. The high expression of vascular endothelial growth factor-A in the tumors provided adequate conditions to promote the permeability in the tumors, and to finally form the enhanced permeability and retention effect. In conclusion, our siRNA delivery is specific to the PC-3 orthotopic tumors in nude mice, and is practically feasible to treat tumors.	[Yuan, Yuan; Cao, Dongliang; Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Div Dis Models, Ctr Neurol Dis & Canc, Nagoya, Aichi 4668550, Japan; [Yuan, Yuan; Cao, Dongliang; Kadomatsu, Kenji; Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Makita, Naoki] Sumitomo Dainippon Pharma Co Ltd, Technol Res & Dev, Formulat Res & Dev Labs, Ibaraki, Japan; [Mihara, Keichiro] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan	Takei, Y (reprint author), Nagoya Univ, Grad Sch Med, Div Dis Models, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	takei@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		Ministry of Education, Culture, Sports, Science, and Technology of Japan [17016030]; Japan Society for the Promotion of Science [21590305, 24590348]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17016030) and from the Japan Society for the Promotion of Science (21590305 and 24590348).	Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Singh RR, 2009, CLIN CANCER RES, V15, P613, DOI 10.1158/1078-0432.CCR-08-1846; Inaba S, 2012, MOL THER, V20, P356, DOI 10.1038/mt.2011.221; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Ishimoto T, 2008, MOL THER, V16, P387, DOI 10.1038/sj.mt.6300360; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; Miele E, 2012, INT J NANOMED, V7, P3637, DOI 10.2147/IJN.S23696; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425; Takei Y, 2002, J BIOL CHEM, V277, P23800, DOI 10.1074/jbc.M112100200; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; You OH, 2013, BIOORG MED CHEM LETT, V23, P2692, DOI 10.1016/j.bmcl.2013.02.080; Takei Y, 2006, CANCER, V107, P864, DOI 10.1002/cncr.22068; SENGER DR, 1986, CANCER RES, V46, P5629; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-03-0814; Ochiya T, 1999, NAT MED, V5, P707; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Ofek P, 2010, FASEB J, V24, P3122, DOI 10.1096/fj.09-149641; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Santel A, 2006, GENE THER, V13, P1360, DOI 10.1038/sj.gt.3302778; Gjertsen BT, 1998, CANCER METAST REV, V17, P345, DOI 10.1023/A:1006170332301; Takei Y, 2005, INT J CANCER, V114, P490, DOI 10.1002/ijc.20781; Sheikh H, 2000, J CELL SCI, V113, P1021; Azuma K, 2010, BIOCHEM BIOPH RES CO, V391, P1075, DOI 10.1016/j.bbrc.2009.12.024; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Takei Y, 2001, CANCER RES, V61, P8486; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; Bilensoy E, 2010, EXPERT OPIN DRUG DEL, V7, P795, DOI 10.1517/17425247.2010.485983; Fujimoto Ichiro, 2014, Ther Deliv, V5, P369, DOI 10.4155/tde.14.8; Hadaschik BA, 2007, UROL ONCOL-SEMIN ORI, V25, P413, DOI 10.1016/j.urolonc.2007.05.010; Tuomela JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-81; Ikenaga N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040434; Karnak D, 2010, CURR DRUG TARGETS, V11, P699; Maeda Hiroshi, 2014, Ther Deliv, V5, P627, DOI 10.4155/tde.14.36; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; Takei Y, 2005, GENE THER MOL BIOL, V9, P257; Takei Y, 2008, MOL CANCER THER, V7, P211, DOI 10.1158/1535-7163.MCT-07-0319	45	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2159-3337	2159-3345		NUCLEIC ACID THER	Nucl. Acid Ther.	APR 1	2015	25	2					85	94		10.1089/nat.2014.0526		10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Research & Experimental Medicine	CE4XG	WOS:000351833000004		
J	Fujimoto, E; Sato-Mito, N; Okita, I; Uemura, S; Ishimoto, T; Sato, K				Fujimoto, Eka; Sato-Mito, Natsuko; Okita, Ikue; Uemura, Satomi; Ishimoto, Tsuyoshi; Sato, Kazuto			Daily rhythm and heat shock protein expression in obese ob/ob mice	NUTRITIONAL NEUROSCIENCE			English	Article						Drinking; HSP; Locomotor activity; Obesity; Rhythm	LEPTIN-DEFICIENT MICE; INSULIN-RESISTANCE; CIRCADIAN-CLOCK; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DIET; HEAT-SHOCK-PROTEIN-72; SLEEP; MOUSE; LIVER	Objectives: This study examined heat shock protein (HSP) 70 expression and rhythms of drinking behavior and locomotor activity in obesity, in order to clarify the involvement of HSPs in obesity-induced disturbance of circadian rhythms. Methods: C57BL/6J ob/ob mice were used as a murine model of severe obesity. Drinking behavior and locomotor activity of male C57BL/6J ( control) mice and ob/ob mice were recorded with the behavioral analyzing system. HSP70 concentration in the homogenized supernatant of each tissue, including the brain, liver, and kidney, was measured by an enzyme-linked immunosorbent assay. Results: We observed an attenuated locomotor activity rhythm in the ob/ob mice compared with the control mice at 13 weeks of age and especially at 27 weeks of age. The drinking rhythm was little affected by obesity. HSP70 protein expression was reduced in the brain and kidney of the ob/ob mice compared with the control mice. However, HSP70 expression in the liver was not altered. Discussion: This study suggests that the obesity-induced reduction of HSP70 expression in the brain and kidney can be directly or indirectly associated with disturbance of rhythms of the master clock and peripheral clocks. The study provides a link between circadian rhythm and HSP expression in obesity; the disturbance of these factors may lead to the progression of metabolic disorders.	[Fujimoto, Eka; Okita, Ikue; Uemura, Satomi; Ishimoto, Tsuyoshi; Sato, Kazuto] Japan Womens Univ, Dept Food & Nutr, Tokyo 1128681, Japan; [Sato-Mito, Natsuko] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan	Sato, K (reprint author), Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	sato-k@fc.jwu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Chan RSM, 2010, INT J ENV RES PUB HE, V7, P765, DOI 10.3390/ijerph7030765; Choi YH, 2008, BEHAV BRAIN RES, V188, P100, DOI 10.1016/j.bbr.2007.10.024; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpreju.00304.2005; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Figueiredo D, 2007, CELL TISSUE RES, V329, P91, DOI 10.1007/s00441-007-0414-6; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Kaneko K, 2009, BRAIN RES, V1263, P58, DOI 10.1016/j.brainres.2008.12.071; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Kavanagh K, 2009, CELL STRESS CHAPERON, V14, P291, DOI 10.1007/s12192-008-0084-7; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; BRAY GA, 1979, PHYSIOL REV, V59, P719; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Hooper PL, 2009, CELL STRESS CHAPERON, V14, P113, DOI 10.1007/s12192-008-0073-x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; Buraczynska M, 2009, CLIN SCI, V116, P81, DOI 10.1042/CS20070411; Fortes MB, 2009, CELL STRESS CHAPERON, V14, P273, DOI 10.1007/s12192-008-0082-9; FUKAGAWA K, 1988, INT J OBESITY, V12, P481; HO A, 1988, PHYSIOL BEHAV, V43, P651, DOI 10.1016/0031-9384(88)90221-1; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Kitanaka N, 2012, BRAIN RES, V1429, P155, DOI 10.1016/j.brainres.2011.10.037; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Ooie T, 2005, LIFE SCI, V77, P869, DOI 10.1016/j.lfs.2004.12.034; Oswal A, 2007, OBES REV, V8, P293, DOI 10.1111/j.1467-789X.2007.00378.x; Prosser RA, 2003, NEUROSCI LETT, V336, P139, DOI 10.1016/s0304-3940(02)01234-X; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Sandstrom ME, 2009, AMINO ACIDS, V37, P279, DOI 10.1007/s00726-008-0144-4; Sans-Fuentes MA, 2010, PHYSIOL BEHAV, V99, P487, DOI 10.1016/j.physbeh.2009.12.023; Wigmore SJ, 2007, INT J MOL MED, V19, P413	42	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.	APR	2015	18	3					110	117		10.1179/1476830513Y.0000000103		8	Neurosciences; Nutrition & Dietetics	Neurosciences & Neurology; Nutrition & Dietetics	CD5IU	WOS:000351122000003		
